PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Obeid, S; Welte, W; Diederichs, K; Marx, A				Obeid, Samra; Welte, Wolfram; Diederichs, Kay; Marx, Andreas			Amino Acid Templating Mechanisms in Selection of Nucleotides Opposite Abasic Sites by a Family A DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APURINIC APYRIMIDINIC SITES; DIFFERENT SEQUENCE CONTEXTS; STRUCTURAL BASIS; TRANSLESION SYNTHESIS; A-RULE; REPLICATION FIDELITY; CRYSTAL-STRUCTURES; ACTIVE-SITE; MUTATIONAL SPECIFICITY; KLENOW FRAGMENT	Cleavage of the N-glycosidic bond that connects the nucleobase to the backbone in DNA leads to abasic sites, the most frequent lesion under physiological conditions. Several DNA polymerases preferentially incorporate an A opposite this lesion, a phenomenon termed "A-rule." Accordingly, KlenTaq, the large fragment of Thermus aquaticus DNA polymerase I, incorporates a nucleotide opposite an abasic site with efficiencies of A > G > T > C. Here we provide structural insights into constraints of the active site during nucleotide selection opposite an abasic site. It appears that these confines govern the nucleotide selection mainly by interaction of the incoming nucleotide with Tyr-671. Depending on the nucleobase, the nucleotides are differently positioned opposite Tyr-671 resulting in different alignments of the functional groups that are required for bond formation. The distances between the alpha-phosphate and the 3'-primer terminus increases in the order A < G < T, which follows the order of incorporation efficiency. Additionally, a binary KlenTaq structure bound to DNA containing an abasic site indicates that binding of the nucleotide triggers a remarkable rearrangement of enzyme and DNA template. The ability to resolve the stacking arrangement might be dependent on the intrinsic properties of the respective nucleotide contributing to nucleotide selection. Furthermore, we studied the incorporation of a non-natural nucleotide opposite an abasic site. The nucleotide was often used in studying stacking effects in DNA polymerization. Here, no interaction with Tyr-761 as found for the natural nucleotides is observed, indicating a different reaction path for this non-natural nucleotide.	[Obeid, Samra; Marx, Andreas] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Welte, Wolfram; Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Obeid, Samra; Welte, Wolfram; Diederichs, Kay; Marx, Andreas] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Univ Str 10, D-78457 Constance, Germany.	andreas.marx@uni-konstanz.de			Deutsche Forschungsgemeinschaft [SPP 1170]; Zukunftskolleg, University of Konstanz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zukunftskolleg, University of Konstanz	This work was supported by the Deutsche Forschungsgemeinschaft through a grant in SPP 1170.; Supported by funding from the Zukunftskolleg, University of Konstanz.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Betz K, 2010, ANGEW CHEM INT EDIT, V49, P5181, DOI 10.1002/anie.200905724; Choi JY, 2010, J MOL BIOL, V404, P34, DOI 10.1016/j.jmb.2010.09.015; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Di Pasquale F, 2008, J AM CHEM SOC, V130, P10748, DOI 10.1021/ja8028284; Efrati E, 1997, J BIOL CHEM, V272, P2559; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiala KA, 2007, J BIOL CHEM, V282, P8188, DOI 10.1074/jbc.M610718200; Florian J, 2005, P NATL ACAD SCI USA, V102, P6819, DOI 10.1073/pnas.0408173102; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; GOODMAN MF, 1994, ANN NY ACAD SCI, V726, P132, DOI 10.1111/j.1749-6632.1994.tb52804.x; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Hwang HS, 2004, BIOCHEMISTRY-US, V43, P14612, DOI 10.1021/bi0489558; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Joyce CM, 2010, BBA-PROTEINS PROTEOM, V1804, P1032, DOI 10.1016/j.bbapap.2009.07.021; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; Li Y, 1999, P NATL ACAD SCI USA, V96, P9491, DOI 10.1073/pnas.96.17.9491; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; LOAKES D, 1994, NUCLEIC ACIDS RES, V22, P4039, DOI 10.1093/nar/22.20.4039; Loakes D, 2001, NUCLEIC ACIDS RES, V29, P2437, DOI 10.1093/nar/29.12.2437; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Motea EA, 2011, NUCLEIC ACIDS RES, V39, P1623, DOI 10.1093/nar/gkq925; Nair DT, 2011, J MOL BIOL, V406, P18, DOI 10.1016/j.jmb.2010.12.016; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; Obeid S, 2011, CHEMBIOCHEM, V12, P1574, DOI 10.1002/cbic.201000783; Obeid S, 2010, P NATL ACAD SCI USA, V107, P21327, DOI 10.1073/pnas.1013804107; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; Reineks EZ, 2004, BIOCHEMISTRY-US, V43, P393, DOI 10.1021/bi034948s; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Sheriff A, 2008, BIOCHEMISTRY-US, V47, P8527, DOI 10.1021/bi800324r; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Smith CL, 1998, NUCLEOS NUCLEOT, V17, P541, DOI 10.1080/07328319808005197; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Suzuki M, 1996, P NATL ACAD SCI USA, V93, P9670, DOI 10.1073/pnas.93.18.9670; Taylor JS, 2002, MUTAT RES-FUND MOL M, V510, P55, DOI 10.1016/S0027-5107(02)00252-X; Vineyard D, 2007, ORG BIOMOL CHEM, V5, P3623, DOI 10.1039/b712480e; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zahn KE, 2007, BIOCHEMISTRY-US, V46, P10551, DOI 10.1021/bi7008807; Zahn KE, 2011, CURR OPIN STRUC BIOL, V21, P358, DOI 10.1016/j.sbi.2011.03.008	66	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14099	14108		10.1074/jbc.M111.334904	http://dx.doi.org/10.1074/jbc.M111.334904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22318723	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000303996300063
J	Malik, P; Tabarraei, A; Kehlenbach, RH; Korfali, N; Iwasawa, R; Graham, SV; Schirmer, EC				Malik, Poonam; Tabarraei, Alijan; Kehlenbach, Ralph H.; Korfali, Nadia; Iwasawa, Ryota; Graham, Sheila V.; Schirmer, Eric C.			Herpes Simplex Virus ICP27 Protein Directly Interacts with the Nuclear Pore Complex through Nup62, Inhibiting Host Nucleocytoplasmic Transport Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; REGULATORY PROTEIN; BINDING-PROTEIN; GENE-REGULATION; CAPSID PROTEIN; HNRNP A1; ALPHA PROTEIN-ICP27; KARYOPHERIN-BETA; IMPORT RECEPTORS; ELEMENT CTE	The herpes simplex virus ICP27 protein is important for the expression and nuclear export of viral mRNAs. Although several binding sites have been mapped along the ICP27 sequence for various RNA and protein partners, including the transport receptor TAP of the host cell nuclear transport machinery, several aspects of ICP27 trafficking through the nuclear pore complex remain unclear. We investigated if ICP27 could interact directly with the nuclear pore complex itself, finding that ICP27 directly binds the core nucleoporin Nup62. This is confirmed through co-immunoprecipitation and in vitro binding assays with purified components. Mapping with ICP27 deletion and point mutants further shows that the interaction requires sequences in both the N and C termini of ICP27. Expression of wild type ICP27 protein inhibited both classical, importin alpha/beta-dependent and transportin-dependent nuclear import. In contrast, an ICP27 point mutant that does not interact with Nup62 had no such inhibitory effect. We suggest that ICP27 association with Nup62 provides additional binding sites at the nuclear pore for ICP27 shuttling, thus supporting ICP27-mediated transport. We propose that ICP27 competes with some host cell transport receptors for binding, resulting in inhibition of those host transport pathways.	[Malik, Poonam] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Malik, Poonam; Korfali, Nadia; Iwasawa, Ryota; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Malik, Poonam; Tabarraei, Alijan; Graham, Sheila V.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland; [Kehlenbach, Ralph H.] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Gottingen	Malik, P (corresponding author), Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Ctr Translat & Chem Biol, Michael Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	p.malik@ed.ac.uk; sheila.graham@gla.ac.uk	Tabarraei, Alijan/D-4954-2016; Malik, Poonam/A-1756-2008	Tabarraei, Alijan/0000-0002-8167-5469; Malik, Poonam/0000-0002-1733-722X; Kehlenbach, Ralph/0000-0003-4920-9916; Schirmer, Eric/0000-0003-2635-1338; Graham, Sheila/0000-0002-7140-8279	Royal Society UK [RG090330]; Medical Research Council [G9826324]; Wellcome Trust [076616]; Wellcome Trust Centre for Cell Biology [077707]; Royal Society [DH051766, SS072172]; Education Section of the Ministry of Health and Medical Sciences, Iran; MRC [G9826324] Funding Source: UKRI	Royal Society UK(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Centre for Cell Biology(Wellcome Trust); Royal Society(Royal Society of London); Education Section of the Ministry of Health and Medical Sciences, Iran; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Royal Society UK Research Grant RG090330 (to P. M.) and Medical Research Council Program Grant G9826324 (to J. Barklie Clements/S. V. G.). This work was also supported by the Wellcome Trust through Senior Research Fellowship 076616 (to E. C. S.) and Wellcome Trust Centre for Cell Biology core funding 077707.; Recipient of Royal Society Research Fellowship Award DH051766.; Supported by a Ph.D. studentship from the Education Section of the Ministry of Health and Medical Sciences, Iran.; Supported by Royal Society Undergraduate Summer Studentship SS072172 (to P. M.).	Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Aubert M, 2001, J VIROL, V75, P1013, DOI 10.1128/JVI.75.2.1013-1030.2001; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; CULLEN BR, 1994, INFECT AGENT DIS, V3, P68; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Ellison KS, 2000, J VIROL, V74, P7307, DOI 10.1128/JVI.74.16.7307-7319.2000; Ellison KS, 2005, J VIROL, V79, P4120, DOI 10.1128/JVI.79.7.4120-4131.2005; Escudero-Paunetto L, 2010, VIROLOGY, V401, P155, DOI 10.1016/j.virol.2010.02.023; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399; Fontaine-Rodriguez EC, 2008, J VIROL, V82, P3538, DOI 10.1128/JVI.02395-07; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1997, J CELL SCI, V110, P1325; GERACE L, 1982, J CELL BIOL, V95, P826, DOI 10.1083/jcb.95.3.826; Gruffat H, 2002, J VIROL, V76, P9635, DOI 10.1128/JVI.76.19.9635-9644.2002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Han Z, 2006, J VIROL, V80, P5251, DOI 10.1128/JVI.02570-05; HARDWICKE MA, 1994, J VIROL, V68, P4797, DOI 10.1128/JVI.68.8.4797-4810.1994; Hernandez FP, 2010, J VIROL, V84, P4124, DOI 10.1128/JVI.02319-09; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hofemeister H, 2008, J VIROL, V82, P8392, DOI 10.1128/JVI.00951-08; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Lengyel J, 2002, J VIROL, V76, P11866, DOI 10.1128/JVI.76.23.11866-11879.2002; Lengyel J, 2006, VIROLOGY, V352, P368, DOI 10.1016/j.virol.2006.04.044; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; Mears WE, 1998, VIROLOGY, V242, P128, DOI 10.1006/viro.1997.9006; MEARS WE, 1995, J VIROL, V69, P935, DOI 10.1128/JVI.69.2.935-947.1995; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; MICHAEL WM, 1995, CELL, V83, P415; Nelson LM, 2003, VIROLOGY, V306, P162, DOI 10.1016/S0042-6822(02)00025-9; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Pearson A, 2004, J VIROL, V78, P23, DOI 10.1128/JVI.78.1.23-32.2004; Pellet P. E., 2007, FIELDS VIROLOGY, P2501; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; PHELAN A, 1993, P NATL ACAD SCI USA, V90, P9056, DOI 10.1073/pnas.90.19.9056; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; RICE SA, 1988, J VIROL, V62, P3814, DOI 10.1128/JVI.62.10.3814-3823.1988; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; RICE SA, 1994, J VIROL, V68, P823, DOI 10.1128/JVI.68.2.823-833.1994; RICE SA, 1993, J VIROL, V67, P1778, DOI 10.1128/JVI.67.4.1778-1787.1993; Rojas S, 2010, J VIROL, V84, P2200, DOI 10.1128/JVI.00917-09; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Sandri-Goldin RM, 2008, FRONT BIOSCI-LANDMRK, V13, P5241, DOI 10.2741/3078; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schmitt I, 2001, J BIOL CHEM, V276, P42355, DOI 10.1074/jbc.M103916200; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Smith RWP, 2005, BIOCHEM SOC T, V33, P499, DOI 10.1042/BST0330499; Soliman TM, 2000, J VIROL, V74, P2814, DOI 10.1128/JVI.74.6.2814-2825.2000; Soliman TM, 2000, J VIROL, V74, P7600, DOI 10.1128/JVI.74.16.7600-7609.2000; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Tsuji T, 2007, J BIOL CHEM, V282, P13875, DOI 10.1074/jbc.M611629200; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Zhi Y, 1999, J VIROL, V73, P3246, DOI 10.1128/JVI.73.4.3246-3257.1999; Zhi Y, 1999, VIROLOGY, V257, P341, DOI 10.1006/viro.1999.9698	84	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12277	12292		10.1074/jbc.M111.331777	http://dx.doi.org/10.1074/jbc.M111.331777			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334672	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000302782200068
J	Bustard, DE; Menolfi, D; Jeppsson, K; Ball, LG; Dewey, SC; Shirahige, K; Sjogren, C; Branzei, D; Cobb, JA				Bustard, Denise E.; Menolfi, Demis; Jeppsson, Kristian; Ball, Lindsay G.; Dewey, Sidney Carter; Shirahige, Katsuhiko; Sjogren, Camilla; Branzei, Dana; Cobb, Jennifer A.			During Replication Stress, Non-Smc Element 5 (Nse5) Is Required for Smc5/6 Protein Complex Functionality at Stalled Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; SUMO LIGASE; SMC5-SMC6 COMPLEX; CHECKPOINT; HELICASE; MUTANTS; ROLES; CONJUGATION; COMPONENT; SUBUNIT	The Smc5/6 complex belongs to the SMC (structural maintenance of chromosomes) family, which also includes cohesin and condensin. In Saccharomyces cerevisiae, the Smc5/6 complex contains six essential non-Smcelements, Nse1-6. Very little is known about how these additional elements contribute to complex function except for Nse2/Mms21, which is an E3 small ubiquitin-like modifier (SUMO) ligase important for Smc5 sumoylation. Characterization of two temperature-sensitive mutants, nse5-ts1 and nse5-ts2, demonstrated the importance of Nse5 within the Smc5/6 complex for its stability and functionality at forks during hydroxyurea-induced replication stress. Both NSE5 alleles showed a marked reduction in Smc5 sumoylation to levels lower than those observed with mms2111, a mutant of Mms21 that is deficient in SUMO ligase activity. However, a phenotypic comparison of nse5-ts1 and nse5-ts2 revealed a separation of importance between Smc5 sumoylation and the function of the Smc5/6 complex during replication. Only cells carrying the nse5-ts1 allele exhibited defects such as dissociation of the replisome from stalled forks, formation of fork-associated homologous recombination intermediates, and hydroxyurea sensitivity that is additive with mms21-11. These defects are attributed to a failure in Smc5/6 localization to forks in nse5-ts1 cells. Overall, these data support the premise that Nse5 is important for vital interactions between components within the Smc5/6 complex, and for its functionality during replication stress.	[Bustard, Denise E.; Ball, Lindsay G.; Cobb, Jennifer A.] Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Menolfi, Demis; Branzei, Dana] Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Menolfi, Demis] Univ Milan, I-20122 Milan, Italy; [Jeppsson, Kristian; Dewey, Sidney Carter; Sjogren, Camilla] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Genome Struct & Funct, Ctr Epigenet Dis,Bunkyo Ku, Tokyo 1130032, Japan	University of Calgary; IFOM - FIRC Institute of Molecular Oncology; University of Milan; Karolinska Institutet; University of Tokyo	Cobb, JA (corresponding author), Univ Calgary, So Alberta Canc Res Inst, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	jcobb@ucalgary.ca	Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022; Menolfi, Demis/GSM-8062-2022	Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; Bjorkegren, Camilla/0000-0001-7354-9270; Menolfi, Demis/0000-0002-3824-9931	Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board [23575]; Canadian Institutes of Health Research [MOP-82736]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 10637]; European Research Council (ERC) [REPSUBREP242928]; European Research Council; Swedish Research Council; Swedish Cancer Society; Vinnova; Swedish Foundation for Strategic Research (SSF)	Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council (ERC)(European Research Council (ERC)European Commission); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Vinnova(Vinnova); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	This work was supported by grants from the Alberta Heritage Foundation for Medical Research (AHFMR), Alberta Cancer Board Grant 23575, and Canadian Institutes of Health Research Grant MOP-82736 (to J. A. C.); Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant IG 10637 and European Research Council (ERC) Grant REPSUBREP242928 (to D. B.); and the European Research Council, the Swedish Research Council, the Swedish Cancer Society, Vinnova, and the Swedish Foundation for Strategic Research (SSF) (to C. S.).	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Aushubel F. M., 1994, CURRENT PROTOCOLS MO; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Chavez A, 2011, J BIOL CHEM, V286, P5119, DOI 10.1074/jbc.M110.201608; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Cost GJ, 2006, GENETICS, V172, P2185, DOI 10.1534/genetics.105.053876; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hu B, 2005, MOL MICROBIOL, V55, P1735, DOI 10.1111/j.1365-2958.2005.04531.x; Hwang JY, 2008, DNA REPAIR, V7, P1426, DOI 10.1016/j.dnarep.2008.05.006; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kegel A, 2011, NATURE, V471, P392, DOI 10.1038/nature09791; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Potts PR, 2009, DNA REPAIR, V8, P499, DOI 10.1016/j.dnarep.2009.01.009; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tittel-Elmer M, 2009, EMBO J, V28, P1142, DOI 10.1038/emboj.2009.60; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	39	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11374	11383		10.1074/jbc.M111.336263	http://dx.doi.org/10.1074/jbc.M111.336263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303010	Green Published, hybrid			2022-12-27	WOS:000302780100067
J	Choi, HS; Su, WM; Han, GS; Plote, D; Xu, Z; Carman, GM				Choi, Hyeon-Son; Su, Wen-Min; Han, Gil-Soo; Plote, Devin; Xu, Zhi; Carman, George M.			Pho85p-Pho80p Phosphorylation of Yeast Pah1p Phosphatidate Phosphatase Regulates Its Activity, Location, Abundance, and Function in Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; ACID-PHOSPHATASE; MULTISITE PHOSPHORYLATION; ORTHOLOGUE PAH1P; CTP SYNTHETASE; BUDDING YEAST; STABILITY	The yeast Pah1p phosphatidate phosphatase, which catalyzes the penultimate step in the synthesis of triacylglycerol and plays a role in the transcriptional regulation of phospholipid synthesis genes, is a cytosolic enzyme that associates with the nuclear/endoplasmic reticulum membrane to catalyze the dephosphorylation of phosphatidate to yield diacylglycerol. Pah1p is phosphorylated on seven (Ser-110, Ser-114, Ser-168, Ser-602, Thr-723, Ser-744, and Ser-748) sites that are targets for proline-directed protein kinases. In this work, we showed that the seven sites are phosphorylated by Pho85p-Pho80p, a protein kinase-cyclin complex known to regulate a variety of cellular processes. The phosphorylation of recombinant Pah1p was time-and dose-dependent and dependent on the concentrations of ATP (3.7 mu M) and Pah1p (0.25 mu M). Phosphorylation reduced (6-fold) the catalytic efficiency (V-max/K-m) of Pah1p and reduced (3-fold) its interaction (K-d) with liposomes. Alanine mutations of the seven sites ablated the inhibitory effect that Pho85p-Pho80p had on Pah1p activity and on the interaction with liposomes. Analysis of pho85 Delta mutant cells, phosphate-starved wild type cells, and cells expressing phosphorylation-deficient forms of Pah1p indicated that loss of Pho85p-Pho80p phosphorylation reduced Pah1p abundance. In contrast, lack of Nem1p-Spo7p, the phosphatase complex that dephosphorylates Pah1p at the nuclear/endoplasmic reticulum membrane, stabilized Pah1p abundance. Although loss of phosphorylation caused a decrease in abundance, a greater amount of Pah1p was associated with membranes when compared with phosphorylated enzyme, and the loss of phosphorylation allowed bypass of the Nem1p-Spo7p requirement for Pah1p function in the synthesis of triacylglycerol.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Plote, Devin/0000-0002-7715-4142; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from USPHS [GM-50679]; National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 from the USPHS.; We thank Erin O'Shea for the pho85 Delta mutant and the plasmids to express Pho85p-Pho80p. We also acknowledge Richard Ludescher for the use of the fluorometer used in the liposome binding assays. The mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593 for the support of the University of Medicine and Dentistry of New Jersey Neuroproteomics Core Facility.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BASHFORD CL, 1979, BIOPHYS J, V25, P63, DOI 10.1016/S0006-3495(79)85278-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; LIN YP, 1990, J BIOL CHEM, V265, P166; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	68	75	78	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11290	11301		10.1074/jbc.M112.346023	http://dx.doi.org/10.1074/jbc.M112.346023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334681	Green Published, hybrid			2022-12-27	WOS:000302780100060
J	Havens, CG; Shobnam, N; Guarino, E; Centore, RC; Zou, L; Kearsey, SE; Walter, JC				Havens, Courtney G.; Shobnam, Nadia; Guarino, Estrella; Centore, Richard C.; Zou, Lee; Kearsey, Stephen E.; Walter, Johannes C.			Direct Role for Proliferating Cell Nuclear Antigen in Substrate Recognition by the E3 Ubiquitin Ligase CRL4(Cdt2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT KINASE INHIBITOR; XENOPUS EGG EXTRACTS; DNA-POLYMERASE ALPHA; S-PHASE; STRUCTURAL BASIS; CDT1 PROTEOLYSIS; FISSION YEAST; HISTONE H3; PIP BOX; CHROMATIN ASSOCIATION	The E3 ubiquitin ligase Cullin-ring ligase 4-Cdt2 (CRL4(Cdt2)) is emerging as an important cell cycle regulator that targets numerous proteins for destruction in S phase and after DNA damage, including Cdt1, p21, and Set8. CRL4(Cdt2) substrates contain a "PIP degron," which consists of a canonical proliferating cell nuclear antigen (PCNA) interaction motif (PIP box) and an adjacent basic amino acid. Substrates use their PIP box to form a binary complex with PCNA on chromatin and the basic residue to recruit CRL4(Cdt2) for substrate ubiquitylation. Using Xenopus egg extracts, we identify an acidic residue in PCNA that is essential to support destruction of all CRL4(Cdt2) substrates. This PCNA residue, which adjoins the basic amino acid of the bound PIP degron, is dispensable for substrate binding to PCNA but essential for CRL4(Cdt2) recruitment to chromatin. Our data show that the interaction of CRL4(Cdt2) with substrates requires molecular determinants not only in the substrate degron but also on PCNA. The results illustrate a potentially general mechanism by which E3 ligases can couple ubiquitylation to the formation of protein-protein interactions.	[Havens, Courtney G.; Shobnam, Nadia; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Guarino, Estrella; Kearsey, Stephen E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Centore, Richard C.; Zou, Lee] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; University of Oxford; Harvard University; Massachusetts General Hospital	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,Bldg C2-226A, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Walter, Johannes/0000-0002-4186-7570	National Institutes of Health [GM80676, GM082014, GM089150]; Cancer Research UK [C814/A9035]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676, F32GM089150, F32GM082014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM80676 (to J. C. W.), GM082014 (to C. G. H.), and GM089150 (to R. C. C.). This work was also supported by Cancer Research UK Grant C814/A9035 (to S. E. K.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; Chuang LC, 2005, J BIOL CHEM, V280, P35290, DOI 10.1074/jbc.M506430200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Guarino E, 2011, NUCLEIC ACIDS RES, V39, P5978, DOI 10.1093/nar/gkr222; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Liu C, 2005, EMBO J, V24, P3940, DOI 10.1038/sj.emboj.7600854; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nguyen H, 1999, MOL CELL BIOL, V19, P1190; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Scrima A, 2011, FEBS LETT, V585, P2818, DOI 10.1016/j.febslet.2011.04.064; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Stokes MP, 2003, J CELL BIOL, V163, P245, DOI 10.1083/jcb.200306006; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu SC, 2007, J BIOL CHEM, V282, P15462, DOI 10.1074/jbc.M610758200; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; You ZS, 2002, GENE DEV, V16, P1182, DOI 10.1101/gad.985302; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	65	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11410	11421		10.1074/jbc.M111.337683	http://dx.doi.org/10.1074/jbc.M111.337683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303007	Green Published, hybrid			2022-12-27	WOS:000302780100070
J	Yuyama, K; Sun, H; Mitsutake, S; Igarashi, Y				Yuyama, Kohei; Sun, Hui; Mitsutake, Susumu; Igarashi, Yasuyuki			Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-beta by Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; SPHINGOMYELIN SYNTHASE; FIBRIL FORMATION; PROTEIN; CELLS; ENDOCYTOSIS; ASSOCIATION; ACTIVATION; CERAMIDE	Background: Exosome is a membrane vesicle released from several types of cells, including neurons. Results: Neuronal exosomes accelerate A beta fibril formation, and the exosome-associated A beta is taken into microglia to degrade it. Conclusion: Exosomes promote A beta clearance. Significance: These findings provide a new function of exosome in the brain and also suggest its involvement in the development of Alzheimer disease.	[Yuyama, Kohei; Sun, Hui; Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan	Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan.	yigarash@pharm.hokudai.ac.jp	Mitsutake, Susumu/A-4082-2012; Yuyama, Kohei/A-7454-2012					Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kimura N, 2007, NEUROREPORT, V18, P1669, DOI 10.1097/WNR.0b013e3282f0d2ab; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levi G., 1989, DISSECTION TISSUE CU, P154; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Magnus T, 2001, J IMMUNOL, V167, P5004, DOI 10.4049/jimmunol.167.9.5004; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yuyama K, 2008, J NEUROCHEM, V105, P217, DOI 10.1111/j.1471-4159.2007.05128.x; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	54	370	391	5	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10977	10989		10.1074/jbc.M111.324616	http://dx.doi.org/10.1074/jbc.M111.324616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303002	Green Published, hybrid			2022-12-27	WOS:000302780100026
J	Frankel, MB; Schneewind, O				Frankel, Matthew B.; Schneewind, Olaf			Determinants of Murein Hydrolase Targeting to Cross-wall of Staphylococcus aureus Peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; GRAM-POSITIVE BACTERIA; RIBITOL TEICHOIC-ACIDS; BACILLUS-SUBTILIS W23; CELL-WALL; LYSM DOMAINS; LINKAGE UNIT; METHICILLIN RESISTANCE; NUCLEOTIDE-SEQUENCE	Cells of eukaryotic or prokaryotic origin express proteins with LysM domains that associate with the cell wall envelope of bacteria. The molecular properties that enable LysM domains to interact with microbial cell walls are not yet established. Staphylococcus aureus, a spherical microbe, secretes two murein hydrolases with LysM domains, Sle1 and LytN. We show here that the LysM domains of Sle1 and LytN direct murein hydrolases to the staphylococcal envelope in the vicinity of the crosswall, the mid-cell compartment for peptidoglycan synthesis. LysM domains associate with the repeating disaccharide beta-N-acetylmuramic acid, (1 -> 4)-beta-N-acetylglucosamine of staphylococcal peptidoglycan. Modification of N-acetylmuramic acid with wall teichoic acid, a ribitol-phosphate polymer tethered to murein linkage units, prevents the LysM domain from binding to peptidoglycan. The localization of LytN and Sle1 to the crosswall is abolished in staphylococcal tagO mutants, which are defective for wall teichoic acid synthesis. We propose a model whereby the LysM domain ensures septal localization of LytN and Sle1 followed by processive cleavage of peptidoglycan, thereby exposing new LysM binding sites in the cross-wall and separating bacterial cells.	[Frankel, Matthew B.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health, NIAID, Infectious Disease Branch [AI038897]; NIAID, National Institutes of Health [AI085709]; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID) [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, F32AI085709, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health, NIAID, Infectious Disease Branch; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Infectious Disease Branch, Grant AI038897 (to O. S.).; Supported by NIAID, National Institutes of Health, Postdoctoral Fellowship Award AI085709.; Member of and supported by the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institutes of Health, NIAID, Grant 1-U54-AI-057153). To whom correspondence should be addressed: Dept. of Microbiology, University of Chicago, 920 E. 58th St., Chicago, IL. Tel.: 773-834-9060; Fax: 773-834-8150; E-mail: oschnee@bsd.uchicago.edu.	ANDERSON JS, 1965, P NATL ACAD SCI USA, V53, P881, DOI 10.1073/pnas.53.4.881; ARCHIBALD A, 1961, NATURE, V191, P570, DOI 10.1038/191570a0; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BLUMBERG PM, 1972, P NATL ACAD SCI USA, V69, P3751, DOI 10.1073/pnas.69.12.3751; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; COLEY J, 1976, FEBS LETT, V61, P240, DOI 10.1016/0014-5793(76)81047-2; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; GARVEY KJ, 1986, NUCLEIC ACIDS RES, V14, P10001, DOI 10.1093/nar/14.24.10001; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1119, DOI 10.1021/bi00905a036; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GIESBRECHT P, 1976, INT REV CYTOL, V44, P225, DOI 10.1016/S0074-7696(08)61651-4; Grundling A, 2006, J BACTERIOL, V188, P2463, DOI 10.1128/JB.188.7.2463-2472.2006; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Grundling A, 2006, J BACTERIOL, V188, P6286, DOI 10.1128/JB.00457-06; HANCOCK IC, 1976, FEBS LETT, V69, P75, DOI 10.1016/0014-5793(76)80657-6; HARRINGTON CR, 1985, EUR J BIOCHEM, V153, P639, DOI 10.1111/j.1432-1033.1985.tb09348.x; HENZE U, 1993, J BACTERIOL, V175, P1612, DOI 10.1128/JB.175.6.1612-1620.1993; HIGASHI Y, 1970, J BIOL CHEM, V245, P3697; HIGASHI Y, 1967, P NATL ACAD SCI USA, V57, P1878, DOI 10.1073/pnas.57.6.1878; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kern J, 2010, J MOL BIOL, V401, P757, DOI 10.1016/j.jmb.2010.06.059; KOJIMA N, 1985, J BACTERIOL, V161, P299, DOI 10.1128/JB.161.1.299-306.1985; Komatsuzawa H, 1997, MICROBIOL IMMUNOL, V41, P469, DOI 10.1111/j.1348-0421.1997.tb01880.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LIU TY, 1967, J BIOL CHEM, V242, P471; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; MATSUHASHI M, 1965, P NATL ACAD SCI USA, V54, P587, DOI 10.1073/pnas.54.2.587; MAUEL C, 1989, MOL GEN GENET, V215, P388, DOI 10.1007/BF00427034; MCARTHUR HAI, 1978, FEBS LETT, V86, P193, DOI 10.1016/0014-5793(78)80561-4; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; PARK JT, 1952, J BIOL CHEM, V194, P897; PARK JT, 1957, SCIENCE, V125, P99, DOI 10.1126/science.125.3238.99; POXTON IR, 1978, BIOCHEM J, V175, P1033, DOI 10.1042/bj1751033; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; REEDER WJ, 1971, J IMMUNOL, V106, P334; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4787; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; SALTON MRJ, 1952, NATURE, V170, P746, DOI 10.1038/170746a0; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; STROMINGER JL, 1967, FED PROC, V26, P9; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; YOKOYAMA K, 1986, EUR J BIOCHEM, V161, P479, DOI 10.1111/j.1432-1033.1986.tb10469.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	76	61	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10460	10471		10.1074/jbc.M111.336404	http://dx.doi.org/10.1074/jbc.M111.336404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303016	hybrid, Green Published			2022-12-27	WOS:000302167200073
J	Hamada, H; Kurusu, T; Okuma, E; Nokajima, H; Kiyoduka, M; Koyano, T; Sugiyama, Y; Okada, K; Koga, J; Saji, H; Miyao, A; Hirochika, H; Yamane, H; Murata, Y; Kuchitsu, K				Hamada, Haruyasu; Kurusu, Takamitsu; Okuma, Eiji; Nokajima, Hiroshi; Kiyoduka, Masahiro; Koyano, Tomoko; Sugiyama, Yoshimi; Okada, Kazunori; Koga, Jinichiro; Saji, Hikaru; Miyao, Akio; Hirochika, Hirohiko; Yamane, Hisakazu; Murata, Yoshiyuki; Kuchitsu, Kazuyuki			Regulation of a Proteinaceous Elicitor-induced Ca2+ Influx and Production of Phytoalexins by a Putative Voltage-gated Cation Channel, OsTPC1, in Cultured Rice Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE CHANNELS; MOLECULAR-CLONING; CALCIUM; DEFENSE; DEATH; GENE; IDENTIFICATION; ACTIVATION; BIOSYNTHESIS; KINASES	Pathogen/microbe-or plant-derived signaling molecules (PAMPs/MAMPs/DAMPs) or elicitors induce increases in the cytosolic concentration of free Ca2+ followed by a series of defense responses including biosynthesis of antimicrobial secondary metabolites called phytoalexins; however, the molecular links and regulatory mechanisms of the phytoalexin biosynthesis remains largely unknown. A putative voltage-gated cation channel, OsTPC1 has been shown to play a critical role in hypersensitive cell death induced by a fungal xylanase protein (TvX) in suspension-cultured rice cells. Here we show that TvX induced a prolonged increase in cytosolic Ca2+, mainly due to a Ca2+ influx through the plasma membrane. Membrane fractionation by two-phase partitioning and immunoblot analyses revealed that OsTPC1 is localized predominantly at the plasma membrane. In retrotransposon- insertional Ostpc1 knock-out cell lines harboring a Ca2+-sensitive photoprotein, aequorin, TvX-induced Ca2+ elevation was significantly impaired, which was restored by expression of OsTPC1. TvX-induced production of major diterpenoid phytoalexins and the expression of a series of diterpene cyclase genes involved in phytoalexin biosynthesis were also impaired in the Ostpc1 cells. Whole cell patch clamp analyses of OsTPC1 heterologously expressed in HEK293T cells showed its voltage-dependent Ca2+-permeability. These results suggest that OsTPC1 plays a crucial role in TvX-induced Ca2+ influx as a plasma membrane Ca2+ permeable channel consequently required for the regulation of phytoalexin biosynthesis in cultured rice cells.	[Hamada, Haruyasu; Kurusu, Takamitsu; Nokajima, Hiroshi; Kiyoduka, Masahiro; Koyano, Tomoko; Sugiyama, Yoshimi; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Kurusu, Takamitsu; Kuchitsu, Kazuyuki] Tokyo Univ Sci, RIST, Noda, Chiba 2788510, Japan; [Okuma, Eiji; Murata, Yoshiyuki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Okada, Kazunori; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Koga, Jinichiro] Meiji Co Ltd, Food Sci Res Labs, Sakado, Saitama 3500289, Japan; [Saji, Hikaru] Natl Inst Environm Studies, Div Environm Biol, Tsukuba, Ibaraki 3058506, Japan; [Miyao, Akio; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki 3058602, Japan	Tokyo University of Science; Tokyo University of Science; Okayama University; University of Tokyo; Meiji Holdings Co., Ltd.; National Institute for Environmental Studies - Japan; National Institute of Agrobiological Sciences - Japan	Kuchitsu, K (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	kuchitsu@rs.noda.tus.ac.jp	Kurusu, Takamitsu/GMW-8766-2022; Kurusu, Takamitsu/GMW-8785-2022; Murata, Yoshiyuki/B-2098-2011; Kuchitsu, Kazuyuki/G-3024-2013; Miyao, Akio/V-7306-2019	Kurusu, Takamitsu/0000-0001-7740-3199; Kurusu, Takamitsu/0000-0001-7740-3199; Kuchitsu, Kazuyuki/0000-0001-8854-0375; Miyao, Akio/0000-0002-2822-2866; Koga, Jinichiro/0000-0003-2106-9894	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23380027, 23117718, 21117516, 21658118, 21200067, 21780041]; Japanese Society for Promotion of Science; Japan Science and Technology Agency [221Z03504]; Nara Institute of Science and Technology; MEXT; Grants-in-Aid for Scientific Research [21200067] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Nara Institute of Science and Technology; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research No. 23380027, 23117718, 21117516, 21658118 (to K. K.) and No. 21200067, 21780041 (to T. K.) from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and Japanese Society for Promotion of Science, by a grant from Japan Science and Technology Agency, for Adaptable and Seamless Technology Transfer Program through target-driven R&D (221Z03504) (to T. K.), and by a Grant-in-Aid for Plant Graduate Student from Nara Institute of Science and Technology, supported by MEXT (to H.H.).	BAILEY BA, 1991, PLANT PHYSIOL, V97, P1181, DOI 10.1104/pp.97.3.1181; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hashimoto K, 2005, PLANT BIOTECHNOL, V22, P235, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.22.235; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Igasaki Tomohiro, 2002, Bulletin of the Forestry and Forest Products Research Institute, V1, P235; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Islam MM, 2010, PLANT CELL PHYSIOL, V51, P302, DOI 10.1093/pcp/pcq001; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Kadota Y, 2004, BIOCHEM BIOPH RES CO, V317, P823, DOI 10.1016/j.bbrc.2004.03.114; Kadota Y, 2004, PLANT CELL PHYSIOL, V45, P160, DOI 10.1093/pcp/pch020; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; KUCHITSU K, 1993, PROTOPLASMA, V174, P79, DOI 10.1007/BF01404046; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kurusu T, 2004, PLANT CELL PHYSIOL, V45, P693, DOI 10.1093/pcp/pch082; Kurusu T, 2010, PLANT SIGNAL BEHAV, V5, P1045, DOI [10.4161/psb.5.8.12407, 10.1104/pp.109.151852]; Kurusu T, 2011, J PLANT RES, V124, P415, DOI 10.1007/s10265-010-0388-4; Kurusu T, 2010, PLANT PHYSIOL, V153, P678, DOI 10.1104/pp.109.151852; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Mithofer Axel, 2002, Biological Procedures Online, V4, P105, DOI 10.1251/bpo40; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navazio L, 2002, PLANTA, V215, P596, DOI 10.1007/s00425-002-0776-7; Navazio L, 2001, PLANT PHYSIOL, V125, P2129, DOI 10.1104/pp.125.4.2129; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Otomo K, 2004, BIOSCI BIOTECH BIOCH, V68, P2001, DOI 10.1271/bbb.68.2001; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; Song WY, 2008, INT J BIOL SCI, V4, P116; SU RC, 1992, PLANT CELL REP, V12, P45, DOI 10.1007/BF00232422; Tanaka N, 2004, MOL GENET GENOMICS, V271, P566, DOI 10.1007/s00438-004-1002-z; Tronchet M, 2001, PLANT J, V27, P115, DOI 10.1046/j.1365-313x.2001.01072.x; Umemura K, 2002, PLANT CELL PHYSIOL, V43, P778, DOI 10.1093/pcp/pcf090; Wang YJ, 2005, J EXP BOT, V56, P3051, DOI 10.1093/jxb/eri302; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Zhang XCG, 2002, PLANTA, V215, P312, DOI 10.1007/s00425-002-0739-z	57	18	20	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9931	9939		10.1074/jbc.M111.337659	http://dx.doi.org/10.1074/jbc.M111.337659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270358	Green Published, hybrid			2022-12-27	WOS:000302167200025
J	Spertini, C; Baisse, B; Spertini, O				Spertini, Caroline; Baisse, Benedicte; Spertini, Olivier			Ezrin-Radixin-Moesin-binding Sequence of PSGL-1 Glycoprotein Regulates Leukocyte Rolling on Selectins and Activation of Extracellular Signal-regulated Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; ERM PROTEINS; IN-VIVO; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; TYROSINE KINASE; FLOW CONDITIONS; ADHESION; LIGAND-1; CELLS	P-selectin glycoprotein ligand-1 (PSGL-1) mediates the capture (tethering) of free-flowing leukocytes and subsequent rolling on selectins. PSGL-1 interactions with endothelial selectins activate Src kinases and spleen tyrosine kinase (Syk), leading to alpha(L)beta(2) integrin-dependent leukocyte slow rolling, which promotes leukocyte recruitment into tissues. In addition, but through a distinct pathway, PSGL-1 engagement activates ERK. Because ezrin, radixin and moesin proteins (ERMs) link PSGL-1 to actin cytoskeleton and because they serve as adaptor molecules between PSGL-1 and Syk, we examined the role of PSGL-1 ERM-binding sequence (EBS) on cell capture, rolling, and signaling through Syk and MAPK pathways. We carried out mutational analysis and observed that deletion of EBS severely reduced 32D leukocyte tethering and rolling on L-, P-, and E-selectin and slightly increased rolling velocity. Alanine substitution of Arg-337 and Lys-338 showed that these residues play a key role in supporting leukocyte tethering and rolling on selectins. Importantly, EBS deletion or Arg-337 and Lys-338 mutations abrogated PSGL-1-induced ERK activation, whereas they did not prevent Syk phosphorylation or E-selectin-induced leukocyte slow rolling. These studies demonstrate that PSGL-1 EBS plays a critical role in recruiting leukocytes on selectins and in activating the MAPK pathway, whereas it is dispensable to phosphorylate Syk and to lead to alpha(L)beta(2)-dependent leukocyte slow rolling.	[Spertini, Olivier] Univ Lausanne Hosp, Serv Hematol, CH-1011 Lausanne, Switzerland; Univ Lausanne Hosp, Cent Hematol Lab, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, O (corresponding author), Univ Lausanne Hosp, Serv Hematol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Olivier.Spertini@chuv.ch			Swiss National Foundation for Scientific Research [310030_127368]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation for Scientific Research Grant 310030_127368 (to O. S.).	Abbal C, 2006, BLOOD, V108, P3352, DOI 10.1182/blood-2006-04-013912; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Azab AK, 2012, BLOOD, V119, P1468, DOI 10.1182/blood-2011-07-368050; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Buscher K, 2010, J BIOL CHEM, V285, P13490, DOI 10.1074/jbc.M110.102640; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Krasik EF, 2004, BIOPHYS J, V87, P2919, DOI 10.1529/biophysj.104.039693; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Park EYH, 2002, BIOPHYS J, V82, P1835, DOI 10.1016/S0006-3495(02)75534-3; Pospieszalska MK, 2009, CELL MOL BIOENG, V2, P207, DOI 10.1007/s12195-009-0063-9; Python JL, 2010, BIOCHEM BIOPH RES CO, V397, P621, DOI 10.1016/j.bbrc.2010.06.012; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Sperandio M, 2001, J IMMUNOL, V167, P2268, DOI 10.4049/jimmunol.167.4.2268; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; Stein JV, 1999, J EXP MED, V189, P37, DOI 10.1084/jem.189.1.37; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tauxe C, 2008, J BIOL CHEM, V283, P28536, DOI 10.1074/jbc.M802865200; Urzainqui A, 2002, IMMUNITY, V17, P401, DOI 10.1016/S1074-7613(02)00420-X; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zarbock A, 2011, ARCH BIOCHEM BIOPHYS, V510, P112, DOI 10.1016/j.abb.2011.02.009	42	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10693	10702		10.1074/jbc.M111.318022	http://dx.doi.org/10.1074/jbc.M111.318022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311979	hybrid, Green Published			2022-12-27	WOS:000302167200094
J	Dhatwalia, R; Singh, H; Oppenheimer, M; Karr, DB; Nix, JC; Sobrado, P; Tanner, JJ				Dhatwalia, Richa; Singh, Harkewal; Oppenheimer, Michelle; Karr, Dale B.; Nix, Jay C.; Sobrado, Pablo; Tanner, John J.			Crystal Structures and Small-angle X-ray Scattering Analysis of UDP-galactopyranose Mutase from the Pathogenic Fungus Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDIZED STATE; GALACTOFURANOSE; PROTEINS; SYSTEM; PHENIX	UDP-galactopyranose mutase (UGM) is a flavoenzyme that catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, which is a central reaction in galactofuranose biosynthesis. Galactofuranose has never been found in humans but is an essential building block of the cell wall and extracellular matrix of many bacteria, fungi, and protozoa. The importance of UGM for the viability of many pathogens and its absence in humans make UGM a potential drug target. Here we report the first crystal structures and small-angle x-ray scattering data for UGM from the fungus Aspergillus fumigatus, the causative agent of aspergillosis. The structures reveal that Aspergillus UGM has several extra secondary and tertiary structural elements that are not found in bacterial UGMs yet are important for substrate recognition and oligomerization. Small-angle x-ray scattering data show that Aspergillus UGM forms a tetramer in solution, which is unprecedented for UGMs. The binding of UDP or the substrate induces profound conformational changes in the enzyme. Two loops on opposite sides of the active site move toward each other by over 10 angstrom to cover the substrate and create a closed active site. The degree of substrate-induced conformational change exceeds that of bacterial UGMs and is a direct consequence of the unique quaternary structure of Aspergillus UGM. Galactopyranose binds at the re face of the FAD isoalloxazine with the anomeric carbon atom poised for nucleophilic attack by the FAD N5 atom. The structural data provide new insight into substrate recognition and the catalytic mechanism and thus will aid inhibitor design.	[Dhatwalia, Richa; Singh, Harkewal; Karr, Dale B.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Oppenheimer, Michelle; Sobrado, Pablo] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tanner, JJ (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X	National Institutes of Health [R01GM094469]; National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM094469 (to P. S. and J. J. T.).; We thank Dr. Norma Duke, Dr. Greg Hura, and Dr. Jonathan Schuermann for help with x-ray data collection and processing. Part of this work is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Chong S, 2006, EUR J RADIOL, V59, P371, DOI 10.1016/j.ejrad.2006.04.017; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullerton SWB, 2003, BIOCHEMISTRY-US, V42, P2104, DOI 10.1021/bi027077f; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Huang ZH, 2003, BIOORG CHEM, V31, P494, DOI 10.1016/j.bioorg.2003.08.002; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Knutsen AP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/843763; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kradin RL, 2008, ARCH PATHOL LAB MED, V132, P606, DOI 10.1043/1543-2165(2008)132[606:TPOPDD]2.0.CO;2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McMahon SA, 1999, ACTA CRYSTALLOGR D, V55, P399, DOI 10.1107/S0907444998010877; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Samarakoon P, 2008, Chron Respir Dis, V5, P19, DOI 10.1177/1479972307085637; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Soltero-Higgin M, 2004, NAT STRUCT MOL BIOL, V11, P539, DOI 10.1038/nsmb772; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tefsen B., 2011, GLYCOBIOLOG IN PRESS; Virnig C, 2007, CURR OPIN PULM MED, V13, P67, DOI 10.1097/MCP.0b013e328010c812; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	46	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9041	9051		10.1074/jbc.M111.327536	http://dx.doi.org/10.1074/jbc.M111.327536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294687	Green Published, hybrid			2022-12-27	WOS:000301797800034
J	Munashingha, PR; Lee, CH; Kang, YH; Shin, YK; Nguyen, TA; Seo, YS				Munashingha, Palinda Ruvan; Lee, Chul-Hwan; Kang, Young-Hoon; Shin, Yong-Keol; Tuan Anh Nguyen; Seo, Yeon-Soo			The Trans-autostimulatory Activity of Rad27 Suppresses dna2 Defects in Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC FLAP ENDONUCLEASE-1; REPLICATION IN-VITRO; RHO FAMILY GTPASES; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; LAGGING-STRAND; SUBSTRATE-SPECIFICITY; MUTATION AVOIDANCE; REPAIR PATHWAYS; FEN-1 NUCLEASE	Dna2 and Rad27 (yeast Fen1) are the two endonucleases critical for Okazaki fragment processing during lagging strand DNA synthesis that have been shown to interact genetically and physically. In this study, we addressed the functional consequences of these interactions by examining whether purified Rad27 of Saccharomyces cerevisiae affects the enzymatic activity of Dna2 and vice versa. For this purpose, we constructed Rad27DA (catalytically defective enzyme with an Asp to Ala substitution at amino acid 179) and found that it significantly stimulated the endonuclease activity of wild type Dna2, but failed to do so with Dna2 Delta 405N that lacks the N-terminal 405 amino acids. This was an unexpected finding because dna2 Delta 405N cells were still partially suppressed by overexpression of rad27DA in vivo. Further analyses revealed that Rad27 is a trans-autostimulatory enzyme, providing an explanation why overexpression of Rad27, regardless of its catalytic activity, suppressed dna2 mutants as long as an endogenous wild type Rad27 is available. We found that the C-terminal 16-amino acid fragment of Rad27, a highly polybasic region due to the presence of multiple positively charged lysine and arginine residues, was sufficient and necessary for the stimulation of both Rad27 and Dna2. Our findings provide further insight into how Dna2 and Rad27 jointly affect the processing of Okazaki fragments in eukaryotes.	[Munashingha, Palinda Ruvan; Lee, Chul-Hwan; Kang, Young-Hoon; Shin, Yong-Keol; Tuan Anh Nguyen; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Ctr DNA Replicat & Genome Instabil, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Lee, Chul-Hwan/0000-0003-0643-0100; Nguyen, Tuan Anh/0000-0001-7793-2699	National Research Foundation of Korea from the Ministry of Education, Science and Technology [20100000009]	National Research Foundation of Korea from the Ministry of Education, Science and Technology	This work was supported by National Research Foundation of Korea Grant 20100000009 from the Ministry of Education, Science and Technology.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Cho IT, 2009, J BIOL CHEM, V284, P10387, DOI 10.1074/jbc.M808893200; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; DENIS D, 1993, MOL CELL BIOL, V13, P2882, DOI 10.1128/MCB.13.5.2882; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2004, NUCLEIC ACIDS RES, V32, P2520, DOI 10.1093/nar/gkh576; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gary R, 1999, MOL CELL BIOL, V19, P5373; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Hubscher U, 2001, MOL CELLS, V12, P149; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; Kang MJ, 2010, NUCLEIC ACIDS RES, V38, P7611, DOI 10.1093/nar/gkq651; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Karanja KK, 2009, GENETICS, V183, P63, DOI 10.1534/genetics.109.103937; Lee CH, 2010, NUCLEIC ACIDS RES, V38, P1583, DOI 10.1093/nar/gkp1135; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Qiu JZ, 2001, J BIOL CHEM, V276, P4901, DOI 10.1074/jbc.M007825200; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Stewart JA, 2006, J BIOL CHEM, V281, P38565, DOI 10.1074/jbc.M606884200; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313	49	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8675	8687		10.1074/jbc.M111.326470	http://dx.doi.org/10.1074/jbc.M111.326470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22235122	Green Published, hybrid			2022-12-27	WOS:000301797800002
J	Nambiar, M; Raghavan, SC				Nambiar, Mridula; Raghavan, Sathees C.			Mechanism of Fragility at BCL2 Gene Minor Breakpoint Cluster Region during t(14;18) Chromosomal Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V(D)J RECOMBINATION EFFICIENCY; POLYMERASE-CHAIN-REACTION; B DNA STRUCTURES; MAJOR BREAKPOINT; FOLLICULAR LYMPHOMA; GENOMIC-INSTABILITY; NUCLEOTIDE-SEQUENCE; ACTIVATING GENE; SIGNAL SEQUENCE; CODING ENDS	The t(14;18) translocation in follicular lymphoma is one of the most common chromosomal translocations. Breaks in chromosome 18 are localized at the 3'-UTR of BCL2 gene or downstream and are mainly clustered in either the major breakpoint region or the minor breakpoint cluster region (mcr). The recombination activating gene (RAG) complex induces breaks at IgH locus of chromosome 14, whereas the mechanism of fragility at BCL2 mcr remains unclear. Here, for the first time, we show that RAGs can nick mcr; however, the mechanism is unique. Three independent nicks of equal efficiency are generated, when both Mg2+ and Mn2+ are present, unlike a single nick during V(D)J recombination. Further, we demonstrate that RAG binding and nicking at the mcr are independent of nonamer, whereas a CCACCTCT motif plays a critical role in its fragility, as shown by sequential mutagenesis. More importantly, we recapitulate the BCL2 mcr translocation and find that mcr can undergo synapsis with a standard recombination signal sequence within the cells, in a RAG-dependent manner. Further, mutation to the CCACCTCT motif abolishes recombination within the cells, indicating its vital role. Hence, our data suggest a novel, physiologically relevant, nonamer-independent mechanism of RAG nicking at mcr, which may be important for generation of chromosomal translocations in humans.	[Nambiar, Mridula; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR) India [27(0164)/07/EMR-II:2007]	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR) India (27(0164)/07/EMR-II:2007) (to S. C. R.).	Albinger-Hegyi A, 2002, AM J PATHOL, V160, P823, DOI 10.1016/S0002-9440(10)64905-X; BAKHSHI A, 1987, P NATL ACAD SCI USA, V84, P2396, DOI 10.1073/pnas.84.8.2396; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; Buchonnet G, 2002, LEUKEMIA, V16, P1852, DOI 10.1038/sj.leu.2402568; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Galili N, 1987, Haematol Blood Transfus, V31, P167; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li WH, 2001, MOL CELL BIOL, V21, P3935, DOI 10.1128/MCB.21.12.3935-3946.2001; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Naik AK, 2010, J BIOL CHEM, V285, P7587, DOI 10.1074/jbc.M109.089631; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; NGAN BY, 1989, BLOOD, V73, P1759; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raghavan SC, 2005, MOL CELL BIOL, V25, P6475, DOI 10.1128/MCB.25.15.6475-6484.2005; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, CELL CYCLE, V3, P762; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Rahman NS, 2006, J BIOL CHEM, V281, P12370, DOI 10.1074/jbc.M507906200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; RETH MG, 1986, EMBO J, V5, P2131, DOI 10.1002/j.1460-2075.1986.tb04476.x; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; SAKANO H, 1981, NATURE, V290, P562, DOI 10.1038/290562a0; Santagata S, 1998, J BIOL CHEM, V273, P16325, DOI 10.1074/jbc.273.26.16325; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; Sigel A., 2000, MANGANESE ITS ROLE B, V37; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2010, BLOOD, V116, P1993, DOI 10.1182/blood-2010-05-286492; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	49	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8688	8701		10.1074/jbc.M111.307363	http://dx.doi.org/10.1074/jbc.M111.307363			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275374	Green Published, hybrid			2022-12-27	WOS:000301797800003
J	Robinson, AK; Leal, BZ; Chadwell, LV; Wang, RJ; Ilangovan, U; Kaur, Y; Junco, SE; Schirf, V; Osmulski, PA; Gaczynska, M; Hinck, AP; Demeler, B; McEwen, DG; Kim, CA				Robinson, Angela K.; Leal, Belinda Z.; Chadwell, Linda V.; Wang, Renjing; Ilangovan, Udayar; Kaur, Yogeet; Junco, Sarah E.; Schirf, Virgil; Osmulski, Pawel A.; Gaczynska, Maria; Hinck, Andrew P.; Demeler, Borries; McEwen, Donald G.; Kim, Chongwoo A.			The Growth-Suppressive Function of the Polycomb Group Protein Polyhomeotic Is Mediated by Polymerization of Its Sterile Alpha Motif (SAM) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY EXPERIMENTS; SEX-COMB; CHROMATIN; REPRESSION; SYSTEM; CORE; TEL	Polyhomeotic (Ph), a member of the Polycomb Group (PcG), is a gene silencer critical for proper development. We present a previously unrecognized way of controlling Ph function through modulation of its sterile alpha motif (SAM) polymerization leading to the identification of a novel target for tuning the activities of proteins. SAM domain containing proteins have been shown to require SAM polymerization for proper function. However, the role of the Ph SAM polymer in PcG-mediated gene silencing was uncertain. Here, we first show that Ph SAM polymerization is indeed required for its gene silencing function. Interestingly, the unstructured linker sequence N-terminal to Ph SAM can shorten the length of polymers compared with when Ph SAM is individually isolated. Substituting the native linker with a random, unstructured sequence (RLink) can still limit polymerization, but not as well as the native linker. Consequently, the increased polymeric Ph RLink exhibits better gene silencing ability. In the Drosophila wing disc, Ph RLink expression suppresses growth compared with no effect for wild-type Ph, and opposite to the overgrowth phenotype observed for polymer-deficient Ph mutants. These data provide the first demonstration that the inherent activity of a protein containing a polymeric SAM can be enhanced by increasing SAM polymerization. Because the SAM linker had not been previously considered important for the function of SAM-containing proteins, our finding opens numerous opportunities to manipulate linker sequences of hundreds of polymeric SAM proteins to regulate a diverse array of intracellular functions.	[Robinson, Angela K.; Leal, Belinda Z.; Wang, Renjing; Ilangovan, Udayar; Kaur, Yogeet; Junco, Sarah E.; Schirf, Virgil; Hinck, Andrew P.; Demeler, Borries; McEwen, Donald G.; Kim, Chongwoo A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chadwell, Linda V.; McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Osmulski, Pawel A.; Gaczynska, Maria] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kim, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	chong@biochem.uthscsa.edu	Osmulski, Pawel/C-7751-2019	Osmulski, Pawel/0000-0002-5359-9200; Wong, Sarah/0000-0002-9992-2907; Demeler, Borries/0000-0002-2414-9518; Hinck, Andrew/0000-0003-3320-8054	NIH [RR022200/RGM103662B]; American Cancer Society [RSG-08-285-01-GMC]; American Heart Association [0830111N]; Department of Defense [BC075278]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Susan T. Weintraub for comments on the manuscript. The UltraScan development is supported by NIH Grant RR022200/RGM103662B (to B. D.). Computational analysis was performed at the Texas Advanced Computing Center on Lonestar and Ranger using NSF TeraGrid allocation TG-MCB070039 (to B. D.).; This work was supported by the American Cancer Society (RSG-08-285-01-GMC), the American Heart Association (0830111N), and the Department of Defense Breast Cancer Research Program (BC075278) (to C. A. K.).	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brookes E., 2006, ANAL ULTRACENTRIFUGA, VVIII, P78; Brookes EH, 2007, GECCO P; Brookes E, 2008, COLLOID POLYM SCI, V286, P139, DOI 10.1007/s00396-007-1714-9; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Di Pietro SM, 2010, EMBO J, V29, P1033, DOI 10.1038/emboj.2010.5; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Feng SQ, 2011, EMBO REP, V12, P157, DOI 10.1038/embor.2010.188; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schatz PJ, 1996, METHOD ENZYMOL, V267, P171; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Wang RJ, 2011, BIOCHEMISTRY-US, V50, P4998, DOI 10.1021/bi101487s; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	40	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8702	8713		10.1074/jbc.M111.336115	http://dx.doi.org/10.1074/jbc.M111.336115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275371	Green Published, hybrid			2022-12-27	WOS:000301797800004
J	Basu, S; Rajakaruna, S; Menko, AS				Basu, Subhasree; Rajakaruna, Suren; Menko, A. Sue			Insulin-like Growth Factor Receptor-1 and Nuclear Factor kappa B Are Crucial Survival Signals That Regulate Caspase-3-mediated Lens Epithelial Cell Differentiation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-APOPTOTIC FUNCTIONS; DNA STRAND BREAKS; FACTOR-I RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; TERMINAL DIFFERENTIATION; CASPASE ACTIVATION; GENE-EXPRESSION; IGF-I; CANCER; PATHWAY	It is now known that the function of the caspase family of proteases is not restricted to effectors of programmed cell death. For example, there is a significant non-apoptotic role for caspase-3 in cell differentiation. Our own studies in the developing lens show that caspase-3 is activated downstream of the canonical mitochondrial death pathway to act as a molecular switch in signaling lens cell differentiation. Importantly, for this function, caspase-3 is activated at levels far below those that induce apoptosis. We now have provided evidence that regulation of caspase-3 for its role in differentiation induction is dependent on the insulin-like growth factor-1 receptor (IGF-1R) survival-signaling pathway. IGF-1R executed this regulation of caspase-3 by controlling the expression of molecules in the Bcl-2 and inhibitor of apoptosis protein (IAP) families. This effect of IGF-1R was mediated through NF kappa B, demonstrated here to function as a crucial downstream effector of IGF-1R. Inhibition of expression or activation of NF kappa B blocked expression of survival proteins in the Bcl-2 and IAP families and removed controls on the activation state of caspase-3. The high level of caspase-3 activation that resulted from inhibiting this IGF-1R/NF kappa B signaling pathway redirected cell fate from differentiation toward apoptosis. These results provided the first evidence that the IGF-1R/NF kappa B cell survival signal is a crucial regulator of the level of caspase-3 activation for its non-apoptotic function in signaling cell differentiation.	[Basu, Subhasree; Rajakaruna, Suren; Menko, A. Sue] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Menko, AS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu		Menko, A. Sue/0000-0002-7514-4696	National Institutes of Health [EY10577, EY014258]; NATIONAL EYE INSTITUTE [R01EY014258, R01EY010577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY10577 and EY014258 (to A. S. M.).	Alberobello AT, 2010, J BIOL CHEM, V285, P6563, DOI 10.1074/jbc.M109.097410; ALEMANY J, 1990, P NATL ACAD SCI USA, V87, P3353, DOI 10.1073/pnas.87.9.3353; ALEMANY J, 1989, J BIOL CHEM, V264, P17559; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; BEEBE DC, 1980, P NATL ACAD SCI-BIOL, V77, P490, DOI 10.1073/pnas.77.1.490; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Chandrasekher G, 2004, INVEST OPHTH VIS SCI, V45, P3577, DOI 10.1167/iovs.04-0279; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; D'Amours D, 2001, J CELL SCI, V114, P3771; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Karasic TB, 2010, EXP CELL RES, V316, P1994, DOI 10.1016/j.yexcr.2010.04.014; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Le ACN, 2001, DEV BIOL, V233, P394, DOI 10.1006/dbio.2001.0194; Leonard M, 2008, DEV BIOL, V319, P298, DOI 10.1016/j.ydbio.2008.04.036; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; MENKO AS, 1984, DEV BIOL, V103, P129, DOI 10.1016/0012-1606(84)90014-9; Mirkes PE, 2002, TERATOLOGY, V65, P228, DOI 10.1002/tera.10049; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Rios J, 2011, ONCOLOGY-NY, V25, P1014; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shirke S, 2001, MECH DEVELOP, V101, P167, DOI 10.1016/S0925-4773(00)00584-0; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Walker J, 2009, EXP EYE RES, V88, P216, DOI 10.1016/j.exer.2008.06.020; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Weber GF, 2006, INVEST OPHTH VIS SCI, V47, P4490, DOI 10.1167/iovs.06-0401; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wesierska-Gadek J, 2004, J CELL BIOCHEM, V93, P774, DOI 10.1002/jcb.20181; Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	54	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8384	8397		10.1074/jbc.M112.341586	http://dx.doi.org/10.1074/jbc.M112.341586			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275359	Green Published, hybrid			2022-12-27	WOS:000301349400053
J	Wright, CJ; Agboke, F; Muthu, M; Michaelis, KA; Mundy, MA; La, P; Yang, G; Dennery, PA				Wright, Clyde J.; Agboke, Fadeke; Muthu, Manasa; Michaelis, Katherine A.; Mundy, Miles A.; La, Ping; Yang, Guang; Dennery, Phyllis A.			Nuclear Factor-kappa B (NF-kappa B) Inhibitory Protein I kappa B beta Determines Apoptotic Cell Death following Exposure to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; DNA-BINDING; ALPHA; ACTIVATION; EXPRESSION; INFLAMMATION; LETHALITY; PATHWAY; LIFE	The transcription factor NF-kappa B regulates the cellular response to inflammatory and oxidant stress. Although many studies have evaluated NF-kappa B activity following exposure to oxidative stress, the role of the I kappa B family of inhibitory proteins in modulating this activity remains unclear. Specifically, the function of I kappa B beta in mediating the cellular response to oxidative stress has not been evaluated. We hypothesized that blocking oxidative stress-induced NF-kappa B signaling through I kappa B beta would prevent apoptotic cell death. Using I kappa B beta knock-in mice (AKBI), in which the I kappa B alpha gene is replaced with the I kappa B beta cDNA, we show that I kappa B beta overexpression prevented oxidative stress-induced apoptotic cell death. This was associated with retention of NF-kappa B subunits in the nucleus and maintenance of NF-kappa B activity. Furthermore, the up-regulation of pro-apoptotic genes in WT murine embryonic fibroblasts (MEFs) exposed to serum starvation was abrogated in AKBI MEFs. Inhibition of apoptosis was observed in WT MEFs overexpressing I kappa B beta with simultaneous I kappa B alpha knockdown, whereas I kappa B beta overexpression alone did not produce this effect. These findings represent a necessary but not sufficient role of I kappa B beta in preventing oxidant stress-induced cell death.	[Wright, Clyde J.; Michaelis, Katherine A.] Univ Colorado Denver Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80045 USA; [Agboke, Fadeke; Muthu, Manasa; Mundy, Miles A.; La, Ping; Yang, Guang; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA; [Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Wright, CJ (corresponding author), Univ Colorado Denver Sch Med, Dept Pediat, Pediat Heart Lung Ctr, Aurora, CO 80045 USA.	clyde.wright@ucdenver.edu	Dennery, Phyllis/GQG-9113-2022	Michaelis, Katherine/0000-0002-3225-3649; Mundy, Miles/0000-0003-2173-4268; Dennery, Phyllis/0000-0001-5745-1855	National Institutes of Health [K08 HL098562, HL058752-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058752, K08HL098562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants K08 HL098562 (to C. J. W.) and HL058752-11 (to P. A. D.).	ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Fan CG, 2004, J CLIN INVEST, V113, P746, DOI 10.1172/JCI200417337; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goyeneche AA, 2006, REPRODUCTION, V131, P103, DOI 10.1530/rep.1.00751; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Memet S, 1999, J IMMUNOL, V163, P5994; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suyang H, 1996, MOL CELL BIOL, V16, P5444; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Weil R, 1997, J BIOL CHEM, V272, P9942	31	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6230	6239		10.1074/jbc.M111.318246	http://dx.doi.org/10.1074/jbc.M111.318246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223647	Green Published, hybrid			2022-12-27	WOS:000300791800016
J	Yoo, BK; Lamarre, I; Martin, JL; Negrerie, M				Yoo, Byung-Kuk; Lamarre, Isabelle; Martin, Jean-Louis; Negrerie, Michel			Quaternary Structure Controls Ligand Dynamics in Soluble Guanylate Cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; NITRIC-OXIDE DYNAMICS; NOSTOC H-NOX; CARBON-MONOXIDE; RELAXING FACTOR; MOLECULAR-BASIS; HEME DOMAINS; BINDING; ACTIVATION; MYOGLOBIN	Soluble guanylate cyclase (sGC) is the mammalian endogenous nitric oxide (NO) receptor. The mechanisms of activation and deactivation of this heterodimeric enzyme are unknown. For deciphering them, functional domains can be overexpressed. We have probed the dynamics of the diatomic ligands NO and CO within the isolated heme domain beta(1)(190) of human sGC by piconanosecond absorption spectroscopy. After photo-excitation of nitrosylated sGC, only NO geminate rebinding occurs in 7.5 ps. In beta(1)(190), both photo-dissociation of 5c-NO and photo-oxidation occur, contrary to sGC, followed by NO rebinding (7 ps) and back-reduction (230 ps and 2 ns). In full-length sGC, CO geminately rebinding to the heme does not occur. In contrast, CO geminately rebinds to beta(1)(190) with fast multiphasic process (35, 171, and 18 ns). We measured the bimolecular association rates k(on) = 0.075 +/- 0.01 x 10(6) M(-1.)s(-1) for sGC and 0.83 +/- 0.1 x 10(6) M(-1.)s(-1) for beta(1)(190). These different dynamics reflect conformational changes and less proximal constraints in the isolated heme domain with respect to the dimeric native sGC. We concluded that the alpha-subunit and the beta(1)(191-619) domain exert structural strains on the heme domain. These strains are likely involved in the transmission of the energy and relaxation toward the activated state after Fe2+-His bond breaking. This also reveals the heme domain plasticity modulated by the associated domains and subunit.	[Yoo, Byung-Kuk; Lamarre, Isabelle; Martin, Jean-Louis; Negrerie, Michel] CNRS UMR 7645 Ecole Polytech, Lab Opt & Biosci, INSERM U696, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut National de la Sante et de la Recherche Medicale (Inserm)	Negrerie, M (corresponding author), CNRS UMR 7645 Ecole Polytech, Lab Opt & Biosci, INSERM U696, F-91128 Palaiseau, France.	michel.negrerie@polytechnique.fr	Yoo, Byung-Kuk/A-2980-2011; Yoo, Byung-Kuk/R-2347-2017; Negrerie, Michel/L-2283-2018	Yoo, Byung-Kuk/0000-0002-2610-6685; Negrerie, Michel/0000-0001-9918-031X	Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by a Fondation pour la Recherche Medicale fellowship (to B.-K. Y.).	Balakrishnan G, 2009, J BIOL INORG CHEM, V14, P741, DOI 10.1007/s00775-009-0487-7; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRUNE B, 1990, EUR J BIOCHEM, V192, P683, DOI 10.1111/j.1432-1033.1990.tb19276.x; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Deinum G, 1996, BIOCHEMISTRY-US, V35, P1540; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kruglik SG, 2007, J BIOL CHEM, V282, P5053, DOI 10.1074/jbc.M604327200; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Negrerie M, 2001, J BIOL CHEM, V276, P46815, DOI 10.1074/jbc.M102224200; Negrerie M, 1999, J BIOL CHEM, V274, P24694, DOI 10.1074/jbc.274.35.24694; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P4346, DOI 10.1021/bi9708693; Sato A, 2007, P NATL ACAD SCI USA, V104, P9627, DOI 10.1073/pnas.0611560104; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; Sugimoto T, 1998, BIOPHYS J, V75, P2188, DOI 10.1016/S0006-3495(98)77662-3; Tsai AL, 2010, BIOCHEMISTRY-US, V49, P6587, DOI 10.1021/bi1002234; Weinert EE, 2010, ANGEW CHEM INT EDIT, V49, P720, DOI 10.1002/anie.200904799; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Ye X, 2005, J AM CHEM SOC, V127, P5854, DOI 10.1021/ja042365f; Zhong FF, 2010, AMINO ACIDS, V39, P399, DOI 10.1007/s00726-009-0453-2	41	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6851	6859		10.1074/jbc.M111.299297	http://dx.doi.org/10.1074/jbc.M111.299297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223482	hybrid, Green Published			2022-12-27	WOS:000300791800070
J	Ulrich, DL; Lynch, J; Wang, Y; Fukuda, Y; Nachagari, D; Du, GQ; Sun, DX; Fan, YP; Tsurkan, L; Potter, PM; Rehg, JE; Schuetz, JD				Ulrich, Dagny L.; Lynch, John; Wang, Yao; Fukuda, Yu; Nachagari, Deepa; Du, Guoqing; Sun, Daxi; Fan, Yiping; Tsurkan, Lyudmila; Potter, Philip M.; Rehg, Jerold E.; Schuetz, John D.			ATP-dependent Mitochondrial Porphyrin Importer ABCB6 Protects against Phenylhydrazine Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; KRUPPEL-LIKE FACTOR; HEME OXYGENASE-1; ERYTHROPOIETIC PROTOPORPHYRIA; PROMOTER REGION; CELL-SURVIVAL; FERROCHELATASE; MICE; IDENTIFICATION; MITOFERRIN-1	Abcb6 is a mammalian mitochondrial ATP-binding cassette (ABC) transporter that regulates de novo porphyrin synthesis. In previous studies, haploinsufficient (Abcb6(+/-)) embryonic stem cells showed impaired porphyrin synthesis. Unexpectedly, Abcb6(-/-) mice derived from these stem cells appeared phenotypically normal. We hypothesized that other ATP-dependent and/or -independent mechanisms conserve porphyrins. Here, we demonstrate that Abcb6(-/-) mice lack mitochondrial ATP-driven import of coproporphyrin III. Gene expression analysis revealed that loss of Abcb6 results in up-regulation of compensatory porphyrin and iron pathways, associated with elevated protoporphyrin IX (PPIX). Phenylhydrazine-induced stress caused higher mortality in Abcb6(-/-) mice, possibly because of sustained elevation of PPIX and an inability to convert PPIX to heme despite elevated ferrochelatase levels. Therefore, Abcb6 is the sole ATP-dependent porphyrin importer, and loss of Abcb6 produces up-regulation of heme and iron pathways necessary for normal development. However, under extreme demand for porphyrins (e.g. phenylhydrazine stress), these adaptations appear inadequate, which suggests that under these conditions Abcb6 is important for optimal survival.	[Ulrich, Dagny L.; Lynch, John; Wang, Yao; Fukuda, Yu; Nachagari, Deepa; Du, Guoqing; Sun, Daxi; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Fan, Yiping] St Jude Childrens Res Hosp, Dept Res Informat, Memphis, TN 38105 USA; [Tsurkan, Lyudmila; Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Fukuda, Yu/GLT-1434-2022; Rehg, Jerold E/N-8111-2018; Potter, Philip/J-4515-2013	Potter, Philip/0000-0001-8922-8535; Fukuda, Yu/0000-0001-6182-540X	National Institutes of Health [ES058571, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported, in whole or in part, by National Institutes of Health Grants ES058571, P30 CA21745, and CA21865. This work was also supported by American Lebanese Syrian Associated Charities.	Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen GG, 2004, J CELL BIOCHEM, V92, P1246, DOI 10.1002/jcb.20157; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Emadi-Konjin HP, 2002, BBA-GENE STRUCT EXPR, V1574, P117, DOI 10.1016/S0167-4781(01)00340-2; FENG WC, 1994, J BIOL CHEM, V269, P1493; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; Goerz G, 1996, BRIT J DERMATOL, V134, P880; Hyde B. B., 2012, CELL DEATH DIFFER, V19, P1; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; KOLLER ME, 1980, BIOCHEM J, V188, P329, DOI 10.1042/bj1880329; Kramer MF, 2000, GENE, V247, P153, DOI 10.1016/S0378-1119(00)00103-7; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Labbe RF, 1999, CLIN CHEM, V45, P2060; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Li F M, 1987, Biomed Chromatogr, V2, P164, DOI 10.1002/bmc.1130020408; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Magness ST, 2002, BLOOD, V100, P1470, DOI 10.1182/blood-2001-12-0283; Medlock AE, 2000, BIOCHEMISTRY-US, V39, P7461, DOI 10.1021/bi000134p; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; O'Callaghan KM, 2010, J BIOL CHEM, V285, P381, DOI 10.1074/jbc.M109.063248; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rampon C, 2009, FASEB J, V23, P4181, DOI 10.1096/fj.09-129262; Rebeiz N, 1996, ARCH BIOCHEM BIOPHYS, V333, P475, DOI 10.1006/abbi.1996.0417; Rettmer RL, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e37; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; TUGORES A, 1994, J BIOL CHEM, V269, P30789; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Winzerling JJ, 2001, J PEDIATR-US, V139, P134, DOI 10.1067/mpd.2001.115574; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	44	47	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12679	12690		10.1074/jbc.M111.336180	http://dx.doi.org/10.1074/jbc.M111.336180			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22294697	hybrid, Green Published			2022-12-27	WOS:000302903700008
J	Hur, JY; Teranishi, Y; Kihara, T; Yamamoto, NG; Inoue, M; Hosia, W; Hashimoto, M; Winblad, B; Frykman, S; Tjernberg, LO				Hur, Ji-Yeun; Teranishi, Yasuhiro; Kihara, Takahiro; Yamamoto, Natsuko Goto; Inoue, Mitsuhiro; Hosia, Waltteri; Hashimoto, Masakazu; Winblad, Bengt; Frykman, Susanne; Tjernberg, Lars O.			Identification of Novel gamma-Secretase-associated Proteins in Detergent-resistant Membranes from Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ATP SYNTHASE COMPLEX; LIPID RAFT PROTEINS; ALZHEIMERS-DISEASE; A-BETA; VESICULAR TRAFFICKING; ENRICHED MICRODOMAINS; PRESENILIN MUTATIONS; CELL-MEMBRANES; TALKING POINT	In Alzheimer disease, oligomeric amyloid beta-peptide (A beta) species lead to synapse loss and neuronal death. gamma-Secretase, the transmembrane protease complex that mediates the final catalytic step that liberates A beta from its precursor protein (APP), has a multitude of substrates, and therapeutics aimed at reducing A beta production should ideally be specific for APP cleavage. It has been shown that APP can be processed in lipid rafts, and gamma-secretase-associated proteins can affect A beta production. Here, we use a biotinylated inhibitor for affinity purification of gamma-secretase and associated proteins and mass spectrometry for identification of the purified proteins, and we identify novel gamma-secretase-associated proteins in detergent-resistant membranes from brain. Furthermore, we show by small interfering RNA-mediated knockdown of gene expression that a subset of the gamma-secretase-associated proteins, in particular voltage-dependent anion channel 1 (VDAC1) and contactin-associated protein 1 (CNTNAP1), reduced A beta production (A beta 40 and A beta 42) by around 70%, whereas knockdown of presenilin 1, one of the essential gamma-secretase complex components, reduced A beta production by 50%. Importantly, these proteins had a less pronounced effect on Notch processing. We conclude that VDAC1 and CNTNAP1 associate with gamma-secretase in detergent-resistant membranes and affect APP processing and suggest that molecules that interfere with	[Hur, Ji-Yeun; Teranishi, Yasuhiro; Kihara, Takahiro; Yamamoto, Natsuko Goto; Inoue, Mitsuhiro; Hosia, Waltteri; Hashimoto, Masakazu; Winblad, Bengt; Frykman, Susanne; Tjernberg, Lars O.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Kl Alzheimer Dis Res Ctr, Dainippon Sumitomo Pharma Alzheimer Ctr, SE-14157 Huddinge, Sweden	Karolinska Institutet	Hur, JY (corresponding author), Blickagangen 6D, S-14157 Huddinge, Sweden.	hurj@mskcc.org		Hur, Ji Yeun/0000-0002-9895-3090	Gamla Tjanarinnor; Knut and Alice Wallenberg Foundation; Dainippon Sumitomo Pharma	Gamla Tjanarinnor; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.)	This work was supported by Gamla Tjanarinnor (to J.-Y.H.), Knut and Alice Wallenberg Foundation, and Dainippon Sumitomo Pharma.	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Aoki M, 2008, NEUROREPORT, V19, P1085, DOI 10.1097/WNR.0b013e328302c858; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Berntenis N., 2007, World Intellectual Property Organization Patent, Patent No. [WO/2007/140971, 2007140971]; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blonder J, 2005, J PROTEOME RES, V4, P523, DOI 10.1021/pr049790s; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Buckholtz NS, 2011, NATURE, V475, pS8, DOI 10.1038/475S8a; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Compton AG, 2008, AM J HUM GENET, V83, P714, DOI 10.1016/j.ajhg.2008.10.022; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Ferrer I, 2009, J BIOENERG BIOMEMBR, V41, P425, DOI 10.1007/s10863-009-9243-5; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gollan L, 2003, J CELL BIOL, V163, P1213, DOI 10.1083/jcb.200309147; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kimberly WT, 2003, J NEUROSCI RES, V74, P353, DOI 10.1002/jnr.10736; Lee K. H., 2006, World Intellectual Property Organization Patent, Patent No. [WO/2006/110621, 2006110621]; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Luider T. M., 2008, World Intellectual Property Organization Patent, Patent No. [WO/2008/085035, 2008085035]; Man P, 2005, PROTEOMICS, V5, P113, DOI 10.1002/pmic.200400887; Martosella J, 2006, J PROTEOME RES, V5, P1301, DOI 10.1021/pr060051g; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Pavlov PF, 2009, J CELL MOL MED, V13, P4137, DOI 10.1111/j.1582-4934.2009.00892.x; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Raimondo F, 2005, EXPERT REV PROTEOMIC, V2, P793, DOI 10.1586/14789450.2.5.793; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Rees R. C., 2009, World Intellectual Property Organization Patent, Patent No. [WO/2009/156747, 2009156747]; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; Teranishi Y, 2010, J CELL MOL MED, V14, P2675, DOI 10.1111/j.1582-4934.2009.00907.x; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Williamson R, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-120; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	68	43	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11991	12005		10.1074/jbc.M111.246074	http://dx.doi.org/10.1074/jbc.M111.246074			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22315232	Green Published, hybrid			2022-12-27	WOS:000302782200037
J	Khandros, E; Mollan, TL; Yu, X; Wang, XM; Yao, Y; D'Souza, J; Gell, DA; Olson, JS; Weiss, MJ				Khandros, Eugene; Mollan, Todd L.; Yu, Xiang; Wang, Xiaomei; Yao, Yu; D'Souza, Janine; Gell, David A.; Olson, John S.; Weiss, Mitchell J.			Insights into Hemoglobin Assembly through in Vivo Mutagenesis of alpha- Hemoglobin Stabilizing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE; HEMIN DISSOCIATION; GLOBIN BINDING; BETA-CHAINS; AHSP; ERYTHROPOIESIS; THALASSEMIA; CYTOGLOBIN; OXIDATION; SUBUNITS	alpha-Hemoglobin stabilizing protein (AHSP) is believed to facilitate adult Hemoglobin A assembly and protect against toxic free alpha-globin subunits. Recombinant AHSP binds multiple forms of free alpha-globin to stabilize their structures and inhibit precipitation. However, AHSP also stimulates auto-oxidation of alpha O-2 subunit and its rapid conversion to a partially unfolded bishistidyl hemichrome structure. To investigate these biochemical properties, we altered the evolutionarily conserved AHSP proline 30 in recombinantly expressed proteins and introduced identical mutations into the endogenous murine Ahsp gene. In vitro, the P30W AHSP variant bound oxygenated alpha chains with 30-fold increased affinity. Both P30W and P30A mutant proteins also caused decreased rates of alpha O-2 autooxidation as compared with wildtype AHSP. Despite these abnormalities, mice harboring P30A or P30W Ahsp mutations exhibited no detectable defects in erythropoiesis at steady state or during induced stresses. Further biochemical studies revealed that the AHSP P30A and P30W substitutions had minimal effects on AHSP interactions with ferric alpha subunits. Together, our findings indicate that the ability of AHSP to stabilize nascent alpha chain folding intermediates prior to hemin reduction and incorporation into adult Hemoglobin A is physiologically more important than AHSP interactions with ferrous alpha O-2 subunits.	[Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr 316B, Philadelphia, PA 19104 USA; [Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Mollan, Todd L.; Olson, John S.] Rice Univ, Biochem & Cell Biol Dept, Houston, TX 77251 USA; [Khandros, Eugene; Yu, Xiang; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Tasmania; Menzies Institute for Medical Research; Rice University; University of Pennsylvania	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr 316B, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu	Weiss, Mitchell J/A-1245-2013; yu, xiang/B-1653-2010; Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; Gell, David/0000-0003-0382-1181	National Institutes of Health [DK061692, HL087427, HL47020, GM35649, GM008362]; Robert A. Welch Foundation [C-0612]; DiGaetano family; National Institutes of Health through the NHLBI [3T32GM007170-35S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692, R56DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008362, T32GM007170, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); DiGaetano family; National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061692 (to M. J. W.), HL087427 (to M. J. W.), HL47020 (to J. S. O.), GM35649 (to J. S. O.), GM008362 (to T. L. M. through the Biotechnology Predoctoral Training Program at Rice University), and 3T32GM007170-35S1 (to E. K. through the NHLBI Medical Scientist Training Program). This work was also supported by Robert A. Welch Foundation Grant C-0612 (to J. S. O.) and the DiGaetano family.	Adachi K, 2002, J BIOL CHEM, V277, P13415, DOI 10.1074/jbc.M200857200; ADVANI R, 1992, BLOOD, V79, P1058; Alter B P, 1981, Prog Clin Biol Res, V60, P157; ANTONINI E, 1966, J MOL BIOL, V17, P29, DOI 10.1016/S0022-2836(66)80092-X; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bogacheva O, 2008, J BIOL CHEM, V283, P36665, DOI 10.1074/jbc.M807844200; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Favero ME, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/373859; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; JOSHI W, 1983, J LAB CLIN MED, V102, P46; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; MANNU F, 1995, BLOOD, V86, P2014, DOI 10.1182/blood.V86.5.2014.bloodjournal8652014; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Pesce A, 2002, ACTA CRYSTALLOGR D, V58, P1848, DOI 10.1107/S090744490201260X; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; RACHMILEWITZ EA, 1974, SEMIN HEMATOL, V11, P441; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; ROUYERFESSARD P, 1989, J BIOL CHEM, V264, P19092; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCHRIER SL, 1989, BLOOD, V74, P2194; SCHULMAN HM, 1974, BIOCHEM BIOPH RES CO, V56, P220, DOI 10.1016/S0006-291X(74)80337-2; SCHULMAN HM, 1974, CAN J BIOCHEM CELL B, V52, P665, DOI 10.1139/o74-095; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; SHINAR E, 1989, J CLIN INVEST, V83, P404, DOI 10.1172/JCI113898; SHINAR E, 1987, BLOOD, V70, P158; SORENSEN S, 1990, BLOOD, V75, P1333; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Turbpaiboon C, 2006, BRIT J HAEMATOL, V132, P370, DOI 10.1111/j.1365-2141.2005.05865.x; Vasseur C, 2011, AM J HEMATOL, V86, P199, DOI 10.1002/ajh.21918; Vasseur C, 2009, CLIN BIOCHEM, V42, P1818, DOI 10.1016/j.clinbiochem.2009.05.011; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Vitagliano L, 2004, EUR J BIOCHEM, V271, P1651, DOI 10.1111/j.1432-1033.2004.04054.x; Wajcman H, 2008, HEMOGLOBIN, V32, P327, DOI 10.1080/03630260802173833; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; WINTERBOURN CC, 1974, J CLIN INVEST, V54, P678, DOI 10.1172/JCI107806; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	70	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11325	11337		10.1074/jbc.M111.313205	http://dx.doi.org/10.1074/jbc.M111.313205			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22287545	hybrid, Green Published			2022-12-27	WOS:000302780100063
J	Valdearcos, M; Esquinas, E; Meana, C; Pena, L; Gil-de-Gomez, L; Balsinde, J; Balboa, MA				Valdearcos, Martin; Esquinas, Esperanza; Meana, Clara; Pena, Lucia; Gil-de-Gomez, Luis; Balsinde, Jesus; Balboa, Maria A.			Lipin-2 Reduces Proinflammatory Signaling Induced by Saturated Fatty Acids in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IVA PHOSPHOLIPASE A(2); N-TERMINAL KINASE; INSULIN-RESISTANCE; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; ADIPOSE-TISSUE; NUCLEAR-FACTOR; ACTIVATION; CELLS; GENE	Lipin-2 is a member of the lipin family of enzymes, which are key effectors in the biosynthesis of lipids. Mutations in the humanlipin-2 gene are associated with inflammatory-based disorders; however, the role of lipin-2 in cells of the immune system remains obscure. In this study, we have investigated the role of lipin-2 in the proinflammatory action of saturated fatty acids in murine and human macrophages. Depletion of lipin-2 promotes the increased expression of the proinflammatory genes Il6, Ccl2, and Tnf alpha, which depends on the overstimulation of the JNK1/c-Jun pathway by saturated fatty acids. In contrast, overexpression of lipin-2 reduces the release of proinflammatory factors. Metabolically, the absence of lipin-2 reduces the cellular content of triacylglycerol in saturated fatty acid-overloaded macrophages. Collectively, these studies demonstrate a protective role for lipin-2 in proinflammatory signaling mediated by saturated fatty acids that occurs concomitant with an enhanced cellular capacity for triacylglycerol synthesis. The data provide new insights into the role of lipin-2 in human and murine macrophage biology and may open new avenues for controlling the fatty acid-related low grade inflammation that constitutes the sine qua non of obesity and associated metabolic disorders.	[Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; Ctr Invest Biomed Red Diabet & Enfermedad Metab A, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Balboa, MA (corresponding author), CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain.	mbalboa@ibgm.uva.es	Balsinde, Jesús/C-7833-2018; Meana, Clara/AAN-4887-2020; Balboa, María A./V-9493-2018	Balsinde, Jesús/0000-0002-4157-6714; Balboa, María A./0000-0002-2130-5298; Gil-de-Gomez, Luis/0000-0002-7864-3976; Meana, Clara/0000-0003-3580-6058; Valdearcos Contreras, Martin/0000-0002-5784-2458	Spanish Ministry of Science and Innovation [SAF2010-18831, BFU2010-18826]; Regional Government of Castile and Leon [BIO39/VA04/10]; Regional Government of Castile and Leon, Spain; Spanish National Research Council	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Castile and Leon; Regional Government of Castile and Leon, Spain; Spanish National Research Council	This work was supported in part by Spanish Ministry of Science and Innovation Grants SAF2010-18831 and BFU2010-18826 and Regional Government of Castile and Leon Grant BIO39/VA04/10.; Supported by a predoctoral fellowship from the Regional Government of Castile and Leon, Spain.; Supported by a predoctoral fellowship from the Spanish National Research Council (Junta de Ampliacion de Estudios Program).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Astudillo AM, 2011, J BIOL CHEM, V286, P35299, DOI 10.1074/jbc.M111.277137; Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; BALBOA MA, 1995, J BIOL CHEM, V270, P11738, DOI 10.1074/jbc.270.20.11738; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bremmer S, 2010, J AM ACAD DERMATOL, V63, P1058, DOI 10.1016/j.jaad.2009.09.053; Casas J, 2010, J LIPID RES, V51, P388, DOI 10.1194/jlr.M001461; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799; Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SMITH SW, 1957, J BIOL CHEM, V228, P915; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEISS SB, 1958, J BIOL CHEM, V231, P53	46	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10894	10904		10.1074/jbc.M112.342915	http://dx.doi.org/10.1074/jbc.M112.342915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334674	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000302780100018
J	Kawabata, T; Tanimura, S; Asai, K; Kawasaki, R; Matsumaru, Y; Kohno, M				Kawabata, Takumi; Tanimura, Susumu; Asai, Kohei; Kawasaki, Ryohei; Matsumaru, Yumi; Kohno, Michiaki			Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SIGNALING PATHWAY; CANCER-THERAPY; CONSTITUTIVE ACTIVATION; DESTABILIZING AGENTS; MITOTIC ARREST; PHOSPHORYLATION; BLOCKADE; DESTRUCTION; ARRY-142886	Blockade of the ERK signaling pathway by ERK kinase (MEK) inhibitors selectively enhances the induction of apoptosis by microtubule inhibitors in tumor cells in which this pathway is constitutively activated. We examined the mechanism by which such drug combinations induce enhanced cell death by applying time-lapse microscopy to track the fate of individual cells. MEK inhibitors did not affect the first mitosis after drug exposure, but most cells remained arrested in interphase without entering a second mitosis. Low concentrations of microtubule inhibitors induced prolonged mitotic arrest followed by exit of cells from mitosis without division, with most cells remaining viable. However, the combination of a MEK inhibitor and a microtubule inhibitor induced massive cell death during prolonged mitosis. Impairment of spindle assembly checkpoint function by RNAi-mediated depletion of Mad2 or BubR1 markedly suppressed such prolonged mitotic arrest and cell death. The cell death was accompanied by up-regulation of the pro-apoptotic protein Bim (to which MEK inhibitors contributed) and by down-regulation of the anti-apoptotic protein Mcl-1 (to which microtubule and MEK inhibitors contributed synergistically). Whereas RNAi-mediated knockdown of Bim suppressed cell death, stabilization of Mcl-1 by RNAi-mediated depletion of Mule slowed its onset. Depletion of Mcl-1 sensitized tumor cells to MEK inhibitor-induced cell death, an effect that was antagonized by knockdown of Bim. The combination of MEK and microtubule inhibitors thus targets Bim and Mcl-1 in a cooperative manner to induce massive cell death in tumor cells with aberrant ERK pathway activation.	[Kawabata, Takumi; Tanimura, Susumu; Asai, Kohei; Kawasaki, Ryohei; Matsumaru, Yumi; Kohno, Michiaki] Nagasaki Univ, Lab Cell Regulat, Dept Pharmaceut Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Tanimura, Susumu] Nagasaki Univ Res Ctr Genom Instabil & Carcinogen, Nagasaki 8528523, Japan; [Kohno, Michiaki] Kyoto Univ, Dept Biochem Genet, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Nagasaki University; Nagasaki University; Kyoto University	Kohno, M (corresponding author), Nagasaki Univ, Lab Cell Regulat, Dept Pharmaceut Sci, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kohnom@nagasaki-u.ac.jp	Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Kaestner P, 2010, J CELL BIOCHEM, V111, P258, DOI 10.1002/jcb.22721; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kohno M, 2011, BIOL PHARM BULL, V34, P1781, DOI 10.1248/bpb.34.1781; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McDaid HM, 2005, CANCER RES, V65, P2854, DOI 10.1158/0008-5472.CAN-04-4391; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; OKA H, 1995, CANCER RES, V55, P4182; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Tanimura S, 2009, BIOCHEM BIOPH RES CO, V378, P650, DOI 10.1016/j.bbrc.2008.11.109; Watanabe K, 2010, CLIN CANCER RES, V16, P1170, DOI 10.1158/1078-0432.CCR-09-2482; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	40	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10289	10300		10.1074/jbc.M111.319426	http://dx.doi.org/10.1074/jbc.M111.319426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270368	Green Published, hybrid			2022-12-27	WOS:000302167200058
J	Lo, D; Dai, MS; Sun, XX; Zeng, SX; Lu, H				Lo, Dorothy; Dai, Mu-Shui; Sun, Xiao-Xin; Zeng, Shelya X.; Lu, Hua			Ubiquitin- and MDM2 E3 Ligase-independent Proteasomal Turnover of Nucleostemin in Response to GTP Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOPHENOLIC-ACID; ACTIVATES P53; INHIBITION; PROMOTES; UBIQUITYLATION; PROLIFERATION; DEGRADATION; NUCLEOLUS; PROTEINS; CELLS	Nucleostemin (NS) is a nucleolar GTP-binding protein essential for ribosomal biogenesis, proliferation, and animal embryogenesis. It remains largely unclear how this protein is regulated. While working on its role in suppression of MDM2 and activation of p53, we observed that NS protein (but not mRNA) levels decreased drastically in response to GTP depletion. When trying to further elucidate the molecular mechanism(s) underlying this unusual phenomenon, we found that NS was degraded independently of ubiquitin and MDM2 upon GTP depletion. First, depletion of GTP by treating cells with mycophenolic acid decreased the level of NS without apparently affecting the levels of other nucleolar proteins. Second, mutant NS defective in GTP binding and exported to the nucleoplasm was much less stable than wild-type NS. Although NS was ubiquitinated in cells, its polyubiquitination was independent of Lys-48 or Lys-63 in the ubiquitin molecule. Inactivation of E1 in E1 temperature-sensitive mouse embryonic fibroblast (MEF) cells failed to prevent the proteasomal degradation of NS. The proteasomal turnover of NS was also MDM2-independent, as its half-life in p53/MDM2 double knock-out MEF cells was the same as that in wild-type MEF cells. Moreover, NS ubiquitination was MDM2-independent. Mycophenolic acid or doxorubicin induced NS degradation in various human cancerous cells regardless of the status of MDM2. Hence, these results indicate that NS undergoes a ubiquitin-and MDM2-independent proteasomal degradation when intracellular GTP levels are markedly reduced and also suggest that ubiquitination of NS may be involved in regulation of its function rather than stability.	[Lo, Dorothy; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Lo, Dorothy; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Dai, Mu-Shui; Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	Tulane University; Tulane University; Oregon Health & Science University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			National Institutes of Health from NCI [CA095441, CA079721, CA129828]; NATIONAL CANCER INSTITUTE [R01CA129828, R01CA079721, R01CA095441] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA095441, CA079721, and CA129828 from NCI (to H. L.).	Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; LOWE JK, 1977, CANCER RES, V37, P736; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Siddiqi S, 2008, CIRC RES, V103, P89, DOI 10.1161/CIRCRESAHA.107.169334; Stewart DP, 2010, MOL CELL BIOL, V30, P3099, DOI 10.1128/MCB.01266-09; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507	28	16	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10013	10020		10.1074/jbc.M111.335141	http://dx.doi.org/10.1074/jbc.M111.335141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318725	Green Published, hybrid			2022-12-27	WOS:000302167200033
J	Ahmad, B; Lapidus, LJ				Ahmad, Basir; Lapidus, Lisa J.			Curcumin Prevents Aggregation in alpha-Synuclein by Increasing Reconfiguration Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE; POLYPEPTIDES; DISEASE	alpha-Synuclein is a protein that is intrinsically disordered in vitro and prone to aggregation, particularly at high temperatures. In this work, we examined the ability of curcumin, a compound found in turmeric, to prevent aggregation of the protein. We found strong binding of curcumin to alpha-synuclein in the hydrophobic non-amyloid-beta component region and complete inhibition of oligomers or fibrils. We also found that the reconfiguration rate within the unfolded protein was significantly increased at high temperatures. We conclude that alpha-synuclein is prone to aggregation because its reconfiguration rate is slow enough to expose hydrophobic residues on the same time scale that bimolecular association occurs. Curcumin rescues the protein from aggregation by increasing the reconfiguration rate into a faster regime.	[Ahmad, Basir; Lapidus, Lisa J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Michigan State University	Lapidus, LJ (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	lapidus@msu.edu	Ahmad, Basir/O-9344-2017	Ahmad, Basir/0000-0002-0120-5097	National Science Foundation [MCB-0825001]; Michigan State University High Performance Computing Center; Institute for Cyber Enabled Research	National Science Foundation(National Science Foundation (NSF)); Michigan State University High Performance Computing Center; Institute for Cyber Enabled Research	This work was supported by National Science Foundation Grant MCB-0825001.; We thank Charles Hoogstraten for helpful discussions, Gary Pielak for the kind gift of the alpha-synuclein plasmid, and Terry Ball for mutation and expression of the protein. We acknowledge the support of the Michigan State University High Performance Computing Center and the Institute for Cyber Enabled Research.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Amer DAM, 2006, EXP BRAIN RES, V173, P223, DOI 10.1007/s00221-006-0539-y; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chen YJ, 2009, J PHYS CHEM B, V113, P16209, DOI 10.1021/jp904189b; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GONNELLI M, 1995, BIOCHEMISTRY-US, V34, P13847, DOI 10.1021/bi00042a017; Kumar P, 2011, INT J MOL SCI, V12, P694, DOI 10.3390/ijms12010694; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lapidus LJ, 2002, J MOL BIOL, V319, P19, DOI 10.1016/S0022-2836(02)00193-6; Lapidus LJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258101; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Singh VR, 2007, BIOCHEMISTRY-US, V46, P10046, DOI 10.1021/bi700270j; Sneharani AH, 2010, J AGR FOOD CHEM, V58, P11130, DOI 10.1021/jf102826q; Sneharani AH, 2009, J AGR FOOD CHEM, V57, P10386, DOI 10.1021/jf902464p; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	25	118	119	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9193	9199		10.1074/jbc.M111.325548	http://dx.doi.org/10.1074/jbc.M111.325548			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267729	hybrid, Green Published			2022-12-27	WOS:000301797800047
J	Belyaeva, OV; Lee, SA; Adams, MK; Chang, CB; Kedishvili, NY				Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Chang, Chenbei; Kedishvili, Natalia Y.			Short Chain Dehydrogenase/Reductase Rdhe2 Is a Novel Retinol Dehydrogenase Essential for Frog Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ACID SYNTHESIS; GENE-EXPRESSION; VITAMIN-A; ORGAN DIFFERENTIATION; CELL-DIFFERENTIATION; BILATERAL SYMMETRY; NUCLEAR RECEPTORS; BINDING-PROTEIN; XENOPUS-EMBRYOS	The enzymes responsible for the rate-limiting step in retinoic acid biosynthesis, the oxidation of retinol to retinaldehyde, during embryogenesis and in adulthood have not been fully defined. Here, we report that a novel member of the short chain dehydrogenase/reductase superfamily, frog sdr16c5, acts as a highly active retinol dehydrogenase (rdhe2) that promotes retinoic acid biosynthesis when expressed in mammalian cells. In vivo assays of rdhe2 function show that overexpression of rdhe2 in frog embryos leads to posteriorization and induction of defects resembling those caused by retinoic acid toxicity. Conversely, antisense morpholino-mediated knockdown of endogenous rdhe2 results in phenotypes consistent with retinoic acid deficiency, such as defects in anterior neural tube closure, microcephaly with small eye formation, disruption of somitogenesis, and curved body axis with bent tail. Higher doses of morpholino induce embryonic lethality. Analyses of retinoic acid levels using either endogenous retinoic acid-sensitive gene hoxd4 or retinoic acid reporter cell line both show that the levels of retinoic acid are significantly decreased in rdhe2 morphants. Taken together, these results provide strong evidence that Xenopus rdhe2 functions as a retinol dehydrogenase essential for frog embryonic development in vivo. Importantly, the retinol oxidizing activity of frog rdhe2 is conserved in its mouse homologs, suggesting that rdhe2-related enzymes may represent the previously unrecognized physiologically relevant retinol dehydrogenases that contribute to retinoic acid biosynthesis in higher vertebrates.	[Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; [Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA; [Chang, Chenbei] Univ Alabama Birmingham, Dept Cell Biol, Sch Dent, Birmingham, AL 35294 USA; [Chang, Chenbei] Univ Alabama Birmingham, Dept Cell Biol, Sch Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Belyaeva, OV (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,Kaul 466, Birmingham, AL 35294 USA.	belyaeva@uab.edu; nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X; Kedishvili, Natalia/0000-0001-6917-4891	National Institutes of Health [AA12153, GM83029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA12153 (to N. Y. K.) and GM83029 (to C. C.).	Albalat R, 2011, GENOME BIOL EVOL, V3, P985, DOI 10.1093/gbe/evr084; Bavik C, 1996, P NATL ACAD SCI USA, V93, P3110, DOI 10.1073/pnas.93.7.3110; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Chen YL, 2001, MECH DEVELOP, V101, P91, DOI 10.1016/S0925-4773(00)00558-X; Chung SSW, 2009, DEVELOPMENT, V136, P2091, DOI 10.1242/dev.020040; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IRIE T, 1991, ZOOL SCI, V8, P855; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Lee SA, 2009, CHEM-BIOL INTERACT, V178, P182, DOI 10.1016/j.cbi.2008.09.019; Liu LQ, 2012, BIRTH DEFECTS RES B, V95, P79, DOI 10.1002/bdrb.20344; Lloret-Vilaspasa F, 2010, INT J DEV BIOL, V54, P599, DOI 10.1387/ijdb.082705fl; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matsuzaka Y, 2002, BIOCHEM BIOPH RES CO, V297, P1171, DOI 10.1016/S0006-291X(02)02344-6; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nie SY, 2006, DEV DYNAM, V235, P301, DOI 10.1002/dvdy.20623; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7; ROSS AC, 1994, ADV EXP MED BIOL, V352, P187; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stern RS, 1997, LANCET, V350, P349, DOI 10.1016/S0140-6736(97)05257-4; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; WAGNER M, 1992, DEVELOPMENT, V116, P55; Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	65	25	26	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9061	9071		10.1074/jbc.M111.336727	http://dx.doi.org/10.1074/jbc.M111.336727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291023	Green Published, hybrid			2022-12-27	WOS:000301797800036
J	Calderon, MR; Verway, M; An, BS; Difeo, A; Bismar, TA; Ann, DK; Martignetti, JA; Shalom-Barak, T; White, JH				Calderon, Mario R.; Verway, Mark; An, Beum-Soo; DiFeo, Analisa; Bismar, Tarek A.; Ann, David K.; Martignetti, John A.; Shalom-Barak, Tali; White, John H.			Ligand-dependent Corepressor (LCoR) Recruitment by Kruppel-like Factor 6 (KLF6) Regulates Expression of the Cyclin-dependent Kinase Inhibitor CDKN1A Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER GROWTH; TUMOR-SUPPRESSOR GENE; UP-REGULATION; E-CADHERIN; TRANSCRIPTIONAL ACTIVATION; RECEPTOR COREPRESSOR; DOWN-REGULATION; REPRESSION; ANDROGEN; PROTEIN	The widely expressed transcriptional coregulator, ligand-dependent corepressor (LCoR), initially characterized as a regulator of nuclear receptor-mediated transactivation, functions through recruitment of C-terminal binding proteins (CtBPs) and histone deacetylases (HDACs) to its N-terminal and central domains, respectively. We performed a yeast two-hybrid screen for novel cofactors, and identified an interaction between the C-terminal domain of LCoR and the transcription factor Kruppel-like factor 6 (KLF6), a putative tumor suppressor in prostate cancer. Subsequent experiments revealed LCoR regulation of several KLF6 target genes notably p21(WAF1/CIP1) (CDKN1A) and to a lesser extent E-cadherin (CDH1), indicating that LCoR regulates gene transcription through multiple classes of transcription factors. In multiple cancer cells, LCoR and KLF6 bind together on the promoters of the genes encoding CDKN1A and CDH1. LCoR contributes to KLF6-mediated transcriptional repression in a promoter-and cell type-dependent manner. Its inhibition of reporter constructs driven by the CDKN1A and CDH1 promoters in PC-3 prostate carcinoma cells is sensitive to treatment with the HDAC inhibitor trichostatin A. Additionally, the LCoR cofactor CtBP1 bound the same promoters and augmented the LCoR-dependent repression in PC-3 cells. Consistent with their inferred roles in transcriptional repression, siRNA-mediated knockdown of KLF6, LCoR, or CtBP1 in PC-3 cells induced expression of CDKN1A and CDH1 and additional KLF6 target genes. We propose a novel model of LCoR function in which promoter-bound KLF6 inhibits transcription of the CDKN1A gene and other genes as well by tethering a transcriptional corepressor complex containing LCoR, with specific contributions by CtBP1 and HDACs.	[Calderon, Mario R.; Verway, Mark; An, Beum-Soo; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Bismar, Tarek A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2V 1P9, Canada; [Ann, David K.] City Hope Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Shalom-Barak, Tali] Univ Pittsburgh, Dept OBGYN & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15213 USA	McGill University; McGill University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Calgary; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	White, JH (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	Bismar, Tarek/ABH-6129-2020; white, john h/N-9782-2013	white, john h/0000-0002-4785-2687; DiFeo, Analisa/0000-0001-8319-6763; Calderon, Mario R/0000-0001-6618-1789	Canadian Institutes of Health Research; Montreal Centre for Experimental Therapeutics in Cancer	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Centre for Experimental Therapeutics in Cancer	This work was supported in part by a Canadian Institutes of Health Research Operating grant (to J. H. W.).; Supported by a studentship from the Montreal Centre for Experimental Therapeutics in Cancer.	Aaltomaa S, 1999, PROSTATE, V39, P8; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Asim M, 2011, J BIOL CHEM, V286, P37108, DOI 10.1074/jbc.M111.292771; Baretton GB, 1999, BRIT J CANCER, V80, P546, DOI 10.1038/sj.bjc.6690390; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fizazi K, 2002, CLIN CANCER RES, V8, P775; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Hall CL, 2010, CANCER RES, V70, P9916, DOI 10.1158/0008-5472.CAN-10-0440; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Kaipparettu BA, 2008, INT J CANCER, V123, P66, DOI 10.1002/ijc.23480; Kojima S, 2000, BLOOD, V95, P1309; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Madison DL, 2010, ONCOGENE, V29, P6027, DOI 10.1038/onc.2010.338; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roy S, 2008, CELL CYCLE, V7, P1828, DOI 10.4161/cc.7.12.6024; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sugibayashi R, 2002, ANTICANCER RES, V22, P713; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; YANG ZY, 1995, NAT MED, V1, P1052, DOI 10.1038/nm1095-1052	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8662	8674		10.1074/jbc.M111.311605	http://dx.doi.org/10.1074/jbc.M111.311605			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277651	hybrid, Green Published			2022-12-27	WOS:000301797800001
J	Hagen-Euteneuer, N; Lutjohann, D; Park, H; Merrill, AH; van Echten-Deckert, G				Hagen-Euteneuer, Nadine; Luetjohann, Dieter; Park, Hyejung; Merrill, Alfred H., Jr.; van Echten-Deckert, Gerhild			Sphingosine 1-Phosphate (S1P) Lyase Deficiency Increases Sphingolipid Formation via Recycling at the Expense of de Novo Biosynthesis in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; SERINE PALMITOYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; LIPID HOMEOSTASIS; CULTURED NEURONS; METABOLISM; CHOLESTEROL; PROTEINS; SALVAGE	Sphingosine 1-phosphate lyase (S1P lyase) irreversibly cleaves sphingosine 1-phosphate (S1P) in the final step of sphingolipid catabolism. As sphingoid bases and their 1-phosphate are not only metabolic intermediates but also highly bioactive lipids that modulate a wide range of physiological processes, it would be predicted that their elevation might induce adjustments in other facets of sphingolipid metabolism and/or alter cell behavior. Indeed, we have previously reported that S1P lyase deficiency causes neurodegeneration and other adverse symptoms. We next asked the question whether and how S1P lyase deficiency affects the metabolism of (glyco)sphingolipids and cholesterol, two lipid classes that might be involved in the neurodegenerative processes observed in S1P lyase-deficient mice. As predicted, there was a considerable increase in free and phosphorylated sphingoid bases upon elimination of S1P lyase, but to our surprise, rather than increasing, the mass of (glyco) sphingolipids persisted at wild type levels. This was discovered to be due to reduced de novo sphingoid base biosynthesis and a corresponding increase in the recycling of the backbones via the salvage pathway. There was also a considerable increase in cholesterol esters, although free cholesterol persisted at wild type levels, which might be secondary to the shifts in sphingolipid metabolism. All in all, these findings show that accumulation of free and phosphorylated sphingoid bases by loss of S1P lyase causes an interesting readjustment of the balance between de novo biosynthesis and recycling to maintain (glyco) sphingolipid homeostasis. These changes, and their impact on the metabolism of other cellular lipids, should be explored as possible contributors to the neurodegeneration in S1P lyase deficiency.	[van Echten-Deckert, Gerhild] Univ Bonn, Kekule Inst, Membrane Biol & Lipid Biochem Unit, Life & Med Sci LIMES Inst, D-53121 Bonn, Germany; [Luetjohann, Dieter] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Bonn; University of Bonn; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	van Echten-Deckert, G (corresponding author), Univ Bonn, Kekule Inst, Membrane Biol & Lipid Biochem Unit, Life & Med Sci LIMES Inst, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	g.echten.deckert@uni-bonn.de		Merrill, Alfred/0000-0002-6673-968X	Deutsche Forschungsgemeinschaft [EC 118/6-1]; NIH [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (EC 118/6-1) (to G. v. E.-D.) and by NIH Grant GM069338 (to A. H. M.).	Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Chigorno V, 1997, EUR J BIOCHEM, V250, P661, DOI 10.1111/j.1432-1033.1997.00661.x; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Riboni L, 1996, FEBS LETT, V391, P336, DOI 10.1016/0014-5793(96)00772-7; RIBONI L, 1994, FEBS LETT, V352, P323, DOI 10.1016/0014-5793(94)00984-8; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Worgall Tilla S., 2008, V49, P371, DOI 10.1007/978-1-4020-8830-8_14	42	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9128	9136		10.1074/jbc.M111.302380	http://dx.doi.org/10.1074/jbc.M111.302380			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291021	Green Published, hybrid			2022-12-27	WOS:000301797800042
J	Montefusco, DJ; Newcomb, B; Gandy, JL; Brice, SE; Matmati, N; Cowart, LA; Hannun, YA				Montefusco, David J.; Newcomb, Benjamin; Gandy, Jason L.; Brice, Sarah E.; Matmati, Nabil; Cowart, L. Ashley; Hannun, Yusuf A.			Sphingoid Bases and the Serine Catabolic Enzyme CHA1 Define a Novel Feedforward/Feedback Mechanism in the Response to Serine Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGANINE N-ACYLTRANSFERASE; HEAT-STRESS RESPONSE; SACCHAROMYCES-CEREVISIAE; DE-NOVO; THREONINE CATABOLISM; SIGNALING PATHWAY; YEAST; SPHINGOLIPIDS; BIOSYNTHESIS; CERAMIDE	Targets of bioactive sphingolipids in Saccharomyces cerevisiae were previously identified using microarray experiments focused on sphingolipid-dependent responses to heat stress. One of these heat-induced genes is the serine deamidase/dehydratase Cha1 known to be regulated by increased serine availability. This study investigated the hypothesis that sphingolipids may mediate the induction of Cha1 in response to serine availability. The results showed that inhibition of de novo synthesis of sphingolipids, pharmacologically or genetically, prevented the induction of Cha1 in response to increased serine availability. Additional studies implicated the sphingoid bases phytosphingosine and dihydrosphingosine as the likely mediators of Cha1 up-regulation. The yeast protein kinases Pkh1 and Pkh2, known sphingoid base effectors, were found to mediate CHA1 up-regulation via the transcription factor Cha4. Because the results disclosed a role for sphingolipids in negative feedback regulation of serine metabolism, we investigated the effects of disrupting this mechanism on sphingolipid levels and on cell growth. Intriguingly, exposure of the cha1 Delta strain to high serine resulted in hyperaccumulation of endogenous serine and in turn a significant accumulation of sphingoid bases and ceramides. Under these conditions, the cha1 Delta strain displayed a significant growth defect that was sphingolipid-dependent. Together, this work reveals a feedforward/feedback loop whereby the sphingoid bases serve as sensors of serine availability and mediate up-regulation of Cha1 in response to serine availability, which in turn regulates sphingolipid levels by limiting serine accumulation.	[Montefusco, David J.; Newcomb, Benjamin; Gandy, Jason L.; Brice, Sarah E.; Matmati, Nabil; Cowart, L. Ashley; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA.	hannun@musc.edu			National Institutes of Health [2R01GM063265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM063265 (to Y. A. H.).	Bachelor MA, 2011, J DERMATOL SCI, V63, P164, DOI 10.1016/j.jdermsci.2011.06.001; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BORNAES C, 1993, MOL CELL BIOL, V13, P7604, DOI 10.1128/MCB.13.12.7604; BORNAES C, 1992, GENETICS, V131, P531; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Collart M. A., 2001, CURRENT PROTOCOLS MO; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Edinger AL, 2009, BIOCHEM SOC T, V37, P253, DOI 10.1042/BST0370253; Frank MP, 2007, J CHROMATOGR B, V852, P646, DOI 10.1016/j.jchromb.2007.01.002; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Holmberg S, 1996, GENETICS, V144, P467; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kim S, 2000, GENETICS, V156, P1519; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Ogawa H, 2006, BBA-PROTEINS PROTEOM, V1764, P961, DOI 10.1016/j.bbapap.2006.02.010; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; PETERSEN JGL, 1988, GENETICS, V119, P527; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tan EH, 2010, ANN ONCOL, V21, P217, DOI 10.1093/annonc/mdp520; Uemura S, 2007, J BIOL CHEM, V282, P8613, DOI 10.1074/jbc.M606649200; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Yamada T, 2008, BBA-GEN SUBJECTS, V1780, P809, DOI 10.1016/j.bbagen.2008.01.020	50	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9280	9289		10.1074/jbc.M111.313445	http://dx.doi.org/10.1074/jbc.M111.313445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277656	hybrid, Green Published			2022-12-27	WOS:000301797800056
J	Mor-Cohen, R; Rosenberg, N; Einav, Y; Zelzion, E; Landau, M; Mansour, W; Averbukh, Y; Seligsohn, U				Mor-Cohen, Ronit; Rosenberg, Nurit; Einav, Yulia; Zelzion, Ehud; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri			Unique Disulfide Bonds in Epidermal Growth Factor (EGF) Domains of beta 3 Affect Structure and Function of alpha IIb beta 3 and alpha v beta 3 Integrins in Different Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLANZMANN THROMBASTHENIA; AFFINITY MODULATION; MOLECULAR-DYNAMICS; BETA(3) SUBUNIT; BINDING SITE; OUTSIDE-IN; ACTIVATION; ALPHA(V)BETA(3); LIGAND; ALPHA(IIB)BETA(3)	The beta 3 subunit of alpha IIb beta 3 and alpha v beta 3 integrins contains four epidermal growth factor (EGF)-like domains. Each domain harbors four disulfide bonds of which one is unique for integrins. We previously discerned a regulatory role of the EGF-4 Cys-560-Cys-583 unique bond for alpha IIb beta 3 activation. In this study we further investigated the role of all four integrin unique bonds in both alpha IIb beta 3 and alpha v beta 3. We created beta 3 mutants harboring serine substitutions of each or both cysteines that disrupt the four unique bonds (Cys-437-Cys-457 in EGF-1, Cys-473-Cys-503 in EGF-2, Cys-523-Cys-544 in EGF-3, and Cys-560-Cys-583 in EGF-4) and transfected them into baby hamster kidney cells together with normal alpha v or alpha IIb. Flow cytometry was used to measure surface expression of alpha IIb beta 3 and alpha v beta 3 and their activity state by soluble fibrinogen binding. Most cysteine substitutions caused similarly reduced surface expression of both receptors. Disrupting all four unique disulfide bonds by single cysteine substitutions resulted in variable constitutive activation of alpha IIb beta 3 and alpha v beta 3. In contrast, whereas double C437S/C457S and C473S/C503S mutations yielded constitutively active alpha IIb beta 3 and alpha v beta 3, the C560S/C583S mutation did not, and the C523S/C544S mutation only yielded constitutively active alpha IIb beta 3. Activation of C523S/C544S alpha v beta 3 mutant by activating antibody and dithiothreitol was also impaired. Molecular dynamics of C523S/C544S beta 3 in alpha IIb beta 3 but not in alpha v beta 3 displayed an altered stable conformation. Our findings indicate that unique disulfide bonds in beta 3 differently affect the function of alpha IIb beta 3 and alpha v beta 3 and suggest a free sulfhydryl-dependent regulatory role for Cys-560-Cys-583 in both alpha IIb beta 3 and alpha v beta 3 and for Cys-523-Cys-544 only in alpha v beta 3.	[Mor-Cohen, Ronit; Rosenberg, Nurit; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri] Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; [Mor-Cohen, Ronit; Rosenberg, Nurit; Landau, Meytal; Mansour, Wissam; Averbukh, Yulia; Seligsohn, Uri] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Einav, Yulia; Zelzion, Ehud] Holon Inst Technol, Fac Sci, Math Biol Unit, IL-58102 Holon, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Mor-Cohen, R (corresponding author), Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel.	ronit.cohen@sheba.health.gov.il	Mor-Cohen, Ronit/AAB-8657-2020; Landau, Meytal/J-3075-2012; Landau, Meytal/AAF-3479-2021	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430				Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Byzova TV, 1998, J CELL BIOL, V143, P2081, DOI 10.1083/jcb.143.7.2081; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; COLLER BS, 1991, BLOOD, V77, P75; Donald JE, 2010, J BIOL CHEM, V285, P38658, DOI 10.1074/jbc.M110.170670; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faccio R, 2002, J CELL SCI, V115, P2919; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hato T, 2008, J BIOL CHEM, V283, P5662, DOI 10.1074/jbc.M707246200; Hauschner H, 2010, BLOOD, V115, P4542, DOI 10.1182/blood-2009-10-251066; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hogg PJ, 2009, J THROMB HAEMOST, V7, P13, DOI 10.1111/j.1538-7836.2009.03364.x; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HU DD, 1995, J BIOL CHEM, V270, P9917, DOI 10.1074/jbc.270.17.9917; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Legler DF, 2001, J CELL SCI, V114, P1545; Lorger M, 2009, P NATL ACAD SCI USA, V106, P10666, DOI 10.1073/pnas.0903035106; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; O'Neill S, 2000, J BIOL CHEM, V275, P36984, DOI 10.1074/jbc.M003279200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pelletier AJ, 1996, J BIOL CHEM, V271, P1364, DOI 10.1074/jbc.271.3.1364; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; SHATTIL SJ, 1995, THROMB HAEMOSTASIS, V74, P149; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Tadokoro S, 2002, BLOOD, V99, P931, DOI 10.1182/blood.V99.3.931; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, P NATL ACAD SCI USA, V98, P11175, DOI 10.1073/pnas.201420198; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Yan BX, 2001, BIOCHEMISTRY-US, V40, P8861, DOI 10.1021/bi002902i; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	64	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8879	8891		10.1074/jbc.M111.311043	http://dx.doi.org/10.1074/jbc.M111.311043			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308022	hybrid, Green Published			2022-12-27	WOS:000301797800019
J	Pusapati, GV; Eiseler, T; Rykx, A; Vandoninck, S; Derua, R; Waelkens, E; Van Lint, J; von Wichert, G; Seufferlein, T				Pusapati, Ganesh V.; Eiseler, Tim; Rykx, An; Vandoninck, Sandy; Derua, Rita; Waelkens, Etienne; Van Lint, Johan; von Wichert, Goetz; Seufferlein, Thomas			Protein Kinase D Regulates RhoA Activity via Rhotekin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MEDIATED PHOSPHORYLATION; MOLECULAR-CLONING; EFFECTOR RHOTEKIN; BINDING PARTNER; NUCLEAR EXPORT; CELL MOTILITY; PDZ PROTEIN; ACTIVATION; SECRETION; FAMILY	The members of the protein kinase D (PKD) family of serine/threonine kinases are major targets for tumor-promoting phorbol esters, G protein-coupled receptors, and activated protein kinase C isoforms (PKCs). The expanding list of cellular processes in which PKDs exert their function via phosphorylation of various substrates include proliferation, apoptosis, migration, angiogenesis, and vesicle trafficking. Therefore, identification of novel PKD substrates is necessary to understand the profound role of this kinase family in signal transduction. Here, we show that rhotekin, an effector of RhoA GTPase, is a novel substrate of PKD. We identified Ser-435 in rhotekin as the potential site targeted by PKD in vivo. Expression of a phosphomimetic S435E rhotekin mutant resulted in an increase of endogenous active RhoA GTPase levels. Phosphorylation of rhotekin by PKD2 modulates the anchoring of the RhoA in the plasma membrane. Consequently, the S435E rhotekin mutant displayed enhanced stress fiber formation when expressed in serum-starved fibroblasts. Our data thus identify a novel role of PKD as a regulator of RhoA activity and actin stress fiber formation through phosphorylation of rhotekin.	[Seufferlein, Thomas] Univ Halle Wittenberg, Dept Internal Med 1, Div Med, D-06120 Halle, Saale, Germany; [Pusapati, Ganesh V.; von Wichert, Goetz] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Rykx, An; Vandoninck, Sandy; Derua, Rita; Waelkens, Etienne; Van Lint, Johan] Univ Leuven, Dept Cellular & Mol Med, B-3000 Louvain, Belgium	Martin Luther University Halle Wittenberg; Ulm University; KU Leuven	Seufferlein, T (corresponding author), Univ Halle Wittenberg, Dept Internal Med 1, Div Med, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	thomas.seufferlein@uk-halle.de	Van Lint, Johan/P-9073-2019; Seufferlein, Thomas TW/P-7147-2018	Van Lint, Johan/0000-0002-0275-571X; Pusapati, Ganesh/0000-0002-1406-2566	German Federal Ministry of Education and Research [PKB-01GS08209-4]; Research Training Group [1041]; International Graduate School in Molecular Medicine, Ulm; Fonds voor Weten-schappelijk Onderzoek, Vlaanderen [G.0612.07]; Belgian Federal Government [6/18]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Research Training Group; International Graduate School in Molecular Medicine, Ulm; Fonds voor Weten-schappelijk Onderzoek, Vlaanderen(FWO); Belgian Federal Government	This work was funded in part by German Federal Ministry of Education and Research Grant PKB-01GS08209-4 (to T. S.).; Recipient of a fellowship during the initial part of the study from Research Training Group 1041 and the International Graduate School in Molecular Medicine, Ulm. Present address: Dept. of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305-5307.; Work in the laboratory of this author is supported by the Fonds voor Weten-schappelijk Onderzoek, Vlaanderen (G.0612.07) and by the Interuniversity Attraction Poles Program of the Belgian Federal Government (Interuniversity Attraction Poles 6/18).	Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; De Kimpe L, 2009, CELL SIGNAL, V21, P253, DOI 10.1016/j.cellsig.2008.10.015; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Fan J, 2005, J CANCER RES CLIN, V131, P157, DOI 10.1007/s00432-004-0638-8; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fu Q, 2000, GENOMICS, V66, P328, DOI 10.1006/geno.2000.6212; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Ito H, 2006, BIOCHEM J, V397, P389, DOI 10.1042/BJ20052015; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Janssens K, 2009, CELL SIGNAL, V21, P282, DOI 10.1016/j.cellsig.2008.10.012; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Le Page SL, 2003, AM J PHYSIOL-CELL PH, V285, pC1197, DOI 10.1152/ajpcell.00083.2003; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Liu CA, 2004, ONCOGENE, V23, P8731, DOI 10.1038/sj.onc.1208106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Nagata K, 2009, MED MOL MORPHOL, V42, P9, DOI 10.1007/s00795-008-0433-8; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200	49	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9473	9483		10.1074/jbc.M112.339564	http://dx.doi.org/10.1074/jbc.M112.339564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22228765	hybrid, Green Published			2022-12-27	WOS:000301797800076
J	Hashimoto, K; Eckert, C; Anschutz, U; Scholz, M; Held, K; Waadt, R; Reyer, A; Hippler, M; Becker, D; Kudla, J				Hashimoto, Kenji; Eckert, Christian; Anschuetz, Uta; Scholz, Martin; Held, Katrin; Waadt, Rainer; Reyer, Antonella; Hippler, Michael; Becker, Dirk; Kudla, Joerg			Phosphorylation of Calcineurin B-like (CBL) Calcium Sensor Proteins by Their CBL-interacting Protein Kinases (CIPKs) Is Required for Full Activity of CBL-CIPK Complexes toward Their Target Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; SIGNALING PATHWAY; REGULATES SALT; CA2+ SIGNALS; K+ CHANNEL; SOS2; ACTIVATION; DOMAIN; MECHANISMS; RESPONSES	Calcineurin B-like proteins (CBLs) represent a family of calcium sensor proteins that interact with a group of serine/threonine kinases designated as CBL-interacting protein kinases (CIPKs). CBL-CIPK complexes are crucially involved in relaying plant responses to many environmental signals and in regulating ion fluxes. However, the biochemical characterization of CBL-CIPK complexes has so far been hampered by low activities of recombinant CIPKs. Here, we report on an efficient wheat germ extract-based in vitro transcription/translation protocol that yields active full-length wild-type CIPK proteins. We identified a conserved serine residue within the C terminus of CBLs as being phosphorylated by their interacting CIPKs. Remarkably, our studies revealed that CIPK-dependent CBL phosphorylation is strictly dependent on CBL-CIPK interaction via the CIPK NAF domain. The phosphorylation status of CBLs does not appear to influence the stability, localization, or CIPK interaction of these calcium sensor proteins in general. However, proper phosphorylation of CBL1 is absolutely required for the in vivo activation of the AKT1 K+ channel by CBL1-CIPK23 and CBL9-CIPK23 complexes in oocytes. Moreover, we show that by combining CBL1, CIPK23, and AKT1, we can faithfully reconstitute CBL-dependent enhancement of phosphorylation of target proteins by CIPKs in vitro. In addition, we report that phosphorylation of CBL1 by CIPK23 is also required for the CBL1-dependent enhancement of CIPK23 activity toward its substrate. Together, these data identify a novel general regulatory mechanism of CBL-CIPK complexes in that CBL phosphorylation at their flexible C terminus likely provokes conformational changes that enhance specificity and activity of CBL-CIPK complexes toward their target proteins.	[Hashimoto, Kenji; Eckert, Christian; Scholz, Martin; Held, Katrin; Waadt, Rainer; Hippler, Michael; Kudla, Joerg] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Anschuetz, Uta; Reyer, Antonella; Becker, Dirk] Univ Wurzburg, Julius von Sachs Inst Mol Pflanzenphysiol & Bioph, D-97082 Wurzburg, Germany	University of Munster; University of Wurzburg	Kudla, J (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 4, D-48149 Munster, Germany.	jkudla@uni-muenster.de	Kudla, Jörg/C-2174-2012	Kudla, Jörg/0000-0002-8238-767X; Michael, Hippler/0000-0001-9670-6101; Reyer, Antonella/0000-0002-4993-8695; Waadt, Rainer/0000-0002-6772-3006; Becker, Dirk/0000-0003-0723-4160	Deutsche Forschungsgemeinschaft [964]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft grants within the frame of the Research Unit 964 (to D. B., M. H., and J. K.).	Akaboshi M, 2008, J MOL BIOL, V377, P246, DOI 10.1016/j.jmb.2008.01.006; Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Berridge MJ, 2003, BIOCHEM SOC T, V31, P930; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Du WM, 2011, PLANT PHYSIOL, V156, P2235, DOI 10.1104/pp.111.173377; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geiger D, 2009, J BIOL CHEM, V284, P21288, DOI 10.1074/jbc.M109.017574; Gong DM, 2002, J BIOL CHEM, V277, P42088, DOI 10.1074/jbc.M205504200; Gong DM, 2002, PLANT PHYSIOL, V130, P256, DOI 10.1104/pp.004507; Gong DM, 2002, J BIOL CHEM, V277, P28340, DOI 10.1074/jbc.M107719200; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hedrich R, 2006, CELL, V125, P1221, DOI 10.1016/j.cell.2006.06.017; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Lin HX, 2009, PLANT CELL, V21, P1607, DOI 10.1105/tpc.109.066217; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mahajan S, 2006, FEBS J, V273, P907, DOI 10.1111/j.1742-4658.2006.05111.x; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Nagae M, 2003, ACTA CRYSTALLOGR D, V59, P1079, DOI 10.1107/S0907444903007029; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Sanchez-Barrena MJ, 2005, J MOL BIOL, V345, P1253, DOI 10.1016/j.jmb.2004.11.025; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Waadt Rainer, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4995; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Webb AAR, 1996, ADV BOT RES, V22, P45; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	69	118	142	6	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7956	7968		10.1074/jbc.M111.279331	http://dx.doi.org/10.1074/jbc.M111.279331			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253446	Green Published, hybrid			2022-12-27	WOS:000301349400012
J	Lai, CW; Otero, JH; Hendershot, LM; Snapp, E				Lai, Chunwei Walter; Otero, Joel H.; Hendershot, Linda M.; Snapp, Erik			ERdj4 Protein Is a Soluble Endoplasmic Reticulum (ER) DnaJ Family Protein That Interacts with ER-associated Degradation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDED PROTEINS; QUALITY-CONTROL; ATPASE ACTIVITY; LIVING CELLS; SACCHAROMYCES-CEREVISIAE; DISULFIDE REDUCTASE; MEMBRANE-PROTEIN; BIP; TRANSLOCON; TRANSPORT	Protein localization within cells regulates accessibility for interactions with co-factors and substrates. The endoplasmic reticulum (ER) BiP co-factor ERdj4 is up-regulated by ER stress and has been implicated in ER-associated degradation (ERAD) of multiple unfolded secretory proteins. Several other ERdj family members tend to interact selectively with nascent proteins, presumably because those ERdj proteins associate with the Sec61 translocon that facilitates entry of nascent proteins into the ER. How ERdj4 selects and targets terminally misfolded proteins for destruction remains poorly understood. In this study, we determined properties of ERdj4 that might aid in this function. ERdj4 was reported to retain its signal sequence and to be resistant to mild detergent extraction, suggesting that it was an integral membrane protein. However, live cell photobleaching analyses of GFP-tagged ERdj4 revealed that the protein exhibits diffusion coefficients uncommonly high for an ER integral membrane protein and more similar to the mobility of a soluble luminal protein. Biochemical characterization established that the ERdj4 signal sequence is cleaved to yield a soluble protein. Importantly, we found that both endogenous and overexpressed ERdj4 associate with the integral membrane protein, Derlin-1. Our findings now directly link ERdj4 to the ERAD machinery and suggest a model in which ERjd4 could help recruit clients from throughout the ER to ERAD sites.	[Lai, Chunwei Walter; Snapp, Erik] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Otero, Joel H.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Yeshiva University; Albert Einstein College of Medicine; St Jude Children's Research Hospital	Snapp, E (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10464 USA.	erik-lee.snapp@einstein.yu.edu	Hendershot, Linda/N-8124-2018; Snapp, Erik Lee/H-7152-2019	Hendershot, Linda/0000-0002-5473-0274; Snapp, Erik Lee/0000-0001-9482-2272; Lai, Chunwei/0000-0003-3805-4736	National Institutes of Health [R01GM086530, 1R21AG032544, R01GM054068, T32GM07288]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530, R01GM054068, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086530 and 1R21AG032544 (to E. S. and C. W. L.) and R01GM054068 (to L. M. H. and J. H. O.).; Supported by National Institutes of Health Medical Scientist Training Program Grant T32GM07288.; Supported by the American Lebanese Syrian Associated Charities.	Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Drenth JPH, 2004, GASTROENTEROLOGY, V126, P1819, DOI 10.1053/j.gastro.2004.02.023; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Lai CW, 2010, MOL BIOL CELL, V21, P1909, DOI 10.1091/mbc.E09-12-1066; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; Snapp E.L., 2003, CURRENT PROTOCOLS CE; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412	59	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7969	7978		10.1074/jbc.M111.311290	http://dx.doi.org/10.1074/jbc.M111.311290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267725	Green Published, hybrid			2022-12-27	WOS:000301349400013
J	Holmuhamedov, EL; Czerny, C; Beeson, CC; Lemasters, JJ				Holmuhamedov, Ekhson L.; Czerny, Christoph; Beeson, Craig C.; Lemasters, John J.			Ethanol Suppresses Ureagenesis in Rat Hepatocytes ROLE OF ACETALDEHYDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; MITOCHONDRIAL PERMEABILITY TRANSITION; DEPENDENT ANION CHANNEL; OXIDATIVE STRESS; MEMBRANE PERMEABILITY; CELL-DEATH; UREA CYCLE; VDAC; INJURY; METABOLISM	We proposed previously that closure of voltage-dependent anion channels (VDAC) in the mitochondrial outer membrane after ethanol exposure leads to suppression of mitochondrial metabolite exchange. Because ureagenesis requires extensive mitochondrial metabolite exchange, we characterized the effect of ethanol and its metabolite, acetaldehyde (AcAld), on total and ureagenic respiration in cultured rat hepatocytes. Ureagenic substrates increased cellular respiration from 15.8 +/- 0.9 nmol O-2/min/10(6) cells (base line) to 29.4 +/- 1.7 nmol O-2/min/10(6) cells in about 30 min. Ethanol (0-200 mM) suppressed extra respiration after ureagenic substrates (ureagenic respiration) by up to 51% but not base line respiration. Urea formation also declined proportionately. Inhibition of alcohol dehydrogenase, cytochrome P450 2E1, and catalase with 4-methylpyrazole, trans1,2-dichloroethylene, and 3-amino-1,2,3-triazole restored ethanol-suppressed ureagenic respiration by 46, 37, and 66%, respectively. By contrast, inhibition of aldehyde dehydrogenase with phenethyl isothiocyanate increased the inhibitory effect of ethanol on ureagenic respiration by an additional 60%. AcAld, an intermediate product of ethanol oxidation, suppressed ureagenic respiration with an apparent IC50 of 125 mu M. AcAld also inhibited entry of 3-kDa rhodamine-conjugated dextran in the mitochondrial intermembrane space of digitonin-permeabilized hepatocytes, indicative of VDAC closure. In conclusion, AcAld, derived from ethanol metabolism, suppresses ureagenesis in hepatocytes mediated by closure of VDAC.	[Holmuhamedov, Ekhson L.; Beeson, Craig C.; Lemasters, John J.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, Charleston, SC 29425 USA; [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Holmuhamedov, Ekhson L.] Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Czerny, Christoph] Goethe Univ Frankfurt, Dept Trauma Surg, Frankfurt, Germany	Medical University of South Carolina; Medical University of South Carolina; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Goethe University Frankfurt	Lemasters, JJ (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, 280 Calhoun St,MSC 140,QF213, Charleston, SC 29425 USA.	ekhson.holmuhamedov@aurora.org; JJLemasters@musc.edu	Holmuhamedov, Ekhson L/P-5228-2016	Holmuhamedov, Ekhson L/0000-0002-0809-350X	National Institutes of Health [DK073336, DK37034, AA017756, HL101240-01]; Cancer Center [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK037034, R37DK037034, R01DK073336, R01DK037034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073336 (to J. J. L.), DK37034 (to J. J. L.), AA017756 (to J. J. L.), and HL101240-01 (to E. L. H.). Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 (to the Hollings Cancer Center, Medical University of South Carolina).	Albano E, 2006, P NUTR SOC, V65, P278, DOI 10.1079/PNS2006496; [Anonymous], 1996, GUID CAR US LAB AN; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; BRADFORD BU, 1993, ARCH BIOCHEM BIOPHYS, V303, P172, DOI 10.1006/abbi.1993.1269; Cahill A, 2002, ALCOHOL CLIN EXP RES, V26, P907, DOI 10.1097/00000374-200206000-00022; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Crabb David W, 2007, Novartis Found Symp, V285, P4; Cunningham CC, 2001, BIOL SIGNAL RECEPT, V10, P271; Davis PK, 1998, COMP BIOCHEM PHYS B, V119, P527, DOI 10.1016/S0305-0491(98)00014-5; DEITRICH RA, 2007, NOVART FDN SYMP, V285, P40; Deitrich RA, 2007, NOVART FDN SYMP, V285, P198; Deitrich Richard A, 2007, Novartis Found Symp, V285, P23; Fernandez-Checa JC, 1997, ALCOHOL HEALTH RES W, V21, P321; FERNANDEZCHECA JC, 1993, ALCOHOL, V10, P469, DOI 10.1016/0741-8329(93)90067-X; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; GRANT DAW, 1988, BRIT J ADDICT, V83, P1255; Hasselblatt M, 2006, ALCOHOL ALCOHOLISM, V41, P372, DOI 10.1093/alcalc/agl032; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2011, BIOPHYS J, V100, P460; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Kessova I, 2003, CURR MOL MED, V3, P509, DOI 10.2174/1566524033479609; KOOP DR, 1990, CHEM RES TOXICOL, V3, P377, DOI 10.1021/tx00016a017; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Lakshman Raj, 2005, Alcohol Clin Exp Res, V29, P1726, DOI 10.1097/01.alc.0000179379.03078.8f; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemasters JJ, 2007, J GASTROEN HEPATOL, V22, pS31, DOI 10.1111/j.1440-1746.2006.04643.x; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; LINDROS KO, 1995, J PHARMACOL EXP THER, V275, P79; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mathews JM, 1998, CHEM RES TOXICOL, V11, P778, DOI 10.1021/tx970227g; MAUGHAN RJ, 1982, CLIN CHIM ACTA, V122, P231, DOI 10.1016/0009-8981(82)90282-0; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pediaditakis P, 2010, BIOCHEM J, V431, P411, DOI 10.1042/BJ20091741; Qian T, 1997, AM J PHYSIOL-CELL PH, V273, pC1783, DOI 10.1152/ajpcell.1997.273.6.C1783; Reuben A, 2006, CURR OPIN GASTROEN, V22, P263; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Sastre J, 2007, FRONT BIOSCI, V12, P1200, DOI 10.2741/2138; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Smith PS, 2007, FREE RADICAL BIO MED, V42, P787, DOI 10.1016/j.freeradbiomed.2006.11.032; THURMAN RG, 1975, FED PROC, V34, P2075; Tikunov A, 2010, ARCH BIOCHEM BIOPHYS, V495, P174, DOI 10.1016/j.abb.2010.01.008; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; TSUKAMOTO H, 1993, ALCOHOL, V10, P465, DOI 10.1016/0741-8329(93)90066-W; Tuma DJ, 2003, ALCOHOL RES HEALTH, V27, P285; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Withers PC, 1998, CLIN EXP PHARMACOL P, V25, P722, DOI 10.1111/j.1440-1681.1998.tb02284.x	62	37	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7692	7700		10.1074/jbc.M111.293399	http://dx.doi.org/10.1074/jbc.M111.293399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228763	hybrid, Green Published			2022-12-27	WOS:000301060200068
J	Krupka, M; Rivas, G; Rico, AI; Vicente, M				Krupka, Marcin; Rivas, German; Isabel Rico, Ana; Vicente, Miguel			Key Role of Two Terminal Domains in the Bidirectional Polymerization of FtsA Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSA; MEMBRANE TARGETING SEQUENCE; ACTIN-LIKE FTSA; Z-RING; SELF-INTERACTION; ZIPA; ULTRACENTRIFUGATION; LOCALIZATION; REGION	The effect of two different truncations involving either the 1C domain or the simultaneous absence of the S12-13 beta-strands of the FtsA protein from Streptococcus pneumoniae, located at opposite terminal sides in the molecular structure, suggests that they are essential for ATP-dependent polymerization. These two truncated proteins are not able to polymerize themselves but can be incorporated to some extent into the FtsA(+) polymers during the assembling process. Consequently, they block the growth of the FtsA(+) polymers and slow down the polymerization rate. The combined action of the two truncated proteins produces an additive effect on the inhibition of FtsA(+) polymerization, indicating that each truncation affects a different interaction site within the FtsA molecule.	[Krupka, Marcin; Isabel Rico, Ana; Vicente, Miguel] CSIC, CNB, Madrid 28049, Spain; [Rivas, German] CSIC, CIB, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Vicente, M (corresponding author), CSIC, CNB, C Darwin 3,Campus Cantoblanco, Madrid 28049, Spain.	mvicente@cnb.csic.es	Rivas, German/AAG-7458-2022; Rico, Ana Isabel/A-5242-2010; Rivas, German/AFL-7528-2022	Rivas, German/0000-0003-3450-7478; Rico, Ana Isabel/0000-0001-6021-3970; Rivas, German/0000-0003-3450-7478	Spanish Ministerio de Educacion y Ciencia [BIO2008-04478-C03]; European Commission [HEALTH-F3-2009-223431]; La Caixa Foundation	Spanish Ministerio de Educacion y Ciencia(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); La Caixa Foundation(La Caixa Foundation)	This work was supported by the Spanish Ministerio de Educacion y Ciencia through Grant BIO2008-04478-C03 and by the European Commission through Contract HEALTH-F3-2009-223431 (DIVINOCELL) (both to M. V. and G. R.).; A Ph.D. fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB).	Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carettoni D, 2003, PROTEINS, V50, P192, DOI 10.1002/prot.10244; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2007, J BACTERIOL, V189, P646, DOI 10.1128/JB.00992-06; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	35	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7756	7765		10.1074/jbc.M111.311563	http://dx.doi.org/10.1074/jbc.M111.311563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247552	hybrid, Green Published			2022-12-27	WOS:000301060200074
J	Zhang, DW; Shan, SO				Zhang, Dawei; Shan, Shu-ou			Translation Elongation Regulates Substrate Selection by the Signal Recognition Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; SRP RNA; TRIGGER FACTOR; PRESECRETORY PROTEINS; MICROSOMAL-MEMBRANES; SECRETORY PROTEIN; CRYSTAL-STRUCTURE; NASCENT CHAINS	The signal recognition particle (SRP) is a universally conserved cellular machinery responsible for delivering membrane and secretory proteins to the proper cellular destination. The precise mechanism by which fidelity is achieved by the SRP pathway within the in vivo environment is yet to be understood. Previous studies have focused on the SRP pathway in isolation. Here we describe another important factor that modulates substrate selection by the SRP pathway: the ongoing synthesis of the nascent polypeptide chain by the ribosome. A slower translation elongation rate rescues the targeting defect of substrate proteins bearing mutant, suboptimal signal sequences both in vitro and in vivo. Consistent with a kinetic origin of this effect, similar rescue of protein targeting was also observed with mutant SRP receptors or SRP RNAs that specifically compromise the kinetics of SRP-receptor interaction during protein targeting. These data are consistent with a model in which ongoing protein translation is in constant kinetic competition with the targeting of the nascent proteins by the SRP and provides an important factor to regulate the fidelity of substrate selection by the SRP.	[Zhang, Dawei; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu			National Institutes of Health [GM078024]; Beckman Young Investigator Award; Packard and Lucile Award in Science and Engineering; Henry Dreyfus Teacher-Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Young Investigator Award; Packard and Lucile Award in Science and Engineering; Henry Dreyfus Teacher-Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078024 (to S. S.).; Supported by career awards from the Beckman Young Investigator Award, the Packard and Lucile Award in Science and Engineering, and the Henry Dreyfus Teacher-Scholar Award. To whom correspondence should be addressed: Div. of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-396-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.	Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DOUD SK, 1993, BIOCHEMISTRY-US, V32, P1251, DOI 10.1021/bi00056a008; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Jander G, 1996, J BACTERIOL, V178, P3049, DOI 10.1128/jb.178.11.3049-3058.1996; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Lakshmipathy SK, 2010, J BIOL CHEM, V285, P27911, DOI 10.1074/jbc.M110.134163; LEE CA, 1986, J BACTERIOL, V166, P878, DOI 10.1128/jb.166.3.878-883.1986; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Saraogi I, 2011, J AM CHEM SOC, V133, P14936, DOI 10.1021/ja206626g; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Sharma A, 2010, METHODS MOL BIOL, V619, P339, DOI 10.1007/978-1-60327-412-8_20; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WICKNER W, 1995, P NATL ACAD SCI USA, V92, P9433, DOI 10.1073/pnas.92.21.9433; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; Zhang D., 2011, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M1111.011585, DOI 10.1074/MCP.M1111.011585]; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	49	28	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7652	7660		10.1074/jbc.M111.325001	http://dx.doi.org/10.1074/jbc.M111.325001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228766	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000301060200064
J	Murakami, Y; Kanzawa, N; Saito, K; Krawitz, PM; Mundlos, S; Robinson, PN; Karadimitris, A; Maeda, Y; Kinoshita, T				Murakami, Yoshiko; Kanzawa, Noriyuki; Saito, Kazunobu; Krawitz, Peter M.; Mundlos, Stefan; Robinson, Peter N.; Karadimitris, Anastasios; Maeda, Yusuke; Kinoshita, Taroh			Mechanism for Release of Alkaline Phosphatase Caused by Glycosylphosphatidylinositol Deficiency in Patients with Hyperphosphatasia Mental Retardation Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; MEMBRANE-PROTEINS; BIOSYNTHESIS; TRANSAMIDASE; ATTACHMENT; EXPRESSION; PROMOTER; SEIZURES; MUTATION; MANNOSE	Hyperphosphatasia mental retardation syndrome (HPMR), an autosomal recessive disease characterized by mental retardation and elevated serum alkaline phosphatase (ALP) levels, is caused by mutations in the coding region of the phosphatidylinositol glycan anchor biosynthesis, class V (PIGV) gene, the product of which is a mannosyltransferase essential for glycosylphosphatidylinositol (GPI) biosynthesis. Mutations found in four families caused amino acid substitutions A341E, A341V, Q256K, and H385P, which drastically decreased expression of the PIGV protein. Hyperphosphatasia resulted from secretion of ALP, a GPI-anchored protein normally expressed on the cell surface, into serum due to PIGV deficiency. In contrast, a previously reported PIGM deficiency, in which there is a defect in the transfer of the first mannose, does not result in hyperphosphatasia. To provide insights into the mechanism of ALP secretion in HPMR patients, we took advantage of CHO cell mutants that are defective in various steps of GPI biosynthesis. Secretion of ALP requires GPI transamidase, which in normal cells, cleaves the C-terminal GPI attachment signal peptide and replaces it with GPI. The GPI-anchored protein was secreted substantially into medium from PIGV-, PIGB-, and PIGF-deficient CHO cells, in which incomplete GPI bearing mannose was accumulated. In contrast, ALP was degraded in PIGL-, DPM2-, or PIGX-deficient CHO cells, in which incomplete shorter GPIs that lacked mannose were accumulated. Our results suggest that GPI transamidase recognizes incomplete GPI bearing mannose and cleaves a hydrophobic signal peptide, resulting in secretion of soluble ALP. These results explain the molecular mechanism of hyperphosphatasia in HPMR.	[Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 5650871, Japan; [Murakami, Yoshiko; Kanzawa, Noriyuki; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Lab Immunoglycobiol, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Saito, Kazunobu] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Suita, Osaka 5650871, Japan; [Krawitz, Peter M.; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet & Humangenet, D-13353 Berlin, Germany; [Karadimitris, Anastasios] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England	Osaka University; Osaka University; Osaka University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	Kinoshita, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Kinoshita, Taroh/C-7353-2009; Mundlos, Stefan/ABH-9585-2020; Krawitz, Peter M/F-3142-2012	Krawitz, Peter M/0000-0002-3194-8625; Mundlos, Stefan/0000-0002-9788-3166; Robinson, Peter/0000-0002-0736-9199	Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare of Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Hong YJ, 2003, MOL BIOL CELL, V14, P1780, DOI 10.1091/mbc.E02-12-0794; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Kinoshita T, 1995, ADV IMMUNOL, V60, P57, DOI 10.1016/S0065-2776(08)60584-2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KODUKULA K, 1993, J CELL BIOL, V120, P657, DOI 10.1083/jcb.120.3.657; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Lauc G, 2006, BBA-GEN SUBJECTS, V1760, P584, DOI 10.1016/j.bbagen.2005.11.014; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Thompson MD, 2010, AM J MED GENET A, V152A, P1661, DOI 10.1002/ajmg.a.33438; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Vainauskas S, 2004, J BIOL CHEM, V279, P6540, DOI 10.1074/jbc.M312191200	20	71	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6318	6325		10.1074/jbc.M111.331090	http://dx.doi.org/10.1074/jbc.M111.331090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228761	Green Published, hybrid			2022-12-27	WOS:000300791800024
J	Liu, SP; Ammirati, MJ; Song, X; Knafels, JD; Zhang, J; Greasley, SE; Pfefferkorn, JA; Qiu, XY				Liu, Shenping; Ammirati, Mark J.; Song, Xi; Knafels, John D.; Zhang, Jeff; Greasley, Samantha E.; Pfefferkorn, Jeffrey A.; Qiu, Xiayang			Insights into Mechanism of Glucokinase Activation OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC GLUCOKINASE; DEPENDENT DIABETES-MELLITUS; X-RAY SOLUTION; ALLOSTERIC ACTIVATORS; REGULATORY PROTEIN; MACROMOLECULAR STRUCTURES; KINETIC COOPERATIVITY; CLINICAL CANDIDATE; LIVER GLUCOKINASE; CRYSTAL-STRUCTURE	Human glucokinase (GK) is a principal regulating sensor of plasma glucose levels. Mutations that inactivate GK are linked to diabetes, and mutations that activate it are associated with hypoglycemia. Unique kinetic properties equip GK for its regulatory role: although it has weak basal affinity for glucose, positive cooperativity in its binding of glucose causes a rapid increase in catalytic activity when plasma glucose concentrations rise above euglycemic levels. In clinical trials, small molecule GK activators (GKAs) have been efficacious in lowering plasma glucose and enhancing glucose-stimulated insulin secretion, but they carry a risk of overly activating GK and causing hypoglycemia. The theoretical models proposed to date attribute the positive cooperativity of GK to the existence of distinct protein conformations that interconvert slowly and exhibit different affinities for glucose. Here we report the respective crystal structures of the catalytic complex of GK and of a GK-glucose complex in a wide open conformation. To assess conformations of GK in solution, we also carried out small angle x-ray scattering experiments. The results showed that glucose dose-dependently converts GK from an apo conformation to an active open conformation. Compared with wild type GK, activating mutants required notably lower concentrations of glucose to be converted to the active open conformation. GKAs decreased the level of glucose required for GK activation, and different compounds demonstrated distinct activation profiles. These results lead us to propose a modified mnemonic model to explain cooperativity in GK. Our findings may offer new approaches for designing GKAs with reduced hypoglycemic risk.	[Liu, Shenping; Ammirati, Mark J.; Song, Xi; Knafels, John D.; Zhang, Jeff; Pfefferkorn, Jeffrey A.; Qiu, Xiayang] Pfizer Groton Labs, Groton, CT 06340 USA; [Greasley, Samantha E.] Pfizer La Jolla Labs, San Diego, CA 92121 USA	Pfizer; Pfizer	Liu, SP (corresponding author), Pfizer Groton Labs, Eastern Point Rd, Groton, CT 06340 USA.	shenping.liu@pfizer.com						AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; Bebernitz GR, 2009, J MED CHEM, V52, P6142, DOI 10.1021/jm900839k; Bricogne G., 2010, BUSTER VERSION 2 9; BUC J, 1977, EUR J BIOCHEM, V80, P593, DOI 10.1111/j.1432-1033.1977.tb11916.x; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; DeLano W.L, PYMOL MOL GRAPHICS S; Dunten P, 2004, FRONT DIABETES, V16, P145; Efanov AM, 2005, ENDOCRINOLOGY, V146, P3696, DOI 10.1210/en.2005-0377; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Filipski K. J., 2010, 240 ACS NAT M BOST A; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Heredia VV, 2006, BIOCHEMISTRY-US, V45, P7553, DOI 10.1021/bi060253q; Heredia VV, 2006, J BIOL CHEM, V281, P40201, DOI 10.1074/jbc.M607987200; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kester R. F., 2009, 238 ACS NAT M WASH D; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Larion M, 2010, BIOCHEMISTRY-US, V49, P8902, DOI 10.1021/bi1008672; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; LIN SX, 1990, J BIOL CHEM, V265, P9670; Magnuson MA, 2004, FRONT DIABETES, V16, P1; Mahalingam B, 1999, DIABETES, V48, P1698, DOI 10.2337/diabetes.48.9.1698; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Molnes J, 2011, FEBS J, V278, P2372, DOI 10.1111/j.1742-4658.2011.08160.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z., 2001, INT TABLES CRYSTALLO, VF, P226; Petit P, 2011, ACTA CRYSTALLOGR D, V67, P929, DOI 10.1107/S0907444911036729; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Pfefferkorn JA, 2011, MEDCHEMCOMM, V2, P828, DOI 10.1039/c1md00116g; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Segal I. H, 1993, ENZYME KINETICS BEHA, P189; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Yang L., 2010, SAXS WAXS DATA COLLE; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	51	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13598	13610		10.1074/jbc.M111.274126	http://dx.doi.org/10.1074/jbc.M111.274126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22298776	Green Published, hybrid			2022-12-27	WOS:000303996300016
J	Lan, L; Nakajima, S; Kapetanaki, MG; Hsieh, CL; Fagerburg, M; Thickman, K; Rodriguez-Collazo, P; Leuba, SH; Levine, AS; Rapic-Otrin, V				Lan, Li; Nakajima, Satoshi; Kapetanaki, Maria G.; Hsieh, Ching L.; Fagerburg, Matthew; Thickman, Karen; Rodriguez-Collazo, Pedro; Leuba, Sanford H.; Levine, Arthur S.; Rapic-Otrin, Vesna			Monoubiquitinated Histone H2A Destabilizes Photolesion-containing Nucleosomes with Concomitant Release of UV-damaged DNA-binding Protein E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-E; CYCLOBUTANE PYRIMIDINE DIMERS; CHROMATIN REMODELING COMPLEX; RING UBIQUITIN LIGASES; CORE PARTICLE; ANGSTROM RESOLUTION; CELLULAR-RESPONSE; MAMMALIAN-CELLS; GENE-PRODUCT	How the nucleotide excision repair (NER) machinery gains access to damaged chromatinized DNA templates and how the chromatin structure is modified to promote efficient repair of the non-transcribed genome remain poorly understood. The UV-damaged DNA-binding protein complex (UV-DDB, consisting of DDB1 and DDB2, the latter of which is mutated in xeroderma pigmentosum group E patients, is a substrate-recruiting module of the cullin 4B-based E3 ligase complex, DDB1-CUL4B(DDB2). We previously reported that the deficiency of UV-DDB E3 ligases in ubiquitinating histone H2A at UV-damaged DNA sites in the xeroderma pigmentosum group E cells contributes to the faulty NER in these skin cancer-prone patients. Here, we reveal the mechanism by which monoubiquitination of specific H2A lysine residues alters nucleosomal dynamics and subsequently initiates NER. We show that DDB1-CUL4B(DDB2) E3 ligase specifically binds to mononucleosomes assembled with human recombinant histone octamers and nucleosome-positioning DNA containing cyclobutane pyrimidine dimers or 6-4 photoproducts photolesions. We demonstrate functionally that ubiquitination of H2A Lys-119/Lys-120 is necessary for destabilization of nucleosomes and concomitant release of DDB1-CUL4BDDB2 from photolesion-containing DNA. Nucleosomes in which these lysines are replaced with arginines are resistant to such structural changes, and arginine mutants prevent the eviction of H2A and dissociation of polyubiquitinated DDB2 from UV-damaged nucleosomes. The partial eviction of H3 from the nucleosomes is dependent on ubiquitinated H2A Lys-119/Lys-120. Our results provide mechanistic insight into how post-translational modification of H2A at the site of a photolesion initiates the repair process and directly affects the stability of the human genome.	[Rapic-Otrin, Vesna] Univ Pittsburgh, Hillman Canc Ctr, UPCI Res Pavil, Inst Canc, Pittsburgh, PA 15213 USA; [Lan, Li; Nakajima, Satoshi; Kapetanaki, Maria G.; Hsieh, Ching L.; Thickman, Karen; Levine, Arthur S.; Rapic-Otrin, Vesna] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Fagerburg, Matthew; Rodriguez-Collazo, Pedro; Leuba, Sanford H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rapic-Otrin, V (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, UPCI Res Pavil, Inst Canc, Suite 2-6,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	vesnaro@pitt.edu		Leuba, Sanford/0000-0003-0278-7997	National Institutes of Health [GM07787, CA122177, P30CA047904]; University of Pittsburgh School of Medicine; NATIONAL CANCER INSTITUTE [K01CA122177, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM07787 (to S. H. L.) and CA122177 (to P. R.-C.). This work was also supported by a University of Pittsburgh School of Medicine start-up fund to V. R.-O.; We thank Alana Cheeks-Lomax for helping with the cloning and expression of CUL4B, Jelena Grahovac for assisting with the cloning and purifying the core histones, Dr. Jennifer Guerrero-Santoro for E3 ligase expertise, and Dr. Guillermo Calero for protein purification expertise. We appreciate the helpful discussion with our colleagues at the University of Pittsburgh Cancer Institute and members of the Program of Molecular and Cellular Cancer Biology. University of Pittsburgh Cancer Institute shared resources were supported in part by National Institutes of Health Award P30CA047904.	Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Araki M, 2000, MUTAT RES-DNA REPAIR, V459, P147, DOI 10.1016/S0921-8777(99)00067-1; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; DAVIES N, 1994, BBA-GENE STRUCT EXPR, V1218, P187, DOI 10.1016/0167-4781(94)90009-4; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; EICKBUSH TH, 1988, J BIOL CHEM, V263, P18972; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jason LJM, 2005, J BIOL CHEM, V280, P4975, DOI 10.1074/jbc.M410203200; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Nakajima S, 2004, J BIOL CHEM, V279, P46674, DOI 10.1074/jbc.M406070200; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P964, DOI 10.1021/bi00429a007; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shukla MS, 2011, NUCLEIC ACIDS RES, V39, P2559, DOI 10.1093/nar/gkq1174; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; van Holde K.E., 1988, CHROMATIN; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Yeh J. I., 2012, P NATL ACA IN PRESS; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang L, 2009, CELL CYCLE, V8, P3953, DOI 10.4161/cc.8.23.10115; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982; Zhu QZ, 2010, J CELL PHYSIOL, V223, P283, DOI 10.1002/jcp.22060; Zhu QZ, 2009, DNA REPAIR, V8, P262, DOI 10.1016/j.dnarep.2008.11.007	76	45	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12036	12049		10.1074/jbc.M111.307058	http://dx.doi.org/10.1074/jbc.M111.307058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334663	Green Published, hybrid			2022-12-27	WOS:000302782200041
J	Beh, CT; McMaster, CR; Kozminski, KG; Menon, AK				Beh, Christopher T.; McMaster, Christopher R.; Kozminski, Keith G.; Menon, Anant K.			A Detour for Yeast Oxysterol Binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLECKSTRIN HOMOLOGY DOMAIN; OSBP-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; ENDOPLASMIC-RETICULUM; DEPENDENT ACTIVATION; VESICULAR TRANSPORT; STEROL TRAFFICKING; LIPID-PHOSPHATASE	Oxysterol binding protein-related proteins, including the yeast proteins encoded by the OSH gene family (OSH1-OSH7), are implicated in the non-vesicular transfer of sterols between intracellular membranes and the plasma membrane. In light of recent studies, we revisited the proposal that Osh proteins are sterol transfer proteins and present new models consistent with known Osh protein functions. These models focus on the role of Osh proteins as sterol-dependent regulators of phosphoinositide and sphingolipid pathways. In contrast to their posited role as non-vesicular sterol transfer proteins, we propose that Osh proteins coordinate lipid signaling and membrane reorganization with the assembly of tethering complexes to promote molecular exchanges at membrane contact sites.	[Beh, Christopher T.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [McMaster, Christopher R.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; [McMaster, Christopher R.] Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; [Kozminski, Keith G.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Kozminski, Keith G.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA; [Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Simon Fraser University; Dalhousie University; Dalhousie University; University of Virginia; University of Virginia; Cornell University	Beh, CT (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	ctbeh@sfu.ca	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; McMaster, Christopher/0000-0003-0822-5776; Beh, Christopher/0000-0003-0201-6316	Canadian Cancer Society Research Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; National Science Foundation [0723342]; National Institutes of Health [GM71041, GM55427]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by grants from the Canadian Cancer Society Research Institute and the Natural Sciences and Engineering Research Council of Canada (to C. T. B.).; Supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. To whom correspondence may be addressed. E-mail: christopher.mcmaster@dal.ca.; Supported by National Science Foundation Grant 0723342.; Supported by National Institutes of Health Grants GM71041 and GM55427.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Anniss AM, 2002, DNA CELL BIOL, V21, P571, DOI 10.1089/104454902320308942; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Fairn GD, 2005, BIOCHEM CELL BIOL, V83, P631, DOI 10.1139/o05-064; Fairn GD, 2005, BIOCHEM J, V387, P889, DOI 10.1042/BJ20041915; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; JIANG B, 1994, YEAST, V10, P341, DOI 10.1002/yea.320100307; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; KANDUTSCH AA, 1977, P NATL ACAD SCI USA, V74, P2500, DOI 10.1073/pnas.74.6.2500; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; LeBlanc MA, 2010, J BIOL CHEM, V285, P33875, DOI 10.1074/jbc.M110.147264; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lehto M, 2001, J LIPID RES, V42, P1203; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Olkkonen VM, 2004, BIOCHEM CELL BIOL, V82, P87, DOI 10.1139/o03-088; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reiner S, 2006, MOL BIOL CELL, V17, P90, DOI 10.1091/mbc.e05-06-0515; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SAAD HY, 1965, J PHARM SCI, V54, P1205, DOI 10.1002/jps.2600540826; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Sullivan DP, 2009, EUKARYOT CELL, V8, P161, DOI 10.1128/EC.00135-08; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; URBANI L, 1990, J BIOL CHEM, V265, P1919; Wang PH, 2005, EMBO J, V24, P2989, DOI 10.1038/sj.emboj.7600764; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V815, P33, DOI 10.1016/0005-2736(85)90470-5	72	49	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11481	11488		10.1074/jbc.R111.338400	http://dx.doi.org/10.1074/jbc.R111.338400			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334669	hybrid, Green Published			2022-12-27	WOS:000302780100076
J	Han, BG; Kim, KH; Lee, SJ; Jeong, KC; Cho, JW; Noh, KH; Kim, TW; Kim, SJ; Yoon, HJ; Suh, SW; Lee, S; Lee, BI				Han, Byeong-Gu; Kim, Kyoung Hoon; Lee, Sang Jae; Jeong, Kyung-Chae; Cho, Jea-Won; Noh, Kyung Hee; Kim, Tae Woo; Kim, Soon-Jong; Yoon, Hye-Jin; Suh, Se Won; Lee, Sangho; Lee, Byung Il			Helical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; CRYSTAL-STRUCTURE; CELL-DEATH; IAP PROTEINS; COMPLEX; AAC-11; BINDING; CONSERVATION; BROMODOMAIN; EXPRESSION	Apoptosis inhibitor 5 (API5) is an anti-apoptotic protein that is up-regulated in various cancer cells. Here, we present the crystal structure of human API5. API5 exhibits an elongated all alpha-helical structure. The N-terminal half of API5 is similar to the HEAT repeat and the C-terminal half is similar to the ARM (Armadillo-like) repeat. HEAT and ARM repeats have been implicated in protein-protein interactions, suggesting that the cellular roles of API5 may be to mediate protein-protein interactions. Various components of multiprotein complexes have been identified as API5-interacting protein partners, suggesting that API5 may act as a scaffold for multiprotein complexes. API5 exists as a monomer, and the functionally important heptad leucine repeat does not exhibit the predicted a dimeric leucine zipper. Additionally, Lys-251, which can be acetylated in cells, plays important roles in the inhibition of apoptosis under serum deprivation conditions. The acetylation of this lysine also affects the stability of API5 in cells.	[Han, Byeong-Gu; Lee, Sang Jae; Jeong, Kyung-Chae; Cho, Jea-Won; Lee, Byung Il] Natl Canc Ctr, Res Inst, Div Convergence Technol, Biomol Funct Res Branch, Goyang 410769, Gyeonggi, South Korea; [Kim, Kyoung Hoon; Yoon, Hye-Jin; Suh, Se Won] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151747, South Korea; [Kim, Kyoung Hoon; Yoon, Hye-Jin; Suh, Se Won] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151747, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Grad Sch Med, Dept Biomed Sci, Seoul 136701, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam 534729, South Korea; [Han, Byeong-Gu; Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Mokpo National University; Sungkyunkwan University (SKKU)	Lee, BI (corresponding author), Natl Canc Ctr, Res Inst, Div Convergence Technol, Biomol Funct Res Branch, Goyang 410769, Gyeonggi, South Korea.	bilee@ncc.re.kr	Lee, Sangho/P-4204-2018; Lee, Sang Jae/AAX-7611-2021; Suh, Won/H-8306-2013	Lee, Sangho/0000-0003-3886-4579; Lee, Sang Jae/0000-0002-5366-2900; Suh, Won/0000-0002-1768-4635	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2010-0020993]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0020993 (to B. I. L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim JW, 2000, LAB INVEST, V80, P587, DOI 10.1038/labinvest.3780063; Krejci P, 2007, J LEUKOCYTE BIOL, V82, P1363, DOI 10.1189/jlb.0607425; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Ren K, 2010, PATHOL ONCOL RES, V16, P229, DOI 10.1007/s12253-009-9215-4; Rigou P, 2009, EMBO J, V28, P1576, DOI 10.1038/emboj.2009.106; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Sasaki H, 2001, LUNG CANCER-J IASLC, V34, P53, DOI 10.1016/S0169-5002(01)00213-6; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tewari M, 1997, CANCER RES, V57, P4063; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Van den Berghe L, 2000, MOL ENDOCRINOL, V14, P1709, DOI 10.1210/me.14.11.1709; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Wang ZM, 2010, MED SCI MONITOR, V16, pCR357; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yang SY, 2009, TRENDS MOL MED, V15, P225, DOI 10.1016/j.molmed.2009.03.003; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	57	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10727	10737		10.1074/jbc.M111.317594	http://dx.doi.org/10.1074/jbc.M111.317594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334682	Green Published, hybrid			2022-12-27	WOS:000302780100002
J	Azakir, BA; Di Fulvio, S; Kinter, J; Sinnreich, M				Azakir, Bilal A.; Di Fulvio, Sabrina; Kinter, Jochen; Sinnreich, Michael			RETRACTED: Proteasomal Inhibition Restores Biological Function of Mis-sense Mutated Dysferlin in Patient-derived Muscle Cells (Retracted article. See vol. 292, pg. 12542, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							GIRDLE MUSCULAR-DYSTROPHY; IN-VITRO; MULTIPLE-MYELOMA; GENE; DEGRADATION; EXPRESSION; MUTATIONS; MEMBRANE; MYOPATHY; DEFICIENCY	Dysferlin is a transmembrane protein implicated in surface membrane repair of muscle cells. Mutations in dysferlin cause the progressive muscular dystrophies Miyoshi myopathy, limb girdle muscular dystrophy 2B, and distal anterior compartment myopathy. Dysferlinopathies are inherited in an autosomal recessive manner, and many patients with this disease harbor mis-sense mutations in at least one of their two pathogenic DYSF alleles. These patients have significantly reduced or absent dysferlin levels in skeletal muscle, suggesting that dysferlin encoded by mis-sense alleles is rapidly degraded by the cellular quality control system. We reasoned that mis-sense mutated dysferlin, if salvaged from degradation, might be biologically functional. We used a dysferlin-deficient human myoblast culture harboring the common R555W mis-sense allele and a DYSF-null allele, as well as control human myoblast cultures harboring either two wild-type or two null alleles. We measured dysferlin protein and mRNA levels, resealing kinetics of laser-induced plasmalemmal wounds, myotube formation, and cellular viability after treatment of the human myoblast cultures with the proteasome inhibitors lactacystin or bortezomib (Velcade). We show that endogenous R555W mis-sense mutated dysferlin is degraded by the proteasomal system. Inhibition of the proteasome by lactacystin or Velcade increases the levels of R555W mis-sense mutated dysferlin. This salvaged protein is functional as it restores plasma membrane resealing in patient-derived myoblasts and reverses their deficit in myotube formation. Bortezomib and lactacystin did not cause cellular toxicity at the regimen used. Our results raise the possibility that inhibition of the degradation pathway of mis-sense mutated dysferlin could be used as a therapeutic strategy for patients harboring certain dysferlin mis-sense mutations.	[Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, CH-4031 Basel, Switzerland; [Sinnreich, Michael] Univ Basel Hosp, Neuromuscular Res Grp, Dept Biomed, CH-4031 Basel, Switzerland; Univ Basel, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Sinnreich, M (corresponding author), Univ Basel Hosp, Neuromuscular Res Grp, Dept Neurol, Petersgraben 4, CH-4031 Basel, Switzerland.	msinnreich@uhbs.ch	Azakir, Bilal/AAP-9345-2020; Kinter, Jochen/C-4515-2008	Azakir, Bilal/0000-0003-3084-0265; Sinnreich, Michael/0000-0002-9835-1276	Myosuisse; Association Francaise contre les Myopathies; Muscular Dystrophy Association Canada-Amyotrophic Lateral Sclerosis Society Canada-Canadian Institutes of Health Research (MDAC-ALS-CIHR); Swiss National Science Foundation; German Ministry of Education and Research (BMBF, Bonn, Germany)	Myosuisse; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association Canada-Amyotrophic Lateral Sclerosis Society Canada-Canadian Institutes of Health Research (MDAC-ALS-CIHR)(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Ministry of Education and Research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF))	This work was supported by Myosuisse, Association Francaise contre les Myopathies, Muscular Dystrophy Association Canada-Amyotrophic Lateral Sclerosis Society Canada-Canadian Institutes of Health Research (MDAC-ALS-CIHR) Partnership, and the Swiss National Science Foundation.; We thank Muscle Tissue Culture Collection for providing the myoblast samples used in this study. The Muscle Tissue Culture Collection is part of the German network on muscular dystrophies (MD-NET, service structure S1, 01GM0601) funded by the German Ministry of Education and Research (BMBF, Bonn, Germany). The Muscle Tissue Culture Collection is a partner of EuroBio-Bank and TREAT-NMD. We thank Dr. E. Shoubridge and Timothy Johns for help with the E6E7 retroviral infection of the human myoblast cultures; Dr. K. Bushby, Newcastle, for the GFP-cDNA; Beat Erne and Steven Salomon for technical assistance; and Drs. M. Filipowicz, J. Sinnreich, M. Ruegg, and J. Halter for helpful discussions.	Aartsma-Rus A, 2010, EUR J HUM GENET, V18, P889, DOI 10.1038/ejhg.2010.4; Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Belanto JJ, 2010, NEUROMUSCULAR DISORD, V20, P111, DOI 10.1016/j.nmd.2009.12.003; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Bonuccelli G, 2007, CELL CYCLE, V6, P1242, DOI 10.4161/cc.6.10.4182; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; De Luna N, 2004, J NEUROPATH EXP NEUR, V63, P1104, DOI 10.1093/jnen/63.10.1104; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; Diaz-Manera J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.35; Galbiati F, 2000, J BIOL CHEM, V275, P37702, DOI 10.1074/jbc.M006657200; GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0; Gazzerro E, 2010, AM J PATHOL, V176, P1863, DOI 10.2353/ajpath.2010.090468; Hideshima T, 2001, CANCER RES, V61, P3071; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Krahn M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000951; Krahn M, 2009, HUM MUTAT, V30, pE345, DOI 10.1002/humu.20910; Liewluck T, 2009, CLIN NEUROL NEUROSUR, V111, P613, DOI 10.1016/j.clineuro.2009.05.001; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Nguyen K, 2007, ARCH NEUROL-CHICAGO, V64, P1176, DOI 10.1001/archneur.64.8.1176; Nguyen Karine, 2005, Hum Mutat, V26, P165, DOI 10.1002/humu.9355; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Sinnreich M, 2006, NEUROLOGY, V66, P1114, DOI 10.1212/01.wnl.0000204358.89303.81; Sterz J, 2008, EXPERT OPIN INV DRUG, V17, P879, DOI 10.1517/13543784.17.6.879 ; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wang BJ, 2010, J APPL PHYSIOL, V109, P901, DOI 10.1152/japplphysiol.01366.2009; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wein N, 2010, HUM MUTAT, V31, P136, DOI 10.1002/humu.21160	36	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10344	10354		10.1074/jbc.M111.329078	http://dx.doi.org/10.1074/jbc.M111.329078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318734	hybrid, Green Published			2022-12-27	WOS:000302167200062
J	Han, CY; Umemoto, T; Omer, M; Den Hartigh, LJ; Chiba, T; Leboeuf, R; Buller, CL; Sweet, IR; Pennathur, S; Abel, ED; Chait, A				Han, Chang Yeop; Umemoto, Tomio; Omer, Mohamed; Den Hartigh, Laura J.; Chiba, Tsuyoshi; Leboeuf, Renee; Buller, Carolyn L.; Sweet, Ian R.; Pennathur, Subramaniam; Abel, E. Dale; Chait, Alan			NADPH Oxidase-derived Reactive Oxygen Species Increases Expression of Monocyte Chemotactic Factor Genes in Cultured Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-DEPENDENT MECHANISM; LIPID RAFT MICRODOMAINS; LOW-GRADE INFLAMMATION; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OXIDATIVE STRESS; MITOCHONDRIAL SUPEROXIDE; GLUCOSE METABOLISM; ENDOTHELIAL-CELLS	Excess glucose and free fatty acids delivered to adipose tissue causes local inflammation, which contributes to insulin resistance. Glucose and palmitate generate reactive oxygen species (ROS) in adipocytes, leading to monocyte chemotactic factor gene expression. Docosahexaenoate (DHA) has the opposite effect. In this study, we evaluated the potential sources of ROS in the presence of excess nutrients. Differentiated 3T3-L1 adipocytes were exposed to palmitate andDHA(250 mu M) in either 5 or 25mM glucose to evaluate the relative roles of mitochondrial electron transport and NADPH oxidases (NOX) as sources of ROS. Excess glucose and palmitate did not increase mitochondrial oxidative phosphorylation. However, glucose exposure increased glycolysis. Of the NOX family members, only NOX4 was expressed in adipocytes. Moreover, its activity was increased by excess glucose and palmitate and decreased by DHA. Silencing NOX4 inhibited palmitate- and glucose-stimulated ROS generation and monocyte chemotactic factor gene expression. NADPH, a substrate for NOX, and pentose phosphate pathway activity increased with glucose but not palmitate and decreased with DHA exposure. Inhibition of the pentose phosphate pathway by glucose-6-phosphate dehydrogenase inhibitors and siRNA suppressed ROS generation and monocyte chemotactic factor gene expression induced by both glucose and palmitate. Finally, both high glucose and palmitate induced NOX4 translocation into lipid rafts, effects that were blocked by DHA. Excess glucose and palmitate generate ROS via NOX4 rather than by mitochondrial oxidation in cultured adipocytes. NOX4 is regulated by both NADPH generated in the PPP and translocation of NOX4 into lipid rafts, leading to expression of monocyte chemotactic factors.	[Chait, Alan] Univ Washington, Diabet & Obes Ctr Excellence, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98195 USA; [Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA; [Buller, Carolyn L.; Pennathur, Subramaniam] Univ Michigan, Div Nephrol, Dept Med, Ann Arbor, MI 48105 USA	University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan	Chait, A (corresponding author), Univ Washington, Diabet & Obes Ctr Excellence, Div Metab Endocrinol & Nutr, Dept Med, 815 Mercer St,Box 358055, Seattle, WA 98195 USA.	achait@u.washington.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health [HL-094352, P30-DK-035816, DK-082841, DK-089503, DK-17047, DK092065]; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, R01HL098227, R56HL094352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK035816, P30DK017047, R24DK082841, R01DK092065, P30DK089503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-094352, P30-DK-035816, DK-082841, and DK-089503 (to S. P.), and DK-17047.; Established investigator of the American Heart Association and supported by the American Diabetes Association and National Institutes of Health Grant DK092065.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bolterman RJ, 2005, HYPERTENSION, V46, P943, DOI 10.1161/01.HYP.0000174602.59935.d5; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; CLEARY MP, 1986, INT J OBESITY, V10, P193; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Foncea R, 2000, BIOL RES, V33, P89; Frayn KN, 2008, DIABETOLOGIA, V51, P394, DOI 10.1007/s00125-007-0901-z; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Goueffic Y, 2007, ATHEROSCLEROSIS, V195, P23, DOI 10.1016/j.atherosclerosis.2006.11.023; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hansen LL, 1999, J BIOL CHEM, V274, P25078, DOI 10.1074/jbc.274.35.25078; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; KATZ J, 1966, J BIOL CHEM, V241, P727; KATZ J, 1960, J BIOL CHEM, V235, P2165; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Li HW, 2009, HYPERTENSION, V53, P1054, DOI 10.1161/HYPERTENSIONAHA.108.120642; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; MARETTE A, 1991, BIOCHEM J, V277, P119, DOI 10.1042/bj2770119; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OLEFSKY JM, 1977, ENDOCRINOLOGY, V100, P1169; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Patel C, 2007, J CLIN ENDOCR METAB, V92, P4476, DOI 10.1210/jc.2007-0778; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; RODBELL M, 1964, J BIOL CHEM, V239, P375; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	56	123	129	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10379	10393		10.1074/jbc.M111.304998	http://dx.doi.org/10.1074/jbc.M111.304998			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22287546	hybrid, Green Published			2022-12-27	WOS:000302167200065
J	Kitajima, T; Jigami, Y; Chiba, Y				Kitajima, Toshihiko; Jigami, Yoshifumi; Chiba, Yasunori			Cytotoxic Mechanism of Selenomethionine in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY METHIONINE PERMEASE; IONIZATION MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; TRANSFER-RNA; SELENOCYSTEINE; SELENIUM; METABOLISM; TOXICITY; SULFUR; GENE	Although selenium is an essential element, its excessive uptake is detrimental to living organisms. The significance of selenium for living organisms has been exploited for various purposes. However, the molecular basis of selenium toxicity is not completely understood. Here, we applied a capillary electrophoresis time-of-flight mass spectrometry-based metabolomics approach to analysis of yeast cells treated with selenomethionine. The data indicated that intracellular thiol compounds are significantly decreased, and diselenide and selenosulfide compounds are increased in selenomethionine-treated cells. The growth defect induced by selenomethionine was recovered by extracellular addition of cysteine and by genetic modification of yeast cells that have an additional de novo synthetic pathway for cysteine. Because cysteine is an intermediate of thiol compounds, these results suggested that the loss of a reduced form of thiol compounds due to selenomethionine causes a growth defect of yeast cells.	[Kitajima, Toshihiko; Jigami, Yoshifumi; Chiba, Yasunori] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Chiba, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	y-chiba@aist.go.jp	Kitajima, Toshihiko/K-2894-2013; Kitajima, Toshihiko/D-2463-2016; Chiba, Yasunori/L-7993-2018	Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086; Chiba, Yasunori/0000-0002-6401-5071				Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Bockhorn J, 2008, P NATL ACAD SCI USA, V105, P17682, DOI 10.1073/pnas.0805642105; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHEREST H, 1969, J BACTERIOL, V97, P328, DOI 10.1128/JB.97.1.328-336.1969; EUSTICE DC, 1981, PLANT PHYSIOL, V67, P1054, DOI 10.1104/pp.67.5.1054; HATFIELD D, 1982, P NATL ACAD SCI-BIOL, V79, P6215, DOI 10.1073/pnas.79.20.6215; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi0611614; Kitajima T, 2010, APPL ENVIRON MICROB, V76, P6351, DOI 10.1128/AEM.01026-10; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Malkowski MG, 2007, P NATL ACAD SCI USA, V104, P6678, DOI 10.1073/pnas.0610337104; Nakamuro K, 2000, J HEALTH SCI, V46, P418; Nauser T, 2012, AMINO ACIDS, V42, P39, DOI 10.1007/s00726-010-0602-7; Palace VP, 2004, ECOTOX ENVIRON SAFE, V58, P17, DOI 10.1016/j.ecoenv.2003.08.019; Pappas AC, 2008, COMP BIOCHEM PHYS B, V151, P361, DOI 10.1016/j.cbpb.2008.08.009; PLEASANTS JC, 1989, J AM CHEM SOC, V111, P6553, DOI 10.1021/ja00199a012; Rao YL, 2010, ANAL CHEM, V82, P8121, DOI 10.1021/ac1011798; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Sors TG, 2005, PHOTOSYNTH RES, V86, P373, DOI 10.1007/s11120-005-5222-9; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; YAMAGATA S, 1974, J BIOCHEM, V75, P1221, DOI 10.1093/oxfordjournals.jbchem.a130505; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	37	16	17	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10032	10038		10.1074/jbc.M111.324244	http://dx.doi.org/10.1074/jbc.M111.324244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311978	hybrid, Green Published			2022-12-27	WOS:000302167200035
J	Pickering, AM; Linder, RA; Zhang, HQ; Forman, HJ; Davies, KJA				Pickering, Andrew M.; Linder, Robert A.; Zhang, Hongqiao; Forman, Henry J.; Davies, Kelvin J. A.			Nrf2-dependent Induction of Proteasome and Pa28 alpha beta Regulator Are Required for Adaptation to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; PROTEIN OXIDATION; OXIDIZED PROTEINS; LON PROTEASE; NITRIC-OXIDE; MITOCHONDRIAL ACONITASE; ENDOTHELIAL-CELLS; GENE-EXPRESSION; UP-REGULATION; DEGRADATION	The ability to adapt to acute oxidative stress (e.g. H2O2, peroxynitrite, menadione, and paraquat) through transient alterations in gene expression is an important component of cellular defense mechanisms. We show that such adaptation includes Nrf2-dependent increases in cellular capacity to degrade oxidized proteins that are attributable to increased expression of the 20 S proteasome and the Pa28 alpha beta (11 S) proteasome regulator. Increased cellular levels of Nrf2, translocation of Nrf2 from the cytoplasm to the nucleus, and increased binding of Nrf2 to antioxidant response elements (AREs) or electrophile response elements (EpREs) in the 5'-untranslated region of the proteasome beta 5 subunit gene (demonstrated by chromatin immuno-precipitation (or ChIP) assay) are shown to be necessary requirements for increased proteasome/Pa28 alpha beta levels, and for maximal increases in proteolytic capacity and stress resistance; Nrf2 siRNA and the Nrf2 inhibitor retinoic acid both block these adaptive changes and the Nrf2 inducers DL-sulforaphane, lipoic acid, and curcumin all replicate them without oxidant exposure. The immunoproteasome is also induced during oxidative stress adaptation, contributing to overall capacity to degrade oxidized proteins and stress resistance. Two of the three immunoproteasome subunit genes, however, contain no ARE/EpRE elements, and Nrf2 inducers, inhibitors, and siRNA all have minimal effects on immunoproteasome expression during adaptation to oxidative stress. Thus, immunoproteasome appears to be (at most) minimally regulated by the Nrf2 signal transduction pathway.	[Pickering, Andrew M.; Linder, Robert A.; Zhang, Hongqiao; Forman, Henry J.; Davies, Kelvin J. A.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Pickering, Andrew M.; Linder, Robert A.; Davies, Kelvin J. A.] Univ So Calif, Div Mol & Computat Biol, Dept Biol Sci, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA; [Zhang, Hongqiao; Forman, Henry J.] Univ Calif Merced, Merced, CA 95343 USA	University of Southern California; University of Southern California; University of California System; University of California Merced	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Davis Sch Gerontol, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Davies, Kelvin/0000-0001-7790-3003; Forman, Henry Jay/0000-0001-5838-2791	National Institutes of Health [RO1-ES003598]; ARRA from the NIEHS [3RO1-ES003598-22S2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES003598 and ARRA Supplement 3RO1-ES003598-22S2 from the NIEHS (to K. J. A. D.).	Ahn K, 1996, J BIOL CHEM, V271, P18237, DOI 10.1074/jbc.271.30.18237; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102; Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; DAVIES KJA, 1993, BIOCHEM SOC T, V21, P346, DOI 10.1042/bst0210346; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; DAVIES KJA, 1987, J BIOL CHEM, V262, P8227; Ding QX, 2004, J NEUROCHEM, V91, P1211, DOI 10.1111/j.1471-4159.2004.02802.x; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Foss GS, 1999, J BIOL CHEM, V274, P35196, DOI 10.1074/jbc.274.49.35196; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Gan NQ, 2010, TOXICOL APPL PHARM, V247, P129, DOI 10.1016/j.taap.2010.06.005; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; KAMANNA VS, 1991, AM J PHYSIOL, V261, pF163, DOI 10.1152/ajprenal.1991.261.1.F163; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kotamraju S, 2003, P NATL ACAD SCI USA, V100, P10653, DOI 10.1073/pnas.1933581100; Kraft DC, 2006, ANN NY ACAD SCI, V1067, P420, DOI 10.1196/annals.1354.060; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Namiki S, 2005, FEBS LETT, V579, P2781, DOI 10.1016/j.febslet.2005.04.012; Ngo JK, 2009, FREE RADICAL BIO MED, V46, P1042, DOI 10.1016/j.freeradbiomed.2008.12.024; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; PACIFICI RE, 1991, GERONTOLOGY, V37, P166; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Reinheckel T, 2000, METH MOL B, V99, P49; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shenvi SV, 2009, PHARMACOL RES, V60, P229, DOI 10.1016/j.phrs.2009.06.003; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; Teoh CY, 2004, ARCH BIOCHEM BIOPHYS, V423, P88, DOI 10.1016/j.abb.2003.12.001; Thomas S, 2007, FREE RADICAL BIO MED, V42, P1049, DOI 10.1016/j.freeradbiomed.2007.01.005; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Whittier JE, 2004, J BIOL CHEM, V279, P46135, DOI 10.1074/jbc.M406048200; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Zhang H, 2008, AM J RESP CELL MOL, V38, P483, DOI 10.1165/rcmb.2007-0260OC; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002	69	214	220	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10021	10031		10.1074/jbc.M111.277145	http://dx.doi.org/10.1074/jbc.M111.277145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308036	hybrid, Green Published			2022-12-27	WOS:000302167200034
J	Shi, SY; Martin, RG; Duncan, RE; Choi, D; Lu, SY; Schroer, SA; Cai, EP; Luk, CT; Hopperton, KE; Domenichiello, AF; Tang, C; Naples, M; Dekker, MJ; Giacca, A; Adeli, K; Wagner, KU; Bazinet, RP; Woo, M				Shi, Sally Yu; Martin, Ruben Garcia; Duncan, Robin E.; Choi, Diana; Lu, Shun-Yan; Schroer, Stephanie A.; Cai, Erica P.; Luk, Cynthia T.; Hopperton, Kathryn E.; Domenichiello, Anthony F.; Tang, Christine; Naples, Mark; Dekker, Mark J.; Giacca, Adria; Adeli, Khosrow; Wagner, Kay-Uwe; Bazinet, Richard P.; Woo, Minna			Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; BETA-CELL HYPERPLASIA; GROWTH-HORMONE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RECEPTOR; MICE; INHIBITION; EXPRESSION; INFLAMMATION	Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease and is now considered to be the hepatic manifestation of the metabolic syndrome. However, the role of steatosis per se and the precise factors required in the progression to steatohepatitis or insulin resistance remain elusive. The JAK-STAT pathway is critical in mediating signaling of a wide variety of cytokines and growth factors. Mice with hepatocyte-specific deletion of Janus kinase 2 (L-JAK2 KO mice) develop spontaneous steatosis as early as 2 weeks of age. In this study, we investigated the metabolic consequences of jak2 deletion in response to diet-induced metabolic stress. To our surprise, despite the profound hepatosteatosis, deletion of hepatic jak2 did not sensitize the liver to accelerated inflammatory injury on a prolonged high fat diet (HFD). This was accompanied by complete protection against HFD-induced whole-body insulin resistance and glucose intolerance. Improved glucose-stimulated insulin secretion and an increase in beta-cell mass were also present in these mice. Moreover, L-JAK2 KO mice had progressively reduced adiposity in association with blunted hepatic growth hormone signaling. These mice also exhibited increased resting energy expenditure on both chow and high fat diet. In conclusion, our findings indicate a key role of hepatic JAK2 in metabolism such that its absence completely arrests steatohepatitis development and confers protection against diet-induced systemic insulin resistance and glucose intolerance.	[Shi, Sally Yu; Martin, Ruben Garcia; Choi, Diana; Lu, Shun-Yan; Schroer, Stephanie A.; Cai, Erica P.; Luk, Cynthia T.; Woo, Minna] Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada; [Shi, Sally Yu; Choi, Diana; Cai, Erica P.; Luk, Cynthia T.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Duncan, Robin E.; Hopperton, Kathryn E.; Domenichiello, Anthony F.; Bazinet, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Tang, Christine; Giacca, Adria] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON M5S 1A8, Canada; [Naples, Mark; Dekker, Mark J.; Adeli, Khosrow] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M3B 1W5, Canada; [Woo, Minna] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M3B 1W5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,101 Coll St,10th Floo, Toronto, ON M5G 1L7, Canada.	mwoo@uhnres.utoronto.ca	Cai, Erica/ABE-4408-2020; Duncan, Robin/AAH-7465-2021; Wagner, Kay-Uwe/B-6044-2009; Martin, Ruben Garcia/AAA-8538-2021	Martin, Ruben Garcia/0000-0003-2049-4960; Shi, Sally Yu/0000-0002-5528-3824; Hopperton, Kathryn/0000-0003-0146-2744; Wagner, Kay-Uwe/0000-0002-5081-0226; Cai, Erica/0000-0003-2386-5747; Adeli, Khosrow/0000-0002-5839-5709	Canadian Institute of Health Research [MOP-191501]; Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk; NSERC; Spanish National Research Fellowship from Ibercaja Foundation (Spain); CIHR Federick Banting; Charles Best Canada Graduate Scholarship - Doctoral; Eliot Phillipson Clinician Scientist Training Program; BBDC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish National Research Fellowship from Ibercaja Foundation (Spain); CIHR Federick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship - Doctoral; Eliot Phillipson Clinician Scientist Training Program; BBDC	This work was supported by operating grants from Canadian Institute of Health Research MOP-191501 and Canadian Diabetes Association (to M. W.).; Supported by the Banting and Best Diabetes Centre (BBDC)-Novo Nordisk Studentship and the NSERC Alexander Graham Bell Canada Graduate Scholarship.; Supported by the Spanish National Research Fellowship from Ibercaja Foundation (Spain).; Supported by the CIHR Federick Banting and Charles Best Canada Graduate Scholarship - Doctoral.; Supported by the Canadian Diabetes Association Doctoral Student Research Award.; Supported by the Eliot Phillipson Clinician Scientist Training Program and the BBDC post-doctoral fellowship.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; BRAY GA, 1969, J CLIN ENDOCR METAB, V29, P119, DOI 10.1210/jcem-29-1-119; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen CT, 2008, J LIPID RES, V49, P147, DOI 10.1194/jlr.M700386-JLR200; Cheung L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-60; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Duez H, 2009, ENDOCRINOLOGY, V150, P56, DOI 10.1210/en.2008-1137; Escribano O, 2009, DIABETES, V58, P820, DOI 10.2337/db08-0551; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; Wolthers T, 1996, J CLIN ENDOCR METAB, V81, P1416, DOI 10.1210/jc.81.4.1416; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Younossi ZM, 1998, MODERN PATHOL, V11, P560; Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672	44	50	51	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10277	10288		10.1074/jbc.M111.317453	http://dx.doi.org/10.1074/jbc.M111.317453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275361	hybrid, Green Published			2022-12-27	WOS:000302167200057
J	Telezhkin, V; Reilly, JM; Thomas, AM; Tinker, A; Brown, DA				Telezhkin, Vsevolod; Reilly, Joanne M.; Thomas, Alison M.; Tinker, Andrew; Brown, David A.			Structural Requirements of Membrane Phospholipids for M-type Potassium Channel Activation and Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE BINDING; KCNQ CHANNELS; HIGH-AFFINITY; PIP2; PHOSPHATIDYLSERINE; ORGANIZATION; MODULATION; PROTEINS; SUBUNITS	M-channels are voltage-gated potassium channels that regulate cell excitability. They are heterotetrameric assemblies of Kv7.2 and Kv7.3 subunits. Their opening requires the presence of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). However, the specificity of PI(4,5)P-2 as a binding and activating ligand is unknown. Here, we tested the ability of different phosphoinositides and lipid phosphates to activate or bind to M-channel proteins. Activation of functional channels was measured in membrane patches isolated from cells coexpressing Kv7.2 and Kv7.3 subunits. Channels were activated to similar extents (maximum open probability of similar to 0.8 at 0 mV) by 0.1-300 mu M dioctanoyl homologs of the three endogenous phosphoinositides, PI(4)P, PI(4,5)P-2, and PI(3,4,5)P-3, with sensitivity increasing with increasing numbers of phosphates. Non-acylated inositol phosphates had no effect up to 100 mu M. Channels were also activated with increasing efficacy by 1-300 mu M concentrations of the monoacyl monophosphates fingolimod phosphate, sphingosine 1-phosphate, and lysophosphatidic acid but not by phosphate-free fingolimod or sphingosine or by phosphate-masked phosphatidylcholine or phosphatidyl-glycerol. An overlay assay confirmed that a fusion protein containing the full-length C terminus of Kv7.2 could bind to a broad range of phosphoinositides and phospholipids. A mutated Kv7.2 C-terminal construct with reduced sensitivity to PI(4,5)P showed significantly less binding to most polyphosphoinositides. We concluded that M-channels bind to, and are activated by, a wide range of lipid phosphates, with a minimum requirement for an acyl chain and a phosphate headgroup. In this, they more closely resemble inwardly rectifying Kir6.2 potassium channels than the more PI(4,5)P-2-specific Kir2 channels. Notwithstanding, the data also support the view that the main endogenous activator of M-channels is PI(4,5)P-2.	[Telezhkin, Vsevolod; Reilly, Joanne M.; Brown, David A.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Thomas, Alison M.; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Heart Ctr, London EC1M 6BQ, England	University of London; University College London; University of London; Queen Mary University London	Brown, DA (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	d.a.brown@ucl.ac.uk	Brown, David A/J-9019-2012	Telezhkin, Vsevolod/0000-0002-5054-8774	Wellcome Trust [085419]; British Heart Foundation [RG/10/10/28447]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by Grant 085419 from the Wellcome Trust and Grant RG/10/10/28447 from the British Heart Foundation.	ALLAN D, 1983, BIOCHEM J, V213, P555, DOI 10.1042/bj2130555; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Stephens L, 2000, FR MOLEC B, V27, P32; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Telezhkin V., 2010, F20 2010 NEUR M PLAN; Thomas AM, 2006, J MEMBRANE BIOL, V211, P43, DOI 10.1007/s00232-006-0014-5; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Tucker SJ, 2008, J GEN PHYSIOL, V131, P431, DOI 10.1085/jgp.200709936; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	41	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10001	10012		10.1074/jbc.M111.322552	http://dx.doi.org/10.1074/jbc.M111.322552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303005	Green Published, hybrid			2022-12-27	WOS:000302167200032
J	Zhang, Y; Chan, NC; Ngo, HB; Gristick, H; Chan, DC				Zhang, Yan; Chan, Nickie C.; Ngo, Huu B.; Gristick, Harry; Chan, David C.			Crystal Structure of Mitochondrial Fission Complex Reveals Scaffolding Function for Mitochondrial Division 1 (Mdv1) Coiled Coil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; WD REPEAT PROTEIN; MAMMALIAN-CELLS; PEROXISOMAL FISSION; FIS1; DNM1P; FUSION; DRP1; RECRUITMENT; MITOPHAGY	The mitochondrial fission machinery is best understood in the yeast Saccharomyces cerevisiae, where Fis1, Mdv1, and Dnm1 are essential components. Fis1 is a mitochondrial outer membrane protein that recruits the dynamin-related GTPase Dnm1 during the fission process. This recruitment occurs via Mdv1, which binds both Fis1 and Dnm1 and therefore functions as a molecular adaptor linking the two molecules. Mdv1 has a modular structure, consisting of an N-terminal extension that binds Fis1, a central coiled coil for dimerization, and a C-terminal WD40 repeat region that binds Dnm1. We have solved the crystal structure of a dimeric Mdv1-Fis1 complex that contains both the N-terminal extension and coiled-coil regions of Mdv1. Consistent with previous studies, Mdv1 binds Fis1 through a U-shaped helix-loop-helix motif, and dimerization of the Mdv1-Fis1 complex is mediated by the antiparallel coiled coil of Mdv1. However, the complex is surprisingly compact and rigid due to two additional contacts mediated by the surface of the Mdv1 coiled coil. The coiled coil packs against both Fis1 and the second helix of the Mdv1 helix-loop-helix motif. Mutational analyses showed that these contacts are important for mitochondrial fission activity. These results indicate that, in addition to dimerization, the unusually long Mdv1 coiled coil serves a scaffolding function to stabilize the Mdv1-Fis1 complex.	[Chan, Nickie C.; Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Zhang, Yan; Chan, Nickie C.; Ngo, Huu B.; Gristick, Harry; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Chan, DC (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu		Zhang, Yan/0000-0001-8376-3190	National Institutes of Health [GM083121, GM062967]; American Heart Association; Gordon and Betty Moore Foundation; Sanofi-Aventis; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources [P41RR001209]; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083121, R01GM062967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Sanofi-Aventis(Sanofi-Aventis); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083121 and GM062967.; Supported in part by a postdoctoral fellowship from the American Heart Association.; We thank Janet Shaw for yeast strains, constructs, and helpful discussions. Some of the initial screening was done at the Molecular Observatory at California Institute of Technology, which is supported by the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by National Institutes of Health National Center for Research Resources Bio-medical Technology Program Grant P41RR001209 and NIGMS.	Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Tooley JE, 2011, ACTA CRYSTALLOGR F, V67, P1310, DOI 10.1107/S1744309111029368; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	37	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9855	9861		10.1074/jbc.M111.329359	http://dx.doi.org/10.1074/jbc.M111.329359			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303011	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-27	WOS:000302167200018
J	Berrout, J; Jin, M; Mamenko, M; Zaika, O; Pochynyuk, O; O'Neil, RG				Berrout, Jonathan; Jin, Min; Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh; O'Neil, Roger G.			Function of Transient Receptor Potential Cation Channel Subfamily V Member 4 (TRPV4) as a Mechanical Transducer in Flow-sensitive Segments of Renal Collecting Duct System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; CONNECTING TUBULE; PRIMARY CILIUM; ACTIVATION; POLYCYSTIN-2; SECRETION; TRANSPORT; SENSATION; PATHWAYS; CALCIUM	The TRPV4 Ca2+-permeable channel is sensitive to mechanical stimuli. In the current study we have employed immunocytochemical staining in kidney slices and functional assessments (Ca2+ imaging) in isolated, split-opened, tubule segments to define TRPV4 sites of expression and flow-dependent function in the collecting duct system. Staining patterns revealed strong expression of TRPV4 along the entire collecting duct system with highest levels at the apical (luminal)/subapical region of the principal cells (PCs), the dominant cell type, with more diffuse staining in intercalated cells (ICs). Using fluorescence Ca2+ imaging and the selective TRPV4 agonist, GSK1016790A, we demonstrated functional TRPV4 channels in PCs and ICs of split-opened cortical collecting ducts and connecting tubules. The agonist was ineffective in inducing a rise in [Ca2+](i) in the absence of extracellular Ca2+ or in tubules from TRPV4-deficient animals. Most importantly, a 10-fold elevation in luminal (apical) fluid flow induced a rapid and sustained influx of Ca2+ that was abolished by the TRPV channel inhibitor, ruthenium red, or in tubules isolated from TRPV4 deficient animals. We concluded that TRPV4 is highly expressed along the entire collecting duct system where it appears to function as a sensor/transducer of flow-induce mechanical stresses.	[Berrout, Jonathan; Jin, Min; Mamenko, Mykola; Zaika, Oleg; Pochynyuk, Oleh; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	O'Neil, RG (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, 6431 Fannin St,Rm MSB 4-132, Houston, TX 77030 USA.	roger.g.oneil@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715	National Institutes of Health [R01 DK070950, R21 DE018522]; American Heart Association [SDG2230391]; American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported, in whole or in part, by National Institutes of Health Grants R01 DK070950 (to R. G. O.) and R21 DE018522 (to R. G. O.). This work was also supported by American Heart Association Grant SDG2230391 (to O. P.) and the Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (to O. P.).	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Jin M., 2012, CELL CALCIU IN PRESS; Jin M, 2011, TRP CHANNELS, P353; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; LATTA H, 1961, J BIOPHYS BIOCHEM CY, V11, P248, DOI 10.1083/jcb.11.1.248; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P851, DOI 10.1161/ATVBAHA.109.196584; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pluznick JL, 2005, AM J PHYSIOL-RENAL, V288, pF846, DOI 10.1152/ajprenal.00340.2004; Pochynyuk O, 2008, J BIOL CHEM, V283, P36599, DOI 10.1074/jbc.M807129200; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TANIGUCHI J, 1994, J MEMBRANE BIOL, V140, P123; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010	41	72	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8782	8791		10.1074/jbc.M111.308411	http://dx.doi.org/10.1074/jbc.M111.308411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298783	Green Published, hybrid			2022-12-27	WOS:000301797800011
J	von Lohneysen, K; Noack, D; Hayes, P; Friedman, JS; Knaus, UG				von Loehneysen, Katharina; Noack, Deborah; Hayes, Patti; Friedman, Jeffrey S.; Knaus, Ulla G.			Constitutive NADPH Oxidase 4 Activity Resides in the Composition of the B-loop and the Penultimate C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME B(558); NOX-FAMILY; TRANSMEMBRANE; INHIBITION; GP91(PHOX); STABILITY; EVOLUTION; ARGININE; SUBUNIT; PEPTIDE	Redox regulation of signaling molecules contributes critically to propagation of intracellular signals. The main source providing reactive oxygen species (ROS) for these physiological processes are activated NADPH oxidases (Nox/Duox family). In a pathophysiological context, some NADPH oxidase complexes produce large amounts of ROS either as part of the antimicrobial immune defense or as pathologic oxidative stress in many chronic diseases. Thus, understanding the switch from a dormant, inactive conformation to the active state of these enzymes will aid the development of inhibitors. As exogenously expressed Nox4 represents the only constitutively active enzyme in this family, analysis of structural determinants that permit this active conformation was undertaken. Our focus was directed toward a cell-based analysis of the first intracellular loop, the B-loop, and the C-terminus, two regions of Nox family enzymes that are essential for electron transfer. Mutagenesis of the B-loop identified several unique residues and a polybasic motif that contribute to the catalytic activity of Nox4. By using a multifaceted approach, including Nox4-Nox2 chimeras, mutagenesis, and insertion of Nox2 domains, we show here that the penultimate 22 amino acids of Nox4 are involved in constitutive ROS generation. The appropriate spacing of the C-terminal Nox4 sequence may cooperate with a discrete arginine-based interaction site in the B-loop, providing an intrinsically active interface that could not be disrupted by peptides derived from the Nox4 C-terminus. These results indicate that accessibility for a Nox4-specific peptide inhibitor might be difficult to achieve in vivo.	[Hayes, Patti; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland; [von Loehneysen, Katharina; Noack, Deborah; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University College Dublin; Scripps Research Institute	Knaus, UG (corresponding author), Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland.	Ulla.Knaus@ucd.ie			National Institutes of Health [1RO1 DK080232]; Science Foundation Ireland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 DK080232 (to J. S. F.). This work was also supported by Science Foundation Ireland award (to U. G. K.).	Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; Picciocchi A, 2011, J BIOL CHEM, V286, P28357, DOI 10.1074/jbc.M111.220418; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhou XS, 2008, AM J PHYSIOL-HEART C, V295, pH1008, DOI 10.1152/ajpheart.00114.2008	24	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8737	8745		10.1074/jbc.M111.332494	http://dx.doi.org/10.1074/jbc.M111.332494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277655	Green Published, hybrid			2022-12-27	WOS:000301797800007
J	Arima, Y; Hayashi, H; Sasaki, M; Hosonaga, M; Goto, TM; Chiyoda, T; Kuninaka, S; Shibata, T; Ohata, H; Nakagama, H; Taya, Y; Saya, H				Arima, Yoshimi; Hayashi, Hidemi; Sasaki, Mikako; Hosonaga, Mari; Goto, Takaaki M.; Chiyoda, Tatsuyuki; Kuninaka, Shinji; Shibata, Tatsuhiro; Ohata, Hirokazu; Nakagama, Hitoshi; Taya, Yoichi; Saya, Hideyuki			Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; MIR-200 FAMILY; FEEDBACK LOOP; TRANSITION; CELLS; INVASION; METASTASIS; EXPRESSION; PLASTICITY	We previously showed that depletion of the retinoblastoma protein (RB) induces down-regulation of the adhesion molecule E-cadherin and thereby triggers the epithelial-mesenchymal transition. To further characterize the effect of RB inactivation on the phenotype of cancer cells, we have now examined RB expression in human breast cancer cell lines and clinical specimens. We found that RB-inactive cells exhibit a mesenchymal-like morphology and are highly invasive. We also found that ZEB proteins, transcriptional repressors of the E-cadherin gene, are markedly up-regulated in these cells in a manner sensitive to the miR-200 family of microRNAs. Moreover, depletion of ZEB in RB-inactive cells suppressed cell invasiveness and proliferation and induced epithelial marker expression. These results implicate ZEB in induction of the epithelial-mesenchymal transition, as well as in maintenance of the mesenchymal phenotype in RB-inactive cells. We also developed a screening program for inhibitors of ZEB1 expression and thereby identified several cyclin-dependent kinase inhibitors that blocked both ZEB1 expression and RB phosphorylation. Together, our findings suggest that RB inactivation contributes to tumor progression not only through loss of cell cycle control but also through up-regulation of ZEB expression and induction of an invasive phenotype.	[Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo 1608582, Japan; [Arima, Yoshimi; Sasaki, Mikako; Goto, Takaaki M.; Chiyoda, Tatsuyuki; Kuninaka, Shinji; Saya, Hideyuki] Japan Sci & Technol Agcy, CREST, Tokyo 1020075, Japan; [Hayashi, Hidemi] Link Genom Inc, Dept Biomed Res & Dev, Tokyo 1030024, Japan; [Hosonaga, Mari] Tokyo Med Univ, Dept Breast Oncol, Tokyo 1600023, Japan; [Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Tokyo 1040045, Japan; [Ohata, Hirokazu] Natl Canc Ctr, Div Canc Differentiat, Tokyo 1040045, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Tokyo 1040045, Japan; [Taya, Yoichi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore	Keio University; Japan Science & Technology Agency (JST); Tokyo Medical University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National University of Singapore	Saya, H (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hsaya@a5.keio.jp	Chiyoda, Tatsuyuki/K-9325-2013; Arima, Yoshimi/J-8057-2013; Shibata, Tatsuhiro/AAO-1278-2021; Chiyoda, Tatsuyuki/Q-1971-2019; Kuninaka, Shinji/J-7158-2013; Saya, Hideyuki/J-4325-2013; Chiyoda, Tatsuyuki/GLR-5573-2022; Shibata, Tatsuhiro/ABA-8234-2020	Chiyoda, Tatsuyuki/0000-0002-8214-2242; Saya, Hideyuki/0000-0001-6610-1902; Arima, Yoshimi/0000-0002-2384-1406	Ministry of Health and Welfare of Japan; Keio University; MEXT; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Keio University; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Health and Welfare of Japan (to H. S.), a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (to Y. A.), and a Grant-in-Aid for Young Scientists (B) from MEXT (to Y. A.).; We thank E. Knudsen for providing Ad-RB Am; T. Yamori for providing the Screening Committee of Anticancer Drugs (SCADS) inhibitor kits I, II, and III, which is supported by a Grant-in-Aid for Scientific Research on Priority Area "Cancer" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Y. Hata (Link Genomics Inc.), K. Hizume (Shimadzu Corporation); K. Matsumoto for technical assistance; and laboratory members for discussion.	Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Dasgupta P, 2006, CURR MOL MED, V6, P719; Dawson S J, 2009, Eur J Cancer, V45 Suppl 1, P27, DOI 10.1016/S0959-8049(09)70013-9; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hajra KM, 2002, CANCER RES, V62, P1613; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Kong DX, 2010, BIOL PHARM BULL, V33, P1600, DOI 10.1248/bpb.33.1600; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	26	59	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7896	7906		10.1074/jbc.M111.313759	http://dx.doi.org/10.1074/jbc.M111.313759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262832	Green Published, hybrid			2022-12-27	WOS:000301349400006
J	Chen, SY; Gulla, S; Cai, CM; Balk, SP				Chen, Shaoyong; Gulla, Sarah; Cai, Changmeng; Balk, Steven P.			Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; HUMAN LNCAP CELLS; CYCLE PROGRESSION; GENE-EXPRESSION; S-PHASE; DOMAIN; BICALUTAMIDE; SITES; G(1); EZH2	Our previous findings indicated that androgen receptor (AR) phosphorylation at serine 81 is stimulated by the mitotic cyclin-dependent kinase 1 (CDK1). In this report, we extended our previous study and confirmed that Ser-81 phosphorylation increases during mitosis, coincident with CDK1 activation. We further showed blocking cell cycle at G(1) or S phase did not disrupt androgen-induced Ser-81 phosphorylation and AR-dependent transcription, consistent with a recent report that AR was phosphorylated at Ser-81 and activated by the transcriptional CDK9. To assess the function of Ser-81 phosphorylation in prostate cancer (PCa) cells expressing endogenous AR, we developed a ligand switch strategy using a ligand-binding domain mutation (W741C) that renders AR responsive to the antagonist bicalutamide. An S81A/W741C double mutant AR stably expressed in PCa cells failed to transactivate the endogenous AR-regulated PSA or TMPRSS2 genes. ChIP showed that the S81A mutation prevented ligand-induced AR recruitment to these genes, and cellular fractionation revealed that the S81A mutation globally abrogated chromatin binding. Conversely, the AR fraction rapidly recruited to chromatin after androgen stimulation was highly enriched for Ser-81 phosphorylation. Finally, inhibition of CDK1 and CDK9 decreased AR Ser-81 phosphorylation, chromatin binding, and transcriptional activity. These findings indicate that Ser-81 phosphorylation by CDK9 stabilizes AR chromatin binding for transcription and suggest that CDK1-mediated Ser-81 phosphorylation during mitosis provides a pool of Ser-81 phosphorylation AR that can be readily recruited to chromatin for gene reactivation and may enhance AR activity in PCa.	[Chen, Shaoyong; Gulla, Sarah; Cai, Changmeng; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chen, SY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Ctr Life Sci Bldg,Rm 432,3 Blackfan Circle, Boston, MA 02215 USA.	schen@bidmc.harvard.edu	CHEN, Shaoyong/ABF-3357-2021; Cai, Changmeng/AAE-6835-2020	Cai, Changmeng/0000-0002-8701-2586	National Institutes of Health [R01CA111803, K99/R00 CA135592]; Dana-Farber/Harvard Cancer Center (DF/HCC) [P50-CA90381]; SPORE; Department of Defense [PC040499]; Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R00CA135592, K99CA135592, R01CA111803, P50CA090381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center (DF/HCC); SPORE; Department of Defense(United States Department of Defense); Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111803 (to S. P. B.) and K99/R00 CA135592 (to S. C.). This work was also supported by Dana-Farber/Harvard Cancer Center (DF/HCC) Prostate Specialized Program in Research Excellence (SPORE) Grant P50-CA90381 (to S. P. B.), a SPORE Career Development Award (to S. C.), Department of Defense postdoctoral award PC040499, a Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program, and the Hershey Family Prostate Cancer Research Fund and the Prostate Cancer Foundation.	Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bisson WH, 2008, J MOL GRAPH MODEL, V27, P452, DOI 10.1016/j.jmgm.2008.08.001; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hara T, 2003, CANCER RES, V63, P149; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Imbach P, 1999, BIOORG MED CHEM LETT, V9, P91, DOI 10.1016/S0960-894X(98)00691-X; JENSTER G, 1994, BIOCHEMISTRY-US, V33, P14064, DOI 10.1021/bi00251a015; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kumar S, 2008, BBA-MOL CELL RES, V1783, P59, DOI 10.1016/j.bbamcr.2007.11.002; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Shen HC, 2005, VITAM HORM, V71, P301, DOI 10.1016/S0083-6729(05)71010-4; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VANLAAR JH, 1990, BIOCHEM BIOPH RES CO, V166, P193, DOI 10.1016/0006-291X(90)91930-Q; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605	54	71	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8571	8583		10.1074/jbc.M111.325290	http://dx.doi.org/10.1074/jbc.M111.325290			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275373	Green Published, hybrid			2022-12-27	WOS:000301349400070
J	Heo, JB; Sung, S; Assmann, SM				Heo, Jae Bok; Sung, Sibum; Assmann, Sarah M.			Ca2+-dependent GTPase, Extra-large G Protein 2 (XLG2), Promotes Activation of DNA-binding Protein Related to Vernalization 1 (RTV1), Leading to Activation of Floral Integrator Genes and Early Flowering in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; GAMMA-SUBUNIT; HETEROCHROMATIN PROTEIN-1; REGULATORY COMPONENT; TRANSCRIPTION FACTOR; STRUCTURAL-ANALYSIS; COUPLED RECEPTORS; ADENYLATE-CYCLASE; ESCHERICHIA-COLI; BETA-SUBUNIT	Heterotrimeric G proteins, consisting of G alpha, G beta, and G gamma sub-units, play important roles in plant development and cell signaling. In Arabidopsis, in addition to one prototypical G protein alpha subunit, GPA1, there are three extra-large G proteins, XLG1, XLG2, and XLG3, of largely unknown function. Each extra-large G (XLG) protein has a C-terminal G alpha-like region and a similar to 400 amino acid N-terminal extension. Here we show that the three XLG proteins specifically bind and hydrolyze GTP, despite the fact that these plant-specific proteins lack key conserved amino acid residues important for GTP binding and hydrolysis of GTP in mammalian G alpha proteins. Moreover, unlike other known G alpha proteins, these activities require Ca2+ instead of Mg2+ as a cofactor. Yeast two-hybrid library screening and in vitro protein pull-down assays revealed that XLG2 interacts with the nuclear protein RTV1(related to vernalization 1). Electrophoretic mobility shift assays show that RTV1 binds to DNA in vitro in a non-sequence-specific manner and that GTP-bound XLG2 promotes the DNA binding activity of RTV1. Overexpression of RTV1 results in early flowering. Combined overexpression of XLG2 and RTV1 enhances this early flowering phenotype and elevates expression of the floral pathway integrator genes, FT and SOC1, but does not repress expression of the floral repressor, FLC. Chromatin immunoprecipitation assays show that XLG2 increases RTV1 binding to FT and SOC1 promoters. Thus, a Ca2+-dependent G protein, XLG2, promotes RTV1 DNA binding activity for a subset of floral integrator genes and contributes to floral transition.	[Assmann, Sarah M.] Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Heo, Jae Bok; Sung, Sibum] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Heo, Jae Bok] Dong A Univ, Dept Mol Biotechnol, Pusan 604714, South Korea; [Heo, Jae Bok] Dong A Univ, Ctr Silver Bio Industrializat BK21, Pusan 604714, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Dong A University; Dong A University	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.	sma3@psu.edu	Sung, Sibum/AAM-6500-2020		United States Department of Agriculture [2003-35304-13924]; Penn State; National Science Foundation [IOS 0950785]; SSAC [PJ008087]; National Research Foundation of Korea; Korean Government (MEST) [2011-0013137]; Direct For Biological Sciences [0950785] Funding Source: National Science Foundation	United States Department of Agriculture(United States Department of Agriculture (USDA)); Penn State; National Science Foundation(National Science Foundation (NSF)); SSAC; National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by United States Department of Agriculture Grant 2003-35304-13924 and Penn State funding (to S. M. A.), by National Science Foundation Grant IOS 0950785 (to S. S.), and Next-Generation BioGreen 21 Program SSAC Grant PJ008087 and a National Research Foundation of Korea Grant funded by the Korean Government (MEST Grant 2011-0013137) (to J. B. H.).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Assmann Sarah M, 2004, Sci STKE, V2004, pre20; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Barren B, 2007, J NEUROSCI RES, V85, P3505, DOI 10.1002/jnr.21414; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DESPRES C, 1995, PLANT CELL, V7, P589, DOI 10.1105/tpc.7.5.589; Ding L, 2008, PLANT J, V53, P248, DOI 10.1111/j.1365-313X.2007.03335.x; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gookin TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r120; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Heo JB, 2005, PLANT CELL PHYSIOL, V46, P2005, DOI 10.1093/pcp/pci215; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Imaizumi T., 2007, SCI STKE, ppe32; Johnson KD, 2002, METHODS, V26, P27, DOI 10.1016/S1046-2023(02)00005-1; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Lee YRJ, 1999, PLANT MOL BIOL, V40, P55, DOI 10.1023/A:1026483823176; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Nahm MY, 2003, PLANT CELL PHYSIOL, V44, P1341, DOI 10.1093/pcp/pcg163; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Pandey S, 2008, PLANT J, V55, P311, DOI 10.1111/j.1365-313X.2008.03506.x; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; SMIGEL MD, 1982, RECENT PROG HORM RES, V38, P601; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhu HF, 2009, MOL PLANT, V2, P513, DOI 10.1093/mp/ssp001	75	41	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8242	8253		10.1074/jbc.M111.317412	http://dx.doi.org/10.1074/jbc.M111.317412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22232549	Green Published, hybrid			2022-12-27	WOS:000301349400039
J	Kuwahara, T; Tonegawa, R; Ito, G; Mitani, S; Iwatsubo, T				Kuwahara, Tomoki; Tonegawa, Reina; Ito, Genta; Mitani, Shohei; Iwatsubo, Takeshi			Phosphorylation of alpha-Synuclein Protein at Ser-129 Reduces Neuronal Dysfunction by Lowering Its Membrane Binding Property in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; LINKED MUTATIONS; RAT MODEL; AGGREGATION; MICE; VARIANTS; DAF-16; PHOSPHOLIPIDS; DUPLICATION	alpha-Synuclein is causative for autosomal dominant familial Parkinson disease and dementia with Lewy bodies, and the phosphorylation of alpha-synuclein at residue Ser-129 is a key posttranslational modification detected in Parkinson disease/dementia with Lewy bodies lesions. However, the role of Ser-129 phosphorylation on the pathogenesis of Parkinson disease/dementia with Lewy bodies remains unclear. Here we investigated the neurotoxicity of Ser-129-substituted alpha-synuclein in the transgenic Caenorhabditis elegans (Tg worm) model of synucleinopathy. Tg worms pan-neuronally overexpressing nonphosphorylatable (S129A) alpha-synuclein showed severe defects including motor dysfunction, growth retardation, and synaptic abnormalities. In contrast, Tg worms expressing phosphorylation mimic (S129D) alpha-synuclein exhibited nearly normal phenotypes. Biochemical fractionation revealed that the level of membrane-bound alpha-synuclein was significantly increased in S129A-alpha-synuclein Tg worms, whereas S129D- as well as A30P-alpha-synuclein displayed lower membrane binding properties. Furthermore, A30P/S129A double mutant alpha-synuclein did not cause neuronal dysfunction and displayed low membrane binding property. In human neuroblastoma SH-SY5Y cells, localization of S129A-alpha-synuclein to membranes was significantly increased. Finally, gene expression profiling of S129A-Tg worms revealed a dramatic up-regulation of Daf-16/FOXO pathway genes, which likely act against the dysfunction caused by S129A-alpha-synuclein. These results imply a role of Ser-129 phosphorylation of alpha-synuclein in the attenuation of alpha-synuclein-induced neuronal dysfunction and downstream stress response by lowering the membrane binding property.	[Kuwahara, Tomoki; Ito, Genta; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan; [Kuwahara, Tomoki; Tonegawa, Reina; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Sch Med, Tokyo 1628666, Japan	University of Tokyo; University of Tokyo; Tokyo Women's Medical University	Iwatsubo, T (corresponding author), 7-3-1 Hongo Bunkyo Ku, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp	Kuwahara, Tomoki/AAT-7119-2021; Ito, Genta/L-2581-2015; Kuwahara, Tomoki/AAX-2459-2020	Kuwahara, Tomoki/0000-0003-1788-7018; Ito, Genta/0000-0001-6370-1099; Tonegawa-Kuji, Reina/0000-0001-7998-939X	National Institutes of Health National Center for Research Resources; Ministry of Education, Culture, Sports, Science and Technology of Japan.	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Culture, Sports, Science and Technology of Japan.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Caenorhabditis Genetics Center, funded by the National Institutes of Health National Center for Research Resources, for providing worms carrying daf-16(mu86) and juIs1. We thank Dr. N. Nukina and Dr. F. Oyama for DNA microarray analysis. We also thank members of the Iwatsubo laboratory and Dr. D. MacLeod for helpful suggestions and discussions.; This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; BRENNER S, 1974, GENETICS, V77, P71; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Fiske M, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/392180; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McFarland NR, 2009, J NEUROPATH EXP NEUR, V68, P515, DOI 10.1097/NEN.0b013e3181a24b53; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Unger EL, 2006, NEUROBIOL DIS, V21, P431, DOI 10.1016/j.nbd.2005.08.005; Visanji NP, 2011, J BIOL CHEM, V286, P35863, DOI 10.1074/jbc.M111.253450; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	54	61	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7098	7109		10.1074/jbc.M111.237131	http://dx.doi.org/10.1074/jbc.M111.237131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232559	Green Published, hybrid			2022-12-27	WOS:000301060200014
J	Vivien, C; Scerbo, P; Girardot, F; Le Blay, K; Demeneix, BA; Coen, L				Vivien, Celine; Scerbo, Pierluigi; Girardot, Fabrice; Le Blay, Karine; Demeneix, Barbara A.; Coen, Laurent			Non-viral Expression of Mouse Oct4, Sox2, and Klf4 Transcription Factors Efficiently Reprograms Tadpole Muscle Fibers in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; GENERATION; GENE; STATE; DIFFERENTIATION; METAMORPHOSIS; METHYLATION; MECHANISMS; DEATH	Adult mammalian cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by a limited combination of transcription factors. To date, most current iPSC generation protocols rely on viral vector usage in vitro, using cells removed from their physiological context. Such protocols are hindered by low derivation efficiency and risks associated with genome modifications of reprogrammed cells. Here, we reprogrammed cells in an in vivo context using non-viral somatic transgenesis in Xenopus tadpole tail muscle, a setting that provides long term expression of non-integrated transgenes in vivo. Expression of mouse mOct4, mSox2, and mKlf4 (OSK) led rapidly and reliably to formation of proliferating cell clusters. These clusters displayed the principal hallmarks of pluripotency: alkaline phosphatase activity, up-regulation of key epigenetic and chromatin remodeling markers, and reexpression of endogenous pluripotent markers. Furthermore, these clusters were capable of differentiating into derivatives of the three germ layers in vitro and into neurons and muscle fibers in vivo. As in situ reprogramming occurs along with muscle tissue repair, the data provide a link between these two processes and suggest that they act synergistically. Notably, every OSK injection resulted in cluster formation. We conclude that reprogramming is achievable in an anamniote model and propose that in vivo approaches could provide rapid and efficient alternative for non-viral iPSC production. The work opens new perspectives in basic stem cell research and in the longer term prospect of regenerative medicine protocols development.	[Vivien, Celine; Scerbo, Pierluigi; Girardot, Fabrice; Le Blay, Karine; Demeneix, Barbara A.; Coen, Laurent] Museum Natl Hist Nat, Dept Regulat Dev & Diversite Mol, CNRS 7221, Unite Mixte Rech, F-75231 Paris, France	Museum National d'Histoire Naturelle (MNHN)	Demeneix, BA (corresponding author), Museum Natl Hist Nat, Dept Regulat Dev & Diversite Mol, CNRS 7221, Unite Mixte Rech, F-75231 Paris, France.	bdem@mnhn.fr; coen@mnhn.fr	Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Girardot, Fabrice/0000-0002-0916-877X; Scerbo, Pierluigi/0000-0002-3360-4367	European Union; French Programme National de Recherche sur les Perturbateurs Endocriniens program; French Ministry of Research	European Union(European Commission); French Programme National de Recherche sur les Perturbateurs Endocriniens program; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by European Union grant Crescendo and the French Programme National de Recherche sur les Perturbateurs Endocriniens program.; Recipient of a Ph.D. grant from the French Ministry of Research.	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Braun S, 2008, CURR GENE THER, V8, P391, DOI 10.2174/156652308786070998; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chan J, 2004, METHOD CELL BIOL, V76, P475; Coen L, 2001, P NATL ACAD SCI USA, V98, P7869, DOI 10.1073/pnas.141226798; Coen L, 2007, P NATL ACAD SCI USA, V104, P8502, DOI 10.1073/pnas.0608877104; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; DELUZE A, 1993, P NATL ACAD SCI USA, V90, P7322, DOI 10.1073/pnas.90.15.7322; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Duenas-Carrera S, 2004, CURR OPIN MOL THER, V6, P146; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hayden EC, 2011, NATURE, V473, P272, DOI 10.1038/473272a; Heng JCD, 2010, COLD SH Q B, V75, P237, DOI 10.1101/sqb.2010.75.003; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; Jullien J, 2010, P NATL ACAD SCI USA, V107, P5483, DOI 10.1073/pnas.1000599107; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Rowe I, 2005, DEV DYNAM, V233, P76, DOI 10.1002/dvdy.20312; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shibota Y, 2000, DIFFERENTIATION, V66, P227, DOI 10.1046/j.1432-0436.2000.660409.x; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026406; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	56	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7427	7435		10.1074/jbc.M111.324368	http://dx.doi.org/10.1074/jbc.M111.324368			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232554	Green Published, hybrid			2022-12-27	WOS:000301060200043
J	Zhou, BY; Liu, YX; Kahn, M; Ann, DK; Han, A; Wang, HJ; Nguyen, C; Flodby, P; Zhong, Q; Krishnaveni, MS; Liebler, JM; Minoo, P; Crandall, ED; Borok, Z				Zhou, Beiyun; Liu, Yixin; Kahn, Michael; Ann, David K.; Han, Arum; Wang, Hongjun; Cu Nguyen; Flodby, Per; Zhong, Qian; Krishnaveni, Manda S.; Liebler, Janice M.; Minoo, Parviz; Crandall, Edward D.; Borok, Zea			Interactions Between beta-Catenin and Transforming Growth Factor-beta Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; GENE-EXPRESSION; MYOFIBROBLAST TRANSITION; EXTRACELLULAR-MATRIX; DIFFERENTIAL ROLES; CELL TRANSITION; WNT PATHWAYS; SMAD3; P300	Interactions between transforming growth factor-beta (TGF-beta) and Wnt are crucial to many biological processes, although specific targets, rationale for divergent outcomes (differentiation versus block of epithelial proliferation versus epithelial-mesenchymal transition (EMT)) and precise mechanisms in many cases remain unknown. We investigated beta-catenin-dependent and transforming growth factor-beta 1 (TGF-beta 1) interactions in pulmonary alveolar epithelial cells (AEC) in the context of EMT and pulmonary fibrosis. We previously demonstrated that ICG-001, a small molecule specific inhibitor of the beta-catenin/CBP (but not beta-catenin/p300) interaction, ameliorates and reverses pulmonary fibrosis and inhibits TGF-beta 1-mediated alpha-smooth muscle actin (alpha-SMA) and collagen induction in AEC. We now demonstrate that TGF-beta 1 induces LEF/TCF TOPFLASH reporter activation and nuclear beta-catenin accumulation, while LiCl augments TGF-beta-induced alpha-SMA expression, further confirming co-operation between beta-catenin- and TGF-beta-dependent signaling pathways. Inhibition and knockdown of Smad3, knockdown of beta-catenin and overexpression of ICAT abrogated effects of TGF-beta 1 on alpha-SMA transcription/expression, indicating a requirement for beta-catenin in these Smad3-dependent effects. Following TGF-beta treatment, co-immunoprecipitation demonstrated direct interaction between endogenous Smad3 and beta-catenin, while chromatin immunoprecipitation (ChIP)re-ChIP identified spatial and temporal regulation of alpha-SMA via complex formation among Smad3, beta-catenin, and CBP. ICG-001 inhibited alpha-SMA expression/transcription in response to TGF-beta as well as alpha-SMA promoter occupancy by beta-catenin and CBP, demonstrating a previously unknown requisite TGF-beta 1/beta-catenin/CBP-mediated pro-EMT signaling pathway. Clinical relevance was shown by beta-catenin/Smad3 co-localization and CBP expression in AEC of IPF patients. These findings suggest a new therapeutic approach to pulmonary fibrosis by specifically uncoupling CBP/catenin-dependent signaling downstream of TGF-beta.	[Zhou, Beiyun; Liu, Yixin; Wang, Hongjun; Flodby, Per; Zhong, Qian; Krishnaveni, Manda S.; Liebler, Janice M.; Crandall, Edward D.; Borok, Zea] Univ So Calif, Will Rogers Inst Pulm, Res Ctr, Div Pulm & Crit Care Med,Dept Med, Los Angeles, CA 90033 USA; [Kahn, Michael; Cu Nguyen; Borok, Zea] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Minoo, Parviz] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pediat, Los Angeles, CA 90033 USA; [Han, Arum] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Dermatol, Los Angeles, CA 90033 USA; [Ann, David K.] City Hope Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; City of Hope; Beckman Research Institute of City of Hope	Borok, Z (corresponding author), IRD 620,2020 Zonal Ave, Los Angeles, CA 90033 USA.	zborok@usc.edu	Borok, Zea/J-9015-2013; CRANDALL, EDWARD/AAD-8382-2020	Borok, Zea/0000-0001-8673-8177; Wu, Arum/0000-0003-1038-7176	National Institutes of Health. [DE014183, DE010742, ES017034, ES018782, HL038578, HL038621, HL056590, HL062569, HL089445, HL073722, HL095349]; Hastings Foundation; Whittier Foundation; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073722, R01HL095349, R01HL038578, R37HL038578, R01HL038621, R01HL056590, R01HL062569, R37HL062569, R01HL089445, R01HL112638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018782, R01ES017034] Funding Source: NIH RePORTER	National Institutes of Health.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation; Whittier Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Grants DE014183 (to D. K. A.), DE010742 (to D. K. A.), ES017034 (to E. D. C.), ES018782 (to E. D. C.), HL038578 (to Z. B.), HL038621 (to E. D. C.), HL056590 (to P. M.), HL062569 (to Z. B.), HL089445 (to Z. B.), HL073722 (to M. K.), and HL095349 (to P. M.) from the National Institutes of Health. This work was also supported by the Hastings Foundation and the Whittier Foundation.	Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Dong YF, 2005, J CELL BIOCHEM, V95, P1057, DOI 10.1002/jcb.20466; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Han MLK, 2010, RESP MED, V104, P724, DOI 10.1016/j.rmed.2009.11.019; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; LaGamba D, 2005, DEV DYNAM, V234, P132, DOI 10.1002/dvdy.20489; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Minoo P, 2010, INT J BIOCHEM CELL B, V42, P809, DOI 10.1016/j.biocel.2010.02.011; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nawshad A, 2007, J CELL SCI, V120, P1646, DOI 10.1242/jcs.003129; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian XX, 2009, BIOCHEM BIOPH RES CO, V380, P478, DOI 10.1016/j.bbrc.2009.01.124; Tian YC, 2002, AM J PATHOL, V160, P1619, DOI 10.1016/S0002-9440(10)61109-1; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	59	193	201	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7026	7038		10.1074/jbc.M111.276311	http://dx.doi.org/10.1074/jbc.M111.276311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241478	Green Published, hybrid			2022-12-27	WOS:000301060200008
J	Mosedale, M; Egodage, S; Calma, RC; Chi, NW; Chessler, SD				Mosedale, Merrie; Egodage, Sonya; Calma, Rei C.; Chi, Nai-Wen; Chessler, Steven D.			Neurexin-1 alpha Contributes to Insulin-containing Secretory Granule Docking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-NEUREXINS; CELL-ADHESION; BETA-CELL; SYNAPSE FORMATION; PLASMA-MEMBRANE; PROTEIN; EXOCYTOSIS; GRANUPHILIN; EXPRESSION; NEUROLIGIN	Neurexins are a family of transmembrane, synaptic adhesion molecules. In neurons, neurexins bind to both sub-plasma membrane and synaptic vesicle-associated constituents of the secretory machinery, play a key role in the organization and stabilization of the presynaptic active zone, and help mediate docking of synaptic vesicles. We have previously shown that neurexins, like many other protein constituents of the neurotransmitter exocytotic machinery, are expressed in pancreatic beta cells. We hypothesized that the role of neurexins in beta cells parallels their role in neurons, with beta-cell neurexins helping to mediate insulin granule docking and secretion. Here we demonstrate that beta cells express a more restricted pattern of neurexin transcripts than neurons, with a clear predominance of neurexin-1 alpha expressed in isolated islets. Using INS-1E beta cells, we found that neurexin-1 alpha interacts with membrane-bound components of the secretory granule-docking machinery and with the granule-associated protein granuphilin. Decreased expression of neurexin-1 alpha, like decreased expression of granuphilin, reduces granule docking at the beta-cell membrane and improves insulin secretion. Perifusion of neurexin-1 alpha KO mouse islets revealed a significant increase in second-phase insulin secretion with a trend toward increased first-phase secretion. Upon glucose stimulation, neurexin-1 alpha protein levels decrease. This glucose-induced down-regulation may enhance glucose-stimulated insulin secretion. We conclude that neurexin-1 alpha is a component of the beta-cell secretory machinery and contributes to secretory granule docking, most likely through interactions with granuphilin. Neurexin-1 alpha is the only transmembrane component of the docking machinery identified thus far. Our findings provide new insights into the mechanisms of insulin granule docking and exocytosis.	[Chessler, Steven D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Chessler, Steven D.] Univ Calif San Diego, Sch Med, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Mosedale, Merrie] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, Res Serv, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Chessler, SD (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr MC,0983, La Jolla, CA 92093 USA.	schessler@ucsd.edu		Mosedale, Merrie/0000-0003-1968-6666	National Institutes of Health [R01DK080971, DK17047, T32 GM007752]; Juvenile, Diabetes Research Foundation [37-2009-44]; University of California, San Diego; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080971, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile, Diabetes Research Foundation(Juvenile Diabetes Research Foundation); University of California, San Diego(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080971 (to S.D.C.), Juvenile, Diabetes Research Foundation Grant 37-2009-44 (to S.D.C.), and the University of California, San Diego, Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752. The University of Washington DERC is supported by National Institutes of Health Grant DK17047.	Abderrahmani A, 2004, FEBS LETT, V565, P133, DOI 10.1016/j.febslet.2004.04.002; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Barg S, 2003, PHARMACOL TOXICOL, V92, P3, DOI 10.1034/j.1600-0773.2003.920102.x; Barg S, 2008, BIOCHEM SOC T, V36, P294, DOI 10.1042/BST0360294; Benninger RKP, 2011, J PHYSIOL-LONDON, V589, P5453, DOI 10.1113/jphysiol.2011.218909; Berninghausen O, 2007, J NEUROCHEM, V103, P1855, DOI 10.1111/j.1471-4159.2007.04918.x; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Coppola T, 2002, MOL BIOL CELL, V13, P1906, DOI 10.1091/mbc.02-02-0025; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Gottmann K, 2008, J NEUROSCI RES, V86, P223, DOI 10.1002/jnr.21484; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; Hays LB, 2005, J ENDOCRINOL, V185, P57, DOI 10.1677/joe.1.05934; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hou JC, 2009, ENDOCRINOLOGY, V150, P4056, DOI 10.1210/en.2008-1685; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; ISHIHARA H, 1995, AM J PHYSIOL-ENDOC M, V269, pE897, DOI 10.1152/ajpendo.1995.269.5.E897; Jiang FX, 2001, MOL MED, V7, P107, DOI 10.1007/BF03401944; Jiang XH, 2011, J SURG RES, V171, P120, DOI 10.1016/j.jss.2009.11.730; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Konstantinova I, 2004, BIOESSAYS, V26, P1069, DOI 10.1002/bies.20105; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Maffei A, 2004, ENDOCRINOLOGY, V145, P4513, DOI 10.1210/en.2004-0691; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Molinete M, 2000, DIABETOLOGIA, V43, P1157, DOI 10.1007/s001250051507; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; OCONNOR VM, 1993, FEBS LETT, V326, P255, DOI 10.1016/0014-5793(93)81802-7; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; PERIN MS, 1994, J BIOL CHEM, V269, P8576; Regazzi R, 1996, J CELL SCI, V109, P2265; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Suckow AT, 2006, J MOL ENDOCRINOL, V36, P187, DOI 10.1677/jme.1.01866; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Todorov I, 2006, PANCREAS, V32, P130, DOI 10.1097/01.mpa.0000202945.78331.93; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Torii S, 2002, MOL CELL BIOL, V22, P5518, DOI 10.1128/MCB.22.15.5518-5526.2002; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; VALERA A, 1994, J BIOL CHEM, V269, P28543; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang H, 2011, J BIOL CHEM, V286, P32244, DOI 10.1074/jbc.M111.268631; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Zatyka M, 2008, HUM MOL GENET, V17, P190, DOI 10.1093/hmg/ddm296; Zhang Y, 2001, FEBS LETT, V497, P99, DOI 10.1016/S0014-5793(01)02450-4	67	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6350	6361		10.1074/jbc.M111.299081	http://dx.doi.org/10.1074/jbc.M111.299081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235116	Green Published, hybrid			2022-12-27	WOS:000300791800027
J	Stoeckius, M; Erat, A; Fujikawa, T; Hiromura, M; Koulova, A; Otterbein, L; Bianchi, C; Tobiasch, E; Dagon, Y; Sellke, FW; Usheva, A				Stoeckius, Marlon; Erat, Anna; Fujikawa, Tatsuya; Hiromura, Makoto; Koulova, Anna; Otterbein, Leo; Bianchi, Cesario; Tobiasch, Edda; Dagon, Yossi; Sellke, Frank W.; Usheva, Anny			Essential Roles of Raf/Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway, YY1, and Ca2+ Influx in Growth Arrest of Human Vascular Smooth Muscle Cells by Bilirubin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; HEART-DISEASE; TRANSCRIPTION; PHOSPHORYLATION; PROGRESSION; INHIBITOR; LIFE	The biological effects of bilirubin, still poorly understood, are concentration-dependent ranging from cell protection to toxicity. Here we present data that at high nontoxic physiological concentrations, bilirubin inhibits growth of proliferating human coronary artery smooth muscle cells by three events. It impairs the activation of Raf/ERK/MAPK pathway and the cellular Raf and cyclin D1 content that results in retinoblastoma protein hypophosphorylation on amino acids S608 and S780. These events impede the release of YY1 to the nuclei and its availability to regulate the expression of genes and to support cellular proliferation. Moreover, altered calcium influx and calpain II protease activation leads to proteolytical degradation of transcription factor YY1. We conclude that in the serum-stimulated human vascular smooth muscle primary cell cultures, bilirubin favors growth arrest, and we propose that this activity is regulated by its interaction with the Raf/ERK/MAPK pathway, effect on cyclin D1 and Raf content, altered retinoblastoma protein profile of hypophosphorylation, calcium influx, and YY1 proteolysis. We propose that these activities together culminate in diminished 5 S and 45 S ribosomal RNA synthesis and cell growth arrest. The observations provide important mechanistic insight into the molecular mechanisms underlying the transition of human vascular smooth muscle cells from proliferative to contractile phenotype and the role of bilirubin in this transition.	[Usheva, Anny] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Bianchi, Cesario; Sellke, Frank W.] Brown Univ, Alpert Med Sch, Div Cardiothorac Surg, Providence, RI 02912 USA; [Hiromura, Makoto] RIKEN Kobe Inst, Multiple Mol Imaging Res Lab, Kobe, Hyogo 6500047, Japan; [Tobiasch, Edda] Bonn Rhein Sieg Univ Appl Sci, D-53359 Rheinbach, Germany; [Erat, Anna] Univ Zurich Hosp, Clin Internal Med, CH-8091 Zurich, Switzerland	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Brown University; RIKEN; Hochschule Bonn Rhein Sieg; University of Zurich; University Zurich Hospital	Usheva, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, 3 Blackfan Circle,CLS 701, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu	bianchi, cesario/H-6238-2012; Dagon, Yossi/AAI-5882-2020	Stoeckius, Marlon/0000-0002-5658-029X	National Institutes of Health [R01HL062458, RO1HL46716, RO1HL69024]; Swiss Public Health Institute; Finnish Medical Society; Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458, R01HL069024, R01HL046716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss Public Health Institute; Finnish Medical Society; Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL062458 (to A. U.) and RO1HL46716 and RO1HL69024 (to F. W. S.). This work was also supported by a fellowship from the Swiss Public Health Institute, the Finnish Medical Society, and the Academy of Finland (to A. E.).	Beohar N, 2004, CIRCULATION, V109, P108, DOI 10.1161/01.CIR.0000105724.30980.CD; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Dumaz N, 2005, MOL CELL, V17, P164, DOI 10.1016/j.molcel.2005.01.001; Felton-Edkins ZA, 2003, CELL CYCLE, V2, P181, DOI 10.4161/cc.2.3.375; Garnovskaya MN, 2004, J BIOL CHEM, V279, P24899, DOI 10.1074/jbc.M311622200; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hahm Joon Soo, 1992, Korean Journal of Internal Medicine (English Edition), V7, P18; KUROSE K, 1995, NUCLEIC ACIDS RES, V23, P3704, DOI 10.1093/nar/23.18.3704; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; MUSTAFA MG, 1969, J BIOL CHEM, V244, P6403; Ollinger R, 2005, CIRCULATION, V112, P1030, DOI 10.1161/CIRCULATIONAHA.104.528802; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; Sen CK, 1996, FEBS LETT, V385, P58, DOI 10.1016/0014-5793(96)00346-8; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Taille C, 2003, J BIOL CHEM, V278, P27160, DOI 10.1074/jbc.M300364200; Troughton JA, 2007, EUR J CARDIOV PREV R, V14, P79, DOI 10.1097/01.hjr.0000230097.81202.9f; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Walowitz JL, 1998, J BIOL CHEM, V273, P6656, DOI 10.1074/jbc.273.12.6656; Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009	24	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15418	15426		10.1074/jbc.M111.266510	http://dx.doi.org/10.1074/jbc.M111.266510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22262839	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000304006300023
J	Zhang, X; Pino, GM; Shephard, F; Kiss-Toth, E; Qwarnstrom, EE				Zhang, Xiao; Pino, Gemma Montagut; Shephard, Freya; Kiss-Toth, Endre; Qwarnstrom, Eva E.			Distinct Control of MyD88 Adapter-dependent and Akt Kinase-regulated Responses by the Interleukin (IL)-1RI Co-receptor, TILRR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SECONDARY STRUCTURE; INDUCED APOPTOSIS; RECEPTOR; ACTIVATION; TOLL; PROTEIN; AMPLIFICATION; EXPRESSION; LOOP	Inflammatory responses are controlled through members of the interleukin-1 receptor (IL-1R)/Toll-like receptor superfamily. Our earlier work demonstrates that the IL-1 receptor type 1 (IL-1RI) co-receptor, Toll-like and IL-1 receptor regulator (TILRR), amplifies IL-1 activation of NF-kappa B and inflammatory genes. Here we show that TILRR similarly promotes IL-1-induced anti-apoptotic signals and reduces caspase-3 activity. Further, the TILRR-induced effects on cell survival and inflammatory responses are controlled through distinct parts of the IL-1RI regulatory Toll IL-1 receptor (TIR) domain. Alanine-scanning mutagenesis identified a functional TILRR mutant (R425A), which blocked increases in cell survival and upstream activation of Akt but had no effect on amplification of MyD88-dependent inflammatory responses. A second mutant (D448A) blocked TILRR potentiation of MyD88-dependent signals and inflammatory activation but had no impact on cell survival. Secondary structure predictions suggested that the mutations induce distinct alterations in the alpha-helical structure of the TILRR core protein. The results indicate a role for TILRR in selective amplification of NF-kappa B responses through IL-1RI and suggest that the specificity is determined by changes in receptor conformation and adapter protein recruitment.	[Zhang, Xiao; Pino, Gemma Montagut; Shephard, Freya; Qwarnstrom, Eva E.] Univ Sheffield, Cell Biol Grp, Dept Cardiovasc Sci, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Kiss-Toth, Endre] Univ Sheffield, Cell Signalling Grp, Dept Cardiovasc Sci, Sch Med, Sheffield S10 2RX, S Yorkshire, England; [Qwarnstrom, Eva E.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Sheffield; University of Sheffield; University of Washington; University of Washington Seattle	Qwarnstrom, EE (corresponding author), Univ Sheffield, Cell Biol Grp, Dept Cardiovasc Sci, Sch Med, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	e.qwarnstrom@sheffield.ac.uk	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Zhang, Xiao/0000-0002-3894-8513; Qwarnstrom, Eva/0000-0003-4417-8663	Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056]; British Heart Foundation [PG/2000094, PG/07/094/23742]; Biotechnology and Biological Sciences Research Council [BB/J009687/1] Funding Source: researchfish; BBSRC [BB/J009687/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/C515798/1; BBS/B/04056) and the British Heart Foundation (PG/2000094; PG/07/094/23742) (to E. E. Q.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Burow ME, 2000, BIOCHEM BIOPH RES CO, V271, P342, DOI 10.1006/bbrc.2000.2626; Davis CN, 2006, P NATL ACAD SCI USA, V103, P2953, DOI 10.1073/pnas.0510802103; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200; Zhang X, 2010, J BIOL CHEM, V285, P7222, DOI 10.1074/jbc.M109.073429	23	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12348	12352		10.1074/jbc.C111.321711	http://dx.doi.org/10.1074/jbc.C111.321711			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22262840	hybrid, Green Published			2022-12-27	WOS:000302782200074
J	Gao, ZH; Cox, JL; Gilmore, JM; Ormsbee, BD; Mallanna, SK; Washburn, MP; Rizzino, A				Gao, Zhiguang; Cox, Jesse L.; Gilmore, Joshua M.; Ormsbee, Briana D.; Mallanna, Sunil K.; Washburn, Michael P.; Rizzino, Angie			Determination of Protein Interactome of Transcription Factor Sox2 in Embryonic Stem Cells Engineered for Inducible Expression of Four Reprogramming Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; INTERACTION NETWORK; CARCINOMA-CELLS; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; MOUSE; NANOG; COMPLEX; INTEGRATION	Unbiased proteomic screens provide a powerful tool for defining protein-protein interaction networks. Previous studies employed multidimensional protein identification technology to identify the Sox2-interactome in embryonic stem cells (ESC) undergoing differentiation in response to a small increase in the expression of epitope-tagged Sox2. Thus far the Sox2-interactome in ESC has not been determined. To identify the Sox2-interactome in ESC, we engineered ESC for inducible expression of different combinations of epitope-tagged Sox2 along with Oct4, Klf4, and c-Myc. Epitope-tagged Sox2 was used to circumvent the lack of suitable Sox2 antibodies needed to perform an unbiased proteomic screen of Sox2-associated proteins. Although i-OS-ESC differentiate when both Oct4 and Sox2 are elevated, i-OSKM-ESC do not differentiate even when the levels of the four transcription factors are coordinately elevated similar to 2-3-fold. Our findings with i-OS-ESC and i-OSKM-ESC provide new insights into the reasons why ESC undergo differentiation when Sox2 and Oct4 are elevated in ESC. Importantly, the use of i-OSKM-ESC enabled us to identify the Sox2-interactome in undifferentiated ESC. Using multidimensional protein identification technology, we identified >70 proteins that associate with Sox2 in ESC. We extended these findings by testing the function of the Sox2-assoicated protein Smarcd1 and demonstrate that knockdown of Smarcd1 disrupts the self-renewal of ESC and induces their differentiation. Together, our work provides the first description of the Sox2-interactome in ESC and indicates that Sox2 along with other master regulators is part of a highly integrated protein-protein interaction landscape in ESC.	[Gao, Zhiguang; Cox, Jesse L.; Ormsbee, Briana D.; Mallanna, Sunil K.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gilmore, Joshua M.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gilmore, Joshua M.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Nebraska System; University of Nebraska Medical Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	arizzino@unmc.edu		Washburn, Michael/0000-0001-7568-2585	National Institutes of Health [GM 080571]; Nebraska Department of Health [2009-01]; NCI, National Institutes of Health Cancer Biology [CA009476]; NCI, National Institutes of Health Cancer Center [fCA 36727]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health; NCI, National Institutes of Health Cancer Biology; NCI, National Institutes of Health Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grant GM 080571. This work was also supported by the Nebraska Department of Health (Stem Cell 2009-01).; Supported in part by NCI, National Institutes of Health Cancer Biology Training Grant CA009476.; We thank Michelle Desler and Phillip Wilder for technical assistance. Core facilities of the UNMC Eppley Cancer Center were supported in part by NCI, National Institutes of Health Cancer Center Support Grant fCA 36727.	Bartova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027281; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	40	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11384	11397		10.1074/jbc.M111.320143	http://dx.doi.org/10.1074/jbc.M111.320143			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334693	hybrid, Green Published			2022-12-27	WOS:000302780100068
J	Haldar, S; Chattopadhyay, K				Haldar, Shubhasis; Chattopadhyay, Krishnananda			Interconnection of Salt-induced Hydrophobic Compaction and Secondary Structure Formation Depends on Solution Conditions REVISITING EARLY EVENTS OF PROTEIN FOLDING AT SINGLE MOLECULE RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; HYDROGEN-BOND FORMATION; X-RAY-SCATTERING; CYTOCHROME-C; UNFOLDED STATES; COLLAPSE; UREA; KINETICS; DENATURATION; FLUCTUATIONS	What happens in the early stage of protein folding remains an interesting unsolved problem. Rapid kinetics measurements with cytochrome c using submillisecond continuous flow mixing devices suggest simultaneous formation of a compact collapsed state and secondary structure. These data seem to indicate that collapse formation is guided by specific short and long range interactions (heteropolymer collapse). A contrasting interpretation also has been proposed, which suggests that the collapse formation is rapid, nonspecific, and a trivial solvent related compaction, which could as well be observed by a homopolymer (homopolymer collapse). We address this controversy using fluorescence correlation spectroscopy (FCS), which enables us to monitor the salt-induced compaction accompanying collapse formation and the associated time constant directly at single molecule resolution. In addition, we follow the formation of secondary structure using far UV CD. The data presented here suggest that both these models (homopolymer and heteropolymer) could be applicable depending on the solution conditions. For example, the formation of secondary structure and compact state is not simultaneous in aqueous buffer. In aqueous buffer, formation of the compact state occurs through a two-state co-operative transition following heteropolymer formalism, whereas secondary structure formation takes place gradually. In contrast, in the presence of urea, a compaction of the protein radius occurs gradually over an extended range of salt concentration following homopolymer formalism. The salt-induced compaction and the formation of secondary structure take place simultaneously in the presence of urea.	[Haldar, Shubhasis; Chattopadhyay, Krishnananda] Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, Council Sci & Ind Res, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chattopadhyay, K (corresponding author), Indian Inst Chem Biol, Prot Folding & Dynam Lab, Struct Biol & Bioinformat Div, Council Sci & Ind Res, 4 Raja SC Mullick Rd, Kolkata 700032, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	Council for Scientific and Industrial Research Empower Project [OLP004]; Indian Institute of Chemical Biology	Council for Scientific and Industrial Research Empower Project; Indian Institute of Chemical Biology(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council for Scientific and Industrial Research Empower Project Grant OLP004.; We thank Professor S. Maiti of the Tata Institute of Fundamental Research for the Maximum Entropy Method analysis software. We also thank Professors Elliot Elson and Carl Frieden of the Washington University School of Medicine for critical comments on this work. Professor S. Roy of the Indian Institute of Chemical Biology is acknowledged for help and support.	Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Caflisch A, 1999, STRUCT FOLD DES, V7, P477, DOI 10.1016/S0969-2126(99)80064-1; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chattopadhyay K, 2002, BIOCHEMISTRY-US, V41, P4040, DOI 10.1021/bi012042l; Chen EF, 2004, J AM CHEM SOC, V126, P11175, DOI 10.1021/ja0400077; Chen HM, 2007, P NATL ACAD SCI USA, V104, P10459, DOI 10.1073/pnas.0704073104; CHU B, 1995, MACROMOLECULES, V28, P180, DOI 10.1021/ma00105a024; Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Gast K, 1997, FEBS LETT, V403, P245, DOI 10.1016/S0014-5793(97)00058-6; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; Hagen SJ, 2000, J MOL BIOL, V301, P1019, DOI 10.1006/jmbi.2000.3969; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Haldar S, 2011, LANGMUIR, V27, P5842, DOI 10.1021/la200580z; Haldar S, 2010, J BIOL CHEM, V285, P25314, DOI 10.1074/jbc.M110.116673; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; Kimura T, 2005, P NATL ACAD SCI USA, V102, P2748, DOI 10.1073/pnas.0407982102; Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009; Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106; Meng WL, 2011, PROTEINS, V79, P3500, DOI 10.1002/prot.23145; Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; O'Brien EP, 2007, J AM CHEM SOC, V129, P7346, DOI 10.1021/ja069232+; Oostenbrink C, 2005, PHYS CHEM CHEM PHYS, V7, P53, DOI 10.1039/b413167c; Pascher T, 1996, SCIENCE, V271, P1558, DOI 10.1126/science.271.5255.1558; Pletneva EV, 2005, J MOL BIOL, V345, P855, DOI 10.1016/j.jmb.2004.10.085; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Sinha KK, 2007, J MOL BIOL, V370, P385, DOI 10.1016/j.jmb.2007.04.061; Sosnick TR, 1997, P NATL ACAD SCI USA, V94, P8545, DOI 10.1073/pnas.94.16.8545; Sosnick TR, 1996, PROTEINS, V24, P413; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Stumpe MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000221; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Uversky VN, 2002, FEBS LETT, V515, P79, DOI 10.1016/S0014-5793(02)02441-9; Werner JH, 2006, P NATL ACAD SCI USA, V103, P11130, DOI 10.1073/pnas.0604712103; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang OW, 1997, BIOCHEMISTRY-US, V36, P3959, DOI 10.1021/bi9627626; Zhu PW, 1997, J CHEM PHYS, V106, P6492, DOI 10.1063/1.474098; Ziv G, 2009, PHYS CHEM CHEM PHYS, V11, P83, DOI 10.1039/b813961j; Ziv G, 2009, J AM CHEM SOC, V131, P2942, DOI 10.1021/ja808305u; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	53	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11546	11555		10.1074/jbc.M111.315648	http://dx.doi.org/10.1074/jbc.M111.315648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303014	hybrid, Green Published			2022-12-27	WOS:000302780100082
J	Stohl, EA; Chan, YA; Hackett, KT; Kohler, PL; Dillard, JP; Seifert, HS				Stohl, Elizabeth A.; Chan, Yolande A.; Hackett, Kathleen T.; Kohler, Petra L.; Dillard, Joseph P.; Seifert, H. Steven			Neisseria gonorrhoeae Virulence Factor NG1686 Is a Bifunctional M23B Family Metallopeptidase That Influences Resistance to Hydrogen Peroxide and Colony Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PILIN-ANTIGENIC-VARIATION; GRAM-NEGATIVE BACTERIUM; FALLOPIAN-TUBE MUCOSA; CELL-SEPARATION; PEPTIDOGLYCAN HYDROLASE; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; CAULOBACTER-CRESCENTUS; NATURAL TRANSFORMATION	Background: Deletion of N. gonorrhoeae virulence factor ng1686 results in increased sensitivity to H2O2 and PMN-mediated killing. Results: NG1686 has endopeptidase and carboxypeptidase activities. Conclusion: NG1686 is a M23B family zinc metallopeptidase with bifunctional activity. Significance: This is the first demonstration of a metallopeptidase affecting both resistance to H2O2 and PMN-mediated killing in any bacterium.	[Stohl, Elizabeth A.; Seifert, H. Steven] Feinberg Sch Med, Dept Microbiol Immunol, NW Med Sch, Chicago, IL 60611 USA; [Chan, Yolande A.; Hackett, Kathleen T.; Kohler, Petra L.; Dillard, Joseph P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Stohl, EA (corresponding author), Feinberg Sch Med, Dept Microbiol Immunol, NW Med Sch, 303 E Chicago Ave, Chicago, IL 60611 USA.	e-stohl@northwestern.edu			National Institutes of Health [RO1 AI44239, R37 AI33493, R01 AI047958, U19 AI01448-16, T32 AI055397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R21AI044239, R37AI033493, T32AI055397, K08AI001448, R01AI047958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI44239 and R37 AI33493 (to H. S. S.), R01 AI047958 (to J. P. D.), U19 AI01448-16 (to E. A. S.), and T32 AI055397 (to P. L. K.).	BERNADSKY G, 1994, J BACTERIOL, V176, P5225, DOI 10.1128/JB.176.17.5225-5232.1994; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; Criss AK, 2008, CELL MICROBIOL, V10, P2257, DOI 10.1111/j.1462-5822.2008.01205.x; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; DOKTER WHA, 1994, J BIOL CHEM, V269, P4201; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; FRANGIPANE JV, 1992, INFECT IMMUN, V60, P1793, DOI 10.1128/IAI.60.5.1793-1799.1992; Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Goley ED, 2010, MOL MICROBIOL, V77, P56, DOI 10.1111/j.1365-2958.2010.07222.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HOOK EW, 1985, ANN INTERN MED, V102, P229, DOI 10.7326/0003-4819-102-2-229; JAYASWAL RK, 1990, J BACTERIOL, V172, P5783, DOI 10.1128/jb.172.10.5783-5788.1990; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MELLY MA, 1981, J INFECT DIS, V143, P423, DOI 10.1093/infdis/143.3.423; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; REST RF, 1982, INFECT IMMUN, V36, P737, DOI 10.1128/IAI.36.2.737-744.1982; ROSENTHAL RS, 1987, INFECT IMMUN, V55, P2117, DOI 10.1128/IAI.55.9.2117-2120.1987; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Seib KL, 2005, INFECT IMMUN, V73, P5269, DOI 10.1128/IAI.73.8.5269-5272.2005; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Soler-Garcia AA, 2004, MICROB PATHOGENESIS, V37, P55, DOI 10.1016/j.micpath.2004.04.007; Stefanova ME, 2004, EUR J BIOCHEM, V271, P23, DOI 10.1046/j.1432-1033.2003.03886.x; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Stentz R, 2009, MOL MICROBIOL, V72, P779, DOI 10.1111/j.1365-2958.2009.06683.x; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Turner S, 2003, BIOCHEM J, V373, P865, DOI 10.1042/BJ20030088; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026845; World Health Organization, 2011, WHORHR114; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0	57	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11222	11233		10.1074/jbc.M111.338830	http://dx.doi.org/10.1074/jbc.M111.338830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334697	Green Published, hybrid			2022-12-27	WOS:000302780100050
J	Kim, SD; Pahuja, KB; Ravazzola, M; Yoon, J; Boyadjiev, SA; Hammamoto, S; Schekman, R; Orci, L; Kim, J				Kim, Sun-Don; Pahuja, Kanika Bajaj; Ravazzola, Mariella; Yoon, Joonsik; Boyadjiev, Simeon A.; Hammamoto, Susan; Schekman, Randy; Orci, Lelio; Kim, Jinoh			SEC23-SEC31 the Interface Plays Critical Role for Export of Procollagen from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENTICULO-SUTURAL DYSPLASIA; TO-GOLGI TRANSPORT; COPII COAT; COLLAGEN SECRETION; INTERMEDIATE COMPARTMENT; VESICLE FORMATION; STRUCTURAL BASIS; LIVING CELLS; ER; PROTEIN	COPII proteins are essential for exporting most cargo molecules from the endoplasmic reticulum. The membrane-facing surface of the COPII proteins (especially SEC23-SEC24) interacts directly or indirectly with the cargo molecules destined for exit. As we characterized the SEC23A mutations at the SEC31 binding site identified from patients with cranio-lenticulo-sutural dysplasia, we discovered that the SEC23-SEC31 interface can also influence cargo selection. Remarkably, M702V SEC23A does not compromise COPII assembly, vesicle size, and packaging of cargo molecules into COPII vesicles that we have tested but induces accumulation of procollagen in the endoplasmic reticulum when expressed in normal fibroblasts. We observed that M702V SEC23A activates SAR1B GTPase more than wildtype SEC23A when SEC13-SEC31 is present, indicating that M702V SEC23A causes premature dissociation of COPII from the membrane. Our results indicate that a longer stay of COPII proteins on the membrane is required to cargo procollagen than other molecules and suggest that the SEC23-SEC31 interface plays a critical role in capturing various cargo molecules.	[Kim, Sun-Don; Yoon, Joonsik; Boyadjiev, Simeon A.; Kim, Jinoh] Univ Calif Davis, Med Ctr, Genet Sect, Dept Pediat, Sacramento, CA 95817 USA; [Pahuja, Kanika Bajaj; Hammamoto, Susan; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ravazzola, Mariella; Orci, Lelio] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Geneva	Kim, J (corresponding author), Univ Calif Davis, Med Ctr, Genet Sect, Dept Pediat, 2805 50th St,MIND Inst Wet Lab 1421, Sacramento, CA 95817 USA.	jinoh.kim@ucdmc.ucdavis.edu	Kim, Jinoh/AAF-9178-2020	Kim, Jinoh/0000-0003-2841-147X; Bajaj Pahuja, Kanika/0000-0001-8977-9812	MOEHRD [KRF-2007-357-E00005]; Children's Miracle Network; NIDCR, National Institutes of Health [DE016886]; Howard Hughes Medical Institute; Swiss National Science Foundation; Academic Senate Faculty; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016886] Funding Source: NIH RePORTER	MOEHRD(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Children's Miracle Network; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academic Senate Faculty; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported in part by the Korean Research Fellowship (Foundation Fellowship (MOEHRD: KRF-2007-357-E00005).; Supported in part by an Endowed Chair from the Children's Miracle Network and by Grant DE016886 from NIDCR, National Institutes of Health.; Supported in part by the Howard Hughes Medical Institute.; Supported by the Swiss National Science Foundation.; Supported by an Academic Senate Faculty Research Award. To whom correspondence should be addressed: Sect. of Genetics, Dept. of Pediatrics, University of California Davis Medical Center, 2805 50th St., The M.I.N.D. Institute Wet Laboratory 1421, Sacramento, CA 95817. Tel.: 916-703-0451; Fax: 916-703-0370; E-mail: jinoh.kim@ucdmc.ucdavis.edu.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boyadjiev SA, 2011, CLIN GENET, V80, P169, DOI 10.1111/j.1399-0004.2010.01550.x; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P43; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P49; FRIEND DS, 1967, J CELL BIOL, V35, P357, DOI 10.1083/jcb.35.2.357; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Sato K, 2004, J BIOL CHEM, V279, P1330, DOI 10.1074/jbc.C300457200; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	50	32	33	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10134	10144		10.1074/jbc.M111.283382	http://dx.doi.org/10.1074/jbc.M111.283382			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298774	Green Published, hybrid			2022-12-27	WOS:000302167200045
J	Kobayashi, K; Sudiarta, IP; Kodama, T; Fukushima, T; Ara, K; Ozaki, K; Sekiguchi, J				Kobayashi, Kaori; Sudiarta, I. Putu; Kodama, Takeko; Fukushima, Tatsuya; Ara, Katsutoshi; Ozaki, Katsuya; Sekiguchi, Junichi			Identification and Characterization of a Novel Polysaccharide Deacetylase C (PdaC) from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE DEACETYLASE; YYCFG 2-COMPONENT SYSTEM; SENSOR HISTIDINE KINASE; CHITIN DEACETYLASE; COLLETOTRICHUM-LINDEMUTHIANUM; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN STRUCTURE; ENTEROCOCCUS-FAECALIS; VIRULENCE FACTOR; CELL-DIVISION	Cell wall metabolism and cell wall modification are very important processes that bacteria use to adjust to various environmental conditions. One of the main modifications is deacetylation of peptidoglycan. The polysaccharide deacetylase homologue, Bacillus subtilis YjeA (renamed PdaC), was characterized and found to be a unique deacetylase. The pdaC deletion mutant was sensitive to lysozyme treatment, indicating that PdaC acts as a deacetylase. The purified recombinant and truncated PdaC from Escherichia coli deacetylated B. subtilis peptidoglycan and its polymer, (-GlcNAc-MurNAc[-L-Ala-D-Glu]-)(n). Surprisingly, RP-HPLC and ESI-MS/MS analyses showed that the enzyme deacetylates N-acetylmuramic acid (MurNAc) not GlcNAc from the polymer. Contrary to Streptococcus pneumoniae PgdA, which shows high amino acid sequence similarity with PdaC and is a zinc-dependent GlcNAc deacetylase toward peptidoglycan, there was less dependence on zinc ion for deacetylation of peptidoglycan by PdaC than other metal ions (Mn2+, Mg2+, Ca2+). The kinetic values of the activity toward B. subtilis peptidoglycan were K-m = 4.8 mM and k(cat) = 0.32 s(-1). PdaC also deacetylated N-acetylglucosamine (GlcNAc) oligomers with a K-m = 12.3 mM and k(cat) = 0.24 s(-1) toward GlcNAc(4). Therefore, PdaC has GlcNAc deacetylase activity toward GlcNAc oligomers and MurNAc deacetylase activity toward B. subtilis peptidoglycan.	[Kobayashi, Kaori; Sudiarta, I. Putu; Sekiguchi, Junichi] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan; [Fukushima, Tatsuya] Shinshu Univ, Div Gene Res, Dept Life Sci, Res Ctr Human & Environm Sci, Ueda, Nagano 3868567, Japan; [Kodama, Takeko; Ara, Katsutoshi; Ozaki, Katsuya] Kao Corp, Biol Sci Labs, Haga, Tochigi 3213497, Japan	Shinshu University; Shinshu University; KAO Corporation	Sekiguchi, J (corresponding author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp		Sudiarta, I Putu/0000-0003-1381-388X	New Energy and Industrial Technology Department Organization (NEDO); Global COE of the Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19380047];  [22248008];  [21780067]	New Energy and Industrial Technology Department Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Global COE of the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-aid for Scientific Research (B) (19380047) and (A) (22248008), a New Energy and Industrial Technology Department Organization (NEDO) grant (to J.S.), a Grant-in-aid for Young Scientists (21780067) (to T. F.), and the Global COE programs (to J.S., T. F., and I. P. S.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ALFONSO C, 1995, CURR MICROBIOL, V30, P49, DOI 10.1007/BF00294524; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2008, J BIOL CHEM, V283, P11117, DOI 10.1074/jbc.M706626200; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; HAYASHI H, 1973, BIOCHEM BIOPH RES CO, V50, P641, DOI 10.1016/0006-291X(73)91292-8; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Ng KL, 2007, J BIOCHEM, V142, P647, DOI 10.1093/jb/mvm177; Nugroho FA, 1999, J BACTERIOL, V181, P6230, DOI 10.1128/JB.181.20.6230-6237.1999; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Popowska M, 2009, J MICROBIOL BIOTECHN, V19, P932, DOI 10.4014/jmb.0810.557; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Sambrook J., 2002, MOL CLONING LAB MANU; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Silvaggi JM, 2004, J BACTERIOL, V186, P8089, DOI 10.1128/JB.186.23.8089-8095.2004; Sudiarta IP, 2010, BIOCHEM BIOPH RES CO, V398, P606, DOI 10.1016/j.bbrc.2010.07.001; Szurmant H, 2007, METHOD ENZYMOL, V422, P396, DOI 10.1016/S0076-6879(06)22020-2; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; TSIGOS I, 1995, J BIOL CHEM, V270, P26286, DOI 10.1074/jbc.270.44.26286; Tsigos I, 1999, EUR J BIOCHEM, V261, P698, DOI 10.1046/j.1432-1327.1999.00311.x; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	48	33	35	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9765	9776		10.1074/jbc.M111.329490	http://dx.doi.org/10.1074/jbc.M111.329490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22277649	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000302167200010
J	Yang, ZQ; Gu, P; Shao, XY; Li, ZQ; Zhou, Y; Lu, LM; Chou, KY				Yang, Zhiqiang; Gu, Peng; Shao, Xiaoyi; Li, Zuoqing; Zhou, Yun; Lu, Liming; Chou, Kuang-Yen			Mutated Major Histocompatibility Complex Class II Transactivator Up-regulates Interleukin-33-dependent Differentiation of Th2 Subset through Nod2 Binding for NLR (NOD-like Receptor) Signaling Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; NF-KAPPA-B; T-CELLS; CONSTRUCTS LACKING; TERMINAL DOMAIN; CUTTING EDGE; IL-1 FAMILY; EXPRESSION; MHC; EFFECTOR	Dominant-negative mutants of class II transactivator (mCIITAs) with N-terminal depletion have been used to repress the transcription of class II genes in xenotransplantation. Here, we report that mCIITA overexpressing myeloid cell line Ana-1 (Ana-1-mCIITA) derived from a C57BL/6 mouse was able to down-regulate the MHC class II expression and reverse immune responses from Th1 (IL-2(+)IFN-gamma(+)STAT4(+)) to Th2 (IL-4(+)IL-5(+)IL-10(+)IL-13(+)STAT6(+)) when cocultured with T cells. Mechanism analysis indicated that the mCIITA protein is able to initiate a NOD-like receptor-related signaling pathway via binding of the cytoplasmic Nod2 protein, which was followed by activating RIP2, caspase 1, and IKK-alpha/beta. This ensures the expression of the genes encoding the cytokines IL-33, IL-1 beta, and TNF-alpha; however, only the highly expressed IL-33 is responsible for inducing the type 2 response, with a skewed Th2 cytokine secretion (IL-4(+)IL-5(+)IL-10(+)IL-13(+)IL-2(-)IFN-gamma(-)), which was completely prevented by the deactivation of the Nod2 gene with siRNA or by the blockage of the IL-33-related signaling using the mAb ST2L against the IL-33 receptor. mCIITA-mediated Th2 conversion was also successfully induced in vivo in a mCIITA-transgenic C57BL/6 mouse model. These results indicate that the Th1/Th2 balance could be regulated by an Nterminus-depleted CIITA molecule via NOD-like receptor-related signaling, a property valuable for disease control, especially for inducing transplantation tolerance via the repression of class II expression and the attenuation of a Th1-dominant response.	[Gu, Peng; Shao, Xiaoyi; Li, Zuoqing; Zhou, Yun; Lu, Liming] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Yang, Zhiqiang; Chou, Kuang-Yen] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	lulunew2003@163.com; kychouimm@sjtu.edu.cn	Gu, Peng/GPW-7040-2022		Natural Science Foundation of China [30530690, 30772018, 30700766]; Foundation of Shanghai Sci-Tech Council [07JC14033]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Sci-Tech Council	This study was supported by the Natural Science Foundation of China Grants 30530690, 30772018, and 30700766 and the Foundation of Shanghai Sci-Tech Council 07JC14033.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Imanishi T, 2007, J IMMUNOL, V178, P6715, DOI 10.4049/jimmunol.178.11.6715; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lohr J, 2009, MICROBES INFECT, V11, P589, DOI 10.1016/j.micinf.2009.04.012; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ou QS, 2004, J CLIN IMMUNOL, V24, P97, DOI 10.1023/B:JOCI.0000018068.37899.6d; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rietdijk ST, 2008, CURR OPIN PHARMACOL, V8, P261, DOI 10.1016/j.coph.2008.04.003; Salomon B, 1998, J IMMUNOL, V161, P5138; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; So T, 2006, P NATL ACAD SCI USA, V103, P3740, DOI 10.1073/pnas.0600205103; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Yun S, 1998, TRANSPLANTATION, V66, P103, DOI 10.1097/00007890-199807150-00016; Yun S, 1997, INT IMMUNOL, V9, P1545, DOI 10.1093/intimm/9.10.1545; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	41	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9972	9981		10.1074/jbc.M111.288498	http://dx.doi.org/10.1074/jbc.M111.288498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294690	Green Published, hybrid			2022-12-27	WOS:000302167200029
J	Covaleda, G; del Rivero, MA; Chavez, MA; Aviles, FX; Reverter, D				Covaleda, Giovanni; Alonso del Rivero, Maday; Chavez, Maria A.; Aviles, Francesc X.; Reverter, David			Crystal Structure of Novel Metallocarboxypeptidase Inhibitor from Marine Mollusk Nerita versicolor in Complex with Human Carboxypeptidase A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PROTEIN; CRYSTALLOGRAPHY; SEQUENCE; CLONING	NvCI is a novel exogenous proteinaceous inhibitor of metallocarboxypeptidases from the marine snail Nerita versicolor. The complex between human carboxypeptidase A4 and NvCI has been crystallized and determined at 1.7 angstrom resolution. The NvCI structure defines a distinctive protein fold basically composed of a two-stranded antiparallel beta-sheet connected by three loops and the inhibitory C-terminal tail and stabilized by three disulfide bridges. NvCI is a tight-binding inhibitor that interacts with the active site of the enzyme in a substrate-like manner. NvCI displays an extended and novel interface with human carboxypeptidase A4, responsible for inhibitory constants in the picomolar range for some members of the M14A subfamily of carboxypeptidases. This makes NvCI the strongest inhibitor reported so far for this family. The structural homology displayed by the C-terminal tails of different carboxypeptidase inhibitors represents a relevant example of convergent evolution.	[Covaleda, Giovanni; Aviles, Francesc X.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain; [Covaleda, Giovanni; Aviles, Francesc X.; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra 08193, Barcelona, Spain; [Alonso del Rivero, Maday; Chavez, Maria A.] Univ Habana, Fac Biol, Ctr Estudio Prot, Havana, Cuba	Autonomous University of Barcelona; Autonomous University of Barcelona; Universidad de la Habana	Aviles, FX (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Bellaterra 08193, Barcelona, Spain.	francescxavier.aviles@uab.es; david.reverter@uab.cat	Reverter, David/H-5360-2015; Aviles, Francesc Xavier/F-3482-2019; Cortes, Giovanni Covaleda/D-1575-2018; Avilés, Francesc Xavier/A-2664-2015	Reverter, David/0000-0002-5347-0992; Aviles, Francesc Xavier/0000-0002-1399-6789; Cortes, Giovanni Covaleda/0000-0002-7621-852X; Avilés, Francesc Xavier/0000-0002-1399-6789; Alonso del Rivero Antigua, Maday/0000-0003-1988-6852	Ministerio de Ciencia e Innovacion of Spain [BFU2008-0364, BIO2010-22321-C02]; European Community [MIRG-CT-2007-200346, LIVIMODE 241919]; Universitat Autonoma de Barcelona [FI-UAB-2007]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission); Universitat Autonoma de Barcelona	This work was in part supported by Grants BFU2008-0364 and BIO2010-22321-C02 from the Ministerio de Ciencia e Innovacion of Spain and by Grants MIRG-CT-2007-200346 and LIVIMODE 241919 (FP7-Health-2009) from the European Community.; Supported by Universitat Autonoma de Barcelona Scholarship FI-UAB-2007.; Supported by the Ramon y Cajal Program of the Ministerio de Ciencia e Innovacion of Spain. To whom correspondence may be addressed. Tel.: 93-586-8955; Fax: 93-581-2011; E-mail: david. reverter@uab.cat.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DeLano W.L, PYMOL MOL GRAPHICS S; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez D, 2010, CHEM BIOL DRUG DES, V75, P29, DOI 10.1111/j.1747-0285.2009.00907.x; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; HASS GM, 1975, BIOCHEMISTRY-US, V14, P1334, DOI 10.1021/bi00677a036; Huang HJ, 1999, CANCER RES, V59, P2981; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Marino-Buslje C, 2000, EUR J BIOCHEM, V267, P1502, DOI 10.1046/j.1432-1327.2000.01150.x; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pallares I, 2008, ACTA CRYSTALLOGR D, V64, P784, DOI 10.1107/S0907444908013474; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; Reverter D, 1998, J BIOL CHEM, V273, P3535, DOI 10.1074/jbc.273.6.3535; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; REYNOLDS DS, 1989, P NATL ACAD SCI USA, V86, P9480, DOI 10.1073/pnas.86.23.9480; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Vendrell J., 2004, HDB METALLOPROTEINS, V3, P176; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	32	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9250	9258		10.1074/jbc.M111.330100	http://dx.doi.org/10.1074/jbc.M111.330100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294694	hybrid, Green Published			2022-12-27	WOS:000301797800053
J	Li, N; Zhang, CG; Li, BQ; Liu, XH; Huang, Y; Xu, SJ; Gu, LC				Li, Ning; Zhang, Conggang; Li, Bingqing; Liu, Xiuhua; Huang, Yan; Xu, Sujuan; Gu, Lichuan			Unique Iron Coordination in Iron-chelating Molecule Vibriobactin Helps Vibrio cholerae Evade Mammalian Siderocalin-mediated Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE; IDENTIFICATION; ENTEROBACTIN; TRANSPORT; BINDING; CLONING; SYSTEM; ACQUISITION; INFECTION; GENETICS	Iron is essential for the survival of almost all bacteria. Vibrio cholerae acquires iron through the secretion of a catecholate siderophore called vibriobactin. At present, how vibriobactin chelates ferric ion remains controversial. In addition, the mechanisms underlying the recognition of ferric vibriobactin by the siderophore transport system and its delivery into the cytoplasm specifically have not been clarified. In this study, we report the high-resolution structures of the ferric vibriobactin periplasmic binding protein ViuP and its complex with ferric vibriobactin. The holo-ViuP structure reveals that ferric vibriobactin does not adopt the same iron coordination as that of other catecholate siderophores such as enterobactin. The three catechol moieties donate five, rather than six, oxygen atoms as iron ligands. The sixth iron ligand is provided by a nitrogen atom from the second oxazoline ring. This kind of iron coordination results in the protrusion of the second catechol moiety and renders the electrostatic surface potential of ferric vibriobactin less negatively polarized compared with ferric enterobactin. To accommodate ferric vibriobactin, ViuP has a deeper subpocket to hold the protrusion of the second catechol group. This structural characteristic has not been observed in other catecholate siderophore-binding proteins. Biochemical data show that siderocalin, which is part of the mammalian innate immune system, cannot efficiently sequester ferric vibriobactin in vitro, although it can capture many catecholate siderophores with high efficiency. Our findings suggest that the unique iron coordination found in ferric vibriobactin may be utilized by some pathogenic bacteria to evade the siderocalin-mediated innate immune response of mammals.	[Li, Ning; Zhang, Conggang; Li, Bingqing; Liu, Xiuhua; Huang, Yan; Xu, Sujuan; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Xiuhua] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China	Shandong University; Hebei University	Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lcgu@sdu.edu.cn			State Key Laboratory of Microbial Technology of Shandong University; Hi-Tech Research and Development Program of China [2006AA02A324]	State Key Laboratory of Microbial Technology of Shandong University; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the State Key Laboratory of Microbial Technology of Shandong University and by Grant 2006AA02A324 from the Hi-Tech Research and Development Program of China.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARNOLD RR, 1977, SCIENCE, V197, P263, DOI 10.1126/science.327545; BERGERON RJ, 1990, J BACTERIOL, V172, P2650, DOI 10.1128/jb.172.5.2650-2657.1990; Braun V, 1998, MET IONS BIOL SYST, V35, P67; BUTTERTON JR, 1994, J BACTERIOL, V176, P5631, DOI 10.1128/JB.176.18.5631-5638.1994; Butterton JR, 2000, J BACTERIOL, V182, P1731, DOI 10.1128/JB.182.6.1731-1738.2000; BUTTERTON JR, 1992, J BACTERIOL, V174, P3729, DOI 10.1128/JB.174.11.3729-3738.1992; Dertz EA, 2006, J AM CHEM SOC, V128, P22, DOI 10.1021/ja055898c; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KARPISHIN TB, 1992, ANGEW CHEM INT EDIT, V31, P466, DOI 10.1002/anie.199204661; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MULDER GD, 1989, J INFECT DIS, V159, P809, DOI 10.1093/infdis/159.4.809-a; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKUJO N, 1994, BIOMETALS, V7, P109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Strong R. K., 2005, LIPOCALINS, P83; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wyckoff EE, 1999, J BACTERIOL, V181, P7588, DOI 10.1128/JB.181.24.7588-7596.1999; Wyckoff EE, 1997, J BACTERIOL, V179, P7055, DOI 10.1128/jb.179.22.7055-7062.1997; Wyckoff EE, 2001, J BACTERIOL, V183, P1830, DOI 10.1128/JB.183.5.1830-1834.2001; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106	37	22	22	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8912	8919		10.1074/jbc.M111.316034	http://dx.doi.org/10.1074/jbc.M111.316034			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291019	hybrid, Green Published			2022-12-27	WOS:000301797800022
J	Schmid-Siegert, E; Loscos, J; Farmer, EE				Schmid-Siegert, Emanuel; Loscos, Jorge; Farmer, Edward E.			Inducible Malondialdehyde Pools in Zones of Cell Proliferation and Developing Tissues in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; LIPID-PEROXIDATION; LIQUID-CHROMATOGRAPHY; THIOBARBITURIC ACID; LINOLENIC ACID; JASMONIC ACID; DNA-DAMAGE; ALDEHYDES; MUTANT; PROTEINS	Malondialdehyde (MDA) is a natural and widespread genotoxin. Given its potentially deleterious effects, it is of interest to establish the identities of the cell types containing this aldehyde. We used in situ chemical trapping with 2-thiobarbituric acid and mass spectrometry with a deuterated standard to characterize MDA pools in the vegetative phase in Arabidopsis thaliana. In leaves, MDA occurred predominantly in the intracellular compartment of mesophyll cells and was enriched in chloroplasts where it was derived primarily from triunsaturated fatty acids (TFAs). High levels of MDA (most of which was unbound) were found within dividing cells in the root tip cell proliferation zone. The bulk of this MDA did not originate from TFAs. We confirmed the localization of MDA in transversal root sections. In addition to MDA in proliferating cells near the root tip we found evidence for the presence of MDA in pericyle cells. Remodeling of non-TFA-derived MDA pools occurred when seedlings were infected with the fungus Botrytis cinerea. Treatment of uninfected seedlings with mediators of plant stress responses (jasmonic acid or salicylic acid) increased seedling MDA levels over 20-fold. In summary, major pools of MDA are associated with cell division foci containing stem cells. The aldehyde is pathogen-inducible in these regions and its levels are increased by cellular mediators that impact defense and growth.	[Schmid-Siegert, Emanuel; Loscos, Jorge; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Schmid-Siegert, Emanuel/N-8657-2019; Schmid-Siegert, Emanuel/G-5067-2012; Loscos, Jorge/F-3082-2013; Farmer, Edward E/H-1635-2011; Loscos, Jorge/A-7827-2008	Schmid-Siegert, Emanuel/0000-0003-1339-5120; Loscos, Jorge/0000-0003-1435-1779; Loscos, Jorge/0000-0003-1435-1779	Swiss National Science Foundation NCCR; SNSF [3100A0-122441]; Marie Curie Postdoctoral Fellowship	Swiss National Science Foundation NCCR(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF)); Marie Curie Postdoctoral Fellowship(European Commission)	This work was supported in part by Swiss National Science Foundation NCCR Plant Survival Grant and by SNSF Grant 3100A0-122441.; Supported by a Marie Curie Postdoctoral Fellowship.	CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Clausen C, 2004, PLANTA, V220, P30, DOI 10.1007/s00425-004-1325-3; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Gindro K, 2001, FEMS MICROBIOL LETT, V204, P101, DOI 10.1111/j.1574-6968.2001.tb10870.x; Glauser G, 2009, J BIOL CHEM, V284, P34506, DOI 10.1074/jbc.M109.061432; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Jauh GY, 1999, PLANT CELL, V11, P1867, DOI 10.1105/tpc.11.10.1867; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; Long JG, 2009, NEUROCHEM RES, V34, P786, DOI 10.1007/s11064-008-9882-7; Mano J, 2009, PLANTA, V230, P639, DOI 10.1007/s00425-009-0964-9; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Marnett LJ, 2002, TOXICOLOGY, V181, P219, DOI 10.1016/S0300-483X(02)00448-1; Mauch F, 2001, PLANT J, V25, P67, DOI 10.1046/j.1365-313x.2001.00940.x; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2009, J BIOL CHEM, V284, P1702, DOI 10.1074/jbc.M807114200; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Pan XQ, 2008, PHYTOCHEMISTRY, V69, P1773, DOI 10.1016/j.phytochem.2008.02.008; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Schalk M, 1998, PLANT PHYSIOL, V118, P209, DOI 10.1104/pp.118.1.209; Slatter DA, 2000, DIABETOLOGIA, V43, P550, DOI 10.1007/s001250051342; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; TATUM VL, 1990, LIPIDS, V25, P226, DOI 10.1007/BF02535752; Voulgaridou GP, 2011, MUTAT RES-FUND MOL M, V711, P13, DOI 10.1016/j.mrfmmm.2011.03.006; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2010, PLANTA, V231, P1077, DOI 10.1007/s00425-010-1112-2; YEO HC, 1994, ANAL BIOCHEM, V220, P391, DOI 10.1006/abio.1994.1355	35	19	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8954	8962		10.1074/jbc.M111.322842	http://dx.doi.org/10.1074/jbc.M111.322842			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298768	Green Published, hybrid			2022-12-27	WOS:000301797800026
J	Chartron, JW; VanderVelde, DG; Rao, M; Clemons, WM				Chartron, Justin W.; VanderVelde, David G.; Rao, Meera; Clemons, William M., Jr.			Get5 Carboxyl-terminal Domain Is a Novel Dimerization Motif That Tethers an Extended Get4/Get5 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-ANCHORED PROTEINS; STRUCTURAL-CHARACTERIZATION; MOLECULAR-BASIS; INSERTION; SYSTEM; MODEL; HOMODIMERIZATION; SPECIFICITY; INTEGRATION; CHAPERONES	Tail-anchored trans-membrane proteins are targeted to membranes post-translationally. The proteins Get4 and Get5 form an obligate complex that catalyzes the transfer of tail-anchored proteins destined to the endoplasmic reticulum from Sgt2 to the cytosolic targeting factor Get3. Get5 forms a homodimer mediated by its carboxyl domain. We show here that a conserved motif exists within the carboxyl domain. A high resolution crystal structure and solution NMR structures of this motif reveal a novel and stable helical dimerization domain. We additionally determined a solution NMR structure of a divergent fungal homolog, and comparison of these structures allows annotation of specific stabilizing interactions. Using solution x-ray scattering and the structures of all folded domains, we present a model of the full-length Get4/Get5 complex.	[Chartron, Justin W.; VanderVelde, David G.; Rao, Meera; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,M-C 114-96, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009; Chartron, Justin/L-9096-2019	Clemons, William M/0000-0002-0021-889X; Chartron, Justin/0000-0003-1734-3424; VanderVelde, David/0000-0002-2907-0366	Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis; United States Department of Energy; National Institutes of Health [R01GM097572]; Searle Scholar program; Burroughs-Wellcome Fund career award for the biological sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097572] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis(Sanofi-Aventis); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar program; Burroughs-Wellcome Fund career award for the biological sciences(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Molecular Observatory at Caltech is supported by the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program. Operations at SSRL are supported by the United States Department of Energy and the National Institutes of Health.; Supported by National Institutes of Health Grant R01GM097572, the Searle Scholar program, and a Burroughs-Wellcome Fund career award for the biological sciences. To whom correspondence should be addressed: California Institute of Technology, 1200 E. California Blvd., M/C 114-96, Pasadena, CA 91125. Tel.: 626-395-1796; E-mail: clemons@caltech.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Beuck C, 2010, STRUCTURE, V18, P377, DOI 10.1016/j.str.2009.12.016; Bolon DN, 2005, P NATL ACAD SCI USA, V102, P12724, DOI 10.1073/pnas.0506124102; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhlman B, 2001, P NATL ACAD SCI USA, V98, P10687, DOI 10.1073/pnas.181354398; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simpson PJ, 2010, STRUCTURE, V18, P897, DOI 10.1016/j.str.2010.07.003; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020	52	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8310	8317		10.1074/jbc.M111.333252	http://dx.doi.org/10.1074/jbc.M111.333252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262836	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000301349400045
J	Reid, PJ; Mohammad-Qureshi, SS; Pavitt, GD				Reid, Peter J.; Mohammad-Qureshi, Sarah S.; Pavitt, Graham D.			Identification of Intersubunit Domain Interactions within Eukaryotic Initiation Factor (eIF) 2B, the Nucleotide Exchange Factor for Translation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTITUTED ENZYME; CATALYTIC DOMAIN; EPSILON-SUBUNIT; ALPHA-SUBUNIT; MECHANISM; COMPLEX; BINDING; PHOSPHORYLATION; EIF2B-EPSILON	In eukaryotic translation initiation, eIF2B is the guanine nucleotide exchange factor (GEF) required for reactivation of the G protein eIF2 between rounds of protein synthesis initiation. eIF2B is unusually complex with five subunits (alpha-epsilon) necessary for GEF activity and its control by phosphorylation of eIF2 alpha. In addition, inherited mutations in eIF2B cause a fatal leukoencephalopathy. Here we describe experiments examining domains of eIF2B gamma and epsilon that both share sequence and predicted tertiary structure similarity with a family of phosphohexose sugar nucleotide pyrophosphorylases. Firstly, using a genetic approach, we find no evidence to support a significant role for a potential nucleotide-binding region within the pyrophosphorylase-like domain (PLD) of eIF2B epsilon for nucleotide exchange. These findings are at odds with one mechanism for nucleotide exchange proposed previously. By using a series of constructs and a co-expression and precipitation strategy, we find that the eIF2B epsilon and -gamma PLDs and a shared second domain predicted to form a left-handed beta helix are all critical for inter-protein interactions between eIF2B subunits necessary for eIF2B complex formation. We have identified extensive interactions between the PLDs and left-handed beta helix domains that form the eIF2B gamma epsilon subcomplex and propose a model for domain interactions between eIF2B subunits.	[Reid, Peter J.; Mohammad-Qureshi, Sarah S.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	graham.pavitt@manchester.ac.uk	Pavitt, Graham D/A-1363-2010	Pavitt, Graham D/0000-0002-8593-2418	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/F013272/1] Funding Source: researchfish; BBSRC [BB/F013272/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council.	Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P4618, DOI 10.1128/MCB.13.8.4618; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P1920, DOI 10.1128/MCB.13.3.1920; Dev K, 2010, MOL CELL BIOL, V30, P5218, DOI 10.1128/MCB.00265-10; Dev K, 2009, J MOL BIOL, V392, P701, DOI 10.1016/j.jmb.2009.07.030; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Hiyama TB, 2009, J MOL BIOL, V392, P937, DOI 10.1016/j.jmb.2009.07.054; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Manchester KL, 1997, BIOCHEM BIOPH RES CO, V239, P223, DOI 10.1006/bbrc.1997.7462; Manchester KL, 2001, BIOCHEM BIOPH RES CO, V289, P643, DOI 10.1006/bbrc.2001.6010; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mohammad-Qureshi SS, 2008, BIOCHEM SOC T, V36, P658, DOI 10.1042/BST0360658; Mohammad-Qureshi SS, 2007, METHOD ENZYMOL, V431, P1, DOI 10.1016/S0076-6879(07)31001-X; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; Nika J, 2000, J BIOL CHEM, V275, P26011, DOI 10.1074/jbc.M003718200; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; PRICE N, 1994, BIOCHIMIE, V76, P748, DOI 10.1016/0300-9084(94)90079-5; Richardson JP, 2004, MOL CELL BIOL, V24, P2352, DOI 10.1128/MCB.24.6.2352-2363.2004; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang XM, 2012, J BIOL CHEM, V287, P8263, DOI 10.1074/jbc.M111.331553; Williams DD, 2001, J BIOL CHEM, V276, P3733, DOI 10.1074/jbc.M008041200; Yang WM, 1996, MOL CELL BIOL, V16, P6603	48	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8275	8285		10.1074/jbc.M111.331645	http://dx.doi.org/10.1074/jbc.M111.331645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238343	hybrid, Green Published			2022-12-27	WOS:000301349400042
J	Zhao, HT; Wang, XX; Zhu, DD; Cui, SJ; Li, X; Cao, Y; Ma, LG				Zhao, Hongtao; Wang, Xiaoxue; Zhu, Dandan; Cui, Sujuan; Li, Xia; Cao, Ying; Ma, Ligeng			A Single Amino Acid Substitution in IIIf Subfamily of Basic Helix-Loop-Helix Transcription Factor AtMYC1 Leads to Trichome and Root Hair Patterning Defects by Abolishing Its Interaction with Partner Proteins in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-CELL DIFFERENTIATION; RECEPTOR-LIKE KINASE; FUNCTIONAL DIVERSITY; BHLH PROTEINS; FACTOR FAMILY; GENE ENCODES; MYB GENES; THALIANA; EXPRESSION; INITIATION	Plant trichomes and root hairs are powerful models for the study of cell fate determination. In Arabidopsis thaliana, trichome and root hair initiation requires a combination of three groups of proteins, including the WD40 repeat protein TRANSPARENT TESTA GLABRA1 (TTG1), R2R3 repeat MYB protein GLABRA1 (GL1), or WEREWOLF (WER) and the IIIf subfamily of basic helix-loop-helix (bHLH) protein GLABRA3 (GL3) or ENHANCER OF GLABRA3 (EGL3). The bHLH component acts as a docking site for TTG1 and MYB proteins. Here, we isolated a mutant showing defects in trichome and root hair patterning that carried a point mutation (R173H) in AtMYC1 that encodes the fourth member of IIIf bHLH family protein. Genetic analysis revealed partial redundant yet distinct function between AtMYC1 and GL3/EGL3. GLABRA2 (GL2), an important transcription factor involved in trichome and root hair control, was down-regulated in Atmyc1 plants, suggesting the requirement of AtMYC1 for appropriate GL2 transcription. Like its homologs, AtMYC1 formed a complex with TTG1 and MYB proteins but did not dimerized. In addition, the interaction of AtMYC1 with MYB proteins and TTG1 was abrogated by the R173H substitution in Atmyc1-1. We found that this amino acid (Arg) is conserved in the AtMYC1 homologs GL3/EGL3 and that it is essential for their interaction with MYB proteins and for their proper functions. Our findings indicate that AtMYC1 is an important regulator of trichome and root hair initiation, and they reveal a novel amino acid necessary for protein-protein interactions and gene function in IIIf subfamily bHLH transcription factors.	[Zhao, Hongtao; Zhu, Dandan; Cui, Sujuan; Cao, Ying; Ma, Ligeng] Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China; [Ma, Ligeng] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Zhao, Hongtao; Li, Xia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources, State Key Lab Plant Cell & Chromosome Engn, Shijiazhuang 050021, Hebei, Peoples R China; [Wang, Xiaoxue] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Hebei Normal University; Capital Normal University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; National Institute of Biological Sciences, Beijing	Ma, LG (corresponding author), Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China.	Ligeng.ma@mail.hebtu.edu.cn	li, xia/HHZ-7468-2022		China MOST 973 Project [2012CB910900, 2012CB114200]; Hebei Province key laboratory	China MOST 973 Project; Hebei Province key laboratory	This work was supported by China MOST 973 Project Grants 2012CB910900 and 2012CB114200 and by the Hebei Province key laboratory program.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Balkunde R, 2010, CURR TOP DEV BIOL, V91, P299, DOI 10.1016/S0070-2153(10)91010-7; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Digiuni S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.54; Dolan L, 2006, J EXP BOT, V57, P51, DOI 10.1093/jxb/erj037; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; Feller A, 2006, J BIOL CHEM, V281, P28964, DOI 10.1074/jbc.M603262200; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Kirik V, 2005, DEVELOPMENT, V132, P1477, DOI 10.1242/dev.01708; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Kwak SH, 2008, PLANT SIGNAL BEHAV, V3, P110, DOI 10.4161/psb.3.2.4969; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Larkin JC, 1996, DEVELOPMENT, V122, P997; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; Lee MM, 2001, DEVELOPMENT, V128, P1539; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Maes L, 2008, PLANT PHYSIOL, V148, P1453, DOI 10.1104/pp.108.125385; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Ohashi Y, 2002, PLANT J, V29, P359, DOI 10.1046/j.0960-7412.2001.01214.x; Payne CT, 2000, GENETICS, V156, P1349; Pesch M, 2009, CURR OPIN PLANT BIOL, V12, P587, DOI 10.1016/j.pbi.2009.07.015; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Symonds VV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002069; Szymanski DB, 1998, DEVELOPMENT, V125, P1161; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga-Wada R, 2011, INT REV CEL MOL BIO, V286, P67, DOI 10.1016/B978-0-12-385859-7.00002-1; Urao T, 1996, PLANT MOL BIOL, V32, P571, DOI 10.1007/BF00019112; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang SC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-81; Wang ZJ, 2009, PLANT MOL BIOL, V69, P121, DOI 10.1007/s11103-008-9411-8; Wester K, 2009, DEVELOPMENT, V136, P1487, DOI 10.1242/dev.021733; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	59	56	70	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14109	14121		10.1074/jbc.M111.280735	http://dx.doi.org/10.1074/jbc.M111.280735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22334670	Green Published, hybrid			2022-12-27	WOS:000303996300064
J	Yang, Z; Drew, DP; Jorgensen, B; Mandel, U; Bach, SS; Ulvskov, P; Levery, SB; Bennett, EP; Clausen, H; Petersen, BL				Yang, Zhang; Drew, Damian P.; Jorgensen, Bodil; Mandel, Ulla; Bach, Soren S.; Ulvskov, Peter; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik; Petersen, Bent L.			Engineering Mammalian Mucin-type O-Glycosylation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; ENDOPLASMIC-RETICULUM; THERAPEUTIC PROTEINS; ARABIDOPSIS-THALIANA; GOLGI-APPARATUS; IN-VIVO; NICOTIANA-BENTHAMIANA; PROLYL 4-HYDROXYLASE; GALNAC-TRANSFERASES	Mucin-type O-glycosylation is an important post-translational modification that confers a variety of biological properties and functions to proteins. This post-translational modification has a particularly complex and differentially regulated biosynthesis rendering prediction and control of where O-glycans are attached to proteins, and which structures are formed, difficult. Because plants are devoid of GalNAc-type O-glycosylation, we have assessed requirements for establishing human GalNAc O-glycosylation de novo in plants with the aim of developing cell systems with custom-designed O-glycosylation capacity. Transient expression of a Pseudomonas aeruginosa Glc(NAc) C4-epimerase and a human polypeptide GalNActransferase in leaves of Nicotiana benthamiana resulted in GalNAc O-glycosylation of co-expressed human O-glycoprotein substrates. A chimeric YFP construct containing a 3.5 tandem repeat sequence of MUC1 was glycosylated with up to three and five GalNAc residues when co-expressed with GalNAc-T2 and a combination of GalNAc-T2 and GalNAc-T4, respectively, as determined by mass spectrometry. O-Glycosylation was furthermore demonstrated on a tandem repeat of MUC16 and interferon alpha 2b. In plants, prolines in certain classes of proteins are hydroxylated and further substituted with plant-specific O-glycosylation; unsubstituted hydroxyprolines were identified in our MUC1 construct. In summary, this study demonstrates that mammalian type O-glycosylation can be established in plants and that plants may serve as a host cell for production of recombinant O-glycoproteins with custom-designed O-glycosy-lation. The observed hydroxyproline modifications, however, call for additional future engineering efforts.	[Drew, Damian P.; Bach, Soren S.; Ulvskov, Peter; Petersen, Bent L.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Jorgensen, Bodil] Univ Copenhagen, Dept Agr & Ecol, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Yang, Zhang] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, DK-4200 Slagelse, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Dept Cellular Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Dept Mol Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Petersen, BL (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	blp@life.ku.dk	Jørgensen, Bodil/F-6551-2014; Bennett, Eric/AAG-6120-2020; Petersen, Bent/H-9437-2014; clausen, henrik/AAD-8016-2021; Ulvskov, Peter/I-1228-2014; Yang, Zhang/I-8934-2016	Jørgensen, Bodil/0000-0002-0453-1277; Bennett, Eric/0000-0002-4976-0647; Petersen, Bent/0000-0002-2004-9077; Ulvskov, Peter/0000-0003-3776-818X; Clausen, Henrik/0000-0002-0915-5055; Mandel, Ulla/0000-0001-7012-9836; Yang, Zhang/0000-0002-4756-5813	Danish Council for Strategic Research [DSF 09-063090]; Danish Council for Independent Research [DFF 09-066624/274-09-0314]; University of Copenhagen	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by Danish Council for Strategic Research Grant DSF 09-063090, Danish Council for Independent Research Grant DFF 09-066624/274-09-0314, and a program of excellence from the University of Copenhagen.	Alonso AP, 2010, PLANT PHYSIOL, V153, P915, DOI 10.1104/pp.110.155713; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Bennett E. P., 2011, GLYCOBIOLOGY, DOI [10.1093/glcob/cwr1182, DOI 10.1093/GLCOB/CWR1182]; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Berninsone P, 1998, ANN NY ACAD SCI, V842, P91, DOI 10.1111/j.1749-6632.1998.tb09636.x; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Daskalova SM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-62; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; El Amrani A, 2004, PLANT PHYSIOL, V135, P16, DOI 10.1104/pp.103.032649; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gerlach JQ, 2011, ADV EXP MED BIOL, V705, P257, DOI 10.1007/978-1-4419-7877-6_12; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hashimoto K, 2009, CARBOHYD RES, V344, P881, DOI 10.1016/j.carres.2009.03.001; Henrissat B., 2009, ESSENTIALS GLYCOBIOL, P89; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Joshi L, 2005, CURR OPIN PLANT BIOL, V8, P223, DOI 10.1016/j.pbi.2005.01.003; Karnoup AS, 2005, GLYCOBIOLOGY, V15, P965, DOI 10.1093/glycob/cwi077; Kaulfurst-Soboll H, 2011, J BIOL CHEM, V286, P22955, DOI 10.1074/jbc.M110.196097; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kieliszewski M. J., 2010, ANN PLANT REV, P321, DOI DOI 10.1002/9781444391015.CH13; Kilcoyne M, 2009, J PLANT PHYSIOL, V166, P219, DOI 10.1016/j.jplph.2008.05.007; Kishimoto T, 1999, ARCH BIOCHEM BIOPHYS, V370, P271, DOI 10.1006/abbi.1999.1406; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; MITSUI T, 1990, PLANT CELL PHYSIOL, V31, P15; Nagels B, 2011, PLANT PHYSIOL, V155, P1103, DOI 10.1104/pp.110.168773; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Petersen BL, 2009, GLYCOCONJUGATE J, V26, P1235, DOI 10.1007/s10719-009-9242-0; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Reaves M. L., 2011, Research in Plant Biology, V1, P49; Sabbatini PJ, 2007, CLIN CANCER RES, V13, P4170, DOI 10.1158/1078-0432.CCR-06-2949; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Segawa H, 2002, EUR J BIOCHEM, V269, P128, DOI 10.1046/j.0014-2956.2001.02632.x; Seveno M, 2004, NAT BIOTECHNOL, V22, P1351, DOI 10.1038/nbt1104-1351; Shah MM, 2003, NAT BIOTECHNOL, V21, P1470, DOI 10.1038/nbt912; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yin BJ, 2011, PROTEIN CELL, V2, P41, DOI 10.1007/s13238-011-1007-4; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8	69	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11911	11923		10.1074/jbc.M111.312918	http://dx.doi.org/10.1074/jbc.M111.312918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334671	hybrid, Green Published			2022-12-27	WOS:000302782200030
J	Culurgioni, S; Munoz, IG; Moreno, A; Palacios, A; Villate, M; Palmero, I; Montoya, G; Blanco, FJ				Culurgioni, Simone; Munoz, Ines G.; Moreno, Alberto; Palacios, Alicia; Villate, Maider; Palmero, Ignacio; Montoya, Guillermo; Blanco, Francisco J.			Crystal Structure of Inhibitor of Growth 4 (ING4) Dimerization Domain Reveals Functional Organization of ING Family of Chromatin-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ING4; HISTONE H3K4ME3 RECOGNITION; PLANT HOMEODOMAIN; SPLICE VARIANTS; COILED-COIL; CELL-GROWTH; PHD FINGER; GENE; CANCER; ACETYLATION	The protein ING4 binds to histone H3 trimethylated at Lys-4 (H3K4me3) through its C-terminal plant homeodomain, thus recruiting the HBO1 histone acetyltransferase complex to target promoters. The structure of the plant homeodomain finger bound to an H3K4me3 peptide has been described, as well as the disorder and flexibility in the ING4 central region. We report the crystal structure of the ING4 N-terminal domain, which shows an antiparallel coiled-coil homodimer with each protomer folded into a helix-loop-helix structure. This arrangement suggests that ING4 can bind simultaneously two histone tails on the same or different nucleosomes. Dimerization has a direct impact on ING4 tumor suppressor activity because monomeric mutants lose the ability to induce apoptosis after genotoxic stress. Homology modeling based on the ING4 structure suggests that other ING dimers may also exist.	[Munoz, Ines G.; Montoya, Guillermo] UAM, CSIC, Macromol Crystallog Grp, Spanish Natl Canc Ctr CNIO, E-28029 Madrid, Spain; [Moreno, Alberto; Palmero, Ignacio] UAM, CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, E-48011 Bilbao, Spain; [Culurgioni, Simone; Palacios, Alicia; Villate, Maider; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, E-48160 Derio, Spain	Autonomous University of Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Basque Foundation for Science; CIC bioGUNE	Montoya, G (corresponding author), CNIO, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	gmontoya@cnio.es; fblanco@cicbiogune.es	Munoz, Ines G/M-3285-2014; cancer, biogune/H-7276-2012; Blanco, Francisco J/D-4401-2009; Ortega, Alicia Palacios/F-7710-2019; Palmero, Ignacio/B-4346-2013; Ortega, Alicia Palacios/AAD-4449-2020	Munoz, Ines G/0000-0001-6732-4059; Blanco, Francisco J/0000-0003-2545-4319; Ortega, Alicia Palacios/0000-0002-7906-1417; Ortega, Alicia Palacios/0000-0002-7906-1417	Spanish Ministerio de Ciencia e Innovacion [SAF2009-09031, BFU2011-23815, CSD2006-00023, CTQ2011-28680]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants SAF2009-09031 (to I. P.), BFU2011-23815 and CSD2006-00023 (to G. M.), and CTQ2011-28680 (to F. J. B.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; BOHRMANN B, 1993, ULTRAMICROSCOPY, V49, P235, DOI 10.1016/0304-3991(93)90230-U; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Culurgioni S, 2010, ACTA CRYSTALLOGR F, V66, P567, DOI 10.1107/S1744309110010080; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Goeman F, 2005, MOL CELL BIOL, V25, P422, DOI 10.1128/MCB.25.1.422-431.2005; Gonzalez L, 2006, ONCOGENE, V25, P5173, DOI 10.1038/sj.onc.1209526; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Li XM, 2009, J CANCER RES CLIN, V135, P829, DOI 10.1007/s00432-008-0519-7; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Moreno A, 2010, CARCINOGENESIS, V31, P1932, DOI 10.1093/carcin/bgq171; MORGAN RS, 1978, INT J PEPT PROT RES, V11, P209; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Palacios A, 2010, J MOL BIOL, V396, P1117, DOI 10.1016/j.jmb.2009.12.049; Palmero I, 2002, ONCOGENE, V21, P2939, DOI 10.1038/sj/onc/1205371; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Raho G, 2007, ONCOGENE, V26, P5247, DOI 10.1038/sj.onc.1210335; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Unoki M, 2006, J BIOL CHEM, V281, P34677, DOI 10.1074/jbc.M606296200; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Wang YM, 2006, FEBS LETT, V580, P3787, DOI 10.1016/j.febslet.2006.05.065; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	48	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10876	10884		10.1074/jbc.M111.330001	http://dx.doi.org/10.1074/jbc.M111.330001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334692	hybrid, Green Published			2022-12-27	WOS:000302780100016
J	Valderrama, JA; Durante-Rodriguez, G; Blazquez, B; Garcia, JL; Carmona, M; Diaz, E				Andres Valderrama, J.; Durante-Rodriguez, Gonzalo; Blazquez, Blas; Luis Garcia, Jose; Carmona, Manuel; Diaz, Eduardo			Bacterial Degradation of Benzoate CROSS-REGULATION BETWEEN AEROBIC AND ANAEROBIC PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-KETOADIPATE PATHWAY; BURKHOLDERIA-XENOVORANS LB400; CARBON CATABOLITE REPRESSION; GRAM-NEGATIVE BACTERIA; AROMATIC-COMPOUNDS; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; PSEUDOMONAS-PUTIDA; PHENYLACETIC ACID	We have studied for the first time the transcriptional regulatory circuit that controls the expression of the box genes encoding the aerobic hybrid pathway used to assimilate benzoate via coenzyme A (CoA) derivatives in bacteria. The promoters responsible for the expression of the box cluster in the beta-proteobacterium Azoarcus sp., their cognate transcriptional repressor, the BoxR protein, and the inducer molecule (benzoyl-CoA) have been characterized. The BoxR protein shows a significant sequence identity to the BzdR transcriptional repressor that controls the bzd genes involved in the anaerobic degradation of benzoate. Because the boxR gene is present in all box clusters so far identified in bacteria, the BoxR/benzoyl-CoA regulatory system appears to be a widespread strategy to control this aerobic hybrid pathway. Interestingly, the paralogous BoxR and BzdR regulators act synergistically to control the expression of the box and bzd genes. This cross-regulation between anaerobic and aerobic pathways for the catabolism of aromatic compounds has never been shown before, and it may reflect a biological strategy to increase the cell fitness in organisms that survive in environments subject to changing oxygen concentrations.	[Andres Valderrama, J.; Durante-Rodriguez, Gonzalo; Blazquez, Blas; Luis Garcia, Jose; Carmona, Manuel; Diaz, Eduardo] CSIC, Ctr Invest Biol, Dept Environm Biol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Diaz, E (corresponding author), CSIC, Ctr Invest Biol, Dept Environm Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	ediaz@cib.csic.es	Valderrama, Jonathan Andres/AAC-1098-2021; Diaz, Eduardo/F-8605-2016; Castiñeira, Blas Blázquez/J-1353-2014; Durante-Rodríguez, Gonzalo/H-3000-2013; Garcia Lopez, Jose Luis/G-9139-2015	Diaz, Eduardo/0000-0002-9731-6524; Durante-Rodríguez, Gonzalo/0000-0003-3113-9868; Valderrama Traslavina, J. Andres/0000-0001-7440-4225; Garcia Lopez, Jose Luis/0000-0002-9238-2485; Carmona, Manuel/0000-0002-1591-7618; Blazquez, Blas/0000-0003-4099-6909	Comision Interministerial de Ciencia y Tecnologia [BIO2009-10438, CSD2007-00005]; Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation	This work was supported by grants BIO2009-10438 and CSD2007-00005 from the Comision Interministerial de Ciencia y Tecnologia.; Recipients of predoctoral fellowships from the Plan Nacional de Formacion de Personal Investigador-Ministry of Science and Innovation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bleichrodt FS, 2010, MICROBIOL-SGM, V156, P1313, DOI 10.1099/mic.0.037424-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzostowicz PC, 2003, APPL ENVIRON MICROB, V69, P1598, DOI 10.1128/AEM.69.3.1598-1606.2003; Carmona Manuel, 2008, P97; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cervin MA, 1998, NUCLEIC ACIDS RES, V26, P3806, DOI 10.1093/nar/26.16.3806; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Diaz E, 2004, INT MICROBIOL, V7, P173; Dombroski AJ, 1997, J BIOL CHEM, V272, P3487; Durante-Rodriguez G, 2006, J BACTERIOL, V188, P2343, DOI 10.1128/JB.188.7.2343-2354.2006; Durante-Rodriguez G, 2008, MICROBIOL-SGM, V154, P306, DOI 10.1099/mic.0.2007/011361-0; Durante-Rodriguez G, 2010, J BIOL CHEM, V285, P35694, DOI 10.1074/jbc.M110.143503; Ezezika OC, 2006, APPL ENVIRON MICROB, V72, P1749, DOI 10.1128/AEM.72.3.1749-1758.2006; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kawaguchi K, 2006, FEMS MICROBIOL LETT, V257, P208, DOI 10.1111/j.1574-6968.2006.00165.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; Maxam A M, 1980, Methods Enzymol, V65, P499; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Parales RE, 2006, PSEUDOMONAS, VOL 4: MOLECULAR BIOLOGY OF EMERGING ISSUES, P287; Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; Rather LJ, 2011, J BIOL CHEM, V286, P29241, DOI 10.1074/jbc.M111.236893; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuhle K, 2003, J BACTERIOL, V185, P4920, DOI 10.1128/JB.185.16.4920-4929.2003; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Takeda H, 2010, J BACTERIOL, V192, P4741, DOI 10.1128/JB.00429-10; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200	66	60	60	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10494	10508		10.1074/jbc.M111.309005	http://dx.doi.org/10.1074/jbc.M111.309005			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303008	Green Published, hybrid			2022-12-27	WOS:000302167200076
J	Chen, CH; Hsieh, TJ; Lin, KD; Lin, HY; Lee, MY; Hung, WW; Hsiao, PJ; Shin, SJ				Chen, Chao-Hung; Hsieh, Tusty-Jiuan; Lin, Kun-Der; Lin, Hsing-Yi; Lee, Mei-Yueh; Hung, Wei-Wen; Hsiao, Pi-Jung; Shin, Shyi-Jang			Increased Unbound Retinol-binding Protein 4 Concentration Induces Apoptosis through Receptor-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETIC-PATIENTS; VITAMIN-A; INSULIN-RESISTANCE; SERUM-LEVELS; RETINOL-BINDING-PROTEIN-4; PATHWAYS; KIDNEY; PLASMA; ACID; HOMEOSTASIS	The increase of apo-/holo-retinol-binding protein 4 (RBP4) concentrations has been found in subjects with renal dysfunction and even in diabetic patients with microalbuminuria. Holo-RBP4 is recognized to possess cytoprotective function. Therefore, we supposed that the relative increase in apo-RBP4 might induce cell damage. In this study, we investigated the signal transduction that activated apoptosis in response to the increase of apo-/holo-RBP4 concentration. We found that increase of apo-/holo-RBP4 concentration ratio delayed the displacement of RBP4 with "stimulated by retinoic acid 6 '' (STRA6), enhanced Janus kinase 2 (JAK2)/STAT5 cascade, up-regulated adenylate cyclase 6 (AC6), increased cAMP, enhanced JNK1/p38 cascade, suppressed CRBP-I/RAR alpha (cellular retinol-binding protein/retinoic acid receptor alpha) expression, and led to apoptosis in HK-2 and human umbilical vein endothelial cells. Furthermore, STRA6, JAK2, STAT5, JNK1, or p38 siRNA and cAMP-PKA inhibitor reversed the repression of CRBP-I/RAR alpha and apoptosis in apo-RBP4 stimulation. In conclusion, this study indicates that the increase of apo-/holo-RBP4 concentration may influence STRA6 signaling, finally causing apoptosis.	[Lin, Kun-Der; Lin, Hsing-Yi; Lee, Mei-Yueh; Hung, Wei-Wen; Hsiao, Pi-Jung; Shin, Shyi-Jang] Kaohsiung Med Univ, Div Endocrinol & Metab, Kaohsiung Med Univ Hosp, Kaohsiung 80708, Taiwan; [Hsieh, Tusty-Jiuan; Hsiao, Pi-Jung; Shin, Shyi-Jang] Kaohsiung Med Univ, Coll Med, Kaohsiung Med Univ Hosp, Sch Med, Kaohsiung 80708, Taiwan; [Chen, Chao-Hung] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung Med Univ Hosp, Kaohsiung 80708, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Shin, SJ (corresponding author), Kaohsiung Med Univ, Div Endocrinol & Metab, Kaohsiung Med Univ Hosp, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.	sjshin@kmu.edu.tw		Hung, Wei Wen/0000-0002-5976-6321; Hsieh, Tusty-Jiuan/0000-0001-5387-6522	National Science Council of Taiwan [NSC-95-2314-B-037-040-MY3]; Kaohsiung Medical University Hospital [KMUH98-7R21, KMUH99-8R08]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (NSC-95-2314-B-037-040-MY3) and the Kaohsiung Medical University Hospital (KMUH98-7R21 and KMUH99-8R08).	BERNARD A, 1988, CLIN CHIM ACTA, V171, P85, DOI 10.1016/0009-8981(88)90293-8; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chang YH, 2008, DIABETES-METAB RES, V24, P629, DOI 10.1002/dmrr.894; Chavez AO, 2009, AM J PHYSIOL-ENDOC M, V296, pE758, DOI 10.1152/ajpendo.90737.2008; Frey SK, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-29; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; HELLER J, 1975, J BIOL CHEM, V250, P3613; Henze A, 2010, BIOCHEM BIOPH RES CO, V393, P79, DOI 10.1016/j.bbrc.2010.01.082; Henze A, 2008, DIABETES, V57, P3323, DOI 10.2337/db08-0866; Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jaconi S, 1996, EUR J ENDOCRINOL, V134, P576, DOI 10.1530/eje.0.1340576; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kumar S, 2009, J BIOL CHEM, V284, P14760, DOI 10.1074/jbc.M900925200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Napoli JL, 2000, NUTR REV, V58, P230, DOI 10.1111/j.1753-4887.2000.tb01870.x; Nezzar H, 2007, MOL VIS, V13, P1641; Raila J, 2007, KIDNEY INT, V72, P505, DOI 10.1038/sj.ki.5002372; SIEGENTHALER G, 1987, BIOCHEM BIOPH RES CO, V143, P418, DOI 10.1016/0006-291X(87)91370-2; Singh AB, 2012, J CELL PHYSIOL, V227, P2632, DOI 10.1002/jcp.23005; SOPRANO DR, 1986, J LIPID RES, V27, P166; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Tian W, 2000, AM J PHYSIOL-RENAL, V279, pF593, DOI 10.1152/ajprenal.2000.279.4.F593; Tripathi A, 2008, INT IMMUNOL, V20, P327, DOI 10.1093/intimm/dxm145; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2002, J BIOL CHEM, V277, P41693, DOI 10.1074/jbc.M207095200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ziegelmeier M, 2007, DIABETES CARE, V30, P2588, DOI 10.2337/dc07-0275; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	38	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9694	9707		10.1074/jbc.M111.301721	http://dx.doi.org/10.1074/jbc.M111.301721			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308028	Green Published, hybrid			2022-12-27	WOS:000302167200004
J	Gu, ZL; Liu, WH; Wei, J; Yan, Z				Gu, Zhenglin; Liu, Wenhua; Wei, Jing; Yan, Zhen			Regulation of N-Methyl-D-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-DEPENDENT MECHANISM; LONG-TERM DEPRESSION; PREFRONTAL CORTEX; SYNAPTIC-TRANSMISSION; WORKING-MEMORY; ANXIOLYTIC-LIKE; BRAIN-FUNCTION; MICE LACKING; LIM-KINASE; GROUP-II	Emerging evidence suggests that metabotropic glutamate receptors (mGluRs) are potential novel targets for brain disorders associated with the dysfunction of prefrontal cortex (PFC), a region critical for cognitive and emotional processes. Because N-methyl-D-aspartic acid receptor (NMDAR) dysregulation has been strongly associated with the pathophysiology of mental illnesses, we examined the possibility that mGluRs might be involved in modulating PFC functions by targeting postsynaptic NMDARs. We found that application of prototypical group III mGluR agonists significantly reduced NMDAR-mediated synaptic and ionic currents in PFC pyramidal neurons, which was mediated by mGluR7 localized at postsynaptic neurons and involved the beta-arrestin/ERK signaling pathway. The mGluR7 modulation of NMDAR currents was prevented by agents perturbing actin dynamics and by the inhibitor of cofilin, a major actin-depolymerizing factor. Consistently, biochemical and immunocytochemical results demonstrated that mGluR7 activation increased cofilin activity and F-actin depolymerization via an ERK-dependent mechanism. Furthermore, mGluR7 reduced the association of NMDARs with the scaffolding protein PSD-95 and the surface level of NMDARs in an actin-dependent manner. These data suggest that mGluR7, by affecting the cofilin/actin signaling, regulates NMDAR trafficking and function. Because ablation of mGluR7 leads to a variety of behavioral symptoms related to PFC dysfunction, such as impaired working memory and reduced anxiety and depression, our results provide a potential mechanism for understanding the role of mGluR7 in mental health and disorders.	[Gu, Zhenglin; Liu, Wenhua; Wei, Jing; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [MH84233, MH85774]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233, R01MH085774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH84233 and MH85774 (to Z. Y.).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bradley SR, 1996, J NEUROSCI, V16, P2044; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Bushell TJ, 1996, BRIT J PHARMACOL, V117, P1457, DOI 10.1111/j.1476-5381.1996.tb15306.x; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Fendt M, 2008, MOL PSYCHIATR, V13, P970, DOI 10.1038/sj.mp.4002073; Field JR, 2011, TRENDS MOL MED, V17, P689, DOI 10.1016/j.molmed.2011.08.004; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; Holscher C, 2004, BEHAV BRAIN RES, V154, P473, DOI 10.1016/j.bbr.2004.03.015; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Iacovelli L, 2002, J NEUROCHEM, V82, P216, DOI 10.1046/j.1471-4159.2002.00929.x; Jiang Q, 2006, J NEUROSCI, V26, P4318, DOI 10.1523/JNEUROSCI.0118-06.2006; Kinzie JM, 1997, J COMP NEUROL, V385, P372; Kosinski CM, 1999, J COMP NEUROL, V415, P266; Lavreysen H, 2008, CURR MED CHEM, V15, P671, DOI 10.2174/092986708783885246; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Martin G, 1997, J NEUROPHYSIOL, V78, P3028, DOI 10.1152/jn.1997.78.6.3028; Martin R, 2007, EUR J NEUROSCI, V26, P312, DOI 10.1111/j.1460-9568.2007.05660.x; Masugi M, 1999, J NEUROSCI, V19, P955; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitsukawa K, 2006, NEUROPSYCHOPHARMACOL, V31, P1112, DOI 10.1038/sj.npp.1300926; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; OHISHI H, 1995, J COMP NEUROL, V360, P555, DOI 10.1002/cne.903600402; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Palucha A, 2004, NEUROPHARMACOLOGY, V46, P151, DOI 10.1016/j.neuropharm.2003.09.006; Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pisani A, 1997, NEUROPHARMACOLOGY, V36, P845, DOI 10.1016/S0028-3908(96)00177-3; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spooren WPJM, 2000, J PHARMACOL EXP THER, V295, P1267; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Wang X, 2003, J NEUROSCI, V23, P9852; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	68	45	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10265	10275		10.1074/jbc.M111.325175	http://dx.doi.org/10.1074/jbc.M111.325175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22287544	Green Published, hybrid			2022-12-27	WOS:000302167200056
J	Seye, CI; Agca, Y; Agca, C; Derbigny, W				Seye, Cheikh I.; Agca, Yuksel; Agca, Cansu; Derbigny, Wilbert			P2Y(2) Receptor-mediated Lymphotoxin-alpha Secretion Regulates Intercellular Cell Adhesion Molecule-1 Expression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2 PURINERGIC RECEPTORS; HUMAN DENDRITIC CELLS; TUMOR-NECROSIS-FACTOR; NUCLEOTIDE RECEPTORS; ENDOTHELIAL-CELLS; P2X(7) RECEPTOR; CULTURED ASTROCYTES; CYTOKINE SECRETION; P-2 PURINOCEPTORS; EXTRACELLULAR ATP	The proinflammatory cytokine lymphotoxin-alpha (LTA) is thought to contribute to the pathogenesis of atherosclerosis. However, the mechanisms that regulate its expression in vascular smooth muscle cells (VSMC) are poorly understood. The ability of exogenous nucleotides to stimulate LTA production was evaluated in VSMC by ELISA. The P2Y(2) nucleotide receptor (P2Y(2)R) agonist UTP stimulates a strong and sustained release of LTA from WT but not P2Y(2)R(-/-) SMC. Assessment of LTA gene transcription by LTA promoter-luciferase construct indicated that LTA levels are controlled at the level of transcription. We show using RNAi techniques that knockdown of the actin-binding protein filamin-A (FLNa) severely impaired nucleotide-induced Rho activation and consequent Rho-mediated LTA secretion. Reintroduction of FLNa in FLNa RNAi SMC rescued UTP-induced LTA expression. In addition, we found that UTP-stimulated LTA secretion is not sensitive to brefeldin A, which blocks the formation of vesicles involved in protein transport from the endoplasmic reticulum to the Golgi apparatus, suggesting that P2Y(2)R/filamin-mediated secretion of LTA is independent of the endoplasmic reticulum/Golgi secretory vesicle route. Furthermore, UTP selectively induces ICAM-1 expression in WT but not SMC expressing a truncated P2Y2R deficient in LTA secretion. These data suggest that P2Y2R recruits FLNa to provide a cytoskeletal scaffold necessary for Rho signaling pathway upstream of LTA release and subsequent stimulation of ICAM-1 expression on vascular smooth muscle cells.	[Seye, Cheikh I.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Derbigny, Wilbert] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Agca, Yuksel; Agca, Cansu] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65201 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia	Seye, CI (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS 332, Indianapolis, IN 46202 USA.	cseye@iupui.edu			Showalter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI072072] Funding Source: NIH RePORTER	Showalter Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Showalter Foundation (to C. I. S.).	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Asselbergs FW, 2007, CLIN SCI, V112, P291, DOI 10.1042/CS20060200; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; BODIN P, 1995, EXPERIENTIA, V51, P256, DOI 10.1007/BF01931108; Chaulet H, 2001, CIRC RES, V89, P772, DOI 10.1161/hh2101.098617; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Ciccarelli R, 1999, GLIA, V25, P93, DOI 10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139, DOI 10.1152/ajpcell.1999.276.5.C1139; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Erlinge D, 1998, BIOCHEM BIOPH RES CO, V248, P864, DOI 10.1006/bbrc.1998.9083; Ferrari D, 2000, FEBS LETT, V486, P217, DOI 10.1016/S0014-5793(00)02306-1; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 2000, FASEB J, V14, P2466, DOI 10.1096/fj.00-0031com; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Hobert ME, 2002, J BIOL CHEM, V277, P51025, DOI 10.1074/jbc.M210466200; HOGQUIST KA, 1991, J IMMUNOL, V147, P2181; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; KOBAYASHI Y, 1984, J BIOCHEM-TOKYO, V95, P1775, DOI 10.1093/oxfordjournals.jbchem.a134790; Liao ZJ, 2007, J CELL SCI, V120, P1654, DOI 10.1242/jcs.03441; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ostrom R. S., 2001, AM J PHYSIOL, V281, P524; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Pedersen S, 1999, BBA-BIOMEMBRANES, V1416, P271, DOI 10.1016/S0005-2736(98)00228-4; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Pillois X, 2002, CIRC RES, V90, P678, DOI 10.1161/01.RES.0000013700.98464.8E; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Seye C. I., 2006, PURINERG SIGNAL, pC471; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Seye CI, 2002, CIRCULATION, V106, P2720, DOI 10.1161/01.CIR.0000038111.00518.35; Seye CI, 1997, ARTERIOSCL THROM VAS, V17, P3602, DOI 10.1161/01.ATV.17.12.3602; Solini A, 1999, J CELL SCI, V112, P297; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Ware C F, 1995, Curr Top Microbiol Immunol, V198, P175; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H; Warny M, 2001, J BIOL CHEM, V276, P26051, DOI 10.1074/jbc.M102568200; Weiser S, 2007, CYTOKINE, V37, P84, DOI 10.1016/j.cyto.2007.02.021; Weisman GA, 1996, J PHARMACOL EXP THER, V277, P1; Wilden PA, 1998, AM J PHYSIOL-HEART C, V275, pH1209, DOI 10.1152/ajpheart.1998.275.4.H1209; Yu N, 2008, CIRC RES, V102, P581, DOI 10.1161/CIRCRESAHA.107.162271; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	54	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10535	10543		10.1074/jbc.M111.313189	http://dx.doi.org/10.1074/jbc.M111.313189			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298782	Green Published, hybrid			2022-12-27	WOS:000302167200079
J	Stringer, B; Udofa, EA; Antalis, TM				Stringer, Brett; Udofa, Ekemini A.; Antalis, Toni M.			Regulation of the Human Plasminogen Activator Inhibitor Type 2 Gene COOPERATION OF AN UPSTREAM SILENCER AND TRANSACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; SERPIN SUPERFAMILY; JUN FAMILY; FOS-JUN; KAPPA-B; EXPRESSION; AP-1; INDUCTION	Transcriptional up-regulation of the plasminogen activator inhibitor type-2 (PAI-2) gene is a major response to cellular stress. The expression of PAI-2 is induced by a variety of cytokines and growth factors that act in a cell type-and differentiation stage-dependent manner. We previously reported that the human SERPINB2 gene promoter is controlled by three major transcription regulatory domains: an inducible proximal promoter, an upstream silencer (PAUSE-1), and a distal transactivator region between -5100 and -3300, which appears to overcome inhibition mediated by the silencer. The distal transactivator region is inducible by the phorbol ester PMA, a potent activator of the protein kinase C (PKC) pathway that is a powerful inducer of PAI-2 gene expression in monocytes, macrophages, and myelomonocytic cells as well as in epidermal keratinocytes. Here we show that a 21-bp region (-4952/-4932), containing an AP-1 element, is both necessary and sufficient for PMA-induced transactivator activity in PAI-2-expressing U937 cells. This site specifically binds FosB in PAI-2expressing U937 cells but not in HeLa cells that do not express PAI-2, and overexpression of FosB, c-Fos, or c-Jun in HeLa cells is sufficient to cause derepression of transcription from the SERPINB2 promoter. Although FosB is likely to be involved in transactivator-mediated derepression of PAI-2 transcription in macrophage-like cells, as exemplified by the U937 cell line, c-Jun may be functional in other cell types. These data suggest a model for the transcriptional control of the human PAI-2 gene and further our understanding of the molecular basis for its tissue-specific expression.	[Udofa, Ekemini A.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Udofa, Ekemini A.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Queensland, Brisbane, Qld 4029, Australia; Queensland Inst Med Res, Brisbane, Qld 4029, Australia	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Queensland; QIMR Berghofer Medical Research Institute	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu	Stringer, Brett/GZB-1390-2022	Riley, Ekemini/0000-0001-7040-5191; Stringer, Brett/0000-0003-4552-9736	National Institutes of Health [R01CA098369]; National Health and Medical Research Council, Australia; NATIONAL CANCER INSTITUTE [R01CA098369, P30CA134274, R56CA098369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA098369. This work was also supported by the National Health and Medical Research Council, Australia.	Andela VB, 2000, CANCER RES, V60, P6557; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ANTALIS TM, 1991, NUCLEIC ACIDS RES, V19, P4301, DOI 10.1093/nar/19.15.4301; Antalis TM, 1996, BLOOD, V88, P3686, DOI 10.1182/blood.V88.10.3686.bloodjournal88103686; ANTALIS TM, 1993, GENE, V134, P201, DOI 10.1016/0378-1119(93)90094-J; Beikler T, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-30; Chambers SK, 1997, INT J CANCER, V74, P571, DOI 10.1002/(SICI)1097-0215(19971219)74:6<571::AID-IJC2>3.3.CO;2-Z; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; COUSIN E, 1991, NUCLEIC ACIDS RES, V19, P3881, DOI 10.1093/nar/19.14.3881; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; DICKINSON JA, 1995, CELL IMMUNOL, V165, P92, DOI 10.1006/cimm.1995.1191; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; GAN HX, 1995, J IMMUNOL, V155, P1304; Ganesh S, 1997, BRIT J CANCER, V75, P1793, DOI 10.1038/bjc.1997.306; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KAWANO T, 1968, NATURE, V217, P253, DOI 10.1038/217253a0; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; KRUITHOF EKO, 1988, BIOCHEM BIOPH RES CO, V156, P383, DOI 10.1016/S0006-291X(88)80852-0; KUMAR S, 1991, J BIOL CHEM, V266, P20960; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; LYONSGIORDANO B, 1994, HISTOCHEMISTRY, V101, P105, DOI 10.1007/BF00269356; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Musashi M, 2000, INT J HEMATOL, V72, P12; Nordengren J, 2002, INT J CANCER, V97, P379, DOI 10.1002/ijc.1611; Ogbourne SM, 2001, NUCLEIC ACIDS RES, V29, P3919, DOI 10.1093/nar/29.19.3919; Ohkuchi A, 2001, AM J REPROD IMMUNOL, V46, P252, DOI 10.1034/j.1600-0897.2001.d01-10.x; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; PULVERER BJ, 1993, ONCOGENE, V8, P407; Rajaram N, 1997, EMBO J, V16, P2917, DOI 10.1093/emboj/16.10.2917; Ramirez-Carrozzi VR, 2001, J MOL BIOL, V305, P411, DOI 10.1006/jmbi.2000.4286; Risse BC, 1998, HISTOCHEM CELL BIOL, V110, P559, DOI 10.1007/s004180050318; Roes EM, 2002, AM J OBSTET GYNECOL, V187, P1019, DOI 10.1067/mob.2002.126280; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x; Shafren DR, 1999, J VIROL, V73, P7193, DOI 10.1128/JVI.73.9.7193-7198.1999; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smith R, 2007, WORLD J SURG, V31, P493, DOI 10.1007/s00268-006-0289-9; Welter JF, 1995, ONCOGENE, V11, P2681; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Zhou HM, 2001, CANCER RES, V61, P970	51	9	10	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10579	10589		10.1074/jbc.M111.318758	http://dx.doi.org/10.1074/jbc.M111.318758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334683	Green Published, hybrid			2022-12-27	WOS:000302167200083
J	Hosing, AS; Valerie, NCK; Dziegielewski, J; Brautigan, DL; Larner, JM				Hosing, Amol S.; Valerie, Nicholas C. K.; Dziegielewski, Jaroslaw; Brautigan, David L.; Larner, James M.			PP6 Regulatory Subunit R1 Is Bidentate Anchor for Targeting Protein Phosphatase-6 to DNA-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; HUMAN CANCER-CELLS; CATALYTIC SUBUNIT; IONIZING-RADIATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; AUTOPHOSPHORYLATION; REPAIR; DOMAIN; PK	DNA-dependent protein kinase (DNA-PK) becomes activated in response toDNAdouble strand breaks, initiating repair by the non-homologous end joining pathway. DNA.PK complexes with the regulatory subunit SAPSR1 (R1) of protein phosphatase-6 (PP6). Knockdown of either R1 or PP6c prevents DNA-PK activation in response to ionizing radiation-induced DNA damage and radiosensitizes glioblastoma cells. Here, we demonstrate that R1 is necessary for and bridges the interaction between DNA-PK and PP6c. Using R1 deletion mutants, DNA-PK binding was mapped to two distinct regions of R1 spanning residues 1-326 and 522-700. Either region expressed alone was sufficient to bind DNA-PK, but only deletion of residues 1-326, not 522-700, eliminated interaction of R1 with DNA-PK. We assign 1-326 as the dominant domain and 522700 as the supporting region. These results demonstrate that R1 acts as a bidentate anchor to DNA-PK and recruits PP6c. Targeting the dominant interface with small molecule or peptidomimetic inhibitors could specifically prevent activation of DNA-PK and thereby sensitize cells to ionizing radiation and other genotoxic agents.	[Hosing, Amol S.; Valerie, Nicholas C. K.; Dziegielewski, Jaroslaw; Larner, James M.] Univ Virginia Hlth Syst, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Larner, JM (corresponding author), Univ Virginia Hlth Syst, Dept Radiat Oncol, POB 800383, Charlottesville, VA 22908 USA.	jml2p@virginia.edu		Valerie, Nicholas/0000-0002-9423-964X	National Institutes of Health [5R01CA142823-02]; NATIONAL CANCER INSTITUTE [R01CA142823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grant 5R01CA142823-02 (to J. M. L.).	ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Anbarasan S, 2010, APPL ENVIRON MICROB, V76, P356, DOI 10.1128/AEM.00357-09; ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bastians H, 1996, J CELL SCI, V109, P2865; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Collis SJ, 2003, CANCER RES, V63, P1550; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; Guergnon J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-24; Ismail IH, 2004, ONCOGENE, V23, P873, DOI 10.1038/sj.onc.1207303; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; MANN DJ, 1993, EMBO J, V12, P4833, DOI 10.1002/j.1460-2075.1993.tb06173.x; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Morales-Johansson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006331; Peng YL, 2002, CANCER RES, V62, P6400; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shinohara ET, 2005, CANCER RES, V65, P4987, DOI 10.1158/0008-5472.CAN-04-4250; Soubeyrand S, 2003, CANCER RES, V63, P1198; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Veuger SJ, 2003, CANCER RES, V63, P6008; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106	41	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9230	9239		10.1074/jbc.M111.333708	http://dx.doi.org/10.1074/jbc.M111.333708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298787	hybrid, Green Published			2022-12-27	WOS:000301797800051
J	Paulus, A; Rossius, SGH; Dijk, M; de Vries, S				Paulus, Angela; Rossius, Sebastiaan Gijsbertus Hendrik; Dijk, Madelon; de Vries, Simon			Oxoferryl-Porphyrin Radical Catalytic Intermediate in Cytochrome bd Oxidases Protects Cells from Formation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; D TERMINAL OXIDASE; ESCHERICHIA-COLI; QUINOL OXIDASE; SUBUNIT-I; UBIQUINOL OXIDASE; PEROXIDASE COMPOUND; BINUCLEAR CENTER; HEME-HEME; WILD-TYPE	The quinol-linked cytochrome bd oxidases are terminal oxidases in respiration. These oxidases harbor a low spin heme b(558) that donates electrons to a binuclear heme b(595)/heme d center. The reaction with O-2 and subsequent catalytic steps of the Escherichia coli cytochrome bd-I oxidase were investigated by means of ultra-fast freeze-quench trapping followed by EPR and UV-visible spectroscopy. After the initial binding of O-2, the O-O bond is heterolytically cleaved to yield a kinetically competent heme d oxoferryl porphyrin pi-cation radical intermediate (compound I) magnetically interacting with heme b(595). Compound I accumulates to 0.75-0.85 per enzyme in agreement with its much higher rate of formation (similar to 20,000 s(-1)) compared with its rate of decay (similar to 1,900 s(-1)). Compound I is next converted to a short lived heme d oxoferryl intermediate (compound II) in a phase kinetically matched to the oxidation of heme b(558) before completion of the reaction. The results indicate that cytochrome bd oxidases like the heme-copper oxidases break the O-O bond in a single four-electron transfer without a peroxide intermediate. However, in cytochrome bd oxidases, the fourth electron is donated by the porphyrin moiety rather than by a nearby amino acid. The production of reactive oxygen species by the cytochrome bd oxidase was below the detection level of 1 per 1000 turnovers. We propose that the two classes of terminal oxidases have mechanistically converged to enzymes in which the O-O bond is broken in a single four-electron transfer reaction to safeguard the cell from the formation of reactive oxygen species.	[Paulus, Angela; Rossius, Sebastiaan Gijsbertus Hendrik; Dijk, Madelon; de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Sect Enzymol, NL-2628 BC Delft, Netherlands	Delft University of Technology	de Vries, S (corresponding author), Delft Univ Technol, Dept Biotechnol, Sect Enzymol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	s.devries@tudelft.nl			ECHO from the Netherlands Organization for Scientific Research [700.54.003]	ECHO from the Netherlands Organization for Scientific Research	This work was supported by ECHO Grant 700.54.003 from the Netherlands Organization for Scientific Research (to S. d. V.).	Arutyunyan AM, 2008, BIOCHEMISTRY-US, V47, P1752, DOI 10.1021/bi701884g; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Belevich I, 2007, J BIOL CHEM, V282, P28514, DOI 10.1074/jbc.M705562200; Borisov VB, 2002, BIOCHEMISTRY-US, V41, P1654, DOI 10.1021/bi0158019; Borisov VB, 2008, BIOCHEMISTRY-US, V47, P7907, DOI 10.1021/bi800435a; Borisov VB, 2006, FEBS LETT, V580, P4823, DOI 10.1016/j.febslet.2006.07.072; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P503, DOI 10.1016/j.bbabio.2011.02.007; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fujii H, 1996, INORG CHEM, V35, P2373, DOI 10.1021/ic9513752; GOTOH T, 1974, ARCH BIOCHEM BIOPHYS, V163, P476, DOI 10.1016/0003-9861(74)90504-9; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; HATATANAKA A, 1987, BIOCHIM BIOPHYS ACTA, V893, P289, DOI 10.1016/0005-2728(87)90050-8; HEWSON WD, 1979, J BIOL CHEM, V254, P3182; Hildebrand DP, 1998, J INORG BIOCHEM, V70, P11, DOI 10.1016/S0162-0134(98)00007-5; HILL BC, 1994, BIOCHEMISTRY-US, V33, P15110, DOI 10.1021/bi00254a021; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; INGLEDEW WJ, 1992, BIOCHEM J, V282, P255, DOI 10.1042/bj2820255; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; KAHLOW MA, 1991, BIOCHEMISTRY-US, V30, P11485, DOI 10.1021/bi00113a001; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; KAYSSER TM, 1995, BIOCHEMISTRY-US, V34, P13491, DOI 10.1021/bi00041a029; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; MANDON D, 1992, INORG CHEM, V31, P4404, DOI 10.1021/ic00047a031; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; MEINHARDT SW, 1989, BIOCHIM BIOPHYS ACTA, V975, P175, DOI 10.1016/S0005-2728(89)80216-6; Mogi T, 2006, BIOCHEMISTRY-US, V45, P15785, DOI 10.1021/bi0615792; Mogi T, 2009, J BIOCHEM, V145, P763, DOI 10.1093/jb/mvp033; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; OOSTERHUIS WT, 1973, J CHEM PHYS, V58, P4757, DOI 10.1063/1.1679055; Osborne JP, 1999, BBA-BIOENERGETICS, V1410, P32, DOI 10.1016/S0005-2728(98)00171-6; POOLE RK, 1982, FEBS LETT, V150, P147, DOI 10.1016/0014-5793(82)81323-9; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Rappaport F, 2010, BBA-BIOENERGETICS, V1797, P1657, DOI 10.1016/j.bbabio.2010.05.010; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schroder Imke, 2008, P1; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; SPENCER ME, 1974, J BACTERIOL, V117, P954, DOI 10.1128/JB.117.3.954-959.1974; Sun J, 1996, BIOCHEMISTRY-US, V35, P2403, DOI 10.1021/bi9518252; SUN J, 1995, BIOCHEMISTRY-US, V34, P12144, DOI 10.1021/bi00038a007; TSUBAKI M, 1981, P NATL ACAD SCI-BIOL, V78, P3581, DOI 10.1073/pnas.78.6.3581; TSUBAKI M, 1993, FEBS LETT, V335, P13, DOI 10.1016/0014-5793(93)80430-3; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200; YANG FD, 1986, J BIOL CHEM, V261, P4987; Yang K, 2008, FEBS LETT, V582, P3705, DOI 10.1016/j.febslet.2008.09.038; Yang K, 2007, BIOCHEMISTRY-US, V46, P3270, DOI 10.1021/bi061946+; Zhang J, 2001, BIOCHEMISTRY-US, V40, P8548, DOI 10.1021/bi010469m; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	61	30	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8830	8838		10.1074/jbc.M111.333542	http://dx.doi.org/10.1074/jbc.M111.333542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22287551	Green Published, hybrid			2022-12-27	WOS:000301797800015
J	Bae, S; Kang, T; Hong, J; Lee, S; Choi, J; Jhun, H; Kwak, A; Hong, K; Kim, E; Jo, S; Kim, S				Bae, Suyoung; Kang, Taebong; Hong, Jaewoo; Lee, Siyoung; Choi, Jida; Jhun, Hyunjhung; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun			Contradictory Functions (Activation/Termination) of Neutrophil Proteinase 3 Enzyme (PR3) in Interleukin-33 Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; CYTOKINE PRODUCTION; HUMAN BASOPHILS; IL-33; ST2; CELLS; GENE; EXPRESSION; MATURATION; INDUCTION	IL-1 family ligand does not possess a typical hydrophobic signal peptide and needs a processing enzyme for maturation. The maturation process of IL-33 (IL-1F11), a new member of the IL-1 family ligand, remains unclear. Precursor IL-33 ligand affinity column isolates neutrophil proteinase 3 (PR3) from human urinary proteins. PR3 is a known IL-1 family ligand-processing enzyme for IL-1 beta (IL-1F2) and IL-18 (IL-1F4), including other inflammatory cytokines. We investigated PR3 in the maturation process of precursor IL-33 because we isolated urinary PR3 by using the precursor IL-33 ligand affinity column. PR3 converted inactive human and mouse precursor IL-33 proteins to biological active forms; however, the increase of PR3 incubation time abrogated IL-33 activities. Unlike caspase-1-cleaved precursor IL-18, PR3 cut precursor IL-33 and IL-18 at various sites and yielded multibands. The increased incubation period of PR3 abated mature IL-33 in a time-dependent manner. The result is consistent with the decreased bioactivity of IL-33 along with the increased PR3 incubation time. Six different human and mouse recombinant IL-33 proteins were expressed by the predicted consensus amino acid sequence of PR3 cleavage sites and tested for bioactivities. The human IL-33/p1 was highly active, but human IL-33/p2 and p3 proteins were inactive. Our results suggest the dual functions (activation/termination) of PR3 in IL-33 biological activity.	[Bae, Suyoung; Hong, Jaewoo; Lee, Siyoung; Choi, Jida; Jhun, Hyunjhung; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 143701, South Korea; [Kang, Taebong] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju 380701, South Korea	Konkuk University; Konkuk University	Kim, S (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 143701, South Korea.	soohyun@konkuk.ac.kr		kang, tae-bong/0000-0003-1441-9470; Hong, Jaewoo/0000-0003-3456-3672	National Research Foundation; Korean Government [WCU R33-2008-000-10022-0, KRF-2008-313-C00644]; Ministry of Health & Welfare, Republic of Korea [A100460]	National Research Foundation; Korean Government(Korean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation funded by Korean Government Grants WCU R33-2008-000-10022-0 and KRF-2008-313-C00644 and Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A100460.	Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bae S, 2010, HYBRIDOMA, V29, P17, DOI 10.1089/hyb.2009.0054; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Csernok E, 1996, CLIN EXP IMMUNOL, V105, P104, DOI 10.1046/j.1365-2249.1996.d01-715.x; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; ROBACHEGALLEA S, 1995, J BIOL CHEM, V270, P23688, DOI 10.1074/jbc.270.40.23688; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Suzukawa Maho, 2008, Lab Invest, V88, P1245, DOI 10.1038/labinvest.2008.82; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003	48	48	50	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8205	8213		10.1074/jbc.M111.295055	http://dx.doi.org/10.1074/jbc.M111.295055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270365	Green Published, hybrid			2022-12-27	WOS:000301349400036
J	Monne, M; Miniero, DV; Daddabbo, L; Robinson, AJ; Kunji, ERS; Palmieri, F				Monne, Magnus; Miniero, Daniela Valeria; Daddabbo, Lucia; Robinson, Alan J.; Kunji, Edmund R. S.; Palmieri, Ferdinando			Substrate Specificity of the Two Mitochondrial Ornithine Carriers Can Be Swapped by Single Mutation in Substrate Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME; RECONSTITUTED CARNITINE CARRIER; SACCHAROMYCES-CEREVISIAE; OXOGLUTARATE CARRIER; BACTERIAL EXPRESSION; TRANSPORT PROTEIN; AMINO-ACIDS; FUNCTIONAL-CHARACTERIZATION; BOVINE MITOCHONDRIA	Mitochondrial carriers are a large family of proteins that transport specific metabolites across the inner mitochondrial membrane. Sequence and structure analysis has indicated that these transporters have substrate binding sites in a similar location of the central cavity consisting of three major contact points. Here we have characterized mutations of the proposed substrate binding site in the human ornithine carriers ORC1 and ORC2 by carrying out transport assays with a set of different substrates. The different substrate specificities of the two isoforms, which share 87% identical amino acids, were essentially swapped by exchanging a single residue located at position 179 that is arginine in ORC1 and glutamine in ORC2. Altogether the substrate specificity changes demonstrate that Arg-179 and Glu-180 of contact point II bind the C-alpha carboxylate and amino group of the substrates, respectively. Residue Glu-77 of contact point I most likely interacts with the terminal amino group of the substrate side chain. Furthermore, it is likely that all three contact points are involved in the substrate-induced conformational changes required for substrate translocation because Arg-179 is probably connected with Arg-275 of contact point III through Trp-224 by cation-pi interactions. Mutations at position 179 also affected the turnover number of the ornithine carrier severely, implying that substrate binding to residue 179 is a rate-limiting step of the catalytic transport cycle. Given that Arg-179 is located in the vicinity of the matrix gate, it is concluded that it is a key residue in the opening of the carrier to the matrix side.	[Monne, Magnus; Miniero, Daniela Valeria; Daddabbo, Lucia; Palmieri, Ferdinando] Univ Bari, Lab Biochem & Mol Biol, Dept Pharmacobiol, I-70125 Bari, Italy; [Monne, Magnus] Univ Basilicata, Dept Chem, I-85100 Potenza, Italy; [Robinson, Alan J.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 2XY, England; [Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; University of Basilicata; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	Kunji, Edmund/AAH-2362-2020; Miniero, Daniela Valeria/P-9786-2019; Monné, Magnus/D-5642-2012	Kunji, Edmund/0000-0002-0610-4500; Miniero, Daniela Valeria/0000-0002-3324-9692; Monné, Magnus/0000-0003-2344-3878	Ministero dell'Universita e della Ricerca (MIUR); Center of Excellence in Genomics; Italian Human ProteomeNet [RBRN07BMCT_009 (MIUR)]; Medical Research Council; European Community under European Drug Initiative on Channels and Transporters (EDICT) Consortium [HEALTH-F4-2007-201924]; Medical Research Council [MC_U105674181, MC_U105663139] Funding Source: researchfish; MRC [MC_U105674181, MC_U105663139] Funding Source: UKRI	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics; Italian Human ProteomeNet; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community under European Drug Initiative on Channels and Transporters (EDICT) Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MIUR), the Center of Excellence in Genomics, the Italian Human ProteomeNet Grant RBRN07BMCT_009 (MIUR), and the Medical Research Council (to A. J. R. and E. R. S. K.). The collaboration was funded by the European Community Seventh Framework Programme FP7/2007-2013 under Grant HEALTH-F4-2007-201924, European Drug Initiative on Channels and Transporters (EDICT) Consortium.	Al-Hassnan ZN, 2008, J NEUROL SCI, V264, P187, DOI 10.1016/j.jns.2007.08.003; Aluvila S, 2010, J BIOL CHEM, V285, P27314, DOI 10.1074/jbc.M110.137364; BISACCIA F, 1985, BIOCHIM BIOPHYS ACTA, V810, P362, DOI 10.1016/0005-2728(85)90222-1; Briggs C, 1999, BIOCHEMISTRY-US, V38, P5096, DOI 10.1021/bi982945n; Camacho JA, 1999, NAT GENET, V22, P151, DOI 10.1038/9658; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Echtay KS, 2001, BIOCHEMISTRY-US, V40, P5243, DOI 10.1021/bi002130q; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fiermonte G, 2008, NEW ENGL J MED, V358, P1408, DOI 10.1056/NEJMc0707353; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Giangregorio N, 2010, BBA-BIOENERGETICS, V1797, P839, DOI 10.1016/j.bbabio.2010.03.017; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Huizing M, 1997, AM J HUM GENET, V61, P1239, DOI 10.1086/301628; Indiveri C, 1997, BIOCHEM J, V327, P349, DOI 10.1042/bj3270349; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1065, P231, DOI 10.1016/0005-2736(91)90235-Z; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; INDIVERI C, 1994, BBA-BIOMEMBRANES, V1189, P65, DOI 10.1016/0005-2736(94)90281-X; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Klingenberg M, 1976, ENZYMES BIOLOGICAL M, V3, P383; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Lawrence SA, 2011, J BIOL CHEM, V286, P31480, DOI 10.1074/jbc.M111.272187; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Marobbio CMT, 2002, EMBO J, V21, P5653, DOI 10.1093/emboj/cdf583; Miniero DV, 2011, BBA-BIOENERGETICS, V1807, P302, DOI 10.1016/j.bbabio.2010.12.005; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2012, ENCY BIOL C IN PRESS; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/BSE0470037, 10.1042/bse0470037]; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Palmieri L, 1999, FEBS LETT, V462, P472, DOI 10.1016/S0014-5793(99)01555-0; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Palmieri L, 2006, BBA-BIOENERGETICS, V1757, P1277, DOI 10.1016/j.bbabio.2006.03.025; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; Salvi S, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1221; Stipani V, 2001, BIOCHEMISTRY-US, V40, P15805, DOI 10.1021/bi011616j; Tessa A, 2009, HUM MUTAT, V30, P741, DOI 10.1002/humu.20930; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trotter PJ, 2005, ARCH BIOCHEM BIOPHYS, V442, P21, DOI 10.1016/j.abb.2005.07.016; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200	54	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7925	7934		10.1074/jbc.M111.324855	http://dx.doi.org/10.1074/jbc.M111.324855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262851	Green Published, hybrid			2022-12-27	WOS:000301349400009
J	Post, DMB; Yu, LP; Krasity, BC; Choudhury, B; Mandel, MJ; Brennan, CA; Ruby, EG; McFall-Ngai, MJ; Gibson, BW; Apicella, MA				Post, Deborah M. B.; Yu, Liping; Krasity, Benjamin C.; Choudhury, Biswa; Mandel, Mark J.; Brennan, Caitlin A.; Ruby, Edward G.; McFall-Ngai, Margaret J.; Gibson, Bradford W.; Apicella, Michael A.			O-antigen and Core Carbohydrate of Vibrio fischeri Lipopolysaccharide COMPOSITION AND ANALYSIS OF THEIR ROLE IN EUPRYMNA SCOLOPES LIGHT ORGAN COLONIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-ANALYSIS; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; MASS-SPECTROMETRY; FLAGELLIN; ACID; LIPOOLIGOSACCHARIDES; POLYSACCHARIDE; GLYCOSYLATION; RESOLUTION	Vibrio fischeri exists in a symbiotic relationship with the Hawaiian bobtail squid, Euprymna scolopes, where the squid provides a home for the bacteria, and the bacteria in turn provide camouflage that helps protect the squid from night-time predators. Like other Gram-negative organisms, V. fischeri expresses lipopolysaccharide (LPS) on its cell surface. The structure of the O-antigen and the core components of the LPS and their possible role in colonization of the squid have not previously been determined. In these studies, an O-antigen ligase mutant, waaL, was utilized to determine the structures of these LPS components and their roles in colonization of the squid. WaaL ligates the O-antigen to the core of the LPS; thus, LPS from waaL mutants lacks O-antigen. Our results show that the V. fischeri waaL mutant has a motility defect, is significantly delayed in colonization, and is unable to compete with the wildtype strain in co-colonization assays. Comparative analyses of the LPS from the wild-type and waaL strains showed that the V. fischeri LPS has a single O-antigen repeat composed of yersiniose, 8-epi-legionaminic acid, and N-acetylfucosamine. In addition, the LPS from the waaL strain showed that the core structure consists of L-glycero-D-manno-heptose, D-glycero-D-manno-heptose, glucose, 3-deoxy-D-manno-octulosonic acid, N-acetylgalactosamine, 8-epi-legionaminic acid, phosphate, and phosphoethanolamine. These studies indicate that the unusual V. fischeri O-antigen sugars play a role in the early phases of bacterial colonization of the squid.	[Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Yu, Liping] Univ Iowa, Carver Coll Med NMR Facil, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Krasity, Benjamin C.; Brennan, Caitlin A.; Ruby, Edward G.; McFall-Ngai, Margaret J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Choudhury, Biswa] Univ Calif San Diego, La Jolla, CA 92093 USA; [Mandel, Mark J.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Gibson, Bradford W.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of Iowa; Buck Institute for Research on Aging; University of Iowa; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; Northwestern University; University of California System; University of California San Francisco	Apicella, MA (corresponding author), Univ Iowa, Dept Microbiol, 51 Newton Rd, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu		Brennan, Caitlin/0000-0002-6074-9502; Mandel, Mark/0000-0001-6506-6711; Yu, Liping/0000-0003-3536-6427	National Institutes of Health [PO1 AI44642, RO1 AI24616, R01 AI50661, R01 RR 12294, IOS 0817232]; University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR012294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, P01AI044642, R01AI050661, T32AI007414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 AI44642 and RO1 AI24616 (to B. W. G. and M. A. A.), R01 AI50661 (to M. M.-N.), and R01 RR 12294 and IOS 0817232 (to E. G. R. and M. M.-N.). This work was also supported by University of Wisconsin Medical Scientist Training Program (to the M. M.-N. laboratory).	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Abeyrathne PD, 2007, MOL MICROBIOL, V65, P1345, DOI 10.1111/j.1365-2958.2007.05875.x; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Apicella Michael A., 2008, V431, P3; Banoub JH, 2010, MASS SPECTROM REV, V29, P606, DOI 10.1002/mas.20258; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; BOETTCHER KJ, 1994, CURR MICROBIOL, V29, P279, DOI 10.1007/BF01577441; Bowden MG, 1998, MOL MICROBIOL, V30, P275, DOI 10.1046/j.1365-2958.1998.01060.x; BRADE H, 1985, J BACTERIOL, V161, P795, DOI 10.1128/JB.161.2.795-798.1985; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; CHARY KVR, 1993, J MAGN RESON SER B, V102, P81, DOI 10.1006/jmrb.1993.1065; Chattejee SN, 2003, BBA-MOL BASIS DIS, V1639, P65, DOI 10.1016/j.bbadis.2003.08.004; Cox AD, 1997, CARBOHYD RES, V304, P191, DOI 10.1016/S0008-6215(97)00207-3; Cox AD, 1996, CARBOHYD RES, V290, P43, DOI 10.1016/0008-6215(96)00135-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUNLAP PV, 1989, J BACTERIOL, V171, P1199, DOI 10.1128/jb.171.2.1199-1202.1989; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Foster JS, 2000, DEV BIOL, V226, P242, DOI 10.1006/dbio.2000.9868; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Goon S, 2003, MOL MICROBIOL, V50, P659, DOI 10.1046/j.1365-2958.2003.03725.x; HAN TJ, 1992, J BACTERIOL, V174, P3140, DOI 10.1128/jb.174.10.3140-3146.1992; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hashii N, 2003, CARBOHYD RES, V338, P2711, DOI 10.1016/j.carres.2003.06.003; Hashii N, 2003, CARBOHYD RES, V338, P1063, DOI 10.1016/S0008-6215(03)00078-8; Holst O, 2003, ADV EXP MED BIOL, V529, P219; IGUCHI T, 1995, FEMS MICROBIOL LETT, V130, P287, DOI 10.1016/0378-1097(95)00220-Y; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King JD, 2009, INNATE IMMUN-LONDON, V15, P261, DOI 10.1177/1753425909106436; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Le Quere AJL, 2006, J BIOL CHEM, V281, P28981, DOI 10.1074/jbc.M513639200; Lee P. N., 2009, COLD SPRING HARBOR P; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lyell NL, 2008, APPL ENVIRON MICROB, V74, P7059, DOI 10.1128/AEM.01330-08; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mattos KA, 2005, GLYCOBIOLOGY, V15, P313, DOI 10.1093/glycob/cwi009; MCFALLNGAI MJ, 1991, SCIENCE, V254, P1491, DOI 10.1126/science.1962208; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; MELAUGH W, 1994, BIOCHEMISTRY-US, V33, P13070, DOI 10.1021/bi00248a016; Millikan DS, 2004, J BACTERIOL, V186, P4315, DOI 10.1128/JB.186.13.4315-4325.2004; MONTGOMERY MK, 1993, BIOL BULL, V184, P296, DOI 10.2307/1542448; Morgenstein RM, 2010, J BACTERIOL, V192, P3213, DOI 10.1128/JB.00196-10; Nyberg NT, 2005, J AM CHEM SOC, V127, P6154, DOI 10.1021/ja050878w; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Olsson U, 2005, CARBOHYD RES, V340, P167, DOI 10.1016/j.carres.2004.11.008; Petersen BO, 2006, CARBOHYD RES, V341, P550, DOI 10.1016/j.carres.2005.11.020; Phillips NJ, 2011, J BIOL CHEM, V286, P21203, DOI 10.1074/jbc.M111.239475; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; PHILLIPS NJ, 1993, BIOCHEMISTRY-US, V32, P2003, DOI 10.1021/bi00059a017; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Pupo E, 2004, ELECTROPHORESIS, V25, P2156, DOI 10.1002/elps.200405980; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RUBY EG, 1993, ARCH MICROBIOL, V159, P160, DOI 10.1007/BF00250277; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Sato H, 2005, CARBOHYD RES, V340, P469, DOI 10.1016/j.carres.2004.12.011; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; SONESSON A, 1994, MICROBIOL-SGM, V140, P1261, DOI 10.1099/00221287-140-6-1261; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Studer SV, 2008, J BACTERIOL, V190, P5915, DOI 10.1128/JB.00148-08; Tabei SMB, 2009, J BACTERIOL, V191, P2851, DOI 10.1128/JB.01406-08; Tambalo DD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-219; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Tsvetkov YE, 2001, CARBOHYD RES, V335, P221, DOI 10.1016/S0008-6215(01)00235-X; Vinogradov E, 2009, CARBOHYD RES, V344, P484, DOI 10.1016/j.carres.2008.12.017; Wollenberg MS, 2012, ISME J, V6, P352, DOI 10.1038/ismej.2011.92; Wuthrich K, 1986, NMR PROTEINS NUCL AC; ZUBKOV VA, 1992, CARBOHYD RES, V225, P189, DOI 10.1016/S0008-6215(00)90496-8	73	47	47	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8515	8530		10.1074/jbc.M111.324012	http://dx.doi.org/10.1074/jbc.M111.324012			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247546	Green Published, hybrid			2022-12-27	WOS:000301349400065
J	Shi, S; Deng, YZ; Zhao, JS; Ji, XD; Shi, J; Feng, YX; Li, G; Li, JJ; Zhu, D; Koeffler, HP; Zhao, Y; Xie, D				Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Shi, Jun; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Zhu, Di; Koeffler, H. Phillip; Zhao, Yun; Xie, Dong			RACK1 Promotes Non-small-cell Lung Cancer Tumorigenicity through Activating Sonic Hedgehog Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DEVELOPMENTAL PATHWAYS; PATCHED-GLI; CARCINOMA; WNT; PHOSPHORYLATION; EXPRESSION; DROSOPHILA; TRANSDUCTION; REQUIREMENT	Non-small-cell lung cancer (NSCLC) is a deadly disease due to lack of effective diagnosis biomarker and therapeutic target. Much effort has been made in defining gene defects in NSCLC, but its full molecular pathogenesis remains unexplored. Here, we found RACK1 (receptor of activated kinase 1) was elevated in most NSCLC, and its expression level correlated with key pathological characteristics including tumor differentiation, stage, and metastasis. In addition, RACK1 activated sonic hedgehog signaling pathway by interacting with and activating Smoothened to mediate Gli1-dependent transcription in NSCLC cells. And silencing RACK1 dramatically inhibited in vivo tumor growth and metastasis by blocking the sonic hedgehog signaling pathway. These results suggest that RACK1 represents a new promising diagnosis biomarker and therapeutic target for NSCLC.	[Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Shi, Shuo; Deng, Yue-Zhen; Zhao, Jiang-Sha; Ji, Xiao-Dan; Feng, Yu-Xiong; Li, Guo; Li, Jing-Jing; Xie, Dong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Shi, Jun] Second Peoples Hosp Zhuhai, Zhuhai 519000, Guangdong, Peoples R China; [Zhu, Di] Dana Farber Canc Inst, Boston, MA 02115 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 119077, Singapore; [Zhao, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Harvard University; Dana-Farber Cancer Institute; National University of Singapore; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xie, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Mol Oncol Lab, 294 Tai Yuan Rd, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn		Xie, Dong/0000-0002-1150-8657; Xie, Dong/0000-0003-2804-8578	National Basic Research Program of China [2010CB912102]; Ministry of Science and Technology [2012ZX10002009-017]; National Natural Science Foundation of China [30930023, 90813023, Y239X31111, 81021002, 31100551, 81070325]; National Natural Science Funds for Distinguished Young Scholar [30725010]; Nature Science Foundation of China-Guangdong [U0932001]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Nature Science Foundation of China-Guangdong	This work was supported by National Basic Research Program of China Grant 2010CB912102, Ministry of Science and Technology Key Program 2012ZX10002009-017, National Natural Science Foundation of China 30930023, 90813023, Y239X31111, 81021002, 31100551, 81021002, and 81070325, National Natural Science Funds for Distinguished Young Scholar Grant 30725010, and Nature Science Foundation of China-Guangdong Joint Fund U0932001.	Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Battaini F, 1997, TRENDS NEUROSCI, V20, P410, DOI 10.1016/S0166-2236(97)01084-9; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Calura E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-630; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Daniel VC, 2006, RESPIROLOGY, V11, P234, DOI 10.1111/j.1440-1843.2006.00838.x; Fujita E, 1997, BIOCHEM BIOPH RES CO, V238, P658, DOI 10.1006/bbrc.1997.7262; Gialmanidis IP, 2009, LUNG CANCER, V66, P64, DOI 10.1016/j.lungcan.2009.01.007; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; He B, 2005, CLIN LUNG CANCER, V7, P54, DOI 10.3816/CLC.2005.n.022; Hu LJ, 2006, J MOL NEUROSCI, V29, P55, DOI 10.1385/JMN:29:1:55; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Kadrmas JL, 2007, DEV DYNAM, V236, P2207, DOI 10.1002/dvdy.21217; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li CL, 2002, INT IMMUNOPHARMACOL, V2, P823, DOI 10.1016/S1567-5769(02)00023-1; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nagashio R, 2010, LUNG CANCER, V69, P54, DOI 10.1016/j.lungcan.2009.09.015; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015; Paul S, 2008, NEOPLASMA, V55, P165; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Subauste MC, 2009, CANCER BIOL THER, V8, P2297; Toftgard R, 2000, CELL MOL LIFE SCI, V57, P1720, DOI 10.1007/PL00000654; Van Scoyk M, 2008, TRANSL RES, V151, P175, DOI 10.1016/j.trsl.2007.12.011; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Velcheti V, 2007, J THORAC ONCOL, V2, P7, DOI 10.1097/JTO.0b013e31802c0276; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Walterhouse DO, 1999, ENVIRON HEALTH PERSP, V107, P167, DOI 10.2307/3434504; Wang Z, 2008, MOL CELL PROTEOMICS, V7, P1639, DOI 10.1074/mcp.M700520-MCP200; Warburton D, 1999, AM J PHYSIOL-LUNG C, V276, pL697, DOI 10.1152/ajplung.1999.276.5.L697; Warburton David, 1999, Current Opinion in Pediatrics, V11, P188, DOI 10.1097/00008480-199906000-00002; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yagui-Beltran Adam, 2006, Thorac Surg Clin, V16, P379, DOI 10.1016/j.thorsurg.2006.07.001; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhao Y, 2007, FLY, V1, P333, DOI 10.4161/fly.5570; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	54	73	78	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7845	7858		10.1074/jbc.M111.315416	http://dx.doi.org/10.1074/jbc.M111.315416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262830	Green Published, hybrid			2022-12-27	WOS:000301349400002
J	Withers, S; Lu, FC; Kim, H; Zhu, YM; Ralph, J; Wilkerson, CG				Withers, Saunia; Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John; Wilkerson, Curtis G.			Identification of Grass-specific Enzyme That Acylates Monolignols with p-Coumarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALLS; LIGNIN BIOSYNTHESIS; SINAPYL ACETATE; MAIZE LIGNIN; NMR; PLANTS; KENAF; UNITS; ACID; RICE	Lignin is a major component of plant cell walls that is essential to their function. However, the strong bonds that bind the various subunits of lignin, and its cross-linking with other plant cell wall polymers, make it one of the most important factors in the recalcitrance of plant cell walls against polysaccharide utilization. Plants make lignin from a variety of monolignols including p-coumaryl, coniferyl, and sinapyl alcohols to produce the three primary lignin units: p-hydroxyphenyl, guaiacyl, and syringyl, respectively, when incorporated into the lignin polymer. In grasses, these monolignols can be enzymatically preacylated by p-coumarates prior to their incorporation into lignin, and these monolignol conjugates can also be "monomer" precursors of lignin. Although monolignol p-coumarate-derived units may comprise up to 40% of the lignin in some grass tissues, the p-coumarate moiety from such conjugates does not enter into the radical coupling (polymerization) reactions of lignification. With a greater understanding of monolignol p-coumarate conjugates, grass lignins could be engineered to contain fewer pendent p-coumarate groups and more monolignol conjugates that improve lignin cleavage. We have cloned and expressed an enzyme from rice that has p-coumarate monolignol transferase activity and determined its kinetic parameters.	[Wilkerson, Curtis G.] Michigan State Univ, Dept Biochem & Mol Biol, Dept Plant Biol, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Lu, Fachuang; Kim, Hoon; Ralph, John] Univ Wisconsin, Wisconsin Bioenergy Initiat, Madison, WI 53706 USA	Michigan State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wilkerson, CG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Dept Plant Biol, Great Lakes Bioenergy Res Ctr, S124 Plant Biol,178 Wilson Rd, E Lansing, MI 48824 USA.	wilker13@msu.edu	Ralph, John/C-3161-2009; Kim, Hoon/E-8245-2013; Lu, Fachuang/K-6487-2019	Ralph, John/0000-0002-6093-4521; Kim, Hoon/0000-0001-7425-7464; 	Department of Energy Great Lakes Bioenergy Research Center Office of Science [DE-FC02-07ER64494]	Department of Energy Great Lakes Bioenergy Research Center Office of Science(United States Department of Energy (DOE))	This work was supported by the Department of Energy Great Lakes Bioenergy Research Center Office of Science Grant DE-FC02-07ER64494.	Beuerle T, 2002, ANAL BIOCHEM, V302, P305, DOI 10.1006/abio.2001.5574; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; del Rio JC, 2008, J AGR FOOD CHEM, V56, P9525, DOI 10.1021/jf800806h; Del Rio JC, 2007, J AGR FOOD CHEM, V55, P5461, DOI 10.1021/jf0705264; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Grabber JH, 1996, PHYTOCHEMISTRY, V43, P1189, DOI 10.1016/S0031-9422(96)00431-1; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Harkin J.M., 1967, OXIDATIVE COUPLING P, P243; HARRIS PJ, 1980, BIOCHEM SYST ECOL, V8, P153, DOI 10.1016/0305-1978(80)90008-3; HARTLEY RD, 1972, J SCI FOOD AGR, V23, P1347, DOI 10.1002/jsfa.2740231110; Hatfield RD, 1999, J SCI FOOD AGR, V79, P891, DOI 10.1002/(SICI)1097-0010(19990501)79:6&lt;891::AID-JSFA304&gt;3.0.CO;2-#; Hatfield R, 2008, PLANTA, V228, P919, DOI 10.1007/s00425-008-0791-4; Hatfield RD, 2009, PLANTA, V229, P1253, DOI 10.1007/s00425-009-0900-z; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; LANDUCCI LL, 1992, HOLZFORSCHUNG, V46, P505, DOI 10.1515/hfsg.1992.46.6.505; Li SM, 2001, NORD PULP PAP RES J, V16, P63, DOI 10.3183/npprj-2001-16-01-p063-067; Lu F. C., 2005, 13 INT S WOOD FIB PU, P233; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x; Lu FC, 2002, CHEM COMMUN, P90, DOI 10.1039/b109876d; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Lu FC, 1998, J AGR FOOD CHEM, V46, P2911, DOI 10.1021/jf980440y; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; Meyermans H, 2000, J BIOL CHEM, V275, P36899, DOI 10.1074/jbc.M006915200; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Nakano J., 1961, TAPPI, V44, P30; Norman A., 1969, SCIENCE, V165, P784; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; R.D.C. Team, 2010, R LANGUAGE ENV STAT; Ralph J, 1998, J AGR FOOD CHEM, V46, P4616, DOI 10.1021/jf980680d; Ralph J, 1996, J NAT PROD, V59, P341, DOI 10.1021/np960143s; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Ralph J., 2006, SCI LORE PLANT CELL, P285; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph John, 2004, Phytochemistry Reviews, V3, P79, DOI 10.1023/B:PHYT.0000047811.13837.fb; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Santoro N, 2006, ANAL BIOCHEM, V354, P70, DOI 10.1016/j.ab.2006.04.006; Sato Y., 2010, NUCLEIC ACIDS RES, pD1141; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHIMADA M, 1971, TAPPI, V54, P72; SMITH DCC, 1955, J CHEM SOC, P2347, DOI 10.1039/jr9550002347; STOECKIGT J, 1975, Zeitschrift fuer Naturforschung Teil C Biochemie Biophysik Biologie Virologie, V30, P352; Sun RC, 1999, J WOOD CHEM TECHNOL, V19, P335, DOI 10.1080/02773819909349616; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Wagner A, 2011, PLANT J, V67, P119, DOI 10.1111/j.1365-313X.2011.04580.x	48	119	131	7	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8347	8355		10.1074/jbc.M111.284497	http://dx.doi.org/10.1074/jbc.M111.284497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267741	Green Published, hybrid			2022-12-27	WOS:000301349400049
J	Peng, X; Maiers, JL; Choudhury, D; Craig, SW; Demali, KA				Peng, Xiao; Maiers, Jessica L.; Choudhury, Dilshad; Craig, Susan W.; Demali, Kris A.			alpha-Catenin Uses a Novel Mechanism to Activate Vinculin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING MEMBRANE PROTRUSION; ADHERENS JUNCTION; EPITHELIAL-CELLS; STRUCTURAL BASIS; ACTIN-FILAMENTS; BETA-CATENIN; CADHERIN; ADHESION; TALIN; COMPLEX	Vinculin, an actin-binding protein, is emerging as an important regulator of adherens junctions. In focal-adhesions, vinculin is activated by simultaneous binding of talin to its head domain and actin filaments to its tail domain. Talin is not present in adherens junctions. Consequently, the identity of the ligand that activates vinculin in cell-cell junctions is not known. Here we show that in the presence of F-actin, alpha-catenin, a cytoplasmic component of the cadherin adhesion complex, activates vinculin. Direct binding of alpha-catenin to vinculin is critical for this event because a point mutant (alpha-catenin L344P) lacking high affinity binding does not activate vinculin. Furthermore, unlike all known vinculin activators, alpha-catenin binds to and activates vinculin independently of an A50I substitution in the vinculin head, a mutation that inhibits vinculin binding to talin and IpaA. Collectively, these data suggest that alpha-catenin employs a novel mechanism to activate vinculin and may explain how vinculin is differentially recruited and/or activated in cell-cell and cell-matrix adhesions.	Univ Iowa, Roy J Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Choudhury, Dilshad; Craig, Susan W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Iowa; Johns Hopkins University	Demali, KA (corresponding author), Carver Coll Med, Dept Biochem, 51 Newton Rd, Iowa City, IA 52242 USA.	kris-demali@uiowa.edu	Peng, Xiao/B-1748-2013; Maiers, Jessica/AAL-8037-2021	DeMali, Kris/0000-0003-0906-1371	National Institutes of Health [1K01CA111818, R01GM041605]; American Cancer Society [115274]; American Heart Association [0910127G]; NATIONAL CANCER INSTITUTE [K01CA111818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1K01CA111818 and American Cancer Society Research Scholar Grant 115274 (to K. A. D.), National Institutes of Health Grant R01GM041605 (to S. W. C.), and American Heart Association Predoctoral Fellowship 0910127G (to X. P.).	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hazan RB, 1997, J BIOL CHEM, V272, P32448, DOI 10.1074/jbc.272.51.32448; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Izard T, 2004, J BIOL CHEM, V279, P27667, DOI 10.1074/jbc.M403076200; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Peng X, 2010, J CELL SCI, V123, P567, DOI 10.1242/jcs.056432; Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Van Nhieu GT, 2007, EMBO J, V26, P4588; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Weiss EE, 1998, J CELL BIOL, V141, P755, DOI 10.1083/jcb.141.3.755; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07	35	49	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7728	7737		10.1074/jbc.M111.297481	http://dx.doi.org/10.1074/jbc.M111.297481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235119	Green Published, hybrid			2022-12-27	WOS:000301060200071
J	Lamb, FS; Hook, JS; Hilkin, BM; Huber, JN; Volk, APD; Moreland, JG				Lamb, Fred S.; Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.			Endotoxin Priming of Neutrophils Requires Endocytosis and NADPH Oxidase-dependent Endosomal Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CELL-FREE SYSTEM; COLONY-STIMULATING FACTOR; BACTERIAL LIPOPOLYSACCHARIDE; RESPIRATORY BURST; PLASMA-MEMBRANE; P38 MAPK; ACTIVATION; PHOSPHORYLATION; TRANSLOCATION	NADPH oxidase 2 (Nox2)-generated reactive oxygen species (ROS) are critical for neutrophil (polymorphonuclear leukocyte (PMN)) microbicidal function. Nox2 also plays a role in intracellular signaling, but the site of oxidase assembly is unknown. It has been proposed to occur on secondary granules. We previously demonstrated that intracellular NADPH oxidase-derived ROS production is required for endotoxin priming. We hypothesized that endotoxin drives Nox2 assembly on endosomes. Endotoxin induced ROS generation within an endosomal compartment as quantified by flow cytometry (dihydrorhodamine 123 and Oxyburst Green). Inhibition of endocytosis by the dynamin-II inhibitor Dynasore blocked endocytosis of dextran, intracellular generation of ROS, and priming of PMN by endotoxin. Confocal microscopy demonstrated a ROS-containing endosomal compartment that co-labeled with gp91(phox), p40(phox), p67(phox), and Rab5, but not with the secondary granule marker CD66b. To further characterize this compartment, PMNs were fractionated by nitrogen cavitation and differential centrifugation, followed by free flow electrophoresis. Specific subfractions made superoxide in the presence of NADPH by cell-free assay (cytochrome c). Subfraction content of membrane and cytosolic subunits of Nox2 correlated with ROS production. Following priming, there was a shift in the light membrane subfractions where ROS production was highest. CD66b was not mobilized from the secondary granule compartment. These data demonstrate a novel, nonphagosomal intracellular site for Nox2 assembly. This compartment is endocytic in origin and is required for PMN priming by endotoxin.	[Lamb, Fred S.; Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.] Univ Iowa, Dept Pediat, Div Crit Care, Iowa City, IA 52242 USA; [Hook, Jessica S.; Hilkin, Brieanna M.; Huber, Jody N.; Volk, A. Paige Davis; Moreland, Jessica G.] Univ Iowa, Inflammat Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Moreland, JG (corresponding author), Univ Iowa, Dept Pediat, Div Crit Care, 200 Hawkins Dr, Iowa City, IA 52242 USA.	jessica-moreland@uiowa.edu		Lamb, Fred/0000-0003-2955-5133	National Institutes of Health [RO1AI073872, AI079445, RO1 HL62483, 2P01A104462011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079445, R01AI073872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI073872 (to J. G. M.), AI079445 (to A. P. D. V.), RO1 HL62483 (to F. S. L.), and 2P01A104462011 (to J. G. M.).	Ambruso DR, 2004, MOL GENET METAB, V81, P313, DOI 10.1016/j.ymgme.2004.01.009; Anderson KE, 2010, BLOOD, V116, P4978, DOI 10.1182/blood-2010-03-275602; BASS DA, 1986, J IMMUNOL, V136, P860; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; CHOLLETMARTIN S, 1992, AM REV RESPIR DIS, V146, P990, DOI 10.1164/ajrccm/146.4.990; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Eckels PC, 2009, AM J PHYSIOL-CELL PH, V297, pC886, DOI 10.1152/ajpcell.00416.2008; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Huang YW, 2009, J BIOL CHEM, V284, P29644, DOI 10.1074/jbc.M109.045682; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Inaba M, 2008, CLIN EXP RHEUMATOL, V26, P52; Karlsson A, 2002, ANTIOXID REDOX SIGN, V4, P49, DOI 10.1089/152308602753625852; Kitchens RL, 1998, J IMMUNOL, V161, P5534; Kobayashi T, 1998, J CELL SCI, V111, P81; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Mansfield PJ, 2002, J LAB CLIN MED, V140, P9, DOI 10.1067/mlc.2002.124551; Matsuda JJ, 2010, J BIOL CHEM, V285, P22862, DOI 10.1074/jbc.M109.099838; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McLaughlin NJD, 2008, J IMMUNOL, V180, P8192, DOI 10.4049/jimmunol.180.12.8192; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; MCPHAIL LC, 1985, J CLIN INVEST, V75, P1735, DOI 10.1172/JCI111884; Miller FJ, 2010, ANTIOXID REDOX SIGN, V12, P583, DOI 10.1089/ars.2009.2857; Moreland JG, 2007, J BIOL CHEM, V282, P33958, DOI 10.1074/jbc.M705289200; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Ogura H, 1999, J TRAUMA, V46, P774, DOI 10.1097/00005373-199905000-00004; PICK E, 1987, J BIOL CHEM, V262, P16476; Saltoh SI, 2009, IMMUNOBIOLOGY, V214, P594, DOI 10.1016/j.imbio.2008.11.012; Sela S, 2005, J AM SOC NEPHROL, V16, P2431, DOI 10.1681/ASN.2004110929; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; SUEMATSU M, 1987, J CLIN LAB IMMUNOL, V24, P125; Swain SD, 2002, ANTIOXID REDOX SIGN, V4, P69, DOI 10.1089/152308602753625870; Tamassia N, 2007, J IMMUNOL, V178, P7344, DOI 10.4049/jimmunol.178.11.7344; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; Volk APD, 2011, J INNATE IMMUN, V3, P298, DOI 10.1159/000321439; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105	47	36	37	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12395	12404		10.1074/jbc.M111.306530	http://dx.doi.org/10.1074/jbc.M111.306530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22235113	hybrid, Green Published			2022-12-27	WOS:000302782200079
J	Wang, HT; Hu, Y; Tong, D; Huang, J; Gu, LY; Wu, XR; Chung, FL; Li, GM; Tang, MS				Wang, Hsiang-Tsui; Hu, Yu; Tong, Dan; Huang, Jian; Gu, Liya; Wu, Xue-Ru; Chung, Fung-Lung; Li, Guo-Min; Tang, Moon-Shong			Effect of Carcinogenic Acrolein on DNA Repair and Mutagenic Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; LUNG-CANCER; DEOXYGUANOSINE ADDUCT; LIPID-PEROXIDATION; OXIDATIVE STRESS; POLYMERASE-ETA; CHINESE-WOMEN; APOPTOSIS; MITOCHONDRIA; MECHANISM	Acrolein (Acr), a ubiquitous environmental contaminant, is a human carcinogen. Acr can react with DNA to form mutagenic alpha- and gamma-hydroxy-1, N-2-cyclic propano-2'-deoxyguanosine adducts (alpha-OH-Acr-dG and gamma-OH-Acr-dG). We demonstrate here that Acr-dG adducts can be efficiently repaired by the nucleotide excision repair (NER) pathway in normal human bronchial epithelia (NHBE) and lung fibroblasts (NHLF). However, the same adducts were poorly processed in cell lysates isolated from Acr-treated NHBE and NHLF, suggesting that Acr inhibits NER. In addition, we show that Acr treatment also inhibits base excision repair and mismatch repair. Although Acr does not change the expression of XPA, XPC, hOGG1, PMS2 or MLH1genes, it causes a reduction of XPA, XPC, hOGG1, PMS2, and MLH1 proteins; this effect, however, can be neutralized by the proteasome inhibitor MG132. Acr treatment further enhances both bulky and oxidative DNA damage-induced mutagenesis. These results indicate that Acr not only damages DNA but can also modify DNA repair proteins and further causes degradation of these modified repair proteins. We propose that these two detrimental effects contribute to Acr mutagenicity and carcinogenicity.	[Wang, Hsiang-Tsui; Hu, Yu; Tang, Moon-Shong] NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol & Pathol, New York, NY 10987 USA; [Tong, Dan; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Tong, Dan; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Chung, Fung-Lung] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA	New York University; New York University; University of Kentucky; Wuhan University; Georgetown University	Tang, MS (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA.	moon-shong.tang@nyumc.org	Li, Guo-Min/I-5016-2014	Wu, Xue-Ru/0000-0001-6058-6291; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [CA114541, ES014641, CA99007, CA134892, GM089684, ES00260]; Kentucky Lung Cancer Research Grant; Chinese 111 project [B06018]; NATIONAL CANCER INSTITUTE [R01CA114541, R01CA134892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES014641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Grant; Chinese 111 project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA114541, ES014641, CA99007, CA134892, GM089684, and ES00260. This work was also supported by a Kentucky Lung Cancer Research Grant (to G.-M. L.) and Chinese 111 project B06018.	Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; CHUNG FL, 1984, CANCER RES, V44, P990; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; COHEN SM, 1992, CANCER RES, V52, P3577; Comes R, 2002, 43 WHO; CURREN RD, 1988, MUTAT RES, V209, P17, DOI 10.1016/0165-7992(88)90104-2; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; Hoffman D.H.S., 1990, HDB EXPT PHARM, P70; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kawanishi M, 1998, MUTAT RES-GEN TOX EN, V417, P65, DOI 10.1016/S1383-5718(98)00093-X; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kern JC, 2002, CHEM-BIOL INTERACT, V139, P79, DOI 10.1016/S0009-2797(01)00295-2; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; KOO LC, 1990, INT J EPIDEMIOL, V19, pS14, DOI 10.1093/ije/19.Supplement_1.S14; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Mehta M, 2008, MUTAT RES-GEN TOX EN, V657, P116, DOI 10.1016/j.mrgentox.2008.08.015; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Roy J, 2010, CAN J PHYSIOL PHARM, V88, P353, DOI 10.1139/Y09-134; Roy J, 2009, CHEM-BIOL INTERACT, V181, P154, DOI 10.1016/j.cbi.2009.07.001; Sanchez AM, 2003, CHEM RES TOXICOL, V16, P1019, DOI 10.1021/tx034066u; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Seow A, 2000, CANCER EPIDEM BIOMAR, V9, P1215; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; Tanel A, 2005, BBA-MOL CELL RES, V1743, P255, DOI 10.1016/j.bbamcr.2004.11.007; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; VanderVeen LA, 2001, J BIOL CHEM, V276, P9066, DOI 10.1074/jbc.M008900200; Wang HT, 2009, CHEM RES TOXICOL, V22, P511, DOI 10.1021/tx800369y; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yang IY, 2002, BIOCHEMISTRY-US, V41, P13826, DOI 10.1021/bi0264723; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; Zhang SY, 2007, CHEM RES TOXICOL, V20, P565, DOI 10.1021/tx700023z; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	41	63	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12379	12386		10.1074/jbc.M111.329623	http://dx.doi.org/10.1074/jbc.M111.329623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22275365	hybrid, Green Published			2022-12-27	WOS:000302782200077
J	Barneda-Zahonero, B; Servitja, JM; Badiola, N; Minano-Molina, AJ; Fado, R; Saura, CA; Rodriguez-Alvarez, J				Barneda-Zahonero, Bruna; Servitja, Joan-Marc; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose			Nurr1 Protein Is Required for N-Methyl-D-aspartic Acid (NMDA) Receptor-mediated Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; NR2B SUBUNIT; BDNF GENE; IN-VIVO; RAT; DEATH; ACTIVATION	NMDA receptor(NMDAR) stimulation promotes neuronal survival during brain development. Cerebellar granule cells (CGCs) need NMDAR stimulation to survive and develop. These neurons differentiate and mature during its migration from the external granular layer to the internal granular layer, and lack of excitatory inputs triggers their apoptotic death. It is possible to mimic this process in vitro by culturing CGCs in low KCl concentrations (5 mM) in the presence or absence of NMDA. Using this experimental approach, we have obtained whole genome expression profiles after 3 and 8 h of NMDA addition to identify genes involved in NMDA-mediated survival of CGCs. One of the identified genes was Nurr1, a member of the orphan nuclear receptor subfamily Nr4a. Our results report a direct regulation of Nurr1 by CREB after NMDAR stimulation. ChIP assay confirmed CREB binding to Nurr1 promoter, whereas CREB shRNA blocked NMDA-mediated increase in Nurr1 expression. Moreover, we show that Nurr1 is important for NMDAR survival effect. We show that Nurr1 binds to Bdnf promoter IV and that silencing Nurr1 by shRNA leads to a decrease in brain-derived neurotrophic factor (BDNF) protein levels and a reduction of NMDA neuroprotective effect. Also, we report that Nurr1 and BDNF show a similar expression pattern during postnatal cerebellar development. Thus, we conclude that Nurr1 is a downstream target of CREB and that it is responsible for the NMDA-mediated increase in BDNF, which is necessary for the NMDA-mediated prosurvival effect on neurons.	[Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Barneda-Zahonero, Bruna; Badiola, Nahuai; Minano-Molina, Alfredo J.; Fado, Rut; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08193, Spain; [Servitja, Joan-Marc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Servitja, Joan-Marc] CIBER Diabet & Enfermedades Metab CIBERDEM, Barcelona 08036, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Rodriguez-Alvarez, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencias, Edificio M,Campus Bellaterra, E-08193 Barcelona, Spain.	jose.rodriguez@uab.es	Badiola, Nahuai/C-6526-2011; Andrés, Fadó Fadó/L-8585-2014; Saura, Carlos A/D-2727-2011; Miñano-Molina, Alfredo J/C-9863-2011; Saura, Carlos A/AFM-9239-2022; Rodriguez-Alvarez, Jose/F-8403-2011	Badiola, Nahuai/0000-0001-9488-5628; Andrés, Fadó Fadó/0000-0002-3293-2342; Saura, Carlos A/0000-0003-3692-5657; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Barneda Zahonero, Bruna/0000-0002-6557-5222; SERVITJA, JOAN-MARC/0000-0002-1241-8004	Ministerio de Ciencia e Innovacion [SAF2008-01904, SAF2011-30281, SAF2010-20925]; CIBERNED [CB06/05/0042]; Universitat Autonoma de Barcelona; Gobierno Vasco; Generalitat de Catalunya	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Universitat Autonoma de Barcelona; Gobierno Vasco(Basque Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (Grants SAF2008-01904, SAF2011-30281, and RENEVAS) and CIBERNED (Grant CB06/05/0042) (to J. R. A) and the Ministerio de Ciencia e Innovacion (Grant SAF2010-20925) (to C. A. S.).; Recipient of a predoctoral fellowship from the Universitat Autonoma de Barcelona.; Recipient of a predoctoral fellowship from the Gobierno Vasco.; Recipient of a predoctoral fellowship from the Generalitat de Catalunya.	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Borghesani PR, 2002, DEVELOPMENT, V129, P1435; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGOYNE RD, 1988, BRAIN RES REV, V13, P77, DOI 10.1016/0165-0173(88)90006-9; Contestabile A., 2002, CEREBELLUM, V1, P41; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Enguita M, 2005, MOL PHARMACOL, V67, P1237, DOI 10.1124/mol.104.007062; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Fukuchi M, 2004, J NEUROSCI RES, V77, P26, DOI 10.1002/jnr.20132; GALLO V, 1987, J NEUROSCI, V7, P2203; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KUBO T, 1995, DEV BRAIN RES, V85, P249, DOI 10.1016/0165-3806(94)00220-T; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; Mancini JD, 2007, NEUROSCI LETT, V429, P87, DOI 10.1016/j.neulet.2007.09.079; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; McEvoy AN, 2002, J IMMUNOL, V168, P2979, DOI 10.4049/jimmunol.168.6.2979; Monti B, 2000, EUR J NEUROSCI, V12, P3117, DOI 10.1046/j.1460-9568.2000.00189.x; Monti B, 2002, EUR J NEUROSCI, V16, P1490, DOI 10.1046/j.1460-9568.2002.02232.x; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Okazawa M, 2009, J NEUROSCI, V29, P2938, DOI 10.1523/JNEUROSCI.5932-08.2009; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ryu H, 2003, J NEUROSCI, V23, P3597; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tarnok K, 2008, J NEUROCHEM, V104, P818, DOI 10.1111/j.1471-4159.2007.05051.x; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; TRANI E, 1995, J NEUROCHEM, V65, P2441; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xifro X, 2005, EUR J NEUROSCI, V21, P827, DOI 10.1111/j.1460-9568.2005.03935.x; Yang YX, 2008, NEUROREPORT, V19, P867, DOI 10.1097/WNR.0b013e3282ffda48; Zhang FX, 1998, J BIOL CHEM, V273, P26596, DOI 10.1074/jbc.273.41.26596; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	58	41	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11351	11362		10.1074/jbc.M111.272427	http://dx.doi.org/10.1074/jbc.M111.272427			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22294685	hybrid, Green Published			2022-12-27	WOS:000302780100065
J	Fidalgo, M; Guerrero, A; Fraile, M; Iglesias, C; Pombo, CM; Zalvide, J				Fidalgo, Miguel; Guerrero, Ana; Fraile, Maria; Iglesias, Cristina; Pombo, Celia M.; Zalvide, Juan			Adaptor Protein Cerebral Cavernous Malformation 3 (CCM3) Mediates Phosphorylation of the Cytoskeletal Proteins Ezrin/Radixin/Moesin by Mammalian Ste20-4 to Protect Cells from Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20-LIKE KINASE-3 MST3; OXIDANT STRESS; GCKIII PROTEINS; CHEMICAL ANOXIA; ERM PROTEINS; IN-VITRO; EZRIN; ACTIVATION; MUTATIONS; DEATH	While studying the functions of CCM3/PDCD10, a gene encoding an adaptor protein whose mutation results in vascular malformations, we have found that it is involved in a novel response to oxidative stress that results in phosphorylation and activation of the ezrin/radixin/moesin (ERM) family of proteins. This phosphorylation protects cells from accidental cell death induced by oxidative stress. We also present evidence that ERM phosphorylation is performed by the GCKIII kinase Mst4, which is activated and relocated to the cell periphery after oxidative stress. The cellular levels of Mst4 and its activation after oxidative stress depend on the presence of CCM3, as absence of the latter impairs the phosphorylation of ERM proteins and enhances death of cells exposed to reactive oxygen species. These findings shed new light on the response of cells to oxidative stress and identify an important pathophysiological situation in which ERM proteins and their phosphorylation play a significant role.	[Zalvide, Juan] Univ Santiago de Compostela, Dept Physiol, Lab Cell Signalling & Canc Res, Sch Med, Santiago De Compostela 15705, A Coruna, Spain; Univ Santiago de Compostela, Ctr Singular Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela 15705, A Coruna, Spain; Inst Invest Sanitarias IDIS, Santiago De Compostela 15705, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Zalvide, J (corresponding author), Univ Santiago de Compostela, Dept Physiol, Lab Cell Signalling & Canc Res, Sch Med, San Francisco S-N, Santiago De Compostela 15705, A Coruna, Spain.	juan.zalvide@usc.es	Pombo, Celia M/L-4479-2014; Zalvide, Juan/ABG-4050-2020; Fidalgo, Miguel/I-7006-2019; Guerrero, Ana/AAZ-2162-2021	Fidalgo, Miguel/0000-0003-1134-2674; Guerrero, Ana/0000-0002-4622-9201; Zalvide, Juan/0000-0001-7645-156X; Pombo, Celia M/0000-0003-2541-9468	Xunta de Galicia [INCITE 09 208 110 PR]; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS) [PI080655]; Ministerio de Ciencia e Innovacion [SAF2011-24940]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Xunta de Galicia grant INCITE 09 208 110 PR (to C. M. P.) and Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS) grant PI080655 and Ministerio de Ciencia e Innovacion grant SAF2011-24940 (to J. Z.).	Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bretscher A, 1997, J CELL SCI, V110, P3011; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Chen L, 2009, STROKE, V40, P1474, DOI 10.1161/STROKEAHA.108.527135; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hipfner DR, 2004, GENE DEV, V18, P2243, DOI 10.1101/gad.303304; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; KANNO T, 1994, FREE RADICAL RES, V21, P223, DOI 10.3109/10715769409056574; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; Pombo CM, 1997, J BIOL CHEM, V272, P29372, DOI 10.1074/jbc.272.46.29372; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schleider E, 2011, NEUROGENETICS, V12, P83, DOI 10.1007/s10048-010-0261-6; Tamma G, 2007, AM J PHYSIOL-CELL PH, V292, pC1476, DOI 10.1152/ajpcell.00375.2006; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08; Zhu Y, 2011, NEUROSURGERY, V69, P722, DOI 10.1227/NEU.0b013e318219569f	43	55	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11556	11565		10.1074/jbc.M111.320259	http://dx.doi.org/10.1074/jbc.M111.320259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291017	Green Published, hybrid			2022-12-27	WOS:000302780100083
J	Morcavallo, A; Genua, M; Palummo, A; Kletvikova, E; Jiracek, J; Brzozowski, AM; Iozzo, RV; Belfiore, A; Morrione, A				Morcavallo, Alaide; Genua, Marco; Palummo, Angela; Kletvikova, Emilia; Jiracek, Jiri; Brzozowski, Andrzej M.; Iozzo, Renato V.; Belfiore, Antonino; Morrione, Andrea			Insulin and Insulin-like Growth Factor II Differentially Regulate Endocytic Sorting and Stability of Insulin Receptor Isoform A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER-CANCER CELLS; HUMAN-BREAST-CANCER; DEPENDENT ENDOCYTOSIS; DOWN-REGULATION; HEPATOMA-CELLS; MESSENGER-RNA; BINDING; DEGRADATION; INTERNALIZATION; PROTEINS	The insulin receptor isoform A (IR-A) binds both insulin and insulin-like growth factor (IGF)-II, although the affinity for IGF-II is 3-10-fold lower than insulin depending on a cell and tissue context. Notably, in mouse embryonic fibroblasts lacking the IGF-IR and expressing solely the IR-A (R-/IR-A), IGF-II is a more potent mitogen than insulin. As receptor endocytosis and degradation provide spatial and temporal regulation of signaling events, we hypothesized that insulin and IGF-II could affect IR-A biological responses by differentially regulating IR-A trafficking. Using R-/IR-A cells, we discovered that insulin evoked significant IR-A internalization, a process modestly affected by IGF-II. However, the differential internalization was not due to IR-A ubiquitination. Notably, prolonged stimulation of R-/IR-A cells with insulin, but not with IGF-II, targeted the receptor to a degradative pathway. Similarly, the docking protein insulin receptor substrate 1 (IRS-1) was down-regulated after prolonged insulin but not IGF-II exposure. Similar results were also obtained in experiments using [NMeTyr(B26)]-insulin, an insulin analog with IR-A binding affinity similar to IGF-II. Finally, we discovered that IR-A was internalized through clathrin-dependent and -independent pathways, which differentially regulated the activation of downstream effectors. Collectively, our results suggest that a lower affinity of IGF-II for the IR-A promotes lower IR-A phosphorylation and activation of early downstream effectors vis a vis insulin but may protect IR-A and IRS-1 from down-regulation thereby evoking sustained and robust mitogenic stimuli.	[Morcavallo, Alaide; Genua, Marco; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Urol, Philadelphia, PA 19107 USA; [Morcavallo, Alaide; Genua, Marco; Morrione, Andrea] Thomas Jefferson Univ, Kimmel Canc Ctr, Endocrine Mech & Hormone Act Program, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Morcavallo, Alaide; Palummo, Angela; Belfiore, Antonino] Univ Catanzaro, Dept Hlth & Endocrinol, I-88100 Catanzaro, Italy; [Kletvikova, Emilia; Jiracek, Jiri] Acad Sci Czech Republic, Vvl, Inst Organ Chem & Biochem, Prague 616610, Czech Republic; [Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Jefferson University; Jefferson University; Jefferson University; Jefferson University; Magna Graecia University of Catanzaro; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Belfiore, A (corresponding author), Univ Magna Grecia, Dept Hlth, Endocrinol Unit, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy.	belfiore@unicz.it; andrea.morrione@jefferson.edu	Belfiore, Antonino/B-4652-2011; Iozzo, Renato/AAS-1980-2020; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Genua, Marco/J-4159-2018	Belfiore, Antonino/0000-0002-6181-4193; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Genua, Marco/0000-0002-0764-8163; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 DK068419]; Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10625]; Fondazione Cassa di Risparmio di Calabria e Lucania, Ministero dell' Istruzione, dell' Universita e della Ricerca [2008BKRFBH_005]; Academy of Sciences of the Czech Republic [Z40550506]; NATIONAL CANCER INSTITUTE [R01CA039481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Benjamin Perkins Bladder Cancer Fund; Martin Greitzer Fund; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Calabria e Lucania, Ministero dell' Istruzione, dell' Universita e della Ricerca; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK068419 (to A. M.), the Benjamin Perkins Bladder Cancer Fund and the Martin Greitzer Fund (to A. M.), and grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC Grant 10625), AIRC project Calabria 2011 and Fondazione Cassa di Risparmio di Calabria e Lucania, Programmi di Ricerca di Rilevante Interesse Nazionale-Ministero dell' Istruzione, dell' Universita e della Ricerca (PRIN-MIUR) Grant 2008BKRFBH_005 (to A. B.), and Research Project of the Academy of Sciences of the Czech Republic Grant Z40550506 (to J. J.).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2003, Breast Dis, V17, P73; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Giudice J, 2011, J CELL SCI, V124, P801, DOI 10.1242/jcs.076869; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 1996, BIOCHEM J, V315, P271; Hansen H, 1996, J BIOL CHEM, V271, P8882, DOI 10.1074/jbc.271.15.8882; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; HWANG DL, 1985, J RECEPTOR RES, V5, P27, DOI 10.3109/10799898509041869; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KRYWICKI RF, 1992, BREAST CANCER RES TR, V22, P7, DOI 10.1007/BF01833329; Laviola L, 1997, J CLIN INVEST, V99, P830, DOI 10.1172/JCI119246; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Lovat F, 2009, CARCINOGENESIS, V30, P861, DOI 10.1093/carcin/bgp050; MCCLAIN DA, 1988, DIABETES, V37, P806, DOI 10.2337/diabetes.37.6.806; Metalli D, 2010, AM J PATHOL, V176, P2997, DOI 10.2353/ajpath.2010.090904; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MIURA M, 1995, J BIOL CHEM, V270, P22639, DOI 10.1074/jbc.270.38.22639; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; Morrione A, 1997, J BIOL CHEM, V272, P26382, DOI 10.1074/jbc.272.42.26382; Morrione A, 1997, P NATL ACAD SCI USA, V94, P3777, DOI 10.1073/pnas.94.8.3777; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOUNTJOY KG, 1987, CANCER RES, V47, P6500; PACCAUD JP, 1992, J BIOL CHEM, V267, P13101; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; PAPA V, 1993, CANCER RES, V53, P3736; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; ROSE DW, 1994, P NATL ACAD SCI USA, V91, P797, DOI 10.1073/pnas.91.2.797; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Seto ES, 2002, GENE DEV, V16, P1314, DOI 10.1101/gad.989602; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Webster NJG, 1997, BIOCHEM MOL MED, V62, P139, DOI 10.1006/bmme.1997.2648; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; ZAPF A, 1994, ENDOCRINOLOGY, V134, P2445, DOI 10.1210/en.134.6.2445	67	60	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11422	11436		10.1074/jbc.M111.252478	http://dx.doi.org/10.1074/jbc.M111.252478			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318726	Green Published, hybrid			2022-12-27	WOS:000302780100071
J	Liu, QS; Kirubakaran, S; Hur, W; Niepel, M; Westover, K; Thoreen, CC; Wang, JH; Ni, J; Patricelli, MP; Vogel, K; Riddle, S; Waller, DL; Traynor, R; Sanda, T; Zhao, Z; Kang, SA; Zhao, J; Look, AT; Sorger, PK; Sabatini, DM; Gray, NS				Liu, Qingsong; Kirubakaran, Sivapriya; Hur, Wooyoung; Niepel, Mario; Westover, Kenneth; Thoreen, Carson C.; Wang, Jinhua; Ni, Jing; Patricelli, Matthew P.; Vogel, Kurt; Riddle, Steve; Waller, David L.; Traynor, Ryan; Sanda, Takaomi; Zhao, Zheng; Kang, Seong A.; Zhao, Jean; Look, A. Thomas; Sorger, Peter K.; Sabatini, David M.; Gray, Nathanael S.			Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISCOVERY; ACTIVATION; PROTEINS; COMPLEX; POTENT; MODEL; TOR	An intensive recent effort to develop ATP-competitive mTOR inhibitors has resulted in several potent and selective molecules such as Torin1, PP242, KU63794, and WYE354. These inhibitors are being widely used as pharmacological probes of mTOR-dependent biology. To determine the potency and specificity of these agents, we have undertaken a systematic kinome-wide effort to profile their selectivity and potency using chemical proteomics and assays for enzymatic activity, protein binding, and disruption of cellular signaling. Enzymatic and cellular assays revealed that all four compounds are potent inhibitors of mTORC1 and mTORC2, with Torin1 exhibiting similar to 20-fold greater potency for inhibition of Thr-389 phosphorylation on S6 kinases (EC50 = 2 nM) relative to other inhibitors. In vitro biochemical profiling at 10 mu M revealed binding of PP242 to numerous kinases, although WYE354 and KU63794 bound only to p38 kinases and PI3K isoforms and Torin1 to ataxia telangiectasia mutated, ATM and Rad3-related protein, and DNA-PK. Analysis of these protein targets in cellular assays did not reveal any off-target activities for Torin1, WYE354, and KU63794 at concentrations below 1 mu M but did show that PP242 efficiently inhibited the RET receptor (EC50, 42 nM) and JAK1/2/3 kinases (EC50, 780 nM). In addition, Torin1 displayed unusually slow kinetics for inhibition of the mTORC1/2 complex, a property likely to contribute to the pharmacology of this inhibitor. Our results demonstrated that, with the exception of PP242, available ATP-competitive compounds are highly selective mTOR inhibitors when applied to cells at concentrations below 1 mu M and that the compounds may represent a starting point for medicinal chemistry efforts aimed at developing inhibitors of other PI3K kinase-related kinases.	[Liu, Qingsong; Kirubakaran, Sivapriya; Hur, Wooyoung; Thoreen, Carson C.; Wang, Jinhua; Ni, Jing; Waller, David L.; Zhao, Jean; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, Boston, MA 02115 USA; [Niepel, Mario; Sorger, Peter K.] Harvard Univ, Sch Med, Ctr Cell Decis Proc, Boston, MA 02115 USA; [Niepel, Mario; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Westover, Kenneth] Harvard Radiat Oncol Program, Boston, MA 02115 USA; [Vogel, Kurt; Riddle, Steve] Invitrogen Corp, Madison, WI 53719 USA; [Patricelli, Matthew P.] ActivX Biosci Inc, La Jolla, CA 92037 USA; [Traynor, Ryan] Univ Dundee, Coll Life Sci, Dundee Div Signal Transduct Therapy, Natl Ctr Prot Kinase Profiling, Dundee DD1 5EH, Scotland; [Sanda, Takaomi; Look, A. Thomas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Zhao, Zheng] Chinese Acad Sci, High Magnet Field Lab, Hefei 230031, Anhui, Peoples R China; [Kang, Seong A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kang, Seong A.; Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Thermo Fisher Scientific; Kyorin Pharmaceutical Co Ltd; University of Dundee; Harvard University; Dana-Farber Cancer Institute; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Gray, NS (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol,Dana Farber Canc Inst, 250 Longwood Ave, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu	Kirubakaran, Sivapriya/ABH-9621-2020; Liu, Qingsong/AFS-0714-2022; Westover, Ken/AAZ-1795-2020; Niepel, Mario/G-5443-2011; 刘, 青松/AEM-1932-2022	Kirubakaran, Sivapriya/0000-0002-7200-7602; Liu, Qingsong/0000-0002-7829-2547; Westover, Ken/0000-0003-3653-5923; Niepel, Mario/0000-0003-1415-6295; 刘, 青松/0000-0002-7829-2547; /0000-0002-1446-7256; Sorger, Peter/0000-0002-3364-1838	National Institutes of Health [HG006097, RO1 AI47389, CA103866]; William Lawrence and Blanche Hughes Fund; Children's Leukemia Research Association; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Fund; Children's Leukemia Research Association; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant HG006097 (to Q. L., M.N., and P.K.S.).; Supported by National Institutes of Health Grants RO1 AI47389 and CA103866.; Supported by grants from the William Lawrence and Blanche Hughes Fund, the Children's Leukemia Research Association, and the Japan Society for the Promotion of Science.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bhagwat SV, 2011, MOL CANCER THER, V10, P1394, DOI 10.1158/1535-7163.MCT-10-1099; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hendriks BS, 2010, BIOINFORMATICS, V26, P432, DOI 10.1093/bioinformatics/btp667; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Millard BL, 2011, NAT METHODS, V8, P487, DOI [10.1038/NMETH.1600, 10.1038/nmeth.1600]; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	32	73	81	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9742	9752		10.1074/jbc.M111.304485	http://dx.doi.org/10.1074/jbc.M111.304485			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22223645	Green Published, hybrid			2022-12-27	WOS:000302167200008
J	Amunugama, R; He, YJ; Willcox, S; Forties, RA; Shim, KS; Bundschuh, R; Luo, Y; Griffith, J; Fishel, R				Amunugama, Ravindra; He, Yujiong; Willcox, Smaranda; Forties, Robert A.; Shim, Kang-Sup; Bundschuh, Ralf; Luo, Yu; Griffith, Jack; Fishel, Richard			RAD51 Protein ATP Cap Regulates Nucleoprotein Filament Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; RECA-PROTEIN; METHANOCOCCUS-VOLTAE; COMPLEX-FORMATION; HOMOLOGOUS RECOMBINATION; CRYSTAL-STRUCTURE; GENETIC-RECOMBINATION; POTASSIUM DEPENDENCE; DAMAGE RESPONSE; REPAIR PROTEINS	RAD51 mediates homologous recombination by forming an active DNA nucleoprotein filament (NPF). A conserved aspartate that forms a salt bridge with the ATP gamma-phosphate is found at the nucleotide-binding interface between RAD51 subunits of the NPF known as the ATP cap. The salt bridge accounts for the nonphysiological cation(s) required to fully activate the RAD51 NPF. In contrast, RecA homologs and most RAD51 paralogs contain a conserved lysine at the analogous structural position. We demonstrate that substitution of human RAD51(Asp-316) with lysine (HsRAD51(D316K)) decreases NPF turnover and facilitates considerably improved recombinase functions. Structural analysis shows that archaebacterial Methanococcus voltae RadA(D302K) (MvRAD51(D302K)) and HsRAD51(D316K) form extended active NPFs without salt. These studies suggest that the HsRAD51(Asp-316) salt bridge may function as a conformational sensor that enhances turnover at the expense of recombinase activity.	[Amunugama, Ravindra; Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA; [Amunugama, Ravindra; Shim, Kang-Sup; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Forties, Robert A.; Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [He, Yujiong; Luo, Yu] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Willcox, Smaranda; Griffith, Jack] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Saskatchewan; University of North Carolina; University of North Carolina Chapel Hill	Fishel, R (corresponding author), Ohio State Med Ctr, Wiseman Hall,Rm 385,400 W 12th Ave, Columbus, OH 43210 USA.	rfishel@osu.edu	Bundschuh, Ralf A/B-9623-2008	Bundschuh, Ralf A/0000-0002-6699-8614	National Sciences and Engineering Research Counsel; National Research Counsel; Canadian Institutes of Health Research [63860]; Province of Saskatchewan; Western Economic Diversification Canada; University or Saskatchewan; National Institutes of Health [GM31819, ES13773, GM080176]; National Science Foundation [DMR-0706002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM080176] Funding Source: NIH RePORTER	National Sciences and Engineering Research Counsel; National Research Counsel; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University or Saskatchewan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Poirier and Charles Bell for helpful discussions. Crystallographic work was performed at the Canadian Light Source, which is supported by National Sciences and Engineering Research Counsel, National Research Counsel, Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University or Saskatchewan.; This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and ES13773 (to J. G.) and GM080176 (to R. F.). This work was also supported by Canadian Institutes of Health Research Grant 63860 (to Y. L.) and National Science Foundation Grant DMR-0706002 (to R. B.).	Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; De Zutter SK, 1999, J MOL BIOL, V293, P769, DOI 10.1006/jmbi.1999.3200; DeLano W.L, PYMOL MOL GRAPHICS S; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li Y, 2009, ACTA CRYSTALLOGR D, V65, P602, DOI 10.1107/S0907444909011871; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu J, 2011, NATURE, V479, P245, DOI 10.1038/nature10522; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; Qian XG, 2006, J MOL BIOL, V360, P537, DOI 10.1016/j.jmb.2006.05.058; Qian XG, 2006, J BIOL CHEM, V281, P39380, DOI 10.1074/jbc.M607785200; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Shim KS, 2004, J BIOL CHEM, V279, P30385, DOI 10.1074/jbc.M306066200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	50	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8724	8736		10.1074/jbc.M111.239426	http://dx.doi.org/10.1074/jbc.M111.239426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275364	Green Published, hybrid			2022-12-27	WOS:000301797800006
J	Andersen, LM; Andreasen, PA; Svendsen, I; Keemink, J; Ostergaard, H; Persson, E				Andersen, Lisbeth M.; Andreasen, Peter A.; Svendsen, Ivan; Keemink, Janneke; Ostergaard, Henrik; Persson, Egon			Antibody-induced Enhancement of Factor VIIa Activity through Distinct Allosteric Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VIIA; TISSUE FACTOR; BLOOD-COAGULATION; CRYSTAL-STRUCTURE; ENZYMATIC-ACTIVITY; INTRINSIC ACTIVITY; EXTRINSIC PATHWAY; FACTOR-IX; FACTOR-X; ACTIVATION	In the absence of its cofactor tissue factor (TF), coagulation factor VIIa (FVIIa) predominantly exists in a zymogen-like, catalytically incompetent state. Here we demonstrate that conformation-specific monoclonal antibodies (mAbs) can be used to characterize structural features determining the activity of FVIIa. We isolated two classes of mAbs, which both increased the catalytic efficiency of FVIIa more than 150-fold. The effects of the antibodies were retained with a FVIIa variant, which has been shown to be inert to allosteric activation by the natural activator TF, suggesting that the antibodies and TF employ distinct mechanisms of activation. The antibodies could be classified into two groups based on their patterns of affinities for different conformations of FVIIa. Whereas one class of antibodies affected both the K-m and k(cat), the other class mainly affected the K-m. The antibody-induced activity enhancement could be traced to maturation of the S1 substrate binding pocket and the oxyanion hole, evident by an increased affinity for p-aminobenzamidine, an increased rate of antithrombin inhibition, an increased rate of incorporation of diisopropylfluorophosphate, and an enhanced fraction of molecules with a buried N terminus of the catalytic domain in the presence of antibodies. As demonstrated by site-directed mutagenesis, the two groups of antibodies appear to have overlapping, although clearly different, epitopes in the 170-loop. Our findings suggest that binding of ligands to specific residues in the 170-loop or its spatial vicinity may stabilize the S1 pocket and the oxyanion hole, and they may have general implications for the molecular understanding of FVIIa regulatory mechanisms.	[Persson, Egon] Novo Nordisk AS, Haemostasis Biol, DK-2760 Malov, Denmark; [Andersen, Lisbeth M.; Andreasen, Peter A.; Keemink, Janneke] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Novo Nordisk; Aarhus University	Persson, E (corresponding author), Novo Nordisk AS, Haemostasis Biol, Novo Nordisk Pk,G8-1-61, DK-2760 Malov, Denmark.	egpe@novonordisk.com		Persson, Egon/0000-0003-3005-4926				Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dickinson CD, 1997, J BIOL CHEM, V272, P19875, DOI 10.1074/jbc.272.32.19875; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kerschbaumer RJ, 2004, J BIOL CHEM, V279, P40445, DOI 10.1074/jbc.M405966200; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Larsen KS, 2007, BIOCHEM J, V405, P429, DOI 10.1042/BJ20061901; MARKWARDT F, 1968, EUR J BIOCHEM, V6, P502, DOI 10.1111/j.1432-1033.1968.tb00473.x; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; NICOLAISEN EM, 1992, FEBS LETT, V306, P157, DOI 10.1016/0014-5793(92)80989-T; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; PEDERSEN AH, 1990, J BIOL CHEM, V265, P16786; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, J BIOL CHEM, V276, P29195, DOI 10.1074/jbc.M102187200; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 1996, FEBS LETT, V385, P241, DOI 10.1016/0014-5793(96)00400-0; Persson E, 2010, THROMB RES, V125, pS11, DOI 10.1016/j.thromres.2010.01.023; Persson E, 2009, FEBS J, V276, P3099, DOI 10.1111/j.1742-4658.2009.07028.x; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Scheiflinger F, 2008, J THROMB HAEMOST, V6, P315, DOI 10.1111/j.1538-7836.2007.02868.x; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Yoshihara E, 1996, FEBS LETT, V394, P179, DOI 10.1016/0014-5793(96)00945-3	34	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8994	9001		10.1074/jbc.M111.312330	http://dx.doi.org/10.1074/jbc.M111.312330			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275370	hybrid, Green Published			2022-12-27	WOS:000301797800030
J	Hashimoto, K; Cho, YJ; Yang, IY; Akagi, J; Ohashi, E; Tateishi, S; de Wind, N; Hanaoka, F; Ohmori, H; Moriya, M				Hashimoto, Keiji; Cho, Youngjin; Yang, In-Young; Akagi, Jun-ichi; Ohashi, Eiji; Tateishi, Satoshi; de Wind, Niels; Hanaoka, Fumio; Ohmori, Haruo; Moriya, Masaaki			The Vital Role of Polymerase zeta and REV1 in Mutagenic, but Not Correct, DNA Synthesis across Benzo[a]pyrene-dG and Recruitment of Polymerase zeta by REV1 to Replication-stalled Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED MUTAGENESIS; TRANSLESION SYNTHESIS; Y-FAMILY; XERODERMA-PIGMENTOSUM; PROTEIN INTERACTS; DCMP TRANSFERASE; MAMMALIAN-CELLS; BRCT DOMAIN; C-TERMINUS; ERROR-FREE	The DNA synthesis across DNA lesions, termed translesion synthesis (TLS), is a complex process influenced by various factors. To investigate this process in mammalian cells, we examined TLS across a benzo[a] pyrene dihydrodiol epoxide-derived dG adduct (BPDE-dG) using a plasmid bearing a single BPDE-dG and genetically engineered mouse embryonic fibroblasts (MEFs). In wild-type MEFs, TLS was extremely miscoding (>90%) with G -> T transversions being predominant. Knockout of the Rev1 gene decreased both the TLS efficiency and the miscoding frequency. Knockout of the Rev3L gene, coding for the catalytic subunit of pol zeta, caused even greater decreases in these two TLS parameters; almost all residual TLS were error-free. Thus, REV1 and pol zeta are critical to mutagenic, but not accurate, TLS across BPDE-dG. The introduction of human REV1 cDNA into Rev1(-/-) MEFs restored the mutagenic TLS, but a REV1 mutant lacking the C terminus did not. Yeast and mammalian three-hybrid assays revealed that the REV7 subunit of pol zeta mediated the interaction between REV3 and the REV1 C terminus. These results support the hypothesis that REV1 recruits pol zeta through the interaction with REV7. Our results also predict the existence of a minor REV1-independent pol zeta recruitment pathway. Finally, although mutagenic TLS across BPDE-dG largely depends on RAD18, experiments using Polk(-/-) Polh(-/-) Poli(-/-) triple-gene knockout MEFs unexpectedly revealed that another polymerase(s) could insert a nucleotide opposite BPDE-dG. This indicates that a non-Y family polymerase(s) can insert a nucleotide opposite BPDE-dG, but the subsequent extension from miscoding termini depends on REV1-pol zeta in a RAD18-dependent manner.	[Ohashi, Eiji; Ohmori, Haruo] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Hashimoto, Keiji; Cho, Youngjin; Yang, In-Young; Moriya, Masaaki] SUNY Stony Brook, Biol Chem Lab, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Akagi, Jun-ichi; Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 1718588, Japan; [Tateishi, Satoshi] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [de Wind, Niels] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2300 RC Leiden, Netherlands	Kyoto University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Gakushuin University; Kumamoto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ohmori, H (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hohmori@virus.kyoto-u.ac.jp; maki@pharm.stonybrook.edu	Ohashi, Eiji/AAO-5794-2021	Ohashi, Eiji/0000-0002-1771-5585	National Institutes of Health [CA076163, ES018833]; NATIONAL CANCER INSTITUTE [R01CA076163, R56CA076163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018833] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22131008] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA076163 and ES018833 (to M. M.).	Akagi JI, 2009, DNA REPAIR, V8, P585, DOI 10.1016/j.dnarep.2008.12.006; Andersen PL, 2011, MOL BIOL CELL, V22, P2373, DOI 10.1091/mbc.E10-12-0938; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; de Groote FH, 2011, DNA REPAIR, V10, P915, DOI 10.1016/j.dnarep.2011.04.033; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Gibbs PEM, 2000, P NATL ACAD SCI USA, V97, P4186, DOI 10.1073/pnas.97.8.4186; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jansen JG, 2005, NUCLEIC ACIDS RES, V33, P356, DOI 10.1093/nar/gki189; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Moriya M, 1996, BIOCHEMISTRY-US, V35, P16646, DOI 10.1021/bi9608875; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Narita T, 2010, GENES CELLS, V15, P1228, DOI 10.1111/j.1365-2443.2010.01457.x; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Ohmori H, 2009, ADV PROTEIN CHEM STR, V78, P99, DOI 10.1016/S1876-1623(09)78004-0; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Takata K, 2009, EMBO J, V28, P313, DOI 10.1038/emboj.2008.303; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wiltrout ME, 2011, GENETICS, V187, P21, DOI 10.1534/genetics.110.124172; Yang IY, 2009, J BIOL CHEM, V284, P191, DOI 10.1074/jbc.M806414200; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1; Zhou Y, 2010, NUCLEIC ACIDS RES, V38, P5036, DOI 10.1093/nar/gkq225	48	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9613	9622		10.1074/jbc.M111.331728	http://dx.doi.org/10.1074/jbc.M111.331728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303021	Green Published, hybrid			2022-12-27	WOS:000301797800092
J	Lee, S; Jang, E; Kim, JH; Kim, JH; Lee, WH; Suk, K				Lee, Shinrye; Jang, Eunha; Kim, Jong-Heon; Kim, Jae-Hong; Lee, Won-Ha; Suk, Kyoungho			Lipocalin-type Prostaglandin D-2 Synthase Protein Regulates Glial Cell Migration and Morphology through Myristoylated Alanine-rich C-Kinase Substrate PROSTAGLANDIN D-2-INDEPENDENT EFFECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; BETA-TRACE PROTEIN; ALZHEIMERS-DISEASE; RHO-GTPASE; RAT-BRAIN; LYSOPHOSPHATIDIC ACID; ASTROCYTE MORPHOLOGY; MULTIPLE-SCLEROSIS; REACTIVE GLIOSIS; DOWN-REGULATION	Prostaglandin D synthase (PGDS) is responsible for the conversion of PGH(2) to PGD(2). Two distinct types of PGDS have been identified: hematopoietic-type PGDS (H-PGDS) and lipocalin-type PGDS (L-PGDS). L-PGDS acts as both a PGD(2)-synthesizing enzyme and as an extracellular transporter of various lipophilic small molecules. Although L-PGDS is one of the most abundant proteins in the cerebrospinal fluid, little is known about the function of L-PGDS in the central nervous system (CNS). To better understand the role of L-PGDS in the CNS, effects of L-PGDS on the migration and morphology of glial cells were investigated. The L-PGDS protein accelerated the migration of cultured glial cells. Expression of the L-pgds gene was detected in glial cells and neurons. L-PGDS protein also induced morphological changes in glia similar to the characteristic phenotypic changes in reactive gliosis. L-PGDS-induced cell migration was associated with augmented formation of actin filaments and focal adhesion, which was accompanied by activation of AKT, RhoA, and JNK pathways. L-PGDS protein injected into the mouse brain promoted migration and accumulation of astrocytes in vivo. Furthermore, the cell migration-promoting effect of L-PGDS on glial cells was independent of the PGD(2) products. The L-PGDS protein interacted with myristoylated alanine-rich protein kinase C substrate (MARCKS) to promote cell migration. These results demonstrate the critical role of L-PGDS as a secreted lipocalin in the regulation of glial cell migration and morphology. The results also indicate that L-PGDS may participate in reactive gliosis in an autocrine or paracrine manner, and may have pathological implications in neuroinflammatory diseases.	[Lee, Shinrye; Jang, Eunha; Kim, Jong-Heon; Kim, Jae-Hong; Suk, Kyoungho] Kyungpook Natl Univ, Dept Pharmacol, Brain Sci & Engn Inst, CMRI,Sch Med, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 700422, South Korea	Kyungpook National University; Kyungpook National University	Suk, K (corresponding author), 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr			Ministry of Education, Science and Technology (MEST) of Korean government [2009-0078941]; National Research Foundation; MEST [2010-0029460]	Ministry of Education, Science and Technology (MEST) of Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Ministry of Education, Science and Technology (MEST) of Korean government Grant 2009-0078941 from the National Research Foundation and the Basic Science Research Program Grant 2010-0029460 from the National Research Foundation funded by the MEST.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Blodorn B, 1999, J NEUROSCI RES, V57, P730; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Chen CJ, 2006, EUR J NEUROSCI, V23, P1977, DOI 10.1111/j.1460-9568.2006.04728.x; Disatnik MH, 2002, J CELL SCI, V115, P2151; Dulong S, 2004, BIOCHEM J, V382, P1015, DOI 10.1042/BJ20040347; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grill M, 2006, NEUROPHARMACOLOGY, V50, P165, DOI 10.1016/j.neuropharm.2005.08.005; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; Hirawa N, 2002, HYPERTENSION, V39, P449, DOI 10.1161/hy0202.102835; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Joo M, 2009, AM J PHYSIOL-LUNG C, V296, pL771, DOI 10.1152/ajplung.90320.2008; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Maesaka JK, 2001, KIDNEY INT, V60, P1692, DOI 10.1046/j.1523-1755.2001.00989.x; MASANA Y, 1995, NEUROSCI RES, V23, P217, DOI 10.1016/0168-0102(95)00936-N; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Miwa Y, 2004, BIOCHEM BIOPH RES CO, V322, P428, DOI 10.1016/j.bbrc.2004.07.143; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Monneret G, 2001, BLOOD, V98, P1942, DOI 10.1182/blood.V98.6.1942; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Ragolia L, 2003, AM J PHYSIOL-CELL PH, V284, pC119, DOI 10.1152/ajpcell.00247.2002; Ragolia L, 2001, NEUROREPORT, V12, P2623, DOI 10.1097/00001756-200108280-00008; Ragolia L, 2007, PROSTAG OTH LIPID M, V83, P25, DOI 10.1016/j.prostaglandins.2006.09.006; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; Schuligoi R, 2005, BIOCHEM BIOPH RES CO, V335, P684, DOI 10.1016/j.bbrc.2005.07.130; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Seo M, 2010, FASEB J, V24, P464, DOI 10.1096/fj.09-137562; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Suidan HS, 1997, GLIA, V21, P244, DOI 10.1002/(SICI)1098-1136(199710)21:2<244::AID-GLIA7>3.0.CO;2-6; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; URADE Y, 1985, J BIOL CHEM, V260, P2410; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Xin XR, 2009, J MOL NEUROSCI, V39, P366, DOI 10.1007/s12031-009-9214-7; Zhao Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1611, DOI 10.1152/ajpcell.2000.279.5.C1611	82	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9414	9428		10.1074/jbc.M111.330662	http://dx.doi.org/10.1074/jbc.M111.330662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275363	hybrid, Green Published			2022-12-27	WOS:000301797800071
J	Rossmann, MG				Rossmann, Michael G.			Crystallography, Evolution, and the Structure of Viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL FOURIER SYNTHESIS; ISOMORPHOUS REPLACEMENT METHOD; DNA PACKAGING MOTOR; DENGUE VIRUS; CRYOELECTRON MICROSCOPY; FUNCTIONAL IMPLICATIONS; LACTATE DEHYDROGENASE; COXSACKIEVIRUS B3; ATOMIC-STRUCTURE; GIANT MIMIVIRUS	My undergraduate education in mathematics and physics was a good grounding for graduate studies in crystallographic studies of small organic molecules. As a postdoctoral fellow in Minnesota, I learned how to program an early electronic computer for crystallographic calculations. I then joined Max Perutz, excited to use my skills in the determination of the first protein structures. The results were even more fascinating than the development of techniques and provided inspiration for starting my own laboratory at Purdue University. My first studies on dehydrogenases established the conservation of nucleotide-binding structures. Having thus established myself as an independent scientist, I could start on my most cherished ambition of studying the structure of viruses. About a decade later, my laboratory had produced the structure of a small RNA plant virus and then, in another six years, the first structure of a human common cold virus. Many more virus structures followed, but soon it became essential to supplement crystallography with electron microscopy to investigate viral assembly, viral infection of cells, and neutralization of viruses by antibodies. A major guide in all these studies was the discovery of evolution at the molecular level. The conservation of three-dimensional structure has been a recurring theme, from my experiences with Max Perutz in the study of hemoglobin to the recognition of the conserved nucleotide-binding fold and to the recognition of the jelly roll fold in the capsid protein of a large variety of viruses.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall Struct Biol, W Lafayette, IN 47907 USA.	mr@purdue.edu			National Institutes of Health; National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	I apologize to the many friends and colleagues whose work I have mentioned but have not referenced. Wherever possible, I have named the person, but because of the limitation of the number of references, I have cited only my own work. I also wish to thank the many postdoctoral fellows, graduate students, collaborators, friends, colleagues, and technicians who have made the work described here possible. I also wish to thank Sheryl Kelly, who helped to prepare this article for print. I have been very fortunate that my wife, Audrey, understood, as she often pointed out, that marriage to a scientist requires a very special kind of wife. Furthermore, Audrey welcomed everybody who came to my laboratory, helping all to settle into life in Lafayette. She insisted on knowing about every new arrival and made sure she knew all of his or her specific needs and interests. I am very grateful for the many years of generous support by the National Institutes of Health and the National Science Foundation, for industrial support especially from the Sterling-Winthrop Co., and for help from Purdue University.	ABADZAPATERO C, 1980, NATURE, V286, P33, DOI 10.1038/286033a0; ADAMS MJ, 1970, NATURE, V227, P1098, DOI 10.1038/2271098a0; BLOW DM, 1964, J MOL BIOL, V8, P65, DOI 10.1016/S0022-2836(64)80149-2; BLOW DM, 1961, ACTA CRYSTALLOGR, V14, P1195, DOI 10.1107/S0365110X61003454; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; CHENG RH, 1995, CELL, V80, P621; Cherrier MV, 2009, P NATL ACAD SCI USA, V106, P11085, DOI 10.1073/pnas.0904716106; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; CULLIS AF, 1961, PROC R SOC LON SER-A, V265, P15, DOI 10.1098/rspa.1961.0220; DODSON E, 1966, J MOL BIOL, V16, P227, DOI 10.1016/S0022-2836(66)80275-9; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; HAAS DJ, 1970, ACTA CRYSTALL B-STRU, VB 26, P998, DOI 10.1107/S0567740870003485; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101; Kuhn RJ, 2005, ADV VIRUS RES, V64, P263, DOI 10.1016/S0065-3527(05)64008-0; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; LUO M, 1987, SCIENCE, V235, P182, DOI 10.1126/science.3026048; MAIN P, 1966, ACTA CRYSTALLOGR, V21, P67, DOI 10.1107/S0365110X66002342; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; MUCKELBAUER JK, 1995, STRUCTURE, V3, P653, DOI 10.1016/S0969-2126(01)00201-5; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; OLSON NH, 1993, P NATL ACAD SCI USA, V90, P507, DOI 10.1073/pnas.90.2.507; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROSSMANN MG, 1960, ACTA CRYSTALLOGR, V13, P221, DOI 10.1107/S0365110X60000510; ROSSMANN MG, 1979, J APPL CRYSTALLOGR, V12, P225, DOI 10.1107/S0021889879012218; ROSSMANN MG, 1979, J APPL CRYSTALLOGR, V12, P570, DOI 10.1107/S0021889879013273; Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005; ROSSMANN MG, 1961, ACTA CRYSTALLOGR, V14, P641, DOI 10.1107/S0365110X61001960; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; ROSSMANN MG, 1961, ACTA CRYSTALLOGR, V14, P383, DOI 10.1107/S0365110X61001297; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROSSMANN MG, 1983, J APPL CRYSTALLOGR, V16, P629, DOI 10.1107/S002188988301119X; SMITH TJ, 1986, SCIENCE, V233, P1286, DOI 10.1126/science.3018924; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Xiao CA, 2005, J MOL BIOL, V353, P493, DOI 10.1016/j.jmb.2005.08.060; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang W, 2002, J VIROL, V76, P11645, DOI 10.1128/JVI.76.22.11645-11658.2002; Zhang XZ, 2011, P NATL ACAD SCI USA, V108, P14837, DOI 10.1073/pnas.1107847108; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	53	3	4	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9552	9559		10.1074/jbc.X112.348961	http://dx.doi.org/10.1074/jbc.X112.348961			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22318719	hybrid, Green Published			2022-12-27	WOS:000301797800086
J	Achila, D; Gulati, M; Jain, N; Britton, RA				Achila, David; Gulati, Megha; Jain, Nikhil; Britton, Robert A.			Biochemical Characterization of Ribosome Assembly GTPase RbgA in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; ESCHERICHIA-COLI; CELL-CYCLE; SUBUNIT; BIOGENESIS; YLQF; YQEH; RNA	The ribosome biogenesis GTPase A protein RbgA is involved in the assembly of the large ribosomal subunit in Bacillus subtilis, and homologs of RbgA are implicated in the biogenesis of mitochondrial, chloroplast, and cytoplasmic ribosomes in archaea and eukaryotes. The precise function of how RbgA contributes to ribosome assembly is not understood. Defects in RbgA give rise to a large ribosomal subunit that is immature and migrates at 45 S in sucrose density gradients. Here, we report a detailed biochemical analysis of RbgA and its interaction with the ribosome. We found that RbgA, like most other GTPases, exhibits a very slow k(cat) (14 h(-1)) and has a high K-m (90 mu M). Homology modeling of the RbgA switch I region using the K-loop GTPase MnmE as a template suggested that RbgA requires K+ ions for GTPase activity, which was confirmed experimentally. Interaction with 50 S subunits, but not 45 S intermediates, increased GTPase activity by similar to 55-fold. Stable association with 50 S subunits and 45 S intermediates was nucleotide-dependent, and GDP did not support strong interaction with either of the subunits. GTP and guanosine 5'-(beta,gamma-imido)triphosphate (GMPPNP) were sufficient to promote association with the 45 S intermediate, whereas only GMPPNP was able to support binding to the 50 S subunit, presumably due to the stimulation of GTP hydrolysis. These results support a model in which RbgA promotes a late step in ribosome biogenesis and that one role of GTP hydrolysis is to stimulate dissociation of RbgA from the ribosome.	[Achila, David; Gulati, Megha; Jain, Nikhil; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Britton, RA (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 6175 BPS, E Lansing, MI 48824 USA.	rbritton@msu.edu	Jain, Nikhil/B-5107-2013	Jain, Nikhil/0000-0002-9091-6156	National Science Foundation [0643565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Science Foundation CAREER Award 0643565 (to R. A. B.).	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; DeLano W.L, PYMOL MOL GRAPHICS S; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; GOLLOP N, 1991, J BACTERIOL, V173, P2265, DOI 10.1128/JB.173.7.2265-2270.1991; Heifets A, 2010, J MOL GRAPH MODEL, V29, P93, DOI 10.1016/j.jmgm.2010.05.005; Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NOMURA M, 1970, NATURE, V228, P744, DOI 10.1038/228744a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843	33	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8417	8423		10.1074/jbc.M111.331322	http://dx.doi.org/10.1074/jbc.M111.331322			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267738	Green Published, hybrid			2022-12-27	WOS:000301349400056
J	Song, Q; Sherrer, SM; Suo, ZC; Taylor, JS				Song, Qian; Sherrer, Shanen M.; Suo, Zucai; Taylor, John-Stephen			Preparation of Site-specific T = (m)CG cis-syn Cyclobutane Dimer-containing Template and Its Error-free Bypass by Yeast and Human Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-THYMINE DIMER; DNA-POLYMERASE; PYRIMIDINE DIMERS; REPLICATIVE BYPASS; LESION BYPASS; POL-ETA; DEAMINATION; 5-METHYLCYTOSINE; PHOTOPRODUCTS; MUTATIONS	C-to-T mutations are a hallmark of UV light and, in humans, occur preferentially at methylated Py(m)CG sites, which are also sites of preferential cyclobutane pyrimidine dimer (CPD) formation. In response, cells have evolved DNA damage bypass polymerases, of which polymerase eta (pol eta) appears to be specifically adapted to synthesize past cis-syn CPDs. Although T = T CPDs are stable, CPDs containing C or 5-methylcytosine (C-m) are not and spontaneously deaminate to U or T at pH 7 and 37 C over a period of hours or days, making their preparation and study difficult. Furthermore, there is evidence to suggest that, depending on solvent polarity, a C or an C-m in a CPD can adopt three tautomeric forms, one of which could code as T. Although many in vitro studies have established that synthesis past T or U in a CPD by pol eta occurs in a highly error-free manner, the only in vitro evidence that synthesis past C or C-m in a CPD also occurs in an error-free manner is for an C-m in the 5'-position of an C-m = T CPD. Herein, we describe the preparation and characterization of an oligodeoxynucleotide containing a CPD of a T(m)CG site, one of the major sites of C methylation and C-to-T mutations found in the p53 gene of basal and squamous cell cancers. We also demonstrate that both yeast and human pol eta synthesize past the 3'-C-m CPD in a >99% error-free manner, consistent with the highly water-exposed nature of the active site.	[Song, Qian; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Sherrer, Shanen M.; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA	Washington University (WUSTL); Ohio State University	Taylor, JS (corresponding author), Washington Univ, Dept Chem, 1 Brookings Dr, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Institutes of Health [CA40463]; American Heart Association [GRT00014861]; NATIONAL CANCER INSTITUTE [R01CA040463, R37CA040463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA40463 (to J.-S. T. and Z. S.).; Supported by American Heart Association Great Rivers Affiliate Predoctoral Fellowship GRT00014861.	BARAK Y, 1995, J BIOL CHEM, V270, P24174, DOI 10.1074/jbc.270.41.24174; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BROWN DM, 1968, J CHEM SOC C, P2050, DOI 10.1039/j39680002050; Brown JA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/871939; Cannistraro VJ, 2010, NUCLEIC ACIDS RES, V38, P6943, DOI 10.1093/nar/gkq582; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Cannistraro VJ, 2004, J BIOL CHEM, V279, P18288, DOI 10.1074/jbc.M400282200; Danilov VI, 2000, CHEM PHYS LETT, V328, P75, DOI 10.1016/S0009-2614(00)00909-X; Danilov VI, 2001, J BIOMOL STRUCT DYN, V19, P179, DOI 10.1080/07391102.2001.10506730; DUPUYMAN.N, 1967, J CHIM PHYS PCB, V64, P708, DOI 10.1051/jcp/1967640708; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Horsfall MJ, 1997, J BACTERIOL, V179, P2835, DOI 10.1128/jb.179.9.2835-2839.1997; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Hwang HS, 2005, BIOCHEMISTRY-US, V44, P4850, DOI 10.1021/bi048244+; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LIU FT, 1978, BIOCHEMISTRY-US, V17, P4865, DOI 10.1021/bi00616a003; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; SETLOW RB, 1965, P NATL ACAD SCI USA, V53, P1111, DOI 10.1073/pnas.53.5.1111; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sherrer SM, 2011, NUCLEIC ACIDS RES, V39, P609, DOI 10.1093/nar/gkq719; Smith CA, 1998, J BIOL CHEM, V273, P21933, DOI 10.1074/jbc.273.34.21933; Song QA, 2011, J BIOL CHEM, V286, P6329, DOI 10.1074/jbc.M110.183178; Sun LP, 2003, BIOCHEMISTRY-US, V42, P9431, DOI 10.1021/bi0345687; Sun LP, 2000, BIOCHEMISTRY-US, V39, P14603, DOI 10.1021/bi001446v; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; Taylor JS, 2002, MUTAT RES-FUND MOL M, V510, P55, DOI 10.1016/S0027-5107(02)00252-X; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; WANG CI, 1991, P NATL ACAD SCI USA, V88, P9072, DOI 10.1073/pnas.88.20.9072; Wang YS, 1999, CHEM RES TOXICOL, V12, P1077, DOI 10.1021/tx9900831; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 2001, P NATL ACAD SCI USA, V98, P8355, DOI 10.1073/pnas.121007298; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; You HY, 2000, CARCINOGENESIS, V21, P2113, DOI 10.1093/carcin/21.11.2113; You YH, 1999, J MOL BIOL, V293, P493, DOI 10.1006/jmbi.1999.3174; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	50	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8021	8028		10.1074/jbc.M111.333591	http://dx.doi.org/10.1074/jbc.M111.333591			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262850	Green Published, hybrid			2022-12-27	WOS:000301349400018
J	Geisler, C; Jarvis, DL				Geisler, Christoph; Jarvis, Donald L.			Substrate Specificities and Intracellular Distributions of Three N-glycan Processing Enzymes Functioning at a Key Branch Point in the Insect N-Glycosylation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; LOBES GENE ENCODES; ACETYLGLUCOSAMINYLTRANSFERASE-I; DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; GLYCOPROTEIN-SYNTHESIS; TRICHOPLUSIA-NI; SF9 CELLS; UDP-N-ACETYLGLUCOSAMINE-ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I; SUBCELLULAR-LOCALIZATION	Man(alpha 1-6)[GlcNAc(beta 1-2) Man(alpha 1-3)] ManGlcNAc(2) is a key branch point intermediate in the insect N-glycosylation pathway because it can be either trimmed by a processing beta-N-acetylglucosaminidase (FDL) to produce paucimannosidic N-glycans or elongated by N-acetylglucosaminyltransferase II (GNT-II) to produce complex N-glycans. N-Acetylglucosaminyltransferase I (GNT-I) contributes to branch point intermediate production and can potentially reverse the FDL trimming reaction. However, there has been no concerted effort to evaluate the relationships among these three enzymes in any single insect system. Hence, we extended our previous studies on Spodoptera frugiperda (Sf) FDL to include GNT-I and -II. Sf-GNT-I and -II cDNAs were isolated, the predicted protein sequences were analyzed, and both gene products were expressed and their acceptor substrate specificities and intracellular localizations were determined. Sf-GNT-I transferred N-acetylglucosamine to Man(5)GlcNAc(2), Man(3)GlcNAc(2), and GlcNAc(beta 1-2) Man(alpha 1-6)[Man(alpha 1-3)] ManGlcNAc(2), demonstrating its role in branch point intermediate production and its ability to reverse FDL trimming. Sf-GNT-II only transferred N-acetylglucosamine to Man(alpha 1-6)[GlcNAc(beta 1-2)-Man( alpha 1-3)] ManGlcNAc(2), demonstrating that it initiates complex N-glycan production, but cannot use Man(3)GlcNAc(2) to produce hybrid or complex structures. Fluorescently tagged Sf-GNT-I and -II co-localized with an endogenous Sf Golgi marker and Sf-FDL co-localized with Sf-GNT-I and -II, indicating that all three enzymes are Golgi resident proteins. Unexpectedly, fluorescently tagged Drosophila melanogaster FDL also co-localized with Sf-GNT-I and an endogenous Drosophila Golgi marker, indicating that it is a Golgi resident enzyme in insect cells. Thus, the substrate specificities and physical juxtapositioning of GNT-I, GNT-II, and FDL support the idea that these enzymes function at the N-glycan processing branch point and are major factors determining the net outcome of the insect cell N-glycosylation pathway.	[Geisler, Christoph; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	dljarvis@uwyo.edu		Jarvis, Donald/0000-0002-8104-7155	National Institutes of Health from NIGMS [R01GM49734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049734] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM49734 from the NIGMS.	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; BURKE J, 1992, J BIOL CHEM, V267, P24433; Buster Daniel W, 2010, J Vis Exp, DOI 10.3791/1982; Chen SH, 2002, BBA-GEN SUBJECTS, V1573, P271, DOI 10.1016/S0304-4165(02)00393-8; Chen W, 2001, BIOCHEMISTRY-US, V40, P8765, DOI 10.1021/bi015538b; Cormier-Daire V, 2000, J MED GENET, V37, P875, DOI 10.1136/jmg.37.11.875; DAGOSTARO GAF, 1995, J BIOL CHEM, V270, P15211, DOI 10.1074/jbc.270.25.15211; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; Fujiyama K, 2001, J BIOSCI BIOENG, V92, P569, DOI 10.1263/jbb.92.569; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Geisler C, 2010, BIOTECHNOL PROGR, V26, P34, DOI 10.1002/btpr.298; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; Haines N, 2005, GLYCOBIOLOGY, V15, P335, DOI 10.1093/glycob/cwi017; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hollister J, 2002, BIOCHEMISTRY-US, V41, P15093, DOI 10.1021/bi026455d; Hsu TA, 1997, J BIOL CHEM, V272, P9062; JARVIS DL, 1991, VIROLOGY, V185, P795, DOI 10.1016/0042-6822(91)90551-L; Kawar Z, 2001, J BIOL CHEM, V276, P16335, DOI 10.1074/jbc.M100119200; Kawar Z, 2000, GLYCOBIOLOGY, V10, P347, DOI 10.1093/glycob/10.4.347; Kawar Z, 1997, GLYCOBIOLOGY, V7, P433, DOI 10.1093/glycob/7.3.433; Kawar Z, 2001, INSECT BIOCHEM MOLEC, V31, P289, DOI 10.1016/S0965-1748(00)00121-1; KERSCHER S, 1995, DEV BIOL, V168, P613, DOI 10.1006/dbio.1995.1106; Kim K, 2002, GLYCOBIOLOGY, V12, P73, DOI 10.1093/glycob/12.2.73; Kim YK, 2009, GLYCOBIOLOGY, V19, P301, DOI 10.1093/glycob/cwn138; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Kondylis V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017173; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; LAL A, 1994, J BIOL CHEM, V269, P9872; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marz L., 1995, GLYCOPROTEINS, P543; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; MOLLER G, 1992, GLYCOCONJUGATE J, V9, P180, DOI 10.1007/BF00731163; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; NISHIU J, 1995, BIOSCI BIOTECH BIOCH, V59, P1750, DOI 10.1271/bbb.59.1750; Ogonah OW, 1996, BIO-TECHNOL, V14, P197, DOI 10.1038/nbt0296-197; OPPENHEIMER CL, 1981, J BIOL CHEM, V256, P799; OPPENHEIMER CL, 1981, J BIOL CHEM, V256, P1477; Park YI, 1999, GLYCOCONJUGATE J, V16, P629, DOI 10.1023/A:1007029017400; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Rabouille C, 1999, J CELL SCI, V112, P3319; RECK F, 1994, GLYCOCONJUGATE J, V11, P210, DOI 10.1007/BF00731220; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; SARKAR M, 1991, P NATL ACAD SCI USA, V88, P234, DOI 10.1073/pnas.88.1.234; Sarkar M, 2001, BIOL CHEM, V382, P209, DOI 10.1515/BC.2001.028; Short JR, 2010, J GEN VIROL, V91, P1514, DOI 10.1099/vir.0.020156-0; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tan J, 1996, AM J HUM GENET, V59, P810; TAN J, 1995, EUR J BIOCHEM, V231, P317, DOI 10.1111/j.1432-1033.1995.tb20703.x; Tremblay LO, 2000, J BIOL CHEM, V275, P31655, DOI 10.1074/jbc.M004935200; Tremblay LO, 1998, GLYCOBIOLOGY, V8, P585, DOI 10.1093/glycob/8.6.585; Tsitilou SG, 2003, BIOCHEM BIOPH RES CO, V312, P1372, DOI 10.1016/j.bbrc.2003.11.059; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Vadaie N, 2004, J BIOL CHEM, V279, P33501, DOI 10.1074/jbc.M404925200; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; vanDie I, 1996, GLYCOBIOLOGY, V6, P157, DOI 10.1093/glycob/6.2.157; Viswanathan K, 2006, J BIOL CHEM, V281, P15929, DOI 10.1074/jbc.M512186200; Wagner R, 1996, GLYCOBIOLOGY, V6, P165, DOI 10.1093/glycob/6.2.165; Wagner R, 1996, J VIROL, V70, P4103, DOI 10.1128/JVI.70.6.4103-4109.1996; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	77	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7084	7097		10.1074/jbc.M111.296814	http://dx.doi.org/10.1074/jbc.M111.296814			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238347	Green Published, hybrid			2022-12-27	WOS:000301060200013
J	Kaya, AI; Onaran, HO; Ozcan, G; Ambrosio, C; Costa, T; Balli, S; Ugur, O				Kaya, Ali I.; Onaran, H. Ongun; Ozcan, Gulnihal; Ambrosio, Caterina; Costa, Tommaso; Balli, Sezen; Ugur, Ozlem			Cell Contact-dependent Functional Selectivity of beta(2)-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; BETA-ADRENERGIC-RECEPTORS; MAP KINASE; B-RAF; ADHESION; TRANSDUCTION; INHIBITION; BINDING; EQUILIBRIUM; INTEGRINS	Activation of beta(2)-adrenegic receptor (beta(2)-AR) leads to an increase in intracellular cAMP and activation of ERK. These two signals are activated by the interaction of the receptor with different transducer partners. We showed that the intrinsic activities of beta(2)-AR ligands for stimulating cAMP production and ERK phosphorylation responses in HEK-293 cells were not correlated. The lack of correlation resulted mainly from the discrepancy between the intrinsic activities of two groups of ligands for these two responses: The first group consisted of clenbuterol, cimaterol, procaterol, and terbutaline which acted as full agonists for cAMP production but displayed very weak effect on ERK phosphorylation. The second group comprised adrenaline and noradrenaline which displayed higher intrinsic activity for the ERK phosphorylation than for the cAMP response. Thus, both groups behaved as functionally selective ligands. The functional selectivity of the first group was observable only in adherent cells when confluence was approximately 100%. When cell-cell contact was minimized either by decreasing the density of the adherent cells or by bringing the cells into suspension, the first group of ligands gained the ability to stimulate ERK phosphorylation without a change in their effect on cAMP production. In contrast, selectivity of the second group was independent of the adherence state of the cells. Our results show that the inherent "bias" of ligands in coupling a G protein-coupled receptor to different transducers may not always be revealed as functional selectivity when there is a "cross-talk" between the signaling pathways activated by the same receptor.	[Kaya, Ali I.; Onaran, H. Ongun; Ozcan, Gulnihal; Balli, Sezen; Ugur, Ozlem] Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey; [Kaya, Ali I.; Onaran, H. Ongun] Ankara Univ, Fac Med, Mol Biol & Technol Res & Dev Unit, TR-06100 Ankara, Turkey; [Ambrosio, Caterina; Costa, Tommaso] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy	Ankara University; Ankara University; Istituto Superiore di Sanita (ISS)	Ugur, O (corresponding author), Ankara Univ, Fac Med, Dept Pharmacol, TR-06100 Ankara, Turkey.	ougur@medicine.ankara.edu.tr	costa, tommaso/AAD-3714-2019; Ozcan, Gulnihal/A-1086-2013; Ugur, Özlem/J-3169-2019; Onaran, Ongun/AAI-5348-2020; ambrosio, caterina/M-7952-2017	costa, tommaso/0000-0002-8729-3357; Ugur, Özlem/0000-0002-5404-5242; Onaran, Ongun/0000-0001-6766-4774; Ozcan, Gulnihal/0000-0001-5354-0148; ambrosio, caterina/0000-0002-0807-9003	Turkish Scientific and Technical Research Council [107S086, 110S159]	Turkish Scientific and Technical Research Council(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by Grants 107S086 and 110S159 from the Turkish Scientific and Technical Research Council.	Amber-Cicek F, 2008, EUR J PHARMACOL, V590, P12, DOI 10.1016/j.ejphar.2008.05.012; Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Aplin AE, 1998, PHARMACOL REV, V50, P197; Casella I, 2011, BIOCHEM J, V438, P191, DOI 10.1042/BJ20110374; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kukkonen JP, 2001, TRENDS PHARMACOL SCI, V22, P616, DOI 10.1016/S0165-6147(00)01864-2; Laakko T, 2003, J BIOL CHEM, V278, P31621, DOI 10.1074/jbc.M304700200; LAZOU A, 1994, CIRC RES, V75, P932, DOI 10.1161/01.RES.75.5.932; Lin TH, 1997, J BIOL CHEM, V272, P8849; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; MILLIGAN G, 1988, BIOCHEM J, V255, P1; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Qiu WS, 2000, J BIOL CHEM, V275, P31921, DOI 10.1074/jbc.M003327200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shikata Y, 1999, BIOCHEM BIOPH RES CO, V257, P234, DOI 10.1006/bbrc.1999.0441; Short SM, 1998, MOL BIOL CELL, V9, P1969, DOI 10.1091/mbc.9.8.1969; Short SM, 2000, J BIOL CHEM, V275, P12970, DOI 10.1074/jbc.275.17.12970; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Ugur O, 1997, BIOCHEM J, V323, P765, DOI 10.1042/bj3230765; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098	40	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6362	6374		10.1074/jbc.M111.301820	http://dx.doi.org/10.1074/jbc.M111.301820			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22241475	hybrid, Green Published			2022-12-27	WOS:000300791800028
J	Luo, HY; Wu, ZH; Tremblay, J; Thorin, E; Peng, JZ; Lavoie, JL; Hu, B; Stoyanova, E; Cloutier, G; Qi, SJ; Wu, T; Cameron, M; Wu, JP				Luo, Hongyu; Wu, Zenghui; Tremblay, Johanne; Thorin, Eric; Peng, Junzheng; Lavoie, Julie L.; Hu, Bing; Stoyanova, Ekatherina; Cloutier, Guy; Qi, Shijie; Wu, Tao; Cameron, Mark; Wu, Jiangping			Receptor Tyrosine Kinase Ephb6 Regulates Vascular Smooth Muscle Contractility and Modulates Blood Pressure in Concert with Sex Hormones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HYPERTENSION; EPHRIN-B2; CELLS; EXPRESSION; RHO; NEOVASCULARIZATION; HOMEOSTASIS; ARTERIAL; ESTROGEN; LIGANDS	Eph kinases constitute the largest receptor tyrosine kinase family, and their ligands, ephrins (Efns), are also cell surface molecules. Our study is the first to assess the role of Ephb6 in blood pressure (BP) regulation. We observed that EphB6 and all three of its Efnb ligands were expressed on vascular smooth muscle cells (VSMC) in mice. We discovered that small arteries from castrated Ephb6 gene KO males showed increased contractility, RhoA activation, and constitutive myosin light chain phosphorylation ex vivo compared with their WT counterparts. Consistent with this finding, castrated Ephb6 KO mice presented heightened BP compared with castrated WT controls. In vitro experiments in VSMC revealed that cross-linking Efnbs but not Ephb6 resulted in reduced VSMC contractions, suggesting that reverse signaling through Efnbs was responsible for the observed BP phenotype. The reverse signaling was mediated by an adaptor protein Grip1. Additional experiments demonstrated decreased 24-h urine catecholamines in male Ephb6 KO mice, probably as a compensatory feedback mechanism to keep their BP in the normal range. After castration, however, such compensation was abolished in Ephb6 KO mice and was likely the reason why BP increased overtly in these animals. It suggests that Ephb6 has a target in the nervous/endocrine system in addition to VSMC, regulating a testosterone-dependent catecholamine compensatory mechanism. Our study discloses that Ephs and Efns, in concert with testosterone, play a critical role in regulating small artery contractility and BP.	[Luo, Hongyu; Wu, Zenghui; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Stoyanova, Ekatherina; Cloutier, Guy; Qi, Shijie; Wu, Jiangping] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ H2L 4M1, Canada; [Wu, Jiangping] Ctr Hosp Univ Montreal, Serv Nephrol, Montreal, PQ H2L 4M1, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wu, Tao] Zhejiang Univ, Inst Cardiol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Bing] AmeriPath, Orlando, FL 32809 USA; [Cameron, Mark] Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2C4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Zhejiang University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Wu, JP (corresponding author), Hop Notre Dame De Bon Secours, CRCHUM, Pavill DeSeve,Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Tremblay, Johanne/E-2154-2013; Cameron, Mark/O-6775-2019; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013	Cameron, Mark/0000-0003-4768-4094; Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769	Canadian Institutes of Health [MOP57697, MOP69089, MOP97829, MOP14496, CMI72323]; Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research; Zhejiang Provincial Natural Science Foundation of China [Y2080374]; National Natural Sciences Foundation of China [30800999]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation; J.-Louis Levesque Foundation; Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Canadian Institutes of Health Research Grants MOP57697 and MOP69089 (to J. W.), MOP97829 (to H. L.), MOP14496 (to J. T. and E. T.), and CMI72323 (to G. C.). It was also financed by a grant from the Heart and Stroke Foundation of Quebec, Quebec Ministry of Economic Development, Innovation and Exportation Grant PSR-SIIRI-069, and funds from the J.-Louis Levesque Foundation (to J. W.). This study was also made possible by a group grant from Fonds de la Recherche en Sante du Quebec for Transfusional and Hemovigilance Medical Research (to J. W.). T. W. was supported in part by grants from the Zhejiang Provincial Natural Science Foundation of China (Grant Y2080374) and the National Natural Sciences Foundation of China (Projects for Young Scientists 30800999).	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Ashraf MS, 2006, CURR HYPERTENS REP, V8, P368, DOI 10.1007/s11906-006-0080-1; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Iglarz M, 2003, CURR HYPERTENS REP, V5, P144, DOI 10.1007/s11906-003-0071-4; Kienitz T, 2008, KIDNEY BLOOD PRESS R, V31, P71, DOI 10.1159/000119417; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Versari D, 2009, BRIT J PHARMACOL, V157, P527, DOI 10.1111/j.1476-5381.2009.00240.x; Victor RG, 2008, CURR HYPERTENS REP, V10, P241, DOI 10.1007/s11906-008-0045-7; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weir MR, 2008, J CLIN HYPERTENS, V10, P146, DOI 10.1111/j.1751-7176.2008.07439.x; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	40	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6819	6829		10.1074/jbc.M111.293365	http://dx.doi.org/10.1074/jbc.M111.293365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223652	hybrid, Green Published			2022-12-27	WOS:000300791800067
J	Shi, XL; Yao, D; Chen, C				Shi, Xiaolei; Yao, Dan; Chen, Chi			Identification of N-Acetyltaurine as a Novel Metabolite of Ethanol through Metabolomics-guided Biochemical Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; FATTY LIVER; COENZYME-A; LIQUID-CHROMATOGRAPHY; PLASMA ACETATE; RAT-LIVER; TAURINE; INJURY	The influence of ethanol on the small molecule metabolome and the role of CYP2E1 in ethanol-induced hepatotoxicity were investigated using liquid chromatography-mass spectrometry (LC-MS)-based metabolomics platform and Cyp2e1-null mouse model. Histological and biochemical examinations of ethanol-exposed mice indicated that the Cyp2e1-null mice were more resistant to ethanol-induced hepatic steatosis and transaminase leakage than the wild-type mice, suggesting CYP2E1 contributes to ethanol-induced toxicity. Metabolomic analysis of urinary metabolites revealed time- and dose-dependent changes in the chemical composition of urine. Along with ethyl glucuronide and ethyl sulfate, N-acetyltaurine (NAT) was identified as a urinary metabolite that is highly responsive to ethanol exposure and is correlated with the presence of CYP2E1. Subsequent stable isotope labeling analysis using deuterated ethanol determined that NAT is a novel metabolite of ethanol. Among three possible substrates of NAT biosynthesis (taurine, acetyl-CoA, and acetate), the level of taurine was significantly reduced, whereas the levels of acetyl-CoA and acetate were dramatically increased after ethanol exposure. In vitro incubation assays suggested that acetate is the main precursor of NAT, which was further confirmed by the stable isotope labeling analysis using deuterated acetate. The incubations of tissues and cellular fractions with taurine and acetate indicated that the kidney has the highest NAT synthase activity among the tested organs, whereas the cytosol is the main site of NAT biosynthesis inside the cell. Overall, the combination of biochemical and metabolomic analysis revealed NAT is a novel metabolite of ethanol and a potential biomarker of hyperacetatemia.	[Shi, Xiaolei; Yao, Dan; Chen, Chi] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Shi, XL (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave,225 FScN, St Paul, MN 55108 USA.	chichen@umn.edu	Chen, Chi/AAF-5343-2020	Chen, Chi/0000-0001-9703-604X	University of Minnesota	University of Minnesota(University of Minnesota System)	This work was supported by a University of Minnesota startup fund (to C.C.).	Anton RF, 2002, ALCOHOL CLIN EXP RES, V26, P1215, DOI 10.1097/01.ALC.0000023986.42254.F5; ARAGON CMG, 1991, ALCOHOL CLIN EXP RES, V15, P165, DOI 10.1111/j.1530-0277.1991.tb01848.x; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BODE C, 1970, BIOCHIM BIOPHYS ACTA, V210, P448, DOI 10.1016/0005-2760(70)90041-X; Bradford BU, 2008, TOXICOL APPL PHARM, V232, P236, DOI 10.1016/j.taap.2008.06.022; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; BUCKLEY BM, 1977, BIOCHEM J, V166, P539, DOI 10.1042/bj1660539; Bykov I, 2004, ALCOHOL ALCOHOLISM, V39, P499, DOI 10.1093/alcalc/agh103; Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704; Cederbaum AI, 2001, FREE RADICAL BIO MED, V31, P1524, DOI 10.1016/S0891-5849(01)00741-9; Chen C, 2008, J BIOL CHEM, V283, P4543, DOI 10.1074/jbc.M706299200; Chen C, 2007, DRUG METAB REV, V39, P581, DOI 10.1080/03602530701497804; Chung FM, 2005, NEPHROL DIAL TRANSPL, V20, P1610, DOI 10.1093/ndt/gfh842; DALZIEL K, 1966, BIOCHEM J, V100, P34, DOI 10.1042/bj1000034; DESCH G, 1978, CLIN CHIM ACTA, V85, P231, DOI 10.1016/0009-8981(78)90300-5; Freeman TL, 2005, ALCOHOL CLIN EXP RES, V29, P1310, DOI 10.1097/01.ALC.0000171484.52201.52; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Higashi T, 2010, J PHARMACEUT BIOMED, V52, P809, DOI 10.1016/j.jpba.2010.03.001; Hines IN, 2004, AM J PHYSIOL-GASTR L, V287, pG310, DOI 10.1152/ajpgi.00094.2004; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Isayama F, 2003, FREE RADICAL BIO MED, V35, P1568, DOI 10.1016/j.freeradbiomed.2003.09.007; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; KEILIN D, 1945, BIOCHEM J, V39, P293, DOI 10.1042/bj0390293; Kerai MDJ, 1999, ALCOHOL ALCOHOLISM, V34, P529, DOI 10.1093/alcalc/34.4.529; Kerai MDJ, 2001, ALCOHOL ALCOHOLISM, V36, P29, DOI 10.1093/alcalc/36.1.29; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; LIEBER CS, 1995, NEW ENGL J MED, V333, P1058, DOI 10.1056/NEJM199510193331607; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; Manna SK, 2010, J PROTEOME RES, V9, P4176, DOI 10.1021/pr100452b; MARQUEZ FJ, 1986, J CHROMATOGR, V380, P275, DOI 10.1016/S0378-4347(00)83656-7; Masuo Y, 2009, ELECTROPHORESIS, V30, P1259, DOI 10.1002/elps.200900045; Maxwell CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015963; Mayer J, 2006, ARCH MICROBIOL, V186, P61, DOI 10.1007/s00203-006-0123-7; McClain CJ, 2004, AM J PHYSIOL-GASTR L, V287, pG497, DOI 10.1152/ajpgi.00171.2004; Mukamal KJ, 2005, STROKE, V36, P1830, DOI 10.1161/01.STR.0000177587.76846.89; MURTHY VK, 1972, METABOLISM, V21, P213, DOI 10.1016/0026-0495(72)90043-1; Nakamura K, 2003, ARCH TOXICOL, V77, P591, DOI 10.1007/s00204-003-0465-8; Norberg A, 2003, CLIN PHARMACOKINET, V42, P1; NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K; PARK SS, 1986, BIOCHEM PHARMACOL, V35, P2855, DOI 10.1016/0006-2952(86)90476-4; Ponnio M, 1999, ALCOHOL CLIN EXP RES, V23, P1060, DOI 10.1111/j.1530-0277.1999.tb04225.x; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; ROINE RP, 1988, ALCOHOL ALCOHOLISM, V23, P123; ROSMAN AS, 1994, CLIN CHEM, V40, P1641; Sable HJK, 2005, ALCOHOL, V35, P129, DOI 10.1016/j.alcohol.2005.03.001; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; SMITH RF, 1986, ANN CLIN BIOCHEM, V23, P285, DOI 10.1177/000456328602300307; THEORELL H, 1961, NATURE, V192, P47, DOI 10.1038/192047a0; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j; Vasiliou V, 2006, PHARMACOGENET GENOM, V16, P51, DOI 10.1097/01.fpc.0000182777.95555.56; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; WATANABE A, 1985, EXPERIENTIA, V41, P1421, DOI 10.1007/BF01950014; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; WORRALL S, 1993, DIGEST DIS, V11, P265, DOI 10.1159/000171418; Wurst FM, 2006, ADDICTION, V101, P204, DOI 10.1111/j.1360-0443.2005.01245.x; Wurst FM, 2003, ADDICTION, V98, P51, DOI 10.1046/j.1359-6357.2003.00588.x; WYMER A, 1990, J GEN INTERN MED, V5, P192, DOI 10.1007/BF02600531; Yalcin A, 1999, CURR MED RES OPIN, V15, P310, DOI 10.1185/03007999909116502; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; Zivkovic AM, 2009, ALCOHOL CLIN EXP RES, V33, P751, DOI 10.1111/j.1530-0277.2008.00892.x	73	42	43	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6336	6349		10.1074/jbc.M111.312199	http://dx.doi.org/10.1074/jbc.M111.312199			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228769	Green Published, hybrid			2022-12-27	WOS:000300791800026
J	Lee, KY; Bang, SW; Yoon, SW; Lee, SH; Yoon, JB; Hwang, DS				Lee, Kyung Yong; Bang, Sung Woong; Yoon, Sang Wook; Lee, Seung-Hoon; Yoon, Jong-Bok; Hwang, Deog Su			Phosphorylation of ORC2 Protein Dissociates Origin Recognition Complex from Chromatin and Replication Origins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE-DEPENDENT REGULATION; DNA-REPLICATION; CELL-CYCLE; MULTIPLE MECHANISMS; RE-REPLICATION; BINDING; ATP; INITIATION; IDENTIFICATION; REREPLICATION	During the late M to the G1 phase of the cell cycle, the origin recognition complex (ORC) binds to the replication origin, leading to the assembly of the prereplicative complex for subsequent initiation of eukaryotic chromosome replication. We found that the cell cycle-dependent phosphorylation of human ORC2, one of the six subunits of ORC, dissociates ORC2, -3, -4, and -5 (ORC2-5) subunits from chromatin and replication origins. Phosphorylation at Thr-116 and Thr-226 of ORC2 occurs by cyclin-dependent kinase during the S phase and is maintained until the M phase. Phosphorylation of ORC2 at Thr-116 and Thr-226 dissociated the ORC2-5 from chromatin. Consistent with this, the phosphomimetic ORC2 protein exhibited defective binding to replication origins as well as to chromatin, whereas the phosphodefective protein persisted in binding throughout the cell cycle. These results suggest that the phosphorylation of ORC2 dissociates ORC from chromatin and replication origins and inhibits binding of ORC to newly replicated DNA.	[Lee, Kyung Yong; Bang, Sung Woong; Yoon, Sang Wook; Hwang, Deog Su] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Lee, Seung-Hoon; Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Hwang, DS (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	dshwang@snu.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	Ministry for Health and Welfare [1120180]; National Research Foundation of Korea [20110008014 NRF, 2009-0078699]; Brain Korea 21 Project; Korean Ministry of Science and Technology	Ministry for Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	* This work was supported by National R&D Program for Cancer Control, Ministry for Health and Welfare, Grant 1120180; Basic Science Research Program through the National Research Foundation of Korea Grant 20110008014 NRF; and Nuclear R&D Program of National Research Foundation of Korea Grant 2009-0078699.; <SUP>1</SUP> Supported by the second stage of the Brain Korea 21 Project.; <SUP>2</SUP> Supported by a grant from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Baldinger T, 2009, MOL CELL BIOL, V29, P140, DOI 10.1128/MCB.00981-08; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Delmolino LM, 2001, J BIOL CHEM, V276, P26947, DOI 10.1074/jbc.M101870200; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Findeisen M, 1999, EUR J BIOCHEM, V264, P415, DOI 10.1046/j.1432-1327.1999.00613.x; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Lygerou Z, 1999, J CELL SCI, V112, P3703; Makise M, 2009, J BIOL CHEM, V284, P3396, DOI 10.1074/jbc.M804293200; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vas A, 2001, MOL CELL BIOL, V21, P5767, DOI 10.1128/MCB.21.17.5767-5777.2001; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620	46	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11891	11898		10.1074/jbc.M111.338467	http://dx.doi.org/10.1074/jbc.M111.338467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334659	Green Published, hybrid			2022-12-27	WOS:000302782200028
J	Maruta, T; Noshi, M; Tanouchi, A; Tamoi, M; Yabuta, Y; Yoshimura, K; Ishikawa, T; Shigeoka, S				Maruta, Takanori; Noshi, Masahiro; Tanouchi, Aoi; Tamoi, Masahiro; Yabuta, Yukinori; Yoshimura, Kazuya; Ishikawa, Takahiro; Shigeoka, Shigeru			H2O2-triggered Retrograde Signaling from Chloroplasts to Nucleus Plays Specific Role in Response to Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCORBATE PEROXIDASE ISOENZYMES; PROGRAMMED CELL-DEATH; OXYGEN GENE NETWORK; ARABIDOPSIS-THALIANA; HIGH-LIGHT; SINGLET OXYGEN; NEGATIVE REGULATOR; SALICYLIC-ACID; PHOTOOXIDATIVE STRESS; TRANSCRIPTION FACTOR	Recent findings have suggested that reactive oxygen species (ROS) are important signaling molecules for regulating plant responses to abiotic and biotic stress and that there exist source- and kind-specific pathways for ROS signaling. In plant cells, a major source of ROS is chloroplasts, in which thylakoid membrane-bound ascorbate peroxidase (tAPX) plays a role in the regulation of H2O2 levels. Here, to clarify the signaling function of H2O2 derived from the chloroplast, we created a conditional system for producing H2O2 in the organelle by chemical-dependent tAPX silencing using estrogen-inducible RNAi. When the expression of tAPX was silenced in leaves, levels of oxidized protein in chloroplasts increased in the absence of stress. Microarray analysis revealed that tAPX silencing affects the expression of a large set of genes, some of which are involved in the response to chilling and pathogens. In response to tAPX silencing, the transcript levels of C-repeat/DRE binding factor (CBF1), a central regulator for cold acclimation, was suppressed, resulting in a high sensitivity of tAPX-silenced plants to cold. Furthermore, tAPX silencing enhanced the levels of salicylic acid (SA) and the response to SA. Interestingly, we found that tAPX silencing-responsive genes were up-or down-regulated by high light (HL) and that tAPX silencing had a negative effect on expression of ROS-responsive genes under HL, suggesting synergistic and antagonistic roles of chloroplastic H2O2 in HL response. These findings provide a new insight into the role of H2O2-triggered retrograde signaling from chloroplasts in the response to stress in planta.	[Maruta, Takanori; Noshi, Masahiro; Tanouchi, Aoi; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Yabuta, Yukinori] Tottori Univ, Sch Agr Biol & Environm Sci, Fac Agr, Tottori 6808553, Japan; [Yoshimura, Kazuya] Chubu Univ, Coll Biosci & Biotechnol, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Kindai University (Kinki University); Tottori University; Chubu University; Shimane University	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Ishikawa, Takahiro/AAX-5792-2021; Yabuta, Yukinori/T-3615-2019; Tamoi, Masahiro/AAJ-1054-2021	Yabuta, Yukinori/0000-0002-6982-8522; Maruta, Takanori/0000-0003-4144-7821	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22248042]; Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research [22248042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (A) 22248042 (to S. S.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by Scientific Research for Plant Graduate Students from the Nara Institute of Science and Technology (to T. M.).	Adamiec M, 2008, ACTA BIOCHIM POL, V55, P161, DOI 10.18388/abp.2008_3176; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bechtold N, 1998, METH MOL B, V82, P259; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Fragniere C, 2011, FEBS LETT, V585, P1847, DOI 10.1016/j.febslet.2011.04.039; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Gechev TS, 2005, IUBMB LIFE, V57, P181, DOI 10.1080/15216540500090793; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Ishikawa K, 2010, PLANT SIGNAL BEHAV, V5, P839, DOI [10.4161/psb.5.7.11820, 10.1104/pp.109.140442]; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kim CH, 2008, EMBO REP, V9, P435, DOI 10.1038/embor.2008.57; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kruijt M, 2005, MOL PLANT PATHOL, V6, P85, DOI 10.1111/j.1364-3703.2004.00264.x; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; Maruta T, 2011, PLANT SCI, V180, P655, DOI 10.1016/j.plantsci.2011.01.014; Maruta T, 2010, PLANT CELL PHYSIOL, V51, P190, DOI 10.1093/pcp/pcp177; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2010, TRENDS PLANT SCI, V15, P370, DOI 10.1016/j.tplants.2010.04.008; Morishita T, 2009, PLANT CELL PHYSIOL, V50, P2210, DOI 10.1093/pcp/pcp159; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Phee BK, 2004, PROTEOMICS, V4, P3560, DOI 10.1002/pmic.200400982; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Rizhsky L, 2003, J BIOL CHEM, V278, P38921, DOI 10.1074/jbc.M304987200; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; SHIGEOKA S, 1987, BIOCHEM J, V242, P511, DOI 10.1042/bj2420511; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Yabuta Y, 2004, PLANT CELL PHYSIOL, V45, P1586, DOI 10.1093/pcp/pch181; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yoshimura K, 2000, PLANT PHYSIOL, V123, P223, DOI 10.1104/pp.123.1.223; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	58	146	155	1	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11717	11729		10.1074/jbc.M111.292847	http://dx.doi.org/10.1074/jbc.M111.292847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334687	Green Published, hybrid			2022-12-27	WOS:000302782200011
J	Shu, YL; Habchi, J; Costanzo, S; Padilla, A; Brunel, J; Gerlier, D; Oglesbee, M; Longhi, S				Shu, Yaoling; Habchi, Johnny; Costanzo, Stephanie; Padilla, Andre; Brunel, Joanna; Gerlier, Denis; Oglesbee, Michael; Longhi, Sonia			Plasticity in Structural and Functional Interactions between the Phosphoprotein and Nucleoprotein of Measles Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; INTRINSICALLY DISORDERED PROTEINS; MOLECULAR RECOGNITION FEATURES; SECONDARY STRUCTURE ANALYSES; VESICULAR STOMATITIS-VIRUS; STRAND RNA VIRUSES; NUCLEOCAPSID PROTEIN; CRYSTAL-STRUCTURE; MATRIX PROTEIN; UNSTRUCTURED PROTEINS	The measles virus (MeV) phosphoprotein (P) tethers the polymerase to the nucleocapsid template for transcription and genome replication. Binding of P to nucleocapsid is mediated by the X domain of P (XD) and a conserved sequence (Box-2) within the C-terminal domain of the nucleoprotein (N-TAIL). XD binding induces N-TAIL alpha-helical folding, which in turn has been proposed to stabilize the polymerase-nucleocapsid complex, with cycles of binding and release required for transcription and genome replication. The current work directly assessed the relationships among XD-induced N-TAIL folding, XD-N-TAIL binding affinity, and polymerase activity. Amino acid substitutions that abolished XD-induced N-TAIL alpha-helical folding were created within Box-2 of Edmonston MeV N-TAIL. Polymerase activity in minireplicons was maintained despite a 35-fold decrease in XD-N-TAIL binding affinity or reduction/loss of XD-induced N-TAIL alpha-helical folding. Recombinant infectious virus was recovered for all mutants, and transcriptase elongation rates remained within a 1.7-fold range of parent virus. Box-2 mutations did however impose a significant cost to infectivity, reflected in an increase in the amount of input genome required to match the infectivity of parent virus. Diminished infectivity could not be attributed to changes in virion protein composition or production of defective interfering particles, where changes from parent virus were within a 3-fold range. The results indicated that MeV polymerase activity, but not infectivity, tolerates amino acid changes in the XD-binding region of the nucleoprotein. Selectional pressure for conservation of the Box-2 sequence may thus reflect a role in assuring the fidelity of polymerase functions or the assembly of viral particles required for optimal infectivity.	[Shu, Yaoling; Oglesbee, Michael] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Habchi, Johnny; Costanzo, Stephanie; Longhi, Sonia] Aix Marseille Univ, Lab AFMB, CNRS, UMR 7257, F-13288 Marseille, France; [Padilla, Andre] Univ Montpellier 1, Ctr Biochim Struct, CNRS, INSERM,U554,UMR 5048, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 2, Ctr Biochim Struct, CNRS, INSERM,U554,UMR 5048, F-34090 Montpellier, France; [Brunel, Joanna; Gerlier, Denis] Univ Lyon 1, Ecole Normale Super Lyon, Lab Virol Humaine, INSERM,U758, F-69365 Lyon, France	University System of Ohio; Ohio State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Oglesbee, M (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.	michael.oglesbee@cvm.osu.edu; Sonia.Longhi@afmb.univ-mrs.fr	BRUNEL, JOANNA/C-6322-2015; Gerlier, Denis/L-6094-2014; LONGHI, Sonia/M-5305-2014	BRUNEL, JOANNA/0000-0002-3978-9833; Gerlier, Denis/0000-0001-5539-456X; LONGHI, Sonia/0000-0002-6829-6771; PADILLA, ANDRE/0000-0001-9702-4612	National Institutes of Health from NINDS [R01 NS031693-11A2]; CNRS; Agence Nationale de la Recherche [ANR-05-MIIM-035-02, ANR-08-PCVI-0020-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031693] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS031693-11A2 from NINDS (to M. O.). This work was also supported by the CNRS and the Agence Nationale de la Recherche programs "Microbiologie et Immunologie" (ANR-05-MIIM-035-02) and "Physico-Chimie du Vivant" (ANR-08-PCVI-0020-01) (to D. G. and S. L.).	Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bischak CG, 2010, BIOPHYS J, V99, P1676, DOI 10.1016/j.bpj.2010.06.060; Blocquel D, 2012, MOL BIOSYST, V8, P392, DOI 10.1039/c1mb05401e; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; BROWN HR, 1987, ARCH VIROL, V94, P163, DOI 10.1007/BF01313735; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; DIALLO A, 1994, J GEN VIROL, V75, P233, DOI 10.1099/0022-1317-75-1-233; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; DUBOISDALCQ M, 1973, J VIROL, V12, P909, DOI 10.1128/JVI.12.4.909-918.1973; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Gerlier D, 2009, CURR TOP MICROBIOL, V329, P163; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Habchi J, 2012, WILEY SER PROTEIN P, P47; Habchi J, 2012, MOL BIOSYST, V8, P69, DOI 10.1039/c1mb05204g; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; HIRANO A, 1993, J VIROL, V67, P1848, DOI 10.1128/JVI.67.4.1848-1853.1993; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Liljeroos L, 2011, P NATL ACAD SCI USA, V108, P18085, DOI 10.1073/pnas.1105770108; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Longhi S., 2011, NEGATIVE STRAND RNA, P95; Longhi S, 2010, PROTEIN PEPTIDE LETT, V17, P961, DOI 10.2174/092986610791498894; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Plemper RK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002058; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rager M, 2002, EMBO J, V21, P2364, DOI 10.1093/emboj/21.10.2364; Riedl P, 2002, VIRUS RES, V83, P1, DOI 10.1016/S0168-1702(01)00379-3; ROBBINS SJ, 1980, J GEN VIROL, V47, P301, DOI 10.1099/0022-1317-47-2-301; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; SURYANARAYANA K, 1994, J VIROL, V68, P1532, DOI 10.1128/JVI.68.3.1532-1543.1994; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vincent S, 1999, VIROLOGY, V265, P185, DOI 10.1006/viro.1999.0064; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yanagi Y, 2009, CURR TOP MICROBIOL, V329, P13; Yegambaram K, 2010, PROTEIN SCI, V19, P893, DOI 10.1002/pro.354; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	81	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11951	11967		10.1074/jbc.M111.333088	http://dx.doi.org/10.1074/jbc.M111.333088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22318731	Green Published, hybrid			2022-12-27	WOS:000302782200034
J	Mollan, TL; Khandros, E; Weiss, MJ; Olson, JS				Mollan, Todd L.; Khandros, Eugene; Weiss, Mitchell J.; Olson, John S.			Kinetics of alpha-Globin Binding to alpha-Hemoglobin Stabilizing Protein (AHSP) Indicate Preferential Stabilization of Hemichrome Folding Intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPARATED HUMAN ALPHA; HEMIN DISSOCIATION; BETA-THALASSEMIA; PROSTHETIC GROUPS; T-STATE; CHAINS; SUBUNITS; MECHANISM; ERYTHROPOIESIS; OXYHEMOGLOBIN	Human alpha-hemoglobin stabilizing protein (AHSP) is a conserved mammalian erythroid protein that facilitates the production of Hemoglobin A by stabilizing free alpha-globin. AHSP rapidly binds to ferrous alpha with association (k '(AHSP)) and dissociation (k(AHSP)) rate constants of approximate to 10 mu M-1 s(-1) and 0.2 s(-1), respectively, at pH 7.4 at 22 degrees C. A small slow phase was observed when AHSP binds to excess ferrous alpha CO. This slow phase appears to be due to cis to trans prolyl isomerization of the Asp(29)-Pro(30) peptide bond in wild-type AHSP because it was absent when alpha CO was mixed with P30A and P30W AHSP, which are fixed in the trans conformation. This slow phase was also absent when met(Fe3+)-alpha reacted with wild-type AHSP, suggesting that met-alpha is capable of rapidly binding to either Pro(30) conformer. Both wildtype and Pro(30)-substituted AHSPs drive the formation of a met-alpha hemichrome conformation following binding to either met-or oxy(Fe2+)-alpha. The dissociation rate of the met-alpha AHSP complex (k(AHSP) approximate to 0.002 s(-1)) is similar to 100-fold slower than that for ferrous alpha AHSPcomplexes, resulting in a much higher affinity of AHSP for met-alpha. Thus, in vivo, AHSP acts as a molecular chaperone by rapidly binding and stabilizing met-alpha hemichrome folding intermediates. The low rate of met-alpha dissociation also allows AHSP to have a quality control function by kinetically trapping ferric alpha and preventing its incorporation into less stable mixed valence Hemoglobin A tetramers. Reduction of AHSP-bound met-alpha allows more rapid release to beta subunits to form stable fully, reduced hemoglobin dimers and tetramers.	[Mollan, Todd L.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Khandros, Eugene; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Khandros, Eugene; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	Rice University; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892,MS-140, Houston, TX 77251 USA.	olson@rice.edu	Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403	National Institutes of Health [HL47020, GM35649, DK61692, HL087427, GM008362]; Welch Grant [C-0612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427, R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061692, R01DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL47020 (to J. S. O.), GM35649 (to J. S. O.), DK61692 (to M. J. W.), HL087427 (to M. J. W.), and GM008362 (to T. L. M.). This work was also supported by Welch Grant C-0612 (to J. S. O.).	ALPERT B, 1980, PHOTOCHEM PHOTOBIOL, V31, P1, DOI 10.1111/j.1751-1097.1980.tb03674.x; ANTONINI E, 1977, ANNU REV BIOPHYS BIO, V6, P239, DOI 10.1146/annurev.bb.06.060177.001323; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P13; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; BENZ EJ, 1974, SEMIN HEMATOL, V11, P463; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Biswal BK, 2002, ACTA CRYSTALLOGR D, V58, P1155, DOI 10.1107/S0907444902007138; BOYER PD, 1954, J AM CHEM SOC, V76, P4331, DOI 10.1021/ja01646a025; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; BUCCI E, 1965, J BIOL CHEM, V240, pP551; BUNN HF, 1987, BLOOD, V69, P1; BUNN HF, 1966, P NATL ACAD SCI USA, V56, P974, DOI 10.1073/pnas.56.3.974; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Culbertson D. S., 2010, THESIS RICE U; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FRIEDMAN FK, 1979, ANNU REV BIOCHEM, V48, P217, DOI 10.1146/annurev.bi.48.070179.001245; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; GERACI G, 1969, J BIOL CHEM, V244, P4664; Gomes C. M., 2011, PROTEIN FOLDING META, P97; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; KAWAMURA Y, 1983, J BIOCHEM-TOKYO, V93, P1159, DOI 10.1093/oxfordjournals.jbchem.a134241; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; LEUTZINGER Y, 1981, P NATL ACAD SCI-BIOL, V78, P780, DOI 10.1073/pnas.78.2.780; MANSOURI A, 1973, BIOCHEMISTRY-US, V12, P4946, DOI 10.1021/bi00748a020; MCDONALD MJ, 1987, J BIOL CHEM, V262, P5951; MCGOVERN P, 1976, J BIOL CHEM, V251, P7871; Mollan T. L., 2011, THESIS RICE U; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; MRABET NT, 1986, J BIOL CHEM, V261, P5222; MRABET NT, 1986, J BIOL CHEM, V261, P1111; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SHAEFFER JR, 1984, J BIOL CHEM, V259, P4544; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; VALDES R, 1978, P NATL ACAD SCI USA, V75, P311, DOI 10.1073/pnas.75.1.311; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490; WAKS M, 1973, J BIOL CHEM, V248, P6462; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; YIP YK, 1972, J BIOL CHEM, V247, P7237; YIP YK, 1977, P NATL ACAD SCI USA, V74, P64, DOI 10.1073/pnas.74.1.64; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200; Zoldak G, 2009, BIOCHEMISTRY-US, V48, P10423, DOI 10.1021/bi9014242	70	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11338	11350		10.1074/jbc.M111.313247	http://dx.doi.org/10.1074/jbc.M111.313247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298770	Green Published, hybrid			2022-12-27	WOS:000302780100064
J	Schiavinato, A; Becker, AKA; Zanetti, M; Corallo, D; Milanetto, M; Bizzotto, D; Bressan, G; Guljelmovic, M; Paulsson, M; Wagener, R; Braghetta, P; Bonaldo, P				Schiavinato, Alvise; Becker, Ann-Kathrin A.; Zanetti, Miriam; Corallo, Diana; Milanetto, Martina; Bizzotto, Dario; Bressan, Giorgio; Guljelmovic, Marija; Paulsson, Mats; Wagener, Raimund; Braghetta, Paola; Bonaldo, Paolo			EMILIN-3, Peculiar Member of Elastin Microfibril Interface-located Protein (EMILIN) Family, Has Distinct Expression Pattern, Forms Oligomeric Assemblies, and Serves as Transforming Growth Factor beta (TGF-beta) Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN/HEPARAN SULFATE BINDING; SECONDARY STRUCTURE; MOLECULAR-CLONING; COILED-COIL; DOMAINS; HEPARIN; PROTEOGLYCANS; GLYCOPROTEIN; MULTIMERIN; INTERACTS	EMILIN-3 is a glycoprotein of the extracellular matrix belonging to a family that contains a characteristic N-terminal cysteine-rich EMI domain. Currently, EMILIN-3 is the least characterized member of the elastin microfibril interface-located protein (EMILIN)/Multimerin family. Using RNA, immunohistochemical, and protein chemistry approaches, we carried out a detailed characterization of the expression and biochemical properties of EMILIN-3 in mouse. During embryonic and postnatal development, EMILIN-3 showed a peculiar and dynamic pattern of gene expression and protein distribution. EMILIN-3 mRNA was first detected at E8.5-E9.5 in the tail bud and in the primitive gut, and at later stages it became abundant in the developing gonads and osteogenic mesenchyme. Interestingly and in contrast to other EMILIN/Multimerin genes, EMILIN-3 was not found in the cardiovascular system. Despite the absence of the globular C1q domain, immunoprecipitation and Western blot analyses demonstrated that EMILIN-3 forms disulfide-bonded homotrimers and higher order oligomers. Circular dichroism spectroscopy indicated that the most C-terminal part of EMILIN-3 has a substantial alpha-helical content and forms coiled coil structures involved in EMILIN-3 homo-oligomerization. Transfection experiments with recombinant constructs showed that the EMI domain contributes to the higher order self-assembly but was dispensable for homotrimer formation. EMILIN-3 was found to bind heparin with high affinity, a property mediated by the EMI domain, thus revealing a new function for this domain that may contribute to the interaction of EMILIN-3 with other extracellular matrix and/or cell surface molecules. Finally, in vitro experiments showed that EMILIN-3 is able to function as an extracellular regulator of the activity of TGF-beta ligands.	[Schiavinato, Alvise; Zanetti, Miriam; Corallo, Diana; Milanetto, Martina; Bizzotto, Dario; Bressan, Giorgio; Guljelmovic, Marija; Braghetta, Paola; Bonaldo, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Becker, Ann-Kathrin A.; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Padua; University of Cologne; University of Cologne; University of Cologne	Bonaldo, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale G Colombo 3, I-35121 Padua, Italy.	bonaldo@bio.unipd.it	Corallo, Diana/K-6403-2016; Corallo, Diana/Q-4286-2019; Braghetta, Paola/K-5478-2016	Corallo, Diana/0000-0001-7075-1414; Braghetta, Paola/0000-0003-2547-8679; Bonaldo, Paolo/0000-0002-9571-8140; BIZZOTTO, Dario/0000-0002-9036-5016	University of Padova [CPDA075559]; Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale); German Research Council (Deutsche Forschungsgemeinschaft) [WA1338/2-6, SFB 829]	University of Padova; Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the University of Padova (Grant CPDA075559), the Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale), and the German Research Council (Deutsche Forschungsgemeinschaft Grants WA1338/2-6 and SFB 829).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Braghetta P, 2002, MATRIX BIOL, V21, P603, DOI 10.1016/S0945-053X(02)00072-0; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Doi M, 2004, BIOCHEM BIOPH RES CO, V313, P888, DOI 10.1016/j.bbrc.2003.11.181; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; Doliana R, 2000, J BIOL CHEM, V275, P785, DOI 10.1074/jbc.275.2.785; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HAYWARD CPM, 1991, BLOOD, V77, P2556; HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246; HODGES R S, 1990, Peptide Research, V3, P123; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Larrain J, 2000, DEVELOPMENT, V127, P821; Leimeister C, 2002, DEV BIOL, V249, P204, DOI 10.1006/dbio.2002.0764; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Milanetto M, 2008, DEV DYNAM, V237, P222, DOI 10.1002/dvdy.21402; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Parsi MK, 2010, MATRIX BIOL, V29, P393, DOI 10.1016/j.matbio.2010.03.005; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Sambrook J., 2001, MOL CLONING LAB MANU; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	42	27	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11498	11515		10.1074/jbc.M111.303578	http://dx.doi.org/10.1074/jbc.M111.303578			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334695	Green Published, hybrid			2022-12-27	WOS:000302780100078
J	Aleshin, AE; Schraufstatter, IU; Stec, B; Bankston, LA; Liddington, RC; DiScipio, RG				Aleshin, Alexander E.; Schraufstatter, Ingrid U.; Stec, Boguslaw; Bankston, Laurie A.; Liddington, Robert C.; DiScipio, Richard G.			Structure of Complement C6 Suggests a Mechanism for Initiation and Unidirectional, Sequential Assembly of Membrane Attack Complex (MAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I MODULES; PORE FORMATION; CRYSTAL-STRUCTURE; COMPONENT; BINDING; PROTEINS; REVEALS; SYSTEM; C7; C9	The complement membrane attack complex (MAC) is formed by the sequential assembly of C5b with four homologous proteins as follows: one copy each of C6, C7, and C8 and 12-14 copies of C9. Together these form a lytic pore in bacterial membranes. C6 through C9 comprise a MAC-perforin domain flanked by 4-9 "auxiliary" domains. Here, we report the crystal structure of C6, the first and longest of the pore proteins to be recruited by C5b. Comparisons with the structures of the C8 alpha beta gamma heterodimer and perforin show that the central domain of C6 adopts a "closed" (perforin-like) state that is distinct from the "open" conformations in C8. We further show that C6, C8 alpha, and C8 beta contain three homologous subdomains ("upper," "lower," and "regulatory") related by rotations about two hinge points. In C6, the regulatory segment includes four auxiliary domains that stabilize the closed conformation, inhibiting release of membrane-inserting elements. In C8 beta, rotation of the regulatory segment is linked to an opening of the central beta-sheet of its clockwise partner, C8 alpha. Based on these observations, we propose a model for initiation and unidirectional propagation of the MAC in which the auxiliary domains play key roles: in the assembly of the C5b-8 initiation complex; in driving and regulating the opening of the beta-sheet of the MAC-performin domain of each new recruit as it adds to the growing pore; and in stabilizing the final pore. Our model of the assembled pore resembles those of the cholesterol-dependent cytolysins but is distinct from that recently proposed for perforin.	[Aleshin, Alexander E.; Stec, Boguslaw; Bankston, Laurie A.; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Schraufstatter, Ingrid U.; DiScipio, Richard G.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [R21 HL094878]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; Multiple Sclerosis National Research Institute [4061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Multiple Sclerosis National Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL094878 (to I. U. S.). This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038 (to R. C. L.) and Multiple Sclerosis National Research Institute Grant 4061 (to R. G. D.).	Adams P. D., 2010, ACTA CRYSTALLOGR D, V66, P2123; Arias-Moreno X, 2010, PROTEINS, V78, P950, DOI 10.1002/prot.22619; BHAKDI S, 1980, J IMMUNOL, V124, P2451; BHAKDI S, 1978, P NATL ACAD SCI USA, V75, P5655, DOI 10.1073/pnas.75.11.5655; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corvini M, 2004, ANN ALLERG ASTHMA IM, V93, P200, DOI 10.1016/S1081-1206(10)61476-7; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; DiScipio R. G, 1998, COMPLEMENT SYSTEM, P50; DISCIPIO RG, 1988, J BIOL CHEM, V263, P549; DISCIPIO RG, 1992, J BIOL CHEM, V267, P17087; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1989, J BIOL CHEM, V264, P16197; DISCIPIO RG, 1994, PROTEIN EXPRES PURIF, V5, P170, DOI 10.1006/prep.1994.1027; DOURMASHKIN RR, 1978, IMMUNOLOGY, V35, P205; DUCRET F, 1988, REV MED INTERNE, V9, P534, DOI 10.1016/S0248-8663(88)80021-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; HAEFLIGER JA, 1989, J BIOL CHEM, V264, P18041; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HU VW, 1981, J IMMUNOL, V127, P380; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kimura A, 2009, DEV COMP IMMUNOL, V33, P77, DOI 10.1016/j.dci.2008.07.005; Kimura A, 2009, FISH SHELLFISH IMMUN, V27, P768, DOI 10.1016/j.fsi.2009.08.008; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KOLB WP, 1975, P NATL ACAD SCI USA, V72, P1687, DOI 10.1073/pnas.72.5.1687; LAINE RO, 1989, NATURE, V341, P63, DOI 10.1038/341063a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; Lovelace LL, 2011, J BIOL CHEM, V286, P17585, DOI 10.1074/jbc.M111.219766; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Orren A, 2004, SAMJ S AFR MED J, V94, P345; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelan MM, 2009, J BIOL CHEM, V284, P19637, DOI 10.1074/jbc.M901993200; Plumb ME, 1999, BIOCHEMISTRY-US, V38, P8478, DOI 10.1021/bi9904858; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; PODACK ER, 1981, P NATL ACAD SCI-BIOL, V78, P4544, DOI 10.1073/pnas.78.7.4544; PODACK ER, 1984, J BIOL CHEM, V259, P8641; PODACK ER, 1982, J EXP MED, V156, P268, DOI 10.1084/jem.156.1.268; PODACK ER, 1978, J IMMUNOL, V120, P1841; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Scibek JJ, 2002, BIOCHEMISTRY-US, V41, P14546, DOI 10.1021/bi026641j; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SILVERSMITH RE, 1986, BIOCHEMISTRY-US, V25, P7717, DOI 10.1021/bi00371a065; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzuki MM, 2002, J MOL EVOL, V54, P671, DOI 10.1007/s00239-001-0068-z; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Taylor KM, 1997, IMMUNOLOGY, V91, P20, DOI 10.1046/j.1365-2567.1997.00225.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1984, J BIOL CHEM, V259, P7857; TSCHOPP J, 1985, J IMMUNOL, V134, P495; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; WURZNER R, 1995, J CLIN INVEST, V95, P1877, DOI 10.1172/JCI117868; WURZNER R, 1995, IMMUNOLOGY, V85, P214; ZALMAN LS, 1990, MOL IMMUNOL, V27, P533, DOI 10.1016/0161-5890(90)90072-8	70	70	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10210	10222		10.1074/jbc.M111.327809	http://dx.doi.org/10.1074/jbc.M111.327809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267737	Green Published, hybrid			2022-12-27	WOS:000302167200052
J	Arakaki, M; Ishikawa, M; Nakamura, T; Iwamoto, T; Yamada, A; Fukumoto, E; Saito, M; Otsu, K; Harada, H; Yamada, Y; Fukumoto, S				Arakaki, Makiko; Ishikawa, Masaki; Nakamura, Takashi; Iwamoto, Tsutomu; Yamada, Aya; Fukumoto, Emiko; Saito, Masahiro; Otsu, Keishi; Harada, Hidemitsu; Yamada, Yoshihiko; Fukumoto, Satoshi			Role of Epithelial-Stem Cell Interactions during Dental Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EPIPROFIN; IN-VITRO; PLURIPOTENT; EXPRESSION; INDUCTION; TEETH; IDENTIFICATION; AMELOBLASTIN; MODEL; FATE	Epithelial-mesenchymal interactions regulate the growth and morphogenesis of ectodermal organs such as teeth. Dental pulp stem cells (DPSCs) are a part of dental mesenchyme, derived from the cranial neural crest, and differentiate into dentin forming odontoblasts. However, the interactions between DPSCs and epithelium have not been clearly elucidated. In this study, we established a mouse dental pulp stem cell line (SP) comprised of enriched side population cells that displayed a multipotent capacity to differentiate into odontogenic, osteogenic, adipogenic, and neurogenic cells. We also analyzed the interactions between SP cells and cells from the rat dental epithelial SF2 line. When cultured with SF2 cells, SP cells differentiated into odontoblasts that expressed dentin sialophosphoprotein. This differentiation was regulated by BMP2 and BMP4, and inhibited by the BMP antagonist Noggin. We also found that mouse iPS cells cultured with mitomycin C-treated SF2-24 cells displayed an epithelial cell-like morphology. Those cells expressed the epithelial cell markers p63 and cytokeratin-14, and the ameloblast markers ameloblastin and enamelin, whereas they did not express the endodermal cell marker Gata6 or mesodermal cell marker brachyury. This is the first report of differentiation of iPS cells into ameloblasts via interactions with dental epithelium. Co-culturing with dental epithelial cells appears to induce stem cell differentiation that favors an odontogenic cell fate, which may be a useful approach for tooth bioengineering strategies.	[Arakaki, Makiko; Nakamura, Takashi; Iwamoto, Tsutomu; Yamada, Aya; Fukumoto, Emiko; Fukumoto, Satoshi] Tohoku Univ, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 9808575, Japan; [Ishikawa, Masaki; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Chiba 2788510, Japan; [Otsu, Keishi; Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan	Tohoku University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tokyo University of Science; Iwate Medical University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp	Nakamura, Takashi/A-8931-2012; Iwamoto, Tsutomu/AAA-6597-2019; Nakamura, Takashi/P-7796-2016; Harada, Hidemitsu/P-5692-2017; Iwamoto, Tsutomu/AAI-8952-2021	Nakamura, Takashi/0000-0001-9904-1037; Iwamoto, Tsutomu/0000-0001-8472-605X; Nakamura, Takashi/0000-0001-9904-1037; Harada, Hidemitsu/0000-0002-9724-8568; Fukumoto, Satoshi/0000-0002-5046-6891	NIDCR, National Institutes of Health; Ministry of Education, Science, and Culture of Japan [20679006, 21792054, 21792154]; NEXT program [LS010]; Takeda Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000483, ZIADE000485, ZIADE000720] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23593013, 22659373, 22791774] Funding Source: KAKEN	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDCR, National Institutes of Health (to Y. Y.). This work was also supported by Grants-in-aid 20679006 (to S. F.), 21792054 (to A. Y.), 21792154 (to E. F.) from the Ministry of Education, Science, and Culture of Japan, and the NEXT program (LS010, to S. F.), and by grants from the Takeda Science Foundation.	BAROFFIO A, 1991, DEVELOPMENT, V112, P301; Chang CB, 1998, J NEUROBIOL, V36, P128, DOI 10.1002/(SICI)1097-4695(199808)36:2<128::AID-NEU3>3.0.CO;2-3; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; Chen YP, 1996, DEVELOPMENT, V122, P3035; Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hu B, 2006, J DENT RES, V85, P416, DOI 10.1177/154405910608500504; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Klotz O, 1905, J EXP MED, V7, P633, DOI 10.1084/jem.7.6.633; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Li LW, 2011, GENE EXPR PATTERNS, V11, P163, DOI 10.1016/j.gep.2010.11.001; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Nakamura T, 2011, J ORAL BIOSCI, V53, P22, DOI 10.2330/joralbiosci.53.22; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Nam H, 2009, BIOCHEM BIOPH RES CO, V386, P135, DOI 10.1016/j.bbrc.2009.05.141; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; So KH, 2011, INT J CARDIOL, V153, P277, DOI 10.1016/j.ijcard.2010.08.052; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ten Cate A R, 1996, Oral Dis, V2, P55; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314; Yokoi T, 2007, CELL TISSUE RES, V327, P301, DOI 10.1007/s00441-006-0257-6; Yoshida Y, 2011, J MOL CELL CARDIOL, V50, P327, DOI 10.1016/j.yjmcc.2010.10.026; Yoshizaki K, 2008, J BIOL CHEM, V283, P3385, DOI 10.1074/jbc.M704913200; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	97	100	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10590	10601		10.1074/jbc.M111.285874	http://dx.doi.org/10.1074/jbc.M111.285874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298769	hybrid, Green Published			2022-12-27	WOS:000302167200084
J	Bisping, E; Ikeda, S; Sedej, M; Wakula, P; McMullen, JR; Tarnavski, O; Sedej, S; Izumo, S; Pu, WT; Pieske, B				Bisping, Egbert; Ikeda, Sadakatsu; Sedej, Miriam; Wakula, Paulina; McMullen, Julie R.; Tarnavski, Oleg; Sedej, Simon; Izumo, Seigo; Pu, William T.; Pieske, Burkert			Transcription Factor GATA4 Is Activated but Not Required for Insulin-like Growth Factor 1 (IGF1)-induced Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; HEART-FAILURE; PHYSIOLOGICAL HYPERTROPHY; PROTEIN-SYNTHESIS; GENE-EXPRESSION; PATHWAY; VITRO; CARDIOMYOCYTES; KINASE; VIVO	Insulin-like growth factor 1 (IGF1) promotes a physiological type of cardiac hypertrophy and has therapeutic effects in heart disease. Here, we report the relationship of IGF1 to GATA4, an essential transcription factor in cardiac hypertrophy and cell survival. In cultured neonatal rat ventricular myocytes, we compared the responses to IGF1 (10 nmol/liter) and phenylephrine (PE, 20 mu mol/liter), a known GATA4 activator, in concentrations promoting a similar extent of hypertrophy. IGF1 and PE both increased nuclear accumulation of GATA4 and phosphorylation at Ser(105) (PE, 2.4fold; IGF1, 1.8fold; both, p < 0.05) and increased GATA4 DNA binding activity as indicated by ELISA and by chromatin IP of selected promoters. Although IGF1 and PE each activated GATA4 to the same degree, GATA4 knockdown by RNA interference only blocked hypertrophy by PE but not by IGF1. PE induction of a panel of GATA4 target genes (Nppa, Nppb, Tnni3, Myl1, and Acta1) was inhibited by GATA4 knockdown. In contrast, IGF1 regulated only Acta1 in a GATA4-dependent fashion. Consistent with the in vitro findings, Gata4 haploinsufficiency in mice did not alter cardiac structure, hyperdynamic function, or antifibrotic effects induced by myocardial overexpression of the IGF1 receptor. Our data indicate that GATA4 is activated by the IGF1 pathway, but although it is required for responses to pathological stimuli, it is not necessary for the effects of IGF1 on cardiac structure and function.	[Bisping, Egbert; Wakula, Paulina; Sedej, Simon; Pieske, Burkert] Med Univ Graz, Dept Cardiol, A-8036 Graz, Austria; [Bisping, Egbert; Sedej, Miriam; Pieske, Burkert] Univ Gottingen, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; [Ikeda, Sadakatsu; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [McMullen, Julie R.] Baker IDI Heart & Diabet Res Inst, Melbourne, Vic 8008, Australia; [Izumo, Seigo] CVM Consulting, Brookline, MA 02445 USA; [Tarnavski, Oleg] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Medical University of Graz; University of Gottingen; Harvard University; Boston Children's Hospital; Baker Heart and Diabetes Institute; Novartis	Pieske, B (corresponding author), Med Univ Graz, Dept Cardiol, Auenbruggerpl 15, A-8036 Graz, Austria.	burkert.pieske@medunigraz.at	Pu, William/AAJ-8301-2020; Sedej, Simon/L-3066-2015; Pieske, Burkert/M-8089-2016	Pu, William/0000-0002-4551-8079; Sedej, Simon/0000-0002-4419-6821; Pieske, Burkert/0000-0002-6466-5306	National Institutes of Health [HL095712]; German national genomic research network [NGFN-01GS0422]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German national genomic research network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095712 (to W. T. P.). This work was also supported by German national genomic research network grant NGFN-01GS0422 (to E. B. and B. P.). S. I. and O.T. participated in this research while employees of Novartis Institute for Biomedical Research (Cambridge, MA).	Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Charron F, 1999, MOL CELL BIOL, V19, P4355; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Diedrichs H, 2004, EUR J HEART FAIL, V6, P3, DOI 10.1016/j.ejheart.2003.07.007; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hall JL, 2004, PHYSIOL GENOMICS, V17, P283, DOI 10.1152/physiolgenomics.00004.2004; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje; Kuester C., 2005, THESIS JW GOETHE U; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Le Corvoisier P, 2007, J CLIN ENDOCR METAB, V92, P180, DOI 10.1210/jc.2006-1313; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pretorius L, 2008, CLIN EXP PHARMACOL P, V35, P438, DOI 10.1111/j.1440-1681.2008.04893.x; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Satomi-Kobayashi S, 2004, CIRC J, V68, P247, DOI 10.1253/circj.68.247; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Shen WH, 2005, J ENDOCRINOL, V185, P275, DOI 10.1677/joe.1.06080; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; von Lewinski D, 2003, CIRC RES, V92, P169, DOI 10.1161/01.RES.0000051885.70159.12; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022	37	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9827	9834		10.1074/jbc.M111.338749	http://dx.doi.org/10.1074/jbc.M111.338749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22228770	Green Published, hybrid			2022-12-27	WOS:000302167200015
J	Ramani, VC; Pruett, PS; Thompson, CA; DeLucas, LD; Sanderson, RD				Ramani, Vishnu C.; Pruett, Pamela S.; Thompson, Camilla A.; DeLucas, Lawrence D.; Sanderson, Ralph D.			Heparan Sulfate Chains of Syndecan-1 Regulate Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; AGGRESSIVE TUMOR PHENOTYPE; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PSEUDOMONAS-AERUGINOSA; SURFACE PROTEOGLYCAN; SOLUBLE SYNDECAN-1; MULTIPLE-MYELOMA; HELA-CELLS; CANCER	Matrix metalloproteinases release intact syndecan-1 ectodomains from the cell surface giving rise to a soluble, shed form of the proteoglycan. Although it is known that shed syndecan-1 controls diverse pathophysiological responses in cancer, wound healing, inflammation, infection, and immunity, the mechanisms regulating shedding remain unclear. We have discovered that the heparan sulfate chains present on syndecan core proteins suppress shedding of the proteoglycan. Syndecan shedding is dramatically enhanced when the heparan sulfate chains are enzymatically degraded or absent from the core protein. Exogenous heparan sulfate or heparin does not inhibit shedding, indicating that heparan sulfate must be attached to the core protein to suppress shedding. Regulation of shedding by heparan sulfate occurs in multiple cell types, for both syndecan-1 and syndecan-4 and in murine and human syndecans. Mechanistically, the loss of heparan sulfate enhances the susceptibility of the core protein to proteolytic cleavage by matrix metalloproteinases. Enhanced shedding of syndecan-1 following loss of heparan sulfate is accompanied by a dramatic increase in core protein synthesis. This suggests that in response to an increase in the rate of shedding, cells attempt to maintain a significant level of syndecan-1 on the cell surface. Together these data indicate that the amount of heparan sulfate present on syndecan core proteins regulates both the rate of syndecan shedding and core protein synthesis. These findings assign new functions to heparan sulfate chains, thereby broadening our understanding of their physiological importance and implying that therapeutic inhibition of heparan sulfate degradation could impact the progression of some diseases.	[Ramani, Vishnu C.; Thompson, Camilla A.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Pruett, Pamela S.; DeLucas, Lawrence D.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [DeLucas, Lawrence D.; Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Sanderson, Ralph D.] Univ Alabama Birmingham, Ctr Metab Bone Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 814 SHEL,1530 3rd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340, P30 AR48311, P30 AI027767]; NATIONAL CANCER INSTITUTE [R01CA135075, R01CA138340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.).; We thank Enid Keyser for technical assistance in flow cytometry and sorting and the Analytical and Preparative Cytometry Facility (supported by National Institutes of Health Grant P30 AR48311) of the Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center at the University of Alabama, Birmingham. We thank the University of Alabama, Birmingham, Center for AIDS Research DNA Sequencing Core Facility (supported by National Institutes of Health Grant P30 AI027767) for DNA sequencing.	Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Hayashida K, 2008, J BIOL CHEM, V283, P35435, DOI 10.1074/jbc.M804172200; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Joensuu H, 2002, CANCER RES, V62, P5210; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Live DH, 1996, P NATL ACAD SCI USA, V93, P12759, DOI 10.1073/pnas.93.23.12759; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2011, J BIOL CHEM, V286, P30377, DOI 10.1074/jbc.M111.254789; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; SANDERSON RD, 1992, J IMMUNOL, V148, P3902; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Sorensen HP, 2008, J BIOL CHEM, V283, P31920, DOI 10.1074/jbc.M804113200; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	40	83	86	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9952	9961		10.1074/jbc.M111.330803	http://dx.doi.org/10.1074/jbc.M111.330803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298773	Green Published, hybrid			2022-12-27	WOS:000302167200027
J	Iwamura, A; Fukami, T; Higuchi, R; Nakajima, M; Yokoi, T				Iwamura, Atsushi; Fukami, Tatsuki; Higuchi, Ryota; Nakajima, Miki; Yokoi, Tsuyoshi			Human alpha/beta Hydrolase Domain Containing 10 (ABHD10) Is Responsible Enzyme for Deglucuronidation of Mycophenolic Acid Acyl-glucuronide in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-TRANSPLANT RECIPIENTS; ARYLACETAMIDE DEACETYLASE; IDENTIFICATION; HYDROLYSIS; PROTEIN; CARBOXYLESTERASES; PHARMACOKINETICS; ACTIVATION; METABOLITE; MICROSOMES	Mycophenolic acid (MPA), the active metabolite of the immunosuppressant mycophenolate mofetil (MMF), is primarily metabolized by glucuronidation to a phenolic glucuronide (MPAG) and an acyl glucuronide (AcMPAG). It is known that AcMPAG, which may be an immunotoxic metabolite, is deglucuronidated in human liver. However, it has been reported that recombinant beta-glucuronidase does not catalyze this reaction. AcMPAG deglucuronidation activity was detected in both human liver cytosol (HLC) and microsomes (HLM). In this study, the enzyme responsible for AcMPAG deglucuronidation was identified by purification from HLC with column chromatographic purification steps. The purified enzyme was identified as alpha/beta hydrolase domain containing 10 (ABHD10) by amino acid sequence analysis. Recombinant ABHD10 expressed in Sf9 cells efficiently deglucuronidated AcMPAG with a K-m value of 100.7 +/- 10.2 mu M, which was similar to those in HLM, HLC, and human liver homogenates (HLH). Immunoblot analysis revealed ABHD10 protein expression in both HLC and HLM. The AcMPAG deglucuronidation by recombinant ABHD10, HLC, and HLH were potently inhibited by AgNO3, CdCl2, CuCl2, PMSF, bis-p-nitrophenylphosphate, and DTNB. The CLint value of AcMPAG formation from MPA, which was catalyzed by human UGT2B7, in HLH was increased by 1.8-fold in the presence of PMSF. Thus, human ABHD10 would affect the formation of AcMPAG, the immunotoxic metabolite.	[Iwamura, Atsushi; Fukami, Tatsuki; Higuchi, Ryota; Nakajima, Miki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Dept Drug Metab & Toxicol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yokoi, T (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Dept Drug Metab & Toxicol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Yokoi, Tsuyoshi/0000-0002-3239-2817; Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [23590174]; Grants-in-Aid for Scientific Research [23590174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 23590174.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullingham RES, 1998, CLIN PHARMACOKINET, V34, P429, DOI 10.2165/00003088-199834060-00002; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujiyama N, 2009, XENOBIOTICA, V39, P407, DOI 10.1080/00498250902807338; Fukami T, 2008, PHARMACOGENET GENOM, V18, P911, DOI 10.1097/FPC.0b013e32830b0c5e; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; HEYMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P609, DOI 10.1515/bchm2.1967.348.1.609; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; IWATSUBO K, 1965, JPN J PHARMACOL, V15, P244, DOI 10.1254/jjp.15.244; Johnson G, 2000, MOL IMMUNOL, V37, P707, DOI 10.1016/S0161-5890(00)00104-8; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; Labar G, 2007, CHEMBIOCHEM, V8, P1293, DOI 10.1002/cbic.200700139; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langmann T, 1997, BBA-GENE STRUCT EXPR, V1350, P65, DOI 10.1016/S0167-4781(96)00142-X; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; LEVVY GA, 1952, BIOCHEM J, V52, P464, DOI 10.1042/bj0520464; Li F, 2009, MOL BIOL REP, V36, P691, DOI 10.1007/s11033-008-9230-7; MINAGAWA T, 1995, BIOCHEM PHARMACOL, V49, P1361, DOI 10.1016/0006-2952(95)00071-7; Picard N, 2005, DRUG METAB DISPOS, V33, P139, DOI 10.1124/dmd.104.001651; Preuss CV, 1996, BIOCHEM PHARMACOL, V51, P1661, DOI 10.1016/0006-2952(96)00134-7; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; ROWE BJ, 1984, J PHARMACOL EXP THER, V230, P237; Shipkova M, 2004, PROTEOMICS, V4, P2728, DOI 10.1002/pmic.200300836; Shipkova M, 1999, BRIT J PHARMACOL, V126, P1075, DOI 10.1038/sj.bjp.0702399; Shipkova M, 2002, THER DRUG MONIT, V24, P390, DOI 10.1097/00007691-200206000-00011; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; SMITH PC, 1990, J PHARMACOL EXP THER, V252, P218; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; Suzuki E, 2010, DRUG METAB DISPOS, V38, P1538, DOI 10.1124/dmd.110.032938; Tabata T, 2004, DRUG METAB DISPOS, V32, P1103, DOI 10.1124/dmd.104.000554; Takahashi S, 2009, DRUG METAB DISPOS, V37, P956, DOI 10.1124/dmd.108.024331; Watanabe A, 2009, DRUG METAB DISPOS, V37, P1513, DOI 10.1124/dmd.109.026567; Wieland E, 2000, CLIN BIOCHEM, V33, P107, DOI 10.1016/S0009-9120(99)00101-0; Xu G, 2002, CLIN CANCER RES, V8, P2605; Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147; Yamazaki H, 1999, DRUG METAB DISPOS, V27, P1260	36	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9240	9249		10.1074/jbc.M111.271288	http://dx.doi.org/10.1074/jbc.M111.271288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294686	Green Published, hybrid			2022-12-27	WOS:000301797800052
J	Zhao, Y; He, W; Liu, WF; Liu, CC; Feng, LK; Sun, L; Yan, YB; Hang, HY				Zhao, Yun; He, Wei; Liu, Wei-Feng; Liu, Chun-Chun; Feng, Li-Kui; Sun, Lei; Yan, Yong-Bin; Hang, Hai-Ying			Two Distinct States of Escherichia coli Cells That Overexpress Recombinant Heterogeneous beta-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL INCLUSION-BODIES; PROTEIN AGGREGATION; FLOW-CYTOMETRY; BODY FORMATION; EXPRESSION; SOLUBILITY; CHAPERONES; AGGRESOMES; STRATEGIES; QUALITY	The mechanism by which inclusion bodies form is still not well understood, partly because the dynamic processes of the inclusion body formation and its solubilization have hardly been investigated at an individual cell level, and so the important detailed information has not been acquired for the mechanism. In this study, we investigated the in vivo folding and aggregation of Aspergillus phoenicis beta-D-galactosidase fused to a red fluorescence protein in individual Escherichia coli cells. The folding status and expression level of the recombinant beta-D-galactosidase at an individual cell level was analyzed by flow cytometry in combination with transmission electron microscopy and Western blotting. We found that individual E. coli cells fell into two distinct states, one containing only inclusion bodies accompanied with low galactosidase activity and the other containing the recombinant soluble galactosidase accompanied with high galactosidase activity. The majority of the E. coli cells in the later state possessed no inclusion bodies. The two states of the cells were shifted to a cell state with high enzyme activity by culturing the cells in isopropyl 1-thio-beta-D-galactopyranoside-free medium after an initial protein expression induction in isopropyl 1-thio-beta-D-galactopyranoside-containing medium. This shift of the cell population status took place without the level change of the beta-D-galactosidase protein in individual cells, indicating that the factor(s) besides the crowdedness of the recombinant protein play a major role in the cell state transition. These results shed new light on the mechanism of inclusion body formation and will facilitate the development of new strategies in improving recombinant protein quality.	[Liu, Wei-Feng; Feng, Li-Kui; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Sun, Lei] Chinese Acad Sci, Inst Biophys, Ctr Biol Imaging, Beijing 100101, Peoples R China; [Zhao, Yun; He, Wei; Liu, Chun-Chun; Hang, Hai-Ying] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China; [Zhao, Yun; He, Wei; Liu, Chun-Chun] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yan, YB (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn; hh91@sun5.ibp.ac.cn	Yan, Yong-Bin/A-4282-2008; He, Wei/K-4776-2014; Feng, Likui/AAC-4957-2020	Yan, Yong-Bin/0000-0002-8565-3558; Feng, Likui/0000-0003-4601-4224	National Key Basic Research Program of China (973) [2011CBA00906]; Ministry of Science and Technology [2011YQ03013404]; National Natural Science Foundation of China [30970559]	National Key Basic Research Program of China (973)(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2011CBA00906 (to H.-Y.H.) from the National Key Basic Research Program of China (973) and Grant 2011YQ03013404 (to H.-Y.H.) from the National Special Projects for Key Scientific Instruments and Equipment Development of Ministry of Science and Technology, and Grant 30970559 (to Y.-B.Y.) from the National Natural Science Foundation of China.	Ami D, 2005, FEBS LETT, V579, P3433, DOI 10.1016/j.febslet.2005.04.085; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carrio MM, 2005, J BACTERIOL, V187, P3599, DOI 10.1128/JB.187.10.3599-3601.2005; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; Carrio MM, 2000, FEBS LETT, V471, P7, DOI 10.1016/S0014-5793(00)01357-0; Choe WS, 2003, BIOTECHNOL BIOENG, V81, P221, DOI 10.1002/bit.10471; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Fruitos E, 2005, BIOTECHNOL BIOENG, V90, P869, DOI 10.1002/bit.20496; Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004; GATENBY AA, 1990, TRENDS BIOTECHNOL, V8, P354, DOI 10.1016/0167-7799(90)90224-L; Hedhammar M, 2005, J BIOTECHNOL, V119, P133, DOI 10.1016/j.jbiotec.2005.03.024; Hunt I, 2005, PROTEIN EXPRES PURIF, V40, P1, DOI 10.1016/j.pep.2004.10.018; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; LavergneMazeau F, 1996, APPL ENVIRON MICROB, V62, P3042, DOI 10.1128/AEM.62.8.3042-3046.1996; [Lei Hongxing 雷红星], 2011, [生物物理学报, Acta Biophysica Sinica], V27, P187; Lei HX, 2010, PROTEIN CELL, V1, P312, DOI 10.1007/s13238-010-0046-6; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Patkar A, 2002, J BIOTECHNOL, V93, P217, DOI 10.1016/S0168-1656(01)00399-6; PLOVINS A, 1994, APPL ENVIRON MICROB, V60, P4638, DOI 10.1128/AEM.60.12.4638-4641.1994; Sambrook J., 2002, MOL CLONING LAB MANU; SCHEIN CH, 1989, BIO-TECHNOL, V7, P1141; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; STRANDBERG L, 1991, APPL ENVIRON MICROB, V57, P1669, DOI 10.1128/AEM.57.6.1669-1674.1991; TAYLOR G, 1986, BIO-TECHNOL, V4, P553, DOI 10.1038/nbt0686-553; Teschke Carolyn M., 1992, Current Opinion in Biotechnology, V3, P468, DOI 10.1016/0958-1669(92)90073-R; Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	36	13	15	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9259	9268		10.1074/jbc.M111.327668	http://dx.doi.org/10.1074/jbc.M111.327668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303013	hybrid, Green Published			2022-12-27	WOS:000301797800054
J	Faries, KM; Kressel, LL; Wander, MJ; Holten, D; Laible, PD; Kirmaier, C; Hanson, DK				Faries, Kaitlyn M.; Kressel, Lucas L.; Wander, Marc J.; Holten, Dewey; Laible, Philip D.; Kirmaier, Christine; Hanson, Deborah K.			High Throughput Engineering to Revitalize a Vestigial Electron Transfer Pathway in Bacterial Photosynthetic Reaction Centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSULATUS REACTION CENTERS; SPHAEROIDES REACTION-CENTER; PRIMARY CHARGE SEPARATION; REACTION-CENTER MUTANT; RHODOBACTER-SPHAEROIDES; PHOTOSYSTEM-I; M-SIDE; RHODOPSEUDOMONAS-CAPSULATA; DIRECTED EVOLUTION; QUINONE REDUCTION	Photosynthetic reaction centers convert light energy into chemical energy in a series of transmembrane electron transfer reactions, each with near 100% yield. The structures of reaction centers reveal two symmetry-related branches of cofactors (denoted A and B) that are functionally asymmetric; purple bacterial reaction centers use the A pathway exclusively. Previously, site-specific mutagenesis has yielded reaction centers capable of transmembrane charge separation solely via the B branch cofactors, but the best overall electron transfer yields are still low. In an attempt to better realize the architectural and energetic factors that underlie the directionality and yields of electron transfer, sites within the protein-cofactor complex were targeted in a directed molecular evolution strategy that implements streamlined mutagenesis and high throughput spectroscopic screening. The polycistronic approach enables efficient construction and expression of a large number of variants of a heteroligomeric complex that has two intimately regulated subunits with high sequence similarity, common features of many prokaryotic and eukaryotic transmembrane protein assemblies. The strategy has succeeded in the discovery of several mutant reaction centers with increased efficiency of the B pathway; they carry multiple substitutions that have not been explored or linked using traditional approaches. This work expands our understanding of the structure-function relationships that dictate the efficiency of biological energy-conversion reactions, concepts that will aid the design of bio-inspired assemblies capable of both efficient charge separation and charge stabilization.	[Faries, Kaitlyn M.; Holten, Dewey; Kirmaier, Christine] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Kressel, Lucas L.; Wander, Marc J.; Laible, Philip D.; Hanson, Deborah K.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Washington University (WUSTL); United States Department of Energy (DOE); Argonne National Laboratory	Kirmaier, C (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	kirmaier@wustl.edu; dkhanson@anl.gov		Faries, Kaitlyn/0000-0003-1777-7716	United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG-02-09ER16116];  [DE-AC02-06CH11357]	United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); 	This work was supported by Grant DE-FG-02-09ER16116 from the United States Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences (to C. K., D. H., P. D. L., and D. K. H.). Argonne, a United States Department of Energy Office of Science laboratory, is operated under Contract DE-AC02-06CH11357.	ALLEN JP, 1995, J BIOENERG BIOMEMBR, V27, P275, DOI 10.1007/BF02110097; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; BYLINA EJ, 1988, NATURE, V336, P182, DOI 10.1038/336182a0; BYLINA EJ, 1989, BIO-TECHNOL, V7, P69, DOI 10.1038/nbt0189-69; BYLINA EJ, 1988, ISRAEL J CHEM, V28, P73; BYLINA EJ, 1986, PLASMID, V16, P175, DOI 10.1016/0147-619X(86)90055-7; CHANG CH, 1991, BIOCHEMISTRY-US, V30, P5352, DOI 10.1021/bi00236a005; Chuang JI, 2006, BIOCHEMISTRY-US, V45, P3845, DOI 10.1021/bi0601048; COLEMAN WJ, 1993, NATURE, V366, P517, DOI 10.1038/366517a0; Coleman WJ, 1990, STRUCTURE FUNCTION B, P273; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; de Boer AL, 2002, BIOCHEMISTRY-US, V41, P3081, DOI 10.1021/bi011450m; de Boer AL, 2002, PHOTOSYNTH RES, V71, P221, DOI 10.1023/A:1015533126685; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DiMagno TJ, 1998, SPECTROCHIM ACTA A, V54, P1247, DOI 10.1016/S1386-1425(98)00074-2; Dong SY, 2010, NAT PROTOC, V5, P561, DOI 10.1038/nprot.2009.239; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; Haffa ALM, 2005, J PHYS CHEM B, V109, P19923, DOI 10.1021/jp052007e; HANSON DK, 1992, BIOCHIM BIOPHYS ACTA, V1102, P260, DOI 10.1016/0005-2728(92)90108-E; HELLER BA, 1995, SCIENCE, V269, P940, DOI 10.1126/science.7638616; HELLER BA, 1995, BIOCHEMISTRY-US, V34, P5294, DOI 10.1021/bi00015a045; Heller BA, 1996, BIOCHEMISTRY-US, V35, P15418, DOI 10.1021/bi961362f; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; JIA YW, 1993, J PHYS CHEM-US, V97, P13180, DOI 10.1021/j100152a024; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Katilius E, 1999, J PHYS CHEM B, V103, P7386, DOI 10.1021/jp991670y; Katilius E, 2003, J PHYS CHEM B, V107, P12029, DOI 10.1021/jp035013o; Kee HL, 2006, BIOCHEMISTRY-US, V45, P7314, DOI 10.1021/bi060277x; KIRMAIER C, 1991, SCIENCE, V251, P922, DOI 10.1126/science.2000491; Kirmaier C, 1999, BIOCHEMISTRY-US, V38, P11516, DOI 10.1021/bi9908585; Kirmaier C, 2005, J PHYS CHEM B, V109, P24160, DOI 10.1021/jp054726z; Kirmaier C, 2003, CHEM PHYS, V294, P305, DOI [10.1016/S0301-0104(03)00283-0, 10.1016/S0301 -0104(03)00283-0]; Kirmaier C, 2003, BIOCHEMISTRY-US, V42, P2016, DOI 10.1021/bi026973o; Kirmaier C, 2002, J PHYS CHEM B, V106, P1799, DOI 10.1021/jp013264w; Kirmaier C, 2001, BIOCHEMISTRY-US, V40, P12132, DOI 10.1021/bi0113263; KIRMAIER C, 1988, P NATL ACAD SCI USA, V85, P7562, DOI 10.1073/pnas.85.20.7562; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Laible PD, 2003, BIOCHEMISTRY-US, V42, P1718, DOI 10.1021/bi026959b; Laible PD, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P849; Li J, 2000, PHOTOSYNTH RES, V64, P41, DOI 10.1023/A:1026531925602; MCDOWELL LM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P239, DOI 10.1016/0005-2728(90)90153-U; Paddock ML, 2005, BIOCHEMISTRY-US, V44, P6920, DOI 10.1021/bi047559m; Ramesh VM, 2004, BIOCHEMISTRY-US, V43, P1369, DOI 10.1021/bi0354177; ROBLES SJ, 1990, SCIENCE, V248, P1402, DOI 10.1126/science.2192455; Sambrook J., 2002, MOL CLONING LAB MANU; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; TAGUCHI AKW, 1992, BIOCHEMISTRY-US, V31, P10345, DOI 10.1021/bi00157a024; Wakeham MC, 2005, BIOCHEM SOC T, V33, P851, DOI 10.1042/BST0330851; Wakeham MC, 2003, BBA-BIOENERGETICS, V1607, P53, DOI 10.1016/j.bbabio.2003.08.008; Wakeham MC, 2003, FEBS LETT, V540, P234, DOI 10.1016/S0014-5793(03)00270-9; Watson AJ, 2005, BBA-BIOENERGETICS, V1710, P34, DOI 10.1016/j.bbabio.2005.08.005; WEAVER PF, 1975, ARCH MICROBIOL, V105, P207, DOI 10.1007/BF00447139; WILLIAMS JC, 1992, BIOCHEMISTRY-US, V31, P11029, DOI 10.1021/bi00160a012; Wise KJ, 2002, TRENDS BIOTECHNOL, V20, P387, DOI 10.1016/S0167-7799(02)02023-1; YOUVAN DC, 1985, GENE, V38, P19, DOI 10.1016/0378-1119(85)90199-4; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005	58	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8507	8514		10.1074/jbc.M111.326447	http://dx.doi.org/10.1074/jbc.M111.326447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247556	hybrid, Green Published			2022-12-27	WOS:000301349400064
J	Happonen, KE; Furst, CM; Saxne, T; Heinegard, D; Blom, AM				Happonen, Kaisa E.; Furst, Camilla Melin; Saxne, Tore; Heinegard, Dick; Blom, Anna M.			PRELP Protein Inhibits the Formation of the Complement Membrane Attack Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; C4B-BINDING PROTEIN; BINDING; GLYCOPROTEINS; ARTHRITIS; HEPARIN; DOMAIN; CD59	PRELP is a 58-kDa proteoglycan found in a variety of extracellular matrices, including cartilage and at several basement membranes. In rheumatoid arthritis (RA), the cartilage tissue is destroyed and fragmented molecules, including PRELP, are released into the synovial fluid where they may interact with components of the complement system. In a previous study, PRELP was found to interact with the complement inhibitor C4b-binding protein, which was suggested to locally down-regulate complement activation in joints during RA. Here we show that PRELP directly inhibits all pathways of complement by binding C9 and thereby prevents the formation of the membrane attack complex (MAC). PRELP does not interfere with the interaction between C9 and already formed C5b-8, but inhibits C9 polymerization thereby preventing formation of the lytic pore. The alternative pathway is moreover inhibited already at the level of C3-convertase formation due to an interaction between PRELP and C3. This suggests that PRELP may down-regulate complement attack at basement membranes and on damaged cartilage and therefore limit pathological complement activation in inflammatory disease such as RA. The net outcome of PRELP-mediated complement inhibition will highly depend on the local concentration of other complement modulating molecules as well as on the local concentration of available complement proteins.	[Happonen, Kaisa E.; Furst, Camilla Melin; Blom, Anna M.] Lund Univ, Skane Univ Hosp, Wallenberg Lab, Dept Lab Med,Div Med Prot Chem, S-20502 Lund, Sweden; [Saxne, Tore; Heinegard, Dick] Lund Univ, BMC, Sect Rheumatol Mol Skeletal Biol, Dept Clin Sci, S-21185 Lund, Sweden	Lund University; Skane University Hospital; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Wallenberg Lab, Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Melin Furst, Camilla/0000-0001-5487-4270; Happonen, Kaisa/0000-0002-8346-6302	National Institutes of Health (NIAMS); Swedish Research Council [K2009-68X-14928-06-3, 2008-2201]; Swedish Foundation for Strategic Research; European Community; Foundation of sterlund; Foundation of Kock; Foundation of Crafoord; King Gustaf V's 80th Anniversary; Royal Physiographic Society in Lund; Swedish Rheumatism Association; Swedish Society of Medicine; Knut and Alice Wallenberg; Inga-Britt and Arne Lundberg; Foundation of the National Board of Health and Welfare; Skane University Hospital	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Community(European Commission); Foundation of sterlund; Foundation of Kock; Foundation of Crafoord; King Gustaf V's 80th Anniversary; Royal Physiographic Society in Lund; Swedish Rheumatism Association; Swedish Society of Medicine; Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Inga-Britt and Arne Lundberg; Foundation of the National Board of Health and Welfare; Skane University Hospital	This work was supported, in whole or in part, by grants from the National Institutes of Health (NIAMS), Swedish Research Council (K2009-68X-14928-06-3 and 2008-2201), Swedish Foundation for Strategic Research, the European Community's FP6 funding ("Autocure"), Foundations of sterlund, Kock, Crafoord, King Gustaf V's 80th Anniversary, The Royal Physiographic Society in Lund, Swedish Rheumatism Association, Swedish Society of Medicine, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg as well as grants for clinical research from the Foundation of the National Board of Health and Welfare and the Skane University Hospital.	BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Blom AM, 2009, ANN RHEUM DIS, V68, P136, DOI 10.1136/ard.2007.085753; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Ferreira VP, 2010, IMMUNOBIOLOGY, V215, P932, DOI 10.1016/j.imbio.2010.02.002; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Jeppsson J. O., 1974, ISOLATION FRAGMENTAT; Kalchishkova N, 2011, J BIOL CHEM, V286, P27915, DOI 10.1074/jbc.M111.242834; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Nandakumar KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013511; PODACK ER, 1978, J IMMUNOL, V120, P1841; Rucci N, 2009, J CELL BIOL, V187, P669, DOI 10.1083/jcb.200906014; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; VOLANAKIS JE, 1974, J IMMUNOL, V113, P9; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Williams AS, 2004, ARTHRITIS RHEUM-US, V50, P3035, DOI 10.1002/art.20478	25	39	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8092	8100		10.1074/jbc.M111.291476	http://dx.doi.org/10.1074/jbc.M111.291476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267731	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000301349400025
J	Pruitt, RN; Chumbler, NM; Rutherford, SA; Farrow, MA; Friedman, DB; Spiller, B; Lacy, DB				Pruitt, Rory N.; Chumbler, Nicole M.; Rutherford, Stacey A.; Farrow, Melissa A.; Friedman, David B.; Spiller, Ben; Lacy, D. Borden			Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RHO-PROTEINS; SURFACE BINDING; DOMAIN; CLEAVAGE; CELLS; ENTEROTOXIN; SITE; GLYCOSYLTRANSFERASES; GLUCOSYLATION	The principle virulence factors in Clostridium difficile pathogenesis are TcdA and TcdB, homologous glucosyltransferases capable of inactivating small GTPases within the host cell. We present crystal structures of the TcdA glucosyltransferase domain in the presence and absence of the co-substrate UDPglucose. Although the enzymatic core is similar to that of TcdB, the proposed GTPase-binding surface differs significantly. We show that TcdA is comparable with TcdB in its modification of Rho family substrates and that, unlike TcdB, TcdA is also capable of modifying Rap family GTPases both in vitro and in cells. The glucosyltransferase activities of both toxins are reduced in the context of the holotoxin but can be restored with autoproteolytic activation and glucosyltransferase domain release. These studies highlight the importance of cellular activation in determining the array of substrates available to the toxins once delivered into the cell.	[Pruitt, Rory N.; Rutherford, Stacey A.; Farrow, Melissa A.; Spiller, Ben; Lacy, D. Borden] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; [Chumbler, Nicole M.] Vanderbilt Univ, Chem & Phys Biol Grad Program, Sch Med, Nashville, TN 37232 USA; [Friedman, David B.; Lacy, D. Borden] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Spiller, Ben] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [P30DK058404]; National Institutes of Health, NIAID [AI095755-01]; Burroughs Wellcome Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, T32GM065086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30DK058404 (Vanderbilt Digestive Disease Research Center) and National Institutes of Health, NIAID, Grant AI095755-01. This work was also supported by an Investigator in Pathogenesis of Infectious Disease award from the Burroughs Wellcome Foundation (to D. B. L.). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Chaves-Olarte E, 1999, J BIOL CHEM, V274, P11046, DOI 10.1074/jbc.274.16.11046; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; DOVE CH, 1990, INFECT IMMUN, V58, P480, DOI 10.1128/IAI.58.2.480-488.1990; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLORIN I, 1986, MICROB PATHOGENESIS, V1, P373, DOI 10.1016/0882-4010(86)90069-0; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; LYERLY DM, 1992, INFECT IMMUN, V60, P4633, DOI 10.1128/IAI.60.11.4633-4639.1992; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; MITCHELL TJ, 1986, GUT, V27, P78, DOI 10.1136/gut.27.1.78; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; SULLIVAN NM, 1982, INFECT IMMUN, V35, P1032, DOI 10.1128/IAI.35.3.1032-1040.1982; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	51	61	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8013	8020		10.1074/jbc.M111.298414	http://dx.doi.org/10.1074/jbc.M111.298414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267739	Green Published, hybrid			2022-12-27	WOS:000301349400017
J	Tachikawa, M; Kanagawa, M; Yu, CC; Kobayashi, K; Toda, T				Tachikawa, Masaji; Kanagawa, Motoi; Yu, Chih-Chieh; Kobayashi, Kazuhiro; Toda, Tatsushi			Mislocalization of Fukutin Protein by Disease-causing Missense Mutations Can Be Rescued with Treatments Directed at Folding Amelioration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; FUKUYAMA-TYPE; LAMININ-BINDING; ABNORMAL GLYCOSYLATION; GENE-MUTATIONS; MUSCLE-CELLS; PHENOTYPE; LOCALIZATION	Fukuyama-type congenital muscular dystrophy (FCMD), the second most common childhood muscular dystrophy in Japan, is caused by alterations in the fukutin gene. Mutations in fukutin cause abnormal glycosylation of alpha-dystroglycan, a cell surface laminin receptor; however, the exact function and pathophysiological role of fukutin are unclear. Although the most prevalent mutation in Japan is a founder retrotransposal insertion, point mutations leading to abnormal glycosylation of alpha-dystroglycan have been reported, both in Japan and elsewhere. To understand better the molecular pathogenesis of fukutin-deficient muscular dystrophies, we constructed 13 disease-causing missense fukutin mutations and examined their pathological impact on cellular localization and alpha-dystroglycan glycosylation. When expressed in C2C12 myoblast cells, wild-type fukutin localizes to the Golgi apparatus, whereas the missense mutants A170E, H172R, H186R, and Y371C instead accumulated in the endoplasmic reticulum. Protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) also mislocalizes when co-expressed with these missense mutants. The results of nocodazole and brefeldin A experiments suggested that these mutant proteins were not transported to the Golgi via the anterograde pathway. Furthermore, we found that low temperature culture or curcumin treatment corrected the subcellular location of these missense mutants. Expression studies using fukutin-null mouse embryonic stem cells showed that the activity responsible for generating the laminin-binding glycan of alpha-dystroglycan was retained in these mutants. Together, our results suggest that some disease-causing missense mutations cause abnormal folding and localization of fukutin protein, and therefore we propose that folding amelioration directed at correcting the cellular localization may provide a therapeutic benefit to glycosylation-deficient muscular dystrophies.	[Tachikawa, Masaji; Kanagawa, Motoi; Yu, Chih-Chieh; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan	Kobe University	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan of National Center of Neurology and Psychiatry [23B-5]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23249049]; Japan Society for the Promotion of Science [18790220]; Takeda Science Foundation; Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology	Ministry of Health, Labor, and Welfare of Japan of National Center of Neurology and Psychiatry; Research on Psychiatric and Neurological Diseases and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology	This work was supported by the Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry 23B-5 and Research on Psychiatric and Neurological Diseases and Mental Health (H20-016), Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research (A) 23249049 (to T. T.), Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 18790220 (to M. T.), Takeda Science Foundation (to M. K.), and Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Cotarelo RP, 2008, CLIN GENET, V73, P139, DOI 10.1111/j.1399-0004.2007.00936.x; de Bernabe DBV, 2003, J MED GENET, V40, P845; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dolatshad NF, 2005, EXP CELL RES, V309, P370, DOI 10.1016/j.yexcr.2005.06.017; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2006, ANN NEUROL, V60, P603, DOI 10.1002/ana.21006; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; Keramaris-Vrantsis E, 2007, MUSCLE NERVE, V36, P455, DOI 10.1002/mus.20833; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kobayashi K, 2001, FEBS LETT, V489, P192, DOI 10.1016/S0014-5793(01)02088-9; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Matsumoto H, 2005, NEUROMUSCULAR DISORD, V15, P342, DOI 10.1016/j.nmd.2005.01.009; Matsumoto H, 2004, J BIOCHEM, V135, P709, DOI 10.1093/jb/mvh086; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Silan F, 2003, ANN NEUROL, V53, P392, DOI 10.1002/ana.10491; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2009, NEUROMUSCULAR DISORD, V19, P182, DOI 10.1016/j.nmd.2008.12.005; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshioka M, 2008, BRAIN DEV-JPN, V30, P59, DOI 10.1016/j.braindev.2007.05.012	43	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8398	8406		10.1074/jbc.M111.300905	http://dx.doi.org/10.1074/jbc.M111.300905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275357	Green Published, hybrid			2022-12-27	WOS:000301349400054
J	Shan, Q; Lynch, JW				Shan, Qiang; Lynch, Joseph W.			Incompatibility between a Pair of Residues from the Pre-M1 Linker and Cys-loop Blocks Surface Expression of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; LONG QT SYNDROME; X-RAY-STRUCTURE; NICOTINIC RECEPTORS; ACETYLCHOLINE-RECEPTOR; AGONIST BINDING; ENDOPLASMIC-RETICULUM; CHARGED RESIDUES; CHLORIDE CHANNEL; QUALITY-CONTROL	Regulation of cell membrane excitability can be achieved either by modulating the functional properties of cell membrane-expressed single channels or by varying the number of expressed channels. Whereas the structural basis underlying single channel properties has been intensively studied, the structural basis contributing to surface expression is less well characterized. Here we demonstrate that homologous substitution of the pre-M1 linker from the beta subunit prevents surface expression of the alpha 1 glycine receptor chloride channel. By investigating a series of chimeras comprising alpha 1 and beta subunits, we hypothesized that this effect was due to incompatibility between a pair of positively charged residues, which lie in close proximity to each other in the tertiary structure, from the pre-M1 linker and Cys-loop. Abolishing either positive charge restored surface expression. We propose that incompatibility (electrostatic repulsion) between this pair of residues misfolds the glycine receptor, and in consequence, the protein is retained in the cytoplasm and prevented from surface expression by the quality control machinery. This hypothesis suggests a novel mechanism, i.e. residue incompatibility, for explaining the mutation-induced reduction in channel surface expression, often present in the cases of hereditary hyperekplexia.	[Shan, Qiang] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; [Shan, Qiang; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Sydney; University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia.	qshan@yahoo.com	Lynch, Joseph/C-8636-2009		Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROCHEM, V111, P837, DOI 10.1111/j.1471-4159.2009.06372.x; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	44	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7535	7542		10.1074/jbc.M111.325126	http://dx.doi.org/10.1074/jbc.M111.325126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22267740	hybrid, Green Published			2022-12-27	WOS:000301060200054
J	Shen, DL; Gloster, TM; Yuzwa, SA; Vocadlo, DJ				Shen, David L.; Gloster, Tracey M.; Yuzwa, Scott A.; Vocadlo, David J.			Insights into O-Linked N-Acetylglucosamine (O-GlcNAc) Processing and Dynamics through Kinetic Analysis of O-GlcNAc Transferase and O-GlcNAcase Activity on Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INSIGHTS; CYTOSOLIC PROTEINS; NUCLEAR; PHOSPHORYLATION; GLYCOSYLATION; GLCNACYLATION; MECHANISM; COMPLEX; TAU; KINASE	Cellular O-linked N-acetylglucosamine (O-GlcNAc) levels are modulated by two enzymes: uridine diphosphate-N-acetyl-D-glucosamine: polypeptidyltransferase (OGT) and O-GlcNAcase (OGA). To quantitatively address the activity of these enzymes on protein substrates, we generated five structurally diverse proteins in both unmodified and O-GlcNAc-modified states. We found a remarkably invariant upper limit for k(cat)/K-m values for human OGA (hOGA)-catalyzed processing of these modified proteins, which suggests that hOGA processing is driven by the GlcNAc moiety and is independent of the protein. Human OGT(hOGT) activity ranged more widely, by up to 15-fold, suggesting that hOGT is the senior partner in fine tuning protein O-GlcNAc levels. This was supported by the observation that Km,app values for UDP-GlcNAc varied considerably (from 1 mu M to over 20 mu M), depending on the protein substrate, suggesting that some OGT substrates will be nutrient-responsive, whereas others are constitutively modified. The ratios of kcat/Km values obtained from hOGT and hOG Akinetic studies enable a prediction of the dynamic equilibrium position of O-GlcNAc levels that can be recapitulated in vitro and suggest the relative O-GlcNAc stoichiometries of target proteins in the absence of other factors. We show that changes in the specific activities of hOGT and hOGA measured in vitro on calcium/calmodulin-dependent kinase IV (CaMKIV) and its pseudophosphorylated form can account for previously reported changes in CaMKIV O-GlcNAc levels observed in cells. These studies provide kinetic evidence for the interplay between O-GlcNAc and phosphorylation on proteins and indicate that these effects can be mediated by changes in hOGT and hOGA kinetic activity.	[Gloster, Tracey M.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Shen, David L.; Yuzwa, Scott A.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Vocadlo, DJ (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This research was supported by grants from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada.; Sir Henry Wellcome postdoctoral fellow and recipient of a Michael Smith Foundation for Health Research (MSFHR) trainee award.; Recipient of a doctoral award from the Natural Sciences and Engineering Research Council of Canada.	Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dauphinee SM, 2005, J CELL BIOCHEM, V96, P579, DOI 10.1002/jcb.20508; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Kanno T, 2010, NEUROCHEM RES, V35, P782, DOI 10.1007/s11064-010-0135-1; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Leavy TM, 2007, BIOORG MED CHEM LETT, V17, P3851, DOI 10.1016/j.bmcl.2007.05.008; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lim KH, 2002, J MICROBIOL BIOTECHN, V12, P306; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Okafo G, 1997, ANAL CHEM, V69, P4985, DOI 10.1021/ac9707139; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Ryu IH, 2011, BIOCHEM BIOPH RES CO, V408, P52, DOI 10.1016/j.bbrc.2011.03.115; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Simanek EE, 1998, CHEM REV, V98, P833, DOI 10.1021/cr940226i; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2011, AMINO ACIDS, V40, P857, DOI 10.1007/s00726-010-0705-1	56	82	82	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15395	15408		10.1074/jbc.M111.310664	http://dx.doi.org/10.1074/jbc.M111.310664			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22311971	hybrid, Green Published			2022-12-27	WOS:000304006300021
J	Heaton, BE; Herrou, J; Blackwell, AE; Wysocki, VH; Crosson, S				Heaton, Brook E.; Herrou, Julien; Blackwell, Anne E.; Wysocki, Vicki H.; Crosson, Sean			Molecular Structure and Function of the Novel BrnT/BrnA Toxin-Antitoxin System of Brucella abortus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING SITES; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; YOEB TOXIN; F-PLASMID; YEFM-YOEB; PROTEIN; TRANSLATION; EXPRESSION; DEATH	Type II toxin-antitoxin (TA) systems are expressed from two-gene operons that encode a cytoplasmic protein toxin and its cognate protein antitoxin. These gene cassettes are often present in multiple copies on bacterial chromosomes, where they have been reported to regulate stress adaptation and persistence during antimicrobial treatment. We have identified a novel type II TA cassette in the intracellular pathogen Brucella abortus that consists of the toxin gene, brnT, and its antitoxin, brnA. BrnT is coexpressed and forms a 2: 2 tetrameric complex with BrnA, which neutralizes BrnT toxicity. The BrnT2-BrnA2 tetramer binds its own promoter via BrnA, and autorepresses its expression; its transcription is strongly induced in B. abortus by various stressors encountered by the bacterial cell during infection of a mammalian host. Although highly divergent at the primary sequence level, an atomic resolution (1.1 angstrom) crystal structure of BrnT reveals a secondary topology related to the RelE family of type II ribonuclease toxins. However, overall tertiary structural homology to other RelE family toxins is low. A functional characterization of BrnT by site-directed mutagenesis demonstrates a correspondence between its in vitro activity as a ribonuclease and control of bacteriostasis in vivo. We further present an analysis of the conserved and variable features of structure required for RNA scission in BrnT and the RelE toxin family. This structural investigation informs a model of the RelE-fold as an evolutionarily flexible scaffold that has been selected to bind structurally disparate antitoxins, and exhibit distinct toxin activities including RNA scission and DNA gyrase inhibition.	[Heaton, Brook E.; Crosson, Sean] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; [Herrou, Julien] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Heaton, Brook E.; Crosson, Sean] Argonne Natl Lab, Howard T Ricketts Lab, Argonne, IL 60439 USA; [Blackwell, Anne E.; Wysocki, Vicki H.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Arizona	Crosson, S (corresponding author), 929 E 57th St,GCIS W138, Chicago, IL 60637 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022; Pacific-Southwest, RCE/B-6155-2009	Crosson, Sean/0000-0002-1727-322X; Herrou, Julien/0000-0002-8585-8043; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health [1-U54-AI-057153]; National Science Foundation MRI; Pacific Southwest Regional Center for Excellence [1U54-AI-065359]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI(National Science Foundation (NSF)); Pacific Southwest Regional Center for Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-U54-AI-057153 to the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE) from the NIAID (to S. C.), by a National Science Foundation MRI grant for development of the custom tandem mass spectrometer, and the Pacific Southwest Regional Center for Excellence Grant 1U54-AI-065359 (to V. H. W.).; Supported by an National Science Foundation Graduate Research Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; ANDERSON TD, 1986, VET PATHOL, V23, P219, DOI 10.1177/030098588602300301; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bailey SES, 2009, J BACTERIOL, V191, P762, DOI 10.1128/JB.01331-08; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P1958, DOI 10.1107/S0907444902016645; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; JAFFE A, 1985, J BACTERIOL, V163, P841; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; MAKI S, 1992, J BIOL CHEM, V267, P12244; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SEVCIK J, 1993, EUR J BIOCHEM, V216, P301, DOI 10.1111/j.1432-1033.1993.tb18145.x; TANFORD C, 1967, J AM CHEM SOC, V89, P5023, DOI 10.1021/ja00995a034; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tian QB, 1996, BIOCHEM BIOPH RES CO, V225, P679, DOI 10.1006/bbrc.1996.1229; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yuan J, 2011, J BACTERIOL, V193, P611, DOI 10.1128/JB.01185-10	67	41	44	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12098	12110		10.1074/jbc.M111.332163	http://dx.doi.org/10.1074/jbc.M111.332163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334680	hybrid, Green Published			2022-12-27	WOS:000302782200046
J	Nishii, T; Oikawa, Y; Ishida, Y; Kawaichi, M; Matsuda, E				Nishii, Tomonori; Oikawa, Yu; Ishida, Yasumasa; Kawaichi, Masashi; Matsuda, Eishou			CtBP-interacting BTB Zinc Finger Protein (CIBZ) Promotes Proliferation and G1/S Transition in Embryonic Stem Cells via Nanog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; ES CELLS; FUNCTIONAL-ANALYSIS; MOUSE EMBRYOS; EXPRESSION; DIFFERENTIATION; PLURIPOTENCY; TERATOCARCINOMA; IDENTIFICATION; APOPTOSIS	Mouse embryonic stem cells (ESCs) require transcriptional regulation to ensure rapid proliferation that allows for self-renewal. However, the molecular mechanism by which transcriptional factors regulate this rapid proliferation remains largely unknown. Here we present data showing that CIBZ, a BTB domain zinc finger transcriptional factor, is a key transcriptional regulator for regulation of ESC proliferation. Here we show that deletion or siRNA knockdown of CIBZ inhibits ESC proliferation. Cell cycle analysis shows that loss of CIBZ delays the progression of ESCs through the G1 to S phase transition. Conversely, constitutive ectopic expression of exogenous CIBZ in ESCs promotes proliferation and accelerates G1/S transition. These findings suggest that regulation of the G1/S transition explains, in part, CIBZ-associated ESC proliferation. Our data suggest that CIBZ acts through the post-transcriptionally regulates the expression of Nanog, a positive regulator of ESC proliferation and G1/S transition, but does not affect Oct3/4 and Sox2 protein expression. Notably, constitutive overexpression of Nanog partially rescued the proliferation defect caused by CIBZ knockdown, indicating the role of CIBZ in ESC proliferation and G1/S transition at least in part depends on the Nanog protein level.	[Nishii, Tomonori; Ishida, Yasumasa; Kawaichi, Masashi; Matsuda, Eishou] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara 6300192, Japan; [Oikawa, Yu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, Kyoto 6028566, Japan	Nara Institute of Science & Technology; Kyoto Prefectural University of Medicine	Matsuda, E (corresponding author), Nara Inst Sci & Technol, Div Gene Funct Anim, 8916-5 Takayama, Nara 6300192, Japan.	ematsuda@bs.naist.jp			Global COE from Japan's Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [22590272] Funding Source: KAKEN	Global COE from Japan's Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (C), and the Global COE program, from Japan's Ministry of Education, Culture, Sports, Science, and Technology.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen TJ, 2012, MOL BIOL REP, V39, P1855, DOI 10.1007/s11033-011-0928-6; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koledova Z, 2010, STEM CELLS DEV, V19, P181, DOI 10.1089/scd.2009.0065; Liu N, 2008, J CELL BIOCHEM, V104, P2348, DOI 10.1002/jcb.21795; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda E, 2004, P NATL ACAD SCI USA, V101, P4170, DOI 10.1073/pnas.0400604101; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Neganova I, 2008, J ANAT, V213, P30, DOI 10.1111/j.1469-7580.2008.00931.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Tanaka Y, 2007, BLOOD, V110, P107, DOI 10.1182/blood-2006-08-039628; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Zeng XM, 2003, STEM CELLS, V21, P647, DOI 10.1634/stemcells.21-6-647; Zhang JY, 2005, BIOCHEM BIOPH RES CO, V338, P1098, DOI 10.1016/j.bbrc.2005.10.071; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009	31	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12417	12424		10.1074/jbc.M111.333856	http://dx.doi.org/10.1074/jbc.M111.333856			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22315219	hybrid, Green Published			2022-12-27	WOS:000302782200081
J	Fujimoto, K; Matsuura, K; Hu-Wang, E; Lu, R; Shi, YB				Fujimoto, Kenta; Matsuura, Kazuo; Hu-Wang, Eileen; Lu, Rosemary; Shi, Yun-Bo			Thyroid Hormone Activates Protein Arginine Methyltransferase 1 Expression by Directly Inducing c-Myc Transcription during Xenopus Intestinal Stem Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTEMBRYONIC DEVELOPMENT; EPITHELIAL DEVELOPMENT; RECEPTOR SUPERFAMILY; GENE REPRESSION; TR-ALPHA; METAMORPHOSIS; LAEVIS; RECRUITMENT; PROLIFERATION; MECHANISMS	Adult organ-specific stem cells are essential for organ homeostasis and tissue repair and regeneration. The formation of such stem cells during vertebrate development is poorly understood. Intestinal remodeling during thyroid hormone (T3)-dependent Xenopus metamorphosis resembles postembryonic intestinal maturation in mammals. During metamorphosis, the intestine is remodeled de novo via a yet unknown mechanism. Protein arginine methyltransferase 1 (PRMT1) is up-regulated in and required for adult intestinal stem cells during metamorphosis. PRMT1 up-regulation is the earliest known molecular event for the developing stem cells and is also conserved during zebrafish and mouse intestinal development. To analyze how PRMT1 is specifically up-regulated during the formation of the adult intestinal stem cells, wecloned the Xenopus PRMT1 promoter and characterized it in CaCo-2 cells, a human cell line with intestinal stem cell characteristics. Through a series deletion and mutational analyses, we showed that the stem cell-associated transcription factor c-Myc could bind to a conserved site in the first intron to activate the promoter. Furthermore, we demonstrated that during metamorphosis, both c-Myc and PRMT1 were highly up-regulated, specifically in the remodeling intestine but not the resorbing tail, and that c-Myc was induced by T3 prior to PRMT1 up-regulation. In addition, we showed that T3 directly activated the c-Myc gene during metamorphosis in the intestine via binding of the T3 receptor to the c-Myc promoter. These results suggest that T3 induces c-Myc transcription directly in the intestine, that c-Myc, in turn, activates PRMT1 expression, and that this is an important gene regulation cascade controlling intestinal stem cell development.	[Fujimoto, Kenta; Matsuura, Kazuo; Hu-Wang, Eileen; Lu, Rosemary; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, Lab Gene Regulat & Dev, PCRM,NIH, Bethesda, MD 20892 USA.	Shi@helix.nih.gov		Shi, Yun-Bo/0000-0002-6330-0639	NICHD, National Institutes of Health; Japan Society for the Promotion of Sciences (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Society for the Promotion of Sciences (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the NICHD, National Institutes of Health intramural research program. This work was also supported by a fellowship by the Japan Society for the Promotion of Sciences (NIH) (to K. F.). This work was also supported by a Fellowship for Japanese Biochemical and Behavioral Researchers at NIH from Japan Society for the Promotion of Science (to K. F.).	Amano T, 1998, DEV GROWTH DIFFER, V40, P177; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Bagamasbad P, 2008, J BIOL CHEM, V283, P2275, DOI 10.1074/jbc.M709306200; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Batut J, 2005, P NATL ACAD SCI USA, V102, P15128, DOI 10.1073/pnas.0502483102; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; Buchholz DR, 2004, GENE EXPR PATTERNS, V4, P321, DOI 10.1016/j.modgep.2003.10.005; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Denver RJ, 2009, DEV BIOL, V326, P155, DOI 10.1016/j.ydbio.2008.11.005; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Fujimoto K, 2006, DEV GROWTH DIFFER, V48, P223, DOI 10.1111/j.1440-169x.2006.00859.x; Gilbert L.I., 1996, METAMORPHOSIS POSTEM; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Harper J, 2011, P NATL ACAD SCI USA, V108, P10585, DOI 10.1073/pnas.1105852108; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Ishizuya-Oka A, 2001, CELL TISSUE RES, V303, P187, DOI 10.1007/s004410000291; Ishizuya-Oka A, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-37; Ishizuya-Oka A, 2009, FASEB J, V23, P2568, DOI 10.1096/fj.08-128124; Ishizuya-Oka A, 2006, DEV DYNAM, V235, P3240, DOI 10.1002/dvdy.20969; ISHIZUYAOKA A, 1991, IN VITRO CELL DEV B, V27, P853; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jepsen K, 2002, J CELL SCI, V115, P689; Jones P. L., 2003, CURRENT TOPICS MICRO; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARSHALL JA, 1978, J EXP ZOOL, V203, P31, DOI 10.1002/jez.1402030104; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; MCAVOY JW, 1977, J EXP ZOOL, V202, P129, DOI 10.1002/jez.1402020115; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muncan V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1463; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Plateroti M, 1999, GASTROENTEROLOGY, V116, P1367, DOI 10.1016/S0016-5085(99)70501-9; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Schreiber AM, 2009, DEV BIOL, V331, P89, DOI 10.1016/j.ydbio.2009.04.033; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; SHI YB, 1992, J BIOL CHEM, V267, P733; Shi YB, 1996, CURR TOP DEV BIOL, V32, P205, DOI 10.1016/S0070-2153(08)60429-9; Shi YB, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-30; Shi YB, 2009, THYROID, V19, P987, DOI 10.1089/thy.2009.0041; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Toner P. G., 1971, DIGESTIVE SYSTEM ULT; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439	77	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10039	10050		10.1074/jbc.M111.335661	http://dx.doi.org/10.1074/jbc.M111.335661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315222	Green Published, hybrid			2022-12-27	WOS:000302167200036
J	Huang, XY; Hernick, M				Huang, Xinyi; Hernick, Marcy			Examination of Mechanism of N-Acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside Deacetylase (MshB) Reveals Unexpected Role for Dynamic Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM SYNTHETASE; RATE-LIMITING STEPS; MYCOBACTERIUM-TUBERCULOSIS; MYCOTHIOL BIOSYNTHESIS; CARBAPENAM SYNTHETASE; CRYSTAL-STRUCTURE; UCSF CHIMERA; ENZYME; AMINOPEPTIDASE; INHIBITION	Actinomycetes are a group of Gram-positive bacteria that includes pathogenic mycobacterial species, such as Mycobacterium tuberculosis. These organisms do not have glutathione and instead utilize the small molecule mycothiol (MSH) as their primary reducing agent and for the detoxification of xenobiotics. Due to these important functions, enzymes involved in MSH biosynthesis and MSH-dependent detoxification are targets for drug development. The metal-dependent deacetylase N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) catalyzes the hydrolysis of N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside to form 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside and acetate in MSH biosynthesis. Herein we examine the chemical mechanism of MshB. We demonstrate that the side chains of Asp-15, Tyr-142, His-144, and Asp-146 are important for catalytic activity. We show that NaF is an uncompetitive inhibitor of MshB, consistent with a metal-water/hydroxide functioning as the reactive nucleophile in the catalytic mechanism. We have previously shown that MshB activity has a bell-shaped dependence on pH with pK(a) values of similar to 7.3 and 10.5 (Huang, X., Kocabas, E. and Hernick, M. (2011) J. Biol. Chem. 286, 2027520282). Mutagenesis experiments indicate that the observed pK(a) values reflect ionization of Asp-15 and Tyr-142, respectively. Together, findings from our studies suggest that MshB functions through a general acid-base pair mechanism with the side chain of Asp-15 functioning as the general base catalyst and His-144 serving as the general acid catalyst, whereas the side chain of Tyr-142 probably assists in polarizing substrate/stabilizing the oxyanion intermediate. Additionally, our results indicate that Tyr-142 is a dynamic side chain that plays key roles in catalysis, modulating substrate binding, chemistry, and product release.	[Huang, Xinyi; Hernick, Marcy] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hernick, M (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	hernickm@vt.edu		Hernick, Marcy/0000-0002-2839-5767	Jeffress Memorial Trust [J960]; National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Jeffress Memorial Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Jeffress Memorial Trust Grant J960 (to M. H.).; Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR001081).	Arnett SO, 2007, BIOCHEMISTRY-US, V46, P9337, DOI 10.1021/bi0618464; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Fan F, 2009, CURR OPIN CHEM BIOL, V13, P451, DOI 10.1016/j.cbpa.2009.07.018; Gammon DW, 2010, BIOORGAN MED CHEM, V18, P2501, DOI 10.1016/j.bmc.2010.02.049; Gutierrez-Lugo MT, 2008, J MED CHEM, V51, P2606, DOI 10.1021/jm070719i; Gutierrez-Lugo MT, 2009, J BIOMOL SCREEN, V14, P643, DOI 10.1177/1087057109335743; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Harris MN, 1999, FEBS LETT, V455, P321, DOI 10.1016/S0014-5793(99)00879-0; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P547; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Javid-Majd F, 2000, BIOCHEMISTRY-US, V39, P1285, DOI 10.1021/bi992177f; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Li NG, 2009, CURR MED CHEM, V16, P3805, DOI 10.2174/092986709789178037; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; McCarthy AA, 2004, J MOL BIOL, V335, P1131, DOI 10.1016/j.jmb.2003.11.034; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Metaferia BB, 2007, J MED CHEM, V50, P6326, DOI 10.1021/jm070669h; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P2641, DOI 10.1016/S0968-0896(03)00154-8; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raber ML, 2009, BIOCHEMISTRY-US, V48, P4959, DOI 10.1021/bi900432n; Raber ML, 2009, J BIOL CHEM, V284, P207, DOI 10.1074/jbc.M805390200; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Schneck JL, 2010, BIOCHEMISTRY-US, V49, P7151, DOI 10.1021/bi100824v; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Supuran CT, 2010, BIOORG MED CHEM LETT, V20, P3467, DOI 10.1016/j.bmcl.2010.05.009; Todd MJ, 2000, BIOCHEMISTRY-US, V39, P5389, DOI 10.1021/bi992287m; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; White RJ, 2003, CURR OPIN PHARMACOL, V3, P502, DOI 10.1016/S1471-4892(03)00115-2	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10424	10434		10.1074/jbc.M111.320184	http://dx.doi.org/10.1074/jbc.M111.320184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315231	Green Published, hybrid			2022-12-27	WOS:000302167200069
J	Singh, R; Grigg, JC; Armstrong, Z; Murphy, MEP; Eltis, LD				Singh, Rahul; Grigg, Jason C.; Armstrong, Zachary; Murphy, Michael E. P.; Eltis, Lindsay D.			Distal Heme Pocket Residues of B-type Dye-decolorizing Peroxidase ARGININE BUT NOT ASPARTATE IS ESSENTIAL FOR PEROXIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; HORSERADISH-PEROXIDASE; BINDING; IDENTIFICATION	DypB from Rhodococcus jostii RHA1 is a bacterial dye-decolorizing peroxidase (DyP) that oxidizes lignin and Mn(II). Three residues interact with the iron-bound solvent species in ferric DypB: Asn-246 and the conserved Asp-153 and Arg-244. Substitution of either Asp-153 or Asn-246 with alanine minimally affected the second order rate constant for Compound I formation (k(1) similar to 10(5) M(-1)s(-1)) and the specificity constant (k(cat)/K-m) for H2O2. Even in the D153A/N246A double variant, these values were reduced less than 30-fold. However, these substitutions dramatically reduced the stability of Compound I (t(1/2) similar to 0.13 s) as compared with the wild-type enzyme (540 s). By contrast, substitution of Arg-244 with leucine abolished the peroxidase activity, and heme iron of the variant showed a pH-dependent transition from high spin (pH 5) to low spin (pH 8.5). Two variants were designed to mimic the plant peroxidase active site: D153H, which was more than an order of magnitude less reactive with H2O2, and N246H, which had no detectable peroxidase activity. X-ray crystallographic studies revealed that structural changes in the variants are confined to the distal heme environment. The data establish an essential role for Arg-244 in Compound I formation in DypB, possibly through charge stabilization and proton transfer. The principle roles of Asp-153 and Asn-246 appear to be in modulating the subsequent reactivity of Compound I. These results expand the range of residues known to catalyze Compound I formation in heme peroxidases.	[Singh, Rahul; Grigg, Jason C.; Armstrong, Zachary; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@mail.ubc.ca	Singh, Rahul/A-6891-2009; Murphy, Michael/R-6805-2017; Eltis, Lindsay D/J-8272-2015; Armstrong, Zachary/U-3635-2019	Singh, Rahul/0000-0002-1467-7915; Murphy, Michael/0000-0003-2589-0014; Eltis, Lindsay D/0000-0002-6774-8158; Armstrong, Zachary/0000-0002-4086-2946	Natural Sciences and Engineering Research Council of Canada; National Research Council of Canada; Canadian Institutes of Health Research; Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery grants (to L. D. E. and M. E. P. M.), respectively.; Part of this work was performed at the Canadian Light Source, which is supported by Natural Sciences and Engineering Research Council of Canada, the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Efimov I, 2011, J AM CHEM SOC, V133, P15376, DOI 10.1021/ja2007017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk J. E., 1964, PORPHYRINS METALLOPO, P804; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047; Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50; Kong LY, 2010, ARCH MICROBIOL, V192, P585, DOI 10.1007/s00203-010-0585-5; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Mildvan AS, 2004, BIOCHEMISTRY-US, V43, P14517, DOI 10.1021/bi048052e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036; Xiao YW, 2004, BIOCHEMISTRY-US, V43, P12809, DOI 10.1021/bi049238g; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	33	77	78	6	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10623	10630		10.1074/jbc.M111.332171	http://dx.doi.org/10.1074/jbc.M111.332171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308037	Green Published, hybrid			2022-12-27	WOS:000302167200087
J	Zeitvogel, J; Dalpke, A; Eiz-Vesper, B; Kracht, M; Dittrich-Breiholz, O; Werfel, T; Wittmann, M				Zeitvogel, Jana; Dalpke, Alexander; Eiz-Vesper, Britta; Kracht, Michael; Dittrich-Breiholz, Oliver; Werfel, Thomas; Wittmann, Miriam			Human Primary Keratinocytes Show Restricted Ability to Up-regulate Suppressor of Cytokine Signaling (SOCS)3 Protein Compared with Autologous Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOPIC-DERMATITIS; T-CELLS; SOCS PROTEINS; IL-27; GP130; ACTIVATION; RECEPTOR; STAT1; INTERLEUKIN-18; TRANSDUCTION	Suppressor of cytokine signaling (SOCS)3 belongs to a family of proteins that are known to exert important functions as inducible feedback inhibitors and are crucial for the balance of immune responses. There is evidence for a deregulated immune response in chronic inflammatory skin diseases. Thus, it was the aim of this study to investigate the regulation of SOCS proteins involved in intracellular signaling pathways occurring during inflammatory skin diseases and analyze their impact on the course of inflammatory responses. Because we and others have previously described that the cytokine IL-27 has an important impact on the chronic manifestation of inflammatory skin diseases, we focused here on the signaling induced by IL-27 in human primary keratinocytes compared with autologous blood-derived macrophages. Here, we demonstrate that SOCS3 is critically involved in regulating the cell-specific response to IL-27. SOCS3 was found to be significantly up-regulated by IL-27 in macrophages but not in keratinocytes. Other STAT3-activating cytokines investigated, including IL-6, IL-22, and oncostatin M, also failed to up-regulate SOCS3 in keratinocytes. Lack of SOCS3 up-regulation in skin epithelial cells was accompanied by prolonged STAT1 and STAT3 phosphorylation and enhanced CXCL10 production upon IL-27 stimulation compared with macrophages. Overexpression of SOCS3 in keratinocytes significantly diminished this enhanced CXCL10 production in response to IL-27. We conclude from our data that keratinocytes have a cell type-specific impaired capacity to up-regulate SOCS3 which may crucially determine the course of chronic inflammatory skin diseases.	[Zeitvogel, Jana; Werfel, Thomas; Wittmann, Miriam] Hannover Med Sch, Dept Immunodermatol & Allergy Res, D-30625 Hannover, Germany; [Eiz-Vesper, Britta] Hannover Med Sch, Inst Transfus Med, D-30625 Hannover, Germany; [Dittrich-Breiholz, Oliver] Hannover Med Sch, Inst Physiol Chem, D-30625 Hannover, Germany; [Dalpke, Alexander] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany; [Wittmann, Miriam] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	Hannover Medical School; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; University of Leeds	Zeitvogel, J (corresponding author), Hannover Med Sch, Dept Immunodermatol & Allergy Res, Carl Neuberg Str 1, D-30625 Hannover, Germany.	zeitvogel.jana@mh-hannover.de	Zeitvogel, Jana/G-1712-2013; Werfel, Thomas/B-6921-2012	Kracht, Michael/0000-0002-8501-043X; Wittmann, Miriam/0000-0003-2328-4926	Deutsche Forschungsgemeinschaft [SFB566, A6, GRK1441]; Royal Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Royal Society(Royal Society of London)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB566, A6, GRK1441, and a research grant from the Royal Society.	Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Horiuchi Y, 2006, CLIN EXP DERMATOL, V31, P100, DOI 10.1111/j.1365-2230.2005.01979.x; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pierconti F, 2011, PROSTATE, V71, P318, DOI 10.1002/pros.21245; Purwar R, 2006, J INVEST DERMATOL, V126, P1043, DOI 10.1038/sj.jid.5700085; Purwar R, 2006, J IMMUNOL, V177, P4444, DOI 10.4049/jimmunol.177.7.4444; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Shibata S, 2010, J INVEST DERMATOL, V130, P1034, DOI 10.1038/jid.2009.349; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Teofili L, 2008, INT J CANCER, V123, P1586, DOI 10.1002/ijc.23694; Wang D, 2008, ARTHRITIS RHEUM, V58, P3205, DOI 10.1002/art.23868; Wittmann M, 2005, J INVEST DERMATOL, V124, P1225, DOI 10.1111/j.0022-202X.2005.23715.x; Wittmann M, 2009, J ALLERGY CLIN IMMUN, V124, P81, DOI 10.1016/j.jaci.2009.04.026; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zeitvogel J., 2009, EUR J IMMUNOL, V39, pS209	32	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9923	9930		10.1074/jbc.M111.280370	http://dx.doi.org/10.1074/jbc.M111.280370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294695	Green Published, hybrid			2022-12-27	WOS:000302167200024
J	Prasad, M; Thomas, JL; Whittal, RM; Bose, HS				Prasad, Manoj; Thomas, James L.; Whittal, Randy M.; Bose, Himangshu S.			Mitochondrial 3 beta-Hydroxysteroid Dehydrogenase Enzyme Activity Requires Reversible pH-dependent Conformational Change at the Intermembrane Space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MOLTEN GLOBULE STATE; CYTOCHROME-C; HUMAN TYPE-1; IMPORT; INTERMEDIATE; STEROIDOGENESIS; MECHANISMS; MEMBRANES	The inner mitochondrial membrane protein 3 beta-hydroxysteroid dehydrogenase 2 (3 beta HSD2) synthesizes progesterone and androstenedione through its dehydrogenase and isomerase activities. This bifunctionality requires 3 beta HSD2 to undergo a conformational change. Given its proximity to the proton pump, we hypothesized that pH influences 3 beta HSD2 conformation and thus activity. Circular dichroism (CD) showed that between pH 7.4 and 4.5, 3 beta HSD2 retained its primarily alpha-helical character with a decrease in alpha-helical content at lower pH values, whereas the beta-sheet content remained unchanged throughout. Titrating the pH back to 7.4 restored the original conformation within 25 min. Metabolic conversion assays indicated peak 3 beta HSD2 activity at pH 4.5 with similar to 2-fold more progesterone synthesized at pH 4.5 than at pH 3.5 and 7.4. Increasing the 3 beta HSD2 concentration from 1 to 40 mu g resulted in a 7-fold increase in progesterone at pH 4.5, but no change at pH 7.4. Incubation with guanidinum hydrochloride (GdmHCl) showed a three-step cooperative unfolding of 3 beta HSD2 from pH 7.4 to 4.5, possibly due to the native state unfolding to the intermediate ion core state. With further decreases in pH, increasing concentrations of GdmHCl led to rapid two-step unfolding that may represent complete loss of structure. Between pH 4 and 5, the two intermediate states appeared stable. Stopped-flow kinetics showed slower unfolding at around pH 4, where the protein is in a pseudostable state. Based on our data, we conclude that at pH 4-5, 3 beta HSD2 takes on a molten globule conformation that promotes the dual functionality of the enzyme.	[Thomas, James L.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA; [Bose, Himangshu S.] Mem Univ Med Ctr, Savannah, GA 31404 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	Mercer University; University of Alberta	Bose, HS (corresponding author), Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Prasad, Manoj/I-9623-2014	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation; Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.), the Anderson Cancer Institute, and the Mercer University School of Medicine.; Funding for equipment in the Mass Spectrometry Facility at the University of Alberta is supported by the Canada Foundation for Innovation and Alberta Science and Research Investment Program	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Ali V, 1999, BIOCHEMISTRY-US, V38, P13635, DOI 10.1021/bi9907835; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Brooks CL, 1998, P NATL ACAD SCI USA, V95, P11037, DOI 10.1073/pnas.95.19.11037; CHAN HS, 1991, ANNU REV BIOPHYS BIO, V20, P447, DOI 10.1146/annurev.biophys.20.1.447; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; Cunningham EL, 2003, BIOCHEMISTRY-US, V42, P13212, DOI 10.1021/bi035409q; Fasman G.D., 1996, CIRCULAR DICHROISM C; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glick B.S., 1992, CELL, V69, P347; Huang C.Y., 1982, METHOD ENZYMOL, V87, P525; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; KUWAJIMA K, 1991, BIOCHEMISTRY-US, V30, P7693, DOI 10.1021/bi00245a005; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pawlak KJ, 2011, J BIOL CHEM, V286, P39130, DOI 10.1074/jbc.M111.290031; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; Privalov PL, 1996, J MOL BIOL, V258, P707, DOI 10.1006/jmbi.1996.0280; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rajapaksha M, 2011, BIOCHEMISTRY-US, V50, P11015, DOI 10.1021/bi2016102; REDFIELD C, 1994, J MOL BIOL, V238, P23, DOI 10.1006/jmbi.1994.1265; RHEAUME E, 1991, MOL ENDOCRINOL, V5, P1147, DOI 10.1210/mend-5-8-1147; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Thomas JL, 2003, J BIOL CHEM, V278, P35483, DOI 10.1074/jbc.M304752200; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; Thomas JL, 2002, J BIOL CHEM, V277, P42795, DOI 10.1074/jbc.M208537200; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; WANG JL, 1971, J BIOL CHEM, V246, P1185; Woody RW, 1996, CIRCULAR DICHROISM C, P109	46	26	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9534	9546		10.1074/jbc.M111.333278	http://dx.doi.org/10.1074/jbc.M111.333278			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262841	Green Published, hybrid			2022-12-27	WOS:000301797800084
J	Ashpole, NM; Song, WH; Brustovetsky, T; Engleman, EA; Brustovetsky, N; Cummins, TR; Hudmon, A				Ashpole, Nicole M.; Song, Weihua; Brustovetsky, Tatiana; Engleman, Eric A.; Brustovetsky, Nickolay; Cummins, Theodore R.; Hudmon, Andy			Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Inhibition Induces Neurotoxicity via Dysregulation of Glutamate/Calcium Signaling and Hyperexcitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; CULTURED HIPPOCAMPAL-NEURONS; FOCAL CEREBRAL-ISCHEMIA; INDUCED CELL-DEATH; SELF-ASSOCIATION; SENSORY NEURONS; BRAIN-INJURY; SLICE MODEL; RAT; RECEPTOR	Aberrant glutamate and calcium signalings are neurotoxic to specific neuronal populations. Calcium/calmodulin-dependent kinase II (CaMKII), a multifunctional serine/threonine protein kinase in neurons, is believed to regulate neurotransmission and synaptic plasticity in response to calcium signaling produced by neuronal activity. Importantly, several CaMKII substrates control neuronal structure, excitability, and plasticity. Here, we demonstrate that CaMKII inhibition for >4 h using small molecule and peptide inhibitors induces apoptosis in cultured cortical neurons. The neuronal death produced by prolonged CaMKII inhibition is associated with an increase in TUNEL staining and caspase-3 cleavage and is blocked with the translation inhibitor cycloheximide. Thus, this neurotoxicity is consistent with apoptotic mechanisms, a conclusion that is further supported by dysregulated calcium signaling with CaMKII inhibition. CaMKII inhibitory peptides also enhance the number of action potentials generated by a ramp depolarization, suggesting increased neuronal excitability with a loss of CaMKII activity. Extracellular glutamate concentrations are augmented with prolonged inhibition of CaMKII. Enzymatic buffering of extracellular glutamate and antagonism of the NMDA subtype of glutamate receptors prevent the calcium dysregulation and neurotoxicity associated with prolonged CaMKII inhibition. However, in the absence of CaMKII inhibition, elevated glutamate levels do not induce neurotoxicity, suggesting that a combination of CaMKII inhibition and elevated extracellular glutamate levels results in neuronal death. In sum, the loss of CaMKII observed with multiple pathological states in the central nervous system, including epilepsy, brain trauma, and ischemia, likely exacerbates programmed cell death by sensitizing vulnerable neuronal populations to excitotoxic glutamate signaling and inducing an excitotoxic insult itself.	[Ashpole, Nicole M.; Song, Weihua; Brustovetsky, Nickolay; Cummins, Theodore R.; Hudmon, Andy] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Engleman, Eric A.; Hudmon, Andy] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hudmon, A (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 950 W Walnut St,R2-480, Indianapolis, IN 46202 USA.	ahudmon@iupui.edu			National Institutes of Health [NS053422, NS050131]; Ralph W. and Grace M. Showalter; Indiana State Department of Health [ISDH/A70-0-0-079212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050131, R01NS053422, R56NS053422, R01NS078008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter; Indiana State Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS053422 (to T. R. C.) and NS050131 (to N. B.). This work was also supported by Ralph W. and Grace M. Showalter and the Indiana State Department of Health Spinal Cord Brain Injury Research Grant ISDH/A70-0-0-079212 (to A. H.).	ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; BEATON GH, 1957, ARCH BIOCHEM BIOPHYS, V70, P288, DOI 10.1016/0003-9861(57)90104-2; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; CHURN SB, 1995, J NEUROSCI, V15, P3200; CHURN SB, 1992, J NEUROCHEM, V59, P1221, DOI 10.1111/j.1471-4159.1992.tb08431.x; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Coultrap SJ, 2011, ACTA PHARMACOL SIN, V32, P861, DOI 10.1038/aps.2011.68; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; Fan W, 2006, BRAIN RES, V1067, P48, DOI 10.1016/j.brainres.2005.10.030; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Goebel DJ, 2009, BRAIN RES, V1256, P190, DOI 10.1016/j.brainres.2008.12.051; HAJIMOHAMMADREZA I, 1995, J NEUROSCI, V15, P4093; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Laabich A, 2000, MOL BRAIN RES, V85, P32, DOI 10.1016/S0169-328X(00)00226-6; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PERLIN JB, 1992, EPILEPSY RES, V11, P111, DOI 10.1016/0920-1211(92)90045-U; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Tao-Cheng JH, 2002, NEUROSCIENCE, V115, P435, DOI 10.1016/S0306-4522(02)00451-7; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang Y, 2005, J NEUROPHYSIOL, V94, P3670, DOI 10.1152/jn.00489.2005; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; WESTGATE SA, 1994, J NEUROCHEM, V63, P2217; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yamagata Y, 2006, NEUROSCIENCE, V140, P981, DOI 10.1016/j.neuroscience.2006.02.054; Zalewska T, 1996, NEUROREPORT, V7, P637, DOI 10.1097/00001756-199601310-00062; Zhang YH, 2008, J PHYSIOL-LONDON, V586, P3113, DOI 10.1113/jphysiol.2008.152439	52	65	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8495	8506		10.1074/jbc.M111.323915	http://dx.doi.org/10.1074/jbc.M111.323915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253441	Green Published, hybrid			2022-12-27	WOS:000301349400063
J	Guo, L; Mishra, G; Markham, JE; Li, MY; Tawfall, A; Welti, R; Wang, XM				Guo, Liang; Mishra, Girish; Markham, Jonathan E.; Li, Maoyin; Tawfall, Amanda; Welti, Ruth; Wang, Xuemin			Connections between Sphingosine Kinase and Phospholipase D in the Abscisic Acid Signaling Pathway in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; STOMATAL CLOSURE; GUARD-CELLS; TRANSDUCTION; PROTEIN; BINDING; GROWTH; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS; EXPRESSION	Phosphatidic acid (PA) and phytosphingosine 1-phosphate (phyto-S1P) both are lipid messengers involved in plant response to abscisic acid (ABA). Our previous data indicate that PA binds to sphingosine kinase (SPHK) and increases its phyto-S1P-producing activity. To understand the cellular and physiological functions of the PA-SPHK interaction, we isolated Arabidopsis thaliana SPHK mutants sphk1-1 and sphk2-1 and characterized them, together with phospholipase D alpha 1 knockout, pld alpha 1, in plant response to ABA. Compared with wild-type (WT) plants, the SPHK mutants and pld alpha 1 all displayed decreased sensitivity to ABA-promoted stomatal closure. Phyto-S1P promoted stomatal closure in sphk1-1 and sphk2-1, but not in pld alpha 1, whereas PA promoted stomatal closure in sphk1-1, sphk2-1, and pld alpha 1. The ABA activation of PLD alpha 1 in leaves and protoplasts was attenuated in the SPHK mutants, and the ABA activation of SPHK was reduced in pld alpha 1. In response to ABA, the accumulation of long-chain base phosphates was decreased in pld alpha 1, whereas PA production was decreased in SPHK mutants, compared with WT. Collectively, these results indicate that SPHK and PLD alpha 1 act together in ABA response and that SPHK and phyto-S1P act upstream of PLD alpha 1 and PA in mediating the ABA response. PA is involved in the activation of SPHK, and activation of PLD alpha 1 requires SPHK activity. The data suggest that SPHK/phyto-S1P and PLD alpha 1A are co-dependent in amplification of response to ABA, mediating stomatal closure in Arabidopsis.	[Guo, Liang; Mishra, Girish; Li, Maoyin; Tawfall, Amanda; Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Guo, Liang; Mishra, Girish; Markham, Jonathan E.; Li, Maoyin; Tawfall, Amanda; Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Welti, Ruth] Kansas State Univ, Div Biol, Kansas Lipid Res Ctr, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center; Kansas State University	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; Markham, Jennifer/0000-0003-2397-3131; wang, xuemin/0000-0002-6251-6745; Welti, Ruth/0000-0003-4373-2538; Li, Maoyin/0000-0002-9976-1349	National Science Foundation [IOS-0818740, EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; United States Department of Agriculture [2007-35318-18393]; United States Department of Energy [DE-SC0001295]; Kansas Technology Enterprise Corporation; Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE); National Institutes of Health [P20RR16475]; Kansas State University; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Department of Energy(United States Department of Energy (DOE)); Kansas Technology Enterprise Corporation; Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation Grant IOS-0818740, United States Department of Agriculture Grant 2007-35318-18393, and United States Department of Energy Grant DE-SC0001295.; PA analyses were performed at the Kansas Lipidomics Research Center, where equipment acquisition and method development were funded by National Science Foundation Grants EPS 0236913, MCB 0455318 and 0920663, the DBI 0521587, Kansas Technology Enterprise Corporation, Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE), National Institutes of Health Grant P20RR16475, and the Kansas State University.	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Chen M, 2008, PLANT CELL, V20, P1862, DOI 10.1105/tpc.107.057851; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dunn TM, 2004, ANN BOT-LONDON, V93, P483, DOI 10.1093/aob/mch071; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Imai H, 2005, PLANT CELL PHYSIOL, V46, P375, DOI 10.1093/pcp/pci023; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Lynch DV, 2009, TRENDS PLANT SCI, V14, P463, DOI 10.1016/j.tplants.2009.06.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ritchie S, 1998, P NATL ACAD SCI USA, V95, P2697, DOI 10.1073/pnas.95.5.2697; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	42	76	86	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8286	8296		10.1074/jbc.M111.274274	http://dx.doi.org/10.1074/jbc.M111.274274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275366	hybrid, Green Published			2022-12-27	WOS:000301349400043
J	Zappelli, C; van der Zwaan, C; Thijssen-Timmer, DC; Mertens, K; Meijer, AB				Zappelli, Claudia; van der Zwaan, Carmen; Thijssen-Timmer, Daphne C.; Mertens, Koen; Meijer, Alexander B.			Novel Role for Galectin-8 Protein as Mediator of Coagulation Factor V Endocytosis by Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTHROMBINASE COMPLEX; PARTIAL GLYCOSYLATION; THROMBIN GENERATION; BINDING PROTEINS; PLASMA; DOMAIN; CELLS; EXPRESSION; RECOGNITION; PLATELETS	Galectin-8 (Gal8) interacts with beta-galactoside-containing glycoproteins and has recently been implicated to play a role in platelet activation. It has been suggested that Gal8 may also interact with platelet coagulation factor V (FV). This indispensable cofactor is stored in alpha-granules of platelets via a poorly understood endocytic mechanism that only exists in megakaryocytes (platelet precursor cells). In this study, we now assessed the putative role of Gal8 for FV biology. Surface plasmon resonance analysis and a solid phase binding assay revealed that Gal8 binds FV. The data further show that beta-galactosides block the interaction between FV and Gal8. These findings indicate that Gal8 specifically interacts with FV in a carbohydrate-dependent manner. Confocal microscopy studies and flow cytometry analysis demonstrated that megakaryocytic DAMI cells internalize FV. Flow cytometry showed that these cells express Gal8 on their cell surface. Reducing the functional presence of Gal8 on the cells either by an anti-Gal8 antibody or by siRNA technology markedly impaired the endocytic uptake of FV. Compatible with the apparent role of Gal8 for FV uptake, endocytosis of FV was also affected in the presence of beta-galactosides. Strikingly, thrombopoietin-differentiated DAMI cells, which represent a more mature megakaryocytic state, not only lose the capacity to express cell-surface bound Gal8 but also lose the ability to internalize FV. Collectively, our data reveal a novel role for the tandem repeat Gal8 in promoting FV endocytosis.	[Zappelli, Claudia; van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Thijssen-Timmer, Daphne C.] Sanquin Res, Dept Hematopoiesis, NL-1105 AZ Amsterdam, Netherlands; [Thijssen-Timmer, Daphne C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3435 CG Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl			Sanquin Blood Supply Foundation [PPOC-10-012]	Sanquin Blood Supply Foundation	This work was supported by Grant PPOC-10-012 from Sanquin Blood Supply Foundation.	Romaniuk MA, 2010, BIOCHEM J, V432, P535, DOI 10.1042/BJ20100538; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bos MHA, 2005, J THROMB HAEMOST, V3, P522, DOI 10.1111/j.1538-7836.2005.01181.x; Bouchard BA, 2008, J THROMB HAEMOST, V6, P638, DOI 10.1111/j.1538-7836.2008.02894.x; Bouchard BA, 2005, J THROMB HAEMOST, V3, P541, DOI 10.1111/j.1538-7836.2005.01190.x; Camire RM, 1998, BLOOD, V92, P3035, DOI 10.1182/blood.V92.9.3035.421k54_3035_3041; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Giampaolo A, 2005, BRIT J HAEMATOL, V128, P108, DOI 10.1111/j.1365-2141.2004.05279.x; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Graham JE, 2009, HEALTH PSYCHOL, V28, P621, DOI 10.1037/a0015208; GREENBERG SM, 1988, BLOOD, V72, P1968; HANDAGAMA P, 1993, BLOOD, V82, P135, DOI 10.1182/blood.V82.1.135.bloodjournal821135; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Kim SW, 1999, BIOCHEMISTRY-US, V38, P11448, DOI 10.1021/bi991275y; Leffler H, 2001, Results Probl Cell Differ, V33, P57; Lev PR, 2011, PLATELETS, V22, P28, DOI 10.3109/09537104.2010.515271; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Pacienza N, 2008, FASEB J, V22, P1113, DOI 10.1096/fj.07-9524com; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Phillips JE, 2004, J THROMB HAEMOST, V2, P1806, DOI 10.1111/j.1538-7836.2004.00919.x; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Suehiro Y, 2005, THROMB HAEMOSTASIS, V94, P585, DOI 10.1160/TH05-02-0141; TRACY PB, 1984, J CLIN INVEST, V74, P1221, DOI 10.1172/JCI111531; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhu WQ, 2001, BIOCHEM BIOPH RES CO, V280, P1183, DOI 10.1006/bbrc.2001.4256; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	42	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8327	8335		10.1074/jbc.M111.305151	http://dx.doi.org/10.1074/jbc.M111.305151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267735	hybrid, Green Published			2022-12-27	WOS:000301349400047
J	Churamani, D; Geach, TJ; Ramakrishnan, L; Prideaux, N; Patel, S; Dale, L				Churamani, Dev; Geach, Timothy J.; Ramakrishnan, Latha; Prideaux, Nicole; Patel, Sandip; Dale, Leslie			The Signaling Protein CD38 Is Essential for Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL CYCLASE; ADENINE-DINUCLEOTIDE PHOSPHATE; MOLECULAR CHARACTERIZATION; 2-PORE CHANNELS; CALCIUM; CELLS; EXPRESSION; NAADP; DIFFERENTIATION; MESSENGERS	CD38 is a multifunctional protein possessing ADP-ribosyl cyclase activity responsible for both the synthesis and the degradation of several Ca2+-mobilizing second messengers. Although a variety of functions have been ascribed to CD38, such as immune responses, insulin secretion, and social behavior in adults, nothing is known of its role during embryonic development when Ca2+ signals feature prominently. Here, we report the identification and functional expression of CD38 from Xenopus laevis, a key model organism for the study of vertebrate development. We show that CD38 expression and endogenous ADP-ribosyl cyclase activity are developmentally regulated during cellular differentiation. Chemical or molecular inhibition of CD38 abolished ADP-ribosyl cyclase activity and disrupted elongation of the anterior-posterior axis and differentiation of skeletal muscle, culminating in embryonic death. Our data uncover a previously unknown role for CD38 as an essential regulator of embryonic development.	[Churamani, Dev; Geach, Timothy J.; Ramakrishnan, Latha; Prideaux, Nicole; Patel, Sandip; Dale, Leslie] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Anat Bldg,Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; l.dale@ucl.ac.uk	Patel, Sandip/O-9591-2015	Patel, Sandip/0000-0001-7247-2013	Biotechnology and Biological Sciences Research Council [BBS/B/0661X, BB/D018110/1, BB/G013721/1]; Medical Research Council; BBSRC [BB/G013721/1, BB/D018110/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BBS/B/0661X (to L. D.) and BB/D018110/1 and BB/G013721/1 (to S. P.) from the Biotechnology and Biological Sciences Research Council and a Ph. D. studentship from the Medical Research Council (to L. R.).	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Itoh M, 1998, J IMMUNOL, V161, P3974; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Ladher RK, 2000, DEV BIOL, V218, P183, DOI 10.1006/dbio.1999.9586; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Leise WF, 2004, DEVELOPMENT, V131, P1703, DOI 10.1242/dev.01054; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Ramakrishnan L, 2010, J BIOL CHEM, V285, P19900, DOI 10.1074/jbc.M110.105312; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slusarski DC, 2007, DEV BIOL, V307, P1, DOI 10.1016/j.ydbio.2007.04.043; Vigano A, 1998, LANCET, V352, P1905, DOI 10.1016/S0140-6736(05)60396-0; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386; Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104	29	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6974	6978		10.1074/jbc.C111.323618	http://dx.doi.org/10.1074/jbc.C111.323618			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223651	Green Published, hybrid			2022-12-27	WOS:000301060200003
J	Garcia-Hoz, C; Sanchez-Fernandez, G; Garcia-Escudero, R; Fernandez-Velasco, M; Palacios-Garcia, J; Ruiz-Meana, M; Diaz-Meco, MT; Leitges, M; Moscat, J; Garcia-Dorado, D; Bosca, L; Mayor, F; Ribas, C				Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Garcia-Escudero, Ramon; Fernandez-Velasco, Maria; Palacios-Garcia, Julia; Ruiz-Meana, Marisol; Diaz-Meco, Maria Teresa; Leitges, Michael; Moscat, Jorge; Garcia-Dorado, David; Bosca, Lisardo; Mayor, Federico, Jr.; Ribas, Catalina			Protein Kinase C (PKC) zeta-mediated G alpha(q) Stimulation of ERK5 Protein Pathway in Cardiomyocytes and Cardiac Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANGIOTENSIN-II; HYPERTROPHIC RESPONSE; HEART-FAILURE; DILATED CARDIOMYOPATHY; CELL-PROLIFERATION; SIGNALING PATHWAYS; ACTIVATION; RECEPTOR; PHOSPHORYLATION	Gq-coupled G protein-coupled receptors (GPCRs) mediate the actions of a variety of messengers that are key regulators of cardiovascular function. Enhanced G alpha(q)-mediated signaling plays an important role in cardiac hypertrophy and in the transition to heart failure. We have recently described that G alpha(q) acts as an adaptor protein that facilitates PKC zeta-mediated activation of ERK5 in epithelial cells. Because the ERK5 cascade is known to be involved in cardiac hypertrophy, we have investigated the potential relevance of this pathway in cardiovascular Gq-dependent signaling using both cultured cardiac cell types and chronic administration of angiotensin II in mice. We find that PKC zeta is required for the activation of the ERK5 pathway by Gq-coupled GPCR in neonatal and adult murine cardiomyocyte cultures and in cardiac fibroblasts. Stimulation of ERK5 by angiotensin II is blocked upon pharmacological inhibition or siRNA-mediated silencing of PKC zeta in primary cultures of cardiac cells and in neonatal cardiomyocytes isolated from PKC zeta-deficient mice. Moreover, upon chronic challenge with angiotensin II, these mice fail to promote the changes in the ERK5 pathway, in gene expression patterns, and in hypertrophic markers observed in wild-type animals. Taken together, our results show that PKC zeta is essential for Gq-dependent ERK5 activation in cardiomyocytes and cardiac fibroblasts and indicate a key cardiac physiological role for the Gq/PKC zeta/ERK5 signaling axis.	[Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Univ Autonoma Madrid, Dept Biol Mol, CSIC, E-28049 Madrid, Spain; [Garcia-Hoz, Carlota; Sanchez-Fernandez, Guzman; Palacios-Garcia, Julia; Mayor, Federico, Jr.; Ribas, Catalina] Inst Invest Sanitaria La Princesa, Madrid 28006, Spain; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol, Mol Oncol Unit, Madrid 28040, Spain; [Fernandez-Velasco, Maria] Inst Invest Hosp La Paz, IdiPAZ, Madrid 28029, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Res Inst, Barcelona 08035, Spain; [Diaz-Meco, Maria Teresa; Moscat, Jorge] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, La Jolla, CA 92037 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Bosca, Lisardo] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Sanford Burnham Prebys Medical Discovery Institute; University of Oslo; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Mayor, F (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain.	fmayor@cbm.uam.es; cribas@cbm.uam.es	Garcia-Escudero, Ramon/A-2735-2012; Mayor, Federico/N-7644-2016; Leitges, Michael/AAN-1953-2021; Bosca, Lisardo/A-2059-2008; velasco, maria fernandez/AAO-5062-2021	Garcia-Escudero, Ramon/0000-0001-5640-6542; Bosca, Lisardo/0000-0002-0253-5469; Diaz-Meco, Maria/0000-0003-0147-0998; Garcia-Hoz, Carlota/0000-0001-8268-4159; Leitges, Michael/0000-0003-4203-6995; Mayor Menendez, Federico/0000-0003-1434-8449	Ministerio de Ciencia e Innovacion [SAF2008-00552]; Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III [RD06-0014/0037]; Comunidad de Madrid [S-SAL-0159-2006]; Instituto de Salud Carlos III [PI080461]; NATIONAL CANCER INSTITUTE [R01CA134530] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Ramon Areces; Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF2008-00552), Fundacion Ramon Areces, The Cardiovascular Network (RECAVA) of Instituto de Salud Carlos III (RD06-0014/0037), Comunidad de Madrid (S-SAL-0159-2006 to F. M.), and Instituto de Salud Carlos III (PI080461 to C. R.).	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borges L, 2008, BIOCHEM BIOPH RES CO, V374, P641, DOI 10.1016/j.bbrc.2008.07.085; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhingra R, 2005, J AM COLL CARDIOL, V45, P685, DOI 10.1016/j.jacc.2004.11.046; Diaz-Rodriguez E, 2010, J CELL SCI, V123, P3146, DOI 10.1242/jcs.070516; Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Ecarnot-Laubriet A, 2002, BBA-MOL BASIS DIS, V1586, P233, DOI 10.1016/S0925-4439(01)00101-6; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Geng J, 2009, BIOCHEM BIOPH RES CO, V388, P517, DOI 10.1016/j.bbrc.2009.08.025; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1297, DOI 10.1152/ajpcell.00617.2005; Harris DM, 2008, CLIN SCI, V115, P79, DOI 10.1042/CS20070442; Harris DM, 2006, J MOL CELL CARDIOL, V40, P589, DOI 10.1016/j.yjmcc.2006.03.001; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kimura TE, 2010, CIRC RES, V106, P961, DOI 10.1161/CIRCRESAHA.109.209320; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Larkin JE, 2004, PHYSIOL GENOMICS, V18, P152, DOI 10.1152/physiolgenomics.00057.2004; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Liao YL, 2004, CIRCULATION, V110, P692, DOI 10.1161/01.CIR.0000137831.08683.E1; Liggett SB, 2006, J CLIN INVEST, V116, P875, DOI 10.1172/JCI28234; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mende U, 2001, J MOL CELL CARDIOL, V33, P1477, DOI 10.1006/jmcc.2001.1411; Mirotsou M, 2006, PHYSIOL GENOMICS, V27, P86, DOI 10.1152/physiolgenomics.00028.2006; Mishra S, 2010, J CARDIOVASC PHARM, V56, P598, DOI 10.1097/FJC.0b013e3181e1d263; Missbichler A, 2001, EUR J MED RES, V6, P105; Molhoek SG, 2004, HEART, V90, P97, DOI 10.1136/heart.90.1.97; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2011, NAT IMMUNOL, V12, P12, DOI 10.1038/ni0111-12; Nakamura K, 2010, METHODS MOL BIOL, V661, P91, DOI 10.1007/978-1-60761-795-2_5; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Obara Y, 2010, MOL PHARMACOL, V77, P10, DOI 10.1124/mol.109.060236; Ohnesorge N, 2010, J BIOL CHEM, V285, P26199, DOI 10.1074/jbc.M110.103127; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Parmentier JH, 2003, HYPERTENSION, V41, P794, DOI 10.1161/01.HYP.0000047873.76255.0B; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Salles G, 2005, HYPERTENSION, V46, P1207, DOI 10.1161/01.HYP.0000185517.53179.43; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sentex E, 2006, CAN J PHYSIOL PHARM, V84, P227, DOI 10.1139/Y05-120; Smeets PJH, 2008, PHYSIOL GENOMICS, V36, P15, DOI 10.1152/physiolgenomics.90296.2008; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yamazaki T, 1999, J HUM HYPERTENS, V13, pS43, DOI 10.1038/sj.jhh.1000747; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhao Z, 2010, J CELL BIOCHEM, V109, P653, DOI 10.1002/jcb.22441; Zhao Z, 2009, MOL CELL BIOCHEM, V322, P171, DOI 10.1007/s11010-008-9954-7; Zhu YC, 1997, AM J CARDIOL, V80, pA110, DOI 10.1016/S0002-9149(97)00465-7	74	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7792	7802		10.1074/jbc.M111.282210	http://dx.doi.org/10.1074/jbc.M111.282210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232556	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000301060200077
J	Liu, WZ; Singh, R; Choi, CS; Lee, HY; Keramati, AR; Samuel, VT; Lifton, RP; Shulman, GI; Mani, A				Liu, Wenzhong; Singh, Rajvir; Choi, Cheol Soo; Lee, Hui-Young; Keramati, Ali R.; Samuel, Varman T.; Lifton, Richard P.; Shulman, Gerald I.; Mani, Arya			Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOCYTE DIFFERENTIATION; GENOME-WIDE ASSOCIATION; DIET-INDUCED OBESITY; WNT CORECEPTOR LRP6; BETA-CATENIN; INSULIN-RESISTANCE; OXIDATIVE-METABOLISM; LEPTIN RECEPTOR; GENE; PHOSPHORYLATION	Body fat, insulin resistance, and type 2 diabetes are often linked together, but the molecular mechanisms that unify their association are poorly understood. Wnt signaling regulates adipogenesis, and its altered activity has been implicated in the pathogenesis of type 2 diabetes and metabolic syndrome. LRP6(+/-) mice on a high fat diet were protected against diet-induced obesity and hepatic and adipose tissue insulin resistance compared with their wild-type (WT) littermates. Brown adipose tissue insulin sensitivity and reduced adiposity of LRP6(+/-) mice were accounted for by diminished Wnt-dependent mTORC1 activity and enhanced expression of brown adipose tissue PGC1-alpha and UCP1. LRP6(+/-) mice also exhibited reduced endogenous hepatic glucose output, which was due to diminished FoxO1-dependent expression of the key gluconeogenic enzyme glucose-6-phosphatase (G6pase). In addition, in vivo and in vitro studies showed that loss of LRP6 allele is associated with increased leptin receptor expression, which is a likely cause of hepatic insulin sensitivity in LRP6(+/-) mice. Our study identifies LRP6 as a nutrient-sensitive regulator of body weight and glucose metabolism and as a potential target for pharmacological interventions in obesity and diabetes.	[Liu, Wenzhong; Singh, Rajvir; Choi, Cheol Soo; Lee, Hui-Young; Keramati, Ali R.; Samuel, Varman T.; Lifton, Richard P.; Shulman, Gerald I.; Mani, Arya] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406799, South Korea; [Lifton, Richard P.; Mani, Arya] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Lifton, Richard P.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Gachon University; Yale University; Howard Hughes Medical Institute; Yale University	Mani, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med, FMP3,333 Cedar St, New Haven, CT 06520 USA.	arya.mani@yale.edu	SINGH, RAJVIR/C-8191-2012; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Keramati, Ali/0000-0002-8728-1508; Lee, Hui-Young/0000-0002-3464-6382	National Institutes of Health [R01HL094784-01, R01HL094574-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094784, R01HL094574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL094784-01 and R01HL094574-03 (to A. M.).	Anderwald C, 2002, MOL ENDOCRINOL, V16, P1612, DOI 10.1210/me.16.7.1612; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Crowley V, 2001, NUTR METAB CARDIOVAS, V11, P70; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; de la Concepcion MLR, 2005, FEBS LETT, V579, P1670, DOI 10.1016/j.febslet.2005.02.021; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z; Huang W, 2006, ENDOCRINOLOGY, V147, P1480, DOI 10.1210/en.2005-0731; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kang S, 2005, MOL CELL BIOL, V25, P1272, DOI 10.1128/MCB.25.4.1272-1282.2005; Koch A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/473540; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Le D, 2007, SURG ENDOSC, V21, P1593, DOI 10.1007/s00464-006-9185-5; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mancuso P, 2011, J IMMUNOL, V186, P1081, DOI 10.4049/jimmunol.1001470; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rossmeis M, 2004, INT J OBESITY, V28, pS38, DOI 10.1038/sj.ijo.0802855; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Takada Ichiro, 2008, Clin Calcium, V18, P656, DOI CliCa0805656661; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uchiyama T, 2011, CANCER SCI, V102, P367, DOI 10.1111/j.1349-7006.2010.01803.x; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Vaidya D, 2010, DIABETES CARE, V33, P1376, DOI 10.2337/dc09-2211; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007	49	59	61	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7213	7223		10.1074/jbc.M111.286724	http://dx.doi.org/10.1074/jbc.M111.286724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232553	Green Published, hybrid			2022-12-27	WOS:000301060200024
J	Czesak, M; Le Francois, B; Millar, AM; Deria, M; Daigle, M; Visvader, JE; Anisman, H; Albert, PR				Czesak, Margaret; Le Francois, Brice; Millar, Anne M.; Deria, Mariam; Daigle, Mireille; Visvader, Jane E.; Anisman, Hymie; Albert, Paul R.			Increased Serotonin-1A (5-HT1A) Autoreceptor Expression and Reduced Raphe Serotonin Levels in Deformed Epidermal Autoregulatory Factor-1 (Deaf-1) Gene Knock-out Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MAJOR DEPRESSIVE DISORDER; 1A RECEPTOR GENE; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; ANTIDEPRESSANT-TREATMENT; CHRONIC FLUOXETINE; TREATMENT RESPONSE; MESSENGER-RNA; BINDING	Altered regulation of the serotonin-1A (5-HT1A) receptor gene is implicated in major depression and mood disorders. The functional human 5-HT1A C(-1019) G promoter polymorphism (rs6295), which prevents the binding of Deaf-1/NUDR leading to dysregulation of the receptor, has been associated with major depression. In cell models Deaf-1 displays dual activity, repressing 5-HT1A autoreceptor expression in serotonergic raphe cells while enhancing postsynaptic 5-HT1A heteroreceptor expression in nonserotonergic neurons. A functional Deaf-1 binding site on the mouse 5-HT1A promoter was recognized by Deaf-1 in vitro and in vivo and mediated dual activity of Deaf-1 on 5-HT1A gene transcription. To address regulation by Deaf-1 in vivo, Deaf-1 knock-out mice bred to a C57BL/6 background were compared with wild-type siblings for changes in 5-HT1A RNA and protein by quantitative RT-PCR, in situ hybridization, and immunofluorescence. In the dorsal raphe, Deaf-1 knockout mice displayed increased 5-HT1A mRNA, protein, and 5-HT1A-positive cell counts but reduced 5-HT levels, whereas other serotonergic markers, such as tryptophan hydroxylase (TPH)- or 5-HT-positive cells and TPH2 RNA levels, were unchanged. By contrast, 5-HT1A mRNA and 5-HT1A-positive cells were reduced in the frontal cortex of Deaf-1-null mice, with no significant change in hippocampal 5-HT1A RNA, protein, or cell counts. The region-specific alterations of brain 5-HT1A gene expression and reduced raphe 5-HT content in Deaf-1(-/-) mice indicate the importance of Deaf-1 in regulation of 5-HT1A gene expression and provide insight into the role of the 5-HT1A G(-1019) allele in reducing serotonergic neurotransmission by derepression of 5-HT1A autoreceptors.	[Czesak, Margaret; Le Francois, Brice; Millar, Anne M.; Deria, Mariam; Daigle, Mireille; Albert, Paul R.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada; [Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; Walter & Eliza Hall Institute; Carleton University	Albert, PR (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa Hosp Res Inst Neurosci, Ottawa, ON K1H 8M5, Canada.	palbert@uottawa.ca	Albert, Paul/E-4804-2010	Albert, Paul/0000-0002-1809-3554; Le Francois, Brice/0000-0002-0065-398X; Deria, Pravas/0000-0001-7998-4492	Canadian Institutes of Health Research [MOP-36437, MOP-115098]; National Health and Medical Research Council, Australia; National Science and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research Grants MOP-36437 and MOP-115098 (to P.R.A.) and a grant from the National Health and Medical Research Council, Australia (to J.E.V.). The Heart and Stroke Foundation Centre for Stroke Recovery supported some equipment used for these studies.; Supported by a Canada Graduate Scholarship Doctoral Award from the Canadian Institutes of Health Research.; Supported by summer studentships from the National Science and Engineering Council of Canada.	Abbas SY, 2007, SYNAPSE, V61, P531, DOI 10.1002/syn.20399; Arias B, 2005, J PSYCHOPHARMACOL, V19, P166, DOI 10.1177/0269881105049037; Baune BT, 2008, NEUROSCI LETT, V436, P111, DOI 10.1016/j.neulet.2008.03.001; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; Boldrini M, 2008, J PSYCHIATR RES, V42, P433, DOI 10.1016/j.jpsychires.2007.05.004; Bonnin A, 2006, NEUROSCIENCE, V141, P781, DOI 10.1016/j.neuroscience.2006.04.036; Bortolozzi A, 2004, J NEUROCHEM, V88, P1373, DOI 10.1046/j.1471-4159.2003.02267.x; Bortolozzi A, 2012, MOL PSYCHIATR, V17, P612, DOI 10.1038/mp.2011.92; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Castro ME, 2003, NEUROPHARMACOLOGY, V44, P93, DOI 10.1016/S0028-3908(02)00340-4; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; CHARNEY DS, 1990, ANNU REV MED, V41, P437; Czesak M, 2006, J NEUROSCI, V26, P1864, DOI 10.1523/JNEUROSCI.2643-05.2006; Czesak M, 2007, J NEUROSCI METH, V164, P59, DOI 10.1016/j.jneumeth.2007.04.002; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; Drevets WC, 2007, NUCL MED BIOL, V34, P865, DOI 10.1016/j.nucmedbio.2007.06.008; Ferguson KL, 2005, EMBO J, V24, P4381, DOI 10.1038/sj.emboj.7600887; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; He M, 2001, BRAIN RES, V902, P11, DOI 10.1016/S0006-8993(01)02271-5; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hensler JG, 2002, NEUROPSYCHOPHARMACOL, V26, P565, DOI 10.1016/S0893-133X(01)00395-5; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hong CJ, 2006, PHARMACOGENOMICS J, V6, P27, DOI 10.1038/sj.tpj.6500340; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Jacobsen KX, 2008, MOL CELL NEUROSCI, V38, P349, DOI 10.1016/j.mcn.2008.03.007; Jacobsen KX, 2011, J NEUROCHEM, V116, P1066, DOI 10.1111/j.1471-4159.2010.07161.x; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kishi T, 2009, J HUM GENET, V54, P629, DOI 10.1038/jhg.2009.84; Kusserow H, 2004, MOL BRAIN RES, V129, P104, DOI 10.1016/j.molbrainres.2004.06.028; Le Francois B, 2008, NEUROPHARMACOLOGY, V55, P977, DOI 10.1016/j.neuropharm.2008.06.046; Le Poul E, 2000, NEUROPHARMACOLOGY, V39, P110, DOI 10.1016/S0028-3908(99)00088-X; Lemonde S, 2004, J NEUROCHEM, V88, P857, DOI 10.1046/j.1471-4159.2003.02223.x; Lemonde S, 2003, J NEUROSCI, V23, P8788; Liu C, 2010, NAT NEUROSCI, V13, P1190, DOI 10.1038/nn.2623; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JF, 1998, BIOL PSYCHIAT, V43, P547, DOI 10.1016/S0006-3223(97)00484-8; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Parsey RV, 2010, BIOL PSYCHIAT, V68, P170, DOI 10.1016/j.biopsych.2010.03.023; Parsey RV, 2006, NEUROPSYCHOPHARMACOL, V31, P1745, DOI 10.1038/sj.npp.1300992; Parsey RV, 2006, BIOL PSYCHIAT, V59, P106, DOI 10.1016/j.biopsych.2005.06.016; Paxinos G., 2001, MOUSE BRAIN; Pineyro G, 1999, PHARMACOL REV, V51, P533; POMPEIANO M, 1992, J NEUROSCI, V12, P440; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2011, J NEUROSCI, V31, P6008, DOI 10.1523/JNEUROSCI.5836-10.2011; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Richer M, 2002, EUR J PHARMACOL, V435, P195, DOI 10.1016/S0014-2999(01)01607-7; Rueter LE, 1998, J PHARMACOL EXP THER, V285, P404; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Serretti A, 2004, INT J NEUROPSYCHOPH, V7, P453, DOI 10.1017/S1461145704004687; Shively CA, 2006, ARCH GEN PSYCHIAT, V63, P396, DOI 10.1001/archpsyc.63.4.396; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Sullivan GM, 2009, BIOL PSYCHIAT, V66, P223, DOI 10.1016/j.biopsych.2009.01.028; Szewczyk B, 2009, INT J NEUROPSYCHOPH, V12, P155, DOI 10.1017/S1461145708009012; Wang L, 2008, J PSYCHOPHARMACOL, V22, P904, DOI 10.1177/0269881107081522; Yevtushenko OO, 2010, J AFFECT DISORDERS, V123, P308, DOI 10.1016/j.jad.2009.09.007; Yu YWY, 2006, EUR NEUROPSYCHOPHARM, V16, P498, DOI 10.1016/j.euroneuro.2005.12.004; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540	65	57	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6615	6627		10.1074/jbc.M111.293027	http://dx.doi.org/10.1074/jbc.M111.293027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22232550	hybrid, Green Published			2022-12-27	WOS:000300791800049
J	Yao, X; Chong, HH; Zhang, C; Waltersperger, S; Wang, MT; Cui, S; He, YX				Yao, Xue; Chong, Huihui; Zhang, Chao; Waltersperger, Sandro; Wang, Meitian; Cui, Sheng; He, Yuxian			Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 CORE STRUCTURE; ATOMIC-STRUCTURE; RESISTANCE; ENFUVIRTIDE; ENTRY; DESIGN; DOMAIN; T-20; SUSCEPTIBILITY	Sifuvirtide (SFT) is an electrostatically constrained alpha-helical peptide fusion inhibitor showing potent anti-HIV activity, good safety, and pharmacokinetic profiles, and it is currently under phase II clinical trials in China. In this study, we demonstrate its potent and broad anti-HIV activity by using diverse HIV-1 subtypes and variants, including subtypes A, B, and C that dominate the AIDS epidemic worldwide, and subtypes B', CRF07_BC, and CRF01_AE recombinants that are currently circulating in China, and those possessing cross-resistance to the first and second generation fusion inhibitors. To elucidate its mechanism of action, we determined the crystal structure of SFT in complex with its target N-terminal heptad repeat region (NHR) peptide (N36), which fully supports our rational inhibitor design and reveals its key motifs and residues responsible for the stability and anti-HIV activity. As anticipated, SFT adopts fully helical conformation stabilized by the multiple engineered salt bridges. The designing of SFT also provide novel inter-helical salt bridges and hydrogen bonds that improve the affinity of SFT to NHR trimer. The extra serine residue and acetyl group stabilize alpha-helicity of the N-terminal portion of SFT, whereas Thr-119 serves to stabilize the hydrophobic NHR pocket. In addition, our structure demonstrates that the residues critical for drug resistance, located at positions 37, 38, 41, and 43 of NHR, are irreplaceable for maintaining the stable fusogenic six-helix bundle structure. Our data present important information for developing SFT for clinical use and for designing novel HIV fusion inhibitors.	[Yao, Xue; Chong, Huihui; Zhang, Chao; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Yao, Xue; Chong, Huihui; Zhang, Chao; Cui, Sheng; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China; [Waltersperger, Sandro; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Cui, S (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, 9 Dong Dan San Tiao, Beijing 100730, Peoples R China.	cuisheng2007@yahoo.com.cn; yhe@ipb.pumc.edu.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; Wang, Meitian/D-3208-2013	Sheng, CUI/0000-0001-6329-3582; Wang, Meitian/0000-0002-5340-3036	Natural Science Foundation of China [30870123, 81025009]; National 973 Program of China [2010CB530100]; National Science and Technology Major Project [2009ZX10004-303]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program of China(National Basic Research Program of China); National Science and Technology Major Project	This work was supported by Natural Science Foundation of China Grant 30870123, National Outstanding Youth Award 81025009 from Natural Science Foundation of China, National 973 Program of China Grant 2010CB530100, and National Science and Technology Major Project Grant 2009ZX10004-303.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Ashkenazi A, 2011, BBA-BIOMEMBRANES, V1808, P2352, DOI 10.1016/j.bbamem.2011.06.020; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Brenner B, 2003, AIDS, V17, pF1, DOI 10.1097/00002030-200301030-00001; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chinnadurai R, 2005, AIDS, V19, P1401, DOI 10.1097/01.aids.0000180785.25800.de; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P11129, DOI 10.1128/JVI.01060-08; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; Jette L, 2005, ENDOCRINOLOGY, V146, P3052, DOI 10.1210/en.2004-1286; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Martin-Carbonero L, 2004, AIDS REV, V6, P61; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; McCutchan FE, 2000, AIDS, V14, pS31; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zhang CY, 2009, INT J INFECT DIS, V13, pE212, DOI 10.1016/j.ijid.2008.12.010; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	51	60	62	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6788	6796		10.1074/jbc.M111.317883	http://dx.doi.org/10.1074/jbc.M111.317883			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228771	Green Published, hybrid			2022-12-27	WOS:000300791800064
J	Yuan, L; Le Bras, A; Sacharidou, A; Itagaki, K; Zhan, YM; Kondo, M; Carman, CV; Davis, GE; Aird, WC; Oettgen, P				Yuan, Lei; Le Bras, Alexandra; Sacharidou, Anastasia; Itagaki, Kiyoshi; Zhan, Yumei; Kondo, Maiko; Carman, Christopher V.; Davis, George E.; Aird, William C.; Oettgen, Peter			ETS-related Gene (ERG) Controls Endothelial Cell Permeability via Transcriptional Regulation of the Claudin 5 (CLDN5) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; NF-KAPPA-B; VASCULAR INFLAMMATION; TNF-ALPHA; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; TRANSMIGRATION; ANGIOGENESIS; DYSFUNCTION	ETS-related gene (ERG) is a member of the ETS transcription factor family. Our previous studies have shown that ERG expression is highly enriched in endothelial cells (EC) both in vitro and in vivo. ERG expression is markedly repressed in response to inflammatory stimuli. It has been shown that ERG is a positive regulator of several EC-restricted genes including VE-cadherin, endoglin, and von Willebrand factor, and a negative regulator of other genes such as interleukin (IL)-8 and intercellular adhesion molecule (ICAM)-1. In this study we have identified a novel role for ERG in the regulation of EC barrier function. ERG knockdown results in marked increases in EC permeability. This is associated with a significant increase of stress fiber and gap formation in EC. Furthermore, we identify CLDN5 as a downstream target of ERG in EC. Thus, our results suggest that ERG plays a pivotal role in regulating EC barrier function and that this effect is mediated in part through its regulation of CLDN5 gene expression.	[Yuan, Lei; Le Bras, Alexandra; Zhan, Yumei; Kondo, Maiko; Oettgen, Peter] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Div Cardiol,Dept Med, Boston, MA 02215 USA; [Yuan, Lei; Le Bras, Alexandra; Zhan, Yumei; Kondo, Maiko; Carman, Christopher V.; Aird, William C.; Oettgen, Peter] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Div Mol & Vasc Med,Dept Med, Boston, MA 02215 USA; [Itagaki, Kiyoshi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Surg, Boston, MA 02215 USA; [Sacharidou, Anastasia; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA; [Davis, George E.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; Univ Missouri, Dalton Cardiovasc Sci Ctr, Columbia, MO 65212 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Oettgen, P (corresponding author), Beth Israel Deaconess Med Ctr, Res N Rm 270D,330 Brookline Ave, Boston, MA 02115 USA.	joettgen@caregroup.harvard.edu	Oettgen, Peter/AAF-5026-2021; Carman, Christopher V./AAX-8995-2020; Carman, Christopher/L-8108-2016; Itagaki, Kiyoshi/M-5501-2015	Carman, Christopher V./0000-0001-7358-2548; Carman, Christopher/0000-0001-7358-2548; Itagaki, Kiyoshi/0000-0002-6033-1122; Le Bras, Alexandra/0000-0001-7898-4618	National Institutes of Health [P01 HL76540, R01 HL04006]; American Heart Association [EIA0740012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104006, P01HL076540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL76540 (to P.O. and W.C.A.) and R01 HL04006 (to C.V.C.). This work was also supported by American Heart Association Established Investigator Award EIA0740012 (to P.O.).	Aghajanian A, 2008, J THROMB HAEMOST, V6, P1453, DOI 10.1111/j.1538-7836.2008.03087.x; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Bayless KJ, 2002, J CELL SCI, V115, P1123; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Burek M, 2010, ARTERIOSCL THROM VAS, V30, P298, DOI 10.1161/ATVBAHA.109.197582; Burek M, 2009, MOL CELL ENDOCRINOL, V298, P19, DOI 10.1016/j.mce.2008.09.041; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Garcia C, 2010, DIABETES METAB, V36, P327, DOI 10.1016/j.diabet.2010.07.001; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hasegawa Y, 2004, BIOCHEM BIOPH RES CO, V316, P52, DOI 10.1016/j.bbrc.2004.02.019; He XJ, 1998, PFLUG ARCH EUR J PHY, V435, P375, DOI 10.1007/s004240050526; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kaarteenaho-Wiik R, 2009, J HISTOCHEM CYTOCHEM, V57, P187, DOI 10.1369/jhc.2008.951566; Khan F, 2010, NAT REV RHEUMATOL, V6, P253, DOI 10.1038/nrrheum.2010.44; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Morita K, 2003, EXP DERMATOL, V12, P289, DOI 10.1034/j.1600-0625.2003.120309.x; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ni WH, 2004, ARTERIOSCL THROM VAS, V24, P534, DOI 10.1161/01.ATV.0000118275.60121.2b; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Petrache I, 2001, AM J PHYSIOL-LUNG C, V280, pL1168, DOI 10.1152/ajplung.2001.280.6.L1168; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vouret-Craviari V, 1998, MOL BIOL CELL, V9, P2639, DOI 10.1091/mbc.9.9.2639; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	34	61	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6582	6591		10.1074/jbc.M111.300236	http://dx.doi.org/10.1074/jbc.M111.300236			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235125	Green Published, hybrid			2022-12-27	WOS:000300791800046
J	Lomberk, G; Mathison, AJ; Grzenda, A; Seo, S; Demars, CJ; Rizvi, S; Bonilla-Velez, J; Calvo, E; Fernandez-Zapico, ME; Iovanna, J; Buttar, NS; Urrutia, R				Lomberk, Gwen; Mathison, Angela J.; Grzenda, Adrienne; Seo, Seungmae; Demars, Cathrine J.; Rizvi, Sumera; Bonilla-Velez, Juliana; Calvo, Ezequiel; Fernandez-Zapico, Martin E.; Iovanna, Juan; Buttar, Navtej S.; Urrutia, Raul			Sequence-specific Recruitment of Heterochromatin Protein 1 via Interaction with Kruppel-like Factor 11, a Human Transcription Factor Involved in Tumor Suppression and Metabolic Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DROSOPHILA-MELANOGASTER; CHROMOSOMAL-PROTEIN; SHADOW DOMAIN; BINDING-SITE; HP1 PROTEINS; FACTOR KLF11; CELL-GROWTH; HISTONE H3; LYSINE 9	Heterochromatin protein 1 (HP1) proteins are "gatekeepers" of epigenetic gene silencing that is mediated by lysine 9 of histone H3 methylation (H3K9me). Current knowledge supports a paradigm whereby HP1 proteins achieve repression by binding to H3K9me marks and interacting to H3K9 histone methyltransferases (HMTs), such as SUV39H1, which methylate this residue on adjacent nucleosomes thereby compacting chromatin and silencing gene expression. However, the mechanism underlying the recruitment of this epigenetic regulator to target gene promoters remains poorly characterized. In the current study, we reveal for the first time a mechanism whereby HP1 is recruited to promoters by a well characterized Kruppel-like transcription factor (KLF), in a sequence-specific manner, to mediate complex biological phenomena. A PXVXL HP1-interacting domain identified at position 487-491 of KLF11 mediates the binding of HP1 alpha and KLF11 in vitro and in cultured cells. KLF11 also recruits HP1 alpha and its histone methyltransferase, SUV39H1, to promoters to limit KLF11-mediated gene activation. Indeed, a KLF11 Delta HP1 mutant derepresses KLF11-regulated cancer genes, by inhibiting HP1-SUV39H1 recruitment, decreasing H3K9me3, while increasing activation-associated marks. Biologically, impairment of KLF11-mediated HP1-HMT recruitment abolishes tumor suppression, providing direct evidence that HP1-HMTs act in a sequence-specific manner to achieve this function rather than its well characterized binding to methylated chromatin without intermediary. Collectively, these studies reveal a novel role for HP1 as a cofactor in tumor suppression, expand our mechanistic understanding of a KLF associated to human disease, and outline cellular and biochemical mechanisms underlying this phenomenon, increasing the specificity of targeting HP1-HMT complexes to gene promoters.	[Lomberk, Gwen; Urrutia, Raul] Mayo Clin, GI Res Unit, Dept Biochem & Mol Biol, Lab Epigenet & Chromatin Dynam,GIH Div, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ 61V 462, Canada; [Iovanna, Juan] INSERM, U624, F-13288 Marseille, France	Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lomberk, G (corresponding author), Mayo Clin, GI Res Unit, Dept Biochem & Mol Biol, Lab Epigenet & Chromatin Dynam,GIH Div, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	lomberk.gwen@mayo.edu	Iovanna, Juan/M-9805-2017; Lomberk, Gwen/AAL-8490-2020; Grzenda, Adrienne L/K-4421-2019	Iovanna, Juan/0000-0003-1822-2237; Lomberk, Gwen/0000-0001-5463-789X; Grzenda, Adrienne L/0000-0001-5952-6953; Mathison, Angela/0000-0002-6763-2710; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK52913, CA110022-01, DK76845, T32-CA148073, CA102701]; Mayo Foundation; Fraternal Order of Eagles; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL CANCER INSTITUTE [T32CA148073, P20CA102701, P50CA102701, R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK076845, R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Fraternal Order of Eagles; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.), CA110022-01 and DK76845 (to N. S. B.), T32-CA148073 (to A. G.), and CA102701 (to M. E. F. Z.), the Mayo Foundation, and the Fraternal Order of Eagles (to G. L.) and the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567).	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Badugu R, 2005, CHROMOSOMA, V113, P370, DOI 10.1007/s00412-004-0324-2; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Belbin TJ, 2002, CANCER RES, V62, P1184; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Brown JL, 2010, DEVELOPMENT, V137, P2597, DOI 10.1242/dev.047761; Brown JL, 2005, NUCLEIC ACIDS RES, V33, P5181, DOI 10.1093/nar/gki827; Buck A, 2006, MOL CANCER RES, V4, P861, DOI 10.1158/1541-7786.MCR-06-0081; Buttar N, 2009, GASTROENTEROLOGY, V136, pA83; Cammas F, 2002, J CELL SCI, V115, P3439; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Emery DW, 2007, J CELL BIOCHEM, V100, P1045, DOI 10.1002/jcb.21093; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Kirschmann DA, 2000, CANCER RES, V60, P3359; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MD, 2004, J CLIN INVEST, V114, P1107, DOI 10.1172/JCI200422269; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; Nishimura K, 2006, ANTICANCER RES, V26, P4349; Potapova A, 2010, EUR J HAEMATOL, V84, P298, DOI 10.1111/j.1600-0609.2009.01389.x; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stephens GE, 2005, BIOCHEMISTRY-US, V44, P13394, DOI 10.1021/bi051006+; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tell R, 2011, AM J PATHOL, V178, P672, DOI 10.1016/j.ajpath.2010.10.017; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Uchida D, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-62; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	57	43	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13026	13039		10.1074/jbc.M112.342634	http://dx.doi.org/10.1074/jbc.M112.342634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22318730	Green Published, hybrid			2022-12-27	WOS:000302903700041
J	Wienk, H; Tishchenko, E; Belardinelli, R; Tomaselli, S; Dongre, R; Spurio, R; Folkers, GE; Gualerzi, CO; Boelens, R				Wienk, Hans; Tishchenko, Evgeny; Belardinelli, Riccardo; Tomaselli, Simona; Dongre, Ramachandra; Spurio, Roberto; Folkers, Gert E.; Gualerzi, Claudio O.; Boelens, Rolf			Structural Dynamics of Bacterial Translation Initiation Factor IF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI; BACILLUS-STEAROTHERMOPHILUS; BINDING-SITE; SIGNAL-TRANSDUCTION; PROTEIN-SYNTHESIS; SCALAR COUPLINGS; CHEMICAL-SHIFT; HYDROGEN-BONDS; G-DOMAIN	Bacterial translation initiation factor IF2 promotes ribosomal subunit association, recruitment, and binding of fMet-tRNA to the ribosomal P-site and initiation dipeptide formation. Here, we present the solution structures of GDP-bound and apo-IF2-G2 of Bacillus stearothermophilus and provide evidence that this isolated domain binds the 50 S ribosomal subunit and hydrolyzes GTP. Differences between the free and GDP-bound structures of IF2-G2 suggest that domain reorganization within the G2-G3-C1 regions underlies the different structural requirements of IF2 during the initiation process. However, these structural signals are unlikely forwarded from IF2-G2 to the C-terminal fMet-tRNA binding domain (IF2-C2) because the connected IF2-C1 and IF2-C2 modules show completely independent mobility, indicating that the bacterial interdomain connector lacks the rigidity that was found in the archaeal IF2 homolog aIF5B.	[Belardinelli, Riccardo; Spurio, Roberto; Gualerzi, Claudio O.] Univ Camerino, Genet Lab, Dept Biosci & Biotechnol, I-62032 Camerino, Macerata, Italy; [Wienk, Hans; Tishchenko, Evgeny; Tomaselli, Simona; Dongre, Ramachandra; Folkers, Gert E.; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, NL-3584 CH Utrecht, Netherlands	University of Camerino; Utrecht University	Gualerzi, CO (corresponding author), Univ Camerino, Genet Lab, Dept Biosci & Biotechnol, I-62032 Camerino, Macerata, Italy.	claudio.gualerzi@unicam.it; r.boelens@uu.nl	Folkers, Gert E/C-2863-2009; Wienk, Hans/P-8929-2015; Boelens, Rolf/B-4702-2009; Belardinelli, Riccardo/I-4363-2013; tomaselli, simona/A-6075-2012	Folkers, Gert E/0000-0003-1070-0505; Wienk, Hans/0000-0001-9577-0064; Boelens, Rolf/0000-0002-6939-8913; Belardinelli, Riccardo/0000-0002-3333-0466; tomaselli, simona/0000-0002-8627-6838; Spurio, Roberto/0000-0002-7611-4341	European Union [RII3-026145, 261863]; Netherlands Foundation for Scientific Research; MIUR; European Community	European Union(European Commission); Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MIUR(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission)	This work was supported in part by European Union EU-NMR Contract RII3-026145, Bio-NMR Contract 261863, the Netherlands Foundation for Scientific Research, and MIUR-PRIN 2003 Grant (to C. O. G.).; Recipient of a Mary Curie fellowship from the European Community.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Boelens R, 2002, CURR PROTEIN PEPT SC, V3, P107, DOI 10.2174/1389203023380765; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; Caserta E, 2010, J MOL BIOL, V396, P118, DOI 10.1016/j.jmb.2009.11.026; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Farrar CT, 1997, STRUCTURE, V5, P1055, DOI 10.1016/S0969-2126(97)00257-8; GIESSNERPRETTRE C, 1977, NUCLEIC ACIDS RES, V4, P99, DOI 10.1093/nar/4.1.99; Grigoriadou C, 2007, J MOL BIOL, V373, P562, DOI 10.1016/j.jmb.2007.07.032; Gualerzi CO, 2010, ISR J CHEM, V50, P80, DOI 10.1002/ijch.201000006; GUALERZI CO, 1991, J BIOL CHEM, V266, P16356; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P3726, DOI 10.1073/pnas.95.7.3726; LAALAMI S, 1991, J MOL BIOL, V220, P335, DOI 10.1016/0022-2836(91)90017-Z; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lohr F, 2000, J AM CHEM SOC, V122, P9289, DOI 10.1021/ja001345k; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Marzi S, 2003, RNA, V9, P958, DOI 10.1261/rna.2116303; Meunier S, 2000, EMBO J, V19, P1918, DOI 10.1093/emboj/19.8.1918; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Milon P, 2008, MOL CELL, V30, P712, DOI 10.1016/j.molcel.2008.04.014; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Milon P, 2010, EMBO REP, V11, P312, DOI 10.1038/embor.2010.12; Mishima M, 2000, J AM CHEM SOC, V122, P5883, DOI 10.1021/ja000005w; Misselwitz R, 1997, BIOCHEMISTRY-US, V36, P3170, DOI 10.1021/bi962613n; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; PON CL, 1985, J BIOL CHEM, V260, P8918; REDFIELD AG, 1990, BIOCHEMISTRY-US, V29, P3509, DOI 10.1021/bi00466a013; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SEVERINI M, 1991, J BIOL CHEM, V266, P22800; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Spurio R, 2000, J BIOL CHEM, V275, P2447, DOI 10.1074/jbc.275.4.2447; Szkaradkiewicz K, 2000, EUR J BIOCHEM, V267, P4290, DOI 10.1046/j.1432-1327.2000.01480.x; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; VACHON G, 1990, BIOCHEMISTRY-US, V29, P9728, DOI 10.1021/bi00493a031; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wienk H, 2005, PROTEIN SCI, V14, P2461, DOI 10.1110/ps.051531305; Wijmenga SS, 1998, PROG NUCL MAG RES SP, V32, P287, DOI 10.1016/S0079-6565(97)00023-X; WISHART DS, 1994, J BIOMOL NMR, V4, P171	65	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10922	10932		10.1074/jbc.M111.333393	http://dx.doi.org/10.1074/jbc.M111.333393			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22308033	Green Published, hybrid			2022-12-27	WOS:000302780100021
J	Marr, N; Foglia, J; Terebiznik, M; Athenstaedt, K; Zaremberg, V				Marr, Nancy; Foglia, Julena; Terebiznik, Mauricio; Athenstaedt, Karin; Zaremberg, Vanina			Controlling Lipid Fluxes at Glycerol-3-phosphate Acyltransferase Step in Yeast UNIQUE CONTRIBUTION OF Gat1p TO OLEIC ACID-INDUCED LIPID PARTICLE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PHOSPHATIDIC-ACID; PHOSPHOLIPID-SYNTHESIS; PARTICLES; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; LOCALIZATION; SENSITIVITY	The ability to channel excess fatty acids into neutral lipids like triacylglycerol (TAG) is a critical strategy used by cells to maintain lipid homeostasis. Upon activation to acyl-CoA, fatty acids become readily available as substrates for acyltransferases involved in neutral lipid synthesis. Neutral lipids are then packed into organelles derived from the endoplasmic reticulum called lipid particles (LPs). The first acylation step in the de novo pathway for TAG synthesis is catalyzed by glycerol-3-phosphate acyltransferases (GPATs). Two isoforms, Gat1p/Gpt2p and Gat2p/Sct1p, are present in the yeast Saccharomyces cerevisiae. Previous evidence indicated that these enzymes contribute differentially to the synthesis of TAG in actively growing cells. In this work we studied the role of the yeast GPATs in the formation of LPs induced by a surplus of oleic acid. Yeast lacking Gat1p (but not Gat2p) were sensitive to oleate and failed to accumulate LPs induced by this unsaturated fatty acid. It is shown that oleate induces dephosphorylation of Gat1p as well as an increment in its levels. Most importantly, we identified novel Gat1p crescent structures that are formed in the presence of oleate. These structures are connected with the endoplasmic reticulum and are intimately associated with LPs. Nosuch structures were observed for Gat2p. Acrucial point of control of lipid fluxes at the GPAT step is proposed.	[Marr, Nancy; Foglia, Julena; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Terebiznik, Mauricio] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Athenstaedt, Karin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Calgary; University of Toronto; University Toronto Scarborough; Graz University of Technology	Zaremberg, V (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca		Athenstaedt, Karin/0000-0001-7198-3989	National Sciences and Engineering Research Council; Austrian Science Fund [P21251]; Austrian Science Fund (FWF) [P 21251] Funding Source: researchfish	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by operating grants from the National Sciences and Engineering Research Council (to V. Z. and M. T.), a University Faculty Award from National Sciences and Engineering Research Council (to V. Z.), and by Austrian Science Fund Project P21251 (to K. A.).	Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Coleman RA, 2007, CELL METAB, V5, P87, DOI 10.1016/j.cmet.2007.01.004; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DAUM G, 1982, J BIOL CHEM, V257, P3028; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	29	18	18	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10251	10264		10.1074/jbc.M111.314112	http://dx.doi.org/10.1074/jbc.M111.314112			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267742	hybrid, Green Published			2022-12-27	WOS:000302167200055
J	Pohleven, J; Renko, M; Magister, S; Smith, DF; Kunzler, M; Strukelj, B; Turk, D; Kos, J; Sabotic, J				Pohleven, Jure; Renko, Miha; Magister, Spela; Smith, David F.; Kuenzler, Markus; Strukelj, Borut; Turk, Dusan; Kos, Janko; Sabotic, Jerica			Bivalent Carbohydrate Binding Is Required for Biological Activity of Clitocybe nebularis Lectin (CNL), the N, N '-Diacetyllactosediamine (GalNAc beta 1-4GlcNAc, LacdiNAc)-specific Lectin from Basidiomycete C. nebularis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE INHIBITORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; MARASMIUS-OREADES; MACROMOLECULAR STRUCTURES; COPRINOPSIS-CINEREA; SECONDARY-STRUCTURE; STRUCTURAL BASIS; HIGHER FUNGI; T-CELLS	Lectins are carbohydrate-binding proteins that exert their biological activity by binding to specific cell glycoreceptors. We have expressed CNL, a ricin B-like lectin from the basidiomycete Clitocybe nebularis in Escherichia coli. The recombinant lectin, rCNL, agglutinates human blood group A erythrocytes and is specific for the unique glycan N, N'-diacetyllactosediamine (GalNAc beta 1-4GlcNAc, LacdiNAc) as demonstrated by glycan microarray analysis. We here describe the crystal structures of rCNL in complex with lactose and LacdiNAc, defining its interactions with the sugars. CNL is a homodimeric lectin, each of whose monomers consist of a single ricin B lectin domain with its beta-trefoil fold and one carbohydrate-binding site. To study the mode of CNL action, a nonsugar-binding mutant and nondimerizing monovalent CNL mutants that retain carbohydrate-binding activity were prepared. rCNL and the mutants were examined for their biological activities against Jurkat human leukemic T cells and the hypersensitive nematode Caenorhabditis elegans mutant strain pmk-1. rCNL was toxic against both, although the mutants were inactive. Thus, the bivalent carbohydrate-binding property of homodimeric CNL is essential for its activity, providing one of the rare pieces of evidence that certain activities of lectins are associated with their multivalency.	[Pohleven, Jure; Magister, Spela; Strukelj, Borut; Kos, Janko; Sabotic, Jerica] Jozef Stefan Inst, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Renko, Miha; Turk, Dusan] Ctr Excellence CIPKeBiP, SI-1000 Ljubljana, Slovenia; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuenzler, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland; [Strukelj, Borut; Kos, Janko] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Emory University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Ljubljana	Pohleven, J (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia.	jure.pohleven@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Turk, Dusan/0000-0003-0205-6609; Kunzler, Markus/0000-0003-1275-0629	Research Agency of the Republic of Slovenia [P4-0127, J4-4123, P1-0048, PR-02266]; ETH Zurich; Swiss National Science Foundation [31003A-130671]; National Institutes of Health NIGMS [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	Research Agency of the Republic of Slovenia(Slovenian Research Agency - Slovenia); ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Research Agency of the Republic of Slovenia Grants P4-0127 and J4-4123 (to J. K.) and Grants P1-0048 and PR-02266 (to D. T.), ETH Zurich, and Swiss National Science Foundation Grant 31003A-130671 (to M. K.).; We thank Dr. Joze Brzin (Dept. of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia) for assistance with the work on lectins; Prof. Roger H. Pain (Dept. of Biotechnology, Jozef Stefan Institute, Ljubljana, Slovenia) for assistance with CD spectroscopy analysis and for critical review of the manuscript; Dr. Dusan Zigon (Dept. of Environmental Sciences, Jozef Stefan Institute, Ljubljana, Slovenia) for performing the mass spectrometry analysis; Silvia Bleuler-Martinez (Dept. of Biology, Institute of Microbiology, ETH, Zurich, Switzerland) for technical assistance with nematode biotoxicity assays; and Dr. Jamie Heimburg-Molinaro (Dept. of Biochemistry, Emory University School of Medicine, Atlanta, GA) for work on glycan microarrays. The glycan microarray analyses were conducted in collaboration with the Protein-Carbohydrate Interaction Core H, and the carbohydrate compound LDN was provided by the Carbohydrate Synthesis/Protein Expression Core, both of the Consortium for Functional Glycomics funded by National Institutes of Health NIGMS Grant GM62116.	Adams L, 1996, BBA-MOL CELL RES, V1312, P137, DOI 10.1016/0167-4889(96)00031-6; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Candy L, 2001, BIOCHEM BIOPH RES CO, V282, P655, DOI 10.1006/bbrc.2001.4626; Chavez LL, 2006, P NATL ACAD SCI USA, V103, P10254, DOI 10.1073/pnas.0510110103; Goldstein IJ, 2007, COMPREHENSIVE GLYCOS, V3, P601; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; Guillot J, 1997, BIOCHEM SYST ECOL, V25, P203, DOI 10.1016/S0305-1978(96)00110-X; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Hirano K., 2009, Patent No. [International PatentWO2010064683, 2010064683]; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Kadirvelraj R, 2011, GLYCOBIOLOGY, V21, P973, DOI 10.1093/glycob/cwr030; Kidric M, 2002, BIOCHEM BIOPH RES CO, V297, P962, DOI 10.1016/S0006-291X(02)02328-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kunzler M, 2010, METHOD ENZYMOL, V480, P141, DOI 10.1016/S0076-6879(10)80007-2; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace KE, 1999, J IMMUNOL, V163, P3801; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Pohleven J, 2011, APPL MICROBIOL BIOT, V91, P1141, DOI 10.1007/s00253-011-3236-0; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Renko M, 2010, J BIOL CHEM, V285, P308, DOI 10.1074/jbc.M109.043331; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; Saarinen J, 2003, Patent No. [WO/2003/016464, 2003016464]; Sabotic J, 2007, PROTEIN EXPRES PURIF, V53, P104, DOI 10.1016/j.pep.2006.11.015; Sabotic J, 2012, J BIOL CHEM, V287, P3898, DOI 10.1074/jbc.M111.285304; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; Sulzenbacher G, 2010, J MOL BIOL, V400, P715, DOI 10.1016/j.jmb.2010.05.038; TAHIROV TH, 1995, J MOL BIOL, V250, P354, DOI 10.1006/jmbi.1995.0382; Tateno H, 2004, ARCH BIOCHEM BIOPHYS, V427, P101, DOI 10.1016/j.abb.2004.04.013; Turk D., 1992, THESIS TU MUNCHEN GE; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; WEINER MP, 1994, PCR METH APPL, V4, pS131; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575	53	46	49	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10602	10612		10.1074/jbc.M111.317263	http://dx.doi.org/10.1074/jbc.M111.317263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298779	Green Published, hybrid			2022-12-27	WOS:000302167200085
J	Zhu, NL; Asahina, K; Wang, J; Ueno, A; Lazaro, R; Miyaoka, Y; Miyajima, A; Tsukamoto, H				Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Miyaoka, Yuichiro; Miyajima, Atsushi; Tsukamoto, Hidekazu			Hepatic Stellate Cell-derived Delta-like Homolog 1 (DLK1) Protein in Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL MELANOMA METASTASIS; ADIPOCYTE DIFFERENTIATION; RAT HEPATOCYTES; RECEPTOR; PREF-1; ACTIVATION; ADIPOGENESIS; EXPRESSION; GENE; HETEROGENEITY	Hepatic stellate cells (HSCs) undergo myofibroblastic activation in liver fibrosis and regeneration. This phenotypic switch is mechanistically similar to dedifferentiation of adipocytes as such the necdin-Wnt pathway causes epigenetic repression of the master adipogenic gene Ppar gamma, to activate HSCs. Now we report that delta-like 1 homolog (DLK1) is expressed selectively in HSCs in the adult rodent liver and induced in liver fibrosis and regeneration. Dlk1 knockdown in activated HSCs, causes suppression of necdin and Wnt, epigenetic derepression of Ppar gamma, and morphologic and functional reversal to quiescent cells. Hepatic Dlk1 expression is induced 40-fold at 24 h after partial hepatectomy (PH) in mice. HSCs and hepatocytes (HCs) isolated from the regenerating liver show Dlk1 induction in both cell types. In HC and HSC co-culture, increased proliferation and Dlk1 expression by HCs from PH are abrogated with anti-DLK1 antibody (Ab). Dlk1 and Wnt10b expression by Sham HCs are increased by co-culture with PH HSCs, and these effects are abolished with anti-DLK Ab. A tail vein injection of anti-DLK1 Ab at 6 h after PH reduces early HC proliferation and liver growth, accompanied by decreased Wnt10b, nonphosphorylated beta-catenin, p-beta-catenin (Ser-552), cyclins (cyclin D and cyclin A), cyclin-dependent kinases (CDK4, and CDK1/2), p-ERK1/2, and p-AKT. In the mouse developing liver, HSC precursors and HSCs express high levels of Dlk1, concomitant with Dlk1 expression by hepatoblasts. These results suggest novel roles of HSC-derived DLK1 in activating HSCs via epigenetic Ppar gamma repression and participating in liver regeneration and development in a manner involving the mesenchymal-epithelial interaction.	[Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Tsukamoto, Hidekazu] Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA; [Zhu, Nian-Ling; Asahina, Kinji; Wang, Jiaohong; Ueno, Akiko; Lazaro, Raul; Tsukamoto, Hidekazu] Univ So Calif, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90033 USA; [Miyaoka, Yuichiro; Miyajima, Atsushi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138656, Japan; [Tsukamoto, Hidekazu] Greater Los Angeles Healthcare Syst, Dept Vet Affairs, Los Angeles, CA 90073 USA	University of Southern California; University of Southern California; University of Tokyo	Tsukamoto, H (corresponding author), Univ So Calif, Dept Pathol, Keck Sch Med, 1333 San Pablo St,MMR-402, Los Angeles, CA 90033 USA.	htsukamo@usc.edu	Asahina, Kinji/X-8794-2019	Asahina, Kinji/0000-0003-0398-8395; Miyaoka, Yuichiro/0000-0002-8874-4738	National Institutes of Health [P50AA011999, R24AA012885, U01AA018663, RC2AA019392, R01AA020753]; Medical Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, R01AA020753, R24AA012885, P50AA011999, RC2AA019392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P50AA011999 (to H. T.), R24AA012885 (to H. T.), U01AA018663 (to H. T.), RC2AA019392 (to H. T.), and R01AA020753 (to K. A.). This work was also supported by the Medical Research Service of the Department of Veterans Affairs (to H. T.).	Abdallah BM, 2011, J BONE MINER RES, V26, P1457, DOI 10.1002/jbmr.346; Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Asai K, 2006, LIVER INT, V26, P595, DOI 10.1111/j.1478-3231.2006.01267.x; Bauer SR, 1998, MOL CELL BIOL, V18, P5247, DOI 10.1128/MCB.18.9.5247; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; ENZAN H, 1994, HEPATOLOGY, V19, P895, DOI 10.1016/0270-9139(94)90289-5; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Higashi N, 2005, ANAT REC PART A, V286A, P899, DOI 10.1002/ar.a.20230; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Olaso E, 1997, HEPATOLOGY, V26, P634, DOI 10.1053/jhep.1997.v26.pm0009303493; Olaso E, 2003, HEPATOLOGY, V37, P674, DOI 10.1053/jhep.2003.50068; Pan RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194498; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Sung CK, 2004, AM J PHYSIOL-GASTR L, V286, pG722, DOI 10.1152/ajpgi.00411.2003; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Watanabe S, 1998, BIOCHEM BIOPH RES CO, V250, P486, DOI 10.1006/bbrc.1998.9339; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Zhu NL, 2010, J BIOL CHEM, V285, P30463, DOI 10.1074/jbc.M110.156703	45	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10355	10367		10.1074/jbc.M111.312751	http://dx.doi.org/10.1074/jbc.M111.312751			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298767	hybrid, Green Published			2022-12-27	WOS:000302167200063
J	Agarwal, S; Agarwal, S; Jin, H; Pancholi, P; Pancholi, V				Agarwal, Shivani; Agarwal, Shivangi; Jin, Hong; Pancholi, Preeti; Pancholi, Vijay			Serine/Threonine Phosphatase (SP-STP), Secreted from Streptococcus pyogenes, Is a Pro-apoptotic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; CYTOLYSIN-MEDIATED TRANSLOCATION; ACTIN-BASED MOTILITY; EPITHELIAL-CELLS; NAD(+) GLYCOHYDROLASE; VIRULENCE FACTOR; STREPTOLYSIN-O; DEATH PATHWAY; HISTONE H3; PHOSPHORYLATION	This investigation illustrates an important property of eukaryote-type serine/threonine phosphatase (SP-STP) of group A Streptococcus (GAS) in causing programmed cell death of human pharyngeal cells. The secretory nature of SP-STP, its elevated expression in the intracellular GAS, and the ability of wild-type GAS but not the GAS mutant devoid of SP-STP to cause apoptosis of the host cell both in vitro and in vivo suggest that GAS deploys SP-STP as an important virulence determinant to exploit host cell machinery for its own advantage during infection. The exogenously added SP-STP is able to enter the cytoplasm and subsequently traverses into the nucleus in a temporal fashion to cause apoptosis of the pharyngeal cells. The programmed cell death induced by SP-STP, which requires active transcription and de novo protein synthesis, is also caspase-dependent. Furthermore, the entry of SP-STP into the cytoplasm is dependent on its secondary structure as the catalytically inactive SP-STP with an altered structure is unable to internalize and cause apoptosis. The ectopically expressed wildtype SP-STP was found to be in the nucleus and conferred apoptosis of Detroit 562 pharyngeal cells. However, the catalytically inactive SP-STP was unable to cause apoptosis even when intracellularly expressed. The ability of SP-STP to activate pro-apoptotic signaling cascades both in the cytoplasm and in the nucleus resulted in mitochondrial dysfunctioning and perturbation in the phosphorylation status of histones in the nucleus. SP-STP thus not only functions as a virulence regulator but also as an important factor responsible for host-related pathogenesis.	[Agarwal, Shivani; Agarwal, Shivangi; Jin, Hong; Pancholi, Preeti; Pancholi, Vijay] Ohio State Univ, Dept Pathol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), Ohio State Univ, Dept Pathol, Coll Med, 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	Vijay.Pancholi@osumc.edu	Pancholi, Vijay/E-3810-2011	Agarwal, Shivangi/0000-0002-2406-7678	National Institutes of Health [AI64912, AI76889]; Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076889, R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI64912 and AI76889 (to V. P.). This work was also supported by Ohio State University departmental funds (to P. P.).	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Agarwal S, 2011, J BIOL CHEM, V286, P41368, DOI 10.1074/jbc.M111.286690; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; BODE AM, 2005, SCI STKE, pRE4; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Dong ZG, 2006, MOL CARCINOGEN, V45, P416, DOI 10.1002/mc.20220; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Hagimoto N, 1999, AM J RESP CELL MOL, V21, P436, DOI 10.1165/ajrcmb.21.3.3397; Jeon ES, 2007, J CELL BIOCHEM, V100, P1536, DOI 10.1002/jcb.21141; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kim JY, 2011, APOPTOSIS, V16, P114, DOI 10.1007/s10495-010-0550-4; Kobayashi S, 2005, GENES CELLS, V10, P253, DOI 10.1111/j.1365-2443.2005.00835.x; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Medina E, 2003, INFECT IMMUN, V71, P5376, DOI 10.1128/IAI.71.9.5376-5380.2003; Meehl MA, 2004, MOL MICROBIOL, V52, P1665, DOI 10.1111/j.1365-2958.2004.04082.x; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; North JA, 2011, NUCLEIC ACIDS RES, V39, P6465, DOI 10.1093/nar/gkr304; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Pancholi V, 2010, J BIOL CHEM, V285, P30861, DOI 10.1074/jbc.M110.153825; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Riddle DJ, 2010, J BACTERIOL, V192, P3735, DOI 10.1128/JB.00234-10; Ryan PA, 2007, PLOS COMPUT BIOL, V3, P1177, DOI 10.1371/journal.pcbi.0030132; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305; THERIOT JA, 1994, CELL, V76, P505, DOI 10.1016/0092-8674(94)90114-7; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Tong Y, 2001, MOL CANCER THER, V1, P95; Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902	52	19	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9147	9167		10.1074/jbc.M111.316554	http://dx.doi.org/10.1074/jbc.M111.316554			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262847	Green Published, hybrid			2022-12-27	WOS:000301797800044
J	Boucard, AA; Ko, JW; Sudhof, TC				Boucard, Antony A.; Ko, Jaewon; Suedhof, Thomas C.			High Affinity Neurexin Binding to Cell Adhesion G-protein-coupled Receptor CIRL1/Latrophilin-1 Produces an Intercellular Adhesion Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN RECEPTOR; EXCITATORY SYNAPSE FORMATION; BETA-NEUREXINS; SURFACE PROTEINS; CA2+ CHANNELS; FAMILY; NEUROLIGINS; LATROPHILIN; EXOCYTOSIS; INTERACTS	The G-protein-coupled receptor CIRL1/latrophilin-1 (CL1) and the type-1 membrane proteins neurexins represent distinct neuronal cell adhesion molecules that exhibit no similarities except for onecommonfunction: both proteins are receptors for alpha-latrotoxin, a component of black widow spider venom that induces massive neurotransmitter release at synapses. Unexpectedly, we have now identified a direct binding interaction between the extracellular domains of CL1 and neurexins that is regulated by alternative splicing of neurexins at splice site 4 (SS4). Using saturation binding assays, we showed that neurexins lacking an insert at SS4 bind to CL1 with nanomolar affinity, whereas neurexins containing an insert at SS4 are unable to bind. CL1 competed for neurexin binding with neuroligin-1, a well characterized neurexin ligand. The extracellular sequences of CL1 contain five domains (lectin, olfactomedin-like, serine/threonine-rich, hormone-binding, and G-protein-coupled receptor autoproteolysis-inducing (GAIN) domains). Of these domains, the olfactomedin-like domain mediates neurexin binding as shown by deletion mapping. Cell adhesion assays using cells expressing neurexins and CL1 revealed that their interaction produces a stable intercellular adhesion complex, indicating that their interaction can be trans-cellular. Thus, our data suggest that CL1 constitutes a novel ligand for neurexins that may be localized postsynaptically based on its well characterized interaction with intracellular SH3 and multiple ankyrin repeats adaptor proteins (SHANK) and could form a trans-synaptic complex with presynaptic neurexins.	[Boucard, Antony A.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Boucard, Antony A.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Boucard, AA (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 265 Campus Dr, Stanford, CA 94305 USA.	aboucard@stanford.edu; tcs1@stanford.edu	Boucard, Antony/CAJ-3093-2022; Boucard, Antony/ABA-9769-2020	BOUCARD, Antony Jr/0000-0002-5538-0464	Canadian Institutes of Health Research; Human Frontier Science Program Organization [LT00021/2008-L]; NIH [R37 MH052804-18]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program Organization(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by a fellowship grant from the Canadian Institutes of Health Research (to A. A. B.) and Human Frontier Science Program Organization Grant LT00021/2008-L (to J. K.). This study was also supported by NIH Grant R37 MH052804-18.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Cheng SB, 2009, J BIOL CHEM, V284, P23251, DOI 10.1074/jbc.M109.017384; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; DAVLETOV BA, 1995, J BIOL CHEM, V270, P23903, DOI 10.1074/jbc.270.41.23903; Davletov BA, 1996, J BIOL CHEM, V271, P23239, DOI 10.1074/jbc.271.38.23239; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kreienkamp HJ, 2000, J BIOL CHEM, V275, P32387, DOI 10.1074/jbc.C000490200; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schioth HB, 2010, ADV EXP MED BIOL, V706, P1; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	53	120	123	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9399	9413		10.1074/jbc.M111.318659	http://dx.doi.org/10.1074/jbc.M111.318659			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262843	Green Published, hybrid			2022-12-27	WOS:000301797800070
J	Gersch, M; List, A; Groll, M; Sieber, SA				Gersch, Malte; List, Anja; Groll, Michael; Sieber, Stephan A.			Insights into Structural Network Responsible for Oligomerization and Activity of Bacterial Virulence Regulator Caseinolytic Protease P (ClpP) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; BETA-LACTONES; COMPLEX; ANTIBIOTICS; RECOGNITION; PROTEOLYSIS; ACTIVATION; INHIBITORS	The barrel-shaped caseinolytic protease P (ClpP) is a main virulence regulator in the bacterial pathogen Staphylococcus aureus (SaClpP). It consists of two heptameric rings forming a homotetradecamer with an inner chamber that houses the 14 active sites. We recently showed that SaClpP is able to adopt a compressed, inactive conformation. We present here the 2.3 angstrom resolution structure of SaClpP in its closed, active conformation as well as the structure of the S98A mutant. Comprehensive mutational analysis aiming at destabilizing one or the other or both conformations was able to pinpoint key residues involved in this catalytic switch and in the heptamer-heptamer interaction. By probing the active site serine with a covalently modifying beta-lactone probe, we could show that the tetradecameric organization is essential for a proper formation of the active site. Structural data suggest that a highly conserved hydrogen-bonding network links oligomerization to activity. A comparison of ClpP structures from different organisms provides suggestive evidence for the presence of a universal mechanism regulating ClpP activity in which binding of one subunit to the corresponding subunit on the other ring interface is necessary for the functional assembly of the catalytic triad and thus for protease function. This mechanism ensures controlled access to the active sites of a highly unspecific protease.	[Gersch, Malte; List, Anja; Groll, Michael; Sieber, Stephan A.] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich	Sieber, SA (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	stephan.sieber@tum.de	Groll, Michael/F-5572-2015		Deutsche Forschungsgemeinschaft [SFB749]; Center for Integrated Protein Science Munich; European Research Council (ERC); German National Academic Foundation; Fonds der Chemischen Industrie, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; European Research Council (ERC)(European Research Council (ERC)); German National Academic Foundation; Fonds der Chemischen Industrie, Germany(Fonds der Chemischen Industrie)	This work was supported by the Deutsche Forschungsgemeinschaft (Emmy Noether program), SFB749, Center for Integrated Protein Science Munich, and the European Research Council (ERC starting grant). Data collection was conducted at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland.; Recipient of fellowships from the German National Academic Foundation and the Fonds der Chemischen Industrie, Germany.	Baker T. A., 2012, BIOCHIM BIOPHYS ACTA, V1825, P15; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2009, CHEMBIOCHEM, V10, P663, DOI 10.1002/cbic.200800743; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Kolygo K, 2009, J STRUCT BIOL, V168, P267, DOI 10.1016/j.jsb.2009.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; TURK D, 1992, THESIS TU MUNCHEN MU; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	37	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9484	9494		10.1074/jbc.M111.336222	http://dx.doi.org/10.1074/jbc.M111.336222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291011	hybrid, Green Published			2022-12-27	WOS:000301797800077
J	Hamming, OJ; Kang, LS; Svensson, A; Karlsen, JL; Rahbek-Nielsen, H; Paludan, SR; Hjorth, SA; Bondensgaard, K; Hartmann, R				Hamming, Ole J.; Kang, Lishan; Svensson, Anders; Karlsen, Jesper L.; Rahbek-Nielsen, Henrik; Paludan, Soren R.; Hjorth, Siv A.; Bondensgaard, Kent; Hartmann, Rune			Crystal Structure of Interleukin-21 Receptor (IL-21R) Bound to IL-21 Reveals That Sugar Chain Interacting with WSXWS Motif Is Integral Part of IL-21R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; TRYPTOPHAN RESIDUE; EQUIVALENT MOTIF; COMPLEX REVEALS; LIGAND-BINDING; T-CELLS; GENERATION; PROTEIN; COMMON	IL-21 is a class I cytokine that exerts pleiotropic effects on both innate and adaptive immune responses. It signals through a heterodimeric receptor complex consisting of the IL-21 receptor (IL-21R) and the common gamma-chain. A hallmark of the class I cytokine receptors is the class I cytokine receptor signature motif (WSXWS). The exact role of this motif has not been determined yet; however, it has been implicated in diverse functions, including ligand binding, receptor internalization, proper folding, and export, as well as signal transduction. Furthermore, the WXXW motif is known to be a consensus sequence for C-mannosylation. Here, we present the crystal structure of IL-21 bound to IL-21R and reveal that the WSXWS motif of IL-21R is C-mannosylated at the first tryptophan. We furthermore demonstrate that a sugar chain bridges the two fibronectin domains that constitute the extracellular domain of IL-21R and anchors at the WSXWS motif through an extensive hydrogen bonding network, including mannosylation. The glycan thus transforms the V-shaped receptor into an A-frame. This finding offers a novel structural explanation of the role of the class I cytokine signature motif.	[Hamming, Ole J.; Karlsen, Jesper L.; Hartmann, Rune] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Paludan, Soren R.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Kang, Lishan] Novo Nordisk China R&D, Beijing 102206, Peoples R China; [Svensson, Anders; Rahbek-Nielsen, Henrik; Hjorth, Siv A.; Bondensgaard, Kent] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark	Aarhus University; Aarhus University; Novo Nordisk; Novo Nordisk	Hartmann, R (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.	rh@mb.au.dk		Hartmann, Rune/0000-0003-1159-066X; Hjorth, Siv Annegrethe/0000-0002-6470-650X	Danish Cancer Society; Danish Council for Independent Research Natural Science; Novo Nordisk Foundation	Danish Cancer Society(Danish Cancer Society); Danish Council for Independent Research Natural Science(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by a research fellowship from the Danish Cancer Society (to O. J. H.) and by grants from the Danish Cancer Society, the Danish Council for Independent Research Natural Science, and the Novo Nordisk Foundation (to R. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; CHIBA T, 1992, BIOCHEM BIOPH RES CO, V184, P485, DOI 10.1016/0006-291X(92)91220-K; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Doucey MA, 1999, GLYCOBIOLOGY, V9, P435, DOI 10.1093/glycob/9.5.435; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Furmanek A, 2003, BIOCHEMISTRY-US, V42, P8452, DOI 10.1021/bi034112p; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hashmi MH, 2010, EXPERT OPIN BIOL TH, V10, P807, DOI 10.1517/14712598.2010.480971; HILTON DJ, 1995, P NATL ACAD SCI USA, V92, P190, DOI 10.1073/pnas.92.1.190; Hilton DJ, 1996, J BIOL CHEM, V271, P4699; HOFSTEENGE J, 1994, BIOCHEMISTRY-US, V33, P13524, DOI 10.1021/bi00250a003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kang LS, 2010, J BIOL CHEM, V285, P12223, DOI 10.1074/jbc.M110.101444; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; MIYAZAKI T, 1991, EMBO J, V10, P3191, DOI 10.1002/j.1460-2075.1991.tb04881.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; QUELLE DE, 1992, MOL CELL BIOL, V12, P4553, DOI 10.1128/MCB.12.10.4553; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Tauber MT, 1998, GROWTH HORM IGF RES, V8, P211, DOI 10.1016/S1096-6374(98)80113-5; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; Velankar S, 2011, ACTA CRYSTALLOGR D, V67, P324, DOI 10.1107/S090744491004117X; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X	45	60	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9454	9460		10.1074/jbc.M111.311084	http://dx.doi.org/10.1074/jbc.M111.311084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22235133	Green Published, hybrid			2022-12-27	WOS:000301797800074
J	Quanz, M; Herbette, A; Sayarath, M; de Koning, L; Dubois, T; Sun, JS; Dutreix, M				Quanz, Maria; Herbette, Aurelie; Sayarath, Mano; de Koning, Leanne; Dubois, Thierry; Sun, Jian-Sheng; Dutreix, Marie			Heat Shock Protein 90 alpha (Hsp90 alpha) Is Phosphorylated in Response to DNA Damage and Accumulates in Repair Foci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; NF-KAPPA-B; CATALYTIC SUBUNIT; CELL-SURFACE; TUMOR-CELLS; NUCLEAR TRANSLOCATION; RADIATION RESPONSE; KINASE-ACTIVITY; HSP90; ACTIVATION	DNA damage triggers a complex signaling cascade involving a multitude of phosphorylation events. We found that the threonine 7 (Thr-7) residue of heat shock protein 90 alpha (Hsp90 alpha) was phosphorylated immediately after DNA damage. The phosphorylated Hsp90 alpha then accumulated at sites of DNA double strand breaks and formed repair foci with slow kinetics, matching the repair kinetics of complex DNA damage. The phosphorylation of Hsp90 alpha was dependent on phosphatidylinositol 3-kinase-like kinases, including the DNA-dependent protein kinase (DNA-PK) in particular. DNA-PK plays an essential role in the repair of DNA double strand breaks by nonhomologous end-joining and in the signaling of DNA damage. It is also present in the cytoplasm of the cell and has been suggested to play a role in cytoplasmic signaling pathways. Using stabilized double-stranded DNA molecules to activate DNA-PK, we showed that an active DNA-PK complex could be assembled in the cytoplasm, resulting in phosphorylation of the cytoplasmic pool of Hsp90 alpha. In vivo, reverse phase protein array data for tumors revealed that basal levels of Thr-7-phosphorylated Hsp90 alpha were correlated with phosphorylated histone H2AX levels. The Thr-7 phosphorylation of the ubiquitously produced and secreted Hsp90 alpha may therefore serve as a surrogate biomarker of DNA damage. These findings shed light on the interplay between central DNA repair enzymes and an essential molecular chaperone.	[Quanz, Maria; Dutreix, Marie] Univ Paris 11, Inst Curie, Ctr Univ, CNRS,INSERM,UMR3347,U1021, F-91405 Orsay, France; [Quanz, Maria; Herbette, Aurelie; Sayarath, Mano; Sun, Jian-Sheng] DNA Therapeut, F-91058 Evry, France; [de Koning, Leanne; Dubois, Thierry] Inst Curie, Dept Rech Translat, F-75010 Paris, France; [Sun, Jian-Sheng] Museum Natl Hist Nat, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Museum National d'Histoire Naturelle (MNHN)	Quanz, M (corresponding author), Univ Paris 11, Inst Curie, Ctr Univ, CNRS,INSERM,UMR3347,U1021, Bat 112, F-91405 Orsay, France.	maria.quanz@curie.fr	Quanz, Maria/AAA-4424-2020; Dubois, Thierry/D-2852-2017	Dubois, Thierry/0000-0003-4739-6164	Institut Curie; CNRS; INSERM; l'Agence National de le Recherche [ANR-08-Biot-009-02]; DNA Therapeutics SA	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Agence National de le Recherche(French National Research Agency (ANR)); DNA Therapeutics SA	This work was supported by Institut Curie, CNRS, INSERM, and l'Agence National de le Recherche Grant ANR-08-Biot-009-02. M. Quanz is recipient of a Ph.D. fellowship cofinanced by DNA Therapeutics SA. A. Herbette and M. Sayarath are employees of DNA Therapeutics SA. M. Dutreix and J-S. Sun are cofounders of DNA Therapeutics SA, the company holding the patent for Dbait 32Hc.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bisht KS, 2003, CANCER RES, V63, P8984; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gulmann C, 2006, J PATHOL, V208, P595, DOI 10.1002/path.1958; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Kim JE, 2009, CELL CYCLE, V8, P2932; Koike M, 2005, EXP CELL RES, V305, P266, DOI 10.1016/j.yexcr.2004.12.027; Krull S, 2010, EMBO J, V29, P1659, DOI 10.1038/emboj.2010.54; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu SK, 2008, CANCER METAST REV, V27, P445, DOI 10.1007/s10555-008-9137-8; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Moore R, 2004, ONCOGENE, V23, P6726, DOI 10.1038/sj.onc.1207675; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; PERDEW GH, 1993, EXP CELL RES, V209, P350, DOI 10.1006/excr.1993.1320; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; PRABHAKAR BS, 1990, J CLIN INVEST, V86, P1301, DOI 10.1172/JCI114838; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Quanz M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006298; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	68	71	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8803	8815		10.1074/jbc.M111.320887	http://dx.doi.org/10.1074/jbc.M111.320887			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270370	Green Published, hybrid			2022-12-27	WOS:000301797800013
J	de Castro, RO; Zhang, J; Groves, JR; Barbu, EA; Siraganian, RP				de Castro, Rodrigo Orlandini; Zhang, Juan; Groves, Jacqueline R.; Barbu, Emilia Alina; Siraganian, Reuben P.			Once Phosphorylated, Tyrosines in Carboxyl Terminus of Protein-tyrosine Kinase Syk Interact with Signaling Proteins, Including TULA-2, a Negative Regulator of Mast Cell Degranulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; ACTIVATION LOOP TYROSINES; ADAPTER PROTEINS; ACTIN CYTOSKELETON; PHOSPHATASE; SLP-76; SHIP; IDENTIFICATION; SPECIFICITY	Activation of the high affinity IgE-binding receptor (Fc epsilon RI) results in the tyrosine phosphorylation of two conserved tyrosines located close to the COOH terminus of the protein-tyrosine kinase Syk. Synthetic peptides representing the last 10 amino acids of the tail of Syk with these two tyrosines either nonphosphorylated or phosphorylated were used to precipitate proteins from mast cell lysates. Proteins specifically precipitated by the phosphorylated peptide were identified by mass spectrometry. These included the adaptor proteins SLP-76, Nck-1, Grb2, and Grb2-related adaptor downstream of Shc (GADS) and the protein phosphatases SHIP-1 and TULA-2 (also known as UBASH3B or STS-1). The presence of these in the precipitates was further confirmed by immunoblotting. Using the peptides as probes in far Western blots showed direct binding of the phosphorylated peptide to Nck-1 and SHIP-1. Immunoprecipitations suggested that there were complexes of these proteins associated with Syk especially after receptor activation; in these complexes are Nck, SHIP-1, SLP-76, Grb2, and TULA-2 (UBASH3B or STS-1). The decreased expression of TULA-2 by treatment of mast cells with siRNA increased the Fc epsilon RI-induced tyrosine phosphorylation of the activation loop tyrosines of Syk and the phosphorylation of phospholipase C-gamma 2. There was parallel enhancement of the receptor-induced degranulation and activation of nuclear factor for T cells or nuclear factor kappa B, indicating that TULA-2, like SHIP-1, functions as a negative regulator of Fc epsilon RI signaling in mast cells. Therefore, once phosphorylated, the terminal tyrosines of Syk bind complexes of proteins that are positive and negative regulators of signaling in mast cells.	[de Castro, Rodrigo Orlandini; Zhang, Juan; Groves, Jacqueline R.; Barbu, Emilia Alina; Siraganian, Reuben P.] NIDCR, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Siraganian, RP (corresponding author), NIDCR, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA.	rs53x@nih.gov			National Institutes of Health, NIDCR	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health National Institutes of Health Intramural Research Program, NIDCR.	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Alvarez-Errico D, 2009, IMMUNOL REV, V232, P195, DOI 10.1111/j.1600-065X.2009.00834.x; Barbu EA, 2010, J BIOL CHEM, V285, P15761, DOI 10.1074/jbc.M110.109413; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Carpino N, 2009, MOL IMMUNOL, V46, P3224, DOI 10.1016/j.molimm.2009.08.015; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Chen YT, 2009, BIOCHEMISTRY-US, V48, P8129, DOI 10.1021/bi9008648; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; de Castro RO, 2011, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2011/507291; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GOLDSTEIN B, 1989, BIOPHYS J, V56, P955, DOI 10.1016/S0006-3495(89)82741-9; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Huber M, 2002, IMMUNOL LETT, V82, P17, DOI 10.1016/S0165-2478(02)00012-3; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jordan MS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002501; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kambayashi T, 2009, IMMUNOL REV, V232, P99, DOI 10.1111/j.1600-065X.2009.00825.x; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Odai H, 1997, BLOOD, V89, P2745, DOI 10.1182/blood.V89.8.2745; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Siraganian RP, 2010, FEBS LETT, V584, P4933, DOI 10.1016/j.febslet.2010.08.006; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wu JN, 2004, J IMMUNOL, V172, P6768, DOI 10.4049/jimmunol.172.11.6768; Yamasaki S, 2008, INT IMMUNOL, V20, P1289, DOI 10.1093/intimm/dxn085; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang J, 2007, J BIOL CHEM, V282, P37669, DOI 10.1074/jbc.M705168200; Zhang JA, 2010, J IMMUNOL, V184, P7178, DOI 10.4049/jimmunol.0904169; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	59	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8194	8204		10.1074/jbc.M111.326850	http://dx.doi.org/10.1074/jbc.M111.326850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267732	hybrid, Green Published			2022-12-27	WOS:000301349400035
J	Doyle, JD; Danthi, P; Kendall, EA; Ooms, LS; Wetzel, JD; Dermody, TS				Doyle, Joshua D.; Danthi, Pranav; Kendall, Emily A.; Ooms, Laura S.; Wetzel, J. Denise; Dermody, Terence S.			Molecular Determinants of Proteolytic Disassembly of the Reovirus Outer Capsid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATES MEMBRANE DISRUPTION; REVERSE GENETICS SYSTEM; PROTEASE INHIBITOR E64; L-CELLS; PERSISTENT INFECTIONS; CATHEPSIN-L; MAMMALIAN REOVIRUSES; PENETRATION PROTEIN; CARBOXY-TERMINUS; INFLUENZA-VIRUS	Following attachment and internalization, mammalian reoviruses undergo intracellular proteolytic disassembly followed by viral penetration into the cytoplasm. The initiating event in reovirus disassembly is the cathepsin-mediated proteolytic degradation of viral outer capsid protein sigma 3. A single tyrosine-to-histidine mutation at amino acid 354 (Y354H) of strain type 3 Dearing (T3D) sigma 3 enhances reovirus disassembly and confers resistance to protease inhibitors such as E64. The sigma 3 amino acid sequence of strain type 3 Abney (T3A) differs from that of T3D at eight positions including Y354H. However, T3A displays disassembly kinetics and protease sensitivity comparable with T3D. We hypothesize that one or more additional sigma 3 polymorphisms suppress the Y354H phenotype and restore T3D disassembly characteristics. To test this hypothesis, we engineered a panel of reovirus variants with T3A sigma 3 polymorphisms introduced individually into T3D-sigma 3Y354H. We evaluated E64 resistance and in vitro cathepsin L susceptibility of these viruses and found that one containing a glycine-to-glutamate substitution at position 198 (G198E) displayed disassembly kinetics and E64 sensitivity similar to those properties of T3A and T3D. Additionally, viruses containing changes at positions 233 and 347 (S233L and I347T) developed de novo compensatory mutations at position 198, strengthening the conclusion that residue 198 is a key determinant of sigma 3 proteolytic susceptibility. Variants with Y354H in sigma 3 lost infectivity more rapidly than T3A or T3D following heat treatment, an effect abrogated by G198E. These results identify a regulatory network of residues that control sigma 3 cleavage and capsid stability, thus providing insight into the regulation of nonenveloped virus disassembly.	[Doyle, Joshua D.; Ooms, Laura S.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Danthi, Pranav; Kendall, Emily A.; Wetzel, J. Denise; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Doyle, Joshua D.; Danthi, Pranav; Kendall, Emily A.; Ooms, Laura S.; Wetzel, J. Denise; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Dermody, TS (corresponding author), Vanderbilt Univ, Sch Med, Lamb Ctr Pediat Res, D7235 MCN, Nashville, TN 37232 USA.	terry.dermody@vanderbilt.edu	Danthi, Pranav/H-6330-2019	Danthi, Pranav/0000-0001-6199-6022; Kendall, Emily/0000-0002-0083-422X	National Institutes of Health from USPHS [T32 GM008554]; National Institutes of Health [R01 AI032539]; Elizabeth B. Lamb Center for Pediatric Research; United States Public Health Service [CA68485, DK20593]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth B. Lamb Center for Pediatric Research; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM008554 from USPHS (to J. D. D.) and R01 AI032539 (to T. S. D.). This work was also supported by the Elizabeth B. Lamb Center for Pediatric Research.; We express our appreciation to Karl Boehme and Greg Wilson for careful review of the manuscript and to Chris Aiken for helpful suggestions. We thank John Mort for the kind gift of purified cathepsin L. Additional support was provided by United States Public Health Service Awards CA68485 for the Vanderbilt Cancer Center and DK20593 for the Vanderbilt Diabetes Research and Training Center.	Baer GS, 1999, J VIROL, V73, P9532, DOI 10.1128/JVI.73.11.9532-9543.1999; Baer GS, 1997, J VIROL, V71, P4921, DOI 10.1128/JVI.71.7.4921-4928.1997; Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; Carmona E, 1996, BIOCHEMISTRY-US, V35, P8149, DOI 10.1021/bi952736s; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; Clark KM, 2006, J VIROL, V80, P671, DOI 10.1128/JVI.80.2.671-681.2006; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Ebert DH, 2004, J BIOL CHEM, V279, P3837, DOI 10.1074/jbc.M310048200; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ebert DH, 2001, J VIROL, V75, P3197, DOI 10.1128/JVI.75.7.3197-3206.2001; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; HAND R, 1973, J VIROL, V11, P223, DOI 10.1128/JVI.11.2.223-231.1973; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Johnson EM, 2009, J VIROL, V83, P9630, DOI 10.1128/JVI.01095-09; KEDL R, 1995, J VIROL, V69, P552, DOI 10.1128/JVI.69.1.552-559.1995; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; ROSEN L, 1960, AM J HYG, V71, P258, DOI 10.1093/oxfordjournals.aje.a120109; SCHIFF LA, 2007, FIELDS VIROLOGY, P1853; SILVERSTEIN SC, 1972, VIROLOGY, V47, P797, DOI 10.1016/0042-6822(72)90571-5; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wetzel JD, 1997, J VIROL, V71, P1362, DOI 10.1128/JVI.71.2.1362-1369.1997; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wilson GJ, 2002, J VIROL, V76, P9832, DOI 10.1128/JVI.76.19.9832-9843.2002; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	40	24	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8029	8038		10.1074/jbc.M111.334854	http://dx.doi.org/10.1074/jbc.M111.334854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253447	hybrid, Green Published			2022-12-27	WOS:000301349400019
J	Paulmann, M; Arnold, T; Linke, D; Ozdirekcan, S; Kopp, A; Gutsmann, T; Kalbacher, H; Wanke, I; Schuenemann, VJ; Habeck, M; Burck, J; Ulrich, AS; Schittek, B				Paulmann, Maren; Arnold, Thomas; Linke, Dirk; Oezdirekcan, Suat; Kopp, Annika; Gutsmann, Thomas; Kalbacher, Hubert; Wanke, Ines; Schuenemann, Verena J.; Habeck, Michael; Buerck, Jochen; Ulrich, Anne S.; Schittek, Birgit			Structure-Activity Analysis of the Dermcidin-derived Peptide DCD-1L, an Anionic Antimicrobial Peptide Present in Human Sweat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIENTED CIRCULAR-DICHROISM; LIPID-BILAYERS; PERMEABLE CHANNELS; MEMBRANES; BACTERIAL; SPECTROSCOPY; ORGANISMS; DEFENSE; PROTEIN; MODE	Dermcidin encodes the anionic amphiphilic peptide DCD-1L, which displays a broad spectrum of antimicrobial activity under conditions resembling those in human sweat. Here, we have investigated its mode of antimicrobial activity. We found that DCD-1L interacts preferentially with negatively charged bacterial phospholipids with a helix axis that is aligned flat on a lipid bilayer surface. Upon interaction with lipid bilayers DCD-1L forms oligomeric complexes that are stabilized by Zn2+. DCD-1L is able to form ion channels in the bacterial membrane, and we propose that Zn2+-induced self-assembly of DCD-1L upon interaction with bacterial lipid bilayers is a prerequisite for ion channel formation. These data allow us for the first time to propose a molecular model for the antimicrobial mechanism of a naturally processed human anionic peptide that is active under the harsh conditions present in human sweat.	[Paulmann, Maren; Wanke, Ines; Schittek, Birgit] Univ Tubingen, Dept Dermatol, D-72074 Tubingen, Germany; [Arnold, Thomas; Linke, Dirk; Oezdirekcan, Suat; Schuenemann, Verena J.; Habeck, Michael] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Kopp, Annika; Gutsmann, Thomas] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany; [Buerck, Jochen; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces IBG 2, D-76344 Eggenstein Leopoldshafen, Germany; [Buerck, Jochen; Ulrich, Anne S.] Inst Organ Chem CFN, D-76344 Eggenstein Leopoldshafen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Forschungszentrum Borstel; Eberhard Karls University of Tubingen; Helmholtz Association; Karlsruhe Institute of Technology	Schittek, B (corresponding author), Univ Tubingen, Dept Dermatol, Liebermeisterstr 25, D-72074 Tubingen, Germany.	birgit.schittek@med.uni-tuebingen.de	Gutsmann, Thomas/E-6100-2011; Ulrich, Anne S/H-5519-2013; Linke, Dirk/F-9147-2010	Ulrich, Anne S/0000-0001-5571-9483; Linke, Dirk/0000-0003-3150-6752; Habeck, Michael/0000-0002-2188-5667; Schittek, Birgit/0000-0003-0081-2001	Deutsche Forschungsgemeinschaft [SFB766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB766.	Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Bruhn H, 2006, DEV COMP IMMUNOL, V30, P597, DOI 10.1016/j.dci.2005.09.002; Burck J, 2008, BIOPHYS J, V95, P3872, DOI 10.1529/biophysj.108.136085; Chen FY, 2002, BIOPHYS J, V82, P908, DOI 10.1016/S0006-3495(02)75452-0; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cipakova I, 2006, PROTEIN EXPRES PURIF, V45, P269, DOI 10.1016/j.pep.2005.07.002; Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084; DUCLOHIER H, 1989, BIOPHYS J, V56, P1017, DOI 10.1016/S0006-3495(89)82746-8; Flad T, 2002, J IMMUNOL METHODS, V270, P53, DOI 10.1016/S0022-1759(02)00229-6; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Goumon Y, 1998, J BIOL CHEM, V273, P29847, DOI 10.1074/jbc.273.45.29847; Grage SL, 2010, METHODS MOL BIOL, V618, P183, DOI 10.1007/978-1-60761-594-1_13; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Harris F., 2011, CURR CHEM BIOL, V5, P142; Harris F, 2009, CURR PROTEIN PEPT SC, V10, P585, DOI 10.2174/138920309789630589; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson CS, 1999, PROG NUCL MAG RES SP, V34, P203, DOI 10.1016/S0079-6565(99)00003-5; Jung HH, 2010, BMB REP, V43, P362, DOI 10.5483/BMBRep.2010.43.5.362; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KORDEL M, 1988, J BACTERIOL, V170, P84, DOI 10.1128/jb.170.1.84-88.1988; Lai R, 2002, BIOCHEM BIOPH RES CO, V295, P796, DOI 10.1016/S0006-291X(02)00762-3; Lai YP, 2005, BIOCHEM BIOPH RES CO, V328, P243, DOI 10.1016/j.bbrc.2004.12.143; Lange C, 2007, BBA-BIOMEMBRANES, V1768, P2627, DOI 10.1016/j.bbamem.2007.06.021; Lee IH, 1997, INFECT IMMUN, V65, P2898, DOI 10.1128/IAI.65.7.2898-2903.1997; Li M, 2009, ANTIMICROB AGENTS CH, V53, P4200, DOI 10.1128/AAC.00428-09; Malkoski M, 2001, ANTIMICROB AGENTS CH, V45, P2309, DOI 10.1128/AAC.45.8.2309-2315.2001; OLAH GA, 1988, J CHEM PHYS, V89, P2531, DOI 10.1063/1.455047; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; PUSKIN JS, 1977, J MEMBRANE BIOL, V35, P39, DOI 10.1007/BF01869939; Rieg S, 2005, J IMMUNOL, V174, P8003, DOI 10.4049/jimmunol.174.12.8003; Rieg S, 2006, J INVEST DERMATOL, V126, P354, DOI 10.1038/sj.jid.5700041; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Senyurek I, 2009, ANTIMICROB AGENTS CH, V53, P2499, DOI 10.1128/AAC.01679-08; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Windisch D, 2010, BIOPHYS J, V99, P1764, DOI 10.1016/j.bpj.2010.06.073; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	44	72	75	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8434	8443		10.1074/jbc.M111.332270	http://dx.doi.org/10.1074/jbc.M111.332270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262861	Green Published, hybrid			2022-12-27	WOS:000301349400058
J	Veiga-da-Cunha, M; Hadi, F; Balligand, T; Stroobant, V; Van Schaftingen, E				Veiga-da-Cunha, Maria; Hadi, Farah; Balligand, Thomas; Stroobant, Vincent; Van Schaftingen, Emile			Molecular Identification of Hydroxylysine Kinase and of Ammoniophospholyases Acting on 5-Phosphohydroxy-L-lysine and Phosphoethanolamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; RAT-LIVER; PROTEIN FAMILIES; PHOSPHO-LYASE; O-PHOSPHOHYDROXYLYSINE; PARTIAL PURIFICATION; MAXIMUM-LIKELIHOOD; PREFRONTAL CORTEX; BIPOLAR DISORDER; METABOLISM	The purpose of the present work was to identify the catalytic activity of AGXT2L1 and AGXT2L2, two closely related, putative pyridoxal-phosphate-dependent enzymes encoded by vertebrate genomes. The existence of bacterial homologues (40-50% identity with AGXT2L1 and AGXT2L2) forming bi- or trifunctional proteins with a putative kinase belonging to the family of aminoglycoside phosphotransferases suggested that AGXT2L1 and AGXT2L2 acted on phosphorylated and aminated compounds. Vertebrate genomes were found to encode a homologue (AGPHD1) of these putative bacterial kinases, which was therefore likely to phosphorylate an amino compound bearing a hydroxyl group. These and other considerations led us to hypothesize that AGPHD1 corresponded to 5-hydroxy-L-lysine kinase and that AGXT2L1 and AGXT2L2 catalyzed the pyridoxal-phosphate-dependent breakdown of phosphoethanolamine and 5-phosphohydroxy-L-lysine. The three recombinant human proteins were produced and purified to homogeneity. AGPHD1 was indeed found to catalyze the GTP-dependent phosphorylation of 5-hydroxy-L-lysine. The phosphorylation product made by this enzyme was metabolized by AGXT2L2, which converted it to ammonia, inorganic phosphate, and 2-aminoadipate semialdehyde. AGXT2L1 catalyzed a similar reaction on phosphoethanolamine, converting it to ammonia, inorganic phosphate, and acetaldehyde. AGPHD1 and AGXT2L2 are likely to be the mutated enzymes in 5-hydroxylysinuria and 5-phosphohydroxylysinuria, respectively. The high level of expression of AGXT2L1 in human brain, as well as data in the literature linking AGXT2L1 to schizophrenia and bipolar disorders, suggest that these diseases may involve a perturbation of brain phosphoethanolamine metabolism. AGXT2L1 and AGXT2L2, the first ammoniophospholyases to be identified, belong to a family of aminotransferases acting on omega-amines.	[Veiga-da-Cunha, Maria; Hadi, Farah; Balligand, Thomas; Van Schaftingen, Emile] de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium; [Stroobant, Vincent] de Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Catholic Univ Louvain, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), de Duve Inst, Physiol Chem Lab, Ave Hippocrate,Box B1-75-08, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Balligand, Thomas/0000-0003-0156-8936; Van Schaftingen, Emile/0000-0002-6199-7647	Fonds National de la Recherche Scientifique and Fonds de la Recherche Scientifique Medicale; Center of Excellence des Desordres Inflammatoires dans les Affections Neurologiques Programme of the Region Wallonne; ASCO Industries	Fonds National de la Recherche Scientifique and Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Center of Excellence des Desordres Inflammatoires dans les Affections Neurologiques Programme of the Region Wallonne; ASCO Industries	This work was supported by grants from the Fonds National de la Recherche Scientifique and Fonds de la Recherche Scientifique Medicale, the Center of Excellence des Desordres Inflammatoires dans les Affections Neurologiques Programme of the Region Wallonne, and ASCO Industries.	Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; ANSELL GB, 1954, BIOCHEM J, V57, P70, DOI 10.1042/bj0570070; ASTRUP T, 1951, ACTA PHYSIOL SCAND, V24, P202, DOI 10.1111/j.1748-1716.1951.tb00838.x; Beautler HO, 1990, METHOD ENZYMAT AN, V8, P369; BENSON PF, 1969, ARCH DIS CHILD, V44, P134, DOI 10.1136/adc.44.233.134-a; Bergmeyer Beutler, 1990, METHODS ENZYMATIC AN; Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925; COLE DEC, 1988, CLIN BIOCHEM, V21, P297, DOI 10.1016/S0009-9120(88)80084-5; DENT CE, 1953, BRIT J CANCER, V7, P166, DOI 10.1038/bjc.1953.16; Donini S, 2009, BIOCHEM J, V422, P265, DOI 10.1042/BJ20090748; DORLAND L, 1990, CLIN CHIM ACTA, V188, P221, DOI 10.1016/0009-8981(90)90203-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEDDE KN, 1990, AM J HUM GENET, V47, P767; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FLESHOOD H L, 1970, Archives of Biochemistry and Biophysics, V141, P423, DOI 10.1016/0003-9861(70)90158-X; FLESHOOD HL, 1970, J BIOL CHEM, V245, P4414; GOODMAN SI, 1972, BIOCHEM MED METAB B, V6, P344, DOI 10.1016/0006-2944(72)90020-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamana K, 1997, J GEN APPL MICROBIOL, V43, P49, DOI 10.2323/jgam.43.49; HILES RA, 1972, J NUTR, V102, P195, DOI 10.1093/jn/102.2.195; HILES RA, 1972, J BIOL CHEM, V247, P646; HOEFNAGEL D, 1970, LANCET, V1, P1342; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jensen JE, 2002, BRIT J PSYCHIAT, V180, P39, DOI 10.1192/bjp.180.1.39; JONES A, 1973, BIOCHEM J, V134, P959, DOI 10.1042/bj1340959; Kim S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-413; KISS Z, 1992, EUR J BIOCHEM, V209, P467, DOI 10.1111/j.1432-1033.1992.tb17311.x; KISS Z, 1993, FEBS LETT, V333, P229, DOI 10.1016/0014-5793(93)80659-I; Lykidis A, 2001, J BIOL CHEM, V276, P2174, DOI 10.1074/jbc.M008794200; Maliekal P, 2006, GLYCOBIOLOGY, V16, P165, DOI 10.1093/glycob/cwj050; MCCLARD RW, 1979, ANAL BIOCHEM, V96, P500, DOI 10.1016/0003-2697(79)90612-2; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; PARKER CE, 1970, LANCET, V1, P1119; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; SODA K, 1968, BIOCHEMISTRY-US, V7, P4102, DOI 10.1021/bi00851a045; STOFFEL W, 1969, H-S Z PHYSIOL CHEM, V350, P1233, DOI 10.1515/bchm2.1969.350.2.1233; Tamaki N, 2000, METHOD ENZYMOL, V324, P376; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074/jbc.M605861200; TSAI CH, 1974, J BIOL CHEM, V249, P5790; TSAI CH, 1974, J BIOL CHEM, V249, P5784; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Veiga-da-Cunha M, 2009, BIOCHEM J, V423, P323, DOI 10.1042/BJ20090986; VIETOR KW, 1977, EUR J PEDIATR, V126, P61, DOI 10.1007/BF00443124; Wang KS, 2011, AM J MED GENET B, V156B, P671, DOI 10.1002/ajmg.b.31209; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WIJBURG H, 1992, EUR J PEDIATR, V151, P311, DOI 10.1007/BF02072238	51	39	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7246	7255		10.1074/jbc.M111.323485	http://dx.doi.org/10.1074/jbc.M111.323485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241472	Green Published, hybrid			2022-12-27	WOS:000301060200027
J	Yin, LM; Edwards, MA; Li, J; Yip, CM; Deber, CM				Yin, Lois M.; Edwards, Michelle A.; Li, Jessica; Yip, Christopher M.; Deber, Charles M.			Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED-SPECTROSCOPY; LIPID-BILAYERS; PROTEINS; ORGANIZATION; SELECTIVITY; MICROSCOPY; PREDICTION; BACTERIAL; AMIDE; AFM	Cationic antimicrobial peptides (CAPs) occur as important innate immunity agents in many organisms, including humans, and offer a viable alternative to conventional antibiotics, as they physically disrupt the bacterial membranes, leading to membrane lysis and eventually cell death. In this work, we studied the biophysical and microbiological characteristics of designed CAPs varying in hydrophobicity levels and charge distributions by a variety of biophysical and biochemical approaches, including in-tandem atomic force microscopy, attenuated total reflection-FTIR, CD spectroscopy, and SDS-PAGE. Peptide structural properties were correlated with their membrane-disruptive abilities and antimicrobial activities. In bacterial lipid model membranes, a time-dependent increase in aggregated beta-strand-type structure in CAPs with relatively high hydrophobicity (such as KKKKKKALFALW-LAFLA-NH2) was essentially absent in CAPs with lower hydrophobicity (such as KKKKKKAAFAAWAAFAA-NH2). Redistribution of positive charges by placing three Lys residues at both termini while maintaining identical sequences minimized self-aggregation above the dimer level. Peptides containing four Leu residues were destructive to mammalian model membranes, whereas those with corresponding Ala residues were not. This finding was mirrored in hemolysis studies in human erythrocytes, where Ala-only peptides displayed virtually no hemolysis up to 320 mu M, but the four-Leu peptides induced 40-80% hemolysis at the same concentration range. All peptides studied displayed strong antimicrobial activity against Pseudomonas aeruginosa (minimum inhibitory concentrations of 4-32 mu M). The overall findings suggest optimum routes to balancing peptide hydrophobicity and charge distribution that allow efficient penetration and disruption of the bacterial membranes without damage to mammalian (host) membranes.	[Yin, Lois M.; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Yin, Lois M.; Yip, Christopher M.; Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S IA8, Canada; [Edwards, Michelle A.; Li, Jessica; Yip, Christopher M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, Div Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	deber@sickkids.ca		Yip, Christopher/0000-0003-4507-556X	Canadian Institutes of Health Research (CIHR) [FRN-79284]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 194435]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant FRN-79284 (to C. M. D.) and Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN 194435 (to C. M. Y.).	Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; Burrows LL, 2006, J ANTIMICROB CHEMOTH, V57, P899, DOI 10.1093/jac/dkl056; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Dzwolak W, 2004, J AM CHEM SOC, V126, P3762, DOI 10.1021/ja039138i; Florin-Christensen J, 2001, P NATL ACAD SCI USA, V98, P7736, DOI 10.1073/pnas.131580998; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Glukhov E, 2008, BIOPOLYMERS, V89, P360, DOI 10.1002/bip.20917; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; La Rocca P, 1999, BIOPHYS CHEM, V76, P145, DOI 10.1016/S0301-4622(98)00232-4; Lear JD, 2004, BIOPHYS J, V87, P3421, DOI 10.1529/biophysj.103.032839; Leptihn S, 2010, BIOCHEMISTRY-US, V49, P9161, DOI 10.1021/bi1011578; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mukherjee S, 2007, J PHYS CHEM B, V111, P4596, DOI 10.1021/jp0689060; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oreopoulos J, 2009, J STRUCT BIOL, V168, P21, DOI 10.1016/j.jsb.2009.02.011; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Van Mau N, 1999, J MEMBRANE BIOL, V167, P241; Verity JE, 2009, BIOPHYS J, V97, P1225, DOI 10.1016/j.bpj.2009.06.013; Vie V, 2000, BIOPHYS J, V78, P846, DOI 10.1016/S0006-3495(00)76642-2; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yin L. M., 2011, P 22 AM PEPT S SAN D, P252; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	36	250	258	6	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7738	7745		10.1074/jbc.M111.303602	http://dx.doi.org/10.1074/jbc.M111.303602			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253439	hybrid, Green Published			2022-12-27	WOS:000301060200072
J	Rosenzweig, R; Bronner, V; Zhang, DN; Fushman, D; Glickman, MH				Rosenzweig, Rina; Bronner, Vered; Zhang, Daoning; Fushman, David; Glickman, Michael H.			Rpn1 and Rpn2 Coordinate Ubiquitin Processing Factors at Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUBIQUITIN-BINDING PROTEIN; DEUBIQUITINATING ENZYME; REGULATORY PARTICLE; 26S PROTEASOME; CRYSTAL-STRUCTURE; UBA DOMAINS; ATPASE SUBUNITS; HEAT; COMPLEX; DEGRADATION	Substrates tagged with (poly) ubiquitin for degradation can be targeted directly to the 26 S proteasome where they are proteolyzed. Independently, ubiquitin conjugates may also be delivered by bivalent shuttles. The majority of shuttles attach to the proteasome through a ubiquitin-like domain (UBL) while anchoring cargo at a C-terminal polyubiquitin-binding domain(s). We found that two shuttles of this class, Rad23 and Dsk2, dock at two different receptor sites embedded within a single subunit of the 19 S proteasome regulatory particle, Rpn1. Their association/dissociation constants and affinities for Rpn1 are similar. In contrast, another UBL-containing protein, the deubiquitinase Ubp6, is also anchored by Rpn1, yet it dissociates slower, thus behaving as an occasional proteasome subunit that is distinct from the transiently associated shuttles. Two neighboring subunits, Rpn10 and Rpn13, show a marked preference for polyubiquitin over UBLs. Rpn10 attaches to the central solenoid portion of Rpn1, although this association is stabilized by the presence of a third subunit, Rpn2. Rpn13 binds directly to Rpn2. These intrinsic polyubiquitin receptors may compete with substrate shuttles for their polyubiquitin-conjugate cargos, thereby aiding release of the emptied shuttles. By binding multiple ubiquitin-processing factors simultaneously, Rpn1 is uniquely suited to coordinate substrate recruitment, deubiquitination, and movement toward the catalytic core. The broad range of affinities for ubiquitin, ubiquitin-like, and non-ubiquitin signals by adjacent yet nonoverlapping sites all within the base represents a hub of activity that coordinates the intricate relay of substrates within the proteasome, and consequently it influences substrate residency time and commitment to degradation.	[Bronner, Vered; Fushman, David] Biorad Haifa Ltd, Prot Funct Div, Technion City, IL-32000 Haifa, Israel; [Rosenzweig, Rina; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Zhang, Daoning] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20910 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; University System of Maryland; University of Maryland College Park	Fushman, D (corresponding author), Biorad Haifa Ltd, Prot Funct Div, Technion City, IL-32000 Haifa, Israel.	fushman@umd.edu; glickman@techunix.technion.ac.il		Glickman, Michael/0000-0002-1222-8104; Rosenzweig, Rina/0000-0002-4019-5135	National Institutes of Health [GM095755]; Israel Science Foundation; United States-Israel Binational Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095755 (to D. F. and M. H. G.). This work was also supported by grants from the Israel Science Foundation (to M. H. G.) and by the United States-Israel Binational Science Foundation (to M. H. G. and D. F.).	Aksel T, 2011, STRUCTURE, V19, P349, DOI 10.1016/j.str.2010.12.018; Alag R, 2009, PROTEIN SCI, V18, P2115, DOI 10.1002/pro.226; Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Andersen KM, 2005, ESSAYS BIOCHEM, V41, P49, DOI 10.1042/EB0410049; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bar-Nun S., 2011, BIOCHIM BIOPHYS ACTA, V1823, P67; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6311; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fatimababy AS, 2010, FEBS J, V277, P796, DOI 10.1111/j.1742-4658.2009.07531.x; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kajava AV, 2004, J STRUCT BIOL, V146, P425, DOI 10.1016/j.jsb.2004.01.013; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kennedy SA, 2009, J MOL BIOL, V392, P115, DOI 10.1016/j.jmb.2009.06.062; Kippert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007148; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Luna-Vargas MPA, 2011, EMBO REP, V12, P365, DOI 10.1038/embor.2011.33; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Maupin-Furlow JA, 2006, CURR TOP DEV BIOL, V75, P125, DOI 10.1016/S0070-2153(06)75005-0; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; Tyrrell A, 2010, P NATL ACAD SCI USA, V107, P19796, DOI 10.1073/pnas.1010648107; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Walters KJ, 2008, MOL CELL, V32, P459, DOI 10.1016/j.molcel.2008.10.020; Wang SH, 2009, PLANT CELL PHYSIOL, V50, P1721, DOI 10.1093/pcp/pcp105; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wyndham AM, 1999, PROTEIN SCI, V8, P1268, DOI 10.1110/ps.8.6.1268; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	93	85	86	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14659	14671		10.1074/jbc.M111.316323	http://dx.doi.org/10.1074/jbc.M111.316323			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22318722	Green Published, hybrid			2022-12-27	WOS:000304003200032
J	Gurba, KN; Hernandez, CC; Hu, NN; Macdonald, RL				Gurba, Katharine N.; Hernandez, Ciria C.; Hu, Ningning; Macdonald, Robert L.			GABRB3 Mutation, G32R, Associated with Childhood Absence Epilepsy Alters alpha 1 beta 3 gamma 2L gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Expression and Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURE; GLYCOSYLATION; BIOGENESIS; ALPHA-1; SITE; IDENTIFICATION; PEPTIDES	A GABA(A) receptor beta 3 subunit mutation, G32R, has been associated with childhood absence epilepsy. We evaluated the possibility that this mutation, which is located adjacent to the most N-terminal of three beta 3 subunit N-glycosylation sites, might reduce GABAergic inhibition by increasing glycosylation of beta 3 subunits. The mutation had three major effects on GABA(A) receptors. First, coexpression of beta 3(G32R) subunits with alpha 1 or alpha 3 and gamma 2L subunits in HEK293T cells reduced surface expression of gamma 2L subunits and increased surface expression of beta 3 subunits, suggesting a partial shift from ternary alpha beta 3 gamma 2L receptors to binary alpha beta 3 and homomeric beta 3 receptors. Second, beta 3(G32R) subunits were more likely than beta 3 subunits to be N-glycosylated at Asn-33, but increases in glycosylation were not responsible for changes in subunit surface expression. Rather, both phenomena could be attributed to the presence of a basic residue at position 32. Finally, alpha 1 beta 3(G32R)gamma 2L receptors had significantly reduced macroscopic current density. This reduction could not be explained fully by changes in subunit expression levels (because gamma 2L levels decreased only slightly) or glycosylation (because reduction persisted in the absence of glycosylation at Asn-33). Single channel recording revealed that alpha 1 beta 3(G32R)gamma 2L receptors had impaired gating with shorter mean open time. Homology modeling indicated that the mutation altered salt bridges at subunit interfaces, including regions important for subunit oligomerization. Our results suggest both a mechanism for mutation-induced hyperexcitability and a novel role for the beta 3 subunit N-terminal alpha-helix in receptor assembly and gating.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Gurba, Katharine N.] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave, Nashville, TN 37232 USA.	robert.macdonald@vanderbilt.edu		Hernandez, Ciria/0000-0001-9715-1734	NINDS NIH HHS [R01 NS051590] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051590] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Castillo M, 2009, J NEUROCHEM, V108, P1399, DOI 10.1111/j.1471-4159.2009.05924.x; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Everett K, 2007, EPILEPSY RES, V75, P145, DOI 10.1016/j.eplepsyres.2007.05.004; Everett KV, 2007, EUR J HUM GENET, V15, P463, DOI 10.1038/sj.ejhg.5201783; Fillman SG, 2010, INT J DEV NEUROSCI, V28, P513, DOI 10.1016/j.ijdevneu.2010.05.004; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hernandez CC, 2011, J PHYSIOL-LONDON, V589, P5857, DOI 10.1113/jphysiol.2011.218883; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kamei N, 2010, BIOCHEM BIOPH RES CO, V391, P557, DOI 10.1016/j.bbrc.2009.11.098; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Lu Jian-jun, 2005, Zhonghua Er Ke Za Zhi, V43, P133; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Smit AB, 2003, ANN NY ACAD SCI, V998, P81, DOI 10.1196/annals.1254.010; Sutachan JJ, 2005, BRAIN RES, V1058, P30, DOI 10.1016/j.brainres.2005.07.050; Tanaka M, 2008, AM J HUM GENET, V82, P1249, DOI 10.1016/j.ajhg.2008.04.020; Taylor PM, 1999, J NEUROSCI, V19, P6360; Tretter V, 1997, J NEUROSCI, V17, P2728; TWYMAN RE, 1990, J PHYSIOL-LONDON, V423, P193, DOI 10.1113/jphysiol.1990.sp018018; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031	48	39	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12083	12097		10.1074/jbc.M111.332528	http://dx.doi.org/10.1074/jbc.M111.332528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22303015	Green Published, hybrid			2022-12-27	WOS:000302782200045
J	Madsen, KL; Thorsen, TS; Rahbek-Clemmensen, T; Eriksen, J; Gether, U				Madsen, Kenneth L.; Thorsen, Thor S.; Rahbek-Clemmensen, Troels; Eriksen, Jacob; Gether, Ulrik			Protein Interacting with C Kinase 1 (PICK1) Reduces Reinsertion Rates of Interaction Partners Sorted to Rab11-dependent Slow Recycling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM DEPRESSION; PDZ-DOMAIN; DOPAMINE TRANSPORTER; DIFFERENTIAL REGULATION; PKC PHOSPHORYLATION; COUPLED RECEPTORS; NMDA RECEPTORS; BAR DOMAINS; IN-VIVO	The scaffolding protein PICK1 (protein interacting with C kinase 1) contains an N-terminal PSD-95/Discs large/ZO-1 (PDZ) domain and a central lipid-binding Bin/amphiphysin/Rvs (BAR) domain. PICK1 is thought to regulate trafficking of its PDZ binding partners but different and even opposing functions have been suggested. Here, we apply ELISA-based assays and confocal microscopy in HEK293 cells with inducible PICK1 expression to assess in an isolated system the ability of PICK1 to regulate trafficking of natural and engineered PDZ binding partners. The dopamine transporter (DAT), which primarily sorts to degradation upon internalization, did not form perinuclear clusters with PICK1, and PICK1 did not affect DAT internalization/recycling. However, transfer of the PICK1-binding DAT C terminus to the beta(2)-adrenergic receptor, which sorts to recycling upon internalization, led to formation of PICK1 co-clusters in Rab11-positive compartments. Furthermore, PICK1 inhibited Rab11-mediated recycling of the receptor in a BAR and PDZ domain-dependent manner. In contrast, transfer of the DAT C terminus to the delta-opioid receptor, which sorts to degradation, did not result in PICK1 co-clusters or any change in internalization/recycling. Further support for a role of PICK1 determined by its PDZ cargo was obtained for the PICK1 interaction partner prolactin-releasing peptide receptor (GPR10). GPR10 co-localized with Rab11 and clustered with PICK1 upon constitutive internalization but co-localized with the late endosomal marker Rab7 and did not cluster with PICK1 upon agonist-induced internalization. Our data suggest a selective role of PICK1 in clustering and reducing the recycling rates of PDZ domain binding partners sorted to the Rab11-dependent recycling pathway.	[Gether, Ulrik] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Mol Neuropharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, DK-2200 Copenhagen N, Denmark	Lundbeckfonden; University of Copenhagen; University of Copenhagen	Gether, U (corresponding author), Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Dept Neurosci & Pharmacol, Fac Hlth Sci,Panum Inst, 18-6,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Madsen, Kenneth/C-7778-2012	Madsen, Kenneth/0000-0001-9274-6691; Rahbek-Clemmensen, Troels/0000-0003-2067-5411; Gether, Ulrik/0000-0002-0020-3807; Eriksen, Jacob/0000-0003-0726-9769	National Institutes of Health [P01 DA 12408]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Medical Research Councils; University of Copenhagen; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Councils(Danish Medical Research Council); University of Copenhagen; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.). This work was also supported by the Lundbeck Foundation (to U. G.), the Novo Nordisk Foundation, the Danish Medical Research Councils (to U. G. and K. M.), and the University of Copenhagen Program of Excellence (BioScaRT) (to U. G.).	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Baer K, 2007, MOL CELL NEUROSCI, V35, P339, DOI 10.1016/j.mcn.2007.03.009; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chmelar RS, 2006, J BIOL CHEM, V281, P35381, DOI 10.1074/jbc.M605954200; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dev KK, 2000, J NEUROSCI, V20, P7252; Dev KK, 2007, CURR TOP MED CHEM, V7, P3, DOI 10.2174/156802607779318343; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hanley JG, 2006, BIOCHEM SOC T, V34, P931, DOI 10.1042/BST0340931; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Jin WY, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-39; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lauffer BEL, 2009, J BIOL CHEM, V284, P2448, DOI 10.1074/jbc.M806370200; Lavezzari G, 2004, J NEUROSCI, V24, P6383, DOI 10.1523/JNEUROSCI.1890-04.2004; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Madsen KL, 2005, J BIOL CHEM, V280, P20539, DOI 10.1074/jbc.M500577200; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; MARCHESE A, 1995, GENOMICS, V29, P335, DOI 10.1006/geno.1995.9996; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sossa KG, 2006, MOL CELL NEUROSCI, V31, P574, DOI 10.1016/j.mcn.2005.11.011; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	76	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12293	12308		10.1074/jbc.M111.294702	http://dx.doi.org/10.1074/jbc.M111.294702			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22303009	Green Published, hybrid			2022-12-27	WOS:000302782200069
J	Strack, S; Cribbs, JT				Strack, Stefan; Cribbs, J. Thomas			Allosteric Modulation of Drp1 Mechanoenzyme Assembly and Mitochondrial Fission by the Variable Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; DEPENDENT PROTEIN-KINASE; PEROXISOMAL FISSION; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; S-NITROSYLATION; PHOSPHORYLATION; DEATH; TRANSLOCATION; MICROSCOPY	Background: Mechanisms of Drp1-mediated mitochondrial fission are poorly understood. Results: Substitution of the Drp1 variable domain causes a spectrum of assembly and activity phenotypes but does not compromise the stalk domain-mediated recruitment of Drp1 to the mitochondrial anchoring protein Mff. Conclusion: The variable domain modulates Drp1 activity through oligomeric assembly. Significance: Insight into Drp1 regulatory mechanisms is essential for understanding mitochondrial biology.	[Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS057714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS043254, R01NS056244, R01NS057714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS043254, NS056244, and NS057714 (to S. S.)	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	36	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10990	11001		10.1074/jbc.M112.342105	http://dx.doi.org/10.1074/jbc.M112.342105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334657	Green Published, hybrid			2022-12-27	WOS:000302780100027
J	Doi, K; Li, RS; Sung, SS; Wu, HW; Liu, Y; Manieri, W; Krishnegowda, G; Awwad, A; Dewey, A; Liu, X; Amin, S; Cheng, CW; Qin, Y; Schonbrunn, E; Daughdrill, G; Loughran, TP; Sebti, S; Wang, HG				Doi, Kenichiro; Li, Rongshi; Sung, Shen-Shu; Wu, Hongwei; Liu, Yan; Manieri, Wanda; Krishnegowda, Gowdahalli; Awwad, Andy; Dewey, Alden; Liu, Xin; Amin, Shantu; Cheng, Chunwei; Qin, Yong; Schonbrunn, Ernst; Daughdrill, Gary; Loughran, Thomas P., Jr.; Sebti, Said; Wang, Hong-Gang			Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY PROTEINS; EFFICIENTLY INDUCES APOPTOSIS; BH3 MIMETIC ABT-737; IMMUNOHISTOCHEMICAL ANALYSIS; BH3-ONLY PROTEINS; CANCER; INHIBITOR; CELLS; LEUKEMIA; THERAPY	The anti-apoptotic Bcl-2 family of proteins, including Bcl-2, Bcl-X-L and Mcl-1, are well-validated drug targets for cancer treatment. Several small molecules have been designed to interfere with Bcl-2 and its fellow pro-survival family members. While ABT-737 and its orally active analog ABT-263 are the most potent and specific inhibitors to date that bind Bcl-2 and Bcl-X-L with high affinity but have a much lower affinity for Mcl-1, they are not very effective as single agents in certain cancer types because of elevated levels of Mcl-1. Accordingly, compounds that specifically target Mcl-1 may overcome this resistance. In this study, we identified and characterized the natural product marinopyrrole A as a novel Mcl-1-specific inhibitor and named it maritoclax. We found that maritoclax binds to Mcl-1, but not Bcl-X-L, and is able to disrupt the interaction between Bim and Mcl-1. Moreover, maritoclax induces Mcl-1 degradation via the proteasome system, which is associated with the pro-apoptotic activity of maritoclax. Importantly, maritoclax selectively kills Mcl-1-dependent, but not Bcl-2- or Bcl-X-L-dependent, leukemia cells and markedly enhances the efficacy of ABT-737 against hematologic malignancies, including K562, Raji, and multidrug-resistant HL60/VCR, by similar to 60- to 2000-fold at 1-2 mu M. Taken together, these results suggest that maritoclax represents a new class of Mcl-1 inhibitors, which antagonizes Mcl-1 and overcomes ABT-737 resistance by targeting Mcl-1 for degradation.	[Doi, Kenichiro; Sung, Shen-Shu; Krishnegowda, Gowdahalli; Amin, Shantu; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Awwad, Andy; Dewey, Alden; Liu, Xin; Amin, Shantu; Loughran, Thomas P., Jr.; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Li, Rongshi; Liu, Yan; Manieri, Wanda; Schonbrunn, Ernst; Sebti, Said] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Wu, Hongwei] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33612 USA; [Cheng, Chunwei; Qin, Yong] Sichuan Univ, W China Sch Pharm, Chengdu 610041, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Sichuan University	Wang, HG (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015	Wang, Hong-Gang/0000-0003-0551-0571; Schonbrunn, Ernst/0000-0002-3589-3510; GOWDA, KRISHNE/0000-0002-6042-0520	National Institutes of Health [CA118210]; Moffitt Cancer Center; National Science Foundation [MCB0939014]; American Cancer Society [RSG-07-89-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA098472, P01CA118210, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center; National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA118210, by Moffitt Cancer Center startup funds (to R. L.), and by the National Science Foundation (Award No. MCB0939014) and the American Cancer Society (RSG-07-89-01-GMC) (to G. W. D.).	Acoca S, 2011, PROTEINS, V79, P2624, DOI 10.1002/prot.23083; Albershardt TC, 2011, J BIOL CHEM, V286, P24882, DOI 10.1074/jbc.M111.255828; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cheng CW, 2010, J COMB CHEM, V12, P541, DOI 10.1021/cc100052j; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gomez-Bougie P, 2011, BIOCHEM BIOPH RES CO, V413, P460, DOI 10.1016/j.bbrc.2011.08.118; Haste NM, 2011, ANTIMICROB AGENTS CH, V55, P3305, DOI 10.1128/AAC.01211-10; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hu XD, 2008, J AM CHEM SOC, V130, P13820, DOI 10.1021/ja802683u; Hughes CC, 2008, ORG LETT, V10, P629, DOI 10.1021/ol702952n; Hughes CC, 2009, J AM CHEM SOC, V131, P12094, DOI 10.1021/ja903149u; Ji M, 2009, BRIT J HAEMATOL, V145, P648, DOI 10.1111/j.1365-2141.2009.07678.x; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krajewska M, 1997, CANCER RES, V57, P1605; KRAJEWSKI S, 1994, AM J PATHOL, V145, P515; Liao AJ, 2011, BLOOD, V118, P2793, DOI 10.1182/blood-2011-01-331447; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Quinn BA, 2011, EXPERT OPIN INV DRUG, V20, P1397, DOI 10.1517/13543784.2011.609167; Reed J C, 1997, Adv Pharmacol, V41, P501, DOI 10.1016/S1054-3589(08)61070-4; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Woods NT, 2007, CANCER RES, V67, P10744, DOI 10.1158/0008-5472.CAN-07-3148; Wuilleme-Toumi S, 2007, BIOCHEM BIOPH RES CO, V361, P865, DOI 10.1016/j.bbrc.2007.07.070; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307	43	125	132	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10224	10235		10.1074/jbc.M111.334532	http://dx.doi.org/10.1074/jbc.M111.334532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311987	Green Published, hybrid			2022-12-27	WOS:000302167200053
J	Isobe, Y; Arita, M; Matsueda, S; Iwamoto, R; Fujihara, T; Nakanishi, H; Taguchi, R; Masuda, K; Sasaki, K; Urabe, D; Inoue, M; Arai, H				Isobe, Yosuke; Arita, Makoto; Matsueda, Shinnosuke; Iwamoto, Ryo; Fujihara, Takuji; Nakanishi, Hiroki; Taguchi, Ryo; Masuda, Koji; Sasaki, Kenji; Urabe, Daisuke; Inoue, Masayuki; Arai, Hiroyuki			Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID MEDIATORS; FATTY-ACIDS; INFLAMMATION; RESOLUTION; OMEGA-3-FATTY-ACIDS; BIOSYNTHESIS; PRODUCTS; ASPIRIN; FAMILY; N-3	Bioactive mediators derived from omega-3 eicosapentaenoic acid (EPA) elicit potent anti-inflammatory actions. Here, we identified novel EPA metabolites, including 8,18-dihydroxyei-cosapentaenoic acid (8,18-diHEPE), 11,18-diHEPE, 12,18-diHEPE, and 17,18-diHEPE from 18-HEPE. Unlike resolvins E1 and E2, both of which are biosynthesized by neutrophils via the 5-lipoxygenase pathway, these metabolites are biosynthesized by eosinophils via the 12/15-lipoxygenase pathway. Among them, two stereoisomers of 17,18-diHEPE, collectively termed resolvin E3 (RvE3), displayed a potent anti-inflammatory action by limiting neutrophil infiltration in zymosan-induced peritonitis. The planar structure of RvE3 was unambiguously determined to be 17,18-dihydroxy-5Z, 8Z, 11Z, 13E, 15E-EPE by high resolution NMR, and the two stereoisomers were assigned to have 17,18R- and 17,18S-dihydroxy groups, respectively, using chemically synthesized 18R- and 18S-HEPE as precursors. Both 18R- and 18S-RvE3 inhibited neutrophil chemotaxis in vitro at low nanomolar concentrations. These findings suggest that RvE3 contributes to the beneficial actions of EPA in controlling inflammation and related diseases.	[Isobe, Yosuke; Arita, Makoto; Matsueda, Shinnosuke; Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Sasaki, Kenji; Urabe, Daisuke; Inoue, Masayuki] Univ Tokyo, Dept Integral Analyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Isobe, Yosuke; Iwamoto, Ryo; Fujihara, Takuji; Masuda, Koji] Univ Tokyo, Grad Sch Pharmaceut Sci, Business Acad Collaborat Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Fujihara, Takuji; Masuda, Koji] Shionogi Res Labs, Toyonaka, Osaka 5610825, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Shionogi & Company Limited; Japan Science & Technology Agency (JST)	Arita, M (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	marita@mol.f.u-tokyo.ac.jp		Nakanishi, Hiroki/0000-0002-5108-1598; Arita, Makoto/0000-0001-9902-0463	Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Core Research for Evolutional Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ono Medical Research Foundation; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (to M. A.), Core Research for Evolutional Science and Technology (to H. A. and R. T.), grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. A.), Ono Medical Research Foundation (to M. A.), and the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry (to H. A.).	Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; MACMILLAN DK, 1994, J BIOL CHEM, V269, P26663; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogawa S, 2009, ORG LETT, V11, P3602, DOI 10.1021/ol901350g; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; POWELL WS, 1995, J IMMUNOL, V154, P4123; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027	27	172	178	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10525	10534		10.1074/jbc.M112.340612	http://dx.doi.org/10.1074/jbc.M112.340612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275352	hybrid, Green Published			2022-12-27	WOS:000302167200078
J	Li, DQ; Zhang, WJ; Liu, Y; Haneline, LS; Shou, WN				Li, Deqiang; Zhang, Wenjun; Liu, Ying; Haneline, Laura S.; Shou, Weinian			Lack of Plakoglobin in Epidermis Leads to Keratoderma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; BETA-CATENIN; PALMOPLANTAR KERATODERMAS; F9 CELLS; ROLES; DISEASE; HEART; HAIR; SKIN; KERATINOCYTES	Loss-of-function mutation of Jup has been associated with Naxos disease, which is characterized by arrhythmogenic cardiomyopathy and the cutaneous disorder palmoplantar keratoderma. Previously, we have shown that genetic ablation of Jup in cardiomyocytes in mice leads to arrhythmogenic cardiomyopathy similar to Naxos disease in humans. Currently, to determine the pathogenesis of Naxos disease-associated keratoderma, we generated Jup mutant mice by inactivating Jup restrictively in keratinocytes. Jup mutant mice largely recapitulated the clinical features of human palmoplantar keratoderma: overcornification and thickening of the epidermis. Jup mutant mice also suffered skin ulceration and inflammation. Cell apoptosis and proliferation were significantly elevated in Jup mutant epidermis. Ultrastructural analyses revealed the disruption of the assembly of desmosomes and adherens junctions in Jup mutant epidermis. We also demonstrated the compensational increase in beta-catenin at Jup mutant cell-cell junctions without altering its signaling activities. Our findings provide important insights for understanding the pathogenesis of human palmoplantar keratoderma.	[Li, Deqiang; Zhang, Wenjun; Liu, Ying; Haneline, Laura S.; Shou, Weinian] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Li, Deqiang; Zhang, Wenjun; Shou, Weinian] Indiana Univ Sch Med, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Liu, Ying; Haneline, Laura S.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Shou, WN (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, R4-302D,1044 W Walnut, Indianapolis, IN 46202 USA.	wshou@iupui.edu			National Institutes of Health [HL81092, HL70259, HL85098]; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098, R01HL081092, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092, HL70259, and HL85098 (all to W. S.). This work was also supported by the Riley Children's Foundation (to W. S.).	Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Cabral RM, 2010, J INVEST DERMATOL, V130, P1543, DOI 10.1038/jid.2010.7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Erken H, 2011, BRIT J DERMATOL, V165, P917, DOI 10.1111/j.1365-2133.2011.10455.x; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; Garcia-Gras E, 2006, J CLIN INVEST, V116, P2012, DOI 10.1172/JCI27751; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Itin PH, 2005, CLIN DERMATOL, V23, P15, DOI 10.1016/j.clindermatol.2004.09.005; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Klymkowsky MW, 1999, MOL BIOL CELL, V10, P3151, DOI 10.1091/mbc.10.10.3151; Li DQ, 2011, HUM MOL GENET, V20, P4582, DOI 10.1093/hmg/ddr392; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malminen M, 2003, BRIT J DERMATOL, V149, P255, DOI 10.1046/j.1365-2133.2003.05438.x; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; NIELSEN PG, 1984, DERMATOLOGICA, V168, P293, DOI 10.1159/000249727; Pigors M, 2011, HUM MOL GENET, V20, P1811, DOI 10.1093/hmg/ddr064; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Shimizu M, 2008, MOL CELL BIOL, V28, P825, DOI 10.1128/MCB.02375-06; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; van Steensel MAM, 2010, GIORN ITAL DERMAT V, V145, P763; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhurinsky J, 2000, J CELL SCI, V113, P3127	27	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10435	10443		10.1074/jbc.M111.299669	http://dx.doi.org/10.1074/jbc.M111.299669			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315228	Green Published, hybrid			2022-12-27	WOS:000302167200070
J	Wei, ZK; Peterson, JM; Lei, X; Cebotaru, L; Wolfgang, MJ; Baldeviano, GC; Wong, GW				Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Cebotaru, Liudmila; Wolfgang, Michael J.; Baldeviano, G. Christian; Wong, G. William			C1q/TNF-related Protein-12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Models of Obesity and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET RETINAL DEGENERATION; C1Q/TNF FAMILY-MEMBERS; FATTY-ACID OXIDATION; BETA-CELL FUNCTION; ADIPOSE-TISSUE; MACULAR DEGENERATION; GLUCOSE-HOMEOSTASIS; ADIPONECTIN; KINASE; GENE	Despite the prevalence of insulin resistance and type 2 diabetes mellitus, their underlying mechanisms remain incompletely understood. Many secreted endocrine factors and the intertissue cross-talk they mediate are known to be dysregulated in type 2 diabetes mellitus. Here, we describe CTRP12, a novel adipokine with anti-diabetic actions. The mRNA and circulating levels of CTRP12 were decreased in a mouse model of obesity, but its expression in adipocytes was increased by the anti-diabetic drug rosiglitazone. A modest rise in circulating levels of CTRP12 by recombinant protein administration was sufficient to lower blood glucose in wild-type, leptin-deficient ob/ob, and diet-induced obese mice. A short term elevation of serum CTRP12 by adenovirus-mediated expression improved glucose tolerance and insulin sensitivity, normalized hyperglycemia and hyperinsulinemia, and lowered postprandial insulin resistance in obese and diabetic mice. CTRP12 improves insulin sensitivity in part by enhancing insulin signaling in the liver and adipose tissue. Further, CTRP12 also acts in an insulin-independent manner; in cultured hepatocytes and adipocytes, CTRP12 directly activated the PI3K-Akt signaling pathway to suppress gluconeogenesis and promote glucose uptake, respectively. Collectively, these data establish CTRP12 as a novel metabolic regulator linking adipose tissue to whole body glucose homeostasis through insulin-dependent and independent mechanisms.	[Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Cebotaru, Liudmila; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Sch Med, Baltimore, MD 21205 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Dept Biol Chem, Sch Med, Baltimore, MD 21205 USA; [Baldeviano, G. Christian] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21205 USA; [Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Wolfgang, Michael J.; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171, NS072241]; American Heart Association [SDG2260721, SDG2310008, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; American Heart Association; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P60DK079637, P30DK079637, R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK084171 (to G. W. W.) and NS072241 (to M. J. W.). This work was also supported in part by American Heart Association Grants SDG2260721 (to G. W. W.) and SDG2310008 (to M. J. W.) and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.	Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; CANTELLO BCC, 1994, J MED CHEM, V37, P3977, DOI 10.1021/jm00049a017; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; de Raemy-Schenk AM, 2006, ASSAY DRUG DEV TECHN, V4, P525, DOI 10.1089/adt.2006.4.525; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	38	111	123	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10301	10315		10.1074/jbc.M111.303651	http://dx.doi.org/10.1074/jbc.M111.303651			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275362	Green Published, hybrid			2022-12-27	WOS:000302167200059
J	Chen, CY; Samuel, TK; Krause, M; Dailey, HA; Hamza, I				Chen, Caiyong; Samuel, Tamika K.; Krause, Michael; Dailey, Harry A.; Hamza, Iqbal			Heme Utilization in the Caenorhabditis elegans Hypodermal Cells Is Facilitated by Heme-responsive Gene-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; BINDING PROTEIN; MOLECULAR CHARACTERIZATION; CYTOCHROME-C; IRON UPTAKE; IDENTIFICATION; TRANSPORT; REDOX; DIFFERENTIATION; RESISTANCE	The roundworm Caenorhabditis elegans is a heme auxotroph that requires the coordinated actions of HRG-1 heme permeases to transport environmental heme into the intestine and HRG-3, a secreted protein, to deliver intestinal heme to other tissues including the embryo. Here we show that heme homeostasis in the extraintestinal hypodermal tissue was facilitated by the transmembrane protein HRG-2. Systemic heme deficiency up-regulated hrg-2 mRNA expression over 200-fold in the main body hypodermal syncytium, hyp 7. HRG-2 is a type I membrane protein that binds heme and localizes to the endoplasmic reticulum and apical plasma membrane. Cytochrome heme profiles are aberrant in HRG-2-deficient worms, a phenotype that was partially suppressed by heme supplementation. A heme-deficient yeast strain, ectopically expressing worm HRG-2, revealed significantly improved growth at submicromolar concentrations of exogenous heme. Taken together, our results implicate HRG-2 as a facilitator of heme utilization in the Caenorhabditis elegans hypodermis and provide a mechanism for the regulation of heme homeostasis in an extraintestinal tissue.	[Chen, Caiyong; Samuel, Tamika K.; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chen, Caiyong; Samuel, Tamika K.; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Krause, Michael] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, 2413 ANSC,Bldg 142, College Pk, MD 20742 USA.	hamza@umd.edu		Krause, Michael/0000-0001-6127-3940; Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health (NIH) [R01DK74797]; NIH from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R56DK032303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01DK74797 (extramural funding) (to I. H.) and an NIH Intramural Research Program grant from the NIDDK (to M. K.).	Allhorn M, 2005, FREE RADICAL BIO MED, V38, P557, DOI 10.1016/j.freeradbiomed.2004.12.013; BALLA G, 1991, LAB INVEST, V64, P648; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Dong J, 2008, J MOL BIOL, V376, P621, DOI 10.1016/j.jmb.2007.11.094; DORFMAN BZ, 1969, GENETICS, V61, P377; Epstein HF, 1995, METHOD CELL BIOL, V48, P437; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; HARVEY JW, 1982, BLOOD, V60, P1227; Harwaldt P, 2002, BIOL CHEM, V383, P821, DOI 10.1515/BC.2002.086; HILL KK, 1995, GENETICS, V141, P595; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; Labouesse Michel, 2006, WormBook, P1; Liao VHC, 2002, J BIOL CHEM, V277, P42049, DOI 10.1074/jbc.M206740200; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nass R., 2007, CURRENT PROTOCOLS TO, P191; NAUSEEF WM, 1992, BLOOD, V80, P2622; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; NICHOLSON DW, 1989, P NATL ACAD SCI USA, V86, P4340, DOI 10.1073/pnas.86.12.4340; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Praitis V, 2001, GENETICS, V157, P1217; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Richard-Fogal CL, 2009, EMBO J, V28, P2349, DOI 10.1038/emboj.2009.189; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Shadel GS, 1999, AM J HUM GENET, V65, P1230, DOI 10.1086/302630; Smith K. M., 1975, PORPHYRINS METALLOPO; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIPPING E, 1976, BIOCHEM J, V157, P461, DOI 10.1042/bj1570461; Van Rossum AJ, 2004, INFECT IMMUN, V72, P2780, DOI 10.1128/IAI.72.5.2780-2790.2004; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; Zhan B, 2005, INFECT IMMUN, V73, P6903, DOI 10.1128/IAI.73.10.6903-6911.2005; Zhu YH, 2002, CELL GROWTH DIFFER, V13, P431	59	26	32	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9601	9612		10.1074/jbc.M111.307694	http://dx.doi.org/10.1074/jbc.M111.307694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303006	Green Published, hybrid			2022-12-27	WOS:000301797800091
J	Lee, KK; Yonehara, S				Lee, Kyung-Kwon; Yonehara, Shin			Identification of Mechanism That Couples Multisite Phosphorylation of Yes-associated Protein (YAP) with Transcriptional Coactivation and Regulation of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; CELL-PROLIFERATION; CONTACT INHIBITION; TUMOR-SUPPRESSOR; TEAD/TEF FAMILY; GROWTH-CONTROL; DNA-DAMAGE; IN-VIVO; P73	The transcriptional coactivator Yes-associated protein (YAP) has been implicated in tumorigenesis by regulating cell proliferation and apoptosis. YAP interacts with the transcription factor TEAD and is essential in mediating TEAD-dependent gene expression. Here we show that YAP is hyperphosphorylated and activated in response to genotoxic stress such as UV irradiation and cisplatin treatment. Using high resolution mobility shift assay for phosphorylated proteins, we identified multiple sites of phosphorylation induced by UV irradiation. Pretreatment with p38 and JNK inhibitors completely suppressed the mobility retardation of phosphorylated YAP in UV-irradiated cells. Co-immunoprecipitation experiments showed that the physical interaction of YAP with TEAD was markedly enhanced by UV irradiation or CDDP treatment but suppressed by pretreatment with p38 and JNK inhibitors. Similarly, pretreatment with p38 and JNK inhibitors suppressed the expression of YAP/TEAD target genes, which were elevated on exposure to genotoxic stress. Using phosphomimetic and phosphorylation-deficient YAP mutants, we showed that the coactivator activity of YAP correlated with its state of phosphorylation and sensitivity to cisplatin-induced apoptosis. Our results demonstrate that multisite phosphorylation of YAP induces YAP/TEAD-dependent gene expression and provides a mechanism by which YAP regulates apoptosis differently depending on cellular context.	[Lee, Kyung-Kwon; Yonehara, Shin] Kyoto Univ, Lab Mol & Cellular Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Lee, KK (corresponding author), Kyoto Univ, Lab Mol & Cellular Biol, Grad Sch Biostudies, Sakyo Ku, SCRB Bldg G,Yoshida Konoe Cho, Kyoto 6068501, Japan.	kklee@lif.kyoto-u.ac.jp						Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blandino G, 2004, CELL CYCLE, V3, P886; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Lee KK, 2002, J BIOL CHEM, V277, P12351, DOI 10.1074/jbc.M108138200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Oh H, 2009, ONCOGENE, V28, P1916, DOI 10.1038/onc.2009.43; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Tomlinson V, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.7; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	40	28	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9568	9578		10.1074/jbc.M111.296954	http://dx.doi.org/10.1074/jbc.M111.296954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308035	hybrid, Green Published			2022-12-27	WOS:000301797800088
J	Li, XX; Liu, KX; Li, FD; Wang, JC; Huang, HD; Wu, JH; Shi, YY				Li, Xinxin; Liu, Kaixian; Li, Fudong; Wang, Juncheng; Huang, Hongda; Wu, Jihui; Shi, Yunyu			Structure of C-terminal Tandem BRCT Repeats of Rtt107 Protein Reveals Critical Role in Interaction with Phosphorylated Histone H2A during DNA Damage Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; CRYSTAL-STRUCTURE; CHECKPOINT; DOMAIN; PHOSPHOPEPTIDE; RECRUITMENT; 53BP1; YEAST; COMPLEX	Rtt107 (regulator of Ty1 transposition 107; Esc4) is a DNA repair protein from Saccharomyces cerevisiae that can restore stalled replication forks following DNA damage. There are six BRCT (BRCA1 C-terminal) domains in Rtt107 that act as binding sites for other recruited proteins during DNA repair. Several Rtt107 binding partners have been identified, including Slx4, Rtt101, Rad55, and the Smc5/6 (structural maintenance of chromosome) protein complex. Rtt107 can reportedly be recruited to chromatin in the presence of Rtt101 and Rtt109 upon DNA damage, but the chromatin-binding site of Rtt107 has not been identified. Here, we report our investigation of the interaction between phosphorylated histone H2A (gamma H2A) and the C-terminal tandem BRCT repeats (BRCT5-BRCT6) of Rtt107. The crystal structures of BRCT5-BRCT6 alone and in a complex with gamma H2A reveal the molecular basis of the Rtt107-gamma H2A interaction. We used in vitro mutagenesis and a fluorescence polarization assay to confirm the location of the Rtt107 motif that is crucial for this interaction. In addition, these assays indicated that this interaction requires the phosphorylation of H2A. An in vivo phenotypic analysis in yeast demonstrated the critical role of BRCT5-BRCT6 and its interaction with gamma H2A during the DNA damage response. Our results shed new light on the molecular mechanism by which Rtt107 is recruited to chromatin in response to stalled DNA replication forks.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Liu, Kaixian/0000-0001-9711-6509	National Basic Research Program of China 973 Program [2011CB966302, 2011CB911104]; Chinese National Natural Science Foundation [30830031, 31170693]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 Program Grants 2011CB966302 and 2011CB911104 and by Chinese National Natural Science Foundation Grants 30830031 and 31170693.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Dore AS, 2006, DNA REPAIR, V5, P362, DOI 10.1016/j.dnarep.2005.11.004; Downey M, 2010, MOL CELL, V39, P162, DOI 10.1016/j.molcel.2010.07.007; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster ER, 2005, FEBS J, V272, P3231, DOI 10.1111/j.1742-4658.2005.04741.x; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Germann SM, 2011, DNA REPAIR, V10, P210, DOI 10.1016/j.dnarep.2010.11.001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Leung GP, 2011, J BIOL CHEM, V286, P26250, DOI 10.1074/jbc.M111.235200; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moore JD, 2007, GENETICS, V176, P15, DOI 10.1534/genetics.106.063792; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Scholes DT, 2001, GENETICS, V159, P1449; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JR, 1998, YEAST, V14, P565, DOI 10.1002/(SICI)1097-0061(19980430)14:6<565::AID-YEA251>3.0.CO;2-B; Ullal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020152; Watts FZ, 2010, DNA REPAIR, V9, P103, DOI 10.1016/j.dnarep.2009.10.010; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40	46	35	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9137	9146		10.1074/jbc.M111.311860	http://dx.doi.org/10.1074/jbc.M111.311860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262834	Green Published, hybrid			2022-12-27	WOS:000301797800043
J	Carter, AS; Tahmaseb, K; Compton, SA; Matson, SW				Carter, Annamarie S.; Tahmaseb, Kambiz; Compton, Sarah A.; Matson, Steven W.			Resolving Holliday Junctions with Escherichia coli UvrD Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK REVERSAL; NICKED CIRCULAR DNA; MISMATCH REPAIR; GENE-PRODUCT; II UVRD; RECOMBINATION PROTEINS; BRANCH MIGRATION; GENOME STABILITY; POLYMERASE-I; FULLY DUPLEX	The Escherichia coli UvrD helicase is known to function in the mismatch repair and nucleotide excision repair pathways and has also been suggested to have roles in recombination and replication restart. The primary intermediate DNA structure in these two processes is the Holliday junction. UvrD has been shown to unwind a variety of substrates including partial duplex DNA, nicked DNA, forked DNA structures, blunt duplex DNA and RNA-DNA hybrids. Here, we demonstrate that UvrD also catalyzes the robust unwinding of Holliday junction substrates. To characterize this unwinding reaction we have employed steady-state helicase assays, pre-steady-state rapid quench helicase assays, DNaseI footprinting, and electron microscopy. We conclude that UvrD binds initially to the junction compared with binding one of the blunt ends of the four-way junction to initiate unwinding and resolves the synthetic substrate into two double-stranded fork structures. We suggest that UvrD, along with its mismatch repair partners, MutS and MutL, may utilize its ability to unwind Holliday junctions directly in the prevention of homeologous recombination. UvrD may also be involved in the resolution of stalled replication forks by unwinding the Holliday junction intermediate to allow bypass of the blockage.	[Carter, Annamarie S.; Tahmaseb, Kambiz; Matson, Steven W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Carter, Annamarie S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Compton, Sarah A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			National Institutes of Health [GM33476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grant GM33476 (to S. W. M.).	ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Flores MJ, 2004, EMBO REP, V5, P983, DOI 10.1038/sj.embor.7400262; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; KUHN B, 1979, COLD SPRING HARB SYM, V43, P63, DOI 10.1101/SQB.1979.043.01.011; KUHN B, 1979, J BIOL CHEM, V254, P1343; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; LUNDBLAD V, 1985, GENETICS, V109, P3; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MAPLES VF, 1982, P NATL ACAD SCI-BIOL, V79, P5616, DOI 10.1073/pnas.79.18.5616; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; OEDA K, 1982, NATURE, V298, P98, DOI 10.1038/298098a0; Petranovic M, 2001, BIOCHIMIE, V83, P1041, DOI 10.1016/S0300-9084(01)01346-3; RADMAN M, 1995, PHILOS T ROY SOC B, V347, P97, DOI 10.1098/rstb.1995.0015; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P4128, DOI 10.1021/bi00066a039; Stambuk S, 1998, GENETICS, V150, P533; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; WASHBURN BK, 1993, J BACTERIOL, V175, P341, DOI 10.1128/JB.175.2.341-350.1993; WESSEL R, 1990, EUR J BIOCHEM, V189, P277, DOI 10.1111/j.1432-1033.1990.tb15487.x; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	50	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8126	8134		10.1074/jbc.M111.314047	http://dx.doi.org/10.1074/jbc.M111.314047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267744	Green Published, hybrid			2022-12-27	WOS:000301349400028
J	Jung, TY; Li, D; Park, JT; Yoon, SM; Tran, PL; Oh, BH; Janecek, S; Park, SG; Woo, EJ; Park, KH				Jung, Tae-Yang; Li, Dan; Park, Jong-Tae; Yoon, Se-Mi; Phuong Lan Tran; Oh, Byung-Ha; Janecek, Stefan; Park, Sung Goo; Woo, Eui-Jeon; Park, Kwan-Hwa			Association of Novel Domain in Active Site of Archaic Hyperthermophilic Maltogenic Amylase from Staphylothermus marinus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH-BINDING DOMAIN; VULGARIS R-47 ALPHA-AMYLASE-1; COMPLETE GENOME SEQUENCE; FAMILY 11 XYLANASE; ALPHA-AMYLASE; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; PYROCOCCUS-FURIOSUS; SUBSTRATE-BINDING; STRUCTURAL BASIS	Staphylothermus marinus maltogenic amylase (SMMA) is a novel extreme thermophile maltogenic amylase with an optimal temperature of 100 degrees C, which hydrolyzes alpha-(1-4)-glycosyl linkages in cyclodextrins and in linear malto-oligosaccharides. This enzyme has along N-terminal extension that is conserved among archaic hyperthermophilic amylases but is not found in other hydrolyzing enzymes from the glycoside hydrolase 13 family. The SMMA crystal structure revealed that the N-terminal extension forms an N' domain that is similar to carbohydrate-binding module 48, with the strand-loop-strand region forming a part of the substrate binding pocket with several aromatic residues, including Phe-95, Phe-96, andTyr-99. A structural comparison with conventional cyclodextrin-hydrolyzing enzymes revealed a striking resemblance between the SMMA N' domain position and the dimeric N domain position in bacterial enzymes. This result suggests that extremophilic archaea that live at high temperatures may have adopted a novel domain arrangement that combines all of the substrate binding components within a monomeric subunit. The SMMA structure provides a molecular basis for the functional properties that are unique to hyperthermophile malto-genic amylases from archaea and that distinguish SMMA from moderate thermophilic or mesophilic bacterial enzymes.	[Jung, Tae-Yang; Yoon, Se-Mi; Park, Sung Goo; Woo, Eui-Jeon] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea; [Jung, Tae-Yang; Oh, Byung-Ha] Korea Res Inst Biosci & Biotechnol, KAIST Inst BioCentury, Dept Biol Sci, Taejon 305701, South Korea; [Li, Dan] Changchun Univ, Dept Food Sci & Engn, Changchun 130022, Peoples R China; [Park, Jong-Tae] Chungnam Natl Univ, Dept Food Sci & Technol, Taejon 305764, South Korea; [Phuong Lan Tran; Park, Kwan-Hwa] Sangmyung Univ, Dept Food Serv Management & Nutr, Seoul 110743, South Korea; [Janecek, Stefan] Slovak Acad Sci, Inst Mol Biol, SK-84551 Bratislava, Slovakia; [Janecek, Stefan] Univ SS Cyril & Methodius, Fac Nat Sci, Dept Biotechnol, SK-91701 Trnava, Slovakia; [Woo, Eui-Jeon] Univ Sci & Technol, Dept Analyt Biosci, Taejon 305333, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Changchun University; Chungnam National University; Sang Myung University; Slovak Academy of Sciences; University of SS Cyril & Methodius Trnava	Woo, EJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea.	ejwoo@kribb.re.kr; parkkh@snu.ac.kr	Oh, Byung-Ha/C-2061-2011; Janecek, Stefan/J-4725-2014	Jung, Taeyang/0000-0003-3862-3433; Park, Jong-Tae/0000-0002-0650-6948; TRAN, PHUONG LAN/0000-0003-2667-6239; Woo, Eui-Jeon/0000-0001-6983-0270	Marine and Extreme Genome Research Center from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0083290/2011-0017040]; National Natural Science Foundation of China [31000760]; Slovak Grant Agency VEGA [2/0148/11]	Marine and Extreme Genome Research Center from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This research was supported in part by the Marine and Extreme Genome Research Center program from the Ministry of Land, Transport, and Maritime Affairs, Republic of Korea, and the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (Grants 2009-0083290/2011-0017040).; Supported by National Natural Science Foundation of China Grant 31000760.; Supported by Slovak Grant Agency VEGA Grant 2/0148/11.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Abe A, 2004, J MOL BIOL, V335, P811, DOI 10.1016/j.jmb.2003.10.078; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson I, 2008, J BACTERIOL, V190, P2957, DOI 10.1128/JB.01949-07; Arab H, 2000, INT J SYST EVOL MICR, V50, P2101, DOI 10.1099/00207713-50-6-2101; Auh JH, 2006, J AGR FOOD CHEM, V54, P2314, DOI 10.1021/jf051887r; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feese MD, 2000, J MOL BIOL, V301, P451, DOI 10.1006/jmbi.2000.3977; FIALA G, 1986, SYST APPL MICROBIOL, V8, P106, DOI 10.1016/S0723-2020(86)80157-6; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Georis J, 2000, PROTEIN SCI, V9, P466; Giardina T, 2001, J MOL BIOL, V313, P1149, DOI 10.1006/jmbi.2001.5097; Greaves RB, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-18; Greaves RB, 2009, BIOCHEM BIOPH RES CO, V380, P581, DOI 10.1016/j.bbrc.2009.01.145; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; IMANAKA T, 1989, J BACTERIOL, V171, P369, DOI 10.1128/jb.171.1.369-374.1989; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Katsuya Y, 1998, J MOL BIOL, V281, P885, DOI 10.1006/jmbi.1998.1992; Kawamura S, 1996, BIOCHEMISTRY-US, V35, P1195, DOI 10.1021/bi951581l; Kawashima T, 2000, P NATL ACAD SCI USA, V97, P14257, DOI 10.1073/pnas.97.26.14257; Kim TJ, 1999, APPL ENVIRON MICROB, V65, P1644; Kim TJ, 2001, BIOCHEMISTRY-US, V40, P14182, DOI 10.1021/bi015531u; Kim TJ, 2000, BIOCHEMISTRY-US, V39, P6773, DOI 10.1021/bi992575i; Kim YW, 2003, APPL ENVIRON MICROB, V69, P4866, DOI 10.1128/AEM.69.8.4866-4874.2003; Koay A, 2007, FEBS LETT, V581, P5055, DOI 10.1016/j.febslet.2007.09.044; Koay A, 2010, FEBS LETT, V584, P3499, DOI 10.1016/j.febslet.2010.07.015; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Li D, 2010, NEW BIOTECHNOL, V27, P300, DOI 10.1016/j.nbt.2010.04.001; Li XL, 2010, APPL MICROBIOL BIOT, V85, P1821, DOI 10.1007/s00253-009-2190-6; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Machovic M, 2006, CELL MOL LIFE SCI, V63, P2710, DOI 10.1007/s00018-006-6246-9; Machovic M, 2008, BIOLOGIA, V63, P1057, DOI 10.2478/s11756-008-0162-4; Marteinsson VT, 1999, INT J SYST BACTERIOL, V49, P351, DOI 10.1099/00207713-49-2-351; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Ohtaki A, 2006, CARBOHYD RES, V341, P1041, DOI 10.1016/j.carres.2006.01.029; Oslancova A, 2002, CELL MOL LIFE SCI, V59, P1945, DOI 10.1007/PL00012517; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; Park SH, 2007, BIOSCI BIOTECH BIOCH, V71, P1564, DOI 10.1271/bbb.70017; Penninga D, 1996, J BIOL CHEM, V271, P32777, DOI 10.1074/jbc.271.51.32777; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Robb FT, 2001, METHOD ENZYMOL, V330, P134; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner P, 2005, BIOLOGIA, V60, P79; Unsworth LD, 2007, FEBS J, V274, P4044, DOI 10.1111/j.1742-4658.2007.05954.x; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkov I. Yu., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P499; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Yang SJ, 2004, APPL ENVIRON MICROB, V70, P5988, DOI 10.1128/AEM.70.10.5988-5995.2004; You C, 2010, BIOTECHNOL BIOENG, V105, P861, DOI 10.1002/bit.22623	72	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7979	7989		10.1074/jbc.M111.304774	http://dx.doi.org/10.1074/jbc.M111.304774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22223643	hybrid, Green Published			2022-12-27	WOS:000301349400014
J	Cote, M; Zheng, YM; Li, K; Xiang, SH; Albritton, LM; Liu, SL				Cote, Marceline; Zheng, Yi-Min; Li, Kun; Xiang, Shi-Hua; Albritton, Lorraine M.; Liu, Shan-Lu			Critical Role of Leucine-Valine Change in Distinct Low pH Requirements for Membrane Fusion between Two Related Retrovirus Envelopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAAGSIEKTE SHEEP RETROVIRUS; NASAL TUMOR-VIRUS; INFECTIOUS-ANEMIA VIRUS; MURINE LEUKEMIA-VIRUS; ONCOGENIC TRANSFORMATION; CELL ENTRY; RODENT FIBROBLASTS; HISTIDINE-RESIDUES; COMPLETE SEQUENCE; RECEPTOR HYAL2	Many viruses use a pH-dependent pathway for fusion with host cell membrane, the mechanism of which is still poorly understood. Here we report that a subtle leucine (Leu)-valine (Val) change at position 501 in the envelope glycoproteins (Envs) of two related retroviruses, jaagsiekte sheep retrovirus (JSRV) and enzootic nasal tumor virus (ENTV), is responsible for their distinct low pH requirements for membrane fusion and infection. The Leu and Val residues are predicted to reside within the C-terminal heptad repeat (HR2) region of JSRV and ENTV Envs, particularly proximal to the hairpin turn of the putative six-helix bundle (6HB). Substitution of the JSRV Leu with a Val blocked the Env-mediated membrane fusion at pH 5.0, whereas replacement of the ENTV Val with a Leu rendered the ENTV Env capable of fusing at pH 5.0. ALeu-Val change has no apparent effect on the stability of native Env, but appears to stabilize an intermediate induced by receptor binding. These results are consistent with the existence of at least two metastable conformations of these viral glycoproteins, the native prefusion conformation and a receptor-induced metastable intermediate. Collectively, this work represents an interesting perhaps unique example whereby a simple Leu-Val change has critical impact on pH-dependent virus fusion and entry.	[Zheng, Yi-Min; Li, Kun; Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Cote, Marceline; Liu, Shan-Lu] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Xiang, Shi-Hua] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Albritton, Lorraine M.] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Missouri System; University of Missouri Columbia; McGill University; University of Nebraska System; University of Nebraska Lincoln; University of Tennessee System; University of Tennessee Health Science Center	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	liushan@missouri.edu	Li, Kun/E-5255-2017; Cote, Marceline/AAA-6386-2021; Liu, Shan-Lu/L-5923-2016	Li, Kun/0000-0002-8582-2913; Liu, Shan-Lu/0000-0003-1620-3817	National Institutes of Health Public Health Service [R01CA081171]; Canadian Institutes of Health Research; University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de la Recherche en Sante du Quebec (FRSQ); NATIONAL CANCER INSTITUTE [R01CA081171] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant R01CA081171 (to L. M. A.), the Canadian Institutes of Health Research, and a fund from the University of Missouri at Columbia (to S.-L. L.).; Supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Fonds de la Recherche en Sante du Quebec (FRSQ). Present address: Dept. of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.	Allen TE, 2002, J GEN VIROL, V83, P2733, DOI 10.1099/0022-1317-83-11-2733; Arnaud F, 2007, PLOS PATHOG, V3, P1716, DOI 10.1371/journal.ppat.0030170; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Coffin J, 1997, RETROVIRUSES; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cosset FL, 2011, ADV GENET, V73, P121, DOI 10.1016/B978-0-12-380860-8.00004-5; Cote M, 2008, J VIROL, V82, P9023, DOI 10.1128/JVI.00648-08; Cote M, 2008, J VIROL, V82, P2543, DOI 10.1128/JVI.01852-07; Cote M, 2011, VIROLOGY, V421, P173, DOI 10.1016/j.virol.2011.09.022; Cote M, 2009, J VIROL, V83, P11447, DOI 10.1128/JVI.00748-09; Cousens C, 1999, J VIROL, V73, P3986, DOI 10.1128/JVI.73.5.3986-3993.1999; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Delos SE, 2010, J VIROL, V84, P5687, DOI 10.1128/JVI.02583-09; DeMartini JC, 2001, J VIROL, V75, P4239, DOI 10.1128/JVI.75.9.4239-4246.2001; Dirks C, 2002, J VIROL, V76, P2141, DOI 10.1128/JVI.76.5.2141-2149.2002; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; FAN H, 2003, CURRENT TOPICS MICRO, V275; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jin S, 2005, J VIROL, V79, P14489, DOI 10.1128/JVI.79.23.14489-14497.2005; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Liu SL, 2007, ONCOGENE, V26, P789, DOI 10.1038/sj.onc.1209850; Liu SL, 2003, J VIROL, V77, P2850, DOI 10.1128/JVI.77.5.2850-2858.2003; Liu T, 1997, PROTEIN SCI, V6, P1937, DOI 10.1002/pro.5560060914; Maeda N, 2001, P NATL ACAD SCI USA, V98, P4449, DOI 10.1073/pnas.071547598; Markosyan RM, 2009, J VIROL, V83, P10048, DOI 10.1128/JVI.00316-09; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; NUSSBAUM O, 1993, J VIROL, V67, P7402, DOI 10.1128/JVI.67.12.7402-7405.1993; Ortin A, 2003, J GEN VIROL, V84, P2245, DOI 10.1099/vir.0.19125-0; Palmarini M, 2000, J VIROL, V74, P8065, DOI 10.1128/JVI.74.17.8065-8076.2000; Qin ZL, 2009, J VIROL, V83, P4670, DOI 10.1128/JVI.02646-08; Rachakonda PS, 2007, FASEB J, V21, P995, DOI 10.1096/fj.06-7052hyp; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; REDMOND S, 1984, VIROLOGY, V133, P393, DOI 10.1016/0042-6822(84)90405-7; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Van Hoeven NS, 2005, J VIROL, V79, P87, DOI 10.1128/JVI.79.1.87-94.2005; Walsh SR, 2010, VIRUS RES, V151, P74, DOI 10.1016/j.virusres.2010.04.002; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wootton SK, 2006, J VIROL, V80, P9322, DOI 10.1128/JVI.00865-06; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10	54	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7640	7651		10.1074/jbc.M111.334722	http://dx.doi.org/10.1074/jbc.M111.334722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235118	hybrid, Green Published			2022-12-27	WOS:000301060200063
J	Mayer, C; Slater, L; Erat, MC; Konrat, R; Vakonakis, I				Mayer, Christina; Slater, Leanne; Erat, Michele C.; Konrat, Robert; Vakonakis, Ioannis			Structural Analysis of the Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Intracellular Domain Reveals a Conserved Interaction Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH PROTEIN; VAR GENES; CYTOADHERENCE; LIGAND; BINDING	Plasmodium falciparum-infected red blood cells adhere to endothelial cells, thereby obstructing the microvasculature. Erythrocyte adherence is directly associated with severe malaria and increased disease lethality, and it is mediated by the PfEMP1 family. PfEMP1 clustering in knob-like protrusions on the erythrocyte membrane is critical for cytoadherence, however the molecular mechanisms behind this system remain elusive. Here, we show that the intracellular domains of the PfEMP1 family (ATS) share a unique molecular architecture, which comprises a minimal folded core and extensive flexible elements. A conserved flexible segment at the ATS center is minimally restrained by the folded core. Yeast-two-hybrid data and a novel sequence analysis method suggest that this central segment contains a conserved protein interaction epitope. Interestingly, ATS in solution fails to bind the parasite knob-associated histidine-rich protein (KAHRP), an essential cytoadherence component. Instead, we demonstrate that ATS associates with PFI1780w, a member of the Plasmodium helical interspersed sub-telomeric (PHIST) family. PHIST domains are widespread in exported parasite proteins, however this is the first specific molecular function assigned to any variant of this family. We propose that PHIST domains facilitate protein interactions, and that the conserved ATS epitope may be targeted to disrupt the parasite cytoadherence system.	[Mayer, Christina; Slater, Leanne; Erat, Michele C.; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Konrat, Robert] Univ Vienna, Dept Biomol Struct Chem, A-1030 Vienna, Austria	University of Oxford; University of Vienna	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Wellcome Trust; Marie Curie Fellowships programme (FP7); Royal Society	Wellcome Trust(Wellcome Trust); Marie Curie Fellowships programme (FP7); Royal Society(Royal Society of London)	This work was supported by the Wellcome Trust (to C. M. and I. V.) and the Marie Curie Fellowships programme (FP7) and the Royal Society (to M. C. E.).	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bonnefoy S, 2008, CELL, V134, P20, DOI 10.1016/j.cell.2008.06.040; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hora R, 2009, J BIOL CHEM, V284, P6260, DOI 10.1074/jbc.M809756200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Narang P, 2005, PHYS CHEM CHEM PHYS, V7, P2364, DOI 10.1039/b502226f; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Platzer G, 2011, BIOCHEMISTRY-US, V50, P6113, DOI 10.1021/bi200291e; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	28	46	46	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7182	7189		10.1074/jbc.M111.330779	http://dx.doi.org/10.1074/jbc.M111.330779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249178	hybrid, Green Published			2022-12-27	WOS:000301060200021
J	Pasquier, J; Galas, L; Boulange-Lecomte, C; Rioult, D; Bultelle, F; Magal, P; Webb, G; Le Foll, F				Pasquier, Jennifer; Galas, Ludovic; Boulange-Lecomte, Celine; Rioult, Damien; Bultelle, Florence; Magal, Pierre; Webb, Glenn; Le Foll, Frank			Different Modalities of Intercellular Membrane Exchanges Mediate Cell-to-cell P-glycoprotein Transfers in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACQUIRED MULTIDRUG-RESISTANCE; EPIGENETIC CHANGES; DRUG-RESISTANCE; BCRP ABCG2; EXPRESSION; AMPLIFICATION; GENE; MDR1; DOXORUBICIN; INDUCTION	Multi-drug resistance (MDR) is a phenomenon by which tumor cells exhibit resistance to a variety of chemically unrelated chemotherapeutic drugs. The classical form of multidrug resistance is connected to overexpression of membrane P-glycoprotein (P-gp), which acts as an energy dependent drug efflux pump. P-glycoprotein expression is known to be controlled by genetic and epigenetic mechanisms. Until now processes of P-gp gene up-regulation and resistant cell selection were considered sufficient to explain the emergence of MDR phenotype within a cell population. Recently, however, "non-genetic" acquisitions of MDR by cell-to-cell P-gp transfers have been pointed out. In the present study we show that intercellular transfers of functional P-gp occur by two different but complementary modalities through donor-recipient cells interactions in the absence of drug selection pressure. P-glycoprotein and drug efflux activity transfers were followed over 7 days by confocal microscopy and flow cytometry in drug-sensitive parental MCF-7 breast cancer cells co-cultured with P-gp overexpressing resistant variants. An early process of remote transfer was established based on the release and binding of P-gp-containing microparticles. Microparticle-mediated transfers were detected after only 4 h of incubation. We also identify an alternative mode of transfer by contact, consisting of cell-to-cell P-gp trafficking by tunneling nanotubes bridging neighboring cells. Our findings supply new mechanistic evidences for the extragenetic emergence of MDR in cancer cells and indicate that new treatment strategies designed to overcome MDR may include inhibition of both microparticles and Tunneling nanotube-mediated intercellular P-gp transfers.	[Pasquier, Jennifer; Boulange-Lecomte, Celine; Rioult, Damien; Bultelle, Florence; Le Foll, Frank] Univ Le Havre, Lab Ecotoxicol, F-76058 Le Havre, France; [Pasquier, Jennifer; Galas, Ludovic] Univ Rouen, IRIB, INSERM, PRIMACEN, F-76821 Mont St Aignan, France; [Magal, Pierre] Univ Bordeaux, UMR CNRS 5251, IMB, F-33076 Bordeaux, France; [Magal, Pierre] Univ Bordeaux, INRIA Sud Ouest Anubis, F-33076 Bordeaux, France; [Webb, Glenn] Vanderbilt Univ, Stevenson Ctr, Dept Math, Nashville, TN 37240 USA	Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University	Le Foll, F (corresponding author), Univ Le Havre, Lab Ecotoxicol, F-76058 Le Havre, France.	frank.lefoll@univ-lehavre.fr	Webb, Glenn/AAW-7228-2021; galas, ludovic/A-2500-2014	Le Foll, Frank/0000-0002-9585-9250; Boulange-Lecomte, Celine/0000-0002-2461-7473; magal, pierre/0000-0002-4776-0061; Pasquier, Jennifer/0000-0002-2465-7942	European Regional Development Fund	European Regional Development Fund(European Commission)	This work was supported by European Regional Development Fund as part of the Interreg IVA project Admin (Trans-Channel Advanced Microscopy network).	Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; BELLI JA, 1990, CANCER RES, V50, P2191; Callaghan R, 2008, J CLIN PHARMACOL, V48, P365, DOI 10.1177/0091270007311568; Chekhun VF, 2006, CANCER LETT, V231, P87, DOI 10.1016/j.canlet.2005.01.038; Choi CH, 1999, MOL CELLS, V9, P314; Demeule M, 1999, AM J PHYSIOL-RENAL, V277, pF832, DOI 10.1152/ajprenal.1999.277.6.F832; Fojo T, 2007, DRUG RESIST UPDATE, V10, P59, DOI 10.1016/j.drup.2007.02.002; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hawkins BT, 2010, J CEREBR BLOOD F MET, V30, P1593, DOI 10.1038/jcbfm.2010.117; Hawkins BT, 2010, J NEUROSCI, V30, P1417, DOI 10.1523/JNEUROSCI.5103-09.2010; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KLIMECKI WT, 1994, BLOOD, V83, P2451; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; LEIGHTON JC, 1995, HEMATOL ONCOL CLIN N, V9, P251, DOI 10.1016/S0889-8588(18)30095-9; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Marin M, 2005, BIOCHEM BIOPH RES CO, V334, P1266, DOI 10.1016/j.bbrc.2005.07.010; Meesungnoen J, 2002, CAN J PHYSIOL PHARM, V80, P1054, DOI 10.1139/Y02-132; Mizutani T, 2008, CURR DRUG METAB, V9, P167, DOI 10.2174/138920008783571756; Nieth C, 2005, J CHEMOTHERAPY, V17, P215, DOI 10.1179/joc.2005.17.2.215; Oleinikov VA, 2006, FEBS LETT, V580, P4953, DOI 10.1016/j.febslet.2006.07.069; Pajic M, 2004, ONCOL REP, V11, P1091; Pasquier J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-5; PASTAN I, 1987, NEW ENGL J MED, V316, P1388; Rafii A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003894; Reed K, 2008, EPIGENETICS-US, V3, P270, DOI 10.4161/epi.3.5.6868; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9; Shedden K, 2003, CANCER RES, V63, P4331; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	44	101	103	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7374	7387		10.1074/jbc.M111.312157	http://dx.doi.org/10.1074/jbc.M111.312157			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228759	Green Published, hybrid			2022-12-27	WOS:000301060200039
J	Nakano, T; Ouchi, R; Kawazoe, J; Pack, SP; Makino, K; Ide, H				Nakano, Toshiaki; Ouchi, Ryo; Kawazoe, Junya; Pack, Seung Pil; Makino, Keisuke; Ide, Hiroshi			T7 RNA Polymerases Backed up by Covalently Trapped Proteins Catalyze Highly Error Prone Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; II ELONGATION COMPLEX; CROSS-LINKS; ESCHERICHIA-COLI; DNA-DAMAGE; MECHANISM; INITIATION; MISINCORPORATION; OXANINE; STRAND	RNA polymerases (RNAPs) transcribe genes through the barrier of nucleoproteins and site-specific DNA-binding proteins on their own or with the aid of accessory factors. Proteins are often covalently trapped on DNA by DNA damaging agents, forming DNA-protein cross-links (DPCs). However, little is known about how immobilized proteins affect transcription. To elucidate the effect of DPCs on transcription, we constructed DNA templates containing site-specific DPCs and performed in vitro transcription reactions using phage T7 RNAP. We show here that DPCs constitute strong but not absolute blocks to in vitro transcription catalyzed by T7 RNAP. More importantly, sequence analysis of transcripts shows that RNAPs roadblocked not only by DPCs but also by the stalled leading RNAP become highly error prone and generate mutations in the upstream intact template regions. This contrasts with the transcriptional mutations induced by conventional DNA lesions, which are delivered to the active site or its proximal position in RNAPs and cause direct misincorporation. Our data also indicate that the trailing RNAP stimulates forward translocation of the stalled leading RNAP, promoting the translesion bypass of DPCs. The present results provide new insights into the transcriptional fidelity and mutual interactions of RNAPs that encounter persistent roadblocks.	[Nakano, Toshiaki; Ouchi, Ryo; Kawazoe, Junya; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Pack, Seung Pil] Korea Univ, Dept Biotechnol & Bioinformat, Jochiwon 339700, Chungnam, South Korea; [Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan	Hiroshima University; Korea University; Kyoto University	Ide, H (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.	ideh@hiroshima-u.ac.jp	Ide, Hiroshi/G-9042-2019	Nakano, Toshiaki/0000-0002-5274-2909	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; National Research Foundation of Korea; Ministry of Education, Science and Technology of Korea [2010-0010110]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a Grant-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H.I.), Grants-in-aid for Scientific Research (B) (to H.I.) and for Young Scientists (B) (to T.N.) from the Japan Society for the Promotion of Science, and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea (2010-0010110; to S.P.P.).	Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; BLANK A, 1986, BIOCHEMISTRY-US, V25, P5920, DOI 10.1021/bi00368a013; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brueckner F, 2009, ACTA CRYSTALLOGR D, V65, P112, DOI 10.1107/S0907444908039875; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; DEMERCOYROL L, 1992, EUR J BIOCHEM, V206, P49, DOI 10.1111/j.1432-1033.1992.tb16900.x; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Guo Q, 2006, J MOL BIOL, V358, P241, DOI 10.1016/j.jmb.2006.02.001; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; IKEDA RA, 1986, P NATL ACAD SCI USA, V83, P3614, DOI 10.1073/pnas.83.11.3614; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Kubori T, 1997, NUCLEIC ACIDS RES, V25, P2640, DOI 10.1093/nar/25.13.2640; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Nakano T, 2005, NUCLEIC ACIDS RES, V33, P2181, DOI 10.1093/nar/gki513; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Pack SP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm619; Pack SP, 2005, NUCLEIC ACIDS RES, V33, P5771, DOI 10.1093/nar/gki865; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Wang D, 2010, P NATL ACAD SCI USA, V107, P9584, DOI 10.1073/pnas.1002565107; ZHOU W, 1995, CELL, V82, P577, DOI 10.1016/0092-8674(95)90030-6; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	45	40	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6562	6572		10.1074/jbc.M111.318410	http://dx.doi.org/10.1074/jbc.M111.318410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235136	hybrid, Green Published			2022-12-27	WOS:000300791800044
J	Nykanen, NP; Kysenius, K; Sakha, P; Tammela, P; Huttunen, HJ				Nykanen, Niko-Petteri; Kysenius, Kai; Sakha, Prasanna; Tammela, Paivi; Huttunen, Henri J.			gamma-Aminobutyric Acid Type A (GABA(A)) Receptor Activation Modulates Tau Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; PROLYL ISOMERASE PIN1; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; MOUSE-BRAIN; IN-VITRO; PROTEIN; INHIBITION; NEURODEGENERATION	Abnormal phosphorylation and aggregation of the microtubule-associated protein Tau are hallmarks of various neurodegenerative diseases, such as Alzheimer disease. Molecular mechanisms that regulate Tau phosphorylation are complex and currently incompletely understood. We have developed a novel live cell reporter system based on protein-fragment complementation assay to study dynamic changes in Tau phosphorylation status. In this assay, fusion proteins of Tau and Pin1 (peptidyl-prolyl cis-trans-isomerase 1) carrying complementary fragments of a luciferase protein serve as a sensor of altered protein-protein interaction between Tau and Pin1, a critical regulator of Tau dephosphorylation at several disease-associated proline-directed phosphorylation sites. Using this system, we identified several structurally distinct GABA(A) receptor modulators as novel regulators of Tau phosphorylation in a chemical library screen. GABA(A) receptor activation promoted specific phosphorylation of Tau at the AT8 epitope (Ser-199/Ser-202/Thr-205) in cultures of mature cortical neurons. Increased Tau phosphorylation by GABA(A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3 beta kinase activity.	[Nykanen, Niko-Petteri; Kysenius, Kai; Sakha, Prasanna; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, Fac Pharm, FIN-00014 Helsinki, Finland; [Tammela, Paivi] Univ Helsinki, Ctr Drug Res, Fac Pharm, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, Fac Pharm, POB 56,Viikinkaari 4, FIN-00014 Helsinki, Finland.	Henri.Huttunen@helsinki.fi	Kysenius, Kai/U-6388-2019; Tammela, Päivi/A-4670-2010	Tammela, Päivi/0000-0003-4697-8066; Kysenius, Kai/0000-0003-1038-2850; Huttunen, Henri/0000-0002-9867-4438; Nykanen, Niko-Petteri/0000-0002-3489-1441	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; European Union [206918]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission)	This work was supported by grants from the Academy of Finland, Sigrid Juselius Foundation, Biocentrum Helsinki, and Finnish Cultural Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under Grant Agreement 206918. H. J. H. is a cofounder, employee and shareholder of Hermo Pharma Ltd.	Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARALDI M, 1979, SCIENCE, V205, P821, DOI 10.1126/science.462192; Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Busceti CL, 2008, J NEUROSCI, V28, P3234, DOI 10.1523/JNEUROSCI.0159-08.2008; Charney DS., 2005, GOODMAN GILMANS PHAR, P401; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Galas MC, 2006, J BIOL CHEM, V281, P19296, DOI 10.1074/jbc.M601849200; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kato-Negishi M, 2004, DEV BRAIN RES, V152, P99, DOI 10.1016/j.devbrainres.2004.05.013; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lebel M, 2011, SYNAPSE, V65, P69, DOI 10.1002/syn.20818; Lebel M, 2009, NEUROPHARMACOLOGY, V57, P392, DOI 10.1016/j.neuropharm.2009.06.041; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; PELECH SL, 1995, NEUROBIOL AGING, V16, P247, DOI 10.1016/0197-4580(94)00187-6; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Saito M, 2010, NEUROCHEM RES, V35, P651, DOI 10.1007/s11064-009-0116-4; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Wagner U, 1996, J CELL SCI, V109, P1537; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	58	32	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6743	6752		10.1074/jbc.M111.309385	http://dx.doi.org/10.1074/jbc.M111.309385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235112	Green Published, hybrid			2022-12-27	WOS:000300791800060
J	Steichen, JM; Kuchinskas, M; Keshwani, MM; Yang, J; Adams, JA; Taylor, SS				Steichen, Jon M.; Kuchinskas, Michael; Keshwani, Malik M.; Yang, Jie; Adams, Joseph A.; Taylor, Susan S.			Structural Basis for the Regulation of Protein Kinase A by Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; MECHANISM; AUTOPHOSPHORYLATION; DOMAIN; EXCHANGE; BINDING; SITES; MODEL	The catalytic subunit of cAMP-dependent protein kinase (PKA) is a member of the AGC group of protein kinases. Whereas PKA has served as a structural model for the protein kinase superfamily, all previous structures of the catalytic subunit contain a phosphorylated activation loop. To understand the structural effects of activation loop phosphorylation at Thr-197 we used a PKA mutant that does not autophosphorylate at Thr-197. The enzyme crystallized in the apo-state, and the structure was solved to 3.0 angstrom. The N-lobe is rotated by 18 relative to the wild-type apoenzyme, which illustrates that the enzyme likely exists in a wide range of conformations in solution due to the uncoupling of the N- and C-lobes. Several regions of the protein including the activation loop are disordered in the structure, and there are alternate main chain conformations for the magnesium positioning loop and catalytic loop causing a complete loss of hydrogen bonding between these two active site structural elements. These alterations are reflected in a 20-fold decrease in the apparent phosphoryl transfer rate as measured by pre-steady-state kinetic methods.	[Steichen, Jon M.; Kuchinskas, Michael; Yang, Jie; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Adams, Joseph A.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [GM19301]; University of California San Diego through National Institutes of Health from the NIGMS [T32 GM007752]; Ruth L. Kirschstein National Research Service [NIH/NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R37GM019301, R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego through National Institutes of Health from the NIGMS; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM19301 (to S. S. T.). This work was also supported by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from the NIGMS (to J. M. S.) and by Ruth L. Kirschstein National Research Service Award NIH/NCI T32 CA009523 (to J. M. S. and M. K.).	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626	31	65	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14672	14680		10.1074/jbc.M111.335091	http://dx.doi.org/10.1074/jbc.M111.335091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334660	Green Published, hybrid			2022-12-27	WOS:000304003200033
J	Guiet, R; Verollet, C; Lamsoul, I; Cougoule, C; Poincloux, R; Labrousse, A; Calderwood, DA; Glogauer, M; Lutz, PG; Maridonneau-Parini, I				Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Calderwood, David A.; Glogauer, Michael; Lutz, Pierre G.; Maridonneau-Parini, Isabelle			Macrophage Mesenchymal Migration Requires Podosome Stabilization by Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL MIGRATION; ACTIN REORGANIZATION; PLASMA-MEMBRANE; PHOSPHORYLATION; TRIGGERS; DOMAINS; BINDING; HCK; ORGANIZATION; ARCHITECTURE	Filamin A (FLNa) is a cross-linker of actin filaments and serves as a scaffold protein mostly involved in the regulation of actin polymerization. It is distributed ubiquitously, and null mutations have strong consequences on embryonic development in humans, with organ defects which suggest deficiencies in cell migration. We have reported previously that macrophages, the archetypal migratory cells, use the protease-and podosome-dependent mesenchymal migration mode in dense three-dimensional environments, whereas they use the protease- and podosome-independent amoeboid mode in more porous matrices. Because FLNa has been shown to localize to podosomes, we hypothesized that the defects seen in patients carrying FLNa mutations could be related to the capacity of certain cell types to form podosomes. Using strategies based on FLNa knock-out, knockdown, and rescue, we show that FLNa (i) is involved in podosome stability and their organization as rosettes and three-dimensional podosomes, (ii) regulates the proteolysis of the matrix mediated by podosomes in macrophages, (iii) is required for podosome rosette formation triggered by Hck, and (iv) is necessary for mesenchymal migration but dispensable for amoeboid migration. These new functions assigned to FLNa, particularly its role in mesenchymal migration, could be directly related to the defects in cell migration described during the embryonic development in FLNa-defective patients.	[Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Lutz, Pierre G.; Maridonneau-Parini, Isabelle] CNRS, IPBS, UMR 5089, Toulouse, France; [Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Lutz, Pierre G.; Maridonneau-Parini, Isabelle] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol & Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Glogauer, Michael] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Yale University; Yale University; University of Toronto	Maridonneau-Parini, I (corresponding author), CNRS, IPBS, UMR 5089, 205 Route Narbonne, Toulouse, France.	Isabelle.Maridonneau-Parini@ipbs.fr	COUGOULE, Céline/ABB-4180-2021; Glogauer, Michael/D-2504-2011; Poincloux, Renaud/AAD-4746-2019; Maridonneau-Parini, Isabelle/F-1985-2011; Calderwood, David A/AAC-6954-2019; Lutz, Pierre/B-8822-2009	Poincloux, Renaud/0000-0003-2884-1744; Calderwood, David A/0000-0002-0791-4142; Lamsoul, Isabelle/0000-0002-7769-5627; Glogauer, Michael/0000-0002-6248-5977; Labrousse, Arnaud/0000-0002-6525-6627; Maridonneau-Parini, Isabelle/0000-0003-0189-0976; Lutz, Pierre/0000-0003-0590-9101; Verollet, Christel/0000-0002-1079-9085	ARC [2010-120-1733, 8505]; ANR [2010-01301]; Fondation pour la Recherche Medicale; Sidaction; National Institutes of Health [GM068600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Sidaction; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by ARC 2010-120-1733, ARC Equipement 8505, and ANR 2010-01301.; Supported by Fondation pour la Recherche Medicale.; Supported by Sidaction.; Supported by National Institutes of Health Grant GM068600.	Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Camilli TC, 2011, PIGM CELL MELANOMA R, V24, P175, DOI 10.1111/j.1755-148X.2010.00792.x; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; Cejudo-Martin P, 2011, GENESIS, V49, P209, DOI 10.1002/dvg.20732; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Huttenlocher A, 2011, COLD SPRING HARB PER, V3; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Labernadie A, 2010, P NATL ACAD SCI USA, V107, P21016, DOI 10.1073/pnas.1007835107; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Leung R, 2010, J BONE MINER RES, V25, P1077, DOI 10.1359/jbmr.091114; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Lu J, 2005, EPILEPSY BEHAV, V7, P143, DOI 10.1016/j.yebeh.2005.05.001; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Poincloux R, 2007, J CELL PHYSIOL, V213, P212, DOI 10.1002/jcp.21112; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; Verollet C, 2010, J IMMUNOL, V184, P7030, DOI 10.4049/jimmunol.0903345; Vincent C, 2007, J BIOL CHEM, V282, P19565, DOI 10.1074/jbc.M701501200; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	53	61	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13051	13062		10.1074/jbc.M111.307124	http://dx.doi.org/10.1074/jbc.M111.307124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334688	hybrid, Green Published			2022-12-27	WOS:000302903700046
J	Xu, YB; Moeller, A; Jun, SY; Le, M; Yoon, BY; Kim, JS; Lee, K; Ha, NC				Xu, Yongbin; Moeller, Arne; Jun, So-Young; Le, Minho; Yoon, Bo-Young; Kim, Jin-Sik; Lee, Kangseok; Ha, Nam-Chul			Assembly and Channel Opening of Outer Membrane Protein in Tripartite Drug Efflux Pumps of Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; FUSION PROTEIN; PERIPLASMIC COMPONENT; TIP REGION; TOLC; TRANSPORTER; DOMAIN; RESISTANCE; HAIRPIN	Gram-negative bacteria are capable of expelling diverse xenobiotic substances from within the cell by use of three-component efflux pumps in which the energy-activated inner membrane transporter is connected to the outer membrane channel protein via the membrane fusion protein. In this work, we describe the crystal structure of the membrane fusion protein MexA from the Pseudomonas aeruginosa MexAB-OprM pump in the hexameric ring arrangement. Electron microscopy study on the chimeric complex of MexA and the outer membrane protein OprM reveals that MexA makes a tip-to-tip interaction with OprM, which suggests a docking model for MexA and OprM. This docking model agrees well with genetic results and depicts detailed interactions. Opening of the OprM channel is accompanied by the simultaneous exposure of a protein structure resembling a six-bladed cogwheel, which intermeshes with the complementary cogwheel structure in the MexA hexamer. Taken together, we suggest an assembly and channel opening model for the MexAB-OprM pump. This study provides a better understanding of multidrug resistance in Gram-negative bacteria.	[Le, Minho; Lee, Kangseok] Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea; [Xu, Yongbin; Jun, So-Young; Yoon, Bo-Young; Kim, Jin-Sik; Ha, Nam-Chul] Pusan Natl Univ, Coll Pharm, Dept Mfg Pharm, Pusan 609735, South Korea; [Xu, Yongbin; Jun, So-Young; Yoon, Bo-Young; Kim, Jin-Sik; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Pusan 609735, South Korea; [Moeller, Arne] Scripps Res Inst, La Jolla, CA 92037 USA	Chung Ang University; Pusan National University; Pusan National University; Scripps Research Institute	Lee, K (corresponding author), Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr		Moeller, Arne/0000-0003-1101-5366	National Research Foundation of Korea [NRF-2009-0072268]; National Institutes of Health [P50 GM073197]; National Institutes of Health though the National Center for Research Resources [RR17573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health though the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Research Foundation of Korea Grant NRF-2009-0072268 (to N.-C. H.). This work made use of beamline NW3A at Photon Factory (Tsukuba, Japan).; Supported by National Institutes of Health Roadmap Award P50 GM073197.; We thank Pohang Accelerator Laboratory (Pohang, Korea) for help with data processing. Electron microscopy imaging was performed at the National Resource for Automated Molecular Microscopy, which was supported by the National Institutes of Health though the National Center for Research Resources P41 Program RR17573.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Ge Q, 2009, J BACTERIOL, V191, P4365, DOI 10.1128/JB.00204-09; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Husain F, 2004, J BACTERIOL, V186, P8533, DOI 10.1128/JB.186.24.8533-8536.2004; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; Janganan TK, 2011, J BIOL CHEM, V286, P5484, DOI 10.1074/jbc.M110.187658; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Kim S, 2008, J MICROBIOL BIOTECHN, V18, P845; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; LEDUC M, 1989, J GEN MICROBIOL, V135, P1243; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Marcyjaniak M, 2004, J BIOL CHEM, V279, P43982, DOI 10.1074/jbc.M406735200; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Modali SD, 2011, MOL MICROBIOL, V81, P937, DOI 10.1111/j.1365-2958.2011.07744.x; MORSHED SRM, 1995, BIOCHEM BIOPH RES CO, V210, P356, DOI 10.1006/bbrc.1995.1669; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Otwinosky Z., 1997, METHODS ENZYMOLOGY A, V276; Piao S, 2008, ACTA CRYSTALLOGR F, V64, P391, DOI 10.1107/S1744309108008701; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stegmeier JF, 2006, BIOCHEMISTRY-US, V45, P10303, DOI 10.1021/bi060320g; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2011, CHEM BIOL, V18, P454, DOI 10.1016/j.chembiol.2011.02.011; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Trepout S, 2007, EUR BIOPHYS J BIOPHY, V36, P1029, DOI 10.1007/s00249-007-0208-5; Trepout S, 2010, BBA-BIOMEMBRANES, V1798, P1953, DOI 10.1016/j.bbamem.2010.06.019; Xu Y, 2011, J BIOL CHEM, V286, P17910, DOI 10.1074/jbc.M111.238535; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00189; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x	55	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11740	11750		10.1074/jbc.M111.329375	http://dx.doi.org/10.1074/jbc.M111.329375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22308040	Green Published, hybrid			2022-12-27	WOS:000302782200013
J	Nobumori, Y; Shouse, GP; Fan, L; Liu, X				Nobumori, Yumiko; Shouse, Geoffrey P.; Fan, Li; Liu, Xuan			HEAT Repeat 1 Motif Is Required for B56 gamma-containing Protein Phosphatase 2A (B56 gamma-PP2A) Holoenzyme Assembly and Tumor-suppressive Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; C-MYC; CANCER; ALPHA; GENE; TRANSFORMATION; MUTATIONS; COMPLEXES; P53	Background: How HEAT repeats contribute to PP2A assembly and function was unknown. Results: A tumor-associated mutation within HEAT repeat 1 disrupts PP2A function. Conclusion: HEAT repeat 1 is required for B56 gamma-PP2A assembly and tumor-suppressive function. Significance: This work provides structural insights into HEAT repeats and illuminates a mechanism to inactivate B56 gamma-PP2A.	[Nobumori, Yumiko; Shouse, Geoffrey P.; Fan, Li; Liu, Xuan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Liu, X (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	xuan.liu@ucr.edu		Shouse, Geoffrey/0000-0002-7917-5713	National Institutes of Health [CA0751]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA0751 (to X.L.).	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; McCright B, 1996, GENOMICS, V36, P168, DOI 10.1006/geno.1996.0438; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	20	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11030	11036		10.1074/jbc.M111.334094	http://dx.doi.org/10.1074/jbc.M111.334094			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315229	hybrid, Green Published			2022-12-27	WOS:000302780100031
J	Dong, Y; He, YW; de Boer, L; Stack, MS; Lumley, JW; Clements, JA; Hooper, JD				Dong, Ying; He, Yaowu; de Boer, Leonore; Stack, M. Sharon; Lumley, John W.; Clements, Judith A.; Hooper, John D.			The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EGF RECEPTOR; TYROSINE PHOSPHORYLATION; OVARIAN CARCINOMAS; TUMOR PROGRESSION; CANCER CELLS; UP-REGULATION; SRC KINASES; CROSS-TALK; E-CADHERIN	Epidermal growth factor (EGF) activation of the EGF receptor (EGFR) is an important mediator of cell migration, and aberrant signaling via this system promotes a number of malignancies including ovarian cancer. We have identified the cell surface glycoprotein CDCP1 as a key regulator of EGF/EGFR-induced cell migration. We show that signaling via EGF/EGFR induces migration of ovarian cancer Caov3 and OVCA420 cells with concomitant up-regulation of CDCP1 mRNA and protein. Consistent with a role in cell migration CDCP1 relocates from cell-cell junctions to punctate structures on filopodia after activation of EGFR. Significantly, disruption of CDCP1 either by silencing or the use of a function blocking antibody efficiently reduces EGF/EGFR-induced cell migration of Caov3 and OVCA420 cells. We also show that up-regulation of CDCP1 is inhibited by pharmacological agents blocking ERK but not Src signaling, indicating that the RAS/RAF/MEK/ERK pathway is required downstream of EGF/EGFR to induce increased expression of CDCP1. Our immunohistochemical analysis of benign, primary, and metastatic serous epithelial ovarian tumors demonstrates that CDCP1 is expressed during progression of this cancer. These data highlight a novel role for CDCP1 in EGF/EGFR-induced cell migration and indicate that targeting of CDCP1 may be a rational approach to inhibit progression of cancers driven by EGFR signaling including those resistant to anti-EGFR drugs because of activating mutations in the RAS/RAF/MEK/ERK pathway.	[He, Yaowu; Hooper, John D.] Mater Med Res Inst, Brisbane, Qld 4101, Australia; [Dong, Ying; de Boer, Leonore; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Canc Res Program, Kelvin Grove, Qld 4059, Australia; [Stack, M. Sharon] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Lumley, John W.] Wesley Med Ctr, Auchenflower, Qld 4066, Australia	Mater Research; Queensland University of Technology (QUT); University of Missouri System; University of Missouri Columbia; Wesley Hospital	Hooper, JD (corresponding author), Mater Med Res Inst, Brisbane, Qld 4101, Australia.	jhooper@mmri.mater.org.au	Dong, Ying/C-3511-2012; Hooper, John/C-1481-2016	Hooper, John/0000-0003-1054-8486; HE, Yaowu/0000-0002-7828-263X; Clements, Judith/0000-0001-6026-1964	Wesley Research Institute [2008/06]; Cancer Council Queensland [614205]; National Health and Medical Research Council of Australia [550523]; Principal Research Fellowship [1005717]	Wesley Research Institute; Cancer Council Queensland(Cancer Council Queensland); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship	This work was supported by Wesley Research Institute Grant 2008/06 (to J.D.H.), Cancer Council Queensland Grant 614205 (to J.D.H.), National Health and Medical Research Council of Australia Grant 550523 (to Y.D. and J.A.C.), and Principal Research Fellowship 1005717 (to J.A.C.).	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Casar B., 2011, ONCOGENE IN PRESS; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; Fischer K, 1998, FEBS LETT, V438, P101, DOI 10.1016/S0014-5793(98)01279-4; Gotoh N, 2011, INT J CLIN EXP PATHO, V4, P403; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lim R, 2007, INT J CANCER, V120, P2426, DOI 10.1002/ijc.22352; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ong A, 2000, INT J CANCER, V85, P430, DOI 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Poon SL, 2009, MOL ENDOCRINOL, V23, P1646, DOI 10.1210/me.2009-0147; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Uekita T, 2011, CANCER SCI, V102, P1943, DOI 10.1111/j.1349-7006.2011.02052.x; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zhong H, 2000, CANCER RES, V60, P1541	61	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9792	9803		10.1074/jbc.M111.335448	http://dx.doi.org/10.1074/jbc.M111.335448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315226	Green Published, hybrid			2022-12-27	WOS:000302167200012
J	Tian, G; Tepikin, AV; Tengholm, A; Gylfe, E				Tian, Geng; Tepikin, Alexei V.; Tengholm, Anders; Gylfe, Erik			cAMP Induces Stromal Interaction Molecule 1 (STIM1) Puncta but neither Orai1 Protein Clustering nor Store-operated Ca2+ Entry (SOCE) in Islet Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM; CYTOPLASMIC CALCIUM; INSULIN-SECRETION; PHOSPHOLIPASE-C; CRAC CHANNEL; MOUSE; GLUCOSE; ALPHA; ACTIVATION	The events leading to the activation of store-operated Ca2+ entry (SOCE) involve Ca2+ depletion of the endoplasmic reticulum (ER) resulting in translocation of the transmembrane Ca2+ sensor protein, stromal interaction molecule 1 (STIM1), to the junctions between ER and the plasma membrane where it binds to the Ca2+ channel protein Orai1 to activate Ca2+ influx. Using confocal and total internal reflection fluorescence microscopy, we studied redistribution kinetics of fluorescence-tagged STIM1 and Orai1 as well as SOCE in insulin-releasing beta-cells and glucagon-secreting alpha-cells within intact mouse and human pancreatic islets. ER Ca2+ depletion triggered accumulation of STIM1 puncta in the subplasmalemmal ER where they co-clustered with Orai1 in the plasma membrane and activated SOCE. Glucose, which promotes Ca2+ store filling and inhibits SOCE, stimulated retranslocation of STIM1 to the bulk ER. This effect was evident at much lower glucose concentrations in alpha-than in beta-cells consistent with involvement of SOCE in the regulation of glucagon secretion. Epinephrine stimulated subplasmalemmal translocation of STIM1 in beta-cells and retranslocation in beta-cells involving raising and lowering of cAMP, respectively. The cAMP effect was mediated both by protein kinase A and exchange protein directly activated by cAMP. However, the cAMP-induced STIM1 puncta did not co-cluster with Orai1, and there was no activation of SOCE. STIM1 translocation can consequently occur independently of Orai1 clustering and SOCE.	[Tian, Geng; Tengholm, Anders; Gylfe, Erik] Uppsala Univ, Dept Med Cell Biol, SE-75123 Uppsala, Sweden; [Tepikin, Alexei V.] Univ Liverpool, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England	Uppsala University; University of Liverpool	Gylfe, E (corresponding author), Uppsala Univ, Dept Med Cell Biol, BMC Box 571, SE-75123 Uppsala, Sweden.	erik.gylfe@mcb.uu.se		Gylfe, Erik/0000-0002-8414-2107; Tepikin, Alexei/0000-0002-8172-7513	Swedish Research Council; Swedish Diabetes Association; NovoNordisk Foundation; European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD); Family Ernfors Foundation; Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; NovoNordisk Foundation(Novo Nordisk Foundation); European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD); Family Ernfors Foundation; Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by grants from the Swedish Research Council, the Swedish Diabetes Association, NovoNordisk Foundation, European Foundation for the Study of Diabetes and Merck Sharp and Dohme (EFSD/MSD), and the Family Ernfors Foundation.; We are indebted to Helene Dansk and Ing-Marie Morsare for technical assistance and to Professor Sir Michael Berridge, Babraham Institute, Cambridge, United Kingdom, for critically reading the manuscript. Human pancreatic islets were obtained from The Nordic Network for Clinical Islet Transplantation, supported by the Swedish National Strategic Research Initiative Exodiab (Excellence of Diabetes Research in Sweden) and the Juvenile Diabetes Research Foundation.	Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756; Chvanov M, 2008, PFLUG ARCH EUR J PHY, V457, P505, DOI 10.1007/s00424-008-0529-y; Dyachok O, 2001, J CELL SCI, V114, P2179; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GYLFE E, 1991, PFLUG ARCH EUR J PHY, V419, P639, DOI 10.1007/BF00370308; GYLFE E, 1988, J BIOL CHEM, V263, P13750; GYLFE E, 1988, J BIOL CHEM, V263, P5044; HELLMAN B, 1985, BIOMED BIOCHIM ACTA, V44, P63; Hellman B., 1992, NUTR REGULATION INSU, P213; KOH G, 1987, LIFE SCI, V40, P1113, DOI 10.1016/0024-3205(87)90574-1; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu YJ, 2004, CELL CALCIUM, V35, P357, DOI 10.1016/j.ceca.2003.10.002; Liu YJ, 1996, ARCH BIOCHEM BIOPHYS, V334, P295, DOI 10.1006/abbi.1996.0458; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; NAKAKI T, 1980, N-S ARCH PHARMACOL, V313, P151, DOI 10.1007/BF00498572; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SCHUIT FC, 1986, SCIENCE, V232, P875, DOI 10.1126/science.2871625; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Singaravelu K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174029; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Vieira E, 2007, DIABETOLOGIA, V50, P370, DOI 10.1007/s00125-006-0511-1; Vieira E, 2004, N-S ARCH PHARMACOL, V369, P179, DOI 10.1007/s00210-003-0858-5; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou W, 2010, ATHEROSCLEROSIS, V211, P216, DOI 10.1016/j.atherosclerosis.2010.02.012	53	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9862	9872		10.1074/jbc.M111.292854	http://dx.doi.org/10.1074/jbc.M111.292854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298778	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000302167200019
J	Yi, YH; Chang, YS; Lin, CH; Lew, TS; Tang, CY; Tseng, WL; Tseng, CP; Lo, SJ				Yi, Yung-Hsiang; Chang, Yu-Sun; Lin, Chi-Hung; Lew, Tien-Shen; Tang, Chih-Yung; Tseng, Wei-Lien; Tseng, Ching-Ping; Lo, Szecheng J.			Integrin-mediated Membrane Blebbing Is Dependent on Sodium-Proton Exchanger 1 and Sodium-Calcium Exchanger 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; CELL-ADHESION; RECOMBINANT RHODOSTOMIN; NA+/CA2+ EXCHANGERS; HUMAN PLATELETS; NHE1; ACTIVATION; BINDING; DIMERS; FLOW	Integrin signaling and membrane blebbing modulate cell adhesion, spreading, and migration. However, the relationship between integrin signaling and membrane blebbing is unclear. Here, we show that an integrin-ligand interaction induces both membrane blebbing and changes in membrane permeability. Sodium-proton exchanger 1 (NHE1) and sodium-calcium exchanger 1 (NCX1) are membrane proteins located on the bleb membrane. Inhibition of NHE1 disrupts membrane blebbing and decreases changes in membrane permeability. However, inhibition of NCX1 enhances cell blebbing; cells become swollen because of NHE1 induced intracellular sodium accumulation. Our study found that NHE1 induced sodium influx is a driving force for membrane bleb growth, while sodium efflux (and calcium influx) induced by NCX1 in a reverse mode results in membrane bleb retraction. Together, these findings reveal a novel function for NHE1 and NCX1 in membrane blebbing and permeability, and establish a link between membrane blebbing and integrin signaling.	[Yi, Yung-Hsiang; Lo, Szecheng J.] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan; [Yi, Yung-Hsiang; Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Tseng, Wei-Lien; Tseng, Ching-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Lin, Chi-Hung; Lo, Szecheng J.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lew, Tien-Shen] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Dept Physiol, Taipei 100, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University	Lo, SJ (corresponding author), Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan.	losj@mail.cgu.edu.tw		TANG, CHIH-YUNG/0000-0003-1065-2865; Chang, Yu-Sun/0000-0002-6457-3890; TSENG, CHING-PING/0000-0002-2587-210X	Chang Gung Memorial Hospital; Ministry of Education; National Science Council, R.O.C.	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Education; National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital, the Ministry of Education, and the National Science Council, R.O.C.; We thank Scott C. Schuyler (CGU), Simon Silver (CGU visiting professor), and Tung-Tien Sun (New York University) for reviewing the manuscript. We thank two anonymous reviews for their suggestions to the manuscript and NOVA Medical Documentation for proofreading service. We thank Dr. Tsung-Yu Chen (National Yang-Ming University) for providing electrophysiology equipment. Chang Gung University, the Biophotonics Interdisciplinary Research Center, and the Genome Research Center of National Yang-Ming University provided and supported microscopy services.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Chang CP, 2001, BIOCHEM J, V357, P57, DOI 10.1042/0264-6021:3570057; Chang HH, 1997, J BIOMED SCI, V4, P235, DOI 10.1007/BF02253423; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Chang HH, 1997, TOXICON, V35, P195, DOI 10.1016/S0041-0101(96)00121-3; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Norman L, 2011, EUR J CELL BIOL, V90, P37, DOI 10.1016/j.ejcb.2010.09.013; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Wu MP, 2008, BRAIN RES, V1201, P41, DOI 10.1016/j.brainres.2008.01.042; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200	34	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10316	10324		10.1074/jbc.M111.244962	http://dx.doi.org/10.1074/jbc.M111.244962			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270364	hybrid, Green Published			2022-12-27	WOS:000302167200060
J	Punn, A; Chen, J; Delidaki, M; Tang, JY; Liapakis, G; Lehnert, H; Levine, MA; Grammatopoulos, DK				Punn, Anu; Chen, Jing; Delidaki, Maria; Tang, Jiyou; Liapakis, George; Lehnert, Hendrik; Levine, Michael A.; Grammatopoulos, Dimitris K.			Mapping Structural Determinants within Third Intracellular Loop That Direct Signaling Specificity of Type 1 Corticotropin-releasing Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; 7TH TRANSMEMBRANE DOMAIN; CYTOPLASMIC DOMAINS; TRANSDUCTION PATHWAY; ADENYLYL-CYCLASE; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; EXPRESSION; MOTIFS	The type 1 corticotropin-releasing hormone receptor (CRH-R1) influences biological responses important for adaptation to stressful stimuli, through activation of multiple downstream effectors. The structural motifs within CRH-R1 that mediate G protein activation and signaling selectivity are unknown. The aim of this study was to gain insights about important structural determinants within the third intracellular loop (IC3) of the human CRH-R1 alpha important for cAMP and ERK1/2 pathways activation and selectivity. We investigated the role of the juxtamembrane regions of IC3 by mutating amino acid cassettes or specific residues to alanine. Although simultaneous tandem alanine mutations of both juxtamembrane regions Arg(292)-Met(295) and Lys(311)-Lys(314) reduced ligand binding and impaired signaling, all other mutant receptors retained high affinity binding, indistinguishable from wild-type receptor. Agonist-activated receptors with tandem mutations at the proximal or distal terminal segments enhanced activation of adenylyl cyclase by 50-75% and diminished activation of inositol trisphosphate and ERK1/2 by 60-80%. Single Ala mutations identified Arg(292), Lys(297), Arg(310), Lys(311), and Lys(314) as important residues for the enhanced activation of adenylyl cyclase, partly due to reduced inhibition of adenylyl cyclase activity by pertussis toxin-sensitive G proteins. In contrast, mutation of Arg(299) reduced receptor signaling activity and cAMP response. Basic as well as aliphatic amino acids within both juxtamembrane regions were identified as important for ERK1/2 phosphorylation through activation of pertussis toxin-sensitive G proteins as well as G(q) proteins. These data uncovered unexpected roles for key amino acids within the highly conserved hydrophobic N- and C-terminal microdomains of IC3 in the coordination of CRH-R1 signaling activity.	[Punn, Anu; Chen, Jing; Delidaki, Maria; Tang, Jiyou; Lehnert, Hendrik; Grammatopoulos, Dimitris K.] Univ Warwick, Dept Endocrinol & Metab, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Liapakis, George] Univ Crete, Fac Med, Dept Pharmacol, Iraklion 71003, Crete, Greece; [Lehnert, Hendrik] Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Levine, Michael A.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Dept Pediat, Sch Med, Philadelphia, PA 19104 USA	University of Warwick; University of Crete; University of Lubeck; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Grammatopoulos, DK (corresponding author), Univ Warwick, Dept Endocrinol & Metab, Clin Sci Res Inst, Warwick Med Sch, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	d.grammatopoulos@warwick.ac.uk		Levine, Michael/0000-0003-0036-7809; grammatopoulos, dimitris/0000-0002-6296-8290	Wellcome Trust; United States Endocrine Society	Wellcome Trust(Wellcome TrustEuropean Commission); United States Endocrine Society	This work was supported by a Wellcome Trust University Award (to D. K. G.). Dedicated to Wylie Vale and his enormous legacy.; Supported by a United States Endocrine Society summer research fellowship award.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; Berger H, 2006, BRIT J PHARMACOL, V149, P942, DOI 10.1038/sj.bjp.0706926; Brar BK, 2004, ENDOCRINOLOGY, V145, P1718, DOI 10.1210/en.2003-1023; Buck F, 2000, ENDOCRINOLOGY, V141, P3717, DOI 10.1210/en.141.10.3717; Chan KYY, 2001, ENDOCRINOLOGY, V142, P3926, DOI 10.1210/en.142.9.3926; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Conner AC, 2006, BIOCHEMISTRY-US, V45, P12976, DOI 10.1021/bi0615801; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; Cypess AM, 1999, J BIOL CHEM, V274, P19455, DOI 10.1074/jbc.274.27.19455; Estall JL, 2005, J BIOL CHEM, V280, P22124, DOI 10.1074/jbc.M500078200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Grammatopoulos DK, 1999, MOL ENDOCRINOL, V13, P2189, DOI 10.1210/me.13.12.2189; Grammatopoulos DK, 2000, MOL ENDOCRINOL, V14, P2076, DOI 10.1210/me.14.12.2076; Granier S, 2008, REGUL PEPTIDES, V148, P76, DOI 10.1016/j.regpep.2008.01.007; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Huang ZM, 1996, J BIOL CHEM, V271, P33382, DOI 10.1074/jbc.271.52.33382; Karteris E, 2004, J MOL ENDOCRINOL, V32, P21, DOI 10.1677/jme.0.0320021; Lee NH, 1996, MOL PHARMACOL, V50, P140; Markovic D, 2008, MOL ENDOCRINOL, V22, P2505, DOI 10.1210/me.2008-0177; Markovic D, 2010, METHODS MOL BIOL, V634, P285, DOI 10.1007/978-1-60761-652-8_21; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; McPherson G, 1983, PROGR BIOMED, V17, P107; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2007, AM J PHYSIOL-REG I, V293, pR209, DOI 10.1152/ajpregu.00099.2006; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Papadopoulou N, 2004, MOL ENDOCRINOL, V18, P624, DOI 10.1210/me.2003-0365; Peverelli E, 2008, MOL ENDOCRINOL, V22, P676, DOI 10.1210/me.2007-0068; Punn A, 2006, MOL ENDOCRINOL, V20, P3179, DOI 10.1210/me.2006-0255; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Teli T, 2005, MOL ENDOCRINOL, V19, P474, DOI 10.1210/me.2004-0275; Timossi C, 2004, MOL CELL ENDOCRINOL, V223, P17, DOI 10.1016/j.mce.2004.06.004; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Ulfers AL, 2002, BIOCHEMISTRY-US, V41, P11344, DOI 10.1021/bi0259610; Ulloa-Aguirre A, 2007, MOL CELL ENDOCRINOL, V260, P153, DOI 10.1016/j.mce.2005.11.050; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	43	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8974	8985		10.1074/jbc.M111.272161	http://dx.doi.org/10.1074/jbc.M111.272161			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22247544	hybrid, Green Published			2022-12-27	WOS:000301797800028
J	Yang, YS; Murciano, B; Moubri, K; Cibrelus, P; Schetters, T; Gorenflot, A; Delbecq, S; Roumestand, C				Yang, Yin-Shan; Murciano, Brice; Moubri, Karina; Cibrelus, Prisca; Schetters, Theo; Gorenflot, Andre; Delbecq, Stephane; Roumestand, Christian			Structural and Functional Characterization of Bc28.1, Major Erythrocyte-binding Protein from Babesia canis Merozoite Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL INVASION; GIBSONI INFECTION; MEMBRANE-PROTEINS; PARASITE; SEQUENCE; ANTIGEN; BOVIS; IDENTIFICATION; IMMUNIZATION; POLYMORPHISM	Babesiosis (formerly known as piroplasmosis) is a tick-borne disease caused by the intraerythrocytic development of protozoa parasites from the genus Babesia. Like Plasmodium falciparum, the agent of malaria, or Toxoplasma gondii, responsible for human toxoplasmosis, Babesia belongs to the Apicomplexa family. Babesia canis is the agent of the canine babesiosis in Europe. Clinical manifestations of this disease range from mild to severe and possibly lead to death by multiple organ failure. The identification and characterization of parasite surface proteins represent major goals, both for the understanding of the Apicomplexa invasion process and for the vaccine potential of such antigens. Indeed, we have already shown that Bd37, the major antigenic adhesion protein from Babesia divergens, the agent of bovine babesiosis, was able to induce complete protection against various parasite strains. The major merozoite surface antigens of Babesia canis have been described as a 28-kDa membrane protein family, anchored at the surface of the merozoite. Here, we demonstrate that Bc28.1, a major member of this multigenic family, is expressed at high levels at the surface of the merozoite. This protein is also found in the parasite in vitro culture supernatants, which are the basis of effective vaccines against canine babesiosis. We defined the erythrocyte binding function of Bc28.1 and determined its high resolution solution structure using NMR spectroscopy. Surprisingly, although these proteins are thought to play a similar role in the adhesion process, the structure of Bc28.1 from B. canis appears unrelated to the previously published structure of Bd37 from B. divergens. Site-directed mutagenesis experiments also suggest that the mechanism of the interaction with the erythrocyte membrane could be different for the two proteins. The resolution of the structure of Bc28 represents a milestone for the characterization of the parasite erythrocyte binding and its interaction with the host immune system.	[Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048, F-34090 Montpellier, France; [Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] Univ Montpellier 2, Ctr Biochim Struct, CNRS, UMR 5048, F-34090 Montpellier, France; [Yang, Yin-Shan; Murciano, Brice; Roumestand, Christian] INSERM, U1054, F-34090 Montpellier, France; [Murciano, Brice; Moubri, Karina; Cibrelus, Prisca; Gorenflot, Andre; Delbecq, Stephane] Univ Montpellier I, Fac Pharm, EA4558, F-34093 Montpellier 5, France; [Schetters, Theo] Intervet Int BV, Dept Parasitol, NL-5830 AA Boxmeer, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Merck & Company; Intervet International B.V.	Roumestand, C (corresponding author), Univ Montpellier I, Ctr Biochim Struct, CNRS, UMR 5048, 29 Route Navacelles, F-34090 Montpellier, France.	christian.roumestand@cbs.cnrs.fr		ROUMESTAND, Christian/0000-0002-4082-3293; Delbecq, Stephane/0000-0002-2813-1219	Intervet International B.V.; Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs [Fr3050]; Ministere de l'Enseignement Superieur et de la Recherche	Intervet International B.V.(Merck & CompanyIntervet International B.V.); Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported in part by a grant from Intervet International B.V. This work (very high-field NMR at 950 MHz) was also supported by Tres Grands Equipments de Resonance Magnetique Nucleaire a Tres Haut Champs Fr3050.; Ph.D. student supported by an "Axes Prioritaires" grant from Ministere de l'Enseignement Superieur et de la Recherche.	Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; BANNISTER LH, 1990, BLOOD CELLS, V16, P257; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Carcy B, 2006, VET PARASITOL, V138, P33, DOI 10.1016/j.vetpar.2006.01.038; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Delbecq S, 2006, VACCINE, V24, P613, DOI 10.1016/j.vaccine.2005.08.073; Delbecq S, 2008, J MOL BIOL, V375, P409, DOI 10.1016/j.jmb.2007.08.019; Drakulovski P, 2003, INFECT IMMUN, V71, P1056, DOI 10.1128/IAI.71.3.1056-1067.2003; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Rodriguez AE, 2010, VET PARASITOL, V167, P227, DOI 10.1016/j.vetpar.2009.09.024; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Fukumoto S, 2001, J CLIN MICROBIOL, V39, P2603, DOI 10.1128/JCM.39.7.2603-2609.2001; Fukumoto S, 2004, INFECT IMMUN, V72, P1795, DOI 10.1128/IAI.72.3.1795-1798.2004; Fukumoto S, 2007, VACCINE, V25, P1334, DOI 10.1016/j.vaccine.2006.09.083; Garcia J, 2009, VACCINE, V27, P3953, DOI 10.1016/j.vaccine.2009.04.039; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HINES SA, 1995, INFECT IMMUN, V63, P349, DOI 10.1128/IAI.63.1.349-352.1995; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Moreau Y, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P95, DOI 10.1016/0035-9203(89)90611-1; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pollard AM, 2008, INFECT IMMUN, V76, P103, DOI 10.1128/IAI.01170-07; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Precigout E, 2004, INT J PARASITOL, V34, P585, DOI 10.1016/j.ijpara.2004.01.002; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schetters TPM, 2009, J S AFR VET ASSOC, V80, P75; Verdida RA, 2004, J VET MED SCI, V66, P1517, DOI 10.1292/jvms.66.1517; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007	40	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9495	9508		10.1074/jbc.M111.260745	http://dx.doi.org/10.1074/jbc.M111.260745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294693	Green Published, hybrid			2022-12-27	WOS:000301797800078
J	Gong, WB; Zhou, T; Mo, JJ; Perrett, S; Wang, JF; Feng, YG				Gong, Weibin; Zhou, Tao; Mo, Jinjin; Perrett, Sarah; Wang, Jinfeng; Feng, Yingang			Structural Insight into Recognition of Methylated Histone Tails by Retinoblastoma-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE COMPLEX; MACROMOLECULAR STRUCTURE; FAMILY PROTEINS; MOLECULAR-BASIS; CHEMICAL-SHIFT; GROWTH ARREST; NMR; IDENTIFICATION; DOMAIN; PROGRAM	Retinoblastoma-binding protein 1 (RBBP1), also named AT-rich interaction domain containing 4A (ARID4A), is a tumor and leukemia suppressor involved in epigenetic regulation in leukemia and Prader-Willi/Angelman syndromes. Although the involvement in epigenetic regulation is proposed to involve its chromobarrel and/or Tudor domains because of their potential binding to methylated histone tails, the structures of these domains and their interactions with methylated histone tails are still uncharacterized. In this work, we first found that RBBP1 contains five domains by bioinformatics analysis. Three of the five domains, i.e. chromobarrel, Tudor, and PWWP domains, are Royal Family domains, which potentially bind to methylated histone tails. We further purified these domains and characterized their interaction with methylated histone tails by NMR titration experiments. Among the three Royal Family domains, only the chromobarrel domain could recognize trimethylated H4K20 (with an affinity of similar to 3 mM), as well as recognizing trimethylated H3K9, H3K27, and H3K36 (with lower affinities). The affinity could be further enhanced up to 15-fold by the presence of DNA. The structure of the chromobarrel domain of RBBP1 determined by NMR spectroscopy has an aromatic cage. Mutagenesis analysis identified four aromatic residues of the cage as the key residues for methylated lysine recognition. Our studies indicate that the chromobarrel domain of RBBP1 is responsible for recognizing methylated histone tails in chromatin remodeling and epigenetic regulation, which presents a significant advance in our understanding of the mechanism and relationship between RBBP1-related gene suppression and epigenetic regulation.	[Gong, Weibin; Zhou, Tao; Mo, Jinjin; Perrett, Sarah; Wang, Jinfeng; Feng, Yingang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Mo, Jinjin] Beijing Normal Univ, Dept Biochem & Mol Biol, Beijing 100875, Peoples R China; [Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Beijing Normal University; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, JF (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	jfw@sun5.ibp.ac.cn; fengyg@qibebt.ac.cn	Perrett, Sarah/AAS-9483-2020; Feng, Yingang/B-6304-2008	Perrett, Sarah/0000-0003-0137-0997; Feng, Yingang/0000-0002-0879-1316	National Natural Science Foundation of China [30970571, 30770434]; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 30970571 (to Y. F.) and 30770434 (to J. W.) and the China Postdoctoral Science Foundation (to W. G.).	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao JN, 2001, J NATL CANCER I, V93, P1159, DOI 10.1093/jnci/93.15.1159; Cheng Y, 2004, BIOCHEM BIOPH RES CO, V317, P401, DOI 10.1016/j.bbrc.2004.03.068; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Wu MY, 2006, GENE DEV, V20, P2859, DOI 10.1101/gad.1452206; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001	37	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8531	8540		10.1074/jbc.M111.299149	http://dx.doi.org/10.1074/jbc.M111.299149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247551	hybrid, Green Published			2022-12-27	WOS:000301349400066
J	Hsu, CC; Hu, CD				Hsu, Chih-Chao; Hu, Chang-Deng			Critical Role of N-terminal End-localized Nuclear Export Signal in Regulation of Activating Transcription Factor 2 (ATF2) Subcellular Localization and Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; INTRAMOLECULAR INHIBITION; HETERODIMER FORMATION; TRANSDUCTION PATHWAY; PROTEIN-KINASES; PHOSPHORYLATION; BINDING; FAMILY; DOMAIN; LEUCINE	Activating transcription factor 2 (ATF2) belongs to the basic leucine zipper family of transcription factors. ATF2 regulates target gene expression by binding to the cyclic AMP-response element as a homodimer or a heterodimer with c-Jun. Cytoplasmic localization of ATF2 was observed in melanoma, brain tissue from patients with Alzheimer disease, prostate cancer specimens, and ionizing radiation-treated prostate cancer cells, suggesting that alteration of ATF2 subcellular localization may be involved in the pathogenesis of these diseases. We previously demonstrated that ATF2 is a nucleocytoplasmic shuttling protein, and it contains two nuclear localization signals in the basic region and one nuclear export signal (NES) in the leucine zipper domain (named LZ-NES). In the present study, we demonstrate that a hydrophobic stretch in the N terminus, (MKFKLHV7)-M-1, also functions as an NES (termed N-NES) in a chromosome region maintenance 1 (CRM1)-dependent manner. Mutation of both N-NES and LZ-NES results in a predominant nuclear localization, whereas mutation of each individual NES only partially increases the nuclear localization. These results suggest that cytoplasmic localization of ATF2 requires function of at least one of the NESs. Further, mutation of N-NES enhances the transcriptional activity of ATF2, suggesting that the novel NES negatively regulates the transcriptional potential of ATF2. Thus, ATF2 subcellular localization is probably modulated by multiple mechanisms, and further understanding of the regulation of ATF2 subcellular localization under various pathological conditions will provide insight into the pathophysiological role of ATF2 in human diseases.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hu, CD (corresponding author), 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	hu1@purdue.edu			National Science Foundation; American Heart Association; United States Department of Defense; Purdue University Center for Cancer Research; Purdue Research Foundation; Ronal W. Dollens Graduate Scholarship in the Life Sciences; National Institutes of Health, NCI [CCSG CA23168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); United States Department of Defense(United States Department of Defense); Purdue University Center for Cancer Research; Purdue Research Foundation; Ronal W. Dollens Graduate Scholarship in the Life Sciences; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by grants from the National Science Foundation, American Heart Association, and the United States Department of Defense and by Purdue University Center for Cancer Research Small Grants.; Supported by the Purdue Research Foundation Graduate Fellowship and Ronal W. Dollens Graduate Scholarship in the Life Sciences.; We thank Christopher Suarez for critically reading the manuscript. DNA sequencing was conducted in the Purdue University Center for Cancer Research Genomic Core Facility, supported by National Institutes of Health, NCI, Grant CCSG CA23168 (to the Purdue University Center for Cancer Research).	ABDELHAFIZ HA, 1992, MOL ENDOCRINOL, V6, P2079, DOI 10.1210/me.6.12.2079; ALI SA, 1995, BIOTECHNIQUES, V18, P746; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; BENBROOK DM, 1990, ONCOGENE, V5, P295; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Deng XH, 2011, AM J CANCER RES, V1, P834; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Duyndam MCA, 1999, ONCOGENE, V18, P2311, DOI 10.1038/sj.onc.1202584; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; Murai N, 2003, J BIOL CHEM, V278, P44791, DOI 10.1074/jbc.M308059200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamada T, 1997, BRAIN RES, V749, P329, DOI 10.1016/S0006-8993(96)01356-X; Yamasaki T, 2009, J BIOL CHEM, V284, P8567, DOI 10.1074/jbc.M808719200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	56	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8621	8632		10.1074/jbc.M111.294272	http://dx.doi.org/10.1074/jbc.M111.294272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275354	hybrid, Green Published			2022-12-27	WOS:000301349400074
J	Kumar, S; Singh, S; Hinze, D; Josten, M; Sahl, HG; Siepmann, M; Walter, J				Kumar, Sathish; Singh, Sandesh; Hinze, Desiree; Josten, Michaele; Sahl, Hans-Georg; Siepmann, Martin; Walter, Jochen			Phosphorylation of Amyloid-beta Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; A-BETA; EXTRACELLULAR LEVELS; COMMON VARIANTS; PROTEIN; DEGRADATION; PROTEOLYSIS; PATHOGENESIS	Background: Amyloid-beta peptide (A beta) is degraded by different proteases. We recently demonstrated phosphorylation of A beta. Results: Phosphorylation of A beta decreases its clearance by microglial BV-2 cells and selectively inhibits the cleavage by insulin-degrading and angiotensin-converting enzymes. Conclusion: Phosphorylation at Ser-8 negatively regulates A beta degradation. Significance: Phosphorylation could play a dual role in A beta metabolism. It decreases the clearance by microglial cells and also promotes A beta aggregation.	[Kumar, Sathish; Singh, Sandesh; Hinze, Desiree; Siepmann, Martin; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Sect, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047	Deutsche Forschungsgemeinschaft [WA1477/6, SFB645, KFO177/WA1477/4]; BONFOR Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR Program	This work was supported by Deutsche Forschungsgemeinschaft Grants WA1477/6, SFB645, and KFO177/WA1477/4 and the BONFOR Program.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Alvira-Botero Ximena, 2010, Curr Aging Sci, V3, P219; Authier F, 1996, CLIN INVEST MED, V19, P149; Barker R, 2010, BRAIN RES, V1355, P7, DOI 10.1016/j.brainres.2010.08.025; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Cirrito JR, 2003, J NEUROSCI, V23, P8844; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Deane R, 2008, CURR PHARM DESIGN, V14, P1601, DOI 10.2174/138161208784705487; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eikelenboom P, 2011, CURR ALZHEIMER RES, V8, P142, DOI 10.2174/156720511795256080; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Fawcett J, 2001, J BIOL CHEM, V276, P11552, DOI 10.1074/jbc.M007988200; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fluhrer R, 2004, J BIOL CHEM, V279, P1585, DOI 10.1074/jbc.M306653200; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata Nobuhisa, 2003, Nihon Yakurigaku Zasshi, V122, P5; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Kamino K, 1996, NEUROSCI LETT, V208, P195, DOI 10.1016/0304-3940(96)12587-8; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Liu YX, 2007, PEPTIDES, V28, P2348, DOI 10.1016/j.peptides.2007.09.015; Madani R, 2003, TRENDS MOL MED, V9, P183, DOI 10.1016/S1471-4914(03)00050-9; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Milton NGN, 2005, SUB CELL BIOCHEM, V38, P381; Milton NGN, 2001, NEUROREPORT, V12, P3839, DOI 10.1097/00001756-200112040-00047; Miners JS, 2011, AM J TRANSL RES, V3, P73; Miners S, 2009, AM J TRANSL RES, V1, P163; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Panchal M, 2007, CURR NEUROVASC RES, V4, P240, DOI 10.2174/156720207782446315; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; ROSSOR MN, 1993, ANN NY ACAD SCI, V695, P198, DOI 10.1111/j.1749-6632.1993.tb23052.x; ROTH R A, 1985, Diabetes Research and Clinical Practice, V1, P31, DOI 10.1016/S0168-8227(85)80026-7; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; TANZI RE, 1989, TRENDS NEUROSCI, V12, P152, DOI 10.1016/0166-2236(89)90055-6; Thornton-Wells TA, 2008, GENET EPIDEMIOL, V32, P187, DOI 10.1002/gepi.20294; Tucker HM, 2000, J NEUROCHEM, V75, P2172, DOI 10.1046/j.1471-4159.2000.0752172.x; Tucker HM, 2000, J NEUROSCI, V20, P3937; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walter J, 1999, P NATL ACAD SCI USA, V96, P1391, DOI 10.1073/pnas.96.4.1391; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	75	54	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8641	8651		10.1074/jbc.M111.279133	http://dx.doi.org/10.1074/jbc.M111.279133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267728	Green Published, hybrid			2022-12-27	WOS:000301349400076
J	Wang, SB; Song, P; Zou, MH				Wang, Shaobin; Song, Ping; Zou, Ming-Hui			Inhibition of AMP-activated Protein Kinase alpha (AMPK alpha) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes ROLE OF p53 AND SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; NUCLEOTIDE EXCISION-REPAIR; TUMOR-SUPPRESSOR P53; DNA-DAMAGE; INDUCED CARDIOMYOPATHY; INDUCED APOPTOSIS; OXIDATIVE-STRESS; SKELETAL-MUSCLE; TRANSGENIC MICE; GLUCOSE-UPTAKE	Doxorubicin, an anthracycline antibiotic, is widely used in cancer treatment. Doxorubicin produces genotoxic stress and p53 activation in both carcinoma and non-carcinoma cells. Although its side effects in non-carcinoma cells, especially in heart tissue, are well known, the molecular targets of doxorubicin are poorly characterized. Here, we report that doxorubicin inhibits AMP-activated protein kinase (AMPK) resulting in SIRT1 dysfunction and p53 accumulation. Spontaneously immortalized mouse embryonic fibroblasts (MEFs) or H9C2 cardiomyocyte were exposed to doxorubicin at different doses and durations. Cell death and p53, SIRT1, and AMPK levels were examined by Western blot. In MEFs, doxorubicin inhibited AMPK activation, increased cell death, and induced robust p53 accumulation. Genetic deletion of AMPK alpha 1 reduced NAD(+) levels and SIRT1 activity and significantly increased the levels of p53 and cell death. Pre-activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleoside or transfection with an adenovirus encoding a constitutively active AMPK (AMPK-CA) markedly reduced the effects of doxorubicin in MEFs from Ampk alpha 1 knock-out mice. Conversely, pre-inhibition of Ampk further sensitized MEFs to doxorubicin-induced cell death. Genetic knockdown of p53 protected both wild-type and Ampk alpha 1(-/-) MEFs from doxorubicin-induced cell death. p53 accumulation in Ampk alpha 1(-/-) MEFs was reversed by SIRT1 activation by resveratrol. Taken together, these data suggest that AMPK inhibition by doxorubicin causes p53 accumulation and SIRT1 dysfunction in MEFs and further suggest that pharmacological activation of AMPK might alleviate the side effects of doxorubicin.	[Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med,Div Mol Med, Oklahoma City, OK 73104 USA; [Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Med, Oklahoma City, OK 73104 USA; [Wang, Shaobin] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med,Div Mol Med, BSEB 306A, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	wang, shaobin/A-2415-2015; Song, Ping/D-6972-2011; Song, Ping/N-8456-2018; wang, shaobin/D-7168-2011; wang, shaobin/L-8539-2015; Wang, Shaobin/C-5507-2008	wang, shaobin/0000-0002-0931-7210; Song, Ping/0000-0002-2654-6162; Song, Ping/0000-0002-6143-4270; Wang, Shaobin/0000-0002-1751-9162	National Institutes of Health [HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, HL110448]; American Diabetes Association; Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL105157, R01HL096032, R01HL110488, R01HL080499, R43HL110448, R01HL079584, R01HL074399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, and HL110448. This work was also supported by a research award from the American Diabetes Association and by the Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center (all to M.-H. Z.).; A recipient of the National Established Investigator Award from the American Heart Association. To whom correspondence should be addressed: BSEB 306A, Sect. of Molecular Medicine, Dept. of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK 73104. Tel.: 405-271-3974; Fax: 405-271-3973; E-mail: ming-hui-zou@ouhsc.edu.	Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Borras C, 2011, FREE RADICAL RES, V45, P643, DOI 10.3109/10715762.2011.571685; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	61	76	80	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8001	8012		10.1074/jbc.M111.315812	http://dx.doi.org/10.1074/jbc.M111.315812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267730	hybrid, Green Published			2022-12-27	WOS:000301349400016
J	Amaddii, M; Meister, M; Banning, A; Tomasovic, A; Mooz, J; Rajalingam, K; Tikkanen, R				Amaddii, Monia; Meister, Melanie; Banning, Antje; Tomasovic, Ana; Mooz, Juliane; Rajalingam, Krishnaraj; Tikkanen, Ritva			Flotillin-1/Reggie-2 Protein Plays Dual Role in Activation of Receptor-tyrosine Kinase/Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LOW-BUOYANT DENSITY; LIPID RAFTS; MEMBRANE MICRODOMAINS; REGGIE/FLOTILLIN PROTEINS; HUMAN-FIBROBLASTS; PLASMA-MEMBRANE; ERK ACTIVATION; ENDOCYTOSIS; CELLS	Our previous work has shown that the membrane microdomain-associated flotillin proteins are potentially involved in epidermal growth factor (EGF) receptor signaling. Here we show that knockdown of flotillin-1/reggie-2 results in reduced EGF-induced phosphorylation of specific tyrosines in the EGF receptor (EGFR) and in inefficient activation of the downstream mitogen-activated protein (MAP) kinase and Akt signaling. Although flotillin-1 has been implicated in endocytosis, its depletion affects neither the endocytosis nor the ubiquitination of the EGFR. However, EGF-induced clustering of EGFR at the cell surface is altered in cells lacking flotillin-1. Furthermore, we show that flotillins form molecular complexes with EGFR in an EGF/EGFR kinase-independent manner. However, knockdown of flotillin-1 appears to affect the activation of the downstream MAP kinase signaling more directly. We here show that flotillin-1 forms a complex with CRAF, MEK1, ERK, and KSR1 (kinase suppressor of RAS) and that flotillin-1 knockdown leads to a direct inactivation of ERK1/2. Thus, flotillin-1 plays a direct role during both the early phase (activation of the receptor) and late (activation of MAP kinases) phase of growth factor signaling. Our results here unveil a novel role for flotillin-1 as a scaffolding factor in the regulation of classical MAP kinase signaling. Furthermore, our results imply that other receptor-tyrosine kinases may also rely on flotillin-1 upon activation, thus suggesting a general role for flotillin-1 as a novel factor in recepto-rtyrosine kinase/MAP kinase signaling.	[Amaddii, Monia; Meister, Melanie; Banning, Antje; Tomasovic, Ana; Tikkanen, Ritva] Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; [Mooz, Juliane; Rajalingam, Krishnaraj] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany	Justus Liebig University Giessen; Goethe University Frankfurt	Tikkanen, R (corresponding author), Univ Giessen, Inst Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de		Tikkanen, Ritva/0000-0002-8393-1825	German Research Council (Deutsche Forschungsgemeinschaft) [Ti291/6-1, Ti291/6-2]; Emmy Noether Program [RA1739/1-1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Emmy Noether Program(German Research Foundation (DFG))	This work was supported by German Research Council (Deutsche Forschungsgemeinschaft) Grants Ti291/6-1 and Ti291/6-2 (to R. T.) and Emmy Noether Program Grant RA1739/1-1 (to K. R.).	Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; CARPENTIER JL, 1982, J CELL BIOL, V95, P73, DOI 10.1083/jcb.95.1.73; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; Langhorst MF, 2006, FASEB J, V20, P711, DOI 10.1096/fj.05-4760fje; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Melillo RM, 2001, MOL CELL BIOL, V21, P4177, DOI 10.1128/MCB.21.13.4177-4187.2001; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Ringerike T, 2002, J CELL SCI, V115, P1331; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schulte T, 1997, DEVELOPMENT, V124, P577; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Waugh MG, 1998, J BIOL CHEM, V273, P17115, DOI 10.1074/jbc.273.27.17115; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wu YJ, 2003, BIOL CHEM, V384, P1215, DOI 10.1515/BC.2003.134; Xu H, 2001, J BIOL CHEM, V276, P13049, DOI 10.1074/jbc.M009925200; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	52	84	88	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7265	7278		10.1074/jbc.M111.287599	http://dx.doi.org/10.1074/jbc.M111.287599			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232557	Green Published, hybrid			2022-12-27	WOS:000301060200029
J	Iglesias-Guimarais, V; Gil-Guinon, E; Gabernet, G; Garcia-Belinchon, M; Sanchez-Osuna, M; Casanelles, E; Comella, JX; Yuste, VJ				Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.			Apoptotic DNA Degradation into Oligonucleosomal Fragments, but Not Apoptotic Nuclear Morphology, Relies on a Cytosolic Pool of DFF40/CAD Endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; CELL-DEATH; CHROMATIN CONDENSATION; CLEAVAGE; INHIBITOR; PROTEIN; STAUROSPORINE; LOCALIZATION; ASSOCIATION; ABSENCE	Apoptotic cell death is characterized by nuclear fragmentation and oligonucleosomal DNA degradation, mediated by the caspase-dependent specific activation of DFF40/CAD endonuclease. Here, we describe how, upon apoptotic stimuli, SK-N-AS human neuroblastoma-derived cells show apoptotic nuclear morphology without displaying concomitant internucleosomal DNA fragmentation. Cytotoxicity afforded after staurosporine treatment is comparable with that obtained in SH-SY5Y cells, which exhibit a complete apoptotic phenotype. SK-N-AS cell death is a caspase-dependent process that can be impaired by the pan-caspase inhibitor q-VD-OPh. The endogenous inhibitor of DFF40/CAD, ICAD, is correctly processed, and dff40/cad cDNA sequence does not reveal mutations altering its amino acid composition. Biochemical approaches show that both SH-SY5Y and SK-N-AS resting cells express comparable levels of DFF40/CAD. However, the endonuclease is poorly expressed in the cytosolic fraction of healthy SK-N-AS cells. Despite this differential subcellular distribution of DFF40/CAD, we find no differences in the subcellular localization of both pro-caspase-3 and ICAD between the analyzed cell lines. After staurosporine treatment, the preferential processing of ICAD in the cytosolic fraction allows the translocation of DFF40/CAD from this fraction to a chromatin-enriched one. Therefore, the low levels of cytosolic DFF40/CAD detected in SK-N-AS cells determine the absence of DNA laddering after staurosporine treatment. In these cells DFF40/CAD cytosolic levels can be restored by the overexpression of their own endonuclease, which is sufficient to make them proficient at degrading their chromatin into oligonucleosome-size fragments after staurosporine treatment. Altogether, the cytosolic levels of DFF40/CAD are determinants in achieving a complete apoptotic phenotype, including oligonucleosomal DNA degradation.	[Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Gabernet, Gisela; Garcia-Belinchon, Merce; Sanchez-Osuna, Maria; Casanelles, Elisenda; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurosci, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.] Vall Hebron Inst Recerca, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08035, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.] Vall Hebron Inst Recerca, Cell Signaling & Apoptosis Grp, Barcelona 08035, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Yuste, Victor J./C-7071-2008; Comella, Joan/GQA-4279-2022; Gil, Estel/B-9786-2015; Comella, Joan X/D-7333-2012	Yuste, Victor J./0000-0001-5322-9261; Comella, Joan X/0000-0002-6218-0786; Gil, Estel/0000-0003-4502-4623; Gabernet, Gisela/0000-0001-7049-9474	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) [BFU2008-01328, TRA2009-0185, SAF2010-19953]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas [CB06/05/0042]; Generalitat de Catalunya [SGR2009-346]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Spanish Ministerio de Educacion y Ciencia	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas; Generalitat de Catalunya(Generalitat de Catalunya); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) Grants BFU2008-01328 and TRA2009-0185 (to V. J. Y.) and SAF2010-19953 (to J. X. C.), Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas Grant CB06/05/0042, and Generalitat de Catalunya Grant SGR2009-346.; Supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya).; Funded by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia).	Baguley BC, 2011, FRONT BIOSCI-LANDMRK, V16, P1759, DOI 10.2741/3819; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Chen DX, 2000, J BIOL CHEM, V275, P38508, DOI 10.1074/jbc.M003906200; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; de la Taille A, 1999, CANCER RES, V59, P5461; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gozzelino R, 2008, CELL RES, V18, P1020, DOI 10.1038/cr.2008.76; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kuribayashi N, 1996, ANTICANCER RES, V16, P1225; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo M, 2010, CELL RES, V20, P211, DOI 10.1038/cr.2010.9; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nagase H, 2003, CELL DEATH DIFFER, V10, P142, DOI 10.1038/sj.cdd.4401139; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Peitsch Manuel C., 1994, Trends in Cell Biology, V4, P37, DOI 10.1016/0962-8924(94)90002-7; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Sabol SL, 1998, BIOCHEM BIOPH RES CO, V253, P151, DOI 10.1006/bbrc.1998.9770; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2000, EXP CELL RES, V255, P314, DOI 10.1006/excr.2000.4801; Samejima K, 1998, EXP CELL RES, V243, P453, DOI 10.1006/excr.1998.4212; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Tang D, 1998, J BIOL CHEM, V273, P28549, DOI 10.1074/jbc.273.44.28549; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Walker PR, 1999, ANN NY ACAD SCI, V887, P48, DOI 10.1111/j.1749-6632.1999.tb07921.x; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Widlak P, 2006, APOPTOSIS, V11, P1331, DOI 10.1007/s10495-006-6983-0; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; Yan B, 2009, CARCINOGENESIS, V30, P1776, DOI 10.1093/carcin/bgp146; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480; Zhang JH, 2000, BIOCHEM BIOPH RES CO, V274, P225, DOI 10.1006/bbrc.2000.3122	52	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7766	7779		10.1074/jbc.M111.290718	http://dx.doi.org/10.1074/jbc.M111.290718			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253444	hybrid, Green Published			2022-12-27	WOS:000301060200075
J	Tan, EJ; Thuault, S; Caja, L; Carletti, T; Heldin, CH; Moustakas, A				Tan, E-Jean; Thuault, Sylvie; Caja, Laia; Carletti, Tea; Heldin, Carl-Henrik; Moustakas, Aristidis			Regulation of Transcription Factor Twist Expression by the DNA Architectural Protein High Mobility Group A2 during Epithelial-to-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; CANCER; HMGA2; METASTASIS; PROGRESSION	Deciphering molecular mechanisms that control epithelial-to-mesenchymal transition (EMT) contributes to our understanding of how tumor cells become invasive and competent for intravasation. We have established that transforming growth factor beta activates Smad proteins, which induce expression of the embryonic factor high mobility group A2 (HMGA2), which causes mesenchymal transition. HMGA2 associates with Smad complexes and induces expression of an established regulator of EMT, the zinc finger transcription factor Snail. We now show that HMGA2 can also induce expression of a second regulator of EMT, the basic helix-loop-helix transcription factor Twist. Silencing of endogenous Twist demonstrated that this protein acts in a partially redundant manner together with Snail. Double silencing of Snail and Twist reverts mesenchymal HMG-A2-expressing cells to a more epithelial phenotype when compared with single silencing of Snail or Twist. Furthermore, HMGA2 can directly associate with A:T-rich sequences and promote transcription from the Twist promoter. The new evidence proposes a model whereby HMGA2 directly induces multiple transcriptional regulators of the EMT program and, thus, is a potential biomarker for carcinomas displaying EMT during progression to more advanced stages of malignancy.	[Tan, E-Jean; Thuault, Sylvie; Caja, Laia; Carletti, Tea; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, Box 595 Biomed Ctr, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Caja, Laia/J-4618-2019; Tan, E-Jean/J-3425-2019	Caja, Laia/0000-0002-8786-8763; Tan, E-Jean/0000-0002-4631-174X; THUAULT, Sylvie/0000-0003-0133-3803	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC, CAN 2006/1078]; Marie Curie Research Training Network "EpiPlastCarcinoma" under European Union [MRTN-2005-005428]	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Marie Curie Research Training Network "EpiPlastCarcinoma" under European Union	This work was supported in part by the Ludwig Institute for Cancer Research and the Swedish Cancer Society (project numbers: 4855-B03-01XAC and CAN 2006/1078 to A. M.).; Supported by the Marie Curie Research Training Network "EpiPlastCarcinoma" under the European Union FP6 program (project MRTN-2005-005428).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Howe LR, 2003, CANCER RES, V63, P1906; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sgarra R, 2009, J PROTEOME RES, V8, P2978, DOI 10.1021/pr900087r; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658	23	84	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7134	7145		10.1074/jbc.M111.291385	http://dx.doi.org/10.1074/jbc.M111.291385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241470	Green Published, hybrid			2022-12-27	WOS:000301060200017
J	Thompson, JW; Salahudeen, AA; Chollangi, S; Ruiz, JC; Brautigam, CA; Makris, TM; Lipscomb, JD; Tomchick, DR; Bruick, RK				Thompson, Joel W.; Salahudeen, Ameen A.; Chollangi, Srinivas; Ruiz, Julio C.; Brautigam, Chad A.; Makris, Thomas M.; Lipscomb, John D.; Tomchick, Diana R.; Bruick, Richard K.			Structural and Molecular Characterization of Iron-sensing Hemerythrin-like Domain within F-box and Leucine-rich Repeat Protein 5 (FBXL5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHEMOTAXIS PROTEIN; REGULATORY PROTEIN-2; MAMMALIAN IRON; TARGETED DELETION; UBIQUITIN LIGASE; BINDING PROTEIN; HOMEOSTASIS; OXYGEN; MICE; MYOHEMERYTHRIN	Mammalian cells maintain iron homeostasis by sensing changes in bioavailable iron levels and promoting adaptive responses. FBXL5 is a subunit of an E3 ubiquitin ligase complex that mediates the stability of iron regulatory protein 2, an important posttranscriptional regulator of several genes involved in iron metabolism. The stability of FBXL5 is regulated in an iron- and oxygen-responsive manner, contingent upon the presence of its N-terminal domain. Here we present the atomic structure of the FBXL5 N terminus, a hemerythrin-like alpha-helical bundle fold not previously observed in mammalian proteins. The core of this domain employs an unusual assortment of amino acids necessary for the assembly and sensing properties of its diiron center. These regulatory features govern the accessibility of a mapped sequence required for proteasomal degradation of FBXL5. Detailed molecular and structural characterization of the ligand-responsive hemerythrin domain provides insights into the mechanisms by which FBXL5 serves as a unique mammalian metabolic sensor.	[Thompson, Joel W.; Salahudeen, Ameen A.; Chollangi, Srinivas; Ruiz, Julio C.; Brautigam, Chad A.; Tomchick, Diana R.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Makris, Thomas M.; Lipscomb, John D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Minnesota System; University of Minnesota Twin Cities	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu	Makris, Thomas/W-9965-2019; Tomchick, Diana/HGV-2018-2022	Makris, Thomas/0000-0001-7927-620X; Thompson, Joel/0000-0002-5131-3248; Lipscomb, John/0000-0002-8158-5594; A Salahudeen, Ameen/0000-0001-9037-3481; Brautigam, Chad/0000-0001-6563-1338; Tomchick, Diana/0000-0002-7529-4643	University of Texas Board of Regents; Sara and Frank McKnight Graduate Student Fellowship; Burroughs Wellcome Fund; Robert A. Welch Foundation [I-1568]; National Institutes of Health [HL102481]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Center for Research Resources, National Institutes of Health [C06 RR 15437-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024689, R01GM024689] Funding Source: NIH RePORTER	University of Texas Board of Regents; Sara and Frank McKnight Graduate Student Fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Graduate Programs Initiative from the University of Texas Board of Regents.; A Howard Hughes Medical Institute Scholar. Supported by a Sara and Frank McKnight Graduate Student Fellowship.; The Michael L. Rosenberg Scholar in Medical Research. Supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, the Robert A. Welch Foundation (Grant I-1568) and National Institutes of Health Grant HL102481. To whom correspondence should be addressed: University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-6477; Fax: 214-648-0320; E-mail: richard.bruick@utsouthwestern.edu.; The structure shown in this report is derived from work performed on beamlines 19-BM and 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. uChicago Argonne, LLC, operates Argonne for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (Grant C06 RR 15437-01) from the National Center for Research Resources, National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BEARDEN JA, 1967, REV MOD PHYS, V39, P125, DOI 10.1103/RevModPhys.39.125; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carugo O, 2005, TRENDS BIOCHEM SCI, V30, P213, DOI 10.1016/j.tibs.2005.02.009; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEMUYNCK S, 1993, EUR J BIOCHEM, V217, P151, DOI 10.1111/j.1432-1033.1993.tb18230.x; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOLMES MA, 1991, J MOL BIOL, V218, P583, DOI 10.1016/0022-2836(91)90703-9; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; JHA KK, 1980, SOMAT CELL GENET, V6, P603, DOI 10.1007/BF01538640; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kao WC, 2008, J INORG BIOCHEM, V102, P1607, DOI 10.1016/j.jinorgbio.2008.02.008; Kurtz DM, 1999, ESSAYS BIOCHEM, V34, P85, DOI 10.1042/bse0340085; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; MCCORMICK JM, 1991, J AM CHEM SOC, V113, P9066, DOI 10.1021/ja00024a007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; REEM RC, 1987, J AM CHEM SOC, V109, P1216, DOI 10.1021/ja00238a035; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Salahudeen AA, 2009, ANN NY ACAD SCI, V1177, P30, DOI 10.1111/j.1749-6632.2009.05038.x; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Traverso ME, 2010, BIOCHEMISTRY-US, V49, P7060, DOI 10.1021/bi100866b; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wirstam M, 2003, J AM CHEM SOC, V125, P3980, DOI 10.1021/ja017692r; Xiong JJ, 2000, BIOCHEMISTRY-US, V39, P5117, DOI 10.1021/bi992796o; ZHANG JH, 1992, P NATL ACAD SCI USA, V89, P7065, DOI 10.1073/pnas.89.15.7065	42	47	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7357	7365		10.1074/jbc.M111.308684	http://dx.doi.org/10.1074/jbc.M111.308684			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253436	hybrid, Green Published			2022-12-27	WOS:000301060200037
J	Uranbileg, B; Yamamoto, H; Park, JH; Mohanty, AR; Arakawa-Takeuchi, S; Jinno, S; Okayama, H				Uranbileg, Baasanjav; Yamamoto, Hanako; Park, Jung-ha; Mohanty, Atish R.; Arakawa-Takeuchi, Shiho; Jinno, Shigeki; Okayama, Hiroto			Cdc6 Protein Activates p27(KIP1)-bound Cdk2 Protein Only after the Bound p27 Protein Undergoes C-terminal Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN TARGET; CYTOPLASMIC LOCALIZATION; INHIBITOR PROTEINS; KINASES; PATHWAY; COMPLEX; REPLICATION; GENE; EXPRESSION	In mammalian cells Cdk2 activity during the G(1)-S transition is mainly controlled by p27(KIP1). Although the amount and subcellular localization of p27 influence Cdk2 activity, how Cdk2 activity is regulated during this phase transition still remains virtually unknown. Here we report an entirely new mechanism for this regulation. Cdc6 the AAA + ATPase, known to assemble prereplicative complexes on chromosomal replication origins and activate p21(CIP1)-bound Cdk2, also activated p27-bound Cdk2 in its ATPase and cyclin binding motif-dependent manner but only after the p27 bound to the Cdk2 was phosphorylated at the C terminus. ROCK, which mediates a signal for cell anchorage to the extracellular matrix and activates the mTORC1 cascade as well as controls cytoskeleton assembly, was partly responsible for C-terminal phosphorylation of the p27. In vitro reconstitution demonstrated ROCK (Rho-associated kinase)mediated phosphorylation of Cdk2-bound p27 at the C terminus and subsequent activation of the Cdk2 by Cdc6.	[Okayama, Hiroto] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Okayama, H (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp			Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research (S) and the Global Center of Excellence from the Ministry of Education, Science, and Culture of Japan.	Arakawa-Takeuchi S, 2010, FEBS LETT, V584, P2779, DOI 10.1016/j.febslet.2010.05.005; Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen D, 2009, AM J SURG PATHOL, V33, P720, DOI 10.1097/PAS.0b013e3181934244; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kossatz U, 2006, EMBO J, V25, P5159, DOI 10.1038/sj.emboj.7601388; Lin J, 2001, ONCOGENE, V20, P2000, DOI 10.1038/sj.onc.1204375; Lopez-Beltran A, 2010, VIRCHOWS ARCH, V457, P555, DOI 10.1007/s00428-010-0969-6; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mendrzyk F, 2005, J CLIN ONCOL, V23, P8853, DOI 10.1200/JCO.2005.02.8589; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; OTSUKA H, 1976, J CELL PHYSIOL, V87, P213, DOI 10.1002/jcp.1040870209; Pandey D, 2006, BLOOD, V107, P575, DOI 10.1182/blood-2004-11-4377; Park J, 2011, J BIOL CHEM, V286, P23132, DOI 10.1074/jbc.M110.209114; Park SJ, 2011, KOREAN J UROL, V52, P466, DOI 10.4111/kju.2011.52.7.466; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schulze A, 1996, MOL CELL BIOL, V16, P4632; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6275	6283		10.1074/jbc.M111.318295	http://dx.doi.org/10.1074/jbc.M111.318295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223646	Green Published, hybrid			2022-12-27	WOS:000300791800020
J	Abrahamsen, H; O'Neill, AK; Kannan, N; Kruse, N; Taylor, SS; Jennings, PA; Newton, AC				Abrahamsen, Hilde; O'Neill, Audrey K.; Kannan, Natarajan; Kruse, Nicole; Taylor, Susan S.; Jennings, Patricia A.; Newton, Alexandra C.			Peptidyl-prolyl Isomerase Pin1 Controls Down-regulation of Conventional Protein Kinase C Isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; TURN MOTIF PHOSPHORYLATION; BETA-II; SUBCELLULAR-LOCALIZATION; PHOSPHATASE PHLPP; CELL-CYCLE; IN-VIVO; ALPHA; CANCER; DEPHOSPHORYLATION	The down-regulation or cellular depletion of protein kinase C (PKC) attendant to prolonged activation by phorbol esters is a widely described property of this key family of signaling enzymes. However, neither the mechanism of down-regulation nor whether this mechanism occurs following stimulation by physiological agonists is known. Here we show that the peptidylprolyl isomerase Pin1 provides a timer for the lifetime of conventional PKC isozymes, converting the enzymes into a species that can be dephosphorylated and ubiquitinated following activation induced by either phorbol esters or natural agonists. The regulation by Pin1 requires both the catalytic activity of the isomerase and the presence of a Pro immediately following the phosphorylated Thr of the turn motif phosphorylation site, one of two C-terminal sites that is phosphorylated during the maturation of PKC isozymes. Furthermore, the second C-terminal phosphorylation site, the hydrophobic motif, docks Pin1 to PKC. Our data are consistent with a model in which Pin1 binds the hydrophobic motif of conventional PKC isozymes to catalyze the isomerization of the phospho-Thr-Pro peptide bond at the turn motif, thus converting these PKC isozymes into species that can be efficiently down-regulated following activation.	[Abrahamsen, Hilde; O'Neill, Audrey K.; Kannan, Natarajan; Taylor, Susan S.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kannan, Natarajan; Kruse, Nicole; Taylor, Susan S.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [O'Neill, Audrey K.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01 DK54441, GM43154]; NIGMS through the University of California, San Diego [T32 GM007752]; Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R37GM043154, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS through the University of California, San Diego; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 (to A. C. N. and S. S. T.) and GM43154 (to A. C. N.) and Training Grant T32 GM007752 from the NIGMS (to A. O. through the University of California, San Diego Graduate Training Program in Cellular and Molecular Pharmacology). This work was also supported by The Norwegian Research Council (to H. A.).	Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Cenni V, 2002, BIOCHEM J, V363, P537, DOI 10.1042/0264-6021:3630537; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Dutil EM, 2000, J BIOL CHEM, V275, P10697, DOI 10.1074/jbc.275.14.10697; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2006, J BIOL CHEM, V281, P32461, DOI 10.1074/jbc.M604076200; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; JAKEN S, 1981, CANCER RES, V41, P2175; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kramer A, 1998, METH MOL B, V87, P25; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Sedwick CE, 2004, MOL IMMUNOL, V41, P675, DOI 10.1016/j.molimm.2004.01.007; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; SZALLASI Z, 1994, J BIOL CHEM, V269, P27159; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Warfel NA, 2012, J BIOL CHEM, V287, P3610, DOI 10.1074/jbc.R111.318675; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; ZHANG J, 1994, J BIOL CHEM, V269, P19578; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	66	30	31	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13262	13278		10.1074/jbc.M112.349753	http://dx.doi.org/10.1074/jbc.M112.349753			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22318721	Green Published, hybrid			2022-12-27	WOS:000302903700063
J	Zullo, AJ; Lee, S				Zullo, Alfred J.; Lee, Sunhee			Mycobacterial Induction of Autophagy Varies by Species and Occurs Independently of Mammalian Target of Rapamycin Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; TUBERCULOSIS; LC3; MACROPHAGES; MATURATION; SURVIVAL; PROTEIN; IDENTIFICATION; MACROAUTOPHAGY; MECHANISMS	The interaction of host cells with mycobacteria is complex and can lead to multiple outcomes ranging from bacterial clearance to latent infection. Although many factors are involved, the mammalian autophagy pathway is recognized as a determinant that can influence the course of infection. Intervention aimed at utilizing autophagy to clear infection requires an examination of the autophagy and signal transduction induced by mycobacteria under native conditions. With both pathogenic and non-pathogenic mycobacteria, we show that infection correlates with an increase in the mammalian target of rapamycin (mTOR) activity indicating that autophagy induction by mycobacteria occurs in an mTOR-independent manner. Analysis of Mycobacterium smegmatis and Mycobacterium bovis bacille Calmette-Guerin (BCG), which respectively induce high and low autophagy responses, indicates that lipid material is capable of inducing both autophagy and mTOR signaling. Although mycobacterial infection potently induces mTOR activity, we confirm that bacterial viability can be reduced by rapamycin treatment. In addition, our work demonstrates that BCG can reduce autophagy responses to M. smegmatis suggesting that specific mechanisms are used by BCG to minimize host cell autophagy. We conclude that autophagy induction and mTOR signaling take place concurrently during mycobacterial infection and that host autophagy responses to any given mycobacterium stem from multiple factors, including the presence of activating macromolecules and inhibitory mechanisms.	Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Lee, S (corresponding author), Duke Human Vaccine Inst, Global Hlth Res Bldg,909 S LaSalle St, Durham, NC 27710 USA.	sunhee.lee@duke.edu			National Institutes of Health [R21 AI095723-01, U54 AI057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R21AI095723, UC6AI058607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI095723-01 and U54 AI057157 (Southeast Regional Center of Excellence for Emerging Infections and Biodefense). Tuberculosis research was performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6 AI058607). Flow cytometry was performed in the Duke Human Vaccine Institute Research Flow Cytometry Shared Resource Facility (Durham, NC) under the direction of Dr. John F. Whitesides.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Crotzer VL, 2010, IMMUNOLOGY, V131, P9, DOI 10.1111/j.1365-2567.2010.03321.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ogawa M, 2011, MICROBIOL IMMUNOL, V55, P459, DOI 10.1111/j.1348-0421.2011.00343.x; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Ponpuak M, 2011, AUTOPHAGY, V7, P336, DOI 10.4161/auto.7.3.14500; Salh B, 1998, J IMMUNOL, V161, P6947; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093; Zullo AJ, 2009, J BIOL CHEM, V284, P12504, DOI 10.1074/jbc.M809436200	36	67	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12668	12678		10.1074/jbc.M111.320135	http://dx.doi.org/10.1074/jbc.M111.320135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22275355	hybrid, Green Published			2022-12-27	WOS:000302903700007
J	Lynch, TP; Ferrer, CM; Jackson, SR; Shahriari, KS; Vosseller, K; Reginato, MJ				Lynch, Thomas P.; Ferrer, Christina M.; Jackson, S. RaElle; Shahriari, Kristina S.; Vosseller, Keith; Reginato, Mauricio J.			Critical Role of O-Linked beta-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXM1; GENE-EXPRESSION PROFILES; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; NUTRIENT SENSOR; METABOLISM; PROGRESSION; BREAST; GLYCOSYLATION; MECHANISMS	Background: Cancer cells display altered metabolism and expression of the nutrient sensor O-linked beta-N-acetylglucosamine transferase (OGT). Results: Through regulation of FoxM1, OGT contributes to increased invasion, angiogenesis, and metastasis of prostate cancer cells. Conclusion: OGT plays a critical role in prostate cancer. Significance: OGT may provide a novel therapeutic target for treating prostate cancer.	[Lynch, Thomas P.; Ferrer, Christina M.; Jackson, S. RaElle; Shahriari, Kristina S.; Vosseller, Keith; Reginato, Mauricio J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Reginato, MJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St, Philadelphia, PA 19102 USA.	mauricio.reginato@drexelmed.edu	Reginato, Mauricio/I-6155-2013	Reginato, Mauricio/0000-0002-7541-4094	National Institutes of Health [R01 CA155413]; Drexel University College of Medicine CURE; NATIONAL CANCER INSTITUTE [R01CA155413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drexel University College of Medicine CURE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA155413 (to M. J. R.). This work was also supported by Drexel University College of Medicine CURE grants.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Bright RK, 1997, CANCER RES, V57, P995; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dahl E, 2005, J PATHOL, V205, P21, DOI 10.1002/path.1687; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GATENBY RA, 1995, J THEOR BIOL, V176, P447, DOI 10.1006/jtbi.1995.0212; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sauer CG, 2004, VIRCHOWS ARCH, V444, P518, DOI 10.1007/s00428-004-1016-2; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Yang DK, 2009, HUM PATHOL, V40, P464, DOI 10.1016/j.humpath.2008.10.001; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang L, 2004, PROSTATE CANCER P D, V7, P327, DOI 10.1038/sj.pcan.4500750; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	46	203	214	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11070	11081		10.1074/jbc.M111.302547	http://dx.doi.org/10.1074/jbc.M111.302547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22275356	hybrid, Green Published			2022-12-27	WOS:000302780100035
J	Mastroianni, JR; Costales, JK; Zaksheske, J; Selsted, ME; Salzman, NH; Ouellette, AJ				Mastroianni, Jennifer R.; Costales, Jessica K.; Zaksheske, Jennifer; Selsted, Michael E.; Salzman, Nita H.; Ouellette, Andre J.			Alternative Luminal Activation Mechanisms for Paneth Cell alpha-Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; PRECURSOR LIPID II; MATRIX METALLOPROTEINASE-7; ENTERIC SALMONELLOSIS; MICROBIAL ECOLOGY; HOST-DEFENSE; CRYPTDIN-4; PEPTIDES; BACTERIA; MICE	Background: Matrix metalloproteinase-7 (MMP7) processes mouse pro-alpha-defensins to bactericidal forms in Paneth cells, and MMP7(-/-) mice are considered to be alpha-defensin-null. Results: Activated alpha-defensins occur in the colonic lumen of MMP7(-/-) mice. Conclusion: alpha-Defensins are activated in MMP7(-/-) large bowel lumen by alternative proteolytic conversion mechanisms. Significance: MMP7(-/-) mice are unsuitable for studying alpha-defensin deficiency in large intestine.	[Ouellette, Andre J.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, USC Norris Canc Ctr, Los Angeles, CA 90089 USA; [Zaksheske, Jennifer; Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; [Zaksheske, Jennifer; Salzman, Nita H.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA	University of Southern California; Medical College of Wisconsin; Medical College of Wisconsin	Ouellette, AJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, USC Norris Canc Ctr, 1450 Biggy St,NRT 7505, Los Angeles, CA 90089 USA.	aouellet@usc.edu		Salzman, Nita/0000-0003-0939-6139	National Institutes of Health [DK044632, AI059346, AI022931, AI058129, AI057757]; USC Norris Cancer Center Support [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346, R01AI058129, R01AI022931, R21AI057757, R37AI022931, R01AI057757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044632, AI059346 (to A. J. O.), AI022931, AI058129 (to M. E. S.), and AI057757 (to N. H. S.) and by the USC Norris Cancer Center Support Grant P30 CA014089.	Amid C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-606; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HARWIG SSL, 1995, ADV EXP MED BIOL, V371, P251; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1988, GASTROENTEROLOGY, V94, P114, DOI 10.1016/0016-5085(88)90618-X; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Selsted M E, 1993, Genet Eng (N Y), V15, P131; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shim DH, 2010, BIOCHEM BIOPH RES CO, V401, P554, DOI 10.1016/j.bbrc.2010.09.100; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2007, BIOCHEM BIOPH RES CO, V358, P349, DOI 10.1016/j.bbrc.2007.04.132; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	44	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11205	11212		10.1074/jbc.M111.333559	http://dx.doi.org/10.1074/jbc.M111.333559			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334698	Green Published, hybrid			2022-12-27	WOS:000302780100048
J	Nurieva, RI; Podd, A; Chen, YH; Alekseev, AM; Yu, M; Qi, XP; Huang, H; Wen, RR; Wang, JM; Li, HYS; Watowich, SS; Qi, H; Dong, C; Wang, DM				Nurieva, Roza I.; Podd, Andrew; Chen, Yuhong; Alekseev, Andrei M.; Yu, Mei; Qi, Xiaopeng; Huang, Hua; Wen, Renren; Wang, Junmei; Li, Haiyan S.; Watowich, Stephanie S.; Qi, Hai; Dong, Chen; Wang, Demin			STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR BATF CONTROLS; DIFFERENTIATION; AUTOIMMUNITY; ICOS; INTERLEUKIN-21; EXPRESSION; RESPONSES; BCL6	Recent work has identified a new subset of CD4(+) T cells named as Tfh cells that are localized in germinal centers and critical in germinal center formation. Tfh cell differentiation is regulated by IL-6 and IL-21, possibly via STAT3 factor, and B cell lymphoma 6 (Bcl6) is specifically expressed in Tfh cells and required for their lineage specification. In the current study, we characterized the role of STAT5 in Tfh cell development. We found that a constitutively active form of STAT5 effectively inhibited Tfh differentiation by suppressing the expression of Tfh-associated factors (CXCmotif) receptor 5 (CXCR5), musculoaponeurotic fibrosarcoma (c-Maf), Bcl6, basic leucine zipper transcription factor ATF-like (Batf), and IL-21, and STAT5 deficiency greatly enhanced Tfh gene expression. Importantly, STAT5 regulated the expression of Tfh cell suppressor factor B lymphocyte-induced maturation protein 1 (Blimp-1); STAT5 deficiency impaired Blimp-1 expression and resulted in elevated expression of Tfh-specific genes. Similarly, inhibition of IL-2 potentiated Tfh generation, associated with dampened Blimp-1 expression; Blimp-1 overexpression inhibited Tfh gene expression in Stat5-deficient T cells, suggesting that the IL-2/STAT5 axis functions to regulate Blimp-1 expression. In vivo, deletion of STAT5 in CD4(+) T cells resulted in enhanced development of Tfh cells and germinal center B cells and led to an impair-ment of B cell tolerance in a well defined mouse tolerance model. Taken together, this study demonstrates that STAT5 controls Tfh differentiation.	[Nurieva, Roza I.; Alekseev, Andrei M.; Wang, Junmei; Li, Haiyan S.; Watowich, Stephanie S.; Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Podd, Andrew; Yu, Mei; Wen, Renren; Wang, Demin] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Podd, Andrew; Wang, Demin] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Qi, Xiaopeng; Huang, Hua] Natl Jewish Hlth, Dept Med, Div Allergy & Immunol, Denver, CO 80206 USA; [Huang, Hua] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA; [Qi, Hai] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Tsinghua University	Dong, C (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	cdong@mdanderson.org; demin.wang@bcw.edu	dong, chen/B-3181-2009; Yu, Mei/K-2206-2017; Wang, Junmei/N-2256-2014; Wang, Demin/AAX-4449-2020	dong, chen/0000-0002-0084-9130; Wang, Demin/0000-0001-5549-3795; Huang, Hua/0000-0001-7317-8983; Qi, Hai/0000-0001-5475-3989; Watowich, Stephanie/0000-0003-1969-659X	National Institutes of Health [R01 AI079087, PO1 HL44612, R56 AI071239, AI073587, AR059010]; Leukemia and Lymphoma Society; National Institutes of Health through NIAID [RO1 AI083761]; National Institutes of Health through the NIAMS [RO1 AR050772, RC2 AR059010]; M.D. Anderson Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI083761, R56AI071239, R21AI073587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772, RC2AR059010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); M.D. Anderson Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI079087 and PO1 HL44612 (to D. W.), supplement R56 AI071239 (to R. W.), and Grants AI073587 and AR059010 (to S. S. W.). This work was also supported by a Scholar Award from the Leukemia and Lymphoma Society (to D. W.).; Supported by Grant RO1 AI083761 from the National Institutes of Health through the NIAID.; Supported by grants from the National Institutes of Health through the NIAMS (Grants RO1 AR050772 and RC2 AR059010), the Leukemia and Lymphoma Society, and the M.D. Anderson Cancer Center.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	21	170	180	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11234	11239		10.1074/jbc.M111.324046	http://dx.doi.org/10.1074/jbc.M111.324046			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318729	hybrid, Green Published			2022-12-27	WOS:000302780100051
J	Teijido, O; Ujwal, R; Hillerdal, CO; Kullman, L; Rostovtseva, TK; Abramson, J				Teijido, Oscar; Ujwal, Rachna; Hillerdal, Carl-Olof; Kullman, Lisen; Rostovtseva, Tatiana K.; Abramson, Jeff			Affixing N-terminal alpha-Helix to the Wall of the Voltage-dependent Anion Channel Does Not Prevent Its Voltage Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; NEUROSPORA-CRASSA; CRYSTAL-STRUCTURE; VDAC CHANNELS; BCL-2 FAMILY; CELL-DEATH; LOOP 3; PROTEIN; PORIN; OLIGOMERIZATION	The voltage-dependent anion channel (VDAC) governs the free exchange of ions and metabolites between the mitochondria and the rest of the cell. The three-dimensional structure of VDAC1 reveals a channel formed by 19 beta-strands and an N-terminal alpha-helix located near the midpoint of the pore. The position of this alpha-helix causes a narrowing of the cavity, but ample space for metabolite passage remains. The participation of the N-terminus of VDAC1 in the voltage-gating process has been well established, but the molecular mechanism continues to be debated; however, the majority of models entail large conformational changes of this N-terminal segment. Here we report that the pore-lining N-terminal alpha-helix does not undergo independent structural rearrangements during channel gating. We engineered a double Cys mutant in murine VDAC1 that cross-links the alpha-helix to the wall of the beta-barrel pore and reconstituted the modified protein into planar lipid bilayers. The modified murine VDAC1 exhibited typical voltage gating. These results suggest that the N-terminal alpha-helix is located inside the pore of VDAC in the open state and remains associated with beta-strand 11 of the pore wall during voltage gating.	[Teijido, Oscar; Rostovtseva, Tatiana K.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Ujwal, Rachna; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Hillerdal, Carl-Olof; Kullman, Lisen] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Uppsala University	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov; jabramson@mednet.ucla.edu			Eunice Kennedy Shriver NICHD, National Institutes of Health; National Institutes of Health [RO1 GM078844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (to O. T. and T. K. R.) and National Institutes of Health Grant RO1 GM078844 (to J. A.).	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bainbridge G, 1998, FEBS LETT, V432, P117, DOI 10.1016/S0014-5793(98)00846-1; Bainbridge G, 1998, J MOL BIOL, V275, P171, DOI 10.1006/jmbi.1997.1474; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Casadio R, 2002, FEBS LETT, V520, P1, DOI 10.1016/S0014-5793(02)02758-8; Chaptal V, 2010, J STRUCT BIOL, V171, P82, DOI 10.1016/j.jsb.2010.02.005; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, J AM CHEM SOC, V131, P12970, DOI 10.1021/ja902012x; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Xu X, 2001, J MEMBRANE BIOL, V180, P73, DOI 10.1007/s002320010060; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	48	59	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11437	11445		10.1074/jbc.M111.314229	http://dx.doi.org/10.1074/jbc.M111.314229			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22275367	Green Published, hybrid			2022-12-27	WOS:000302780100072
J	Canals, D; Roddy, P; Hannun, YA				Canals, Daniel; Roddy, Patrick; Hannun, Yusuf A.			Protein Phosphatase 1 alpha Mediates Ceramide-induced ERM Protein Dephosphorylation A NOVEL MECHANISM INDEPENDENT OF PHOSPHATIDYLINOSITOL 4, 5-BIPHOSPHATE (PIP2) AND MYOSIN/ERM PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; CELL-MIGRATION; PLASMA-MEMBRANE; SPHINGOSINE 1-PHOSPHATE; ACTIN CYTOSKELETON; BINDING SUBUNIT; EZRIN; PHOSPHORYLATION; DOMAIN; ACTIVATION	ERM (ezrin, radixin, and moesin) proteins are cytoskeletal interacting proteins that bind cortical actin, the plasma membrane, and membrane proteins, which are found in specialized plasma membrane structures such as microvilli and filopodia. ERM proteins are regulated by phosphatidylinositol 4, 5-biphosphate (PIP2) and by phosphorylation of a C-terminal threonine, and its inactivation involves PIP2 hydrolysis and/or myosin phosphatase (MP). Recently, we demonstrated that ERM proteins are also subject to counter regulation by the bioactive sphingolipids ceramide and sphingosine 1-phosphate. Plasma membrane ceramide induces ERM dephosphorylation whereas sphingosine 1-phosphate induces their phosphorylation. In this work, we pursue the mechanisms by which ceramide regulates dephosphorylation. We found that this dephosphorylation was independent of hydrolysis and localization of PIP2 and MP. However, the results show that ERM dephosphorylation was blocked by treatment with protein phosphatase 1 (PP1) pharmacological inhibitors and specifically by siRNA to PP1 alpha, whereas okadaic acid, a PP2A inhibitor, failed. Moreover, a catalytic inactive mutant of PP1 alpha acted as dominant negative of the endogenous PP1 alpha. Additional results showed that the ceramide mechanism of PP1 alpha activation is largely independent of PIP2 hydrolysis and MP. Taken together, these results demonstrate a novel, acute mechanism of ERM regulation dependent on PP1 alpha and plasma membrane ceramide.	[Canals, Daniel; Roddy, Patrick; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123	National Institutes of Health [CA87584, CA97132]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA87584 and CA97132.	ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Endo K, 2009, ONCOGENE, V28, P1725, DOI 10.1038/onc.2009.20; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hishiya A, 1999, J BIOL CHEM, V274, P26705, DOI 10.1074/jbc.274.38.26705; Hla T, 2004, PROSTAG OTH LIPID M, V73, P1, DOI 10.1016/j.prostaglandins.2003.11.001; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kowluru A, 1997, FEBS LETT, V418, P179, DOI 10.1016/S0014-5793(97)01379-3; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Leoni LM, 1998, BIOCHEM PHARMACOL, V55, P1105, DOI 10.1016/S0006-2952(97)00685-0; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; MeivarLevy I, 1997, J BIOL CHEM, V272, P1558, DOI 10.1074/jbc.272.3.1558; Nakamura N, 2000, GENES CELLS, V5, P571, DOI 10.1046/j.1365-2443.2000.00348.x; Oliver Carey J., 1998, Frontiers in Bioscience, V3, pD961; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Scotto-Lavino E, 2010, J BIOL CHEM, V285, P6419, DOI 10.1074/jbc.M109.074773; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Smith ER, 2000, METHOD ENZYMOL, V312, P361; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	56	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10145	10155		10.1074/jbc.M111.306456	http://dx.doi.org/10.1074/jbc.M111.306456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311981	hybrid, Green Published			2022-12-27	WOS:000302167200046
J	Comas-Casellas, E; Martinez-Barriocanal, A; Miro, F; Ejarque-Ortiz, A; Schwartz, S; Martin, M; Sayos, J				Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Miro, Francesc; Ejarque-Ortiz, Aroa; Schwartz, Simo, Jr.; Martin, Margarita; Sayos, Joan			Cloning and Characterization of CD300d, a Novel Member of the Human CD300 Family of Immune Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; ENDOPLASMIC-RETICULUM; INHIBITORY RECEPTOR; CELL-SURFACE; FUNCTIONAL-CHARACTERIZATION; IMMUNOGLOBULIN SUPERFAMILY; INTRACELLULAR EXPRESSION; MYELOID CELLS; PROTEIN	Herein we present the cloning and molecular characterization of CD300d, a member of the human CD300 family of immune receptors. CD300d cDNA was cloned from RNA obtained from human peripheral blood mononuclear cells, and RT-PCR revealed the gene to be expressed in cells of myeloid lineage. The cloned cDNA encoded for a type I protein with a single extracellular Ig V-type domain and a predicted molecular mass of 21.5 kDa. The short cytoplasmic tail is lacking in any known signaling motif, but there is a negatively charged residue (glutamic acid) within the transmembrane domain. CD300d forms complexes with the CD300 family members, with the exception of CD300c. Contrary to other activating members of the CD300 family of receptors, surface expression of CD300d in COS-7-transfected cells required the presence of an immunoreceptor tyrosine-based activating motif-bearing adaptor (Fc epsilon R gamma). Accordingly, we found that CD300d was able to recruit Fc epsilon R gamma. Unexpectedly, we could not detect CD300d on the surface of cells expressing Fc epsilon R gamma, suggesting the existence of unknown mechanisms regulating the trafficking of this molecule. The presence of other CD300 molecules also did not modify the intracellular expression of CD300d. In fact, the presence of CD300d decreased the levels of surface expression of CD300f but not CD300c. Our data suggest that the function of CD300d would be related to the regulation of the expression of other CD300 molecules and the composition of CD300 complexes on the cell surface.	[Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Ejarque-Ortiz, Aroa; Sayos, Joan] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Immunobiol Grp, Barcelona 08035, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Drug Delivery & Targeting, Barcelona 08035, Spain; [Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Ejarque-Ortiz, Aroa; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed, Barcelona 08035, Spain; [Miro, Francesc] Inst Res Biomed, Gene Translat Lab, Barcelona 08028, Spain; [Martin, Margarita] Univ Barcelona, Fac Med, Biochem Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona 7, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Barriocanal, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Immunobiol Grp, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	agueda.martinez@vhir.org	Martinez, Agueda/AAB-7186-2019; Sayos, Joan/B-6119-2009; Schwartz, Simo/H-7776-2012; Miro-Mur, Francesc A./AAT-3013-2020; Andorra, Margarita Martin/H-2025-2015	Martinez, Agueda/0000-0002-8809-160X; Sayos, Joan/0000-0002-4664-3461; Miro-Mur, Francesc A./0000-0003-3936-2693; Andorra, Margarita Martin/0000-0002-9245-4899; Schwartz, Simo/0000-0001-8297-7971; Comas-Casellas, Emma/0000-0002-8567-6848	Plan Nacional I+D [SAF2009-07548]; Fondo de Investigaciones Sanitarias [PI080366, PI1100045]; Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya [2009 SGR 493]; Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III [CP06/00058]	Plan Nacional I+D; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Plan Nacional I+D Grant SAF2009-07548, Fondo de Investigaciones Sanitarias Grants PI080366 and PI1100045, and Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya Grant 2009 SGR 493.; Supported by Contract "Juan de la Cierva" from the Ministerio de Ciencia e Innovacion.; Supported by Contract "Miguel Servet" from the Fondo de Investigaciones Sanitarias from the Instituto de Salud Carlos III (CP06/00058). To whom correspondence may be addressed: Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Tel.: 34-93-489-30-00(ext. 3753); Fax: 34-93-489-38-93; E-mail: joan.sayos@vhir.org.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Alvarez-Errico D, 2007, J IMMUNOL, V178, P808, DOI 10.4049/jimmunol.178.2.808; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hasegawa S, 1999, BLOOD, V93, P2543, DOI 10.1182/blood.V93.8.2543.408k14_2543_2551; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Platzer B, 2010, J BIOL CHEM, V285, P15314, DOI 10.1074/jbc.M110.104281; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Seminario MC, 1999, J IMMUNOL, V162, P6893; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Smith KM, 1998, J IMMUNOL, V161, P7; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034	32	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9682	9693		10.1074/jbc.M111.279224	http://dx.doi.org/10.1074/jbc.M111.279224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291008	Green Published, hybrid			2022-12-27	WOS:000302167200003
J	Kliem, C; Merling, A; Giaisi, M; Kohler, R; Krammer, PH; Li-Weber, M				Kliem, Christian; Merling, Anette; Giaisi, Marco; Koehler, Rebecca; Krammer, Peter H.; Li-Weber, Min			Curcumin Suppresses T Cell Activation by Blocking Ca2+ Mobilization and Nuclear Factor of Activated T Cells (NFAT) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; LYMPHOCYTE-PROLIFERATION; CHEMOPREVENTIVE AGENT; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; GENE-EXPRESSION; CYCLOSPORINE-A; KINASE; CHANNELS	Curcumin is the active ingredient of the spice turmeric and has been shown to have a number of pharmacologic and therapeutic activities including antioxidant, anti-microbial, anti-inflammatory, and anti-carcinogenic properties. The anti-inflammatory effects of curcumin have primarily been attributed to its inhibitory effect on NF-kappa B activity due to redox regulation. In this study, we show that curcumin is an immunosuppressive phytochemical that blocks T cell-activation-induced Ca2+ mobilization with IC50 = similar to 12.5 mu M and thereby prevents NFAT activation and NFAT-regulated cytokine expression. This finding provides a new mechanism for curcumin-mediated anti-inflammatory and immunosuppressive function. We also show that curcumin can synergize with CsA to enhance immunosuppressive activity because of different inhibitory mechanisms. Furthermore, because Ca2+ is also the secondary messenger crucial for the TCR-induced NF-kappa B signaling pathway, our finding also provides another mechanism by which curcumin suppresses NF-kappa B activation.	[Merling, Anette; Giaisi, Marco; Koehler, Rebecca; Krammer, Peter H.; Li-Weber, Min] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Li-Weber, M (corresponding author), German Canc Res Ctr, Tumor Immunol Program D030, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	m.li-weber@dkfz-heidelberg.de						Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Cho NH, 2004, J EXP MED, V200, P681, DOI 10.1084/jem.20040924; Chueh SCJ, 2003, TRANSPLANT P, V35, P1603, DOI 10.1016/S0041-1345(03)00377-4; Cipriani B, 2001, J IMMUNOL, V167, P3454, DOI 10.4049/jimmunol.167.6.3454; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; DUMONT FJ, 1992, J EXP MED, V176, P751, DOI 10.1084/jem.176.3.751; Dyer JL, 2002, CELL CALCIUM, V31, P45, DOI 10.1054/ceca.2001.0259; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gao XH, 2004, BIOCHEM PHARMACOL, V68, P51, DOI 10.1016/j.bcp.2004.03.015; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Im SH, 2004, MOL CELLS, V18, P1; Jang MK, 2001, PLANTA MED, V67, P550, DOI 10.1055/s-2001-16482; Jobin C, 1999, J IMMUNOL, V163, P3474; Jones EA, 2000, J UROLOGY, V163, P999, DOI 10.1016/S0022-5347(05)67871-8; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kang BY, 1999, BRIT J PHARMACOL, V128, P380, DOI 10.1038/sj.bjp.0702803; Ke HM, 2003, BIOCHEM BIOPH RES CO, V311, P1095, DOI 10.1016/S0006-291X(03)01537-7; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Li-Weber M, 2005, J IMMUNOL, V175, P2132, DOI 10.4049/jimmunol.175.4.2132; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Natarajan C, 2002, J IMMUNOL, V168, P6506, DOI 10.4049/jimmunol.168.12.6506; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Piwocka K, 1999, EXP CELL RES, V249, P299, DOI 10.1006/excr.1999.4480; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; Ranjan D, 2004, J SURG RES, V121, P171, DOI 10.1016/j.jss.2004.04.004; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strimpakos AS, 2008, ANTIOXID REDOX SIGN, V10, P511, DOI 10.1089/ars.2007.1769; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Xu YX, 1997, EXP HEMATOL, V25, P413	45	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10200	10209		10.1074/jbc.M111.318733	http://dx.doi.org/10.1074/jbc.M111.318733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303019	Green Published, hybrid			2022-12-27	WOS:000302167200051
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NUCLEAR EXPORT; KINASE-C; DEATH; MICE; ACTIVATION; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION	Nuclear transcription factor Nrf2 regulates the expression and coordinated induction of a battery of genes encoding cytoprotective and drug transporter proteins in response to chemical and radiation stress. This leads to reduced apoptosis, enhanced cell survival, and increased drug resistance. In this study, we investigated the role of Nrf2 in up-regulation of antiapoptotic protein Bcl-2 and its contribution to stress-induced apoptosis and cell survival. Exposure of mouse hepatoma (Hepa-1) and human hepatoblastoma (HepG2) cells to antioxidant tert-butylhydroquinone led to induction of Bcl-2. Mutagenesis and transfection assays identified an antioxidant response element between nucleotides -3148 and -3140 on the reverse strand of the Bcl-2 gene promoter that was essential for activation of Bcl-2 gene expression. Band/supershift and ChIP assays demonstrated binding of Nrf2 to Bcl-2 antioxidant response element. Alterations in Nrf2 led to altered Bcl-2 induction and cellular apoptosis. Moreover, dysfunctional/mutant inhibitor of Nrf2 (INrf2) in human lung cancer cells failed to degrade Nrf2, resulting in an increased Bcl-2 level and decreased etoposide-and UV/gamma radiation-mediated DNA fragmentation. In addition, siRNA-mediated down-regulation of Nrf2 also led to decreased apoptosis and increased cell survival. Furthermore, the specific knockdown of Bcl-2 in Nrf2-activated tumor cells led to increased etoposide-induced apoptosis and decreased cell survival and growth/proliferation. These data provide the first evidence of Nrf2 in control of Bcl-2 expression and apoptotic cell death with implications in antioxidant protection, survival of cancer cells, and drug resistance.	[Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu		Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health [RO1 GM047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM047466.	Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Goel A, 2010, NUTR CANCER, V62, P919, DOI 10.1080/01635581.2010.509835; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	40	337	361	4	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9873	9886		10.1074/jbc.M111.312694	http://dx.doi.org/10.1074/jbc.M111.312694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275372	hybrid, Green Published			2022-12-27	WOS:000302167200020
J	Wilson, M; Hogstrand, C; Maret, W				Wilson, Matthew; Hogstrand, Christer; Maret, Wolfgang			Picomolar Concentrations of Free Zinc(II) Ions Regulate Receptor Protein-tyrosine Phosphatase beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CELL; INHIBITION; ZN(II); FLUCTUATIONS; COORDINATION; PURIFICATION; EQUILIBRIA; TARGETS; STATE	As key enzymes in the regulation of biological phosphorylations, protein-tyrosine phosphatases are central to the control of cellular signaling and metabolism. Zinc(II) ions are known to inhibit these enzymes, but the physiological significance of this inhibition has remained elusive. Employing metal buffering for strict metal control and performing a kinetic analysis, we now demonstrate that zinc(II) ions are reversible inhibitors of the cytoplasmic catalytic domain of the receptor protein-tyrosine phosphatase beta (also known as vascular endothelial protein-tyrosine phosphatase). The K-t(Zn) value is 21 +/- 7 pM, 6 orders of magnitude lower than zinc inhibition reported previously for this enzyme. It exceeds the affinity of the most potent synthetic small molecule inhibitors targeting these enzymes. Inhibition is in the range of cellular zinc( II) ion concentrations, suggesting that zinc regulates this enzyme, which is involved in vascular physiology and angiogenesis. Thus, for some enzymes that are not recognized as zinc metalloenzymes, zinc binding inhibits rather than activates as in classical zinc enzymes. Activation then requires removal of the inhibitory zinc.	[Maret, Wolfgang] Kings Coll London, Met Metab Grp, Div Diabet & Nutr Sci, Sch Med, London SE1 9NH, England; Kings Coll London, Dept Biochem, Sch Biomed Sci, London SE1 9NH, England	University of London; King's College London; University of London; King's College London	Maret, W (corresponding author), Kings Coll London, Met Metab Grp, Div Diabet & Nutr Sci, Sch Med, Franklin Wilkins Bldg 3-79,150 Stamford St, London SE1 9NH, England.	wolfgang.maret@kcl.ac.uk	Hogstrand, Christer/C-9041-2013	Hogstrand, Christer/0000-0001-7545-6975	King's College London	King's College London	This work was supported by funding provided by King's College London.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anwar ZM, 2005, J CHIN CHEM SOC-TAIP, V52, P863, DOI 10.1002/jccs.200500121; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Evdokimov AG, 2006, ACTA CRYSTALLOGR D, V62, P1435, DOI 10.1107/S0907444906037784; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fischer EH, 1999, ADV ENZYME REGUL, V39, P359, DOI 10.1016/S0065-2571(98)00014-4; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Hogstrand C, 1999, TOXICOLOGY, V133, P139, DOI 10.1016/S0300-483X(99)00020-7; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Jansen J, 2011, BIOMED HEALTH RES, V76, P514, DOI 10.3233/978-1-60750-816-8-514; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; RABENSTEIN DL, 1969, J AM CHEM SOC, V91, P2492, DOI 10.1021/ja01038a017; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Samet JM, 2010, ANNU REV PHARMACOL, V50, P215, DOI 10.1146/annurev.pharmtox.010909.105841; SIMONS TJB, 1991, J MEMBRANE BIOL, V123, P63, DOI 10.1007/BF01993964; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/nmeth.1368, 10.1038/NMETH.1368]; WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; ZANDER NF, 1991, BIOCHEMISTRY-US, V30, P6964, DOI 10.1021/bi00242a022; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	47	125	126	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9322	9326		10.1074/jbc.C111.320796	http://dx.doi.org/10.1074/jbc.C111.320796			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275360	hybrid, Green Published			2022-12-27	WOS:000301797800060
J	Brison, Y; Pijning, T; Malbert, Y; Fabre, E; Mourey, L; Morel, S; Potocki-Veronese, G; Monsan, P; Tranier, S; Remaud-Simeon, M; Dijkstra, BW				Brison, Yoann; Pijning, Tjaard; Malbert, Yannick; Fabre, Emeline; Mourey, Lionel; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Tranier, Samuel; Remaud-Simeon, Magali; Dijkstra, Bauke W.			Functional and Structural Characterization of alpha-(1 -> 2) Branching Sucrase Derived from DSR-E Glucansucrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO FERMENTATION; ALPHA-AMYLASE FAMILY; 2 CATALYTIC DOMAINS; LEUCONOSTOC-MESENTEROIDES; GLYCOSYL HYDROLASES; CRYSTAL-STRUCTURE; GNOTOBIOTIC-RATS; OLIGOSACCHARIDES; DEXTRANSUCRASE; SPECIFICITY	Delta N-123-glucan-binding domain-catalytic domain 2 (Delta N-123-GBD-CD2) is a truncated form of the bifunctional glucansucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299. It was constructed by rational truncation of GBD-CD2, which harbors the second catalytic domain of DSR-E. Like GBD-CD2, this variant displays alpha-(1-->2) branching activity when incubated with sucrose as glucosyl donor and (oligo-)dextran as acceptor, transferring glucosyl residues to the acceptor via a ping-pong bi-bi mechanism. This allows the formation of prebiotic molecules containing controlled amounts of alpha-(1-->2) linkages. The crystal structure of the apo alpha-(1-->2) branching sucrase Delta N-123-GBD-CD2 was solved at 1.90 angstrom resolution. The protein adopts the unusual U-shape fold organized in five distinct domains, also found in GTF180-Delta N and GTF-SI glucansucrases of glycoside hydrolase family 70. Residues forming subsite -1, involved in binding the glucosyl residue of sucrose and catalysis, are strictly conserved in both GTF180-Delta N and Delta N-123-GBD-CD2. Subsite +1 analysis revealed three residues (Ala-2249, Gly-2250, and Phe-2214) that are specific to Delta N-123-GBD-CD2. Mutation of these residues to the corresponding residues found in GTF180-Delta N showed that Ala-2249 and Gly-2250 are not directly involved in substrate binding and regiospecificity. In contrast, mutant F2214N had lost its ability to branch dextran, although it was still active on sucrose alone. Furthermore, three loops belonging to domains A and B at the upper part of the catalytic gorge are also specific to Delta N-123-GBD-CD2. These distinguishing features are also proposed to be involved in the correct positioning of dextran acceptor molecules allowing the formation of alpha-(-->2) branches.	[Mourey, Lionel; Tranier, Samuel] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] CNRS, UMR 5504, F-31400 Toulouse, France; [Brison, Yoann; Malbert, Yannick; Fabre, Emeline; Morel, Sandrine; Potocki-Veronese, Gabrielle; Monsan, Pierre; Remaud-Simeon, Magali] INRA, UMR Ingn Syst Biol & Proc 792, F-31400 Toulouse, France; [Pijning, Tjaard; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands; [Mourey, Lionel; Tranier, Samuel] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Monsan, Pierre] Inst Univ France, F-75005 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Groningen; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Tranier, S (corresponding author), CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.	Samuel.Tranier@ipbs.fr; remaud@insa-toulouse.fr; b.w.dijkstra@rug.nl	Veronese, Gabrielle/GTF-3473-2022; Pijning, Tjaard/ABA-2929-2021; Dijkstra, Bauke W./H-4308-2019; Pijning, Tjaard/HDO-3704-2022; Mourey, Lionel/B-5662-2009; Tranier, Samuel/C-6059-2011	Pijning, Tjaard/0000-0003-4107-3663; Dijkstra, Bauke W./0000-0001-9731-6586; Mourey, Lionel/0000-0002-8259-1259; Tranier, Samuel/0000-0001-9751-163X	region Midi-Pyrenees (France); European Molecular Biology Organization	region Midi-Pyrenees (France)(Region Occitanie); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the region Midi-Pyrenees (France) and the European Molecular Biology Organization.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DJOUZI Z, 1995, J APPL BACTERIOL, V79, P117, DOI 10.1111/j.1365-2672.1995.tb00924.x; Djouzi Z, 1997, BRIT J NUTR, V78, P313, DOI 10.1079/BJN19970149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabre E, 2005, J BACTERIOL, V187, P296, DOI 10.1128/JB.187.1.296-303.2005; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Flickinger EA, 2000, J NUTR, V130, P1267, DOI 10.1093/jn/130.5.1267; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Ito K, 2010, ACTA CRYSTALLOGR F, V66, P1086, DOI 10.1107/S1744309110029714; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monsan P, 2010, CURR OPIN MICROBIOL, V13, P293, DOI 10.1016/j.mib.2010.03.002; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pijning T, 2008, BIOCATAL BIOTRANSFOR, V26, P12, DOI 10.1080/10242420701789163; Remaud-Simeon M, 2000, J MOL CATAL B-ENZYM, V10, P117, DOI 10.1016/S1381-1177(00)00119-3; ROBYT JF, 1979, CARBOHYD RES, V68, P95, DOI 10.1016/S0008-6215(00)84059-8; Sarbini SR, 2011, APPL ENVIRON MICROB, V77, P5307, DOI 10.1128/AEM.02568-10; Shah DSH, 2004, J BACTERIOL, V186, P8301, DOI 10.1128/JB.186.24.8301-8308.2004; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; VALETTE P, 1993, J SCI FOOD AGR, V62, P121, DOI 10.1002/jsfa.2740620204; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	35	69	74	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7915	7924		10.1074/jbc.M111.305078	http://dx.doi.org/10.1074/jbc.M111.305078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262856	Green Published, hybrid			2022-12-27	WOS:000301349400008
J	Bullen, HE; Charnaud, SC; Kalanon, M; Riglar, DT; Dekiwadia, C; Kangwanrangsan, N; Torii, M; Tsuboi, T; Baum, J; Ralph, SA; Cowman, AF; de Koning-Ward, TF; Crabb, BS; Gilson, PR				Bullen, Hayley E.; Charnaud, Sarah C.; Kalanon, Ming; Riglar, David T.; Dekiwadia, Chaitali; Kangwanrangsan, Niwat; Torii, Motomi; Tsuboi, Takafumi; Baum, Jacob; Ralph, Stuart A.; Cowman, Alan F.; de Koning-Ward, Tania F.; Crabb, Brendan S.; Gilson, Paul R. d			Biosynthesis, Localization, and Macromolecular Arrangement of the Plasmodium falciparum Translocon of Exported Proteins (PTEX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE INVASION; DENSE GRANULES; MEMBRANE; CLYA; VIRULENCE; REVEALS; VACCINE; TOXIN	To survive within its host erythrocyte, Plasmodium falciparum must export hundreds of proteins across both its parasite plasma membrane and surrounding parasitophorous vacuole membrane, most of which are likely to use a protein complex known as PTEX (Plasmodium translocon of exported proteins). PTEX is a putative protein trafficking machinery responsible for the export of hundreds of proteins across the parasitophorous vacuole membrane and into the human host cell. Five proteins are known to comprise the PTEX complex, and in this study, three of the major stoichiometric components are investigated including HSP101 (a AAA(+) ATPase), a protein of no known function termed PTEX150, and the apparent membrane component EXP2. We show that these proteins are synthesized in the preceding schizont stage (PTEX150 and HSP101) or even earlier in the life cycle (EXP2), and before invasion these components reside within the dense granules of invasive merozoites. From these apical organelles, the protein complex is released into the host cell where it resides with little turnover in the parasitophorous vacuole membrane for most of the remainder of the following cell cycle. At this membrane, PTEX is arranged in a stable macromolecular complex of >1230 kDa that includes an similar to 600-kDa apparently homo-oligomeric complex of EXP2 that can be separated from the remainder of the PTEX complex using non-ionic detergents. Two different biochemical methods undertaken here suggest that PTEX components associate as EXP2-PTEX150-HSP101, with EXP2 associating with the vacuolar membrane. Collectively, these data support the hypothesis that EXP2 oligomerizes and potentially forms the putative membrane-spanning pore to which the remainder of the PTEX complex is attached.	[Bullen, Hayley E.; Charnaud, Sarah C.; Crabb, Brendan S.; Gilson, Paul R. d] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Bullen, Hayley E.; Riglar, David T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Charnaud, Sarah C.] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; [Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia; [Riglar, David T.; Baum, Jacob; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Melbourne, Vic 3052, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Kangwanrangsan, Niwat; Torii, Motomi] Ehime Univ, Grad Sch Med, Dept Mol Parasitol, Toon, Ehime 7910295, Japan; [Tsuboi, Takafumi] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Tsuboi, Takafumi] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Crabb, Brendan S.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Crabb, Brendan S.; Gilson, Paul R. d] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Burnet Institute; University of Melbourne; Monash University; Deakin University; Walter & Eliza Hall Institute; University of Melbourne; Ehime University; Ehime University; Ehime University; University of Melbourne; Monash University	Crabb, BS (corresponding author), Burnet Inst, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	crabb@burnet.edu.au; gilson@burnet.edu.au	de Koning-Ward, Tania F/N-3572-2017; Crabb, Brendan/F-5287-2013; Tsuboi, Takafumi/AAK-6145-2021; Cowman, Alan F/C-7642-2013; Ralph, Stuart/C-8590-2014	de Koning-Ward, Tania F/0000-0001-5810-8063; Cowman, Alan F/0000-0001-5145-9004; Charnaud, Sarah/0000-0002-9029-9696; Riglar, David/0000-0002-5004-4373; Ralph, Stuart/0000-0003-0114-7808; Baum, Jake/0000-0002-0275-352X; Tsuboi, Takafumi/0000-0002-7415-1325; Bullen, Hayley/0000-0003-4923-3019	Australian National Health and Medical Research Council [516740, 533811, 406601]; Pratt Foundation through University of Melbourne; National Health and Medical Research Council; Grants-in-Aid for Scientific Research [23406007] Funding Source: KAKEN	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation through University of Melbourne; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Australian National Health and Medical Research Council Grants 516740, 533811, and 406601).; Supported by a Pratt Foundation Scholarship through University of Melbourne.; Supported by a National Health and Medical Research Council Career Development Fellowship award.	Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Sanders PR, 2007, MOL BIOCHEM PARASIT, V154, P148, DOI 10.1016/j.molbiopara.2007.04.013; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989; TRAGER W, 1992, INFECT IMMUN, V60, P4656, DOI 10.1128/IAI.60.11.4656-4661.1992; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, METHODS MOL BIOL, V607, P73, DOI 10.1007/978-1-60327-331-2_8; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	28	91	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7871	7884		10.1074/jbc.M111.328591	http://dx.doi.org/10.1074/jbc.M111.328591			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253438	Green Published, hybrid			2022-12-27	WOS:000301349400004
J	Ding, Y; Ko, MH; Pehar, M; Kotch, F; Peters, NR; Luo, Y; Salamat, SM; Puglielli, L				Ding, Yun; Ko, Mi Hee; Pehar, Mariana; Kotch, Frank; Peters, Noel R.; Luo, Yun; Salamat, Shahriar M.; Puglielli, Luigi			Biochemical Inhibition of the Acetyltransferases ATase1 and ATase2 Reduces beta-Secretase (BACE1) Levels and A beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; BRAIN; OLIGOMERS; NEURONS; MEMORY; CELLS; ER	The cellular levels of beta-site APP cleaving enzyme 1 (BACE1), the rate-limiting enzyme for the generation of the Alzheimer disease (AD) amyloid beta-peptide (A beta), are tightly regulated by two ER-based acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2. Here we report that both acetyltransferases are expressed in neurons and glial cells, and are up-regulated in the brain of AD patients. We also report the identification of first and second generation compounds that inhibit ATase1/ATase2 and down-regulate the expression levels as well as activity of BACE1. The mechanism of action involves competitive and non-competitive inhibition as well as generation of unstable intermediates of the ATases that undergo degradation.	[Puglielli, Luigi] Univ Wisconsin Madison, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Ding, Yun; Puglielli, Luigi] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI 53705 USA; [Kotch, Frank; Peters, Noel R.; Luo, Yun] Univ Wisconsin Madison, Small Mol Screening Facil, Madison, WI 53705 USA; [Salamat, Shahriar M.] Univ Wisconsin Madison, Dept Pathol, Madison, WI 53705 USA; [Puglielli, Luigi] VA Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center	Puglielli, L (corresponding author), Univ Wisconsin Madison, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health (NIH)/NIA [AG028569, AG033514]; Department of Veterans Affairs; Rotary Coins for Alzheimer Research Trust; UW Institute for Clinical and Translational Research; NCRR/NIH [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG033514, R01AG028569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); Rotary Coins for Alzheimer Research Trust; UW Institute for Clinical and Translational Research; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in whole or in part, by National Institutes of Health (NIH)/NIA Grants AG028569 and AG033514, Department of Veterans Affairs, Rotary Coins for Alzheimer Research Trust Fund, and UW Institute for Clinical and Translational Research (funded through an NCRR/NIH Clinical and Translational Science Award, 1UL1RR025011).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Rodriguez JJ, 2011, MOL NEUROBIOL, V43, P87, DOI 10.1007/s12035-010-8157-x; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	27	31	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8424	8433		10.1074/jbc.M111.310136	http://dx.doi.org/10.1074/jbc.M111.310136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267734	hybrid, Green Published			2022-12-27	WOS:000301349400057
J	Kumarasiri, M; Llarrull, LI; Borbulevych, O; Fishovitz, J; Lastochkin, E; Baker, BM; Mobashery, S				Kumarasiri, Malika; Llarrull, Leticia I.; Borbulevych, Oleg; Fishovitz, Jennifer; Lastochkin, Elena; Baker, Brian M.; Mobashery, Shahriar			An Amino Acid Position at Crossroads of Evolution of Protein Function ANTIBIOTIC SENSOR DOMAIN OF BlaR1 PROTEIN FROM STAPHYLOCOCCUS AUREUS VERSUS CLASS D beta-LACTAMASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; N-ZETA-DECARBOXYLATION; BLAR1 PROTEIN; SENSOR DOMAIN; CRYSTAL-STRUCTURES; ANTIBIOTICS; MECHANISM; LYSINE; ACTIVATION; DESIGN	The integral membrane protein BlaR1 of Staphylococcus aureus senses the presence of beta-lactam antibiotics in the milieu and transduces the information to its cytoplasmic side, where its activity unleashes the expression of a set of genes, including that for BlaR1 itself, which manifest the antibiotic-resistant phenotype. The x-ray structure of the sensor domain of this protein exhibits an uncanny similarity to those of the class D beta-lactamases. The former is a membrane-bound receptor/sensor for the beta-lactam antibiotics, devoid of catalytic competence for substrate turnover, whereas the latter are soluble periplasmic enzymes in Gram-negative bacteria with avid ability for beta-lactam turnover. The two are clearly related to each other from an evolutionary point of view. However, the high resolution x-ray structures for both by themselves do not reveal why one is a receptor and the other an enzyme. It is documented herein that a single amino acid change at position 439 of the BlaR1 protein is sufficient to endow the receptor/sensor protein with modest turnover ability for cephalosporins as substrates. The x-ray structure for this mutant protein and the dynamics simulations revealed how a hydrolytic water molecule may sequester itself in the antibiotic-binding site to enable hydrolysis of the acylated species. These studies document how the nature of the residue at position 439 is critical for the fate of the protein in imparting unique functions on the same molecular template, to result in one as a receptor and in another as a catalyst.	[Kumarasiri, Malika; Llarrull, Leticia I.; Borbulevych, Oleg; Fishovitz, Jennifer; Lastochkin, Elena; Baker, Brian M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mobashery@nd.edu	Baker, Brian/B-4584-2009; Fishovitz, Jennifer/R-8507-2018	Baker, Brian/0000-0002-0864-0964; 	National Institutes of Health [AI33170]; NIAID, National Institutes of Health [HHSN272200700055C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104987, R01AI033170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI33170. This work was also supported by the Network on Antimicrobial Resistance in Staphylococcus aureus program under NIAID, National Institutes of Health Contract HHSN272200700055C.	[Anonymous], 2010, SYB X; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Case DA, 2008, AMBER 11; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher J. F., 2010, ENZYMOLOGY ANTIBACTE; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knox JR, 1996, CHEM BIOL, V3, P937, DOI 10.1016/S1074-5521(96)90182-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu XS, 2004, PROTEINS, V54, P491, DOI 10.1002/prot.10514; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Maveyraud L, 2002, J AM CHEM SOC, V124, P2461, DOI 10.1021/ja016736t; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOBASHERY S, 1990, P NATL ACAD SCI USA, V87, P578, DOI 10.1073/pnas.87.2.578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vercheval L, 2010, BIOCHEM J, V432, P495, DOI 10.1042/BJ20101122; WALEY SG, 1991, BIOCHEM J, V279, P87, DOI 10.1042/bj2790087; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Wilkinson AS, 2003, BIOCHEMISTRY-US, V42, P1950, DOI 10.1021/bi0266941	31	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8232	8241		10.1074/jbc.M111.333179	http://dx.doi.org/10.1074/jbc.M111.333179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262858	Green Published, hybrid			2022-12-27	WOS:000301349400038
J	Pagiatakis, C; Gordon, JW; Ehyai, S; McDermott, JC				Pagiatakis, Christina; Gordon, Joseph W.; Ehyai, Saviz; McDermott, John C.			A Novel RhoA/ROCK-CPI-17-MEF2C Signaling Pathway Regulates Vascular Smooth Muscle Cell Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MEF2C; SERUM RESPONSE FACTOR; MYOSIN PHOSPHATASE; PROTEIN PHOSPHATASE-1; MARKER GENES; MYOCARDIN; DIFFERENTIATION; KINASE; CPI-17; ACTIVATION	Differentiation of vascular smooth muscle cells (VSMC) is a fundamental aspect of normal development and vascular disease. During contraction, VSMCs modulate calcium sensitivity through RhoA/ROCK-mediated inhibition of the myosin light chain phosphatase complex (MLCP). Previous studies have demonstrated that this signaling pathway functions in parallel to increase the expression of smooth muscle genes through the myocardin-family of co-activators. MEF2C fulfills a critical role in VSMC differentiation and regulates myocardin expression, leading us to investigate whether the RhoA/ROCK signaling cascade might regulate MEF2 activity. Depolarization-induced calcium signaling increased the expression of myocardin, which was sensitive to ROCK and p38 MAPK inhibition. We previously identified protein phosphatase 1 alpha (PP1 alpha), a known catalytic subunit of the MLCP in VSMCs, as a potent repressor of MEF2 activity. PP1 alpha inhibition resulted in increased expression of myocardin, while ectopic expression of PP1 alpha inhibited the induction of myocardin by MEF2C. Consistent with these data, shRNA-mediated suppression of a PP1 alpha inhibitor, CPI-17, reduced myocardin expression and inhibited VSMC differentiation, suggesting a pivotal role for CPI-17 in regulating MEF2 activity. These data constitute evidence of a novel signaling cascade that links RhoA-mediated calcium sensitivity to MEF2-dependent myocardin expression in VSMCs through a mechanism involving p38 MAPK, PP1 alpha, and CPI-17.	[Pagiatakis, Christina; Gordon, Joseph W.; Ehyai, Saviz; McDermott, John C.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [McDermott, John C.] York Univ, CRMS, Toronto, ON M3J 1P3, Canada; [Gordon, Joseph W.; McDermott, John C.] York Univ, MHRC, Toronto, ON M3J 1P3, Canada; [McDermott, John C.] York Univ, CRBI, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	McDermott, JC (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	jmcderm@yorku.ca	Pagiatakis, Christina/AAB-3844-2019	Pagiatakis, Christina/0000-0002-9315-9648; Gordon, Joseph/0000-0002-0061-2168	Heart and Stroke Foundation of Canada (HSFC)	Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Heart and Stroke Foundation of Canada (HSFC) (to J. C. M.).	Chu SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL983, DOI 10.1152/ajplung.00454.2005; Cohen PTW, 2002, J CELL SCI, V115, P241; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Hamaguchi T, 2000, BIOCHEM BIOPH RES CO, V274, P825, DOI 10.1006/bbrc.2000.3225; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kim JI, 2009, HISTOCHEM CELL BIOL, V132, P191, DOI 10.1007/s00418-009-0604-2; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lin Q, 1998, DEVELOPMENT, V125, P4565; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Perry RLS, 2009, MOL CELL BIOL, V29, P3355, DOI 10.1128/MCB.00227-08; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Zhao M, 1999, MOL CELL BIOL, V19, P21	36	50	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8361	8370		10.1074/jbc.M111.286203	http://dx.doi.org/10.1074/jbc.M111.286203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275376	hybrid, Green Published			2022-12-27	WOS:000301349400051
J	Zou, L; Cao, S; Kang, NL; Huebert, RC; Shah, VH				Zou, Li; Cao, Sheng; Kang, Ningling; Huebert, Robert C.; Shah, Vijay H.			Fibronectin Induces Endothelial Cell Migration through beta 1 Integrin and Src-dependent Phosphorylation of Fibroblast Growth Factor Receptor-1 at Tyrosines 653/654 and 766	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; I COLLAGEN MATRICES; FACTOR EGF RECEPTOR; C-SRC; SIGNAL-TRANSDUCTION; BINDING-SITE; SH2 DOMAIN; ACTIVATION; INTEGRIN; AUTOPHOSPHORYLATION	The extracellular matrix microenvironment regulates cell phenotype and function. One mechanism by which this is achieved is the transactivation of receptor tyrosine kinases by specific matrix molecules. Here, we demonstrate that the provisional matrix protein, fibronectin (FN), activates fibroblast growth factor (FGF) receptor-1 (FGFR1) independent of FGF ligand in liver endothelial cells. FN activation of FGFR1 requires beta 1 integrin, as evidenced by neutralizing antibody and siRNA-based studies. Complementary genetic and pharmacologic approaches identify that the non-receptor tyrosine kinase Src is required for FN transactivation of FGFR1. Whereas FGF ligand-induced phosphorylation of FGFR1 preferentially activates ERK, FN-induced phosphorylation of FGFR1 preferentially activates AKT, indicating differential downstream signaling of FGFR1 in response to alternate stimuli. Mutation analysis of known tyrosine residues of FGFR1 reveals that tyrosine 653/654 and 766 residues are required for FN-FGFR1 activation of AKT and chemotaxis. Thus, our study mechanistically dissects a new signaling pathway by which FN achieves endothelial cell chemotaxis, demonstrates how differential phosphorylation profiles of FGFR1 can achieve alternate downstream signals, and, more broadly, highlights the diversity of mechanisms by which the extracellular matrix microenvironment regulates cell behavior through transactivation of receptor tyrosine kinases.	[Shah, Vijay H.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA; Mayo Clin, Canc Cell Biol Program, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Shah, VH (corresponding author), Mayo Clin, Gastroenterol Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	shah.vijay@mayo.edu		Huebert, Robert/0000-0002-9812-7573	National Institutes of Health [DK59615-06, HL086990, AA021171-01, P30DK084567]; NATIONAL CANCER INSTITUTE [R01CA160069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059615, P30DK084567, R56DK059615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021171, R37AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59615-06 (to V. H. S.), HL086990 (to V. H. S.), AA021171-01 (to V. H. S.), and P30DK084567 (to the Mayo Clinic Center for Cell Signaling in Gastroenterology).	Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bhaskar V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-61; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Cao S, 2010, J CLIN INVEST, V120, P2379, DOI 10.1172/JCI41203; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Cross MJ, 2000, J CELL SCI, V113, P643; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dell'Era P, 1999, MOL BIOL CELL, V10, P23, DOI 10.1091/mbc.10.1.23; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; di Bonzo LV, 2009, HISTOL HISTOPATHOL, V24, P1323, DOI 10.14670/HH-24.1323; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Erba EB, 2005, MOL CELL PROTEOMICS, V4, P1107, DOI 10.1074/mcp.M500070-MCP200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Hu YL, 2009, J BIOL CHEM, V284, P29905, DOI 10.1074/jbc.M109.049155; Huebert RC, 2010, LAB INVEST, V90, P1770, DOI 10.1038/labinvest.2010.132; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Kang NL, 2010, AM J PATHOL, V177, P1888, DOI 10.2353/ajpath.2010.100187; Kilkenny DM, 2003, J BIOL CHEM, V278, P17448, DOI 10.1074/jbc.M209698200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Larsson H, 1999, J BIOL CHEM, V274, P25726, DOI 10.1074/jbc.274.36.25726; Lei L, 2008, MOL CELL BIOL, V28, P794, DOI 10.1128/MCB.00443-07; Lundin L, 2003, EXP CELL RES, V287, P190, DOI 10.1016/S0014-4827(03)00125-3; Marsden M, 2001, DEVELOPMENT, V128, P3635; Mettouchi A, 2006, EUR J CELL BIOL, V85, P243, DOI 10.1016/j.ejcb.2005.09.010; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nagel M, 1999, DEVELOPMENT, V126, P1975; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Paternostro C, 2010, WORLD J GASTROENTERO, V16, P281, DOI 10.3748/wjg.v16.i3.281; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Sahni A, 2004, BLOOD, V104, P3635, DOI 10.1182/blood-2004-04-1358; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Serini G, 2008, CURR OPIN HEMATOL, V15, P235, DOI 10.1097/MOH.0b013e3282fa745b; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Somanath PR, 2009, CELL BIOCHEM BIOPHYS, V53, P53, DOI 10.1007/s12013-008-9040-5; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Tsakiridis T, 1998, J BIOL CHEM, V273, P28322, DOI 10.1074/jbc.273.43.28322; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang JF, 2001, J BIOL CHEM, V276, P41950, DOI 10.1074/jbc.M101370200; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; ZHAN X, 1994, J BIOL CHEM, V269, P20221	68	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7190	7202		10.1074/jbc.M111.304972	http://dx.doi.org/10.1074/jbc.M111.304972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247553	hybrid, Green Published			2022-12-27	WOS:000301060200022
J	Ono, T; Miyazaki, T; Ishida, Y; Uehata, M; Nagata, K				Ono, Takashi; Miyazaki, Takahiro; Ishida, Yoshihito; Uehata, Masayoshi; Nagata, Kazuhiro			Direct in Vitro and in Vivo Evidence for Interaction between Hsp47 Protein and Collagen Triple Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE HSP47; ENDOPLASMIC-RETICULUM; BINDING-SITES; IV COLLAGEN; PROCOLLAGEN; RECOGNITION; CELLS; STABILIZATION; EXPRESSION; IMPERFECTA	Hsp47 ((h) under bar eat (s) under bar hock (p) under bar rotein (47) under bar), a collagen-specific molecular chaperone, is essential for the maturation of various types of procollagens. Previous studies have suggested that Hsp47 may preferentially recognize the triple-helix form of procollagen rather than unfolded procollagen chains in the endoplasmic reticulum. However, the underlying mechanism has remained unclear because of limitations in the available methods for detecting in vitro and in vivo interactions between Hsp47 and collagen. In this study, we established novel methods for this purpose by adopting a time-resolved FRET technique in vitro and a bimolecular fluorescence complementation technique in vivo. Using these methods, we provide direct evidence that Hsp47 binds to collagen triple helices but not to the monomer form in vitro. We also demonstrate that Hsp47 binds a collagen model peptide in the trimer conformation in vivo. Hsp47 did not bind collagen peptides that had been modified to block their ability to form triple helices in vivo. These results conclusively indicate that Hsp47 recognizes the triple-helix form of procollagen in vitro and in vivo.	[Ishida, Yoshihito; Nagata, Kazuhiro] Kyoto Sangyo Univ, Mol & Cellular Biol Lab, Fac Life Sci, Kita Ku, Kyoto 8038555, Japan; [Ono, Takashi; Uehata, Masayoshi] Mitsubishi Tanabe Pharma Corp, Discovery Mol Pharmacol Dept, Discovery Screening Ctr, Aoba Ku, Yokohama, Kanagawa 2270033, Japan; [Miyazaki, Takahiro] Mitsubishi Tanabe Pharma Corp, Target Discovery & Biomarker Res Dept, Adv Med Res Lab, Aoba Ku, Yokohama, Kanagawa 2270033, Japan	Kyoto Sangyo University; Mitsubishi Tanabe Pharma Corporation; Mitsubishi Tanabe Pharma Corporation	Nagata, K (corresponding author), Kyoto Sangyo Univ, Mol & Cellular Biol Lab, Fac Life Sci, Kita Ku, Kyoto 8038555, Japan.	nagata@cc.kyoto-su.ac.jp		Ono, Takashi/0000-0002-1820-8040	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Byers PH, 2001, PHILOS T ROY SOC B, V356, P151, DOI 10.1098/rstb.2000.0760; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Koide T, 1999, J BIOL CHEM, V274, P34523, DOI 10.1074/jbc.274.49.34523; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; NATSUME T, 1994, J BIOL CHEM, V269, P31224; Nishikawa Y, 2010, BIOORGAN MED CHEM, V18, P3767, DOI 10.1016/j.bmc.2010.04.054; Okano-Kosugi H, 2009, ANAL BIOCHEM, V394, P125, DOI 10.1016/j.ab.2009.07.017; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; SAXENA P, 1992, J BACTERIOL, V174, P1956, DOI 10.1128/jb.174.6.1956-1964.1992; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Tasab M, 2002, J BIOL CHEM, V277, P35007, DOI 10.1074/jbc.M202782200; Thomson CA, 2003, PROTEIN SCI, V12, P1792, DOI 10.1110/ps.0236903; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637	33	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6810	6818		10.1074/jbc.M111.280248	http://dx.doi.org/10.1074/jbc.M111.280248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235129	hybrid, Green Published			2022-12-27	WOS:000300791800066
J	Fernandes, RA; Shore, DA; Vuong, MT; Yu, C; Zhu, XY; Pereira-Lopes, S; Brouwer, H; Fennelly, JA; Jessup, CM; Evans, EJ; Wilson, IA; Davis, SJ				Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Zhu, Xueyong; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Wilson, Ian A.; Davis, Simon J.			T Cell Receptors are Structures Capable of Initiating Signaling in the Absence of Large Conformational Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-RICH SEQUENCE; ANTIGEN RECEPTOR; CRYSTAL-STRUCTURE; TCR-ALPHA; CD3-EPSILON-GAMMA HETERODIMER; SURFACE MOLECULES; TYROSINE KINASE; TCR/CD3 COMPLEX; LOW-AFFINITY; CD3 COMPLEX	Native and non-native ligands of the T cell receptor (TCR), including antibodies, have been proposed to induce signaling in T cells via intra- or intersubunit conformational rearrangements within the extracellular regions of TCR complexes. We have investigated whether any signatures can be found for such postulated structural changes during TCR triggering induced by antibodies, using crystallographic and mutagenesis-based approaches. The crystal structure of murine CD3 epsilon complexed with the mitogenic anti-CD3 epsilon antibody 2C11 enabled the first direct structural comparisons of antibody-liganded and unliganded forms of CD3 epsilon from a single species, which revealed that antibody binding does not induce any substantial rearrangements within CD3 epsilon. Saturation mutagenesis of surface-exposed CD3 epsilon residues, coupled with assays of antibody-induced signaling by the mutated complexes, suggests a new configuration for the complex within which CD3 epsilon is highly exposed and reveals that no large new CD3 epsilon interfaces are required to form during antibody-induced signaling. The TCR complex therefore appears to be a structure that is capable of initiating intracellular signaling in T cells without substantial structural rearrangements within or between the component subunits. Our findings raise the possibility that signaling by native ligands might also be initiated in the absence of large structural rearrangements in the receptor.	[Zhu, Xueyong; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Fernandes, Ricardo A.; Shore, David A.; Vuong, Mai T.; Yu, Chao; Pereira-Lopes, Selma; Brouwer, Heather; Fennelly, Janet A.; Jessup, Claire M.; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England	Scripps Research Institute; University of Oxford; University of Oxford	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; simon.davis@ndm.ox.ac.uk	Fernandes, Ricardo/AAB-8165-2019; Zhu, Xueyong/ABE-3068-2021	Fernandes, Ricardo/0000-0001-5343-3334; Jessup, Claire/0000-0003-1184-6653	National Institutes of Health [AI042266]; Wellcome Trust; United Kingdom Medical Research Council; Fundacao para a Ciencia e a Tecnologia of Portugal; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12010/4] Funding Source: researchfish; MRC [MC_UU_12010/4] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI042266. This work was also supported by the Wellcome Trust, the United Kingdom Medical Research Council, the Fundacao para a Ciencia e a Tecnologia of Portugal, and the Skaggs Institute for Chemical Biology.	Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; BURNS GF, 1982, J IMMUNOL, V129, P1451; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Evans EJ, 2006, J BIOL CHEM, V281, P29309, DOI 10.1074/jbc.M601314200; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Fernandes RA, 2010, CELL, V142, P668, DOI 10.1016/j.cell.2010.08.018; FRANK SJ, 1990, SCIENCE, V249, P174, DOI 10.1126/science.2371564; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gouaillard C, 2001, EUR J IMMUNOL, V31, P3798, DOI 10.1002/1521-4141(200112)31:12<3798::AID-IMMU3798>3.0.CO;2-Z; HUBBARD SJ, 1992, FARADAY DISCUSS, V93, P13, DOI 10.1039/fd9929300013; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Karaivanova V, 1999, HYBRIDOMA, V18, P497; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; KONING F, 1988, J IMMUNOL, V140, P3126; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2010, P NATL ACAD SCI USA, V107, P5094, DOI 10.1073/pnas.1000925107; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; MANOLIOS N, 1994, EUR J IMMUNOL, V24, P84, DOI 10.1002/eji.1830240114; Martinez-Martin N, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000402; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Mohan S, 2009, BIOCHEMISTRY-US, V48, P1390, DOI 10.1021/bi801901d; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; WEISS A, 1984, J IMMUNOL, V133, P123; WEISS A, 1984, P NATL ACAD SCI-BIOL, V81, P4169, DOI 10.1073/pnas.81.13.4169; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394	71	26	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13324	13335		10.1074/jbc.M111.332783	http://dx.doi.org/10.1074/jbc.M111.332783			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22262845	hybrid, Green Published			2022-12-27	WOS:000302903700068
J	Fan, SQ; Huang, W; Wang, LX				Fan, Shu-Quan; Huang, Wei; Wang, Lai-Xi			Remarkable Transglycosylation Activity of Glycosynthase Mutants of Endo-D, an Endo-beta-N-acetylglucosaminidase from Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; MOLECULAR-CLONING; FLAVOBACTERIUM-MENINGOSEPTICUM; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PRIMARY SEQUENCE; STRUCTURAL BASIS; GLYCOPROTEINS	Endo-beta-N-acetylglucosaminidase from Streptococcus pneumoniae (Endo-D) is an endoglycosidase capable of hydrolyzing the Fc N-glycan of intact IgG antibodies after sequential removal of the sialicacid, galactose, and internal GlcNAc residues in the N-glycan. Endo-D also possesses transglycosylation activity with sugar oxazoline as the donor substrate, but the transglycosylation yield is low due to enzymatic hydrolysis of the donor substrate and the product. We report here our study on the hydrolytic and transglycosylation activity of recombinant Endo-D and its selected mutants. We found that Endo-D preferred core-fucosylated N-glycan for hydrolysis but favored nonfucosylated GlcNAc acceptor for transglycosylation. Several mutants showed significantly enhanced transglycosylation efficiency over the wild type enzyme. Two mutants (N322Q and N322A) were identified as typical glycosynthases that demonstrated remarkable transglycosylation activity with only marginal or no product hydrolysis activity. Kinetic studies revealed that the N332Q and N322A glycosynthases had much higher catalytic efficiency for glycosylating the nonfucosylated GlcNAc acceptor. In comparison, the N322Q was much more efficient than N322A for transglycosylation. However, N332Q and N332A could not take more complex N-glycan oxazoline as substrate for transglycosylation, indicating their strict substrate specificity. The usefulness of the N332Q glycosynthase was exemplified by its application for efficient glycosylation remodeling of IgG-Fc domain.	[Fan, Shu-Quan; Huang, Wei; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wang, LX (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Dept Biochem & Mol Biol, 725 W Lombard St, Baltimore, MD 21201 USA.	lwang@som.umaryland.edu	wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8790-2019; Wang, Lai-Xi/E-8755-2019; Huang, Wei/P-9631-2017; Wang, Xin/AAN-8435-2021	Wang, Lai-Xi/0000-0003-4293-5819; Huang, Wei/0000-0001-6432-1848; Wang, Xin/0000-0002-4457-7376	National Institutes of Health [GM080374, GM080374-S1]; China Scholarship Council [2010622098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080374 and GM080374-S1 (to L. X. W.).; Supported in part by a fellowship from the China Scholarship Council (2010622098).	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Amin MN, 2011, J AM CHEM SOC, V133, P14404, DOI 10.1021/ja204831z; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Ochiai H, 2008, J AM CHEM SOC, V130, P13790, DOI 10.1021/ja805044x; Parsons TB, 2010, ORG BIOMOL CHEM, V8, P1861, DOI 10.1039/b926078a; Raju TS, 2006, BIOCHEM BIOPH RES CO, V341, P797, DOI 10.1016/j.bbrc.2006.01.030; Rao V, 1999, PROTEIN SCI, V8, P2338; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; TARENTINO AL, 1993, J BIOL CHEM, V268, P9702; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; Wei YD, 2008, BIOCHEMISTRY-US, V47, P10294, DOI 10.1021/bi800874y; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	38	63	93	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11272	11281		10.1074/jbc.M112.340497	http://dx.doi.org/10.1074/jbc.M112.340497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318728	Green Published, hybrid			2022-12-27	WOS:000302780100055
J	Zhao, B; Lei, L; Kagawa, N; Sundaramoorthy, M; Banerjee, S; Nagy, LD; Guengerich, FP; Waterman, MR				Zhao, Bin; Lei, Li; Kagawa, Norio; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.			Three-dimensional Structure of Steroid 21-Hydroxylase (Cytochrome P450 21A2) with Two Substrates Reveals Locations of Disease-associated Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; DIOXYGEN COMPLEX; PROTON-TRANSFER; ACTIVE-SITE; WILD-TYPE; DEFICIENCY; GENE	Steroid 21-hydroxylase (cytochrome P450 21A2, CYP21A2) deficiency accounts for similar to 95% of individuals with congenital adrenal hyperplasia, a common autosomal recessive metabolic disorder of adrenal steroidogenesis. The effects of amino acid mutations on CYP21A2 activity lead to impairment of the synthesis of cortisol and aldosterone and the excessive production of androgens. In order to understand the structural and molecular basis of this group of diseases, the bovine CYP21A2 crystal structure complexed with the substrate 17-hydroxyprogesterone (17OHP) was determined to 3.0 angstrom resolution. An intriguing result from this structure is that there are two molecules of 17OHP bound to the enzyme, the distal one being located at the entrance of the substrate access channel and the proximal one bound in the active site. The substrate binding features locate the key substrate recognition residues not only around the heme but also along the substrate access channel. In addition, orientation of the skeleton of the proximal molecule is toward the interior of the enzyme away from the substrate access channel. The 17OHP complex of CYP21A2 provides a good relationship between the crystal structure, clinical data, and genetic mutants documented in the literature, thereby enhancing our understanding of congenital adrenal hyperplasia. In addition, the location of certain CYP21A2 mutations provides general understanding of structure/function relationships in P450s.	[Zhao, Bin; Lei, Li; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Sundaramoorthy, Munirathinam; Banerjee, Surajit; Nagy, Leslie D.; Guengerich, F. Peter; Waterman, Michael R.] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Kagawa, Norio] Nagoya Univ, Grad Sch Med, Global Ctr Excellence Program, Nagoya, Aichi 4668550, Japan	Vanderbilt University; Vanderbilt University; Nagoya University	Zhao, B (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 632 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	bin.zhao@vanderbilt.edu; Michael.Waterman@vanderbilt.edu		Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health [GM69970, R37 CA090426, P30 ES000267]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69970 (to M. R. W. and F. P. G.), R37 CA090426 (to F. P. G.), and P30 ES000267 (to F. P. G. and M. R. W.).	Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; Bleicken C, 2009, HUM MUTAT, V30, pE443, DOI 10.1002/humu.20926; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Concolino P, 2010, CLIN CHEM LAB MED, V48, P1057, DOI 10.1515/CCLM.2010.239; Dauber A, 2010, CLIN CHEM, V56, P1245, DOI 10.1373/clinchem.2010.146035; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ghosh D, 2010, J STEROID BIOCHEM, V118, P197, DOI 10.1016/j.jsbmb.2009.09.012; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hatae T, 1996, FEBS LETT, V389, P268, DOI 10.1016/0014-5793(96)00600-X; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; Hlavica P, 2003, J INORG BIOCHEM, V96, P279, DOI 10.1016/S0162-0134(03)00152-1; Jaaskelainen J, 1997, J CLIN ENDOCR METAB, V82, P3293, DOI 10.1210/jc.82.10.3293; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; KAGAWA N, 1991, J BIOL CHEM, V266, P11199; Krone N, 1998, CLIN CHEM, V44, P2075; Krone N, 2009, BEST PRACT RES CL EN, V23, P181, DOI 10.1016/j.beem.2008.10.014; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mornet E, 2000, HUM GENET, V106, P330, DOI 10.1007/s004390051046; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Shaw AM, 2010, NEONATAL NETW, V29, P191, DOI 10.1891/0730-0832.29.3.191; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Wedell A, 2011, ENDOCR DEV, V20, P80, DOI 10.1159/000321223; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1985, P NATL ACAD SCI USA, V82, P1089, DOI 10.1073/pnas.82.4.1089; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	40	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10613	10622		10.1074/jbc.M111.323501	http://dx.doi.org/10.1074/jbc.M111.323501			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262854	Green Published, hybrid			2022-12-27	WOS:000302167200086
J	Morais, S; Salama-Alber, O; Barak, Y; Hadar, Y; Wilson, DB; Lamed, R; Shoham, Y; Bayer, EA				Morais, Sarah; Salama-Alber, Orly; Barak, Yoav; Hadar, Yitzhak; Wilson, David B.; Lamed, Raphael; Shoham, Yuval; Bayer, Edward A.			Functional Association of Catalytic and Ancillary Modules Dictates Enzymatic Activity in Glycoside Hydrolase Family 43 beta-Xylosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS; BIOCHEMICAL-CHARACTERIZATION; SELENOMONAS-RUMINANTIUM; STREPTOMYCES-LIVIDANS; BIFUNCTIONAL PROTEIN; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; EXPRESSION	beta-Xylosidases are hemicellulases that hydrolyze short xylo-oligosaccharides into xylose units, thus complementing endoxylanase degradation of the hemicellulose component of lignocellulosic substrates. Here, we describe the cloning, characterization, and kinetic analysis of a glycoside hydrolase family 43 beta-xylosidase (Xyl43A) from the aerobic cellulolytic bacterium, Thermobifida fusca. Temperature and pH optima of 55-60 degrees C and 5.5-6, respectively, were determined. The apparent K-m value was 0.55 mM, using p-nitrophenyl xylopyranoside as substrate, and the catalytic constant (k(cat)) was 6.72 s(-1). T. fusca Xyl43A contains a catalytic module at the N terminus and an ancillary module (termed herein as Module-A) of undefined function at the C terminus. We expressed the two recombinant modules independently in Escherichia coli and examined their remaining catalytic activity and binding properties. The separation of the two Xyl43A modules caused the complete loss of enzymatic activity, whereas potent binding to xylan was fully maintained in the catalytic module and partially in the ancillary Module-A. Nondenaturing gel electrophoresis revealed a specific noncovalent coupling of the two modules, thereby restoring enzymatic activity to 66.7% (relative to the wild-type enzyme). Module-A contributes a phenylalanine residue that functions as an essential part of the active site, and the two juxtaposed modules function as a single functional entity.	[Morais, Sarah; Salama-Alber, Orly; Barak, Yoav; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Morais, Sarah; Hadar, Yitzhak] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; [Wilson, David B.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel; [Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Cornell University; Tel Aviv University; Technion Israel Institute of Technology	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ed.bayer@weizmann.ac.il	Shoham, Yuval/M-4409-2013	Morais, Sarah/0000-0001-9026-2386	United States-Israel Binational Science Foundation, Jerusalem, Israel; Israeli Centers of Research Excellence (I-CORE) [Center 152/11]; Alternative Energy Research Initiative Bioenergy Consortium; Weizmann Institute of Science Alternative Energy Research Initiative; Israel Science Foundation [966/09, 159/07, 24/11]	United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); Israeli Centers of Research Excellence (I-CORE); Alternative Energy Research Initiative Bioenergy Consortium; Weizmann Institute of Science Alternative Energy Research Initiative; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by grants from the United States-Israel Binational Science Foundation, Jerusalem, Israel, Israeli Centers of Research Excellence (I-CORE) Program (Center 152/11), Alternative Energy Research Initiative Bioenergy Consortium, Brazilian friends of the Weizmann Institute of Science Alternative Energy Research Initiative (research grants from Charles Rothschild, Mario Fleck, and Roberto and Renata Ruhman), Technion-Niedersachsen Research Cooperation Program, and Israel Science Foundation Grants 966/09, 159/07, and 24/11.	Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; BACHMANN SL, 1991, APPL ENVIRON MICROB, V57, P2121, DOI 10.1128/AEM.57.8.2121-2130.1991; Barker IJ, 2010, J PHYS CHEM B, V114, P15389, DOI 10.1021/jp107886e; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; Bourgois TM, 2007, APPL MICROBIOL BIOT, V75, P1309, DOI 10.1007/s00253-007-0956-2; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Chun YC, 1998, J MICROBIOL BIOTECHN, V8, P28; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; GOSALBES MJ, 1991, J BACTERIOL, V173, P7705, DOI 10.1128/jb.173.23.7705-7710.1991; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; IRWIN D, 1994, APPL ENVIRON MICROB, V60, P763, DOI 10.1128/AEM.60.3.763-770.1994; Jordan DB, 2007, BBA-PROTEINS PROTEOM, V1774, P1192, DOI 10.1016/j.bbapap.2007.06.010; Kim JH, 2004, CAN J MICROBIOL, V50, P835, DOI 10.1139/W04-077; KLUEPFEL D, 1990, BIOCHEM J, V267, P45, DOI 10.1042/bj2670045; Kukolya J, 2002, INT J SYST EVOL MICR, V52, P1193, DOI [10.1099/ijs.0.01925-0, 10.1099/00207713-52-4-1193]; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; LaGrange DC, 1997, APPL MICROBIOL BIOT, V47, P262; Leal TF, 2004, FEMS MICROBIOL LETT, V241, P41, DOI 10.1016/j.femsle.2004.10.003; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; McKie VA, 1997, BIOCHEM J, V323, P547, DOI 10.1042/bj3230547; MORIYAMA H, 1987, EUR J BIOCHEM, V166, P539, DOI 10.1111/j.1432-1033.1987.tb13547.x; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Price N. C., 2001, FUNDAMENTALS ENZYMOL, P133; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; SAKKA K, 1993, BIOSCI BIOTECH BIOCH, V57, P268, DOI 10.1271/bbb.57.268; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Smaali I, 2006, APPL MICROBIOL BIOT, V73, P582, DOI 10.1007/s00253-006-0512-5; Tabka MG, 2006, ENZYME MICROB TECH, V39, P897, DOI 10.1016/j.enzmictec.2006.01.021; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; UTT EA, 1991, APPL ENVIRON MICROB, V57, P1227, DOI 10.1128/AEM.57.4.1227-1234.1991; van den Broek LAM, 2005, APPL MICROBIOL BIOT, V67, P641, DOI 10.1007/s00253-004-1850-9; Vandermarliere E, 2007, ACTA CRYSTALLOGR F, V63, P692, DOI 10.1107/S1744309107033702; Whitehead TR, 2001, CURR MICROBIOL, V43, P293, DOI 10.1007/s002840010304; WILSON DB, 1992, CRIT REV BIOTECHNOL, V12, P45, DOI 10.3109/07388559209069187; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; Yoshida S, 2010, J BACTERIOL, V192, P5424, DOI 10.1128/JB.00503-10	45	24	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9213	9221		10.1074/jbc.M111.314286	http://dx.doi.org/10.1074/jbc.M111.314286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270362	hybrid, Green Published			2022-12-27	WOS:000301797800049
J	Solis, E; Zdravkovic, I; Tomlinson, ID; Noskov, SY; Rosenthal, SJ; De Felice, LJ				Solis, Ernesto, Jr.; Zdravkovic, Igor; Tomlinson, Ian D.; Noskov, Sergei Y.; Rosenthal, Sandra J.; De Felice, Louis J.			4-(4-(Dimethylamino)phenyl)-1-methylpyridinium (APP(+)) Is a Fluorescent Substrate for the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIDEPRESSANT BINDING-SITE; REUPTAKE INHIBITORS; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTERS; TRICYCLIC ANTIDEPRESSANTS; HALOPERIDOL METABOLITES; BACTERIAL HOMOLOG; XENOPUS OOCYTES; LIVING CELLS; DOPAMINE	Monoamine transporters terminate synaptic neurotransmission and are molecular targets for antidepressants and psychostimulants. Fluorescent reporters can monitor real-time transport and are amenable for high-throughput screening. However, until now, their use has mostly been successful to study the catecholamine transporters but not the serotonin (5HT) transporter. Here, we use fluorescence microscopy, electrophysiology, pharmacology, and molecular modeling to compare fluorescent analogs of 1-methyl-4-phenylpyridinium (MPP+) as reporters for the human serotonin transporter (hSERT) in single cells. The fluorescent substrate 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) exhibits superior fluorescence uptake in hSERT-expressing HEK293 cells than other MPP+ analogs tested. APP(+) uptake is Na+-and Cl--dependent, displaced by 5HT, and inhibited by fluoxetine, suggesting APP(+) specifically monitors hSERT activity. ASP(+), which was previously used to study catecholamine transporters, is 10 times less potent than APP(+) at inhibiting 5HT uptake and has minimal hSERT-mediated uptake. Furthermore, in hSERT-expressing oocytes voltage-clamped to -60 mV, APP(+) induced fluoxetine-sensitive hSERT-mediated inward currents, indicating APP(+) is a substrate, whereas ASP(+) induced hSERT-mediated outward currents and counteracted 5HT-induced hSERT currents, indicating ASP(+) possesses activity as an inhibitor. Extra-precise ligand receptor docking of APP(+) and ASP(+) in an hSERT homology model showed both ASP(+) and APP(+) docked favorably within the active region; accordingly, comparable concentrations are required to elicit their opposite electrophysiological responses. We conclude APP(+) is better suited than ASP(+) to study hSERT transport fluorometrically.	[Solis, Ernesto, Jr.] Vanderbilt Univ, Sch Med, Grad Training Program Neurosci, Nashville, TN 37235 USA; [Solis, Ernesto, Jr.; De Felice, Louis J.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Zdravkovic, Igor; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Tomlinson, Ian D.; Rosenthal, Sandra J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Virginia Commonwealth University; University of Calgary; Vanderbilt University	Solis, E (corresponding author), 1101 E Marshall St,Room 3-038M, Richmond, VA 23298 USA.	esolis3@vcu.edu		De Felice, Louis/0000-0002-4594-3171; Solis, Jr., Ernesto/0000-0001-9406-9540; Noskov, Sergei/0000-0001-7769-335X	National Institutes of Health [1RC1DA028112-01, DA026947-01A1, EB003728, 5RO3MH61874-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH061874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028112, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants 1RC1DA028112-01, DA026947-01A1, EB003728, and 5RO3MH61874-02.	Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1996, MOL PHARMACOL, V50, P957; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bryan-Lluka LJ, 1999, N-S ARCH PHARMACOL, V360, P109, DOI 10.1007/s002109900060; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Budygin EA, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0002.2002; Busch AE, 1996, J BIOL CHEM, V271, P32599, DOI 10.1074/jbc.271.51.32599; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHANG ASS, 1989, P NATL ACAD SCI USA, V86, P9611, DOI 10.1073/pnas.86.23.9611; Daws LC, 2009, PHARMACOL THERAPEUT, V121, P89, DOI 10.1016/j.pharmthera.2008.10.004; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9; FEIGHNER JP, 1994, FORTSCHR NEUROL PSYC, V62, P9; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Fowler A, 2006, J BIOMOL SCREEN, V11, P1027, DOI 10.1177/1087057106294698; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; GLUCK MR, 1994, J NEUROCHEM, V63, P655; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Haunso A, 2007, J BIOMOL SCREEN, V12, P378, DOI 10.1177/1087057107299524; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Hohage H, 1998, J PHARMACOL EXP THER, V286, P305; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Jorgensen S, 2008, J NEUROSCI METH, V169, P168, DOI 10.1016/j.jneumeth.2007.12.004; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KRUEGER MJ, 1993, J NEUROCHEM, V61, P1546, DOI 10.1111/j.1471-4159.1993.tb13653.x; Li CZ, 2006, CLIN EXP PHARMACOL P, V33, P1088, DOI 10.1111/j.1440-1681.2006.04491.x; Machaca K, 1998, BIOPHYS J, V74, P1286, DOI 10.1016/S0006-3495(98)77842-7; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Murali S, 2006, J PHYS CHEM A, V110, P28, DOI 10.1021/jp053878r; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Nelson N, 1998, J NEUROCHEM, V71, P1785; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramsey IS, 2002, J BIOL CHEM, V277, P14475, DOI 10.1074/jbc.M110783200; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS7, DOI 10.1097/00004714-199606002-00002; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS1, DOI 10.1097/00004714-199606002-00001; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUDNICK G, 1993, MOL PHARMACOL, V43, P271; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schwartz JW, 2006, HANDB EXP PHARM, V175, P23; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Vaswani M, 2004, EXPERT OPIN INV DRUG, V13, P349, DOI 10.1517/13543784.13.4.349; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Wang HW, 2006, ACTA PHARMACOL SIN, V27, P289, DOI 10.1111/j.1745-7254.2006.00274.x; White KJ, 2005, AAPS J, V7; Wright AM, 1998, BRAIN RES, V788, P215, DOI 10.1016/S0006-8993(97)01551-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	71	36	36	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8852	8863		10.1074/jbc.M111.267757	http://dx.doi.org/10.1074/jbc.M111.267757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291010	hybrid, Green Published			2022-12-27	WOS:000301797800017
J	Matenia, D; Hempp, C; Timm, T; Eikhof, A; Mandelkow, EM				Matenia, Dorthe; Hempp, Cindy; Timm, Thomas; Eikhof, Annika; Mandelkow, Eva-Maria			Microtubule Affinity-regulating Kinase 2 (MARK2) Turns on Phosphatase and Tensin Homolog (PTEN)-induced Kinase 1 (PINK1) at Thr-313, a Mutation Site in Parkinson Disease EFFECTS ON MITOCHONDRIAL TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN-INDUCED KINASE-1; OXIDATIVE STRESS; SUBCELLULAR-DISTRIBUTION; RECESSIVE PARKINSONISM; ALZHEIMERS-DISEASE; NEURONS; PROTEIN; PHOSPHORYLATION; MARK/PAR-1; TAU	The kinase MARK2/Par-1 plays key roles in several cell processes, including neurodegeneration such as Alzheimer disease by phosphorylating tau and detaching it from microtubules. In search of interaction partners of MARK2, we identified phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), which is important for the survival of neurons and whose mutations are linked to familial Parkinson disease (PD). MARK2 phosphorylated and activated the cleaved form of PINK1 (Delta N-PINK1; amino acids 156-581). Thr-313 was the primary phosphorylation site, a residue mutated to a non-phosphorylatable form (T313M) in a frequent variant of PD. Mutation of Thr-313 to Met or Glu in PINK1 showed toxic effects with abnormal mitochondrial distribution in neurons. MARK2 and PINK1 were found to colocalize with mitochondria and regulate their transport. Delta N-PINK1 promoted anterograde transport and increased the fraction of stationary mitochondria, whereas full-length PINK1 promoted retrograde transport. In both cases, MARK2 enhanced the effects. The results identify MARK2 as an upstream regulator of PINK1 and Delta N-PINK1 and provide insights into the regulation of mitochondrial trafficking in neurons and neurodegeneration in PD.	[Matenia, Dorthe; Hempp, Cindy; Timm, Thomas; Eikhof, Annika; Mandelkow, Eva-Maria] Deutsch Elektronen Synchrotron DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany; [Mandelkow, Eva-Maria] DZNE, D-53175 Bonn, Germany; [Mandelkow, Eva-Maria] CAESAR, D-53175 Bonn, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR)	Matenia, D (corresponding author), Deutsch Elektronen Synchrotron DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	matenia@mpasmb.desy.de; mandelkow@dzne.de			Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen); European Union	Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen); European Union(European Commission)	This work was supported in part by the Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung und Forschung (Kompetenznetz Degenerativer Demenzen), and European Union (FP7-MEMOSAD project).	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Deas E, 2011, BBA-MOL CELL RES, V1813, P623, DOI 10.1016/j.bbamcr.2010.08.007; Deas E, 2009, EMBO MOL MED, V1, P152, DOI 10.1002/emmm.200900024; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Lin W, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-90; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matenia D, 2005, MOL BIOL CELL, V16, P4410, DOI 10.1091/mbc.E05-01-0081; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mills RD, 2008, J NEUROCHEM, V105, P18, DOI 10.1111/j.1471-4159.2008.05249.x; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pogson JH, 2011, CURR NEUROL NEUROSCI, V11, P283, DOI 10.1007/s11910-011-0187-x; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Schmitt-Ulms G, 2009, CELL MOTIL CYTOSKEL, V66, P661, DOI 10.1002/cm.20394; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Trinczek B, 1999, J CELL SCI, V112, P2355; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	55	46	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8174	8186		10.1074/jbc.M111.262287	http://dx.doi.org/10.1074/jbc.M111.262287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238344	Green Published, hybrid			2022-12-27	WOS:000301349400033
J	Wittnam, JL; Portelius, E; Zetterberg, H; Gustavsson, MK; Schilling, S; Koch, B; Demuth, HU; Blennow, K; Wirths, O; Bayer, TA				Wittnam, Jessica L.; Portelius, Erik; Zetterberg, Henrik; Gustavsson, Mikael K.; Schilling, Stephan; Koch, Birgit; Demuth, Hans-Ulrich; Blennow, Kaj; Wirths, Oliver; Bayer, Thomas A.			Pyroglutamate Amyloid beta (A beta) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL HETEROGENEITY; GLUTAMINYL CYCLASE; MAJOR COMPONENT; SENILE PLAQUES; NEURON LOSS; PEPTIDES; PROTEIN; DEPOSITS; NEURODEGENERATION; AMYLOIDOGENICITY	Pyroglutamate-modified A beta peptides at amino acid position three (A beta(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). A beta(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim of the present work was to study the direct effect of elevated A beta(pE3-42) levels on ongoing AD pathology using transgenic mouse models. To this end, we generated a novel mouse model (TBA42) that produces A beta(pE3-42). TBA42 mice showed age-dependent behavioral deficits and A beta(pE3-42) accumulation. The A beta profile of an established AD mouse model, 5XFAD, was characterized using immunoprecipitation followed by mass spectrometry. Brains from 5XFAD mice demonstrated a heterogeneous mixture of full-length, N-terminal truncated, and modified A beta peptides: A beta(1-42), A beta(1-40), A beta(pE3-40), A beta(pE3-42), A beta(3-42), A beta(4-42), and A beta(5-42). 5XFAD and TBA42 mice were then crossed to generate transgenic FAD42 mice. At 6 months of age, FAD42 mice showed an aggravated behavioral phenotype compared with single transgenic 5XFAD or TBA42 mice. ELISA and plaque load measurements revealed that A beta(pE3) levels were elevated in FAD42 mice. No change in A beta(x-42) or other A beta isoforms was discovered by ELISA and mass spectrometry. These observations argue for a seeding effect of A beta(pE-42) in FAD42 mice.	[Wittnam, Jessica L.; Wirths, Oliver; Bayer, Thomas A.] Univ Gottingen, Univ Med Gottingen, Div Mol Psychiat, D-37075 Gottingen, Germany; [Portelius, Erik; Zetterberg, Henrik; Gustavsson, Mikael K.; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Clin Neurochem Lab, S-41345 Gothenburg, Sweden; [Schilling, Stephan; Koch, Birgit; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Saale, Germany	University of Gottingen; University of Gothenburg; Vivoryon Therapeutics	Bayer, TA (corresponding author), Univ Gottingen, Univ Med Gottingen, Div Mol Psychiat, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Wirths, Oliver/C-7342-2019	Wirths, Oliver/0000-0002-4115-0334				Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Christensen DZ, 2010, NEUROBIOL AGING, V31, P1153, DOI 10.1016/j.neurobiolaging.2008.07.022; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; Galimberti D, 2006, NEUROBIOL AGING, V27, P1763, DOI 10.1016/j.neurobiolaging.2005.10.007; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	58	66	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8154	8162		10.1074/jbc.M111.308601	http://dx.doi.org/10.1074/jbc.M111.308601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267726	Green Published, hybrid			2022-12-27	WOS:000301349400031
J	Zacho, RM; Jensen, L; Terp, R; Jensenius, JC; Thiel, S				Zacho, Rikke M.; Jensen, Lisbeth; Terp, Randi; Jensenius, Jens C.; Thiel, Steffen			Studies of the Pattern Recognition Molecule H-ficolin SPECIFICITY AND PURIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN-BINDING-LECTIN; HAKATA ANTIGEN; COMPLEMENT PATHWAY; ACTIVATION; PROTEIN; MEMBER; ASSOCIATION; COLLECTINS; MONOCYTES; BACTERIA	Ficolins are pattern recognition molecules of the innate immune system. H-ficolin is found in plasma associated with mannan-binding lectin-associated serine proteases (MASPs). When H-ficolin binds to microorganisms the MASPs are activated, which in turn activate the complement system. H-ficolin is the most abundant ficolin in humans, yet its ligand binding characteristics and biological role remain obscure. We examined the binding of H-ficolin to Aerococcus viridans as well as to a more defined artificial target, i.e. acetylated bovine serum albumin. A strict dependence for calcium ions and inhibition at high NaCl concentration was found. The binding to acetylated bovine serum albumin was inhibited by acetylsalicylic acid and sodium acetate as well as by N-acetylated glucosamine and galactosamine (GlcNAc and GalNAc) and glycine (GlyNAc). The binding to A. viridans was sensitive to the same compounds, but, importantly, higher concentrations were needed for inhibition. N-Acetylated cysteine was also inhibitory, but this inhibition was parallel with reduction in the oligomerization of H-ficolin and thus represents structural changes of the molecule. Based on our findings, we developed a procedure for the purification of H-ficolin from serum, involving PEG precipitation, affinity chromatography on Sepharose derivatized with acetylated serum albumin, ion exchange chromatography, and gel permeation chromatography. The purified H-ficolin was observed to elute at 700 kDa, similar to what we find for H-ficolin in whole serum. MASP-2 was co-purified with H-ficolin, and the purified H-ficolin.MASP-2 complex could activate complement as measured by cleavage of complement factor C4. This study extends our knowledge of the specificity of this pattern recognition molecule, and the purified product will enable further studies.	[Zacho, Rikke M.; Jensen, Lisbeth; Terp, Randi; Jensenius, Jens C.; Thiel, Steffen] Univ Aarhus, Dept Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark	Aarhus University	Thiel, S (corresponding author), Univ Aarhus, Dept Med Microbiol & Immunol, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	st@microbiology.au.dk		Thiel, Steffen/0000-0002-4817-155X	Danish Council for Independent Research; Novo Nordisk Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The support from the Danish Council for Independent Research and the Novo Nordisk Foundation is appreciated.	Akaiwa M, 1999, J HISTOCHEM CYTOCHEM, V47, P777, DOI 10.1177/002215549904700607; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Christiansen OB, 1999, SCAND J IMMUNOL, V49, P193; Dagnaes-Hansen F, 2004, LAB ANIM-UK, V38, P321, DOI 10.1258/002367704323133718; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Evans-Osses I, 2010, BIOCHEM BIOPH RES CO, V395, P382, DOI 10.1016/j.bbrc.2010.04.025; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Krarup A, 2005, INFECT IMMUN, V73, P1052, DOI 10.1128/IAI.73.2.1052-1060.2005; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Le Y, 1997, J IMMUNOL METHODS, V204, P43, DOI 10.1016/S0022-1759(97)00029-X; Liu Y, 2005, J IMMUNOL, V175, P3150, DOI 10.4049/jimmunol.175.5.3150; Lu J, 1996, IMMUNOLOGY, V89, P289, DOI 10.1046/j.1365-2567.1996.d01-732.x; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; Matsushita M, 2001, INT IMMUNOPHARMACOL, V1, P359, DOI 10.1016/S1567-5769(00)00045-X; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; Matsushita M, 2000, J IMMUNOL, V165, P2637, DOI 10.4049/jimmunol.165.5.2637; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Matsushita M, 2002, J IMMUNOL, V168, P3502, DOI 10.4049/jimmunol.168.7.3502; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; NAKAJIMA T, 1974, J BIOL CHEM, V249, P7679; NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Sugimoto R, 1998, J BIOL CHEM, V273, P20721, DOI 10.1074/jbc.273.33.20721; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Teh C, 2000, IMMUNOLOGY, V101, P225, DOI 10.1046/j.1365-2567.2000.00099.x; Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145; THIEL S, 1995, PEDIATR ALLERGY IMMU, V6, P20, DOI 10.1111/j.1399-3038.1995.tb00252.x; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Tsujimura M, 2002, CLIN CHIM ACTA, V325, P139, DOI 10.1016/S0009-8981(02)00274-7; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Vorup-Jensen T, 1998, IMMUNOBIOLOGY, V199, P348, DOI 10.1016/S0171-2985(98)80039-9; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; YAE Y, 1991, BIOCHIM BIOPHYS ACTA, V1078, P369, DOI 10.1016/0167-4838(91)90158-V	52	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8071	8081		10.1074/jbc.M111.301044	http://dx.doi.org/10.1074/jbc.M111.301044			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238349	hybrid, Green Published			2022-12-27	WOS:000301349400023
J	An, J; Shi, JX; He, Q; Lui, K; Liu, YX; Huang, Y; Sheikh, MS				An, Jie; Shi, Jingxue; He, Qin; Lui, Ki; Liu, Yuxin; Huang, Ying; Sheikh, M. Saeed			CHCM1/CHCHD6, Novel Mitochondrial Protein Linked to Regulation of Mitofilin and Mitochondrial Cristae Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BINDING PROTEIN; CYTOCHROME-C; COILED-COIL; DNA-DAMAGE; MEMBRANE; IDENTIFICATION; APOPTOSIS; RELEASE; GENE	The structural integrity of mitochondrial cristae is crucial for mitochondrial functions; however, the molecular events controlling the structural integrity and biogenesis of mitochondrial cristae remain to be fully elucidated. Here, we report the functional characterization of a novel mitochondrial protein named CHCM1 (coiled coil helix cristae morphology 1)/CHCHD6. CHCM1/CHCHD6 harbors a coiled coil helix-coiled coil helix domain at its C-terminal end and predominantly localizes to mitochondrial inner membrane. CHCM1/CHCHD6 knockdown causes severe defects in mitochondrial cristae morphology. The mitochondrial cristae in CHCM1/CHCHD6-deficient cells become hollow with loss of structural definitions and reduction in electron-dense matrix. CHCM1/CHCHD6 depletion also leads to reductions in cell growth, ATP production, and oxygen consumption. CHCM1/CHCHD6 through its C-terminal end strongly and directly interacts with the mitochondrial inner membrane protein mitofilin, which is known to also control mitochondrial cristae morphology. CHCM1/CHCHD6 also interacts with other mitofilin-associated proteins, including DISC1 and CHCHD3. Knockdown of CHCM1/CHCHD6 reduces mitofilin protein levels; conversely, mitofilin knockdown leads to reduction in CHCM1 levels, suggesting coordinate regulation between these proteins. Our results further indicate that genotoxic anticancer drugs that induce DNA damage down-regulate CHCM1/CHCHD6 expression in multiple human cancer cells, whereas mitochondrial respiratory chain inhibitors do not affect CHCM1/CHCHD6 levels. CHCM1/CHCHD6 knockdown in human cancer cells enhances chemosensitivity to genotoxic anticancer drugs, whereas its overexpression increases resistance. Collectively, our results indicate that CHCM1/CHCHD6 is linked to regulation of mitochondrial cristae morphology, cell growth, ATP production, and oxygen consumption and highlight its potential as a possible target for cancer therapeutics.	[An, Jie; Shi, Jingxue; He, Qin; Lui, Ki; Liu, Yuxin; Huang, Ying; Sheikh, M. Saeed] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Sheikh, MS (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	sheikhm@upstate.edu		Lui, Ki/0000-0002-1690-4616; Liu, Yuxin/0000-0002-0623-2561	National Institutes of Health [CA157168, ES016668]; NATIONAL CANCER INSTITUTE [R21CA157168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA157168 and ES016668 (to M. S. S.).	Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Corcoran CA, 2008, MOL CANCER RES, V6, P795, DOI 10.1158/1541-7786.MCR-07-2097; Corcoran CA, 2009, J BIOL CHEM, V284, P21955, DOI 10.1074/jbc.M109.024232; Czarnecka A. M, 2007, J CANC MOL, V3, P71; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Goh YC, 2011, CELL MOL LIFE SCI, V68, P1581, DOI 10.1007/s00018-010-0534-0; Gottlieb E, 2006, CELL, V126, P27, DOI 10.1016/j.cell.2006.06.030; He Qin, 2009, Mol Cell Pharmacol, V1, P23; ITO S, 1968, J CELL BIOL, V39, pA168; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Lui HM, 2003, MOL CANCER RES, V1, P508; Luo X, 2005, CELL DEATH DIFFER, V12, P1310, DOI 10.1038/sj.cdd.4401659; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Montalbano J, 2007, J BIOL CHEM, V282, P37640, DOI 10.1074/jbc.M704760200; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; Odgren PR, 1996, J CELL SCI, V109, P2253; Oka T, 2008, MOL BIOL CELL, V19, P2597, DOI 10.1091/mbc.E07-12-1205; Ozawa T, 2007, ACS CHEM BIOL, V2, P176, DOI 10.1021/cb600492a; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Powell MJ, 2011, CANCER RES, V71, P964, DOI 10.1158/0008-5472.CAN-10-3172; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Shoshan-Barmatz V, 2004, BBA-BIOENERGETICS, V1657, P105, DOI 10.1016/j.bbabio.2004.02.009; Sun H, 2010, MOL CANCER RES, V8, P57, DOI 10.1158/1541-7786.MCR-09-0278; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Velours J, 2009, INT J BIOCHEM CELL B, V41, P1783, DOI 10.1016/j.biocel.2009.01.011; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	43	89	97	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7411	7426		10.1074/jbc.M111.277103	http://dx.doi.org/10.1074/jbc.M111.277103			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228767	hybrid, Green Published			2022-12-27	WOS:000301060200042
J	Pasetto, M; Barison, E; Castagna, M; Della Cristina, P; Anselmi, C; Colombatti, M				Pasetto, Matteo; Barison, Erika; Castagna, Monica; Della Cristina, Pietro; Anselmi, Cristina; Colombatti, Marco			Reductive Activation of Type 2 Ribosome-inactivating Proteins Is Promoted by Transmembrane Thioredoxin-related Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DISULFIDE-ISOMERASE; MAMMALIAN-CELLS; A-CHAIN; RICIN; FAMILY; OXIDOREDUCTASE; MECHANISMS; EXOTOXIN; PLANTS	Members of the type 2 ribosome-inactivating proteins (RIPs) family (e.g. ricin, abrin) are potent cytotoxins showing a strong lethal activity toward eukaryotic cells. Type 2 RIPs contain two polypeptide chains (usually named A, for "activity", and B, for "binding") linked by a disulfide bond. The intoxication of the cell is a consequence of a reductive process in which the toxic domain is cleaved from the binding domain by oxidoreductases located in the lumen of the endoplasmic reticulum (ER). The best known example of type 2 RIPs is ricin. Protein disulfide isomerase (PDI) was demonstrated to be involved in the process of ricin reduction; however, when PDI is depleted from cell fraction preparations ricin reduction can still take place, indicating that also other oxidoreductases might be implicated in this process. We have investigated the role of TMX, a transmembrane thioredoxin-related protein member of the PDI family, in the cell intoxication operated by type 2 RIPs ricin and abrin. Overexpressing TMX in A549 cells resulted in a dramatic increase of ricin or abrin cytotoxicity compared with control mock-treated cells. Conversely, no difference in cytotoxicity was observed after treatment of A549 cells or control cells with saporin or Pseudomonas exotoxin A whose intracellular mechanism of activation is not dependent upon reduction (saporin) or only partially dependent upon it (Pseudomonas exotoxin A). Moreover, the silencing of TMX in the prostatic cell line DU145 reduced the sensitivity of the cells to ricin intoxication further confirming a role for this enzyme in intracellular ricin activation.	[Pasetto, Matteo; Barison, Erika; Castagna, Monica; Della Cristina, Pietro; Anselmi, Cristina; Colombatti, Marco] Univ Verona, Dept Pathol & Diagnost, Immunol Sect, Policlin GB Rossi, I-37134 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Pasetto, M (corresponding author), Univ Verona, Dept Pathol & Diagnost, Immunol Sect, Policlin GB Rossi, Ple L Scuro 10, I-37134 Verona, Italy.	biomatteo@tin.it			Fondazione Cariverona (Progetti Bando); Associazione delle Biotecnologie in Oncologia (ABO) Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto	Fondazione Cariverona (Progetti Bando)(Fondazione Cariverona); Associazione delle Biotecnologie in Oncologia (ABO) Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by grants from Fondazione Cariverona (Progetti Bando 2007), by the Associazione delle Biotecnologie in Oncologia (ABO) Foundation, and by Associazione Italiana per la Ricerca sul Cancro (AIRC) Regione Veneto (to M. C.).	BARBIERI L, 1993, BIOCHIM BIOPHYS ACTA, V1154, P237, DOI 10.1016/0304-4157(93)90002-6; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Girbes T, 1996, CELL MOL BIOL, V42, P461; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; LEWIS MS, 1986, J BIOL CHEM, V261, P1571; Lombardi A, 2010, FASEB J, V24, P253, DOI 10.1096/fj.08-118042; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Matsuo Y, 2009, MOL BIOL CELL, V20, P4552, DOI 10.1091/mbc.E09-05-0439; McKee ML, 1999, BIOCHEMISTRY-US, V38, P16507, DOI 10.1021/bi991308+; Morlon-Guyot J, 2009, INFECT IMMUN, V77, P3090, DOI 10.1128/IAI.01390-08; NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230	20	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7367	7373		10.1074/jbc.M111.316828	http://dx.doi.org/10.1074/jbc.M111.316828			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22228764	Green Published, hybrid			2022-12-27	WOS:000301060200038
J	Amrich, CG; Davis, CP; Rogal, WP; Shirra, MK; Heroux, A; Gardner, RG; Arndt, KM; VanDemark, AP				Amrich, Christopher G.; Davis, Christopher P.; Rogal, Walter P.; Shirra, Margaret K.; Heroux, Annie; Gardner, Richard G.; Arndt, Karen M.; VanDemark, Andrew P.			Cdc73 Subunit of Paf1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf1 Complex with Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION-FACTORS; RNA 3'-END FORMATION; SACCHAROMYCES-CEREVISIAE; TUMOR-SUPPRESSOR; HISTONE H2B; BINDING PROTEIN; GENE-EXPRESSION; SITE SELECTION; H3 METHYLATION; PARAFIBROMIN	The conserved Paf1 complex localizes to the coding regions of genes and facilitates multiple processes during transcription elongation, including the regulation of histone modifications. However, the mechanisms that govern Paf1 complex recruitment to active genes are undefined. Here we describe a previously unrecognized domain within the Cdc73 subunit of the Paf1 complex, the Cdc73 C-domain, and demonstrate its importance for Paf1 complex occupancy on transcribed chromatin. Deletion of the C-domain causes phenotypes associated with elongation defects without an apparent loss of complex integrity. Simultaneous mutation of the C-domain and another subunit of the Paf1 complex, Rtf1, causes enhanced mutant phenotypes and loss of histone H3 lysine 36 trimethylation. The crystal structure of the C-domain reveals unexpected similarity to the Ras family of small GTPases. Instead of a deep nucleotide-binding pocket, the C-domain contains a large but comparatively flat surface of highly conserved residues, devoid of ligand. Deletion of the C-domain results in reduced chromatin association for multiple Paf1 complex subunits. We conclude that the Cdc73 C-domain probably constitutes a protein interaction surface that functions with Rtf1 in coupling the Paf1 complex to the RNA polymerase II elongation machinery.	[Amrich, Christopher G.; Davis, Christopher P.; Rogal, Walter P.; Shirra, Margaret K.; Arndt, Karen M.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Washington; University of Washington Seattle	Arndt, KM (corresponding author), Univ Pittsburgh, Dept Biol Sci, 4249 5th Ave, Pittsburgh, PA 15260 USA.	arndt@pitt.edu; andyv@pitt.edu		Davis, Christopher/0000-0003-0112-9458; Gardner, Richard/0000-0003-2162-6275; VanDemark, Andrew/0000-0003-3424-4831	National Institutes of Health [R01GM52593, R21RR025787]; Howard Hughes Medical Institute; Beckman Scholars Award; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Scholars Award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM52593 (to K. M. A.) and R21RR025787 (to R. G. G.). This work was also supported by fellowships from the Howard Hughes Medical Institute (to C. P. D. and W. P. R.) and a Beckman Scholars Award (to C. P. D.).; We are grateful to Erica McGreevy, Kristianna Ricchio, and John Hempel for technical support. We thank Brett Tomson and Alan Hinnebusch for critical reading of the manuscript and Alan Hinnebusch for communication of unpublished results. Operations at the National Synchrotron Light Source are supported by the Department of Energy, Office of Basic Energy Sciences, and the National Institutes of Health. Data collection at the National Synchrotron Light Source was funded by the National Center for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ausubel F., 1988, SHORT PROTOCOLS MOL; Bradley KJ, 2006, CLIN ENDOCRINOL, V64, P299, DOI 10.1111/j.1365-2265.2006.02460.x; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cascon A, 2011, GENE CHROMOSOME CANC, V50, P922, DOI 10.1002/gcc.20911; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jenks MH, 2005, YEAST, V22, P1181, DOI 10.1002/yea.1300; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mosimann C, 2009, MECH DEVELOP, V126, P394, DOI 10.1016/j.mod.2009.02.002; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Mutiu AI, 2007, MOL GENET GENOMICS, V277, P491, DOI 10.1007/s00438-007-0212-6; Newey PJ, 2009, J INTERN MED, V266, P84, DOI 10.1111/j.1365-2796.2009.02107.x; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pimenta FJ, 2006, ORAL ONCOL, V42, P735, DOI 10.1016/j.oraloncology.2005.11.019; Pruneski JA, 2011, EUKARYOT CELL, V10, P1283, DOI 10.1128/EC.05141-11; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; ROSE MD, 1990, METHODS YEAST GENETI, P179; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shirra MK, 2005, GENETICS, V169, P1957, DOI 10.1534/genetics.104.038075; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tan MH, 2004, CLIN CANCER RES, V10, P6629, DOI 10.1158/1078-0432.CCR-04-0493; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomson BN, 2011, GENETICS, V188, P273, DOI 10.1534/genetics.111.128645; Tous C, 2011, EMBO J, V30, P1953, DOI 10.1038/emboj.2011.109; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Zhou K, 2009, P NATL ACAD SCI USA, V106, P6956, DOI 10.1073/pnas.0806302106	72	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10863	10875		10.1074/jbc.M111.325647	http://dx.doi.org/10.1074/jbc.M111.325647			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318720	hybrid, Green Published			2022-12-27	WOS:000302780100015
J	Bigford, GE; Chaudhry, NS; Keane, RW; Holohean, AM				Bigford, Gregory E.; Chaudhry, Nauman S.; Keane, Robert W.; Holohean, Alice M.			5-Hydroxytryptamine 5HT2C Receptors Form a Protein Complex with N-Methyl-D-aspartate GluN2A Subunits and Activate Phosphorylation of Src Protein to Modulate Motoneuronal Depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMBAR SPINAL-CORD; MESSENGER-RNA EXPRESSION; GATED ION CHANNELS; NMDA RECEPTORS; 5-HT2C RECEPTORS; FROG MOTONEURONS; CONSTITUTIVE ACTIVITY; TYROSINE KINASE; AMINO-ACID; GLUTAMATE RECEPTORS	Background: 5-Hydroxytryptamine (5HT) modulates N-methyl-D-aspartate ( NMDA) depolarization. Results: 5HT2C co-immunoprecipitates with GluN2A and enhances NMDA motoneuronal depolarization through phosphorylation of Src(Tyr-416). Conclusion: 5HT modulates NMDA through Src phosphorylation in a molecular complex that is localized in the processes of spinal neurons. Significance: 5HT2C modulation of NMDA excitation is coordinated by a molecular complex.	[Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Holohean, Alice M.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33101 USA; [Bigford, Gregory E.; Chaudhry, Nauman S.; Keane, Robert W.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA; [Bigford, Gregory E.; Keane, Robert W.; Holohean, Alice M.] Miami Vet Affairs Med Ctr, Res Serv, Miami, FL 33125 USA	University of Miami; University of Miami; University of Miami	Holohean, AM (corresponding author), Vet Affairs Med Ctr, Res Serv 151, 1201 NW 16th St, Miami, FL 33125 USA.	aholohean@gmail.com	Bigford, Gregory/GMW-4031-2022		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; Lois Pope Neuroscience Research Fellowship; Miami Project to Cure Paralysis	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Lois Pope Neuroscience Research Fellowship; Miami Project to Cure Paralysis	The work was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Program.; Supported by a Lois Pope Neuroscience Research Fellowship.; We greatly appreciate the help and expertise of Doris Nonner with culturing spinal neurons and Jessie S. Truettner with the development of primers and RT-PCR experiments. We also thank John C. Hackman, W. Dalton Dietrich, and The Miami Project to Cure Paralysis for their support.	Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Alvarez FJ, 1998, J COMP NEUROL, V393, P69; Banes A, 1999, J PHARMACOL EXP THER, V291, P1179; Barnes N. M., 1999, NEUROPHARMACOLOGY, V524, P171; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Beato M, 1998, P ROY SOC B-BIOL SCI, V265, P2073, DOI 10.1098/rspb.1998.0542; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gurevich I, 2002, J NEUROSCI, V22, P10529; HACKMAN JC, 1987, BRAIN RES, V407, P94, DOI 10.1016/0006-8993(87)91222-4; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; HELLENDALL RP, 1993, EXP NEUROL, V120, P186, DOI 10.1006/exnr.1993.1054; HELTON LA, 1994, NEUROREPORT, V5, P2617, DOI 10.1097/00001756-199412000-00053; Hentall ID, 2006, NEUROSCIENCE, V142, P893, DOI 10.1016/j.neuroscience.2006.06.038; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holmes GM, 2005, BRAIN RES, V1057, P65, DOI 10.1016/j.brainres.2005.07.047; HOLOHEAN AM, 1992, BRAIN RES, V579, P8, DOI 10.1016/0006-8993(92)90736-S; Holohean AM, 2004, BRIT J PHARMACOL, V143, P351, DOI 10.1038/sj.bjp.0705935; HOLOHEAN AM, 1992, NEUROSCIENCE, V48, P469, DOI 10.1016/0306-4522(92)90506-W; HOLOHEAN AM, 1990, NEUROSCIENCE, V34, P555, DOI 10.1016/0306-4522(90)90164-Y; Holohean AM, 1999, BRIT J PHARMACOL, V126, P333, DOI 10.1038/sj.bjp.0702263; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, TRENDS NEUROSCI, V24, P259, DOI 10.1016/S0166-2236(00)01792-6; KAUFMAN LM, 1983, SCIENCE, V220, P1394, DOI 10.1126/science.6857258; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2008, J PHYSIOL-LONDON, V586, P3855, DOI 10.1113/jphysiol.2008.153593; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MacLean JN, 2001, J NEUROPHYSIOL, V86, P1131, DOI 10.1152/jn.2001.86.3.1131; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MENGOD G, 1990, BRAIN RES, V524, P139, DOI 10.1016/0006-8993(90)90502-3; MORO O, 1993, J BIOL CHEM, V268, P22273; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Okabe S, 1997, RESP PHYSIOL, V110, P151, DOI 10.1016/S0034-5687(97)00080-7; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; Pluder F, 2006, PHARMACOL THERAPEUT, V112, P1, DOI 10.1016/j.pharmthera.2006.03.001; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; RIDET JL, 1994, J NEUROSCI RES, V38, P109, DOI 10.1002/jnr.490380114; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shay BL, 2005, J NEUROPHYSIOL, V94, P2867, DOI 10.1152/jn.00465.2005; SHOPE SB, 1993, BRAIN RES, V630, P207, DOI 10.1016/0006-8993(93)90658-A; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Takadera T, 2004, BRAIN RES, V1020, P196, DOI 10.1016/j.brainres.2004.06.035; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wallis DI, 1998, CAN J PHYSIOL PHARM, V76, P347, DOI 10.1139/cjpp-76-3-347; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Yang M, 2001, J NEUROCHEM, V77, P580, DOI 10.1046/j.1471-4159.2001.00255.x; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; ZISKINDCONHAIM L, 1990, J NEUROSCI, V10, P125	81	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11049	11059		10.1074/jbc.M111.277806	http://dx.doi.org/10.1074/jbc.M111.277806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291020	Green Published, hybrid			2022-12-27	WOS:000302780100033
J	Amparyup, P; Sutthangkul, J; Charoensapsri, W; Tassanakajon, A				Amparyup, Piti; Sutthangkul, Jantiwan; Charoensapsri, Walaiporn; Tassanakajon, Anchalee			Pattern Recognition Protein Binds to Lipopolysaccharide and beta-1,3-Glucan and Activates Shrimp Prophenoloxidase System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK TIGER SHRIMP; GRAM-NEGATIVE BACTERIA; MANDUCA-SEXTA; MOLECULAR-CLONING; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; FENNEROPENAEUS-CHINENSIS; LIPOTEICHOIC ACID; TOBACCO HORNWORM; INNATE IMMUNITY	The prophenoloxidase (proPO) system is activated upon recognition of pathogens by pattern recognition proteins (PRPs), including a lipopolysaccharide-and beta-1,3-glucan-bindingprotein (LGBP). However, shrimp LGBPs that are involved in the proPO system have yet to be clarified. Here, we focus on characterizing the role of a Penaeus monodon LGBP (PmLGBP) in the proPO system. We found that PmLGBP transcripts are expressed primarily in the hemocytes and are increased at 24 h after pathogenic bacterium Vibrio harveyi challenge. The binding studies carried out using ELISA indicated that recombinant (r) PmLGBP binds to beta-1,3-glucan and LPS with a dissociation constant of 6.86 x 10(-7) M and 3.55 x 10(-7) M, respectively. Furthermore, we found that rPmLGBP could enhance the phenoloxidase (PO) activity of hemocyte suspensions in the presence of LPS or beta-1,3-glucan. Using dsRNA interference-mediated gene silencing assay, we further demonstrated that knockdown of PmLGBP in shrimp in vivo significantly decreased the PmLGBP transcript level but had no effect on the expression of the other immune genes tested, including shrimp antimicrobial peptides (AMPs). However, suppression of proPO expression down-regulated PmLGBP, proPO-activating enzyme (PmPPAE2), and AMPs (penaeidin and crustin). Such PmLGBP down-regulated shrimp showed significantly decreased total PO activity. We conclude that PmLGBP functions as a pattern recognition protein for LPS and beta-1,3-glucan in the shrimp proPO activating system.	[Amparyup, Piti; Sutthangkul, Jantiwan; Charoensapsri, Walaiporn; Tassanakajon, Anchalee] Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, Bangkok 10330, Thailand; [Amparyup, Piti] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Klongluang 12120, Pathumthani, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Ctr Excellence Mol Biol & Genom Shrimp, 254 Phayathai Rd, Bangkok 10330, Thailand.	anchalee.k@chula.ac.th		Charoensapsri, Walaiporn/0000-0002-8651-383X	Thailand Research Fund; Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); Higher Education Research promotion and National Research University of Thailand; Office of the Higher Education Commission [FW 643A]; National Research University of Commission for Higher Education; Ratchada-phiseksomphot Endowment Fund; Royal Golden Jubilee Ph. D. Program; NSTDA [SP52-BT3]	Thailand Research Fund(Thailand Research Fund (TRF)); Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); Higher Education Research promotion and National Research University of Thailand; Office of the Higher Education Commission; National Research University of Commission for Higher Education; Ratchada-phiseksomphot Endowment Fund; Royal Golden Jubilee Ph. D. Program(Thailand Research Fund (TRF)); NSTDA	This work was supported by a fellowship from the Thailand Research Fund (to P. A.) and grants from the Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), the Higher Education Research promotion and National Research University Project of Thailand, Office of the Higher Education Commission (FW 643A), and the National Research University Project of Commission for Higher Education, and the Ratchada-phiseksomphot Endowment Fund. Research equipment was supported by the Thai Government Stimulus Package 2 TKK2555 under the Project for Establishment of Comprehensive Center for Innovative Food, Health Products, and Agriculture.; Recipient of student fellowship from the Royal Golden Jubilee Ph. D. Program, Thailand Research Fund, and the Young Scientist and Technologist Program, NSTDA SP52-BT3.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; Amparyup P, 2007, FISH SHELLFISH IMMUN, V22, P535, DOI 10.1016/j.fsi.2006.07.004; Amparyup P, 2010, DEV COMP IMMUNOL, V34, P168, DOI 10.1016/j.dci.2009.09.004; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; CERENIUS L, 1994, J BIOL CHEM, V269, P29462; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; Charoensapsri W, 2011, DEV COMP IMMUNOL, V35, P115, DOI 10.1016/j.dci.2010.09.002; Charoensapsri W, 2009, DEV COMP IMMUNOL, V33, P811, DOI 10.1016/j.dci.2009.01.006; Charroux B, 2009, MICROBES INFECT, V11, P631, DOI 10.1016/j.micinf.2009.03.004; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P297, DOI 10.1016/j.fsi.2004.08.002; Du XJ, 2007, MOL IMMUNOL, V44, P1085, DOI 10.1016/j.molimm.2006.07.288; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost M. R., 2008, PHENOLOXIDASE INSECT, P69; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Lin YC, 2008, DEV COMP IMMUNOL, V32, P1260, DOI 10.1016/j.dci.2008.05.003; Liu FS, 2009, MOL BIOL REP, V36, P471, DOI 10.1007/s11033-007-9203-2; Liu HP, 2011, DEV COMP IMMUNOL, V35, P51, DOI 10.1016/j.dci.2010.08.005; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Park JW, 2006, J BIOL CHEM, V281, P7747, DOI 10.1074/jbc.M510058200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Romo-Figueroa MG, 2004, DEV COMP IMMUNOL, V28, P713, DOI 10.1016/j.dci.2003.11.008; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Sritunyalucksana K, 2002, DEV COMP IMMUNOL, V26, P237, DOI 10.1016/S0145-305X(01)00074-X; Sumathipala N, 2010, INSECT BIOCHEM MOLEC, V40, P487, DOI 10.1016/j.ibmb.2010.04.008; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Wang KCHC, 2010, DEV COMP IMMUNOL, V34, P49, DOI 10.1016/j.dci.2009.08.003; Wang Y, 2011, INSECT BIOCHEM MOLEC, V41, P322, DOI 10.1016/j.ibmb.2011.01.010; Yang JL, 2010, FISH SHELLFISH IMMUN, V29, P825, DOI 10.1016/j.fsi.2010.07.025; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	49	105	111	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10060	10069		10.1074/jbc.M111.294744	http://dx.doi.org/10.1074/jbc.M111.294744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235126	hybrid, Green Published			2022-12-27	WOS:000302167200038
J	Babot, M; Blancard, C; Pelosi, L; Lauquin, GJM; Trezeguet, V				Babot, Marion; Blancard, Corinne; Pelosi, Ludovic; Lauquin, Guy J. -M.; Trezeguet, Veronique			The Transmembrane Prolines of the Mitochondrial ADP/ATP Carrier Are Involved in Nucleotide Binding and Transport and Its Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP CARRIER; SACCHAROMYCES-CEREVISIAE; ALPHA-HELICES; CONFORMATIONAL-DYNAMICS; CYSTEINE RESIDUES; MEMBRANE; YEAST; PROTEINS; SUBSTRATE; COMPLEX	The mitochondrial ADP/ATP carrier (Ancp) is a paradigm of the mitochondrial carrier family, which allows cross-talk between mitochondria, where cell energy is mainly produced, and cytosol, where cell energy is mainly consumed. The members of this family share numerous structural and functional characteristics. Resolution of the atomic structure of the bovine Ancp, in a complex with one of its specific inhibitors, revealed interesting features and suggested the involvement of some particular residues in the movements of the protein to perform translocation of nucleotides from one side of the membrane to the other. They correspond to three prolines located in the odd-numbered transmembrane helices (TMH), Pro-27, Pro-132, and Pro-229. The corresponding residues of the yeast Ancp (Pro-43, Ser-147, and Pro-247) were mutated into alanine or leucine, one at a time and analysis of the various mutants evidenced a crucial role of Pro-43 and Pro-247 during nucleotide transport. Beside, replacement of Ser-147 with proline does not inactivate Ancp and this is discussed in view of the conservation of the three prolines at equivalent positions in the Ancp sequences. These prolines belong to the signature sequences of the mitochondrial carriers and we propose they play a dual role in the mitochondrial ADP/ATP carrier function and biogenesis. Unexpectedly their mutations cause more general effects on mitochondrial biogenesis and morphology, as evidenced by measurements of respiratory rates, cytochrome contents, and also clearly highlighted by fluorescence microscopy.	[Babot, Marion; Blancard, Corinne; Lauquin, Guy J. -M.; Trezeguet, Veronique] Univ Bordeaux, Lab Physiol Mol & Cellulaire, F-33000 Bordeaux, France; [Babot, Marion; Blancard, Corinne; Lauquin, Guy J. -M.; Trezeguet, Veronique] CNRS, IBGC, UMR 5095, F-33000 Bordeaux, France; [Pelosi, Ludovic] Univ Grenoble 1, Equipe Dynam Organelles & Plasticite Cellulaire, Lab Biol Grande Echelle BGE, iRTSV CEA Grenoble, F-38054 Grenoble 9, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Trezeguet, V (corresponding author), CBMN, UMR 5248, Allee Geoffroy St Hilaire Bat B14Bis, F-33600 Pessac, France.	v.trezeguet@cbmn.u-bordeaux.fr	Pelosi, Ludovic/AAB-9832-2020; Pelosi, Ludovic/M-6406-2014	Pelosi, Ludovic/0000-0002-4198-5681; Trezeguet, Veronique/0000-0003-2487-7571	Universite Bordeaux Segalen; Centre National de la Recherche Scientifique; Region Aquitaine; French Ministere de l'Enseignement Superieur et de la Recherche	Universite Bordeaux Segalen; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported in part by the Universite Bordeaux Segalen, the Centre National de la Recherche Scientifique, and the Region Aquitaine.; Supported by the French Ministere de l'Enseignement Superieur et de la Recherche.	Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BLOCK MR, 1982, BIOCHEMISTRY-US, V21, P5451, DOI 10.1021/bi00265a011; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clemencon B, 2011, J BIOL CHEM, V286, P36119, DOI 10.1074/jbc.M111.277376; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; De Lucas JR, 2008, MOL MEMBR BIOL, V25, P152, DOI 10.1080/09687680701697476; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Della Rocca BM, 2005, MOL MEMBR BIOL, V22, P443, DOI 10.1080/09687860500269335; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; MAJIMA E, 1994, BIOCHEMISTRY-US, V33, P9530, DOI 10.1021/bi00198a019; Majima E, 1998, BIOCHEMISTRY-US, V37, P424, DOI 10.1021/bi9710683; MICHEJDA J, 1990, BIOCHEM BIOPH RES CO, V171, P354, DOI 10.1016/0006-291X(90)91401-D; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Roux R, 1996, BIOCHEMISTRY-US, V35, P16125, DOI 10.1021/bi961715a; Sanchez JF, 2012, BIOORG MED CHEM LETT, V22, P2973, DOI 10.1016/j.bmcl.2012.02.040; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; SOLOMON F, 1991, ANNU REV CELL BIOL, V7, P633, DOI 10.1146/annurev.cellbio.7.1.633; Thomas R, 2009, BIOCHEMISTRY-US, V48, P11883, DOI 10.1021/bi9016395; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Vial S, 2002, J BIOL CHEM, V277, P36100, DOI 10.1074/jbc.M202310200; VIGNAIS PV, 1966, BIOCHIM BIOPHYS ACTA, V118, P465, DOI 10.1016/S0926-6593(66)80090-5; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WOODS A, 1989, J CELL SCI, V93, P491; Zara V, 2007, J CELL SCI, V120, P4099, DOI 10.1242/jcs.018929	47	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10368	10378		10.1074/jbc.M111.320697	http://dx.doi.org/10.1074/jbc.M111.320697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334686	Green Published, hybrid			2022-12-27	WOS:000302167200064
J	Iwashita, Y; Fukuchi, N; Waki, M; Hayashi, K; Tahira, T				Iwashita, Yuji; Fukuchi, Naruhiko; Waki, Mariko; Hayashi, Kenshi; Tahira, Tomoko			Genome-wide Repression of NF-kappa B Target Genes by Transcription Factor MIBP1 and Its Modulation by O-Linked beta-N-Acetylglucosamine (O-GlcNAc) Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; OPEN-ACCESS DATABASE; MASS-SPECTROMETRY; EXPRESSION; GLCNACYLATION; SCHNURRI-2; SITES; IDENTIFICATION; CLONING; NUCLEAR	The transcription factor c-MYC intron binding protein 1 (MIBP1) binds to various genomic regulatory regions, including intron 1 of c-MYC. This factor is highly expressed in postmitotic neurons in the fetal brain and may be involved in various biological steps, such as neurological and immunological processes. In this study, we globally characterized the transcriptional targets of MIBP1 and proteins that interact with MIBP1. Microarray hybridization followed by gene set enrichment analysis revealed that genes involved in the pathways downstream of MYC, NF-kappa B, and TGF-beta were down-regulated when HEK293 cells stably overexpressed MIBP1. In silico transcription factor binding site analysis of the promoter regions of these down-regulated genes showed that the NF-kappa B binding site was the most overrepresented. The up-regulation of genes known to be in the NF-kappa B pathway after the knockdown of endogenous MIBP1 in HT1080 cells supports the view that MIBP1 is a down-regulator of the NF-kappa B pathway. We also confirmed the binding of the MIBP1 to the NF-kappa B site. By immunoprecipitation and mass spectrometry, we detected O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase as a prominent binding partner of MIBP1. Analyses using deletion mutants revealed that a 154-amino acid region of MIBP1 was necessary for its O-GlcNAc transferase binding and O-GlcNAcylation. A luciferase reporter assay showed that NF-kappa B-responsive expression was repressed by MIBP1, and stronger repression by MIBP1 lacking the 154-amino acid region was observed. Our results indicate that the primary effect of MIBP1 expression is the down-regulation of the NF-kappa B pathway and that this effect is attenuated by O-GlcNAc signaling.	[Iwashita, Yuji; Fukuchi, Naruhiko; Waki, Mariko; Hayashi, Kenshi; Tahira, Tomoko] Kyushu Univ, Div Genome Anal, Res Ctr Genet Informat, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Iwashita, Yuji; Tahira, Tomoko] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Tahira, T (corresponding author), Kyushu Univ, Div Genome Anal, Res Ctr Genet Informat, Med Inst Bioregulat, Fukuoka 8128582, Japan.	ttahira@gen.kyushu-u.ac.jp			KAKENHI [17019051, 18310131]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI 17019051 (a grant-in-aid for scientific research in priority areas, "Applied Genomics") and KAKENHI 18310131 (a grant-in-aid for scientific research (B)).	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Allen CE, 2005, MOL B INT U, P213; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Campbell DB, 2003, J COMP NEUROL, V467, P581, DOI 10.1002/cne.10958; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Defrance M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-396; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; Fukuda S, 2002, J BIOCHEM, V131, P349, DOI 10.1093/oxfordjournals.jbchem.a003109; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Johnson RS, 2005, METHODS, V35, P223, DOI 10.1016/j.ymeth.2004.08.014; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LAMBRACHT D, 1995, IMMUNOGENETICS, V41, P375, DOI 10.1007/BF00163995; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MAKINO R, 1994, NUCLEIC ACIDS RES, V22, P5679, DOI 10.1093/nar/22.25.5679; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MITCHELMORE C, 1991, NUCLEIC ACIDS RES, V19, P141, DOI 10.1093/nar/19.1.141; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; Rozen S, 2000, Methods Mol Biol, V132, P365; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Takagi T, 2001, NAT IMMUNOL, V2, P1048, DOI 10.1038/ni728; Takagi T, 2006, BRAIN RES, V1108, P88, DOI 10.1016/j.brainres.2006.06.018; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANTVEER LJ, 1992, P NATL ACAD SCI USA, V89, P8971, DOI 10.1073/pnas.89.19.8971; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	61	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9887	9900		10.1074/jbc.M111.298521	http://dx.doi.org/10.1074/jbc.M111.298521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294689	Green Published, hybrid			2022-12-27	WOS:000302167200021
J	Kuo, PL; Huang, MS; Cheng, DE; Hung, JY; Yang, CJ; Chou, SH				Kuo, Po-Lin; Huang, Ming-Shyan; Cheng, Da-En; Hung, Jen-Yu; Yang, Chih-Jen; Chou, Shah-Hwa			Lung Cancer-derived Galectin-1 Enhances Tumorigenic Potentiation of Tumor-associated Dendritic Cells by Expressing Heparin-binding EGF-like Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HB-EGF; GASTRIC-CANCER; TRANSACTIVATION; AMPHIREGULIN; INFLAMMATION; DISINTEGRIN; MIGRATION; THERAPY; LIGANDS; ADAM17	The interaction between cancer cells and their microenvironment is a vicious cycle that enhances the survival and progression of cancer, resulting in metastasis. This study is the first to indicate that lung cancer-derived galectin-1 secretion is responsible for stimulating tumor-associated dendritic cells (TADCs) production of mature heparin-binding EGF-like growth factor (HBEGF), which, in turn, increases cancer progression. Treatment of galectin-1, present in large amounts in lung cancer conditioned medium and lung cancer patient sera, mimicked the inductive effect of lung cancer conditioned medium on the expression and ectodomain shedding of HBEGF by TNF alpha-converting enzyme/a disintegrin and metalloproteinase 9 (ADAM9) and ADAM17. Significant upregulation of HBEGF has been seen in tumor-infiltrating CD11c(+) dendritic cells in human lung cancer samples. Active cleavage of HBEGF in TADCs by ADAM9 and ADAM17 is associated with increased protein kinase C delta and Lyn signaling. Enhancement of HBEGF production in TADCs increased the proliferation, migration, and epithelial-to-mesenchymal transition abilities of lung cancer. In contrast, inhibiting HBEGF by siRNA suppressed TADC-mediated cancer progression. Moreover, mice injected with galectin-1 knockdown Lewis lung carcinoma showed decreased expression and ectodomain shedding of HBEGF and reduced incidence of cancer development, resulting in increased survival rates. We demonstrate here for the first time that human and mouse DCs are a source of HBEGF, an EGFR ligand with tumorigenic properties. Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.	[Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan; [Kuo, Po-Lin; Huang, Ming-Shyan] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan; [Kuo, Po-Lin; Huang, Ming-Shyan; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 807, Taiwan; [Huang, Ming-Shyan; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung 807, Taiwan; [Cheng, Da-En; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ Hosp, Dept Chest Surg, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, PL (corresponding author), Kaohsiung Med Univ, Inst Clin Med, Coll Med, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw			National Science Council of Taiwan [NSC 99-2320-B-037-017-MY3]; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taipei, Taiwan [DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER011]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taipei, Taiwan; Kaohsiung Medical University Research Foundation	This work was supported by National Science Council of Taiwan grants (NSC 99-2320-B-037-017-MY3), an Excellence for Cancer Research Center grant, the Department of Health, Executive Yuan, Taipei, Taiwan Grant DOH101-TD-C-111-002, and Kaohsiung Medical University Research Foundation Grant KMUER011.	Andrews J, 2011, CANCER J, V17, P104, DOI 10.1097/PPO.0b013e318213f3cf; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Box C, 2010, SEMIN CANCER BIOL, V20, P128, DOI 10.1016/j.semcancer.2010.06.004; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Eikawa S, 2010, J IMMUNOL, V185, P6734, DOI 10.4049/jimmunol.1000225; Gandhi MK, 2007, BLOOD, V110, P1326, DOI 10.1182/blood-2007-01-066100; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kiss J, 2007, EXP HEMATOL, V35, P305, DOI 10.1016/j.exphem.2006.09.015; Koh HS, 2009, MOL CELLS, V28, P553, DOI 10.1007/s10059-009-0150-8; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Kwong C, 2011, J IMMUNOL, V186, P1781, DOI 10.4049/jimmunol.1002998; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Miyamoto S, 2008, ADV EXP MED BIOL, V622, P281, DOI 10.1007/978-0-387-68969-2_23; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	34	34	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9753	9764		10.1074/jbc.M111.321190	http://dx.doi.org/10.1074/jbc.M111.321190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291012	hybrid, Green Published			2022-12-27	WOS:000302167200009
J	Masgras, I; Carrera, S; de Verdier, PJ; Brennan, P; Majid, A; Makhtar, W; Tulchinsky, E; Jones, GDD; Roninson, IB; Macip, S				Masgras, Ionica; Carrera, Samantha; de Verdier, Petra J.; Brennan, Paul; Majid, Aneela; Makhtar, Wan; Tulchinsky, Eugene; Jones, George D. D.; Roninson, Igor B.; Macip, Salvador			Reactive Oxygen Species and Mitochondrial Sensitivity to Oxidative Stress Determine Induction of Cancer Cell Death by p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TUMOR-CELLS; DNA-DAMAGE; INDUCED APOPTOSIS; GENE-EXPRESSION; GROWTH ARREST; CYCLE ARREST; SENESCENCE; P53; FIBROBLASTS; INHIBITOR	p21(Waf1/Cip1/Sdi1) is a cyclin-dependent kinase inhibitor that mediates cell cycle arrest. Prolonged p21 up-regulation induces a senescent phenotype in normal and cancer cells, accompanied by an increase in intracellular reactive oxygen species (ROS). However, it has been shown recently that p21 expression can also lead to cell death in certain models. The mechanisms involved in this process are not fully understood. Here, we describe an induction of apoptosis by p21 in sarcoma cell lines that is p53-independent and can be ameliorated with antioxidants. Similar levels of p21 and ROS caused senescence in the absence of significant death in other cancer cell lines, suggesting a cell-specific response. We also found that cells undergoing p21-dependent cell death had higher sensitivity to oxidants and a specific pattern of mitochondrial polarization changes. Consistent with this, apoptosis could be blocked with targeted expression of catalase in the mitochondria of these cells. We propose that the balance between cancer cell death and arrest after p21 up-regulation depends on the specific effects of p21-induced ROS on the mitochondria. This suggests that selective up-regulation of p21 in cancer cells could be a successful therapeutic intervention for sarcomas and tumors with lower resistance to mitochondrial oxidative damage, regardless of p53 status.	[Masgras, Ionica; Carrera, Samantha; Macip, Salvador] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Majid, Aneela] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Makhtar, Wan; Tulchinsky, Eugene; Jones, George D. D.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [de Verdier, Petra J.] Karolinska Inst, Urol Lab, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Brennan, Paul] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Roninson, Igor B.] Univ S Carolina, S Carolina Coll Pharm, Dept Pharmaceut & Biomed Sci, Translat Canc Therapeut Program, Columbia, SC 29208 USA	University of Leicester; University of Leicester; University of Leicester; Karolinska Institutet; Cardiff University; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Macip, S (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	sm460@le.ac.uk	Masgras, Ionica/ABG-9245-2021; Tulchinsky, Eugene/ABD-7070-2021; Macip, Salvador/K-5985-2014; Macip, Salvador/S-6358-2019; Roninson, Igor/K-1310-2017; Macip, Salvador/P-4233-2019	Masgras, Ionica/0000-0002-9768-460X; Roninson, Igor/0000-0002-9211-1327; Macip, Salvador/0000-0003-1963-8840; Jones, George/0000-0002-9543-2206; WAN MAKHTAR, WAN RATMAAZILA/0000-0003-1630-2137	National Institutes of Health [R01 AG028687]; Medical Research Council; Consejo Nacional de Ciencia y Tecnologia; Swedish Cancer Society [2007/649]; NATIONAL INSTITUTE ON AGING [R01AG028687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Swedish Cancer Society(Swedish Cancer Society); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG028687 (to I. B. R.). This work was also supported by New Blood Lectureship Research Support funding from the Medical Research Council (to S. M.), Consejo Nacional de Ciencia y Tecnologia (to S. C.), and the Swedish Cancer Society Grant Cancerfonden 2007/649 (to P. J. d. V.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aubry JP, 1999, CYTOMETRY, V37, P197, DOI 10.1002/(SICI)1097-0320(19991101)37:3<197::AID-CYTO6>3.0.CO;2-L; Bai JX, 2001, J BIOL CHEM, V276, P4315, DOI 10.1074/jbc.M008895200; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; BOND JA, 1994, ONCOGENE, V9, P1885; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Broude EV, 2007, CELL CYCLE, V6, P1468; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Carrera S, 2010, J BIOL CHEM, V285, P13658, DOI 10.1074/jbc.M109.062562; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Inoue T, 2009, CANCER SCI, V100, P1275, DOI 10.1111/j.1349-7006.2009.01166.x; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; JONGKIND JF, 1982, EXP CELL RES, V138, P409, DOI 10.1016/0014-4827(82)90189-6; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pearce L, 2010, HAEMATOL-HEMATOL J, V95, P514, DOI 10.3324/haematol.2009.014381; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugrue MM, 1999, BIOCHEM BIOPH RES CO, V261, P123, DOI 10.1006/bbrc.1999.0984; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	47	64	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9845	9854		10.1074/jbc.M111.250357	http://dx.doi.org/10.1074/jbc.M111.250357			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311974	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000302167200017
J	Nagamine, S; Tamba, M; Ishimine, H; Araki, K; Shiomi, K; Okada, T; Ohto, T; Kunita, S; Takahashi, S; Wismans, RGP; van Kuppevelt, TH; Masu, M; Keino-Masu, K				Nagamine, Satoshi; Tamba, Michiko; Ishimine, Hisako; Araki, Kota; Shiomi, Kensuke; Okada, Takuya; Ohto, Tatsuyuki; Kunita, Satoshi; Takahashi, Satoru; Wismans, Ronnie G. P.; van Kuppevelt, Toin H.; Masu, Masayuki; Keino-Masu, Kazuko			Organ-specific Sulfation Patterns of Heparan Sulfate Generated by Extracellular Sulfatases Sulf1 and Sulf2 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; 6-O-ENDOSULFATASES; PROTEOGLYCANS; EXPRESSION; BINDING; QSULF1; CANCER; GLYCOSAMINOGLYCANS; DIVERSITY; HSULF-1	Heparan sulfate endosulfatases Sulf1 and Sulf2 hydrolyze 6-O-sulfate in heparan sulfate, thereby regulating cellular signaling. Previous studies have revealed that Sulfs act predominantly on UA2S-GlcNS6S disaccharides and weakly on UA-GlcNS6S disaccharides. However, the specificity of Sulfs and their role in sulfation patterning of heparan sulfate in vivo remained unknown. Here, we performed disaccharide analysis of heparan sulfate in Sulf1 and Sulf2 knock-out mice. Significant increases in Delta UA2S-GlcNS6S were observed in the brain, small intestine, lung, spleen, testis, and skeletal muscle of adult Sulf1(-/-) mice and in the brain, liver, kidney, spleen, and testis of adult Sulf2(-/-) mice. In addition, increases in Delta UA-GlcNS6S were seen in the Sulf1(-/-) lung and small intestine. In contrast, the disaccharide compositions of chondroitin sulfate were not primarily altered, indicating specificity of Sulfs for heparan sulfate. For Sulf1, but not for Sulf2, mRNA expression levels in eight organs of wild-type mice were highly correlated with increases in Delta UA2S-GlcNS6S in the corresponding organs of knock-out mice. Moreover, overall changes in heparan sulfate compositions were greater in Sulf1(-/-) mice than in Sulf2(-/-) mice despite lower levels of Sulf1 mRNA expression, suggesting predominant roles of Sulf1 in heparan sulfate desulfation and distinct regulation of Sulf activities in vivo. Sulf1 and Sulf2 mRNAs were differentially expressed in restricted types of cells in organs, and consequently, the sulfation patterns of heparan sulfate were locally and distinctly altered in Sulf1 and Sulf2 knock-out mice. These findings indicate that Sulf1 and Sulf2 differentially contribute to the generation of organ-specific sulfation patterns of heparan sulfate.	[Nagamine, Satoshi; Tamba, Michiko; Ishimine, Hisako; Araki, Kota; Shiomi, Kensuke; Okada, Takuya; Ohto, Tatsuyuki; Masu, Masayuki; Keino-Masu, Kazuko] Univ Tsukuba, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058577, Japan; [Ohto, Tatsuyuki] Univ Tsukuba, Dept Pediat, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Kunita, Satoshi; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058577, Japan; [Wismans, Ronnie G. P.; van Kuppevelt, Toin H.] Radbout Univ Nijmegen Med Ctr, Dept Matrix Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	University of Tsukuba; University of Tsukuba; University of Tsukuba; Radboud University Nijmegen	Masu, M (corresponding author), Univ Tsukuba, Dept Mol Neurobiol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mmasu@md.tsukuba.ac.jp; kazumasu@md.tsukuba.ac.jp	van Kuppevelt, A.H.M.S.M./L-4463-2015	Okada, Takuya/0000-0002-6485-9469	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research [24110502] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research on Priority Areas by the 21st Century COE program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a research grant from the Mizutani Foundation for Glycoscience.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Hosono-Fukao T, 2011, J NEUROSCI RES, V89, P1840, DOI 10.1002/jnr.22690; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Jenniskens GJ, 2002, DEV DYNAM, V225, P70, DOI 10.1002/dvdy.10138; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Langsdorf A, 2011, GLYCOBIOLOGY, V21, P152, DOI 10.1093/glycob/cwq133; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nagamine S, 2005, DEV BRAIN RES, V159, P135, DOI 10.1016/j.devbrainres.2005.07.006; Nagamine S, 2010, BIOCHEM BIOPH RES CO, V391, P107, DOI 10.1016/j.bbrc.2009.11.011; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1	46	63	64	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9579	9590		10.1074/jbc.M111.290262	http://dx.doi.org/10.1074/jbc.M111.290262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298771	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000301797800089
J	Pazgier, M; Wei, G; Ericksen, B; Jung, G; Wu, ZB; de Leeuw, E; Yuan, WR; Szmacinski, H; Lu, WY; Lubkowski, J; Lehrer, RI; Lu, WY				Pazgier, Marzena; Wei, Gang; Ericksen, Bryan; Jung, Grace; Wu, Zhibin; de Leeuw, Erik; Yuan, Weirong; Szmacinski, Henryk; Lu, Wei-Yue; Lubkowski, Jacek; Lehrer, Robert I.; Lu, Wuyuan			Sometimes It Takes Two to Tango CONTRIBUTIONS OF DIMERIZATION TO FUNCTIONS OF HUMAN alpha-DEFENSIN HNP1 PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-DEFENSINS; PRECURSOR LIPID II; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; PANETH CELLS; MECHANISM; DIMER; PROTEIN; BINDING; HD5	Human myeloid alpha-defensins called HNPs play multiple roles in innate host defense. The Trp-26 residue of HNP1 was previously shown to contribute importantly to its ability to kill S. aureus, inhibit anthrax lethal factor (LF), bind gp120 of HIV-1, dimerize, and undergo further self-association. To gain additional insights into the functional significance of dimerization, we compared wild type HNP1 to dimerization-impaired, N-methylated HNP1 monomers and to disulfide-tethered obligate HNP1 dimers. The structural effects of these modifications were confirmed by x-ray crystallographic analyses. Like the previously studied W26A mutation, N-methylation of Ile-20 dramatically reduced the ability of HNP1 to kill Staphylococcus aureus, inhibit LF, and bind gp120. Importantly, this modification had minimal effect on the ability of HNP1 to kill Escherichia coli. The W26A and MeIle-20 mutations impaired defensin activity synergistically. N-terminal covalent tethering rescued the ability of W26A-HNP1 to inhibit LF but failed to restore its defective killing of S. aureus. Surface plasmon resonance studies revealed that Trp-26 mediated the association of monomers and canonical dimers of HNP1 to immobilized HNP1, LF, and gp120, and also indicated a possible mode of tetramerization of HNP1 mediated by Ile-20 and Leu-25. This study demonstrates that dimerization contributes to some but not all of the many and varied activities of HNP1.	[Pazgier, Marzena; Lubkowski, Jacek] NCI, Macromol Assembly Struct & Cell Signaling Sect, NIH, Frederick, MD 21702 USA; [Pazgier, Marzena; Wei, Gang; Ericksen, Bryan; Wu, Zhibin; de Leeuw, Erik; Yuan, Weirong; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Szmacinski, Henryk; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lubkowski, J (corresponding author), NCI, Macromol Assembly Struct & Cell Signaling Sect, NIH, Frederick, MD 21702 USA.	lubkowsj@mail.nih.gov; wlu@ihv.umaryland.edu	Lu, Weiyue/E-7938-2010; Ericksen, Bryan/F-9047-2012; Wei, Gang/AAH-7377-2019; Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Wei, Gang/0000-0002-9600-0982; Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	United States Department of Energy, Office of Science [W-31-109-Eng38]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng38]; National Institutes of Health [AI072732, AI061482]; NCI, Center for Cancer Research; National Natural Science Foundation of China [30701060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science(United States Department of Energy (DOE)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Use of the Advanced Photon Source was supported by the United States Department of Energy, Offices of Science and of Basic Energy Sciences, under Contract W-31-109-Eng38.; This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.) and by the Intramural Research Program, NCI, Center for Cancer Research (to J. L.).; Supported by National Natural Science Foundation of China Grant 30701060.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1986, Semin Respir Infect, V1, P107; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hornef MW, 2004, NAT IMMUNOL, V5, P836, DOI 10.1038/ni1094; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Lu WY, 1997, BIOCHEMISTRY-US, V36, P673, DOI 10.1021/bi9625612; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Taylor K, 2007, ANTIMICROB AGENTS CH, V51, P1719, DOI 10.1128/AAC.01531-06; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	52	34	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8944	8953		10.1074/jbc.M111.332205	http://dx.doi.org/10.1074/jbc.M111.332205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270360	Green Published, hybrid			2022-12-27	WOS:000301797800025
J	Burkhardt, J; Vonck, J; Langer, JD; Salzer, R; Averhoff, B				Burkhardt, Janin; Vonck, Janet; Langer, Julian D.; Salzer, Ralf; Averhoff, Beate			Unusual N-terminal alpha alpha beta alpha beta beta alpha Fold of PilQ from Thermus thermophilus Mediates Ring Formation and Is Essential for Piliation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL GENETIC-TRANSFORMATION; NEISSERIA-GONORRHOEAE; IV PILI; DNA-BINDING; II SECRETION; TWITCHING MOTILITY; COMPETENCE; PROTEIN; HB27; BIOGENESIS	DNA translocators of natural transformation systems are complex systems critical for the uptake of free DNA and provide a powerful mechanism for adaptation to changing environmental conditions. In natural transformation machineries, outer membrane secretins are suggested to form a multimeric pore for the uptake of external DNA. Recently, we reported on a novel structure of the DNA translocator secretin complex, PilQ, in Thermus thermophilus HB27 comprising a stable cone and cup structure and six ring structures with a large central channel. Here, we report on structural and functional analyses of a set of N-terminal PilQ deletion derivatives in T. thermophilus HB27. We identified 136 N-terminal residues exhibiting an unusual alpha alpha beta alpha beta beta alpha fold as a ring-building domain. Deletion of this domain had a dramatic effect on twitching motility, adhesion, and piliation but did not abolish natural transformation. These findings provide clear evidence that the pilus structures of T. thermophilus are not essential for natural transformation. The truncated complex was not affected in inner and outer membrane association, indicating that the 136 N-terminal residues are not essential for membrane targeting. Analyses of complex formation of the truncated PilQ monomers revealed that the region downstream of residue 136 is required for multimerization, and the region downstream of residue 207 is essential for monomer stability. Possible implications of our findings for the mechanism of DNA uptake are discussed.	[Burkhardt, Janin; Salzer, Ralf; Averhoff, Beate] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Vonck, Janet] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Max Planck Society; Max Planck Society	Averhoff, B (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Averhoff@bio.uni-frankfurt.de		Averhoff, Beate/0000-0003-1460-3649; Vonck, Janet/0000-0001-5659-8863; Langer, Julian David/0000-0002-5190-577X	Deutsche Forschungsgemeinschaft [AV9/6-1]; Max Planck Institute of Biophysics, Frankfurt, Germany; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute of Biophysics, Frankfurt, Germany; European Union(European Commission)	The work was supported by Deutsche Forschungsgemeinschaft Grant AV9/6-1.; We are indebted to Deryck Mills and Friederike Joos (Max Planck Institute of Biophysics, Frankfurt, Germany) for the contribution to piliation analyses of HB27 cells by electron microscopy. Jose Berenguer (Universidad Autonomes de Madrid, Madrid, Spain) is gratefully acknowledged for providing antibodies against T. thermophilus HB27 S-layer protein that were used to analyze the purity of the membrane fractionation. We are also grateful to Bernd Ludwig (Goethe University, Frankfurt, Germany) for the kind gift of plasmid pDM12. We are also grateful to Volker Muller (Goethe University, Frankfurt, Germany) for the many stimulating discussions on secretin complex purification. We thank Werner Kuhlbrandt and Hartmut Michel (Max Planck Institute of Biophysics, Frankfurt, Germany) for support. The Membrane protein Core Center at the Max Planck Institute of Biophysics was supported financially by the European Strategy Forum on Research Infrastructures Instruct program of the European Union.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Averhoff B, 2004, J BIOENERG BIOMEMBR, V36, P25, DOI 10.1023/B:JOBB.0000019595.66733.fa; Averhoff B, 2009, FEMS MICROBIOL REV, V33, P611, DOI 10.1111/j.1574-6976.2008.00160.x; Burkhardt J, 2011, J BIOL CHEM, V286, P9977, DOI 10.1074/jbc.M110.212688; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; de Grado M, 1999, PLASMID, V42, P241, DOI 10.1006/plas.1999.1427; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Drake SL, 1995, MOL MICROBIOL, V18, P975, DOI 10.1111/j.1365-2958.1995.18050975.x; Friedrich A, 2001, APPL ENVIRON MICROB, V67, P3140, DOI 10.1128/AEM.67.7.3140-3148.2001; Friedrich A, 2003, APPL ENVIRON MICROB, V69, P3695, DOI 10.1128/AEM.69.7.3695-3700.2003; Friedrich A, 2002, APPL ENVIRON MICROB, V68, P745, DOI 10.1128/AEM.68.2.745-755.2002; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Han XY, 2007, J BACTERIOL, V189, P5022, DOI 10.1128/JB.00138-07; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06; HIDAKA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1338, DOI 10.1271/bbb.58.1338; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Koomey M, 1998, APMIS, V106, P56; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Koster M, 2000, INT J MED MICROBIOL, V290, P325; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Nesper J, 2008, J BACTERIOL, V190, P4568, DOI 10.1128/JB.00369-08; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Rose I, 2011, EXTREMOPHILES, V15, P191, DOI 10.1007/s00792-010-0343-2; Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schwarzenlander C, 2009, ENVIRON MICROBIOL, V11, P801, DOI 10.1111/j.1462-2920.2008.01801.x; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Tarry M, 2011, J MOL BIOL, V409, P642, DOI 10.1016/j.jmb.2011.04.034; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	57	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8484	8494		10.1074/jbc.M111.334912	http://dx.doi.org/10.1074/jbc.M111.334912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253437	hybrid, Green Published			2022-12-27	WOS:000301349400062
J	Sebollela, A; Freitas-Correa, L; Oliveira, FF; Paula-Lima, AC; Saraiva, LM; Martins, SM; Mota, LD; Torres, C; Alves-Leon, S; de Souza, JM; Carraro, DM; Brentani, H; De Felice, FG; Ferreira, ST				Sebollela, Adriano; Freitas-Correa, Leo; Oliveira, Fabio F.; Paula-Lima, Andrea C.; Saraiva, Leonardo M.; Martins, Samantha M.; Mota, Louise D.; Torres, Cesar; Alves-Leon, Soniza; de Souza, Jorge M.; Carraro, Dirce M.; Brentani, Helena; De Felice, Fernanda G.; Ferreira, Sergio T.			Amyloid-beta Oligomers Induce Differential Gene Expression in Adult Human Brain Slices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEPENDENT MECHANISM; SOLUBLE-PROTEIN OLIGOMERS; D-ASPARTATE RECEPTORS; LONG-TERM DEPRESSION; NERVE-CELL LINE; ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; SYNAPTOPHYSIN MESSAGE	Cognitive decline in Alzheimer disease (AD) is increasingly attributed to the neuronal impact of soluble oligomers of the amyloid-beta peptide (A beta Os). Current knowledge on the molecular and cellular mechanisms underlying the toxicity of A beta Os stems largely from rodent-derived cell/tissue culture experiments or from transgenic models of AD, which do not necessarily recapitulate the complexity of the human disease. Here, we used DNA microarray and RT-PCR to investigate changes in transcription in adult human cortical slices exposed to sublethal doses of A beta Os. The results revealed a set of 27 genes that showed consistent differential expression upon exposure of slices from three different donors to A beta Os. Functional classification of differentially expressed genes revealed that A beta Os impact pathways important for neuronal physiology and known to be dysregulated in AD, including vesicle trafficking, cell adhesion, actin cytoskeleton dynamics, and insulin signaling. Most genes (70%) were down-regulated by A beta O treatment, suggesting a predominantly inhibitory effect on the corresponding pathways. Significantly, A beta Os induced down-regulation of synaptophysin, a presynaptic vesicle membrane protein, suggesting a mechanism by which oligomers cause synapse failure. The results provide insight into early mechanisms of pathogenesis of AD and suggest that the neuronal pathways affected by A beta Os may be targets for the development of novel diagnostic or therapeutic approaches.	[Sebollela, Adriano; Freitas-Correa, Leo; Oliveira, Fabio F.; Paula-Lima, Andrea C.; Saraiva, Leonardo M.; Martins, Samantha M.; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil; [Mota, Louise D.; Torres, Cesar; Carraro, Dirce M.; Brentani, Helena] AC Camargo Hosp, Int Ctr Educ & Res, BR-01509 Sao Paulo, Brazil; [de Souza, Jorge M.] Univ Fed Rio de Janeiro, Div Neurosurg, Clementino Fraga Filho Univ Hosp, BR-21941913 Rio De Janeiro, RJ, Brazil; [Alves-Leon, Soniza] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Div Neurol, Epilepsy Program, BR-21941913 Rio De Janeiro, RJ, Brazil; [Paula-Lima, Andrea C.] Univ Chile, Ctr Mol Studies Cell, Fac Dent, Santiago, Chile	Universidade Federal do Rio de Janeiro; A.C.Camargo Cancer Center; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidad de Chile	Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem, BR-21944590 Rio De Janeiro, RJ, Brazil.	ferreira@bioqmed.ufrj.br	Sebollela, Adriano/O-4385-2014; Ferreira, Sergio/AAZ-1576-2020; Martins, Samantha/AAW-4694-2021; carraro, dirce/C-9179-2009; Paula-Lima, Andrea/I-2537-2013; Leon, Soniza V Alves/J-7786-2012; De Felice, Fernanda G/M-1074-2017; Brentani, Helena/G-6839-2011; Neurociencia, Inct/I-1011-2013	Sebollela, Adriano/0000-0002-7444-9156; Ferreira, Sergio/0000-0001-7160-9866; carraro, dirce/0000-0001-5667-1418; Paula-Lima, Andrea/0000-0002-0466-7561; Brentani, Helena/0000-0001-5192-4682; 	Human Frontiers Science Program; The John Simon Guggenheim Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute for Translational Neuroscience; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Human Frontiers Science Program(Human Frontier Science Program); The John Simon Guggenheim Foundation; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute for Translational Neuroscience; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Human Frontiers Science Program and The John Simon Guggenheim Foundation (to F. G. D.-F.) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and National Institute for Translational Neuroscience (to S. T. F. and F. G. D.-F.).; Recipient of a postdoctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. To whom correspondence may be addressed. E-mail: sebollela@bioqmed.ufrj.br.	Ambree O, 2006, AM J PATHOL, V169, P544, DOI 10.2353/ajpath.2006.051107; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; Brentani RR, 2005, CRIT REV ONCOL HEMAT, V54, P95, DOI 10.1016/j.critrevonc.2004.12.006; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; Callahan LM, 2002, J NEUROPATH EXP NEUR, V61, P384, DOI 10.1093/jnen/61.5.384; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Chevyreva I, 2008, EXP MOL PATHOL, V84, P71, DOI 10.1016/j.yexmp.2007.08.019; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dickey CA, 2003, J NEUROSCI, V23, P5219; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; ELFERINK LA, 1993, J CELL SCI, P75; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Ferreira EN, 2010, DIAGN MOL PATHOL, V19, P45, DOI 10.1097/PDM.0b013e3181ae8186; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Ishibashi KI, 2006, J NEUROSCI RES, V84, P632, DOI 10.1002/jnr.20952; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015; Paula-Lima AC, 2011, ANTIOXID REDOX SIGN, V14, P1209, DOI 10.1089/ars.2010.3287; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reddy PH, 2004, HUM MOL GENET, V13, P1225, DOI 10.1093/hmg/ddh140; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; SABO S, 1995, NEUROSCI LETT, V184, P25, DOI 10.1016/0304-3940(94)11159-G; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vencio RZN, 2005, DNA RES, V12, P211, DOI 10.1093/dnares/dsi007; Verwer RWH, 2002, FASEB J, V16, P54, DOI 10.1096/fj.01-0504com; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Yokota T, 2006, EUR J CLIN INVEST, V36, P820, DOI 10.1111/j.1365-2362.2006.01722.x; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zhang C, 1996, NEUROSCI LETT, V211, P187, DOI 10.1016/0304-3940(96)12761-0; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	76	66	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7436	7445		10.1074/jbc.M111.298471	http://dx.doi.org/10.1074/jbc.M111.298471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235132	Green Published, hybrid			2022-12-27	WOS:000301060200044
J	Xu, ZZ; Payoe, R; Fahlman, RP				Xu, Zhizhong; Payoe, Roshani; Fahlman, Richard P.			The C-terminal Proteolytic Fragment of the Breast Cancer Susceptibility Type 1 Protein (BRCA1) Is Degraded by the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME-MEDIATED DEGRADATION; INDUCED APOPTOSIS; CARDIOVASCULAR DEVELOPMENT; UBIQUITIN LIGASES; CELLS; ARGINYLATION; ACTIVATION; CLEAVAGE; GENE; TRANSFERASE	The breast cancer susceptibility type 1 gene product (BRCA1) is cleaved by caspases upon the activation of apoptotic pathways. After proteolysis the C-terminal fragment has been reported to translocate to the cytoplasm and promote cell death. Here we report that the C-terminal fragment is unstable in cells as it is targeted for degradation by the N-end rule pathway. The data reveals that mutating the wild type N-terminal aspartate, of the C-terminal fragment, to valine stabilizes the fragment. If the N terminus is mutated to another N-terminal destabilizing residue, like arginine, the C-terminal fragment remains unstable in cells. Last, the C-terminal fragment of BRCA1 is stable in cells lacking ATE1, a component of the N-end rule pathway.	[Xu, Zhizhong; Payoe, Roshani; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Xu, Zhizhong; Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	rfahlman@ualberta.ca			Canadian Breast Cancer Foundation (CBCF)	Canadian Breast Cancer Foundation (CBCF)	This work was supported by a research grant from the Canadian Breast Cancer Foundation (CBCF) (to R. P. F.).	An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Blagosklonny MV, 1999, ONCOGENE, V18, P6460, DOI 10.1038/sj.onc.1203068; Choi YH, 2001, INT J ONCOL, V19, P687; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fung AW, 2011, J MOL BIOL, V409, P617, DOI 10.1016/j.jmb.2011.04.033; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Herman-Bachinsky Y, 2007, CELL DEATH DIFFER, V14, P861, DOI 10.1038/sj.cdd.4402079; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Leung CCY, 2011, CELL CYCLE, V10, P2461, DOI 10.4161/cc.10.15.16312; Liu WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014484; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Solary E, 1998, CELL BIOL TOXICOL, V14, P121, DOI 10.1023/A:1007481921502; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Wang F., 2011, MOL BIOL RE IN PRESS; Wickliffe KE, 2008, CELL MICROBIOL, V10, P1352, DOI 10.1111/j.1462-5822.2008.01131.x; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701	47	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7495	7502		10.1074/jbc.M111.301002	http://dx.doi.org/10.1074/jbc.M111.301002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262859	Green Published, hybrid			2022-12-27	WOS:000301060200050
J	Michal, AM; So, CH; Beeharry, N; Shankar, H; Mashayekhi, R; Yen, TJ; Benovic, JL				Michal, Allison M.; So, Christopher H.; Beeharry, Neil; Shankar, Haripriya; Mashayekhi, Rouzbeh; Yen, Timothy J.; Benovic, Jeffrey L.			G Protein-coupled Receptor Kinase 5 Is Localized to Centrosomes and Regulates Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; AURORA-A; NUCLEAR-LOCALIZATION; PHOSPHORYLATION; ARRESTINS; MEMBRANE; DIVISION; TUBULIN; GRK2; TRAFFICKING	G protein-coupled receptor kinases (GRKs) are important regulators of G protein-coupled receptor function and mediate receptor desensitization, internalization, and signaling. While GRKs also interact with and/or phosphorylate many other proteins and modify their function, relatively little is known about the cellular localization of endogenous GRKs. Here we report that GRK5 co-localizes with gamma-tubulin, centrin, and pericentrin in centrosomes. The centrosomal localization of GRK5 is observed predominantly at interphase and although its localization is not dependent on microtubules, it can mediate microtubule nucleation of centrosomes. Knockdown of GRK5 expression leads to G2/M arrest, characterized by a prolonged G2 phase, which can be rescued by expression of wild type but not catalytically inactive GRK5. This G2/ M arrest appears to be due to increased expression of p53, reduced activity of aurora A kinase and a subsequent delay in the activation of polo-like kinase 1. Overall, these studies demonstrate that GRK5 is localized in the centrosome and regulates microtubule nucleation and normal cell cycle progression.	[Michal, Allison M.; So, Christopher H.; Shankar, Haripriya; Mashayekhi, Rouzbeh; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Beeharry, Neil; Yen, Timothy J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Jefferson University; Fox Chase Cancer Center	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu		Yen, Tim/0000-0003-2159-0997	National Institutes of Health [GM44944, CA129626, GM86877, GM44762]; Canadian Heart & Stroke Foundation; DOD [W81XWH-11-1-0201]; Commonwealth of Pennsylvania; Greenberg Fund;  [CA06927]; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA129626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877, R01GM044944, R01GM044762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Heart & Stroke Foundation(Heart & Stroke Foundation of Canada); DOD(United States Department of Defense); Commonwealth of Pennsylvania; Greenberg Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44944 and CA129626 (to J.L.B.) and GM86877 and GM44762 (to T.J.Y.).; Supported in part by a postdoctoral fellowship from the Canadian Heart & Stroke Foundation.; Supported by a core grant (CA06927), the DOD (W81XWH-11-1-0201), an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund.	Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen XQ, 2010, J BIOL CHEM, V285, P12823, DOI 10.1074/jbc.M109.094243; Chen YJ, 2011, J CELL BIOL, V194, P905, DOI 10.1083/jcb.201104114; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Dias SS, 2009, FEBS LETT, V583, P3543, DOI 10.1016/j.febslet.2009.09.057; Dzimiri N, 2004, EUR J PHARMACOL, V489, P167, DOI 10.1016/j.ejphar.2004.03.015; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Jiang XS, 2007, MOL BIOL CELL, V18, P2960, DOI 10.1091/mbc.E07-01-0013; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lukasiewicz KB, 2009, ENVIRON MOL MUTAGEN, V50, P602, DOI 10.1002/em.20533; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Metaye T, 2002, J CLIN ENDOCR METAB, V87, P3279, DOI 10.1210/jc.87.7.3279; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Ruiz-Gomez A, 2000, J BIOL CHEM, V275, P29724, DOI 10.1074/jbc.M001864200; Ruiz-Gomez A, 2007, J BIOL CHEM, V282, P1205, DOI 10.1074/jbc.M607166200; Sardon T, 2008, EMBO J, V27, P2567, DOI 10.1038/emboj.2008.173; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Shao SJ, 2006, J BIOL CHEM, V281, P28943, DOI 10.1074/jbc.M600235200; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vatter P, 2005, FEBS J, V272, P6039, DOI 10.1111/j.1742-4658.2005.04995.x; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wu JH, 2006, J BIOL CHEM, V281, P37758, DOI 10.1074/jbc.M605756200; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	45	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6928	6940		10.1074/jbc.M111.298034	http://dx.doi.org/10.1074/jbc.M111.298034			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223642	Green Published, hybrid			2022-12-27	WOS:000300791800077
J	Shields, MA; Krantz, SB; Bentrem, DJ; Dangi-Garimella, S; Munshi, HG				Shields, Mario A.; Krantz, Seth B.; Bentrem, David J.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.			Interplay between beta 1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; MESENCHYMAL TRANSITION; INTEGRIN EXPRESSION; GENE-EXPRESSION; TUMOR-GROWTH; CARCINOMA; INVASION; RAC	The Snail family of transcription factors has been implicated in pancreatic cancer progression. We recently showed that Snail (Snai1) promotes membrane-type 1 matrix metalloproteinase (MT1-MMP)- and ERK1/2-dependent scattering of pancreatic cancer cells in three-dimensional type I collagen. In this study, we examine the role of Slug (Snai2) in regulating pancreatic cancer cell scattering in three-dimensional type I collagen. Although Slug increased MT1-MMP expression and ERK1/2 activity, Slug-expressing cells failed to scatter in three-dimensional collagen. Moreover, in contrast to Snail-expressing cells, Slug-expressing cells did not demonstrate increased collagen I binding, collagen I-driven motility, or alpha 2 beta 1-integrin expression. Significantly, inhibiting beta 1-integrin function decreased migration and scattering of Snail-expressing cells in three-dimensional collagen. As Rho GTPases have been implicated in invasion and migration, we also analyzed the contribution of Rac1 and Rho signaling to the differential migration and scattering of pancreatic cancer cells. Snail-induced migration and scattering were attenuated by Rac1 inhibition. In contrast, inhibiting Rho-associated kinase ROCK1/2 increased migration and scattering of Slug-expressing cells in three-dimensional collagen and thus phenocopied the effects of Snail in pancreatic cancer cells. Additionally, the increased migration and scattering in three-dimensional collagen of Slug-expressing cells following ROCK1/2 inhibition was dependent on beta 1-integrin function. Overall, these results demonstrate differential effects of Snail and Slug in pancreatic cancer and identify the interplay between Rho signaling and beta 1-integrin that functions to regulate the differential scattering and migration of Snail-and Slug-expressing pancreatic cancer cells.	[Munshi, Hidayatullah G.] Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Krantz, Seth B.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Gastrointestinal & Oncol Surg, Chicago, IL 60611 USA; [Bentrem, David J.; Dangi-Garimella, Surabhi; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Hematol Oncol, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu	Krantz, Seth/T-3900-2019		NCI, National Institutes of Health [R01CA126888]; Department of Veterans Affairs; Baseball Charities Foundation; NATIONAL CANCER INSTITUTE [R01CA126888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); Baseball Charities Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA126888 (to H. G. M.) from the NCI, a Merit grant from the Department of Veterans Affairs (to H. G. M.), and the Baseball Charities Foundation (to M. A. S.).	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dangi-Garimella S, 2010, J BIOL CHEM, V285, P28363, DOI 10.1074/jbc.M110.146019; Diamond ME, 2008, J CELL SCI, V121, P2197, DOI 10.1242/jcs.021782; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Heid I, 2011, GASTROENTEROLOGY, V141, P719, DOI 10.1053/j.gastro.2011.04.043; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P91, DOI 10.1016/S0002-9440(10)64353-2; Jedeszko C., 2008, CURR PROTOC CELL BIO; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krantz Seth B, 2010, Cancers (Basel), V2, P2084, DOI 10.3390/cancers2042084; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Matsuoka T, 2011, CLIN EXP METASTAS, V28, P627, DOI 10.1007/s10585-011-9396-6; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Munshi HG, 2002, J BIOL CHEM, V277, P38159, DOI 10.1074/jbc.M202384200; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Munshi HG, 2002, METHOD CELL BIOL, V69, P195, DOI 10.1016/S0091-679X(02)69013-2; Neal CL, 2011, CELL ADHES MIGR, V5, P249, DOI 10.4161/cam.5.3.15618; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Shofuda K, 1998, J BIOCHEM-TOKYO, V124, P462, DOI 10.1093/oxfordjournals.jbchem.a022136; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Ward ST, 2011, J CELL BIOCHEM, V112, P2966, DOI 10.1002/jcb.23215; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zamir E, 2001, J CELL SCI, V114, P3583; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhang KJ, 2011, LAB INVEST, V91, P426, DOI 10.1038/labinvest.2010.201; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	65	49	51	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6218	6229		10.1074/jbc.M111.308940	http://dx.doi.org/10.1074/jbc.M111.308940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22232555	Green Published, hybrid			2022-12-27	WOS:000300791800015
J	Fauvet, B; Mbefo, MK; Fares, MB; Desobry, C; Michael, S; Ardah, MT; Tsika, E; Coune, P; Prudent, M; Lion, N; Eliezer, D; Moore, DJ; Schneider, B; Aebischer, P; El-Agnaf, OM; Masliah, E; Lashuel, HA				Fauvet, Bruno; Mbefo, Martial K.; Fares, Mohamed-Bilal; Desobry, Carole; Michael, Sarah; Ardah, Mustafa T.; Tsika, Elpida; Coune, Philippe; Prudent, Michel; Lion, Niels; Eliezer, David; Moore, Darren J.; Schneider, Bernard; Aebischer, Patrick; El-Agnaf, Omar M.; Masliah, Eliezer; Lashuel, Hilal A.			alpha-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; FAMILIAL PARKINSONS-DISEASE; IN-VITRO; 3-DIMENSIONAL STRUCTURE; SELF-OLIGOMERIZATION; ALZHEIMERS-DISEASE; RESIDUAL STRUCTURE; TRANSGENIC MICE; EXTENDED-HELIX; CROSS-LINKING	Since the discovery and isolation of alpha-synuclein (alpha-syn) from human brains, it has been widely accepted that it exists as an intrinsically disordered monomeric protein. Two recent studies suggested that alpha-syn produced in Escherichia coli or isolated from mammalian cells and red blood cells exists predominantly as a tetramer that is rich in alpha-helical structure (Bartels, T., Choi, J. G., and Selkoe, D. J. (2011) Nature 477, 107-110; Wang, W., Perovic, I., Chittuluru, J., Kaganovich, A., Nguyen, L. T. T., Liao, J., Auclair, J. R., Johnson, D., Landeru, A., Simorellis, A. K., Ju, S., Cookson, M. R., Asturias, F. J., Agar, J. N., Webb, B. N., Kang, C., Ringe, D., Petsko, G. A., Pochapsky, T. C., and Hoang, Q. Q. (2011) Proc. Natl. Acad. Sci. 108, 17797-17802). However, it remains unknown whether or not this putative tetramer is the main physiological form of alpha-syn in the brain. In this study, we investigated the oligomeric state of alpha-syn in mouse, rat, and human brains. To assess the conformational and oligomeric state of native alpha-syn in complex mixtures, we generated alpha-syn standards of known quaternary structure and conformational properties and compared the behavior of endogenously expressed alpha-syn to these standards using native and denaturing gel electrophoresis techniques, size-exclusion chromatography, and an oligomer-specific ELISA. Our findings demonstrate that both human and rodent alpha-syn expressed in the central nervous system exist predominantly as an unfolded monomer. Similar results were observed when human alpha-syn was expressed in mouse and rat brains as well as mammalian cell lines (HEK293, HeLa, and SH-SY5Y). Furthermore, we show that alpha-syn expressed in E. coli and purified under denaturing or nondenaturing conditions, whether as a free protein or as a fusion construct with GST, is monomeric and adopts a disordered conformation after GST removal. These results do not rule out the possibility that alpha-syn becomes structured upon interaction with other proteins and/or biological membranes.	[Fauvet, Bruno; Mbefo, Martial K.; Fares, Mohamed-Bilal; Desobry, Carole; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Sch Life Sci, Brain Mind Inst,Stn 19, CH-1015 Lausanne, Switzerland; [Michael, Sarah; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Ardah, Mustafa T.; El-Agnaf, Omar M.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain 15551, U Arab Emirates; [Tsika, Elpida; Moore, Darren J.] Ecole Polytech Fed Lausanne, Lab Mol Neurodegenerat Res, CH-1015 Lausanne, Switzerland; [Coune, Philippe; Schneider, Bernard; Aebischer, Patrick] Ecole Polytech Fed Lausanne, Neurodegenerat Dis Lab, CH-1015 Lausanne, Switzerland; [Prudent, Michel; Lion, Niels] Serv Reg Vaudois Transfus Sanguine, CH-1066 Epalinges, Switzerland; [Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY 10065 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California San Diego; United Arab Emirates University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol & Chem Biol Neurodegenerat, Sch Life Sci, Brain Mind Inst,Stn 19, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	, Prudent/R-7420-2016; Aebischer, Patrick/E-1387-2013; Lion, Niels/B-9182-2018; Lashuel, Hilal/M-3500-2017; Schneider, Bernard/H-6168-2011	, Prudent/0000-0001-9470-0179; Lion, Niels/0000-0002-1811-3236; Schneider, Bernard/0000-0001-5485-8748; Tsika, Elpida/0000-0003-4189-4234	National Institutes of Health from NIA [AG019391]; Michael J. Fox Foundation for Parkinson Research; Swiss National Science Foundation [31003AB_135696DE, 31003A_120653]; United Arab Emirates University; Swiss Federal Institute of Technology, Lausanne; ERC; Merck Serono; NATIONAL INSTITUTE ON AGING [R37AG019391, R37AG018440, R01AG019391] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Michael J. Fox Foundation for Parkinson Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United Arab Emirates University; Swiss Federal Institute of Technology, Lausanne; ERC(European Research Council (ERC)European Commission); Merck Serono(Merck & Company); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019391 from NIA (to D. E.). This work was also supported by grants from the Michael J. Fox Foundation for Parkinson Research (to H. A. L., D. J. M., and O. M. E.), the Swiss National Science Foundation Grants 31003AB_135696DE (to P. C., B. S., and P. A.) and 31003A_120653 (to H. A. L., B. F., and M.-B. F.), the United Arab Emirates University (to M. T. A. and O. M. E.), Swiss Federal Institute of Technology, Lausanne (to H. A. L., D. J. M., P. C., B. S., and P. A.), an ERC starting grant (to B. F., C. A. D., and H. A. L.), and a Merck Serono grant (to M.-B. F., and H. A. L.). This work was partially funded by as grant from Merck Serono.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; da Silveira SA, 2009, HUM MOL GENET, V18, P872, DOI 10.1093/hmg/ddn417; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Dusonchet J, 2009, NEUROBIOL DIS, V35, P32, DOI 10.1016/j.nbd.2009.03.013; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Han V, 2010, VOX SANG, V98, P116, DOI 10.1111/j.1423-0410.2009.01249.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang JH, 2003, MOL CELLS, V15, P87; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Lee D, 2001, EUR J BIOCHEM, V268, P295, DOI 10.1046/j.1432-1327.2001.01877.x; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; LENNOX G, 1989, J NEUROL NEUROSUR PS, V52, P1236, DOI 10.1136/jnnp.52.11.1236; Li CG, 2009, BIOCHEMISTRY-US, V48, P8578, DOI 10.1021/bi900872p; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNulty BC, 2006, PROTEIN SCI, V15, P602, DOI 10.1110/ps.051867106; Munoz E, 1997, NEUROSCI LETT, V235, P57, DOI 10.1016/S0304-3940(97)00710-6; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Oueslati A, 2012, J NEUROSCI, V32, P1536, DOI 10.1523/JNEUROSCI.3784-11.2012; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Segers-Nolten IMJ, 2008, PROTEIN SCI, V17, P1395, DOI 10.1110/ps.036103.108; Selkoe D., 2011, PROTOCOL EXCHANGE; Shaikh S, 2008, J NEUROSCI RES, V86, P2071, DOI 10.1002/jnr.21644; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Walker J. M., 2002, PROTEIN PROTOCOLS 2, P57; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Wu KP, 2009, J MOL BIOL, V391, P784, DOI 10.1016/j.jmb.2009.06.063; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	73	384	387	1	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15345	15364		10.1074/jbc.M111.318949	http://dx.doi.org/10.1074/jbc.M111.318949			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22315227	Green Published, hybrid			2022-12-27	WOS:000304006300017
J	Wang, Z; Collighan, RJ; Pytel, K; Rathbone, DL; Li, XL; Griffin, M				Wang, Zhuo; Collighan, Russell J.; Pytel, Kamila; Rathbone, Daniel L.; Li, Xiaoling; Griffin, Martin			Characterization of Heparin-binding Site of Tissue Transglutaminase ITS IMPORTANCE IN CELL SURFACE TARGETING, MATRIX DEPOSITION, AND CELL SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFATE PROTEOGLYCANS; FIBRONECTIN; ADHESION; EXPRESSION; SYNDECAN-1; TRAFFICKING; SEQUENCE	Tissue transglutaminase (TG2) is a multifunctional Ca2+-activated protein cross-linking enzyme secreted into the extracellular matrix (ECM), where it is involved in wound healing and scarring, tissue fibrosis, celiac disease, and metastatic cancer. Extracellular TG2 can also facilitate cell adhesion important in wound healing through a nontransamidating mechanism via its association with fibronectin, heparan sulfates (HS), and integrins. Regulating the mechanism how TG2 is translocated into the ECM therefore provides a strategy for modulating these physiological and pathological functions of the enzyme. Here, through molecular modeling and mutagenesis, we have identified the HS-binding site of TG2 (202)KFLKNAGRDCSRR-SSPVYVGR(222). We demonstrate the requirement of this binding site for translocation of TG2 into the ECM through a mechanism involving cell surface shedding of HS. By synthesizing a peptide NPKFLKNAGRDCSRRSS corresponding to the HS-binding site within TG2, we also demonstrate how this mimicking peptide can in isolation compensate for the RGD-induced loss of cell adhesion on fibronectin via binding to syndecan-4, leading to activation of PKC alpha, pFAK-397, and ERK1/2 and the subsequent formation of focal adhesions and actin cytoskeleton organization. A novel regulatory mechanism for TG2 translocation into the extracellular compartment that depends upon TG2 conformation and the binding of HS is proposed.	[Wang, Zhuo; Collighan, Russell J.; Pytel, Kamila; Rathbone, Daniel L.; Li, Xiaoling; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	m.griffin@aston.ac.uk		WANG, ZHUO/0000-0002-2212-8318; Rathbone, Daniel L/0000-0003-4732-4662; Griffin, Martin/0000-0003-3824-306X	European Commission Marie Curie ITN [MRTN-CT-2006-036032]; European Commission Marie Curie IAPP TRANSCOM [PIA-GA-2010-251506]	European Commission Marie Curie ITN; European Commission Marie Curie IAPP TRANSCOM	This work was supported by European Commission Marie Curie ITN Project TRACKS Contract MRTN-CT-2006-036032 and by European Commission Marie Curie IAPP TRANSCOM Contract PIA-GA-2010-251506.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chou CY, 2011, J BIOL CHEM, V286, P27825, DOI 10.1074/jbc.M111.226340; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1991, J BIOL CHEM, V266, P478; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Jones RA, 1997, J CELL SCI, V110, P2461; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; LEMOSY EK, 1992, J BIOL CHEM, V267, P7880; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; SALO T, 1994, LAB INVEST, V70, P176; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Su G, 2008, CANCER RES, V68, P9558, DOI 10.1158/0008-5472.CAN-08-1645; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; Tsanou E, 2004, J EXP CLIN CANC RES, V23, P641; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015; Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	44	51	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13063	13083		10.1074/jbc.M111.294819	http://dx.doi.org/10.1074/jbc.M111.294819			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22298777	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000302903700047
J	Kwon, JY; Seo, SG; Heo, YS; Yue, SH; Cheng, JX; Lee, KW; Kim, KH				Kwon, Jung Yeon; Seo, Sang Gwon; Heo, Yong-Seok; Yue, Shuhua; Cheng, Ji-Xin; Lee, Ki Won; Kim, Kee-Hong			Piceatannol, Natural Polyphenolic Stilbene, Inhibits Adipogenesis via Modulation of Mitotic Clonal Expansion and Insulin Receptor-dependent Insulin Signaling in Early Phase of Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOPREVENTIVE AGENT RESVERATROL; RAMAN SCATTERING MICROSCOPY; BINDING PROTEIN-BETA; KAPPA-B ACTIVATION; N-TERMINAL KINASE; ADIPOCYTE DIFFERENTIATION; TYROSINE KINASE; GENE-EXPRESSION; ADIPOSE-TISSUE; PHOSPHOINOSITIDE 3-KINASE	Piceatannol, a natural stilbene, is an analog and a metabolite of resveratrol. Despite a well documented health benefit of resveratrol in intervention of the development of obesity, the role of piceatannol in the development of adipose tissue and related diseases is unknown. Here, we sought to determine the function of piceatannol in adipogenesis and elucidate the underlying mechanism. We show that piceatannol inhibits adipogenesis of 3T3-L1 preadipocytes in a dose-dependent manner at noncytotoxic concentrations. This anti-adipogenic property of piceatannol was largely limited to the early event of adipogenesis. In the early phase of adipogenesis, piceatannol-treated preadipocytes displayed a delayed cell cycle entry into G(2)/M phase at 24 h after initiation of adipogenesis. Furthermore, the piceatannol-suppressed mitotic clonal expansion was accompanied by reduced activation of the insulin-signaling pathway. Piceatannol dose-dependently inhibited differentiation mixture-induced phosphorylation of insulin receptor (IR)/insulin receptor substrate-1 (IRS-1)/Akt pathway in the early phase of adipogenesis. Moreover, we showed that piceatannol is an inhibitor of IR kinase activity and phosphatidylinositol 3-kinase (PI3K). Our kinetics study of IR further identified a K-m value for ATP of 57.8 mu M and a K-i value for piceatannol of 28.9 mu M. We also showed that piceatannol directly binds to IR and inhibits IR kinase activity in a mixed noncompetitive manner to ATP, through which piceatannol appears to inhibit adipogenesis. Taken together, our study reveals an anti-adipogenic function of piceatannol and highlights IR and its downstream insulin signaling as novel targets for piceatannol in the early phase of adipogenesis.	[Kwon, Jung Yeon; Kim, Kee-Hong] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Seo, Sang Gwon; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Heo, Yong-Seok] Konkuk Univ, Dept Chem, Seoul 143701, South Korea; [Yue, Shuhua; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Seoul National University (SNU); Konkuk University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kim, KH (corresponding author), Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA.	keehong@purdue.edu	Lee, Ki Won/M-4114-2018		Purdue Research Foundation; National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea [2010-0029233, 2009-0067326]	Purdue Research Foundation; National Research Foundation; Ministry of Education, Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by a Purdue Research Foundation grant (to K. H. K.) and in part by National Research Foundation and Ministry of Education, Science, and Technology, Republic of Korea, Leap Research Program Grants 2010-0029233 and 2009-0067326 (to K. W. L.).	Amri A., 2012, J CONTROLLE IN PRESS; Ashikawa K, 2002, J IMMUNOL, V169, P6490, DOI 10.4049/jimmunol.169.11.6490; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bluher M, 2004, J BIOL CHEM, V279, P31891, DOI 10.1074/jbc.M404569200; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Chowdhury SA, 2005, ANTICANCER RES, V25, P2055; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FERRIGNI NR, 1984, J NAT PROD, V47, P347, DOI 10.1021/np50032a019; Gagnon A, 1999, DIABETES, V48, P691, DOI 10.2337/diabetes.48.4.691; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Gnoni GV, 2009, EUR J CLIN INVEST, V39, P211, DOI 10.1111/j.1365-2362.2008.02077.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; HARING H, 1986, J BIOL CHEM, V261, P3869; Heinrich T, 2010, ACS MED CHEM LETT, V1, P199, DOI 10.1021/ml100044h; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jang YJ, 2009, ANN NY ACAD SCI, V1171, P176, DOI 10.1111/j.1749-6632.2009.04727.x; Johnson JJ, 2011, MOL NUTR FOOD RES, V55, P1169, DOI 10.1002/mnfr.201100117; Kang CH, 2011, TOXICOL IN VITRO, V25, P605, DOI 10.1016/j.tiv.2010.12.006; Kim CY, 2011, J AGR FOOD CHEM, V59, P1012, DOI 10.1021/jf103873k; Kim EJ, 2009, J MED FOOD, V12, P943, DOI 10.1089/jmf.2008.1341; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Ku KL, 2005, J AGR FOOD CHEM, V53, P3877, DOI 10.1021/jf050242o; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larrosa M, 2004, EUR J NUTR, V43, P275, DOI 10.1007/s00394-004-0471-5; Le TT, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2795437; Lee B, 2009, TOXICOL IN VITRO, V23, P1284, DOI 10.1016/j.tiv.2009.07.023; Lee DE, 2011, CARCINOGENESIS, V32, P629, DOI 10.1093/carcin/bgr008; Lee DE, 2010, J BIOL CHEM, V285, P21458, DOI 10.1074/jbc.M109.094797; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee YM, 2009, CANCER LETT, V285, P166, DOI 10.1016/j.canlet.2009.05.011; Matsui Y, 2010, J AGR FOOD CHEM, V58, P11112, DOI 10.1021/jf102650d; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Roupe KA, 2006, J PHARM PHARMACOL, V58, P1443, DOI 10.1211/jpp.58.11.0004; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Son PS, 2010, CARCINOGENESIS, V31, P1442, DOI 10.1093/carcin/bgq099; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Su L, 2000, J BIOL CHEM, V275, P12661, DOI 10.1074/jbc.275.17.12661; Szkudelska K, 2009, J STEROID BIOCHEM, V113, P17, DOI 10.1016/j.jsbmb.2008.11.001; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; THAKKAR K, 1993, J MED CHEM, V36, P2950, DOI 10.1021/jm00072a015; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Wang BH, 1998, PLANTA MED, V64, P195, DOI 10.1055/s-2006-957407; Wang HW, 2009, VIB SPECTROSC, V50, P160, DOI 10.1016/j.vibspec.2008.11.007; Wang HY, 1999, J BIOL CHEM, V274, P32159, DOI 10.1074/jbc.274.45.32159; Wieder T, 2001, LEUKEMIA, V15, P1735, DOI 10.1038/sj.leu.2402284; Wolter F, 2002, J NUTR, V132, P298; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280	66	93	99	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11566	11578		10.1074/jbc.M111.259721	http://dx.doi.org/10.1074/jbc.M111.259721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298784	Green Published, hybrid			2022-12-27	WOS:000302780100084
J	Parker, MW; Xu, P; Li, XB; Vander Kooi, CW				Parker, Matthew W.; Xu, Ping; Li, Xiaobo; Vander Kooi, Craig W.			Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXON 7-ENCODED DOMAIN; HEPARIN-BINDING; RECEPTOR ACTIVATION; CELL MIGRATION; TUMOR-CELLS; SEMAPHORIN; VEGF(165); COMPLEX; GROWTH-FACTOR-165; TRANSDUCTION	Background: Neuropilin is an essential cell surface receptor for VEGF-A in angiogenesis. Results: VEGF-A(164) uniquely physically engages neuropilin using two distinct regions. Conclusion: These data establish the structural basis for selective VEGF-A splice form binding to neuropilin. Significance: Understanding VEGF receptor binding will advance therapeutic targeting of pathological angiogenesis.	[Vander Kooi, Craig W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Vander Kooi, CW (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone Ave,BBSRB B263, Lexington, KY 40536 USA.	craig.vanderkooi@uky.edu	Parker, Matthew/AAW-2444-2020	Parker, Matthew/0000-0001-9845-9108	National Institutes of Health [R01GM094155, T32HL072743]; Kentucky Lung Cancer Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM094155 and Training Grant T32HL072743 (to M. W. P.). This work was also supported by the Kentucky Lung Cancer Research Program.	Appleton BA, 2007, EMBO J, V26, P4902, DOI 10.1038/sj.emboj.7601906; Bates DO, 2002, CANCER RES, V62, P4123; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Jardin BA, 2008, J BIOTECHNOL, V135, P272, DOI 10.1016/j.jbiotec.2008.04.006; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Karpanen T, 2001, CANCER RES, V61, P1786; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Yang Y, 2010, P NATL ACAD SCI USA, V107, P1906, DOI 10.1073/pnas.0914052107	38	125	132	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11082	11089		10.1074/jbc.M111.331140	http://dx.doi.org/10.1074/jbc.M111.331140			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22318724	Green Published, hybrid			2022-12-27	WOS:000302780100036
J	Riolo, MT; Cooper, ZA; Holloway, MP; Cheng, Y; Bianchi, C; Yakirevich, E; Ma, L; Chin, YE; Altura, RA				Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Bianchi, Cesario; Yakirevich, Evgeny; Ma, Li; Chin, Y. Eugene; Altura, Rachel A.			Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 CATALYTIC DOMAINS; ACETYLATION; APOPTOSIS; COMPLEXES; PROGNOSIS; NETWORKS	Survivin is an oncogenic protein that is highly expressed in breast cancer and has a dual function that is dependent on its subcellular localization. In the cytosol, survivin blocks programmed cell death by inactivating caspase proteins; however, in the nucleus it facilitates cell division by regulating chromosomal movement and cytokinesis. In prior work, we showed that survivin is acetylated by CREB-binding protein (CBP), which restricts its localization to the nuclear compartment and thereby inhibits its anti-apoptotic function. Here, we identify histone deacetylase 6 (HDAC6) as responsible for abrogating CBP-mediated survivin acetylation in the estrogen receptor (ER)-positive breast cancer cell line, MCF-7. HDAC6 directly binds survivin, an interaction that is enhanced by CBP. In quiescent breast cancer cells in culture and in malignant tissue sections from ER+ breast tumors, HDAC6 localizes to a perinuclear region of the cell, undergoing transport to the nucleus following CBP activation where it then deacetylates survivin. Genetically modified mouse embryonic fibroblasts that lack mhdac6 localize survivin predominantly to the nuclear compartment, whereas wild-type mouse embryonic fibroblasts localize survivin to distinct cytoplasmic structures. Together, these data imply that HDAC6 deacetylates survivin to regulate its nuclear export, a feature that may provide a novel target for patients with ER+ breast cancer.	[Altura, Rachel A.] Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Altura, Rachel A.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Warren Alpert Med Sch, Dept Surg, Providence, RI 02903 USA; [Yakirevich, Evgeny] Brown Univ, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02903 USA; [Bianchi, Cesario] Brown Univ, Warren Alpert Med Sch, Dept Surg Res, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; Brown University	Altura, RA (corresponding author), Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Rachel_Altura@brown.edu	bianchi, cesario/H-6238-2012	Cooper, Zachary/0000-0003-1059-0940	National Institutes of Health [P20RR017695]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR017695 (to R. A. A.).	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Ceschin DG, 2011, GENE DEV, V25, P1132, DOI 10.1101/gad.619211; Chan KS, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.34; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Federico M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/475641; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Pavlyukov MS, 2011, J BIOL CHEM, V286, P23296, DOI 10.1074/jbc.M111.237586; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	31	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10885	10893		10.1074/jbc.M111.308791	http://dx.doi.org/10.1074/jbc.M111.308791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334690	Green Published, hybrid			2022-12-27	WOS:000302780100017
J	Boehringer, D; O'Farrell, HC; Rife, JP; Ban, NN				Boehringer, Daniel; O'Farrell, Heather C.; Rife, Jason P.; Ban, Nenad			Structural Insights into Methyltransferase KsgA Function in 30S Ribosomal Subunit Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA ADENINE DIMETHYLTRANSFERASE; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; TRANSLATION INITIATION; 3' END; COMPLEX; RESOLUTION; GENE; ERA	The assembly of the ribosomal subunits is facilitated by ribosome biogenesis factors. The universally conserved methyltransferase KsgA modifies two adjacent adenosine residues in the 3'-terminal helix 45 of the 16 S ribosomal RNA (rRNA). KsgA recognizes its substrate adenosine residues only in the context of a near mature 30S subunit and is required for the efficient processing of the rRNA termini during ribosome biogenesis. Here, we present the cryo-EM structure of KsgA bound to a nonmethylated 30S ribosomal subunit. The structure reveals that KsgA binds to the 30S platform with the catalytic N-terminal domain interacting with substrate adenosine residues in helix 45 and the C-terminal domain making extensive contacts to helix 27 and helix 24. KsgA excludes the penultimate rRNA helix 44 from adopting its position in the mature 30S subunit, blocking the formation of the decoding site and subunit joining. We suggest that the activation of methyltransferase activity and subsequent dissociation of KsgA control conformational changes in helix 44 required for final rRNA processing and translation initiation.	[O'Farrell, Heather C.; Rife, Jason P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Boehringer, Daniel; Ban, Nenad] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Virginia Commonwealth University	Rife, JP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	jason.rife@vcu.edu; ban@mol.biol.ethz.ch			Swiss National Science Foundation; National Center of Excellence in Research; European Research Council under the European Community [250071]; Max Roessler prize; Electron Microscopy ETH Zurich (EMEZ)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Excellence in Research; European Research Council under the European Community(European Research Council (ERC)); Max Roessler prize; Electron Microscopy ETH Zurich (EMEZ)	This work was supported by the Swiss National Science Foundation, the National Center of Excellence in Research, Structural Biology program of the Swiss National Science Foundation, and European Research Council Grant 250071 under the European Community's Seventh Framework Programme (to N. B.), and the Max Roessler prize (to N. B.).; We thank Sofia Arpagaus and Peter Tittmann for technical assistance. We are grateful to Gloria Culver for critically reading the manuscript. We thank the Electron Microscopy ETH Zurich (EMEZ) for support.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Connolly K, 2009, TRENDS BIOCHEM SCI, V34, P256, DOI 10.1016/j.tibs.2009.01.011; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Demirci H, 2010, RNA, V16, P2319, DOI 10.1261/rna.2357210; Demirci H, 2009, J MOL BIOL, V388, P271, DOI 10.1016/j.jmb.2009.02.066; Desai PM, 2006, ARCH BIOCHEM BIOPHYS, V449, P57, DOI 10.1016/j.abb.2006.02.028; Desai PM, 2011, BIOCHEMISTRY-US, V50, P854, DOI 10.1021/bi101005r; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; Guo Q, 2011, P NATL ACAD SCI USA, V108, P13100, DOI 10.1073/pnas.1104645108; HELSER TL, 1972, NATURE-NEW BIOL, V235, P6, DOI 10.1038/newbio235006a0; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Inoue K, 2007, J BACTERIOL, V189, P8510, DOI 10.1128/JB.01259-07; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; Jomaa A, 2011, RNA, V17, P697, DOI 10.1261/rna.2509811; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; LAFONTAINE D, 1994, J MOL BIOL, V241, P492, DOI 10.1006/jmbi.1994.1525; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Lu Q, 1998, J BACTERIOL, V180, P5243, DOI 10.1128/JB.180.19.5243-5246.1998; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; MOAZED D, 1986, J MOL BIOL, V191, P483, DOI 10.1016/0022-2836(86)90143-9; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; O'Farrell HC, 2006, RNA, V12, P725, DOI 10.1261/rna.2310406; O'Farrell HC, 2004, J MOL BIOL, V339, P337, DOI 10.1016/j.jmb.2004.02.068; O'Farrell HC, 2003, ACTA CRYSTALLOGR D, V59, P1490, DOI 10.1107/S0907444903011855; O'Farrell Heather C, 2008, BMC Res Notes, V1, P108, DOI 10.1186/1756-0500-1-108; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLDERMANS B, 1979, J BIOL CHEM, V254, P9094; Pulicherla N, 2009, J MOL BIOL, V391, P884, DOI 10.1016/j.jmb.2009.06.015; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; THAMMANA P, 1974, NATURE, V251, P682, DOI 10.1038/251682a0; Tu C, 2011, P NATL ACAD SCI USA, V108, P10156, DOI 10.1073/pnas.1017679108; Tu C, 2009, STRUCTURE, V17, P374, DOI 10.1016/j.str.2009.01.010; VANGEMEN B, 1989, J BACTERIOL, V171, P4002, DOI 10.1128/jb.171.7.4002-4008.1989; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Williamson JR, 2005, Q REV BIOPHYS, V38, P397, DOI 10.1017/S0033583506004264; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woodson SA, 2008, CURR OPIN CHEM BIOL, V12, P667, DOI 10.1016/j.cbpa.2008.09.024; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	56	54	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10453	10459		10.1074/jbc.M111.318121	http://dx.doi.org/10.1074/jbc.M111.318121			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308031	Green Published, hybrid			2022-12-27	WOS:000302167200072
J	Geng, H; Sakato, M; DeRocco, V; Yamane, K; Du, CW; Erie, DA; Hingorani, M; Hsieh, P				Geng, Hui; Sakato, Miho; DeRocco, Vanessa; Yamane, Kazuhiko; Du, Chunwei; Erie, Dorothy A.; Hingorani, Manju; Hsieh, Peggy			Biochemical Analysis of the Human Mismatch Repair Proteins hMutS alpha MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; NUCLEOTIDE-BINDING SITES; HUMAN NUCLEAR EXTRACTS; MUTL-ALPHA; DNA-REPAIR; DOMINANT MUTATIONS; MISPAIR-BINDING; ATR KINASE; COMPLEX; MSH2	The heterodimeric human MSH2-MSH6 protein initiates DNA mismatch repair (MMR) by recognizing mismatched bases that result from replication errors. Msh2(G674A) or Msh6(T1217D) mice that have mutations in or near the ATP binding site of MSH2 or ATP hydrolysis catalytic site of MSH6 develop cancer and have a reduced lifespan due to loss of the MMR pathway (Lin, D. P., Wang, Y., Scherer, S. J., Clark, A. B., Yang, K., Avdievich, E., Jin, B., Werling, U., Parris, T., Kurihara, N., Umar, A., Kucherlapati, R., Lipkin, M., Kunkel, T. A., and Edelmann, W. (2004) Cancer Res. 64, 517522; Yang, G., Scherer, S. J., Shell, S. S., Yang, K., Kim, M., Lipkin, M., Kucherlapati, R., Kolodner, R. D., and Edelmann, W. (2004) Cancer Cell 6, 139150). Mouse embryonic fibroblasts from these mice retain an apoptotic response to DNA damage. Mutant human MutS alpha proteins MSH2(G674A)-MSH6(wt) and MSH2(wt)-MSH6T(1219D) are profiled in a variety of functional assays and as expected fail to support MMR in vitro, although they retain mismatch recognition activity. Kinetic analyses of DNA binding and ATPase activities and examination of the excision step of MMR reveal that the two mutants differ in their underlying molecular defects. MSH2(wt)-MSH6(T1219D) fails to couple nucleotide binding and mismatch recognition, whereas MSH2(G674A)-MSH6(wt) has a partial defect in nucleotide binding. Nevertheless, both mutant proteins remain bound to the mismatch and fail to promote efficient excision thereby inhibiting MMR in vitro in a dominant manner. Implications of these findings for MMR and DNA damage signaling by MMR proteins are discussed.	[Geng, Hui; Yamane, Kazuhiko; Du, Chunwei; Hsieh, Peggy] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Sakato, Miho; Hingorani, Manju] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [DeRocco, Vanessa; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wesleyan University; University of North Carolina; University of North Carolina Chapel Hill	Hsieh, P (corresponding author), 9000 Rockville Pike,5 Mem Dr,MSC 0538,Bldg 5 Rm 3, Bethesda, MD 20892 USA.	peggyh@intra.niddk.nih.gov			National Institutes of Health of NIDDK [F31 GM087096, GM 079480]; State of Connecticut Department of Public Health [2011-0138]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052030] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1022203] Funding Source: National Science Foundation	National Institutes of Health of NIDDK; State of Connecticut Department of Public Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIDDK (to H. G., C. D., K.Y., and P. H.) and Grants F31 GM087096 (to V. R.) and GM 079480 (to D. A. E.). This work was also supported by State of Connecticut Department of Public Health Grant 2011-0138 (to M.H.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; BRENOWITZ M, 1991, J BIOL CHEM, V266, P1281; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; FANG WH, 1993, J BIOL CHEM, V268, P11838; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Geng H, 2011, ANAL BIOCHEM, V413, P179, DOI 10.1016/j.ab.2011.02.017; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lutzen A, 2008, MUTAT RES-FUND MOL M, V645, P44, DOI 10.1016/j.mrfmmm.2008.08.015; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	54	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9777	9791		10.1074/jbc.M111.316919	http://dx.doi.org/10.1074/jbc.M111.316919			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22277660	Green Published, hybrid			2022-12-27	WOS:000302167200011
J	Okuda-Ashitaka, E; Minami, T; Tsubouchi, S; Kiyonari, H; Iwamatsu, A; Noda, T; Handa, H; Ito, S				Okuda-Ashitaka, Emiko; Minami, Toshiaki; Tsubouchi, Shingo; Kiyonari, Hiroshi; Iwamatsu, Akihiro; Noda, Tetsuo; Handa, Hiroshi; Ito, Seiji			Identification of NIPSNAP1 as a Nocistatin-interacting Protein Involving Pain Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE AFFINITY BEADS; NOCICEPTIN/ORPHANIN FQ; ORPHANIN FQ; GENE; MICE; NUCLEUS; RATS; INVOLVEMENT; EXPRESSION; RECEPTORS	4-Nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1 (NIPSNAP1) is a molecule of physiologically unknown function, although it is predominantly expressed in the brain, spinal cord, liver, and kidney. We identified NIPSNAP1 as a protein that interacts with the neuropeptide nocistatin (NST) from synaptosomal membranes of mouse spinal cord using high-performance affinity latex beads. NST, which is produced from the same precursor protein as an opioid-like neuropeptide nociceptin/orphanin FQ (N/OFQ), has opposite effects on pain transmission evoked by N/OFQ. The calculated full-length pre-protein of NIPSNAP1 was 33 kDa, whereas the N-terminal truncated form of NIPSNAP1 (29 kDa) was ubiquitously expressed in the neuronal tissues, especially in synaptic membrane and mitochondria of brain. The 29-kDa NIPSNAP1 was distributed on the cell surface, and NST interacted with the 29-kDa but not the 33-kDa NIPSNAP1. Although intrathecal injection of N/OFQ induced tactile allodynia in both wild-type and NIPSNAP1-deficient mice, the inhibition of N/OFQ-evoked tactile allodynia by NST seen in wild-type mice was completely lacking in the deficient mice. These results suggest that NIPSNAP1 is an interacting molecule of NST and plays a crucial role in pain transmission.	[Okuda-Ashitaka, Emiko] Osaka Inst Technol, Dept Biomed Engn, Asahi Ku, Osaka 5358585, Japan; [Okuda-Ashitaka, Emiko] Kansai Med Univ, Dept Med Chem, Moriguchi, Osaka 5708506, Japan; [Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Takatsuki, Osaka 5698686, Japan; [Tsubouchi, Shingo; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Iwamatsu, Akihiro] Prot Res Network, Yokohama, Kanagawa 2360004, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan	Osaka Institute of Technology; Kansai Medical University; Osaka Medical College; Tokyo Institute of Technology; RIKEN; Japanese Foundation for Cancer Research	Okuda-Ashitaka, E (corresponding author), Osaka Inst Technol, Dept Biomed Engn, Asahi Ku, 5-16-1 Omiya, Osaka 5358585, Japan.	ashitaka@bme.oit.ac.jp	Noda, Tetsuo/B-1667-2016; Kiyonari, Hiroshi/N-7936-2015		Japan Society for the Promotion of Science; Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid for scientific research (S), (B), and (C) from the Japan Society for the Promotion of Science (to E. O.-A., T. M., and S. I.) and the Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (to E. O.-A.).	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Buechler C, 2004, GENOMICS, V83, P1116, DOI 10.1016/j.ygeno.2003.12.011; Chen YL, 2009, MOL CELL NEUROSCI, V40, P76, DOI 10.1016/j.mcn.2008.09.003; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Fantin M, 2007, BRIT J PHARMACOL, V152, P549, DOI 10.1038/sj.bjp.0707377; Gavioli EC, 2002, BRIT J PHARMACOL, V136, P764, DOI 10.1038/sj.bjp.0704739; Ge ZJ, 2007, NEUROSCI LETT, V413, P233, DOI 10.1016/j.neulet.2006.11.077; Hiramatsu M, 1999, EUR J PHARMACOL, V367, P151, DOI 10.1016/S0014-2999(99)00003-5; Inoue M, 2003, J PHARMACOL EXP THER, V306, P141, DOI 10.1124/jpet.103.049361; Ito S, 2000, Prog Brain Res, V129, P205; Kamei J, 2004, EUR J PHARMACOL, V489, P77, DOI 10.1016/j.ejphar.2003.12.020; Lee AH, 2002, CELL MICROBIOL, V4, P739, DOI 10.1046/j.1462-5822.2002.00225.x; Murata T, 2004, GENE EXPR PATTERNS, V5, P171, DOI 10.1016/j.modgep.2004.08.007; Nakagawa T, 1999, NEUROSCI LETT, V265, P64, DOI 10.1016/S0304-3940(99)00202-5; Nakano H, 2000, J PHARMACOL EXP THER, V292, P331; Nautiyal M, 2010, EUR J NEUROSCI, V32, P560, DOI 10.1111/j.1460-9568.2010.07326.x; Ohtsu Y, 2005, ANAL BIOCHEM, V338, P245, DOI 10.1016/j.ab.2004.10.006; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; Okuda-Ashitaka E, 2000, PEPTIDES, V21, P1101, DOI 10.1016/S0196-9781(00)00247-3; OkudaAshitaka E, 1996, MOL BRAIN RES, V43, P96, DOI 10.1016/S0169-328X(96)00165-9; Olszewski PK, 2000, BRAIN RES, V872, P181, DOI 10.1016/S0006-8993(00)02535-X; Satoh K, 2002, GENES CELLS, V7, P187, DOI 10.1046/j.1356-9597.2001.00505.x; Schoeber JPH, 2008, PFLUG ARCH EUR J PHY, V457, P91, DOI 10.1007/s00424-008-0494-5; Seroussi E, 1998, GENE, V212, P13, DOI 10.1016/S0378-1119(98)00098-5; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Sun RQ, 2001, NEUROREPORT, V12, P1789, DOI 10.1097/00001756-200106130-00054; Surendran S, 2005, NEUROCHEM INT, V46, P595, DOI 10.1016/j.neuint.2005.02.010; Tummala H, 2010, EUR J NEUROSCI, V31, P1926, DOI 10.1111/j.1460-9568.2010.07248.x; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; Verhagen AM, 2007, CELL DEATH DIFFER, V14, P348, DOI 10.1038/sj.cdd.4402001; Wang XY, 1998, GENOMICS, V49, P448, DOI 10.1006/geno.1998.5239; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamamoto T, 1999, NEUROSCI LETT, V262, P179, DOI 10.1016/S0304-3940(99)00073-7; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	35	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10403	10413		10.1074/jbc.M111.271866	http://dx.doi.org/10.1074/jbc.M111.271866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311985	Green Published, hybrid			2022-12-27	WOS:000302167200067
J	Kode, A; Mosialou, I; Silva, BC; Joshi, S; Ferron, M; Rached, MT; Kousteni, S				Kode, Aruna; Mosialou, Ioanna; Silva, Barbara C.; Joshi, Sneha; Ferron, Mathieu; Rached, Marie Therese; Kousteni, Stavroula			FoxO1 Protein Cooperates with ATF4 Protein in Osteoblasts to Control Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; SERUM OSTEOCALCIN; GENE-EXPRESSION; BETA-CELL; DIFFERENTIATION; CARBOXYLATION; METABOLISM; REGULATOR	The Forkhead transcription factor FoxO1 inhibits through its expression in osteoblasts beta-cell proliferation, insulin secretion, and sensitivity. At least part of the FoxO1 metabolic functions result from its ability to suppress the activity of osteocalcin, an osteoblast-derived hormone favoring glucose metabolism and energy expenditure. In searching for mechanisms mediating the metabolic actions of FoxO1, we focused on ATF4, because this transcription factor also affects glucose metabolism through its expression in osteoblasts. We show here that FoxO1 co-localizes with ATF4 in the osteoblast nucleus, and physically interacts with and promotes the transcriptional activity of ATF4. Genetic experiments demonstrate that FoxO1 and ATF4 cooperate to increase glucose levels and decrease glucose tolerance. These effects result from a synergistic effect of the two transcription factors to suppress the activity of osteocalcin through up-regulating expression of the phosphatase catalyzing osteocalcin inactivation. As a result, insulin production by beta-cells and insulin signaling in the muscle, liver and white adipose tissue are compromised and fat weight increases by the FoxO1/ATF4 interaction. Taken together these observations demonstrate that FoxO1 and ATF4 cooperate in osteoblasts to regulate glucose homeostasis.	[Kode, Aruna; Mosialou, Ioanna; Silva, Barbara C.; Joshi, Sneha; Rached, Marie Therese; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY 10032 USA; [Ferron, Mathieu; Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Kousteni, Stavroula] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Kousteni, S (corresponding author), Russ Berrie Med Sci Pavil,1150 St Nicholas Ave,Rm, New York, NY 10032 USA.	sk2836@columbia.edu	Ferron, Mathieu/M-7794-2013		NIDDK, National Institutes of Health [DK063608-07]; National Institutes of Health [R01-AR055931, 3-R01-AR055931-02S1, P01-AG032959]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to Dr Timothy Townes for providing Atf4<SUP>+/-</SUP> mice. We are also thankful to Charles Duncan and Jayesh G. Shah for technical assistance. We are thankful to the histology and metabolic units facilities of the Diabetes and Endocrinology Research Center of Columbia University Medical Center (supported by NIDDK, National Institutes of Health Grant DK063608-07) for help with histological analysis.; This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR055931, 3-R01-AR055931-02S1, and P01-AG032959.	Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Ferron M, 2010, BIOCHEM BIOPH RES CO, V397, P691, DOI 10.1016/j.bbrc.2010.06.008; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hwang Y. C., 2011, OSTEOPOROS IN PRESS; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI 10.1359/JBMR.081234; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	29	51	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8757	8768		10.1074/jbc.M111.282897	http://dx.doi.org/10.1074/jbc.M111.282897			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298775	hybrid, Green Published			2022-12-27	WOS:000301797800009
J	Bao, BA; Lai, CP; Naus, CC; Morgan, JR				Bao, Brian A.; Lai, Charles P.; Naus, Christian C.; Morgan, Jeffrey R.			Pannexin1 Drives Multicellular Aggregate Compaction via a Signaling Cascade That Remodels the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEATION PORE INHIBITION; MEDIATED CELL-ADHESION; ATP RELEASE; PHARMACOLOGICAL-PROPERTIES; P2X(7) RECEPTOR; 1 CHANNELS; EXPRESSION; CONNEXIN-43; FAMILY; DYNAMICS	Pannexin 1 (Panx1) is a novel gap junction protein shown to have tumor-suppressive properties. To model its in vivo role in the intratumor biomechanical environment, we investigated whether Panx1 channels modulate the dynamic assembly of multicellular C6 glioma aggregates. Treatment with carbenoxolone and probenecid, which directly and specifically block Panx1 channels, respectively, showed that Panx1 is involved in accelerating aggregate assembly. Experiments further showed that exogenous ATP can reverse the inhibitive effects of carbenoxolone and that aggregate compaction is sensitive to the purinergic antagonist suramin. With a close examination of the F-actin microfilament network, these findings show that Panx1 channels act as conduits for ATP release that stimulate the P2X7 purinergic receptor pathway, in turn up-regulating actomyosin function. Using a unique three-dimensional scaffold-free method to quantify multicellular interactions, this study shows that Panx1 is intimately involved in regulating intercellular biomechanical interactions pivotal in the progression of cancer.	[Bao, Brian A.; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Lai, Charles P.; Naus, Christian C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	Brown University; University of British Columbia	Morgan, JR (corresponding author), Brown Univ, Biomed Ctr, G-B 393,171 Meeting St, Providence, RI 02912 USA.	Jeffrey_morgan@brown.edu	Lai, Charles Pin-Kuang/D-5442-2017	Lai, Charles Pin-Kuang/0000-0001-8050-7060; Morgan, Jeffrey/0000-0002-7546-3443	National Institutes of Health [R01EB008664-01A1]; Brown University; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded, in whole or in part, by National Institutes of Health Grant R01EB008664-01A1. This work was also supported by the Brown University M.D./Ph.D. program and the Canadian Institutes of Health Research (CCN). J. R. M. has an equity interest in MicroTissues, Inc. This relationship has been reviewed and managed by Brown University in accordance with its conflict of interest policies.	Bao B, 2011, FASEB J, V25, P255, DOI 10.1096/fj.10-155291; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Cotrina ML, 1998, J NEUROSCI, V18, P8794; Dahl Gerhard, 2009, P287, DOI 10.1007/978-1-59745-489-6_12; Dean DM, 2009, CELL MOTIL CYTOSKEL, V66, P129, DOI 10.1002/cm.20335; Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Foty RA, 1996, DEVELOPMENT, V122, P1611; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MOSCONA A, 1952, J ANAT, V86, P287; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Rago AP, 2009, TISSUE ENG PT A, V15, P387, DOI 10.1089/ten.tea.2008.0107; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sabala P, 2001, BRIT J PHARMACOL, V132, P393, DOI 10.1038/sj.bjp.0703843; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Wei W, 2008, CANCER LETT, V260, P79, DOI 10.1016/j.canlet.2007.10.025; Youssef J, 2011, P NATL ACAD SCI USA, V108, P6993, DOI 10.1073/pnas.1102559108; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	47	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8407	8416		10.1074/jbc.M111.306522	http://dx.doi.org/10.1074/jbc.M111.306522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267745	Green Published, hybrid			2022-12-27	WOS:000301349400055
J	Yang, N; Ma, P; Lang, JS; Zhang, YL; Deng, JJ; Ju, XW; Zhang, GY; Jiang, CY				Yang, Ning; Ma, Ping; Lang, Jianshe; Zhang, Yanli; Deng, Jiejie; Ju, Xiangwu; Zhang, Gongyi; Jiang, Chengyu			Phosphatidylinositol 4-Kinase III beta Is Required for Severe Acute Respiratory Syndrome Coronavirus Spike-mediated Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS CORONAVIRUS; CATHEPSIN-L; CONVERTING ENZYME; PROTEIN; COV; INFECTION; ACE2; GLYCOPROTEIN; TRAFFICKING; RECEPTOR	Phosphatidylinositol kinases (PI kinases) play an important role in the life cycle of several viruses after infection. Using gene knockdown technology, we demonstrate that phosphatidylinositol 4-kinase III beta (PI4KB) is required for cellular entry by pseudoviruses bearing the severe acute respiratory syndrome-coronavirus (SARS-CoV) spike protein and that the cell entry mediated by SARS-CoV spike protein is strongly inhibited by knockdown of PI4KB. Consistent with this observation, pharmacological inhibitors of PI4KB blocked entry of SARS pseudo-virions. Further research suggested that PI4P plays an essential role in SARS-CoV spike-mediated entry, which is regulated by the PI4P lipid microenvironment. We further demonstrate that PI4KB does not affect virus entry at the SARS-CoV S-ACE2 binding interface or at the stage of virus internalization but rather at or before virus fusion. Taken together, these results indicate a new function for PI4KB and suggest a new drug target for preventing SARS-CoV infection.	[Yang, Ning; Ma, Ping; Lang, Jianshe; Zhang, Yanli; Deng, Jiejie; Ju, Xiangwu; Jiang, Chengyu] Tsinghua Univ, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhang, Gongyi] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; National Jewish Health	Jiang, CY (corresponding author), Tsinghua Univ, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China.	chengyujiang@gmail.com			Ministry of Science and Technology of China [2009CB522105]; Ministry of Education [B08007]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education	This work was supported by Ministry of Science and Technology of China Grant 2009CB522105 and Ministry of Education 111 Project Grant B08007.	Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dunn EF, 2011, J VIROL, V85, P422, DOI 10.1128/JVI.01671-10; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023710; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lim YS, 2011, J BIOL CHEM, V286, P11290, DOI 10.1074/jbc.M110.194472; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ng ML, 2003, J MED VIROL, V71, P323, DOI 10.1002/jmv.10499; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang S, 2008, VIRUS RES, V136, P8, DOI 10.1016/j.virusres.2008.03.004; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Zhang QF, 2004, J MED VIROL, V73, P332, DOI 10.1002/jmv.20095	37	33	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8457	8467		10.1074/jbc.M111.312561	http://dx.doi.org/10.1074/jbc.M111.312561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253445	Green Published, hybrid			2022-12-27	WOS:000301349400060
J	Zhu, MH; Fuller, DM; Zhang, WG				Zhu, Minghua; Fuller, Deirdre M.; Zhang, Weiguo			The Role of Ras Guanine Nucleotide Releasing Protein 4 in Fc epsilon RI-mediated Signaling, Mast Cell Function, and T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL-BINDING MOTIFS; MYELOID-LEUKEMIA; ACTIVATION; RASGRP4; PHOSPHORYLATION; EXPRESSION; ADAPTER; KINASE; LAT	The RasGRP (Ras guanine nucleotide-releasing protein) family proteins are guanine nucleotide exchange factors that activate Ras GTPases, ultimately leading to MAPK activation and many cellular processes. The RasGRP family has four members. Published studies demonstrate that RasGRP1, RasGRP2, and RasGRP3 play critical roles in T cells, platelets, and B cells, respectively. RasGRP4 is highly expressed in mast cells. Although previous data suggest that it is important in mast cell development and function, the role of RasGRP4 in mast cells and allergic responses has not been clearly demonstrated. In this study, we generated RasGRP4(-/-) mice to examine the function of RasGRP4. Analyses of these mice showed that mast cells were able to develop normally in vivo and in vitro. Despite high levels of RasGRP4 expression in mast cells, RasGRP4 deficiency led to only a modest reduction in Fc epsilon RI-mediated degranulation and cytokine production. Interestingly, mast cells deficient in both RasGRP1 and RasGRP4 had a much more severe block in Fc epsilon RI-mediated signaling and mast cell function. We also made the unexpected finding that RasGRP4 functions during thymocyte development. Our data suggest that after the engagement of immunoreceptors, immune cells likely employ multiple members of the RasGRP family to transduce critical signals.	[Zhu, Minghua; Fuller, Deirdre M.; Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Zhang, WG (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Box 3010, Durham, NC 27710 USA.	zhang033@mc.duke.edu	Zhu, Minghua/ABH-2671-2020		National Institutes of Health [AI048674, AI056156]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI056156, R56AI048674, R01AI048674, R01AI056156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported, in whole or in part, by National Institutes of Health Grants AI048674 and AI056156.	Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Dupuy AJ, 2001, J BIOL CHEM, V276, P11804, DOI 10.1074/jbc.M008970200; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; Katsoulotos GP, 2008, J BIOL CHEM, V283, P1610, DOI 10.1074/jbc.M707042200; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Martinez-Florensa M, 2011, J LEUKOCYTE BIOL, V89, P63, DOI 10.1189/jlb.0509342; Matsuda S, 2004, EMBO J, V23, P2577, DOI 10.1038/sj.emboj.7600268; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Springett GM, 2004, BIOESSAYS, V26, P730, DOI 10.1002/bies.20057; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	22	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8135	8143		10.1074/jbc.M111.320580	http://dx.doi.org/10.1074/jbc.M111.320580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262848	Green Published, hybrid			2022-12-27	WOS:000301349400029
J	Bonzo, JA; Ferry, CH; Matsubara, T; Kim, JH; Gonzalez, FJ				Bonzo, Jessica A.; Ferry, Christina H.; Matsubara, Tsutomu; Kim, Jung-Hwan; Gonzalez, Frank J.			Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4 alpha in Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-7; HORMONE RECEPTOR SUPERFAMILY; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROSTATE-CANCER; MOUSE; HNF4-ALPHA; FIBROSIS	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) regulates genes involved in lipid and bile acid synthesis, gluconeogenesis, amino acid metabolism, and blood coagulation. In addition to its metabolic role, HNF4 alpha is critical for hepatocyte differentiation, and loss of HNF4 alpha is associated with hepatocellular carcinoma. The hepatocyte-specific Hnf4a knock-out mouse develops severe hepatomegaly and steatosis resulting in premature death, thereby limiting studies of the role of this transcription factor in the adult animal. In addition, gene compensation may complicate analysis of the phenotype of these mice. To overcome these issues, an acute Hnf4a knock-out mouse model was generated through use of the tamoxifen-inducible ErT2cre coupled to the serum albumin gene promoter. Microarray expression analysis revealed up-regulation of genes associated with proliferation and cell cycle control only in the acute liver-specific Hnf4 alpha-null mouse. BrdU and ki67 staining confirmed extensive hepatocyte proliferation in this model. Proliferation was associated with induction of the hepatomitogen Bmp7 as well as reduced basal apoptotic activity. The p53/p63 apoptosis effector gene Perp was further identified as a direct HNF4 alpha target gene. These data suggest that HNF4 alpha maintains hepatocyte differentiation in the adult healthy liver, and its loss may directly contribute to hepatocellular carcinoma development, thus indicating this factor as a possible liver tumor suppressor gene.	[Bonzo, Jessica A.; Ferry, Christina H.; Matsubara, Tsutomu; Kim, Jung-Hwan; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gonzalez, FJ (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, 9000 Rockville Pike,Bldg 37,Rm 3106, Bethesda, MD 20892 USA.	gonzalef@mail.nih.gov		Kim, Jung Hwan/0000-0002-2975-4899	National Cancer Institute, National Institutes of Health (NIH); NIGMS, National Institutes of Health; National Institutes of Health Summer Internship Program; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Summer Internship Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the intramural research program at the National Cancer Institute, National Institutes of Health (NIH).; Supported by the Pharmacology Research Associate program through NIGMS, National Institutes of Health.; Supported by the National Institutes of Health Summer Internship Program.	Alarmo EL, 2006, GENE CHROMOSOME CANC, V45, P411, DOI 10.1002/gcc.20307; Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453; Attardi LD, 2000, GENE DEV, V14, P704; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chayanupatkul M, 2009, EUR J PEDIATR SURG, V19, P246, DOI 10.1055/s-0029-1216378; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Ferlay J, 2010, IARC CANCERBASE, V10; Fiaschetti G, 2011, ONCOGENE, V30, P2823, DOI 10.1038/onc.2011.10; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Howlader N, 2011, SEER CANC STAT REV 1; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Kalkuhl A, 1996, CARCINOGENESIS, V17, P609, DOI 10.1093/carcin/17.3.609; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu JW, 2012, CARCINOGENESIS, V33, P209, DOI 10.1093/carcin/bgr224; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; Morrissey C, 2010, NEOPLASIA, V12, P192, DOI 10.1593/neo.91836; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; NOLTEN LA, 1995, MOL ENDOCRINOL, V9, P1488, DOI 10.1210/me.9.11.1488; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Reczek EE, 2003, MOL CANCER RES, V1, P1048; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Rothhammer T, 2005, CANCER RES, V65, P448; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shaw JJ, 2011, EXPERT REV GASTROENT, V5, P365, DOI [10.1586/egh.11.20, 10.1586/EGH.11.20]; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stanulovic VS, 2007, HEPATOLOGY, V45, P433, DOI 10.1002/hep.21456; Stroup D, 2000, J LIPID RES, V41, P1; Sugimoto H, 2007, FASEB J, V21, P256, DOI 10.1096/fj.06-6837com; Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Wang SN, 2011, J CELL BIOCHEM, V112, P1130, DOI 10.1002/jcb.23027; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yin C, 2008, HEPATOLOGY, V48, P1528, DOI 10.1002/hep.22510; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039	58	125	126	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7345	7356		10.1074/jbc.M111.334599	http://dx.doi.org/10.1074/jbc.M111.334599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241473	Green Published, hybrid			2022-12-27	WOS:000301060200036
J	Sadleir, KR; Vassar, R				Sadleir, Katherine R.; Vassar, Robert			Cdk5 Protein Inhibition and A beta 42 Increase BACE1 Protein Level in Primary Neurons by a Post-transcriptional Mechanism IMPLICATIONS OF CDK5 AS A THERAPEUTIC TARGET FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; CYCLIN-DEPENDENT KINASE-5; ALZHEIMERS-DISEASE; A-BETA; TAU-PHOSPHORYLATION; POSTSYNAPTIC DENSITIES; MEMORY DEFICITS; TRANSGENIC MICE; ACTIVATOR P25	The beta-secretase enzyme BACE1 initiates production of the amyloid-beta (A beta) peptide that comprises plaques in Alzheimer disease (AD) brain. BACE1 levels are increased in AD, potentially accelerating A beta generation, but the mechanisms of BACE1 elevation are not fully understood. Cdk5/p25 has been implicated in neurodegeneration and BACE1 regulation, suggesting therapeutic Cdk5 inhibition for AD. In addition, caspase 3 has been implicated in BACE1 elevation. Here, we show that the Cdk5 level and p25:p35 ratio were elevated and correlated with BACE1 level in brains of AD patients and 5XFAD transgenic mice. Mouse primary cortical neurons treated with A beta 42 oligomers had increased BACE1 level and p25:p35 ratio. Surprisingly, the A beta 42-induced BACE1 elevation was not blocked by Cdk5 inhibitors CP68130 and roscovitine, and instead the BACE1 level was increased greater than with A beta 42 treatment alone. Moreover, Cdk5 inhibitors alone elevated BACE1 in a time-and dose-dependent manner that coincided with increased caspase 3 cleavage and decreased Cdk5 level. Caspase 3 inhibitor benzyloxycarbonyl-VAD failed to prevent the A beta 42-induced BACE1 increase. Further experiments suggested that the A beta 42-induced BACE1 elevation was the result of a post-transcriptional mechanism. We conclude that A beta 42 may increase the BACE1 level independently of either Cdk5 or caspase 3 and that Cdk5 inhibition for AD may cause BACE1 elevation, a potentially negative therapeutic outcome.	[Sadleir, Katherine R.; Vassar, Robert] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Sadleir, Katherine R/N-1199-2019	Sadleir, Katherine R/0000-0001-8310-841X	National Institutes of Health [R01AG17917, 5T32AG00026, F32AG033445, R01AG030142]; NATIONAL INSTITUTE ON AGING [F32AG033445, R01AG017917, R01AG030142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge Dr. David A. Bennett and the Rush Memory and Aging Project (National Institutes of Health Grant R01AG17917) for the generous gift of human brain samples, Dr. Lit-Fui Lau (Pfizer, Inc.) for the donation of the selective Cdk5 inhibitor CP681301, and the laboratories of Drs. Linda Van Eldik, D. Martin Watterson, and Mary Jo Ladu for A beta 42 preparation and helpful advice.; This work was supported, in whole or in part, by National Institutes of Health Grants 5T32AG00026 and F32AG033445 (to K. R. S.) and R01AG030142 (to R. V.).	Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borghi R, 2002, NEUROLOGY, V58, P589, DOI 10.1212/WNL.58.4.589; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chiocco MJ, 2004, J BIOL CHEM, V279, P52535, DOI 10.1074/jbc.M409680200; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kerokoski P, 2001, BIOCHEM BIOPH RES CO, V280, P998, DOI 10.1006/bbrc.2001.4240; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mengesdorf T, 2002, P NATL ACAD SCI USA, V99, P15042, DOI 10.1073/pnas.232588799; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nguyen KC, 2002, J ALZHEIMERS DIS, V4, P123, DOI 10.3233/JAD-2002-4207; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selznick LA, 1999, J NEUROPATH EXP NEUR, V58, P1020, DOI 10.1097/00005072-199909000-00012; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Su JH, 2001, BRAIN RES, V898, P350, DOI 10.1016/S0006-8993(01)02018-2; Takashima A, 2001, NEUROSCI LETT, V306, P37, DOI 10.1016/S0304-3940(01)01864-X; Tandon A, 2003, J NEUROCHEM, V86, P572, DOI 10.1046/j.1471-4159.2003.01865.x; Taniguchi S, 2001, FEBS LETT, V489, P46, DOI 10.1016/S0014-5793(00)02431-5; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Wen Y, 2008, J NEUROSCI, V28, P2624, DOI 10.1523/JNEUROSCI.5245-07.2008; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Yoo BC, 2001, NATURE, V411, P763, DOI 10.1038/35081146; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x	64	50	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7224	7235		10.1074/jbc.M111.333914	http://dx.doi.org/10.1074/jbc.M111.333914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223639	hybrid, Green Published			2022-12-27	WOS:000301060200025
J	Nakai, T; Ono, K; Kuroda, S; Tanizawa, K; Okajima, T				Nakai, Tadashi; Ono, Kazutoshi; Kuroda, Shun'ichi; Tanizawa, Katsuyuki; Okajima, Toshihide			An Unusual Subtilisin-like Serine Protease Is Essential for Biogenesis of Quinohemoprotein Amine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARACOCCUS-DENITRIFICANS; PSEUDOMONAS-PUTIDA; PATHWAY; INTERMEDIATE; SUPERFAMILY; PEPTIDES; PROTEINS; COFACTOR; BACTERIA; SERPINS	Quinohemoprotein amine dehydrogenase (QHNDH), an alpha beta gamma heterotrimer present in the periplasm of several Gram-negative bacteria, catalyzes the oxidative deamination of various aliphatic amines such as n-butylamine for assimilation as carbon and energy sources. The gamma subunit of mature QHNDH contains a protein-derived quinone cofactor, cysteine tryptophylquinone, and three intrapeptidyl thioether cross-links between Cys and Asp or Glu residues. In its cytoplasmic nascent form, the gamma subunit has a 28-residue N-terminal leader peptide that is necessary for the production of active QHNDH but must be removed in the following maturation process. Here, we describe the role of a subtilisin-like serine protease encoded in the fifth ORF of the n-butylamine-utilizing operon of Paracoccus denitrificans (termed ORF5) in QHNDH biogenesis. ORF5 disruption caused bacterial cell growth inhibition in n-butylamine-containing medium and production of inactive QHNDH, in which the gamma subunit retained the leader peptide. Supply of plasmid-encoded ORF5 restored the cell growth and production of active QHNDH, containing the correctly processed gamma subunit. ORF5 expressed in Escherichia coli but not its catalytic triad mutant cleaved synthetic peptides surrogating for the gamma subunit leader peptide, although extremely slowly. The cleaved leader peptide remained unstably bound to ORF5, most likely as an acyl enzyme intermediate attached to the active-site Ser residue. These results demonstrate that ORF5 is essential for QHNDH biogenesis, serving as a processing protease to cleave the gamma subunit leader peptide nearly in a disposable manner.	[Nakai, Tadashi; Ono, Kazutoshi; Kuroda, Shun'ichi; Tanizawa, Katsuyuki; Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Osaka University	Okajima, T (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.	tokajima@sanken.osaka-u.ac.jp	Nakai, Tadashi/F-8047-2010	Nakai, Tadashi/0000-0001-9770-8168; Okajima, Toshihide/0000-0003-1733-9580	Japan Society for the Promotion of Science [18370043, 18350085, 23570135]; Protein Research Foundation; Japan Foundation of Applied Enzymology	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Protein Research Foundation; Japan Foundation of Applied Enzymology(Japan Foundation of Applied Enzymology)	This work was supported by Japan Society for the Promotion of Science Grants in Aid for Scientific Research Category B 18370043 (to K.T.) and 18350085 (to T.O.) and Category C 23570135 (to T.N.), by a Kaneko/Narita research grant from the Protein Research Foundation (to T.N.), and by a research fund from the Japan Foundation of Applied Enzymology (to K.T.).	Adachi O, 1998, BIOSCI BIOTECH BIOCH, V62, P469, DOI 10.1271/bbb.62.469; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kocher T, 2005, ANAL CHEM, V77, P172, DOI 10.1021/ac0489115; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; NISHINO T, 1977, J BIOL CHEM, V252, P2934; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; PAGE MD, 1994, J BACTERIOL, V176, P5919, DOI 10.1128/jb.176.19.5919-5928.1994; PAZ MA, 1991, J BIOL CHEM, V266, P689; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takayama M, 2001, J AM SOC MASS SPECTR, V12, P420, DOI 10.1016/S1044-0305(01)00218-5; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Ye S, 2001, CURR OPIN STRUC BIOL, V11, P740, DOI 10.1016/S0959-440X(01)00275-5	25	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6530	6538		10.1074/jbc.M111.324756	http://dx.doi.org/10.1074/jbc.M111.324756			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22235135	Green Published, hybrid			2022-12-27	WOS:000300791800041
J	Conner, MT; Conner, AC; Bland, CE; Taylor, LHJ; Brown, JEP; Parri, HR; Bill, RM				Conner, Matthew T.; Conner, Alex C.; Bland, Charlotte E.; Taylor, Luke H. J.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.			Rapid Aquaporin Translocation Regulates Cellular Water Flow MECHANISM OF HYPOTONICITY-INDUCED SUBCELLULAR LOCALIZATION OF AQUAPORIN 1 WATER CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; VOLUME REGULATION; COLLECTING DUCT; CATION CHANNEL; K+ CHANNELS; NULL MICE; CELLS; TRAFFICKING; RECEPTOR	The control of cellular water flow is mediated by the aquaporin (AQP) family of membrane proteins. The structural features of the family and the mechanism of selective water passage through the AQP pore are established, but there remains a gap in our knowledge of how water transport is regulated. Two broad possibilities exist. One is controlling the passage of water through the AQP pore, but this only has been observed as a phenomenon in some plant and microbial AQPs. An alternative is controlling the number of AQPs in the cell membrane. Here, we describe a novel pathway in mammalian cells whereby a hypotonic stimulus directly induces intracellular calcium elevations through transient receptor potential channels, which trigger AQP1 translocation. This translocation, which has a direct role in cell volume regulation, occurs within 30 s and is dependent on calmodulin activation and phosphorylation of AQP1 at two threonine residues by protein kinase C. This direct mechanism provides a rationale for the changes in water transport that are required in response to constantly changing local cellular water availability. Moreover, because calcium is a pluripotent and ubiquitous second messenger in biological systems, the discovery of its role in the regulation of AQP translocation has ramifications for diverse physiological and pathophysiological processes, as well as providing an explanation for the rapid regulation of water flow that is necessary for cell homeostasis.	[Conner, Matthew T.; Bland, Charlotte E.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Conner, Matthew T.; Bland, Charlotte E.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.; Taylor, Luke H. J.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Aston University; Aston University; University of Warwick	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk	Bill, Roslyn M/D-4554-2012; Parri, Rheinallt/D-1748-2013; Brown, James E/A-7503-2012	Bill, Roslyn M/0000-0003-1331-0852; Parri, Rheinallt/0000-0002-1412-2688	European Commission [201924 EDICT]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Framework Programme 7 Grant 201924 EDICT (to R. M. B.).	Acs P, 1997, J BIOL CHEM, V272, P22148, DOI 10.1074/jbc.272.35.22148; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Beech DJ, 2003, CELL CALCIUM, V33, P433, DOI 10.1016/S0143-4160(03)00054-X; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; BENGA G, 1986, EUR J CELL BIOL, V41, P252; Bouley R, 2009, AM J PHYSIOL-RENAL, V297, pF1575, DOI 10.1152/ajprenal.90762.2008; Brown D, 1998, AM J PHYSIOL-RENAL, V275, pF328, DOI 10.1152/ajprenal.1998.275.3.F328; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Ding YF, 2004, AM J PHYSIOL-CELL PH, V287, pC413, DOI 10.1152/ajpcell.00537.2003; Dolensek J, 2011, PHYSIOL RES, V60, pS29, DOI 10.33549/physiolres.932176; EVELOFF JL, 1987, AM J PHYSIOL, V252, pF1, DOI 10.1152/ajprenal.1987.252.1.F1; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Fisher SK, 2008, J NEUROCHEM, V106, P1998, DOI 10.1111/j.1471-4159.2008.05510.x; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Homann U, 2002, P NATL ACAD SCI USA, V99, P10215, DOI 10.1073/pnas.152324399; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; Jans D, 2000, PFLUG ARCH EUR J PHY, V439, P504, DOI 10.1007/s004240050970; Kocanova S, 2006, PHOTOCHEM PHOTOBIOL, V82, P720, DOI 10.1562/2005-09-26-RA-696; Krane CM, 2007, MAMM GENOME, V18, P452, DOI 10.1007/s00335-007-9041-5; LANKFORD SP, 1991, AM J PHYSIOL, V261, pF554, DOI 10.1152/ajprenal.1991.261.3.F554; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Liu K, 1998, PLANT CELL, V10, P1957, DOI 10.1105/tpc.10.11.1957; Luckey AE, 2003, ARCH SURG-CHICAGO, V138, P1055, DOI 10.1001/archsurg.138.10.1055; Maric K, 2001, BIOPHYS J, V80, P1783, DOI 10.1016/S0006-3495(01)76148-6; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noda Y, 2005, BIOL CELL, V97, P885; Parri HR, 2010, EUR J NEUROSCI, V32, P29, DOI 10.1111/j.1460-9568.2010.07281.x; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Querfurth HW, 1998, BIOCHEM J, V334, P79, DOI 10.1042/bj3340079; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Wang Y, 2007, J NUTR, V137, p1509S, DOI 10.1093/jn/137.6.1509S; Yang BX, 2000, HUM GENE THER, V11, P567, DOI 10.1089/10430340050015752; Yasui H, 2008, BIOCHEM BIOPH RES CO, V373, P613, DOI 10.1016/j.bbrc.2008.06.086; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang W, 2007, J BIOL CHEM, V282, P20933, DOI 10.1074/jbc.M703858200; ZOREC R, 1993, FEBS LETT, V333, P283, DOI 10.1016/0014-5793(93)80671-G	62	64	67	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11516	11525		10.1074/jbc.M111.329219	http://dx.doi.org/10.1074/jbc.M111.329219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334691	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000302780100079
J	Racioppi, L; Noeldner, PK; Lin, FM; Arvai, S; Means, AR				Racioppi, Luigi; Noeldner, Pamela K.; Lin, Fumin; Arvai, Stephanie; Means, Anthony R.			Calcium/Calmodulin-dependent Protein Kinase Kinase 2 Regulates Macrophage-mediated Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; DENDRITIC CELLS; TYROSINE PHOSPHORYLATION; ACTIN REORGANIZATION; ADHESION KINASE; PYK2; ACTIVATION; MECHANISMS; EXPRESSION; SIGNALS	Calcium/calmodulin-dependent kinase kinase 2 (CaMKK2) plays a key role in regulating food intake and energy expenditure at least in part by its actions in hypothalamic neurons. Previously, we showed that loss of CaMKK2 protected mice from high-fat diet (HFD)-induced obesity and glucose intolerance. However, although pair feeding HFD to WT mice to match food consumption of CAMKK2-null mice slowed weight gain, it failed to protect from glucose intolerance. Here we show that relative to WT mice, HFD-fed CaMKK2-null mice are protected from inflammation in adipose and remain glucose-tolerant. Moreover, loss of CaMKK2 also protected mice from endotoxin shock and fulminant hepatitis. We explored the expression of CaMKK2 in immune cells and found it to be restricted to those of the monocyte/macrophage lineage. CaMKK2-null macrophages exhibited a remarkable deficiency to spread, phagocytose bacteria, and synthesize cytokines in response to the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Mechanistically, loss of CaMKK2 uncoupled the TLR4 cascade from activation of protein tyrosine kinase 2 (PYK2; also known as PTK2B). Our findings uncover an important function for CaMKK2 in mediating mechanisms that control the amplitude of macrophage inflammatory responses to excess nutrients or pathogen derivatives.	[Racioppi, Luigi] Duke Univ, Med Ctr, Div Cellular Therapy, Dept Med, Durham, NC 27710 USA; [Racioppi, Luigi; Noeldner, Pamela K.; Lin, Fumin; Arvai, Stephanie; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Racioppi, Luigi; Means, Anthony R.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy	Duke University; Duke University; University of Naples Federico II	Racioppi, L (corresponding author), Duke Univ, Med Ctr, Div Cellular Therapy, Dept Med, 213 Res Dr,Box 3961 DUMC,245 CARL Bldg, Durham, NC 27710 USA.	luigi.racioppi@duke.edu	racioppi, luigi/AGB-8665-2022; racioppi, luigi/GNP-0349-2022; LIN, Fumin/D-5709-2015	racioppi, luigi/0000-0002-9207-6752; LIN, Fumin/0000-0003-1229-0685	National Institutes of Health [GM033976]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM033976 (to A. R. M.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Colomer J., 2007, V45, P169; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N; Fujimoto T, 2011, BIOCHEM BIOPH RES CO, V410, P45, DOI 10.1016/j.bbrc.2011.05.102; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GutierrezRamos JC, 1997, IMMUNOL TODAY, V18, P329, DOI 10.1016/S0167-5699(97)01085-2; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; LETARI O, 1991, J IMMUNOL, V147, P980; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nerlov C, 2010, BIOESSAYS, V32, P680, DOI 10.1002/bies.201000004; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Teng EC, 2011, J LEUKOCYTE BIOL, V90, P897, DOI 10.1189/jlb.0311152; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	65	80	82	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11579	11591		10.1074/jbc.M111.336032	http://dx.doi.org/10.1074/jbc.M111.336032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334678	Green Published, hybrid			2022-12-27	WOS:000302780100085
J	Wang, A; Savas, U; Hsu, MH; Stout, CD; Johnson, EF				Wang, An; Savas, Uzen; Hsu, Mei-Hui; Stout, C. David; Johnson, Eric F.			Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; INHIBITION; METABOLISM; CYP2D6; PURIFICATION; EXPRESSION; MECHANISM; P4502C5; COMPLEX; PROTEIN	Human cytochrome P450 2D6 contributes to the metabolism of >15% of drugs used in clinical practice. This study determined the structure of P450 2D6 complexed with a substrate and potent inhibitor, prinomastat, to 2.85 angstrom resolution by x-ray crystallography. Prinomastat binding is well defined by electron density maps with its pyridyl nitrogen bound to the heme iron. The structure of ligand-bound P450 2D6 differs significantly from the ligand-free structure reported for the P450 2D6 Met-374 variant (Protein Data Bank code 2F9Q). Superposition of the structures reveals significant differences for beta sheet 1, helices A, F, F', G '', G, and H as well as the helix B-C loop. The structure of the ligand complex exhibits a closed active site cavity that conforms closely to the shape of prinomastat. The closure of the open cavity seen for the 2F9Q structure reflects a change in the direction and pitch of helix F and introduction of a turn at Gly-218, which is followed by a well defined helix F' that was not observed in the 2F9Q structure. These differences reflect considerable structural flexibility that is likely to contribute to the catalytic versatility of P450 2D6, and this new structure provides an alternative model for in silico studies of substrate interactions with P450 2D6.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wang, An; Savas, Uzen; Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB8, La Jolla, CA 92037 USA.	dave@scripps.edu; johnson@scripps.edu			National Institutes of Health [GM031001]; Pfizer Global Research and Development; United States Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR; National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Global Research and Development(Pfizer); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM031001 (to E. F. J.). This work was also supported by Pfizer Global Research and Development. Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences.; The technical support of LacThu Tonnu for the preparation and crystallization of P450 2D6 and the help provided by the support staff at Stanford Synchrotron Radiation Lightsource for data collection are greatly appreciated. We also thank Pfizer Global Research and Development for providing prinomastat for the purification and crystallization of the prinomastat P450 2D6 complex and Ben Burke, Caroline Lee, Michael Wester, and Michael Zientek for helpful discussions during the course of this work. The Stanford Synchrotron Radiation Lightsource, Structural Molecular Biology Program, is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by National Institutes of Health, NCRR, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes HJ, 1996, METHOD ENZYMOL, V272, P3, DOI 10.1016/S0076-6879(96)72003-7; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; CRESPI CL, 1995, PHARMACOGENETICS, V5, P234, DOI 10.1097/00008571-199508000-00007; Dehal SS, 1997, CANCER RES, V57, P3402; Ellis SW, 1996, BIOCHEM J, V316, P647, DOI 10.1042/bj3160647; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GEGNER JA, 1991, P NATL ACAD SCI USA, V88, P750, DOI 10.1073/pnas.88.3.750; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; Hande KR, 2004, CLIN CANCER RES, V10, P909, DOI 10.1158/1078-0432.CCR-0981-3; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; Ingelman-Sundberg M, 2010, BIOCHEM BIOPH RES CO, V396, P90, DOI 10.1016/j.bbrc.2010.02.162; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KROEMER HK, 1995, LIFE SCI, V56, P2285, DOI 10.1016/0024-3205(95)00223-S; Kuzmic P, 2004, METHOD ENZYMOL, V383, P366; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Masuda K, 2005, CHIRALITY, V17, P37, DOI 10.1002/chir.20092; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; OMURA T, 1964, J BIOL CHEM, V239, P2379; Pearson J, 2011, ARCH BIOCHEM BIOPHYS, V511, P69, DOI 10.1016/j.abb.2011.04.008; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Shin JG, 1999, DRUG METAB DISPOS, V27, P1078; VONBAHR C, 1985, BIOCHEM PHARMACOL, V34, P2501, DOI 10.1016/0006-2952(85)90533-7; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Wester MR, 2002, METHOD ENZYMOL, V357, P73; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	37	77	79	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10834	10843		10.1074/jbc.M111.307918	http://dx.doi.org/10.1074/jbc.M111.307918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22308038	Green Published, hybrid			2022-12-27	WOS:000302780100012
J	Li, J; Chu, MY; Wang, SS; Chan, D; Qi, SK; Wu, M; Zhou, ZL; Li, JW; Nishi, E; Qin, J; Wong, JM				Li, Jing; Chu, Mingyue; Wang, Shanshan; Chan, Doug; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Nishi, Eiichiro; Qin, Jun; Wong, Jiemin			Identification and Characterization of Nardilysin as a Novel Dimethyl H3K4-binding Protein Involved in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE DIBASIC CONVERTASE; LINKED MENTAL-RETARDATION; HISTONE H3; PHD FINGER; HETEROCHROMATIN FORMATION; CHROMATIN MODIFICATIONS; LYSINE-4 METHYLATION; COREPRESSOR COMPLEX; PLANT HOMEODOMAIN; STRUCTURAL BASIS	Histone methylation on lysine residues is believed to function primarily as docking sites to recruit specific proteins termed as histone code "readers" or "effectors." Each lysine residue can be mono-, di, and tri-methylated and different methylation states can have different effect on chromatin function. While an increasing number of proteins have been identified and characterized as specific effectors for methylated histones, very few of the proteins are known to recognize a particular state of methylation. In this study, we identified nardilysin (NRDc), a member of M16 family metalloendopeptidases, as a novel dimethyl-H3K4 (H3K4me2)-binding protein. Among three methylated states, NRDc binds preferentially H3K4me2 both in vitro and in vivo. Biochemical purification demonstrated that NRDc interacts with the NCoR/SMRT corepressor complex. We identified target genes repressed by NRDc through microarray. We showed that NRDc is physically associated with and recruits the NCoR complex to some of the repressed genes and this association correlates with binding of H3K4me2. Thus, our study has identified a novel H3K4me2-binding protein and revealed a role of NRDc in transcriptional regulation.	[Li, Jing; Chu, Mingyue; Wang, Shanshan; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Li, Jing; Chu, Mingyue; Wang, Shanshan; Qi, Shankang; Wu, Meng; Zhou, Zhongliang; Li, Jiwen; Wong, Jiemin] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Chan, Doug; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068501, Japan	East China Normal University; East China Normal University; Baylor College of Medicine; Kyoto University	Wong, JM (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 DongchuanRoad, Shanghai 200241, Peoples R China.	jmweng@bio.ecnu.edu.cn	Wu, Meng/N-9345-2014; Nishi, Eiichiro/A-8246-2019	Wu, Meng/0000-0001-8436-2209; Nishi, Eiichiro/0000-0002-8188-8026; Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [90919025]; Ministry of Science and Technology of China [2009CB918402, 2009CB825601, 2010CB944903]; Science and Technology Commission of Shanghai Municipality [09PJ1404200, 09DJ1400400]; ECNU [2009037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); ECNU	This study was partially supported by grants from the National Natural Science Foundation of China (90919025), the Ministry of Science and Technology of China (2009CB918402, 2009CB825601, 2010CB944903), the Science and Technology Commission of Shanghai Municipality (09PJ1404200, 09DJ1400400), and the PhD Program Scholarship Fund of ECNU 2009 (2009037).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fumagalli P, 1998, GENOMICS, V47, P238, DOI 10.1006/geno.1997.5078; Guenther MG, 2000, GENE DEV, V14, P1048; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kessler J. H., NAT IMMUNOL, V12, P45; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; PIEROTTI AR, 1994, P NATL ACAD SCI USA, V91, P6078, DOI 10.1073/pnas.91.13.6078; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Upadhyay AK, 2011, PROG DRUG RES, V67, P107, DOI 10.1007/978-3-7643-8989-5_6; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	44	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10089	10098		10.1074/jbc.M111.313965	http://dx.doi.org/10.1074/jbc.M111.313965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294699	Green Published, hybrid			2022-12-27	WOS:000302167200041
J	Wang, F; Olson, EM; Shyng, SL				Wang, Fang; Olson, Erik M.; Shyng, Show-Ling			Role of Derlin-1 Protein in Proteostasis Regulation of ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; SULFONYLUREA RECEPTOR; TRANSMEMBRANE DOMAIN; QUALITY-CONTROL; SUBUNIT STOICHIOMETRY; DEFECTIVE TRAFFICKING; MISFOLDED PROTEINS; INSULIN-SECRETION; MUTATIONS; HYPERINSULINISM	ATP-sensitive potassium (K-ATP) channels composed of sulfonylurea receptor 1 (SUR1) and Kir6.2 regulate insulin secretion by linking glucose metabolism with membrane potential. The number of K-ATP channels in the plasma membrane affects the sensitivity of beta-cells to glucose. Aberrant surface channel expression leads to insulin secretion disease. Previously, we have shown that K-ATP channel proteins undergo endoplasmic reticulum (ER)-associated degradation (ERAD) via the ubiquitin-proteasome pathway, and inhibition of proteasome function results in an increase in channel surface expression. Here, we investigated whether Derlin-1, a protein involved in retrotranslocation of misfolded or misassembled proteins across the ER membrane for degradation by cytosolic proteasomes, plays a role in ERAD and, in turn, biogenesis efficiency of K-ATP channels. We show that both SUR1 and Kir6.2 form a complex with Derlin-1 and an associated AAA-ATPase, p97. Overexpression of Derlin-1 led to a decrease in the biogenesis efficiency and surface expression of K-ATP channels. Conversely, knockdown of Derlin-1 by RNA interference resulted in increased processing of SUR1 and a corresponding increase in surface expression of K-ATP channels. Importantly, knockdown of Derlin-1 increased the abundance of disease-causing misfolded SUR1 or Kir6.2 proteins and even partially rescued surface expression in a mutant channel. We conclude that Derlin-1, by being involved in ERAD of SUR1 and Kir6.2, has a role in modulating the biogenesis efficiency and surface expression of K-ATP channels. The results suggest that physiological or pathological changes in Derlin-1 expression levels may affect glucose-stimulated insulin secretion by altering surface expression of K-ATP channels.	[Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, Portland, OR 97239 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu	Wang, Fang/GLT-2750-2022	Wang, Fang/0000-0003-1093-052X	National Institutes of Health [DK57699]; March of Dimes Research Grant Foundation [1-2001-707]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Research Grant Foundation(March of Dimes); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57699 (to S.-L. S.). This work was also supported by March of Dimes Research Grant Foundation Grant 1-2001-707 (to S.-L. S.) and a Scholarship from the China Scholarship Council (to F. W.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen PC, 2011, AM J PHYSIOL-CELL PH, V300, pC506, DOI 10.1152/ajpcell.00429.2010; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crawshaw SG, 2007, MOL MEMBR BIOL, V24, P113, DOI 10.1080/09687860600988727; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Matsuoka T, 2000, CIRC RES, V87, P873, DOI 10.1161/01.RES.87.10.873; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Peroz D, 2009, J BIOL CHEM, V284, P5250, DOI 10.1074/jbc.M806459200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schwieger I, 2008, MOL PHARMACOL, V73, P697, DOI 10.1124/mol.107.040931; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tusnady GE, 2008, BIOINFORMATICS, V24, P1469, DOI 10.1093/bioinformatics/btn202; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	53	19	21	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10482	10493		10.1074/jbc.M111.312223	http://dx.doi.org/10.1074/jbc.M111.312223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311976	Green Published, hybrid			2022-12-27	WOS:000302167200075
J	Gu, L; Ngo, S; Guo, ZF				Gu, Lei; Ngo, Sam; Guo, Zhefeng			Solid-support Electron Paramagnetic Resonance (EPR) Studies of A beta 40 Monomers Reveal a Structured State with Three Ordered Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; SPIN-LABELED PROTEINS; ALZHEIMERS-DISEASE; CONFORMATIONAL EQUILIBRIA; MASS-SPECTROMETRY; NITROXIDE MOTION; KEY RESIDUES; T4 LYSOZYME; PEPTIDES; DYNAMICS	Alzheimer disease is associated with the pathological accumulation of amyloid-beta peptide (A beta) in the brain. Soluble A beta oligomers formed during early aggregation process are believed to be neurotoxins and causative agents in Alzheimer disease. A beta monomer is the building block for amyloid assemblies. A comprehensive understanding of the structural features of A beta monomer is crucial for delineating the mechanism of A beta oligomerization. Here we investigated the structures of A beta 40 monomer using a solid-support approach, in which A beta 40 monomers are tethered on the solid support via an N-terminal His tag to prevent further aggregation. EPR spectra of tethered A beta 40 with spin labels at 18 different positions show that A beta 40 monomers adopt a completely disordered structure under denaturing conditions. Under native conditions, however, EPR spectra suggest that A beta 40 monomers adopt both a disordered state and a structured state. The structured state of A beta 40 monomer has three more ordered segments at 14-18, 29-30, and 38-40. Interactions between these segments may stabilize the structured state, which likely plays an important role in A beta aggregation.	[Gu, Lei; Ngo, Sam; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Gu, Lei/GWQ-6785-2022; Guo, Zhefeng/A-2069-2013	Guo, Zhefeng/0000-0003-1992-7255	Larry L. Hillblom Foundation	Larry L. Hillblom Foundation	This work was supported by the Larry L. Hillblom Foundation.	Amirgoulova EV, 2004, CHEMPHYSCHEM, V5, P552, DOI 10.1002/cphc.200400024; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bora RP, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3249609; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cote S, 2011, J CHEM THEORY COMPUT, V7, P2584, DOI 10.1021/ct1006967; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; GUO Z, 2003, THESIS U CALIFORNIA; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Irie K, 2005, J BIOSCI BIOENG, V99, P437, DOI 10.1263/jbb.99.437; Iurascu MI, 2009, ANAL BIOANAL CHEM, V395, P2509, DOI 10.1007/s00216-009-3164-3; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lim KH, 2007, CHEMBIOCHEM, V8, P1251, DOI 10.1002/cbic.200700194; Lim KH, 2007, BIOCHEM BIOPH RES CO, V353, P443, DOI 10.1016/j.bbrc.2006.12.043; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2007, CHEMBIOCHEM, V8, P2308, DOI 10.1002/cbic.200700240; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Sepkhanova I, 2009, APPL MAGN RESON, V36, P209, DOI 10.1007/s00723-009-0019-1; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sgourakis NG, 2011, J MOL BIOL, V405, P570, DOI 10.1016/j.jmb.2010.10.015; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wilchek M, 2003, J BIOCHEM BIOPH METH, V55, P67, DOI 10.1016/S0165-022X(02)00178-1; Wilchek M, 1999, REACT FUNCT POLYM, V41, P263, DOI 10.1016/S1381-5148(99)00042-5; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEM BIOPH RES CO, V362, P410, DOI 10.1016/j.bbrc.2007.07.198; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	52	14	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9081	9089		10.1074/jbc.M111.292086	http://dx.doi.org/10.1074/jbc.M111.292086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277652	Green Published, hybrid			2022-12-27	WOS:000301797800038
J	Kaur, H; Ganguli, D; Bachhawat, AK				Kaur, Hardeep; Ganguli, Dwaipayan; Bachhawat, Anand K.			Glutathione Degradation by the Alternative Pathway (DUG Pathway) in Saccharomyces cerevisiae Is Initiated by (Dug2p-Dug3p)(2) Complex, a Novel Glutamine Amidotransferase (GATase) Enzyme Acting on Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCYL AMINOPEPTIDASE; SULFUR METABOLISM; ESCHERICHIA-COLI; AMINO-ACIDS; TRANSPEPTIDASE; YEAST; SYNTHASE; PROTEIN; TRANSFERASE; ACTIVATION	The recently identified, fungi-specific alternative pathway of glutathione degradation requires the participation of three genes, DUG1, DUG2, and DUG3. Dug1p has earlier been shown to function as a Cys-Gly-specific dipeptidase. In the present study, we describe the characterization of Dug2p and Dug3p. Dug3p has a functional glutamine amidotransferase (GATase) II domain that is catalytically important for glutathione degradation as demonstrated through mutational analysis. Dug2p, which has an N-terminal WD40 and a C-terminal M20A peptidase domain, has no peptidase activity. The previously demonstrated Dug2p-Dug3p interaction was found to be mediated through the WD40 domain of Dug2p. Dug2p was also shown to be able to homodimerize, and this was mediated by its M20A peptidase domain. In vitro reconstitution assays revealed that Dug2p and Dug3p were required together for the cleavage of glutathione into glutamate and Cys-Gly. Purification through gel filtration chromatography confirmed the formation of a Dug2p-Dug3p complex. The functional complex had a molecular weight that corresponded to (Dug2p-Dug3p)(2) in addition to higher molecular weight oligomers and displayed Michaelis-Menten kinetics. (Dug2p-Dug3p)(2) had a K-m for glutathione of 1.2 mM, suggesting a novel GATase enzyme that acted on glutathione. Dug1p activity in glutathione degradation was found to be restricted to its Cys-Gly peptidase activity, which functioned downstream of the (Dug2p-Dug3p)(2) GATase. The DUG2 and DUG3 genes, but not DUG1, were derepressed by sulfur limitation. Based on these studies and the functioning of GATases, a mechanism is proposed for the functioning of the Dug proteins in the degradation of glutathione.	[Kaur, Hardeep; Ganguli, Dwaipayan; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India; [Bachhawat, Anand K.] Indian Inst Sci Educ & Res IISER Mohali, Sas Nagar, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indian Institute of Science Education & Research (IISER) - Mohali	Bachhawat, AK (corresponding author), IISERM, Sas Nagar 140306, Punjab, India.	anand@iisermohali.ac.in			Department of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant-in-aid project from the Department of Science and Technology and Department of Biotechnology, Government of India (to A. K. B.).; Recipient of a research fellowship form Council of Scientific and Industrial Research, Government of India.	[Anonymous], 1991, Methods Enzymol, V194, P1; BAROUKI R, 1984, J BIOL CHEM, V259, P7970; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P268, DOI 10.1073/pnas.76.1.268; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Ito S, 2009, GEN THORAC CARDIOVAS, V57, P591, DOI 10.1007/s11748-009-0445-x; JASPERS CJ, 1984, BIOCHIMIE, V66, P71, DOI 10.1016/0300-9084(84)90193-7; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Mehdi K, 2001, BIOCHEM J, V359, P631, DOI 10.1042/0264-6021:3590631; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Nakano Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1790, DOI 10.1271/bbb.60027; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PENNINCKX M, 1980, EUR J BIOCHEM, V104, P119, DOI 10.1111/j.1432-1033.1980.tb04407.x; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Sambrook J., 2002, MOL CLONING LAB MANU; Smith JL, 1998, CURR OPIN STRUC BIOL, V8, P686, DOI 10.1016/S0959-440X(98)80087-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Springael JY, 2003, BIOCHEM J, V371, P589, DOI 10.1042/BJ20021893; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; van den Heuvel RHH, 2004, CELL MOL LIFE SCI, V61, P669, DOI 10.1007/s00018-003-3316-0; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	38	29	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8920	8931		10.1074/jbc.M111.327411	http://dx.doi.org/10.1074/jbc.M111.327411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277648	hybrid, Green Published			2022-12-27	WOS:000301797800023
J	Mori, Y; Matsui, T; Furutani, Y; Yoshihara, Y; Fukuda, M				Mori, Yasunori; Matsui, Takahide; Furutani, Yutaka; Yoshihara, Yoshihiro; Fukuda, Mitsunori			Small GTPase Rab17 Regulates Dendritic Morphogenesis and Postsynaptic Development of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; LONG-TERM POTENTIATION; RECYCLING ENDOSOMES; AMPA RECEPTORS; FILOPODIA FORMATION; EPITHELIAL-CELLS; NMDA RECEPTOR; PC12 CELLS; TRAFFICKING; BINDING	Neurons are compartmentalized into two morphologically, molecularly, and functionally distinct domains: axons and dendrites, and precise targeting and localization of proteins within these domains are critical for proper neuronal functions. It has been reported that several members of the Rab family small GTPases that are key mediators of membrane trafficking, regulate axon-specific trafficking events, but little has been elucidated regarding the molecular mechanisms that underlie dendrite-specific membrane trafficking. Here we show that Rab17 regulates dendritic morphogenesis and postsynaptic development in mouse hippocampal neurons. Rab17 is localized at dendritic growth cones, shafts, filopodia, and mature spines, but it is mostly absent in axons. We also found that Rab17 mediates dendrite growth and branching and that it does not regulate axon growth or branching. Moreover, shRNA-mediated knockdown of Rab17 expression resulted in a dramatically reduced number of dendritic spines, probably because of impaired filopodia formation. These findings have revealed the first molecular link between membrane trafficking and dendritogenesis.	[Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Furutani, Yutaka; Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	Tohoku University; RIKEN	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Yoshihara, Yoshihiro/N-6481-2015; Matsui, Takahide/S-4986-2018; Fukuda, MItsunori/I-1511-2015; Furutani, Yutaka/C-3652-2017	Yoshihara, Yoshihiro/0000-0002-0319-7166; Matsui, Takahide/0000-0002-3342-0170; Fukuda, MItsunori/0000-0002-8620-5853; Furutani, Yutaka/0000-0002-2945-0166	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan; Grants-in-Aid for Scientific Research [20113006, 22700324] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to Y. M., Y. F., Y. Y., and M. F.) and by a grant from the Global COE Program (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan (to Y. M. and M. F.).	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Dailey ME, 1996, J NEUROSCI, V16, P2983; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yu E, 2008, P NATL ACAD SCI USA, V105, P16003, DOI 10.1073/pnas.0804825105; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	44	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8963	8973		10.1074/jbc.M111.314385	http://dx.doi.org/10.1074/jbc.M111.314385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291024	hybrid, Green Published			2022-12-27	WOS:000301797800027
J	Hanania, R; Sun, HS; Xu, KW; Pustylnik, S; Jeganathan, S; Harrison, RE				Hanania, Raed; Sun, He Song; Xu, Kewei; Pustylnik, Sofia; Jeganathan, Sujeeve; Harrison, Rene E.			Classically Activated Macrophages Use Stable Microtubules for Matrix Metalloproteinase-9 (MMP-9) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-B; POSTTRANSLATIONAL MODIFICATION; ENDOPLASMIC-RETICULUM; CELL-SURFACE; CALRETICULIN; EXPRESSION; PROTEIN; MEMBRANE; BINDING; METALLOPROTEINASE-9	As major effector cells of the innate immune response, macrophages must adeptly migrate from blood to infected tissues. Endothelial transmigration is accomplished by matrix metalloproteinase (MMP)-induced degradation of basement membrane and extracellular matrix components. The classical activation of macrophages with LPS and IFN-gamma causes enhanced microtubule (MT) stabilization and secretion of MMPs. Macrophages up-regulate MMP-9 expression and secretion upon immunological challenge and require its activity for migration during the inflammatory response. However, the dynamics of MMP-9 production and intracellular distribution as well as the mechanisms responsible for its trafficking are unknown. Using immunofluorescent imaging, we localized intracellular MMP-9 to small Golgi-derived cytoplasmic vesicles that contained calreticulin and protein-disulfide isomerase in activated RAW 264.7 macrophages. We demonstrated vesicular organelles of MMP-9 aligned along stable subsets of MTs and showed that selective modulation of MT dynamics contributes to the enhanced trafficking of MMP-9 extracellularly. We found a Rab3D-dependent association of MMP-9 vesicles with the molecular motor kinesin, whose association with the MT network was greatly enhanced after macrophage activation. Finally, we implicated kinesin 5B and 3B isoforms in the effective trafficking of MMP-9 extracellularly.	[Sun, He Song; Xu, Kewei; Pustylnik, Sofia; Jeganathan, Sujeeve; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Hanania, Raed] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Toronto; University Toronto Scarborough; University of Ottawa	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP-68992]; Ontario Early Researcher Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-68992 (to R. E. H.).; Recipient of a CIHR New Investigator Award and an Ontario Early Researcher Award. To whom correspondence should be addressed. Tel.: 416-287-7377; Fax: 416-287-7676; E-mail: harrison@utsc.utoronto.ca.	Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Baksh S, 1995, J BIOL CHEM, V270, P31338, DOI 10.1074/jbc.270.52.31338; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; BU CH, 1995, J BIOL CHEM, V270, P18563, DOI 10.1074/jbc.270.31.18563; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; HIGGINBOTHAM JN, 1992, CLIN EXP IMMUNOL, V88, P492; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; KJELDSEN L, 1994, BLOOD, V83, P1640, DOI 10.1182/blood.V83.6.1640.bloodjournal8361640; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; LIAO GJ, 1995, J CELL SCI, V108, P3473; Makowski GS, 1996, ANAL BIOCHEM, V236, P353, DOI 10.1006/abio.1996.0179; MANFREDI JJ, 1982, J CELL BIOL, V94, P688, DOI 10.1083/jcb.94.3.688; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Millar AL, 2002, HISTOL HISTOPATHOL, V17, P929, DOI 10.14670/HH-17.929; Min DQ, 2002, J IMMUNOL, V168, P2449, DOI 10.4049/jimmunol.168.5.2449; MITCHISON TJ, 1995, PHILOS T ROY SOC B, V349, P299, DOI 10.1098/rstb.1995.0117; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen HL, 1997, J CELL SCI, V110, P281; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Rahat MA, 2006, J LEUKOCYTE BIOL, V79, P706, DOI 10.1189/jlb.0605302; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Ross M. H., 2006, HISTOLOGY TEXT ATLAS, P256; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rupani R, 2004, PIGM CELL RES, V17, P281, DOI 10.1111/j.1600-0749.2004.00148.x; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Skubitz KM, 2000, FEBS LETT, V469, P52, DOI 10.1016/S0014-5793(00)01240-0; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; WATANABE H, 1993, J CELL SCI, V104, P991; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; WIRTH JJ, 1985, INFECT IMMUN, V49, P61, DOI 10.1128/IAI.49.1.61-66.1985; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	72	71	71	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8468	8483		10.1074/jbc.M111.290676	http://dx.doi.org/10.1074/jbc.M111.290676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270361	Green Published, hybrid			2022-12-27	WOS:000301349400061
J	Yan, D; Avtanski, D; Saxena, NK; Sharma, D				Yan, Dan; Avtanski, Dimiter; Saxena, Neeraj K.; Sharma, Dipali			Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires beta-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; MAMMARY-TUMOR GROWTH; CARCINOMA CELLS; IN-VIVO; HISTONE ACETYLTRANSFERASES; SIGNALING PROMOTES; FEMALE MICE; STEM-CELLS; E-CADHERIN; RECEPTOR	Perturbations in the adipocytokine profile, especially higher levels of leptin, are a major cause of breast tumor progression and metastasis; the underlying mechanisms, however, are not well understood. In particular, it remains elusive whether leptin is involved in epithelial-mesenchymal transition (EMT). Here, we provide molecular evidence that leptin induces breast cancer cells to undergo a transition from epithelial to spindle-like mesenchymal morphology. Investigating the downstream mediator(s) that may direct leptin-induced EMT, we found functional interactions between leptin, metastasis-associated protein 1 (MTA1), and Wnt1 signaling components. Leptin increases accumulation and nuclear translocation of beta-catenin leading to increased promoter recruitment. Silencing of beta-catenin or treatment with the small molecule inhibitor, ICG-001, inhibits leptin-induced EMT, invasion, and tumorsphere formation. Mechanistically, leptin stimulates phosphorylation of glycogen synthase kinase 3 beta (GSK3 beta) via Akt activation resulting in a substantial decrease in the formation of the GSK3 beta-LKB1-Axin complex that leads to increased accumulation of beta-catenin. Leptin treatment also increases Wnt1 expression that contributes to GSK3 beta phosphorylation. Inhibition of Wnt1 abrogates leptin-stimulated GSK3 beta phosphorylation. We also discovered that leptin increases the expression of an important modifier of Wnt1 signaling, MTA1, which is integral to leptin-mediated regulation of the Wnt/beta-catenin pathway as silencing of MTA1 inhibits leptin-induced Wnt1 expression, GSK3 beta phosphorylation, and beta-catenin activation. Furthermore, analysis of leptin-treated breast tumors shows increased expression of Wnt1, pGSK3 beta, and vimentin along with higher nuclear accumulation of beta-catenin and reduced E-cadherin expression providing in vivo evidence for a previously unrecognized cross-talk between leptin and MTA1/Wnt signaling in epithelial-mesenchymal transition of breast cancer cells.	[Avtanski, Dimiter; Sharma, Dipali] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Avtanski, Dimiter; Sharma, Dipali] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Yan, Dan] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Saxena, Neeraj K.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Emory University; University System of Maryland; University of Maryland Baltimore	Sharma, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB 1,Rm 145, Baltimore, MD 21231 USA.	dsharma7@jhmi.edu	Yan, Dan/B-1793-2012; Avtanski, Dimiter/W-6187-2018	Yan, Dan/0000-0001-7531-5814; Avtanski, Dimiter/0000-0002-4479-6448	National Institutes of Health [K01DK076742, R03DK089130, R01CA131294]; NATIONAL CANCER INSTITUTE [R01CA131294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076742, R03DK089130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK076742 and R03DK089130 (to N. K. S.) and R01CA131294 (to D. S.).	Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014; Artac M., 2011, MED ONCOL IN PRESS; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Candidus S, 1996, CANCER RES, V56, P49; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chua SC, 2004, AM J PHYSIOL-ENDOC M, V286, pE384, DOI 10.1152/ajpendo.00349.2003; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dogan S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1840; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fusco R, 2010, ENDOCR-RELAT CANCER, V17, P373, DOI 10.1677/ERC-09-0340; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez RR, 2001, ENDOCRINE, V15, P157, DOI 10.1385/ENDO:15:2:157; Gonzalez RR, 2001, ENDOCRINE, V16, P21, DOI 10.1385/ENDO:16:1:21; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Guo SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021467; Hajra KM, 2002, CANCER RES, V62, P1613; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Knight BB, 2011, ENDOCR-RELAT CANCER, V18, P413, DOI 10.1530/ERC-11-0075; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Kumar R, 2010, CANCER RES, V70, P6598, DOI 10.1158/0008-5472.CAN-10-0907; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; McMurtry V, 2009, CLIN EXP METASTAS, V26, P197, DOI 10.1007/s10585-008-9231-x; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tessitore L, 2000, INT J MOL MED, V5, P421; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	65	152	156	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8598	8612		10.1074/jbc.M111.322800	http://dx.doi.org/10.1074/jbc.M111.322800			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270359	hybrid, Green Published			2022-12-27	WOS:000301349400072
J	Chung, BM; Murray, CI; Van Eyk, JE; Coulombe, PA				Chung, Byung-Min; Murray, Christopher I.; Van Eyk, Jennifer E.; Coulombe, Pierre A.			Identification of Novel Interaction between Annexin A2 and Keratin 17 EVIDENCE FOR RECIPROCAL REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EPIDERMOLYSIS-BULLOSA SIMPLEX; IN-VITRO; PROTEIN-SYNTHESIS; EPITHELIAL-CELLS; TAIL DOMAIN; EXPRESSION; PHOSPHORYLATION; SKIN; CARCINOMA	Keratins are cytoplasmic intermediate filament proteins providing crucial structural support in epithelial cells. Keratin expression has diagnostic and even prognostic value in disease settings, and recent studies have uncovered modulatory roles for select keratin proteins in signaling pathways regulating cell growth and cell death. Elevated keratin expression in select cancers is correlated with higher expression of EGF receptor (EGFR), whose overexpression and/or mutation give rise to cancer. To explore the role of keratins in oncogenic signaling pathways, we examined the regulation of epithelial growth-associated keratin 17 (K17) in response to EGFR activation. K17 is specifically up-regulated in detergent-soluble fraction upon EGFR activation, and immunofluorescence analysis revealed alterations in K17-containing filaments. Interestingly, we identified AnxA2 as a novel interacting partner of K17, and this interaction is antagonized by EGFR activation. K17 and AnxA2 proteins show reciprocal regulation. Modulating expression of AnxA2 altered K17 stability, and AnxA2 overexpression delays EGFR-mediated change in K17 detergent solubility. Down-regulation of K17 expression, in turn, results in decreased AnxA2 phosphorylation at Tyr-23. These findings uncover a novel interaction involving K17 and AnxA2 and identify AnxA2 as a potential regulator of keratin filaments.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Murray, Christopher I.; Van Eyk, Jennifer E.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Van Eyk, Jennifer E.] Johns Hopkins Univ, Johns Hopkins Bayview Prote Ctr, Div Cardiol, Dept Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St,Room W8041, Baltimore, MD 21205 USA.	coulombe@jhsph.edu	Chung, Byung Min/H-6219-2019	Chung, Byung Min/0000-0003-1262-5107	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR44232]; Johns Hopkins Institute for Clinical and Translational Research [UL1 RR025005]; National Cancer Institute [T32CA009110]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Johns Hopkins Institute for Clinical and Translational Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR44232 (to P. A. C.), by Johns Hopkins Institute for Clinical and Translational Research Grant UL1 RR025005 (to J. E. V. E.), and by National Cancer Institute Training Grant T32CA009110 (to B.-M. C.).	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; BARIBAULT H, 1989, J CELL BIOL, V109, P1665, DOI 10.1083/jcb.109.4.1665; Bernot KM, 2004, METHOD CELL BIOL, V78, P453; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; GARBUGLIA M, 1995, BIOCHEM BIOPH RES CO, V208, P901, DOI 10.1006/bbrc.1995.1420; Gu LH, 2005, MOL BIOL CELL, V16, P1427, DOI 10.1091/mbc.E04-06-0498; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; KASAHARA K, 1993, J BIOL CHEM, V268, P23531; KESKIOJA J, 1981, J CELL BIOL, V90, P537, DOI 10.1083/jcb.90.2.537; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kim TT, 1998, OTOLARYNG HEAD NECK, V118, P324, DOI 10.1016/S0194-5998(98)70309-2; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; MA ASP, 1994, IN VITRO CELL DEV-AN, V30A, P329; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Munz B, 1997, J INVEST DERMATOL, V108, P307, DOI 10.1111/1523-1747.ep12286470; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Rothhut B, 1997, CELL MOL LIFE SCI, V53, P522, DOI 10.1007/s000180050066; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Tatenhorst L, 2006, NEUROPATH APPL NEURO, V32, P271, DOI 10.1111/j.1365-2990.2006.00720.x; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Wang YN, 2003, J BIOL CHEM, V278, P45848, DOI 10.1074/jbc.M302630200; Zhang F, 2009, J PROTEOME RES, V8, P5041, DOI 10.1021/pr900461c; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390; Zhong LP, 2009, PROTEOM CLIN APPL, V3, P322, DOI 10.1002/prca.200800123	44	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7573	7581		10.1074/jbc.M111.301549	http://dx.doi.org/10.1074/jbc.M111.301549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235123	Green Published, hybrid			2022-12-27	WOS:000301060200057
J	Jahnke, M; Trowsdale, J; Kelly, AP				Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.			Ubiquitination of Human Leukocyte Antigen (HLA)-DM by Different Membrane-associated RING-CH (MARCH) Protein Family E3 Ligases Targets Different Endocytic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HLA-DR; INVARIANT CHAIN; DENDRITIC CELLS; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; RAPID INTERNALIZATION; DOWN-REGULATION; AMINO-ACIDS; IN-VIVO	HLA-DMplays an essential role in the peptide loading of classical class II molecules and is present both at the cell surface and in late endosomal peptide-loading compartments. Trafficking of DM within antigen-presenting cells is complex and is, in part, controlled by a tyrosine-based targeting signal present in the cytoplasmic tail of DM beta. Here, we show that DM also undergoes post-translational modification through ubiquitination of a single lysine residue present in the cytoplasmic tail of the alpha chain, DM alpha. Ubiquitination of DM by MARCH1 and MARCH9 induced loss of DM molecules from the cell surface by a mechanism that cumulatively involved both direct attachment of ubiquitin chains to DM alpha and a functional tyrosine-based signal on DM beta. In contrast, MARCH8-induced loss of surface DM was entirely dependent upon the tyrosine signal on DM beta. In the absence of this tyrosine residue, levels of DM remained unchanged irrespective of whether DM alpha was ubiquitinated by MARCH8. The influence of MARCH8 was indirect and may have resulted from modification of components of the endocytic machinery by ubiquitination.	[Jahnke, Martin; Trowsdale, John; Kelly, Adrian P.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Kelly, AP (corresponding author), Univ Cambridge, Dept Pathol, Div Immunol, Tennis Court Rd, Cambridge CB2 1QP, England.	apk23@mole.bio.cam.ac.uk			Wellcome Trust; Medical Research Council; National Institute of Health Research Cambridge Biomedical Research Centre; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the Medical Research Council, and the National Institute of Health Research Cambridge Biomedical Research Centre.	AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BREMNES B, 1994, J CELL SCI, V107, P2021; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Copier J, 1996, J IMMUNOL, V157, P1017; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Gauvreau ME, 2009, TRAFFIC, V10, P1518, DOI 10.1111/j.1600-0854.2009.00948.x; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hammond C, 1998, J IMMUNOL, V161, P3282; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2010, MOL CELLS, V29, P229, DOI 10.1007/s10059-010-0051-x; KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; PIETERS J, 1993, J CELL SCI, V106, P831; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SOSA MA, 1993, J BIOL CHEM, V268, P12537; ten Broeke T, 2010, TRAFFIC, V11, P324, DOI 10.1111/j.1600-0854.2009.01024.x; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Walter RB, 2008, TRAFFIC, V9, P267, DOI 10.1111/j.1600-0854.2007.00682.x; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7256	7264		10.1074/jbc.M111.305961	http://dx.doi.org/10.1074/jbc.M111.305961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247549	hybrid, Green Published			2022-12-27	WOS:000301060200028
J	Kerschbaumer, RJ; Rieger, M; Volkel, D; Le Roy, D; Roger, T; Garbaraviciene, J; Boehncke, WH; Mullberg, J; Hoet, RM; Wood, CR; Antoine, G; Thiele, M; Savidis-Dacho, H; Dockal, M; Ehrlich, H; Calandra, T; Scheiflinger, F				Kerschbaumer, Randolf J.; Rieger, Manfred; Voelkel, Dirk; Le Roy, Didier; Roger, Thierry; Garbaraviciene, Jurate; Boehncke, Wolf-Henning; Muellberg, Juergen; Hoet, Rene M.; Wood, Clive R.; Antoine, Gerhard; Thiele, Michael; Savidis-Dacho, Helga; Dockal, Michael; Ehrlich, Hartmut; Calandra, Thierry; Scheiflinger, Friedrich			Neutralization of Macrophage Migration Inhibitory Factor (MIF) by Fully Human Antibodies Correlates with Their Specificity for the beta-Sheet Structure of MIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYED-TYPE HYPERSENSITIVITY; AFFINITY HUMAN-ANTIBODIES; D-DOPACHROME TAUTOMERASE; CRYSTAL-STRUCTURE; REGULATORY ROLE; CONTACT HYPERSENSITIVITY; MONOCLONAL-ANTIBODIES; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS; LETHAL ENDOTOXEMIA	The macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that recently emerged as an attractive therapeutic target for a variety of diseases. A diverse panel of fully human anti-MIF antibodies was generated by selection from a phage display library and extensively analyzed in vitro. Epitope mapping studies identified antibodies specific for linear as well as structural epitopes. Experimental animal studies revealed that only those antibodies binding epitopes within amino acids 50-68 or 86-102 of the MIF molecule exerted protective effects in models of sepsis or contact hypersensitivity. Within the MIF protein, these two binding regions form a beta-sheet structure that includes the MIF oxidoreductase motif. We therefore conclude that this beta-sheet structure is a crucial region for MIF activity and a promising target for anti-MIF antibody therapy.	[Kerschbaumer, Randolf J.; Rieger, Manfred; Voelkel, Dirk; Antoine, Gerhard; Thiele, Michael; Savidis-Dacho, Helga; Dockal, Michael; Ehrlich, Hartmut; Scheiflinger, Friedrich] Baxter Innovat GmbH, Baxter Biomed Res Ctr, A-2304 Orth, Austria; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Le Roy, Didier; Roger, Thierry; Calandra, Thierry] Univ Lausanne, CH-1011 Lausanne, Switzerland; [Garbaraviciene, Jurate; Boehncke, Wolf-Henning] Clin JW Goethe Univ, Dept Dermatol, D-60590 Frankfurt, Germany; [Muellberg, Juergen; Hoet, Rene M.; Wood, Clive R.] Dyax Corp, Cambridge, MA 02139 USA	Baxter International Inc; Baxter Innovations GmbH; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kerschbaumer, RJ (corresponding author), Baxter Innovat GmbH, Baxter Biomed Res Ctr, Uferstr 15, A-2304 Orth, Austria.	randolf_kerschbaumer@baxter.com	Scheiflinger, Friedrich/AAO-6307-2020; Calandra, Thierry/D-9017-2015; Roger, Thierry/G-2007-2012	Calandra, Thierry/0000-0003-3051-1285; Roger, Thierry/0000-0002-9358-0109; LE ROY, Didier/0000-0001-8954-5442	Baxter	Baxter	R. J. K., M. R., D. V., G. A., M. T., H. S.-D., M. D., H. E., and F. S. are employees of Baxter Innovations GmbH. D. L. R., T. R., J. G., W.-H. B., and T. C. have research funding agreements, and J. M., R. M. H., and C. R. W. have research and license agreements with Baxter.	Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Emonts M, 2007, CLIN INFECT DIS, V44, P1321, DOI 10.1086/514344; Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hoi AY, 2006, J IMMUNOL, V177, P5687, DOI 10.4049/jimmunol.177.8.5687; Ichiyama H, 2004, CYTOKINE, V26, P187, DOI 10.1016/j.cyto.2004.02.007; Kato Y, 1996, P NATL ACAD SCI USA, V93, P3007, DOI 10.1073/pnas.93.7.3007; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Le Roy D, 1999, J IMMUNOL, V162, P7454; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Ludwig RJ, 2010, AM J PATHOL, V176, P1339, DOI 10.2353/ajpath.2010.081100; Ludwig RJ, 2009, IMMUNOLOGY, V128, P196, DOI 10.1111/j.1365-2567.2009.03100.x; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Mikulowska A, 1997, J IMMUNOL, V158, P5514; Mischke R, 1997, FEBS LETT, V414, P226, DOI 10.1016/S0014-5793(97)01039-9; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Nguyen MT, 2003, J BIOL CHEM, V278, P33654, DOI 10.1074/jbc.M301735200; Niino M, 2000, J NEUROL SCI, V179, P127, DOI 10.1016/S0022-510X(00)00397-X; Onodera S, 1999, CYTOKINE, V11, P163, DOI 10.1006/cyto.1998.0402; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Regis EG, 2010, VIROLOGY, V399, P31, DOI 10.1016/j.virol.2009.12.018; Rinta S, 2008, J NEUROIMMUNOL, V205, P135, DOI 10.1016/j.jneuroim.2008.09.002; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Senter PD, 2002, P NATL ACAD SCI USA, V99, P144, DOI 10.1073/pnas.011569399; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Shimizu T, 2001, J INVEST DERMATOL, V116, P989, DOI 10.1046/j.0022-202x.2001.01366.x; Sprong T, 2007, SHOCK, V27, P482, DOI 10.1097/01.shk.0000246898.65692.34; Stosic-Grujicic S, 2009, AUTOIMMUN REV, V8, P244, DOI 10.1016/j.autrev.2008.07.037; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Tomura T, 1999, J IMMUNOL, V162, P195; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; ZANETTI G, 1992, J IMMUNOL, V148, P1890; Zhang Y, 2011, INT IMMUNOPHARMACOL, V11, P1333, DOI 10.1016/j.intimp.2011.04.017	63	45	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7446	7455		10.1074/jbc.M111.329664	http://dx.doi.org/10.1074/jbc.M111.329664			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238348	Green Published, hybrid			2022-12-27	WOS:000301060200045
J	Minhas, A; Sharma, A; Kaur, H; Rawal, Y; Ganesan, K; Mondal, AK				Minhas, Anupriya; Sharma, Anupam; Kaur, Harsimran; Rawal, Yashpal; Ganesan, Kaliannan; Mondal, Alok K.			Conserved Ser/Arg-rich Motif in PPZ Orthologs from Fungi Is Important for Its Role in Cation Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHATASE-Z; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; FUNCTIONAL-CHARACTERIZATION; INHIBITORY SUBUNIT; YEAST; GENE; EXPRESSION; MECHANISM	PPZ1 orthologs, novel members of a phosphoprotein phosphatase family of phosphatases, are found only in fungi. They regulate diverse physiological processes in fungi e. g. ion homeostasis, cell size, cell integrity, etc. Although they are an important determinant of salt tolerance in fungi, their physiological role remained unexplored in any halotolerant species. In this context we report here molecular and functional characterization of DhPPZ1 from Debaryomyces hansenii, which is one of the most halotolerant and osmotolerant species of yeast. Our results showed that DhPPZ1 knock-out strain displayed higher tolerance to toxic cations, and unlike in Saccharomyces cerevisiae, Na+/H+ antiporter appeared to have an important role in this process. Besides salt tolerance, DhPPZ1 also had role in cell wall integrity and growth in D. hansenii. We have also identified a short, serine-arginine-rich sequence motif in DhPpz1p that is essential for its role in salt tolerance but not in other physiological processes. Taken together, these results underscore a distinct role of DhPpz1p in D. hansenii and illustrate an example of how organisms utilize the same molecular tool box differently to garner adaptive fitness for their respective ecological niches.	[Minhas, Anupriya; Sharma, Anupam; Kaur, Harsimran; Rawal, Yashpal; Ganesan, Kaliannan; Mondal, Alok K.] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Mondal, AK (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	alok@imtech.res.in	MAHTO, ANUPAM SHARMA/CAG-1514-2022; Rawal, Yashpal/X-7527-2019	MAHTO, ANUPAM SHARMA/0000-0002-9974-3001; RAWAL, YASHPAL/0000-0001-9209-788X; MINHAS, ANU/0000-0001-6871-9896	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Recipients of Senior Research Fellowships from the Council of Scientific and Industrial Research, India.	Aggarwal M, 2006, EUKARYOT CELL, V5, P262, DOI 10.1128/EC.5.2.262-271.2006; Aggarwal M., 2009, BIOTECHNOLOGY DIVERS, P65; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Briknarova K, 2005, J BIOL CHEM, V280, P21908, DOI 10.1074/jbc.M501258200; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Clotet J, 1996, J BIOL CHEM, V271, P26349, DOI 10.1074/jbc.271.42.26349; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; Golemis EA, 1997, ADV MOLEC BIOL, P43; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUGHES V, 1993, EUR J BIOCHEM, V216, P269, DOI 10.1111/j.1432-1033.1993.tb18142.x; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Meena N, 2010, J BIOL CHEM, V285, P12121, DOI 10.1074/jbc.M109.075721; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Minhas A, 2009, FEMS YEAST RES, V9, P95, DOI 10.1111/j.1567-1364.2008.00457.x; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; POSAS F, 1992, J BIOL CHEM, V267, P11734; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szoor B, 1998, BBA-PROTEIN STRUCT M, V1388, P260, DOI 10.1016/S0167-4838(98)00201-5; Venturi GM, 2000, GENETICS, V155, P69; Vissi E, 2001, YEAST, V18, P115, DOI 10.1002/1097-0061(20010130)18:2<115::AID-YEA653>3.0.CO;2-G; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	37	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7301	7312		10.1074/jbc.M111.299438	http://dx.doi.org/10.1074/jbc.M111.299438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232558	hybrid, Green Published			2022-12-27	WOS:000301060200032
J	Takagi, K; Kim, S; Yukii, H; Ueno, M; Morishita, R; Endo, Y; Kato, K; Tanaka, K; Saeki, Y; Mizushima, T				Takagi, Kenji; Kim, Sangwoo; Yukii, Haruka; Ueno, Mika; Morishita, Ryo; Endo, Yaeta; Kato, Koichi; Tanaka, Keiji; Saeki, Yasushi; Mizushima, Tsunehiro			Structural Basis for Specific Recognition of Rpt1p, an ATPase Subunit of 26 S Proteasome, by Proteasome-dedicated Chaperone Hsm3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 20S PROTEASOMES; REGULATORY PARTICLE; MOLECULAR-GRAPHICS; ASSEMBLY PATHWAY; NMR SYSTEM; YEAST; COMPLEX; CRYSTALLOGRAPHY; MATURATION; SOFTWARE	The 26 S proteasome is a 2.5-MDa molecular machine that degrades ubiquitinated proteins in eukaryotic cells. It consists of a proteolytic core particle and two 19 S regulatory particles (RPs) composed of 6 ATPase (Rpt) and 13 non-ATPase (Rpn) subunits. Multiple proteasome-dedicated chaperones facilitate the assembly of the proteasome, but little is known about the detailed mechanisms. Hsm3, a 19 S RP dedicated chaperone, transiently binds to the C-terminal domain of the Rpt1 subunit and forms a tetrameric complex, Hsm3-Rpt1-Rpt2-Rpn1, during maturation of the ATPase ring of 19 S RP. To elucidate the structural basis of Hsm3 function, we determined the crystal structures of Hsm3 and its complex with the C-terminal domain of the Rpt1 subunit (Rpt1C). Hsm3 has a C-shaped structure that consists of 11 HEAT repeats. The structure of the Hsm3-Rpt1C complex revealed that the interacting surface between Hsm3 and Rpt1 is a hydrophobic core and a complementary charged surface. Mutations in the Hsm3-Rpt1 surface resulted in the assembly defect of the 26 S proteasome. Furthermore, a structural model of the Hsm3-Rpt ring complex and an in vitro binding assay suggest that Hsm3 can bind Rpt2 in addition to Rpt1. Collectively, our results provide the structural basis of the molecular functions of Hsm3 for the RP assembly.	[Yukii, Haruka; Ueno, Mika; Tanaka, Keiji; Saeki, Yasushi] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Picobiol Inst, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Takagi, Kenji; Kim, Sangwoo; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Morishita, Ryo] Ehime Univ, CellFree Sci Co Ltd, Venture Business Lab 4F, Matsuyama, Ehime 7908577, Japan; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Tokyo Metropolitan Institute of Medical Science; University of Hyogo; Nagoya City University; Ehime University; Ehime University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Saeki, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	saeki-ys@igakuken.or.jp; mizushi@sci.u-hyogo.ac.jp	Kim, Sangwoo/F-8043-2013; Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Mizushima, Tsunehiro/0000-0002-6631-2889; Kato, Koichi/0000-0001-7187-9612	Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Targeted Proteins Research program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Targeted Proteins Research program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant-in-aid for scientific research on innovative areas (to T. M.), grant-in-aid for challenging exploratory research (to T. M.), The Naito Foundation (to T. M.), grant-in-aid for JSPS fellows (to K. Takagi), grant-in-aid for young scientists (to Y. S.), grant-in-aid for specially promoted Research (to K. Tanaka), and the Targeted Proteins Research program (to R. M., Y. E., K. K., K. Tanaka, and T. M.).	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kim S, 2010, J BIOL CHEM, V285, P15159, DOI 10.1074/jbc.M110.104042; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sakata E, 2011, MOL CELL, V42, P637, DOI 10.1016/j.molcel.2011.04.021; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	43	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12172	12182		10.1074/jbc.M112.345876	http://dx.doi.org/10.1074/jbc.M112.345876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334676	Green Published, hybrid			2022-12-27	WOS:000302782200059
J	Jawhara, S; Mogensen, E; Maggiotto, F; Fradin, C; Sarazin, A; Dubuquoy, L; Maes, E; Guerardel, Y; Janbon, G; Poulain, D				Jawhara, Samir; Mogensen, Estelle; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Maes, Emmanuel; Guerardel, Yann; Janbon, Guilhem; Poulain, Daniel			Murine Model of Dextran Sulfate Sodium-induced Colitis Reveals Candida glabrata Virulence and Contribution of beta-Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALBICANS SEROTYPE-A; CELL-WALL MANNAN; CHEMICALLY-INDUCED COLITIS; INTENSIVE-CARE-UNIT; MONOCLONAL-ANTIBODIES; PATHOGENIC YEAST; INTESTINAL COLONIZATION; INFLAMMATORY RESPONSES; INVASIVE CANDIDIASIS; EPITHELIAL-CELLS	Candida glabrata, like Candida albicans, is an opportunistic yeast pathogen that has adapted to colonize all segments of the human gastrointestinal tract and vagina. The C. albicans cell wall expresses beta-1,2-linked mannosides (beta-Mans), promoting its adherence to host cells and tissues. Because beta-Mans are also present in C. glabrata, their role in C. glabrata colonization and virulence was investigated in a murine model of dextran sulfate sodium (DSS)-induced colitis. Five clustered genes of C. glabrata encoding beta-mannosyltransferases, BMT2-BMT6, were deleted simultaneously. beta-Man expression was studied by Western blotting, flow cytometry, and NMR analysis. Mortality, clinical, histologic, and colonization scores were determined in mice receiving DSS and different C. glabrata strains. The results show that C. glabrata bmt2-6 strains had a significant reduction in beta-1,2-Man expression and a disappearance of beta-1,2mannobiose in the acid-stable domain. A single gavage of C. glabrata wild-type strain in mice with DSS-induced colitis caused a loss of body weight, colonic inflammation, and mortality. Mice receiving C. glabrata bmt2-6 mutant strains had normal body weight and reduced colonic inflammation. Lower numbers of colonies of C. glabrata bmt2-6 were recovered from stools and different parts of the gastrointestinal tract. Histopathologic examination revealed that the wild-type strain had a greater ability to colonize tissue and cause tissue damage. These results showed that C. glabrata has a high pathogenic potential in DSS-induced colitis, where beta-Mans contribute to colonization and virulence.	[Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Maes, Emmanuel; Guerardel, Yann; Poulain, Daniel] Univ Lille Nord France, F-59000 Lille, France; [Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Poulain, Daniel] Univ Lille 2, F-59000 Lille, France; [Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Poulain, Daniel] INSERM U995, F-59000 Lille, France; [Mogensen, Estelle; Janbon, Guilhem] Inst Pasteur, F-75724 Paris, France; [Poulain, Daniel] Serv Parasitol Mycol, F-59000 Lille, France; [Poulain, Daniel] Ctr Hosp Reg Univ Lille, F-59000 Lille, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, UGSF, F-59650 Villeneuve Dascq, France; [Maes, Emmanuel; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Poulain, D (corresponding author), Fac Med Lille, INSERM U995, 1 Pl Verdun, F-59045 Lille, France.	jawhars@ccf.org; dpoulain@univ-lille2.fr	Janbon, Guilhem/AAL-6607-2021; Fradin, Chantal/N-2382-2018; Dubuquoy, laurent/J-4978-2015; Jawhara, Samir/A-9310-2019; Jawhara, Samir/AAC-5789-2019; Poulain, Daniel/C-8683-2014; Dubuquoy, Laurent/N-1623-2019; Janbon, Guilhem/AAW-7398-2021; Poulain, Daniel/I-6095-2018	Fradin, Chantal/0000-0002-3883-4401; Dubuquoy, laurent/0000-0003-3596-5497; Jawhara, Samir/0000-0002-2759-975X; Jawhara, Samir/0000-0002-2759-975X; Janbon, Guilhem/0000-0002-4788-1154; Guerardel, Yann/0000-0003-4967-9512; Poulain, Daniel/0000-0002-0729-5468	ERA-NET [ANR 09 MIEN 03 01]; Lesaffre International [C0592-1]; Centre Commun de Mesure RMN de l'Universite de Lille 1	ERA-NET; Lesaffre International; Centre Commun de Mesure RMN de l'Universite de Lille 1	This work was supported in part by ERA-NET Pathogenomics 006 02 "Fungal Glycoshield Project"; ANR 09 MIEN 03 01 "CaBMTs" project " Structure and Functions of Candida albicans beta-1,2-Mannosyltransferases"; and FP7 Health 260338 " ALLFUN" project " Fungi in the Setting of Inflammation, Allergy, and Autoimmune Diseases: Translating Basic Science into Clinical Practices."; Supported by Lesaffre International Grant C0592-1. Present address: Dept. of Molecular Cardiology, Lerner Research Institute/NB5-48, 9500 Euclid Ave., Cleveland, OH 44195. E-mail: jawhars@ccf.org.; We thank Annick Masset, Caroline Dubuquoy, Emilie Gantier, and Edmone Erdual for excellent technical assistance and Val Hopwood for editing the manuscript. The 400 MHz facility was funded by the Centre Commun de Mesure RMN de l'Universite de Lille 1.	Cormack BP, 1999, GENETICS, V151, P979; Cutler JE, 2001, MED MYCOL, V39, P75, DOI 10.1080/714030992; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Dongari-Bagtzoglou A, 2009, ORAL MICROBIOL IMMUN, V24, P249, DOI 10.1111/j.1399-302X.2009.00505.x; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Edlind TD, 2010, ANTIMICROB AGENTS CH, V54, P4733, DOI 10.1128/AAC.00605-10; Elguezabal N, 2004, ORAL DIS, V10, P81, DOI 10.1046/j.1354-523X.2003.00969.x; Elguezabal N, 2009, EUR J ORAL SCI, V117, P474, DOI 10.1111/j.1600-0722.2009.00642.x; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; FAILLE C, 1992, CARBOHYD RES, V236, P17, DOI 10.1016/0008-6215(92)85004-J; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Fradin C, 2008, INFECT IMMUN, V76, P4509, DOI 10.1128/IAI.00368-08; Fukazawa Y, 1997, J MED VET MYCOL, V35, P87; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; HOPWOOD V, 1986, INFECT IMMUN, V54, P222, DOI 10.1128/IAI.54.1.222-227.1986; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; Jouault T, 1997, CLIN DIAGN LAB IMMUN, V4, P328, DOI 10.1128/CDLI.4.3.328-333.1997; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; KOBAYASHI H, 1992, PHYTOCHEMISTRY, V31, P1147, DOI 10.1016/0031-9422(92)80250-I; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOBAYASHI H, 1992, CARBOHYD RES, V231, P105, DOI 10.1016/0008-6215(92)84012-H; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee I, 2010, AM J INFECT CONTROL, V38, P740, DOI 10.1016/j.ajic.2010.02.016; Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304; Maes E, 2009, J BIOCHEM, V145, P413, DOI 10.1093/jb/mvp008; Martinez-Esparza Maria, 2009, V470, P85, DOI 10.1007/978-1-59745-204-5_8; Masuoka J, 2004, INFECT IMMUN, V72, P6230, DOI 10.1128/IAI.72.11.6230-6236.2004; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Mohanty S, 2007, INDIAN J MED RES, V126, P216; Okawa Y, 2006, BIOL PHARM BULL, V29, P187, DOI 10.1248/bpb.29.187; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Playford EG, 2010, DRUGS, V70, P823, DOI 10.2165/10898550-000000000-00000; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SHIBATA N, 1989, CARBOHYD RES, V187, P239, DOI 10.1016/0008-6215(89)80006-0; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Suzuki Shigeo, 1997, Current Topics in Medical Mycology, V8, P57; Swinne D, 2009, EPIDEMIOL INFECT, V137, P1037, DOI 10.1017/S0950268808001763; Tada R, 2008, MICROB PATHOGENESIS, V44, P379, DOI 10.1016/j.micpath.2007.10.013; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; TRINEL PA, 1992, INFECT IMMUN, V60, P3845, DOI 10.1128/IAI.60.9.3845-3851.1992; Whittem C.G., 2010, J VIS EXP	52	31	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11313	11324		10.1074/jbc.M111.329300	http://dx.doi.org/10.1074/jbc.M111.329300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291009	hybrid, Green Published			2022-12-27	WOS:000302780100062
J	Sun, XY; Wei, YP; Xiong, Y; Wang, XC; Xie, AJ; Wang, XL; Yang, Y; Wang, Q; Lu, YM; Liu, R; Wang, JZ				Sun, Xu-Ying; Wei, Yu-Ping; Xiong, Yan; Wang, Xiao-Chuan; Xie, Ao-Ji; Wang, Xiu-Lian; Yang, Yang; Wang, Qun; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi			Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MILD COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; NEUROBLASTOMA-CELLS; RAT HIPPOCAMPUS; TRANSGENIC MICE; NEURONAL DEATH; BRAIN; PHOSPHORYLATION	Background: Tangle distribution is largely overlapped with zinc-containing glutamatergic neurons. Synaptically released zinc may be involved in tau hyperphosphorylation. Results: Increased synaptic activity induces tau hyperphosphorylation by synaptic zinc through PP2A inhibition. Conclusion: Synaptic activity promotes tau hyperphosphorylation, and synaptically released zinc plays a central role. Significance: Therapies targeted to maintaining zinc homeostasis and moderating synaptic activity may benefit AD by reducing tauopathy.	[Sun, Xu-Ying; Wei, Yu-Ping; Xiong, Yan; Wang, Xiao-Chuan; Xie, Ao-Ji; Wang, Xiu-Lian; Yang, Yang; Wang, Qun; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430030, Peoples R China; [Wang, Xiao-Chuan; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi] Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Ministry of Education, China	Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430030, Peoples R China.	rong.liu@mail.hust.edu.cn	Xie, Aoji/AFT-5035-2022	Liu, Rong/0000-0001-7477-6520	Fundamental Research Funds for the Central Universities, HUST [2010MS050]; National Natural Science Foundation of China [81130079]; Alzheimer's Association [IIRG-09-133433]	Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Association(Alzheimer's Association)	This work was supported by Fundamental Research Funds for the Central Universities, HUST, (No: 2010MS050), the National Natural Science Foundation of China (No: 81130079), and Alzheimer's Association (IIRG-09-133433).	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Ketterman JK, 2008, J NEUROSCI RES, V86, P422, DOI 10.1002/jnr.21488; Kim I, 2011, NEUROREPORT, V22, P839, DOI 10.1097/WNR.0b013e32834c0a2d; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lavoie N, 2007, J PHYSIOL-LONDON, V578, P275, DOI 10.1113/jphysiol.2006.121848; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu R, 2005, J NEUROCHEM, V94, P1225, DOI 10.1111/j.1471-4159.2005.03270.x; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; RIEDERER BM, 1992, HISTOCHEM J, V24, P783, DOI 10.1007/BF01046350; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; SLOMIANKA L, 1990, NEUROSCIENCE, V38, P843, DOI 10.1016/0306-4522(90)90076-G; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Takeda A, 2010, BRAIN RES, V1323, P59, DOI 10.1016/j.brainres.2010.01.085; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002	46	99	106	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11174	11182		10.1074/jbc.M111.309070	http://dx.doi.org/10.1074/jbc.M111.309070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334661	hybrid, Green Published			2022-12-27	WOS:000302780100045
J	Chen, CK; Sawaya, MR; Phillips, ML; Reisler, E; Quinlan, ME				Chen, Christine K.; Sawaya, Michael R.; Phillips, Martin L.; Reisler, Emil; Quinlan, Margot E.			Multiple Forms of Spire-Actin Complexes and their Functional Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT NUCLEATION; EFFECTOR VOPL; WH2 DOMAINS; CORDON-BLEU; F-ACTIN; COFILIN; MECHANISM; FAMILY; CAPPUCCINO; CONTACTS	Spire is a WH2 domain-containing actin nucleator essential for establishing an actin mesh during oogenesis. In vitro, in addition to nucleating filaments, Spire can sever them and sequester actin monomers. Understanding how Spire is capable of these disparate functions and which are physiologically relevant is an important goal. To study severing, we examined the effect of Drosophila Spire on preformed filaments in bulk and single filament assays. We observed rapid depolymerization of actin filaments by Spire, which we conclude is largely due to its sequestration activity and enhanced by its weak severing activity. We also studied the solution and crystal structures of Spire-actin complexes. We find structural and functional differences between constructs containing four WH2 domains (Spir-ABCD) and two WH2 domains (Spir-CD) that may provide insight into the mechanisms of nucleation and sequestration. Intriguingly, we observed lateral interactions between actin monomers associated with Spir-ABCD, suggesting that the structures built by these four tandem WH2 domains are more complex than originally imagined. Finally, we propose that Spire-actin mixtures contain both nuclei and sequestration structures.	[Chen, Christine K.; Sawaya, Michael R.; Phillips, Martin L.; Reisler, Emil; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil; Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu			National Institutes of Health [R01 GM096133]; Burroughs-Wellcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [5-FY10-81]; U.S. Public Health Service [GM077190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM096133, a Burroughs-Wellcome Fund Career Award in the Biomedical Sciences, and a March of Dimes Foundation, Basil O'Connor Starter Scholar Award (# 5-FY10-81) (to M. E. Q). This work was also supported by U.S. Public Health Service Grant GM077190 (to E. R.).	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Le Goff C, 2006, BIOL CELL, V98, P697, DOI 10.1042/BC20050095; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sitar T, 2011, P NATL ACAD SCI USA, V108, P19575, DOI 10.1073/pnas.1115465108; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Tam VC, 2010, MBIO, V1, DOI 10.1128/mBio.00289-10; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	30	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10684	10692		10.1074/jbc.M111.317792	http://dx.doi.org/10.1074/jbc.M111.317792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334675	Green Published, hybrid			2022-12-27	WOS:000302167200093
J	Gao, J; Takeuchi, H; Zhang, Z; Fukuda, M; Hirata, M				Gao, Jing; Takeuchi, Hiroshi; Zhang, Zhao; Fukuda, Mitsunori; Hirata, Masato			Phospholipase C-related but Catalytically Inactive Protein (PRIP) Modulates Synaptosomal-associated Protein 25 (SNAP-25) Phosphorylation and Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; KINASE-C; DEPENDENT PHOSPHORYLATION; NEUROTRANSMITTER RELEASE; DIFFERENTIAL PHOSPHORYLATION; CRYSTAL-STRUCTURE; CALYCULIN-A; BINDING; SNARE; INHIBITION	Exocytosis is one of the most fundamental cellular events. The basic mechanism of the final step, membrane fusion, is mediated by the formation of the SNARE complex, which is modulated by the phosphorylation of proteins controlled by the concerted actions of protein kinases and phosphatases. We have previously shown that a protein phosphatase-1 (PP1) anchoring protein, phospholipase C-related but catalytically inactive protein (PRIP), has an inhibitory role in regulated exocytosis. The current study investigated the involvement of PRIP in the phospho-dependent modulation of exocytosis. Dephosphorylation of synaptosome-associated protein of 25 kDa (SNAP-25) was mainly catalyzed by PP1, and the process was modulated by wild-type PRIP but not by the mutant (F97A) lacking PP1 binding ability in in vitro studies. We then examined the role of PRIP in phospho-dependent regulation of exocytosis in cell-based studies using pheochromocytoma cell line PC12 cells, which secrete noradrenalin. Exogenous expression of PRIP accelerated the dephosphorylation process of phosphorylated SNAP-25 after forskolin or phorbol ester treatment of the cells. The phospho-states of SNAP-25 were correlated with noradrenalin secretion, which was enhanced by forskolin or phorbol ester treatment and modulated by PRIP expression in PC12 cells. Both SNAP-25 and PP1 were co-precipitated in anti-PRIP immunocomplex isolated from PC12 cells expressing PRIP. Collectively, together with our previous observation regarding the roles of PRIP in PP1 regulation, these results suggest that PRIP is involved in the regulation of the phospho-states of SNAP-25 by modulating the activity of PP1, thus regulating exocytosis.	[Gao, Jing; Takeuchi, Hiroshi; Zhang, Zhao; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech, Sendai, Miyagi 9808578, Japan	Kyushu University; Tohoku University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan.	hirata1@dent.kyushu-u.ac.jp	Fukuda, MItsunori/I-1511-2015; Takeuchi, Hiroshi/I-8849-2019	Fukuda, MItsunori/0000-0002-8620-5853; Takeuchi, Hiroshi/0000-0003-0033-2913	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Shimabara Foundation; Japan China Medical Association; Japanese Government	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shimabara Foundation; Japan China Medical Association; Japanese Government	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to J. G., H. T., and M. H.), the Shimabara Foundation (to H. T.), and the Japan China Medical Association (to J. G.).; Foreign graduate student supported by the Japanese Government.	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; DAVLETOV B, 1993, J BIOL CHEM, V268, P6816; DECAMILLI P, 1991, TRENDS PHARMACOL SCI, V12, P446, DOI 10.1016/0165-6147(91)90631-2; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Gao J, 2010, ADV ENZYME REGUL, V50, P237, DOI 10.1016/j.advenzreg.2009.10.011; Gao J, 2009, CELL SIGNAL, V21, P1180, DOI 10.1016/j.cellsig.2009.03.008; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; GUTIERREZ LM, 1994, NEUROSCI LETT, V178, P55, DOI 10.1016/0304-3940(94)90288-7; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Nagy G, 2002, J NEUROSCI, V22, P9278; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; OHO C, 1995, NEUROSCI LETT, V186, P208, DOI 10.1016/0304-3940(95)11317-P; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Takeuchi H, 1997, BBA-MOL CELL RES, V1359, P275, DOI 10.1016/S0167-4889(97)00109-2; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tolar LA, 1998, J NEUROSCI, V18, P10250; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200	56	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10565	10578		10.1074/jbc.M111.294645	http://dx.doi.org/10.1074/jbc.M111.294645			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311984	Green Published, hybrid			2022-12-27	WOS:000302167200082
J	Gerson, KD; Shearstone, JR; Maddula, VSRK; Seligmann, BE; Mercurio, AM				Gerson, Kristin D.; Shearstone, Jeffrey R.; Maddula, V. S. R. Krishna; Seligmann, Bruce E.; Mercurio, Arthur M.			Integrin beta 4 Regulates SPARC Protein to Promote Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; ALPHA 6 BETA-1; NF-KAPPA-B; ALPHA-6-BETA-4 INTEGRIN; GROWTH-FACTOR; IN-VITRO; MATRICELLULAR PROTEIN; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; MDA-MB-435 CELLS	The alpha 6 beta 4 integrin (referred to as "beta 4" integrin) is a receptor for laminins that promotes carcinoma invasion through its ability to regulate key signaling pathways and cytoskeletal dynamics. An analysis of published Affymetrix GeneChip data to detect downstream effectors involved in beta 4-mediated invasion of breast carcinoma cells identified SPARC, or secreted protein acidic and rich in cysteine. This glycoprotein has been shown to play an important role in matrix remodeling and invasion. Our analysis revealed that manipulation of beta 4 integrin expression and signaling impacted SPARC expression and that SPARC facilitates beta 4-mediated invasion. Expression of beta 4 in beta 4-deficient cells reduced the expression of a specific microRNA (miR-29a) that targets SPARC and impedes invasion. In cells that express endogenous beta 4, miR-29a expression is low and beta 4 ligation facilitates the translation of SPARC through a TOR-dependent mechanism. The results obtained in this study demonstrate that beta 4 can regulate SPARC expression and that SPARC is an effector of beta 4-mediated invasion. They also highlight a potential role for specific miRNAs in executing the functions of integrins.	[Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Maddula, V. S. R. Krishna; Seligmann, Bruce E.] High Throughput Genom Inc, Tucson, AZ 85706 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB 408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Shearstone, Jeffrey/0000-0002-6875-1826	National Institutes of Health [CA80789]; Department of Defense [BC100607]; Arizona Science Foundation; NATIONAL CANCER INSTITUTE [R01CA080789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Arizona Science Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA80789 (to A. M. M.). This work was also supported by Department of Defense Breast Cancer Fellowship BC100607 (to K. D. G.). Bruce Seligmann works in a leadership role for, and owns stock in, HTG, Inc., the company that produces and markets the qNPA assay. He has no affiliation with, nor does he consult with, the University of Massachusetts. This work was carried out using funds from the Arizona Science Foundation through a grant to the University of Arizona, David Galbraith, PI, for which HTG is the industry collaborator. Krishna Maddula works as a postdoctoral fellow for, and owns stock in, HTG, Inc., the company that produces and markets the qNPA assay. He has no affiliation with, nor does he consult with, the University of Massachusetts.	Abiatari I, 2009, INT J ONCOL, V35, P1111, DOI 10.3892/ijo_00000426; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chlenski A, 2007, ONCOGENE, V26, P4513, DOI 10.1038/sj.onc.1210247; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gilles C, 1998, CANCER RES, V58, P5529; Girotti MR, 2011, J INVEST DERMATOL, V131, P2438, DOI 10.1038/jid.2011.239; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacob K, 1999, CANCER RES, V59, P4453; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Kirschmann DA, 2002, CANCER RES, V62, P4478; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kunigal S, 2006, INT J ONCOL, V29, P1349; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; McKnight DAC, 2006, J CELL BIOCHEM, V97, P288, DOI 10.1002/jeb.20644; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schultz C, 2002, CANCER RES, V62, P6270; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; SHAW LM, 1993, J BIOL CHEM, V268, P11401; Shaw LM, 1996, CANCER RES, V56, P959; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thomas SL, 2010, NEURO-ONCOLOGY, V12, P941, DOI 10.1093/neuonc/noq048; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Wewer UM, 1997, AM J PATHOL, V151, P1191; Wong SY, 2008, CLIN EXP METASTAS, V25, P109, DOI 10.1007/s10585-007-9126-2; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712	79	31	33	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9835	9844		10.1074/jbc.M111.317727	http://dx.doi.org/10.1074/jbc.M111.317727			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308039	Green Published, hybrid			2022-12-27	WOS:000302167200016
J	Rajabi, H; Ahmad, R; Jin, CN; Kosugi, M; Alam, M; Joshi, MD; Kufe, D				Rajabi, Hasan; Ahmad, Rehan; Jin, Caining; Kosugi, Michio; Alam, Maroof; Joshi, Maya Datt; Kufe, Donald			MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; BETA-CATENIN; KINASE-ACTIVITY; WNT; PROTEIN; DOMAIN; GENE; BINDING; TARGET; OVEREXPRESSION	MUC1 is a heterodimeric glycoprotein that is overexpressed in breast cancers. The present studies demonstrate that the oncogenic MUC1 C-terminal subunit (MUC1-C) associates with the TCF7L2 transcription factor. The MUC1-C cytoplasmic domain (MUC1-CD) binds directly to the TCF7L2 C-terminal region. MUC1-C blocks the interaction between TCF7L2 and the C-terminal-binding protein (CtBP), a suppressor of TCF7L2-mediated transcription. TCF7L2 and MUC1-C form a complex on the cyclin D1 gene promoter and MUC1-C promotes TCF7L2-mediated transcription by the recruitment of beta-catenin and p300. Silencing MUC1-C in human breast cancer cells down-regulated activation of the cyclin D1 promoter and decreased cyclin D1 expression. In addition, a MUC1-C inhibitor blocked the interaction with TCF7L2 and suppressed cyclin D1 levels. These findings indicate that the MUC1-C oncoprotein contributes to TCF7L2 activation and thereby promotes cyclin D1 expression in breast cancer cells.	[Rajabi, Hasan; Ahmad, Rehan; Jin, Caining; Kosugi, Michio; Alam, Maroof; Joshi, Maya Datt; Kufe, Donald] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		National Institutes of Health [CA97098, CA42802, CA100707]; NCI; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA097098, R01CA166480, R01CA042802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA97098, CA42802, and CA100707 awarded by the NCI.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Atcha FA, 2003, J BIOL CHEM, V278, P16169, DOI 10.1074/jbc.M213218200; Atcha FA, 2007, MOL CELL BIOL, V27, P8352, DOI 10.1128/MCB.02132-06; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Brannon M, 1999, DEVELOPMENT, V126, P3159; Cuilliere-Dartigues P, 2006, ONCOGENE, V25, P4441, DOI 10.1038/sj.onc.1209471; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Duraisamy S, 2007, INT J ONCOL, V31, P671; Duval A, 2000, CANCER RES, V60, P3872; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; GILLETT C, 1994, CANCER RES, V54, P1812; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; Huang L, 2003, CANCER BIOL THER, V2, P702; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	45	62	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10703	10713		10.1074/jbc.M111.323311	http://dx.doi.org/10.1074/jbc.M111.323311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318732	Green Published, hybrid			2022-12-27	WOS:000302167200095
J	Wang, WY; Linsdell, P				Wang, Wuyang; Linsdell, Paul			Alternating Access to the Transmembrane Domain of the ATP-binding Cassette Protein Cystic Fibrosis Transmembrane Conductance Regulator (ABCC7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; CL-CHANNEL; CONFORMATIONAL-CHANGES; POSITIVE CHARGES; PORE; TRANSPORTERS; IDENTIFICATION; PERMEATION; VESTIBULE; MECHANISM	The cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel is a member of the ATP-binding cassette (ABC) protein family, most members of which act as active transporters. Actively transporting ABC proteins are thought to alternate between "outwardly facing" and "inwardly facing" conformations of the transmembrane substrate pathway. In CFTR, it is assumed that the outwardly facing conformation corresponds to the channel open state, based on homology with other ABC proteins. We have used patch clamp recording to quantify the rate of access of cysteine-reactive probes to cysteines introduced into two different transmembrane regions of CFTR from both the intracellular and extracellular solutions. Two probes, the large [2-sulfonatoethyl] methanethiosulfonate (MTSES) molecule and permeant Au(CN)(2)(-) ions, were applied to either side of the membrane to modify cysteines substituted for Leu-102 (first transmembrane region) and Thr-338 (sixth transmembrane region). Channel opening and closing were altered by mutations in the nucleotide binding domains of the channel. We find that, for both MTSES and Au(CN)(2)(-), access to these two cysteines from the cytoplasmic side is faster in open channels, whereas access to these same sites from the extracellular side is faster in closed channels. These results are consistent with alternating access to the transmembrane regions, however with the open state facing inwardly and the closed state facing outwardly. Our findings therefore prompt revision of current CFTR structural and mechanistic models, as well as having broader implications for transport mechanisms in all ABC proteins. Our results also suggest possible locations of both functional and dysfunctional ("vestigial") gates within the CFTR permeation pathway.	[Wang, Wuyang; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 4R2, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, POB 15000, Halifax, NS B3H 4R2, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273; Wang, Wuyang/0000-0003-1875-5463	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Beck EJ, 2008, J BIOL CHEM, V283, P4957, DOI 10.1074/jbc.M702235200; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; El Hiani Y, 2010, J BIOL CHEM, V285, P32126, DOI 10.1074/jbc.M110.113332; Fatehi M, 2007, BIOPHYS J, V92, P1241, DOI 10.1529/biophysj.106.095349; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Li MS, 2009, BRIT J PHARMACOL, V157, P1065, DOI 10.1111/j.1476-5381.2009.00258.x; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 1998, J PHYSIOL-LONDON, V512, P1, DOI 10.1111/j.1469-7793.1998.001bf.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Miller C, 2010, P NATL ACAD SCI USA, V107, P959, DOI 10.1073/pnas.0913576107; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Wang WY, 2012, BBA-BIOMEMBRANES, V1818, P851, DOI 10.1016/j.bbamem.2011.12.025; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Zhang LA, 2011, BBA-BIOMEMBRANES, V1808, P399, DOI 10.1016/j.bbamem.2010.08.012; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	34	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10156	10165		10.1074/jbc.M112.342972	http://dx.doi.org/10.1074/jbc.M112.342972			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303012	Green Published, hybrid			2022-12-27	WOS:000302167200047
J	Pou, C; la Cour, CM; Stoddart, LA; Millan, MJ; Milligan, G				Pou, Chantevy; la Cour, Clotilde Mannoury; Stoddart, Leigh A.; Millan, Mark J.; Milligan, Graeme			Functional Homomers and Heteromers of Dopamine D-2L and D-3 Receptors Co-exist at the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID CB1 RECEPTOR; G-PROTEIN ACTIVATION; TIME-RESOLVED FRET; OPIOID RECEPTOR; OREXIN OX1; AGONIST; BRAIN; DIMERIZATION; BINDING; DIMERS	Human dopamine D-2long and D-3 receptors were modified by N-terminal addition of SNAP or CLIP forms of O-6-alkylguanine-DNA-alkyltransferase plus a peptide epitope tag. Cells able to express each of these four constructs only upon addition of an antibiotic were established and used to confirm regulated and inducible control of expression, the specificity of SNAP and CLIP tag covalent labeling reagents, and based on homogenous time-resolved fluorescence resonance energy transfer, the presence of cell surface D-2long and D-3 receptor homomers. Following constitutive expression of reciprocal constructs, potentially capable of forming and reporting the presence of cell surface D-2long-D-3 heteromers, individual clones were assessed for levels of expression of the constitutively expressed protomer. This was unaffected by induction of the partner protomer and the level of expression of the partner required to generate detectable cell surface D-2long-D-3 heteromers was defined. Such homomers and heteromers were found to co-exist and using a reconstitution of function approach both homomers and heteromers of D-2long and D-3 receptors were shown to be functional, potentially via trans-activation of associated G protein. These studies demonstrate the ability of dopamine D-2long and D-3 receptors to form both homomers and heteromers, and show that in cells expressing each subtype a complex mixture of homomers and heteromers co-exists at steady state. These data are of potential importance both to disorders in which D-2long and D-3 receptors are implicated, like schizophrenia and Parkinson disease, and also to drugs exerting their actions via these sites.	[Pou, Chantevy; Stoddart, Leigh A.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [la Cour, Clotilde Mannoury; Millan, Mark J.] Inst Rech Servier, Unite Rech & Decouverte Neurosci, F-78290 Croissy Sur Seine, France	University of Glasgow; Servier; Institut de Recherches Internationales Servier	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Stoddart, Leigh/0000-0002-4469-0600	MRC [G0900050] Funding Source: UKRI; Medical Research Council [G0900050] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Alvarez-Curto E, 2010, ANAL BIOANAL CHEM, V398, P167, DOI 10.1007/s00216-010-3823-4; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Baragli A, 2007, CELL SIGNAL, V19, P2304, DOI 10.1016/j.cellsig.2007.07.007; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Franco R, 2010, SYNAPSE, V64, P566, DOI 10.1002/syn.20775; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hasbi A, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-26; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, SYNAPSE, V40, P137, DOI 10.1002/syn.1035; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; LIST SJ, 1981, P NATL ACAD SCI-BIOL, V78, P2620, DOI 10.1073/pnas.78.4.2620; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Maggio R, 2003, J NEUROCHEM, V87, P631, DOI 10.1046/j.1471-4159.2003.02038.x; Maggio R, 2009, PARKINSONISM RELAT D, V15, pS2, DOI 10.1016/S1353-8020(09)70826-0; Maggio R, 2010, CURR OPIN PHARMACOL, V10, P100, DOI 10.1016/j.coph.2009.10.001; Maggio Roberto, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS139, DOI 10.1016/j.parkreldis.2008.04.018; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2004, BIOCHEM SOC T, V32, P847, DOI 10.1042/BST0320847; Milligan G, 2009, BRIT J PHARMACOL, V158, P1, DOI 10.1111/j.1476-5381.2009.00422.x; Milligan G, 2007, CURR OPIN PHARMACOL, V7, P521, DOI 10.1016/j.coph.2007.06.007; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; Nickolls SA, 2004, NEUROPHARMACOLOGY, V47, P860, DOI 10.1016/j.neuropharm.2004.06.010; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Novi F, 2007, J NEUROCHEM, V102, P1410, DOI 10.1111/j.1471-4159.2007.04660.x; O'Dowd BF, 2011, EUR J PHARMACOL, V658, P74, DOI 10.1016/j.ejphar.2011.02.030; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Perreault ML, 2011, CNS NEUROSCI THER, V17, P52, DOI 10.1111/j.1755-5949.2010.00228.x; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Schetz J. A., 2007, HDB CONT NEUROPHARMA, P221; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Tadori Y, 2011, EUR J PHARMACOL, V666, P43, DOI 10.1016/j.ejphar.2011.05.050; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Van Craenenbroeck K, 2011, FEBS J, V278, P1333, DOI 10.1111/j.1742-4658.2011.08052.x; Wang M, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-25; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Ward RJ, 2011, BRIT J PHARMACOL, V162, P1439, DOI 10.1111/j.1476-5381.2010.01156.x; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748	61	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8864	8878		10.1074/jbc.M111.326678	http://dx.doi.org/10.1074/jbc.M111.326678			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291025	Green Published, hybrid			2022-12-27	WOS:000301797800018
J	Prieto-Garcia, A; Zheng, D; Adachi, R; Xing, W; Lane, WS; Chung, K; Anderson, P; Hansbro, PM; Castells, M; Stevens, RL				Prieto-Garcia, Alicia; Zheng, Dominick; Adachi, Roberto; Xing, Wei; Lane, William S.; Chung, Kyungmee; Anderson, Paul; Hansbro, Philip M.; Castells, Mariana; Stevens, Richard L.			Mast Cell Restricted Mouse and Human Tryptase.Heparin Complexes Hinder Thrombin-induced Coagulation of Plasma and the Generation of Fibrin by Proteolytically Destroying Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY ARTHRITIS; SUBSTRATE-SPECIFICITY; BACTERIAL-INFECTIONS; EXPERIMENTAL COLITIS; PROTEASE INHIBITORS; SERINE PROTEASES; HEPARIN; EXPRESSION; TRYPTASES; GENE	The mouse and human TPSB2 and TPSAB1 genes encode tetramer-forming tryptases stored in the secretory granules of mast cells (MCs) ionically bound to heparin-containing serglycin proteoglycans. In mice these genes encode mouse MC protease-6 (mMCP-6) and mMCP-7. The corresponding human genes encode a family of serine proteases that collectively are called hTryptase-beta. We previously showed that the alpha chain of fibrinogen is a preferred substrate of mMCP-7. We now show that this plasma protein also is highly susceptible to degradation by hTryptase-beta. and mMCP-6.heparin complexes and that Lys575 is a preferred cleavage site in the protein alpha chain. Because cutaneous mouse MCs store substantial amounts of mMCP-6.heparin complexes in their secretory granules, the passive cutaneous anaphylaxis reaction was induced in the skin of mMCP-6(+)/mMCP-7(-) and mMCP-6(+)/mMCP-7(-) C57BL/6 mice. In support of the in vitro data, fibrin deposits were markedly increased in the skin of the double-deficient mice 6 h after IgE-sensitized animals were given the relevant antigen. Fibrinogen is a major constituent of the edema fluid that accumulates in tissues when MCs degranulate. Our discovery that mouse and human tetramer-forming tryptases destroy fibrinogen before this circulating protein can be converted to fibrin changes the paradigm of how MCs hinder fibrin deposition and blood coagulation internally. Because of the adverse consequences of fibrin deposits in tissues, our data explain why mice and humans lack a circulating protease inhibitor that rapidly inactivates MC tryptases and why mammals have two genes that encode tetramer-forming serine proteases that preferentially degrade fibrinogen.	[Prieto-Garcia, Alicia; Zheng, Dominick; Xing, Wei; Chung, Kyungmee; Anderson, Paul; Castells, Mariana; Stevens, Richard L.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Prieto-Garcia, Alicia; Zheng, Dominick; Xing, Wei; Chung, Kyungmee; Anderson, Paul; Castells, Mariana; Stevens, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Lane, William S.] Harvard Univ, FAS Ctr Syst Biol, Harvard Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Stevens, RL (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Smith Bldg,Rm 616B,1 Jimmy Fund Way, Boston, MA 02115 USA.	rstevens@rics.bwh.harvard.edu	Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Adachi, Roberto/0000-0002-0146-0768; Prieto-Garcia, Alicia/0000-0003-3915-1941; Zheng, Dominick/0000-0002-2399-9916	National Institutes of Health [AI065858, AI059746]; Cancer Prevention and Research Institute of Texas [RP110166]; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R01AI059746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Harvard Club of Australia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065858 and AI059746. This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP110166 and by a research fellowship grant from the Harvard Club of Australia Foundation.	ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; ATKINS FM, 1983, J IMMUNOL, V131, P1420; ATKINS FM, 1985, LAB INVEST, V52, P278; FABIAN I, 1978, BIOCHIM BIOPHYS ACTA, V544, P69, DOI 10.1016/0304-4165(78)90210-6; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GHILDYAL N, 1994, J IMMUNOL, V153, P2624; Ghildyal N, 1996, J EXP MED, V184, P1061, DOI 10.1084/jem.184.3.1061; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Huang CF, 1997, J BIOL CHEM, V272, P31885, DOI 10.1074/jbc.272.50.31885; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Huang CF, 2001, J BIOL CHEM, V276, P26276, DOI 10.1074/jbc.M102356200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hunt JE, 1996, J BIOL CHEM, V271, P2851, DOI 10.1074/jbc.271.5.2851; Isozaki Y, 2006, SCAND J GASTROENTERO, V41, P944, DOI 10.1080/00365520500529470; Jackson NE, 2008, J BIOL CHEM, V283, P34178, DOI 10.1074/jbc.M807553200; Kaieda S, 2010, J BIOL CHEM, V285, P21478, DOI 10.1074/jbc.M110.114991; KETTELHUT BV, 1991, J INVEST DERMATOL, V96, pS15, DOI 10.1111/1523-1747.ep12468942; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; MCNEIL HP, 1992, P NATL ACAD SCI USA, V89, P11174, DOI 10.1073/pnas.89.23.11174; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; Niles AL, 1998, BIOTECHNOL APPL BIOC, V28, P125; Oh SW, 2002, J IMMUNOL, V168, P1992, DOI 10.4049/jimmunol.168.4.1992; PEJLER G, 1993, J BIOL CHEM, V268, P11817; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Samoszuk M, 2003, INT J CANCER, V107, P159, DOI 10.1002/ijc.11340; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; SHWORAK NW, 1993, HAEMOSTASIS, V23, P161; SVENDSEN L, 1972, FOLIA HAEMATOL (LEIPZ), V98, P446; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Thomas VA, 1998, BIOCHEMISTRY-US, V37, P2291, DOI 10.1021/bi972119z; Tremaine WJ, 2002, ALIMENT PHARM THERAP, V16, P407, DOI 10.1046/j.1365-2036.2002.01194.x; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Zhang J, 2011, CIRC RES, V108, P1316, DOI 10.1161/CIRCRESAHA.111.243758	45	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7834	7844		10.1074/jbc.M111.325712	http://dx.doi.org/10.1074/jbc.M111.325712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235124	hybrid, Green Published			2022-12-27	WOS:000301349400001
J	Zhang, DW; Mosley, AL; Ramisetty, SR; Rodriguez-Molina, JB; Washburn, MP; Ansari, AZ				Zhang, David W.; Mosley, Amber L.; Ramisetty, Sreenivasa R.; Rodriguez-Molina, Juan B.; Washburn, Michael P.; Ansari, Aseem Z.			Ssu72 Phosphatase-dependent Erasure of Phospho-Ser7 Marks on the RNA Polymerase II C-terminal Domain Is Essential for Viability and Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CTD CODE; SACCHAROMYCES-CEREVISIAE; POLYADENYLATION FACTOR; PROCESSING FACTORS; FISSION YEAST; PROTEIN; PHOSPHORYLATION; KINASE; COMPLEX	The C-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) serves an important role in coordinating stage-specific recruitment and release of cellular machines during transcription. Dynamic placement and removal of phosphorylation marks on different residues of a repeating heptapeptide (YSPTSPS) of the CTD underlies the engagement of relevant cellular machinery. Whereas sequential placement of phosphorylation marks is well explored, genome-wide engagement of phosphatases that remove these CTD marks is poorly understood. In particular, identifying the enzyme that erases phospho-Ser7 (Ser7-P) marks is especially important, because we find that substituting this residue with a glutamate, a phospho-mimic, is lethal. Our observations implicate Ssu72 as a Ser7-P phosphatase. We report that removal of all phospho-CTD marks during transcription termination is mechanistically coupled. An inability to remove these marks prevents Pol II from terminating efficiently and will likely impede subsequent assembly into the pre-initiation complex.	[Zhang, David W.; Rodriguez-Molina, Juan B.; Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Zhang, David W.; Rodriguez-Molina, Juan B.; Ansari, Aseem Z.] Univ Wisconsin, Genome Ctr, Madison, WI 53706 USA; [Mosley, Amber L.; Ramisetty, Sreenivasa R.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Stowers Institute for Medical Research; Indiana University System; Indiana University Bloomington	Ansari, AZ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ansari@biochem.wisc.edu	Ansari, Aseem/AAF-4945-2019	Washburn, Michael/0000-0001-7568-2585; Rodriguez Molina, Juan/0000-0003-3305-9722	National Institutes of Health NHGRI [5T32HG002760]; NSF [MCB 07147]; W. M. Keck award; Shaw Scholar award; Vilas Associate award; R. Burris pre-doctoral fellowship; Stowers Institute for Medical Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; Direct For Biological Sciences [0747197] Funding Source: National Science Foundation	National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); W. M. Keck award; Shaw Scholar award; Vilas Associate award; R. Burris pre-doctoral fellowship; Stowers Institute for Medical Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health NHGRI Training Grant to the Genomic Sciences Training Program (5T32HG002760) (to J. B. R.). This work was also supported by NSF (MCB 07147), W. M. Keck, Shaw Scholar, and Vilas Associate awards (to A. Z. A.).; Supported by the R. Burris pre-doctoral fellowship.; Supported by the Stowers Institute for Medical Research.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cannon JF, 2010, ADV APPL MICROBIOL, V73, P27, DOI 10.1016/S0065-2164(10)73002-1; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Florens Laurence, 2006, V328, P159; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; He XY, 2005, MOL CELL, V19, P619, DOI 10.1016/j.molcel.2005.07.016; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hirschi A, 2010, NAT STRUCT MOL BIOL, V17, P1051, DOI 10.1038/nsmb.1868; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Stiller JW, 2000, YEAST, V16, P57, DOI 10.1002/(SICI)1097-0061(20000115)16:1<57::AID-YEA509>3.0.CO;2-E; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; WEST ML, 1995, GENETICS, V140, P1223; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471	61	79	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8541	8551		10.1074/jbc.M111.335687	http://dx.doi.org/10.1074/jbc.M111.335687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235117	Green Published, hybrid			2022-12-27	WOS:000301349400067
J	Makovski, A; Yaffe, E; Shpungin, S; Nir, U				Makovski, Adar; Yaffe, Etai; Shpungin, Sally; Nir, Uri			Intronic Promoter Drives the BORIS-regulated Expression of FerT in Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-TESTIS ANTIGENS; TYROSINE KINASE; LUNG-CANCER; 5-METHYLCYTOSINE CONTENT; TRANSCRIPT FERT; ACTIVATION; GENE; BINDING; CTCF; DNA	Fer is an intracellular tyrosine kinase that accumulates in most mammalian tissues. A truncated variant of Fer, FerT, is uniquely detected in spermatogenic cells and is absent from normal somatic tissues. Here, we show that in addition to Fer, FerT also accumulates in CC cells and in metastases derived from colorectal tumors, but not in normal human cells. Thus, FerT is a new member of the CTA protein family. Transcription of the ferT gene in CC cells was found to be driven by an intronic promoter residing in intron 10 of the fer gene and to be regulated by another CTA, the Brother of the Regulator of Imprinted Sites(BORIS) transcription factor. BORIS binds to the ferT promoter and down-regulation of BORIS significantly decreases the expression of ferT in CC cells. Accumulation of the ferT RNA was also regulated by the DNA methylation status and paralleled the expression profile of the boris transcript. Accordingly, the intronic ferT promoter was found to be hypomethylated in cancer cells expressing the FerT protein, by comparison with non-expressers. Collectively, we show here that FerT is a new CTA whose accumulation in CC cells, commonly considered low CTA expressers, is controlled by a novel transcription regulatory mechanism.	[Makovski, Adar; Yaffe, Etai; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	SILVERSTEIN, ADAR MAKOVSKI/P-1300-2019		Ministry of Health	Ministry of Health	This work was supported by a grant from the Israeli Chief Scientist of the Ministry of Health.	Allard P, 2000, MOL CELL ENDOCRINOL, V159, P63, DOI 10.1016/S0303-7207(99)00205-1; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Ben-Dor I, 1999, CELL GROWTH DIFFER, V10, P113; Bhan S, 2011, CLIN CANCER RES, V17, P4267, DOI 10.1158/1078-0432.CCR-11-0653; Boon T, 1997, CURR OPIN IMMUNOL, V9, P681, DOI 10.1016/S0952-7915(97)80049-0; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Carmel M, 2000, GENE, V241, P87, DOI 10.1016/S0378-1119(99)00464-3; D'Arcy V, 2008, BRIT J CANCER, V98, P571, DOI 10.1038/sj.bjc.6604181; FEINBERG AP, 1988, CANCER RES, V48, P1159; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HAZAN B, 1993, CELL GROWTH DIFFER, V4, P443; Hikri E, 2009, CELL SIGNAL, V21, P588, DOI 10.1016/j.cellsig.2008.12.011; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KESHET E, 1990, MOL CELL BIOL, V10, P5021, DOI 10.1128/MCB.10.9.5021; Kierszenbaum AL, 2008, DEV DYNAM, V237, P3882, DOI 10.1002/dvdy.21789; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; LETWIN K, 1988, ONCOGENE, V3, P621; Nguyen P, 2008, CANCER RES, V68, P5546, DOI 10.1158/0008-5472.CAN-08-1005; Pasder O, 2006, ONCOGENE, V25, P4194, DOI 10.1038/sj.onc.1209695; Priel-Halachmi S, 2000, J BIOL CHEM, V275, P28902, DOI 10.1074/jbc.M003402200; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P7372, DOI 10.1093/nar/gkm896; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scudellari M, 2011, NAT MED, V17, P916, DOI 10.1038/nm0811-916; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Woloszynska-Read Anna, 2007, Cancer Immun, V7, P21; Zendman AJW, 2003, J CELL PHYSIOL, V194, P272, DOI 10.1002/jcp.10215	35	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6100	6112		10.1074/jbc.M111.327106	http://dx.doi.org/10.1074/jbc.M111.327106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223638	Green Published, hybrid			2022-12-27	WOS:000300791800004
J	Balan, V; Nangia-Makker, P; Kho, DH; Wang, Y; Raz, A				Balan, Vitaly; Nangia-Makker, Pratima; Kho, Dhong Hyo; Wang, Yi; Raz, Avraham			Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAINS; CELL-SURFACE; CANCER-CELLS; C-ABL; IN-VIVO; BINDING; ANGIOGENESIS; PROGRESSION; SECRETION; FAMILY	Galectin-3 is a chimeric carbohydrate-binding protein, which interacts with cell surface carbohydrate-containing molecules and extracellular matrix glycoproteins and has been implicated in various biological processes such as cell growth, angiogenesis, motility, and metastasis. It is expressed in a wide range of tumor cells and is associated with tumor progression. The functions of galectin-3 are dependent on its localization and post-translational modifications such as cleavage and phosphorylation. Recently, we showed that galectin-3 Tyr-107 is phosphorylated by c-Abl; concomitantly, it was also shown that galectin-3 can be cleaved at this site by prostate-specific antigen (PSA), a chymotrypsin-like serine protease, after Tyr-107, resulting in loss of galectin-3 multivalency while preserving its carbohydrate binding activity. Galectin-3 is largely a monomer in solution but may form a homodimer by self-association through its carbohydrate recognition domain, whereas, in the presence of a ligand, galectin-3 polymerizes up to pentamers utilizing its N-terminal domain. Oligomerization is a unique feature of secreted galectin-3, which allows its function by forming ordered galectinglycan structures, i.e. lattices, on the cell surface or through direct engagement of specific cell surface glycoconjugates by traditional ligand-receptor binding. We questioned whether Tyr-107 phosphorylation by c-Abl affects galectin-3 cleavage by PSA. The data suggest a role for galectin-3 in prostate cells associated with increased activity of c-Abl kinase and loss of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activity. In addition, the ratio of phosphorylated/dephosphorylated galectin-3 might be used as a complementary value to that of PSA for prognosis of prostate cancer and a novel therapeutic target for the treatment of prostate cancer.	[Balan, Vitaly] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Balan, V (corresponding author), Wayne State Univ, Dept Oncol, Karmanos Canc Inst, 110 E Warren Ave, Detroit, MI 48201 USA.	balanv@karmanos.org		Nangia-Makker, Pratima/0000-0002-1917-169X	National Institutes of Health; American Cancer Society [IRG 11-053-01-IRG]; NATIONAL CANCER INSTITUTE [R01CA046120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. R.). This work was also supported by American Cancer Society Grant "The interplay between prostate-specific antigen and galectin-3 during prostate cancer progression" IRG 11-053-01-IRG (to V. B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Balan V, 2010, BBA-MOL CELL RES, V1803, P1198, DOI 10.1016/j.bbamcr.2010.06.007; Barboni EAM, 2000, GLYCOBIOLOGY, V10, P1201, DOI 10.1093/glycob/10.11.1201; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Davoodpour P, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-161; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Geiger B., 2011, COLD SPRING HARB PER, V3; Glinsky VV, 2003, CANCER RES, V63, P3805; HUFLEJT ME, 1993, J BIOL CHEM, V268, P26712; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Lehr JE, 1998, J NATL CANCER I, V90, P118, DOI 10.1093/jnci/90.2.118; Li X, 2010, CELL DEATH DIFFER, V17, P1277, DOI 10.1038/cdd.2010.8; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mazurek N, 2000, J BIOL CHEM, V275, P36311, DOI 10.1074/jbc.M003831200; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; Mazurek N, 2007, J BIOL CHEM, V282, P21337, DOI 10.1074/jbc.M608810200; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Menon S, 2011, BIOCHEM BIOPH RES CO, V410, P91, DOI 10.1016/j.bbrc.2011.05.112; Merseburger AS, 2008, PROSTATE, V68, P72, DOI 10.1002/pros.20688; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nakahara S, 2006, J BIOL CHEM, V281, P39649, DOI 10.1074/jbc.M608069200; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2007, CANCER RES, V67, P11760, DOI 10.1158/0008-5472.CAN-07-3233; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Ochieng J, 1998, BBA-GEN SUBJECTS, V1379, P97, DOI 10.1016/S0304-4165(97)00086-X; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Saraswati S, 2011, PROSTATE, V71, P197, DOI 10.1002/pros.21236; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; Yamazaki K, 2001, BIOCHEM BIOPH RES CO, V280, P1077, DOI 10.1006/bbrc.2000.4193; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	45	29	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	2012	287	8					5192	5198		10.1074/jbc.C111.331686	http://dx.doi.org/10.1074/jbc.C111.331686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	897HE	22232548	hybrid, Green Published			2022-12-27	WOS:000300638000002
J	Park, SY; Bae, DJ; Kim, MJ; Piao, ML; Kim, IS				Park, Seung-Yoon; Bae, Dong-Jun; Kim, Mi-Jin; Piao, Mei Lan; Kim, In-San			Extracellular Low pH Modulates Phosphatidylserine-dependent Phagocytosis in Macrophages by Increasing Stabilin-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; CELL CORPSE CLEARANCE; APOPTOTIC CELLS; SCAVENGER RECEPTOR; HEME OXYGENASE-1; BLOOD-FLOW; IN-VITRO; RECOGNITION; MECHANISM; ACIDOSIS	Microenvironmental acidosis is a common feature of inflammatory loci, in which clearance of apoptotic cells is necessary for the resolution of inflammation. Although it is known that a low pH environment affects immune function, its effect on apoptotic cell clearance by macrophages has not been fully investigated. Here, we show that treatment of macrophages with low pH medium resulted in increased expression of stabilin-1 out of several receptors, which are known to be involved in PS-dependent removal of apoptotic cells. Reporter assays showed that the -120/ -1 region of the mouse stabilin-1 promoter was a low pH-responsive region and provided evidence that extracellular low pH mediated transcriptional activation of stabilin-1 via Ets-2. Furthermore, extracellular low pH activated JNK, thereby inducing translocation of Ets-2 into the nucleus. When macrophages were preincubated with low pH medium, phagocytosis of phosphatidylserine-exposed red blood cells and phosphatidylserine-coated beads by macrophages was enhanced. Blockade of stabilin-1 in macrophages abolished the enhancement of phagocytic activity by low pH. Thus, our results demonstrate that a low pH microenvironment up-regulates stabilin-1 expression in macrophages, thereby modulating the phagocytic capacity of macrophages, and suggest roles for stabilin-1 and Ets-2 in the maintenance of tissue homeostasis by the immune system.	[Bae, Dong-Jun; Piao, Mei Lan; Kim, In-San] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, Taegu 700422, South Korea; [Park, Seung-Yoon; Kim, Mi-Jin] Dongguk Univ, Sch Med, Dept Biochem, Gyeongju 780714, South Korea; [Kim, In-San] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea	Kyungpook National University; Dongguk University; Korea Institute of Science & Technology (KIST)	Kim, IS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, 101 Dongin Dong, Taegu 700422, South Korea.	iskim@knu.ac.kr	김, 인산/I-8988-2014; Kim, Mi Jin/GXH-9639-2022; Kim, In-San/D-3956-2017		National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0068687, 2011-0016102, R11-2008-044-03001-0]; Korea government [2010-0029206]; Converging Research Center through Ministry of Education, Science, and Technology [2010K001054]; Brain Korea 21 Project	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government(Korean Government); Converging Research Center through Ministry of Education, Science, and Technology; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grants 2009-0068687 and 2011-0016102; by the National Research Foundation of Korea funded by Korea government Grant 2010-0029206; by the Converging Research Center Program through Ministry of Education, Science, and Technology Grant 2010K001054; by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant R11-2008-044-03001-0; and by the Brain Korea 21 Project.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Chung SW, 2006, J IMMUNOL, V176, P2414, DOI 10.4049/jimmunol.176.4.2414; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; DUBOS RJ, 1955, LANCET, V2, P1; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; GOERDT S, 1993, AM J PATHOL, V142, P1409; Grimshaw MJ, 2001, EUR J IMMUNOL, V31, P480, DOI 10.1002/1521-4141(200102)31:2<480::AID-IMMU480>3.0.CO;2-L; Han MF, 2008, J BIOL CHEM, V283, P32715, DOI 10.1074/jbc.M806769200; Hanly EJ, 2007, SURGERY, V142, P357, DOI 10.1016/j.surg.2007.02.017; Kim S, 2010, INT J BIOCHEM CELL B, V42, P1154, DOI 10.1016/j.biocel.2010.03.024; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; KOPANIAK MM, 1980, AM J PATHOL, V98, P485; Kzhyshkowska J, 2005, IMMUNOBIOLOGY, V210, P161, DOI 10.1016/j.imbio.2005.05.022; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Libera J, 1997, BLOOD, V90, P1684, DOI 10.1182/blood.V90.4.1684.1684_1684_1693; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, MOL CELL BIOL, V28, P5288, DOI 10.1128/MCB.01993-07; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; TANNOCK IF, 1989, CANCER RES, V49, P4373; VANZWIETEN R, 1981, J CLIN INVEST, V68, P310, DOI 10.1172/JCI110250; VAUPEL P, 1989, CANCER RES, V49, P6449; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	41	43	44	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11261	11271		10.1074/jbc.M111.310953	http://dx.doi.org/10.1074/jbc.M111.310953			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334667	Green Published, hybrid			2022-12-27	WOS:000302780100054
J	Balasubramanian, PG; Beckmann, A; Warnken, U; Schnolzer, M; Schuler, A; Bornberg-Bauer, E; Holstein, TW; Ozbek, S				Balasubramanian, Prakash G.; Beckmann, Anna; Warnken, Uwe; Schnoelzer, Martina; Schueler, Andreas; Bornberg-Bauer, Erich; Holstein, Thomas W.; Oezbek, Suat			Proteome of Hydra Nematocyst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CNIDARIAN NEMATOCYST; BIOLOGICAL ROLES; MINI-COLLAGENS; RICH PROTEIN; VENOM; CELL; DISCHARGE; EVOLUTION; WALL; MINICOLLAGENS	Stinging cells or nematocytes of jellyfish and other cnidarians represent one of the most poisonous and sophisticated cellular inventions in animal evolution. This ancient cell type is unique in containing a giant secretory vesicle derived from the Golgi apparatus. The organelle structure within the vesicle comprises an elastically stretched capsule (nematocyst) to which a long tubule is attached. During exocytosis, the barbed part of the tubule is accelerated with > 5 million g in < 700 ns, enabling a harpoon-like discharge (Nuchter, T., Benoit, M., Engel, U., Ozbek, S., and Holstein, T. W. (2006) Curr. Biol. 16, R316-R318). Hitherto, the molecular components responsible for the organelle's biomechanical properties were largely unknown. Here, we describe the proteome of nematocysts from the freshwater polyp Hydra magnipapillata. Our analysis revealed an unexpectedly complex secretome of 410 proteins with venomous and lytic but also adhesive or fibrous properties. In particular, the insoluble fraction of the nematocyst represents a functional extracellular matrix structure of collagenous and elastic nature. This finding suggests an evolutionary scenario in which exocytic vesicles harboring a venomous secretome assembled a sophisticated predatory structure from extracellular matrix motif proteins.	[Holstein, Thomas W.; Oezbek, Suat] Heidelberg Univ, Ctr Organismal Studies, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany; [Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schueler, Andreas; Bornberg-Bauer, Erich] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munster	Holstein, TW (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Dept Mol Evolut & Genom, Neuenheimer Feld 230, D-69120 Heidelberg, Germany.	holstein@uni-hd.de; suat.oezbek@cos.uni-heidelberg.de	Özbek, Suat/D-3701-2014; Bornberg-Bauer, Erich/A-1563-2013	Bornberg-Bauer, Erich/0000-0002-1826-3576; Linn, Anna/0000-0002-6897-4114; Ozbek, Suat/0000-0003-2569-3942; Holstein, Thomas/0000-0003-0480-4674	Deutsche Forschungsgemeinschaft [HO 1088-4/1-2]; Heidelberg Excellence Cluster CellNetworks; Volkswagen Foundation [I184 830]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg Excellence Cluster CellNetworks; Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 1088-4/1-2, the Heidelberg Excellence Cluster CellNetworks, and the Volkswagen Foundation (I184 830).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P69, DOI 10.1083/jcb.5.1.69; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P79, DOI 10.1083/jcb.5.1.79; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; CLEMENTS S, 1985, J BIOL CHEM, V260, P3471; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Denker E, 2008, CURR BIOL, V18, pR858, DOI 10.1016/j.cub.2008.07.031; Eble JA, 2010, MATRIX BIOL, V29, P239, DOI 10.1016/j.matbio.2010.01.004; Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; Hausmann K, 1978, Int Rev Cytol, V52, P197, DOI 10.1016/S0074-7696(08)60757-3; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland JW, 2011, P ROY SOC B-BIOL SCI, V278, P546, DOI 10.1098/rspb.2010.1301; HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; HOLSTEIN TW, 1990, NATURE, V346, P21, DOI 10.1038/346021b0; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104; Jungo F, 2005, TOXICON, V45, P293, DOI 10.1016/j.toxicon.2004.10.018; Koch AW, 1998, J CELL SCI, V111, P1545; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-21; KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159; LENHOFF HM, 1957, BIOCHIM BIOPHYS ACTA, V26, P204, DOI 10.1016/0006-3002(57)90074-4; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MARISCAL RN, 1974, Z ZELLFORSCH MIK ANA, V147, P149, DOI 10.1007/BF00582789; Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Sher D, 2009, TOXICON, V54, P1148, DOI 10.1016/j.toxicon.2009.02.036; Szczepanek S, 2002, J CELL SCI, V115, P745; Vollrath F, 2005, CURR BIOL, V15, pR364, DOI 10.1016/j.cub.2005.05.014; WEBER J, 1989, EUR J BIOCHEM, V184, P465, DOI 10.1111/j.1432-1033.1989.tb15039.x; WEBER J, 1990, J BIOL CHEM, V265, P9664; WESTFALL JA, 1983, J CELL SCI, V63, P245; WONG RSC, 1979, J BIOL CHEM, V254, P4800; YAROSS MS, 1978, J CELL SCI, V34, P1	49	71	73	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9672	9681		10.1074/jbc.M111.328203	http://dx.doi.org/10.1074/jbc.M111.328203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291027	hybrid, Green Published			2022-12-27	WOS:000302167200002
J	Fayyad-Kazan, H; Rouas, R; Fayyad-Kazan, M; Badran, R; El Zein, N; Lewalle, P; Najar, M; Hamade, E; Jebbawi, F; Merimi, M; Romero, P; Burny, A; Badran, B; Martiat, P				Fayyad-Kazan, Hussein; Rouas, Redouane; Fayyad-Kazan, Mohammad; Badran, Rabih; El Zein, Nabil; Lewalle, Philippe; Najar, Medhi; Hamade, Eva; Jebbawi, Fadi; Merimi, Makram; Romero, Pedro; Burny, Arsene; Badran, Bassam; Martiat, Philippe			MicroRNA Profile of Circulating CD4-positive Regulatory T Cells in Human Adults and Impact of Differentially Expressed MicroRNAs on Expression of Two Genes Essential to Their Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; FOXP3 EXPRESSION; NONDIVIDING CELLS; IMMUNE-SYSTEM; TGF-BETA; IN-VIVO; CTLA-4; ACTIVATION; MIRNA; INTERLEUKIN-2	Regulatory T cells (Tregs) are characterized by a high expression of IL-2 receptor alpha chain (CD25) and of forkhead box P3 (FOXP3), the latter being essential for their development and function. Another major player in the regulatory function is the cytotoxic T-lymphocyte associated molecule-4 (CTLA-4) that inhibits cytotoxic responses. However, the regulation of CTLA-4 expression remains less well explored. We therefore studied the microRNA signature of circulating CD4(+) Tregs isolated from adult healthy donors and identified a signature composed of 15 differentially expressed microRNAs. Among those, miR-24, miR-145, and miR-210 were down-regulated in Tregs compared with controls and were found to have potential target sites in the 3'-UTR of FOXP3 and CTLA-4; miR-24 and miR-210 negatively regulated FOXP3 expression by directly binding to their two target sites in its 3'-UTR. On the other hand, miR-95, which is highly expressed in adult peripheral blood Tregs, positively regulated FOXP3 expression via an indirect mechanism yet to be identified. Finally, we showed that miR-145 negatively regulated CTLA-4 expression in human CD4(+) adult peripheral blood Tregs by binding to its target site in CTLA-4 transcript 3'-UTR. To our knowledge, this is the first identification of a human adult peripheral blood CD4(+) Treg microRNA signature. Moreover, unveiling one mechanism regulating CTLA-4 expression is novel and may lead to a better understanding of the regulation of this crucial gene.	[Fayyad-Kazan, Hussein; Rouas, Redouane; Fayyad-Kazan, Mohammad; Badran, Rabih; El Zein, Nabil; Lewalle, Philippe; Najar, Medhi; Jebbawi, Fadi; Merimi, Makram; Burny, Arsene; Martiat, Philippe] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, B-1000 Brussels, Belgium; [Hamade, Eva; Badran, Bassam] Lebanese Univ, Fac Sci, EDST PRASE, Dept Biochem,Lab Immunol, Hadath Beirut, Lebanon; [Romero, Pedro] Ludwig Inst Canc Res, Lausanne Branch, Div Clin Oncoimmunol, CH-1005 Lausanne, Switzerland	Institut Jules Bordet; Universite Libre de Bruxelles; Lebanese University; Ludwig Institute for Cancer Research	Martiat, P (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, 121 Blvd Waterloo, B-1000 Brussels, Belgium.	pmartiat@ulb.ac.be	Jebbawi, Fadi/AAD-6063-2020	el zein, nabil/0000-0002-8596-5359; Fayyad-Kazan, Hussein/0000-0002-3465-4630	Belgian Fonds National de la Recherche Scientifique (FRSM, Televie); Lebanese University; MEDIC Foundation; International Brachet Stiftung, les Amis de l'Institut Bordet; Van Buuren Foundation; Lambeau Marteaux Foundation; Hoguet Foundation; European Union	Belgian Fonds National de la Recherche Scientifique (FRSM, Televie)(Fonds de la Recherche Scientifique - FNRS); Lebanese University; MEDIC Foundation; International Brachet Stiftung, les Amis de l'Institut Bordet; Van Buuren Foundation; Lambeau Marteaux Foundation; Hoguet Foundation; European Union(European Commission)	This work was supported by grants from the Belgian Fonds National de la Recherche Scientifique (FRSM, Televie), the Lebanese University, the MEDIC Foundation, the International Brachet Stiftung, les Amis de l'Institut Bordet, and the Van Buuren, Lambeau Marteaux, and Hoguet Foundations.; Supported in part by a European Union grant, "Cancer Immunotherapy."	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Ariyan C, 2003, J IMMUNOL, V171, P5673, DOI 10.4049/jimmunol.171.11.5673; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Birzele F, 2011, NUCLEIC ACIDS RES, V39, P7946, DOI 10.1093/nar/gkr444; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Fayyad-Kazan H, 2010, J BIOL CHEM, V285, P20481, DOI 10.1074/jbc.M110.119628; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha Tai-You, 2009, Immune Netw, V9, P209, DOI 10.4110/in.2009.9.6.209; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Jandus C, 2008, CANCER IMMUNOL IMMUN, V57, P1795, DOI 10.1007/s00262-008-0507-4; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; Kavvoura FK, 2005, AM J EPIDEMIOL, V162, P3, DOI 10.1093/aje/kwi165; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kremer JM, 2003, NEW ENGL J MED, V349, P1907, DOI 10.1056/NEJMoa035075; Liao GX, 2010, INT IMMUNOL, V22, P259, DOI 10.1093/intimm/dxq001; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pallante P, 2010, ENDOCR-RELAT CANCER, V17, pF91, DOI 10.1677/ERC-09-0217; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pfoertner S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r54; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Raghavan S, 2005, FEMS IMMUNOL MED MIC, V44, P121, DOI 10.1016/j.femsim.2004.10.017; Ribas A, 2005, J CLIN ONCOL, V23, P8968, DOI 10.1200/JCO.2005.01.109; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang XB, 2001, SCAND J IMMUNOL, V54, P453, DOI 10.1046/j.1365-3083.2001.00985.x; Wulczyn FG, 2010, ADV EXP MED BIOL, V700, P85, DOI 10.1007/978-1-4419-7823-3_9; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	69	64	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9910	9922		10.1074/jbc.M111.337154	http://dx.doi.org/10.1074/jbc.M111.337154			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22294691	Green Published, hybrid			2022-12-27	WOS:000302167200023
J	Plantier, L; Besnard, V; Xu, Y; Ikegami, M; Wert, SE; Hunt, AN; Postle, AD; Whitsett, JA				Plantier, Laurent; Besnard, Valerie; Xu, Yan; Ikegami, Machiko; Wert, Susan E.; Hunt, Alan N.; Postle, Anthony D.; Whitsett, Jeffrey A.			Activation of Sterol-response Element-binding Proteins (SREBP) in Alveolar Type II Cells Enhances Lipogenesis Causing Pulmonary Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID LIPASE; HERMANSKY-PUDLAK-SYNDROME; GENE-EXPRESSION; SURFACTANT HOMEOSTASIS; EPITHELIAL-CELLS; LUNG MATURATION; NEUTRAL LIPIDS; KNOCKOUT MICE; C/EBP-ALPHA; DISEASE	Pulmonary inflammation is associated with altered lipid synthesis and clearance related to diabetes, obesity, and various inherited metabolic disorders. In many tissues, lipogenesis is regulated at the transcriptional level by the activity of sterol-response element-binding proteins (SREBP). The role of SREBP activation in the regulation of lipid metabolism in the lung was assessed in mice in which both Insig1 and Insig2 genes, encoding proteins that bind and inhibit SREBPs in the endoplasmic reticulum, were deleted in alveolar type 2 cells. Although deletion of either Insig1 or Insig2 did not alter SREBP activity or lipid homeostasis, deletion of both genes (Insig1/2(Delta/Delta) mice) activated SREBP1, causing marked accumulation of lipids that consisted primarily of cholesterol esters and triglycerides in type 2 epithelial cells and alveolar macrophages. Neutral lipids accumulated in type 2 cells in association with the increase in mRNAs regulating fatty acid, cholesterol synthesis, and inflammation. Although bronchoalveolar lavage fluid phosphatidylcholine was modestly decreased, lung phospholipid content and lung function were maintained. Insig1/2(Delta/Delta) mice developed lung inflammation and airspace abnormalities associated with the accumulation of lipids in alveolar type 2 cells, alveolar macrophages, and within alveolar spaces. Deletion of Insig1/2 activated SREBP-enhancing lipogenesis in respiratory epithelial cells resulting in lipotoxicity-related lung inflammation and tissue remodeling.	[Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Sect Neonatol Perinatal & Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA; [Hunt, Alan N.; Postle, Anthony D.] Univ Southampton, Fac Med, Div Clin & Expt Sci, Southampton SO16 6YD, Hants, England	Cincinnati Children's Hospital Medical Center; University of Southampton	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Sect Neonatol Perinatal & Pulm Biol, Perinatal Inst, MLC7029,3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org	Plantier, Laurent/GVT-8757-2022; Hunt, Alan N/A-7432-2008	Hunt, Alan N/0000-0001-5938-2152; Postle, Anthony/0000-0001-7361-0756; , Yan/0000-0003-2025-027X; Plantier, Laurent/0000-0002-3426-2936; Besnard, Valerie/0000-0002-2614-629X	National Institutes of Health [HL085610, HL105433]; Societe de Pneumologie de Langue Francaise; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL085610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe de Pneumologie de Langue Francaise; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085610 (to J. A. W.) and HL105433 (to Y. X.).; Supported by a travel grant from the Societe de Pneumologie de Langue Francaise.	Agassandian M, 2004, AM J RESP CELL MOL, V31, P227, DOI 10.1165/rcmb.2004-0038OC; Baldan A, 2008, J IMMUNOL, V180, P3560, DOI 10.4049/jimmunol.180.5.3560; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707; Ecker J, 2007, BIOCHEM BIOPH RES CO, V352, P805, DOI 10.1016/j.bbrc.2006.11.087; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Feng Y, 2001, ATHEROSCLEROSIS, V158, P331, DOI 10.1016/S0021-9150(01)00453-1; Foster DJ, 2010, AM J PHYSIOL-LUNG C, V298, pL392, DOI 10.1152/ajplung.00041.2009; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ikegami M, 2008, J APPL PHYSIOL, V104, P1753, DOI 10.1152/japplphysiol.00875.2007; KODOLOVA IM, 1982, ARK PATOL, V44, P35; Leonenko Z, 2007, BIOPHYS J, V93, P674, DOI 10.1529/biophysj.107.106310; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Minai OA, 2000, RESP MED, V94, P1241, DOI 10.1053/rmed.2000.0942; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; REINILA A, 1977, DIABETOLOGIA, V13, P305, DOI 10.1007/BF01223270; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; TORDAY J, 1995, BBA-LIPID LIPID MET, V1254, P198, DOI 10.1016/0005-2760(94)00184-Z; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Whitsett JA, 2010, INNATE IMMUN-LONDON, V16, P138, DOI 10.1177/1753425910366879; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC	46	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10099	10114		10.1074/jbc.M111.303669	http://dx.doi.org/10.1074/jbc.M111.303669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267724	Green Published, hybrid			2022-12-27	WOS:000302167200042
J	Xia, HP; Cheung, WKC; Ng, SS; Jiang, XC; Jiang, SS; Sze, J; Leung, GKK; Lu, G; Chan, DTM; Bian, XW; Kung, HF; Poon, WS; Lin, MC				Xia, Hongping; Cheung, William K. C.; Ng, Samuel S.; Jiang, Xiaochun; Jiang, Songshan; Sze, Johnny; Leung, Gilberto K. K.; Lu, Gang; Chan, Danny T. M.; Bian, Xiu-Wu; Kung, Hsiang-Fu; Poon, Wai Sang; Lin, Marie C.			Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOBLASTOMA-MULTIFORME; INVASION; TUMOR; CANCER; DIFFERENTIATION; IDENTIFICATION; GENES; PROLIFERATION; PLURIPOTENCY; PROGRESSION	miR-124 is a brain-enriched microRNA that plays a crucial role in neural development and has been shown to be down-regulated in glioma and medulloblastoma, suggesting its possible involvement in brain tumor progression. Here, we show that miR-124 is down-regulated in a panel of different grades of glioma tissues and in all of the human glioma cell lines we examined. By integrated bioinformatics analysis and experimental confirmation, we identified SNAI2, which is often up-regulated in glioma, as a direct functional target of miR-124. Because SNAI2 has been shown to regulate stem cell functions, we examined the roles of miR-124 and SNAI2 in glioma cell stem-like traits. The results showed that overexpression of miR-124 and knockdown of SNAI2 reduced neurosphere formation, CD133(+) cell subpopulation, and stem cell marker (BMI1, Nanog, and Nestin) expression, and these effects could be rescued by re-expression of SNAI2. Furthermore, enhanced miR-124 expression significantly inhibited glioma cell invasion in vitro. Finally, stable overexpression of miR-124 and knockdown of SNAI2 inhibited the tumorigenicity and invasion of glioma cells in vivo. These findings reveal, for the first time, that the tumor suppressor activity of miR-124 could be partly due to its inhibitory effects on glioma stem-like traits and invasiveness through SNAI2.	[Xia, Hongping; Sze, Johnny; Lu, Gang; Chan, Danny T. M.; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Brain Tumour Ctr, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Sze, Johnny; Lu, Gang; Chan, Danny T. M.; Poon, Wai Sang; Lin, Marie C.] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Cheung, William K. C.; Ng, Samuel S.; Sze, Johnny; Lin, Marie C.] Chinese Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Xia, Hongping; Jiang, Xiaochun] Sun Yat Sen Univ, Wannan Med Coll, Yijishan Hosp, Dept Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Leung, Gilberto K. K.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Bian, Xiu-Wu; Kung, Hsiang-Fu; Lin, Marie C.] Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Bian, Xiu-Wu; Kung, Hsiang-Fu; Lin, Marie C.] Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Kung, Hsiang-Fu] Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Sun Yat Sen University; Wannan Medical College; Sun Yat Sen University; University of Hong Kong; Army Medical University; Army Medical University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Poon, WS (corresponding author), Chinese Univ Hong Kong, Brain Tumour Ctr, Shatin, Hong Kong, Peoples R China.	wpoon@cuhk.edu.hk; mcllin@surgery.cuhk.edu.hk	XIA, HONGPING/AAK-7100-2020; Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011; Bian, Xiu-Wu/D-4736-2017; Leung, Gilberto Ka Kit/C-4337-2009	Bian, Xiu-Wu/0000-0003-4383-0197; Leung, Gilberto Ka Kit/0000-0003-3147-3057; LU, Gang/0000-0001-5921-1839	Research Grants Council of the Hong Kong Special Administrative Region, China [467109, 470911]; National Basic Research Program of China (973 Program) [2010CB529400, 2010CB912800]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Grants 467109 and 470911 from the Research Grants Council of the Hong Kong Special Administrative Region, China, and by Grants 2010CB529400 and 2010CB912800 from the National Basic Research Program of China (973 Program).	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207, DOI 10.1007/BF00691091; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lee MR, 2010, STEM CELLS, V28, P1550, DOI 10.1002/stem.490; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Novakova J, 2009, BIOCHEM BIOPH RES CO, V386, P1, DOI 10.1016/j.bbrc.2009.06.034; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Perez-Mancera PA, 2005, ONCOGENE, V24, P3073, DOI 10.1038/sj.onc.1208505; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Scrideli CA, 2008, J NEURO-ONCOL, V88, P281, DOI 10.1007/s11060-008-9579-4; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vitali R, 2008, CLIN CANCER RES, V14, P4622, DOI 10.1158/1078-0432.CCR-07-5210; Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006; Wong JWJ, 2010, J NEUROSCI, V30, P3868, DOI 10.1523/JNEUROSCI.0442-10.2010; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169; Xie ZG, 2009, NEUROCHEM RES, V34, P2055, DOI 10.1007/s11064-009-0079-5; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	49	142	151	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9962	9971		10.1074/jbc.M111.332627	http://dx.doi.org/10.1074/jbc.M111.332627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22253443	Green Published, hybrid			2022-12-27	WOS:000302167200028
J	Lee, J; Kim, D; Choi, J; Choi, H; Ryu, JH; Jeong, J; Park, EJ; Kim, SH; Kim, S				Lee, Junghun; Kim, Donghyun; Choi, Jonghyun; Choi, Hyounjeong; Ryu, Jae-Ha; Jeong, Jinhyun; Park, Eun-Jin; Kim, Seon-Hee; Kim, Sunyoung			Dehydrodiconiferyl Alcohol Isolated from Cucurbita moschata Shows Anti-adipogenic and Anti-lipogenic Effects in 3T3-L1 Cells and Primary Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; GROWTH-FACTOR-I; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; TRANSGENIC MICE; BINDING PROTEINS; GENE-EXPRESSION; STEM-CELL; OBESITY; LIGNIN	A water-soluble extract from the stems of Cucurbita moschata, code named PG105, was previously found to contain strong anti-obesity activities in a high fat diet-induced obesity mouse model. One of its biological characteristics is that it inhibits 3T3-L1 adipocyte differentiation. To isolate the biologically active compound(s), conventional solvent fractionation was performed, and the various fractions were tested for anti-adipogenic activity using Oil Red O staining method. A single spot on thin layer chromatography of the chloroform fraction showed a potent anti-adipogenic activity. When purified, the structure of its major component was resolved as dehydrodiconiferyl alcohol (DHCA), a lignan, by NMR and mass spectrometry analysis. In 3T3-L1 cells, synthesized DHCA significantly reduced the expression of several adipocyte marker genes, including peroxisome proliferator-activated receptor gamma (Pparg), CCAAT/enhancer-binding protein alpha (Cebpa), fatty acid-binding protein 4 (Fabp4), sterol response element-binding protein-1c (Srebp1c), and stearoyl-coenzyme A desaturase-1 (Scd), and decreased lipid accumulation without affecting cell viability. DHCA also suppressed the mitotic clonal expansion of preadipocytes (an early event of adipogenesis), probably by suppressing the DNA binding activity of C/EBP beta, and lowered the production level of cyclinA and cyclin-dependent kinase 2 (Cdk2), coinciding with the decrease in DNA synthesis and cell division. In addition, DHCA directly inhibited the expression of SREBP-1c and SCD-1. Similar observations were made, using primary mouse embryonic fibroblasts. Taken together, our data indicate that DHCA may contain dual activities, affecting both adipogenesis and lipogenesis.	[Lee, Junghun; Kim, Donghyun; Choi, Jonghyun; Choi, Hyounjeong; Kim, Sunyoung] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Ryu, Jae-Ha] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea; [Jeong, Jinhyun] Yonsei Univ, Coll Pharm, Inchon 406840, South Korea; [Park, Eun-Jin; Kim, Seon-Hee] Viromed Co Ltd, Seoul 151747, South Korea	Seoul National University (SNU); Sookmyung Women's University; Yonsei University	Kim, S (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	sunyoung@snu.ac.kr	Kim, Donghyun/J-3609-2019	Kim, Donghyun/0000-0002-5137-2213; Lee, Junghun/0000-0003-4524-0625	National Research Foundation of Korea [2011-0030699]; Brain Research Center [2011 K000287]; Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Grants 2011-0030699 (to J.-H.R.), and 2011 K000287 (to S.K.) from the National Research Foundation of Korea, and the Brain Research Center of the 21st Century Frontier Research Program, respectively, funded by the Ministry of Education, Science and Technology, in which Viromed Co., Ltd. is a participating company.	ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Auld CA, 2007, J CELL BIOCHEM, V100, P204, DOI 10.1002/jcb.21063; Barcelo AR, 2003, FUNCT PLANT BIOL, V30, P577, DOI 10.1071/FP02096; Byers T, 2007, J NUTR, V137, P488, DOI 10.1093/jn/137.2.488; Choi HJ, 2007, BIOCHEM BIOPH RES CO, V359, P419, DOI 10.1016/j.bbrc.2007.05.107; Cook A., 2008, ADIPOSE; Dani C, 1999, CELLS TISSUES ORGANS, V165, P173, DOI 10.1159/000016697; Deedwania P C, 2006, J Assoc Physicians India, V54, P797; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; FREUDENBERG K, 1965, SCIENCE, V148, P595, DOI 10.1126/science.148.3670.595; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gang DR, 1999, CHEM BIOL, V6, P143, DOI 10.1016/S1074-5521(99)89006-1; Gnudi L, 1996, P NUTR SOC, V55, P191, DOI 10.1079/PNS19960020; Greenwood M R, 1977, Curr Concepts Nutr, V5, P119; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Harp JB, 2004, CURR OPIN LIPIDOL, V15, P303, DOI 10.1097/00041433-200406000-00010; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HIRSCH J, 1969, J LIPID RES, V10, P77; Hu K, 2006, ARCH PHARM RES, V29, P563, DOI 10.1007/BF02969265; Jin SH, 2000, J BIOL CHEM, V275, P34344, DOI 10.1074/jbc.M004927200; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu KN, 2002, MOL CELL ENDOCRINOL, V194, P51, DOI 10.1016/S0303-7207(02)00188-0; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; NOSE M, 1995, PHYTOCHEMISTRY, V39, P71, DOI 10.1016/0031-9422(95)95268-Y; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Qiu ZL, 2001, J BIOL CHEM, V276, P11988, DOI 10.1074/jbc.M011729200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tchoukalova YD, 2000, OBES RES, V8, P664, DOI 10.1038/oby.2000.85; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168	47	36	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8839	8851		10.1074/jbc.M111.263434	http://dx.doi.org/10.1074/jbc.M111.263434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262865	hybrid, Green Published			2022-12-27	WOS:000301797800016
J	Lee, SH; Moon, JH; Yoon, SK; Yoon, JB				Lee, Seung-Hoon; Moon, Joo-Hong; Yoon, Sungjoo Kim; Yoon, Jong-Bok			Stable Incorporation of ATPase Subunits into 19 S Regulatory Particle of Human Proteasome Requires Nucleotide Binding and C-terminal Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; ASSEMBLY PATHWAY; STRUCTURAL BASIS; AAA SUBUNITS; ROLES; ACTIVATION; COMPLEX; PA700; DEUBIQUITINATION; RECOGNITION	The 26 S proteasome is a large multi-subunit protein complex that degrades ubiquitinated proteins in eukaryotic cells. Proteasome assembly is a complex process that involves formation of six- and seven-membered ring structures from homologous subunits. Here we report that the assembly of hexameric Rpt ring of the 19 S regulatory particle (RP) requires nucleotide binding but not ATP hydrolysis. Disruption of nucleotide binding to an Rpt subunit by mutation in the Walker A motif inhibits the assembly of the Rpt ring without affecting heterodimer formation with its partner Rpt subunit. Coexpression of the base assembly chaperones S5b and PAAF1 with mutant Rpt1 and Rpt6, respectively, relieves assembly inhibition of mutant Rpts by facilitating their interaction with adjacent Rpt dimers. The mutation in the Walker B motif which impairs ATP hydrolysis does not affect Rpt ring formation. Incorporation of a Walker B mutant Rpt subunit abrogates the ATPase activity of the 19 S RP, suggesting that failure of the mutant Rpt to undergo the conformational transition from an ATP-bound to an ADP-bound state impairs conformational changes in the other five wild-type Rpts in the Rpt ring. In addition, we demonstrate that the C-terminal tails of Rpt subunits possessing core particle (CP)-binding affinities facilitate the cellular assembly of the 19SRP, implying that the 20 S CP may function as a template for base assembly in human cells. Taken together, these results suggest that the ATP-bound conformational state of an Rpt subunit with the exposed C-terminal tail is competent for cellular proteasome assembly.	[Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Lee, Seung-Hoon; Moon, Joo-Hong; Yoon, Jong-Bok] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 262 Seongsanno, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	NRF; MEST [2009-0081317]; Korean Ministry of Science and Technology; Translational Research Center for Protein Function Control, NSF	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Translational Research Center for Protein Function Control, NSF	This work was supported in part by a mid-career Researcher Program through an NRF Grant funded by the MEST (No. 2009-0081317), by grants from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project, and from the Translational Research Center for Protein Function Control, NSF.	Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	42	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9269	9279		10.1074/jbc.M111.316208	http://dx.doi.org/10.1074/jbc.M111.316208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275368	hybrid, Green Published			2022-12-27	WOS:000301797800055
J	Musset, B; Clark, RA; DeCoursey, TE; Petheo, GL; Geiszt, M; Chen, YM; Cornell, JE; Eddy, CA; Brzyski, RG; El Jamali, A				Musset, Boris; Clark, Robert A.; DeCoursey, Thomas E.; Petheo, Gabor L.; Geiszt, Miklos; Chen, Yumin; Cornell, John E.; Eddy, Carlton A.; Brzyski, Robert G.; El Jamali, Amina			NOX5 in Human Spermatozoa EXPRESSION, FUNCTION, AND REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE NOX5-S; ESOPHAGEAL ADENOCARCINOMA CELLS; OXYGEN SPECIES PRODUCTION; HUMAN SPERM SUSPENSIONS; GATED PROTON CHANNEL; HUMAN EOSINOPHILS; SUPEROXIDE-PRODUCTION; RESPIRATORY BURST; ELECTRON CURRENTS; HUMAN NEUTROPHILS	Physiological and pathological processes in spermatozoa involve the production of reactive oxygen species (ROS), but the identity of the ROS-producing enzyme system(s) remains a matter of speculation. We provide the first evidence that NOX5 NADPH oxidase is expressed and functions in human spermatozoa. Immunofluorescence microscopy detected NOX5 protein in both the flagella/neck region and the acrosome. Functionally, spermatozoa exposed to calcium ionophore, phorbol ester, or H2O2 exhibited superoxide anion production, which was blocked by addition of superoxide dismutase, a Ca2+ chelator, or inhibitors of either flavoprotein oxidases (diphenylene iododonium) or NOX enzymes (GKT136901). Consistent with our previous overexpression studies, we found that H2O2-induced superoxide production by primary sperm cells was mediated by the non-receptor tyrosine kinase c-Abl. Moreover, the H(V)1 proton channel, which was recently implicated in spermatozoa motility, was required for optimal superoxide production by spermatozoa. Immunoprecipitation experiments suggested an interaction among NOX5, c-Abl, and H(V)1. H2O2 treatment increased the proportion of motile sperm in a NOX5-dependent manner. Statistical analyses showed a pH-dependent correlation between superoxide production and enhanced sperm motility. Collectively, our findings show that NOX5 is a major source of ROS in human spermatozoa and indicate a role for NOX5-dependent ROS generation in human spermatozoa motility.	[Clark, Robert A.; El Jamali, Amina] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chen, Yumin; Cornell, John E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Eddy, Carlton A.; Brzyski, Robert G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Musset, Boris; DeCoursey, Thomas E.] Rush Univ, Med Ctr, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Petheo, Gabor L.; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Rush University; Semmelweis University	El Jamali, A (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	AkoulouzeBik@uthscsa.edu	Musset, Boris/AAD-4158-2022; Musset, Boris/J-2520-2013; Petheő, Gábor/O-1149-2017; Clark, Robert/Q-6764-2019; DeCoursey, Thomas/A-6820-2009	Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817; Petheő, Gábor/0000-0002-1773-4129; Clark, Robert/0000-0002-4892-3619; DeCoursey, Thomas/0000-0002-4263-180X	National Institutes of Health [T32 HL04776, UL1 RR025767, KL2 RR025766, K01 DK084297, R01-GM087507, P30 CA054174, P30 AG013319, P01 AG019316]; Iacocca Family Foundation; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000118, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025766, UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iacocca Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL04776 (to A. E. J.), UL1 RR025767 (to A. E. J.), Clinical and Translational Science Awards pilot funding (to A. E. J.), KL2 RR025766 (to A. E. J.), K01 DK084297 (to A. E. J.), and Career Development Award R01-GM087507 (to T. E. D.) and an award from the Iacocca Family Foundation (to B. M.). Robert Clark is a scientific co-founder, member of the Scientific Advisory Board, and equity holder in GenKyoTex SA, a Swiss biotechnology start-up company with a primary goal of developing clinically useful inhibitors of the NOX family of NADPH oxidases.; Optical Imaging Facility of the University of Texas Health Science Center at San Antonio, which is supported by National Institutes of Health Grants P30 CA054174 (Cancer Therapy and Research Center), P30 AG013319 (Nathan Shock Center), and P01 AG019316 (Aging, Oxidative Stress and Cell Death). We thank Dr. Craig Witz for arranging initial access to human sperm samples from the University of Texas Medicine Fertility Center, Drs. Victoria Frohlich and Shivani Maffi for expert guidance on confocal microscopy image acquisition and analysis, Maria Gamez and Mario de la Pena for expert technical assistance, and Drs. Susan Smith, Yves Gorin, and Denis Feliers for helpful discussions.	Aitken R John, 2010, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-02062-9_7; Aitken RJ, 1998, J CELL SCI, V111, P645; AITKEN RJ, 1990, INT J ANDROL, V13, P433, DOI 10.1111/j.1365-2605.1990.tb01051.x; Aitken RJ, 2004, FREE RADICAL BIO MED, V36, P994, DOI 10.1016/j.freeradbiomed.2004.01.017; AITKEN RJ, 1994, REPROD FERT DEVELOP, V6, P19, DOI 10.1071/RD9940019; Aitken RJ, 1998, J REPROD FERTIL, P109; Aitken RJ, 2000, J ANDROL, V21, P491; Alexandrino AP, 2011, SPINAL CORD, V49, P435, DOI 10.1038/sc.2010.122; Armstrong JS, 2002, INT J ANDROL, V25, P223, DOI 10.1046/j.1365-2605.2002.00351.x; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; de Lamirande E, 1998, J ANDROL, V19, P585; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; de Lamirande E, 2009, FREE RADICAL BIO MED, V46, P502, DOI 10.1016/j.freeradbiomed.2008.11.004; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; DeCoursey TE, 2010, PHYSIOLOGY, V25, P27, DOI 10.1152/physiol.00039.2009; DELAMIRANDE E, 1992, J ANDROL, V13, P368; DELAMIRANDE E, 1993, FREE RADICAL BIO MED, V14, P157, DOI 10.1016/0891-5849(93)90006-G; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; Ford WCL, 1997, INT J ANDROL, V20, P44; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; KESSOPOULOU E, 1992, J REPROD FERTIL, V94, P463; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; MacLeod J, 1943, AM J PHYSIOL, V138, P0512, DOI 10.1152/ajplegacy.1943.138.3.512; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morgan D., 2002, J GEN PHYSIOL, V119, P2477; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024; Musset B, 2010, J BIOL CHEM, V285, P5117, DOI 10.1074/jbc.C109.082727; Neri-Vidaurri PD, 2006, BIOCHEM BIOPH RES CO, V343, P105, DOI 10.1016/j.bbrc.2006.02.095; PARRISH JJ, 1987, J ANDROL, V8, P259; Petheo GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014081; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Resch CT, 2011, BIOCHEM CELL BIOL, V89, P130, DOI [10.1139/O10-149, 10.1139/o10-149]; Richer SC, 2001, MOL HUM REPROD, V7, P237, DOI 10.1093/molehr/7.3.237; Rivlin J, 2004, BIOL REPROD, V70, P518, DOI 10.1095/biolreprod.103.020487; ROGERS C, 1988, J FORENSIC SCI, V33, P77; Sabeur K, 2007, REPRODUCTION, V134, P263, DOI 10.1530/REP-06-0120; Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Si J, 2007, J BIOL CHEM, V282, P16244, DOI 10.1074/jbc.M700297200; Sotolongo B, 2000, J CELL BIOCHEM, P23; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; VIJAYAKUMAR R, 1986, ARCH ANDROLOGY, V17, P223, DOI 10.3109/01485018608990199; WHITE DR, 1989, GAMETE RES, V22, P163, DOI 10.1002/mrd.1120220205; Whittington K, 1999, INT J ANDROL, V22, P229, DOI 10.1046/j.1365-2605.1999.00173.x; WHO, 2010, EX PROC HUM SEM; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	72	104	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9376	9388		10.1074/jbc.M111.314955	http://dx.doi.org/10.1074/jbc.M111.314955			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291013	Green Published, hybrid			2022-12-27	WOS:000301797800068
J	Wynn, RM; Li, J; Brautigam, CA; Chuang, JL; Chuang, DT				Wynn, R. Max; Li, Jun; Brautigam, Chad A.; Chuang, Jacinta L.; Chuang, David T.			Structural and Biochemical Characterization of Human Mitochondrial Branched-chain alpha-Ketoacid Dehydrogenase Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; CATALYTIC SUBUNIT; CHAPERONINS GROEL; ESCHERICHIA-COLI; PROTEIN; PYRUVATE; COMPLEX; BINDING; EXPRESSION; DOMAIN	The branched-chain alpha-ketoacid dehydrogenase phosphatase (BDP) component of the human branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) has been expressed in Escherichia coli and purified in the soluble form. The monomeric BDP shows a strict dependence on Mn2+ ions for phosphatase activity, whereas Mg2+ and Ca2+ ions do not support catalysis. Metal binding constants for BDP, determined by competition isothermal titration calorimetry, are 2.4 nM and 10 mu M for Mn2+ and Mg2+ ions, respectively. Using the phosphorylated decarboxylase component (p-E1b) of BCKDC as a substrate, BDP shows a specific activity of 68 nmol/min/mg. The Ca2+-independent binding of BDP to the 24-meric transacylase (dihydrolipoyl transacylase; E2b) core of BCKDC results in a 3-fold increase in the dephosphorylation rate of p-E1b. However, the lipoyl prosthetic group on E2b is not essential for BDP binding or E2b-stimulated phosphatase activity. Acidic residues in the C-terminal linker of the E2b lipoyl domain are essential for the interaction between BDP and E2b. The BDP structure was determined by x-ray crystallography to 2.4 angstrom resolution. The BDP structure is dominated by a central beta-sandwich. There are two protrusions forming a narrow cleft similar to 10 angstrom wide, which constitutes the active site. The carboxylate moieties of acidic residues Asp-109, Asp-207, Asp-298, and Asp-337 in the active-site cleft participate in binding two metal ions. Substitutions of these residues with alanine nullify BDP phosphatase activity. Alteration of the nearby Arg-104 increases the Km for p-E1b peptide by 60-fold, suggesting that this residue is critical for the recognition of the native p-E1b protein.	[Wynn, R. Max; Li, Jun; Brautigam, Chad A.; Chuang, Jacinta L.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wynn, RM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	richard.wynn@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [DK26758, DK62306, DK92921]; Welch Foundation [I-1286]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK062306, R01DK026758, R01DK092921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26758, DK62306, and DK92921. This work was also supported by Welch Foundation Grant I-1286.; The x-ray data are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is operated by the University of Chicago at Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We are indebted to Brittany Young for technical assistance.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Bevington PR., 2002, DATA REDUCTION ERROR; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Clugston SL, 2004, BIOCHEM J, V377, P309, DOI 10.1042/BJ20030271; DAMUNI Z, 1986, P NATL ACAD SCI USA, V83, P285, DOI 10.1073/pnas.83.2.285; DAMUNI Z, 1987, J BIOL CHEM, V262, P5129; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; HARRIS RA, 1986, BIOCHEM J, V234, P285, DOI 10.1042/bj2340285; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Hedl M, 2004, PROTEIN SCI, V13, P687, DOI 10.1110/ps.03367504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Huang YS, 1999, BIOCHEM J, V339, P503, DOI 10.1042/0264-6021:3390503; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Irmler A, 2001, P NATL ACAD SCI USA, V98, P12978, DOI 10.1073/pnas.231254998; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Karpova T, 2004, BBA-PROTEINS PROTEOM, V1700, P43, DOI 10.1016/j.bbapap.2004.03.013; Kato M, 2006, EMBO J, V25, P5983, DOI 10.1038/sj.emboj.7601444; Komaki KI, 2003, BBA-GENE STRUCT EXPR, V1630, P130, DOI 10.1016/j.bbaexp.2003.09.004; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Levin MD, 2002, BIOPHYS J, V82, P1809, DOI 10.1016/S0006-3495(02)75531-8; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oyarzabal A, 2011, J INHERIT METAB DIS, V34, pS79; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; PAUL HS, 1982, J BIOL CHEM, V257, P4875; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Turkan A, 2004, BIOCHEMISTRY-US, V43, P15073, DOI 10.1021/bi048901y; Turkan A, 2002, J BIOL CHEM, V277, P14976, DOI 10.1074/jbc.M108434200; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Velazquez-Campoy A, 2001, ARCH BIOCHEM BIOPHYS, V390, P169, DOI 10.1006/abbi.2001.2333; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Wynn RM, 2000, METHOD ENZYMOL, V324, P179; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; WYNN RM, 1992, J BIOL CHEM, V267, P12400; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZHAO Y, 1993, BIOCHEM J, V290, P395, DOI 10.1042/bj2900395	64	16	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9178	9192		10.1074/jbc.M111.314963	http://dx.doi.org/10.1074/jbc.M111.314963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291014	Green Published, hybrid			2022-12-27	WOS:000301797800046
J	Zhou, L; Jones, EV; Murai, KK				Zhou, Lei; Jones, Emma V.; Murai, Keith K.			EphA Signaling Promotes Actin-based Dendritic Spine Remodeling through Slingshot Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SEMLIKI-FOREST-VIRUS; AMPA RECEPTOR TRAFFICKING; FOCAL ADHESION KINASE; SYNAPTIC PLASTICITY; COFILIN DEPHOSPHORYLATION; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; CORTICAL-NEURONS; ADULT CORTEX	Actin cytoskeletal remodeling plays a critical role in transforming the morphology of subcellular structures across various cell types. In the brain, restructuring of dendritic spines through actin cytoskeleletal reorganization is implicated in the regulation of synaptic efficacy and the storage of information in neural circuits. However, the upstream pathways that provoke actin-based spine changes remain only partly understood. Here we show that EphA receptor signaling remodels spines by triggering a sequence of events involving actin filament rearrangement and synapse/spine reorganization. Rapid EphA signaling over minutes activates the actin filament depolymerizing/severing factor cofilin, alters F-actin distribution in spines, and causes transient spine elongation through the phosphatases slingshot 1 (SSH1) and calcineurin/protein phosphatase 2B (PP2B). This early phase of spine extension is followed by synaptic reorganization events that take place over minutes to hours and involve the relocation of pre/postsynaptic components and ultimately spine retraction. Thus, EphA receptors utilize discrete cellular and molecular pathways to promote actin-based structural plasticity of excitatory synapses.	[Zhou, Lei; Jones, Emma V.; Murai, Keith K.] McGill Univ, Dept Neurol & Neurosurg, Montreal Gen Hosp, Res Inst,Hlth Ctr,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	Murai, KK (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Gen Hosp, Res Inst,Hlth Ctr,Ctr Res Neurosci, 1650 Cedar Ave L7-212, Montreal, PQ H3G 1A4, Canada.	keith.murai@mcgill.ca			Canadian Institutes of Health Research; Canada Research Chairs Program; Canadian Foundation for Innovation; EJLB Foundation; Research Institute of the McGill University Health Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); EJLB Foundation; Research Institute of the McGill University Health Centre	This work was supported by the Canadian Institutes of Health Research, the Canada Research Chairs Program, the Canadian Foundation for Innovation, and the EJLB Foundation (to K. K. M.).; Supported by a studentship from Research Institute of the McGill University Health Centre.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Eaton BA, 2003, GENE DEV, V17, P2075, DOI 10.1101/gad.1113703; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hering H, 2003, J NEUROSCI, V23, P11759; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lundstrom Kenneth, 2003, Methods Mol Med, V76, P503; Mateos JM, 2007, J PHYSIOL-LONDON, V581, P129, DOI 10.1113/jphysiol.2006.120550; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	79	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9346	9359		10.1074/jbc.M111.302802	http://dx.doi.org/10.1074/jbc.M111.302802			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22282498	Green Published, hybrid			2022-12-27	WOS:000301797800066
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Neurodegeneration Induced by Clustering of Sialylated Glycosylphosphatidylinositols of Prion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; MOUSE MODEL; SCRAPIE; CELL; CHOLESTEROL; PHOSPHOLIPASE; RAFTS; THY-1	The transmissible spongiform encephalopathies, more commonly known as the prion diseases, are associated with the production and aggregation of disease-related isoforms of the prion protein (PrPSc). The mechanisms by which PrPSc accumulation causes neurodegeneration in these diseases are poorly understood. In cultured neurons, the addition of PrPSc alters cell membranes, increasing cholesterol, activating cytoplasmic phospholipase A(2) (cPLA(2)), and triggering synapse damage. These effects of PrPSc are dependent upon its glycosylphosphatidylinositol (GPI) anchor, suggesting that it is the increased density of GPIs that occurs following the aggregation of PrPSc molecules that triggers neurodegeneration. This hypothesis was supported by observations that cross-linkage of the normal cellular prion protein (PrPC) also increased membrane cholesterol, activated cPLA2, and triggered synapse damage. These effects were not seen after cross-linkage of Thy-1, another GPI-anchored protein, and were dependent on the GPI anchor attached to PrPC containing two acyl chains and sialic acid. We propose that the aggregation of PrPSc, or the cross-linkage of PrPC, causes the clustering of sialic acid-containing GPI anchors at high densities, resulting in altered membrane composition, the pathological activation of cPLA(2), and synapse damage.	[Bate, Clive] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield AL9 7TA, Herts, England; [Williams, Alun] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University of London Royal Veterinary College; University of Cambridge	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-13; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; Haviv Y, 2008, ARCH NEUROL-CHICAGO, V65, P762, DOI 10.1001/archneur.65.6.762; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Horejsi V, 1999, IMMUNOL TODAY, V20, P356, DOI 10.1016/S0167-5699(99)01489-9; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; LUNDJOHANSEN F, 1993, EUR J IMMUNOL, V23, P2782, DOI 10.1002/eji.1830231110; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mok SWF, 2006, BIOCHEM BIOPH RES CO, V348, P697, DOI 10.1016/j.bbrc.2006.07.123; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7935	7944		10.1074/jbc.M111.275743	http://dx.doi.org/10.1074/jbc.M111.275743			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262833	Green Published, hybrid			2022-12-27	WOS:000301349400010
J	Colletti, GA; Miedel, MT; Quinn, J; Andharia, N; Weisz, OA; Kiselyov, K				Colletti, Grace A.; Miedel, Mark T.; Quinn, James; Andharia, Neel; Weisz, Ora A.; Kiselyov, Kirill			Loss of Lysosomal Ion Channel Transient Receptor Potential Channel Mucolipin-1 (TRPML1) Leads to Cathepsin B-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL ABERRATIONS; PROTEIN; IV; MUTATIONS; AUTOPHAGY; TRAFFICKING; INHIBITORS; RELEASE	Mucolipidosis type IV (MLIV) is a lysosomal storage disease caused by mutations in the gene MCOLN1, which codes for the transient receptor potential family ion channel TRPML1. MLIV has an early onset and is characterized by developmental delays, motor and cognitive deficiencies, gastric abnormalities, retinal degeneration, and corneal cloudiness. The degenerative aspects of MLIV have been attributed to cell death, whose mechanisms remain to be delineated in MLIV and in most other storage diseases. Here we report that an acute siRNA-mediated loss of TRPML1specifically causes a leak of lysosomal protease cathepsin B (CatB) into the cytoplasm. CatB leak is associated with apoptosis, which can be prevented by CatB inhibition. Inhibition of the proapoptotic protein Bax prevents TRPML1 KD-mediated apoptosis but does not prevent cytosolic release of CatB. This is the first evidence of a mechanistic link between acute TRPML1 loss and cell death.	[Colletti, Grace A.; Quinn, James; Andharia, Neel; Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Miedel, Mark T.; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Miedel, Mark T.; Weisz, Ora A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kiselyov, K (corresponding author), 4249 5th Ave, Pittsburgh, PA 15260 USA.	kiselyov@pitt.edu		Miedel, Mark/0000-0002-0132-6032; Kiselyov, Kirill/0000-0001-6683-2895	National Institutes of Health [HD058577, ES01678]; National Institutes of Health CTSI [5TL1RR 024155]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058577] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants HD058577 and ES01678 (to K. K.).; Supported by National Institutes of Health predoctoral CTSI fellowship 5TL1RR 024155. Present address: Dept. of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Cheriyath V, 2011, BRIT J CANCER, V104, P957, DOI 10.1038/bjc.2011.42; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frei KP, 1998, NEUROLOGY, V51, P565, DOI 10.1212/WNL.51.2.565; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; HANEWINKEL H, 1987, J BIOL CHEM, V262, P12351; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Krepela E, 2001, NEOPLASMA, V48, P332; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; MACH L, 1993, BIOCHEM J, V293, P437, DOI 10.1042/bj2930437; MACH L, 1992, BIOCHEM J, V282, P577, DOI 10.1042/bj2820577; Michallet MC, 2003, BLOOD, V102, P3719, DOI 10.1182/blood-2003-04-1075; Micsenyi MC, 2009, J NEUROPATH EXP NEUR, V68, P125, DOI 10.1097/NEN.0b013e3181942cf0; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Moles A, 2012, J BIOL CHEM, V287, P1178, DOI 10.1074/jbc.M111.272393; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Rommelaere G, 2011, AM J PHYSIOL-CELL PH, V300, pC1090, DOI 10.1152/ajpcell.00037.2010; Ruivo R, 2009, BBA-MOL CELL RES, V1793, P636, DOI 10.1016/j.bbamcr.2008.12.008; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiffmann R, 1998, P NATL ACAD SCI USA, V95, P1207, DOI 10.1073/pnas.95.3.1207; SCORNIK OA, 1984, J CELL PHYSIOL, V121, P257, DOI 10.1002/jcp.1041210132; SEGLEN PO, 1981, ACTA BIOL MED GER, V40, P1587; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Siegel H, 1998, ELECTROEN CLIN NEURO, V106, P400, DOI 10.1016/S0013-4694(98)00013-3; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun LM, 2010, TOXICOL IN VITRO, V24, P1504, DOI 10.1016/j.tiv.2010.07.013; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; Weimer JM, 2002, NEUROMOL MED, V1, P111, DOI 10.1385/NMM:1:2:111; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yeung BHY, 2006, J BIOL CHEM, V281, P11923, DOI 10.1074/jbc.M508533200; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x	63	41	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8082	8091		10.1074/jbc.M111.285536	http://dx.doi.org/10.1074/jbc.M111.285536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262857	Green Published, hybrid			2022-12-27	WOS:000301349400024
J	Gray, NE; Lam, LN; Yang, KR; Zhou, AY; Koliwad, S; Wang, JC				Gray, Nora E.; Lam, Lily N.; Yang, Karen; Zhou, Anna Y.; Koliwad, Suneil; Wang, Jen-Chywan			Angiopoietin-like 4 (Angptl4) Protein Is a Physiological Mediator of Intracellular Lipolysis in Murine Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; HUMAN ADIPOSE-TISSUE; TRIGLYCERIDE-METABOLISM; GLUCOCORTICOID EXPOSURE; CUSHINGS-SYNDROME; TARGET GENE; PATHOPHYSIOLOGY; LIPOGENESIS; PERILIPIN; INSULIN	Intracellular triacylglycerol (TG) hydrolysis and fatty acid release by the white adipose tissue (WAT) during a fast is stimulated by counter-regulatory factors acting in concert, although how adipocytes integrate these lipolytic inputs is unknown. We tested the role of angiopoietin-like 4 (Angptl4), a secreted protein induced by fasting or glucocorticoid treatment, in modulating intracellular adipocyte lipolysis. Glucocorticoid receptor blockade prevented fasting-induced tissue Angptl4 expression and WAT TG hydrolysis in mice, and TG hydrolysis induced by fasts of 6 or 24 h was greatly reduced in mice lacking Angptl4 (Angptl4(-/-)). Glucocorticoid treatment mimicked the lipolytic effects of fasting, although with slower kinetics, and this too required Angptl4. Thus, fasting-induced WAT TG hydrolysis requires glucocorticoid action and Angptl4. Both fasting and glucocorticoid treatment also increased WAT cAMP levels and downstream phosphorylation of lipolytic enzymes. Angptl4 deficiency markedly reduced these effects, suggesting that Angptl4 may stimulate lipolysis by modulating cAMP-dependent signaling. In support of this, cAMP levels and TG hydrolysis were reduced in primary Angptl4(-/-) murine adipocytes treated with catecholamines, which stimulate cAMP-dependent signaling to promote lipolysis, and was restored by treatment with purified human ANGPTL4. Remarkably, human ANGPTL4 treatment alone increased cAMP levels and induced lipolysis in these cells. Pharmacologic agents revealed that Angptl4 modulation of cAMP-dependent signaling occurs upstream of adenylate cyclase and downstream of receptor activation. We show that Angptl4 is a glucocorticoid-responsive mediator of fasting induced intracellular lipolysis and stimulates cAMP signaling in adipocytes. Such a role is relevant to diseases of aberrant lipolysis, such as insulin resistance.	[Koliwad, Suneil] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gray, Nora E.; Lam, Lily N.; Yang, Karen; Zhou, Anna Y.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Koliwad, Suneil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Koliwad, S (corresponding author), Univ Calif San Francisco, Ctr Diabet, 513 Parnassus Ave, San Francisco, CA 94143 USA.	skoliwad@diabetes.ucsf.edu; walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health [DK83591]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, P30DK026743, K08DK080174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK83591.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Arnaldi G, 2010, NEUROENDOCRINOLOGY, V92, P86, DOI 10.1159/000314213; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Gravholt CH, 2002, OBES RES, V10, P774, DOI 10.1038/oby.2002.105; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Kim HK, 2010, DIABETES, V59, P2772, DOI 10.2337/db10-0145; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Pivonello R, 2010, NEUROENDOCRINOLOGY, V92, P77, DOI 10.1159/000314319; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samra JS, 1998, J CLIN ENDOCR METAB, V83, P626, DOI 10.1210/jc.83.2.626; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SEITZ HJ, 1976, METABOLISM, V25, P1545, DOI 10.1016/0026-0495(76)90107-4; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wang YX, 2004, J NUTR, V134, P1032; Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	40	76	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8444	8456		10.1074/jbc.M111.294124	http://dx.doi.org/10.1074/jbc.M111.294124			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267746	Green Published, hybrid			2022-12-27	WOS:000301349400059
J	Niehaus, TD; Kinison, S; Okada, S; Yeo, YS; Bell, SA; Cui, P; Devarenne, TP; Chappell, J				Niehaus, Tom D.; Kinison, Scott; Okada, Shigeru; Yeo, Yun-soo; Bell, Stephen A.; Cui, Ping; Devarenne, Timothy P.; Chappell, Joe			Functional Identification of Triterpene Methyltransferases from Botryococcus braunii Race B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-ALGA; O-METHYLTRANSFERASES; ARABIDOPSIS-THALIANA; HIGHER-PLANTS; VAR SHOWA; BIOSYNTHESIS; HYDROCARBONS; EVOLUTION; STRAINS; METHYLATION	Botryococcus braunii race B is a colony-forming, green algae that accumulates triterpene oils in excess of 30% of its dry weight. The composition of the triterpene oils is dominated by dimethylated to tetramethylated forms of botryococcene and squalene. Although unusual mechanisms for the biosynthesis of botryococcene and squalene were recently described, the enzyme(s) responsible for decorating these triterpene scaffolds with methyl substituents were unknown. A transcriptome of B. braunii was screened computationally assuming that the triterpene methyltransferases (TMTs) might resemble the S-adenosyl methionine-dependent enzymes described for methylating the side chain of sterols. Six sterol methyltransferase-like genes were isolated and functionally characterized. Three of these genes when co-expressed in yeast with complementary squalene synthase or botryococcene synthase expression cassettes resulted in the accumulation of mono-and dimethylated forms of both triterpene scaffolds. Surprisingly, TMT-1 and TMT-2 exhibited preference for squalene as the methyl acceptor substrate, whereas TMT-3 showed a striking preference for botryococcene as its methyl acceptor substrate. These in vivo preferences were confirmed with in vitro assays utilizing microsomal preparations from yeast overexpressing the respective genes, which encode for membrane-associated enzymes. Structural examination of the in vivo yeast generated mono-and dimethylated products by NMR identified terminal carbons, C-3 and C-22/C-20, as the atomic acceptor sites for the methyl additions to squalene and botryococcene, respectively. These sites are identical to those previously reported for the triterpenes extracted from the algae. The availability of closely related triterpene methyltransferases exhibiting distinct substrate selectivity and successive catalytic activities provides important tools for investigating the molecular mechanisms responsible for the specificities exhibited by these unique enzymes.	[Niehaus, Tom D.; Kinison, Scott; Yeo, Yun-soo; Bell, Stephen A.; Chappell, Joe] Univ Kentucky, Plant Biol Program, Lexington, KY 40546 USA; [Okada, Shigeru] Univ Tokyo, Dept Aquat Biosci, Tokyo 1138657, Japan; [Cui, Ping; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of Kentucky; University of Tokyo; Texas A&M University System; Texas A&M University College Station	Chappell, J (corresponding author), Univ Kentucky, Plant Biol Program, 1405 Vet Dr, Lexington, KY 40546 USA.	chappell@uky.edu	Okada, Shigeru/U-8305-2017	Okada, Shigeru/0000-0003-3663-7778; Devarenne, Timothy/0000-0001-6032-8049; Niehaus, Thomas/0000-0002-3575-8001	National Science Foundation [CBET-0828817]; Sapphire Energy; Japanese Society for the Promotion of Science [21380130]	National Science Foundation(National Science Foundation (NSF)); Sapphire Energy; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the National Science Foundation (CBET-0828817) and Sapphire Energy (to J. C.) and Grant-in-Aid for Scientific Research (B) (21380130) from the Japanese Society for the Promotion of Science (to S. O.).	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; BROWN AC, 1969, PHYTOCHEMISTRY, V8, P543, DOI 10.1016/S0031-9422(00)85397-2; Carland F, 2010, PLANT PHYSIOL, V153, P741, DOI 10.1104/pp.109.152587; Derenne S, 1997, GEOCHIM COSMOCHIM AC, V61, P1879, DOI 10.1016/S0016-7037(97)00042-2; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; Gang DR, 2005, ANNU REV PLANT BIOL, V56, P301, DOI 10.1146/annurev.arplant.56.032604.144128; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; GELPI E, 1968, SCIENCE, V161, P700, DOI 10.1126/science.161.3842.700; GLIKSON M, 1989, ORG GEOCHEM, V14, P595, DOI 10.1016/0146-6380(89)90039-9; Grebenok RJ, 1997, PLANT MOL BIOL, V34, P891, DOI 10.1023/A:1005818210641; Han Y, 2007, GENETICS, V176, P2625, DOI 10.1534/genetics.107.073650; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P3043, DOI 10.1016/0031-9422(89)80276-6; HUANG Z, 1989, PHYTOCHEMISTRY, V28, P1467, DOI 10.1016/S0031-9422(00)97766-5; KAGAN R, 1995, ARCH BIOCHEM BIOPHYS, V316, P657, DOI 10.1006/abbi.1995.1087; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Leustek T, 1997, J BIOL CHEM, V272, P2744, DOI 10.1074/jbc.272.5.2744; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; MALHOTRA HC, 1971, J BIOL CHEM, V246, P4934; Mastalerz M, 1996, ORG GEOCHEM, V24, P301, DOI 10.1016/0146-6380(96)00027-7; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; METZGER P, 1988, PHYTOCHEMISTRY, V27, P1383, DOI 10.1016/0031-9422(88)80199-7; Metzger P, 2002, PHYTOCHEMISTRY, V59, P839, DOI 10.1016/S0031-9422(02)00005-5; METZGER P, 1983, TETRAHEDRON LETT, V24, P4013, DOI 10.1016/S0040-4039(00)88250-7; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2995, DOI 10.1016/0031-9422(85)80043-1; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Metzger P, 1999, TETRAHEDRON, V55, P167, DOI 10.1016/S0040-4020(98)01036-9; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; Morrison R. T., 1973, ORGANIC CHEM, P109; Nes WD, 2000, BBA-MOL CELL BIOL L, V1529, P63, DOI 10.1016/S1388-1981(00)00138-4; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Noel JP, 2003, RECENT ADV PHYTOCHEM, V37, P37; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; Okada S, 1997, TETRAHEDRON, V53, P11307, DOI 10.1016/S0040-4020(97)00705-9; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rodriguez D, 2004, J BIOL CHEM, V279, P8149, DOI 10.1074/jbc.M312351200; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Song LS, 2003, ANAL BIOCHEM, V317, P180, DOI 10.1016/S0003-2697(03)00138-6; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Ueki N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-103; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Yang Y, 2006, ARCH BIOCHEM BIOPHYS, V448, P123, DOI 10.1016/j.abb.2005.08.006; Zhang W, 2007, J BIOL CHEM, V282, P25717, DOI 10.1074/jbc.M703437200; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	51	33	42	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8163	8173		10.1074/jbc.M111.316059	http://dx.doi.org/10.1074/jbc.M111.316059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22241476	Green Published, hybrid			2022-12-27	WOS:000301349400032
J	Karo, J; Peterson, P; Vendelin, M				Karo, Jaanus; Peterson, Pearu; Vendelin, Marko			Molecular Dynamics Simulations of Creatine Kinase and Adenine Nucleotide Translocase in Mitochondrial Membrane Patch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-HEART MITOCHONDRIA; COARSE-GRAINED MODEL; INNER MEMBRANE; DIFFUSION RESTRICTIONS; ADP/ATP CARRIER; ATP SYNTHESIS; FORCE-FIELD; ENERGY; CARDIOLIPIN; TRANSPORT	Interaction between mitochondrial creatine kinase (MtCK) and adenine nucleotide translocase (ANT) can play an important role in determining energy transfer pathways in the cell. Although the functional coupling between MtCK and ANT has been demonstrated, the precise mechanism of the coupling is not clear. To study the details of the coupling, we turned to molecular dynamics simulations. We introduce a new coarse-grained molecular dynamics model of a patch of the mitochondrial inner membrane containing a transmembrane ANT and an MtCK above the membrane. The membrane model consists of three major types of lipids (phosphatidylcholine, phosphatidylethanolamine, and cardiolipin) in a roughly 2: 1: 1 molar ratio. A thermodynamics-based coarse-grained force field, termed MARTINI, has been used together with the GROMACS molecular dynamics package for all simulated systems in this work. Several physical properties of the system are reproduced by the model and are in agreement with known data. This includes membrane thickness, dimension of the proteins, and diffusion constants. We have studied the binding of MtCK to the membrane and demonstrated the effect of cardiolipin on the stabilization of the binding. In addition, our simulations predict which part of the MtCK protein sequence interacts with the membrane. Taken together, the model has been verified by dynamical and structural data and can be used as the basis for further studies.	[Karo, Jaanus; Peterson, Pearu; Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-12618 Tallinn, Estonia	Tallinn University of Technology	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, Akad Tee 21, EE-12618 Tallinn, Estonia.	markov@sysbio.ioc.ee	Vendelin, Marko/AAE-7137-2020	Vendelin, Marko/0000-0002-6459-0391; Peterson, Pearu/0000-0001-7328-4305	Wellcome Trust [WT081755]; Estonian Science Foundation MOBILITAS [MJD80]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Science Foundation MOBILITAS(Estonian Research Council)	This work was supported by Wellcome Trust Fellowship WT081755 (to M. V. and P. P.) and Estonian Science Foundation MOBILITAS Postdoctoral Research Grant MJD80.	Abraham MR, 2002, J BIOL CHEM, V277, P24427, DOI 10.1074/jbc.M201777200; BARBOUR RL, 1984, J BIOL CHEM, V259, P8246; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Carbone P, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829409; Dahlberg M, 2008, J PHYS CHEM B, V112, P11655, DOI 10.1021/jp803414g; Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; GUPTE SS, 1991, BIOCHIM BIOPHYS ACTA, V1069, P131, DOI 10.1016/0005-2736(91)90114-N; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hettling H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002130; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACOBUS WE, 1973, J BIOL CHEM, V248, P4803; Jepihhina N, 2011, BIOPHYS J, V101, P2112, DOI 10.1016/j.bpj.2011.09.025; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; KREBS JJR, 1979, J BIOL CHEM, V254, P5308; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lipskaya TY, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1098, DOI 10.1023/A:1012428812780; Lopez CA, 2009, J CHEM THEORY COMPUT, V5, P3195, DOI 10.1021/ct900313w; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Milano G, 2005, J PHYS CHEM B, V109, P18609, DOI 10.1021/jp0523571; Montgomery D., 2010, APPL STAT PROBABILIT, P524; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murtola T, 2011, SOFT MATTER, V7, P8135, DOI 10.1039/c1sm05367a; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Ollila OHS, 2011, BIOPHYS J, V100, P1651, DOI 10.1016/j.bpj.2011.02.027; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; ROJO M, 1991, FEBS LETT, V281, P123, DOI 10.1016/0014-5793(91)80374-C; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Saks VA, 2004, MOL CELL BIOCHEM, V256, P185, DOI 10.1023/B:MCBI.0000009868.92189.fb; SAKS VA, 1975, EUR J BIOCHEM, V57, P273, DOI 10.1111/j.1432-1033.1975.tb02299.x; Saks VA, 2000, ACTA PHYSIOL SCAND, V168, P635, DOI 10.1046/j.1365-201x.2000.00715.x; SAKS VA, 1986, BIOCHEM BIOPH RES CO, V139, P1262, DOI 10.1016/S0006-291X(86)80314-X; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schlattner U, 2004, J BIOL CHEM, V279, P24334, DOI 10.1074/jbc.M314158200; Schlattner U, 2009, BBA-BIOMEMBRANES, V1788, P2032, DOI 10.1016/j.bbamem.2009.04.018; Sepp M, 2010, BIOPHYS J, V98, P2785, DOI 10.1016/j.bpj.2010.03.025; Sokolova N, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-90; Song B, 2011, MOL PHYS, V109, P1511, DOI 10.1080/00268976.2011.569511; Sun Q, 2005, COMPUT CHEM ENG, V29, P2380, DOI 10.1016/j.compchemeng.2005.05.026; Vendelin M, 2004, BIOPHYS J, V87, P696, DOI 10.1529/biophysj.103.036210; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; Vendelin M, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.N110.147116; Vendelin M, 2010, J BIOL CHEM, V285, P37240, DOI 10.1074/jbc.M110.147116; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; Voth Gregory A., 2009, P1; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wee CL, 2010, BIOPHYS J, V98, P1558, DOI 10.1016/j.bpj.2009.12.4321; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; Wohlert J, 2011, J CHEM THEORY COMPUT, V7, P753, DOI 10.1021/ct100489z; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; WYSS M, 1992, BIOCHIM BIOPHYS ACTA, V1102, P119, DOI 10.1016/0167-4838(92)90506-9; Yefimov S, 2008, BIOPHYS J, V94, P2994, DOI 10.1529/biophysj.107.119966; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	71	16	16	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7467	7476		10.1074/jbc.M111.332320	http://dx.doi.org/10.1074/jbc.M111.332320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241474	hybrid, Green Published			2022-12-27	WOS:000301060200047
J	Lai, CB; Mager, DL				Lai, C. Benjamin; Mager, Dixie L.			Role of Runt-related Transcription Factor 3 (RUNX3) in Transcription Regulation of Natural Cytotoxicity Receptor 1 (NCR1/NKp46), an Activating Natural Killer (NK) Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LINEAGE CHOICE; GENE; MOUSE; EXPRESSION; NKP46; DIFFERENTIATION; PROTEINS; CD8; FAMILY	Natural cytotoxicity receptor 1 (NCR1), also known as NKp46, is a natural killer (NK) lymphocyte-activating receptor. It is involved in major aspects of NK immune function and shows a high degree of lineage specificity in blood and bone marrow. The nature of its NK-restricted expression is not well understood. In this study, we confirm that human NCR1 NK-specific expression is achieved at the mRNA level. We found two key cis-regulatory elements in the immediate vicinity upstream of the gene. One element acts as an essential promoter, whereas the other acts as a tissue-dependent enhancer/repressor. This latter regulatory element contains a runt related-transcription factor (RUNX) recognition motif that preferentially binds RUNX3. Interfering with RUNX proteins using a dominant negative form results in decreased Ncr1 expression. RUNX3 over-expression had the opposite effect. These findings shed light on the role of RUNX3 in the control of an important NK-activating receptor.	[Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Lai, Chieh Min Benjamin/0000-0002-4130-9413	Canadian Institutes of Health Research; British Columbia Cancer Agency	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Agency	This work was supported by a grant from the Canadian Institutes of Health Research with core support provided by the British Columbia Cancer Agency.	Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Elboim M, 2010, J IMMUNOL, V184, P5637, DOI 10.4049/jimmunol.0901644; Fu YX, 2011, J BIOL CHEM, V286, P11803, DOI 10.1074/jbc.M111.222331; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GONG JH, 1994, LEUKEMIA, V8, P652; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Guo Y, 2008, BLOOD, V112, P480, DOI 10.1182/blood-2007-10-120261; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Hayashi K, 2000, J IMMUNOL, V165, P6816, DOI 10.4049/jimmunol.165.12.6816; Hesslein DGT, 2011, ADV IMMUNOL, V109, P45, DOI 10.1016/B978-0-12-387664-5.00002-9; Jozaki K, 2010, ANIM BIOTECHNOL, V21, P156, DOI 10.1080/10495391003617663; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Lai CB, 2009, NUCLEIC ACIDS RES, V37, P3032, DOI 10.1093/nar/gkp174; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2009, BLOOD CELL MOL DIS, V43, P1, DOI 10.1016/j.bcmd.2009.01.009; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ohno SI, 2008, INT IMMUNOL, V20, P71, DOI 10.1093/intimm/dxm120; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Storset AK, 2004, EUR J IMMUNOL, V34, P669, DOI 10.1002/eji.200324504; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Vilches C, 2000, J IMMUNOL, V165, P6416, DOI 10.4049/jimmunol.165.11.6416; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Williams NS, 1998, IMMUNOL REV, V165, P47, DOI 10.1111/j.1600-065X.1998.tb01229.x; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004	53	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7324	7334		10.1074/jbc.M111.306936	http://dx.doi.org/10.1074/jbc.M111.306936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253448	Green Published, hybrid			2022-12-27	WOS:000301060200034
J	Lee, SK; Potempa, M; Kolli, M; Ozen, A; Schiffer, CA; Swanstrom, R				Lee, Sook-Kyung; Potempa, Marc; Kolli, Madhavi; Ozen, Aysegul; Schiffer, Celia A.; Swanstrom, Ronald			Context Surrounding Processing Sites Is Crucial in Determining Cleavage Rate of a Subset of Processing Sites in HIV-1 Gag and Gag-Pro-Pol Polyprotein Precursors by Viral Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P1 AMINO-ACID; TYPE-1 PROTEASE; IN-VITRO; P2 DOMAIN; SYNTHETIC PEPTIDES; HELICAL STRUCTURE; SPACER PEPTIDE; RNA; INHIBITORS	Processing of the human immunodeficiency virus type 1 (HIV-1) Gag and Gag-Pro-Pol polyproteins by the HIV-1 protease (PR) is essential for the production of infectious particles. However, the determinants governing the rates of processing of these substrates are not clearly understood. We studied the effect of substrate context on processing by utilizing a novel protease assay in which a substrate containing HIV-1 matrix (MA) and the N-terminal domain of capsid (CA) is labeled with a FlAsH (fluorescein arsenical hairpin) reagent. When the seven cleavage sites within the Gag and Gag-Pro-Pol polyproteins were placed at the MA/CA site, the rates of cleavage changed dramatically compared with that of the cognate sites in the natural context reported previously. The rate of processing was affected the most for three sites: CA/spacer peptide 1 (SP1) (approximate to 10-fold increase), SP1/nucleocapsid (NC) (approximate to 10-30-fold decrease), and SP2/p6 (approximate to 30-fold decrease). One of two multi-drug- resistant (MDR) PR variants altered the pattern of processing rates significantly. Cleavage sites within the Pro-Pol region were cleaved in a context-independent manner, suggesting for these sites that the sequence itself was the determinant of rate. In addition, a chimera consisting of SP1/NC P4-P1 and MA/CA P1'-P4' residues (ATIM down arrow PIVQ) abolished processing by wild type and MDR proteases, and the reciprocal chimera consisting of MA/CA P4-P1 and SP1/NC P1'-4' (SQNY down arrow IQKG) was cleaved only by one of the MDR proteases. These results suggest that complex substrate interactions both beyond the active site of the enzyme and across the scissile bond contribute to defining the rate of processing by the HIV-1 PR.	[Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Potempa, Marc; Swanstrom, Ronald] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Kolli, Madhavi; Ozen, Aysegul; Schiffer, Celia A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Worcester	Swanstrom, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB7295 Lineberger Bldg,Rm 22-006, Chapel Hill, NC 27599 USA.	risunc@med.unc.edu		Ozen, Aysegul/0000-0002-6240-1948	National Institutes of Health [P01-GM066524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064347, P01GM066524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-GM066524.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; BILLICH S, 1988, J BIOL CHEM, V263, P17905; Blommel PG, 2005, ANAL BIOCHEM, V336, P75, DOI 10.1016/j.ab.2004.09.023; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; CRAVEN RC, 1993, J VIROL, V67, P6246, DOI 10.1128/JVI.67.10.6246-6252.1993; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; Dauber DS, 2002, J VIROL, V76, P1359, DOI 10.1128/JVI.76.3.1359-1368.2002; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; Ermolieff J, 1997, BIOCHEMISTRY-US, V36, P12364, DOI 10.1021/bi971072e; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; Jolley M. E., 1996, J BIOMOL SCREEN, V1, P33; Kaye JF, 1998, J VIROL, V72, P5877, DOI 10.1128/JVI.72.7.5877-5885.1998; King NM, 2002, PROTEIN SCI, V11, P418, DOI 10.1110/ps.25502; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SK, 2001, VIROLOGY, V286, P317, DOI 10.1006/viro.2001.0979; Liu ZG, 2011, PROTEIN J, V30, P173, DOI 10.1007/s10930-011-9316-2; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; Newman JL, 2004, PROTEIN SCI, V13, P2101, DOI 10.1110/ps.04614804; Ozen A, 2011, J MOL BIOL, V410, P726, DOI 10.1016/j.jmb.2011.03.053; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; RICHARDS AD, 1989, FEBS LETT, V247, P113, DOI 10.1016/0014-5793(89)81251-7; Roldan A, 2004, J BIOL CHEM, V279, P39886, DOI 10.1074/jbc.M405632200; Schock HB, 1996, J BIOL CHEM, V271, P31957, DOI 10.1074/jbc.271.50.31957; Sheng NJ, 1997, J VIROL, V71, P5723, DOI 10.1128/JVI.71.8.5723-5732.1997; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Swanstrom R., 1997, P263; TOMASSELLI AG, 1990, BIOCHEMISTRY-US, V29, P264, DOI 10.1021/bi00453a036; TOMASZEK TA, 1992, BIOCHEMISTRY-US, V31, P10153, DOI 10.1021/bi00157a003; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; TRITCH RJ, 1991, J VIROL, V65, P922, DOI 10.1128/JVI.65.2.922-930.1991; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998	46	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13279	13290		10.1074/jbc.M112.339374	http://dx.doi.org/10.1074/jbc.M112.339374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334652	hybrid, Green Published			2022-12-27	WOS:000302903700064
J	Saucedo, AL; Flores-Solis, D; de la Vega, RCR; Ramirez-Cordero, B; Hernandez-Lopez, R; Cano-Sanchez, P; Navarro, RN; Garcia-Valdes, J; Coronas-Valderrama, F; de Roodt, A; Brieba, LG; Possani, LD; del Rio-Portilla, F				Saucedo, Alma Leticia; Flores-Solis, David; de la Vega, Ricardo C. Rodriguez; Ramirez-Cordero, Belen; Hernandez-Lopez, Rogelio; Cano-Sanchez, Patricia; Noriega Navarro, Roxana; Garcia-Valdes, Jesus; Coronas-Valderrama, Fredy; de Roodt, Adolfo; Brieba, Luis G.; Domingos Possani, Lourival; del Rio-Portilla, Federico			New Tricks of an Old Pattern STRUCTURAL VERSATILITY OF SCORPION TOXINS WITH COMMON CYSTEINE SPACING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANIMAL TOXINS; NMR STRUCTURE; POTASSIUM; PEPTIDES; VENOM; KTX; CHANNELS; NOMENCLATURE; SIMULATION; ASSIGNMENT	Scorpion venoms are a rich source of K+ channel-blocking peptides. For the most part, they are structurally related small disulfide-rich proteins containing a conserved pattern of six cysteines that is assumed to dictate their common three-dimensional folding. In the conventional pattern, two disulfide bridges connect an alpha-helical segment to the C-terminal strand of a double- or triple-stranded beta-sheet, conforming a cystine-stabilized alpha/beta scaffold (CS alpha/beta). Here we show that two K+ channel-blocking peptides from Tityus scorpions conserve the cysteine spacing of common scorpion venom peptides but display an unconventional disulfide pattern, accompanied by a complete rearrangement of the secondary structure topology into a CS helix-loop-helix fold. Sequence and structural comparisons of the peptides adopting this novel fold suggest that it would be a new elaboration of the widespread CS alpha/beta scaffold, thus revealing an unexpected structural versatility of these small disulfide-rich proteins. Acknowledgment of such versatility is important to understand how venom structural complexity emerged on a limited number of molecular scaffolds.	[del Rio-Portilla, Federico] Univ Nacl Autonoma Mexico, Dept Quim Macromol, Inst Quim, Mexico City 04510, DF, Mexico; [de la Vega, Ricardo C. Rodriguez; del Rio-Portilla, Federico] Museum Natl Hist Nat, UMR 7138, Dept Syst & Evolut, F-75005 Paris, France; [Hernandez-Lopez, Rogelio] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Noriega Navarro, Roxana; Garcia-Valdes, Jesus] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico; [Coronas-Valderrama, Fredy; Domingos Possani, Lourival] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62191, Morelos, Mexico; [de Roodt, Adolfo] Univ Buenos Aires, Ctr Patol Expt & Aplicada, Fac Med, RA-1281 Buenos Aires, DF, Argentina; [de Roodt, Adolfo] CABA, Adm Nacl Labs, Minist Salud, RA-1281 Buenos Aires, DF, Argentina; [de Roodt, Adolfo] CABA, Inst Salud Dr Carlos G Malbran, Minist Salud, RA-1281 Buenos Aires, DF, Argentina; [Brieba, Luis G.] CINVESTAV Unidad Irapuato, Lab Genom Biodiversidad, Guanajuato 36821, Mexico	Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Buenos Aires; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	del Rio-Portilla, F (corresponding author), Univ Nacl Autonoma Mexico, Dept Quim Macromol, Inst Quim, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	jfrp@unam.mx	Brieba, Luis/I-8447-2016; Cano-Sanchez, Patricia/B-5329-2015; Rodríguez de la Vega, Ricardo/A-4542-2008; Ramirez-Cordero, Belen/O-4297-2019; Ramirez-Cordero, Belen/E-5877-2015; AL, Saucedo/AAA-7910-2020; del Rio Portilla, Federico/B-4351-2015; Flores-Solis, David/F-4949-2015; Possani, Lourival D/J-2397-2013; Saucedo Yáñez, Alma Leticia/D-3400-2018	Brieba, Luis/0000-0002-6073-5207; Rodríguez de la Vega, Ricardo/0000-0002-9852-6654; Ramirez-Cordero, Belen/0000-0003-0037-4777; Ramirez-Cordero, Belen/0000-0003-0037-4777; AL, Saucedo/0000-0002-1028-9122; del Rio Portilla, Federico/0000-0001-8672-0567; Flores-Solis, David/0000-0001-5207-0594; Saucedo Yáñez, Alma Leticia/0000-0002-1028-9122; de Roodt, Adolfo/0000-0003-2607-8060; Cano-Sanchez, Patricia/0000-0003-0242-6542	Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IN205110, IN204110]; Consejo Nacional de Ciencia y Tecnologia [59297]; Marie de Paris; Fundacion Mexico en Harvard	Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Marie de Paris; Fundacion Mexico en Harvard	This work was supported in part by Direccion General de Servicios de Computo Academico y Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico Projects IN205110 (to F. R. P.) and IN204110 (to L. D. P.) and Consejo Nacional de Ciencia y Tecnologia Project 59297 (to F. R. P.).; Invited researcher at the Museum National d'Histoire Naturelle sponsored by the Marie de Paris.; Supported by the Fundacion Mexico en Harvard.	Abdel-Mottaleb Y, 2006, FEBS LETT, V580, P592, DOI 10.1016/j.febslet.2005.12.073; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bordon K. C. F., 2011, 17 C EUR SECT INT SO; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Camargos TS, 2011, PEPTIDES, V32, P1509, DOI 10.1016/j.peptides.2011.05.017; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Coronas FV, 2003, TOXICON, V41, P173, DOI 10.1016/S0041-0101(02)00247-7; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de Roodt AR, 2010, TOXICON, V55, P307, DOI 10.1016/j.toxicon.2009.08.014; de Roodt AR, 2001, J NAT TOXINS, V10, P99; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Fadel V, 2005, TOXICON, V46, P759, DOI 10.1016/j.toxicon.2005.07.018; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Nirthanan S, 2005, BIOCHEM PHARMACOL, V69, P669, DOI 10.1016/j.bcp.2004.10.018; Norton RS, 2008, CURR PHARM DESIGN, V14, P2480, DOI 10.2174/138161208785777478; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Regaya I, 2004, J BIOL CHEM, V279, P55690, DOI 10.1074/jbc.M410055200; Rodriguez de la Vega R. C., 2009, ANIMAL TOXINS STATE, P193; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K., 1986, NMROF PROTEINS NUCL; Xia B, 2002, J BIOMOL NMR, V22, P317, DOI 10.1023/A:1014929925008	46	40	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12321	12330		10.1074/jbc.M111.329607	http://dx.doi.org/10.1074/jbc.M111.329607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22238341	Green Published, hybrid			2022-12-27	WOS:000302782200071
J	Forsberg, M; Holmborn, K; Kundu, S; Dagalv, A; Kjellen, L; Forsberg-Nilsson, K				Forsberg, Maud; Holmborn, Katarina; Kundu, Soumi; Dagalv, Anders; Kjellen, Lena; Forsberg-Nilsson, Karin			Undersulfation of Heparan Sulfate Restricts Differentiation Potential of Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL INDUCTION; MICE DEFICIENT; TRANSCRIPTIONAL REGULATION; MOLECULAR DIVERSITY; CELLULAR UPTAKE; GENE-FUNCTION; SELF-RENEWAL; MAST-CELLS; IN-VITRO; FGF	Heparan sulfate proteoglycans, present on cell surfaces and in the extracellular matrix, interact with growth factors and morphogens to influence growth and differentiation of cells. The sulfation pattern of the heparan sulfate chains formed during biosynthesis in the Golgi compartment will determine the interaction potential of the proteoglycan. The glucosaminyl N-deacetylase/N-sulfotransferase (NDST) enzymes have a key role during biosynthesis, greatly influencing total sulfation of the heparan sulfate chains. The differentiation potential of mouse embryonic stem cells lacking both NDST1 and NDST2 was studied using in vitro differentiation protocols, expression of differentiation markers, and assessment of the ability of the cells to respond to growth factors. The results show that NDST1 and NDST2 are dispensable for mesodermal differentiation into osteoblasts but necessary for induction of adipocytes and neural cells. Gene expression analysis suggested a differentiation block at the primitive ectoderm stage. Also, GATA4, a primitive endoderm marker, was expressed by these cells. The addition of FGF4 or FGF2 together with heparin rescued the differentiation potential to neural progenitors and further to mature neurons and glia. Our results suggest that the embryonic stem cells lacking both NDST1 and NDST2, expressing a very low sulfated heparan sulfate, can take the initial step toward differentiation into all three germ layers. Except for their potential for mesodermal differentiation into osteoblasts, the cells are then arrested in a primitive ectoderm and/or endoderm stage.	[Kundu, Soumi; Forsberg-Nilsson, Karin] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Forsberg, Maud] Uppsala Univ, Biomed Ctr, Uppsala Univ Transgen Facil, S-75123 Uppsala, Sweden; [Forsberg, Maud; Holmborn, Katarina; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, S-75123 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Forsberg-Nilsson, K (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden.	karin.nilsson@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245	Swedish Research Council (Medicine); Swedish Board for Agriculture; Swedish Childhood Cancer Foundation; Swedish Cancer Foundation; Polysackaridforskning AB	Swedish Research Council (Medicine)(Swedish Research Council); Swedish Board for Agriculture; Swedish Childhood Cancer Foundation(European Commission); Swedish Cancer Foundation; Polysackaridforskning AB	This work was supported by grants from the Swedish Research Council (Medicine) (to L. K. and K. F.-N.), the Swedish Board for Agriculture (K. F.-N. and M. F.), the Swedish Childhood Cancer Foundation (to K. F.-N.), the Swedish Cancer Foundation (to K. F.-N. and L. K.), and Polysackaridforskning AB (to L. K.).	Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Bae KH, 2008, BIOMATERIALS, V29, P3376, DOI 10.1016/j.biomaterials.2008.04.035; Berry D, 2004, CHEM BIOL, V11, P487, DOI 10.1016/j.chembiol.2004.03.023; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; BronnerFraser M, 1997, CURR OPIN CELL BIOL, V9, P885, DOI 10.1016/S0955-0674(97)80092-0; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; GAO GX, 1995, EMBO J, V14, P2183, DOI 10.1002/j.1460-2075.1995.tb07212.x; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; HAUB O, 1991, DEVELOPMENT, V112, P397; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jasuja R, 2004, J BIOL CHEM, V279, P51289, DOI 10.1074/jbc.M408129200; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Jordan PM, 2008, J NEUROSCI RES, V86, P35, DOI 10.1002/jnr.21460; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; LINDAHL U, 1965, J BIOL CHEM, V240, P2817; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; MA YG, 1992, DEV BIOL, V154, P45, DOI 10.1016/0012-1606(92)90046-J; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Moreau M, 2004, INT J DEV BIOL, V48, P75, DOI 10.1387/ijdb.15272372; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Phillips BW, 2001, BIOCHEM BIOPH RES CO, V284, P478, DOI 10.1006/bbrc.2001.4987; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Taha MF, 2006, ANAT HISTOL EMBRYOL, V35, P271, DOI 10.1111/j.1439-0264.2006.00680.x; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	58	49	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10853	10862		10.1074/jbc.M111.337030	http://dx.doi.org/10.1074/jbc.M111.337030			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298785	hybrid, Green Published			2022-12-27	WOS:000302780100014
J	Lagarde, WH; Blackwelder, AJ; Minges, JT; Hnat, AT; French, FS; Wilson, EM				Lagarde, William H.; Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.			Androgen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING-DOMAIN; PROTEIN-PROTEIN INTERACTIONS; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; GENE; IDENTIFICATION; INTERDOMAIN; MAGE-11; GROWTH; DEFICIENCY	Naturally occurring germ line mutations in the X-linked human androgen receptor (AR) gene cause incomplete masculinization of the external genitalia by disrupting AR function in males with androgen insensitivity syndrome. Almost all AR missense mutations that cause androgen insensitivity syndrome are located in the highly structured DNA and ligand binding domains. In this report we investigate the functional defect associated with an AR exon 1 missense mutation, R405S, that caused partial androgen insensitivity. The 46,XX heterozygous maternal carrier had a wild-type Arg-405 CGC allele but transmitted an AGC mutant allele coding for Ser-405. At birth, the 46,XY proband had a bifid scrotum, hypospadias, and micropenis consistent with clinical stage 3 partial androgen insensitivity. Androgen-dependent transcriptional activity of AR-R405S expressed in CV1 cells was less than wild-type AR and refractory in androgen-dependent AR NH2- and carboxyl interaction transcription assays that depend on the coregulator effects of melanoma antigen-A11. This mutation created a Ser-405 phosphorylation site evident by the gel migration of an AR-R405S NH2-terminal fragment as a double band that converted to the wild-type single band after treatment with lambda-phosphatase. Detrimental effects of the R405S mutation were related to the proximity of the AR WXXLF motif (WHTLF437)-W-433 required for melanoma antigen-A11 and p300 to stimulate transcriptional activity associated with the AR NH2- and carboxyl-terminal interaction. We conclude that the coregulator effects of melanoma antigen-A11 on the AR NH2- and carboxyl-terminal interaction amplify the androgen-dependent transcriptional response to p300 required for normal human male sex development in utero.	[Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Lagarde, William H.; Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lagarde, William H.] WakeMed Hlth & Hosp, Childrens Diabet & Endocrinol, Raleigh, NC 27610 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; United States Public Health Service from NICHD, National Institutes of Health; Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers [U54-HD35041]; National Cancer Institute Center [P01-CA77739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service from NICHD, National Institutes of Health; Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers; National Cancer Institute Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grant HD16910, by a United States Public Health Service grant from NICHD, National Institutes of Health, and by Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by National Cancer Institute Center Grant P01-CA77739.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bhangoo A, 2010, ASIAN J ANDROL, V12, P561, DOI 10.1038/aja.2010.6; BROWN CJ, 1989, AM J HUM GENET, V44, P264; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheon CK, 2011, EUR J PEDIATR, V170, P1, DOI 10.1007/s00431-010-1189-4; Choong CS, 1996, J CLIN INVEST, V98, P1423, DOI 10.1172/JCI118930; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; Deeb A, 2008, J CLIN ENDOCR METAB, V93, P3691, DOI 10.1210/jc.2008-0737; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; FINKEL T, 1993, J BIOL CHEM, V268, P5; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Goglia U, 2011, FERTIL STERIL, V96, P1165, DOI 10.1016/j.fertnstert.2011.08.033; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gottlieb B., 2011, GENEREVIEWS; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Prince FP, 2001, J ENDOCRINOL, V168, P213, DOI 10.1677/joe.0.1680213; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; REYES FI, 1974, J CLIN ENDOCR METAB, V38, P612, DOI 10.1210/jcem-38-4-612; Robins DM, 2012, MOL CELL ENDOCRINOL, V352, P26, DOI 10.1016/j.mce.2011.06.003; Sarkar P, 2007, CLIN ENDOCRINOL, V67, P743, DOI 10.1111/j.1365-2265.2007.02955.x; Schmidt A, 2010, J BIOL CHEM, V285, P17054, DOI 10.1074/jbc.M109.099002; Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wilson EM, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P241, DOI 10.1007/978-0-387-69179-4_11; WILSON EM, 1976, J BIOL CHEM, V251, P5620; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	71	18	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10905	10915		10.1074/jbc.M111.336081	http://dx.doi.org/10.1074/jbc.M111.336081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334658	Green Published, hybrid			2022-12-27	WOS:000302780100019
J	Paar, M; Jungst, C; Steiner, NA; Magnes, C; Sinner, F; Kolb, D; Lass, A; Zimmermann, R; Zumbusch, A; Kohlwein, SD; Wolinski, H				Paar, Margret; Juengst, Christian; Steiner, Noemi A.; Magnes, Christoph; Sinner, Frank; Kolb, Dagmar; Lass, Achim; Zimmermann, Robert; Zumbusch, Andreas; Kohlwein, Sepp D.; Wolinski, Heimo			Remodeling of Lipid Droplets during Lipolysis and Growth in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ACYL-COA SYNTHETASE; ADIPOSE TRIGLYCERIDE LIPASE; LOW-DENSITY LIPOPROTEIN; PERILIPIN-A; TRIACYLGLYCEROL; PROTEINS; PROMOTES; PHOSPHORYLATION; TRANSLOCATION	Background: Micro-lipid droplets (mLDs) appear in adipocytes upon lipolytic stimulation. LDs may grow by spontaneous, homotypic fusion. Results: Scavenging of fatty acids prevents mLD formation. LDs grow by a slow transfer of lipids between LDs. Conclusion: mLDs form due to fatty acid overflow. LD growth is a controlled process. Significance: Novel mechanistic insights into LD remodeling are provided.	[Paar, Margret; Steiner, Noemi A.; Lass, Achim; Zimmermann, Robert; Kohlwein, Sepp D.; Wolinski, Heimo] Graz Univ, Inst Mol Biosci, Lipid Res Ctr LRC Graz, A-8010 Graz, Austria; [Juengst, Christian; Zumbusch, Andreas] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Magnes, Christoph; Sinner, Frank] Joanneum Res, Inst Biomed & Hlth Sci, HEALTH, A-8036 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, ZMF, Med Res Ctr, A-8010 Graz, Austria	University of Graz; University of Konstanz; Medical University of Graz; Medical University of Graz	Wolinski, H (corresponding author), Graz Univ, Inst Mol Biosci, Lipid Res Ctr LRC Graz, Humboldtstr 50-2, A-8010 Graz, Austria.	heimo.wolinski@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Magnes, Christoph/0000-0002-5153-7444; Wolinski, Heimo/0000-0002-1583-6092; Zimmermann, Robert/0000-0002-7354-870X; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Jungst, Christian/0000-0002-6586-7129; Paar, Margret/0000-0001-5494-8890	Austrian Science Funds, FWF [LIPOTOX F3005-B12]; Ph.D. Program Molecular Enzymology [W901-B05]; Austrian Federal Government for Science and Research; Baden-Wurttemberg Stiftung; Konstanz Research School Chemical Biology; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); Ph.D. Program Molecular Enzymology; Austrian Federal Government for Science and Research; Baden-Wurttemberg Stiftung; Konstanz Research School Chemical Biology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by grants from the Austrian Science Funds, FWF, Project LIPOTOX F3005-B12 (to S. D. K.) and Ph.D. Program Molecular Enzymology, Project W901-B05, and the Austrian Federal Government for Science and Research (Project GOLD, in the framework of the Austrian Genome Program GEN-AU) (to S. D. K. and H. W.).; Supported by contract research "Methoden fur die Lebenswissenschaften" of the Baden-Wurttemberg Stiftung and a personal scholarship from the Konstanz Research School Chemical Biology.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Cogswell Carol J., 1995, P507; EDENS NK, 1990, J LIPID RES, V31, P1423; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBBONS GF, 1995, ADV ENZYME REGUL, V35, P179, DOI 10.1016/0065-2571(94)00006-O; Girish V, 2004, Indian J Cancer, V41, P47; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2004, AM J PHYSIOL-ENDOC M, V287, pE574, DOI 10.1152/ajpendo.00567.2003; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jungst C, 2011, J BIOPHOTONICS, V4, P435, DOI 10.1002/jbio.201000120; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Murphy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015030; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nagayama M, 2010, FEBS LETT, V584, P86, DOI 10.1016/j.febslet.2009.10.088; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pulido MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022931; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wang HJ, 2010, MOL BIOL CELL, V21, P1991, DOI 10.1091/mbc.E09-05-0364; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	60	116	121	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11164	11173		10.1074/jbc.M111.316794	http://dx.doi.org/10.1074/jbc.M111.316794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311986	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000302780100044
J	Reipschlager, S; Kubatzky, K; Taromi, S; Burger, M; Orth, J; Aktories, K; Schmidt, G				Reipschlaeger, Simone; Kubatzky, Katharina; Taromi, Sanaz; Burger, Meike; Orth, Joachim; Aktories, Klaus; Schmidt, Gudula			Toxin-induced RhoA Activity Mediates CCL1-triggered Signal Transducers and Activators of Transcription Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOTOXIC NECROTIZING FACTOR; PASTEURELLA-MULTOCIDA TOXIN; N-TERMINAL KINASE; ESCHERICHIA-COLI; YERSINIA-PSEUDOTUBERCULOSIS; STAT3 ACTIVATION; TARGETING STAT3; GENE-EXPRESSION; C-JUN; RECEPTOR	Background: Rho GTPases are involved in STAT-dependent transcription. However, the connecting signaling pathways are unknown. Results: Activated RhoA induces STAT3 phosphorylation via ROCK, JNK, CCL1 synthesis, and secretion. Conclusion: Auto/paracrine cytokine signaling is a link between RhoA and STAT3. Significance: The knowledge about the connection between RhoA and STAT signaling is crucial for understanding several diseases, especially cancer.	[Reipschlaeger, Simone; Orth, Joachim; Aktories, Klaus; Schmidt, Gudula] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany; [Kubatzky, Katharina] Dept Infectiol Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Taromi, Sanaz; Burger, Meike] Univ Med Ctr, Dept Haematol & Oncol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Schmidt, G (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	Gudula.Schmidt@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022; Maximilian, Burger/E-4077-2012	Aktories, Klaus/0000-0002-5397-0436; Kubatzky, Katharina F./0000-0003-3739-9329	Deutsche Forschungsgemeinschaft [Schm 1385/5-1, SFB850]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Schm 1385/5-1 and SFB850.	Banes-Berceli AK, 2006, AM J PHYSIOL-RENAL, V291, pF116, DOI 10.1152/ajprenal.00502.2005; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Choi YB, 2008, J VIROL, V82, P6501, DOI 10.1128/JVI.02396-07; Dalpke AH, 2003, EUR J IMMUNOL, V33, P1776, DOI 10.1002/eji.200323621; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Rycke J, 1999, VET RES, V30, P221; DERYCKE J, 1990, J CLIN MICROBIOL, V28, P694, DOI 10.1128/JCM.28.4.694-699.1990; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Emdad L, 2009, CANCER BIOL THER, V8, P402, DOI 10.4161/cbt.8.5.7581; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Fujimoto Y, 2011, J HEPATOL, V54, P629, DOI 10.1016/j.jhep.2010.07.021; Gundogdu MS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-225; Haque NS, 2004, BLOOD, V103, P1296, DOI 10.1182/blood-2002-05-1480; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Homey Bernhard, 2007, Chem Immunol Allergy, V93, P181, DOI 10.1159/000100895; Koch G, 1997, J PHARMACOL EXP THER, V283, P901; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Kreiselmeier NE, 2003, AM J PHYSIOL-LUNG C, V285, pL1286, DOI 10.1152/ajplung.00127.2003; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Ongusaha PP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161938; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Orth JHC, 2007, J BIOL CHEM, V282, P3050, DOI 10.1074/jbc.M609018200; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Raptis L, 2011, EXP CELL RES, V317, P1787, DOI 10.1016/j.yexcr.2011.05.008; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stoll T, 2009, TOXICON, V54, P745, DOI 10.1016/j.toxicon.2009.05.038; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 	41	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11183	11194		10.1074/jbc.M111.313395	http://dx.doi.org/10.1074/jbc.M111.313395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311973	hybrid, Green Published			2022-12-27	WOS:000302780100046
J	Rothbard, JB; Kurnellas, MP; Brownell, S; Adams, CM; Su, L; Axtell, RC; Chen, R; Fathman, CG; Robinson, WH; Steinman, L				Rothbard, Jonathan B.; Kurnellas, Michael P.; Brownell, Sara; Adams, Chris M.; Su, Leon; Axtell, Robert C.; Chen, Rong; Fathman, C. Garrison; Robinson, William H.; Steinman, Lawrence			Therapeutic Effects of Systemic Administration of Chaperone alpha B-Crystallin Associated with Binding Proinflammatory Plasma Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; INDUCED APOPTOSIS; CELLS; TRANSLOCATION; ACTIVATION; SEQUESTER; CASPASE-3; PROTEOME	The therapeutic benefit of the small heat shock protein alpha B-crystallin (HspB5) in animal models of multiple sclerosis and ischemia is proposed to arise from its increased capacity to bind proinflammatory proteins at the elevated temperatures within inflammatory foci. By mass spectral analysis, a common set of similar to 70 ligands was precipitated by HspB5 from plasma from patients with multiple sclerosis, rheumatoid arthritis, and amyloidosis and mice with experimental allergic encephalomyelitis. These proteins were distinguished from other precipitated molecules because they were enriched in the precipitate as compared with their plasma concentrations, and they exhibited temperature-dependent binding. More than half of these ligands were acute phase proteins or members of the complement or coagulation cascades. Consistent with this proposal, plasma levels of HspB5 were increased in patients with multiple sclerosis as compared with normal individuals. The combination of the thermal sensitivity of the HspB5 combined with the high local concentration of these ligands at the site of inflammation is proposed to explain the paradox of how a protein believed to exhibit nonspecific binding can bind with some relative apparent selectivity to proinflammatory proteins and thereby modulate inflammation.	[Kurnellas, Michael P.; Brownell, Sara; Axtell, Robert C.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Rothbard, Jonathan B.; Su, Leon; Fathman, C. Garrison; Robinson, William H.] Stanford Univ, Div Rheumatol & Immunol, Sch Med, Dept Med, Stanford, CA 94305 USA; [Adams, Chris M.] Stanford Univ, Stanford Univ Mass Spectrometry, Sch Med, Stanford, CA 94305 USA; [Chen, Rong] Stanford Univ, Sch Med, Div Syst Med, Dept Pediat, Stanford, CA 94305 USA; [Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Beckman B002,279 Campus Dr, Stanford, CA 94305 USA.	Steinman@stanford.edu	Axtell, Robert/AAJ-5053-2021	Robinson, William/0000-0003-4385-704X; Steinman, Lawrence/0000-0002-2437-2250	National Institutes of Health [R01NS55997, UO1 DK078123]; National Multiple Sclerosis Society; Endriz Fund; National Center For Research Resources, National Institutes of Health [S10RR027425]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Endriz Fund; National Center For Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS55997 (to L. S. and W. H. R.) and UO1 DK078123 (to C. G. F. and J.B.R.). This work was also supported by the National Multiple Sclerosis Society (to J.B.R., M. P. K., and L. S.), and the Endriz Fund (to L.S.).; The mass spectrometry was funded by Award Number S10RR027425 from the National Center For Research Resources, National Institutes of Health.	Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cazalla D, 2005, PROTEIN EXPRES PURIF, V42, P54, DOI 10.1016/j.pep.2005.03.035; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	33	65	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9708	9721		10.1074/jbc.M111.337691	http://dx.doi.org/10.1074/jbc.M111.337691			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308023	hybrid, Green Published			2022-12-27	WOS:000302167200005
J	Apostolatos, A; Song, SJ; Acosta, S; Peart, M; Watson, JE; Bickford, P; Cooper, DR; Patel, NA				Apostolatos, Andre; Song, Shijie; Acosta, Sandra; Peart, Mishka; Watson, James E.; Bickford, Paula; Cooper, Denise R.; Patel, Niketa A.			Insulin Promotes Neuronal Survival via the Alternatively Spliced Protein Kinase C delta II Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; PKC-DELTA; BCL-X; INDUCED APOPTOSIS; IMPROVES MEMORY; NT2 CELLS; DEATH; PHOSPHORYLATION; HUMANS; BETA	Insulin signaling pathways in the brain regulate food uptake and memory and learning. Insulin and protein kinase C (PKC) pathways are integrated and function closely together. PKC activation in the brain is essential for learning and neuronal repair. Intranasal delivery of insulin to the central nervous system (CNS) has been shown to improve memory, reduce cerebral atrophy, and reverse neurodegeneration. However, the neuronal molecular mechanisms of these effects have not been studied in depth. PKC delta plays a central role in cell survival. Its splice variants, PKC delta I and PKC delta II, are switches that determine cell survival and fate. PKC delta I promotes apoptosis, whereas PKC delta II promotes survival. Here, we demonstrate that insulin promotes alternative splicing of PKC delta II isoform in HT22 cells. The expression of PKC delta I splice variant remains unchanged. Insulin increases PKC delta II alternative splicing via the PI3K pathway. We further demonstrate that Akt kinase mediates phosphorylation of the splicing factor SC35 to promote PKC delta II alternative splicing. Using overexpression and knockdown assays, we demonstrate that insulin increases expression of Bcl2 and bcl-xL via PKC delta II. We demonstrate increased cell proliferation and increased BrdU incorporation in insulin-treated cells as well as in HT22 cells overexpressing PKC delta II. Finally, we demonstrate in vivo that intranasal insulin promotes cognitive function in mice with concomitant increases in PKC delta II expression in the hippocampus. This is the first report of insulin, generally considered a growth or metabolic hormone, regulating the alternative isoform expression of a key signaling kinase in neuronal cells such that it results in increased neuronal survival.	[Patel, Niketa A.] James A Haley Vet Hosp, Res Serv VAR 151, Tampa, FL 33612 USA; [Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Acosta, Sandra; Bickford, Paula] Univ S Florida, Dept Neurol, Tampa, FL 33612 USA; [Peart, Mishka] Univ S Florida, Honors Coll, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu	Bickford, Paula C/J-5970-2012	Bickford, Paula C/0000-0001-9657-7725; Patel, Niketa A./0000-0003-4811-8596; Apostolatos, Andre/0000-0002-4527-7084	National Institutes of Health from NIDDK [54393]; Dept. of Veterans Affairs; University of South Florida; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Dept. of Veterans Affairs(US Department of Veterans Affairs); University of South Florida; Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant 54393 (to D. R. C.) from NIDDK. This work was also supported by a Dept. of Veterans Affairs Medical Research grant (to N. A. P.) and by a Neuroscience Collaborative grant, University of South Florida (to N. A. P.).	ABEDOHMAE S, 1993, BIOCHEM BIOPH RES CO, V191, P915, DOI 10.1006/bbrc.1993.1304; Adamczyk A, 2010, FEBS LETT, V584, P3504, DOI 10.1016/j.febslet.2010.07.019; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193; Bonini JS, 2005, PHARMACOL BIOCHEM BE, V80, P63, DOI 10.1016/j.pbb.2004.10.008; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Conboy L, 2009, BIOCHEM PHARMACOL, V77, P1254, DOI 10.1016/j.bcp.2008.12.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ferri P, 2006, J NEUROBIOL, V66, P793, DOI 10.1002/neu.20255; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Fujiki M, 2006, J NEUROTRAUM, V23, P1164, DOI 10.1089/neu.2006.23.1164; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gal A, 2008, BRAIN RES BULL, V76, P349, DOI 10.1016/j.brainresbull.2007.11.001; Gallagher HC, 2001, J NEUROCHEM, V77, P425, DOI 10.1046/j.1471-4159.2001.00235.x; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kim JD, 2011, BIOCHEM BIOPH RES CO, V410, P177, DOI 10.1016/j.bbrc.2011.04.096; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Liu SM, 2011, CELL SIGNAL, V23, P1366, DOI 10.1016/j.cellsig.2011.03.019; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; McCracken MA, 2003, MOL CANCER THER, V2, P273; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Sasaki T, 2006, J NEUROSCI RES, V84, P1187, DOI 10.1002/jnr.21036; Schmidt H, 2009, J MED GENET, V46, P217, DOI 10.1136/jmg.2008.062141; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; Yip WK, 2008, ONCOL REP, V19, P319; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	50	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9299	9310		10.1074/jbc.M111.313080	http://dx.doi.org/10.1074/jbc.M111.313080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275369	Green Published, hybrid			2022-12-27	WOS:000301797800058
J	Yao, YX; Harrison, KA; Al-Hassani, M; Murphy, RC; Rezania, S; Konger, RL; Travers, JB				Yao, Yongxue; Harrison, Kathleen A.; Al-Hassani, Mohammed; Murphy, Robert C.; Rezania, Samin; Konger, Raymond L.; Travers, Jeffrey B.			Platelet-activating Factor Receptor Agonists Mediate Xeroderma Pigmentosum A Photosensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ULTRAVIOLET-B RADIATION; INDUCED IMMUNE SUPPRESSION; FACTOR-LIKE PHOSPHOLIPIDS; TOCOPHEROL VITAMIN-E; DNA-REPAIR; GLYCEROPHOSPHOCHOLINE LIPIDS; HYPERSENSITIVITY REACTIONS; ENDOTHELIAL-CELLS; MASS-SPECTROMETRY	To date, oxidized glycerophosphocholines (Ox-GPCs) with platelet-activating factor (PAF) activity produced non-enzymatically have not been definitively demonstrated to mediate any known disease processes. Here we provide evidence that these Ox-GPCs play a pivotal role in the photosensitivity associated with the deficiency of the DNA repair protein xeroderma pigmentosum type A (XPA). It should be noted that XPA-deficient cells are known to have decreased antioxidant defenses. These studies demonstrate that treatment of human XPA-deficient fibroblasts with the pro-oxidative stressor ultraviolet B (UVB) radiation resulted in increased reactive oxygen species and PAF receptor (PAF-R) agonistic activity in comparison with gene-corrected cells. The UVB irradiation-generated PAF-R agonists were inhibited by antioxidants. UVB irradiation of XPA-deficient (Xpa(-/-)) mice also resulted in increased PAF-R agonistic activity and skin inflammation in comparison with control mice. The increased UVB irradiation-mediated skin inflammation and TNF-alpha production in Xpa(-/-) mice were blocked by systemic antioxidants and by PAF-R antagonists. Structural characterization of PAF-R-stimulating activity in UVB-irradiated XPA-deficient fibroblasts using mass spectrometry revealed increased levels of sn-2 short-chain Ox-GPCs along with native PAF. These studies support a critical role for PAF-R agonistic Ox-GPCs in the pathophysiology of XPA photosensitivity.	[Yao, Yongxue; Al-Hassani, Mohammed; Travers, Jeffrey B.] Indiana Univ, Sch Med, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Yao, Yongxue; Al-Hassani, Mohammed; Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Indiana Univ, Sch Med, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Yao, Yongxue; Al-Hassani, Mohammed; Konger, Raymond L.; Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Travers, Jeffrey B.] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Rezania, Samin; Konger, Raymond L.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Harrison, Kathleen A.; Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Travers, JB (corresponding author), Indiana Univ, Sch Med, HB Wells Ctr Pediat Res, 702 Barnhill Dr, Indianapolis, IN 46202 USA.	jtravers@iupui.edu	Murphy, Robert/AAO-5349-2020; Konger, Raymond/E-4970-2012	Murphy, Robert/0000-0002-9430-6515; Travers, Jeffrey/0000-0001-7232-1039	National Institutes of Health [HL062996, HL034303]; Showalter Memorial Foundation; Riley Memorial Association; Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303, R01HL062996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Memorial Foundation; Riley Memorial Association; Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062996 (to J. B. T. and R. L. K.) and HL034303 (to R. C. M.). This work was also supported by grants from the Showalter Memorial Foundation, the Riley Memorial Association, and Veterans Affairs (to J. B. T.).	Anstey AV, 2002, CLIN EXP DERMATOL, V27, P170, DOI 10.1046/j.1365-2230.2002.01040.x; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Berg RJW, 1998, J INVEST DERMATOL, V110, P405, DOI 10.1111/j.1523-1747.1998.00173.x; BICKLEY LK, 1988, CELL BIOL INT REP, V12, P231, DOI 10.1016/0309-1651(88)90100-2; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; CAMUSSI G, 1987, J EXP MED, V166, P1390, DOI 10.1084/jem.166.5.1390; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; CLAY KL, 1990, METHOD ENZYMOL, V187, P134; DEFLORA S, 1995, J CELL BIOCHEM, P33; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Eberlein-Konig B, 1998, J AM ACAD DERMATOL, V38, P45, DOI 10.1016/S0190-9622(98)70537-7; Gebicki JM, 2010, AMINO ACIDS, V39, P1131, DOI 10.1007/s00726-010-0610-7; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Hoffschir F, 1998, FREE RADICAL BIO MED, V24, P809, DOI 10.1016/S0891-5849(97)00350-X; Horio T, 2001, J INVEST DERM SYMP P, V6, P58, DOI 10.1046/j.0022-202x.2001.00019.x; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 1998, J EXP MED, V187, P1779, DOI 10.1084/jem.187.11.1779; JUHLIN L, 1992, ACTA DERM-VENEREOL, V72, P197; KAYGANICHHARRISON KA, 1994, ANAL BIOCHEM, V221, P16, DOI 10.1006/abio.1994.1372; Kojo S, 2004, CURR MED CHEM, V11, P1041, DOI 10.2174/0929867043455567; Konger RL, 2008, PROSTAG OTH LIPID M, V87, P1, DOI 10.1016/j.prostaglandins.2008.04.002; Kuwamoto K, 2000, J INVEST DERMATOL, V114, P241, DOI 10.1046/j.1523-1747.2000.0883x.x; Lehmann P, 2009, AUTOIMMUN REV, V8, P456, DOI 10.1016/j.autrev.2008.12.012; Lehr HA, 1997, J CLIN INVEST, V99, P2358, DOI 10.1172/JCI119417; LEVY DD, 1995, CARCINOGENESIS, V16, P1557, DOI 10.1093/carcin/16.7.1557; Low GKM, 2008, INT J BIOCHEM CELL B, V40, P2583, DOI 10.1016/j.biocel.2008.05.009; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; MICHEL L, 1988, J IMMUNOL, V141, P948; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; Morganti P, 2009, CLIN DERMATOL, V27, P166, DOI 10.1016/j.clindermatol.2008.01.009; Moriwaki S, 2001, PHOTODERMATOL PHOTO, V17, P47, DOI 10.1034/j.1600-0781.2001.017002047.x; Murphy RC, 1996, ADV EXP MED BIOL, V416, P51; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nakamura T, 2000, J DERMATOL SCI, V23, pS13, DOI 10.1016/S0923-1811(99)00072-9; PATEL KD, 1992, J BIOL CHEM, V267, P15168; Pei Y, 1998, J IMMUNOL, V161, P1954; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reed SH, 1996, MOL GEN GENET, V250, P515; Rybanska I, 2003, NEOPLASMA, V50, P389; Scheinfeld N, 2004, PHOTODERMATOL PHOTO, V20, P272, DOI 10.1111/j.1600-0781.2004.00094.x; Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x; SCIBERRAS DG, 1987, BRIT J CLIN PHARMACO, V24, P753, DOI 10.1111/j.1365-2125.1987.tb03242.x; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; Travers JB, 2010, PHOTOCHEM PHOTOBIOL, V86, P949, DOI 10.1111/j.1751-1097.2010.00743.x; Travers JB, 1996, J INVEST DERMATOL, V107, P88, DOI 10.1111/1523-1747.ep12298295; Travers JB, 2008, J INVEST DERMATOL, V128, P455, DOI 10.1038/sj.jid.5701083; Ullrich SE, 2005, MUTAT RES-FUND MOL M, V571, P185, DOI 10.1016/j.mrfmmm.2004.06.059; Vassallo MF, 2010, J ALLERGY CLIN IMMUN, V126, P217, DOI 10.1016/j.jaci.2010.06.011; VUILLAUME M, 1992, CARCINOGENESIS, V13, P321, DOI 10.1093/carcin/13.3.321; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; Wan YS, 2000, INT J MOL MED, V6, P683; Wang HJ, 2005, FREE RADICAL BIO MED, V38, P890, DOI 10.1016/j.freeradbiomed.2004.12.005; Wolf P, 2006, AM J PATHOL, V169, P795, DOI 10.2353/ajpath.2006.060079; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982; Yao YX, 2009, J IMMUNOL, V182, P2842, DOI 10.4049/jimmunol.0802689; Zhang QW, 2008, J INVEST DERMATOL, V128, P1780, DOI 10.1038/sj.jid.5701251; Zhang QW, 2005, J CLIN INVEST, V115, P2855, DOI 10.1172/JCI25429	67	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9311	9321		10.1074/jbc.M111.332395	http://dx.doi.org/10.1074/jbc.M111.332395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22303003	Green Published, hybrid			2022-12-27	WOS:000301797800059
J	Zhu, J; Lin, SJ; Zou, C; Makanji, Y; Jardetzky, TS; Woodruff, TK				Zhu, Jie; Lin, S. Jack; Zou, Chao; Makanji, Yogeshwar; Jardetzky, Theodore S.; Woodruff, Teresa K.			Inhibin alpha-Subunit N Terminus Interacts with Activin Type IB Receptor to Disrupt Activin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; TGF-BETA FAMILY; BIOLOGICAL-ACTIVITY; OVARIAN FOLLICLES; DYNAMIC CHANGES; INDIAN WOMEN; BINDING-SITE; FOLLISTATIN; PITUITARY; BETAGLYCAN	Inhibin is a heterodimeric peptide hormone produced in the ovary that antagonizes activin signaling and FSH synthesis in the pituitary. The inhibin beta-subunit interacts with the activin type II receptor (ActRII) to functionally antagonize activin. The inhibin alpha-subunit mature domain (N terminus) arose relatively early during the evolution of the hormone, and inhibin function is decreased by an antibody directed against the alpha-subunit N-terminal extension region or by deletion of the N-terminal region. We hypothesized that the alpha-subunit N-terminal extension region interacts with the activin type I receptor (ALK4) to antagonize activin signaling in the pituitary. Human or chicken free alpha-subunit inhibited activin signaling in a pituitary gonadotrope-derived cell line (L beta T2) in a dose-dependent manner, whereas an N-terminal extension deletion mutant did not. An alpha-subunit N-terminal peptide, but not a control peptide, was able to inhibit activin A signaling and decrease activin-stimulated FSH synthesis. Biotinylated inhibin A, but not activin A, bound ALK4. Soluble ALK4-ECD bioneutralized human free alpha-subunit in L beta T2 cells, but did not affect activin A function. Competitive binding ELISAs with N-terminal mutants and an N-terminal region peptide confirmed that this region is critical for direct interaction of the alpha-subunit with ALK4. These data expand our understanding of how endocrine inhibin achieves potent antagonism of local, constitutive activin action in the pituitary, through a combined mechanism of competitive binding of both ActRII and ALK4 by each subunit of the inhibin heterodimer, in conjunction with the co-receptor betaglycan, to block activin receptor-ligand binding, complex assembly, and downstream signaling.	[Zhu, Jie; Makanji, Yogeshwar; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Lin, S. Jack; Zou, Chao; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; Stanford University	Woodruff, TK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, 303 E Super St,Lurie 10-250, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health/NICHD [R01 HD37096, HD041857]; NHMRC [GNT1016460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD041857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health/NICHD Grant R01 HD37096 (to T. K. W.). We also thank NIH/NICHD (HD041857) (to T. S. J.) and NHMRC (GNT1016460) (to Y. M.).	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Besecke LM, 1997, ENDOCRINOLOGY, V138, P2841, DOI 10.1210/en.138.7.2841; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; Chand AL, 2007, HUM REPROD, V22, P3241, DOI 10.1093/humrep/dem323; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Cook RW, 2005, J BIOL CHEM, V280, P40177, DOI 10.1074/jbc.M504591200; Cook RW, 2004, SEMIN REPROD MED, V 22, P269, DOI 10.1055/s-2004-831902; DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500; Dixit H, 2006, HUM REPROD, V21, P1643, DOI 10.1093/humrep/del129; Dixit H, 2004, HUM REPROD, V19, P1760, DOI 10.1093/humrep/deh342; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; FINDLAY JK, 1989, J ENDOCRINOL, V120, P59, DOI 10.1677/joe.0.1200059; FINDLAY JK, 1990, REPROD FERT DEVELOP, V2, P205, DOI 10.1071/RD9900205; Fischer WH, 1999, J PROTEIN CHEM, V18, P437, DOI 10.1023/A:1020640725959; Geng LY, 2008, THERIOGENOLOGY, V70, P35, DOI 10.1016/j.theriogenology.2008.02.013; GLENCROSS RG, 1994, J REPROD FERTIL, V100, P599, DOI 10.1530/jrf.0.1000599; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; HILLIER SG, 1987, J ENDOCRINOL, V113, pR3, DOI 10.1677/joe.0.113R003; Jimenez-Krassel F, 2003, ENDOCRINOLOGY, V144, P1876, DOI 10.1210/en.2002-221077; KNIGHT PG, 1989, J MOL ENDOCRINOL, V2, P189, DOI 10.1677/jme.0.0020189; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; LEE VWK, 1986, J ENDOCRINOL, V109, P379, DOI 10.1677/joe.0.1090379; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Marozzi A, 2002, HUM REPROD, V17, P1741, DOI 10.1093/humrep/17.7.1741; MASON AJ, 1986, BIOCHEM BIOPH RES CO, V135, P957, DOI 10.1016/0006-291X(86)91021-1; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Rebar RW, 2008, ANN NY ACAD SCI, V1135, P138, DOI 10.1196/annals.1429.000; RIVIER C, 1991, ENDOCRINOLOGY, V128, P2223, DOI 10.1210/endo-128-5-2223; RIVIER C, 1986, SCIENCE, V234, P205, DOI 10.1126/science.3092356; RIVIER C, 1987, HORM RES, V28, P104, DOI 10.1159/000180934; RIVIER J, 1985, BIOCHEM BIOPH RES CO, V133, P120, DOI 10.1016/0006-291X(85)91849-2; Robertson DM, 2008, MENOPAUSE, V15, P1139, DOI 10.1097/gme.0b013e3181735687; Robertson DM, 2000, REV REPROD, V5, P131, DOI 10.1530/ror.0.0050131; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Schneyer AL, 2000, J CLIN ENDOCR METAB, V85, P3319, DOI 10.1210/jc.85.9.3319; SCOTT RS, 1980, ENDOCRINOLOGY, V107, P1536, DOI 10.1210/endo-107-5-1536; Shelling AN, 2000, HUM REPROD, V15, P2644, DOI 10.1093/humrep/15.12.2644; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2004, MOL CELL ENDOCRINOL, V225, P9, DOI 10.1016/j.mce.2004.02.007; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; Woodruff TK, 1996, ENDOCRINOLOGY, V137, P5463, DOI 10.1210/en.137.12.5463; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; XU JM, 1995, J BIOL CHEM, V270, P6308, DOI 10.1074/jbc.270.11.6308; YAMASHIRO D, 1984, P NATL ACAD SCI-BIOL, V81, P5399, DOI 10.1073/pnas.81.17.5399; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009457	61	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8060	8070		10.1074/jbc.M111.293381	http://dx.doi.org/10.1074/jbc.M111.293381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267736	hybrid, Green Published			2022-12-27	WOS:000301349400022
J	Bouaouina, M; Goult, BT; Huet-Calderwood, C; Bate, N; Brahme, NN; Barsukov, IL; Critchley, DR; Calderwood, DA				Bouaouina, Mohamed; Goult, Benjamin T.; Huet-Calderwood, Clotilde; Bate, Neil; Brahme, Nina N.; Barsukov, Igor L.; Critchley, David R.; Calderwood, David A.			A Conserved Lipid-binding Loop in the Kindlin FERM F1 Domain Is Required for Kindlin-mediated alpha IIb beta 3 Integrin Coactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSKELETAL PROTEIN TALIN; OUT SIGNAL-TRANSDUCTION; UBIQUITIN-LIKE DOMAIN; STRUCTURAL BASIS; PLATELET-AGGREGATION; LEUKOCYTE ADHESION; CYTOPLASMIC TAILS; ACTIVATION; BETA; CELL	The activation of heterodimeric integrin adhesion receptors from low to high affinity states occurs in response to intracellular signals that act on the short cytoplasmic tails of integrin beta subunits. Binding of the talin FERM (four-point-one, ezrin, radixin, moesin) domain to the integrin beta tail provides one key activation signal, but recent data indicate that the kindlin family of FERM domain proteins also play a central role. Kindlins directly bind integrin beta subunit cytoplasmic domains at a site distinct from the talin-binding site, and target to focal adhesions in adherent cells. However, the mechanisms by which kindlins impact integrin activation remain largely unknown. A notable feature of kindlins is their similarity to the integrin-binding and activating talin FERM domain. Drawing on this similarity, here we report the identification of an unstructured insert in the kindlin F1 FERM domain, and provide evidence that a highly conserved polylysine motif in this loop supports binding to negatively charged phospholipid head groups. We further show that the F1 loop and its membrane-binding motif are required for kindlin-1 targeting to focal adhesions, and for the cooperation between kindlin-1 and -2 and the talin head in alpha IIb beta 3 integrin activation, but not for kindlin binding to integrin beta tails. These studies highlight the structural and functional similarities between kindlins and the talin head and indicate that as for talin, FERM domain interactions with acidic membrane phospholipids as well beta-integrin tails contribute to the ability of kindlins to activate integrins.	[Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Huet-Calderwood, Clotilde; Brahme, Nina N.; Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Goult, Benjamin T.; Bate, Neil; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	Yale University; Yale University; Yale University; University of Leicester; University of Liverpool	Calderwood, DA (corresponding author), 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Goult, Benjamin T/B-3127-2009; Calderwood, David A/AAC-6954-2019	Goult, Benjamin T/0000-0002-3438-2807; Calderwood, David A/0000-0002-0791-4142	National Institutes of Health [GM068600, GM068600-S1, GM088240, T32 GM007223]; BBSRC [BB/G003637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003637/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600, R01GM088240, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068600, GM068600-S1, GM088240, and T32 GM007223.	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Bouaouina M, 2011, CURR BIOL, V21, pR99, DOI 10.1016/j.cub.2010.12.002; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; NIGGLI V, 1994, EUR J BIOCHEM, V224, P951, DOI 10.1111/j.1432-1033.1994.00951.x; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schwieger C, 2007, EUR BIOPHYS J BIOPHY, V36, P437, DOI 10.1007/s00249-006-0080-8; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	65	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6979	6990		10.1074/jbc.M111.330845	http://dx.doi.org/10.1074/jbc.M111.330845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235127	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000301060200004
J	Keane, SC; Liu, PH; Leibowitz, JL; Giedroc, DP				Keane, Sarah C.; Liu, Pinghua; Leibowitz, Julian L.; Giedroc, David P.			Functional Transcriptional Regulatory Sequence (TRS) RNA Binding and Helix Destabilizing Determinants of Murine Hepatitis Virus (MHV) Nucleocapsid (N) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE RESPIRATORY SYNDROME; TERMINAL DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SARS-COV; SYNDROME CORONAVIRUS; MOLECULAR-BIOLOGY; REPLICATION FORK; DNA; INFECTIVITY	Coronavirus (CoV) nucleocapsid (N) protein contains two structurally independent RNA binding domains. These are denoted N-terminal domain (NTD) and C-terminal domain and are joined by a charged linker region rich in serine and arginine residues (SR linker). In mouse hepatitis virus (MHV), the NTD binds the transcriptional regulatory sequence (TRS) RNA, a conserved hexanucleotide sequence required for subgenomic RNA synthesis. The NTD is also capable of disrupting a short RNA duplex. We show here that three residues on the beta 3 (Arg-125 and Tyr-127) and beta 5 (Tyr-190) strands play key roles in TRS RNA binding and helix destabilization with Ala substitutions of these residues lethal to the virus. NMR studies of the MHV NTD-TRS complex revealed that this region defines a major RNA binding interface in MHV with site-directed spin labeling studies consistent with a model in which the adenosine-rich 3'-region of TRS is anchored by Arg-125, Tyr-127, and Tyr-190 in a way that is critical for efficient subgenomic RNA synthesis in MHV. Characterization of CoV N NTDs from infectious bronchitis virus and from severe acute respiratory syndrome CoV revealed that, although detailed NTD-TRS determinants are distinct from those of MHVNTD, rapid helix destabilization activity of CoV N NTDs is most strongly correlated with CoV function and virus viability.	[Keane, Sarah C.; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Liu, Pinghua; Leibowitz, Julian L.] Texas A&M Univ Syst, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Giedroc, DP (corresponding author), Indiana Univ, Dept Chem, 212 S Hawthorne Ave, Bloomington, IN 47405 USA.	giedroc@indiana.edu	Giedroc, David/A-8608-2018	Giedroc, David/0000-0002-2342-1620	National Institutes of Health [R01 AI067416]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI067416.	Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106; BARIC RS, 1988, J VIROL, V62, P4280, DOI 10.1128/JVI.62.11.4280-4287.1988; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Clarkson MW, 2009, J BIOMOL NMR, V45, P217, DOI 10.1007/s10858-009-9347-6; COMPTON SR, 1987, J VIROL, V61, P1814, DOI 10.1128/JVI.61.6.1814-1820.1987; Cowley TJ, 2010, J VIROL, V84, P1752, DOI 10.1128/JVI.01758-09; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; CURTH U, 1993, BIOCHEMISTRY-US, V32, P2585, DOI 10.1021/bi00061a016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b; Hurst KR, 2010, J VIROL, V84, P10276, DOI 10.1128/JVI.01287-10; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Johnson RF, 2005, J VIROL, V79, P14570, DOI 10.1128/JVI.79.23.14570-14585.2005; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai M.M.C., 2007, FIELDS VIROLOGY, P1305; LAI MMC, 1984, P NATL ACAD SCI-BIOL, V81, P3626, DOI 10.1073/pnas.81.12.3626; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Ma YL, 2010, PROTEIN CELL, V1, P688, DOI 10.1007/s13238-010-0079-x; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; MONAGHAN A, 1994, NUCLEIC ACIDS RES, V22, P742, DOI 10.1093/nar/22.5.742; Pant K, 2003, J MOL BIOL, V327, P571, DOI 10.1016/S0022-2836(03)00153-0; PARKER MM, 1990, VIROLOGY, V179, P463, DOI 10.1016/0042-6822(90)90316-J; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Sawicki SG, 1998, ADV EXP MED BIOL, V440, P215; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; STUMP WT, 1993, NUCLEIC ACIDS RES, V21, P5480, DOI 10.1093/nar/21.23.5480; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Urbaneja MA, 2002, J MOL BIOL, V318, P749, DOI 10.1016/S0022-2836(02)00043-8; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Yount B, 2002, J VIROL, V76, P11065, DOI 10.1128/JVI.76.21.11065-11078.2002; Yount B, 2006, P NATL ACAD SCI USA, V103, P12546, DOI 10.1073/pnas.0605438103; Zuniga S, 2004, J VIROL, V78, P980, DOI 10.1128/JVI.78.2.980-994.2004; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	52	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7063	7073		10.1074/jbc.M111.287763	http://dx.doi.org/10.1074/jbc.M111.287763			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241479	Green Published, hybrid			2022-12-27	WOS:000301060200011
J	Fridman, E; Lichtstein, D; Rosen, H				Fridman, Eleonora; Lichtstein, David; Rosen, Haim			Formation of New High Density Glycogen-Microtubule Structures Is Induced by Cardiac Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; CARDIOTONIC STEROIDS; EPITHELIAL-CELLS; PROTEIN-KINASES; FXYD PROTEINS; ION-TRANSPORT; OUABAIN; GLYCOSIDES; NA,K-ATPASE; METABOLISM	Cardiac steroids (CS), an important class of naturally occurring compounds, are synthesized in plants and animals. The only established receptor for CS is the ubiquitous Na+, K+-ATPase, a major plasma membrane transporter. The binding of CS to Na+, K+-ATPase causes the inhibition of Na+ and K+ transport and elicits cell-specific activation of several intracellular signaling mechanisms. It is well documented that the interaction of CS with Na+, K+-ATPase is responsible for numerous changes in basic cellular physiological properties, such as electrical plasma membrane potential, cell volume, intracellular [Ca2+] and pH, endocytosed membrane traffic, and the transport of other solutes. In the present study we show that CS induces the formation of dark structures adjacent to the nucleus in human NT2 and ACHN cells. These structures, which are not surrounded by membranes, are clusters of glycogen and a distorted microtubule network. Formation of these clusters results from a relocation of glycogen and microtubules in the cells, two processes that are independent of one another. The molecular mechanisms underlying the formation of the clusters are mediated by the Na+, K+-ATPase, ERK1/2 signaling pathway, and an additional unknown factor. Similar glycogen clusters are induced by hypoxia, suggesting that the CS-induced structural change, described in this study, may be part of a new type of cellular stress response.	[Rosen, Haim] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Lichtstein, David] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosen, H (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel.	haimr@ekmd.huji.ac.il			Israel Science Foundation [1246/08]	Israel Science Foundation(Israel Science Foundation)	This research was supported by Israel Science Foundation Grant 1246/08.	Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Akimova OA, 2008, APOPTOSIS, V13, P670, DOI 10.1007/s10495-008-0204-y; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bamri-Ezzine S, 2003, LAB INVEST, V83, P1069, DOI 10.1097/01.LAB.0000078687.21634.69; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 2007, AM J PHYSIOL-RENAL, V293, pF438, DOI 10.1152/ajprenal.00092.2007; Cannon SC, 2004, NEURON, V43, P153, DOI 10.1016/j.neuron.2004.07.002; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Daniel L, 2010, DEV BIOL, V344, P650, DOI 10.1016/j.ydbio.2010.05.490; De Angelis C, 1998, AM J PHYSIOL-RENAL, V274, pF182, DOI 10.1152/ajprenal.1998.274.1.F182; Dvela Moran, 2007, Pathophysiology, V14, P159, DOI 10.1016/j.pathophys.2007.09.011; EYALGILADI H, 1985, J CELL SCI, V73, P399; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Golden WC, 2006, NEUROSCIENCE, V137, P133, DOI 10.1016/j.neuroscience.2005.10.004; Goldstein I, 2006, BIOL PSYCHIAT, V60, P491, DOI 10.1016/j.biopsych.2005.12.021; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Johkura K, 2004, J ANAT, V205, P247, DOI 10.1111/j.0021-8782.2004.00336.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kelly R. A., 1996, PHARMACOL BASIS THER, P809; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; Lecuona E, 2007, J BIOENERG BIOMEMBR, V39, P391, DOI 10.1007/s10863-007-9102-1; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Mijatovic T, 2008, EXPERT OPIN THER TAR, V12, P1403, DOI [10.1517/14728222.12.11.1403, 10.1517/14728222.12.11.1403 ]; Nef HM, 2007, EUR HEART J, V28, P2456, DOI 10.1093/eurheartj/ehl570; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Paci A, 2000, HYPERTENS RES, V23, pS87, DOI 10.1291/hypres.23.Supplement_S87; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; POST RL, 1972, J BIOL CHEM, V247, P6530; Pressley TA, 1996, MINER ELECTROL METAB, V22, P264; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Rosen H, 2004, MOL BIOL CELL, V15, P1044, DOI 10.1091/mbc.E03-06-0391; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Shearer J, 2002, CAN J APPL PHYSIOL, V27, P179, DOI 10.1139/h02-012; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Tian J, 2003, MOL CELL BIOCHEM, V242, P181, DOI 10.1023/A:1021114501561; Valente RC, 2010, CELL BIOL TOXICOL, V26, P201, DOI 10.1007/s10565-009-9136-8; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	55	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6518	6529		10.1074/jbc.M111.273698	http://dx.doi.org/10.1074/jbc.M111.273698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228762	hybrid, Green Published			2022-12-27	WOS:000300791800040
J	Kleessen, S; Araujo, WL; Fernie, AR; Nikoloski, Z				Kleessen, Sabrina; Araujo, Wagner L.; Fernie, Alisdair R.; Nikoloski, Zoran			Model-based Confirmation of Alternative Substrates of Mitochondrial Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUX BALANCE ANALYSIS; TRANSFER FLAVOPROTEIN; TCA CYCLE; ARABIDOPSIS; METABOLISM; GROWTH; DEHYDROGENASES; OXIDOREDUCTASE; OPTIMALITY; COMPLEX	Background: There are alternative substrates to the mitochondrial respiration. Results: Data-driven model-based analysis renders predictions of alternative substrates to the mitochondrial respiration. Conclusion: Metabolomics data in conjunction with flux-based models can discriminate among hypotheses based on enzymology alone. Significance: This analysis provides a basic framework for in silico studies of alternative pathways in metabolism.	[Kleessen, Sabrina; Araujo, Wagner L.; Fernie, Alisdair R.; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Araujo, Wagner L.] Univ Fed Vicosa, Dept Biol Vegetal, BR-36570000 Vicosa, MG, Brazil; [Nikoloski, Zoran] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Max Planck Society; Universidade Federal de Vicosa; University of Potsdam	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol, Muehlenberg 1, D-14476 Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de	Araújo, Wagner L./I-3291-2013	Araújo, Wagner L./0000-0002-4796-2616; Nikoloski, Zoran/0000-0003-2671-6763	Max-Planck Society; German Ministry of Science and Education [0313924]	Max-Planck Society(Max Planck Society); German Ministry of Science and Education	Supported by the Max-Planck Society.; Supported by German Ministry of Science and Education Grant 0313924. To whom correspondence should be addressed: Max-Planck Institute of Molecular Plant Physiology, Am Muehlenberg 1, 14476 Potsdam-Golm, Germany. Tel.: 49-331-567-8630; Fax: 49-331-567-8615; E-mail: nikoloski@mpimp-golm.mpg.de.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Araujo WL, 2011, PLANT PHYSIOL, V157, P55, DOI 10.1104/pp.111.182188; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Beard DA, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.37; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Cameron AC, 1997, J ECONOMETRICS, V77, P329; CUTHRELL JE, 1987, AICHE J, V33, P1257, DOI 10.1002/aic.690330804; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dirac Paul, 1958, PRINCIPLES QUANTUM M, P58; Engqvist MKM, 2011, J BIOL CHEM, V286, P11382, DOI 10.1074/jbc.M110.194175; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Gagneur J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-175; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; HANNING I, 1993, PLANT PHYSIOL, V103, P1147, DOI 10.1104/pp.103.4.1147; Holmstrom K., 1999, ADV MODEL OPTIM, V1, P47; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Klitgord Niels, 2010, V22, P41; Luo RY, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100071; Luo RY, 2009, P NATL ACAD SCI USA, V106, P847, DOI 10.1073/pnas.0810731105; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Michaeli S, 2011, PLANT J, V67, P485, DOI 10.1111/j.1365-313X.2011.04612.x; Mintz-Oron S, 2009, BIOINFORMATICS, V25, pI247, DOI 10.1093/bioinformatics/btp209; Nagele T, 2010, PLANT PHYSIOL, V153, P260, DOI 10.1104/pp.110.154443; O'Connor G, 2009, J NEUROL, V256, P672, DOI 10.1007/s00415-009-0107-z; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; PASSARELLA S, 1984, BIOCHEM BIOPH RES CO, V121, P770, DOI 10.1016/0006-291X(84)90745-9; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Redestig H, 2011, ANNU PLANT REV, V43, P261, DOI 10.1002/9781444339956.ch9; Rios-Estepa R, 2007, PHYTOCHEMISTRY, V68, P2351, DOI 10.1016/j.phytochem.2007.04.021; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snitkin Evan S, 2008, Genome Inform, V20, P123; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Villadsen JV, 1995, CHEM ENG SCI, V50, P3981, DOI 10.1016/0009-2509(96)81831-8; WAAGE P, 1986, J CHEM EDUC, V63, P1044, DOI 10.1021/ed063p1044; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535	54	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11122	11131		10.1074/jbc.M111.310383	http://dx.doi.org/10.1074/jbc.M111.310383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334689	hybrid, Green Published			2022-12-27	WOS:000302780100040
J	Samuelsson, B				Samuelsson, Bengt			Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW-REACTING SUBSTANCE; RABBIT POLYMORPHONUCLEAR LEUKOCYTES; LEUKOTRIENE A(4) HYDROLASE; PROSTAGLANDIN-E SYNTHASE-1; ARACHIDONIC-ACID; BIOSYNTHESIS; ENDOPEROXIDES; ANAPHYLAXIS; ENZYME; STEREOCHEMISTRY	The role of basic science in the development of health care has received more and more attention. In my own area of research involving the so-called eicosanoids, there are many examples of how studies of structure and function of small molecules, as well as proteins and genes, have led to new therapeutic agents for treatment of a variety of diseases. In most of the cases, the discoveries have resulted in the recognition of novel therapeutic targets amenable to modulation by small molecules. However, there are also examples in which the molecular mechanisms of actions of drugs, discovered by phenotypic screening, have been elucidated. The majority of the examples in this article consist of approved drugs; however, in some cases, ongoing developments of potential therapeutics are cited.	Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Samuelsson, B (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	bengt.samuelsson@ki.se						BERGSTRO.S, 1965, ANNU REV BIOCHEM, V34, P101, DOI 10.1146/annurev.bi.34.070165.000533; BERGSTROM S, 1958, J AM CHEM SOC, V80, P2337, DOI 10.1021/ja01542a081; BERGSTROM S, 1964, BIOCHIM BIOPHYS ACTA, V90, P207, DOI 10.1016/0304-4165(64)90145-X; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; BORGEAT P, 1976, J BIOL CHEM, V251, P7816; BORGEAT P, 1979, J BIOL CHEM, V254, P2643; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Euler U.S.v., 1934, ARCH EXP PATHOL PH, V175, P78, DOI 10.1007/BF01861161; Feldberg W, 1938, J PHYSIOL-LONDON, V94, P187, DOI 10.1113/jphysiol.1938.sp003674; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P6677, DOI 10.1073/pnas.84.19.6677; Goldblatt M., 1933, J SOC CHEM IND LONDO, V52, P1056; Haeggstrom JZ, 2007, PROSTAG OTH LIPID M, V83, P198, DOI 10.1016/j.prostaglandins.2007.01.006; HAEGGSTROM JZ, 1990, BIOCHEM BIOPH RES CO, V173, P431, DOI 10.1016/S0006-291X(05)81076-9; HAMBERG M, 1973, P NATL ACAD SCI USA, V70, P899, DOI 10.1073/pnas.70.3.899; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P345, DOI 10.1073/pnas.71.2.345; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hammarberg T, 2009, J BIOL CHEM, V284, P301, DOI 10.1074/jbc.M808365200; HAMMARSTROM S, 1980, BIOCHEM BIOPH RES CO, V92, P946, DOI 10.1016/0006-291X(80)90794-9; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; JAKSCHIK BA, 1977, P NATL ACAD SCI USA, V74, P4577, DOI 10.1073/pnas.74.10.4577; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kurzrok R, 1930, P SOC EXP BIOL MED, V28, P268; MORRIS HR, 1978, FEBS LETT, V87, P203, DOI 10.1016/0014-5793(78)80332-9; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; ORANGE RP, 1973, J IMMUNOL, V110, P760; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; PIPER PJ, 1969, NATURE, V223, P29, DOI 10.1038/223029a0; RADMARK O, 1980, J BIOL CHEM, V255, P1828; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; SAMUELSS.B, 1965, J AM CHEM SOC, V87, P3011, DOI 10.1021/ja01091a043; SAMUELSSON B, 1979, PROSTAGLANDINS, V17, P785, DOI 10.1016/0090-6980(79)90052-2; SAMUELSSON B, 1963, J AM CHEM SOC, V85, P1878, DOI 10.1021/ja00895a045; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Snelgrove RJ, 2011, THORAX, V66, P550, DOI 10.1136/thoraxjnl-2011-200234; VANDORP DA, 1964, BIOCHIM BIOPHYS ACTA, V90, P204, DOI 10.1016/0304-4165(64)90144-8; Whittaker N, 1976, Prostaglandins, V12, P915; WILLIS AL, 1974, SCIENCE, V183, P325, DOI 10.1126/science.183.4122.325	41	110	114	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10070	10080		10.1074/jbc.X112.351437	http://dx.doi.org/10.1074/jbc.X112.351437			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318727	hybrid, Green Published			2022-12-27	WOS:000302167200039
J	Wilkins, SE; Karttunen, S; Hampton-Smith, RJ; Murchland, I; Chapman-Smith, A; Peet, DJ				Wilkins, Sarah E.; Karttunen, Sarah; Hampton-Smith, Rachel J.; Murchland, Iain; Chapman-Smith, Anne; Peet, Daniel J.			Factor Inhibiting HIF (FIH) Recognizes Distinct Molecular Features within Hypoxia-inducible Factor-alpha (HIF-alpha) versus Ankyrin Repeat Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINYL HYDROXYLASE FACTOR; CIRCULAR-DICHROISM SPECTRA; DOMAIN-CONTAINING PROTEINS; TRANSCRIPTIONAL ACTIVITY; SECONDARY STRUCTURE; BETA-HYDROXYLATION; STRUCTURAL BASIS; S6 ATPASE; HIF-1-ALPHA; DYNAMICS	Factor Inhibiting HIF (FIH) catalyzes the beta-hydroxylation of asparagine residues in HIF-alpha transcription factors as well as ankyrin repeat domain (ARD) proteins such as Notch and Gankyrin. Although FIH-mediated hydroxylation of HIF-alpha is well characterized, ARDs were only recently identified as substrates, and less is known about their recognition and hydroxylation by FIH. We investigated the molecular determinants of FIH substrate recognition, with a focus on differences between HIF and ARD substrates. We show that for ARD proteins, structural context is an important determinant of FIH-recognition, but analyses of chimeric substrate proteins indicate that the ankyrin fold alone is not sufficient to explain the distinct substrate properties of the ARDs compared with HIF. For both substrates the kinetic parameters of hydroxylation are influenced by the amino acids proximal to the target asparagine. Although FIH tolerates a variety of chemically disparate residues proximal to the asparagine, we demonstrate that certain combinations of amino acids are not permissive to hydroxylation. Finally, we characterize a conserved RLL motif in HIF and demonstrate that it mediates a high affinity interaction with FIH in the presence of cell lysate or macromolecular crowding agents. Collectively, our data highlight the importance of residues proximal to the asparagine in determining hydroxylation, and identify additional substrate-specific elements that contribute to distinct properties of HIF and ARD proteins as substrates for FIH. These distinct features are likely to influence FIH substrate choice in vivo and, therefore, have important consequences for HIF regulation.	[Wilkins, Sarah E.; Karttunen, Sarah; Hampton-Smith, Rachel J.; Murchland, Iain; Chapman-Smith, Anne; Peet, Daniel J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Wilkins, Sarah E.; Karttunen, Sarah; Hampton-Smith, Rachel J.; Peet, Daniel J.] Univ Adelaide, ARC Special Res Ctr Mol Genet Dev, Adelaide, SA 5005, Australia	University of Adelaide; University of Adelaide	Peet, DJ (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	daniel.peet@adelaide.edu.au	Peet, Daniel/AAE-6698-2020	Peet, Daniel/0000-0002-6085-8936; Hampton-Smith, Rachel/0000-0002-2887-4338; Wilkins, Sarah/0000-0003-1347-3328	National Health and Medical Research Council of Australia [565515]; ARC Special Research Centre for the Molecular Genetics of Development	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC Special Research Centre for the Molecular Genetics of Development(Australian Research Council)	This work was funded by the National Health and Medical Research Council of Australia and the ARC Special Research Centre for the Molecular Genetics of Development.; Supported by a fellowship awarded by the National Health and Medical Research Council of Australia (ID 565515).	Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Devries IL, 2010, FEBS LETT, V584, P4725, DOI 10.1016/j.febslet.2010.10.060; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Linke S, 2007, METHOD ENZYMOL, V435, P61, DOI 10.1016/S0076-6879(07)35004-0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	45	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8769	8781		10.1074/jbc.M111.294678	http://dx.doi.org/10.1074/jbc.M111.294678			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270367	Green Published, hybrid			2022-12-27	WOS:000301797800010
J	Wu, KL; Peng, GQ; Wilken, M; Geraghty, RJ; Li, F				Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Geraghty, Robert J.; Li, Fang			Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; SARS-CORONAVIRUS; BINDING DOMAIN; SPIKE PROTEIN; CRYSTAL-STRUCTURE; MOLECULAR EVOLUTION; PALM CIVETS; VIRUS; CHINA; GLYCOPROTEIN	The severe acute respiratory syndrome coronavirus (SARSCoV) from palm civets has twice evolved the capacity to infect humans by gaining binding affinity for human receptor angiotensin-converting enzyme 2 (ACE2). Numerous mutations have been identified in the receptor-binding domain (RBD) of different SARS-CoV strains isolated from humans or civets. Why these mutations were naturally selected or how SARS-CoV evolved to adapt to different host receptors has been poorly understood, presenting evolutionary and epidemic conundrums. In this study, we investigated the impact of these mutations on receptor recognition, an important determinant of SARS-CoV infection and pathogenesis. Using a combination of biochemical, functional, and crystallographic approaches, we elucidated the molecular and structural mechanisms of each of these naturally selected RBD mutations. These mutations either strengthen favorable interactions or reduce unfavorable interactions with two virus-binding hot spots on ACE2, and by doing so, they enhance viral interactions with either human (hACE2) or civet (cACE2) ACE2. Therefore, these mutations were viral adaptations to either hACE2 or cACE2. To corroborate the above analysis, we designed and characterized two optimized RBDs. The human-optimized RBD contains all of the hACE2-adapted residues (Phe-442, Phe-472, Asn-479, Asp-480, and Thr-487) and possesses exceptionally high affinity for hACE2 but relative low affinity for cACE2. The civet-optimized RBD contains all of the cACE2-adapted residues (Tyr-442, Pro-472, Arg-479, Gly-480, and Thr-487) and possesses exceptionally high affinity for cACE2 and also substantial affinity for hACE2. These results not only illustrate the detailed mechanisms of host receptor adaptation by SARS-CoV but also provide a molecular and structural basis for tracking future SARS-CoV evolution in animals.	[Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Geraghty, Robert J.] Univ Minnesota, Sch Med, Ctr Drug Design, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-121 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu		Geraghty, Robert/0000-0002-0560-6509	National Institutes of Health [R01 AI089728]; University of Minnesota Academic Health Center; Minnesota Partnership for Biotechnology and Medical Genomics grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Minnesota Partnership for Biotechnology and Medical Genomics grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI089728 (to F. L.). This work was also supported by a University of Minnesota Academic Health Center faculty research development grant (to F. L.) and by a Minnesota Partnership for Biotechnology and Medical Genomics grant (to the University of Minnesota).	Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Lai M.M.C., 2001, FIELDS VIROLOGY, P1163; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445; Liu L, 2007, J VIROL, V81, P4694, DOI 10.1128/JVI.02389-06; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wu KL, 2011, J VIROL, V85, P5331, DOI 10.1128/JVI.02274-10; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	38	108	110	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8904	8911		10.1074/jbc.M111.325803	http://dx.doi.org/10.1074/jbc.M111.325803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291007	hybrid, Green Published			2022-12-27	WOS:000301797800021
J	Grieschat, M; Alekov, AK				Grieschat, Matthias; Alekov, Alexi K.			Glutamate 268 Regulates Transport Probability of the Anion/Proton Exchanger ClC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-/H+ ANTIPORTER; PATCH-CLAMP; XENOPUS OOCYTES; DENTS-DISEASE; PROTEINS; CHANNELS; PERMEATION; ANION; SELECTIVITY; ENDOCYTOSIS	The Cl-/H+ exchange mediated by ClC transporters can be uncoupled by external SCN- and mutations of the proton glutamate, a conserved residue at the internal side of the protein. We show here for the mammalian ClC transporter ClC-5 that acidic internal pH led to a greater increase in currents upon exchanging extracellular Cl- for SCN-. However, transport uncoupling, unitary current amplitudes, and the voltage dependence of the depolarization-induced activation were not altered by low pH values. Therefore, it is likely that an additional gating process regulates ClC-5 transport. Higher internal [H+] and the proton glutamate mutant E268H altered the ratio between ClC-5 transport and nonlinear capacitance, indicating that the gating charge movements in ClC-5 arise from incomplete transport cycles and that internal protons increase the transport probability of ClC-5. This was substantiated by site-directed sulfhydryl modification of the proton glutamate mutant E268C. The mutation exhibited small transport currents together with prominent gating charge movements. The charge restoration using a negatively charged sulfhydryl reagent reinstated also the WT phenotype. Neutralization of the charge of the gating glutamate 211 by the E211C mutation abolished the effect of internal protons, showing that the increased transport probability of ClC-5 results from protonation of this residue. S168P (a mutation that decreases the anion affinity of the central binding site) reduced also the internal pH dependence of ClC-5. These results support the idea that protonation of the gating glutamate 211 at the central anion-binding site of ClC-5 is mediated by the proton glutamate 268.	[Grieschat, Matthias; Alekov, Alexi K.] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Hannover Medical School	Alekov, AK (corresponding author), Hannover Med Sch, Inst Neurophysiol, OE4230,Carl Neuberg Str 1, D-30625 Hannover, Germany.	alekov.alexi@mh-hannover.de	Alekov, Alexi/ABE-4170-2020	Alekov, Alexi/0000-0001-6362-7247	Medical School Hannover	Medical School Hannover	This work was supported by a HiLF grant from the Medical School Hannover.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bossi E, 1999, J PHYSIOL-LONDON, V515, P729, DOI 10.1111/j.1469-7793.1999.729ab.x; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hazama A, 1997, J MEMBRANE BIOL, V155, P175, DOI 10.1007/s002329900169; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Orhan G, 2011, BIOPHYS J, V100, P1233, DOI 10.1016/j.bpj.2011.01.045; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2010, J GEN PHYSIOL, V135, P653, DOI 10.1085/jgp.201010428; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith AJ, 2010, FASEB J, V24, P3696, DOI 10.1096/fj.09-150649; Smith AJ, 2009, AM J PHYSIOL-RENAL, V296, pF390, DOI 10.1152/ajprenal.90526.2008; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	36	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8101	8109		10.1074/jbc.M111.298265	http://dx.doi.org/10.1074/jbc.M111.298265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267722	hybrid, Green Published			2022-12-27	WOS:000301349400026
J	Howarth, JW; Ramisetti, S; Nolan, K; Sadayappan, S; Rosevear, PR				Howarth, Jack W.; Ramisetti, Srinivas; Nolan, Kristof; Sadayappan, Sakthivel; Rosevear, Paul R.			Structural Insight into Unique Cardiac Myosin-binding Protein-C Motif A PARTIALLY FOLDED DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SECONDARY STRUCTURE PREDICTION; CHEMICAL-SHIFT DATA; F-ACTIN; MYBP-C; STRUCTURE VALIDATION; REGULATORY DOMAIN; SKELETAL-MUSCLE; HEART-MUSCLE; TROPONIN-I	The structural role of the unique myosin-binding motif (m-domain) of cardiac myosin-binding protein-C remains unclear. Functionally, the m-domain is thought to directly interact with myosin, whereas phosphorylation of the m-domain has been shown to modulate interactions between myosin and actin. Here we utilized NMR to analyze the structure and dynamics of the m-domain in solution. Our studies reveal that the m-domain is composed of two subdomains, a largely disordered N-terminal portion containing three known phosphorylation sites and a more ordered and folded C-terminal portion. Chemical shift analyses, d(NN)(i, i + 1) NOEs, and N-15{H-1} heteronuclear NOE values show that the C-terminal subdomain (residues 315-351) is structured with three well defined helices spanning residues 317-322, 327-335, and 341-348. The tertiary structure was calculated with CS-Rosetta using complete C-13(alpha), C-13(beta), C-13', N-15, H-1(alpha), and H-1(N) chemical shifts. An ensemble of 20 acceptable structures was selected to represent the C-terminal subdomain that exhibits a novel three-helix bundle fold. The solvent-exposed face of the third helix was found to contain the basic actin-binding motif LK(R/K)XK. In contrast, N-15{H-1} heteronuclear NOE values for the N-terminal subdomain are consistent with a more conformationally flexible region. Secondary structure propensity scores indicate two transient helices spanning residues 265-268 and 293-295. The presence of both transient helices is supported by weak sequential d(NN)(i, i + 1) NOEs. Thus, the m-domain consists of an N-terminal subdomain that is flexible and largely disordered and a C-terminal subdomain having a three-helix bundle fold, potentially providing an actin-binding platform.	[Howarth, Jack W.; Ramisetti, Srinivas; Nolan, Kristof; Rosevear, Paul R.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Sadayappan, Sakthivel] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	University System of Ohio; University of Cincinnati; Loyola University Chicago	Rosevear, PR (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	paul.rosevear@uc.edu		Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [R01HL105826]; American Heart Association [0830311N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL105826 (to S. S.). This work was also supported by American Heart Association Scientist Development Grant 0830311N (to S. S.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Flashman E, 2008, FEBS LETT, V582, P434, DOI 10.1016/j.febslet.2008.01.004; Fougerousse F, 1998, CIRC RES, V82, P130; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Gilbert R, 1999, J CELL SCI, V112, P69; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Oakley CE, 2004, CELL RES, V14, P95, DOI 10.1038/sj.cr.7290208; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Shaffer JF, 2009, J MUSCLE RES CELL M, V30, P303, DOI 10.1007/s10974-010-9207-8; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vardar D, 1999, J MOL BIOL, V294, P1299, DOI 10.1006/jmbi.1999.3321; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395; Yamamoto M, 2006, FEBS LETT, V580, P1789, DOI 10.1016/j.febslet.2006.02.034; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894	57	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8254	8262		10.1074/jbc.M111.309591	http://dx.doi.org/10.1074/jbc.M111.309591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235120	Green Published, hybrid			2022-12-27	WOS:000301349400040
J	Kim, JW; Jang, SM; Kim, CH; An, JH; Kang, EJ; Choi, KH				Kim, Jung-Woong; Jang, Sang-Min; Kim, Chul-Hong; An, Joo-Hee; Kang, Eun-Jin; Choi, Kyung-Hee			New Molecular Bridge between RelA/p65 and NF-kappa B Target Genes via Histone Acetyltransferase TIP60 Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TRANSCRIPTIONAL ACTIVITY; DNA-BINDING; RECEPTOR COACTIVATOR; PRECURSOR PROTEIN; ACTIVATION; EXPRESSION; ACETYLATION; APOPTOSIS; ALPHA	The nuclear factor-kappa B (NF-kappa B) family is involved in the expressions of numerous genes, in development, apoptosis, inflammatory responses, and oncogenesis. In this study we identified four NF-kappa B target genes that are modulated by TIP60. We also found that TIP60 interacts with the NF-kappa B RelA/p65 subunit and increases its transcriptional activity through protein-protein interaction. Although TIP60 binds with RelA/p65 using its histone acetyltransferase domain, TIP60 does not directly acetylate RelA/p65. However, TIP60 maintained acetylated Lys310 RelA/p65 levels in the TNF-alpha-dependent NF-kappa B signaling pathway. In chromatin immunoprecipitation assay, TIP60 was primarily recruited to the IL-6, IL-8, C-IAP1, and XIAP promoters in TNF-alpha stimulation followed by acetylation of histones H3 and H4. Chromatin remodeling by TIP60 involved the sequential recruitment of acetyl-Lys-310 RelA/p65 to its target gene promoters. Furthermore, we showed that up-regulated TIP60 expression was correlated with acetyl-Lys-310 RelA/p65 expressions in hepatocarcinoma tissues. Taken together these results suggest that TIP60 is involved in the NF-kappa B pathway through protein interaction with RelA/p65 and that it modulates the transcriptional activity of RelA/p65 in NF-kappa B-dependent gene expression.	[Kim, Jung-Woong; Jang, Sang-Min; Kim, Chul-Hong; An, Joo-Hee; Kang, Eun-Jin; Choi, Kyung-Hee] Chung Ang Univ, Sch Biol Sci, Seoul 156756, South Korea	Chung Ang University	Choi, KH (corresponding author), Chung Ang Univ, Sch Biol Sci, 221 Heuksuk Dong, Seoul 156756, South Korea.	khchoi@cau.ac.kr		Kim, Chulhong/0000-0001-7249-1257	National Research Foundation of Korea [2009-0079913, 2010-0000409, 2011-0000160]; Korean government (MEST; Ministry of Education, Science and Technology)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST; Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Mid-career Researcher Program through National Research Foundation of Korea Grants 2009-0079913, 2010-0000409, and 2011-0000160 funded by the Korean government (MEST; Ministry of Education, Science and Technology).	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Erl W, 1999, CIRC RES, V84, P668, DOI 10.1161/01.RES.84.6.668; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim JW, 2008, J BIOL CHEM, V283, P20077, DOI 10.1074/jbc.M800161200; Kim JW, 2011, FEBS J, V278, P4394, DOI 10.1111/j.1742-4658.2011.08362.x; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann DA, 2005, J HEPATOL, V42, P610, DOI 10.1016/j.jhep.2005.01.007; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252	61	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7780	7791		10.1074/jbc.M111.278465	http://dx.doi.org/10.1074/jbc.M111.278465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249179	Green Published, hybrid			2022-12-27	WOS:000301060200076
J	Deng, JN; Liu, SX; Zou, LQ; Xu, C; Geng, B; Xu, GH				Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Xu, Chong; Geng, Bin; Xu, Guoheng			Lipolysis Response to Endoplasmic Reticulum Stress in Adipose Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; PRIMARY RAT ADIPOCYTES; NECROSIS-FACTOR-ALPHA; DEPENDENT PROTEIN-KINASE; LIPID STORAGE DROPLETS; TRIGLYCERIDE LIPASE; 3T3-L1 ADIPOCYTES; STIMULATED LIPOLYSIS; ER MEMBRANE; PERILIPIN-A	In obesity and diabetes, adipocytes show significant endoplasmic reticulum (ER) stress, which triggers a series of responses. This study aimed to investigate the lipolysis response to ER stress in rat adipocytes. Thapsigargin, tunicamycin, and brefeldin A, which induce ER stress through different pathways, efficiently activated a time-dependent lipolytic reaction. The lipolytic effect of ER stress occurred with elevated cAMP production and protein kinase A (PKA) activity. Inhibition of PKA reduced PKA phosphosubstrates and attenuated the lipolysis. Although both ERK1/2 and JNK are activated during ER stress, lipolysis is partially suppressed by inhibiting ERK1/2 but not JNK and p38 MAPK and PKC. Thus, ER stress induces lipolysis by activating cAMP/PKA and ERK1/2. In the downstream lipolytic cascade, phosphorylation of lipid droplet-associated protein perilipin was significantly promoted during ER stress but attenuated on PKA inhibition. Furthermore, ER stress stimuli did not alter the levels of hormone-sensitive lipase and adipose triglyceride lipase but caused Ser-563 and Ser-660 phosphorylation of hormone-sensitive lipase and moderately elevated its translocation from the cytosol to lipid droplets. Accompanying these changes, total activity of cellular lipases was promoted to confer the lipolysis. These findings suggest a novel pathway of the lipolysis response to ER stress in adipocytes. This lipolytic activation may be an adaptive response that regulates energy homeostasis but with sustained ER stress challenge could contribute to lipotoxicity, dyslipidemia, and insulin resistance because of persistently accelerated free fatty acid efflux from adipocytes to the bloodstream and other tissues.	[Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Geng, Bin; Xu, Guoheng] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China; [Deng, Jingna; Liu, Shangxin; Zou, Liangqiang; Geng, Bin; Xu, Guoheng] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Xu, Chong] Astronaut Res & Training Ctr China, Beijing 100094, Peoples R China	Peking University	Xu, GH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	xug@bjmu.edu.cn	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	National Basic Research Program of China [2009CB941603, 2012CB517505]; National Natural Science Foundation of China [81070114, 30890042]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941603 and 2012CB517505 and National Natural Science Foundation of China Grants 81070114 and 30890042.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Fricke K, 2004, ENDOCRINOLOGY, V145, P4940, DOI 10.1210/en.2004-0803; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; He JH, 2006, BBA-MOL CELL BIOL L, V1761, P247, DOI 10.1016/j.bbalip.2006.02.001; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matthews CK, 1996, BIOCHEMISTRY-US, P819; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; PELED N, 1981, ANAL BIOCHEM, V112, P219, DOI 10.1016/0003-2697(81)90284-0; Ren TT, 2006, J MOL ENDOCRINOL, V37, P175, DOI 10.1677/jme.1.02061; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zhang TT, 2009, J MOL ENDOCRINOL, V42, P57, DOI 10.1677/JME-08-0130; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	51	84	88	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6240	6249		10.1074/jbc.M111.299115	http://dx.doi.org/10.1074/jbc.M111.299115			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223650	hybrid, Green Published			2022-12-27	WOS:000300791800017
J	Lefebvre, B; Klaus-Heisen, D; Pietraszewska-Bogiel, A; Herve, C; Camut, S; Auriac, MC; Gasciolli, V; Nurisso, A; Gadella, TWJ; Cullimore, J				Lefebvre, Benoit; Klaus-Heisen, Doerte; Pietraszewska-Bogiel, Anna; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Nurisso, Alessandra; Gadella, Theodorus W. J.; Cullimore, Julie			Role of N-Glycosylation Sites and CXC Motifs in Trafficking of Medicago truncatula Nod Factor Perception Protein to Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIKE KINASES; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; LYSM DOMAINS; FLUORESCENT PROTEINS; PLANT IMMUNITY; ARABIDOPSIS; BINDING; RECOGNITION; GENE	The lysin motif receptor-like kinase, NFP (Nod factor perception), is a key protein in the legume Medicago truncatula for the perception of lipochitooligosaccharidic Nod factors, which are secreted bacterial signals essential for establishing the nitrogen-fixing legume-rhizobia symbiosis. Predicted structural and genetic analyses strongly suggest that NFP is at least part of a Nod factor receptor, but few data are available about this protein. Characterization of a variant encoded by the mutant allele nfp-2 revealed the sensitivity of this protein to the endoplasmic reticulum quality control mechanisms, affecting its trafficking to the plasma membrane. Further analysis revealed that the extensive N-glycosylation of the protein is not essential for biological activity. In the NFP extracellular region, two CXC motifs and two other Cys residues were found to be involved in disulfide bridges, and these are necessary for correct folding and localization of the protein. Analysis of the intracellular region revealed its importance for biological activity but suggests that it does not rely on kinase activity. This work shows that NFP trafficking to the plasma membrane is highly sensitive to regulation in the endoplasmic reticulum and has identified structural features of the protein, particularly disulfide bridges involving CXC motifs in the extracellular region that are required for its biological function.	[Lefebvre, Benoit; Klaus-Heisen, Doerte; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Cullimore, Julie] INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Cullimore, Julie] CNRS, Lab Interact Plantes Microorganismes, UMR2594, F-31326 Castanet Tolosan, France; [Pietraszewska-Bogiel, Anna; Gadella, Theodorus W. J.] Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Nurisso, Alessandra] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; University of Amsterdam; University of Geneva; University of Lausanne	Lefebvre, B (corresponding author), INRA CNRS, Lab Plant Microbe Interact, BP 52627, F-31326 Castanet Tolosan, France.	benoit.lefebvre@toulouse.inra.fr	lefebvre, benoit/G-2028-2012	Gadella, Theodorus/0000-0002-7639-219X; Lefebvre, Benoit/0000-0002-3810-605X; Auriac, Marie-Christine/0000-0002-1202-032X; Cullimore, Julie/0000-0001-8804-4849	European Community Marie Curie Research Training Network [MRTN-CT-2006-035546 "NODPERCEPTION"]; National Research Agency [NodBindsLysM, LCOinNONLEGUMES, SYMPASIGNAL]	European Community Marie Curie Research Training Network(European Commission); National Research Agency(French National Research Agency (ANR))	This work was supported in part by the European Community Marie Curie Research Training Network Program Contract MRTN-CT-2006-035546 "NODPERCEPTION" and French National Research Agency Contracts "NodBindsLysM," "LCOinNONLEGUMES," and "SYMPASIGNAL". This work was performed in the Laboratoire des Interactions Plantes-Microorganismes, part of the " Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41).	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bensmihen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026114; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Derewenda U, 2009, BIOCHEMISTRY-US, V48, P8664, DOI 10.1021/bi900437z; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Ivanchenko M, 2000, PLANT J, V24, P79, DOI 10.1046/j.1365-313x.2000.00855.x; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V133, P1893, DOI 10.1104/pp.103.027680; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Saijo Y, 2010, CELL MICROBIOL, V12, P716, DOI 10.1111/j.1462-5822.2010.01472.x; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Song XF, 2010, J INTEGR PLANT BIOL, V52, P774, DOI 10.1111/j.1744-7909.2010.00978.x; Timmers ACJ, 1999, DEVELOPMENT, V126, P3617; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; VANBOKHOVEN H, 1993, J GEN VIROL, V74, P2233, DOI 10.1099/0022-1317-74-10-2233; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Vitha S, 1997, J HISTOCHEM CYTOCHEM, V45, P89, DOI 10.1177/002215549704500112; Waldherr-Teschner M., 1992, Advances in Scientific Visualization, P58; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Zhu Q, 2002, BIOCHEMISTRY-US, V41, P11488, DOI 10.1021/bi026136m	54	31	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10812	10823		10.1074/jbc.M111.281634	http://dx.doi.org/10.1074/jbc.M111.281634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334694	Green Published, hybrid			2022-12-27	WOS:000302780100010
J	Mellroth, P; Daniels, R; Eberhardt, A; Ronnlund, D; Blom, H; Widengren, J; Normark, S; Henriques-Normark, B				Mellroth, Peter; Daniels, Robert; Eberhardt, Alice; Ronnlund, Daniel; Blom, Hans; Widengren, Jerker; Normark, Staffan; Henriques-Normark, Birgitta			LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent Peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN RESISTANCE; PNEUMOCOCCAL AUTOLYSIN; RECOGNITION PROTEIN; SURFACE-PROTEINS; ENZYME-ACTIVITY; PNEUMOLYSIN; FRATRICIDE; VIRULENCE; GENE; ATTENUATION	Background: The regulation of cell wall hydrolysis by the pneumococcal autolysin LytA is poorly understood. Results: The cell wall is susceptible to extracellular LytA only during the stationary phase or after cell wall synthesis inhibition. Conclusion: LytA is regulated on the substrate level, where peptidoglycan modifications likely prevent LytA hydrolysis. Significance: The control of amidases is essential for bacterial survival, cell-wall synthesis, and division.	[Mellroth, Peter; Eberhardt, Alice; Normark, Staffan; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Daniels, Robert] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Ronnlund, Daniel; Blom, Hans; Widengren, Jerker] Albanova Univ Ctr, Royal Inst Technol, Dept Appl Phys, S-10691 Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, S-17176 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital	Mellroth, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	peter.mellroth@ki.se	Mellroth, Peter/F-8214-2013	daniels, Robert/0000-0002-5988-2920; Widengren, Jerker/0000-0003-3200-0374; Mellroth, Peter/0000-0002-3518-1054	VINNOVA; Swedish Research Council; Carl Trygger Foundation; EU; Torsten and Ragnar Soderbergs Foundation; Karolinska Institutet; Swedish Royal Academy of Sciences; Stockholm City Council	VINNOVA(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; EU(European Commission); Torsten and Ragnar Soderbergs Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Royal Academy of Sciences; Stockholm City Council	This work was supported by research grants from VINNOVA (to S.N. and B.H.-N.), the Swedish Research Council (to H.B., B.H.-N., and S.N.), the Carl Trygger Foundation (to R.D.), EU FP7, FLUODIAMON (to J.W.), the Torsten and Ragnar Soderbergs Foundation (to B.H.-N.), the Karolinska Institutet (to S.N. and B.H.-N.), the Swedish Royal Academy of Sciences (to B.H.-N.), and the ALF-bidrag from the Stockholm City Council (to B.H.-N.).	Avery OT, 1923, J EXP MED, V38, P199, DOI 10.1084/jem.38.2.199; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; GARCIA E, 1985, MOL GEN GENET, V201, P225, DOI 10.1007/BF00425663; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Goebel WF, 1929, J EXP MED, V49, P267, DOI 10.1084/jem.49.2.267; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; HOWARD LV, 1974, J BACTERIOL, V117, P796, DOI 10.1128/JB.117.2.796-804.1974; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; MOREILLON P, 1988, J INFECT DIS, V157, P1150, DOI 10.1093/infdis/157.6.1150; Moscoso M, 2010, MOL MICROBIOL, V77, P1052, DOI 10.1111/j.1365-2958.2010.07271.x; NEUFELD F, 1900, Z HYG INFEKTIONSKR, V34, P454; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	38	92	104	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11018	11029		10.1074/jbc.M111.318584	http://dx.doi.org/10.1074/jbc.M111.318584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334685	Green Published, hybrid			2022-12-27	WOS:000302780100030
J	Whitaker, N; Bageshwar, UK; Musser, SM				Whitaker, Neal; Bageshwar, Umesh K.; Musser, Siegfried M.			Kinetics of Precursor Interactions with the Bacterial Tat Translocase Detected by Real-time FRET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCATION; SEC-INDEPENDENT PROTEIN; SIGNAL PEPTIDE BINDING; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; FLUORESCENT PROTEIN; MEMBRANE-BINDING; PROTON GRADIENT; PATHWAY; STEP	The Escherichia coli twin-arginine translocation (Tat) system transports fully folded and assembled proteins across the inner membrane into the periplasmic space. Traditionally, in vitro protein translocation studies have been performed using gel-based transport assays. This technique suffers from low time resolution, and often, an inability to distinguish between different steps in a continuously occurring translocation process. To address these limitations, we have developed an in vitro FRET-based assay that reports on an early step in the Tat translocation process in real-time. The natural Tat substrate pre-SufI was labeled with Alexa532 (donor), and the fluorescent protein mCherry (acceptor) was fused to the C terminus of TatB or TatC. The colored Tat proteins were easily visible during purification, enabling identification of a highly active inverted membrane vesicle (IMV) fraction yielding transport rates with NADH almost an order of magnitude faster than previously reported. Whenpre-SufI was bound to the translocon, FRET was observed for both Tat proteins. FRET was diminished upon addition of nonfluorescent pre-SufI, indicating that the initial binding step is reversible. When the membranes were energized with NADH, the FRET signal was lost after a short delay. These data suggest a model in which a Tat cargo initially associates with the TatBC complex, and an electric field gradient is required for the cargo to proceed to the next stage of transport. This cargo migration away from the TatBC complex requires a significant fraction of the total transport time.	[Whitaker, Neal; Bageshwar, Umesh K.; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, 1114 TAMU, College Stn, TX 77843 USA.	smusser@tamu.edu			National Institutes of Health [R01 GM065534]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065534 (to S. M. M.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Braun NA, 2007, BIOPHYS J, V93, P1993, DOI 10.1529/biophysj.106.098731; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; CLINE K, 1992, J BIOL CHEM, V267, P2688; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Frielingsdorf S, 2007, J BIOL CHEM, V282, P24455, DOI 10.1074/jbc.M702630200; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Luke I, 2009, ARCH MICROBIOL, V191, P919, DOI 10.1007/s00203-009-0516-5; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	43	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11252	11260		10.1074/jbc.M111.324525	http://dx.doi.org/10.1074/jbc.M111.324525			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315217	hybrid, Green Published			2022-12-27	WOS:000302780100053
J	Zhou, FF; Zhang, XF; van Dam, H; ten Dijke, P; Huang, HZ; Zhang, L				Zhou, FangFang; Zhang, Xiaofei; van Dam, Hans; ten Dijke, Peter; Huang, Huizhe; Zhang, Long			Ubiquitin-specific Protease 4 Mitigates Toll-like/Interleukin-1 Receptor Signaling and Regulates Innate Immune Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYME; TRAF6; REQUIRES; KINASE; ALPHA; USP4; TAK1; COMPLEX; CYLD	Background: The TRAF6-mediated Toll-like receptor (TLR)/IL-1 receptor (IL-1R) pathway is essential for innate immune responses and immune homeostasis. Results: USP4 deubiquitinates Lys-63-linked polyubiquitination of TRAF6 and thereby prevents the TLR/IL-1R-induced activation of NF-kappa B and AP-1 transcription factors and subsequent proinflammatory responses. Conclusion: USP4 plays an essential role in the negative regulation of the TLR/IL-1R signaling-mediated innate immune response. Significance: USP4 is an attractive new therapeutic target for modulation of innate immune responses.	[Huang, Huizhe] Chongqing Med Univ, Sch Basic Med, Fac Basic Med Sci, Chongqing 400016, Peoples R China; [Zhou, FangFang; Zhang, Xiaofei; van Dam, Hans; ten Dijke, Peter; Zhang, Long] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Chongqing Medical University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Huang, HZ (corresponding author), Chongqing Med Univ, Sch Basic Med, Fac Basic Med Sci, E Teaching Bldg,Rm 217, Chongqing 400016, Peoples R China.	devbiology@cqmu.edu.cn; l.zhang@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Zhang, Long/AAT-6571-2021; Zhang, Xiafoei/C-8471-2014	Dijke, Peter ten/0000-0002-7234-342X; Zhang, Long/0000-0001-8139-0474; van Dam, Hans/0000-0002-8307-4325	Netherlands Organization for Scientific Research [VICI 016.066.606]; Centre for Biomedical Genetics; National Nature Science Foundation of China [30900748, 31171388]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Netherlands Organization for Scientific Research Grant VICI 016.066.606, the Centre for Biomedical Genetics (to P. t. D.), and National Nature Science Foundation of China Grants 30900748 and 31171388 (to H. H.).	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Gilchrist CA, 1997, J BIOL CHEM, V272, P32280, DOI 10.1074/jbc.272.51.32280; GUPTA K, 1994, ONCOGENE, V9, P1729; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P731, DOI 10.1016/j.bbrc.2005.11.076; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	39	68	69	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11002	11010		10.1074/jbc.M111.328187	http://dx.doi.org/10.1074/jbc.M111.328187			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22262844	Green Published, hybrid			2022-12-27	WOS:000302780100028
J	Aihara, Y; Yamamoto, T; Okajima, K; Yamamoto, K; Suzuki, T; Tokutomi, S; Tanaka, K; Nagatani, A				Aihara, Yusuke; Yamamoto, Takaharu; Okajima, Koji; Yamamoto, Kazuhiko; Suzuki, Tomomi; Tokutomi, Satoru; Tanaka, Kazuma; Nagatani, Akira			Mutations in N-terminal Flanking Region of Blue Light-sensing Light-Oxygen and Voltage 2 (LOV2) Domain Disrupt Its Repressive Activity on Kinase Domain in the Chlamydomonas Phototropin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PHOTORECEPTOR DOMAIN; J-ALPHA HELIX; PHOSPHOLIPID TRANSLOCATION; ARABIDOPSIS PHOTOTROPIN-1; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; BINDING DOMAINS; RECEPTOR; ROLES; NPL1	Phototropin is a light-regulated kinase that mediates a variety of photoresponses such as phototropism, chloroplast positioning, and stomata opening in plants to increase the photosynthetic efficiency. Blue light stimulus first induces local conformational changes in the chromophore-bearing light-oxygen and voltage 2 (LOV2) domain of phototropin, which in turn activates the serine/threonine (Ser/Thr) kinase domain in the C terminus. To examine the kinase activity of full-length phototropin conventionally, we employed the budding yeast Saccharomyces cerevisiae. In this organism, Ser/Thr kinases (Fpk1p and Fpk2p) that show high sequence similarity to the kinase domain of phototropins exist. First, we demonstrated that the phototropin from Chlamydomonas reinhardtii (CrPHOT) could complement loss of Fpk1p and Fpk2p to allow cell growth in yeast. Furthermore, this reaction was blue light-dependent, indicating that CrPHOT was indeed light-activated in yeast cells. We applied this system to a large scale screening for amino acid substitutions in CrPHOT that elevated the kinase activity in darkness. Consequently, we identified a cluster of mutations located in the N-terminal flanking region of LOV2 (R199C, L202L, D203N/G/V, L204P, T207I, and R210H). An in vitro phosphorylation assay confirmed that these mutations substantially reduced the repressive activity of LOV2 on the kinase domain in darkness. Furthermore, biochemical analyses of the representative T207I mutant demonstrated that the mutation affected neither spectral nor multimerization properties of CrPHOT. Hence, the N-terminal flanking region of LOV2, as is the case with the C-terminal flanking J alpha region, appears to play a crucial role in the regulation of kinase activity in phototropin.	[Aihara, Yusuke; Yamamoto, Kazuhiko; Suzuki, Tomomi; Nagatani, Akira] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Yamamoto, Takaharu; Tanaka, Kazuma] Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido 0600815, Japan; [Okajima, Koji; Tokutomi, Satoru] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5998531, Japan	Kyoto University; Hokkaido University; Osaka Metropolitan University	Nagatani, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	nagatani@physiol.bot.kyoto-u.ac.jp	Tanaka, Kazuma/A-4240-2012	Suzuki, Tomomi/0000-0003-0935-5505	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17084002, 22120002]; Japan Society for the Promotion of Science [21370020, 22.1094]; Grants-in-Aid for Scientific Research [22120005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported Grant-in-aid for Scientific Research on Priority Areas 17084002 (to A.N.), Grant-in-aid for Scientific Research on Innovative Areas 22120002 (to A.N.), a Grant-in-aid for the Global COE (Center of Excellence) Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" (to A.N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant-in-aid for Scientific Research (B) 21370020 (to A.N.), and Research Fellowship 22.1094 from the Japan Society for the Promotion of Science (to Y.A.).	Chen EF, 2007, BIOCHEMISTRY-US, V46, P4619, DOI 10.1021/bi602544n; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Guo HM, 2005, BIOPHYS J, V89, P402, DOI 10.1529/biophysj.104.058230; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Jones MA, 2008, PLANT SIGNAL BEHAV, V3, P44, DOI 10.4161/psb.3.1.4848; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kong SG, 2007, PLANT J, V51, P862, DOI 10.1111/j.1365-313X.2007.03187.x; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kutta RJ, 2008, CHEMBIOCHEM, V9, P1931, DOI 10.1002/cbic.200800158; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rose MD., 1990, METHODS YEAST GENETI; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; SIKORSKI RS, 1989, GENETICS, V122, P19; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Yamamoto A, 2009, BIOPHYS J, V96, P2771, DOI 10.1016/j.bpj.2008.12.3924	49	43	43	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9901	9909		10.1074/jbc.M111.324723	http://dx.doi.org/10.1074/jbc.M111.324723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291022	Green Published, hybrid			2022-12-27	WOS:000302167200022
J	Ao, ZJ; Jayappa, KD; Wang, BC; Zheng, YF; Wang, XX; Peng, JY; Yao, XJ				Ao, Zhujun; Jayappa, Kallesh Danappa; Wang, Binchen; Zheng, Yingfeng; Wang, Xiaoxia; Peng, Jinyu; Yao, Xiaojian			Contribution of Host Nucleoporin 62 in HIV-1 Integrase Chromatin Association and Viral DNA Integration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; IMMUNODEFICIENCY-VIRUS TYPE-1; ACUTE MYELOID-LEUKEMIA; P62 COMPLEX; PROTEASOMAL DEGRADATION; PROTEIN IMPORT; HUMAN GENOME; HUMAN-CELLS; REPLICATION; LEDGF/P75	HIV-1 integration is promoted by viral integrase (IN) and its cellular cofactors. The lens epithelium-derived growth factor (LEDGF/p75), an IN interacting cellular cofactor, has been shown to play an important role in HIV-1 chromatin targeting and integration. However, whether other cellular cofactors are also involved in viral replication steps is still elusive. Here, we show that nucleoporin 62 (Nup62) is a chromatin-bound protein and can specifically interact with HIV-1 IN in both soluble nuclear extract and chromatin-bound fractions. The knockdown of Nup62 by shRNA reduced the association of IN with host chromatin and significantly impaired viral integration and replication in HIV-1-susceptible cells. Furthermore, the expression of the IN-binding region of Nup62 in CD4(+) T cells significantly inhibited HIV-1 infection. Taken together, these results indicate that the cellular Nup62 is specifically recruited by HIV-1 IN and contribute to an efficient viral DNA integration.	[Ao, Zhujun; Jayappa, Kallesh Danappa; Wang, Binchen; Zheng, Yingfeng; Wang, Xiaoxia; Peng, Jinyu; Yao, Xiaojian] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Yao, XJ (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, 508 BMSB,745 William Ave, Winnipeg, MB R3E 0J9, Canada.	yao2@cc.umanitoba.ca	JAYAPPA, KALLESH DANAPPA/M-6571-2018; Zheng, Yingfeng/AAE-2983-2022	JAYAPPA, KALLESH DANAPPA/0000-0002-7239-5246; Yao, Xiaojian/0000-0002-5022-1309; Wang, Xiaoxia/0000-0002-6101-417X	Canadian Institutes of Health Research [HOP 81180, HBF 103212]; Canadian Foundation for AIDS Research [023-013]; Canadian Foundation of Innovation; Canadian Institutes of Health Research International Infectious Disease and Global Health; Manitoba Health Research Council/Manitoba Institute of Child Health; International Infectious Disease and Global Health Training Program; China Scholarship Council; Manitoba Medical Service Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research International Infectious Disease and Global Health(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council/Manitoba Institute of Child Health; International Infectious Disease and Global Health Training Program; China Scholarship Council(China Scholarship Council); Manitoba Medical Service Foundation	This work was supported in part by Canadian Institutes of Health Research Grants HOP 81180 and HBF 103212, Canadian Foundation for AIDS Research Grant 023-013, and the Leaders Opportunity Fund Award from the Canadian Foundation of Innovation (to X.-J. Y.).; Recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research International Infectious Disease and Global Health Training Program.; Recipient of scholarship from the Manitoba Health Research Council/Manitoba Institute of Child Health and from the International Infectious Disease and Global Health Training Program.; Recipient of a studentship from the China Scholarship Council.; Recipient of the Basic Science Career Development Research Award from the Manitoba Medical Service Foundation.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2011, HUM GENE THER, V22, P1225, DOI 10.1089/hum.2010.012; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; BUSS F, 1994, J CELL SCI, V107, P631; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; CARMOFONSECA M, 1991, EUR J CELL BIOL, V55, P17; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; CORDES VC, 1993, EUR J CELL BIOL, V60, P185; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Desfarges S, 2010, VIRUSES-BASEL, V2, P111, DOI 10.3390/v2010111; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Han I, 1998, J CELL BIOCHEM, V68, P50, DOI 10.1002/(SICI)1097-4644(19980101)68:1<50::AID-JCB5>3.0.CO;2-V; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Ikeda T, 2004, J VIROL, V78, P11563, DOI 10.1128/JVI.78.21.11563-11573.2004; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zheng YF, 2011, J BIOL CHEM, V286, P17722, DOI 10.1074/jbc.M110.184739; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68	60	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10544	10555		10.1074/jbc.M111.317057	http://dx.doi.org/10.1074/jbc.M111.317057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308026	Green Published, hybrid			2022-12-27	WOS:000302167200080
J	Siddiqi, S; Mansbach, CM				Siddiqi, Shahzad; Mansbach, Charles M., II			Phosphorylation of Sar1b Protein Releases Liver Fatty Acid-binding Protein from Multiprotein Complex in Intestinal Cytosol Enabling It to Bind to Endoplasmic Reticulum (ER) and Bud the Pre-chylomicron Transport Vesicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-MEMBRANES; RETENTION DISEASE; LIPID ABSORPTION; APOLIPOPROTEIN-B; CARGO SELECTION; COPII VESICLES; GOLGI; COAT; IDENTIFICATION; RECEPTOR	Native cytosol requires ATP to initiate the budding of the pre-chylomicron transport vesicle from intestinal endoplasmic reticulum (ER). When FABP1 alone is used, no ATP is needed. Here, we test the hypothesis that in native cytosol FABP1 is present in a multiprotein complex that prevents FABP1 binding to the ER unless the complex is phosphorylated. We found on chromatography of native intestinal cytosol over a Sephacryl S-100 HR column that FABP1 (14 kDa) eluted in a volume suggesting a 75-kDa protein complex that contained four proteins on an anti-FABP1 antibody pulldown. The FABP1-containing column fractions were chromatographed over an anti-FABP1 antibody adsorption column. Proteins co-eluted from the column were identified as FABP1, Sar1b, Sec13, and small VCP/p97-interactive protein by immunoblot, LC-MS/MS, and MALDI-TOF. The four proteins of the complex had a total mass of 77 kDa and migrated on native PAGE at 75 kDa. When the complex was incubated with intestinal ER, there was no increase in FABP1-ER binding. However, when the complex member Sar1b was phosphorylated by PKC zeta and ATP, the complex completely disassembled into its component proteins that migrated at their monomer molecular weight on native PAGE. FABP1, freed from the complex, was now able to bind to intestinal ER and generate the pre-chylomicron transport vesicle (PCTV). No increase in ER binding or PCTV generation was observed in the absence of PKC zeta or ATP. We conclude that phosphorylation of Sar1b disrupts the FABP1-containing four-membered 75-kDa protein complex in cytosol enabling it to bind to the ER and generate PCTV.	[Siddiqi, Shahzad; Mansbach, Charles M., II] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Mansbach, Charles M., II] Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Mansbach, CM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Rm H210,956B Court Ave, Memphis, TN 38163 USA.	cmansbach@uthsc.edu			National Institutes of Health from NIDDK [DK074565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074565] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK074565 from NIDDK (to C. M. M.).	Allen JR, 1997, J BIOL CHEM, V272, P32121, DOI 10.1074/jbc.272.51.32121; Alpers DH, 2000, BBA-MOL CELL BIOL L, V1483, P352, DOI 10.1016/S1388-1981(99)00200-0; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anderson C. M., 1961, MED J AUSTRALIA, V48, P617; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BASS NM, 1985, J BIOL CHEM, V260, P1432; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; Cartwright IJ, 2001, J BIOL CHEM, V276, P48048, DOI 10.1074/jbc.M104229200; Ding L, 2011, J BIOL CHEM, V286, P27027, DOI 10.1074/jbc.M111.235176; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Falomir-Lockhart LJ, 2011, BBA-MOL CELL BIOL L, V1811, P452, DOI 10.1016/j.bbalip.2011.04.005; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Jiang ZG, 2008, J MOL BIOL, V383, P1181, DOI 10.1016/j.jmb.2008.09.006; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kumar NS, 1997, AM J PHYSIOL-GASTR L, V273, pG18, DOI 10.1152/ajpgi.1997.273.1.G18; LUXON BA, 1993, AM J PHYSIOL, V265, pG831, DOI 10.1152/ajpgi.1993.265.5.G831; Luxon BA, 1997, AM J PHYSIOL-CELL PH, V273, pC859, DOI 10.1152/ajpcell.1997.273.3.C859; Mahan JT, 2001, AM J PHYSIOL-GASTR L, V280, pG1187, DOI 10.1152/ajpgi.2001.280.6.G1187; Mansbach CM, 1998, J LIPID RES, V39, P963; MANSBACH CM, 1982, J LIPID RES, V23, P1009; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; ROY CC, 1987, GASTROENTEROLOGY, V92, P390, DOI 10.1016/0016-5085(87)90133-8; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Shugrue CA, 1999, J CELL SCI, V112, P4547; Siddiqi SA, 2006, J CELL SCI, V119, P943, DOI 10.1242/jcs.02803; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, J CELL SCI, V121, P2327, DOI 10.1242/jcs.022780; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; STRALFORS P, 1990, FEBS LETT, V263, P153, DOI 10.1016/0014-5793(90)80726-Y; Thumser AEA, 2000, J LIPID RES, V41, P647; WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365; ZILVERSMIT DB, 1967, FED PROC, V26, P1599	47	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10178	10188		10.1074/jbc.M111.327247	http://dx.doi.org/10.1074/jbc.M111.327247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303004	Green Published, hybrid			2022-12-27	WOS:000302167200049
J	Wang, XL; Wu, Y; Tan, LB; Tian, Z; Liu, JH; Zhu, DS; Zeng, SM				Wang, Xian-Long; Wu, Yi; Tan, Lu-Bin; Tian, Zhen; Liu, Jing-Hao; Zhu, De-Sheng; Zeng, Shen-Ming			Follicle-stimulating Hormone Regulates Pro-apoptotic Protein Bcl-2-interacting Mediator of Cell Death-Extra Long (Bim(EL))-induced Porcine Granulosa Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY; GENE-EXPRESSION; SPLICE VARIANT; FACTOR-I; BIM; TRANSCRIPTION; IDENTIFICATION; SURVIVAL; ATRESIA; MEMBER	The pro-apoptotic protein Bim (B-cell lymphoma-2 (Bcl-2)-interacting modulator of cell death) has recently been identified and shown to promote cell death in response to several stimuli. In this report, we investigated the role of Bim in porcine follicular atresia. Initially, Bim cDNA was cloned and characterized from porcine ovarian tissue. Porcine Bim had three alternative splicing variants (Bim-extra long, Bim-long, and Bim-short), all containing the consensus Bcl-2 homology 3 domain. We then found the Bim-extra long (Bim(EL)) protein, the most abundant isoform of Bim, was strongly expressed and co-localized with apoptotic (TUNEL-positive) granulosa cells from porcine atretic follicles. Furthermore, overexpression of Bim(EL) triggered apoptosis in granulosa cells. In primary granulosa cell cultures under basal conditions, we observed that Bim(EL) expression was dampened by treatment with follicle-stimulating hormone (FSH). The role of the PI3K/Akt pathway in the regulation of repression was clarified by the use of the PI3K inhibitor, LY294002, and by transfection with Akt siRNA. Forkhead Box Protein O3a (FoxO3a), a well defined transcriptional activator of Bim, was phosphorylated at Ser-253 and inactivated after FSH stimulation. Also, FSH abolished FoxO3a nuclear accumulation in response to LY294002. Finally, chromatin immuno-precipitation assays demonstrated that FoxO3a directly bound and activated the bim promoter. Taken together, we conclude that Bim(EL) induces porcine granulosa cell apoptosis during follicular atresia, and its expression is regulated by FSH via the PI3K/Akt/FoxO3a pathway.	[Wang, Xian-Long; Wu, Yi; Tan, Lu-Bin; Tian, Zhen; Zeng, Shen-Ming] China Agr Univ, Lab Anim Embryon Biotechnol, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Liu, Jing-Hao; Zhu, De-Sheng] Peking Univ, Lab Anim Ctr, Beijing 100871, Peoples R China	China Agricultural University; Peking University	Zeng, SM (corresponding author), China Agr Univ, Lab Anim Embryon Biotechnol, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	zengsm@cau.edu.cn	Wang, Xianlong/H-5639-2019; WANG, XIANLONG/Z-1248-2018	WANG, XIANLONG/0000-0002-0563-9060	National Natural Science Foundation of China [31072031]; Ministry of Education of China [109018]; China Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); China Agricultural University	This work was supported in part by National Natural Science Foundation of China Grant 31072031, Key Project of the Ministry of Education of China Grant 109018, and the Graduate Scientific Research Innovation Special Fund of the China Agricultural University.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Asselin E, 2000, BIOL SIGNAL RECEPT, V9, P87; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; BILLIG H, 1994, ENDOCRINOLOGY, V134, P245, DOI 10.1210/en.134.1.245; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen JZ, 2004, INT J BIOCHEM CELL B, V36, P1554, DOI 10.1016/j.biocel.2003.12.015; Chun SY, 1996, ENDOCRINOLOGY, V137, P1447, DOI 10.1210/en.137.4.1447; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fukazawa H, 2004, MOL CANCER THER, V3, P1281; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guthrie HD, 1998, BIOL REPROD, V58, P390, DOI 10.1095/biolreprod58.2.390; GUTHRIE HD, 2005, J ANIM SCI, V83, pE79, DOI DOI 10.2527/2005.8313_; Harris CA, 2001, J BIOL CHEM, V276, P37754; Hsu SY, 2000, PHYSIOL REV, V80, P593, DOI 10.1152/physrev.2000.80.2.593; Hsu SY, 1996, ENDOCRINOLOGY, V137, P4837, DOI 10.1210/en.137.11.4837; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415, DOI 10.1210/endo-129-5-2415; Jin Xuan, 2011, Front Biosci (Schol Ed), V3, P680, DOI 10.2741/s180; Johnson AL, 1999, ENDOCRINOLOGY, V140, P4521, DOI 10.1210/en.140.10.4521; Jolly PD, 1997, BIOL REPROD, V56, P837, DOI 10.1095/biolreprod56.4.837; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Leo CP, 1999, ENDOCRINOLOGY, V140, P5469, DOI 10.1210/en.140.12.5469; Liu JW, 2002, CANCER RES, V62, P2976; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; Matsuda F, 2011, J REPROD DEVELOP, V57, P151, DOI 10.1262/jrd.10-124H; Miao J, 2007, APOPTOSIS, V12, P1691, DOI 10.1007/s10495-007-0093-5; Miyashita MUT, 2001, FEBS LETT, V509, P135, DOI 10.1016/S0014-5793(01)03145-3; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; PELUSO JJ, 1978, J REPROD FERTIL, V54, P275, DOI 10.1530/jrf.0.0540275; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Sasaki H, 2000, CANCER RES, V60, P5659; Song QZ, 1999, EMBO J, V18, P167, DOI 10.1093/emboj/18.1.167; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sun YF, 2001, J BIOL CHEM, V276, P16240, DOI 10.1074/jbc.M010419200; TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799, DOI 10.1210/endo-129-5-2799; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje	49	57	61	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10166	10177		10.1074/jbc.M111.293274	http://dx.doi.org/10.1074/jbc.M111.293274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235114	Green Published, hybrid			2022-12-27	WOS:000302167200048
J	Hoeppner, CZ; Cheng, N; Ye, RD				Hoeppner, Crystal Zoe; Cheng, Ni; Ye, Richard D.			Identification of a Nuclear Localization Sequence in beta-Arrestin-1 and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BETA-ADRENERGIC-RECEPTOR; EXPORT SIGNAL; C-SRC; CRYSTAL-STRUCTURE; PORE COMPLEX; ARRESTIN; PROTEIN; ACTIVATION; BINDING	A mounting body of evidence suggests that beta-arrestin-1 plays important roles in the nucleus, but how beta-arrestin-1 enters the nucleus remains unclear because no nuclear import signal has been identified in the beta-arrestins. We sought to characterize the cellular localization of wild type beta-arrestin-1 and a series of N domain mutants to determine the structural basis and functional implications of beta-arrestin-1 nuclear localization. A seven-residue candidate nuclear localization sequence (NLS) was identified based on sequence analysis. Mutation of the NLS led to a loss of beta-arrestin-1 nuclear localization in transfected cells. Exogenous expression of wild type beta-arrestin-1 enhanced the transcriptional activity of nuclear factor kappa B (NF-kappa B) induced by bradykinin, whereas mutation of the NLS reduced this effect by two-thirds relative to wild type controls. Loss of beta-arrestin-1 nuclear localization was accompanied by reduced recruitment of the CREB-binding protein and altered post-translational modification profile of p65/RelA. Further mutational analysis identified Lys(157) within the putative NLS as being critical to nuclear localization of beta-arrestin-1. Substitution of Lys(157) to Ala led to reduced nuclear localization, decreased promoter binding by p65/RelA and decreased IL-1 beta gene transcription. These results demonstrate a critical role for beta-arrestin-1 nuclear localization in scaffolding and transcriptional regulation.	[Hoeppner, Crystal Zoe; Cheng, Ni; Ye, Richard D.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Ye, RD (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, 835 S Wolcott Ave, Chicago, IL 60612 USA.	yer@uic.edu	Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620	National Institutes of Health [AI033503, HL077806, AI040176]; American Heart Association [0810133Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040176, R01AI033503, R56AI033503, R01AI040176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033503, HL077806, and AI040176.; Recipient of American Heart Association Predoctoral Fellowship 0810133Z.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605, DOI 10.1002/j.1460-2075.1988.tb02986.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rojanathammanee L, 2009, MOL PHARMACOL, V75, P855, DOI 10.1124/mol.108.053397; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	50	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8932	8943		10.1074/jbc.M111.294058	http://dx.doi.org/10.1074/jbc.M111.294058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267743	hybrid, Green Published			2022-12-27	WOS:000301797800024
J	Canaff, L; Vanbellinghen, JF; Kaji, H; Goltzman, D; Hendy, GN				Canaff, Lucie; Vanbellinghen, Jean-Francois; Kaji, Hiroshi; Goltzman, David; Hendy, Geoffrey N.			Impaired Transforming Growth Factor-beta (TGF-beta) Transcriptional Activity and Cell Proliferation Control of a Menin In-frame Deletion Mutant Associated with Multiple Endocrine Neoplasia Type 1 (MEN1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; TUMOR-SUPPRESSOR PROTEIN; GENE-MUTATIONS; FACTOR JUND; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; INACTIVATION; DEREGULATION; INTERACTS	Multiple endocrine neoplasia type 1 (MEN1) is characterized by tumors of the parathyroid, enteropancreas, and anterior pituitary. The MEN1 gene encodes the tumor suppressor menin of 610 amino acids that has multiple protein partners and activities. The particular pathways that, when lost, lead to tumorigenesis are not known. We demonstrated that members of a three-generation MEN1 kindred are heterozygous for a donor splice site mutation at the beginning of intron 3 (IVS3 + 1G -> A). Lymphoblastoid cells of a mutant gene carrier had, in addition to the wild-type menin transcript, an aberrant transcript resulting from use of a cryptic splice site within exon III that splices to the start of exon IV. The predicted menin Delta(184-218) mutant has an in-frame deletion of 35 amino acids but is otherwise of wild-type sequence. The transfected menin Delta(184-218) mutant was well expressed and fully able to mediate the normal inhibition of the activity of the transcriptional regulators JunD and NF-kappa B. However, it was defective in mediating TGF-beta-stimulated Smad3 action in promoter-reporter assays in insulinoma cells. Importantly, lymphoblastoid cells from an individual heterozygous for the mutation had reduced TGF-beta-induced (Smad3) transcriptional activity but normal JunD and NF-kappa B function. In addition, the mutant gene carrier lymphoblastoid cells proliferated faster and were less responsive to the cytostatic effects of TGF-beta than cells from an unaffected family member. In conclusion, the menin mutant exhibits selective loss of the TGF-beta signaling pathway and loss of cell proliferation control contributing to the development of MEN1.	[Canaff, Lucie; Vanbellinghen, Jean-Francois; Goltzman, David; Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Canaff, Lucie; Vanbellinghen, Jean-Francois; Goltzman, David; Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; [Goltzman, David; Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Dept Physiol, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] McGill Univ, Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; [Kaji, Hiroshi] Kinki Univ, Fac Med, Div Diabet & Endocrinol, Osaka 5898511, Japan; [Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka 5898511, Japan	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Kindai University (Kinki University); Kindai University (Kinki University)	Hendy, GN (corresponding author), McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Rm H4-67,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	geoffrey.hendy@mcgill.ca	Kaji, Hiroshi/AAI-5628-2020		Canadian Institutes of Health Research [MOP-9315, MOP-86703]; Research Institute of the McGill University Health Center; Grants-in-Aid for Scientific Research [21591179] Funding Source: KAKEN	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Canadian Institutes of Health Research Grants MOP-9315 (to G. N. H.) and MOP-86703 (to D. G.).; Recipient of a postdoctoral fellowship from the Research Institute of the McGill University Health Center.	Agarwal SK, 2003, P NATL ACAD SCI USA, V100, P10770, DOI 10.1073/pnas.1834524100; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Canaff L, 2012, J CLIN ENDOCR METAB, V97, pE282, DOI 10.1210/jc.2011-0241; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Corbetta S, 2005, ENDOCR-RELAT CANCER, V12, P929, DOI 10.1677/erc.1.00970; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Debelenko LV, 1997, HUM MOL GENET, V6, P2285, DOI 10.1093/hmg/6.13.2285; Dreijerink KMA, 2006, NAT CLIN PRACT ENDOC, V2, P562, DOI 10.1038/ncpendmet0292; Engleka KA, 2007, DEV BIOL, V311, P524, DOI 10.1016/j.ydbio.2007.08.057; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hai N, 2000, CLIN ENDOCRINOL, V52, P509, DOI 10.1046/j.1365-2265.2000.00966.x; Hendy GN, 2009, ADV EXP MED BIOL, V668, P37; Hendy GN, 2005, HORM METAB RES, V37, P375, DOI 10.1055/s-2005-870152; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hussein N, 2008, ENDOCR-RELAT CANCER, V15, P217, DOI 10.1677/ERC-06-0046; Ji Y, 2007, MOL CANCER RES, V5, P1041, DOI 10.1158/1541-7786.MCR-06-0379; Kaji H, 1999, CANCER RES, V59, P5097; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kaji H, 2009, ADV EXP MED BIOL, V668, P59; Kanazawa I., 2011, J BONE MINER RES  S1, V26, pS309; Karges W, 2000, J ENDOCRINOL, V166, P1, DOI 10.1677/joe.0.1660001; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Kawamura J, 2005, ONCOL REP, V14, P47; Kim H, 2003, CANCER RES, V63, P6135; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lacerte A, 2004, MOL ENDOCRINOL, V18, P1558, DOI 10.1210/me.2003-0470; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Marx SJ, 2005, ENDOCR REV, V26, P615, DOI 10.1210/er.2003-0037; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Mould AW, 2009, INT J CANCER, V124, P1122, DOI 10.1002/ijc.24057; Murai MJ, 2011, J BIOL CHEM, V286, P31742, DOI 10.1074/jbc.M111.258186; Naito J, 2005, J BIOL CHEM, V280, P4785, DOI 10.1074/jbc.M408143200; Naito J, 2006, ENDOCRINE, V29, P485, DOI 10.1385/ENDO:29:3:485; Osthus R. C., 1998, AM J HUM GENET S, V63, pA80; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Poncin J, 1999, HUM MUTAT, V13, P54, DOI 10.1002/(SICI)1098-1004(1999)13:1<54::AID-HUMU6>3.0.CO;2-K; Roijers JFM, 2000, INT J MOL MED, V5, P611; Shen HCJ, 2008, ENDOCR-RELAT CANCER, V15, P267, DOI 10.1677/ERC-07-0191; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2004, CANCER RES, V64, P2222, DOI 10.1158/0008-5472.CAN-03-3334; Stewart C, 1998, ONCOGENE, V17, P2485, DOI 10.1038/sj.onc.1202164; Teh BT, 1998, J CLIN ENDOCR METAB, V83, P2621, DOI 10.1210/jc.83.8.2621; Teh BT, 1998, ANN SURG, V228, P99, DOI 10.1097/00000658-199807000-00015; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wu Xinjiang, 2008, Curr Mol Med, V8, P805, DOI 10.2174/156652408786733702; Yaguchi H, 2004, MOL CELL BIOL, V24, P6569, DOI 10.1128/mcb.24.15.6569-6580.2004; Yazgan O, 2001, CANCER RES, V61, P916; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	58	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8584	8597		10.1074/jbc.M112.341958	http://dx.doi.org/10.1074/jbc.M112.341958			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275377	Green Published, hybrid			2022-12-27	WOS:000301349400071
J	Baer, A; Austin, D; Narayanan, A; Popova, T; Kainulainen, M; Bailey, C; Kashanchi, F; Weber, F; Kehn-Hall, K				Baer, Alan; Austin, Dana; Narayanan, Aarthi; Popova, Taissia; Kainulainen, Markus; Bailey, Charles; Kashanchi, Fatah; Weber, Friedemann; Kehn-Hall, Kylene			Induction of DNA Damage Signaling upon Rift Valley Fever Virus Infection Results in Cell Cycle Arrest and Increased Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; NSS PROTEIN; DOWN-REGULATION; GENE-TRANSCRIPTION; MAMMALIAN-CELLS; HISTONE H2AX; S-PHASE; ACTIVATION; KINASE; TFIIH	Rift Valley fever virus (RVFV) is a highly pathogenic arthropod-borne virus infecting a wide range of vertebrate hosts. Of particular interest is the nonstructural NSs protein, which forms large filamentous fibril bundles in the nucleus. Past studies have shown NSs to be a multifaceted protein important for virulence through modulation of the interferon response as well acting as a general inhibitor of transcription. Here we investigated the regulation of the DNA damage signaling cascades by RVFV infection and found virally inducted phosphorylation of the classical DNA damage signaling proteins, ataxia-telangiectasia mutated (ATM) (Ser-1981), Chk.2 (Thr-68), H2A.X (Ser-139), and p53 (Ser-15). In contrast, ataxia-telangiectasia mutated and Rad3-related kinase (ATR) (Ser-428) phosphorylation was decreased following RVFV infection. Importantly, both the attenuated vaccine strain MP12 and the fully virulent strain ZH548 showed strong parallels in their up-regulation of the ATM arm of the DNA damage response and in the down-regulation of the ATR pathway. The increase in DNA damage signaling proteins did not result from gross DNA damage as no increase in DNA damage was observed following infection. Rather the DNA damage signaling was found to be dependent on the viral protein NSs, as an NSs mutant virus was not found to induce the equivalent signaling pathways. RVFV MP12-infected cells also displayed an S phase arrest that was found to be dependent on NSs expression. Use of ATM and Chk. 2 inhibitors resulted in a marked decrease in S phase arrest as well as viral production. These results indicate that RVFV NSs induces DNA damage signaling pathways that are beneficial for viral replication.	[Kehn-Hall, Kylene] George Mason Univ, Biomed Res Lab, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Kainulainen, Markus; Weber, Friedemann] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	George Mason University; Philipps University Marburg	Kehn-Hall, K (corresponding author), George Mason Univ, Biomed Res Lab, Natl Ctr Biodef & Infect Dis, 10650 Pyramid Pl, Manassas, VA 20110 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Weber, Friedemann/AAB-3425-2019	Weber, Friedemann/0000-0001-9737-337X; Kehn-Hall, Kylene/0000-0001-8036-7213	United States Department of Energy [DE-FC52-04NA25455]; Deutsche Forschungsgemeinschaft [We2616/5-2, SFB 593]	United States Department of Energy(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by United States Department of Energy Grant DE-FC52-04NA25455 ( to C. B.) and by Grants We2616/5-2 and SFB 593 (to F. W.) from the Deutsche Forschungsgemeinschaft.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chehab NH, 2000, GENE DEV, V14, P278; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HABENICHT AJR, 1985, J BIOL CHEM, V260, P1370; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; He YA, 2010, J VIROL, V84, P12832, DOI 10.1128/JVI.01216-10; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Li RF, 2011, FUTURE MICROBIOL, V6, P379, DOI [10.2217/FMB.11.16, 10.2217/fmb.11.16]; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Machida K, 2004, J VIROL, V78, P8835, DOI 10.1128/JVI.78.16.8835-8843.2004; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Narayanan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020354; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; Wang TZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-231; Weber F, 2002, VIRUS RES, V88, P129, DOI 10.1016/S0168-1702(02)00125-9; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yoshida K, 2010, CANCER SCI, V101, P831, DOI 10.1111/j.1349-7006.2010.01488.x; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	53	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7399	7410		10.1074/jbc.M111.296608	http://dx.doi.org/10.1074/jbc.M111.296608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223653	Green Published, hybrid			2022-12-27	WOS:000301060200041
J	Chaudhri, RA; Olivares-Navarrete, R; Cuenca, N; Hadadi, A; Boyan, BD; Schwartz, Z				Chaudhri, Reyhaan A.; Olivares-Navarrete, Rene; Cuenca, Natalia; Hadadi, Agreen; Boyan, Barbara D.; Schwartz, Zvi			Membrane Estrogen Signaling Enhances Tumorigenesis and Metastatic Potential of Breast Cancer Cells via Estrogen Receptor-alpha 36 (ER alpha 36)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-PLATE CHONDROCYTES; RECEPTOR-ALPHA; PLASMA-MEMBRANE; BONE METASTASIS; ER-ALPHA; EXPRESSION; VARIANT; ACTIVATION	Protein kinase C (PKC) signaling can be activated rapidly by 17 beta-estradiol (E-2) via nontraditional signaling in ER alpha-positive MCF7 and ER alpha-negative HCC38 breast cancer cells and is associated with tumorigenicity. Additionally, E-2 has been shown to elicit anti-apoptotic effects in cancer cells counteracting pro-apoptotic effects of chemotherapeutics. Supporting evidence suggests the existence of a membrane-associated ER that differs from the traditional receptors, ER alpha and ER beta. Our aim was to identify the ER responsible for rapid PKC activation and to evaluate downstream effects, such as proliferation, apoptosis, and metastasis. RT-PCR, Western blot, and immunofluorescence were used to determine the presence of ER splice variants in multiple cell lines. E-2 effects on PKC activity were measured with and without ER-blocking antibodies. Cell proliferation was determined by [H-3] thymidine incorporation, and cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, (MTT) whereas apoptosis was determined by DNA fragmentation and TUNEL. Quantitative RT-PCR and sandwich ELISA were used to determine the effects on metastatic factors. The role of membrane-dependent signaling in cancer cell invasiveness was examined using an in vitro assay. The results indicate the presence of an ER alpha splice variant, ER alpha 36, in ER alpha-positive MCF7 and ER alpha-negative HCC38 breast cancer cells, which localized to plasma membranes and rapidly activated PKC in response to E-2, leading to deleterious effects such as enhancement of proliferation, protection against apoptosis, and enhancement of metastatic factors. These findings propose ER alpha 36 as a novel target for the development of therapies that can prevent progression of breast cancer in the primary tumor as well as during metastasis.	[Boyan, Barbara D.] Georgia Inst Technol, Dept Biomed Engn, Sch Biol, Atlanta, GA 30332 USA; [Chaudhri, Reyhaan A.; Boyan, Barbara D.] Emory Univ, Atlanta Clin & Translat Sci Inst, Robert W Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA; [Olivares-Navarrete, Rene; Cuenca, Natalia; Boyan, Barbara D.; Schwartz, Zvi] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	Boyan, BD (corresponding author), Georgia Inst Technol, Dept Biomed Engn, Sch Biol, 315 Ferst Dr NW, Atlanta, GA 30332 USA.	barbara.boyan@bme.gatech.edu		Olivares-Navarrete, Rene/0000-0003-1232-9164; Chaudhri, Reyhaan/0000-0003-0482-0412	National Institutes of Health from USPHS [UL1 RR025008]; National Institutes of Health from NCRR [TL1 RR025010]; Price Gilbert, Jr., Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000456, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025010, UL1RR025008] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NCRR; Price Gilbert, Jr., Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants UL1 RR025008 from USPHS and TL1 RR025010 (Clinical and Translational Science Award Program) from NCRR. This work was also supported by the Price Gilbert, Jr., Foundation.	Akhtari M, 2008, CANCER BIOL THER, V7, P3, DOI 10.4161/cbt.7.1.5163; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Boyan BD, 2006, STEROIDS, V71, P286, DOI 10.1016/j.steroids.2005.09.018; Boyan BD, 2003, ENDOCRINOLOGY, V144, P1812, DOI 10.1210/en.2002-221018; Buitrago C, 2010, J STEROID BIOCHEM, V121, P169, DOI 10.1016/j.jsbmb.2010.03.002; Carey I, 1999, INT J ONCOL, V15, P127; Connolly JM, 1997, INT J ONCOL, V10, P71; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; Deng H, 2010, ONCOL REP, V24, P171, DOI 10.3892/or_00000842; Denison TA, 2009, J CELL BIOCHEM, V107, P155, DOI 10.1002/jcb.22111; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; FERNO M, 1995, BREAST CANCER RES TR, V36, P23, DOI 10.1007/BF00690181; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kampa M, 2008, STEROIDS, V73, P953, DOI 10.1016/j.steroids.2007.12.009; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Levin ER, 1999, TRENDS ENDOCRIN MET, V10, P374, DOI 10.1016/S1043-2760(99)00192-7; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; MADSEN MW, 1995, MOL CELL ENDOCRINOL, V109, P197, DOI 10.1016/0303-7207(95)03503-Y; Marino M, 2001, J CELL PHYSIOL, V188, P170, DOI 10.1002/jcp.1105; McMillan J, 2006, BBA-MOL CELL RES, V1763, P381, DOI 10.1016/j.bbamcr.2006.02.010; Merrell M, 2003, BREAST CANCER RES TR, V81, P231, DOI 10.1023/A:1026126430905; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Peng J, 2010, INT J ONCOL, V36, P451, DOI 10.3892/ijo_00000519; Poola I, 2000, J STEROID BIOCHEM, V72, P249, DOI 10.1016/S0960-0760(00)00033-9; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rose AAN, 2006, B CANCER, V93, P931; Schwartz Z, 2002, J STEROID BIOCHEM, V80, P401, DOI 10.1016/S0960-0760(02)00038-9; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song RXD, 2005, TRENDS ENDOCRIN MET, V16, P347, DOI 10.1016/j.tem.2005.06.010; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Sylvia VL, 2000, J STEROID BIOCHEM, V73, P211, DOI 10.1016/S0960-0760(00)00078-9; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; TOUITOU I, 1990, BIOCHEM BIOPH RES CO, V169, P109, DOI 10.1016/0006-291X(90)91440-4; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Weldon CB, 2005, INT J ONCOL, V26, P763; Zhong M, 2011, ENDOCRINOLOGY, V152, P82, DOI 10.1210/en.2010-0509; Zhong M, 2009, CELLS TISSUES ORGANS, V189, P56, DOI 10.1159/000152913	49	80	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7169	7181		10.1074/jbc.M111.292946	http://dx.doi.org/10.1074/jbc.M111.292946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247547	Green Published, hybrid			2022-12-27	WOS:000301060200020
J	Watanabe, HC; Welke, K; Schneider, F; Tsunoda, S; Zhang, F; Deisseroth, K; Hegemann, P; Elstner, M				Watanabe, Hiroshi C.; Welke, Kai; Schneider, Franziska; Tsunoda, Satoshi; Zhang, Feng; Deisseroth, Karl; Hegemann, Peter; Elstner, Marcus			Structural Model of Channelrhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN; OPSIN SHIFT; LIGHT; BACTERIORHODOPSIN; CHLAMYDOMONAS; POLARIZATION; SPECTROSCOPY; SIMULATIONS; PHOTOCYCLE; PHOTOTAXIS	Channelrhodopsins (ChRs) are light-gated cation channels that mediate ion transport across membranes in microalgae (vectorial catalysis). ChRs are now widely used for the analysis of neural networks in tissues and living animals with light (optogenetics). For elucidation of functional mechanisms at the atomic level, as well as for further engineering and application, a detailed structure is urgently needed. In the absence of an experimental structure, here we develop a structural ChR model based on several molecular computational approaches, capitalizing on characteristic patterns in amino acid sequences of ChR1, ChR2, Volvox ChRs, Mesostigma ChR, and the recently identified ChR of the halophilic alga Dunaliella salina. In the present model, we identify remarkable structural motifs that may explain fundamental electrophysiological properties of ChR2, ChR1, and their mutants, and in a crucial validation of the model, we successfully reproduce the excitation energy predicted by absorption spectra.	[Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, D-76131 Karlsruhe, Germany; [Schneider, Franziska; Tsunoda, Satoshi; Hegemann, Peter] Univ Berlin, Inst Biol, D-10115 Berlin, Germany; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Helmholtz Association; Karlsruhe Institute of Technology; Stanford University; Howard Hughes Medical Institute; Stanford University	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Karlstr 12, D-76131 Karlsruhe, Germany.	marcus.elstner@kit.edu	Tsunoda, Satoshi/AAN-7023-2021; Macrae, Rhiannon/AAX-1536-2020; Watanabe, Hiroshi/Q-3928-2019; Watanabe, Hiroshi/E-3724-2017; Elstner, Marcus/H-3463-2013	Watanabe, Hiroshi/0000-0003-4379-8633; Watanabe, Hiroshi/0000-0003-4379-8633; Tsunoda, Satoshi/0000-0003-3636-1521	Japan Society for the Promotion of Science for Young Scientists; Deutsche Forschungsgemeinschaft [FOR1279]	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (to H. C. W.).; Supported by Deutsche Forschungsgemeinschaft Grant FOR1279, "Protein Based Photoswitches."	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A., 2011, THESIS HUMBOLDT U BE; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; BIRGE RR, 1990, J CHEM PHYS, V92, P7179; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Dinner AR, 2003, THEOR CHEM ACC, V109, P118, DOI 10.1007/s00214-002-0417-z; Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Muller M, 2011, J MOL BIOL, V414, P86, DOI 10.1016/j.jmb.2011.09.049; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Neese F, 2003, J CHEM PHYS, V119, P9428, DOI 10.1063/1.1615956; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Phatak P, 2009, J AM CHEM SOC, V131, P7064, DOI 10.1021/ja809767v; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; Shibata M, 2003, J AM CHEM SOC, V125, P13312, DOI 10.1021/ja037343s; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vogeley L, 2004, SCIENCE, V306, P1390, DOI 10.1126/science.1103943; Wanko M, 2005, J PHYS CHEM B, V109, P3606, DOI 10.1021/jp0463060; Wanko M, 2008, J PHYS CHEM B, V112, P11468, DOI 10.1021/jp802409k; Wanko M, 2008, J PHYS CHEM B, V112, P11462, DOI 10.1021/JP802408G; Watanabe Hiroshi C, 2010, Biophysics (Oxf), V6, P67, DOI 10.2142/biophysics.6.67; Wolf S, 2008, FEBS LETT, V582, P3335, DOI 10.1016/j.febslet.2008.08.022; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhu ZY, 2005, BIOCHEMISTRY-US, V44, P82, DOI 10.1021/bi048348k	50	36	36	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7456	7466		10.1074/jbc.M111.320309	http://dx.doi.org/10.1074/jbc.M111.320309			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22241469	hybrid, Green Published			2022-12-27	WOS:000301060200046
J	Sharma, J; Mulherkar, S; Mukherjee, D; Jana, NR				Sharma, Jaiprakash; Mulherkar, Shalaka; Mukherjee, Diptendu; Jana, Nihar Ranjan			Malin Regulates Wnt Signaling Pathway through Degradation of Dishevelled2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LYSINE 63-LINKED UBIQUITINATION; LAFORA-DISEASE; PROTEASOMAL DEGRADATION; GLYCOGEN-SYNTHESIS; CATENIN PATHWAY; PROTEIN; MUTATIONS; LIGASE; PROMOTES	Using yeast-two hybrid screening followed by co-immuno-precipitation assay, we have found that the Lafora disease ubiquitin ligase malin interacts with dishevelled2, a key mediator of Wnt signaling pathway. Overexpression of malin enhances the degradation of dishevelled2 and inhibits Wnt signaling, which is evident from the down-regulation of beta-catenin target genes and the decrease in beta-catenin-mediated transcriptional activity. Partial knockdown of malin significantly increases the level of dishevelled2 and up-regulates Wnt signaling. Several malin mutants are found to be ineffective in degrading dishevelled2 and regulating the Wnt pathway. We have also found that malin enhances K48- and K63-linked ubiquitination of dishevelled2 that could lead to its degradation through both proteasome and autophagy. Altogether, our results indicate that malin regulates Wnt signaling pathway through the degradation of dishevelled2 and suggest possible deregulation of Wnt signaling in Lafora disease.	[Sharma, Jaiprakash; Mulherkar, Shalaka; Mukherjee, Diptendu; Jana, Nihar Ranjan] Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Jana, NR (corresponding author), Natl Brain Res Ctr, Mol & Cellular Neurosci Lab, Manesar 122050, Gurgaon, India.	nihar@nbrc.ac.in		Jana, Nihar/0000-0002-6549-4211	Department of Biotechnology of the Government of India	Department of Biotechnology of the Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology of the Government of India.; Supported by a research fellowship from the Department of Biotechnology of the Government of India.	ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CARPENTER S, 1981, ANN NEUROL, V10, P63, DOI 10.1002/ana.410100116; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Chan EM, 2004, HUM MOL GENET, V13, P1117, DOI 10.1093/hmg/ddh130; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Ganesh S, 2006, J HUM GENET, V51, P1, DOI 10.1007/s10038-005-0321-1; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Puri R, 2012, HUM MOL GENET, V21, P175, DOI 10.1093/hmg/ddr452; Rao SNR, 2010, HUM MOL GENET, V19, P4726, DOI 10.1093/hmg/ddq407; Rao SNR, 2010, J BIOL CHEM, V285, P1404, DOI 10.1074/jbc.M109.006312; Sharma J, 2011, NEUROBIOL DIS, V44, P133, DOI 10.1016/j.nbd.2011.06.013; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; Singh S, 2009, HUM MUTAT, V30, P715, DOI 10.1002/humu.20954; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	44	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6830	6839		10.1074/jbc.M111.315135	http://dx.doi.org/10.1074/jbc.M111.315135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223637	hybrid, Green Published			2022-12-27	WOS:000300791800068
J	Arruda, DC; Santos, LCP; Melo, FM; Pereira, FV; Figueiredo, CR; Matsuo, AL; Mortara, RA; Juliano, MA; Rodrigues, EG; Dobroff, AS; Polonelli, L; Travassos, LR				Arruda, Denise C.; Santos, Luana C. P.; Melo, Filipe M.; Pereira, Felipe V.; Figueiredo, Carlos R.; Matsuo, Alisson L.; Mortara, Renato A.; Juliano, Maria A.; Rodrigues, Elaine G.; Dobroff, Andrey S.; Polonelli, Luciano; Travassos, Luiz R.			beta-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC ACTIVITY; SYNTHETIC PEPTIDE; SURFACE; POLYMERIZATION; TRANSLOCATION; CASPASE; COFILIN; YEAST; CDRS	Complementarity-determining regions (CDRs) from monoclonal antibodies tested as synthetic peptides display anti-infective and antitumor activities, independent of the specificity of the native antibody. Previously, we have shown that the synthetic peptide C7H2, based on the heavy chain CDR 2 from monoclonal antibody C7, a mAb directed to a mannoprotein of Candida albicans, significantly reduced B16F10 melanoma growth and lung colony formation by triggering tumor apoptosis. The mechanism, however, by which C7H2 induced apoptosis in tumor cells remained unknown. Here, we demonstrate that C7H2 interacts with components of the tumor cells cytoskeleton, being rapidly internalized after binding to the tumor cell surface. Mass spectrometry analysis and in vitro validation revealed that beta-actin is the receptor of C7H2 in the tumor cells. C7H2 induces beta-actin polymerization and F-actin stabilization, linked with abundant generation of superoxide anions and apoptosis. Major phenotypes following peptide binding were chromatin condensation, DNA fragmentation, annexin V binding, lamin disruption, caspase 8 and 3 activation, and organelle alterations. Finally, we evaluated the cytotoxic efficacy of C7H2 in a panel of human tumor cell lines. All tumor cell lines studied were equally susceptible to C7H2 in vitro. The C7H2 amide without further derivatization significantly reduced lung metastasis of mice endovenously challenged with B16F10-Nex2 melanoma cells. No significant cytotoxicity was observed toward nontumorigenic cell lines on short incubation in vitro or in naive mice injected with a high dose of the peptide. We believe that C7H2 is a promising peptide to be developed as an anticancer drug.	[Arruda, Denise C.; Santos, Luana C. P.; Melo, Filipe M.; Pereira, Felipe V.; Figueiredo, Carlos R.; Matsuo, Alisson L.; Rodrigues, Elaine G.; Travassos, Luiz R.] Univ Fed Sao Paulo UNIFESP, Unidade Oncol Expt UNONEX, BR-04023062 Sao Paulo, Brazil; [Mortara, Renato A.] Univ Fed Sao Paulo UNIFESP, Div Parasitol, BR-04023062 Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo UNIFESP, Dept Biophys, BR-04023062 Sao Paulo, Brazil; [Matsuo, Alisson L.; Travassos, Luiz R.] Recepta Biopharma, BR-04533014 Sao Paulo, Brazil; [Dobroff, Andrey S.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Polonelli, Luciano] Univ Parma, I-43121 Parma, Italy	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; UTMD Anderson Cancer Center; University of Parma	Travassos, LR (corresponding author), Univ Fed Sao Paulo UNIFESP, Unidade Oncol Expt UNONEX, Rua Botucatu 862,8 Andar, BR-04023062 Sao Paulo, Brazil.	travassos@unifesp.br	Melo, Filipe/L-8170-2019; Travassos, Luiz R/J-3631-2012; de Melo, Filipe Menegatti/J-9918-2014; Rodrigues, Elaine Guadelupe/ABB-6632-2021; Mortara, Renato A./C-1864-2012; Dobroff, Andrey/A-9814-2016; , Denise/AAD-1162-2022; Figueiredo, Carlos Rogerio de/H-1236-2014; Complexos, INCT Fluidos/H-9172-2013; Arruda, Denise C/E-2184-2013; Travassos, Luiz/V-2467-2019; Rodrigues, Elaine G/H-3688-2014	de Melo, Filipe Menegatti/0000-0002-3672-3636; Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; Mortara, Renato A./0000-0002-2311-8349; Dobroff, Andrey/0000-0003-2162-9951; Figueiredo, Carlos Rogerio de/0000-0003-3680-4070; Arruda, Denise C/0000-0002-8807-8835; 	Brazilian National Research Council (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [06/50634-2, 10/51423-0]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Recipients of career fellowships from the Brazilian National Research Council (CNPq).; This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) Grants 06/50634-2 and 10/51423-0.	Barras D, 2011, CURR PHARM BIOTECHNO, V12, P1153, DOI 10.2174/138920111796117337; Bhutia SK, 2008, TRENDS BIOTECHNOL, V26, P210, DOI 10.1016/j.tibtech.2008.01.002; BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; Chen JY, 2009, PEPTIDES, V30, P2365, DOI 10.1016/j.peptides.2009.08.019; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cozzolino R, 2005, CARCINOGENESIS, V26, P733, DOI 10.1093/carcin/bgi017; Daffre S, 2008, STUD NAT PROD CHEM, V35, P597; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dobroff AS, 2010, TRANSL ONCOL, V3, P204, DOI 10.1593/tlo.09316; Dobroff AS, 2002, HYBRIDOMA HYBRIDOM, V21, P321, DOI 10.1089/153685902761022661; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Giammarioli AM, 2008, CANCER RES, V68, P5291, DOI 10.1158/0008-5472.CAN-08-0222; Gomes A, 2010, INDIAN J EXP BIOL, V48, P93; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Janin YL, 2003, AMINO ACIDS, V25, P1, DOI 10.1007/s00726-002-0349-x; Kim BM, 2009, TOXICOL APPL PHARM, V239, P87, DOI 10.1016/j.taap.2009.05.020; Leadsham JE, 2010, CELL DEATH DIFFER, V17, P754, DOI 10.1038/cdd.2009.196; Levee MG, 1996, AM J PHYSIOL-CELL PH, V271, pC1981, DOI 10.1152/ajpcell.1996.271.6.C1981; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Magliani W, 2004, CURR MED CHEM, V11, P1793, DOI 10.2174/0929867043364964; Magliani W, 2009, CURR MED CHEM, V16, P2305, DOI 10.2174/092986709788453104; Miles LA, 2006, J NEUROSCI, V26, P13017, DOI 10.1523/JNEUROSCI.2070-06.2006; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; MOROIANU J, 1993, P NATL ACAD SCI USA, V90, P3815, DOI 10.1073/pnas.90.9.3815; Murray David, 2003, Am J Clin Oncol, V26, pe169, DOI 10.1097/01.coc.0000091359.11281.f4; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; OWEN MJ, 1978, P NATL ACAD SCI USA, V75, P4484, DOI 10.1073/pnas.75.9.4484; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2011, ANTON LEEUW INT J G, V99, P35, DOI 10.1007/s10482-010-9496-3; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rao JY, 1999, J CELL BIOCHEM, V75, P686, DOI 10.1002/(SICI)1097-4644(19991215)75:4<686::AID-JCB14>3.0.CO;2-F; SANDERS SK, 1983, J IMMUNOL, V131, P370; Sato M, 2007, INT J ONCOL, V30, P1453; Savoia D, 2006, EXP PARASITOL, V113, P186, DOI 10.1016/j.exppara.2006.01.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tang HL, 2006, BIOCHEM J, V396, P1, DOI 10.1042/BJ20060241; Wang H, 2004, CANCER RES, V64, P162, DOI 10.1158/0008-5472.CAN-03-1862; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	45	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14912	14922		10.1074/jbc.M111.322362	http://dx.doi.org/10.1074/jbc.M111.322362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334655	Green Published, hybrid			2022-12-27	WOS:000304003200054
J	Buske, PJ; Levin, PA				Buske, Paul J.; Levin, Petra Anne			Extreme C Terminus of Bacterial Cytoskeletal Protein FtsZ Plays Fundamental Role in Assembly Independent of Modulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; DYNAMICS; GTPASE; GENE; RING; POLYMERIZATION; EZRA	Bacterial cell division typically requires assembly of the cytoskeletal protein FtsZ into a ring (Z-ring) at the nascent division site that serves as a foundation for assembly of the division apparatus. High resolution imaging suggests that the Z-ring consists of short, single-stranded polymers held together by lateral interactions. Several proteins implicated in stabilizing the Z-ring enhance lateral interactions between FtsZ polymers in vitro. Here we report that residues at the C terminus of Bacillus subtilis FtsZ (C-terminal variable region (CTV)) are both necessary and sufficient for stimulating lateral interactions in vitro in the absence of modulatory proteins. Swapping the 6-residue CTV from B. subtilis FtsZ with the 4-residue CTV from Escherichia coli FtsZ completely abolished lateral interactions between chimeric B. subtilis FtsZ polymers. The E. coli FtsZ chimera readily formed higher order structures normally seen only in the presence of molecular crowding agents. CTV-mediated lateral interactions are important for the integrity of the Z-ring because B. subtilis cells expressing the B. subtilis FtsZ chimera had a low frequency of FtsZ ring formation and a high degree of filamentation relative to wild-type cells. Site-directed mutagenesis of the B. subtilis CTV suggests that electrostatic forces are an important determinant of lateral interaction potential.	[Buske, Paul J.; Levin, Petra Anne] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	plevin@wustl.edu		Levin, Petra/0000-0003-2071-0547	National Institutes of Health Public Health Service [GM64671]; Levin laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Levin laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant GM64671 (to P. A. L.).; We thank Bill Margolin for the generous gift of antisera against E. coli FtsZ. We also thank Wandy Beatty for assistance with electron microscopy. We are indebted to Laura Romberg, Daniel Haeusser, and Corey Westfall for valuable comments on the manuscript and to members of the Levin laboratory for technical advice, lively discussions, and support.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; BEALL B, 1988, J BACTERIOL, V170, P4855, DOI 10.1128/jb.170.10.4855-4864.1988; BI E, 1992, J BACTERIOL, V174, P5414, DOI 10.1128/JB.174.16.5414-5423.1992; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; DAI K, 1994, J BACTERIOL, V176, P130, DOI 10.1128/JB.176.1.130-136.1994; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; de Oliveira IFF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012048; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gupta P, 2010, ACTA BIOCH BIOPH SIN, V42, P58, DOI 10.1093/abbs/gmp105; Haeusser DP, 2007, J BACTERIOL, V189, P9001, DOI 10.1128/JB.01172-07; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Harwood C.R., 1990, MOL BIOL METHODS BAC; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lan GH, 2008, BIOPHYS J, V95, P4045, DOI 10.1529/biophysj.108.132837; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Osawa M, 2006, J BACTERIOL, V188, P7132, DOI 10.1128/JB.00647-06; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; Raymond A, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-37; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Sambrook J., 2001, MOL CLONING LAB MANU; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; WANG XD, 1993, MOL MICROBIOL, V9, P435, DOI 10.1111/j.1365-2958.1993.tb01705.x; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	59	67	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10945	10957		10.1074/jbc.M111.330324	http://dx.doi.org/10.1074/jbc.M111.330324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298780	Green Published, hybrid			2022-12-27	WOS:000302780100023
J	Eisenach, PA; de Sampaio, PC; Murphy, G; Roghi, C				Eisenach, Patricia A.; de Sampaio, Pedro Correa; Murphy, Gillian; Roghi, Christian			Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Ubiquitination at Lys(581) Increases Cellular Invasion through Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; 1-MATRIX METALLOPROTEINASE; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; DIFFERENT PATHWAYS; OXIDATIVE STRESS; PLASMA-MEMBRANE; CANCER-THERAPY; UP-REGULATION; TUMOR-GROWTH	Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP14) is a zinc-dependent type I transmembrane metalloproteinase playing pivotal roles in the regulation of pericellular proteolysis and cellular migration. Elevated expression levels of MT1-MMP have been demonstrated to correlate with a poor prognosis in cancer. MT1-MMP has a short intracellular domain (ICD) that has been shown to play important roles in cellular migration and invasion, although these ICD-mediated mechanisms remain poorly understood. In this study, we report that MT1-MMP is mono-ubiquitinated at its unique lysine residue (Lys(581)) within the ICD. Our data suggest that this post-translational modification is involved in MT1-MMP trafficking as well as in modulating cellular invasion through type I collagen matrices. By using an MT1-MMP Y573A mutant or the Src family inhibitor PP2, we observed that the previously described Src-dependent MT1-MMP phosphorylation is a prerequisite for ubiquitination. Taken together, these findings show for the first time an additional post-translational modification of MT1-MMP that regulates its trafficking and cellular invasion, which further emphasizes the key role of the MT1-MMP ICD.	[Eisenach, Patricia A.; de Sampaio, Pedro Correa; Murphy, Gillian; Roghi, Christian] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eisenach, PA (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	eisenach@biochem.mpg.de	Roghi, Christian/F-3228-2012	Roghi, Christian/0000-0002-4109-6382; Correa de Sampaio, Pedro/0000-0001-5597-2825	Cancer Research UK; Hutchison Whampoa Ltd.; European Union [LSHC-CT-2003-503297]; German National Academic Foundation (Studienstiftung des DeutschenVolkes); Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia)	Cancer Research UK(Cancer Research UK); Hutchison Whampoa Ltd.; European Union(European Commission); German National Academic Foundation (Studienstiftung des DeutschenVolkes); Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	This work was supported by Cancer Research UK and Hutchison Whampoa Ltd. (to P. A. E., C. R., and G. M.), European Union Framework Programme 6, LSHC-CT-2003-503297 (to G. M. and P. A. E.), the German National Academic Foundation (Studienstiftung des DeutschenVolkes) (to P. A. E.), and the Portuguese Foundation for Science and Technology (Fundacaopara a Ciencia e Tecnologia) (to P. C. d. S.).	An WG, 2000, LEUKEMIA, V14, P1276, DOI 10.1038/sj.leu.2401812; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Aoh QL, 2009, MOL BIOL CELL, V20, P1816, DOI 10.1091/mbc.E08-09-0894; Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cao C, 2005, ONCOGENE, V24, P2433, DOI 10.1038/sj.onc.1208454; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Janssens S, 2006, CARDIOVASC RES, V69, P585, DOI 10.1016/j.cardiores.2005.12.010; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; NOMURA H, 1995, CANCER RES, V55, P3263; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Onishi Y, 2005, BIOCHEM BIOPH RES CO, V336, P799, DOI 10.1016/j.bbrc.2005.08.175; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Roghi C, 2010, FEBS J, V277, P3158, DOI 10.1111/j.1742-4658.2010.07723.x; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Ueno H, 1997, CANCER RES, V57, P2055; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wickramasinghe RD, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-58; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Yoshizaki T, 1997, CANCER, V79, P139, DOI 10.1002/(SICI)1097-0142(19970101)79:1<139::AID-CNCR20>3.0.CO;2-4; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	72	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11533	11545		10.1074/jbc.M111.306340	http://dx.doi.org/10.1074/jbc.M111.306340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315223	Green Published, hybrid			2022-12-27	WOS:000302780100081
J	Huynh, MB; Morin, C; Carpentier, G; Garcia-Filipe, S; Talhas-Perret, S; Barbier-Chassefiere, V; van Kuppevelt, TH; Martelly, I; Albanese, P; Papy-Garcia, D				Minh Bao Huynh; Morin, Christophe; Carpentier, Gilles; Garcia-Filipe, Stephanie; Talhas-Perret, Sofia; Barbier-Chassefiere, Veronique; van Kuppevelt, Toin H.; Martelly, Isabelle; Albanese, Patricia; Papy-Garcia, Dulce			Age-related Changes in Rat Myocardium Involve Altered Capacities of Glycosaminoglycans to Potentiate Growth Factor Functions and Heparan Sulfate-altered Sulfation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; ANTIBODY; PROTEOGLYCANS; LOCALIZATION; RECEPTOR; DOMAINS; BIOLOGY; BINDING; FAMILY; KIDNEY	Glycosaminoglycans (GAGs) are essential components of the extracellular matrix, the natural environment from which cell behavior is regulated by a number or tissue homeostasis guarantors including growth factors. Because most heparin-binding growth factor activities are regulated by GAGs, structural and functional alterations of these polysaccharides may consequently affect the integrity of tissues during critical physiological and pathological processes. Here, we investigated whether the aging process can induce changes in the myocardial GAG composition in rats and whether these changes can affect the activities of particular heparin-binding growth factors known to sustain cardiac tissue integrity. Our results showed an age-dependent increase of GAG levels in the left ventricle. Biochemical and immunohistological studies pointed out heparan sulfates (HS) as the GAG species that increased with age. ELISA-based competition assays showed altered capacities of the aged myocardial GAGs to bind FGF-1, FGF-2, and VEGF but not HB EGF. Mitogenic assays in cultured cells showed an age-dependent decrease of the elderly GAG capacities to potentiate FGF-2 whereas the potentiating effect on VEGF(165) was increased, as confirmed by augmented angiogenic cell proliferation in Matrigel plugs. Moreover, HS disaccharide analysis showed considerably altered 6-O-sulfation with modest changes in N- and 2-O-sulfations. Together, these findings suggest a physiological significance of HS structural and functional alterations during aging. This can be associated with an age-dependent decline of the extracellular matrix capacity to efficiently modulate not only the activity of resident or therapeutic growth factors but also the homing of resident or therapeutic cells.	[Minh Bao Huynh; Morin, Christophe; Carpentier, Gilles; Garcia-Filipe, Stephanie; Talhas-Perret, Sofia; Barbier-Chassefiere, Veronique; Martelly, Isabelle; Albanese, Patricia; Papy-Garcia, Dulce] Univ Paris Est Creteil, CNRS 7149, Lab Croissance Reparat & Regenerat Tissulaires EA, F-94010 Creteil, France; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HC Nijmegen, Netherlands	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Radboud University Nijmegen	Papy-Garcia, D (corresponding author), 61 Ave Gen Gaulle, F-94010 Creteil, France.	papy@u-pec.fr	Morin, christophe/V-6238-2017; van Kuppevelt, A.H.M.S.M./L-4463-2015; Morin, christophe/O-8796-2019	Morin, christophe/0000-0002-2490-7585; Morin, christophe/0000-0002-2490-7585; Carpentier, Gilles/0000-0002-3730-7263	Association Francaise contre les Myopathies [12144]; French Ministry of Superior Education and Research	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Superior Education and Research	This work was supported by Association Francaise contre les Myopathies Grant 12144.; Supported by the French Ministry of Superior Education and Research.	Ashikari-Hada S, 2009, GLYCOBIOLOGY, V19, P644, DOI 10.1093/glycob/cwp031; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blondet B, 2005, J HISTOCHEM CYTOCHEM, V53, P971, DOI 10.1369/jhc.4A6574.2005; Blondet B, 2006, NEUROCHEM RES, V31, P907, DOI 10.1007/s11064-006-9095-x; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Deschamps AM, 2005, CURR OPIN CARDIOL, V20, P211, DOI 10.1097/01.hco.0000162397.44843.83; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Gaffney MM, 2007, BRIT J PHARMACOL, V152, P175, DOI 10.1038/sj.bjp.0707315; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Kardami E, 2007, HEART FAIL REV, V12, P267, DOI 10.1007/s10741-007-9027-0; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lavu M, 2011, J MOL CELL CARDIOL, V50, P742, DOI 10.1016/j.yjmcc.2010.06.007; Lensen JFM, 2006, MATRIX BIOL, V25, P457, DOI 10.1016/j.matbio.2006.06.003; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; Najafi F, 2009, EUR J HEART FAIL, V11, P472, DOI 10.1093/eurjhf/hfp029; Najjam Saloua, 1997, Biochemical Society Transactions, V25, p3S; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Prokopi M, 2011, CIRC RES, V108, P499, DOI 10.1161/CIRCRESAHA.110.226902; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rouet V, 2005, J BIOL CHEM, V280, P32792, DOI 10.1074/jbc.M504492200; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Smetsers TFCM, 2004, J INVEST DERMATOL, V122, P707, DOI 10.1111/j.0022-202X.2004.22316.x; Smits NC, 2004, AM J RESP CELL MOL, V30, P166, DOI 10.1165/rcmb.2003-0198OC; Smits NC, 2010, J BIOL CHEM, V285, P41143, DOI 10.1074/jbc.M110.153791; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Toyoda H, 1999, J CHROMATOGR A, V830, P197, DOI 10.1016/S0021-9673(98)00854-1; Wang XJ, 2008, J MOL CELL CARDIOL, V45, P11, DOI 10.1016/j.yjmcc.2008.03.025; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z; Wijnhoven TJM, 2006, AM J KIDNEY DIS, V48, P250, DOI 10.1053/j.ajkd.2006.05.003; Yung S, 2007, PERITON DIALYSIS INT, V27, pS104; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 ; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	40	36	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11363	11373		10.1074/jbc.M111.335901	http://dx.doi.org/10.1074/jbc.M111.335901			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22298772	hybrid, Green Published			2022-12-27	WOS:000302780100066
J	Hanley, PJ; Kronlage, M; Kirschning, C; del Rey, A; Di Virgilio, F; Leipziger, J; Chessell, IP; Sargin, S; Filippov, MA; Lindemann, O; Mohr, S; Konigs, V; Schillers, H; Bahler, M; Schwab, A				Hanley, Peter J.; Kronlage, Moritz; Kirschning, Carsten; del Rey, Adriana; Di Virgilio, Francesco; Leipziger, Jens; Chessell, Iain P.; Sargin, Sarah; Filippov, Mikhail A.; Lindemann, Otto; Mohr, Simon; Koenigs, Volker; Schillers, Hermann; Baehler, Martin; Schwab, Albrecht			Transient P2X(7) Receptor Activation Triggers Macrophage Death Independent of Toll-like Receptors 2 and 4, Caspase-1, and Pannexin-1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1-BETA RELEASE; CELL-DEATH; INTERLEUKIN-1-BETA RELEASE; CYTOKINE PRODUCTION; MURINE MACROPHAGES; MOUSE MACROPHAGE; ATP RELEASE; INFLAMMASOME; CA2+; MECHANISM	The function of P2X(7) receptors (ATP-gated ion channels) in innate immune cells is unclear. In the setting of Toll-like receptor (TLR) stimulation, secondary activation of P2X(7) ion channels has been linked to pro-caspase-1 cleavage and cell death. Here we show that cell death is a surprisingly early triggered event. We show using live-cell imaging that transient (1-4 min) stimulation of mouse macrophages with high extracellular ATP ([ ATP] e) triggers delayed (hours) cell death, indexed as DEVDase (caspase-3 and caspase-7) activity. Continuous or transient high [ ATP] e did not induce cell death in P2X(7)-deficient (P2X(7)(-/-)) macrophages or neutrophils (in which P2X(7) could not be detected). Blocking sustained Ca2+ influx, a signature of P2X(7) ligation, was highly protective, whereas no protection was conferred in macrophages lacking caspase-1 or TLR2 and TLR4. Furthermore, pannexin-1 (Panx1) deficiency had no effect on transient ATP-induced delayed cell death or ATP-induced Yo-Pro-1 uptake (an index of large pore pathway formation). Thus, "transient" P2X(7) receptor activation and Ca2+ overload act as a death trigger for native mouse macrophages independent of Panx1 and pro-inflammatory caspase-1 and TLR signaling.	[Hanley, Peter J.; Baehler, Martin] Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Kronlage, Moritz; Sargin, Sarah; Lindemann, Otto; Mohr, Simon; Koenigs, Volker; Schillers, Hermann; Schwab, Albrecht] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Kirschning, Carsten] Univ Duisburg Essen, Inst Med Mikrobiol, D-45147 Essen, Germany; [del Rey, Adriana] Univ Marburg, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany; [Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Leipziger, Jens] Aarhus Univ, Inst Physiol & Biophys, DK-8000 Aarhus, Denmark; [Chessell, Iain P.] Neurosci Ctr Excellence, Cambridge CB21 6GH, England; [Filippov, Mikhail A.] Univ Klinikum Heidelberg, Neurol Klin, D-69120 Heidelberg, Germany	University of Munster; University of Munster; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Philipps University Marburg; University of Ferrara; Aarhus University; Ruprecht Karls University Heidelberg	Hanley, PJ (corresponding author), Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	Filippov, Mikhail A/V-7475-2018; DI VIRGILIO, Francesco/O-4634-2019; Hanley, Peter J/H-4915-2017; Di Virgilio, Francesco/J-3754-2018	Filippov, Mikhail A/0000-0003-4739-7482; DI VIRGILIO, Francesco/0000-0003-3566-1362; Di Virgilio, Francesco/0000-0003-3566-1362; Leipziger, Jens/0000-0002-6719-7034; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft (DFG) [SCHW 407/9-3]; Innovative Medizinische Forschung (IMF) from the Westfalische Wilhems-Universitat Munster [HA110710]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Innovative Medizinische Forschung (IMF) from the Westfalische Wilhems-Universitat Munster	This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG) Grant SCHW 407/9-3 (to A. S.) and the Innovative Medizinische Forschung (IMF) Grant HA110710 (to P. J. H.) from the Westfalische Wilhems-Universitat Munster.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Cen H, 2008, FASEB J, V22, P2243, DOI 10.1096/fj.07-099234; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sanz JM, 2000, J IMMUNOL, V164, P4893, DOI 10.4049/jimmunol.164.9.4893; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	41	58	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10650	10663		10.1074/jbc.M111.332676	http://dx.doi.org/10.1074/jbc.M111.332676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22235111	hybrid, Green Published			2022-12-27	WOS:000302167200090
J	Lee, K; Shim, J; Bae, J; Kim, YJ; Lee, J				Lee, Kiho; Shim, Jiwon; Bae, Jaebum; Kim, Young-Joon; Lee, Junho			Stabilization of RNT-1 Protein, Runt-related Transcription Factor (RUNX) Protein Homolog of Caenorhabditis elegans, by Oxidative Stress through Mitogen-activated Protein Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; DEPENDENT PHOSPHORYLATION; MEDIATED DEGRADATION; CELL-PROLIFERATION; MAPK PHOSPHATASE; OSTEOCALCIN GENE; EXPRESSION; METHYLATION; RECEPTOR; CANCER	RUNX proteins are evolutionarily conserved transcription factors known to be involved in various developmental processes. Here we report a new role for a RUNX protein: a role in stress response. We show that RNT-1, the Caenorhabditis elegans RUNX homolog, is constantly produced and degraded by the ubiquitination-proteasome pathway in the intestine of the nematode. RNT-1 was rapidly stabilized by oxidative stress, and the rnt-1-mutant animals were more sensitive to oxidative stress, indicating that rapid RNT-1 stabilization is a defense response against the oxidative stress. The MAP kinase pathway is required for RNT-1 stabilization, and RNT-1 was phosphorylated by SEK-1/PMK-1 in vitro. ChIP-sequencing analysis revealed a feedback loop mechanism of the MAP kinase pathway by the VHP-1 phosphatase in the RNT-1-mediated oxidative stress response. We propose that rnt-1 is regulated at the protein level for its role in the immediate response to environmental challenges in the intestine.	[Lee, Kiho; Shim, Jiwon; Lee, Junho] Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Res Ctr Cellul, Seoul 151742, South Korea; [Bae, Jaebum; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Coll Life Sci & Technol, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Lee, J (corresponding author), Seoul Natl Univ, Dept Biol Sci, WCU Dept Biophys & Chem Biol, Res Ctr Cellul, 56-1 Gwanak Gu, Seoul 151742, South Korea.	elegans@snu.ac.kr	Lee, Junho/AAO-4706-2021; Shim, Jiwon/AAQ-4501-2021	Shim, Jiwon/0000-0003-2409-1130	World Class University; Research Center for Functional Cellulomics	World Class University; Research Center for Functional Cellulomics	This work was supported by the World Class University program and Research Center for Functional Cellulomics.	Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bae SC, 2000, GENE, V241, P255, DOI 10.1016/S0378-1119(99)00488-6; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Ewbank Jonathan J, 2006, WormBook, P1; Friedrich MJ, 2006, J PATHOL, V210, P141, DOI 10.1002/path.2042; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kim EJ, 2008, J UROLOGY, V180, P1141, DOI 10.1016/j.juro.2008.05.002; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee YM, 2011, J CELL BIOCHEM, V112, P394, DOI 10.1002/jcb.22969; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nimmo R, 2005, DEVELOPMENT, V132, P5043, DOI 10.1242/dev.02102; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Qiao M, 2006, J BIOL CHEM, V281, P7118, DOI 10.1074/jbc.M508162200; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rocca A, 2001, MOL BIOL CELL, V12, P1293, DOI 10.1091/mbc.12.5.1293; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shim J, 2008, BIOCHEM BIOPH RES CO, V367, P130, DOI 10.1016/j.bbrc.2007.12.097; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; Sundaram Meera V, 2006, WormBook, P1; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.60	49	12	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10444	10452		10.1074/jbc.M111.314146	http://dx.doi.org/10.1074/jbc.M111.314146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308034	Green Published, hybrid			2022-12-27	WOS:000302167200071
J	Mori, Y; Yamaguchi, M; Terao, Y; Hamada, S; Ooshima, T; Kawabata, S				Mori, Yuka; Yamaguchi, Masaya; Terao, Yutaka; Hamada, Shigeyuki; Ooshima, Takashi; Kawabata, Shigetada			alpha-Enolase of Streptococcus pneumoniae Induces Formation of Neutrophil Extracellular Traps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; SURFACE; PLASMINOGEN; DNA; TRANSMIGRATION; DEGRADATION; RECRUITMENT; PYOGENES; IMMUNITY; CELLS	Streptococcus pneumoniae is the most common causative agent of community-acquired pneumonia throughout the world, with high morbidity and mortality rates. A major feature of pneumococcal pneumonia is abundant neutrophil infiltration. In this study, we identified S. pneumoniae alpha-enolase as a neutrophil binding protein in ligand blot assay and mass spectrometry findings. Scanning electron microscopic and fluorescence microscopic analyses also revealed that S. pneumoniae alpha-enolase induces formation of neutrophil extracellular traps, which have been reported to bind and kill microbes. In addition, cytotoxic assay results showed that alpha-enolase dose-dependently increased the release of extracellular lactate dehydrogenase from human neutrophils as compared with untreated neutrophils. Furthermore, an in vitro cell migration assay using Chemotaxicell culture chambers demonstrated that alpha-enolase possesses neutrophil migrating activity. Interestingly, bactericidal assay findings showed that alpha-enolase increased neutrophil extracellular trap-dependent killing of S. pneumoniae in human blood. Moreover, pulldown assay and mass spectrometry results identified myoblast antigen 24.1D5 as an alpha-enolase-binding protein on human neutrophils, whereas flow cytometric analysis revealed that 24.1D5 was expressed on human neutrophils, but not on human monocytes or T cells. Together, our results indicate that alpha-enolase from S. pneumoniae increases neutrophil migrating activity and induces cell death of human neutrophils by releasing neutrophil extracellular traps. Furthermore, we found that myoblast antigen 24.1D5, which expressed on the surface of neutrophils, bound to alpha-enolase of S. pneumoniae.	[Mori, Yuka; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Mori, Yuka; Ooshima, Takashi] Osaka Univ, Dept Pediat Dent, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Yamaguchi, Masaya] Osaka Univ, Dept Cell Membrane Biol, Inst Sci & Ind Res, Osaka 5670047, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect 6, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; Osaka University; Ministry of Public Health - Thailand	Terao, Y (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	terao@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23593027, 10J01281, 23592700] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as grants-in-aid for scientific research (B), Young Scientists (A), Challenging Exploratory Research, and Research Activity Start-up from the Japan Society for the Promotion of Science, a fellowship from the Japan Society for the Promotion of Science, and a grant from the Takeda Science Foundation.	Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Momose H, 2003, J IMMUNOL, V171, P4227, DOI 10.4049/jimmunol.171.8.4227; Moraes TJ, 2006, CURR OPIN HEMATOL, V13, P21, DOI 10.1097/01.moh.0000190113.31027.d5; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yamaguchi M, 2009, BIOCHEM BIOPH RES CO, V390, P155, DOI 10.1016/j.bbrc.2009.09.099; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	35	82	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10472	10481		10.1074/jbc.M111.280321	http://dx.doi.org/10.1074/jbc.M111.280321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262863	hybrid, Green Published			2022-12-27	WOS:000302167200074
J	Teng, Y; Ngoka, L; Mei, Y; Lesoon, L; Cowell, JK				Teng, Yong; Ngoka, Lambert; Mei, Yun; Lesoon, Leslieann; Cowell, John K.			HSP90 and HSP70 Proteins Are Essential for Stabilization and Activation of WASF3 Metastasis-promoting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CANCER-CELLS; LAMELLIPODIA FORMATION; STATISTICAL-MODEL; DOWN-REGULATION; INVASION; DEGRADATION; CHAPERONES; INHIBITOR; MIGRATION	Inactivation of HSP90 and HSP70 leads to loss of invasion in a variety of cancer cell types, presumably as a result of destabilization of, as yet, undefined clients of these molecular chaperones that influence this phenotype. The WASF3 gene has been shown to be up-regulated in high-grade tumors and its down-regulation leads to loss of invasion and metastasis. WASF3 phosphorylation by ABL kinase is essential for its ability to regulate invasion. Mass spectroscopy analysis now shows that HSP90 is present in the WASF3 immunocomplex from prostate cancer cells. Inactivation of HSP90 in these and other cell types does not affect WASF3 stability but prevents its phosphoactivation as a result of destabilization of ABL. HSP70 was also found in the WASF3 immunocomplex and inactivation of HSP70 results in destabilization of WASF3 through proteasome degradation. Knockdown of WASF3, HSP90, and HSP70 individually, all lead to loss of invasion but as knockdown of WASF3 in the presence of robust expression of HSP90/70 has the same effect, it seems that the influence these chaperone proteins have on invasion is mediated, at least in part, by their control over the critical invasion promoting capacity of the WASF3 protein. Overexpression of HSP70 in WASF3 null cells does not enhance invasion. These observations suggest that targeting HSP90/70 may have efficacy in reducing cancer cell invasion.	[Teng, Yong; Ngoka, Lambert; Mei, Yun; Lesoon, Leslieann; Cowell, John K.] Georgia Hlth Sci Univ Canc Ctr, Augusta, GA 30912 USA		Cowell, JK (corresponding author), Georgia Hlth Sci Univ Canc Ctr, CN4121,1120 15th St,CN 4121A, Augusta, GA 30912 USA.	jcowell@georgiahealth.edu	Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289; Cowell, John/0000-0002-2079-5950	National Institutes of Health from NCI [CA120510]; NATIONAL CANCER INSTITUTE [R01CA120510] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120510 from NCI.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Garg M, 2010, CANCER-AM CANCER SOC, V116, P3785, DOI 10.1002/cncr.25218; Garg M, 2010, EUR J CANCER, V46, P207, DOI 10.1016/j.ejca.2009.10.020; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim MS, 2008, MOL CANCER RES, V6, P1657, DOI 10.1158/1541-7786.MCR-08-0034; Koga F, 2009, ANTICANCER RES, V29, P797; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu XG, 2011, ONCOL REP, V25, P1343, DOI 10.3892/or.2011.1202; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Saliba RS, 2002, J CELL SCI, V115, P2907; Sanderson S, 2006, MOL CANCER THER, V5, P522, DOI 10.1158/1535-7163.MCT-05-0439; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Taiyab A, 2011, BBA-MOL CELL RES, V1813, P213, DOI 10.1016/j.bbamcr.2010.09.012; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yokota S, 2000, CANCER RES, V60, P2942; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692	38	62	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10051	10059		10.1074/jbc.M111.335000	http://dx.doi.org/10.1074/jbc.M111.335000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315230	Green Published, hybrid			2022-12-27	WOS:000302167200037
J	Yeang, HXA; Hamdam, JM; Al-Huseini, LMA; Sethu, S; Djouhri, L; Walsh, J; Kitteringham, N; Park, BK; Goldring, CE; Sathish, JG				Yeang, Han Xian Aw; Hamdam, Junnat M.; Al-Huseini, Laith M. A.; Sethu, Swaminathan; Djouhri, Laiche; Walsh, Joanne; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.			Loss of Transcription Factor Nuclear Factor-Erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Leads to Dysregulation of Immune Functions, Redox Homeostasis, and Intracellular Signaling in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CD8(+) T-CELLS; HISTONE DEACETYLASE INHIBITORS; OXIDATIVE STRESS; IN-VIVO; ACTIVATION; MICE; MATURATION; DISEASE; TCR	Dendritic cells (DCs) are critical mediators of immunity and immune tolerance by orchestrating multiple aspects of T cell activation and function. Immature DCs (iDCs) expressing low levels of co-stimulatory receptors are highly efficient at antigen capture but are poor activators of T cells. Maturation of DCs is associated with increased expression of co-stimulatory molecules. Co-stimulatory receptor gene expression is regulated by intracellular redox, NF-kappa B, and MAPK pathways and by histone deacetylase (HDAC) activity. The transcription factor, Nrf2, is important for maintaining intracellular glutathione (GSH) levels and redox homeostasis and has been implicated in modulating DC co-stimulatory receptor expression. It is unclear whether Nrf2 mediates this effect by GSH-dependent mechanisms and whether it influences DC signaling pathways. Using bone marrow-derived iDCs from Nrf2(+/+) and Nrf2(-/-) mice, we demonstrate that Nrf2(-/-) iDCs have lower basal GSH levels, enhanced co-stimulatory receptor expression, impaired phagocytic functions, and increased antigen-specific CD8 T cell stimulation capacity. Interestingly, lowering GSH levels in Nrf2(+/+) iDCs did not recapitulate the Nrf2(-/-) iDC phenotype. Loss of Nrf2 resulted in elevated basal levels of reactive oxygen species but did not affect basal NF-kappa B activity or p38 MAPK phosphorylation. Using pharmacological inhibitors, we demonstrate that enhanced co-stimulatory receptor phenotype of Nrf2(-/-) iDC does not require ERK activity but is dependent on HDAC activity, indicating a potential interaction between Nrf2 function and HDAC. These results suggest that Nrf2 activity is required to counter rises in intracellular reactive oxygen species and to regulate pathways that control DC co-stimulatory receptor expression.	[Yeang, Han Xian Aw; Hamdam, Junnat M.; Al-Huseini, Laith M. A.; Sethu, Swaminathan; Djouhri, Laiche; Walsh, Joanne; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, Dept Pharmacol, Med Res Council, Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Liverpool	Goldring, CE (corresponding author), Univ Liverpool, Dept Pharmacol, Med Res Council, Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	chrissy@liv.ac.uk; Jean.Sathish@liv.ac.uk	Sethu, Swaminathan/R-8577-2019; Al-Huseini, Laith M Abbas/S-6613-2019	Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Walsh, Joanne/0000-0002-5109-2019; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	Wellcome trust; University Of Liverpool; Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB); Drug Safety Centre; Medical Research Council [G0700654]; Medical Research Council [G0700420, G0700654B] Funding Source: researchfish; MRC [G0700420, G0700654] Funding Source: UKRI	Wellcome trust(Wellcome Trust); University Of Liverpool; Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Drug Safety Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome trust and grants from the University Of Liverpool (to H. X. A. Y.) and the Biotechnology and Biological Sciences Research Council-Integrative Mammalian Biology (BBSRC-IMB) award (to J. M. H.), as part of the Drug Safety Centre supported by the Medical Research Council (grant number G0700654).	Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bachmann MF, 1999, EUR J IMMUNOL, V29, P2156, DOI 10.1002/(SICI)1521-4141(199907)29:07<2156::AID-IMMU2156>3.0.CO;2-P; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Celluzzi CM, 1998, J IMMUNOL, V160, P3081; Chai JG, 1999, J IMMUNOL, V163, P1298; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Delon J, 1998, J EXP MED, V188, P1473, DOI 10.1084/jem.188.8.1473; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Faraco G, 2011, MOL MED, V17, P442, DOI 10.2119/molmed.2011.00077; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kemball CC, 2006, J IMMUNOL, V176, P1814, DOI 10.4049/jimmunol.176.3.1814; Kim HJ, 2008, J ALLERGY CLIN IMMUN, V121, P1255, DOI 10.1016/j.jaci.2008.01.016; Kim HJ, 2007, J ALLERGY CLIN IMMUN, V119, P1225, DOI 10.1016/j.jaci.2007.01.016; Kim HS, 2010, INT IMMUNOPHARMACOL, V10, P1284, DOI 10.1016/j.intimp.2010.07.012; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Micheva I, 2006, BLOOD CELL MOL DIS, V36, P298, DOI 10.1016/j.bcmd.2005.12.029; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Monrad SU, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2517; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nencioni A, 2007, CLIN CANCER RES, V13, P3933, DOI 10.1158/1078-0432.CCR-06-2903; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Reddy NM, 2007, PHYSIOL GENOMICS, V32, P74, DOI 10.1152/physiolgenomics.00126.2007; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rigby S, 2000, EUR J IMMUNOL, V30, P98, DOI 10.1002/1521-4141(200001)30:1<98::AID-IMMU98>3.3.CO;2-R; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	50	50	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10556	10564		10.1074/jbc.M111.322420	http://dx.doi.org/10.1074/jbc.M111.322420			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311972	Green Published, hybrid			2022-12-27	WOS:000302167200081
J	Charlop-Powers, Z; Jakoncic, J; Gurnon, JR; Van Etten, JL; Zhou, MM				Charlop-Powers, Zachary; Jakoncic, Jean; Gurnon, James R.; Van Etten, James L.; Zhou, Ming-Ming			Paramecium bursaria Chlorella Virus 1 Encodes a Polyamine Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YELLOW MOSAIC-VIRUS; VIRAL SET PROTEIN; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; DNA VIRUSES; CHROMATIN; CANCER; PROTOPLASTS; ANNOTATION; SOFTWARE; SEQUENCE	Paramecium bursaria chlorella virus 1 (PBCV-1), a large DNA virus that infects green algae, encodes a histone H3 lysine 27-specific methyltransferase that functions in global transcriptional silencing of the host. PBCV-1 has another gene a654l that encodes a protein with sequence similarity to the GCN5 family histone acetyltransferases. In this study, we report a 1.5 angstrom crystal structure of PBCV-1 A654L in a complex with coenzyme A. The structure reveals a unique feature of A654L that precludes its acetylation of histone peptide substrates. We demonstrate that A654L, hence named viral polyamine acetyltransferase (vPAT), acetylates polyamines such as putrescine, spermidine, cadaverine, and homospermidine present in both PBCV-1 and its host through a reaction dependent upon a conserved glutamate 27. Our study suggests that as the first virally encoded polyamine acetyltransferase, vPAT plays a possible key role in the regulation of polyamine catabolism in the host during viral replication.	[Charlop-Powers, Zachary] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Gurnon, James R.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Gurnon, James R.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA	Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhou, MM (corresponding author), 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu		Charlop-Powers, Zachary/0000-0001-8816-4680	National Institutes of Health [R01HG004508, R01CA87658]; NCRR [P30RR31151]; National Science Foundation EPSCoR [EPS-1004094]; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation EPSCoR(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HG004508 and R01CA87658 (to M.-M. Z.) and NCRR P30RR31151 (to J. L. V. E.). This work was also supported by National Science Foundation EPSCoR EPS-1004094 (to J. L. V. E.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; BALINT R, 1985, VIROLOGY, V144, P181, DOI 10.1016/0042-6822(85)90316-2; BALINT R, 1985, VIROLOGY, V144, P194, DOI 10.1016/0042-6822(85)90317-4; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; Forouhar F, 2005, J BIOL CHEM, V280, P40328, DOI 10.1074/jbc.M505332200; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Persson L, 2009, ESSAYS BIOCHEM, V46, P11, DOI [10.1042/BSE0460002, 10.1042/bse0460002]; SEN D, 1986, BIOCHEMISTRY-US, V25, P1495, DOI 10.1021/bi00355a004; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wei H, 2010, P NATL ACAD SCI USA, V107, P18433, DOI 10.1073/pnas.1009911107; Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007	32	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9547	9551		10.1074/jbc.C111.337816	http://dx.doi.org/10.1074/jbc.C111.337816			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277659	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000301797800085
J	Fu, GS; Xu, T; Shi, Y; Wei, N; Yang, XL				Fu, Guangsen; Xu, Tao; Shi, Yi; Wei, Na; Yang, Xiang-Lei			tRNA-controlled Nuclear Import of a Human tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNATE TRANSFER-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXPORT; AMINOACYLATION; RECOGNITION; CYTOKINE	Aminoacyl-tRNA synthetases, essential components of the cytoplasmic translation apparatus, also have nuclear functions that continue to be elucidated. However, little is known about how the distribution between cytoplasmic and nuclear compartments is controlled. Using a combination of methods, here we showed that human tyrosyl-tRNA synthetase (TyrRS) distributes to the nucleus and that the nuclear import of human TyrRS is regulated by its cognate tRNA(Tyr). We identified a hexapeptide motif in the anticodon recognition domain that is critical for nuclear import of the synthetase. Remarkably, this nuclear localization signal (NLS) sequence motif is also important for interacting with tRNA(Tyr). As a consequence, mutational alteration of the hexapeptide simultaneously attenuated aminoacylation and nuclear localization. Because the NLS is sterically blocked when the cognate tRNA is bound to TyrRS, we hypothesized that the nuclear distribution of TyrRS is regulated by tRNA(Tyr). This expectation was confirmed by RNAi knockdown of tRNA(Tyr) expression, which led to robust nuclear import of TyrRS. Further bioinformatics analysis showed that to have nuclear import of TyrRS directly controlled by tRNA(Tyr) in higher organisms, the NLS of lower eukaryotes was abandoned, whereas the new NLS was evolved from an anticodon-binding hexapeptide motif. Thus, higher organisms developed a strategy to make tRNA a regulator of the nuclear trafficking of its cognate synthetase. The design in principle should coordinate nuclear import of a tRNA synthetase with the demands of protein synthesis in the cytoplasm.	[Yang, Xiang-Lei] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu	Xu, Tao/I-1561-2014; Fu, Guangsen/D-2991-2012; Yang, Xiang-Lei/AAR-7107-2020	Xu, Tao/0000-0002-3436-3024; Yang, Xiang-Lei/0000-0003-2554-084X; Xu, Tao/0000-0002-4085-6191	National Institutes of Health [GM88278]; Skaggs Foundation; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Foundation; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM88278( to X.-L. Y.). This work was also supported by the Skaggs Foundation and a fellowship from the National Foundation for Cancer Research.	Azad AK, 2001, MOL BIOL CELL, V12, P1381, DOI 10.1091/mbc.12.5.1381; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grosshans H, 2000, GENE DEV, V14, P830; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	22	29	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9330	9334		10.1074/jbc.C111.325902	http://dx.doi.org/10.1074/jbc.C111.325902			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291016	Green Published, hybrid			2022-12-27	WOS:000301797800064
J	Gu, S; Kelly, G; Wang, XH; Frenkiel, T; Shevchik, VE; Pickersgill, RW				Gu, Shuang; Kelly, Geoff; Wang, Xiaohui; Frenkiel, Tom; Shevchik, Vladimir E.; Pickersgill, Richard W.			Solution Structure of Homology Region (HR) Domain of Type II Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERWINIA-CHRYSANTHEMI; PROTEIN SECRETION; NEISSERIA-MENINGITIDIS; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; CHEMICAL-SHIFTS; VIBRIO-CHOLERAE; OUTC; PATHWAY; COMPLEX	The type II secretion system of Gram-negative bacteria is important for bacterial pathogenesis and survival; it is composed of 12 mostly multimeric core proteins, which build a sophisticated secretion machine spanning both bacterial membranes. OutC is the core component of the inner membrane subcomplex thought to be involved in both recognition of substrate and interaction with the outer membrane secretin OutD. Here, we report the solution structure of the HR domain of OutC and explore its interaction with the secretin. The HR domain adopts a beta-sandwich-like fold consisting of two beta-sheets each composed of three anti-parallel beta-strands. This structure is strikingly similar to the periplasmic region of PilP, an inner membrane lipoprotein from the type IV pilus system highlighting the common evolutionary origin of these two systems and showing that all the core components of the type II secretion system have a structural or sequence ortholog within the type IV pili system. The HR domain is shown to interact with the N0 domain of the secretin. The importance of this interaction is explored in the context of the functional secretion system.	[Wang, Xiaohui; Shevchik, Vladimir E.] Univ Lyon, F-69003 Lyon, France; [Wang, Xiaohui; Shevchik, Vladimir E.] Univ Lyon 1, F-69622 Villeurbanne, France; [Wang, Xiaohui; Shevchik, Vladimir E.] INSA, F-69621 Villeurbanne, France; [Wang, Xiaohui; Shevchik, Vladimir E.] CNRS, UMR5240, F-69622 Villeurbanne, France; [Gu, Shuang; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Kelly, Geoff; Frenkiel, Tom] Natl Inst Med Res, MRC Biomed NMR Ctr, London NW7 1AA, England	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of London; Queen Mary University London; MRC National Institute for Medical Research	Shevchik, VE (corresponding author), Univ Lyon, F-69003 Lyon, France.	vladimir.shevchik@insa-lyon.fr; r.w.pickersgill@qmul.ac.uk		Shevchik, Vladimir/0000-0002-8031-8638	Biology and Biotechnology Sciences Research Council (U.K); Higher Education Funding Council for England; Queen Mary University of London; French SecPath program [ANR-2010-BLANC-1531]; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish	Biology and Biotechnology Sciences Research Council (U.K); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Queen Mary University of London; French SecPath program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biology and Biotechnology Sciences Research Council (U.K), Higher Education Funding Council for England, and Queen Mary University of London.; Supported by a grant from French ANR-2010-BLANC-1531 SecPath program. To whom correspondence may be addressed: Universite de Lyon, F-69003, Universite Lyon 1, Lyon, F-69622, INSA-Lyon, Villeurbanne F-69621, CNRS, UMR5240, Microbiologie Adaptation et Pathogenie, Lyon F-69622, France. Tel.: 04-72-44-58-27; Fax: 04-72-43-15-84; E-mail: vladimir.shevchik@insa-lyon.fr.	Abendroth J, 2004, J MOL BIOL, V338, P585, DOI 10.1016/j.jmb.2004.01.064; Abendroth J, 2009, J STRUCT BIOL, V168, P313, DOI 10.1016/j.jsb.2009.07.022; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Golovanov AP, 2006, J MOL BIOL, V364, P186, DOI 10.1016/j.jmb.2006.08.078; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Korotkov KV, 2006, J MOL BIOL, V363, P311, DOI 10.1016/j.jmb.2006.08.037; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603	33	19	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9072	9080		10.1074/jbc.M111.300624	http://dx.doi.org/10.1074/jbc.M111.300624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22253442	Green Published, hybrid			2022-12-27	WOS:000301797800037
J	Mallik, L; Arif, E; Sharma, P; Rathore, YS; Wong, HN; Holzman, LB; Ashish; Nihalani, D				Mallik, Leena; Arif, Ehtesham; Sharma, Pankaj; Rathore, Yogendra S.; Wong, Hetty N.; Holzman, Lawrence B.; Ashish; Nihalani, Deepak			Solution Structure Analysis of Cytoplasmic Domain of Podocyte Protein Neph1 Using Small/Wide Angle X-ray Scattering (SWAXS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLIT DIAPHRAGM; ACTIN POLYMERIZATION; PDZ DOMAIN; KINASE; DISSOCIATION; ACTIVATION; MEMBRANE; BINDING; ZO-1	Neph1 is present in podocytes, where it plays a critical role in maintaining the filtration function of the glomerulus, in part through signaling events mediated by its cytoplasmic domain that are involved in actin cytoskeleton organization. To understand the function of this protein, a detailed knowledge of the structure of the Neph1 cytoplasmic domain (Neph1-CD) is required. In this study, the solution structure of this domain was determined by small/wide angle x-ray scattering (SWAXS). Analysis of Neph1-CD by SWAXS suggested that this protein adopts a global shape with a radius of gyration and a maximum linear dimension of 21.3 and 70 angstrom, respectively. These parameters and the data from circular dichroism experiments were used to construct a structural model of this protein. The His-ZO- 1-PDZ1 (first PDZ domain of zonula occludens) domain that binds Neph1-CD was also analyzed by SWAXS, to confirm that it adopts a global structure similar to its crystal structure. We used the SWAXS intensity profile, the structural model of Neph1-CD, and the crystal structure of ZO-1-PDZ1 to construct a structural model of the Neph1-CD.ZO-1-PDZ1 complex. Mapping of the intermolecular interactions suggested that in addition to the C-terminal residues Thr-His-Val, residues Lys-761 and Tyr-762 in Neph1 are also critical for stabilizing the complex. Estimated intensity values from the SWAXS data and in vivo and in vitro pull-down experiments demonstrated loss of binding to ZO-1 when these residues were individually mutated to alanines. Our findings present a structural model that provides novel insights into the molecular structure and function of Neph1-CD.	[Mallik, Leena; Sharma, Pankaj; Rathore, Yogendra S.; Ashish] CSIR Inst Microbial Technol, Chandigarh 160036, India; [Arif, Ehtesham; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Pennsylvania	Ashish (corresponding author), CSIR Inst Microbial Technol, Chandigarh 160036, India.	ashgang@imtech.res.in; deepakn@mail.med.upenn.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020; Mallik, Leena/AAM-4619-2020	Arif, Ehtesham/0000-0001-9638-3189; Holzman, Lawrence/0000-0002-8961-234X	National Institutes of Health, NIDDK [K01 DK072047-03, 5K01DK072047-04, RO1 1R01DK087956, DK080751]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; CSIR; UGC INDIA; CSIR-INDIA [SIP-10, FAC-03]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, K01DK072047, R01DK080751] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC INDIA(University Grants Commission, India); CSIR-INDIA(Council of Scientific & Industrial Research (CSIR) - India); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants K01 DK072047-03, 5K01DK072047-04, and RO1 1R01DK087956 (to D. N.) and National Institutes of Health, NIDDK, Grant DK080751 (to L. B. H.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.; Recipient of research fellowships from CSIR and UGC INDIA.; Work at the laboratory of A. and travel of A. and Y. S. R. from India to Brookhaven National Laboratory was provided by CSIR-INDIA Grants SIP-10 and FAC-03.; Supported in part by the Department of Veterans Affairs.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Moreno JA, 2008, CURR MED CHEM, V15, P1645, DOI 10.2174/092986708784911542; Nihalani D, 2007, MOL CELL BIOL, V27, P2431, DOI 10.1128/MCB.01479-06; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200	25	13	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9441	9453		10.1074/jbc.M111.284927	http://dx.doi.org/10.1074/jbc.M111.284927			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262837	Green Published, hybrid			2022-12-27	WOS:000301797800073
J	Moyle-Heyrman, G; Viswanathan, R; Widom, J; Auble, DT				Moyle-Heyrman, Georgette; Viswanathan, Ramya; Widom, Jonathan; Auble, David T.			Two-step Mechanism for Modifier of Transcription 1 (Mot1) Enzyme-catalyzed Displacement of TATA-binding Protein (TBP) from DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; BASAL TRANSCRIPTION; SWI2/SNF2 ATPASE; FAMILY-MEMBER; PROMOTER DNA; BOX COMPLEX; HUMAN-CELLS; DYNAMICS	The TATA box binding protein (TBP) is a central component of the transcription preinitiation complex, and its occupancy at a promoter is correlated with transcription levels. The TBP-promoter DNA complex contains sharply bent DNA and its interaction lifetime is limited by the ATP-dependent TBP displacement activity of the Snf2/Swi2 ATPase Mot1. Several mechanisms for Mot1 action have been proposed, but how it catalyzes TBP removal from DNA is unknown. To better understand the Mot1 mechanism, native gel electrophoresis and FRET were used to determine how Mot1 affects the trajectory of DNA in the TBP-DNA complex. Strikingly, in the absence of ATP, Mot1 acts to unbend DNA, whereas TBP remains closely associated with the DNA in a stable Mot1-TBP-DNA ternary complex. Interestingly, and in contrast to full-length Mot1, the isolated Mot1 ATPase domain binds DNA, and its affinity for DNA is nucleotide-dependent, suggesting parallels between the Mot1 mechanism and DNA translocation-based mechanisms of chromatin remodeling enzymes. Based on these findings, a model is presented for Mot1 that links a DNA conformational change with ATP-induced DNA translocation.	[Viswanathan, Ramya; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Widom, Jonathan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Moyle-Heyrman, Georgette; Widom, Jonathan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	University of Virginia; Northwestern University; Northwestern University	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu	Viswanathan, Ramya/L-5935-2019		National Institutes of Health [GM054692, GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, R01GM054692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054692 (to J. W.) and GM55763 (to D. T. A.).	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Auble DT, 2009, TRENDS BIOCHEM SCI, V34, P49, DOI 10.1016/j.tibs.2008.10.008; Auble DT, 1999, MOL CELL BIOL, V19, P412; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Banik U, 2001, J BIOL CHEM, V276, P49100, DOI 10.1074/jbc.M109246200; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blosser TR, 2009, NATURE, V462, P1022, DOI 10.1038/nature08627; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Delgadillo RF, 2009, BIOCHEMISTRY-US, V48, P1801, DOI 10.1021/bi8018724; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Masters KM, 2003, J BIOL CHEM, V278, P31685, DOI 10.1074/jbc.M305201200; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Nechushtai R, 2011, P NATL ACAD SCI USA, V108, P2240, DOI 10.1073/pnas.1019502108; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nimonkar AV, 2007, J BIOL CHEM, V282, P30776, DOI 10.1074/jbc.M704767200; Parkhurst KM, 1996, BIOCHEMISTRY-US, V35, P7459, DOI 10.1021/bi9530301; Parkhurst LJ, 2001, BIOPOLYMERS, V61, P180; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; PETRI V, 1995, BIOCHEMISTRY-US, V34, P9977, DOI 10.1021/bi00031a020; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Powell RM, 2002, J BIOL CHEM, V277, P7776, DOI 10.1074/jbc.M110147200; Prasad TK, 2007, J MOL BIOL, V369, P940, DOI 10.1016/j.jmb.2007.04.005; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Stols L, 2007, PROTEIN EXPRES PURIF, V53, P396, DOI 10.1016/j.pep.2007.01.013; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Whittington JE, 2008, BIOCHEMISTRY-US, V47, P7264, DOI 10.1021/bi800139w; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Wu J, 2001, J BIOL CHEM, V276, P14614, DOI 10.1074/jbc.M004402200; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhao XM, 2002, CELL, V108, P615, DOI 10.1016/S0092-8674(02)00648-7	68	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9002	9012		10.1074/jbc.M111.333484	http://dx.doi.org/10.1074/jbc.M111.333484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22298788	Green Published, hybrid			2022-12-27	WOS:000301797800031
J	Seidman, D; Johnson, D; Gerbasi, V; Golden, D; Orlando, R; Hajduk, S				Seidman, David; Johnson, Darryl; Gerbasi, Vincent; Golden, Daniel; Orlando, Ron; Hajduk, Stephen			Mitochondrial Membrane Complex That Contains Proteins Necessary for tRNA Import in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED TRANSFER-RNA; LEISHMANIA-MITOCHONDRIA; IN-VITRO; DEVELOPMENTAL REGULATION; GENE-EXPRESSION; RIBOSOMAL-RNA; BLOOD-STREAM; SEQUENCE; DIFFERENTIATION; LOCALIZATION	The mitochondrial genome of Trypanosoma brucei does not contain genes encoding tRNAs; instead this protozoan parasite must import nuclear-encoded tRNAs from the cytosol for mitochondrial translation. Previously, it has been shown that mitochondrial tRNA import requires ATP hydrolysis and a protein-aceous mitochondrial membrane component. However, little is known about the mitochondrial membrane proteins involved in tRNA binding and translocation into the mitochondrion. Here we report the purification of a mitochondrial membrane complex using tRNA affinity purification and have identified several protein components of the putative tRNA translocon by mass spectrometry. Using an in vivo tRNA import assay in combination with RNA interference, we have verified that two of these proteins, Tb11.01.4590 and Tb09.v1.0420, are involved in mitochondrial tRNA import. Using Protein C Epitope-Tobacco Etch Virus-Protein A Epitope (PTP)-tagged Tb11.01.4590, additional associated proteins were identified including Tim17 and other mitochondrial proteins necessary for mitochondrial protein import. Results presented here identify and validate two novel protein components of the putative tRNA translocon and provide additional evidence that mitochondrial tRNA and protein import have shared components in trypanosomes.	[Seidman, David; Orlando, Ron; Hajduk, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Johnson, Darryl; Orlando, Ron] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gerbasi, Vincent] Northwestern Univ, Dept Biochem Mol & Cell Biol, Evanston, IL 60208 USA; [Golden, Daniel] Merial Ltd, Duluth, GA 30096 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University	Hajduk, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Davidson Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Seidman, David/B-6697-2009	Gerbasi, Robert/0000-0001-5573-0578	National Institutes of Health [R01AI061356]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI061356.	Adhya S, 1997, J BIOL CHEM, V272, P21396, DOI 10.1074/jbc.272.34.21396; Bhattacharyya SN, 2003, MOL CELL BIOL, V23, P5217, DOI 10.1128/MCB.23.15.5217-5224.2003; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; Bomer U, 1997, EMBO J, V16, P2205, DOI 10.1093/emboj/16.9.2205; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Chatterjee S, 2006, J BIOL CHEM, V281, P25270, DOI 10.1074/jbc.M604126200; Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Esseiva AC, 2004, MOL BIOL CELL, V15, P2750, DOI 10.1091/mbc.E03-11-0821; Goswami S, 2006, P NATL ACAD SCI USA, V103, P8354, DOI 10.1073/pnas.0510869103; Gunzl A., 2009, CURR PROTOC PROTEIN, V55; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lima BD, 1996, RNA, V2, P429; Mahapatra S, 1998, NUCLEIC ACIDS RES, V26, P2037, DOI 10.1093/nar/26.9.2037; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; MICHELOTTI EF, 1987, J BIOL CHEM, V262, P927; Mukherjee S, 1999, J BIOL CHEM, V274, P31249, DOI 10.1074/jbc.274.44.31249; Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Paris Z, 2009, RNA, V15, P1398, DOI 10.1261/rna.1589109; PRIEST JW, 1994, MOL BIOCHEM PARASIT, V65, P291, DOI 10.1016/0166-6851(94)90080-9; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Rusconi CP, 1996, GENE DEV, V10, P2870, DOI 10.1101/gad.10.22.2870; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schekman Randy, 2010, Proc Natl Acad Sci U S A, V107, P9476, DOI 10.1073/pnas.1004225107; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, MOL CELL BIOL, V14, P2317, DOI 10.1128/MCB.14.4.2317; Sherrer RL, 2003, MOL CELL BIOL, V23, P9061, DOI 10.1128/MCB.23.24.9061-9072.2003; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Tan THP, 2002, P NATL ACAD SCI USA, V99, P1152, DOI 10.1073/pnas.022522299; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tasker M, 2001, MOL MICROBIOL, V39, P272, DOI 10.1046/j.1365-2958.2001.02252.x; TETLEY L, 1985, J CELL SCI, V74, P1; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	51	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8892	8903		10.1074/jbc.M111.300186	http://dx.doi.org/10.1074/jbc.M111.300186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267727	Green Published, hybrid			2022-12-27	WOS:000301797800020
J	Wang, XM; Wortham, NC; Liu, R; Proud, CG				Wang, Xuemin; Wortham, Noel C.; Liu, Rui; Proud, Christopher G.			Identification of Residues That Underpin Interactions within the Eukaryotic Initiation Factor (eIF2) 2B Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; PARALLEL BETA-HELIX; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; EPSILON-SUBUNIT; PECTATE LYASE; ALPHA-SUBUNIT; FACTOR EIF-2B; PHOSPHORYLATION; PROTEIN	Eukaryotic initiation factor 2B (eIF2B) plays a key role in protein synthesis and in its control. It comprises five different subunits, alpha-epsilon, of which eIF2B epsilon contains the catalytic domain. Formation of the complete complex is crucial for full activity and proper control of eIF2B. Mutations in the genes for eIF2B cause an often severe neurological disorder, "vanishing white matter." eIF2B gamma and eIF2B epsilon contain homologous and conserved domains with sequence similarity to nucleotidyl transferases (NTs) and acyl transferases and can form a binary complex. The latter contain a hexad repeat that mainly comprises isoleucyl residues (hence termed the "I-patch" region). These data reveal that certain residues in the NT domains of eIF2B gamma/epsilon, which are highly conserved throughout eukaryotes, play key roles in the interactions between subunits in the eIF2B complex. Our data show that the I-patch regions are important in the interactions between the catalytic eIF2B gamma epsilon complex and the other subunits. We also studied the functional effects of vanishing white matter mutations in the NT and I-patch domains. Lastly, our data show that eIF2B gamma promotes the expression of eIF2B epsilon, providing a mechanism for achieving correct stoichiometry of these eIF2B subunits in the cell.	[Wang, Xuemin; Wortham, Noel C.; Liu, Rui; Proud, Christopher G.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England; [Wang, Xuemin; Liu, Rui; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Southampton; University of British Columbia	Proud, CG (corresponding author), Univ Southampton, Ctr Biol Sci, Life Sci Bldg, Southampton SO17 1BJ, Hants, England.	c.g.proud@soton.ac.uk	LIU, RUI/P-1991-2019	Proud, Christopher/0000-0003-0704-6442	Biotechnology and Biological Sciences Research Council [BB/G008396/1] Funding Source: Medline; BBSRC [BB/G008396/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anthony TG, 2000, BBA-GENE STRUCT EXPR, V1492, P56, DOI 10.1016/S0167-4781(00)00062-2; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P1920, DOI 10.1128/MCB.13.3.1920; Craddock BL, 1996, BIOCHEM BIOPH RES CO, V220, P843, DOI 10.1006/bbrc.1996.0495; DHOLAKIA JN, 1989, J BIOL CHEM, V264, P20638; DHOLAKIA JN, 1986, P NATL ACAD SCI USA, V83, P6746, DOI 10.1073/pnas.83.18.6746; Fabian JR, 1997, J BIOL CHEM, V272, P12359, DOI 10.1074/jbc.272.19.12359; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; Gomez E, 2002, EMBO J, V21, P5292, DOI 10.1093/emboj/cdf515; Gomez E, 2000, MOL CELL BIOL, V20, P3965, DOI 10.1128/MCB.20.11.3965-3976.2000; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hiyama TB, 2009, J MOL BIOL, V392, P937, DOI 10.1016/j.jmb.2009.07.054; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Liu R, 2011, HUM MUTAT, V32, P1036, DOI 10.1002/humu.21535; Ohlenbusch Andreas, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9325; OLDFIELD S, 1992, EUR J BIOCHEM, V208, P73, DOI 10.1111/j.1432-1033.1992.tb17160.x; PADDON CJ, 1989, GENETICS, V122, P551; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Reid PJ, 2012, J BIOL CHEM, V287, P8275, DOI 10.1074/jbc.M111.331645; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Schulz EC, 2011, CURR OPIN STRUC BIOL, V21, P232, DOI 10.1016/j.sbi.2011.01.009; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Van der Knaap M. S., 2010, ONLINE METABOLIC MOL; Wang XM, 2008, MOL CELL BIOL, V28, P1429, DOI 10.1128/MCB.01512-07; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Williams DD, 2001, J BIOL CHEM, V276, P24697, DOI 10.1074/jbc.M011788200; Yang ZY, 2003, BIOPHYS J, V85, P2599, DOI 10.1016/S0006-3495(03)74682-7; YODER MD, 1995, FASEB J, V9, P335, DOI 10.1096/fasebj.9.5.7896002; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	40	17	17	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8263	8274		10.1074/jbc.M111.331553	http://dx.doi.org/10.1074/jbc.M111.331553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238342	Green Published, hybrid			2022-12-27	WOS:000301349400041
J	Zhang, T; Hwang, HY; Hao, HP; Talbot, C; Wang, JO				Zhang, Tao; Hwang, Ho-Yon; Hao, Haiping; Talbot, Conover, Jr.; Wang, Jiou			Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEAT-SHOCK-FACTOR; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MICE; MESSENGER-RNA; BINDING PROTEIN; DROSOPHILA MODEL; HEXANUCLEOTIDE REPEAT; MOTOR DEFICITS; WILD-TYPE	Transactive response DNA-binding protein (TARDBP/TDP-43), a heterogeneous nuclear ribonucleoprotein (hnRNP) with diverse activities, is a common denominator in several neurodegenerative disorders, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Orthologs of TDP-43 exist in animals ranging from mammals to invertebrates. Here, we systematically studied mutant Caenorhabditis elegans lacking the nematode TDP-43 ortholog, TDP-1. Heterologous expression of human TDP-43 rescued the defects in C. elegans lacking TDP-1, suggesting their functions are conserved. Although the tdp-1 mutants exhibited deficits in fertility, growth, and locomotion, loss of tdp-1 attenuated defects in several C. elegans models of proteotoxicity. Loss of tdp-1 suppressed defects in transgenic C. elegans expressing TDP-43 or CuZn superoxide dismutase, both of which are associated with proteotoxicity in neurodegenerative diseases. Loss of tdp-1 also reduced defects in mutant animals lacking the heat shock factor HSF-1. Transcriptional profiling demonstrated that the loss of TDP-1 altered expression of genes functioning in RNA processing and protein folding. Furthermore, the absence of tdp-1 extended the life span in C. elegans. The life span extension required a FOXO transcriptional factor DAF-16 but not HSF-1. These results suggest that the C. elegans TDP-1 has a role in the regulation of protein homeostasis and aging.	[Zhang, Tao; Hwang, Ho-Yon; Wang, Jiou] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Dept Biochem & Mol Biol,Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hao, Haiping; Talbot, Conover, Jr.] Johns Hopkins Univ, Sch Med, Inst Basic Biomed Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Wang, JO (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, 615 N Wolfe St,E8410, Baltimore, MD 21205 USA.	jiouw@jhmi.edu		Hao, Haiping/0000-0002-8826-1568; Hwang, Ho-Yon/0000-0003-0204-8932	National Institutes of Health [NS062089, NS07432]; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association; Johns Hopkins Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074324, R00NS062089, K99NS062089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association(Muscular Dystrophy Association); Johns Hopkins Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS062089 and NS07432 (to J. W.). This work was also supported by the Robert Packard Center for ALS Research at Johns Hopkins, the Muscular Dystrophy Association, and The Johns Hopkins Claude D. Pepper Older Americans Independence Center.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Bose JK, 2011, J BIOL CHEM, V286, P44441, DOI 10.1074/jbc.M111.237115; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	68	41	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8371	8382		10.1074/jbc.M111.311977	http://dx.doi.org/10.1074/jbc.M111.311977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22232551	hybrid, Green Published			2022-12-27	WOS:000301349400052
J	Zurita-Lopez, CI; Sandberg, T; Kelly, R; Clarke, SG				Zurita-Lopez, Cecilia I.; Sandberg, Troy; Kelly, Ryan; Clarke, Steven G.			Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming omega-N-G-Monomethylated Arginine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; SM PROTEINS; HISTONE H3; SYMMETRIC DIMETHYLARGININE; SUBCELLULAR-LOCALIZATION; IN-VITRO; METHYLATION; BINDING; FAMILY; MEMBER	Full-length human protein arginine methyltransferase 7 (PRMT7) expressed as a fusion protein in Escherichia coli was initially found to generate only omega-N-G-monomethylated arginine residues in small peptides, suggesting that it is a type III enzyme. A later study, however, characterized fusion proteins of PRMT7 expressed in bacterial and mammalian cells as a type II/type I enzyme, capable of producing symmetrically dimethylated arginine (type II activity) as well as small amounts of asymmetric dimethylarginine (type I activity). We have sought to clarify the enzymatic activity of human PRMT7. We analyzed the in vitro methylation products of a glutathione S-transferase (GST)-PRMT7 fusion protein with robust activity using a variety of arginine-containing synthetic peptides and protein substrates, including a GST fusion with the N-terminal domain of fibrillarin (GST-GAR), myelin basic protein, and recombinant human histones H2A, H2B, H3, and H4. Regardless of the methylation reaction conditions (incubation time, reaction volume, and substrate concentration), we found that PRMT7 only produces omega-N-G-monomethylarginine with these substrates. In control experiments, we showed that mammalian GST-PRMT1 and Myc-PRMT5 were, unlike PRMT7, able to dimethylate both peptide P-SmD3 and SmB/D3 to give the expected asymmetric and symmetric products, respectively. These experiments show that PRMT7 is indeed a type III human methyltransferase capable of forming only omega-N-G-monomethylarginine, not asymmetric omega-N-G,N-G-dimethylarginine or symmetric omega-N-G,N-G'-dimethylarginine, under the conditions tested.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Sandberg, Troy/0000-0003-3240-3659; Kelly, Ryan/0000-0001-5003-9104	National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020.	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; Bonham K, 2010, FEBS J, V277, P2096, DOI 10.1111/j.1742-4658.2010.07623.x; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Castellano S, 2010, CHEMMEDCHEM, V5, P398, DOI 10.1002/cmdc.200900459; Cha B, 2011, ONCOGENE, V30, P2379, DOI 10.1038/onc.2010.610; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng DH, 2011, CHEMBIOCHEM, V12, P323, DOI 10.1002/cbic.201000522; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Cook JR, 2006, BIOCHEM BIOPH RES CO, V342, P472, DOI 10.1016/j.bbrc.2006.01.167; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Fielenbach N, 2007, DEV CELL, V12, P443, DOI 10.1016/j.devcel.2007.01.018; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; GARY JD, 1995, J BIOL CHEM, V270, P4076, DOI 10.1074/jbc.270.8.4076; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gros L, 2003, CANCER RES, V63, P164; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kim SJ, 2011, BBA-PROTEINS PROTEOM, V1814, P308, DOI 10.1016/j.bbapap.2010.11.006; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811; LEHMEIER T, 1994, P NATL ACAD SCI USA, V91, P12317, DOI 10.1073/pnas.91.25.12317; Li YJ, 2004, J VIROL, V78, P13325, DOI 10.1128/JVI.78.23.13325-13334.2004; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; McBride AE, 2006, ENZYMES, V24, P51, DOI 10.1016/S1874-6047(06)80005-3; Miranda TB, 2006, BIOCHEM J, V395, P563, DOI 10.1042/BJ20051771; Miranda TB, 2005, BIOCHEM BIOPH RES CO, V336, P831, DOI 10.1016/j.bbrc.2005.08.179; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Takahashi Y, 2011, J RECEPT SIG TRANSD, V31, P168, DOI 10.3109/10799893.2011.555768; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Thomas D, 2010, PROTEIN SCI, V19, P2141, DOI 10.1002/pro.492; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yanagida M, 2004, J BIOL CHEM, V279, P1607, DOI 10.1074/jbc.M305604200; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zheng ZY, 2005, P NATL ACAD SCI USA, V102, P2502, DOI 10.1073/pnas.0409786102	72	168	178	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7859	7870		10.1074/jbc.M111.336271	http://dx.doi.org/10.1074/jbc.M111.336271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22241471	Green Published, hybrid			2022-12-27	WOS:000301349400003
J	Budini, M; Buratti, E; Stuani, C; Guarnaccia, C; Romano, V; De Conti, L; Baralle, FE				Budini, Mauricio; Buratti, Emanuele; Stuani, Cristiana; Guarnaccia, Corrado; Romano, Valentina; De Conti, Laura; Baralle, Francisco E.			Cellular Model of TAR DNA-binding Protein 43 (TDP-43) Aggregation Based on Its C-terminal Gln/Asn-rich Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; SPLICING REGULATION; HNRNP PROTEINS; RNA-METABOLISM; ACID BINDING; CFTR EXON-9	TDP-43 is one of the major components of the neuronal and glial inclusions observed in several neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. These characteristic aggregates are a "landmark" of the disease, but their role in the pathogenesis is still obscure. In previous works, we have shown that the C-terminal Gln/Asnrich region (residues 321-366) of TDP-43 is involved in the interaction of this protein with other members of the heterogeneous nuclear ribonucleoprotein protein family. Furthermore, we have shown that the interaction through this region is important for TDP-43 splicing inhibition of cystic fibrosis transmembrane regulator exon 9, and there were indications that it was involved in the aggregation process. Our experiments show that in cell lines and primary rat neuronal cultures, the introduction of tandem repeats carrying the 331-369-residue Gln/Asn region from TDP-43 can trigger the formation of phosphorylated and ubiquitinated aggregates that recapitulate many but not all the characteristics observed in patients. These results establish a much needed cell-based TDP-43 aggregation model useful to investigate the mechanisms involved in the formation of inclusions and the gain-and loss-of-function consequences of TDP-43 aggregation within cells. In addition, it will be a powerful tool to test novel therapeutic strategies/effectors aimed at preventing/reducing this phenomenon.	[Budini, Mauricio; Buratti, Emanuele; Stuani, Cristiana; Guarnaccia, Corrado; Romano, Valentina; De Conti, Laura; Baralle, Francisco E.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Baralle, FE (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34149 Trieste, Italy.	baralle@icgeb.org	Buratti, Emanuele/K-4691-2016	Buratti, Emanuele/0000-0002-1356-9074	AriSLA	AriSLA	This work was supported by AriSLA.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Anthony K, 2010, BRAIN RES, V1338, P67, DOI 10.1016/j.brainres.2010.03.008; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baumer D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001523; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Budini M, 2011, CURR ALZHEIMER RES, V8, P237, DOI 10.2174/156720511795563719; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Caragounis A, 2010, FREE RADICAL BIO MED, V48, P1152, DOI 10.1016/j.freeradbiomed.2010.01.035; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen M, 2010, CELL CYCLE, V9, P1863, DOI 10.4161/cc.9.10.11675; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2011, FEBS J, V278, P3550, DOI 10.1111/j.1742-4658.2011.08258.x; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Higashi S, 2010, NEUROCHEM INT, V57, P906, DOI 10.1016/j.neuint.2010.09.010; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Strong MJ, 2010, J NEUROL SCI, V288, P1, DOI 10.1016/j.jns.2009.09.029; Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Ule J, 2008, CURR OPIN NEUROBIOL, V18, P516, DOI 10.1016/j.conb.2008.09.018; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Warraich ST, 2010, INT J BIOCHEM CELL B, V42, P1606, DOI 10.1016/j.biocel.2010.06.016; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	83	89	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7512	7525		10.1074/jbc.M111.288720	http://dx.doi.org/10.1074/jbc.M111.288720			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235134	Green Published, hybrid			2022-12-27	WOS:000301060200052
J	Mannervik, B				Mannervik, Bengt			Five Decades with Glutathione and the GSTome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-DISULFIDE INTERCHANGE; TRANS-STILBENE OXIDE; RAT-LIVER CYTOSOL; S-TRANSFERASE; GLYOXALASE-I; AFFINITY CHROMATOGRAPHY; CYTOPLASMIC THIOLTRANSFERASE; CATALYTIC ACTIVITY; MELANOMA-CELLS; HUMAN-PLACENTA	Uncle Folke inspired me to become a biochemist by demonstrating electrophoresis experiments on butterfly hemolymph in his kitchen. Glutathione became the subject for my undergraduate project in 1964 and has remained a focal point in my research owing to its multifarious roles in the cell. Since the 1960s, the multiple forms of glutathione transferase (GST), the GSTome, were isolated and characterized, some of which were discovered in our laboratory. Products of oxidative processes were found to be natural GST substrates. Examples of toxic compounds against which particular GSTs provide protection include 4-hydroxynonenal and ortho-quinones, with possible links to the etiology of Alzheimer and Parkinson diseases and other degenerative conditions. The role of thioltransferase and glutathione reductase in the cellular reduction of disulfides and other oxidized forms of thiols was clarified. Glyoxalase I catalyzes still another glutathione-dependent detoxication reaction. The unusual steady-state kinetics of this zinc-containing enzyme initiated model discrimination by regression analysis. Functional properties of the enzymes have been altered by stochastic mutations based on DNA shuffling and rationally tailored by structure-based redesign. We found it useful to represent promiscuous enzymes by vectors or points in multidimensional substrate-activity space and visualize them by multivariate analysis. Adopting the concept "molecular quasi-species," we describe clusters of functionally related enzyme variants that may emerge in natural as well as directed evolution.	[Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Mannervik, Bengt] Uppsala Univ, Biomed Ctr, Dept Biochem & Organ Chem, SE-75123 Uppsala, Sweden	Stockholm University; Uppsala University	Mannervik, B (corresponding author), Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden.	bengt.mannervik@kemi.uu.se			Swedish Research Council; Swedish Cancer Society; Herbert and Karin Jacobsson Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Herbert and Karin Jacobsson Fund	My wife, Anne-Charlotte, has always been supportive of my scientific activities, particularly in preparing dinner parties with delicious food and entertaining guests from all parts of the world (Fig. 5). More than fifty graduate students, numerous postdoctoral fellows, and an unknown number of undergraduates have implemented and further developed my research plans. I have greatly appreciated their willingness to spend important years of their lives engaged in my research activities, and most of all, I treasure their warm friendship. Kerstin Larson (Stockholm University) and Birgit Olin (Uppsala University) are the co-workers who have spent the longest periods of time in my laboratory, and their dedicated efforts over decades have been invaluable. Major funding for the research has been provided by the Swedish Research Council, the Swedish Cancer Society, and the Herbert and Karin Jacobsson Fund.	AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; ARONSSON AC, 1977, BIOCHEM J, V165, P503, DOI 10.1042/bj1650503; ARONSSON AC, 1978, BIOCHEM BIOPH RES CO, V81, P1235, DOI 10.1016/0006-291X(78)91268-8; ASKELOF P, 1974, FEBS LETT, V38, P263, DOI 10.1016/0014-5793(74)80068-2; ASKELOF P, 1975, BIOCHEM J, V147, P513, DOI 10.1042/bj1470513; AXELSSON K, 1978, BIOCHEMISTRY-US, V17, P2978, DOI 10.1021/bi00608a006; BARTFAI T, 1972, FEBS LETT, V26, P252, DOI 10.1016/0014-5793(72)80585-4; BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158; BJORNESTEDT R, 1992, BIOCHEM J, V282, P505; BOARD PG, 1991, BIOCHEM J, V275, P171, DOI 10.1042/bj2750171; BOOTH J, 1961, BIOCHEM J, V79, P516, DOI 10.1042/bj0790516; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; Brunnstrom A, 2011, LIPIDS, V46, P69, DOI 10.1007/s11745-010-3485-1; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; CARLBERG I, 1986, J BIOL CHEM, V261, P1629; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; COMBES B, 1961, J CLIN INVEST, V40, P981, DOI 10.1172/JCI104337; DISIMPLICIO P, 1989, BIOCHEM J, V263, P679, DOI 10.1042/bj2630679; EIGEN M, 1988, J PHYS CHEM-US, V92, P6881, DOI 10.1021/j100335a010; Emren LO, 2006, P NATL ACAD SCI USA, V103, P10866, DOI 10.1073/pnas.0604030103; ERIKSSON B, 1966, ACTA CHEM SCAND, V20, P1178, DOI 10.3891/acta.chem.scand.20-1178; ERIKSSON B, 1967, ACTA CHEM SCAND, V21, P958, DOI 10.3891/acta.chem.scand.21-0958; Frickel EM, 2001, J BIOL CHEM, V276, P1845, DOI 10.1074/jbc.M005760200; Friden F., 1958, FRASS DROP FREQUENCY; GUTHENBERG C, 1980, BIOCHIM BIOPHYS ACTA, V631, P1, DOI 10.1016/0304-4165(80)90047-1; GUTHENBERG C, 1986, BIOCHEM J, V235, P741, DOI 10.1042/bj2350741; GUTHENBERG C, 1979, ACTA CHEM SCAND B, V33, P595, DOI 10.3891/acta.chem.scand.33b-0595; GUTHENBERG C, 1981, BIOCHIM BIOPHYS ACTA, V661, P255, DOI 10.1016/0005-2744(81)90012-7; GUTHENBERG C, 1979, BIOCHEM BIOPH RES CO, V86, P1304, DOI 10.1016/0006-291X(79)90258-4; HANSSON J, 1991, CANCER RES, V51, P94; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Kobayashi H, 2011, J EXP BOT, V62, P1325, DOI 10.1093/jxb/erq376; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; KOSOWER EM, 1969, NATURE, V224, P117, DOI 10.1038/224117a0; Kurtovic S, 2008, J MOL BIOL, V375, P1365, DOI 10.1016/j.jmb.2007.11.034; Kurtovic S, 2009, BIOCHEMISTRY-US, V48, P9330, DOI 10.1021/bi901168q; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lind C, 1998, BIOCHEM BIOPH RES CO, V247, P481, DOI 10.1006/bbrc.1998.8695; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1980, BIOCHEM J, V190, P125, DOI 10.1042/bj1900125; MANNERVIK B, 1987, CARCINOGENESIS, V8, P1929, DOI 10.1093/carcin/8.12.1929; MANNERVIK B, 1973, BIOCHEM BIOPH RES CO, V53, P1151, DOI 10.1016/0006-291X(73)90585-8; MANNERVIK B, 1982, J BIOL CHEM, V257, P9909; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; MANNERVIK B, 1976, FEBS LETT, V66, P221, DOI 10.1016/0014-5793(76)80508-X; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MANNERVIK B, 1986, CHEM SCRIPTA, V26B, P281; MANNERVIK B, 1973, EUR J BIOCHEM, V37, P270, DOI 10.1111/j.1432-1033.1973.tb02985.x; Mannervik B., 2009, CONT ENZYME KINETICS, P73; Mannervik B., 1978, CONJUGATION REACTION, P101; Mannervik B, 1983, FUNCTIONS GLUTATHION, P75; Mannervik B., 1969, THESIS STOCKHOLM U; Mannervik B., 1974, GLUTATHIONE, P120; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Raffalli-Mathieu F, 2008, BIOCHEM J, V414, P103, DOI 10.1042/BJ20080397; Runarsdottir A, 2010, J MOL BIOL, V401, P451, DOI 10.1016/j.jmb.2010.06.033; SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629; SODERSTROM M, 1988, BIOCHEM J, V250, P713, DOI 10.1042/bj2500713; STENBERG G, 1992, BIOCHEM J, V284, P313, DOI 10.1042/bj2840313; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; TAHIR MK, 1989, BIOCHEM J, V257, P215, DOI 10.1042/bj2570215; WARHOLM M, 1981, BIOCHEM BIOPH RES CO, V98, P512, DOI 10.1016/0006-291X(81)90870-6; WARHOLM M, 1980, ACTA CHEM SCAND B, V34, P607, DOI 10.3891/acta.chem.scand.34b-0607	68	29	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6072	6083		10.1074/jbc.X112.342675	http://dx.doi.org/10.1074/jbc.X112.342675			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22247548	Green Published, hybrid			2022-12-27	WOS:000300791800001
J	Dash, B; Lukas, RJ				Dash, Bhagirathi; Lukas, Ronald J.			Modulation of Gain-of-function alpha 6*-Nicotinic Acetylcholine Receptor by beta 3 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; NEURONAL NICOTINIC RECEPTORS; DOPAMINE RELEASE; REPORTER MUTATION; ALPHA-6 SUBUNITS; IN-VIVO; EXPRESSION; LOCOMOTION; OOCYTES; DOMAIN	We previously have shown that beta 3 subunits either eliminate (e.g. for all-human (h) or all-mouse (m) alpha 6 beta 4 beta 3-nAChR) or potentiate (e.g. for hybrid m alpha 6h beta 4h beta 3- or m alpha 6m beta 4h beta 3-nAChR containing subunits from different species) function of alpha 6*-nAChR expressed in Xenopus oocytes, and that nAChR h alpha 6 subunit residues Asn-143 and Met-145 in N-terminal domain loop E are important for dominant-negative effects of nAChR h beta 3 subunits on h alpha 6*-nAChR function. Here, we tested the hypothesis that these effects of beta 3 subunits would be preserved even if nAChR alpha 6 subunits harbored gain-of-function, leucine- or valine-to-serine mutations at 9' or 13' positions (L9'S or V13'S) in their second transmembrane domains, yielding receptors with heightened functional activity and more amenable to assessment of effects of beta 3 subunit incorporation. However, coexpression with beta 3 subunits potentiates rather than suppresses function of all-human, all-mouse, or hybrid alpha 6((L9'S or V13'S))beta 4*- or alpha 6(N143D+M145V)(L9'S)beta 2*-nAChR. This contrasts with the lack of consistent function when alpha 6((L9'S or V13'S)) and beta 2 subunits are expressed alone or in the presence of wild-type beta 3 subunits. These results provide evidence that gain-of-function h alpha 6h beta 2*-nAChR (i.e. h alpha 6(N143D+M145V)(L9'S)h beta 2h beta 3 nAChR) could be produced in vitro. These studies also indicate that nAChR beta 3 subunits can be assembly partners in functional alpha 6*-nAChR and that 9' or 13' mutations in the nAChR alpha 6 subunit second transmembrane domain can act as gain-of-function and/or reporter mutations. Moreover, our findings suggest that beta 3 subunit coexpression promotes function of alpha 6*-nAChR.	[Dash, Bhagirathi; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [DA015389]; Philip Morris USA Inc.; Philip Morris International; Men's Board of the Barrow Neurological Foundation; Women's Board of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; Men's Board of the Barrow Neurological Foundation; Women's Board of the Barrow Neurological Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA015389 (to R. J. L.), by Philip Morris USA Inc. and Philip Morris International through their External Research Program, and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Chang, Y., and Lukas, R. J. (2008) Molecular and pharmacological characterization of recombinant alpha 6 beta 4*-nAChR. Soc. Neurosci. Abst. 34, 233.13).	Booker TK, 2007, PHARMACOL BIOCHEM BE, V87, P146, DOI 10.1016/j.pbb.2007.04.011; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Capelli AM, 2011, BRIT J PHARMACOL, V163, P313, DOI 10.1111/j.1476-5381.2011.01213.x; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2005, MOL PHARMACOL, V67, P2007, DOI 10.1124/mol.105.011940; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Jackson KJ, 2008, J PHARMACOL EXP THER, V325, P302, DOI 10.1124/jpet.107.132977; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Meyer EL, 2008, J NEUROCHEM, V105, P1761, DOI 10.1111/j.1471-4159.2008.05266.x; Miko A, 2004, J BIOL CHEM, V279, P22833, DOI 10.1074/jbc.M402577200; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Wang N, 2002, J PHYSIOL-LONDON, V542, P347, DOI 10.1113/jphysiol.2001.013456; Wang NS, 2004, J NEUROL SCI, V222, P87, DOI 10.1016/j.jns.2004.04.009; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011	31	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14259	14269		10.1074/jbc.M111.322610	http://dx.doi.org/10.1074/jbc.M111.322610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22315221	Green Published, hybrid			2022-12-27	WOS:000303996300077
J	Corea, ORA; Ki, C; Cardenas, CL; Kim, SJ; Brewer, SE; Patten, AM; Davin, LB; Lewis, NG				Corea, Oliver R. A.; Ki, Chanyoung; Cardenas, Claudia L.; Kim, Sung-Jin; Brewer, Sarah E.; Patten, Ann M.; Davin, Laurence B.; Lewis, Norman G.			Arogenate Dehydratase Isoenzymes Profoundly and Differentially Modulate Carbon Flux into Lignins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL-DEGRADATION PRODUCTS; ARABIDOPSIS-THALIANA; PINUS-TAEDA; PHENYLALANINE; IDENTIFICATION; EXPRESSION; CONFIGURATION; LIGNIFICATION; BIOSYNTHESIS; DATABASE	How carbon flux differentially occurs in vascular plants following photosynthesis for protein formation, phenylpropanoid metabolism (i.e. lignins), and other metabolic processes is not well understood. Our previous discovery/deduction that a six-membered arogenate dehydratase (ADT1-6) gene family encodes the final step in Phe biosynthesis in Arabidopsis thaliana raised the fascinating question whether individual ADT isoenzymes (or combinations thereof) differentially modulated carbon flux to lignins, proteins, etc. If so, unlike all other lignin pathway manipulations that target cell wall/cytosolic processes, this would be the first example of a plastid (chloroplast)-associated metabolic process influencing cell wall formation. Homozygous T-DNA insertion lines were thus obtained for five of the six ADTs and used to generate double, triple, and quadruple knockouts (KOs) in different combinations. The various mutants so obtained gave phenotypes with profound but distinct reductions in lignin amounts, encompassing a range spanning from near wild type levels to reductions of up to similar to 68%. In the various KOs, there were also marked changes in guaiacyl: syringyl ratios ranging from similar to 3:1 to 1:1, respectively; these changes were attributed to differential carbon flux into vascular bundles versus that into fiber cells. Laser microscope dissection/pyrolysis GC/MS, histochemical staining/lignin analyses, and pADT::GUS localization indicated that ADT5 preferentially affects carbon flux into the vascular bundles, whereas the adt3456 knock-out additionally greatly reduced carbon flux into fiber cells. This plastid-localized metabolic step can thus profoundly differentially affect carbon flux into lignins in distinct anatomical regions and provides incisive new insight into different factors affecting guaiacyl: syringyl ratios and lignin primary structure.	[Corea, Oliver R. A.; Ki, Chanyoung; Cardenas, Claudia L.; Kim, Sung-Jin; Brewer, Sarah E.; Patten, Ann M.; Davin, Laurence B.; Lewis, Norman G.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Lewis, NG (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lewisn@wsu.edu		Lewis, Norman/0000-0001-5742-032X; Davin, Laurence/0000-0002-3248-6485	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences [DE-FG-0397ER20259]; United States Department of Agriculture-National Institute of Food and Agriculture [2011-68005-30416]; United States Department of Agriculture [683A757612]; G. Thomas and Anita Hargrove Center for Plant Genomic Research; BioEnergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA)); G. Thomas and Anita Hargrove Center for Plant Genomic Research; BioEnergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by a grant from the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences DE-FG-0397ER20259, which involved all of the lignin, laser microscope dissection, and pyrolysis GC/MS work. Complementation studies were supported by United States Department of Agriculture-National Institute of Food and Agriculture-supported Northwest Advanced Renewable Alliance Grant 2011-68005-30416. This work was also supported by United States Department of Agriculture Grant 683A757612, the G. Thomas and Anita Hargrove Center for Plant Genomic Research, and the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The latter support enabled some of the mutant lines to be screened/selected for subsequent analyses.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altamura MM, 2001, NEW PHYTOL, V151, P381, DOI 10.1046/j.0028-646x.2001.00188.x; Anterola AM, 2002, J BIOL CHEM, V277, P18272, DOI 10.1074/jbc.M112051200; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; Anterola AM, 1999, BIOCHEM BIOPH RES CO, V261, P652, DOI 10.1006/bbrc.1999.1097; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; Blee K, 2001, PHYTOCHEMISTRY, V57, P1159, DOI 10.1016/S0031-9422(01)00150-9; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corea O. R. A., 2010, PLANT BIOL 2010 MONT; Corea O.R.A., 2010, JOINT ANN M AM SOC P; Corea O. R. A., 2012, METHODS MOL IN PRESS; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Dixon R. A., 1999, COMPREHENSIVE NATURA, P773, DOI DOI 10.1016/B978-0-08-091283-7.00030-8; FAIX O, 1990, HOLZ ROH WERKST, V48, P351, DOI 10.1007/BF02639897; FAIX O, 1990, HOLZ ROH WERKST, V48, P281, DOI 10.1007/BF02626519; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; IIYAMA K, 1990, J SCI FOOD AGR, V51, P145, DOI 10.1002/jsfa.2740510202; Jourdes M, 2007, PHYTOCHEMISTRY, V68, P1932, DOI 10.1016/j.phytochem.2007.03.044; JUNG E, 1986, P NATL ACAD SCI USA, V83, P7231, DOI 10.1073/pnas.83.19.7231; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim Kye-Won, 2006, V323, P263; Kim SJ, 2007, PHYTOCHEMISTRY, V68, P1957, DOI 10.1016/j.phytochem.2007.02.032; LAPIERRE C, 1986, HOLZFORSCHUNG, V40, P113, DOI 10.1515/hfsg.1986.40.2.113; Laskar DD, 2006, PLANT J, V48, P674, DOI 10.1111/j.1365-313X.2006.02918.x; Lewis N.G., 1989, CHEM SIGNIFICANCE CO, P23, DOI [DOI 10.1007/978-1-4684-7511-1_2, 10.1007/978-1-4684-7511-1_2]; M?ule C., 1901, BEITRAGE WISSENSCHAF, V4, P166; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; Miesak BH, 2002, PLANT PHYSIOL, V129, P650, DOI 10.1104/pp.005090; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P713; Patten AM, 2005, PHYTOCHEMISTRY, V66, P2092, DOI 10.1016/j.phytochem.2004.12.016; Patten AM, 2010, MOL BIOSYST, V6, P499, DOI 10.1039/b819206e; Rippert P, 2009, PLANT PHYSIOL, V149, P1251, DOI 10.1104/pp.108.130070; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; SIEHL DL, 1988, ARCH BIOCHEM BIOPHYS, V260, P822, DOI 10.1016/0003-9861(88)90513-9; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; vanHeerden PS, 1996, J BIOL CHEM, V271, P12350, DOI 10.1074/jbc.271.21.12350; Vassao DG, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P815; WIESNER J, 1878, SITZUNGSBERICHTE MN, V77, P60; Yamada T, 2008, PLANT CELL, V20, P1316, DOI 10.1105/tpc.107.057455	45	44	45	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11446	11459		10.1074/jbc.M111.322164	http://dx.doi.org/10.1074/jbc.M111.322164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311980	Green Published, hybrid			2022-12-27	WOS:000302780100073
J	Zocher, F; Zeidel, ML; Missner, A; Sun, TT; Zhou, G; Liao, Y; von Bodungen, M; Hill, WG; Meyers, S; Pohl, P; Mathai, JC				Zocher, Florian; Zeidel, Mark L.; Missner, Andreas; Sun, Tung-Tien; Zhou, Ge; Liao, Yi; von Bodungen, Maximilian; Hill, Warren G.; Meyers, Susan; Pohl, Peter; Mathai, John C.			Uroplakins Do Not Restrict CO2 Transport through Urothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLADDER PERMEABILITY BARRIER; COLLECTING DUCT; CARBON-DIOXIDE; MEMBRANE; AQUAPORIN-1; EPITHELIUM; GRADIENT; ABLATION; CHANNELS; CELLS	Background: The tightness of various membrane barriers to CO2 is of unknown molecular origin. Results: The bladder tissue lacks carbonic anhydrase. The resulting low intra-epithelial CO2 concentration gives rise to the apparent CO2 impermeability. Conclusion: Uroplakins do not act to decrease transepithelial CO2 flux. Significance: Enzymatic regulation of CO2 abundance rules out that aquaporins significantly contribute to the maintenance of acid base homeostasis.	[Zocher, Florian; Missner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Zeidel, Mark L.; von Bodungen, Maximilian; Hill, Warren G.; Mathai, John C.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Sun, Tung-Tien; Zhou, Ge; Liao, Yi] NYU, Dept Cell Biol, New York, NY 10016 USA; [Meyers, Susan] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA	Johannes Kepler University Linz; Harvard University; Beth Israel Deaconess Medical Center; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Sun, Tung-Tien/J-4425-2015; Hill, Warren/AAM-1917-2020; Pohl, Peter/A-5361-2008	Sun, Tung-Tien/0000-0002-6841-1063; Hill, Warren/0000-0002-2772-7264; Pohl, Peter/0000-0002-1792-2314	National Institute of Diabetes and Digestive and Kidney Diseases [DK048217, R01DK083299]; Austrian Science Fund (FWF) [P23466]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048217, R37DK048217, R01DK083299] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 23466] Funding Source: researchfish	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was supported by Grant Numbers DK048217 (to M.L.Z.) and R01DK083299 (to W.G.H.) from the National Institute of Diabetes and Digestive and Kidney Diseases. This work was also supported by Austrian Science Fund (FWF) Grant P23466 (to P.P.).	Aboushwareb T, 2009, NEUROUROL URODYNAM, V28, P1028, DOI 10.1002/nau.20688; Boron WF, 2011, CHEMPHYSCHEM, V12, P1017, DOI 10.1002/cphc.201100034; CHANG A, 1994, AM J PHYSIOL-CELL PH, V267, pC1483, DOI 10.1152/ajpcell.1994.267.5.C1483; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; DUBOSE TD, 1982, J CLIN INVEST, V69, P145, DOI 10.1172/JCI110425; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Fang XH, 2002, J PHYSIOL-LONDON, V542, P63, DOI 10.1113/jphysiol.2001.013813; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; Hill WG, 2008, AM J PHYSIOL-RENAL, V294, pF919, DOI 10.1152/ajprenal.00265.2007; Hodges SJ, 2008, J UROLOGY, V179, P2046, DOI 10.1016/j.juro.2007.12.039; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Hub JS, 2006, BIOPHYS J, V91, P842, DOI 10.1529/biophysj.106.081406; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Lavelle J, 2001, Urology, V57, P113, DOI 10.1016/S0090-4295(01)01047-0; Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001; Lavelle JP, 1998, AM J PHYSIOL-RENAL, V274, pF205, DOI 10.1152/ajprenal.1998.274.1.F205; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; POHL P, 1993, BIOCHIM BIOPHYS ACTA, V1145, P279, DOI 10.1016/0005-2736(93)90300-O; RYBERG C, 1948, ACTA PHYSIOL SCAND, V15, P123, DOI 10.1111/j.1748-1716.1948.tb00490.x; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Weinstein AM, 1998, AM J PHYSIOL-RENAL, V274, pF841, DOI 10.1152/ajprenal.1998.274.5.F841; WILBUR KM, 1948, J BIOL CHEM, V176, P147; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zeidel ML, 1996, AM J PHYSIOL-RENAL, V271, pF243, DOI 10.1152/ajprenal.1996.271.2.F243	34	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11011	11017		10.1074/jbc.M112.339283	http://dx.doi.org/10.1074/jbc.M112.339283			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315218	hybrid, Green Published			2022-12-27	WOS:000302780100029
J	Boulay, G; Dubuissez, M; Van Rechem, C; Forget, A; Helin, K; Ayrault, O; Leprince, D				Boulay, Gaylor; Dubuissez, Marion; Van Rechem, Capucine; Forget, Antoine; Helin, Kristian; Ayrault, Olivier; Leprince, Dominique			Hypermethylated in Cancer 1 (HIC1) Recruits Polycomb Repressive Complex 2 (PRC2) to a Subset of Its Target Genes through Interaction with Human Polycomb-like (hPCL) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; DNA-BINDING; TRANSCRIPTIONAL REPRESSION; MICE DEFICIENT; BREAST-CANCER; TUDOR DOMAIN; DROSOPHILA; METHYLATION; RECEPTOR; EZH2	HIC1 (hypermethylated in cancer 1) is a tumor suppressor gene epigenetically silenced or deleted in many human cancers. HIC1 is involved in regulatory loops modulating p53- and E2F1-dependent cell survival, growth control, and stress responses. HIC1 is also essential for normal development because Hic1-deficient mice die perinatally and exhibit gross developmental defects throughout the second half of development. HIC1 encodes a transcriptional repressor with five C2H2 zinc fingers mediating sequence-specific DNA binding and two repression domains: an N-terminal BTB/POZ domain and a central region recruiting CtBP and NuRD complexes. By yeast two-hybrid screening, we identified the Polycomb-like protein hPCL3 as a novel corepressor for HIC1. Using multiple biochemical strategies, we demonstrated that HIC1 interacts with hPCL3 and its paralog PHF1 to form a stable complex with the PRC2 members EZH2, EED, and Suz12. Confirming the implication of HIC1 in Polycomb recruitment, we showed that HIC1 shares some of its target genes with PRC2, including ATOH1. Depletion of HIC1 by siRNA interference leads to a partial displacement of EZH2 from the ATOH1 promoter. Furthermore, in vivo, ATOH1 repression by HIC1 is associated with Polycomb activity during mouse cerebellar development. Thus, our results identify HIC1 as the first transcription factor in mammals able to recruit PRC2 to some target promoters through its interaction with Polycomb-like proteins.	[Boulay, Gaylor; Dubuissez, Marion; Van Rechem, Capucine; Leprince, Dominique] Univ Lille Nord France, Inst Biol Lille, CNRS, UMR8161,Inst Pasteur Lille, F-59021 Lille, France; [Forget, Antoine; Ayrault, Olivier] Ctr Univ Orsay, INSERM, U1005, CNRS,UMR 3306,Inst Curie, F-91405 Orsay, France; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Copenhagen	Leprince, D (corresponding author), Univ Lille Nord France, Inst Biol Lille, CNRS, UMR8161,Inst Pasteur Lille, 1 Rue Prof Calmette,BP 447, F-59021 Lille, France.	dominique.leprince@ibl.fr	Forget, Antoine/AAA-4967-2020; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Helin, Kristian/0000-0003-1975-6097; Van Rechem, Capucine/0000-0002-5408-6124	CNRS; Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Fondation pour la Recherche Medicale (Comite du Nord); Association pour la Recherche contre le Cancer; CNRS/Region Nord-Pas de Calais; AVENIR/INSERM/Inca	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale contre le Cancer (Comite Interregional du Septentrion); Fondation pour la Recherche Medicale (Comite du Nord)(Fondation pour la Recherche Medicale); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); CNRS/Region Nord-Pas de Calais(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); AVENIR/INSERM/Inca	This work was supported in part by grants from the CNRS, the Ligue Nationale contre le Cancer (Comite Interregional du Septentrion), the Fondation pour la Recherche Medicale (Comite du Nord), and the Association pour la Recherche contre le Cancer (to D. L.).; Supported by fellowships from the CNRS/Region Nord-Pas de Calais and the Association pour la Recherche contre le Cancer.; Supported by a AVENIR/INSERM/Inca grant.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Boulay G, 2012, J BIOL CHEM, V287, P5379, DOI 10.1074/jbc.M111.304287; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Briggs KJ, 2008, CANCER RES, V68, P8654, DOI 10.1158/0008-5472.CAN-08-1904; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Casanova M, 2011, DEVELOPMENT, V138, P1471, DOI 10.1242/dev.053652; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P98, DOI 10.1038/nsmb0207-98; Coulson M, 1998, GENOMICS, V48, P381, DOI 10.1006/geno.1997.5201; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dehennaut V, 2009, B CANCER, V96, pE66, DOI 10.1684/bdc.2009.0959; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Fleuriel C, 2009, INT J BIOCHEM CELL B, V41, P26, DOI 10.1016/j.biocel.2008.05.028; Foveau B, 2012, J BIOL CHEM, V287, P5366, DOI 10.1074/jbc.M111.329466; Friberg A, 2010, PROTEIN SCI, V19, P1906, DOI 10.1002/pro.476; Grimmer MR, 2008, GENE DEV, V22, P693, DOI 10.1101/gad.1657808; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jenal M, 2009, MOL CANCER RES, V7, P916, DOI 10.1158/1541-7786.MCR-08-0359; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Mohammad HP, 2011, ONCOGENE, V30, P2659, DOI 10.1038/onc.2010.633; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pospichalova V, 2011, GENESIS, V49, P142, DOI 10.1002/dvg.20719; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Rood BR, 2002, CANCER RES, V62, P3794; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Stankovic-Valentin N, 2006, FEBS J, V273, P2879, DOI 10.1111/j.1742-4658.2006.05301.x; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Van Rechem C, 2010, MOL CELL BIOL, V30, P4045, DOI 10.1128/MCB.00582-09; Van Rechem C, 2009, J BIOL CHEM, V284, P20927, DOI 10.1074/jbc.M109.022350; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zhang W, 2010, ONCOGENE, V29, P2467, DOI 10.1038/onc.2010.12	73	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10509	10524		10.1074/jbc.M111.320234	http://dx.doi.org/10.1074/jbc.M111.320234			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22315224	Green Published, hybrid			2022-12-27	WOS:000302167200077
J	Paatero, I; Jokilammi, A; Heikkinen, PT; Iljin, K; Kallioniemi, OP; Jones, FE; Jaakkola, PM; Elenius, K				Paatero, Ilkka; Jokilammi, Anne; Heikkinen, Pekka T.; Iljin, Kristiina; Kallioniemi, Olli-Pekka; Jones, Frank E.; Jaakkola, Panu M.; Elenius, Klaus			Interaction with ErbB4 Promotes Hypoxia-inducible Factor-1 alpha Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; FACTOR 1-ALPHA; MAMMARY-GLAND; PROLYL HYDROXYLATION; NUCLEAR-LOCALIZATION; CANCER CELLS; HIF-ALPHA; GROWTH; EXPRESSION; ISOFORM	The receptor-tyrosine kinase ErbB4 was identified as a direct regulator of hypoxia-inducible factor-1 alpha (HIF-1 alpha) signaling. Cleaved intracellular domain of ErbB4 directly interacted with HIF-1 alpha in the nucleus, and stabilized HIF-1 alpha protein in both normoxic and hypoxic conditions by blocking its proteasomal degradation. The mechanism of HIF stabilization was independent of VHL and proline hydroxylation but dependent on RACK1. ErbB4 activity was necessary for efficient HRE-driven promoter activity, transcription of known HIF-1 alpha target genes, and survival of mammary carcinoma cells in vitro. In addition, mammary epithelial specific targeting of Erbb4 in the mouse significantly reduced the amount of HIF-1 alpha protein in vivo. ERBB4 expression also correlated with the expression of HIF-regulated genes in a series of 4552 human normal and cancer tissue samples. These data demonstrate that soluble ErbB4 intracellular domain promotes HIF-1 alpha stability and signaling via a novel mechanism.	[Paatero, Ilkka; Jokilammi, Anne; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Paatero, Ilkka; Jokilammi, Anne; Elenius, Klaus] Univ Turku, MediCity Res Lab, FI-20520 Turku, Finland; [Iljin, Kristiina; Kallioniemi, Olli-Pekka] VTT Tech Res Ctr, FI-20520 Turku, Finland; [Heikkinen, Pekka T.; Iljin, Kristiina; Kallioniemi, Olli-Pekka; Jaakkola, Panu M.] Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Paatero, Ilkka; Heikkinen, Pekka T.] Turku Doctoral Programme Biomed Sci, FI-20520 Turku, Finland; [Kallioniemi, Olli-Pekka] Univ Helsinki, Biomedicum, Genome Scale Biol Res Program, FI-00014 Helsinki, Finland; [Kallioniemi, Olli-Pekka] Univ Helsinki, FIMM Inst Mol Med Finland, Biomedicum, FI-00014 Helsinki, Finland; [Jones, Frank E.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Jaakkola, Panu M.; Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FI-20520 Turku, Finland	University of Turku; University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Helsinki; Tulane University; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Paatero, Ilkka/A-6391-2009; Kallioniemi, Olli P/H-5111-2011; Paatero, Ilkka/AAE-7542-2019; Jaakkola, Panu M/B-4355-2012; Elenius, Klaus/AAI-7594-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Paatero, Ilkka/0000-0001-5926-2396; Elenius, Klaus/0000-0001-5700-0827; Iljin, Kristiina/0000-0002-5161-0584; Jaakkola, Panu/0000-0002-2365-4985; Jokilammi, Anne/0000-0002-1675-5737	Academy of Finland; Finnish Cancer Organizations; Foundation of the Finnish Cancer Institute; Marie Curie Canceromics [MEXT-CT-2003-2728]; Sigrid Juselius Foundation; Turku University Foundation; Turku University Central Hospital	Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Foundation of the Finnish Cancer Institute; Marie Curie Canceromics(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Foundation; Turku University Central Hospital	This work was supported by Academy of Finland, Finnish Cancer Organizations, Foundation of the Finnish Cancer Institute, Marie Curie Canceromics (MEXT-CT-2003-2728), Sigrid Juselius Foundation, Turku University Foundation, and Turku University Central Hospital.	Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hollmen M, 2010, FUTURE ONCOL, V6, P37, DOI 10.2217/fon.09.144; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Iivanainen E, 2007, EXP CELL RES, V313, P2896, DOI 10.1016/j.yexcr.2007.03.042; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Veikkolainen V, 2012, J AM SOC NEPHROL, V23, P112, DOI 10.1681/ASN.2011020160; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhong H, 2000, CANCER RES, V60, P1541	45	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9659	9671		10.1074/jbc.M111.299537	http://dx.doi.org/10.1074/jbc.M111.299537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308027	Green Published, hybrid			2022-12-27	WOS:000302167200001
J	Fan, C; Chou, CY; Tong, L; Xiang, S				Fan, Chen; Chou, Chi-Yuan; Tong, Liang; Xiang, Song			Crystal Structure of Urea Carboxylase Provides Insights into the Carboxyltransfer Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PYRUVATE-CARBOXYLASE; ALLOPHANATE HYDROLASE; BIOTIN CARBOXYLASE; AMIDOLYASE; PROTEIN; ENZYME; DOMAIN; COENZYME; ATP; MECHANISM	Urea carboxylase (UC) is conserved in many bacteria, algae, and fungi and catalyzes the conversion of urea to allophanate, an essential step in the utilization of urea as a nitrogen source in these organisms. UC belongs to the biotin-dependent carboxylase superfamily and shares the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains with these other enzymes, but its carboxyltransferase (CT) domain is distinct. Currently, there is no information on the molecular basis of catalysis by UC. We report here the crystal structure of the Kluyveromyces lactis UC and biochemical studies to assess the structural information. Structural and sequence analyses indicate the CT domain of UC belongs to a large family of proteins with diverse functions, including the Bacillus subtilis KipA-KipI complex, which has important functions in sporulation regulation. A structure of the KipA-KipI complex is not currently available, and our structure provides a framework to understand the function of this complex. Most interestingly, in the structure the CT domain interacts with the BCCP domain, with biotin and a urea molecule bound at its active site. This structural information and our follow-up biochemical experiments provided molecular insights into the UC carboxyltransfer reaction. Several structural elements important for the UC carboxyltransfer reaction are found in other biotin-dependent carboxylases and might be conserved within this family, and our data could shed light on the mechanism of catalysis of these enzymes.	[Fan, Chen; Xiang, Song] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Columbia University	Xiang, S (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	sxiang@sibs.ac.cn	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Chou, Chi-Yuan/0000-0002-3400-171X; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [DK067238]; Ministry of Science and Technology of China [2011CB910500, 2010CB912502]; Chinese Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK067238 (to L. T.). This work was also supported by grants from the Ministry of Science and Technology of China 973 Programs 2011CB910500 and 2010CB912502 and the One Hundred Talents Program of the Chinese Academy of Sciences (to S. X.).	Andersen G, 2008, J MOL BIOL, V380, P656, DOI 10.1016/j.jmb.2008.05.029; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Jacques DA, 2011, ACTA CRYSTALLOGR D, V67, P105, DOI 10.1107/S0907444910051127; Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047; Jacques DA, 2008, J MOL BIOL, V384, P422, DOI 10.1016/j.jmb.2008.09.017; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALTWASS.H, 1966, ANAL BIOCHEM, V16, P132, DOI 10.1016/0003-2697(66)90088-1; Kanamori T, 2005, FEMS MICROBIOL LETT, V245, P61, DOI 10.1016/j.femsle.2005.02.023; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; LEFTLEY JW, 1973, J GEN MICROBIOL, V77, P109, DOI 10.1099/00221287-77-1-109; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; ROON RJ, 1972, J BIOL CHEM, V247, P4107; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Singer MA, 2003, COMP BIOCHEM PHYS B, V134, P543, DOI 10.1016/S1096-4959(03)00027-7; Sirko A, 2000, ACTA BIOCHIM POL, V47, P1189, DOI 10.18388/abp.2000_3972; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WHITNEY PA, 1972, J BIOL CHEM, V247, P1349; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zeczycki TN, 2009, BIOCHEMISTRY-US, V48, P4305, DOI 10.1021/bi9003759	48	27	29	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9389	9398		10.1074/jbc.M111.319475	http://dx.doi.org/10.1074/jbc.M111.319475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277658	Green Published, hybrid			2022-12-27	WOS:000301797800069
J	Qureshi, OS; Kaur, S; Hou, TZ; Jeffery, LE; Poulter, NS; Briggs, Z; Kenefeck, R; Willox, AK; Royle, SJ; Rappoport, JZ; Sansom, DM				Qureshi, Omar S.; Kaur, Satdip; Hou, Tie Zheng; Jeffery, Louisa E.; Poulter, Natalie S.; Briggs, Zoe; Kenefeck, Rupert; Willox, Anna K.; Royle, Stephen J.; Rappoport, Joshua Z.; Sansom, David M.			Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-ASSOCIATED MOLECULE-4; SURFACE EXPRESSION; TYROSINE PHOSPHORYLATION; CYTOPLASMIC TAIL; SRC KINASES; ANTIGEN-4; CD28; PROTEIN; GLYCOSPHINGOLIPIDS; LOCALIZATION	CTLA-4 is one of the most important negative regulators of the T cell immune response. However, the subcellular distribution of CTLA-4 is unusual for a receptor that interacts with cell surface transmembrane ligands in that CTLA-4 is rapidly internalized from the plasma membrane. It has been proposed that T cell activation can lead to stabilization of CTLA-4 expression at the cell surface. Here we have analyzed in detail the internalization, recycling, and degradation of CTLA-4. We demonstrate that CTLA-4 is rapidly internalized from the plasma membrane in a clathrin-and dynamin-dependent manner driven by the well characterized YVKM trafficking motif. Furthermore, we show that once internalized, CTLA-4 co-localizes with markers of recycling endosomes and is recycled to the plasma membrane. Although we observed limited co-localization of CTLA-4 with lysosomal markers, CTLA-4 was nonetheless degraded in a manner inhibited by lysosomal blockade. T cell activation stimulated mobilization of CTLA-4, as judged by an increase in cell surface expression; however, this pool of CTLA-4 continued to endocytose and was not stably retained at the cell surface. These data support a model of trafficking whereby CTLA-4 is constitutively internalized in a ligand-independent manner undergoing both recycling and degradation. Stimulation of T cells increases CTLA-4 turnover at the plasma membrane; however, CTLA-4 endocytosis continues and is not stabilized during activation of human T cells. These findings emphasize the importance of clathrin-mediated endocytosis in regulating CTLA-4 trafficking throughout T cell activation.	[Qureshi, Omar S.; Kaur, Satdip; Hou, Tie Zheng; Jeffery, Louisa E.; Briggs, Zoe; Kenefeck, Rupert; Sansom, David M.] Univ Birmingham, MRC Ctr Immune Regulat, Sch Immun & Infect, Sch Med, Birmingham B15 2TT, W Midlands, England; [Poulter, Natalie S.; Rappoport, Joshua Z.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Willox, Anna K.; Royle, Stephen J.] Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England; [Willox, Anna K.; Royle, Stephen J.] Univ Liverpool, Canc Res UK Ctr, Liverpool L69 3BX, Merseyside, England	University of Birmingham; University of Birmingham; University of Liverpool; Cancer Research UK; University of Liverpool	Sansom, DM (corresponding author), Univ Birmingham, MRC Ctr Immune Regulat, Sch Immun & Infect, Sch Med, Birmingham B15 2TT, W Midlands, England.	D.M.Sansom@bham.ac.uk	HOU, TIEZHENG/B-4848-2015; Qureshi, Omar/CAF-4545-2022	Poulter, Natalie/0000-0002-3187-2130; Sansom, David/0000-0001-6506-3115; Kaur, Satdip/0000-0002-0901-9141; Royle, Stephen/0000-0001-8927-6967	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Medical Research Council; Wellcome Trust [092578]; Arthritis Research UK; Biotechnology and Biological Sciences Research Council [BB/H013598/1, BB/D011000/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish; Versus Arthritis [19364] Funding Source: researchfish; BBSRC [BB/H013598/1, BB/D011000/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported by an Medical Research Council Ph.D. studentship.; Supported by the Wellcome Trust (Grant 092578).; Supported by Arthritis Research UK.	Alegre ML, 1998, J IMMUNOL, V161, P3347; Barrat FJ, 1999, P NATL ACAD SCI USA, V96, P8645, DOI 10.1073/pnas.96.15.8645; Benmerah A, 1999, J CELL SCI, V112, P1303; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Catalfamo M, 2008, IMMUNOLOGY, V125, P70, DOI 10.1111/j.1365-2567.2008.02822.x; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chuang E, 1999, J IMMUNOL, V162, P1270; Chuang E, 1997, J IMMUNOL, V159, P144; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Egen JG, 2002, IMMUNITY, V16, P23, DOI 10.1016/S1074-7613(01)00259-X; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Follows ER, 2001, BIOCHEM J, V359, P427, DOI 10.1042/0264-6021:3590427; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Hu H, 2001, BIOCHEM BIOPH RES CO, V288, P573, DOI 10.1006/bbrc.2001.5814; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kozik P, 2010, TRAFFIC, V11, P843, DOI 10.1111/j.1600-0854.2010.01056.x; LEUNG HT, 1995, J BIOL CHEM, V270, P25107, DOI 10.1074/jbc.270.42.25107; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Miyatake S, 1998, BIOCHEM BIOPH RES CO, V249, P444, DOI 10.1006/bbrc.1998.9191; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Sansom DM, 2000, IMMUNOLOGY, V101, P169, DOI 10.1046/j.1365-2567.2000.00121.x; Schneider H, 1999, J IMMUNOL, V163, P1868; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002	34	87	91	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9429	9440		10.1074/jbc.M111.304329	http://dx.doi.org/10.1074/jbc.M111.304329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22262842	hybrid, Green Published			2022-12-27	WOS:000301797800072
J	von Bulow, J; Muller-Lucks, A; Kai, L; Bernhard, F; Beitz, E				von Buelow, Julia; Mueller-Lucks, Annika; Kai, Lei; Bernhard, Frank; Beitz, Eric			Functional Characterization of a Novel Aquaporin from Dictyostelium discoideum Amoebae Implies a Unique Gating Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; CELL-FREE EXPRESSION; PLASMODIUM-FALCIPARUM; CONTRACTILE VACUOLE; WATER CHANNEL; GENE FAMILY; MIP FAMILY; GLYCEROL; PERMEABILITY; TRANSPORT	The social amoeba Dictyostelium discoideum is a widely used model organism for studying basic functions of protozoan and metazoan cells, such as osmoregulation and cell motility. There is evidence from other species that cellular water channels, aquaporins (AQP), are central to both processes. Yet, data on D. discoideum AQPs is almost absent. Despite cloning of two putative D. discoideum AQPs, WacA, and AqpA, water permeability has not been shown. Further, WacA and AqpA are expressed at the late multicellular stage and in spores but not in amoebae. We cloned a novel AQP, AqpB, from amoeboidal D. discoideum cells. Wild-type AqpB was impermeable to water, glycerol, and urea when expressed in Xenopus laevis oocytes. Neither stepwise truncation of the N terminus nor selected point mutations activated the water channel. However, mutational truncation by 12 amino acids of an extraordinary long intracellular loop induced water permeability of AqpB, hinting at a novel gating mechanism. This AqpB mutant was inhibited by mercuric chloride, confirming the presence of a cysteine residue in the selectivity filter as predicted by our structure model. We detected AqpB by Western blot analysis in a glycosylated and a non-glycosylated form throughout all developmental stages. When expressed in D. discoideum amoebae, AqpB-GFP fusion constructs localized to vacuolar structures, to the plasma membrane, and to lamellipodia-like membrane protrusions. We conclude that the localization pattern in conjunction with channel gating may be indicative of AqpB functions in osmoregulation as well as cell motility of D. discoideum.	[Beitz, Eric] Univ Kiel, Inst Pharmaceut, Dept Med & Pharmaceut Chem, D-24118 Kiel, Germany; [Kai, Lei; Bernhard, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany	University of Kiel; Goethe University Frankfurt	Beitz, E (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Med & Pharmaceut Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de	Kai, Lei/ABI-2652-2020	Kai, Lei/0000-0003-0879-7918; Bernhard, Frank/0000-0002-4860-1783	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to E. B.).	Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Beitz E, 2005, BIOL CELL, V97, P373, DOI 10.1042/BC20040095; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Flick KM, 1997, GENE, V195, P127, DOI 10.1016/S0378-1119(97)00078-4; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; GRIMBLEBY F, 1961, NATURE, V189, P835, DOI 10.1038/189835a0; Gupta R, 1999, GLYCOBIOLOGY, V9, P1009, DOI 10.1093/glycob/9.10.1009; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Haynes PA, 1998, GLYCOBIOLOGY, V8, P1, DOI 10.1093/glycob/8.1.1; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Mitra BN, 2000, GENE, V251, P131, DOI 10.1016/S0378-1119(00)00201-8; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Nishihara E, 2008, BIOL CELL, V100, P179, DOI 10.1042/BC20070091; Pavlovic-Djuranovic S, 2006, BBA-BIOMEMBRANES, V1758, P1012, DOI 10.1016/j.bbamem.2005.12.002; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; RAPER KB, 1950, SCIENCE, V112, P450; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tamas MJ, 2003, J BIOL CHEM, V278, P6337, DOI 10.1074/jbc.M209792200; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wu BH, 2010, J BIOL CHEM, V285, P40081, DOI 10.1074/jbc.M110.184457; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Zeuthen T, 2006, MOL MICROBIOL, V61, P1598, DOI 10.1111/j.1365-2958.2006.05325.x; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702	46	21	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7487	7494		10.1074/jbc.M111.329102	http://dx.doi.org/10.1074/jbc.M111.329102			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262860	Green Published, hybrid			2022-12-27	WOS:000301060200049
J	Caban, K; Copeland, PR				Caban, Kelvin; Copeland, Paul R.			Selenocysteine Insertion Sequence (SECIS)-binding Protein 2 Alters Conformational Dynamics of Residues Involved in tRNA Accommodation in 80 S Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; SINGLE-NUCLEOTIDE RESOLUTION; ELONGATION-FACTOR SELB; EF-TU; PEPTIDYLTRANSFERASE CENTER; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; L1 STALK; BINDING; TRANSLATION	Sec-tRNA(Sec) is site-specifically delivered at defined UGA codons in selenoprotein mRNAs. This recoding event is specified by the selenocysteine insertion sequence (SECIS) element and requires the selenocysteine (Sec)-specific elongation factor, eEFSec, and the SECIS binding protein, SBP2. Sec-tRNA(Sec) is delivered to the ribosome by eEFSec-GTP, but this ternary complex is not sufficient for Sec incorporation, indicating that its access to the ribosomal A-site is regulated. SBP2 stably associates with ribosomes, and mutagenic analysis indicates that this interaction is essential for Sec incorporation. However, the ribosomal function of SBP2 has not been elucidated. To shed light on the functional relevance of the SBP2-ribosome interaction, we screened the functional centers of the 28 S rRNA in translationally competent 80 S ribosomes using selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE). We demonstrate that SBP2 specifically alters the reactivity of specific residues in Helix 89 (H89) and expansion segment 31 (ES31). These results are indicative of a conformational change in response to SBP2 binding. Based on the known functions of H89 during translation, we propose that SBP2 allows Sec incorporation by either promoting Sec-tRNA(Sec) accommodation into the peptidyltransferase center and/or by stimulating the ribosome-dependent GTPase activity of eEFSec.	[Caban, Kelvin; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	National Institutes of Health [F31GM081920]; Public Health Service Grants [GM077073, GM094833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077073, R01GM094833, F31GM081920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Research Service Award F31GM081920 from the National Institutes of Health (to K. C.). This work was also supported by Public Health Service Grants GM077073 and GM094833 (to P. R. C.).	Agirrezabala X, 2009, Q REV BIOPHYS, V42, P159, DOI 10.1017/S0033583509990060; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Burakovskii D E, 2007, Mol Biol (Mosk), V41, P1031; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2001, MOL CELL BIOL, V21, P1491, DOI 10.1128/MCB.21.5.1491-1498.2001; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; DIAMOND A, 1981, CELL, V25, P497, DOI 10.1016/0092-8674(81)90068-4; Donovan J, 2008, J BIOL CHEM, V283, P35129, DOI 10.1074/jbc.M806008200; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fahlman RP, 2004, MOL CELL, V16, P799, DOI 10.1016/j.molcel.2004.10.030; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Huttenhofer A, 1998, BIOCHEMISTRY-US, V37, P885, DOI 10.1021/bi972298k; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; JUNG JE, 1994, J BIOL CHEM, V269, P29739; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Mortimer SA, 2009, NAT PROTOC, V4, P1413, DOI 10.1038/nprot.2009.126; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; Rakauskaite R, 2011, RNA, V17, P855, DOI 10.1261/rna.2593211; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Sergiev PV, 2005, J BIOL CHEM, V280, P31882, DOI 10.1074/jbc.M505670200; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Unbehaun A, 2007, EMBO J, V26, P3109, DOI 10.1038/sj.emboj.7601751; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson DN, 2006, CELL MOL LIFE SCI, V63, P2725, DOI 10.1007/s00018-006-6125-4; Yu HJ, 2009, J MOL BIOL, V386, P802, DOI 10.1016/j.jmb.2008.12.071; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	44	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10664	10673		10.1074/jbc.M111.320929	http://dx.doi.org/10.1074/jbc.M111.320929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308032	hybrid, Green Published			2022-12-27	WOS:000302167200091
J	Jin, ZN; Leveque, V; Ma, H; Johnson, KA; Klumpp, K				Jin, Zhinan; Leveque, Vincent; Ma, Han; Johnson, Kenneth A.; Klumpp, Klaus			Assembly, Purification, and Pre-steady-state Kinetic Analysis of Active RNA-dependent RNA Polymerase Elongation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; HIV REVERSE-TRANSCRIPTASE; PROTEIN 5B POLYMERASE; DNA-POLYMERASE; DE-NOVO; NONNUCLEOSIDE INHIBITORS; CRYSTAL-STRUCTURE; NS5B POLYMERASE; MECHANISM; SPECIFICITY	NS5B is the RNA-dependent RNA polymerase responsible for replicating hepatitis C virus (HCV) genomic RNA. Despite more than a decade of work, the formation of a highly active NS5B polymerase.RNA complex suitable for mechanistic and structural studies has remained elusive. Here, we report that through a novel way of optimizing initiation conditions, we were able to generate a productive NS5B.primer.template elongation complex stalled after formation of a 9-nucleotide primer. In contrast to previous reports of very low proportions of active NS5B, we observed that under optimized conditions up to 65% of NS5B could be converted into active elongation complexes. The elongation complex was extremely stable, allowing purification away from excess nucleotide and abortive initiation products so that the purified complex was suitable for pre-steady-state kinetic analyses of polymerase activity. Single turnover kinetic studies showed that CTP is incorporated with apparent K-d and k(pol) values of 39 +/- 3 mu M and 16 +/- 1 s(-1), respectively, giving a specificity constant of k(pol)/K-d of 0.41 mu M-1 s(-1). The kinetics of multiple nucleotide incorporation during processive elongation also were determined. This work establishes a novel way to generate a highly active elongation complex of the medically important NS5B polymerase for structural and functional studies.	[Klumpp, Klaus] Hoffmann La Roche Inc, Virol Discovery, Nutley, NJ 07110 USA; [Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	Roche Holding; University of Texas System; University of Texas Austin	Klumpp, K (corresponding author), Hoffmann La Roche Inc, Virol Discovery, 340 Kingsland St, Nutley, NJ 07110 USA.	klaus.klumpp@roche.com	jin, zhinan/D-4217-2013		Roche	Roche(Roche Holding)	Supported in part by the Roche Postdoc Fellowship program.	Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Bellon-Echeverria I, 2010, ANTIVIR RES, V87, P57, DOI 10.1016/j.antiviral.2010.04.009; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Chinnaswamy S, 2010, J VIROL, V84, P5923, DOI 10.1128/JVI.02446-09; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Cramer J, 2006, BIOCHEMISTRY-US, V45, P3610, DOI 10.1021/bi051483s; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Dutartre H, 2005, J BIOL CHEM, V280, P6359, DOI 10.1074/jbc.M410191200; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Jin ZN, 2011, J BIOL CHEM, V286, P1312, DOI 10.1074/jbc.M110.156737; Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Labonte P, 2002, J BIOL CHEM, V277, P38838, DOI 10.1074/jbc.M204657200; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Leveque VJP, 2003, J VIROL, V77, P9020, DOI 10.1128/JVI.77.16.9020-9028.2003; Liu YY, 2006, BIOCHEMISTRY-US, V45, P11312, DOI 10.1021/bi060511j; Lohmann V, 1998, VIROLOGY, V249, P108, DOI 10.1006/viro.1998.9311; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Tellinghuisen TL, 2011, HEPATITIS C: ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, P1; Tomei L, 2000, J GEN VIROL, V81, P759, DOI 10.1099/0022-1317-81-3-759; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	37	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10674	10683		10.1074/jbc.M111.325530	http://dx.doi.org/10.1074/jbc.M111.325530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303022	hybrid, Green Published			2022-12-27	WOS:000302167200092
J	Lorente, E; Garcia, R; Mir, C; Barriga, A; Lemonnier, FA; Ramos, M; Lopez, D				Lorente, Elena; Garcia, Ruth; Mir, Carmen; Barriga, Alejandro; Lemonnier, Francois A.; Ramos, Manuel; Lopez, Daniel			Role of Metalloproteases in Vaccinia Virus Epitope Processing for Transporter Associated with Antigen Processing (TAP)-independent Human Leukocyte Antigen (HLA)-B7 Class I Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL-PEPTIDASE-II; VIRAL-ANTIGEN; MOLECULES; PROTEIN; AMINOPEPTIDASE; DEFICIENT; PATHWAY; CELLS; MICE; IDENTIFICATION	The transporter associated with antigen processing (TAP) translocates the viral proteolytic peptides generated by the proteasome and other proteases in the cytosol to the endoplasmic reticulum lumen. There, they complex with nascent human leukocyte antigen (HLA) class I molecules, which are subsequently recognized by the CD8(+) lymphocyte cellular response. However, individuals with nonfunctional TAP complexes or tumor or infected cells with blocked TAP molecules are able to present HLA class I ligands generated by TAP-independent processing pathways. Herein, using a TAP-independent polyclonal vaccinia virus-polyspecific CD8(+) T cell line, two conserved vaccinia -derived TAP-independent HLA-B*0702 epitopes were identified. The presentation of these epitopes in normal cells occurs via complex antigen-processing pathways involving the proteasome and/or different subsets of metalloproteinases (amino-, carboxy-, and endoproteases), which were blocked in infected cells with specific chemical inhibitors. These data support the hypothesis that the abundant cellular proteolytic systems contribute to the supply of peptides recognized by the antiviral cellular immune response, thereby facilitating immunosurveillance. These data may explain why TAP-deficient individuals live normal life spans without any increased susceptibility to viral infections.	[Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen, Majadahonda 28220, Madrid, Spain; [Lemonnier, Francois A.] Inst Pasteur, Dept Immunol, Unite Immunite Cellulaire Antivirale, F-75724 Paris 15, France	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lopez, D (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Procesamiento Antigen, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	Lorente, Elena/B-1219-2019; Ramos, Manuel/F-5076-2016; López, Daniel/I-2632-2014	Lorente, Elena/0000-0002-2246-6851; Ramos, Manuel/0000-0002-0404-7936; López, Daniel/0000-0003-0268-5878; Francois, Lemonnier/0000-0002-6741-2742; Barriga, Alejandro/0000-0001-6357-1917	Foundacion para la Investigacion y Prevencion del SIDA en Espana; Ministerio de Ciencia e Innovacion	Foundacion para la Investigacion y Prevencion del SIDA en Espana; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants provided by Foundacion para la Investigacion y Prevencion del SIDA en Espana and Ministerio de Ciencia e Innovacion.	Alzhanova D, 2009, CELL HOST MICROBE, V6, P433, DOI 10.1016/j.chom.2009.09.013; Barrett A. J., 2004, HDB PROTEOLYTIC ENZY, P231; BROYLES SS, 1986, P NATL ACAD SCI USA, V83, P3141, DOI 10.1073/pnas.83.10.3141; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FREED ER, 1972, AM J MED, V52, P411, DOI 10.1016/0002-9343(72)90031-9; Gil-Torregrosa BC, 2000, TRAFFIC, V1, P641, DOI 10.1034/j.1600-0854.2000.010808.x; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HOWELL S, 1993, BIOCHEM J, V290, P159, DOI 10.1042/bj2900159; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Jezek Z, 1988, HUMAN MONKEYPOX; Johnstone C, 2008, J GEN VIROL, V89, P2194, DOI 10.1099/vir.0.2008/002485-0; Johnstone C, 2007, TRAFFIC, V8, P1486, DOI 10.1111/j.1600-0854.2007.00635.x; KOZLOWSKI S, 1993, J IMMUNOL, V151, P4033; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lautscham G, 2003, MICROBES INFECT, V5, P291, DOI 10.1016/S1286-4579(03)00031-5; Lautscham G, 2001, J EXP MED, V194, P1053, DOI 10.1084/jem.194.8.1053; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lopez D, 2000, J IMMUNOL, V164, P5070, DOI 10.4049/jimmunol.164.10.5070; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Lopez D, 2011, J BIOL CHEM, V286, P16910, DOI 10.1074/jbc.M111.234658; Lopez D, 2010, J IMMUNOL, V184, P5193, DOI 10.4049/jimmunol.1000050; Lorente E, 2011, J BIOL CHEM, V286, P38054, DOI 10.1074/jbc.M111.281808; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; Medina F, 2009, J IMMUNOL, V183, P4639, DOI 10.4049/jimmunol.0901356; Meyer VS, 2008, J IMMUNOL, V181, P6371, DOI 10.4049/jimmunol.181.9.6371; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; Neumeister C, 2001, J GEN VIROL, V82, P441, DOI 10.1099/0022-1317-82-2-441; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; Oliveira CC, 2010, J EXP MED, V207, P207, DOI 10.1084/jem.20091429; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; Oseroff C, 2005, P NATL ACAD SCI USA, V102, P13980, DOI 10.1073/pnas.0506768102; Pasquetto V, 2005, J IMMUNOL, V175, P5504, DOI 10.4049/jimmunol.175.8.5504; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schomburg L, 2000, EUR J BIOCHEM, V267, P3198, DOI 10.1046/j.1432-1327.2000.01348.x; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Suri A, 2006, EUR J IMMUNOL, V36, P544, DOI 10.1002/eji.200526235; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Umezawa H, 1976, Methods Enzymol, V45, P678; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Weinzierl AO, 2008, EUR J IMMUNOL, V38, P1503, DOI 10.1002/eji.200838136; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434	63	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9990	10000		10.1074/jbc.M111.314856	http://dx.doi.org/10.1074/jbc.M111.314856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22298786	hybrid, Green Published			2022-12-27	WOS:000302167200031
J	Malik, R; Soh, UJK; Trejo, J; Marchese, A				Malik, Rohit; Soh, Unice J. K.; Trejo, JoAnn; Marchese, Adriano			Novel Roles for the E3 Ubiquitin Ligase Atrophin-interacting Protein 4 and Signal Transduction Adaptor Molecule 1 in G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; BETA-ARRESTIN; C2 DOMAIN; CLATHRIN ADAPTER; SORTING COMPLEX; ERK ACTIVATION; JANUS KINASES; LIPID RAFTS; CXCR4; ENDOCYTOSIS	The CXCL12/CXCR4 signaling axis plays an important role in human health and disease; however, the molecular mechanisms mediating CXCR4 signaling remain poorly understood. Ubiquitin modification of CXCR4 by the E3 ubiquitin ligase AIP4 is required for lysosomal sorting and degradation, which is mediated by the endosomal sorting complex required for transport (ESCRT) machinery. CXCR4 sorting is regulated by an interaction between endosomal localized arrestin-2 and STAM-1, an ESCRT-0 component. Here, we report a novel role for AIP4 and STAM-1 in regulation of CXCR4 signaling that is distinct from their function in CXCR4 trafficking. Depletion of AIP4 and STAM-1 by siRNA caused significant inhibition of CXCR4-induced ERK-1/2 activation, whereas overexpression of these proteins enhanced CXCR4 signaling. We further show that AIP4 and STAM-1 physically interact and that the proline-rich region in AIP4 and the SH3 domain in STAM-1 are essential for the interaction. Overexpression of an AIP4 catalytically inactive mutant and a mutant that shows poor binding to STAM-1 fails to enhance CXCR4-induced ERK-1/2 signaling, as compared with wild-type AIP4, suggesting that the interaction between AIP4 and STAM-1 and the ligase activity of AIP4 are essential for ERK-1/2 activation. Remarkably, a discrete subpopulation of AIP4 and STAM-1 resides in caveolar microdomains with CXCR4 and appears to mediate ERK-1/2 signaling. We propose that AIP4-mediated ubiquitination of STAM-1 in caveolae coordinates activation of ERK-1/2 signaling. Thus, our study reveals a novel function for ubiquitin in the regulation of CXCR4 signaling, which may be broadly applicable to other G protein-coupled receptors.	[Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol, Program Mol Biol, Stritch Sch Med, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Soh, Unice J. K.; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Loyola University Chicago; Loyola University Chicago; University of California System; University of California San Diego	Marchese, A (corresponding author), Loyola Univ Chicago, Dept Pharmacol, Program Mol Biol, Stritch Sch Med, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		TREJO, JOANN/0000-0003-4405-6228; Malik, Rohit/0000-0003-4537-3452	National Institutes of Health [GM075159]; American Heart Association [0910098G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, R01GM075159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM075159 (to A. M.).; Supported by American Heart Association Predoctoral Fellowship 0910098G.	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ahn YH, 2009, J BIOL CHEM, V284, P29399, DOI 10.1074/jbc.M109.044958; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Endo K, 2000, FEBS LETT, V477, P55, DOI 10.1016/S0014-5793(00)01760-9; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lohi O, 1998, APOPTOSIS, V3, P335, DOI 10.1023/A:1009672903627; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	64	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9013	9027		10.1074/jbc.M111.336792	http://dx.doi.org/10.1074/jbc.M111.336792			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275353	Green Published, hybrid			2022-12-27	WOS:000301797800032
J	Ofengeim, D; Shi, P; Miao, BC; Fan, J; Xia, XF; Fan, YB; Lipinski, MM; Hashimoto, T; Polydoro, M; Yuan, JY; Wong, STC; Degterev, A				Ofengeim, Dimitry; Shi, Peng; Miao, Benchun; Fan, Jing; Xia, Xiaofeng; Fan, Yubo; Lipinski, Marta M.; Hashimoto, Tadafumi; Polydoro, Manuela; Yuan, Junying; Wong, Stephen T. C.; Degterev, Alexei			Identification of Small Molecule Inhibitors of Neurite Loss Induced by A beta peptide using High Content Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; NSAID USE; PROTEIN; NAPROXEN; MEMORY	Multiple lines of evidence indicate a strong relationship between A beta peptide-induced neurite degeneration and the progressive loss of cognitive functions in Alzheimer disease (AD) patients and in AD animal models. This prompted us to develop a high content screening assay (HCS) and Neurite Image Quantitator (NeuriteIQ) software to quantify the loss of neuronal projections induced by A beta peptide neurons and enable us to identify new classes of neurite-protective small molecules, which may represent new leads for AD drug discovery. We identified thirty-six inhibitors of A beta-induced neurite loss in the 1,040-compound National Institute of Neurological Disorders and Stroke (NINDS) custom collection of known bioactives and FDA approved drugs. Activity clustering showed that non-steroidal anti-inflammatory drugs (NSAIDs) were significantly enriched among the hits. Notably, NSAIDs have previously attracted significant attention as potential drugs for AD; however their mechanism of action remains controversial. Our data revealed that cyclooxygenase-2 (COX-2) expression was increased following A beta treatment. Furthermore, multiple distinct classes of COX inhibitors efficiently blocked neurite loss in primary neurons, suggesting that increased COX activity contributes to A beta peptide-induced neurite loss. Finally, we discovered that the detrimental effect of COX activity on neurite integrity may be mediated through the inhibition of peroxisome proliferator-activated receptor gamma(PPAR gamma) activity. Overall, our work establishes the feasibility of identifying small molecule inhibitors of A beta-induced neurite loss using the NeuriteIQ pipeline and provides novel insights into the mechanisms of neuroprotection by NSAIDs.	[Shi, Peng; Fan, Jing; Xia, Xiaofeng; Fan, Yubo; Wong, Stephen T. C.] Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX 77030 USA; [Ofengeim, Dimitry; Lipinski, Marta M.; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Miao, Benchun; Degterev, Alexei] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Hashimoto, Tadafumi; Polydoro, Manuela] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Harvard Medical School; Tufts University; Harvard University; Massachusetts General Hospital	Wong, STC (corresponding author), Cornell Univ, Weill Cornell Med Coll, Ithaca, NY 14853 USA.	alexei.degterev@tufts.edu		Hashimoto, Tadafumi/0000-0001-5442-4800; Lipinski, Marta/0000-0002-7537-9014	National Institutes of Health [R01AG028928, NIH R01 LM009161]; John S Dunn Research Foundation; TT and WF Chao Family Foundation; Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE ON AGING [R01AG028928] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S Dunn Research Foundation; TT and WF Chao Family Foundation; Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG028928, NIH R01 LM009161, John S Dunn Research Foundation, TT and WF Chao Family Foundation (to S. T. C. W.), and Smith Family Award for Excellence in Biomedical Research (to A. D.).	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Brioni JD, 2011, J PHARMACOL EXP THER, V336, P38, DOI 10.1124/jpet.110.166876; Cakala M, 2007, PHARMACOL REP, V59, P164; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Conejero-Goldberg C. T., 2008, J MOL NEUROSCI, V35, P7; Dargahi L, 2011, J MOL NEUROSCI, V45, P10, DOI 10.1007/s12031-010-9401-6; Dill J, 2010, J NEUROSCI, V30, P963, DOI 10.1523/JNEUROSCI.5045-09.2010; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Grodstein F, 2008, NEUROEPIDEMIOLOGY, V30, P45, DOI 10.1159/000115749; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Huang Y, 2010, J NEUROSCI METH, V190, P299, DOI 10.1016/j.jneumeth.2010.05.012; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jellinger KA, 2009, J NEUROL, V256, pS270, DOI 10.1007/s00415-009-5243-y; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Schmidt ERE, 2009, PROG NEUROBIOL, V88, P286, DOI 10.1016/j.pneurobio.2009.05.004; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Takeda T, 2010, J PHYS CHEM B, V114, P15394, DOI 10.1021/jp107955v; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zhang Y, 2007, J NEUROSCI METH, V160, P149, DOI 10.1016/j.jneumeth.2006.07.028	30	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8714	8723		10.1074/jbc.M111.290957	http://dx.doi.org/10.1074/jbc.M111.290957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277654	Green Published, hybrid			2022-12-27	WOS:000301797800005
J	Asada, R; Saito, A; Kawasaki, N; Kanemoto, S; Iwamoto, H; Oki, M; Miyagi, H; Izumi, S; Imaizumi, K				Asada, Rie; Saito, Atsushi; Kawasaki, Noritaka; Kanemoto, Soshi; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Izumi, Soutarou; Imaizumi, Kazunori			The Endoplasmic Reticulum Stress Transducer OASIS Is involved in the Terminal Differentiation of Goblet Cells in the Large Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INFLAMMATORY-BOWEL-DISEASE; TRANSCRIPTION FACTOR XBP-1; ER STRESS; CELLULAR PHYSIOLOGY; CREB/ATF-FAMILY; GENE-EXPRESSION; MICE; ASTROCYTES; EPITHELIUM	OASIS is a basic leucine zipper transmembrane transcription factor localized in the endoplasmic reticulum (ER) that is cleaved in its transmembrane region in response to ER stress. This novel ER stress transducer has been demonstrated to express in osteoblasts and astrocytes and promote terminal maturation of these cells. Additionally, OASIS is highly expressed in goblet cells of the large intestine. In this study, we investigated the roles of OASIS in goblet cell differentiation in the large intestine. To analyze the functions of OASIS in goblet cells, we examined morphological changes and the expression of goblet cell differentiation markers in the large intestine of Oasis(-/-) mice. By disrupting the Oasis gene, the number of goblet cells and production of mucus were decreased in the large intestine. Oasis(-/-) goblet cells showed abnormal morphology of mucous vesicles and rough ER. The expression levels of mature goblet cell markers were lower, and conversely those of early goblet cell markers were higher in Oasis(-/-) mice, indicating that differentiation from early to mature goblet cells is impaired in Oasis(-/-) mice. To determine the association of OASIS with other factors involved in goblet cell differentiation, in vitro experiments using a cell culture model were performed. We found that OASIS was activated in response to mild ER stress that is induced in differentiating goblet cells. Knockdown of the Oasis transcript perturbed goblet cell terminal differentiation. Together, our data indicate that OASIS plays crucial roles in promoting the differentiation of early goblet cells to mature goblet cells in the large intestine.	[Asada, Rie; Saito, Atsushi; Kawasaki, Noritaka; Kanemoto, Soshi; Iwamoto, Hideo; Oki, Mami; Miyagi, Hidetaka; Izumi, Soutarou; Imaizumi, Kazunori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University	Imaizumi, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science [22020030, 22800049]; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation; Pharmacological Research Foundation Tokyo; Daiichi-Sankyo Foundation of Life Science; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); Pharmacological Research Foundation Tokyo(Pharmacological Research Foundation, Tokyo); Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation)	This work was partly supported by Japan Society for the Promotion of Science KAKENHI Grants 22020030 and 22800049 and by the Sumitomo Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Astellas Foundation for Research on Metabolic Disorders, Takeda Science Foundation, the Pharmacological Research Foundation Tokyo, the Daiichi-Sankyo Foundation of Life Science, and the Naito Foundation.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Chihara K, 2009, J NEUROCHEM, V110, P956, DOI 10.1111/j.1471-4159.2009.06188.x; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Funamoto T, 2011, BONE, V49, P724, DOI 10.1016/j.bone.2011.06.012; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatayama H, 2007, BIOCHEM BIOPH RES CO, V356, P599, DOI 10.1016/j.bbrc.2007.03.025; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2011, BONE, V48, P514, DOI 10.1016/j.bone.2010.10.176; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shaker A, 2010, TRANSL RES, V156, P180, DOI 10.1016/j.trsl.2010.06.003; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	52	44	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8144	8153		10.1074/jbc.M111.332593	http://dx.doi.org/10.1074/jbc.M111.332593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262831	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000301349400030
J	Hanna, J; Schutz, A; Zimmermann, F; Behlke, J; Sommer, T; Heinemann, U				Hanna, Jennifer; Schuetz, Anja; Zimmermann, Franziska; Behlke, Joachim; Sommer, Thomas; Heinemann, Udo			Structural and Biochemical Basis of Yos9 Protein Dimerization and Possible Contribution to Self-association of 3-Hydroxy-3-methylglutaryl-Coenzyme A Reductase Degradation Ubiquitin-Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; TRAPP; SIGNAL; BET3; RETROTRANSLOCATION; CLASSIFICATION; EXTRACTION; SUGGESTS	In yeast, the membrane-bound HMG-CoA reductase degradation (HRD) ubiquitin-ligase complex is a key player of the ER-associated protein degradation pathway that targets misfolded proteins for proteolysis. Yos9, a component of the luminal submodule of the ligase, scans proteins for specific oligosaccharide modifications, which constitute a critical determinant of the degradation signal. Here, we report the crystal structure of the Yos9 domain that was previously suggested to confer binding to Hrd3, another component of the HRD complex. We observe an alpha beta-roll domain architecture and a dimeric assembly which are confirmed by analytical ultracentrifugation of both the crystallized domain and full-length Yos9. Our binding studies indicate that, instead of this domain, the N-terminal part of Yos9 including the mannose 6-phosphate receptor homology domain mediates the association with Hrd3 in vitro. Our results support the model of a dimeric state of the HRD complex and provide first-time evidence of self-association on its luminal side.	[Hanna, Jennifer; Schuetz, Anja; Zimmermann, Franziska; Behlke, Joachim; Sommer, Thomas; Heinemann, Udo] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sommer, Thomas] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany; [Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Free University of Berlin	Heinemann, U (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850; Schutz, Anja/0000-0002-0606-2574	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [740]; Leibniz Graduate School of Molecular Biophysics, Berlin; Helmholtz Association of German Research Centers	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Leibniz Graduate School of Molecular Biophysics, Berlin; Helmholtz Association of German Research Centers(Helmholtz Association)	This work was supported by Deutsche Forschungsgemeinschaft grants (to U. H. and T. S.) and by Sonderforschungsbereich 740.; Supported by the Leibniz Graduate School of Molecular Biophysics, Berlin.; Associated with the Protein Sample Production Facility at the Max Delbruck Center, which is funded by the Helmholtz Association of German Research Centers.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Heinemann U, 2003, ACCOUNTS CHEM RES, V36, P157, DOI 10.1021/ar010129t; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Kummel D, 2005, EMBO REP, V6, P787, DOI 10.1038/sj.embor.7400463; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102	50	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8633	8640		10.1074/jbc.M111.317644	http://dx.doi.org/10.1074/jbc.M111.317644			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262864	Green Published, hybrid			2022-12-27	WOS:000301349400075
J	Huang, WQ; Hu, LP; Bei, L; Hjort, E; Eklund, EA				Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.			The Leukemia-associated Fusion Protein Tel-Platelet-derived Growth Factor Receptor beta (Tel-PdgfR beta) Inhibits Transcriptional Repression of PTPN13 Gene by Interferon Consensus Sequence Binding Protein (Icsbp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATING MYELOID CELLS; TYROSINE-PHOSPHATASE; GP91(PHOX) EXPRESSION; BCR-ABL; FAS; PU.1; FAP-1; DEATH; MACROPHAGES; P67(PHOX)	Icsbp is an interferon regulatory transcription factor with leukemia suppressor activity. In previous studies, we identified the gene encoding Fas-associated phosphatase 1 (Fap1; the PTPN13 gene) as an Icsbp target. In the current study, we determine that repression of PTPN13 by Icsbp requires cooperation with Tel and histone deacetylase 3 (Hdac3). These factors form a multiprotein complex that requires pre-binding of Tel to the PTPN13 cis element with subsequent recruitment of Icsbp and Hdac3. We found that knockdown of Tel or Hdac3 in myeloid cells increases Fap1 expression and results in Fap1-dependent resistance to Fas-induced apoptosis. The TEL gene was initially identified due to involvement in leukemia-associated chromosomal translocations. The first identified TEL translocation partner was the gene encoding platelet-derived growth factor receptor beta (PdgfR beta). The resulting Tel-PdgfR beta fusion protein exhibits constitutive tyrosine kinase activity and influences cellular proliferation. In the current studies, we find that Tel-PdgfR beta influences apoptosis in a manner that is independent of tyrosine kinase activity. We found that Tel-PdgfR beta expressing myeloid cells have increased Fap1 expression and Fap1-dependent Fas resistance. We determined that interaction between Tel and Tel-PdgfR beta decreases Tel/Icsbp/Hdac3 binding to the PTPN13 cis element, resulting in increased transcription. Therefore, these studies identify a novel mechanism by which the Tel-PdgfR beta oncoprotein may contribute to leukemogenesis.	[Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Huang, Weiqi; Hu, Liping; Bei, Ling; Hjort, Elizabeth; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Hjort, Elizabeth; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu						Atfi A, 1999, ONCOGENE, V18, P3878, DOI 10.1038/sj.onc.1202734; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2007, J BIOL CHEM, V282, P6629, DOI 10.1074/jbc.M607760200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Inazawa J, 1996, GENOMICS, V31, P240, DOI 10.1006/geno.1996.0039; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; Komada Y, 1997, BRIT J HAEMATOL, V99, P325, DOI 10.1046/j.1365-2141.1997.3903204.x; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; LARRICK JW, 1980, J IMMUNOL, V125, P6; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Otten HG, 2004, LEUKEMIA, V18, P1401, DOI 10.1038/sj.leu.2403414; Qian ZJ, 2002, P NATL ACAD SCI USA, V99, P14925, DOI 10.1073/pnas.222491799; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Sharf R, 1997, J BIOL CHEM, V272, P9785; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8110	8125		10.1074/jbc.M111.294884	http://dx.doi.org/10.1074/jbc.M111.294884			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262849	Green Published, hybrid			2022-12-27	WOS:000301349400027
J	Ijuin, T; Takenawa, T				Ijuin, Takeshi; Takenawa, Tadaomi			Regulation of Insulin Signaling and Glucose Transporter 4 (GLUT4) Exocytosis by Phosphatidylinositol 3,4,5-Trisphosphate (PIP3) Phosphatase, Skeletal Muscle, and Kidney Enriched Inositol Polyphosphate Phosphatase (SKIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; MICE LACKING; ADIPOSE-TISSUE; PTEN; RESISTANCE; TRANSLOCATION; FUSION; KINASE; SHIP2	The glucose transporter 4 (GLUT4) is responsible for glucose uptake in the skeletal muscle. Insulin-induced translocation of GLUT4 to the plasma membrane requires phosphatidylinositol 3-kinase activation-mediated generation of phosphatidylinositol 3,4,5-trisphosphate PIP3 and subsequent activation of Akt. Previous studies suggested that skeletal muscle and kidney enriched inositol polyphosphate phosphatase (SKIP) has negative effects on the regulation of insulin signaling in the skeletal muscle cells. Here, we compared its effects on insulin signaling by selective inhibition of SKIP, SHIP2, and phosphatase and tensin homologue on chromosome 10 (PTEN) by short interfering RNA in the C2C12 myoblast cells. Suppression of SKIP significantly increased the insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate levels and Akt phosphorylation. Furthermore, silencing of SKIP, but not of PTEN, increased the insulin-dependent recruitment of GLUT4 vesicles to the plasma membrane. Taken together, these results imply that SKIP negatively regulates insulin signaling and glucose uptake by inhibiting GLUT4 docking and/or fusion to the plasma membrane.	[Ijuin, Takeshi; Takenawa, Tadaomi] Kobe Univ, Dept Lipid Biochem, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kobe University	Takenawa, T (corresponding author), Kobe Univ, Dept Lipid Biochem, Grad Sch Med, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Ijuin, Takeshi/H-7016-2017	Ijuin, Takeshi/0000-0002-0618-1776				Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Farese RV, 2005, BIOCHEM SOC T, V33, P350, DOI 10.1042/BST0330350; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Ijuin T, 2008, MOL CELL BIOL, V28, P5184, DOI 10.1128/MCB.01990-06; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaoka T, 2001, DIABETOLOGIA, V44, P1258, DOI 10.1007/s001250100645; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wada T, 2001, MOL CELL BIOL, V21, P1633, DOI 10.1128/MCB.21.5.1633-1646.2001; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	31	33	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6991	6999		10.1074/jbc.M111.335539	http://dx.doi.org/10.1074/jbc.M111.335539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247557	Green Published, hybrid			2022-12-27	WOS:000301060200005
J	Iram, SH; Cole, SPC				Iram, Surtaj H.; Cole, Susan P. C.			Mutation of Glu(521) or Glu(535) in Cytoplasmic Loop 5 Causes Differential Misfolding in Multiple Domains of Multidrug and Organic Anion Transporter MRP1 (ABCC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN MRP; DISEASE-ASSOCIATED MUTATIONS; NUCLEOTIDE-BINDING DOMAIN; P-GLYCOPROTEIN; PSEUDOXANTHOMA ELASTICUM; VINCRISTINE TRANSPORT; CHEMICAL CHAPERONES; ATP-BINDING; CFTR; GLUTATHIONE	The polytopic 5-domain multidrug resistance protein 1 (MRP1/ABCC1) extrudes a variety of drugs and organic anions across the plasma membrane. Four charged residues in the fifth cytoplasmic loop (CL5) connecting transmembrane helix 9 (TM9) to TM10 are critical for stable expression of MRP1 at the plasma membrane. Thus Ala substitution of Lys(513), Lys(516), Glu(521), and Glu(535) all cause misfolding of MRP1 and target the protein for proteasome-mediated degradation. Of four chemical chaperones tested, 4-phenylbutyric acid (4-PBA) was the most effective at restoring expression of MRP1 mutants K513A, K516A, E521A, and E535A. However, although 4-PBA treatment of K513A resulted in wild-type protein levels (and activity), the same treatment had little or no effect on the expression of K516A. On the other hand, 4-PBA treatment allowed both E521A and E535A to exit the endoplasmic reticulum and be stably expressed at the plasma membrane. However, the 4-PBA-rescued E535A mutant exhibited decreased transport activity associated with reduced substrate affinity and conformational changes in both halves of the transporter. By contrast, E521A exhibited reduced transport activity associated with alterations in the mutant interactions with ATP as well as a distinct conformational change in the COOH- proximal half of MRP1. These findings illustrate the critical and complex role of CL5 for stable expression of MRP1 at the plasma membrane and more specifically show the differential importance of Glu(521) and Glu(535) in interdomain interactions required for proper folding and assembly of MRP1 into a fully transport competent native structure.	[Iram, Surtaj H.; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Cole, Susan P.C./I-6389-2017; Iram, Surtaj Hussain/T-5510-2019	Cole, Susan P.C./0000-0001-6571-6884; Iram, Surtaj/0000-0002-0672-0936	Canadian Institutes of Health Research [MOP-10519]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-10519.	Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Choo-Kang LR, 2001, AM J PHYSIOL-LUNG C, V281, pL58, DOI 10.1152/ajplung.2001.281.1.L58; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Conseil G, 2005, BIOCHEM PHARMACOL, V69, P451, DOI 10.1016/j.bcp.2004.10.014; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Cui LY, 2001, ARCH BIOCHEM BIOPHYS, V392, P153, DOI 10.1006/abbi.2001.2441; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Frezza M, 2011, CURR TOP MED CHEM, V11, P2888, DOI 10.2174/156802611798281311; Grove DE, 2011, METHODS MOL BIOL, V741, P219, DOI 10.1007/978-1-61779-117-8_15; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1998, BRIT J CANCER, V78, P1134, DOI 10.1038/bjc.1998.642; Hipfner DR, 1996, CANCER RES, V56, P3307; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2004, BIOCHEM BIOPH RES CO, V315, P719, DOI 10.1016/j.bbrc.2004.01.111; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Maeno K, 2009, DRUG METAB DISPOS, V37, P1411, DOI 10.1124/dmd.109.026633; Mao QC, 2002, J BIOL CHEM, V277, P28690, DOI 10.1074/jbc.M202182200; Nikles D, 2007, J BIOENERG BIOMEMBR, V39, P489, DOI 10.1007/s10863-007-9120-z; Papp E, 2006, HANDB EXP PHARM, V172, P405; Polgar O, 2009, BBA-BIOMEMBRANES, V1788, P1434, DOI 10.1016/j.bbamem.2009.04.016; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Sheppard DN, 2011, CHEM BIOL, V18, P145, DOI 10.1016/j.chembiol.2011.02.003; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; Uitto J, 2010, J INVEST DERMATOL, V130, P661, DOI 10.1038/jid.2009.411; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011	46	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7543	7555		10.1074/jbc.M111.310409	http://dx.doi.org/10.1074/jbc.M111.310409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22232552	Green Published, hybrid			2022-12-27	WOS:000301060200055
J	Otto, NJ; Green, DE; Masuko, S; Mayer, A; Tanner, ME; Linhardt, RJ; DeAngelis, PL				Otto, Nigel J.; Green, Dixy E.; Masuko, Sayaka; Mayer, Alain; Tanner, Martin E.; Linhardt, Robert J.; DeAngelis, Paul L.			Structure/Function Analysis of Pasteurella multocida Heparosan Synthases TOWARD DEFINING ENZYME SPECIFICITY AND ENGINEERING NOVEL CATALYSTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; CHEMOENZYMATIC SYNTHESIS; IDENTIFICATION; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; GLYCOSAMINOGLYCANS; MUTAGENESIS; POLYMERS; DISTINCT; KFIA	The Pasteurella multocida heparosan synthases, PmHS1 and PmHS2, are homologous (similar to 65% identical) bifunctional glycosyltransferase proteins found in Type D Pasteurella. These unique enzymes are able to generate the glycosaminoglycan heparosan by polymerizing sugars to form repeating disaccharide units from the donor molecules UDP-glucuronic acid (UDP-GlcUA) and UDP-N-acetylglucosamine (UDP-GlcNAc). Although these isozymes both generate heparosan, the catalytic phenotypes of these isozymes are quite different. Specifically, during in vitro synthesis, PmHS2 is better able to generate polysaccharide in the absence of exogenous acceptor (de novo synthesis) than PmHS1. Additionally, each of these enzymes is able to generate polysaccharide using unnatural sugar analogs in vitro, but they exhibit differences in the substitution patterns of the analogs they will employ. A series of chimeric enzymes has been generated consisting of various portions of both of the Pasteurella heparosan synthases in a single polypeptide chain. In vitro radiochemical sugar incorporation assays using these purified chimeric enzymes have shown that most of the constructs are enzymatically active, and some possess novel characteristics including the ability to produce nearly monodisperse polysaccharides with an expanded range of sugar analogs. Comparison of the kinetic properties and the sequences of the wild-type enzymes with the chimeric enzymes has enabled us to identify regions that may be responsible for some aspects of both donor binding specificity and acceptor usage. In combination with previous work, these approaches have enabled us to better understand the structure/function relationship of this unique family of glycosyltransferases.	[DeAngelis, Paul L.] Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA; [Mayer, Alain; Tanner, Martin E.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Masuko, Sayaka; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Dept Biol, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Masuko, Sayaka; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of British Columbia; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	DeAngelis, PL (corresponding author), Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Hlth Sci Ctr, Oklahoma City, OK 73126 USA.	paul-deangelis@ouhsc.edu			National Institutes of Health [HL062244]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL062244 (to R. J. L. and P. L. D.).	Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; LEGAULT DJ, 1995, J BIOL CHEM, V270, P20987, DOI 10.1074/jbc.270.36.20987; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Nguyen AT, 1998, J BIOL CHEM, V273, P25244, DOI 10.1074/jbc.273.39.25244; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Sarrazin S, 2011, COLD SPRING HARB PER, V3; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Xu XH, 1996, J BIOL CHEM, V271, P8818, DOI 10.1074/jbc.271.15.8818; Yeager AR, 2005, J ORG CHEM, V70, P1269, DOI 10.1021/jo0483670	27	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7203	7212		10.1074/jbc.M111.311704	http://dx.doi.org/10.1074/jbc.M111.311704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235128	Green Published, hybrid			2022-12-27	WOS:000301060200023
J	Osipov, AV; Rucktooa, P; Kasheverov, IE; Filkin, SY; Starkov, VG; Andreeva, TV; Sixma, TK; Bertrand, D; Utkin, YN; Tsetlin, VI				Osipov, Alexey V.; Rucktooa, Prakash; Kasheverov, Igor E.; Filkin, Sergey Yu; Starkov, Vladislav G.; Andreeva, Tatyana V.; Sixma, Titia K.; Bertrand, Daniel; Utkin, Yuri N.; Tsetlin, Victor I.			Dimeric alpha-Cobratoxin X-ray Structure LOCALIZATION OF INTERMOLECULAR DISULFIDES AND POSSIBLE MODE OF BINDING TO NICOTINIC ACETYLCHOLINE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; SECONDARY-STRUCTURE; BIOLOGICAL-ACTIVITY; VENOM INTERACTS; NEUROTOXINS; BUNGAROTOXIN; TOXIN; PROTEINS; REVEALS	In Naja kaouthia cobra venom, we have earlier discovered a covalent dimeric form of alpha-cobratoxin (alpha CT-alpha CT) with two intermolecular disulfides, but we could not determine their positions. Here, we report the alpha CT-alpha CT crystal structure at 1.94 angstrom where intermolecular disulfides are identified between Cys(3) in one protomer and Cys(20) of the second, and vice versa. All remaining intramolecular disulfides, including the additional bridge between Cys(26) and Cys(30) in the central loops II, have the same positions as in monomeric alpha-cobratoxin. The three-finger fold is essentially preserved in each protomer, but the arrangement of the alpha CT-alpha CT dimer differs from those of noncovalent crystallographic dimers of three-finger toxins (TFT) or from the kappa-bungarotoxin solution structure. Selective reduction of Cys(26)-Cys(30) in one protomer does not affect the activity against the alpha 7 nicotinic acetylcholine receptor (nAChR), whereas its reduction in both protomers almost prevents alpha 7 nAChR recognition. On the contrary, reduction of one or both Cys(26)-Cys(30) disulfides in alpha CT-alpha CT considerably potentiates inhibition of the alpha 3 beta 2nAChR by the toxin. The heteromeric dimer of alpha-cobratoxin and cytotoxin has an activity similar to that of alpha CT-alpha CT against the alpha 7 nAChR and is more active against alpha 3 beta 2 nAChRs. Our results demonstrate that at least one Cys(26)-Cys(30) disulfide in covalent TFT dimers, similar to the monomeric TFTs, is essential for their recognition by alpha 7 nAChR, although it is less important for interaction of covalent TFT dimers with the alpha 3 beta 2 nAChR.	[Osipov, Alexey V.; Kasheverov, Igor E.; Filkin, Sergey Yu; Starkov, Vladislav G.; Andreeva, Tatyana V.; Utkin, Yuri N.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Rucktooa, Prakash; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Kasheverov, Igor E.; Utkin, Yuri N.] Syneuro, Moscow 117997, Russia; [Bertrand, Daniel] HiQScreen, CH-1206 Geneva, Switzerland	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Netherlands Cancer Institute; Netherlands Cancer Institute	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	vits@mx.ibch.ru	Tsetlin, Victor/X-2491-2018; Utkin, Yuri N./F-1958-2014; Alexey, Osipov/AAQ-1422-2021; Kasheverov, Igor E/F-6024-2014; Utkin, Yuri/L-2952-2019; Filkin, Sergey/B-9991-2016	Utkin, Yuri N./0000-0002-4609-970X; Utkin, Yuri/0000-0002-4609-970X; Rucktooa, Prakash/0000-0003-2050-7389; Sixma, Titia K/0000-0001-6180-0632; Filkin, Sergey/0000-0002-4710-6051; Osipov, Aleksei/0000-0001-7665-4711	EU [202033]; Russian Ministry of Education and Science [02.740.11.0865]; Russian Foundation for Basic Research [09-04-01061, 10-04-00708, 11-04-01011]; Russian Academy of Sciences	EU(European Commission); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by Neurocypres EU FP7 Program Grant 202033, Russian Ministry of Education and Science Contract 02.740.11.0865, Russian Foundation for Basic Research Grants 09-04-01061, 10-04-00708, and 11-04-01011 as well as the Molecular and Cell Biology Program of the Russian Academy of Sciences.	Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHICHEPORTICHE R, 1975, BIOCHEMISTRY-US, V14, P2081, DOI 10.1021/bi00681a007; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kukhtina VV, 2000, EUR J BIOCHEM, V267, P6784, DOI 10.1046/j.1432-1033.2000.01775.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LUETJE CW, 1990, J NEUROCHEM, V55, P632, DOI 10.1111/j.1471-4159.1990.tb04180.x; MARTIN BM, 1983, J BIOL CHEM, V258, P8714; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; OSWALD RE, 1991, BIOCHEMISTRY-US, V30, P4901, DOI 10.1021/bi00234a010; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Roy A, 2010, J BIOL CHEM, V285, P8302, DOI 10.1074/jbc.M109.074161; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x	30	26	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6725	6734		10.1074/jbc.M111.322313	http://dx.doi.org/10.1074/jbc.M111.322313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223648	Green Published, hybrid			2022-12-27	WOS:000300791800058
J	Shi, N; Xie, WB; Chen, SY				Shi, Ning; Xie, Wei-Bing; Chen, Shi-You			Cell Division Cycle 7 Is a Novel Regulator of Transforming Growth Factor-beta-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ACTIN EXPRESSION; PROTEIN-KINASE; SM22-ALPHA TRANSCRIPTION; GENE-EXPRESSION; RESPONSE GENE; 10T1/2 CELLS; MARKER GENES; PROLIFERATION; ATHEROSCLEROSIS	Smooth muscle cell (SMC) differentiation and proliferation occur simultaneously during embryonic development. The underlying mechanisms especially common factors regulating both processes, however, remain largely unknown. The present study has identified cell division cycle 7 (Cdc7) as one of the factors mediating both the proliferation and SMC differentiation. TGF-beta induces Cdc7 expression and phosphorylation in the initial phase of SMC differentiation of pluripotent mesenchymal C3H10T1/2 cells. Cdc7 specific inhibitor or shRNA knockdown suppresses TGF-beta-induced expression of SMC early markers including alpha-SMA, SM22 alpha, and calponin. Cdc7 overexpression, on the other hand, enhances SMC marker expression. Cdc7 function in inducing SMC differentiation is independent of Dumbbell former 4 or Dbf4, the catalytic subunit of Cdc7 critical for cell proliferation, suggesting that Cdc7 mediates SMC differentiation through a mechanism distinct from cell proliferation. Cdc7 regulates SMC differentiation via activating SMC marker gene transcription. Knockdown of Cdc7 by shRNA inhibits SMC marker gene promoter activities. Mechanistically, Cdc7 interacts with Smad3 to induce SMC differentiation. Smad3 is required for Cdc7 function in inducing SMC promoter activities and marker gene expression. Likewise, Cdc7 enhances Smad3 binding to SMC marker promoter via supporting Smad3 nuclear retention and physically interacting with Smad3. Taken together, our studies have demonstrated a novel role of Cdc7 in SMC differentiation.	[Shi, Ning; Xie, Wei-Bing; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shi, Ning/I-5631-2015		National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093429, R01HL107526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants HL093429 and HL107526 (to S. C.) from the National Institutes of Health.	AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Anderson DR, 2007, J MED CHEM, V50, P2647, DOI 10.1021/jm0611004; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li YM, 1997, ENDOCRINOLOGY, V138, P362, DOI 10.1210/en.138.1.362; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Maione R, 1997, BBA-REV CANCER, V1332, pM19, DOI 10.1016/S0304-419X(96)00036-4; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Montagnoli A, 2010, CLIN CANCER RES, V16, P4503, DOI 10.1158/1078-0432.CCR-10-0185; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; SACHS L, 1980, P NATL ACAD SCI-BIOL, V77, P6152, DOI 10.1073/pnas.77.10.6152; SCHWARTZ SM, 1983, P SOC EXP BIOL MED, V173, P1; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706	43	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6860	6867		10.1074/jbc.M111.306209	http://dx.doi.org/10.1074/jbc.M111.306209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223649	Green Published, hybrid			2022-12-27	WOS:000300791800071
J	Kurokawa, K; Ryu, KH; Ichikawa, R; Masuda, A; Kim, MS; Lee, H; Chae, JH; Shimizu, T; Saitoh, T; Kuwano, K; Akira, S; Dohmae, N; Nakayama, H; Lee, BL				Kurokawa, Kenji; Ryu, Kyoung-Hwa; Ichikawa, Rie; Masuda, Akiko; Kim, Min-Su; Lee, Hanna; Chae, Jun-Ho; Shimizu, Takashi; Saitoh, Tatsuya; Kuwano, Koichi; Akira, Shizuo; Dohmae, Naoshi; Nakayama, Hiroshi; Lee, Bok Luel			Novel Bacterial Lipoprotein Structures Conserved in Low-GC Content Gram-positive Bacteria Are Recognized by Toll-like Receptor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN N-ACYLTRANSFERASE; ESCHERICHIA-COLI; GENOME SEQUENCE; STAPHYLOCOCCUS-AUREUS; OUTER-MEMBRANE; CUTTING EDGE; IHEYA RIDGE; KAPPA-B; BACILLUS; TOLL-LIKE-RECEPTOR-1	Bacterial lipoproteins/lipopeptides inducing host innate immune responses are sensed by mammalian Toll-like receptor 2 (TLR2). These bacterial lipoproteins are structurally divided into two groups, diacylated or triacylated lipoproteins, by the absence or presence of an amide-linked fatty acid. The presence of diacylated lipoproteins has been predicted in low-GC content Gram-positive bacteria and mycoplasmas based on the absence of one modification enzyme in their genomes; however, we recently determined triacylated structures in low-GC Gram-positive Staphylococcus aureus, raising questions about the actual lipoprotein structure in other low-GC content Gram-positive bacteria. Here, through intensive MS analyses, we identified a novel and unique bacterial lipoprotein structure containing an N-acyl-S-monoacyl-glyceryl-cysteine (named the lyso structure) from low-GC Gram-positive Enterococcus faecalis, Bacillus cereus, Streptococcus sanguinis, and Lactobacillus bulgaricus. Two of the purified native lyso-form lipoproteins induced proinflammatory cytokine production from mice macrophages in a TLR2-dependent and TLR1-independent manner but with a different dependence on TLR6. Additionally, two other new lipoprotein structures were identified. One is the "N-acetyl" lipoprotein structure containing N-acetyl-S-diacylglyceryl-cysteine, which was found in five Gram-positive bacteria, including Bacillus subtilis. The N-acetyl lipoproteins induced the proinflammatory cytokines through the TLR2/6 heterodimer. The other was identified in a mycoplasma strain and is an unusual diacyl lipoprotein structure containing two amino acids before the lipid-modified cysteine residue. Taken together, our results suggest the existence of novel TLR2-stimulating lyso and N-acetyl forms of lipoproteins that are conserved in low-GC content Gram-positive bacteria and provide clear evidence for the presence of yet to be identified key enzymes involved in the bacterial lipoprotein biosynthesis.	[Ichikawa, Rie; Masuda, Akiko; Dohmae, Naoshi; Nakayama, Hiroshi] RIKEN, Biomol Characterizat Team, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Kurokawa, Kenji; Ryu, Kyoung-Hwa; Kim, Min-Su; Chae, Jun-Ho; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab Insect Symbiosis, Pusan 609735, South Korea; [Lee, Hanna; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Lee, Hanna; Saitoh, Tatsuya; Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Shimizu, Takashi; Kuwano, Koichi] Kurume Univ, Sch Med, Dept Bacteriol, Kurume, Fukuoka 8300011, Japan	RIKEN; Pusan National University; Osaka University; Osaka University; Kurume University	Nakayama, H (corresponding author), RIKEN, Biomol Characterizat Team, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	knife@riken.jp; brlee@pusan.ac.kr	Dohmae, Naoshi/C-2040-2011; Akira, Shizuo/C-3134-2009	Dohmae, Naoshi/0000-0002-5242-9410; 	Bio-Program [2008-2004086]; BK21; National Research Foundation of Korea	Bio-Program; BK21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Bio-Program Grant 2008-2004086 and the BK21 programs supported by the National Research Foundation of Korea (to B. L. L.).	Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Glaser P, 2001, SCIENCE, V294, P849; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; KANEDA T, 1977, BACTERIOL REV, V41, P391, DOI 10.1128/MMBR.41.2.391-418.1977; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lu J, 2001, FEMS MICROBIOL LETT, V205, P291, DOI 10.1111/j.1574-6968.2001.tb10963.x; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Masuda A, 2010, ANAL CHEM, V82, P8939, DOI 10.1021/ac101718x; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rechnitzer H, 2011, MICROBIOL-SGM, V157, P760, DOI 10.1099/mic.0.043208-0; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Serebryakova MV, 2011, J BIOL CHEM, V286, P22769, DOI 10.1074/jbc.M111.231316; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; TOKUNAGA M, 1985, J BIOL CHEM, V260, P5610; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635	42	54	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13170	13181		10.1074/jbc.M111.292235	http://dx.doi.org/10.1074/jbc.M111.292235			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22303020	Green Published, hybrid			2022-12-27	WOS:000302903700055
J	Dolmer, K; Gettins, PGW				Dolmer, Klavs; Gettins, Peter G. W.			How the Serpin alpha(1)-Proteinase Inhibitor Folds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE CENTER LOOP; ALPHA(1)-ANTITRYPSIN DEFICIENCY; PROTEINASE INHIBITION; MOLECULAR-BASIS; BETA-SHEET; MECHANISM; COMPLEX; POLYMERIZATION; INSERTION	Serpins are remarkable and unique proteins in being able to spontaneously fold into a metastable conformation without the aid of a chaperone or prodomain. This metastable conformation is essential for inhibition of proteinases, so that massive serpin conformational change, driven by the favorable energetics of relaxation of the metastable conformation to the more stable one, can kinetically trap the proteinase-serpin acylenzyme intermediate. Failure to direct folding to the metastable conformation would lead to inactive, latent serpin. How serpins fold into such a metastable state is unknown. Using the ability of component peptides from the serpin alpha 1PI to associate, we have now elucidated the pathway by which this serpin efficiently folds into its metastable state. In addition we have established the likely structure of the polymerogenic intermediate of the Z variant of alpha 1PI.	[Dolmer, Klavs; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, M-C 669,900 S Ashland, Chicago, IL 60607 USA.	pgettins@uic.edu	Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X				CREIGHTON TE, 1992, NATURE, V356, P194, DOI 10.1038/356194a0; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; Knaupp AS, 2011, J MOL BIOL, V413, P888, DOI 10.1016/j.jmb.2011.09.013; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Lee KN, 1996, NAT STRUCT BIOL, V3, P497, DOI 10.1038/nsb0696-497; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P5282, DOI 10.1074/jbc.270.10.5282; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Onda M, 2008, J BIOL CHEM, V283, P17568, DOI 10.1074/jbc.M709262200; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363	25	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12425	12432		10.1074/jbc.M111.315465	http://dx.doi.org/10.1074/jbc.M111.315465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334651	hybrid, Green Published			2022-12-27	WOS:000302782200082
J	Vyas, P; Brown, DT				Vyas, Payal; Brown, David T.			N- and C-terminal Domains Determine Differential Nucleosomal Binding Geometry and Affinity of Linker Histone Isotypes H1(0) and H1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; GLOBULAR DOMAIN; SECONDARY STRUCTURE; INTERACTION SURFACE; CRYSTAL-STRUCTURE; SOMATIC SUBTYPES; HIGH-MOBILITY; IN-VIVO; DNA; PHOSPHORYLATION	Eukaryotic linker or H1 histones modulate DNA compaction and gene expression in vivo. In mammals, these proteins exist as multiple isotypes with distinct properties, suggesting a functional significance to the heterogeneity. Linker histones typically have a tripartite structure composed of a conserved central globular domain flanked by a highly variable short N-terminal domain and a longer highly basic C-terminal domain. We hypothesized that the variable terminal domains of individual subtypes contribute to their functional heterogeneity by influencing chromatin binding interactions. We developed a novel dual color fluorescence recovery after photobleaching assay system in which two H1 proteins fused to spectrally separable fluorescent proteins can be co-expressed and their independent binding kinetics simultaneously monitored in a single cell. This approach was combined with domain swap and point mutagenesis to determine the roles of the terminal domains in the differential binding characteristics of the linker histone isotypes, mouse H1(0) and H1c. Exchanging the N-terminal domains between H1(0) and H1c changed their overall binding affinity to that of the other variant. In contrast, switching the C-terminal domains altered the chromatin interaction surface of the globular domain. These results indicate that linker histone subtypes bind to chromatin in an intrinsically specific manner and that the highly variable terminal domains contribute to differences between subtypes. The methods developed in this study will have broad applications in studying dynamic properties of additional histone subtypes and other mobile proteins.	[Vyas, Payal; Brown, David T.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Brown, DT (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	dbrown@umc.edu			Mississippi Idea Networks of Biomedical Research Excellence; National Center for Research Resources [5P20RR016476-11]; NIGMS from the National Institutes of Health [8 P20 GM103476-11]; National Science Foundation [MCB0235800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Mississippi Idea Networks of Biomedical Research Excellence; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mississippi Idea Networks of Biomedical Research Excellence funded by grants from the National Center for Research Resources (5P20RR016476-11) and NIGMS (8 P20 GM103476-11) from the National Institutes of Health. This work was also supported by Grant MCB0235800 from the National Science Foundation (to D. T. B.).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bhan S, 2008, GENE, V414, P10, DOI 10.1016/j.gene.2008.01.025; Bharath MMS, 2003, NUCLEIC ACIDS RES, V31, P4264, DOI 10.1093/nar/gkg481; Bharath MMS, 2002, BIOCHEMISTRY-US, V41, P7617, DOI 10.1021/bi025773+; BOHM L, 1985, FEBS LETT, V193, P1, DOI 10.1016/0014-5793(85)80067-3; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gabrilovich DI, 2002, J LEUKOCYTE BIOL, V72, P285; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; George EM, 2010, J BIOL CHEM, V285, P20891, DOI 10.1074/jbc.M110.108639; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Orrego M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-22; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Raghuram N, 2010, BIOCHEMISTRY-US, V49, P4420, DOI 10.1021/bi100296z; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roque A, 2005, J BIOL CHEM, V280, P32141, DOI 10.1074/jbc.M505636200; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; van Holde KE., 1989, SPRINGER SERIES MOL; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	55	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11778	11787		10.1074/jbc.M111.312819	http://dx.doi.org/10.1074/jbc.M111.312819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334665	hybrid, Green Published			2022-12-27	WOS:000302782200017
J	van Straaten, KE; Routier, FH; Sanders, DAR				van Straaten, Karin E.; Routier, Francoise H.; Sanders, David A. R.			Structural Insight into the Unique Substrate Binding Mechanism and Flavin Redox State of UDP-galactopyranose Mutase from Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; OXIDIZED STATE; GALACTOFURANOSE; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; MUTAGENESIS; VALIDATION; VIRULENCE	UDP-galactopyranose mutase (UGM) is a flavin-containing enzyme that catalyzes the reversible conversion of UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). As in prokaryotic UGMs, the flavin needs to be reduced for the enzyme to be active. Here we present the first eukaryotic UGM structures from Aspergillus fumigatus (AfUGM). The structures are of UGM alone, with the substrate UDP-Galp and with the inhibitor UDP. Additionally, we report the structures of AfUGM bound to substrate with oxidized and reduced flavin. These structures provide insight into substrate recognition and structural changes observed upon substrate binding involving the mobile loops and the critical arginine residues Arg-182 and Arg-327. Comparison with prokaryotic UGM reveals that despite low sequence identity with known prokaryotic UGMs the overall fold is largely conserved. Structural differences between prokaryotic UGM and AfUGM result from inserts in AfUGM. A notable difference from prokaryotic UGMs is that AfUGM contains a third flexible loop (loop III) above the si-face of the isoalloxazine ring that changes position depending on the redox state of the flavin cofactor. This loop flipping has not been observed in prokaryotic UGMs. In addition we have determined the crystals structures and steady-state kinetic constants of the reaction catalyzed by mutants R182K, R327K, R182A, and R327A. These results support our hypothesis that Arg-182 and Arg-327 play important roles in stabilizing the position of the diphosphates of the nucleotide sugar and help to facilitate the positioning of the galactose moiety for catalysis.	[van Straaten, Karin E.; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada; [Routier, Francoise H.] Hannover Med Sch, D-30625 Hannover, Germany	University of Saskatchewan; Hannover Medical School	Sanders, DAR (corresponding author), 110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016; Routier, Francoise/O-1611-2019	Routier, Francoise/0000-0002-7163-0590	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; NSERC; National Research Council of Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported in part by grants from Natural Science and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health Research-Regional Partnership Program (to D. A. R. S.).; We thank the Saskatchewan Health Research Foundation for funding the Molecular Design Research Group of the University of Saskatchewan, Dr. David Palmer (University of Saskatchewan) for many helpful discussions and shared equipment, and Dr. Sean Dalrymple for helpful discussions during manuscript preparation. We thank the staff of macromolecular beam line 08ID-1, Canadian Light Source (CLS), Saskatoon, Saskatchewan, Canada, for their technical assistance during data collection. The structural studies described in this paper were performed at the CLS, which is supported by NSERC, the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; D'Arcy A, 2004, METHODS, V34, P323, DOI 10.1016/j.ymeth.2004.03.023; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodje M. N., 2010, P PCAPAC 2010 OCT 5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kleczka B, 2004, GLYCOBIOLOGY, V14, P1119; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; Novelli JF, 2009, DEV BIOL, V335, P340, DOI 10.1016/j.ydbio.2009.09.010; Oppenheimer M, 2011, BIOCHEM BIOPH RES CO, V407, P552, DOI 10.1016/j.bbrc.2011.03.057; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Straaten K. E., 2012, ACTA CRYS F IN PRESS; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Yao XH, 2009, PROTEINS, V74, P972, DOI 10.1002/prot.22206; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	40	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10780	10790		10.1074/jbc.M111.322974	http://dx.doi.org/10.1074/jbc.M111.322974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334662	hybrid, Green Published			2022-12-27	WOS:000302780100007
J	Wang, XH; Li, JP; Kuo, HK; Chiu, LL; Dement, GA; Lan, JL; Chen, DY; Yang, CY; Hu, HB; Tan, TH				Wang, Xiaohong; Li, Ju-Pi; Kuo, Hui-Kai; Chiu, Li-Li; Dement, Gregory A.; Lan, Joung-Liang; Chen, Der-Yuan; Yang, Chia-Yu; Hu, Hongbo; Tan, Tse-Hua			Down-regulation of B Cell Receptor Signaling by Hematopoietic Progenitor Kinase 1 (HPK1)-mediated Phosphorylation and Ubiquitination of Activated B Cell Linker Protein (BLNK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; CASPASE-MEDIATED CLEAVAGE; KAPPA-B; T-CELLS; HEMATOPOIETIC-PROGENITOR-KINASE-1 HPK1; PSORIATIC-ARTHRITIS; PATHWAY; ADAPTER; EXPRESSION; AUTOIMMUNITY	Background: HPK1 is a hematopoiesis-specific Ste20-like serine/threonine kinase that suppresses immune responses and autoimmunity. Results: HPK1 knock-out B cells show loss of Thr-152 phosphorylation, 14-3-3 binding, and Lys-37/38/42-ubiquitination of BLNK. Conclusion: HPK1 attenuates BCR signaling via inducing phosphorylation and ubiquitination of BLNK. Significance: This is the first report of BLNK ubiquitination that is initiated by HPK1-induced phosphorylation.	[Wang, Xiaohong; Dement, Gregory A.; Hu, Hongbo; Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Li, Ju-Pi; Kuo, Hui-Kai; Yang, Chia-Yu] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan; [Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung 40705, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 11221, Taiwan	Baylor College of Medicine; National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	ttan@bcm.edu	Li, Ju-Pi/AAS-8866-2021; Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Hu, Hongbo/J-8059-2016	Li, Ju-Pi/0000-0003-3406-4865; Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Hu, Hongbo/0000-0002-8177-7641	National Institutes of Health [R01-AI066895, K12 GM84897, T32AI007495]; National Health Research Institutes, Taiwan [98A1-IMPP01-014]; Taichung Veterans General Hospital, Taiwan [TCVGH-NHRI01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taichung Veterans General Hospital, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI066895 (to T.-H.T.) and K12 GM84897 and T32AI007495 (to G. A. D.). This work was also supported by National Health Research Institutes, Taiwan, Grant 98A1-IMPP01-014 (to T.- H. T.) and Taichung Veterans General Hospital, Taiwan, Grant TCVGH-NHRI01 (to J.-L. L.).	Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jang IK, 2009, IMMUNOL REV, V232, P150, DOI 10.1111/j.1600-065X.2009.00842.x; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Stoeckman AK, 2006, GENES IMMUN, V7, P583, DOI 10.1038/sj.gene.6364334; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhang Q, 2011, J AUTOIMMUN, V37, P180, DOI 10.1016/j.jaut.2011.09.006	34	32	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11037	11048		10.1074/jbc.M111.310946	http://dx.doi.org/10.1074/jbc.M111.310946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334673	hybrid, Green Published			2022-12-27	WOS:000302780100032
J	Evjenth, RH; Brenner, AK; Thompson, PR; Arnesen, T; Froystein, NA; Lillehaug, JR				Evjenth, Rune H.; Brenner, Annette K.; Thompson, Paul R.; Arnesen, Thomas; Froystein, Nils Age; Lillehaug, Johan R.			Human Protein N-terminal Acetyltransferase hNaa50p (hNAT5/hSAN) Follows Ordered Sequential Catalytic Mechanism COMBINED KINETIC AND NMR STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERONUCLEAR CORRELATION SPECTRA; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; HISTONE ACETYLTRANSFERASE; ALPHA-ACETYLTRANSFERASE; CHEMICAL-SHIFT; ARD1; YEAST; C-13; MACROMOLECULES	N-alpha-Acetylation is a common protein modification catalyzed by different N-terminal acetyltransferases (NATs). Their essential role in the biogenesis and degradation of proteins is becoming increasingly evident. TheNAThNaa50p preferentially modifies peptides starting with methionine followed by a hydrophobic amino acid. hNaa50p also possesses N-epsilon-autoacetylation activity. So far, no eukaryotic NAT has been mechanistically investigated. In this study, we used NMR spectroscopy, bisubstrate kinetic assays, and product inhibition experiments to demonstrate that hNaa50p utilizes an ordered Bi Bi reaction of the Theorell-Chance type. The NMR results, both the substrate binding study and the dynamic data, further indicate that the binding of acetyl-CoA induces a conformational change that is required for the peptide to bind to the active site. In support of an ordered Bi Bi reaction mechanism, addition of peptide in the absence of acetyl-CoA did not alter the structure of the protein. This model is further strengthened by the NMR results using a catalytically inactive hNaa50p mutant.	[Evjenth, Rune H.; Arnesen, Thomas; Lillehaug, Johan R.] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Brenner, Annette K.; Froystein, Nils Age] Univ Bergen, Dept Chem, N-5020 Bergen, Norway; [Thompson, Paul R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Arnesen, Thomas] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Scripps Research Institute; University of Bergen; Haukeland University Hospital	Evjenth, RH (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5020 Bergen, Norway.	rune.evjenth@mbi.uib.no; johan.lillehaug@mbi.uib.no	Arnesen, Thomas/J-7139-2017; Arnesen, Thomas/Q-8117-2019	Arnesen, Thomas/0000-0002-3005-147X; Arnesen, Thomas/0000-0002-3005-147X				Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Arnesen T, 2006, GENE, V371, P291, DOI 10.1016/j.gene.2005.12.008; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Arnesen T, 2008, CURR CANCER DRUG TAR, V8, P545, DOI 10.2174/156800908786241113; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Evjenth Rune, 2009, BMC Proc, V3 Suppl 6, pS5, DOI 10.1186/1753-6561-3-S6-S5; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Fisher TS, 2005, J BIOL CHEM, V280, P17749, DOI 10.1074/jbc.M412055200; Fluge O, 2002, ONCOGENE, V21, P5056, DOI 10.1038/sj.onc.1205687; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gromyko D, 2010, INT J CANCER, V127, P2777, DOI 10.1002/ijc.25275; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; KAMATH U, 1989, J BIOL CHEM, V264, P5586; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R.L.J, 2005, THESIS ETH ZURICH ZU; Kuo HP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000590; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Pimenta-Marques A, 2008, DEV BIOL, V323, P197, DOI 10.1016/j.ydbio.2008.08.021; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Ren TT, 2008, CANCER LETT, V264, P83, DOI 10.1016/j.canlet.2008.01.028; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schubert M, 1999, J MAGN RESON, V141, P34, DOI 10.1006/jmre.1999.1881; Schubert M, 2001, J MAGN RESON, V153, P186, DOI 10.1006/jmre.2001.2447; Schubert M, 2001, J BIOMOL NMR, V20, P379, DOI 10.1023/A:1011206131623; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Yu M, 2009, ONCOL REP, V21, P909, DOI 10.3892/or_00000303	52	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10081	10088		10.1074/jbc.M111.326587	http://dx.doi.org/10.1074/jbc.M111.326587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22311970	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000302167200040
J	Kondo-Okamoto, N; Noda, NN; Suzuki, SW; Nakatogawa, H; Takahashi, I; Matsunami, M; Hashimoto, A; Inagaki, F; Ohsumi, Y; Okamoto, K				Kondo-Okamoto, Noriko; Noda, Nobuo N.; Suzuki, Sho W.; Nakatogawa, Hitoshi; Takahashi, Ikuko; Matsunami, Miou; Hashimoto, Ayako; Inagaki, Fuyuhiko; Ohsumi, Yoshinori; Okamoto, Koji			Autophagy-related Protein 32 Acts as Autophagic Degron and Directly Initiates Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL PROTEIN; STRUCTURAL BASIS; YEAST; MECHANISM; CARGO; CYTOPLASM; ATG32	Autophagy-related degradation selective for mitochondria (mitophagy) is an evolutionarily conserved process that is thought to be critical for mitochondrial quality and quantity control. In budding yeast, autophagy-related protein 32 (Atg32) is inserted into the outer membrane of mitochondria with its Nand C-terminal domains exposed to the cytosol and mitochondrial intermembrane space, respectively, and plays an essential role in mitophagy. Atg32 interacts with Atg8, a ubiquitin-like protein localized to the autophagosome, and Atg11, a scaffold protein required for selective autophagy-related pathways, although the significance of these interactions remains elusive. In addition, whether Atg32 is the sole protein necessary and sufficient for initiation of autophagosome formation has not been addressed. Here we show that the Atg32 IMS domain is dispensable for mitophagy. Notably, when anchored to peroxisomes, the Atg32 cytosol domain promoted autophagy-dependent peroxisome degradation, suggesting that Atg32 contains a module compatible for other organelle autophagy. X-ray crystallography reveals that the Atg32 Atg8 family-interacting motif peptide binds Atg8 in a conserved manner. Mutations in this binding interface impair association of Atg32 with the free form of Atg8 and mitophagy. Moreover, Atg32 variants, which do not stably interact with Atg11, are strongly defective in mitochondrial degradation. Finally, we demonstrate that Atg32 forms a complex with Atg8 and Atg11 prior to and independent of isolation membrane generation and subsequent autophagosome formation. Taken together, our data implicate Atg32 as a bipartite platform recruiting Atg8 and Atg11 to the mitochondrial surface and forming an initiator complex crucial for mitophagy.	[Kondo-Okamoto, Noriko; Hashimoto, Ayako; Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka 5650871, Japan; [Noda, Nobuo N.; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sapporo, Hokkaido 0600812, Japan; [Suzuki, Sho W.; Nakatogawa, Hitoshi; Takahashi, Ikuko; Matsunami, Miou; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan	Osaka University; Hokkaido University; Tokyo Institute of Technology	Okamoto, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kokamoto@fbs.osaka-u.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Nakatogawa, Hitoshi/D-5155-2015; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Nakatogawa, Hitoshi/0000-0002-5828-0741; Noda, Nobuo/0000-0002-6940-8069; Suzuki, Sho/0000-0002-6563-5387	Ministry of Education, Culture, Science, and Technology of Japan [22770124]; Targeted Proteins Research Program; Specially Promoted Research Grant [19002015]; Scientific Research (C) Grant [20570144]; Scientific Research on Priority Areas Grants [20059034, 22020012]; Scientific Research on Innovative Areas Grant [23113717]; Challenging Exploratory Research Grant [23657090]; Osaka University; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Grants-in-Aid for Scientific Research [22770124, 22020012] Funding Source: KAKEN	Ministry of Education, Culture, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Specially Promoted Research Grant; Scientific Research (C) Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Priority Areas Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research on Innovative Areas Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Challenging Exploratory Research Grant; Osaka University; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid 22770124 from the Ministry of Education, Culture, Science, and Technology of Japan for Young Scientists (B) (to N. K. O.), the Targeted Proteins Research Program (to F. I.), Specially Promoted Research Grant 19002015 (to Y. O.), Scientific Research (C) Grant 20570144 (to K. O.), Scientific Research on Priority Areas Grants 20059034 and 22020012 (to K. O.), Scientific Research on Innovative Areas Grant 23113717 (to K. O.), Challenging Exploratory Research Grant 23657090 (to K. O.), special coordination funds from the Osaka University Life Science Young Independent Researcher Support Program to Disseminate Tenure Tracking System (to K. O.), and by grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to K. O.) and the Sumitomo Foundation (to K. O.).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheong H, 2005, MOL BIOL CELL, V16, P3438, DOI 10.1091/mbc.E04-10-0894; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K., 2012, BIOCH BIOPH IN PRESS; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yorimitsu T, 2005, MOL BIOL CELL, V16, P1593, DOI 10.1091/mbc.E04-11-1035; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang J, 2011, ANTIOXID REDOX SIGN, V14, P1959, DOI 10.1089/ars.2010.3772	40	91	100	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10631	10638		10.1074/jbc.M111.299917	http://dx.doi.org/10.1074/jbc.M111.299917			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308029	hybrid, Green Published			2022-12-27	WOS:000302167200088
J	Wang, S; Li, H; Chen, YH; Wei, HT; Gao, GF; Liu, HQ; Huang, SL; Chen, JL				Wang, Song; Li, Hua; Chen, Yuhai; Wei, Haitao; Gao, George F.; Liu, Hongqiang; Huang, Shile; Chen, Ji-Long			Transport of Influenza Virus Neuraminidase (NA) to Host Cell Surface Is Regulated by ARHGAP21 and Cdc42 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; TRANSMEMBRANE DOMAIN; VESICLE TRAFFICKING; RAFT ASSOCIATION; GOLGI MEMBRANES; ACTIN DYNAMICS; VIRAL ENTRY; COMPLEX; TRANSFORMATION; HEMAGGLUTININ	Influenza virus neuraminidase (NA) is transported to the virus assembly site at the plasma membrane and is a major viral envelope component that plays a critical role in the release of progeny virions and in determination of host range restriction. However, little is known about the host factors that are involved in regulating the intracellular and cell surface transport of NA. Here we identified the Cdc42-specific GAP, ARHGAP21 differentially expressed in host cells infected with influenza A virus using cDNA microarray analysis. Furthermore, we have investigated the involvement of Rho family GTPases in NA transport to the cell surface. We found that expression of constitutively active or inactive mutants of RhoA or Rac1 did not significantly affect the amount of NA that reached the cell surface. However, expression of constitutively active Cdc42 or depletion of ARHGAP21 promoted the transport of NA to the plasma membranes. By contrast, cells expressing shRNA targeting Cdc42 or overexpressing ARHGAP21 exhibited a significant decrease in the amount of cell surface-localized NA. Importantly, silencing Cdc42 reduced influenza A virus replication, whereas silencing ARHGAP21 increased the virus replication. Together, our results reveal that ARHGAP21- and Cdc42-based signaling regulates the NA transport and thereby impacts virus replication.	[Wang, Song; Li, Hua; Chen, Yuhai; Wei, Haitao; Gao, George F.; Liu, Hongqiang; Chen, Ji-Long] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Li, Hua] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Fujian Agriculture & Forestry University	Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, W Beichen Rd, Beijing 100101, Peoples R China.	chenjl@im.ac.cn	Chen, Ji-Long/AAJ-2134-2021; Gao, George Fu/ABD-5229-2021; Huang, Shile/I-1632-2019	Chen, Ji-Long/0000-0002-4274-0563; Huang, Shile/0000-0002-3239-1072; Wei, Haitao/0000-0001-5235-8619	National Basic Research Program (973) of China [2010CB534004]; National Key Technology RD Program [2009BA183B01-8]; Chinese Academy of Sciences [2010-Biols-CAS-0204]; National Natural Science Foundation of China Innovative Research Group [81021003]	National Basic Research Program (973) of China(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China Innovative Research Group	This work was supported by National Basic Research Program (973) of China (2010CB534004), National Key Technology R&D Program (2009BA183B01-8), Intramural grant of the Chinese Academy of Sciences (2010-Biols-CAS-0204), and Hundreds of Talents Program of Chinese Academy of Sciences 2009-2014.; A leading principal investigator of the National Natural Science Foundation of China Innovative Research Group (Grant 81021003).	AKTORIES K, 1995, METHOD ENZYMOL, V256, P184; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; AKTORIES K, 1995, TRENDS CELL BIOL, V5, P441, DOI 10.1016/S0962-8924(00)89107-2; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Barman S, 2000, J VIROL, V74, P6538, DOI 10.1128/JVI.74.14.6538-6545.2000; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; Chen JL, 2004, FEBS LETT, V566, P281, DOI 10.1016/j.febslet.2004.04.061; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fucini RV, 2002, MOL BIOL CELL, V13, P621, DOI 10.1091/mbc.01-11-0547; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Guo G, 2010, ONCOGENE, V29, P3845, DOI 10.1038/onc.2010.149; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hehnly H, 2010, TRAFFIC, V11, P1067, DOI 10.1111/j.1600-0854.2010.01082.x; Hehnly H, 2009, MOL BIOL CELL, V20, P4303, DOI 10.1091/mbc.E09-02-0155; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu D, 2009, SCI CHINA SER C, V52, P428, DOI 10.1007/s11427-009-0062-z; Liu SW, 2011, EUR J PHARMACOL, V660, P460, DOI 10.1016/j.ejphar.2011.04.013; Luna A, 2002, MOL BIOL CELL, V13, P866, DOI 10.1091/mbc.01-12-0579; Malyukova I, 2009, AM J PHYSIOL-GASTR L, V296, pG78, DOI 10.1152/ajpgi.90347.2008; Matas OB, 2005, EUR J CELL BIOL, V84, P699, DOI 10.1016/j.ejcb.2005.05.001; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Valderrama F, 2000, P NATL ACAD SCI USA, V97, P1560, DOI 10.1073/pnas.97.4.1560; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Whittaker G R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002447; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Wilkins TD, 1996, TRENDS MICROBIOL, V4, P49, DOI 10.1016/0966-842X(96)81508-3; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585	48	58	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9804	9816		10.1074/jbc.M111.312959	http://dx.doi.org/10.1074/jbc.M111.312959			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318733	hybrid, Green Published			2022-12-27	WOS:000302167200013
J	Chang, JS; Fernand, V; Zhang, YB; Shin, J; Jun, HJ; Joshi, Y; Gettys, TW				Chang, Ji Suk; Fernand, Vivian; Zhang, Yubin; Shin, Jeho; Jun, Hee-Jin; Joshi, Yagini; Gettys, Thomas W.			NT-PGC-1 alpha Protein Is Sufficient to Link beta(3)-Adrenergic Receptor Activation to Transcriptional and Physiological Components of Adaptive Thermogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGC-1-ALPHA MESSENGER-RNA; WHITE ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; UNCOUPLING PROTEIN; COACTIVATOR PGC-1; BROWN FAT; HEPATIC GLUCONEOGENESIS; GAMMA COACTIVATOR-1; GENE	PGC-1 alpha is an inducible transcriptional coactivator that regulates cellular energy metabolism and adaptation to environmental and nutritional stimuli. In tissues expressing PGC-1 alpha, alternative splicing produces a truncated protein (NT-PGC-1 alpha) corresponding to the first 267 amino acids of PGC-1 alpha. Brown adipose tissue also expresses two novel exon 1b-derived isoforms of PGC-1 alpha and NT-PGC-1 alpha, which are 4 and 13 amino acids shorter in the N termini than canonical PGC-1 alpha and NT-PGC-1 alpha, respectively. To evaluate the ability of NT-PGC-1 alpha to substitute for PGC-1 alpha and assess the isoform-specific role of NT-PGC-1 alpha, adaptive thermogenic responses of adipose tissue were evaluated in mice lacking full-length PGC-1 alpha (FL-PGC-1(-/-)) but expressing slightly shorter but functionally equivalent forms of NT-PGC-1 alpha (NT-PGC-1 alpha(254)). At room temperature, NT-PGC-1 alpha and NT-PGC-1 alpha(254) were produced from conventional exon 1a-derived transcripts in brown adipose tissue of wild type and FL-PGC-1 alpha(-/-) mice, respectively. However, cold exposure shifted transcription to exon 1b, increasing exon 1b-derived mRNA levels. The resulting transcriptional responses produced comparable increases in energy expenditure and maintenance of core body temperature in WT and FL-PGC-1 alpha(-/-) mice. Moreover, treatment of the two genotypes with a selective beta(3)-adrenergic receptor agonist produced similar increases in energy expenditure, mitochondrial DNA, and reductions in adiposity. Collectively, these findings illustrate that the transcriptional and physiological responses to sympathetic input are unabridged in FL-PGC-1 alpha(-/-) mice, and that NT-PGC-1 alpha is sufficient to link beta(3)-androgenic receptor activation to adaptive thermogenesis in adipose tissue. Furthermore, the transcriptional shift from exon 1a to 1b supports isoform-specific roles for NT-PGC-1 alpha in basal and adaptive thermogenesis.	[Chang, Ji Suk; Fernand, Vivian; Zhang, Yubin; Shin, Jeho; Jun, Hee-Jin; Joshi, Yagini; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Gettys, Thomas W/N-1964-2017; Chang, Ji Suk/N-1957-2017	Gettys, Thomas W/0000-0001-7125-7995; 	National Institutes of Health [RO1 DK 074772, P20-RR021945]; PBRC Nutrition Obesity Research Center (NORC) [1P30 DK072476]; COBRE (National Institutes of Health) [P20-RR021945]; NORC (National Institutes of Health) from the National Institutes of Health [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK074772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PBRC Nutrition Obesity Research Center (NORC); COBRE (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (National Institutes of Health) from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 DK 074772 (to T. W. G.) and P20-RR021945 (to T. W. G. and J. S. C.). This work was also supported by PBRC Nutrition Obesity Research Center (NORC) Pilot and Feasibility Grant 1P30 DK072476 (to JSC). This work used Cell Biology & Bioimaging and Genomics core facilities, which are supported in part by COBRE (National Institutes of Health Grant P20-RR021945) and NORC (National Institutes of Health 1P30-DK072476) center grants from the National Institutes of Health.	Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Cheng XL, 2005, J BIOCHEM, V138, P673, DOI 10.1093/jb/mvi169; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Dankert JR, 2008, J NEURAL ENG, V5, P363, DOI 10.1088/1741-2560/5/4/001; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sears IB, 1996, MOL CELL BIOL, V16, P3410; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	37	57	59	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9100	9111		10.1074/jbc.M111.320200	http://dx.doi.org/10.1074/jbc.M111.320200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22282499	hybrid, Green Published			2022-12-27	WOS:000301797800040
J	Gorelik, M; Davidson, AR				Gorelik, Maryna; Davidson, Alan R.			Distinct Peptide Binding Specificities of Src Homology 3 (SH3) Protein Domains Can Be Determined by Modulation of Local Energetics across the Binding Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR; RECOGNITION; COMPLEX; BEM1; NMR; PHOSPHATASE; NETWORK; PTC1P; MOTIF	The yeast Nbp2p SH3 and Bem1p SH3b domains bind certain target peptides with similar high affinities, yet display vastly different affinities for other targets. To investigate this unusual behavior, we have solved the structure of the Nbp2p SH3-Ste20 peptide complex and compared it with the previously determined structure of the Bem1p SH3b bound to the same peptide. Although the Ste20 peptide interacts with both domains in a structurally similar manner, extensive in vitro studies with domain and peptide mutants revealed large variations in interaction strength across the binding interface of the two complexes. Whereas the Nbp2p SH3 made stronger contacts with the peptide core RXXPXXP motif, the Bem1p SH3b domain made stronger contacts with residues flanking the core motif. Remarkably, this modulation of local binding energetics can explain the distinct and highly nuanced binding specificities of these two domains.	[Gorelik, Maryna; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca			Canadian Institutes of Health Research [MOP-13609]; Natural Sciences and Engineering Research Council PGS-D; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Quebec ministere de la recherche en science et technologie; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council PGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Quebec ministere de la recherche en science et technologie; McGill University	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-13609 and by a Natural Sciences and Engineering Research Council PGS-D scholarship (to M. G.). All NMR experiments were recorded at the Quebec/Eastern Canada High Field NMR Facility, supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation, the Quebec ministere de la recherche en science et technologie, and McGill University.	Bauer F, 2005, PROTEIN SCI, V14, P2487, DOI 10.1110/ps.051563605; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849; GEMMECKER G, 1992, J MAGN RESON, V96, P199, DOI 10.1016/0022-2364(92)90304-P; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Goddard T. D., SPARKY 3; Gorelik M, 2011, J BIOL CHEM, V286, P19470, DOI 10.1074/jbc.M111.229294; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hertveldt K, 2006, BIOTECHNOL LETT, V28, P1233, DOI 10.1007/s10529-006-9082-y; Hoelz A, 2006, J MOL BIOL, V358, P509, DOI 10.1016/j.jmb.2006.02.027; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Janz JM, 2007, J BIOL CHEM, V282, P28893, DOI 10.1074/jbc.M702678200; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kim JM, 2008, J MOL BIOL, V377, P889, DOI 10.1016/j.jmb.2008.01.063; Larson SM, 2000, PROTEIN SCI, V9, P2170, DOI 10.1110/ps.9.11.2170; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Luck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025376; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Stein A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002524; Stollar EJ, 2009, J BIOL CHEM, V284, P26918, DOI 10.1074/jbc.M109.028431; Takaku T, 2010, J BIOL CHEM, V285, P19346, DOI 10.1074/jbc.M110.116749; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Winters MJ, 2005, MOL CELL BIOL, V25, P2177, DOI 10.1128/MCB.25.6.2177-2190.2005; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	38	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9168	9177		10.1074/jbc.M111.330753	http://dx.doi.org/10.1074/jbc.M111.330753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277653	Green Published, hybrid			2022-12-27	WOS:000301797800045
J	Hijazi, M; Durand, J; Pichereaux, C; Pont, F; Jamet, E; Albenne, C				Hijazi, May; Durand, Jessica; Pichereaux, Carole; Pont, Frederic; Jamet, Elisabeth; Albenne, Cecile			Characterization of the Arabinogalactan Protein 31 (AGP31) of Arabidopsis thaliana NEW ADVANCES ON THE HYP-O-GLYCOSYLATION OF THE PRO-RICH DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL PROTEINS; MASS-SPECTROMETRY; HYDROXYPROLINE; IDENTIFICATION; EXTENSIN; 4-HYDROXYLASE; GLYCOPROTEINS; PROTEOMICS; CLONING; BINDING	Proteins are important actors in plant cell walls because they contribute to their architecture and their dynamics. Among them, hydroxyproline (Hyp)-rich glycoproteins constitute a complex family of O-glycoproteins with various structures and functions. In this study, we characterized an atypical Hyp-rich glycoprotein, AGP31 (arabinogalactan protein 31), which displays a multidomain organization unique in Arabidopsis thaliana, consisting of a short arabinogalactan protein (AGP) motif, a His stretch, a Pro-rich domain, and a C-terminal PAC (PRP-AGP containing Cys) domain. The use of various mass spectrometry strategies was innovative and powerful: it permitted us to locate Hyp residues, to demonstrate the presence of carbohydrates, and to refine their distribution over the Pro-rich domain. Most Hyp were isolated within repeated motifs such as KAOV, KSOV, K(PO/OP) T, K(PO/OP) V, T(PO/OP) V, and Y(PO/OP) T. A few extensin-like motifs with contiguous Hyp (SOOA and SOOT) were also found. The Pro-rich domain was shown to carry Gal residues on isolated Hyp but also Ara residues. The existence of new type Hyp-O-Gal/Ara-rich motifs not recognized by the beta-glucosyl Yariv reagent but interacting with the peanut agglutinin lectin was proposed. In addition, the N-terminal short AGP motif was assumed to be substituted by arabinogalactans. Altogether, AGP31 was found to be highly heterogeneous in cell walls because arabinogalactans could be absent, Hyp-O-Gal/Ara-rich motifs of different sizes were observed, and truncated forms missing the C-terminal PAC domain were found, suggesting degradation in muro and/or partial glycosylation prior to secretion.	[Albenne, Cecile] CNRS, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Pichereaux, Carole] Univ Toulouse, FR3450, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Pont, Frederic] INSERM, F-31300 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Albenne, C (corresponding author), CNRS, UPS, UMR 5546, Lab Rech Sci Vegetales, BP 42617, F-31326 Castanet Tolosan, France.	albenne@lrsv.ups-tlse.fr	Jamet, Elisabeth/Z-2476-2019; PONT, Frédéric/G-6289-2011	PONT, Frédéric/0000-0002-5493-527X; ALBENNE, Cecile/0000-0001-9856-9745; Pichereaux, Carole/0000-0002-7559-5358	Universite Paul Sabatier (Toulouse, France); CNRS (France); Lebanon ecological association	Universite Paul Sabatier (Toulouse, France); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Lebanon ecological association	This work was supported by the Universite Paul Sabatier (Toulouse, France), the CNRS (France), and a grant from the Lebanon ecological association (to M. H.). This work has been done in the LRSV, part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41).	AVERYHARTFULLARD V, 1988, P NATL ACAD SCI USA, V85, P1082, DOI 10.1073/pnas.85.4.1082; Baldwin TC, 2001, PLANT MOL BIOL, V45, P421, DOI 10.1023/A:1010637426934; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Eudes A, 2008, PLANT CELL PHYSIOL, V49, P1331, DOI 10.1093/pcp/pcn108; Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10; Fowler TJ, 1999, PLANT PHYSIOL, V121, P1081, DOI 10.1104/pp.121.4.1081; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; GIBEAUT DM, 1991, PLANT PHYSIOL, V97, P551, DOI 10.1104/pp.97.2.551; HATA K, 1992, PLANT PHYSIOL, V100, P388, DOI 10.1104/pp.100.1.388; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Jeyaprakash AA, 2005, J MOL BIOL, V347, P181, DOI 10.1016/j.jmb.2005.01.015; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; KLEISSANFRANCISCO SM, 1990, PLANT PHYSIOL, V94, P1897, DOI 10.1104/pp.94.4.1897; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Kotake T, 2005, PLANT PHYSIOL, V138, P1563, DOI 10.1104/pp.105.062562; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu CG, 2007, PLANT PHYSIOL, V145, P863, DOI 10.1104/pp.107.102657; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; SommerKnudsen J, 1996, PLANT J, V9, P71, DOI 10.1046/j.1365-313X.1996.09010071.x; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Zhang Y, 2011, PHYTOCHEMISTRY, V72, P1109, DOI 10.1016/j.phytochem.2010.10.019	51	23	29	0	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9623	9632		10.1074/jbc.M111.247874	http://dx.doi.org/10.1074/jbc.M111.247874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270363	hybrid, Green Published			2022-12-27	WOS:000301797800093
J	Karst, JC; Barker, R; Devi, U; Swann, MJ; Davi, M; Roser, SJ; Ladant, D; Chenal, A				Karst, Johanna C.; Barker, Robert; Devi, Usha; Swann, Marcus J.; Davi, Marilyne; Roser, Stephen J.; Ladant, Daniel; Chenal, Alexandre			Identification of a Region That Assists Membrane Insertion and Translocation of the Catalytic Domain of Bordetella pertussis CyaA Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE TOXIN; VIRULENCE FACTORS; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; MURINE MACROPHAGES; SHEEP ERYTHROCYTES; PORE FORMATION; T-DOMAIN; CALCIUM; PROTEIN	The adenylate cyclase (CyaA) toxin, one of the virulence factors secreted by Bordetella pertussis, the pathogenic bacteria responsible for whooping cough, plays a critical role in the early stages of respiratory tract colonization by this bacterium. The CyaA toxin is able to invade eukaryotic cells by translocating its N-terminal catalytic domain directly across the plasma membrane of the target cells, where, activated by endogenous calmodulin, it produces supraphysiological levels of cAMP. How the catalytic domain is transferred from the hydrophilic extracellular medium into the hydrophobic environment of the membrane and then to the cell cytoplasm remains an unsolved question. In this report, we have characterized the membrane-interacting properties of the CyaA catalytic domain. We showed that a protein covering the catalytic domain (AC384, encompassing residues 1-384 of CyaA) displayed no membrane association propensity. However, a longer polypeptide (AC489), encompassing residues 1-489 of CyaA, exhibited the intrinsic property to bind to membranes and to induce lipid bilayer destabilization. We further showed that deletion of residues 375-485 within CyaA totally abrogated the toxin's ability to increase intracellular cAMP in target cells. These results indicate that, whereas the calmodulin dependent enzymatic domain is restricted to the amino-terminal residues 1-384 of CyaA, the membrane-interacting, translocation-competent domain extends up to residue 489. This thus suggests an important role of the region adjacent to the catalytic domain of CyaA in promoting its interaction with and its translocation across the plasma membrane of target cells.	[Karst, Johanna C.; Davi, Marilyne; Ladant, Daniel; Chenal, Alexandre] CNRS UMR 3528, Inst Pasteur, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, F-75724 Paris 15, France; [Barker, Robert] Inst Laue Langevin, Large Scale Struct Grp, F-38042 Grenoble 9, France; [Devi, Usha; Swann, Marcus J.] Farfield Grp Ltd, Manchester Airport M90 3DQ, England; [Roser, Stephen J.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut Laue-Langevin (ILL); University of Bath	Ladant, D (corresponding author), CNRS UMR 3528, Inst Pasteur, Unite Biochim Interact Macromol, Dept Biol Struct & Chim, 6 Rue Jules Horowitz, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	Barker, Robert D/E-6386-2012; Chenal, Alexandre/C-2240-2009	Barker, Robert D/0000-0002-8645-5385; Chenal, Alexandre/0000-0002-4959-1003; LADANT, Daniel/0000-0003-1955-548X	CNRS; Institut Pasteur [374]; Agence Nationale de la Recherche [ANR-09-JCJC-0012]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, Institut Pasteur (Projet Transversal de Recherche) Grant PTR#374 and the Agence Nationale de la Recherche, Programme Jeunes Chercheurs, Grant ANR-09-JCJC-0012.	Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Carbonetti NH, 2010, FUTURE MICROBIOL, V5, P455, DOI 10.2217/FMB.09.133; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Cheung GYC, 2008, MICROB PATHOGENESIS, V44, P61, DOI 10.1016/j.micpath.2007.08.007; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; Dal Molin F, 2006, EMBO J, V25, P5405, DOI 10.1038/sj.emboj.7601408; EHRMANN IE, 1992, FEBS LETT, V304, P51, DOI 10.1016/0014-5793(92)80587-7; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fiser R, 2009, BBA-BIOMEMBRANES, V1788, P1249, DOI 10.1016/j.bbamem.2009.03.019; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Hirst DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P503, DOI 10.1007/s00249-010-0664-1; Holubova J., 2012, INFECT IMMU IN PRESS; Hughes AV, 2008, LANGMUIR, V24, P1989, DOI 10.1021/la702050b; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Knapp O, 2003, BIOCHEMISTRY-US, V42, P8077, DOI 10.1021/bi034295f; Knapp O, 2008, BBA-BIOMEMBRANES, V1778, P260, DOI 10.1016/j.bbamem.2007.09.026; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017383; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Mock M, 1993, Trends Microbiol, V1, P187, DOI 10.1016/0966-842X(93)90089-A; Mosior M, 1997, MOL MEMBR BIOL, V14, P65, DOI 10.3109/09687689709068436; MULLER G, 1989, BIOCHEMISTRY-US, V28, P9974; PENFOLD J, 1990, J PHYS-CONDENS MAT, V2, P1369, DOI 10.1088/0953-8984/2/6/001; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; Perkins DJ, 2007, MOL MICROBIOL, V66, P1003, DOI 10.1111/j.1365-2958.2007.05972.x; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; Reig N, 2006, FEBS LETT, V580, P5572, DOI 10.1016/j.febslet.2006.08.033; ROGEL A, 1992, J BIOL CHEM, V267, P22599; Sanghera N, 2009, BBA-BIOMEMBRANES, V1788, P2245, DOI 10.1016/j.bbamem.2009.08.005; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Wacklin HP, 2010, CURR OPIN COLLOID IN, V15, P445, DOI 10.1016/j.cocis.2010.05.008; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; White SH, 1998, METHOD ENZYMOL, V295, P62	59	47	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9200	9212		10.1074/jbc.M111.316166	http://dx.doi.org/10.1074/jbc.M111.316166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22241477	Green Published, hybrid			2022-12-27	WOS:000301797800048
J	Sala-Rabanal, M; Wang, SZ; Nichols, CG				Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.			On Potential Interactions between Non-selective Cation Channel TRPM4 and Sulfonylurea Receptor SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; REACTIVE ASTROCYTES; TRAFFICKING; STOICHIOMETRY; SENSITIVITY; ACTIVATION; EXPRESSION; MUTATIONS; PROTEIN; STROKE	The sulfonylurea receptor SUR1 associates with Kir6.2 or Kir6.1 to form K-ATP channels, which link metabolism to excitability in multiple cell types. The strong physical coupling of SUR1 with Kir6 subunits appears exclusive, but recent studies argue that SUR1 also modulates TRPM4, a member of the transient receptor potential family of non-selective cation channels. It has been reported that, following stroke, brain, or spinal cord injury, SUR1 is increased in neurovascular cells at the site of injury. This is accompanied by up-regulation of a non-selective cation conductance with TRPM4-like properties and apparently sensitive to sulfonylureas, leading to the postulation that post-traumatic non-selective cation currents are determined by TRPM4/SUR1 channels. To investigate the mechanistic hypothesis for the coupling between TRPM4 and SUR1, we performed electrophysiological and FRET studies in COSm6 cells expressing TRPM4 channels with or without SUR1. TRPM4-mediated currents were Ca2+-activated, voltage-dependent, underwent desensitization, and were inhibited by ATP but were insensitive to glibenclamide and tolbutamide. These properties were not affected by cotransfection with SUR1. When the same SUR1 was cotransfected with Kir6.2, functional K-ATP channels were formed. In cells cotransfected with Kir6.2, SUR1, and TRPM4, we measured K-ATP-mediated K+ currents and Ca2+-activated, sulfonylurea-insensitive Na+ currents in the same patch, further showing that SUR1 controls K-ATP channel activity but not TRPM4 channels. FRET signal between fluorophore-tagged TRPM4 subunits was similar to that between Kir6.2 and SUR1, whereas there was no detectable FRET efficiency between TRPM4 and SUR1. Our data suggest that functional or structural association of TRPM4 and SUR1 is unlikely.	[Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Wang, Shizhen] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 425 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Sala-Rabanal, Monica/AAU-2383-2021; Nichols, Colin/D-6336-2012; Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756	National Institutes of Health [HL95010]; American Heart Association [10POST4280056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL95010 (to C. G. N.). This work was also supported by Postdoctoral Fellowship 10POST4280056 from the American Heart Association (to S. W.).	Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Favilla CG, 2011, STROKE, V42, P710, DOI 10.1161/STROKEAHA.110.599274; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B., 2001, ION CHANNELS EXCITAB, P237; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Makhina EN, 2001, METHOD PHARMACOL TOX, P261; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Popovich P. G., 2010, EXP NEUROL, V232, P615; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2011, STROKE, V42, pE409, DOI 10.1161/STROKEAHA.111.620666; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2004, J NEUROSURG ANESTH, V16, P98, DOI 10.1097/00008506-200401000-00021; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R., 2007, V179, P269; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	57	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8746	8756		10.1074/jbc.M111.336131	http://dx.doi.org/10.1074/jbc.M111.336131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291026	Green Published, hybrid			2022-12-27	WOS:000301797800008
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			An Acidic Amino Acid Transmembrane Helix 10 Residue Conserved in the Neurotransmitter:Sodium:Symporters Is Essential for the Formation of the Extracellular Gate of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-COTRANSPORT FUNCTION; OOCYTE-MEMBRANE-PATCHES; NEUROTRANSMITTER TRANSPORTERS; RAT-BRAIN; ALTERNATING ACCESS; SEROTONIN TRANSPORTER; SODIUM SYMPORTERS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; XENOPUS OOCYTES	GAT-1 mediates transport of GABA together with sodium and chloride in an electrogenic process enabling efficient GABAergic transmission. Biochemical and modeling studies based on the structure of the bacterial homologue LeuT are consistent with a mechanism whereby the binding pocket is alternately accessible to either side of the membrane and which predicts that the extracellular part of transmembrane domain 10 (TM10) exhibits aqueous accessibility in the outward-facing conformation only. In this study we have engineered cysteine residues in the extracellular half of TM10 of GAT-1 and probed their state-dependent accessibility to sulfhydryl reagents. In three out of four of the accessible cysteine mutants, the inhibition of transport by a membrane impermeant sulfhydryl reagent was diminished under conditions expected to increase the proportion of inward-facing transporters, such as the presence of GABA together with the cotransported ions. A conserved TM10 aspartate residue, whose LeuT counterpart participates in a "thin" extracellular gate, was found to be essential for transport and only the D451E mutant exhibited residual transport activity. D451E exhibited robust sodium-dependent transient currents with a voltage-dependence indicative of an increased apparent affinity for sodium. Moreover the accessibility of an endogenous cysteine to a membrane impermeant sulfhydryl reagent was enhanced by the D451E mutation, suggesting that sodium binding promotes an outward-facing conformation of the transporter. Our results support the idea that TM10 of GAT-1 lines an accessibility pathway from the extracellular space into the binding pocket and plays a role in the opening and closing of the extracellular transporter gate.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Hadassah Med Sch, Inst Med Res Israel Canada, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters; Rosetrees Trust	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission); Rosetrees Trust(Rosetrees Trust)	This work was supported, in whole or in part, by grants from the Israel Science Foundation, the European Union Consortium European Drug Initiative on Channels and Transporters, and the Rosetrees Trust.	Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7159	7168		10.1074/jbc.M111.323634	http://dx.doi.org/10.1074/jbc.M111.323634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235131	Green Published, hybrid			2022-12-27	WOS:000301060200019
J	Ghosh, S; Basu, M; Roy, SS				Ghosh, Sonali; Basu, Moitri; Roy, Sib Sankar			RETRACTED: ETS-1 Protein Regulates Vascular Endothelial Growth Factor-induced Matrix Metalloproteinase-9 and Matrix Metalloproteinase-13 Expression in Human Ovarian Carcinoma Cell Line SKOV-3 (Retracted article. See vol. 295, pg. 17887, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TRANSCRIPTION FACTOR; CANCER-CELLS; KINASE PATHWAYS; GENE-EXPRESSION; VEGF ANTIBODY; IN-VITRO; INVASION; ACTIVATION; BINDING; PROLIFERATION	Matrix metalloproteinase-mediated degradation of extracellular matrix is a crucial event for invasion and metastasis of malignant cells. The expressions of matrix metalloproteinases (MMPs) are regulated by different cytokines and growth factors. VEGF, a potent angiogenic cytokine, induces invasion of ovarian cancer cells through activation of MMPs. Here, we demonstrate that invasion and scattering in SKOV-3 cells were induced by VEGF through the activation of p38 MAPK and PI3K/AKT pathways. VEGF induced the expression of MMP-2, MMP-9, and MMP-13 and hence regulated the metastasis of SKOV-3 ovarian cancer cells, and the activities of these MMPs were reduced after inhibition of PI3K/AKT and p38 MAPK pathways. Interestingly, VEGF induced expression of ETS-1 factor, an important trans-regulator of different MMP genes. ETS-1 bound to both MMP-9 and MMP-13 promoters. Furthermore, VEGF acted through its receptor to perform the said functions. In addition, VEGF-induced MMP-9 and MMP-13 expression and in vitro cell invasion were significantly reduced after knockdown of ETS-1 gene. Again, VEGF-induced MMP-9 and MMP-13 promoter activities were down-regulated in ETS-1 siRNA-transfected cells. VEGF enriched ETS-1 in the nuclear fraction in a dose-dependent manner. VEGF induced expression of ETS-1 and its nuclear localization were blocked by specific inhibitors of the PI3K and p38 MAPK pathways. Therefore, based on these observations, it is hypothesized that the activation of PI3K/AKT and p38 MAPK by VEGF results in ETS-1 gene expression, which activates MMP-9 and MMP-13, leading to the invasion and scattering of SKOV-3 cells. The study provides a mechanistic insight into the prometastatic functions of VEGF-induced expression of relevant MMPs.	[Ghosh, Sonali; Basu, Moitri; Roy, Sib Sankar] CSIR, Cell Biol & Physiol Div, CSIR Indian Inst Chem Biol, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roy, SS (corresponding author), CSIR, Cell Biol & Physiol Div, CSIR Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, India.	sibsankar@iicb.res.in			Council of Scientific and Industrial Research, Government of India (CSIR) [SIP-007, NWP-32]; (DBT-PDF) from the Department of Bio-technology (DBT), Government of India	Council of Scientific and Industrial Research, Government of India (CSIR); (DBT-PDF) from the Department of Bio-technology (DBT), Government of India	This was work was supported in part by the Council of Scientific and Industrial Research, Government of India (CSIR Non-network Project SIP-007 and CSIR Network Project NWP-32).; Recipient of a postdoctoral fellowship (DBT-PDF) from the Department of Bio-technology (DBT), Government of India.	AbuJawdeh GM, 1996, LAB INVEST, V74, P1105; Alipov G, 2005, HISTOPATHOLOGY, V46, P202, DOI 10.1111/j.1365-2559.2005.02059.x; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Belotti D, 2003, CANCER RES, V63, P5224; Belotti D, 2008, MOL CANCER RES, V6, P525, DOI 10.1158/1541-7786.MCR-07-0366; Berube M, 2005, MOL VIS, V11, P1101; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; BOULUKOS KE, 1989, MOL CELL BIOL, V9, P5718, DOI 10.1128/MCB.9.12.5718; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Buggy Y, 2004, BRIT J CANCER, V91, P1308, DOI 10.1038/sj.bjc.6602128; Chang XZ, 2009, J CANCER RES CLIN, V135, P581, DOI 10.1007/s00432-008-0492-1; Di Nezza LA, 2002, CANCER, V94, P1466, DOI 10.1002/cncr.10355; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Ghosh S, 2010, J ENVIRON PATHOL TOX, V29, P17; Ghosh S, 2007, INT IMMUNOPHARMACOL, V7, P1598, DOI 10.1016/j.intimp.2007.08.017; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kumar S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-26; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Martelli AM, 2010, BBA-MOL CELL RES, V1803, P991, DOI 10.1016/j.bbamcr.2010.04.005; Matsuoka H, 2009, EXP CELL RES, V315, P2022, DOI 10.1016/j.yexcr.2009.04.009; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; Menakongka A, 2010, WORLD J GASTROENTERO, V16, P713, DOI 10.3748/wjg.v16.i6.713; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Nakamura Y, 2004, J IMMUNOL, V172, P1945, DOI 10.4049/jimmunol.172.3.1945; Oettgen P, 2010, J ONCOL, V2010, DOI 10.1155/2010/767384; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PAJUSOLA K, 1992, CANCER RES, V52, P5738; Park BK, 2001, CANCER RES, V61, P7647; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Quinn CO, 2000, J MOL ENDOCRINOL, V25, P73, DOI 10.1677/jme.0.0250073; Rabinovich A, 2007, ANTICANCER RES, V27, P267; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Saeki H, 2002, INT J CANCER, V98, P8, DOI 10.1002/ijc.10163; Saha SK, 2007, CELL PHYSIOL BIOCHEM, V19, P67, DOI 10.1159/000099193; Saha SK, 2005, ENDOCRINOLOGY, V146, P2963, DOI 10.1210/en.2004-1440; Sahin A, 2005, INT J MOL MED, V15, P771; Sasaki H, 2001, J SURG RES, V101, P242, DOI 10.1006/jsre.2001.6279; Sato T, 2004, GYNECOL ONCOL, V92, P47, DOI 10.1016/j.ygyno.2003.09.012; Schropfer A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-553; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; TERMAN BI, 1991, ONCOGENE, V6, P1677; Tsuchiya T, 2008, HEPATO-GASTROENTEROL, V55, P930; Wang FQ, 2006, INT J CANCER, V118, P879, DOI 10.1002/ijc.21421; Wang JY, 2008, CANCER BIOL THER, V7, P758, DOI 10.4161/cbt.7.5.5765; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhang A, 2006, ONCOL REP, V15, P831; Zhou HY, 2008, FEBS LETT, V582, P3415, DOI 10.1016/j.febslet.2008.09.004; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404	75	84	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15001	15015		10.1074/jbc.M111.284034	http://dx.doi.org/10.1074/jbc.M111.284034			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22270366	Green Published, hybrid			2022-12-27	WOS:000304003200062
J	Mascareno, E; Galatioto, J; Rozenberg, I; Salciccioli, L; Kamran, H; Lazar, JM; Liu, F; Pedrazzini, T; Siddiqui, MAQ				Mascareno, Eduardo; Galatioto, Josephine; Rozenberg, Inna; Salciccioli, Louis; Kamran, Haroon; Lazar, Jason M.; Liu, Fang; Pedrazzini, Thierry; Siddiqui, M. A. Q.			Cardiac Lineage Protein-1 (CLP-1) Regulates Cardiac Remodeling via Transcriptional Modulation of Diverse Hypertrophic and Fibrotic Responses and Angiotensin II-transforming Growth Factor beta (TGF-beta 1) Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-B; PRESSURE-OVERLOAD; DOWN-REGULATION; HEART-FAILURE; ACTIVATION; SYSTEM; TRANSDUCTION; INHIBITION; MECHANISMS; RECEPTOR	It is well known that the renin-angiotensin system contributes to left ventricular hypertrophy and fibrosis, a major determinant of myocardial stiffness. TGF-beta 1 and renin-angiotensin system signaling alters the fibroblast phenotype by promoting its differentiation into morphologically distinct pathological myofibroblasts, which potentiates collagen synthesis and fibrosis and causes enhanced extracellular matrix deposition. However, the atrial natriuretic peptide, which is induced during left ventricular hypertrophy, plays an anti-fibrogenic and anti-hypertrophic role by blocking, among others, the TGF-beta-induced nuclear localization of Smads. It is not clear how the hypertrophic and fibrotic responses are transcriptionally regulated. CLP-1, the mouse homolog of human hexamethylene bis-acetamide inducible-1 (HEXIM-1), regulates the pTEFb activity via direct association with pTEFb causing inhibition of the Cdk9-mediated serine 2 phosphorylation in the carboxyl-terminal domain of RNA polymerase II. It was recently reported that the serine kinase activity of Cdk9 not only targets RNA polymerase II but also the conserved serine residues of the polylinker region in Smad3, suggesting that CLP-1-mediated changes in pTEFb activity may trigger Cdk9-dependent Smad3 signaling that can modulate collagen expression and fibrosis. In this study, we evaluated the role of CLP-1 in vivo in induction of left ventricular hypertrophy in angiotensinogen-overexpressing transgenic mice harboring CLP-1 heterozygosity. We observed that introduction of CLP-1 haplodeficiency in the transgenic alpha-myosin heavy chain-angiotensinogen mice causes prominent changes in hypertrophic and fibrotic responses accompanied by augmentation of Smad3/Stat3 signaling. Together, our findings underscore the critical role of CLP-1 in remodeling of the genetic response during hypertrophy and fibrosis.	[Mascareno, Eduardo; Galatioto, Josephine; Rozenberg, Inna; Siddiqui, M. A. Q.] Suny Downstate Med Ctr, Dept Cell Biol, Ctr Cardiovasc & Muscle Res, Brooklyn, NY 11203 USA; [Salciccioli, Louis; Kamran, Haroon; Lazar, Jason M.] Suny Downstate Med Ctr, Div Cardiol, Brooklyn, NY 11203 USA; [Liu, Fang] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Pedrazzini, Thierry] Univ Lausanne, Sch Med, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Rutgers State University New Brunswick; University of Lausanne	Siddiqui, MAQ (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Ctr Cardiovasc & Muscle Res, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	maq.siddiqui@downstate.edu			National Institutes of Health [HL073399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073399 (to M. A. Q. S.).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Beckles DL, 2006, VASC PHARMACOL, V45, P350, DOI 10.1016/j.vph.2006.05.006; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9; Espinoza-Derout J, 2007, CARDIOVASC RES, V75, P129, DOI 10.1016/j.cardiores.2007.03.019; Espinoza-Derout J, 2009, CIRC RES, V104, P1347, DOI 10.1161/CIRCRESAHA.108.191726; Franco V, 2004, HYPERTENSION, V44, P746, DOI 10.1161/01.HYP.0000144801.09557.4c; Fukuzawa J, 2000, HYPERTENSION, V35, P1191, DOI 10.1161/01.HYP.35.6.1191; Guo YL, 2004, MOL ENDOCRINOL, V18, P1033, DOI 10.1210/me.2003-0231; Ho M K C, 2009, Curr Mol Pharmacol, V2, P19; Huang F, 2004, MECH DEVELOP, V121, P559, DOI 10.1016/j.mod.2004.04.012; Li YH, 2002, CIRCULATION, V106, P1722, DOI 10.1161/01.CIR.0000029923.57048.61; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Mascareno E, 1998, P NATL ACAD SCI USA, V95, P5590, DOI 10.1073/pnas.95.10.5590; Mazzolai L, 1998, HYPERTENSION, V31, P1324, DOI 10.1161/01.HYP.31.6.1324; Mazzolai L, 2000, HYPERTENSION, V35, P985, DOI 10.1161/01.HYP.35.4.985; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Montano MM, 2008, CIRC RES, V102, P415, DOI 10.1161/CIRCRESAHA.107.157859; Mori T, 2004, CARDIOVASC RES, V61, P771, DOI 10.1016/j.cardiores.2003.12.005; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schnee JM, 2000, CARDIOVASC RES, V46, P264, DOI 10.1016/S0008-6363(00)00044-4; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Wang J, 2005, CIRC RES, V97, P821, DOI 10.1161/01.RES.0000185833.42544.06; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132	34	21	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13084	13093		10.1074/jbc.M111.288944	http://dx.doi.org/10.1074/jbc.M111.288944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22308025	Green Published, hybrid			2022-12-27	WOS:000302903700048
J	Feng, C; Li, YF; Yau, YH; Lee, HS; Tang, XY; Xue, ZH; Zhou, YC; Lim, WM; Cornvik, TC; Ruedl, C; Shochat, SG; Tan, SM				Feng, Chen; Li, Yan-Feng; Yau, Yin-Hoe; Lee, Hui-Shan; Tang, Xiao-Yan; Xue, Zhi-Hong; Zhou, Yi-Chao; Lim, Wei-Min; Cornvik, Tobias C.; Ruedl, Christiane; Shochat, Susana G.; Tan, Suet-Mien			Kindlin-3 Mediates Integrin alpha L beta 2 Outside-in Signaling, and It Interacts with Scaffold Protein Receptor for Activated-C Kinase 1 (RACK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION DEFICIENCY-III; CELL-MIGRATION; LEUKOCYTE ADHESION; BETA-SUBUNIT; MONOCLONAL-ANTIBODY; BINDING-PROTEIN; TALIN; DOMAIN; COACTIVATOR; MECHANISMS	Integrins are heterodimeric type I membrane cell adhesion molecules that are involved in many biological processes. Integrins are bidirectional signal transducers because their cytoplasmic tails are docking sites for cytoskeletal and signaling molecules. Kindlins are cytoplasmic molecules that mediate inside-out signaling and activation of the integrins. The three kindlin paralogs in humans are kindlin-1, -2, and -3. Each of these contains a 4.1-ezrin-radixin-moesin (FERM) domain and a pleckstrin homology domain. Kindlin-3 is expressed in platelets, hematopoietic cells, and endothelial cells. Here we show that kindlin-3 is involved in integrin alpha L beta 2 outside-in signaling. It also promotes micro-clustering of integrin alpha L beta 2. We provide evidence that kindlin-3 interacts with the receptor for activated-C kinase 1 (RACK1), a scaffold protein that folds into a seven-blade propeller. This interaction involves the pleckstrin homology domain of kindlin-3 and blades 5-7 of RACK1. Using the SKW3 human T lymphoma cells, we show that integrin alpha L beta 2 engagement by its ligand ICAM-1 promotes the association of kindlin-3 with RACK1. We also show that kindlin-3 co-localizes with RACK1 in polarized SKW3 cells and human T lymphoblasts. Our findings suggest that kindlin-3 plays an important role in integrin alpha L beta 2 outside-in signaling.	[Feng, Chen; Li, Yan-Feng; Yau, Yin-Hoe; Lee, Hui-Shan; Tang, Xiao-Yan; Xue, Zhi-Hong; Zhou, Yi-Chao; Lim, Wei-Min; Cornvik, Tobias C.; Ruedl, Christiane; Shochat, Susana G.; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Xue, Zhihong/T-8848-2019; li, yan/GTI-4638-2022; Hoe, YAU Yin/A-2817-2011; Ruedl, christiane/A-2219-2011; Tan, Suet/A-2224-2011	Hoe, YAU Yin/0000-0001-8136-2393; Ruedl, christiane/0000-0002-5599-6541; Tan, Suet-Mien/0000-0003-2371-8739	Nanyang Technological University AcRF [RG34/08]; Singapore A*STAR Biomedical Research Council [10/1/22/19/654]	Nanyang Technological University AcRF(Nanyang Technological University); Singapore A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Nanyang Technological University AcRF Grant RG34/08 and by Singapore A*STAR Biomedical Research Council Grant 10/1/22/19/654.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, J INVEST DERMATOL, V131, P245, DOI 10.1038/jid.2010.273; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jung GY, 2011, J CELL BIOCHEM, V112, P2541, DOI 10.1002/jcb.23178; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mochly-Rosen D, 1998, FASEB J, V12, P35; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rajamanonmani R, 2009, J GEN VIROL, V90, P799, DOI 10.1099/vir.0.006874-0; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan SM, 2001, FEBS LETT, V505, P27, DOI 10.1016/S0014-5793(01)02778-8; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; Vararattanavech A, 2009, J BIOL CHEM, V284, P3239, DOI 10.1074/jbc.M802782200	68	55	55	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10714	10726		10.1074/jbc.M111.299594	http://dx.doi.org/10.1074/jbc.M111.299594			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334666	hybrid, Green Published			2022-12-27	WOS:000302780100001
J	Brown, EL; Nishiyama, Y; Dunkle, JW; Aggarwal, S; Planque, S; Watanabe, K; Csencsits-Smith, K; Bowden, MG; Kaplan, SL; Paul, S				Brown, Eric L.; Nishiyama, Yasuhiro; Dunkle, Jesse W.; Aggarwal, Shreya; Planque, Stephanie; Watanabe, Kenji; Csencsits-Smith, Keri; Bowden, M. Gabriela; Kaplan, Sheldon L.; Paul, Sudhir			Constitutive Production of Catalytic Antibodies to a Staphylococcus aureus Virulence Factor and Effect of Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRINOGEN-BINDING-PROTEIN; MYELIN BASIC-PROTEIN; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; CLUMPING FACTOR; IGA ANTIBODIES; NASAL CARRIAGE; DOMAIN; HYDROLYSIS; SITE	Antibodies that recognize microbial B lymphocyte superantigenic epitopes are produced constitutively with no requirement for adaptive immune maturation. We report cleavage of the Staphylococcus aureus virulence factor extracellular fibrinogen-binding protein (Efb) by catalytic antibodies produced with no exposure to the bacterium and reduction of the catalytic antibody activity following infection. IgG catalytic antibodies that specifically hydrolyzed Efb via a nucleophilic catalytic mechanism were found in the blood of healthy humans and aseptic mice free of S. aureus infection. IgG hydrolyzed peptide bonds on the C-terminal side of basic amino acids, including a bond located within the C3b-binding domain of Efb. Efb digested with the IgG lost its ability to bind C3b and inhibit complement-dependent antibody-mediated red blood cell lysis. In addition to catalysis, the IgG expressed saturable Efb binding activity. IgG from S. aureus-infected mice displayed reduced Efb cleaving activity and increased Efb binding activity compared with uninfected controls, suggesting differing effects of the infection on the antibody subsets responsible for the two activities. IgG from children hospitalized for S. aureus infection also displayed reduced Efb cleavage compared with healthy children. These data suggest a potential defense function for constitutively produced catalytic antibodies to a putative superantigenic site of Efb, but an adaptive catalytic response appears to be proscribed.	[Brown, Eric L.; Dunkle, Jesse W.] Univ Texas Sch Publ Hlth, Ctr Infect Dis, Houston, TX 77030 USA; [Nishiyama, Yasuhiro; Aggarwal, Shreya; Planque, Stephanie; Watanabe, Kenji; Csencsits-Smith, Keri; Bowden, M. Gabriela; Paul, Sudhir] Univ Texas Houston Med Sch, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; Texas A&M Univ, Inst Biosci & Technol, Dept Extracellular Matrix Biol, Houston, TX 77030 USA; [Kaplan, Sheldon L.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kaplan, Sheldon L.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Baylor College of Medicine; Baylor College of Medicine	Brown, EL (corresponding author), 1200 Herman Pressler Dr, Houston, TX 77030 USA.	Eric.L.Brown@uth.tmc.edu		Csencsits-Smith, Keri/0000-0002-8477-7903	National Institutes of Health [AI072439]; Covalent Bioscience Inc.; Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Covalent Bioscience Inc.; Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072439, Covalent Bioscience Inc., and the Kleberg Foundation. Eric L. Brown, Yasuhiro Nishiyama, Stephanie Planque, Keri C. Smith, and Sudhir Paul have a financial interest in patents concerning catalytic antibodies to Staphyloccus aureus antigens and use thereof as therapeutics. Sudhir Paul has a financial interest in Covalent Bioscience Inc.	Bangale Y, 2003, FASEB J, V17, P628, DOI 10.1096/fj.02-0475com; Berisha HI, 2002, PULM PHARMACOL THER, V15, P121, DOI 10.1006/pupt.2001.0337; BERMAS BL, 1994, AIDS RES HUM RETROV, V10, P1071, DOI 10.1089/aid.1994.10.1071; Beynon R.J., 2001, PROTEOLYTIC ENZYMES, P317; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; BODEN MK, 1989, INFECT IMMUN, V57, P2358; Bose B, 2005, IMMUNOLOGY, V116, P172, DOI 10.1111/j.1365-2567.2005.02208.x; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Brown EL, 2009, CLIN VACCINE IMMUNOL, V16, P139, DOI 10.1128/CVI.00360-08; BROWN PM, 1994, EUR J BIOCHEM, V225, P223, DOI 10.1111/j.1432-1033.1994.00223.x; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Chen H, 2008, J AM SOC MASS SPECTR, V19, P55, DOI 10.1016/j.jasms.2007.10.009; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Colque-Navarro P, 2000, CLIN DIAGN LAB IMMUN, V7, P14, DOI 10.1128/CDLI.7.1.14-20.2000; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov G, 1999, MOL IMMUNOL, V36, P1215, DOI 10.1016/S0161-5890(99)00141-8; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Hakoda M, 1996, J IMMUNOL, V157, P2976; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; KALAGA R, 1995, J IMMUNOL, V155, P2695; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karray S, 1998, J IMMUNOL, V161, P6681; Kelker HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008555; Kiser KB, 1999, INFECT IMMUN, V67, P5001, DOI 10.1128/IAI.67.10.5001-5006.1999; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 2006, J IMMUNOL, V177, P1355, DOI 10.4049/jimmunol.177.2.1355; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; MARKHAM NP, 1966, J COMP PATHOL, V76, P49, DOI 10.1016/0021-9975(66)90047-8; Mathews C. K., 1999, BIOCHEMISTRY-US, P360; Morris CB, 2000, VACCINE, V18, P1944, DOI 10.1016/S0264-410X(99)00447-8; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2009, J BIOL CHEM, V284, P30627, DOI 10.1074/jbc.M109.032185; OLEKSYSZYN J, 1994, J MED CHEM, V37, P226, DOI 10.1021/jm00028a004; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Palma M, 1996, INFECT IMMUN, V64, P5284, DOI 10.1128/IAI.64.12.5284-5289.1996; Pan B, 2001, J MOL BIOL, V310, P1089, DOI 10.1006/jmbi.2001.4821; Paul S, 1997, J IMMUNOL, V159, P1530; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Paul S, 2011, BLOOD, V117, P2084, DOI 10.1182/blood-2010-12-324335; Paul S, 2010, J CLIN IMMUNOL, V30, pS43, DOI 10.1007/s10875-010-9414-5; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; Planque S, 2010, AIDS, V24, P875, DOI 10.1097/QAD.0b013e3283376e88; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Shannon O, 2004, THROMB HAEMOSTASIS, V91, P779, DOI 10.1160/TH03-05-0287; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; SUN NC, 1989, J VIROL, V63, P3579, DOI 10.1128/JVI.63.9.3579-3585.1989; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Taguchi H, 2008, J BIOL CHEM, V283, P36724, DOI 10.1074/jbc.M806766200; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103; Yang YH, 2010, RHEUMATOLOGY, V49, P34, DOI 10.1093/rheumatology/kep328; Zhou YX, 2002, J IMMUNOL METHODS, V269, P257, DOI 10.1016/S0022-1759(02)00236-3	75	10	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9940	9951		10.1074/jbc.M111.330043	http://dx.doi.org/10.1074/jbc.M111.330043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22303018	Green Published, hybrid			2022-12-27	WOS:000302167200026
J	Fisher, N; Majid, RA; Antoine, T; Al-Helal, M; Warman, AJ; Johnson, DJ; Lawrenson, AS; Ranson, H; O'Neill, PM; Ward, SA; Biagini, GA				Fisher, Nicholas; Majid, Roslaini Abd; Antoine, Thomas; Al-Helal, Mohammed; Warman, Ashley J.; Johnson, David J.; Lawrenson, Alexandre S.; Ranson, Hilary; O'Neill, Paul M.; Ward, Stephen A.; Biagini, Giancarlo A.			Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc(1) Catalytic Turnover and Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION SITE; PLASMODIUM-FALCIPARUM; Q(O) SITE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-BASIS; COMPLEX; DRUG; INHIBITION; BINDING	Atovaquone is an anti-malarial drug used in combination with proguanil (e.g. Malarone (TM)) for the curative and prophylactic treatment of malaria. Atovaquone, a 2-hydroxynaphthoquinone, is a competitive inhibitor of the quinol oxidation (Q(o)) site of the mitochondrial cytochrome bc(1) complex. Inhibition of this enzyme results in the collapse of the mitochondrial membrane potential, disruption of pyrimidine biosynthesis, and subsequent parasite death. Resistance to atovaquone in the field is associated with point mutations in the Q(o) pocket of cytochrome b, most notably near the conserved Pro(260)-Glu(261)-Trp(262)-Tyr(263) (PEWY) region in the ef loop). The effect of this mutation has been extensively studied in model organisms but hitherto not in the parasite itself. Here, we have performed a molecular and biochemical characterization of an atovaquone-resistant field isolate, TM902CB. Molecular analysis of this strain reveals the presence of the Y268S mutation in cytochrome b. The Y268S mutation is shown to confer a 270-fold shift of the inhibitory constant (K-i) for atovaquone with a concomitant reduction in the V-max of the bc1 complex of similar to 40% and a 3-fold increase in the observed K-m for decylubiquinol. Western blotting analyses reveal a reduced iron-sulfur protein content in Y268S bc(1) suggestive of a weakened interaction between this subunit and cytochrome b. Gene expression analysis of the TM902CB strain reveals higher levels of expression, compared with the 3D7 (atovaquone-sensitive) control strain in bc(1) and cytochrome c oxidase genes. It is hypothesized that the observed differential expression of these and other key genes offsets the fitness cost resulting from reduced bc(1) activity.	[Fisher, Nicholas; Majid, Roslaini Abd; Antoine, Thomas; Al-Helal, Mohammed; Warman, Ashley J.; Johnson, David J.; Ranson, Hilary; Ward, Stephen A.; Biagini, Giancarlo A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Lawrenson, Alexandre S.; O'Neill, Paul M.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	saward@liv.ac.uk; Biagini@liverpool.ac.uk	Ward, Steve/G-6003-2015; Biagini, Giancarlo A/F-3449-2011	Ward, Steve/0000-0003-2331-3192; Biagini, Giancarlo A/0000-0001-6356-6595; Ranson, Hilary/0000-0003-2332-8247	Leverhulme Trust; Wellcome Trust; European Union Framework 7 Marie Curie Initial Training Network [215281]; Malaysian Government; National Institute of Health Research (BRC Liverpool)	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Framework 7 Marie Curie Initial Training Network; Malaysian Government; National Institute of Health Research (BRC Liverpool)	This work was supported by grants from the Leverhulme Trust, the Wellcome Trust, the European Union Framework 7 Marie Curie Initial Training Network 215281 (InterMalTraining), the Malaysian Government, and the National Institute of Health Research (BRC Liverpool).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Berry A, 2006, T ROY SOC TROP MED H, V100, P986, DOI 10.1016/j.trstmh.2006.02.004; Berry EA, 2011, BBA-BIOENERGETICS, V1807, P1349, DOI 10.1016/j.bbabio.2011.04.005; Biagini GA, 2006, ANTIMICROB AGENTS CH, V50, P1841, DOI 10.1128/AAC.50.5.1841-1851.2006; Biagini GA, 2008, MOL PHARMACOL, V73, P1347, DOI 10.1124/mol.108.045120; Bourges I, 2005, J BIOL CHEM, V280, P29743, DOI 10.1074/jbc.M505915200; BOWYER JR, 1982, J BIOL CHEM, V257, P8321; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brasseur G, 2004, J BIOL CHEM, V279, P24203, DOI 10.1074/jbc.M311576200; Brasseur G, 2001, BBA-BIOENERGETICS, V1506, P89, DOI 10.1016/S0005-2728(01)00186-4; Bulusu V, 2011, J BIOL CHEM, V286, P9236, DOI 10.1074/jbc.M110.173328; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; Cross RM, 2011, J MED CHEM, V54, P4399, DOI 10.1021/jm200015a; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Fisher N, 2005, PEST MANAG SCI, V61, P973, DOI 10.1002/ps.1066; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Fisher N, 2008, FEMS YEAST RES, V8, P183, DOI 10.1111/j.1567-1364.2007.00328.x; Fivelman Quinton L, 2002, Malar J, V1, P1; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; HAMMOND DJ, 1985, MOL BIOCHEM PARASIT, V14, P97, DOI 10.1016/0166-6851(85)90109-4; Hughes LM, 2011, MOL BIOCHEM PARASIT, V177, P12, DOI 10.1016/j.molbiopara.2011.01.002; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; KNAPP B, 1990, MOL BIOCHEM PARASIT, V40, P1, DOI 10.1016/0166-6851(90)90074-V; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; KUBOYAMA M, 1972, J BIOL CHEM, V247, P6375; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; Merbitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637, DOI 10.1021/bi035344r; Musset L, 2006, MICROBES INFECT, V8, P2599, DOI 10.1016/j.micinf.2006.07.011; Osei-Akoto A., 2009, COCHRANE DB SYST REV, VCD004529, P1; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Peters JM, 2002, ANTIMICROB AGENTS CH, V46, P2435, DOI 10.1128/AAC.46.8.2435-2441.2002; Schwartz E, 2003, CLIN INFECT DIS, V37, P450, DOI 10.1086/375599; Seymour KK, 1997, ANN TROP MED PARASIT, V91, P603, DOI 10.1080/00034989760699; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224	48	56	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9731	9741		10.1074/jbc.M111.324319	http://dx.doi.org/10.1074/jbc.M111.324319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22282497	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000302167200007
J	Balla, A; Toth, DJ; Soltesz-Katona, E; Szakadati, G; Erdelyi, LS; Varnai, P; Hunyady, L				Balla, Andras; Toth, Daniel J.; Soltesz-Katona, Eszter; Szakadati, Gyoengyi; Erdelyi, Laszlo Sandor; Varnai, Peter; Hunyady, Laszlo			Mapping of the Localization of Type 1 Angiotensin Receptor in Membrane Microdomains Using Bioluminescence Resonance Energy Transfer-based Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE CELLS; LIPID RAFTS; II RECEPTOR; H-RAS; K-RAS; AT(1); INTERNALIZATION; PHOSPHORYLATION; VISUALIZATION; REQUIREMENTS	Initiation and termination of signaling of the type I angiotensin receptor (AT(1)-R) can lead to dynamic changes in its localization in plasma membrane microdomains. Several markers were recently developed to investigate membrane microdomains. Here, we used several YFP-labeled fusion constructs (i.e. raft or non-raft plasma membrane markers) to analyze the agonist-induced changes in compartmentalization of AT(1)-R, including internalization or lateral movement between plasma membrane compartments in response to stimulation using bioluminescence resonance energy transfer measurements. Our data demonstrate that angiotensin II (AngII) stimulus changes the microdomain localization of wild type or mutated (DRY -> AAY or TSTS -> AAAA) AT(1)-Rs co-expressed with the fluorescent probes in HEK293 cells. The comparison of the trafficking of AT(1)-R upon AngII stimulus with those of [Sar(1),Ile(8)]AngII or [Sar(1),Ile(4),Ile(8)]AngII stimulus revealed different types of changes, depending on the nature of the ligand. The observed changes in receptor compartmentalization of the AT(1)-R are strikingly different from those of 5HT-2C and EGF receptors, which demonstrate the usefulness of the bioluminescence resonance energy transfer-based measurements in the investigation of receptor trafficking in the plasma membrane in living cell experiments.	[Balla, Andras; Toth, Daniel J.; Soltesz-Katona, Eszter; Szakadati, Gyoengyi; Erdelyi, Laszlo Sandor; Varnai, Peter; Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Semmelweis Univ, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Hungarian Acad Sci, H-1444 Budapest, Hungary	Semmelweis University; Semmelweis University; Hungarian Academy of Sciences	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	Hunyady@eok.sote.hu	Soltész-Katona, Eszter/H-1897-2019; Tóth, Dániel/M-7105-2019	Soltész-Katona, Eszter/0000-0002-9054-740X; Tóth, Dániel/0000-0001-6670-3348; Balla, Andras/0000-0002-6450-2793	Hungarian Scientific Research Fund [OTKA PF63893, OTKA NK72661]; OTKA-Norway [NNF78925]; National Development Agency of Hungary (NFU TAMOP) [4.2.2-08/1/KMR, 4.2.1.B-09/1/KMR-2010-0001]; Hungarian Academy of Sciences	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); OTKA-Norway; National Development Agency of Hungary (NFU TAMOP); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by Hungarian Scientific Research Fund Grants OTKA PF63893, OTKA NK72661, and OTKA-Norway NNF78925 and National Development Agency of Hungary (NFU TAMOP) Grants 4.2.2-08/1/KMR and 4.2.1.B-09/1/KMR-2010-0001.; Supported in part by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences.	AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Becamel C, 2008, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a000152.000101, DOI 10.1038/MP.A000152.000101]; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; CONCHON S, 1994, FEBS LETT, V349, P365, DOI 10.1016/0014-5793(94)00703-9; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hasbi A, 2004, MOL ENDOCRINOL, V18, P1277, DOI 10.1210/me.2003-0440; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Linder AE, 2007, J PHARMACOL EXP THER, V323, P78, DOI 10.1124/jpet.107.123463; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Szidonya L, 2007, BIOCHEM PHARMACOL, V73, P1582, DOI 10.1016/j.bcp.2007.01.012; Turu G, 2006, FEBS LETT, V580, P41, DOI 10.1016/j.febslet.2005.11.044; Ushio-Fukai M, 2006, HYPERTENSION, V48, P797, DOI 10.1161/01.HYP.0000242907.70697.5d; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	33	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9090	9099		10.1074/jbc.M111.293944	http://dx.doi.org/10.1074/jbc.M111.293944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291018	Green Published, hybrid			2022-12-27	WOS:000301797800039
J	Gimenez, LE; Kook, S; Vishnivetskiy, SA; Ahmed, MR; Gurevich, EV; Gurevich, VV				Gimenez, Luis E.; Kook, Seunghyi; Vishnivetskiy, Sergey A.; Ahmed, M. Rafiuddin; Gurevich, Eugenia V.; Gurevich, Vsevolod V.			Role of Receptor-attached Phosphates in Binding of Visual and Non-visual Arrestins to G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION SITES; BETA-2-ADRENERGIC RECEPTOR; KINASE PHOSPHORYLATION; CONFORMATIONAL-CHANGES; FLUORESCENT PROTEIN; CLATHRIN ADAPTER; WILD-TYPE	Arrestins are a small family of proteins that regulate G protein-coupled receptors (GPCRs). Arrestins specifically bind to phosphorylated active receptors, terminating G protein coupling, targeting receptors to endocytic vesicles, and initiating G protein-independent signaling. The interaction of rhodopsin-attached phosphates with Lys-14 and Lys-15 in beta-strand I was shown to disrupt the interaction of alpha-helix I, beta-strand I, and the C-tail of visual arrestin-1, facilitating its transition into an active receptor-binding state. Here we tested the role of conserved lysines in homologous positions of non-visual arrestins by generating K2A mutants in which both lysines were replaced with alanines. K2A mutations in arrestin-1, -2, and -3 significantly reduced their binding to active phosphorhodopsin in vitro. The interaction of arrestins with several GPCRs in intact cells was monitored by a bioluminescence resonance energy transfer (BRET)-based assay. BRET data confirmed the role of Lys-14 and Lys-15 in arrestin-1 binding to non-cognate receptors. However, this was not the case for non-visual arrestins in which the K2A mutations had little effect on net BRETmax values for the M2 muscarinic acetylcholine (M2R), beta(2)-adrenergic (beta(2)AR), or D2 dopamine receptors. Moreover, a phosphorylation-deficient mutant of M2R interacted with wild type non-visual arrestins normally, whereas phosphorylation-deficient beta(2)AR mutants bound arrestins at 20-50% of the level of wild type beta(2)AR. Thus, the contribution of receptor-attached phosphates to arrestin binding varies depending on the receptor-arrestin pair. Although arrestin-1 always depends on receptor phosphorylation, its role in the recruitment of arrestin-2 and -3 is much greater in the case of beta(2)AR than M2R and D2 dopamine receptor.	[Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 2220 Pierce Ave,PRB 417D, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, NS065868]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, EY011500 (all to V. V. G.) and NS065868 (to E. V. G.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	78	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9028	9040		10.1074/jbc.M111.311803	http://dx.doi.org/10.1074/jbc.M111.311803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275358	hybrid, Green Published			2022-12-27	WOS:000301797800033
J	Kuga, A; Kanagawa, M; Sudo, A; Chan, YM; Tajiri, M; Manya, H; Kikkawa, Y; Nomizu, M; Kobayashi, K; Endo, T; Lu, QL; Wada, Y; Toda, T				Kuga, Atsushi; Kanagawa, Motoi; Sudo, Atsushi; Chan, Yiumo Michael; Tajiri, Michiko; Manya, Hiroshi; Kikkawa, Yamato; Nomizu, Motoyoshi; Kobayashi, Kazuhiro; Endo, Tamao; Lu, Qi L.; Wada, Yoshinao; Toda, Tatsushi			Absence of Post-phosphoryl Modification in Dystroglycanopathy Mouse Models and Wild-type Tissues Expressing Non-laminin Binding Form of alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; FUKUTIN-RELATED PROTEIN; EXTRACELLULAR-MATRIX; ABNORMAL GLYCOSYLATION; AGRIN RECEPTOR; MUTATIONS; COMPLEX; GLYCOSYLTRANSFERASE; GLYCOPROTEIN; REQUIRES	alpha-Dystroglycan (alpha-DG) is a membrane-associated glycoprotein that interacts with several extracellular matrix proteins, including laminin and agrin. Aberrant glycosylation of alpha-DG disrupts its interaction with ligands and causes a certain type of muscular dystrophy commonly referred to as dystroglycanopathy. It has been reported that a unique O-mannosyl tetrasaccharide (Neu5Ac-alpha 2,3-Gal-beta 1,4-GlcNAc-beta 1,2-Man) and a phosphodiester-linked modification on O-mannose play important roles in the laminin binding activity of alpha-DG. In this study, we use several dystroglycanopathy mouse models to demonstrate that, in addition to fukutin and LARGE, FKRP (fukutin-related protein) is also involved in the post-phosphoryl modification of O-mannose on alpha-DG. Furthermore, we have found that the glycosylation status of alpha-DG in lung and testis is minimally affected by defects in fukutin, LARGE, or FKRP. alpha-DG prepared from wild-type lung-or testis-derived cells lacks the post-phosphoryl moiety and shows little laminin-binding activity. These results show that FKRP is involved in post-phosphoryl modification rather than in O-mannosyl tetrasaccharide synthesis. Our data also demonstrate that post-phosphoryl modification not only plays critical roles in the pathogenesis of dystroglycanopathy but also is a key determinant of alpha-DG functional expression as a laminin receptor in normal tissues and cells.	[Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Chan, Yiumo Michael; Lu, Qi L.] Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Charlotte, NC 28231 USA; [Tajiri, Michiko; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Tajiri, Michiko; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan; [Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan	Kobe University; Carolinas Medical Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Metropolitan Institute of Gerontology; Tokyo University of Pharmacy & Life Sciences	Toda, T (corresponding author), Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Chou, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021; Kikkawa, Yamato/D-1503-2010; lu, qi/HHS-2115-2022	Kobayashi, Kazuhiro/0000-0001-7801-147X; Manya, Hiroshi/0000-0003-1573-9177; Toda, Tatsushi/0000-0002-0717-1123; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan [23B-5]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23249049, 21790318]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21689030] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research on Psychiatric and Neurological Diseases and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant (23B-5) for Neurological and Mental Disorders and The Research on Psychiatric and Neurological Diseases and Mental Health H20-016 (to T. T.), Grant-in-aid for Scientific Research (A) 23249049 (to T. T.) and a Grant-in-aid for Young Scientists (B) 21790318 (to M. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Takeda Science Foundation (to M. K.).	Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Chiba A, 1997, J BIOL CHEM, V272, P2156; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; Higginson JR, 2005, BIOCHEM SOC T, V33, P1254, DOI 10.1042/BST0331254; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2008, NEUROMUSCULAR DISORD, V18, P45, DOI 10.1016/j.nmd.2007.08.002; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Toda Tatsushi, 2003, Congenital Anomalies, V43, P97, DOI 10.1111/j.1741-4520.2003.tb01033.x; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	42	25	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9560	9567		10.1074/jbc.M111.271767	http://dx.doi.org/10.1074/jbc.M111.271767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270369	hybrid, Green Published			2022-12-27	WOS:000301797800087
J	Peake, KB; Vance, JE				Peake, Kyle B.; Vance, Jean E.			Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-beta-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EVERY ORGAN; NPC1; TRANSPORT; NEURODEGENERATION; IDENTIFICATION; CYCLODEXTRINS; LIPOPROTEINS; DEFICIENCY; METABOLISM	Niemann-Pick C (NPC) disease is an inherited, progressive neurodegenerative disorder caused by mutations in the NPC1 or NPC2 gene that result in an accumulation of unesterified cholesterol in late endosomes/lysosomes (LE/L) and impaired export of cholesterol from LE/L to the endoplasmic reticulum (ER). Recent studies demonstrate that administration of cyclodextrin (CD) to Npc1(-/-) mice eliminates cholesterol sequestration in LE/L of many tissues, including the brain, delays neurodegeneration, and increases lifespan of the mice. We have now investigated cholesterol homeostasis in NPC1-deficient cells of the brain in response to CD. Primary cultures of neurons and glial cells from Npc1(-/-) mice were incubated for 24 h with 0.1 to 10 mM CD after which survival and cholesterol homeostasis were monitored. Although 10 mM CD was profoundly neurotoxic, and altered astrocyte morphology, 0.1 and 1 mM CD were not toxic but effectively mobilized stored cholesterol from the LE/L as indicated by filipin staining. However, 0.1 and 1mM CD altered cholesterol homeostasis in opposite directions. The data suggest that 0.1 mM CD releases cholesterol trapped in LE/L of neurons and astrocytes and increases cholesterol availability at the ER, whereas 1 mM CD primarily extracts cholesterol from the plasma membrane and reduces ER cholesterol. These studies in Npc1(-)/(-) neurons and astrocytes establish a dose of CD (0.1 mM) that would likely be beneficial in NPC disease. The findings are timely because treatment of NPC disease patients with CD is currently being initiated.	[Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Ara Parseghian Medical Research Foundation; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research	Ara Parseghian Medical Research Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by the Ara Parseghian Medical Research Foundation and Canadian Institutes for Health Research (to J. E. V.) as well as graduate studentships from the Natural Sciences and Engineering Research Council of Canada and the Alberta Heritage Foundation for Medical Research (to K. B. P.).	Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Karten B, 2005, BIOCHEM J, V387, P779, DOI 10.1042/BJ20041694; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Peake KB, 2011, BBA-MOL BASIS DIS, V1812, P1121, DOI 10.1016/j.bbadis.2011.06.003; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	26	77	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9290	9298		10.1074/jbc.M111.326405	http://dx.doi.org/10.1074/jbc.M111.326405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277650	Green Published, hybrid			2022-12-27	WOS:000301797800057
J	Kirchberg, K; Michel, H; Alexiev, U				Kirchberg, Kristina; Michel, Hartmut; Alexiev, Ulrike			Net Proton Uptake Is Preceded by Multiple Proton Transfer Steps upon Electron Injection into Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASES; PARACOCCUS-DENITRIFICANS; CATALYTIC CYCLE; PUMPING MECHANISM; UBIQUINOL OXIDASE; ESCHERICHIA-COLI; SURFACE-CHARGE; SUBUNIT-I; PATHWAYS; BACTERIORHODOPSIN	Cytochrome c oxidase (COX), the last enzyme of the respiratory chain of aerobic organisms, catalyzes the reduction of molecular oxygen to water. It is a redox-linked proton pump, whose mechanism of proton pumping has been controversially discussed, and the coupling of proton and electron transfer is still not understood. Here, we investigated the kinetics of proton transfer reactions following the injection of a single electron into the fully oxidized enzyme and its transfer to the hemes using time-resolved absorption spectroscopy and pH indicator dyes. By comparison of proton uptake and release kinetics observed for solubilized COX and COX-containing liposomes, we conclude that the 1-mu s electron injection into Cu-A, close to the positive membrane side (P-side) of the enzyme, already results in proton uptake from both the P-side and the N (negative)-side (1.5 H+/COX and 1 H+/COX, respectively). The subsequent 10-mu s transfer of the electron to heme a is accompanied by the release of 1 proton from the P-side to the aqueous bulk phase, leaving similar to 0.5 H+/COX at this side to electrostatically compensate the charge of the electron. With similar to 200 mu s, all but 0.4 H+ at the N-side are released to the bulk phase, and the remaining proton is transferred toward the hemes to a so-called "pump site." Thus, this proton may already be taken up by the enzyme as early as during the first electron transfer to Cu-A. These results support the idea of a proton-collecting antenna, switched on by electron injection.	[Kirchberg, Kristina; Alexiev, Ulrike] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Kirchberg, Kristina; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Free University of Berlin; Max Planck Society	Alexiev, U (corresponding author), Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany.	alexiev@physik.fu-berlin.de	Alexiev, Ulrike/L-8478-2016		Deutsche Forschungsgemeinschaft [SFB 472, SFB 449]; Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes"; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes"; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 472 (to H. M.) and SFB 449 (to U. A.), the Max-Planck-Gesellschaft, Cluster of Excellence Frankfurt "Macromolecular Complexes" and the Fonds der Chemischen Industrie.	Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Alexiev U, 2000, J BIOL CHEM, V275, P13431, DOI 10.1074/jbc.275.18.13431; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; ALEXIEV U, 1994, BIOCHEMISTRY-US, V33, P298, DOI 10.1021/bi00167a039; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Brzezinski P, 1998, ACTA PHYSIOL SCAND, V163, P7; Brzezinski P, 1998, J BIOENERG BIOMEMBR, V30, P99, DOI 10.1023/A:1020567729941; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; Forte E, 2004, BIOCHEMISTRY-US, V43, P2957, DOI 10.1021/bi035863u; GARCIAHORSMAN JA, 1995, BIOCHEMISTRY-US, V34, P4428, DOI 10.1021/bi00013a035; Hill BC, 2004, BBA-BIOENERGETICS, V1655, P256, DOI 10.1016/j.bbabio.2003.07.006; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kannt A, 1998, FEBS LETT, V434, P17, DOI 10.1016/S0014-5793(98)00942-9; Karpefors M, 1998, BBA-BIOENERGETICS, V1365, P159, DOI 10.1016/S0005-2728(98)00058-9; KLEYMANN G, 1995, BIO-TECHNOL, V13, P155, DOI 10.1038/nbt0295-155; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; LUDWIG B, 1980, P NATL ACAD SCI-BIOL, V77, P196, DOI 10.1073/pnas.77.1.196; Michel H, 1999, NATURE, V402, P602, DOI 10.1038/45133; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mills DA, 1998, BBA-BIOENERGETICS, V1365, P46, DOI 10.1016/S0005-2728(98)00040-1; MORRISON M, 1965, ANAL BIOCHEM, V12, P77, DOI 10.1016/0003-2697(65)90144-2; MULLER M, 1986, METHOD ENZYMOL, V126, P78; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; Papa S, 1998, BIOCHIMIE, V80, P821, DOI 10.1016/S0300-9084(00)88877-X; Papa S, 2006, BBA-BIOENERGETICS, V1757, P1133, DOI 10.1016/j.bbabio.2006.04.009; Popovic DM, 2004, J AM CHEM SOC, V126, P1858, DOI 10.1021/ja038267w; Rich P. R., 1995, FUNCT PLANT BIOL, V22, P479; Riesle J, 1996, BIOCHEMISTRY-US, V35, P6635, DOI 10.1021/bi9600456; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Siletsky SA, 2012, BBA-BIOENERGETICS, V1817, P476, DOI 10.1016/j.bbabio.2011.08.003; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Verkhovsky MI, 2001, BIOCHEMISTRY-US, V40, P7077, DOI 10.1021/bi010030u; Verkhovsky MI, 1999, BBA-BIOENERGETICS, V1412, P184, DOI 10.1016/S0005-2728(99)00053-5; Verkhovsky MI, 2006, BBA-BIOENERGETICS, V1757, P401, DOI 10.1016/j.bbabio.2006.05.026; Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013; Wikstrom M, 2000, BBA-BIOENERGETICS, V1459, P514, DOI 10.1016/S0005-2728(00)00191-2; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341; Zaslavsky D, 2004, P NATL ACAD SCI USA, V101, P10544, DOI 10.1073/pnas.0401521101; Zaslavsky D, 1998, BIOCHEMISTRY-US, V37, P14910, DOI 10.1021/bi981490z	47	19	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8187	8193		10.1074/jbc.M111.338491	http://dx.doi.org/10.1074/jbc.M111.338491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22238345	Green Published, hybrid			2022-12-27	WOS:000301349400034
J	Lai, AZ; Durrant, M; Zuo, DM; Ratcliffe, CDH; Park, M				Lai, Andrea Z.; Durrant, Michael; Zuo, Dongmei; Ratcliffe, Colin D. H.; Park, Morag			Met Kinase-dependent Loss of the E3 Ligase Cbl in Gastric Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; GENE COPY NUMBER; C-CBL; UBIQUITIN LIGASE; DOWN-REGULATION; MEDIATED DIMERIZATION; JUXTAMEMBRANE DOMAIN; NEGATIVE REGULATION	Strict regulation of signaling by receptor tyrosine kinases (RTKs) is essential for normal biological processes, and disruption of this regulation can lead to tumor initiation and progression. Signal duration by the Met RTK is mediated in part by the E3 ligase Cbl. Cbl is recruited to Met upon kinase activation and promotes ubiquitination, trafficking, and degradation of the receptor. The Met RTK has been demonstrated to play a role in various types of cancer. Here, we show that Met-dependent loss of Cbl protein in MET-amplified gastric cancer cell lines represents another mechanism contributing to signal dysregulation. Loss of Cbl protein is dependent on Met kinase activity and is partially rescued with a proteasome inhibitor, lactacystin. Moreover, Cbl loss not only uncouples Met from Cbl-mediated negative regulation but also releases other Cbl targets, such as the EGF receptor, from Cbl-mediated signal attenuation. Thus, Met-dependent Cbl loss may also promote cross-talk through indirect enhancement of EGF receptor signaling.	[Lai, Andrea Z.; Zuo, Dongmei; Ratcliffe, Colin D. H.; Park, Morag] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Lai, Andrea Z.; Durrant, Michael; Ratcliffe, Colin D. H.; Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Park, Morag] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Park, Morag] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Park, M (corresponding author), Goodman Canc Ctr, 1160 Ave Des Pins Ouest,Canc Pavil Room 511, Montreal, PQ H3A 1A3, Canada.	morag.park@mcgill.ca			Cancer Consortium from the Canadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research (CIHR)	Cancer Consortium from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canada Graduate Scholarship (CGS) doctoral research award (to A. L.), a Cancer Consortium grant (to M. D.), and an operating grant (to M. P.), all from the Canadian Institutes of Health Research (CIHR).	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; [Anonymous], 2008, NATURE, V455, P1061; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bisson SA, 2002, ONCOGENE, V21, P3677, DOI 10.1038/sj.onc.1205510; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Christensen JG, 2003, CANCER RES, V63, P7345; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; KEANE MM, 1995, ONCOGENE, V10, P2367; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lo FY, 2011, CANCER-AM CANCER SOC, V117, P5344, DOI 10.1002/cncr.26153; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mak HHL, 2007, ONCOGENE, V26, P7213, DOI 10.1038/sj.onc.1210522; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McLean LA, 2004, CLIN CANCER RES, V10, P155, DOI 10.1158/1078-0432.CCR-0784-3; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 2011, ONCOTARGET, V2, P245; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; RODRIGUES GA, 1993, MOL CELL BIOL, V13, P6711, DOI 10.1128/MCB.13.11.6711; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Wang Y, 1999, J CELL BIOCHEM, V72, P119	57	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8048	8059		10.1074/jbc.M112.339820	http://dx.doi.org/10.1074/jbc.M112.339820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262855	Green Published, hybrid			2022-12-27	WOS:000301349400021
J	Wu, ZC; de Keyzer, J; Kedrov, A; Driessen, AJM				Wu, Zht Cheng; de Keyzer, Jeanine; Kedrov, Alexej; Driessen, Arnold J. M.			Competitive Binding of the SecA ATPase and Ribosomes to the SecYEG Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CONDUCTING CHANNEL; CROSS-CORRELATION SPECTROSCOPY; NASCENT CHAIN COMPLEXES; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCATION; MEMBRANE INSERTION; IN-VIVO; CYTOPLASMIC MEMBRANE; BACTERIAL-MEMBRANE; PRECURSOR PROTEINS	During co-translational membrane insertion of membrane proteins with large periplasmic domains, the bacterial SecYEG complex needs to interact both with the ribosome and the SecA ATPase. Although the binding sites for SecA and the ribosome overlap, it has been suggested that these ligands can interact simultaneously with SecYEG. We used surface plasmon resonance and fluorescence correlation spectroscopy to examine the interaction of SecA and ribosomes with the SecYEG complex present in membrane vesicles and the purified SecYEG complex present in a detergent-solubilized state or reconstituted into nanodiscs. Ribosome binding to the SecYEG complex is strongly stimulated when the ribosomes are charged with nascent chains of the monotopic membrane protein FtsQ. This binding is competed by an excess of SecA, indicating that binding of SecA and ribosomes to SecYEG is mutually exclusive.	[Wu, Zht Cheng; de Keyzer, Jeanine; Kedrov, Alexej; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9747 AG Groningen, Netherlands	University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012	Kedrov, Alexej/0000-0001-9117-752X; Driessen, Arnold J.M./0000-0001-9258-9104	Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO)	Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO)	This work was supported by the Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO).	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; de Keyzer J, 2003, J BIOL CHEM, V278, P29581, DOI 10.1074/jbc.M303490200; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; de Keyzer J, 2007, FEBS LETT, V581, P1859, DOI 10.1016/j.febslet.2007.03.081; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; SALAJSMIC E, 1978, ANTIMICROB AGENTS CH, V14, P797, DOI 10.1128/AAC.14.5.797; Sato K, 1997, J BIOL CHEM, V272, P20082, DOI 10.1074/jbc.272.32.20082; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zito CR, 2003, J BIOL CHEM, V278, P40640, DOI 10.1074/jbc.M308025200	54	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7885	7895		10.1074/jbc.M111.297911	http://dx.doi.org/10.1074/jbc.M111.297911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267723	Green Published, hybrid			2022-12-27	WOS:000301349400005
J	Zhuang, M; Wang, W; De Feo, CJ; Vassell, R; Weiss, CD				Zhuang, Min; Wang, Wei; De Feo, Christopher J.; Vassell, Russell; Weiss, Carol D.			Trimeric, Coiled-coil Extension on Peptide Fusion Inhibitor of HIV-1 Influences Selection of Resistance Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; CROSS-RESISTANCE; ATOMIC-STRUCTURE; MEMBRANE-FUSION; GP41 ECTODOMAIN; CORE STRUCTURE; HEPTAD REPEAT; SIV GP41; ENTRY	Peptides corresponding to N- and C-terminal heptad repeat regions (HR1 and HR2, respectively) of viral fusion proteins can block infection of viruses in a dominant negative manner by interfering with refolding of the viral HR1 and HR2 to form a six-helix bundle (6HB) that drives fusion between viral and host cell membranes. The 6HB of the HIV gp41 (endogenous bundle) consists of an HR1 coiled-coil trimer with grooves lined by antiparallel HR2 helices. HR1 peptides form coiled-coil oligomers that may bind to gp41 HR2 as trimers to form a heterologous 6HB (inhibitor bundle) or to gp41 HR1 as monomers or dimers to form a heterologous coiled coil. To gain insights into mechanisms of Env entry and inhibition by HR1 peptides, we compared resistance to a peptide corresponding to 36 residues in gp41 HR1 (N36) and the same peptide with a coiled-coil trimerization domain fused to its N terminus (IZN36) that stabilizes the trimer and increases inhibitor potency (Eckert, D. M., and Kim, P. S. (2001) Proc. Nat. Acad. Sci. U. S. A. 98, 11187-11192). Whereas N36 selected two genetic pathways with equal probability, each defined by an early mutation in either HR1 or HR2, IZN36 preferentially selected the HR1 pathway. Both pathways conferred cross-resistance to both peptides. Each HR mutation enhanced the thermostability of the endogenous 6HB, potentially allowing the virus to simultaneously escape inhibitors targeting either gp41 HR1 or HR2. These findings inform inhibitor design and identify regions of plasticity in the highly conserved gp41 that modulate virus entry and escape from HR1 peptide inhibitors.	[Weiss, Carol D.] NIH, Off Vaccine Res & Review, Ctr Biol Evaluat & Res, US FDA, Bethesda, MD 20892 USA; [Zhuang, Min] Harbin Med Univ, Dept Microbiol, Harbin 150086, Heilongjiang, Peoples R China	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); Harbin Medical University	Weiss, CD (corresponding author), NIH, Off Vaccine Res & Review, Ctr Biol Evaluat & Res, US FDA, Bldg 29,Rm 532,29 Lincoln Dr, Bethesda, MD 20892 USA.	carol.weiss@fda.hhs.gov	Weiss, Carol D./F-6438-2011	Weiss, Carol D./0000-0002-9965-1289	National Institutes of Health; United States Food and Drug Administration	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Food and Drug Administration	This work was supported in part by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (to C. D. W.). This work was also supported in part by institutional funds from the United States Food and Drug Administration.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Bewley CA, 2002, J BIOL CHEM, V277, P14238, DOI 10.1074/jbc.M201453200; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Caffrey M, 1999, PROTEIN SCI, V8, P1904, DOI 10.1110/ps.8.9.1904; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Chinnadurai R, 2007, J VIROL, V81, P6563, DOI 10.1128/JVI.02546-06; Desmezieres E, 2005, J VIROL, V79, P4774, DOI 10.1128/JVI.79.8.4774-4781.2005; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckert DM, 2001, P NATL ACAD SCI USA, V98, P11187, DOI 10.1073/pnas.201392898; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; Holland AU, 2004, VIROLOGY, V319, P343, DOI 10.1016/j.virol.2003.11.012; HOPE TJ, 1990, J VIROL, V64, P5360, DOI 10.1128/JVI.64.11.5360-5366.1990; Izumi K, 2010, ANTIVIR RES, V87, P179, DOI 10.1016/j.antiviral.2010.04.011; Kilgore NR, 2003, J VIROL, V77, P7669, DOI 10.1128/JVI.77.13.7669-7672.2003; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; ORAVECZ T, 1995, NAT MED, V1, P919, DOI 10.1038/nm0995-919; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Poveda E, 2002, AIDS, V16, P1959, DOI 10.1097/00002030-200209270-00014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang W, 2011, J VIROL, V85, P12929, DOI 10.1128/JVI.05391-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10; Yang ZN, 1999, J STRUCT BIOL, V126, P131, DOI 10.1006/jsbi.1999.4116	44	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8297	8309		10.1074/jbc.M111.324483	http://dx.doi.org/10.1074/jbc.M111.324483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22235115	Green Published, hybrid			2022-12-27	WOS:000301349400044
J	Chen, C; Gorlatova, N; Herzberg, O				Chen, Chen; Gorlatova, Natalia; Herzberg, Osnat			Pliable DNA Conformation of Response Elements Bound to Transcription Factor p63	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CORE DOMAIN; BINDING DOMAIN; P53 BINDING; SEQUENCE; RECOGNITION; HOMOLOG; SITES; LIMB	We show that changes in the nucleotide sequence alter the DNA conformation in the crystal structures of p63 DNA-binding domain (p63DBD) bound to its response element. The conformation of a 22-bp canonical response element containing an AT spacer between the two half-sites is unaltered compared with that containing a TA spacer, exhibiting superhelical trajectory. In contrast, a GC spacers abolishes the DNA superhelical trajectory and exhibits less bent DNA, suggesting that increased GC content accompanies increased double helix rigidity. A 19-bp DNA, representing an AT-rich response element with overlapping half-sites, maintains superhelical trajectory and reveals two interacting p63DBD dimers crossing one another at 120. p63DBD binding assays to response elements of increasing length complement the structural studies. We propose that DNA deformation may affect promoter activity, that the ability of p63DBD to bind to superhelical DNA suggests that it is capable of binding to nucleosomes, and that overlapping response elements may provide a mechanism to distinguish between p63 and p53 promoters.	[Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; Univ Maryland, Dept Chem & Biochem, Rockville, MD 20850 USA		Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu		Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health [R01-GM087922]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM087922. This work was also supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; DeLano W, 2002, PYMOL 0 99; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Laptenko O, 2011, P NATL ACAD SCI USA, V108, P10385, DOI 10.1073/pnas.1105680108; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Malecka KA, 2009, ONCOGENE, V28, P325, DOI 10.1038/onc.2008.400; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nait-Kaoudjt R, 1998, EUR J BIOCHEM, V254, P111, DOI 10.1046/j.1432-1327.1998.2540111.x; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	45	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7477	7486		10.1074/jbc.M111.315820	http://dx.doi.org/10.1074/jbc.M111.315820			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247550	Green Published, hybrid			2022-12-27	WOS:000301060200048
J	Jennings, BC; Linder, ME				Jennings, Benjamin C.; Linder, Maurine E.			DHHC Protein S-Acyltransferases Use Similar Ping-Pong Kinetic Mechanisms but Display Different Acyl-CoA Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PALMITOYLATION; ACYLATION; TRAFFICKING; IDENTIFICATION; LOCALIZATION; ARACHIDONATE; HUNTINGTIN; MEMBRANE; HIP14	DHHCproteins catalyze the reversible S-acylation of proteins at cysteine residues, a modification important for regulating protein localization, stability, and activity. However, little is known about the kinetic mechanism of DHHC proteins. A high-performance liquid chromatography (HPLC), fluorescent peptide-based assay for protein S-acylation activity was developed to characterize mammalian DHHC2 and DHHC3. Time courses and substrate saturation curves allowed the determination of V-max and K-m values for both the peptide N-myristoylated-GCG and palmitoyl-coenzyme A. DHHC proteins acylate themselves upon incubation with palmitoyl-CoA, which is hypothesized to reflect a transient acyl enzyme transfer intermediate. Single turnover assays with DHHC2 and DHHC3 demonstrated that a radiolabeled acyl group on the enzyme transferred to the protein substrate, consistent with a two-step ping-pong mechanism. Enzyme autoacylation and acyltransfer to substrate displayed the same acyl-CoA specificities, further supporting a two-step mechanism. Interestingly, DHHC2 efficiently transferred acyl chains 14 carbons and longer, whereas DHHC3 activity was greatly reduced by acyl-CoAs with chain lengths longer than 16 carbons. The rate and extent of autoacylation of DHHC3, as well as the rate of acyl chain transfer to protein substrate, were reduced with stearoyl-CoA when compared with palmitoyl-CoA. This is the first observation of lipid substrate specificity among DHHC proteins and may account for the differential S-acylation of proteins observed in cells.	[Jennings, Benjamin C.; Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Jennings, Benjamin C.] Washington Univ, Grad Program Biochem, St Louis, MO 63110 USA	Cornell University; Washington University (WUSTL)	Linder, ME (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, CVM Box 41, Ithaca, NY 14853 USA.	mel237@cornell.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM51466]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51466 (to M. E. L.).; Supported by an American Heart Association predoctoral fellowship (Midwest Affiliate).	CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Cook P. F., 2007, ENZYME KINETICS MECH, P59; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; FERYFORGUES S, 1993, J PHOTOCH PHOTOBIO A, V70, P229, DOI 10.1016/1010-6030(93)85048-D; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Lorentzen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.20001370; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; MUSZBEK L, 1993, J BIOL CHEM, V268, P18243; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schroeder H, 1996, J CELL BIOL, V134, P647, DOI 10.1083/jcb.134.3.647; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Varner AS, 2002, ANAL BIOCHEM, V308, P160, DOI 10.1016/S0003-2697(02)00212-9; Veit M, 1996, BIOCHEM J, V318, P163, DOI 10.1042/bj3180163; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zeidman R, 2011, MOL MEMBR BIOL, V28, P473, DOI 10.3109/09687688.2011.630682	34	133	134	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7236	7245		10.1074/jbc.M111.337246	http://dx.doi.org/10.1074/jbc.M111.337246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247542	hybrid, Green Published			2022-12-27	WOS:000301060200026
J	Wu, S; Hong, F; Gewirth, D; Guo, BC; Liu, B; Li, ZH				Wu, Shuang; Hong, Feng; Gewirth, Daniel; Guo, Beichu; Liu, Bei; Li, Zihai			The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK-PROTEIN GP96; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; MASTER CHAPERONE; HSP90; BINDING; GLYCOPROTEIN; COMPLEX; GRP94; COCHAPERONE	The structural basis for molecular chaperones to discern mis-folded proteins has long been an enigma. As the endoplasmic reticulum paralogue of the cytosolic HSP90, gp96 (GRP94, HSP90b1) is an essential molecular chaperone for Toll-like receptors (TLRs) and integrins. However, little is known about its client-binding domain (CBD). Herein, we provide genetic and biochemical evidence to definitively demonstrate that a C-terminal loop structure, formed by residues 652-678, is the critical region of CBD for both TLRs and integrins. Deletion of this region affects neither the intrinsic ATPase activity nor the overall conformation of gp96. However, without it, the chaperoning function of gp96 collapses. We also find a critical Met pair (Met(658)-Met(662)) for the folding of integrins but not TLRs. Moreover, we find that the TLR binding to gp96 is also dependent on the C-terminal dimerization domain but not the N-terminal ATP-binding pocket of gp96. Our study has unveiled surprisingly the exquisite specificity of gp96 in substrate binding and suggests a manipulation of its CBD as an alternative strategy for targeted therapy of a variety of diseases.	[Li, Zihai] Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Wu, Shuang; Li, Zihai] Univ Connecticut, Dept Immunol, Sch Med, Farmington, CT 06030 USA; [Gewirth, Daniel] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA	Medical University of South Carolina; University of Connecticut; Hauptman Woodward Medical Research Institute	Li, ZH (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283, HL100556]; Flow Cytometry Shared Resource; Hollings Cancer Center; Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313, R01CA095130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Shared Resource; Hollings Cancer Center; Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070603, AI077283, and HL100556 (to Z. L.), and by the Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; CADEPOND F, 1993, P NATL ACAD SCI USA, V90, P10434, DOI 10.1073/pnas.90.22.10434; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fang L, 2006, P NATL ACAD SCI USA, V103, P18487, DOI 10.1073/pnas.0609163103; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kliger Y, 2009, P NATL ACAD SCI USA, V106, P13797, DOI 10.1073/pnas.0906514106; KOCH G, 1986, J CELL SCI, V86, P217; LEE AS, 1984, J BIOL CHEM, V259, P4616; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020364; MAZZARELLA RA, 1987, J BIOL CHEM, V262, P8875; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; SHAKNOVICH R, 1992, MOL CELL BIOL, V12, P5059, DOI 10.1128/MCB.12.11.5059; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; SULLIVAN WP, 1993, J BIOL CHEM, V268, P20373; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	36	76	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6735	6742		10.1074/jbc.M111.309526	http://dx.doi.org/10.1074/jbc.M111.309526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223641	hybrid, Green Published			2022-12-27	WOS:000300791800059
J	Zheng, XY; Gessel, MM; Wisniewski, ML; Viswanathan, K; Wright, DL; Bahr, BA; Bowers, MT				Zheng, Xueyun; Gessel, Megan M.; Wisniewski, Meagan L.; Viswanathan, Kishore; Wright, Dennis L.; Bahr, Ben A.; Bowers, Michael T.			Z-Phe-Ala-diazomethylketone (PADK) Disrupts and Remodels Early Oligomer States of the Alzheimer Disease A beta 42 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; SMALL-MOLECULE INHIBITORS; IN-VIVO; MONOMER STRUCTURE; AGGREGATION; NEUROTOXICITY; PATHWAYS; MECHANISMS; DISORDERS; DISTINCT	The oligomerization of the amyloid-beta protein (A beta) is an important event in Alzheimer disease (AD) pathology. Developing small molecules that disrupt formation of early oligomeric states of A beta and thereby reduce the effective amount of toxic oligomers is a promising therapeutic strategy for AD. Here, mass spectrometry and ion mobility spectrometry were used to investigate the effects of a small molecule, Z-Phe-Ala-diazomethylketone(PADK), on the A beta 42 form of the protein. The mass spectrum of a mixture of PADK and A beta 42 clearly shows that PADK binds directly to A beta 42 monomers and small oligomers. Ion mobility results indicate that PADK not only inhibits the formation of A beta 42 dodecamers, but also removes preformed A beta 42 dodecamers from the solution. Electron microscopy images show that PADK inhibits A beta 42 fibril formation in the solution. These results are consistent with a previous study that found that PADK has protective effects in an AD transgenic mouse model. The study of PADK and A beta 42 provides an example of small molecule therapeutic development for AD and other amyloid diseases.	[Zheng, Xueyun; Gessel, Megan M.; Bowers, Michael T.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Wisniewski, Meagan L.; Bahr, Ben A.] Univ N Carolina, Biotechnol Res & Training Ctr, William C Friday Lab, Pembroke, NC 28372 USA; [Viswanathan, Kishore; Wright, Dennis L.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Viswanathan, Kishore] Synapt Dynam Inc, Farmington, CT 06032 USA	University of California System; University of California Santa Barbara; University of North Carolina; University of Connecticut	Bowers, MT (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	bowers@chem.ucsb.edu	Zheng, Xueyun/GWR-2316-2022	Zheng, Xueyun/0000-0001-9782-4521; Wright, Dennis/0000-0003-4634-3351; Gessel, Megan/0000-0001-5706-787X	National Institutes of Health [IPOIAG 027818-010003, R25 GM077634]; Institute for the Study of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM077634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for the Study of Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants IPOIAG 027818-010003 (to M. T. B.) and R25 GM077634 (to B. A. B.). This work was also supported by the Institute for the Study of Aging (to B. A. B.).	Bahr B. A., 2012, REJUVENATIO IN PRESS; Bahr BA, 2009, CURR ALZHEIMER RES, V6, P438, DOI 10.2174/156720509789207903; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Convertino M, 2011, J BIOL CHEM, V286, P41578, DOI 10.1074/jbc.M111.285957; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Dupuis NF, 2011, J AM CHEM SOC, V133, P7240, DOI 10.1021/ja1081537; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Grabenauer M, 2010, J AM CHEM SOC, V132, P8816, DOI 10.1021/ja100243h; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Hawkes CA, 2009, DRUG DEVELOP RES, V70, P111, DOI 10.1002/ddr.20290; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Re F, 2010, CURR MED CHEM, V17, P2990, DOI 10.2174/092986710791959729; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Stains CI, 2007, CHEMMEDCHEM, V2, P1674, DOI 10.1002/cmdc.200700140; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyttenbach T, 2003, TOP CURR CHEM, V225, P207, DOI 10.1007/b10470; Wyttenbach T, 2001, INT J MASS SPECTROM, V212, P13, DOI 10.1016/S1387-3806(01)00517-6; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	42	32	32	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6084	6088		10.1074/jbc.C111.328575	http://dx.doi.org/10.1074/jbc.C111.328575			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22253440	hybrid, Green Published			2022-12-27	WOS:000300791800002
J	Paschoud, S; Guillemot, L; Citi, S				Paschoud, Serge; Guillemot, Laurent; Citi, Sandra			Distinct Domains of Paracingulin Are Involved in Its Targeting to the Actin Cytoskeleton and Regulation of Apical Junction Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; TIGHT JUNCTION; ADHERENS JUNCTIONS; ALPHA-CATENIN; F-ACTIN; ZO-1; CINGULIN; PROTEIN; COMPLEX; BINDING	Paracingulin is an M-r 150-160 kDa cytoplasmic protein of vertebrate epithelial tight and adherens junctions and comprises globular head, coiled-coil rod, and globular tail domains. Unlike its homologous tight junction protein cingulin, paracingulin has been implicated in the control of junction assembly and has been localized at extrajunctional sites in association with actin filaments. Here we analyze the role of paracingulin domains, and specific regions within the head and rod domains, in the function and localization of paracingulin by inducible overexpression of exogenous proteins in epithelial Madin Darby canine kidney (MDCK) cells and by expression of mutated and chimeric constructs in Rat1 fibroblasts and MDCK cells. The overexpression of the rod + tail domains of paracingulin perturbs the development of the tight junction barrier and Rac1 activation during junction assembly by the calcium switch, indicating that regulation of junction assembly by paracingulin is mediated by these domains. Conversely, only constructs containing the head domain target to junctions in MDCK cells and Rat1 fibroblasts. Furthermore, expression of chimeric cingulin and paracingulin constructs in Rat1 fibroblasts and MDCK cells identifies specific sequences within the head and rod domains of paracingulin as critical for targeting to actin filaments and regulation of junction assembly, respectively. In summary, we characterize the functionally important domains of paracingulin that distinguish it from cingulin.	[Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1205 Geneva, Switzerland; [Paschoud, Serge; Guillemot, Laurent; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland	University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Cell Biol, 4 Blvd Yvoy, CH-1205 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	State of Geneva; Section of Biology of the Faculty of Sciences of the University of Geneva; Swiss National Fund [31003A103637, 31003A116763]	State of Geneva; Section of Biology of the Faculty of Sciences of the University of Geneva; Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the State of Geneva, the Section of Biology of the Faculty of Sciences of the University of Geneva, and by Swiss National Fund Grants 31003A103637 and 31003A116763.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Citi S., 2012, ANN N Y ACA IN PRESS; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; D'Atri F, 2001, FEBS LETT, V507, P21, DOI 10.1016/S0014-5793(01)02936-2; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; McCrea P. D., 2009, COLD SPRING HARB PER, V1; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Nakagawa M, 2001, J CELL SCI, V114, P1829; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Samarin S, 2009, FRONT BIOSCI-LANDMRK, V14, P1129, DOI 10.2741/3298; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179	36	7	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13159	13169		10.1074/jbc.M111.315622	http://dx.doi.org/10.1074/jbc.M111.315622			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22315225	hybrid, Green Published			2022-12-27	WOS:000302903700054
J	Lee, JH; Park, AK; Do, H; Park, KS; Moh, SH; Chi, YM; Kim, HJ				Lee, Jun Hyuck; Park, Ae Kyung; Do, Hackwon; Park, Kyoung Sun; Moh, Sang Hyun; Chi, Young Min; Kim, Hak Jun			Structural Basis for Antifreeze Activity of Ice-binding Protein from Arctic Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIATOM FRAGILARIOPSIS-CYLINDRUS; CRYSTAL-STRUCTURE; DOMAIN	Arctic yeast Leucosporidium sp. produces a glycosylated ice-binding protein (LeIBP) with a molecular mass of similar to 25 kDa, which can lower the freezing point below the melting point once it binds to ice. LeIBP is a member of a large class of ice-binding proteins, the structures of which are unknown. Here, we report the crystal structures of non-glycosylated LeIBP and glycosylated LeIBP at 1.57- and 2.43-angstrom resolution, respectively. Structural analysis of the LeIBPs revealed a dimeric right-handed beta-helix fold, which is composed of three parts: a large coiled structural domain, a long helix region (residues 96-115 form a long beta-helix that packs along one face of the beta-helix), and a C-terminal hydrophobic loop region ((243)PFVPAPEVV(251)). Unexpectedly, the C-terminal hydrophobic loop region has an extended conformation pointing away from the body of the coiled structural domain and forms intertwined dimer interactions. In addition, structural analysis of glycosylated LeIBP with sugar moieties attached to Asn(185) provides a basis for interpreting previous biochemical analyses as well as the increased stability and secretion of glycosylated LeIBP. We also determined that the aligned Thr/Ser/Ala residues are critical for ice binding within the B face of LeIBP using site-directed mutagenesis. Although LeIBP has a common beta-helical fold similar to that of canonical hyperactive antifreeze proteins, the ice-binding site is more complex and does not have a simple ice-binding motif. In conclusion, we could identify the ice-binding site of LeIBP and discuss differences in the ice-binding modes compared with other known antifreeze proteins and ice-binding proteins.	[Lee, Jun Hyuck; Do, Hackwon; Park, Kyoung Sun; Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon 406840, South Korea; [Lee, Jun Hyuck; Do, Hackwon; Park, Kyoung Sun; Kim, Hak Jun] Univ Sci & Technol, Dept Polar Sci, Inchon 406840, South Korea; [Park, Ae Kyung; Chi, Young Min] Korea Univ, Coll Life Sci, Div Biotechnol, Seoul 136713, South Korea; [Moh, Sang Hyun] BIO FD&C Co Ltd, Antiaging Res Inst, Inchon 405849, South Korea	Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Korea University	Kim, HJ (corresponding author), Korea Polar Res Inst, Div Polar Life Sci, Inchon 406840, South Korea.	hjkim@kopri.re.kr		, Hackwon/0000-0001-7663-2010	Korea Research Council of Fundamental Science and Technology (KRCF); Korea Polar Research Institute (KOPRI) [PG11010, PE11100]	Korea Research Council of Fundamental Science and Technology (KRCF); Korea Polar Research Institute (KOPRI)	This work was supported by the National Agenda Project from the Korea Research Council of Fundamental Science and Technology (KRCF) and Korea Polar Research Institute (KOPRI) Grant PG11010 and PE11100 (to H. J. K.).	Achenbach JC, 2002, EUR J BIOCHEM, V269, P1219, DOI 10.1046/j.1432-1033.2002.02761.x; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer-Giraldi M, 2011, CRYOBIOLOGY, V63, P210, DOI 10.1016/j.cryobiol.2011.08.006; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Hoshino T, 2003, CAN J BOT, V81, P1175, DOI [10.1139/b03-116, 10.1139/B03-116]; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Krell A, 2008, EUR J PHYCOL, V43, P423, DOI 10.1080/09670260802348615; Kwan AHY, 2005, BIOCHEMISTRY-US, V44, P1980, DOI 10.1021/bi047782j; Lee JK, 2010, CRYOBIOLOGY, V60, P222, DOI 10.1016/j.cryobiol.2010.01.002; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimiya Y, 2008, J MOL BIOL, V382, P734, DOI 10.1016/j.jmb.2008.07.042; Park AK, 2011, ACTA CRYSTALLOGR F, V67, P800, DOI 10.1107/S1744309111018446; Patel SN, 2010, BIOCHEM CELL BIOL, V88, P223, DOI [10.1139/o09-183, 10.1139/O09-183]; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2007, FEMS MICROBIOL ECOL, V61, P214, DOI 10.1111/j.1574-6941.2007.00345.x; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Raymond JA, 2009, CRYOBIOLOGY, V58, P151, DOI 10.1016/j.cryobiol.2008.11.009; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Siemer AB, 2008, J AM CHEM SOC, V130, P17394, DOI 10.1021/ja8047893; Smallwood M, 1999, BIOCHEM J, V340, P385, DOI 10.1042/0264-6021:3400385; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Xiao N, 2010, FEBS J, V277, P394, DOI 10.1111/j.1742-4658.2009.07490.x; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200	43	78	84	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11460	11468		10.1074/jbc.M111.331835	http://dx.doi.org/10.1074/jbc.M111.331835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22303017	Green Published, hybrid			2022-12-27	WOS:000302780100074
J	Sandilos, JK; Chiu, YH; Chekeni, FB; Armstrong, AJ; Walk, SF; Ravichandran, KS; Bayliss, DA				Sandilos, Joanna K.; Chiu, Yu-Hsin; Chekeni, Faraaz B.; Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.; Bayliss, Douglas A.			Pannexin 1, an ATP Release Channel, Is Activated by Caspase Cleavage of Its Pore-associated C-terminal Autoinhibitory Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIND-ME SIGNAL; PH REGULATION; INACTIVATION; CONNEXIN43; INFLAMMASOME; NUCLEOTIDES; INHIBITION; CLEARANCE; APOPTOSIS; CELLS	Pannexin 1 (PANX1) channels mediate release of ATP, a "find-me" signal that recruits macrophages to apoptotic cells; PANX1 activation during apoptosis requires caspase-mediated cleavage of PANX1 at its C terminus, but how the C terminus inhibits basal channel activity is not understood. Here, we provide evidence suggesting that the C terminus interacts with the human PANX1 (hPANX1) pore and that cleavage-mediated channel activation requires disruption of this inhibitory interaction. Basally silent hPANX1 channels localized on the cell membrane could be activated directly by protease-mediated C-terminal cleavage, without additional apoptotic effectors. By serial deletion, we identified a C-terminal region just distal to the caspase cleavage site that is required for inhibition of hPANX1; point mutations within this small region resulted in partial activation of full-length hPANX1. Consistent with the C-terminal tail functioning as a pore blocker, we found that truncated and constitutively active hPANX1 channels could be inhibited, in trans, by the isolated hPANX1 C terminus either in cells or when applied directly as a purified peptide in inside-out patch recordings. Furthermore, using a cysteine cross-linking approach, we showed that relief of inhibition following cleavage requires dissociation of the C terminus from the channel pore. Collectively, these data suggest a mechanism of hPANX1 channel regulation whereby the intact, pore-associated C terminus inhibits the full-length hPANX1 channel and a remarkably well placed caspase cleavage site allows effective removal of key inhibitory C-terminal determinants to activate hPANX1.	[Sandilos, Joanna K.; Chiu, Yu-Hsin; Chekeni, Faraaz B.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Armstrong, Allison J.; Walk, Scott F.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Bayliss, DA (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,5013 Jordan Hall, Charlottesville, VA 22908 USA.	bayliss@virginia.edu	Chiu, Yu-Hsin/AAT-8759-2021	Chiu, Yu-Hsin/0000-0002-4730-8104; Ravichandran, Kodi/0000-0001-9049-1410	National Institutes of Health [F30HL09640, GM064709, NS033583]; Pharmacological Sciences Training Grant [T32GM007055]; American Heart Association [PRE223005]; American Cancer Society [PF-11-024-01-CCG]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055, R01GM064709, T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Fellowship F30HL09640 (to F. B. C.) and Grants GM064709 (to K. S. R.) and NS033583 (to D. A. B.). This work was also supported by a Pharmacological Sciences Training Grant T32GM007055 (to J. K. S. and F. B. C.), a predoctoral fellowship from the American Heart Association (PRE223005, to J. K. S.), and a postdoctoral fellowship from American Cancer Society (PF-11-024-01-CCG to A. J. A.).	ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bargiello T. A., 2011, BIOCH BIOPH IN PRESS; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Chekeni FB, 2011, J MOL MED, V89, P13, DOI 10.1007/s00109-010-0673-7; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; Denault Jean-Bernard, 2008, V414, P191; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Morley GE, 1996, BIOPHYS J, V70, P1294, DOI 10.1016/S0006-3495(96)79686-8; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Williams DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007474; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	30	190	194	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11303	11311		10.1074/jbc.M111.323378	http://dx.doi.org/10.1074/jbc.M111.323378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311983	Green Published, hybrid			2022-12-27	WOS:000302780100061
J	Vladykovskaya, E; Sithu, SD; Haberzettl, P; Wickramasinghe, NS; Merchant, ML; Hill, BG; McCracken, J; Agarwal, A; Dougherty, S; Gordon, SA; Schuschke, DA; Barski, OA; O'Toole, T; D'Souza, SE; Bhatnagar, A; Srivastava, S				Vladykovskaya, Elena; Sithu, Srinivas D.; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Merchant, Michael L.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Gordon, Sharon A.; Schuschke, Dale A.; Barski, Oleg A.; O'Toole, Timothy; D'Souza, Stanley E.; Bhatnagar, Aruni; Srivastava, Sanjay			Lipid Peroxidation Product 4-Hydroxy-trans-2-nonenal Causes Endothelial Activation by Inducing Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER STRESS; CELLS; ADHESION; ATHEROSCLEROSIS; CHAPERONES; APOPTOSIS; DISEASES; OBESITY	Lipid peroxidation products, such as 4-hydroxy-trans-2-nonenal (HNE), cause endothelial activation, and they increase the adhesion of the endothelium to circulating leukocytes. Nevertheless, the mechanisms underlying these effects remain unclear. We observed that in HNE-treated human umbilical vein endothelial cells, some of the protein-HNE adducts colocalize with the endoplasmic reticulum (ER) and that HNE forms covalent adducts with several ER chaperones that assist in protein folding. We also found that at concentrations that did not induce apoptosis or necrosis, HNE activated the unfolded protein response, leading to an increase in XBP-1 splicing, phosphorylation of protein kinase-like ER kinase and eukaryotic translation initiation factor 2 alpha, and the induction of ATF3 and ATF4. This increase in eukaryotic translation initiation factor 2 alpha phosphorylation was prevented by transfection with protein kinase-like ER kinase siRNA. Treatment with HNE increased the expression of the ER chaperones, GRP78 and HERP. Exposure to HNE led to a depletion of reduced glutathione and an increase in the production of reactive oxygen species (ROS); however, glutathione depletion and ROS production by tertbutyl- hydroperoxide did not trigger the unfolded protein response. Pretreatment with a chemical chaperone, phenylbutyric acid, or adenoviral transfection with ATF6 attenuated HNE-induced monocyte adhesion and IL-8 induction. Moreover, phenylbutyric acid and taurine-conjugated ursodeoxycholic acid attenuated HNE-induced leukocyte rolling and their firm adhesion to the endothelium in rat cremaster muscle. These data suggest that endothelial activation by HNE is mediated in part by ER stress, induced by mechanisms independent of ROS production or glutathione depletion. The induction of ER stress may be a significant cause of vascular inflammation induced by products of oxidized lipids.	[Vladykovskaya, Elena; Sithu, Srinivas D.; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Barski, Oleg A.; O'Toole, Timothy; Bhatnagar, Aruni; Srivastava, Sanjay] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Vladykovskaya, Elena; Haberzettl, Petra; Wickramasinghe, Nalinie S.; Merchant, Michael L.; Hill, Bradford G.; McCracken, James; Agarwal, Abhinav; Dougherty, Susan; Barski, Oleg A.; O'Toole, Timothy; Bhatnagar, Aruni; Srivastava, Sanjay] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Sithu, Srinivas D.; Gordon, Sharon A.; Schuschke, Dale A.; D'Souza, Stanley E.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40202 USA; [Hill, Bradford G.; Bhatnagar, Aruni] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Srivastava, S (corresponding author), Univ Louisville, Diabet & Obes Ctr, 580 S Preston St,Delia Baxter Bldg,Rm 204F, Louisville, KY 40202 USA.	s0sriv01@exchange.louisville.edu	Merchant, Michael/F-7109-2013; Hill, Bradford/I-4154-2013; Merchant, Michael L/N-7444-2013; Hill, Bradford/F-9228-2011	Hill, Bradford/0000-0001-5332-8286; Merchant, Michael L/0000-0003-4128-4057; 	National Institutes of Health [ES17260, HL95593, HL55477, HL59378, RR 24489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095593, R01HL059378, R01HL055477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES17260, HL95593, HL55477, HL59378, and RR 24489.	Annangudi SP, 2008, CHEM RES TOXICOL, V21, P1384, DOI 10.1021/tx8000303; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; Baba SP, 2009, DIABETES, V58, P2486, DOI 10.2337/db09-0375; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; BHATNAGAR A, 1990, CIRC RES, V67, P535, DOI 10.1161/01.RES.67.3.535; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Grune T, 1997, FREE RADICAL BIO MED, V23, P357, DOI 10.1016/S0891-5849(96)00586-2; Haberzettl P, 2009, TOXICOL APPL PHARM, V234, P14, DOI 10.1016/j.taap.2008.09.019; Henriksen PA, 2004, J IMMUNOL, V172, P4535, DOI 10.4049/jimmunol.172.7.4535; Herbst U, 1999, J CELL PHYSIOL, V181, P295, DOI 10.1002/(SICI)1097-4652(199911)181:2<295::AID-JCP11>3.0.CO;2-I; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Schuschke Dale A., 1995, Microcirculation (New York), V2, P371, DOI 10.3109/10739689509148281; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Singh SP, 2008, BIOCHEMISTRY-US, V47, P3900, DOI 10.1021/bi702124u; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Srivastava S, 2010, METHOD ENZYMOL, V474, P297, DOI 10.1016/S0076-6879(10)74018-0; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; West JD, 2005, CHEM RES TOXICOL, V18, P1642, DOI 10.1021/tx050211n; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	37	85	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11398	11409		10.1074/jbc.M111.320416	http://dx.doi.org/10.1074/jbc.M111.320416			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22228760	Green Published, hybrid			2022-12-27	WOS:000302780100069
J	de la Fuente, M; Noble, DN; Verma, S; Nieman, MT				de la Fuente, Maria; Noble, Daniel N.; Verma, Sheetal; Nieman, Marvin T.			Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL WORKSPACE; COUPLED RECEPTORS; THROMBIN RECEPTOR; HUMAN PLATELETS; ERYTHROPOIETIN RECEPTOR; ENDOTHELIAL-CELLS; LEUCINE-ZIPPER; RHODOPSIN; SPECIFICITY; MEMBRANE	Thrombin activates platelets by binding and cleaving protease-activated receptors 1 and 4 (PAR1 and PAR4). Because of the importance of PAR4 activation on platelets in humans and mice and emerging roles for PAR4 in other tissues, experiments were done to characterize the interaction between PAR4 homodimers. Bimolecular fluorescence complementation and bioluminescence resonance energy transfer (BRET) were used to examine the PAR4 homodimer interface. In bimolecular fluorescence complementation experiments, PAR4 formed homodimers that were disrupted by unlabeled PAR4 in a concentration-dependent manner, but not by rhodopsin. In BRET experiments, the PAR4 homodimers showed a specific interaction as indicated by a hyperbolic BRET signal in response to increasing PAR4-GFP expression. PAR4 did not interact with rhodopsin in BRET assays. The threshold maximum BRET signal was disrupted in a concentration-dependent manner by unlabeled PAR4. In contrast, rhodopsin was unable to disrupt the BRET signal, indicating that the disruption of the PAR4 homodimer is not due to nonspecific interactions. A panel of rho-PAR4 chimeras and PAR4 point mutants has mapped the dimer interface to hydrophobic residues in transmembrane helix 4. Finally, mutations that disrupted dimer formation had reduced calcium mobilization in response to the PAR4 agonist peptide. These results link the loss of dimer formation to a loss of PAR4 signaling.	[de la Fuente, Maria; Noble, Daniel N.; Verma, Sheetal; Nieman, Marvin T.] Case Western Reserve Univ, Div Hematol Oncol, Cleveland, OH 44106 USA; [Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Nieman, MT (corresponding author), 10900 Euclid Ave,305C Wood Bldg, Cleveland, OH 44106 USA.	nieman@case.edu			National Institutes of Health [1R01HL098217-01A1]; American Heart Association [10SDG2600021]; American Society for Hematology; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society for Hematology; Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HL098217-01A1 (to M. N.). This work was also supported by an American Heart Association beginning grant in aid, American Heart Association Scientist Development Grant 10SDG2600021, and an American Society for Hematology Scholar Award. This work was also supported by the Cytometry and Light Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland under Grant P30 CA43703.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Auge C, 2009, NEUROGASTROENT MOTIL, V21, P1189, DOI 10.1111/j.1365-2982.2009.01310.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Cherezov V, 2010, METHODS MOL BIOL, V654, P141, DOI 10.1007/978-1-60761-762-4_8; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; Dangwal S, 2011, ARTERIOSCL THROM VAS, V31, P624, DOI 10.1161/ATVBAHA.110.219105; Falker K, 2011, BIOCHEM J, V436, P469, DOI 10.1042/BJ20101360; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Herrick-Davis K, 2004, BIOCHEMISTRY-US, V43, P13963, DOI 10.1021/bi048398p; Holinstat M, 2007, MOL PHARMACOL, V71, P686, DOI 10.1124/mol.106.029371; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Huber O, 1999, J CELL SCI, V112, P4415; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; Nieman MT, 2005, FEBS LETT, V579, P25, DOI 10.1016/j.febslet.2004.11.041; Nieman MT, 2004, J PHARMACOL EXP THER, V311, P492, DOI 10.1124/jpet.104.069229; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; Riewald M, 2003, J ENDOTOXIN RES, V9, P317, DOI 10.1179/096805103225002584; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Simon DI, 2007, J AM COLL CARDIOL, V50, P1548, DOI 10.1016/j.jacc.2007.07.023; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Strande JL, 2008, J PHARMACOL EXP THER, V324, P1045, DOI 10.1124/jpet.107.133595; Swift S, 2000, J BIOL CHEM, V275, P2627, DOI 10.1074/jbc.275.4.2627; Vellani V, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-61; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Wang HX, 2009, BIOCHEMISTRY-US, V48, P7132, DOI 10.1021/bi900424h; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x	63	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10414	10423		10.1074/jbc.M112.341438	http://dx.doi.org/10.1074/jbc.M112.341438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22318735	Green Published, hybrid			2022-12-27	WOS:000302167200068
J	Tanaka, T; Padavattan, S; Kumarevel, T				Tanaka, Tomoyuki; Padavattan, Sivaraman; Kumarevel, Thirumananseri			Crystal Structure of Archaeal Chromatin Protein Alba2-Double-stranded DNA Complex from Aeropyrum pernix K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; SIR2; ALBA; MECHANISM; SSH10B	All thermophilic and hyperthermophilic archaea encode homologs of dimeric Alba (Sac10b) proteins that bind cooperatively at high density to DNA. Here, we report the 2.0 angstrom resolution crystal structure of an Alba2 (Ape10b2)-dsDNA complex from Aeropyrum pernix K1. A rectangular tube-like structure encompassing duplex DNA reveals the positively charged residues in the monomer-monomer interface of each dimer packing on either side of the bound dsDNA in successive minor grooves. The extended hairpin loop connecting strands beta 3 and beta 4 undergoes significant conformational changes upon DNA binding to accommodate the other Alba2 dimer during oligomerization. Mutational analysis of key interacting residues confirmed the specificity of Alba2-dsDNA interactions.	[Tanaka, Tomoyuki; Padavattan, Sivaraman; Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan	RIKEN	Kumarevel, T (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	tskvel@spring8.or.jp	Kumarevel, Thirumananseri/C-6275-2012	Kumarevel, Thirumananseri/0000-0001-9326-6585; Padavattan, Sivaraman/0000-0002-1732-5421	RIKEN SPring-8 Center	RIKEN SPring-8 Center	This research work was supported by the "Program for RIKEN SPring-8 Center projects to meet society's needs."	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; DeLano W.L, PYMOL MOL GRAPHICS S; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forbes AJ, 2004, P NATL ACAD SCI USA, V101, P2678, DOI 10.1073/pnas.0306575101; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; KEELING PJ, 1995, P NATL ACAD SCI USA, V92, P5761, DOI 10.1073/pnas.92.13.5761; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	28	24	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10394	10402		10.1074/jbc.M112.343210	http://dx.doi.org/10.1074/jbc.M112.343210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334696	hybrid, Green Published			2022-12-27	WOS:000302167200066
J	Broos, K; Trekels, M; Jose, RA; Demeulemeester, J; Vandenbulcke, A; Vandeputte, N; Venken, T; Egle, B; De Borggraeve, WM; Deckmyn, H; De Maeyer, M				Broos, Katleen; Trekels, Mieke; Jose, Rani Alphonsa; Demeulemeester, Jonas; Vandenbulcke, Aline; Vandeputte, Nele; Venken, Tom; Egle, Brecht; De Borggraeve, Wim M.; Deckmyn, Hans; De Maeyer, Marc			Identification of a Small Molecule That Modulates Platelet Glycoprotein Ib-von Willebrand Factor Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR A1 DOMAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; PROTEIN-PROTEIN INTERACTIONS; TRANSFER DIFFERENCE NMR; CRYSTAL-STRUCTURE; APTAMER ARC1779; ARTERIAL THROMBOSIS; HEALTHY-VOLUNTEERS; RATIONAL DESIGN; SNAKE-VENOM	The von Willebrand factor (VWF) A1-glycoprotein (GP) Ib alpha interaction is of major importance during thrombosis mainly at sites of high shear stress. Inhibitors of this interaction prevent platelet-dependent thrombus formation in vivo, without major bleeding complications. However, the size and/or protein nature of the inhibitors currently in development limit oral bioavailability and clinical development. We therefore aimed to search for a small molecule protein-protein interaction inhibitor interfering with the VWF-GPIb alpha binding. After determination of putative small molecule binding pockets on the surface of VWF-A1 and GPIb alpha using site-finding algorithms and molecular dynamics, high throughput molecular docking was performed on both binding partners. A selection of compounds showing good in silico docking scores into the predicted pockets was retained for testing their in vitro effect on VWF-GPIb alpha complex formation, by which we identified a compound that surprisingly stimulated the VWF-GPIb alpha binding in a ristocetin cofactor ELISA and increased platelet adhesion in whole blood to collagen under arterial shear rate but in contrast inhibited ristocetin-induced platelet aggregation. The selected compound adhering to the predicted binding partner GPIb alpha could be confirmed by saturation transfer difference NMR spectroscopy. We thus clearly identified a small molecule that modulates VWF-GPIb alpha binding and that will now serve as a starting point for further studies and chemical modifications to fully characterize the interaction and to manipulate specific activity of the compound.	[Broos, Katleen; Vandenbulcke, Aline; Vandeputte, Nele; Deckmyn, Hans] Katholieke Univ Leuven, Lab Thrombosis Res, B-8500 Kortrijk, Belgium; [Trekels, Mieke; Demeulemeester, Jonas; Venken, Tom; De Maeyer, Marc] Katholieke Univ Leuven, Lab Biomol Modelling, Dept Chem, Div Biochem Mol & Struct Biol, B-3001 Louvain, Belgium; [Jose, Rani Alphonsa; Egle, Brecht; De Borggraeve, Wim M.] Katholieke Univ Leuven, Dept Chem, Lab Mol Design & Synth, B-3001 Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven	Deckmyn, H (corresponding author), Katholieke Univ Leuven, Lab Thrombosis Res, Campus Kortrijk,E Sabbelaan 53, B-8500 Kortrijk, Belgium.	hans.deckmyn@kuleuven-kulak.be; Marc.demaeyer@fys.kuleuven.be	De Borggraeve, Wim/AGE-5612-2022; Deckmyn, Hans/L-9434-2015; Demeulemeester, Jonas/J-6130-2014; Deckmyn, Hans/N-8932-2019	De Borggraeve, Wim/0000-0001-7813-6192; Deckmyn, Hans/0000-0003-3952-5501; Demeulemeester, Jonas/0000-0002-2660-2478; Deckmyn, Hans/0000-0003-3952-5501; Venken, Tom/0000-0003-0773-1810	Katholieke Universiteit Leuven [IOF-KP 06/001]	Katholieke Universiteit Leuven(KU Leuven)	This work was supported by Knowledge Platform Grant IOF-KP 06/001 from the Katholieke Universiteit Leuven Industrial Research Fund.	Bartunek J, 2008, CIRCULATION, V118, pS656; Benard SA, 2008, BIOCHEMISTRY-US, V47, P4674, DOI 10.1021/bi702428q; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cauwenberghs N, 2000, ARTERIOSCL THROM VAS, V20, P1347, DOI 10.1161/01.ATV.20.5.1347; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; Dudkina AS, 2007, CURR TOP MED CHEM, V7, P952, DOI 10.2174/156802607780906762; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Firbas C, 2010, EXPERT REV CARDIOVAS, V8, P1689, DOI [10.1586/erc.10.154, 10.1586/ERC.10.154]; Fontayne A, 2008, THROMB HAEMOSTASIS, V100, P670, DOI 10.1160/TH08-02-0073; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Gilbert JC, 2007, CIRCULATION, V116, P2678, DOI 10.1161/CIRCULATIONAHA.107.724864; GRETHE G, 1990, J CHEM INF COMP SCI, V30, P511, DOI 10.1021/ci00068a025; Guido RVC, 2008, CURR MED CHEM, V15, P37; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HONIG B, 1993, J PHYS CHEM-US, V97, P1101, DOI 10.1021/j100108a002; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Knobl P, 2009, TRANSFUSION, V49, P2181, DOI 10.1111/j.1537-2995.2009.02232.x; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mayr FB, 2010, TRANSFUSION, V50, P1079, DOI 10.1111/j.1537-2995.2009.02554.x; McEwan PA, 2009, BLOOD, V114, P4883, DOI 10.1182/blood-2009-05-224170; Munoz CD, 2008, J MOL MODEL, V14, P1191, DOI 10.1007/s00894-008-0375-z; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oprea T., 2005, CHEMINFORMATICS DRUG, P141; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; SCHUMPPVONACH B, 1995, CYTOTECHNOLOGY, V17, P133, DOI 10.1007/BF00749401; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shimizu A, 2004, J BIOL CHEM, V279, P16285, DOI 10.1074/jbc.M307230200; Sperandio O, 2010, DRUG DISCOV TODAY, V15, P220, DOI 10.1016/j.drudis.2009.11.007; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TORNAI I, 1993, J CLIN INVEST, V91, P273, DOI 10.1172/JCI116181; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Ulrichts H, 2004, J THROMB HAEMOST, V2, P1622, DOI 10.1111/j.1538-7836.2004.00865.x; Ulrichts H, 2011, BLOOD, V118, P757, DOI 10.1182/blood-2010-11-317859; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanhoorelbeke K, 2000, THROMB HAEMOSTASIS, V83, P107; Vanhoorelbeke K, 2007, CURR PHARM DESIGN, V13, P2684, DOI 10.2174/138161207781662867; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Voet A., 2010, THESIS K U LEUVEN LE; Wu DM, 2002, ARTERIOSCL THROM VAS, V22, P323, DOI 10.1161/hq0202.102321	69	10	12	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9461	9472		10.1074/jbc.M111.311431	http://dx.doi.org/10.1074/jbc.M111.311431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22232560	Green Published, hybrid			2022-12-27	WOS:000301797800075
J	Zhang, YH; Li, ZG; Sacks, DB; Ames, JB				Zhang, Yonghong; Li, Zhigang; Sacks, David B.; Ames, James B.			Structural Basis for Ca2+-induced Activation and Dimerization of Estrogen Receptor alpha by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; TARGET RECOGNITION; LIGHT-SCATTERING; CALCIUM-BINDING; COMPLEX; NMR; ASSOCIATION; MODULATION; PLASTICITY; ESTRADIOL	The estrogen receptor alpha (ER-alpha) regulates expression of target genes implicated in development, metabolism, and breast cancer. Calcium-dependent regulation of ER-alpha is critical for activating gene expression and is controlled by calmodulin (CaM). Here, we present the NMR structures for the two lobes of CaM each bound to a localized region of ER-alpha (residues 287-305). A model of the complete CaM alpha ER-alpha complex was constructed by combining these two structures with additional data. The two lobes of CaM both compete for binding at the same site on ER-alpha (residues 292, 296, 299, 302, and 303), which explains why full-length CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimerization. Exposed glutamate residues in CaM (Glu(11), Glu(14), Glu(84), and Glu(87)) form salt bridges with key lysine residues in ER-alpha (Lys(299), Lys(302), and Lys(303)), which are likely to prevent ubiquitination at these sites and inhibit degradation of ER-alpha. Mutants of ER-alpha at the CaM-binding site (W292A and K299A) weaken binding to CaM, and I298E/K299D disrupts estrogen-induced transcription. CaM facilitates dimerization of ER-alpha in the absence of estrogen, and stimulation of ER-alpha by either Ca2+ and/or estrogen may serve to regulate transcription in a combinatorial fashion.	[Zhang, Yonghong; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	University of California System; University of California Davis; National Institutes of Health (NIH) - USA	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health [EY012347, NS059969]; Intramural Research Program; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.) and by the Intramural Research Program.	BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; BOUHOUTE A, 1995, BIOCHEM BIOPH RES CO, V208, P748, DOI 10.1006/bbrc.1995.1401; Brandt ME, 1997, J BIOL CHEM, V272, P4843, DOI 10.1074/jbc.272.8.4843; Conway K, 2005, BREAST CANCER RES, V7, pR871, DOI 10.1186/bcr1315; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Gallo D, 2008, MOL CELL ENDOCRINOL, V291, P20, DOI 10.1016/j.mce.2008.04.011; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hurth KM, 2004, BIOCHEMISTRY-US, V43, P1891, DOI 10.1021/bi035566p; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li L, 2007, CELL SIGNAL, V19, P439, DOI 10.1016/j.cellsig.2006.08.018; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Maaroufi Y, 2000, BREAST CANCER RES, V2, P444, DOI 10.1186/bcr92; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Pedrero JMG, 2002, MOL ENDOCRINOL, V16, P947; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SCHWABE JWR, 1993, STRUCTURE, V1, P187, DOI 10.1016/0969-2126(93)90020-H; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SINGER AL, 1976, CANCER RES, V36, P60; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	57	32	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9336	9344		10.1074/jbc.M111.334797	http://dx.doi.org/10.1074/jbc.M111.334797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275375	Green Published, hybrid			2022-12-27	WOS:000301797800065
J	Marusic, J; Podlipnik, C; Jevsevar, S; Kuzman, D; Vesnaver, G; Lah, J				Marusic, Jaka; Podlipnik, Crtomir; Jevsevar, Simona; Kuzman, Drago; Vesnaver, Gorazd; Lah, Jurij			Recognition of Human Tumor Necrosis Factor alpha (TNF-alpha) by Therapeutic Antibody Fragment ENERGETICS AND STRUCTURAL FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DOCKING; GRAPHICS PROCESSORS; FORCE-FIELD; BINDING; MECHANISMS; IDENTIFICATION; CHROMATOGRAPHY; DOMAIN; SERVER; TRIMER	Human tumor necrosis factor alpha (TNF-alpha) exists in its functional state as a homotrimeric protein and is involved in inflammation processes and immune response of a human organism. Overproduction of TNF-alpha results in the development of chronic autoimmune diseases that can be successfully treated by inhibitors such as monoclonal antibodies. However, the nature of antibody-TNF-alpha recognition remains elusive due to insufficient understanding of its molecular driving forces. Therefore, we studied the energetics of binding of a therapeutic antibody fragment (Fab) to the native and non-native forms of TNF-alpha by employing calorimetric and spectroscopic methods. Global thermodynamic analysis of data obtained from the corresponding binding and urea-induced denaturation experiments has been supported by structural modeling. We demonstrate that the observed high affinity binding of Fab to TNF-alpha is an enthalpy-driven process due mainly to specific noncovalent interactions taking place at the TNF-alpha-Fab binding interface. It is coupled to entropically unfavorable conformational changes and accompanied by entropically favorable solvation contributions. Moreover, the three-state model analysis of TNF-alpha unfolding shows that at physiological concentrations, TNF-alpha may exist not only as a biologically active trimer but also as an inactive monomer. It further suggests that even small changes of TNF-alpha concentration could have a considerable effect on the TNF-alpha activity. We believe that this study sets the energetic basis for understanding of TNF-alpha inhibition by antibodies and its unfolding linked with the concentration-dependent activity regulation.	Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Marusic, Jaka; Jevsevar, Simona; Kuzman, Drago] Lek Pharmaceut Dd, Sandoz Biopharmaceut, SI-1234 Menges, Slovenia	University of Ljubljana; Novartis; Sandoz		jurij.lah@fkkt.uni-lj.si	Podlipnik, Crtomir/R-6467-2019	Podlipnik, Crtomir/0000-0002-8429-0273	Ministry of Higher Education, Science and Technology; Agency for Research of the Republic of Slovenia [P1-0201, P1-0340]; European Social Fund (ESF)	Ministry of Higher Education, Science and Technology; Agency for Research of the Republic of Slovenia; European Social Fund (ESF)(European Social Fund (ESF))	This work was supported by the Ministry of Higher Education, Science and Technology and by the Agency for Research of the Republic of Slovenia through Grants P1-0201 and P1-0340.; Supported by the European Social Fund (ESF).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARAKAWA T, 1987, J BIOL CHEM, V262, P7484; Barbara JAJ, 1996, IMMUNOL CELL BIOL, V74, P434, DOI 10.1038/icb.1996.73; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; Drobnak I, 2010, J PHYS CHEM B, V114, P8713, DOI 10.1021/jp100525m; Drobnak I, 2009, J MOL BIOL, V392, P63, DOI 10.1016/j.jmb.2009.05.086; ECK MJ, 1989, J BIOL CHEM, V264, P17595; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HLODAN R, 1994, FEBS LETT, V343, P256, DOI 10.1016/0014-5793(94)80567-9; Hubbard S. J., 1993, NACCES VERSION 2 1 1; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LEE KH, 1994, PROTEINS, V20, P68, DOI 10.1002/prot.340200108; LEWITBENTLEY A, 1988, J MOL BIOL, V199, P389, DOI 10.1016/0022-2836(88)90323-3; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Santora LC, 2001, ANAL BIOCHEM, V299, P119, DOI 10.1006/abio.2001.5380; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Terlikowski S J, 2001, Rocz Akad Med Bialymst, V46, P5; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; VILCEK J, 1991, J BIOL CHEM, V266, P7313; Warzocha K, 1997, J CLIN ONCOL, V15, P499, DOI 10.1200/JCO.1997.15.2.499; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1	38	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8613	8620		10.1074/jbc.M111.318451	http://dx.doi.org/10.1074/jbc.M111.318451			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22262846	hybrid, Green Published			2022-12-27	WOS:000301349400073
J	Akin, BL; Jones, LR				Akin, Brandy L.; Jones, Larry R.			Characterizing Phospholamban to Sarco(endo) plasmic Reticulum Ca2+-ATPase 2a (SERCA2a) Protein Binding Interactions in Human Cardiac Sarcoplasmic Reticulum Vesicles Using Chemical Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-ATPASE INHIBITION; FUNCTIONAL INTERACTIONS; HEART-FAILURE; PHYSICAL INTERACTIONS; DYNAMIC INTERACTIONS; CALCIUM-PUMP; DOMAIN; PHOSPHORYLATION; MECHANISM; SKELETAL	Chemical cross-linking was used to study protein binding interactions between native phospholamban (PLB) and SERCA2a in sarcoplasmic reticulum (SR) vesicles prepared from normal and failed human hearts. Lys(27) of PLB was cross-linked to the Ca2+ pump at the cytoplasmic extension of M4(at or near Lys(328)) with the homobifunctional cross-linker, disuccinimidyl glutarate (7.7 angstrom). Cross-linking was augmented by ATP but abolished by Ca2+ or thapsigargin, confirming in native SR vesicles that PLB binds preferentially to E2 (low Ca2+ affinity conformation of the Ca2+-ATPase) stabilized by ATP. To assess the functional effects of PLB binding on SERCA2a activity, the antiPLB antibody, 2D12, was used to disrupt the physical interactions between PLB and SERCA2a in SR vesicles. We observed a tight correlation between 2D12-induced inhibition of PLB cross-linking to SERCA2a and 2D12 stimulation of Ca2+ ATPase activity and Ca2+ transport. The results suggest that the inhibitory effect of PLB on Ca2+-ATPase activity in SR vesicles results from mutually exclusive binding of PLB and Ca2+ to the Ca2+ pump, requiring PLB dissociation for catalytic activation. Importantly, the same result was obtained with SR vesicles prepared from normal and failed human hearts; therefore, we conclude that PLB binding interactions with the Ca2+ pump are largely unchanged in failing myocardium.	[Jones, Larry R.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Jones, LR (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	lrjones@iupui.edu			National Institutes of Health [HL49428]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428, R01HL049428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL49428.	Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2011, BIOCHEM J, V439, P313, DOI 10.1042/BJ20110926; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FUJII J, 1991, J BIOL CHEM, V266, P11669; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1981, J BIOL CHEM, V256, P1809; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Linck B, 1996, CARDIOVASC RES, V31, P625; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; MORRIS GL, 1991, J BIOL CHEM, V266, P11270; MOVSESIAN MA, 1994, CIRCULATION, V90, P653, DOI 10.1161/01.CIR.90.2.653; MOVSESIAN MA, 1990, J CLIN INVEST, V85, P1698, DOI 10.1172/JCI114623; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; SHAM JSK, 1991, AM J PHYSIOL, V261, pH1344, DOI 10.1152/ajpheart.1991.261.4.H1344; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wang HS, 2011, PHYSIOL GENOMICS, V43, P357, DOI 10.1152/physiolgenomics.00032.2010; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y; Zhao W, 2006, CIRCULATION, V113, P995, DOI 10.1161/CIRCULATIONAHA.105.583351	39	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7582	7593		10.1074/jbc.M111.334987	http://dx.doi.org/10.1074/jbc.M111.334987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247554	Green Published, hybrid			2022-12-27	WOS:000301060200058
J	Bernardo, TJ; Dubrovsky, EB				Bernardo, Travis J.; Dubrovsky, Edward B.			The Drosophila Juvenile Hormone Receptor Candidates Methoprene-tolerant (MET) and Germ Cell-expressed (GCE) Utilize a Conserved LIXXL Motif to Bind the FTZ-F1 Nuclear Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEETLE TRIBOLIUM-CASTANEUM; BHLH-PAS FAMILY; FUSHI-TARAZU; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REGULATORS; GENE-EXPRESSION; COACTIVATOR; LIGAND; PROTEIN; DOMAIN	Juvenile hormone (JH) has been implicated in many developmental processes in holometabolous insects, but its mechanism of signaling remains controversial. We previously found that in Drosophila Schneider 2 cells, the nuclear receptor FTZ-F1 is required for activation of the E75A gene by JH. Here, we utilized insect two-hybrid assays to show that FTZ-F1 interacts with two JH receptor candidates, the bHLH-PAS paralogs MET and GCE, in a JH-dependent manner. These interactions are severely reduced when helix 12 of the FTZ-F1 activation function 2 (AF2) is removed, implicating AF2 as an interacting site. Through homology modeling, we found that MET and GCE possess a C-terminal alpha-helix featuring a conserved motif LIXXL that represents a novel nuclear receptor (NR) box. Docking simulations supported by two-hybrid experiments revealed that FTZ-F1-MET and FTZ-F1-GCE heterodimer formation involves a typical NR box-AF2 interaction but does not require the canonical charge clamp residues of FTZ-F1 and relies primarily on hydrophobic contacts, including a unique interaction with helix 4. Moreover, we identified paralog-specific features, including a secondary interaction site found only in MET. Our findings suggest that a novel NR box enables MET and GCE to interact JH-dependently with the AF2 of FTZ-F1.	[Bernardo, Travis J.; Dubrovsky, Edward B.] Fordham Univ, Dept Biol, Bronx, NY 10458 USA; [Dubrovsky, Edward B.] Fordham Univ, Ctr Canc Genet Dis & Gene Regulat, Bronx, NY 10458 USA	Fordham University; Fordham University	Dubrovsky, EB (corresponding author), Fordham Univ, Dept Biol, 441 E Fordham Rd, Bronx, NY 10458 USA.	dubrovsky@fordham.edu		Bernardo, Travis/0000-0003-4432-9724	National Science Foundation [0653567]; Fordham University Graduate School of Arts and Sciences	National Science Foundation(National Science Foundation (NSF)); Fordham University Graduate School of Arts and Sciences	This work was supported by National Science Foundation Grant 0653567 (to E.B.D.) and a Fordham University Graduate School of Arts and Sciences research fellowship (to T.J.B.).	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Baumann A, 2010, GENETICS, V185, P1327, DOI 10.1534/genetics.110.116962; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2011, J BIOL CHEM, V286, P33689, DOI 10.1074/jbc.M111.273458; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim DH, 2008, MOL CELL BIOL, V28, P913, DOI 10.1128/MCB.01140-07; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li DS, 1999, MOL CELL BIOL, V19, P7191; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Mon H, 2009, ANAL BIOCHEM, V392, P180, DOI 10.1016/j.ab.2009.05.033; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Powell SM, 2004, ENDOCR-RELAT CANCER, V11, P117, DOI 10.1677/erc.0.0110117; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rowlands JC, 1996, MOL PHARMACOL, V50, P538; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; Suzuki T, 2001, P NATL ACAD SCI USA, V98, P12403, DOI 10.1073/pnas.221552998; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tan A, 2005, P NATL ACAD SCI USA, V102, P11751, DOI 10.1073/pnas.0500954102; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Xu PL, 2004, MOL ENDOCRINOL, V18, P1887, DOI 10.1210/me.2003-0334; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo J, 2011, J BIOL CHEM, V286, P31225, DOI 10.1074/jbc.M111.252916; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	56	35	40	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7821	7833		10.1074/jbc.M111.327254	http://dx.doi.org/10.1074/jbc.M111.327254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22249180	Green Published, hybrid			2022-12-27	WOS:000301060200080
J	Wu, TT; Zhou, HB; Hong, YF; Li, J; Jiang, XQ; Huang, H				Wu, Tingting; Zhou, Haibo; Hong, Yongfeng; Li, Jing; Jiang, Xinquan; Huang, Hui			miR-30 Family Members Negatively Regulate Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; STEM-CELLS; SMALL RNAS; SMAD1; MICRORNAS; BMP; EXPRESSION; PATHWAYS	miRNAs are endogenously expressed 18- to 25-nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. Recently, it has been indicated that miRNAs are closely related to osteogenesis. Our previous data suggested that miR-30 family members might be important regulators during the biomineralization process. However, whether and how they modulate osteogenic differentiation have not been explored. In this study, we demonstrated that miR-30 family members negatively regulate BMP-2-induced osteoblast differentiation by targeting Smad1 and Runx2. Evidentially, overexpression of miR-30 family members led to a decrease of alkaline phosphatase activity, whereas knockdown of them increased the activity. Then bioinformatic analysis identified potential target sites of the miR-30 family located in the 3' untranslated regions of Smad1 and Runx2. Western blot analysis and quantitative RT-PCR assays demonstrated that miR-30 family members inhibit Smad1 gene expression on the basis of repressing its translation. Furthermore, dual-luciferase reporter assays confirmed that Smad1 is a direct target of miR-30 family members. Rescue experiments that overexpress Smad1 and Runx2 significantly eliminated the inhibitory effect of miR-30 on osteogenic differentiation and provided strong evidence that miR-30 mediates the inhibition of osteogenesis by targeting Smad1 and Runx2. Also, the inhibitory effects of the miR-30 family were validated in mouse bone marrow mesenchymal stem cells. Therefore, our study uncovered that miR-30 family members are key negative regulators of BMP-2-mediated osteogenic differentiation.	[Huang, Hui] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Prosthodont, Shanghai Key Lab Stomatol,Sch Med, Shanghai 200011, Peoples R China; [Zhou, Haibo] Chinese Acad Sci, Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai 200025, Peoples R China; [Zhou, Haibo] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Renji Hosp, Shanghai 200025, Peoples R China; [Zhou, Haibo] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Hong, Yongfeng] Anhui Med Univ, Hosp 2, Hefei 230601, Peoples R China; [Jiang, Xinquan] Shanghai Res Inst Stomatol, Oral Bioengn Lab, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Anhui Medical University	Huang, H (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Prosthodont, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zaoju Rd, Shanghai 200011, Peoples R China.	huanghui_68@126.com	ZHOU, Haibo/M-7373-2017	Zhou, Haibo/0000-0003-2239-7793	National Nature Science Foundation of China [30670555, 81170988]; Shanghai Leading Academic Discipline Project [S30206]; Science and Technology Commission of Shanghai Municipality [11ZR1420200]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Nature Science Foundation of China Grants 30670555 and 81170988, by Shanghai Leading Academic Discipline Project S30206 and by Science and Technology Commission of Shanghai Municipality Grant 11ZR1420200.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyan BD, 2000, J PERIODONTOL, V71, P1278, DOI 10.1902/jop.2000.71.8.1278; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Goda S, 2008, J DENT RES, V87, P782, DOI 10.1177/154405910808700805; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Itoh T, 2010, J BIOL CHEM, V285, P27745, DOI 10.1074/jbc.M110.105080; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Iwata T, 2002, J DENT RES, V81, P387, DOI 10.1177/154405910208100606; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nelson P, 2003, TRENDS BIOCHEM SCI, V28, P534, DOI 10.1016/j.tibs.2003.08.005; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Wang M, 2011, OSTEOARTHR CARTILAGE, V19, P751, DOI 10.1016/j.joca.2011.03.004; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yamazaki M, 2009, J BIOL CHEM, V284, P35987, DOI 10.1074/jbc.M109.070540; Yin QY, 2010, J VIROL, V84, P6318, DOI 10.1128/JVI.00635-10; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	39	137	160	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7503	7511		10.1074/jbc.M111.292722	http://dx.doi.org/10.1074/jbc.M111.292722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22253433	hybrid, Green Published			2022-12-27	WOS:000301060200051
J	Santos, SD; Iuliano, O; Ribeiro, L; Veran, J; Ferreira, JS; Rio, P; Mulle, C; Duarte, CB; Carvalho, AL				Santos, Sandra D.; Iuliano, Olga; Ribeiro, Luis; Veran, Julien; Ferreira, Joana S.; Rio, Pedro; Mulle, Christophe; Duarte, Carlos B.; Carvalho, Ana Luisa			Contactin-associated Protein 1 (Caspr1) Regulates the Traffic and Synaptic Content of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA)-type Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA-RECEPTOR; CORNICHON PROTEINS; AUXILIARY SUBUNITS; SURFACE EXPRESSION; MYELINATED AXONS; PLASTICITY; REQUIRES; ORGANIZATION; PROTEOMICS; COMPLEX	Glutamate receptors of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type mediate fast excitatory synaptic transmission in the CNS. Synaptic strength is modulated by AMPA receptor binding partners, which regulate receptor synaptic targeting and functional properties. We identify Contactin-associated protein 1 (Caspr1) as an AMPA receptor interactor. Caspr1 is present in synapses and interacts with AMPA receptors in brain synaptic fractions. Coexpression of Caspr1 with GluA1 increases the amplitude of glutamate-evoked currents. Caspr1 overexpression in hippocampal neurons increases the number and size of synaptic GluA1 clusters, whereas knockdown of Caspr1 decreases the intensity of synaptic GluA1 clusters. Hence, Caspr1 is a regulator of the trafficking of AMPA receptors to synapses.	[Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, P-3004517 Coimbra, Portugal; [Santos, Sandra D.; Iuliano, Olga; Ribeiro, Luis; Ferreira, Joana S.; Rio, Pedro; Duarte, Carlos B.; Carvalho, Ana Luisa] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Veran, Julien; Mulle, Christophe] Univ Bordeaux, Inst Interdisciplinary Neurosci, CNRS UMR 5297, F-33000 Bordeaux, France	Universidade de Coimbra; Universidade de Coimbra; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Carvalho, AL (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Dept Life Sci, P-3004517 Coimbra, Portugal.	alc@cnc.uc.pt	Duarte, Carlos B/K-6358-2013; Ribeiro, Luís Filipe/U-3826-2017; Ferreira, Joana/AAY-8702-2020; Carvalho, Ana Luisa/K-6367-2013; Ferreira, Joana/I-9447-2014	Duarte, Carlos B/0000-0002-1474-0208; Ribeiro, Luís Filipe/0000-0003-1790-6848; Ferreira, Joana/0000-0002-1049-8063; Carvalho, Ana Luisa/0000-0001-8368-6666; Ferreira, Joana/0000-0002-1049-8063; Mulle, Christophe/0000-0003-2709-6615; Santos, Sandra/0000-0002-1871-3696	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/58955/2004, PTDC/BIA-BCM/71789/2006, PTDC/BIA-BCM/113738/2009)]; FCT [SFRH/BD/11826/2003, SFRH/BD/37522/2007, SFRH/BD/47879/2008]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) Grants POCI/SAU-NEU/58955/2004, PTDC/BIA-BCM/71789/2006, and PTDC/BIA-BCM/113738/2009) and FCT doctoral fellowships SFRH/BD/11826/2003 (to S. D. S.), SFRH/BD/37522/2007 (to J. S. F.), and SFRH/BD/47879/2008 (to L. R.).	Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barberis A, 2008, J NEUROSCI, V28, P6402, DOI 10.1523/JNEUROSCI.1204-08.2008; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Coleman SK, 2003, J NEUROSCI, V23, P798; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Horresh I, 2010, J NEUROSCI, V30, P2480, DOI 10.1523/JNEUROSCI.5225-09.2010; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178	31	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6868	6877		10.1074/jbc.M111.322909	http://dx.doi.org/10.1074/jbc.M111.322909			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22223644	hybrid, Green Published			2022-12-27	WOS:000300791800072
J	Aguirre, JD; Culotta, VC				Aguirre, J. Dafhne; Culotta, Valeria C.			Battles with Iron: Manganese in Oxidative Stress Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CONTAINING SUPEROXIDE DISMUTASES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; DEINOCOCCUS-RADIODURANS; RADIATION-RESISTANCE; HYDROGEN-PEROXIDE; LACTOBACILLUS-PLANTARUM; SIGNALING PATHWAYS; BACILLUS-SUBTILIS; PROTEIN OXIDATION	The redox-active metal manganese plays a key role in cellular adaptation to oxidative stress. As a cofactor for manganese superoxide dismutase or through formation of non-proteinaceous manganese antioxidants, this metal can combat oxidative damage without deleterious side effects of Fenton chemistry. In either case, the antioxidant properties of manganese are vulnerable to iron. Cellular pools of iron can outcompete manganese for binding to manganese superoxide dismutase, and through Fenton chemistry, iron may counteract the benefits of non-proteinaceous manganese antioxidants. In this minireview, we highlight ways in which cells maximize the efficacy of manganese as an antioxidant in the midst of pro-oxidant iron.	[Aguirre, J. Dafhne; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculotta@jhsph.edu		Aguirre, J. Dafhne/0000-0001-7056-9719	National Institutes of Health [R01 ES08996]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant R01 ES08996 (to V. C. C.). This is the fifth article in the Thematic Minireview Series on Metals in Biology 2012.	Al-Maghrebi M, 2002, ARCH BIOCHEM BIOPHYS, V402, P104, DOI 10.1016/S0003-9861(02)00065-6; Anderson ES, 2009, INFECT IMMUN, V77, P3466, DOI 10.1128/IAI.00444-09; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V215, P589, DOI 10.1016/0003-9861(82)90120-5; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; BEYER WF, 1991, J BIOL CHEM, V266, P303; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Cameroni E, 2004, CELL CYCLE, V3, P462; Cellier M, 1997, J LEUKOCYTE BIOL, V61, P96, DOI 10.1002/jlb.61.1.96; Champion OL, 2011, MICROBIOL-SGM, V157, P1115, DOI 10.1099/mic.0.045807-0; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2006, CLIN LAB MED, V26, P491, DOI 10.1016/j.cll.2006.03.009; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Geissdorfer W, 1997, GENE, V186, P305, DOI 10.1016/S0378-1119(96)00728-7; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Iranzo O, 2011, BIOORG CHEM, V39, P73, DOI 10.1016/j.bioorg.2011.02.001; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jackson TA, 2004, ACCOUNTS CHEM RES, V37, P461, DOI 10.1021/ar030272h; Kang Y, 2011, ACTA CRYSTALLOGR F, V67, P1173, DOI 10.1107/S1744309111029186; Kehl-Fie TE, 2011, CELL HOST MICROBE, V10, P158, DOI 10.1016/j.chom.2011.07.004; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Leclere V, 2001, MICROBIOL-SGM, V147, P3105, DOI 10.1099/00221287-147-11-3105; Leitch JM, 2009, J BIOL CHEM, V284, P24679, DOI 10.1074/jbc.R109.040410; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lin SJ, 1996, MOL CELL BIOL, V16, P6303; Lin YT, 2006, FREE RADICAL BIO MED, V40, P1185, DOI 10.1016/j.freeradbiomed.2005.11.007; Liochev SI, 2010, FREE RADICAL BIO MED, V48, P1565, DOI 10.1016/j.freeradbiomed.2010.02.036; Liu XF, 1997, J BIOL CHEM, V272, P11763, DOI 10.1074/jbc.272.18.11763; LIU XF, 1992, J BIOL CHEM, V267, P18298; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; MAY BP, 1989, J BIOL CHEM, V264, P12253; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Naranuntarat A, 2009, J BIOL CHEM, V284, P22633, DOI 10.1074/jbc.M109.026773; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; PRIVALLE CT, 1992, J BIOL CHEM, V267, P9140; Reddi AR, 2011, GENETICS, V189, P1261, DOI 10.1534/genetics.111.134007; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Robinson CK, 2011, J BACTERIOL, V193, P1653, DOI 10.1128/JB.01310-10; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Saenkham P, 2007, J BACTERIOL, V189, P8807, DOI 10.1128/JB.00960-07; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; Shirkey B, 2003, NUCLEIC ACIDS RES, V31, P2995, DOI 10.1093/nar/gkg404; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; Whittaker JW, 2003, BIOCHEM SOC T, V31, P1318; Whittaker MM, 2011, ARCH BIOCHEM BIOPHYS, V505, P213, DOI 10.1016/j.abb.2010.10.021; Whittaker MM, 2009, ARCH BIOCHEM BIOPHYS, V491, P69, DOI 10.1016/j.abb.2009.09.003; Whittaker MM, 2006, BIOPHYS J, V90, P598, DOI 10.1529/biophysj.105.071308; Whittaker MM, 1999, J BIOL CHEM, V274, P34751, DOI 10.1074/jbc.274.49.34751; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Yamakura F, 2007, FREE RADICAL BIO MED, V43, P423, DOI 10.1016/j.freeradbiomed.2007.04.024; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0	87	197	199	1	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13541	13548		10.1074/jbc.R111.312181	http://dx.doi.org/10.1074/jbc.R111.312181			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22247543	Green Published, hybrid			2022-12-27	WOS:000303996300006
J	Liu, SL; Premont, RT; Rockey, DC				Liu, Songling; Premont, Richard T.; Rockey, Don C.			G-protein-coupled Receptor Kinase Interactor-1 (GIT1) Is a New Endothelial Nitric-oxide Synthase (eNOS) Interactor with Functional Effects on Vascular Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; EPIDERMAL-GROWTH-FACTOR; PLASMALEMMAL CAVEOLAE; PHOSPHORYLATION SITES; PORTAL-HYPERTENSION; ANGIOTENSIN-II; IN-VIVO; TRANSLOCATION; CELLS; FAMILY	Endothelial cell nitric-oxide (NO) synthase (eNOS), the enzyme responsible for synthesis of NO in the vasculature, undergoes extensive post-translational modifications that modulate its activity. Here we have identified a novel eNOS interactor, G-protein-coupled receptor (GPCR) kinase interactor-1 (GIT1), which plays an unexpected role in GPCR stimulated NO signaling. GIT1 interacted with eNOS in the endothelial cell cytoplasm, and this robust association was associated with stimulatory eNOS phosphorylation (Ser(1177)), enzyme activation, and NO synthesis. GIT1 knockdown had the opposite effect. Additionally, GIT1 expression was reduced in sinusoidal endothelial cells after liver injury, consistent with previously described endothelial dysfunction in this disease. Re-expression of GIT1 after liver injury rescued the endothelial phenotype. These data emphasize the role of GPCR signaling partners in eNOS function and have fundamental implications for vascular disorders involving dysregulated eNOS.	[Liu, Songling; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Premont, Richard T.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC 27710 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	Rockey, DC (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	don.rockey@utsouthwestern.edu		Premont, Richard/0000-0002-8053-5026	National Institutes of Health [R01 DK 57830]; American Liver Fund Liver Scholar Award; Burroughs Welcome Fund Translational Scientist Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Fund Liver Scholar Award; Burroughs Welcome Fund Translational Scientist Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK 57830 (to D. C. R.).; Recipient of a American Liver Fund Liver Scholar Award.; Recipient of a Burroughs Welcome Fund Translational Scientist Award.	Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; BUSCONI L, 1993, J BIOL CHEM, V268, P8410; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Dessy C, 2000, EMBO J, V19, P4272, DOI 10.1093/emboj/19.16.4272; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Dulin NO, 1999, MOL CELL BIOL, V19, P714; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Figueroa XF, 2002, J PHYSIOL-LONDON, V544, P883, DOI 10.1113/jphysiol.2002.021972; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Govers R, 2002, J HISTOCHEM CYTOCHEM, V50, P779, DOI 10.1177/002215540205000604; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kim S, 2003, J BIOL CHEM, V278, P6291, DOI 10.1074/jbc.M212287200; Ko J, 2003, J NEUROSCI, V23, P1667; Lieu AS, 2006, J NEUROSURG, V105, P103, DOI 10.3171/jns.2006.105.1.103; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Liu SL, 2003, J BIOL CHEM, V278, P49929, DOI 10.1074/jbc.M306930200; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Manabe R, 2002, J CELL SCI, V115, P1497; Meyer MZ, 2006, J BIOL CHEM, V281, P7919, DOI 10.1074/jbc.M600081200; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Nambi P, 1997, MOL CELL BIOCHEM, V175, P29, DOI 10.1023/A:1006827007251; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; Pang JJ, 2011, J MOL CELL CARDIOL, V51, P769, DOI 10.1016/j.yjmcc.2011.06.020; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Pott C, 2006, AM J PHYSIOL-CELL PH, V290, pC1437, DOI 10.1152/ajpcell.00005.2005; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Saji M, 2005, BIOCHEM BIOPH RES CO, V332, P167, DOI 10.1016/j.bbrc.2005.04.109; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Shah V, 1999, GASTROENTEROLOGY, V117, P1222, DOI 10.1016/S0016-5085(99)70408-7; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Shikata Y, 2003, J APPL PHYSIOL, V94, P1193, DOI 10.1152/japplphysiol.00690.2002; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; XUE C, 1995, NEW ENGL J MED, V333, P1642; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Yu Q, 2002, AM J PHYSIOL-GASTR L, V282, pG565, DOI 10.1152/ajpgi.00512.2000; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	63	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12309	12320		10.1074/jbc.M111.320465	http://dx.doi.org/10.1074/jbc.M111.320465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22294688	Green Published, hybrid			2022-12-27	WOS:000302782200070
J	Almeida, AS; Queiroga, CSF; Sousa, MFQ; Alves, PM; Vieira, HLA				Almeida, Ana S.; Queiroga, Claudia S. F.; Sousa, Marcos F. Q.; Alves, Paula M.; Vieira, Helena L. A.			Carbon Monoxide Modulates Apoptosis by Reinforcing Oxidative Metabolism in Astrocytes ROLE OF Bcl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL RESPIRATORY-CHAIN; HEME OXYGENASE-1; THERAPEUTIC APPLICATIONS; CEREBRAL-ISCHEMIA; BRAIN; CELLS; BCL-2; RAT; BIOGENESIS	Modulation of cerebral cell metabolism for improving the outcome of hypoxia-ischemia and reperfusion is a strategy yet to be explored. Because carbon monoxide (CO) is known to prevent cerebral cell death; herein the role of CO in the modulation of astrocytic metabolism, in particular, at the level of mitochondria was investigated. Low concentrations of CO partially inhibited oxidative stress-induced apoptosis in astrocytes, by preventing caspase-3 activation, mitochondrial potential depolarization, and plasmatic membrane permeability. CO exposure enhanced intracellular ATP generation, which was accompanied by an increase on specific oxygen consumption, a decrease on lactate production, and a reduction of glucose use, indicating an improvement of oxidative phosphorylation. Accordingly, CO increased cytochrome c oxidase (COX) enzymatic specific activity and stimulated mitochondrial biogenesis. In astrocytes, COX interacts with Bcl-2, which was verified by immunoprecipitation; this interaction is superior after 24 h of CO treatment. Furthermore, CO enhanced Bcl-2 expression in astrocytes. By silencing Bcl-2 expression with siRNA transfection, CO effects in astrocytes were prevented, namely: (i) inhibition of apoptosis, (ii) increase on ATP generation, (iii) stimulation of COX activity, and (iv) mitochondrial biogenesis. Thus, Bcl-2 expression is crucial for CO modulation of oxidative metabolism and for conferring cytoprotection. In conclusion, CO protects astrocytes against oxidative stress-induced apoptosis by improving metabolism functioning, particularly mitochondrial oxidative phosphorylation.	[Almeida, Ana S.; Queiroga, Claudia S. F.; Sousa, Marcos F. Q.; Alves, Paula M.; Vieira, Helena L. A.] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal; [Queiroga, Claudia S. F.; Alves, Paula M.; Vieira, Helena L. A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Almeida, Ana S.; Queiroga, Claudia S. F.; Vieira, Helena L. A.] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr, P-1169056 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Vieira, HLA (corresponding author), Edificio Lab Associado Oeiras, Biol Cytoprotect Lab, Chron Dis Res Ctr, Campus IGC,Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	helena.vieira@fcm.unl.pt	Alves, Paula M/C-1070-2008; Vieira, Helena/AAZ-9562-2021	Alves, Paula M/0000-0003-1445-3556; Queiroga, Claudia/0000-0002-3984-9576; Vieira, Helena/0000-0001-9415-3742; Almeida, Ana Sofia/0000-0001-7654-9049	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/098747/2008]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/27125/2006, SFRH/BD/43387/2008]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia Project PTDC/SAU-NEU/098747/2008 and by Fellowships SFRH/BPD/27125/2006 (to H. L. A. V.) and SFRH/BD/43387/2008 (to C. S. F. Q.) from Fundacao para a Ciencia e a Tecnologia, Portugal.	Ahlstrom K, 2009, ACTA ANAESTH SCAND, V53, P1036, DOI 10.1111/j.1399-6576.2009.01992.x; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Atkinson B., 1987, BIOCH ENG FUNDAMENTA; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Chen ZX, 2007, CELL DEATH DIFFER, V14, P1617, DOI 10.1038/sj.cdd.4402165; Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Maranga L, 2006, BIOTECHNOL BIOENG, V94, P139, DOI 10.1002/bit.20890; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Panahian N, 1999, J NEUROCHEM, V72, P1187; Queiroga CSF, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-10; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Santos SS, 2005, J NEUROSCI RES, V79, P26, DOI 10.1002/jnr.20279; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Tsui TY, 2007, SHOCK, V27, P165, DOI 10.1097/01.shk.0000239781.71516.61; Tsui TY, 2005, BIOCHEM BIOPH RES CO, V336, P898, DOI 10.1016/j.bbrc.2005.08.187; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	78	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10761	10770		10.1074/jbc.M111.306738	http://dx.doi.org/10.1074/jbc.M111.306738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334654	Green Published, hybrid			2022-12-27	WOS:000302780100005
J	Shilling, D; Mak, DOD; Kang, DE; Foskett, JK				Shilling, Dustin; Mak, Don-On Daniel; Kang, David E.; Foskett, J. Kevin			Lack of Evidence for Presenilins as Endoplasmic Reticulum Ca2+ Leak Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CALCIUM-RELEASE; ALZHEIMERS-DISEASE; FIBROBLASTS; HOMEOSTASIS; MUTATIONS; RESPONSES; ACCUMULATION; HIPPOCAMPAL; TURNOVER; TOPOLOGY	Familial Alzheimer disease (FAD) is linked to mutations in the presenilin (PS) homologs. FAD mutant PS expression has several cellular consequences, including exaggerated intracellular Ca2+ ([Ca2+](i)) signaling due to enhanced agonist sensitivity and increased magnitude of [Ca2+](i) signals. The mechanisms underlying these phenomena remain controversial. It has been proposed that PSs are constitutively active, passive endoplasmic reticulum (ER) Ca2+ leak channels and that FAD PS mutations disrupt this function resulting in ER store overfilling that increases the driving force for release upon ER Ca2+ release channel opening. To investigate this hypothesis, we employed multiple Ca2+ imaging protocols and indicators to directly measure ER Ca2+ dynamics in several cell systems. However, we did not observe consistent evidence that PSs act as ER Ca2+ leak channels. Nevertheless, we confirmed observations made using indirect measurements employed in previous reports that proposed this hypothesis. Specifically, cells lacking PS or expressing a FAD-linked PS mutation displayed increased area under the ionomycin-induced [Ca2+](i) versus time curve (AI) compared with cells expressing WT PS. However, an ER-targeted Ca2+ indicator revealed that this did not reflect overloaded ER stores. Monensin pretreatment selectively attenuated the AI in cells lacking PS or expressing a FAD PS allele. These findings contradict the hypothesis that PSs form ER Ca2+ leak channels and highlight the need to use ER-targeted Ca2+ indicators when studying ER Ca2+ dynamics.	[Shilling, Dustin; Mak, Don-On Daniel; Foskett, J. Kevin] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, B39 Anat Chem Bldg, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Kang, David E./E-5234-2012	Foskett, J. Kevin/0000-0002-8854-0268; Kang, David E./0000-0002-7132-821X	National Institutes of Health [R01 MH059937, R01 GM056328]; NIA, National Institutes of Health [F31 AG038240]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH059937 and R01 GM056328 (to J. K. F.).; Supported by a NIA, National Institutes of Health Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows Grant F31 AG038240.	Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Brunello L, 2009, J CELL MOL MED, V13, P3358, DOI 10.1111/j.1582-4934.2009.00755.x; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fassler M, 2010, TRAFFIC, V11, P250, DOI 10.1111/j.1600-0854.2009.01014.x; Gandy S, 2006, NAT MED, V12, P1121, DOI 10.1038/nm1006-1121; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hirashima N, 1996, NEUROBIOL AGING, V17, P549; ITO E, 1994, P NATL ACAD SCI USA, V91, P534, DOI 10.1073/pnas.91.2.534; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lissandron V, 2010, P NATL ACAD SCI USA, V107, P9198, DOI 10.1073/pnas.1004702107; LIU CM, 1978, J BIOL CHEM, V253, P5892; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; McCombs JE, 2010, MOL BIOSYST, V6, P1640, DOI 10.1039/c001975e; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nelson O, 2011, J BIOL CHEM, V286, P22339, DOI 10.1074/jbc.M111.243063; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Smith IF, 2005, J NEUROCHEM, V94, P1711, DOI 10.1111/j.1471-4159.2005.03332.x; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2006, NAT NEUROSCI, V9, P1354, DOI 10.1038/nn1106-1354; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Zatti G, 2004, NEUROBIOL DIS, V15, P269, DOI 10.1016/j.nbd.2003.11.002; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010	46	72	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10933	10944		10.1074/jbc.M111.300491	http://dx.doi.org/10.1074/jbc.M111.300491			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311977	Green Published, hybrid			2022-12-27	WOS:000302780100022
J	Wang, RR; Li, Q; Helfer, CM; Jiao, J; You, JX				Wang, Ranran; Li, Qing; Helfer, Christine M.; Jiao, Jing; You, Jianxin			Bromodomain Protein Brd4 Associated with Acetylated Chromatin Is Important for Maintenance of Higher-order Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST MITOTIC CHROMOSOMES; P-TEFB; GENE-EXPRESSION; S-PHASE; TRANSCRIPTION; INTERACTS; FIBER; PROGRESSION; CELLS; RECOGNITION	Chromatin structure organization is crucial for regulating many fundamental cellular processes. However, the molecular mechanism that regulates the assembly of higher-order chromatin structure remains poorly understood. In this study, we demonstrate that Brd4 (bromodomain-containing protein 4) protein participates in the maintenance of the higher-order chromatin structure. Brd4, a member of the BET family of proteins, has been shown to play important roles in cellular growth control, cell cycle progression, and cancer development. We apply in situ single cell chromatin imaging and micrococcal nuclease (MNase) assay to show that Brd4 depletion leads to a large scale chromatin unfolding. Adominant-negative inhibitor encoding the double bromodomains (BDI/II) of Brd4 can competitively dissociate endogenous Brd4 from chromatin to trigger severely fragmented chromatin morphology. Mechanistic studies using Brd4 truncation mutants reveal that the Brd4 C-terminal domain is crucial for maintaining normal chromatin structure. Using bimolecular fluorescence complementation technology, we demonstrate that Brd4 molecules interact intermolecularly on chromatin and that replacing Brd4 molecules by BDI/II causes abnormal nucleosome aggregation and chromatin fragmentation. These studies establish a novel structural role of Brd4 in supporting the higher chromatin architecture.	[Wang, Ranran; Li, Qing; Helfer, Christine M.; Jiao, Jing; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	National Institutes of Health from the NCI [R01CA148768, R01CA142723]; China Scholarship Council [2007-3079]; NATIONAL CANCER INSTITUTE [R01CA142723, R01CA148768] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768 and R01CA142723 from the NCI (to J. Y.) and a fellowship from the China Scholarship Council (2007-3079) (to Q. L.).	Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Davis PK, 2003, CANCER BIOL THER, V2, P22; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Filetici P, 2001, FRONT BIOSCI-LANDMRK, V6, pD866, DOI 10.2741/Filetici; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gelato KA, 2008, BIOL CHEM, V389, P353, DOI 10.1515/BC.2008.048; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Mohd-Sarip A, 2004, SCIENCE, V306, P1484, DOI 10.1126/science.1106767; Morales V, 2001, BIOCHIMIE, V83, P1029, DOI 10.1016/S0300-9084(01)01347-5; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	39	90	107	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10738	10752		10.1074/jbc.M111.323493	http://dx.doi.org/10.1074/jbc.M111.323493			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334664	Green Published, hybrid			2022-12-27	WOS:000302780100003
J	Xu, XQ; Francischetti, IMB; Lai, R; Ribeiro, JMC; Andersen, JF				Xu, Xueqing; Francischetti, Ivo M. B.; Lai, Ren; Ribeiro, Jose M. C.; Andersen, John F.			Structure of Protein Having Inhibitory Disintegrin and Leukotriene Scavenging Functions Contained in Single Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINE-BINDING PROTEIN; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; IIB-IIIA; VENOM; RECOGNITION; FIBRINOGEN; INTEGRINS; SALIVA; ALPHA-V-BETA-3	The antihemostatic/antiangiogenic protein tablysin-15 is a member of the CAP (cysteine-rich secretory, antigen 5, and pathogenesis-related 1 protein) superfamily and has been shown to bind the integrins alpha(IIb)beta(3) and alpha(V)beta(3) by means of an Arg-Gly-Asp (RGD) tripeptide sequence. Here we describe the x-ray crystal structure of tablysin-15 and show that the RGD motif is located in a novel structural context. The motif itself is contained in a type II beta-turn structure that is similar in its conformation to the RGD sequence of the cyclic pentapeptide cilengitide when bound to integrin alpha V beta 3. The CAP domain also contains a hydrophobic channel that appears to bind a fatty acid molecule in the crystal structure after purification from Escherichia coli. After delipidation of the protein, tablysin-15 was found to bind proinflammatory cysteinyl leukotrienes with sub-micromolar affinities. The structure of the leukotriene E-4-tablysin-15 complex shows that the ligand binds with the nonfunctionalized end of the fatty acid chain buried in the hydrophobic pocket, whereas the carboxylate end of the ligand binds forms hydrogen bond/salt bridge interactions with polar side chains at the channel entrance. Therefore, tablysin-15 functions as an inhibitor of integrin function and as an anti-inflammatory scavenger of eicosanoids.	[Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Xu, Xueqing; Francischetti, Ivo M. B.; Ribeiro, Jose M. C.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; Kunming Institute of Zoology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lai, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 6550223, Yunnan, Peoples R China.	lairen72@yahoo.com.cn; jandersen@niaid.nih.gov	Ribeiro, Jose/J-7011-2015	Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health of NIAID; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	National Institutes of Health of NIAID; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health intramural research program of NIAID. This work was also supported in part by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Asojo OA, 2011, ACTA CRYSTALLOGR D, V67, P847, DOI [10.1107/S0907444911028198, 10.1107/S0907444911028198847]; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Fujii Y, 2003, J MOL BIOL, V332, P1115, DOI 10.1016/S0022-2836(03)00991-4; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma DY, 2011, THROMB HAEMOSTASIS, V105, P1032, DOI 10.1160/TH11-01-0029; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Padavattan S, 2008, J MOL BIOL, V383, P178, DOI 10.1016/j.jmb.2008.08.023; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; SMITH JW, 1990, J BIOL CHEM, V265, P12267; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Wermelinger LS, 2009, ARCH BIOCHEM BIOPHYS, V482, P25, DOI 10.1016/j.abb.2008.11.023; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu XQ, 2011, J BIOL CHEM, V286, P32383, DOI 10.1074/jbc.M111.268904	42	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10967	10976		10.1074/jbc.M112.340471	http://dx.doi.org/10.1074/jbc.M112.340471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22311975	hybrid, Green Published			2022-12-27	WOS:000302780100025
J	Yin, HQ; Hu, M; Zhang, R; Shen, Z; Flatow, L; You, M				Yin, Huquan; Hu, Ming; Zhang, Ray; Shen, Zheng; Flatow, Laura; You, Min			MicroRNA-217 Promotes Ethanol-induced Fat Accumulation in Hepatocytes by Down-regulating SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; ACTIVATED PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; MAMMALIAN SIRTUIN-1; PROTECTIVE ACTION; LIPID-METABOLISM; EXPRESSION; MICE; INVOLVEMENT; MACROPHAGES	Ethanol-mediated inhibition of hepatic sirtuin 1 (SIRT1) plays a crucial role in the pathogenesis of alcoholic fatty liver disease. Here, we investigated the underlying mechanisms of this inhibition by identifying a new hepatic target of ethanol action, microRNA-217 (miR-217). The role of miR-217 in the regulation of the effects of ethanol was investigated in cultured mouse AML-12 hepatocytes and in the livers of chronically ethanol-fed mice. In AML-12 hepatocytes and in mouse livers, chronic ethanol exposure drastically and specifically induced miR-217 levels and caused excess fat accumulation. Further studies revealed that overexpression of miR-217 in AML-12 cells promoted ethanol-mediated impairments of SIRT1 and SIRT1-regulated genes encoding lipogenic or fatty acid oxidation enzymes. More importantly, miR-217 impairs functions of lipin-1, a vital lipid regulator, in hepatocytes. Taken together, our novel findings suggest that miR-217 is a specific target of ethanol action in the liver and may present as a potential therapeutic target for treating human alcoholic fatty liver disease.	Univ S Florida, Hlth Sci Ctr, Dept Mol Pharmacol, Tampa, FL 33612 USA; Univ S Florida, Hlth Sci Ctr, Dept Physiol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	You, M (corresponding author), Univ S Florida, Coll Med, Sch Basic Biomed Sci, Dept Mol Pharmacol & Physiol, Box 8,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	myou@health.usf.edu	You, Min/I-4973-2012	You, Min/0000-0003-1977-3479	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse [AA-015951, AA-013623]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015951, R01AA013623] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health, National Institute on Alcoholism and Alcohol Abuse, Grants AA-015951 and AA-013623 (to M.Y.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Beckman JD, 2011, J BIOL CHEM, V286, P3194, DOI 10.1074/jbc.M110.148726; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park PH, 2005, AM J PHYSIOL-GASTR L, V289, pG1124, DOI 10.1152/ajpgi.00091.2005; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	39	118	127	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9817	9826		10.1074/jbc.M111.333534	http://dx.doi.org/10.1074/jbc.M111.333534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22308024	Green Published, hybrid			2022-12-27	WOS:000302167200014
J	Soga, N; Kinosita, K; Yoshida, M; Suzuki, T				Soga, Naoki; Kinosita, Kazuhiko, Jr.; Yoshida, Masasuke; Suzuki, Toshiharu			Kinetic Equivalence of Transmembrane pH and Electrical Potential Differences in ATP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON TRANSPORT; DELTA-PSI; ESCHERICHIA-COLI; EPSILON-SUBUNIT; H+/ATP RATIO; C-RING; SYNTHASE; DRIVEN; PHOSPHORYLATION; HYDROLYSIS	ATP synthase is the key player of Mitchell's chemiosmotic theory, converting the energy of transmembrane proton flow into the high energy bond between ADP and phosphate. The proton motive force that drives this reaction consists of two components, the pH difference (Delta pH) across the membrane and transmembrane electrical potential (Delta psi). The two are considered thermodynamically equivalent, but kinetic equivalence in the actual ATP synthesis is not warranted, and previous experimental results vary. Here, we show that with the thermophilic Bacillus PS3 ATP synthase that lacks an inhibitory domain of the epsilon subunit, Delta pH imposed by acid-base transition and Delta psi produced by valinomycin-mediated K+ diffusion potential contribute equally to the rate of ATP synthesis within the experimental range examined (Delta pH -0.3 to 2.2, Delta psi -30 to 140 mV, pH around the catalytic domain 8.0). Either Delta pH or Delta psi alone can drive synthesis, even when the other slightly opposes. Delta psi was estimated from the Nernst equation, which appeared valid down to 1 mM K+ inside the proteoliposomes, due to careful removal of K+ from the lipid.	[Soga, Naoki; Kinosita, Kazuhiko, Jr.] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Yoshida, Masasuke; Suzuki, Toshiharu] Japan Sci & Technol Agcy, Int Cooperat Res Project ICORP, ATP Synth Regulat Project, Koto Ku, Tokyo 1350064, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan	Waseda University; Japan Science & Technology Agency (JST); Kyoto Sangyo University	Kinosita, K (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	kazuhiko@waseda.jp			Japan Society for the Promotion of Science; Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21000011] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Specially Promoted Research by the Japan Society for the Promotion of Science (to K. K.), in part by the ATP Synthesis Regulation Project by the Japan Science and Technology Agency (to M. Y.), and in part by a research fellowship from the Japan Society for the Promotion of Science (to N. S.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2010, SPRINGER SER CHEM PH, V96, P271, DOI 10.1007/978-3-642-02597-6_14; BLOK MC, 1974, BIOCHIM BIOPHYS ACTA, V367, P210, DOI 10.1016/0005-2736(74)90044-3; BOKRANZ M, 1985, BIOCHIM BIOPHYS ACTA, V810, P332, DOI 10.1016/0005-2728(85)90218-X; Borsch M, 2005, BIOCHEM SOC T, V33, P878; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cook GM, 2000, EXTREMOPHILES, V4, P279, DOI 10.1007/s007920070014; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; Forster K, 2010, BBA-BIOENERGETICS, V1797, P1828, DOI 10.1016/j.bbabio.2010.07.013; HANGARTER RP, 1982, BIOCHIM BIOPHYS ACTA, V681, P397, DOI 10.1016/0005-2728(82)90181-5; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; JUNESCH U, 1991, FEBS LETT, V294, P275, DOI 10.1016/0014-5793(91)81447-G; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Kaim G, 1999, EMBO J, V18, P4118, DOI 10.1093/emboj/18.15.4118; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Onoue Y, 2009, BBA-BIOMEMBRANES, V1788, P1332, DOI 10.1016/j.bbamem.2009.01.015; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; ROSING J, 1972, BIOCHIM BIOPHYS ACTA, V267, P275, DOI 10.1016/0005-2728(72)90116-8; SLOOTEN L, 1989, BIOCHIM BIOPHYS ACTA, V976, P150, DOI 10.1016/S0005-2728(89)80224-5; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Steigmiller S, 2008, P NATL ACAD SCI USA, V105, P3745, DOI 10.1073/pnas.0708356105; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2011, J BIOL CHEM, V286, P16807, DOI 10.1074/jbc.M110.209965; TURINA P, 1994, BIOELECTROCH BIOENER, V33, P31, DOI 10.1016/0302-4598(94)87030-6; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	40	29	31	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9633	9639		10.1074/jbc.M111.335356	http://dx.doi.org/10.1074/jbc.M111.335356			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22253434	Green Published, hybrid			2022-12-27	WOS:000301797800094
J	Anderson, DD; Woeller, CF; Chiang, EP; Shane, B; Stover, PJ				Anderson, Donald D.; Woeller, Collynn F.; Chiang, En-Pei; Shane, Barry; Stover, Patrick J.			Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS PATHWAY; MULTIENZYME COMPLEX; COMPARTMENTALIZATION; MITOCHONDRIAL; DISRUPTION; SYNTHASE; PROTEIN; CLONING; CANCER; PHASE	The de novo thymidylate biosynthetic pathway in mammalian cells translocates to the nucleus for DNA replication and repair and consists of the enzymes serine hydroxymethyltransferase 1 and 2 alpha (SHMT1 and SHMT2 alpha), thymidylate synthase, and dihydrofolate reductase. In this study, we demonstrate that this pathway forms a multienzyme complex that is associated with the nuclear lamina. SHMT1 or SHMT2 alpha is required for co-localization of dihydrofolate reductase, SHMT, and thymidylate synthase to the nuclear lamina, indicating that SHMT serves as scaffold protein that is essential for complex formation. The metabolic complex is enriched at sites of DNA replication initiation and associated with proliferating cell nuclear antigen and other components of the DNA replication machinery. These data provide a mechanism for previous studies demonstrating that SHMT expression is rate-limiting for de novo thymidylate synthesis and indicate that de novo thymidylate biosynthesis occurs at replication forks.	[Woeller, Collynn F.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Anderson, Donald D.; Woeller, Collynn F.; Chiang, En-Pei; Stover, Patrick J.] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Chiang, En-Pei] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chiang, En-Pei; Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Cornell University; Cornell University; National Chung Hsing University; University of California System; University of California Berkeley	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu	Chiang, EnPei/K-1694-2013; Woeller, Collynn/U-3877-2019	Chiang, EnPei/0000-0002-0158-0962; Woeller, Collynn/0000-0001-7197-5057	National Institutes of Health [DK58144, HD059120]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58144 and HD059120 (to P. J. S.).	Abdel-Aziz W, 2003, CRIT REV ONCOL HEMAT, V48, P19, DOI 10.1016/S1040-8428(03)00096-9; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Beaudin AE, 2011, AM J CLIN NUTR, V93, P789, DOI 10.3945/ajcn.110.002766; Bekesi A, 2007, BIOCHEM BIOPH RES CO, V355, P643, DOI 10.1016/j.bbrc.2007.01.196; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; DEUTSCH WA, 1982, J BIOL CHEM, V257, P3366; Field Martha S., 2011, Frontiers in Genetics, V2, P36, DOI 10.3389/fgene.2011.00036; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luka Z, 2011, BIOCHEMISTRY-US, V50, P4750, DOI 10.1021/bi200247b; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2011, J BIOL CHEM, V286, P44015, DOI 10.1074/jbc.M111.307629; MacFarlane AJ, 2011, CANCER RES, V71, P2098, DOI 10.1158/0008-5472.CAN-10-1886; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Samsonoff WA, 1997, J BIOL CHEM, V272, P13281, DOI 10.1074/jbc.272.20.13281; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Zanetti KA, 2003, J BIOL CHEM, V278, P10142, DOI 10.1074/jbc.M211569200	43	88	89	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7051	7062		10.1074/jbc.M111.333120	http://dx.doi.org/10.1074/jbc.M111.333120			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22235121	Green Published, hybrid			2022-12-27	WOS:000301060200010
J	Barnes, J; Warejcka, D; Simpliciano, J; Twining, S; Steet, R				Barnes, Jarrod; Warejcka, Debra; Simpliciano, Jennifer; Twining, Sally; Steet, Richard			Latency-associated Peptide of Transforming Growth Factor-beta 1 Is Not Subject to Physiological Mannose Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; GROWTH-FACTOR-BETA; LEUKEMIA INHIBITORY FACTOR; TGF-BETA; 6-PHOSPHATE RECEPTORS; PROCATHEPSIN-D; ACTIVATION; ENZYME; PRECURSOR; THROMBOSPONDIN-1	Latent TGF-beta 1 was one of the first non-lysosomal glycoproteins reported to bear mannose 6-phosphate (Man-6-P) residues on its N-glycans. Prior studies have suggested that this sugar modification regulates the activation of latent TGF-beta 1 by allowing it to bind cell surface-localized Man-6-P receptors. Man-6-P has also been proposed as an anti-scarring therapy based on its ability to directly block the activation of latent TGF-beta 1. A complete understanding of the physiological relevance of latent TGF-beta 1 mannose phosphorylation, however, is still lacking. Here we investigate the degree of mannose phosphorylation on secreted latent TGF-beta 1 and examine its Man-6-P-dependent activation in primary human corneal stromal fibroblasts. Contrary to earlier reports, minimal to no Man-6-P modification was found on secreted and cell-associated latent TGF-beta 1 produced from multiple primary and transformed cell types. Results showed that the inability to detect Man-6-P residues was not due to masking by the latent TGF-beta 1-binding protein (LTBP). Moreover, the efficient processing of glycans on latent TGF-beta 1 to complex type structures was consistent with the lack of mannose phosphorylation during biosynthesis. We further demonstrated that the conversion of corneal stromal fibroblast to myofibroblasts, a well known TGF-beta 1-dependent process, was not altered by Man-6-P addition when latent forms of this growth factor were present. Collectively, these findings indicate that Man-6P- dependent effects on latent TGF-beta 1 activation are not mediated by direct modification of its latency-associated peptide.	[Barnes, Jarrod; Simpliciano, Jennifer; Steet, Richard] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Warejcka, Debra; Twining, Sally] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53202 USA	University System of Georgia; University of Georgia; Medical College of Wisconsin	Steet, R (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rsteet@ccrc.uga.edu	Barnes, Jarrod/V-6127-2019	Barnes, Jarrod/0000-0002-1027-6591	National Institutes of Health, NIGMS [1R01GM086524-01]; National Institutes of Health, NEI [1 R01 EY012731-07]; Cousins Foundation; NATIONAL EYE INSTITUTE [R01EY012731, R01EY021152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086524] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cousins Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant 1R01GM086524-01 (to R. S.) and National Institutes of Health, NEI, Grant 1 R01 EY012731-07 (to S. S. T.). This work was also supported by a graduate fellowship from the Cousins Foundation (to J. B.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Angunawela RI, 2010, J CATARACT REFR SURG, V36, P121, DOI 10.1016/j.jcrs.2009.07.042; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Barnes J, 2011, J BIOL CHEM, V286, P24855, DOI 10.1074/jbc.M111.221432; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Blanchard F, 1998, J BIOL CHEM, V273, P20886, DOI 10.1074/jbc.273.33.20886; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; FAUST PL, 1987, J CELL BIOL, V105, P1947, DOI 10.1083/jcb.105.5.1947; Flaumenhaft R, 1993, Adv Pharmacol, V24, P51, DOI 10.1016/S1054-3589(08)60933-3; FLAUMENHAFT R, 1992, J CELL BIOL, V118, P901, DOI 10.1083/jcb.118.4.901; Ghahary A, 1999, EXP CELL RES, V251, P111, DOI 10.1006/excr.1999.4561; Ghahary A, 2000, GROWTH FACTORS, V17, P167, DOI 10.3109/08977190009001066; Ghahary A, 1999, J CELL PHYSIOL, V180, P61, DOI 10.1002/(SICI)1097-4652(199907)180:1<61::AID-JCP7>3.0.CO;2-R; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Ikushima H, 2000, P NATL ACAD SCI USA, V97, P8439, DOI 10.1073/pnas.97.15.8439; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KOVACINA KS, 1989, BIOCHEM BIOPH RES CO, V160, P393, DOI 10.1016/0006-291X(89)91669-0; Kreiling JL, 2003, J BIOL CHEM, V278, P20628, DOI 10.1074/jbc.M302249200; LEE SJ, 1988, J BIOL CHEM, V263, P3521; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; MIYAZONO K, 1992, J BIOL CHEM, V267, P5668; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; ODEKON LE, 1994, J CELL PHYSIOL, V158, P398, DOI 10.1002/jcp.1041580303; PURCHIO AF, 1988, J BIOL CHEM, V263, P14211; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Sutton G., 1996, LASERS LIGHT OPHTHAL, V6, P117; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Xia Chang-suo, 2010, Orthopedics, V33, P727, DOI 10.3928/01477447-20100826-06; Xia Changsuo, 2011, Orthopedics, V34, P21, DOI 10.3928/01477447-20101123-09; Yang LJ, 2000, WOUND REPAIR REGEN, V8, P538, DOI 10.1046/j.1524-475x.2000.00538.x; Yang Ruixiang, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P64	47	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7526	7534		10.1074/jbc.M111.308825	http://dx.doi.org/10.1074/jbc.M111.308825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262853	Green Published, hybrid			2022-12-27	WOS:000301060200053
J	Brodie, KM; Henderson, BR				Brodie, Kirsty M.; Henderson, Beric R.			Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome A ROLE FOR THE NUCLEAR EXPORT SIGNAL, CRM1, AND AURORA A KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR AMPLIFIED KINASE; GAMMA-TUBULIN-BINDING; E3 LIGASE ACTIVITY; BREAST-CANCER; CELL-CYCLE; UBIQUITIN LIGASE; MICROTUBULE NUCLEATION; MITOTIC SPINDLE; BRCA1-DEPENDENT UBIQUITINATION; GENETIC INSTABILITY	BRCA1 is a DNA damage response protein and functions in the nucleus to stimulate DNA repair and at the centrosome to inhibit centrosome overduplication in response to DNA damage. The loss or mutation of BRCA1 causes centrosome amplification and abnormal mitotic spindle assembly in breast cancer cells. The BRCA1-BARD1 heterodimer binds and ubiquitinates gamma-tubulin to inhibit centrosome amplification and promote microtubule nucleation; however regulation of BRCA1 targeting and function at the centrosome is poorly understood. Here we show that both N and C termini of BRCA1 are required for its centrosomal localization and that BRCA1 moves to the centrosome independently of BARD1 and gamma-tubulin. Mutations in the C-terminal phosphoprotein-binding BRCT domain of BRCA1 prevented localization to centrosomes. Photobleaching experiments identified dynamic (60%) and immobilized (40%) pools of ectopic BRCA1 at the centrosome, and these are regulated by the nuclear export receptor CRM1 (chromosome region maintenance 1) and BARD1. CRM1 mediates nuclear export of BRCA1, and mutation of the export sequence blocked BRCA1 regulation of centrosome amplification in irradiated cells. CRM1 binds to undimerized BRCA1 and is displaced by BARD1. Photobleaching assays implicate CRM1 in driving undimerized BRCA1 to the centrosome and revealed that when BRCA1 subsequently binds to BARD1, it is less well retained at centrosomes, suggesting a mechanism to accelerate BRCA1 release after formation of the active heterodimer. Moreover, Aurora A binding and phosphorylation of BRCA1 enhanced its centrosomal retention and regulation of centrosome amplification. Thus, CRM1, BARD1 and Aurora A promote the targeting and function of BRCA1 at centrosomes.	[Brodie, Kirsty M.; Henderson, Beric R.] Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Millennium Inst, Westmead Hosp, Westmead Inst Canc Res, Darcy Rd,POB 412, Westmead, NSW 2145, Australia.	beric.henderson@sydney.edu.au			Australian Research Council; National Health and Medical Research Council (NHMRC); Cancer Council of New South Wales	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of New South Wales(Cancer Council New South Wales)	This study was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC) and the Cancer Council of New South Wales.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Au WWY, 2005, J BIOL CHEM, V280, P6993, DOI 10.1074/jbc.M408879200; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Brodie KM, 2012, CELL SIGNAL, V24, P451, DOI 10.1016/j.cellsig.2011.09.024; Brodie KM, 2010, CELL SIGNAL, V22, P291, DOI 10.1016/j.cellsig.2009.09.034; Budhu AS, 2005, CELL CYCLE, V4, P1510, DOI 10.4161/cc.4.11.2187; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Deng CX, 2001, MUTAT RES-FUND MOL M, V477, P183, DOI 10.1016/S0027-5107(01)00119-1; EASTON DF, 1995, AM J HUM GENET, V56, P265; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Gillingham AK, 2000, EMBO REP, V1, P524; Gopalan G, 1997, J CELL BIOL, V138, P643, DOI 10.1083/jcb.138.3.643; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Han X, 2008, ONCOGENE, V27, P2969, DOI 10.1038/sj.onc.1210968; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Hsu LC, 2001, CANCER RES, V61, P7713; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Levy-Lahad E, 2007, BRIT J CANCER, V96, P11, DOI 10.1038/sj.bjc.6603535; Liu QY, 2009, BIOCHEM BIOPH RES CO, V384, P383, DOI 10.1016/j.bbrc.2009.04.154; Lotti LV, 2002, GENE CHROMOSOME CANC, V35, P193, DOI 10.1002/gcc.10105; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Ouchi T, 2006, CANCER BIOL THER, V5, P470, DOI 10.4161/cbt.5.5.2845; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Pascreau G, 2010, P NATL ACAD SCI USA, V107, P2932, DOI 10.1073/pnas.0914874107; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Roghi C, 1998, J CELL SCI, V111, P557; Saladino C, 2009, ENVIRON MOL MUTAGEN, V50, P725, DOI 10.1002/em.20477; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Schlegel BP, 2003, ONCOGENE, V22, P983, DOI 10.1038/sj.onc.1206195; Schuchner S, 2005, J BIOL CHEM, V280, P8855, DOI 10.1074/jbc.M413741200; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Shimomura A, 2009, J CANCER RES CLIN, V135, P421, DOI 10.1007/s00432-008-0472-5; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Stenoien DL, 2003, CELL MOTIL CYTOSKEL, V55, P134, DOI 10.1002/cm.10120; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Thomson TM, 2010, BIOCHEM SOC T, V38, P116, DOI 10.1042/BST0380116; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	68	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7701	7716		10.1074/jbc.M111.327296	http://dx.doi.org/10.1074/jbc.M111.327296			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262852	Green Published, hybrid			2022-12-27	WOS:000301060200069
J	Courtemanche, N; Pollard, TD				Courtemanche, Naomi; Pollard, Thomas D.			Determinants of Formin Homology 1 (FH1) Domain Function in Actin Filament Elongation by Formins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; PROCESSIVE ELONGATION; CAPPING PROTEIN; PROFILIN; NUCLEATION; COMPLEX; POLYMERIZATION; CYTOKINESIS; MECHANISM; REQUIREMENTS	Formin-mediated elongation of actin filaments proceeds via association of Formin Homology 2 (FH2) domain dimers with the barbed end of the filament, allowing subunit addition while remaining processively attached to the end. The flexible Formin Homology 1 (FH1) domain, located directly N-terminal to the FH2 domain, contains one or more stretches of polyproline that bind the actin-binding protein profilin. Diffusion of FH1 domains brings associated profilin-actin complexes into contact with the FH2-bound barbed end of the filament, thereby enabling direct transfer of actin. We investigated how the organization of the FH1 domain of budding yeast formin Bni1p determines the rates of profilin-actin transfer onto the end of the filament. Each FH1 domain transfers actin to the barbed end independently of the other and structural evidence suggests a preference for actin delivery from each FH1 domain to the closest long-pitch helix of the filament. The transfer reaction is diffusion-limited and influenced by the affinities of the FH1 polyproline tracks for profilin. Position-specific sequence variations optimize the efficiency of FH1-stimulated polymerization by binding profilin weakly near the FH2 domain and binding profilin more strongly farther away. FH1 domains of many other formins follow this organizational trend. This particular sequence architecture may optimize the efficiency of FH1-stimulated elongation.	[Courtemanche, Naomi; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, KBT 548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			National Institutes of Health [GM-026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM-026338.	Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, NAT CELL BIOL, V6, P1158, DOI 10.1038/ncb1204-1158; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Nolen BJ, 2008, J BIOL CHEM, V283, P26490, DOI 10.1074/jbc.M802607200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Paul AS, 2009, J BIOL CHEM, V284, P12533, DOI 10.1074/jbc.M808587200; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RONISH EW, 1974, BIOPOLYMERS, V13, P1635, DOI 10.1002/bip.1974.360130810; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7	31	49	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7812	7820		10.1074/jbc.M111.322958	http://dx.doi.org/10.1074/jbc.M111.322958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22247555	Green Published, hybrid			2022-12-27	WOS:000301060200079
J	Lin, JLJ; Nakagawa, A; Lin, CL; Hsiao, YY; Yang, WZ; Wang, YT; Doudeva, LG; Skeen-Gaar, RR; Xue, D; Yuan, HNS				Lin, Jason L. J.; Nakagawa, Akihisa; Lin, Chia Liang; Hsiao, Yu-Yuan; Yang, Wei-Zen; Wang, Yi-Ting; Doudeva, Lyudmila G.; Skeen-Gaar, Riley Robert; Xue, Ding; Yuan, Hanna S.			Structural Insights into Apoptotic DNA Degradation by CED-3 Protease Suppressor-6 (CPS-6) from Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ENDONUCLEASE-G; CRYSTAL-STRUCTURE; BINDING; NUCLEASE; MECHANISM; CLEAVAGE; ENDOG; HOMOLOG; VII	Endonuclease G (EndoG) is a mitochondrial protein that traverses to the nucleus and participates in chromosomal DNA degradation during apoptosis in yeast, worms, flies, and mammals. However, it remains unclear how EndoG binds and digests DNA. Here we show that the Caenorhabditis elegans CPS-6, a homolog of EndoG, is a homodimeric Mg2+-dependent nuclease, binding preferentially to G-tract DNA in the optimum low salt buffer at pH7. The crystal structure of CPS-6 was determined at 1.8 angstrom resolution, revealing a mixed alpha beta topology with the two beta beta alpha-metal finger nuclease motifs located distantly at the two sides of the dimeric enzyme. A structural model of the CPS-6-DNA complex suggested a positively charged DNA-binding groove near the Mg2+-bound active site. Mutations of four aromatic and basic residues: Phe(122), Arg(146), Arg(156), and Phe(166), in the protein-DNA interface significantly reduced the DNA binding and cleavage activity of CPS-6, confirming that these residues are critical for CPS-6-DNA interactions. In vivo transformation rescue experiments further showed that the reduced DNase activity of CPS-6 mutants was positively correlated with its diminished cell killing activity in C. elegans. Taken together, these biochemical, structural, mutagenesis, and in vivo data reveal a molecular basis of how CPS-6 binds and hydrolyzes DNA to promote cell death.	[Lin, Jason L. J.; Lin, Chia Liang; Hsiao, Yu-Yuan; Yang, Wei-Zen; Wang, Yi-Ting; Doudeva, Lyudmila G.; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Nakagawa, Akihisa; Skeen-Gaar, Riley Robert; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Lin, Chia Liang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10617, Taiwan	Academia Sinica - Taiwan; University of Colorado System; University of Colorado Boulder; National Tsing Hua University; National Taiwan University	Yuan, HNS (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	hanna@sinica.edu.tw	Yuan, Hanna S./AAA-4005-2021; Hsiao, Yu-Yuan/AAA-7408-2022	Yuan, Hanna S./0000-0001-9671-6967; XUE, DING/0000-0002-8429-8136; Hsiao, Yu-Yuan/0000-0002-9648-5879; Skeen-Gaar, Riley/0000-0003-4670-4591; Lin, Chia-Liang/0000-0002-7158-6091	National Institutes of Health [GM79097]; Academia Sinica; National Science Council, Taiwan; National Synchrotron Radiation Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79097 (to D. X.). This work was also supported by research grants from Academia Sinica (to H. Y.) and the National Science Council, Taiwan (to H. Y.). This work was also supported in part by the National Research Program for Genomic Medicine through the National Synchrotron Radiation Research Center.	Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; BRENNER S, 1974, GENETICS, V77, P71; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; CUMMINGS OW, 1987, J BIOL CHEM, V262, P2005; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Ghosh M, 2005, J BIOL CHEM, V280, P27990, DOI 10.1074/jbc.M501798200; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hsia KC, 2005, CURR OPIN STRUC BIOL, V15, P126, DOI 10.1016/j.sbi.2005.01.015; Hsia KC, 2004, STRUCTURE, V12, P205, DOI 10.1016/j.str.2004.01.004; Hsiao YY, 2011, NAT CHEM BIOL, V7, P236, DOI 10.1038/NCHEMBIO.524; HSU DR, 1994, GENETICS, V137, P999; Huang KJ, 2006, P NATL ACAD SCI USA, V103, P8995, DOI 10.1073/pnas.0603445103; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Kalinowska M, 2005, APOPTOSIS, V10, P821, DOI 10.1007/s10495-005-0410-9; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Lai HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007348; Li CL, 2003, EMBO J, V22, P4014, DOI 10.1093/emboj/cdg377; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Loll B, 2009, NUCLEIC ACIDS RES, V37, P7312, DOI 10.1093/nar/gkp770; Low RL, 2003, MITOCHONDRION, V2, P225, DOI 10.1016/S1567-7249(02)00104-6; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; RUIZCARRILLO A, 1987, EMBO J, V6, P401, DOI 10.1002/j.1460-2075.1987.tb04769.x; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Sokolowska M, 2009, NUCLEIC ACIDS RES, V37, P3799, DOI 10.1093/nar/gkp228; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Wu SL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-6; Wu YC, 2000, GENE DEV, V14, P536	44	10	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7110	7120		10.1074/jbc.M111.316075	http://dx.doi.org/10.1074/jbc.M111.316075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22223640	Green Published, hybrid			2022-12-27	WOS:000301060200015
J	Manning, EP; Guinto, PJ; Tardiff, JC				Manning, Edward P.; Guinto, Pia J.; Tardiff, Jil C.			Correlation of Molecular and Functional Effects of Mutations in Cardiac Troponin T Linked to Familial Hypertrophic Cardiomyopathy AN INTEGRATIVE IN SILICO/IN VITRO APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN FILAMENT; REGULATORY PROTEINS; TAIL DOMAIN; CALCIUM REGULATION; COILED-COILS; MUSCLE; CONTRACTION; BINDING; IDENTIFICATION; MYOFILAMENTS	Nearly 70% of all of the known cTnT mutations that cause familial hypertrophic cardiomyopathy fall within the TNT1 region that is critical to cTn-Tm binding. The high resolution structure of this domain has not been determined, and this lack of information has hindered structure-function analysis. In the current study, a coupled computational experimental approach was employed to correlate changes in cTnT dynamics to basic function using the regulated in vitro motility assay (R-IVM). An in silico approach to calculate forces in terms of a bending coordinate was used to precisely identify decreases in bending forces at residues 105 and 106 within the proposed cTnT "hinge" region. Significant functional changes were observed in multiple functional properties, including a decrease in the cooperativity of calcium activation, the calcium sensitivity of sliding speed, and maximum sliding speed. Correlation of the computational and experimental findings revealed an association between TNT1 flexibility and the cooperativity of thin filament calcium activation where an increase in flexibility led to a decrease in cooperativity. Further analysis of the primary sequence of the TNT1 region revealed a unique pattern of conserved charged TNT1 residues altered by the R92W and R92L mutations and may represent the underlying "structure" modulating this central functional domain. These data provide a framework for further integrated in silico/in vitro approaches that may be extended into a high-throughput predictive screen to overcome the current structural limitations in linking molecular phenotype to genotype in thin filament cardiomyopathies.	[Tardiff, Jil C.] Univ Arizona, Dept Med, Tucson, AZ 85724 USA; [Tardiff, Jil C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Manning, Edward P.; Guinto, Pia J.] Albert Einstein Coll Med Bronx, Dept Physiol & Biophys, Bronx, NY 10461 USA	University of Arizona; University of Arizona; Yeshiva University; Albert Einstein College of Medicine	Tardiff, JC (corresponding author), Univ Arizona, Dept Med, 1656 E Mabel St,MRB 312,MS 245217, Tucson, AZ 85724 USA.	jtardiff@email.arizona.edu			National Institutes of Health [HL075619]; Predoctoral Training Grants [1F31HL085915-01]; American Heart Association [10PRE3610021]; Medical Scientist Training Grant [GM007288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL085915, R01HL075619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Grants; American Heart Association(American Heart Association); Medical Scientist Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported in part by National Institutes of Health Grant HL075619 (to J. C. T.), and Predoctoral Training Grants 1F31HL085915-01 (to P. J. G.) and American Heart Association 10PRE3610021 (to E. P. M.), and Medical Scientist Training Grant GM007288.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chandra M, 1999, J MOL CELL CARDIOL, V31, P867, DOI 10.1006/jmcc.1999.0928; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Clarkson MW, 2004, BIOCHEMISTRY-US, V43, P12448, DOI 10.1021/bi0494424; Clemmens EW, 2005, J PHYSIOL-LONDON, V566, P737, DOI 10.1113/jphysiol.2005.084194; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cuinto PJ, 2007, J THEOR COMPUT CHEM, V6, P413, DOI 10.1142/S0219633607003271; Ertz-Berger BR, 2005, P NATL ACAD SCI USA, V102, P18219, DOI 10.1073/pnas.0509181102; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon AM, 1997, BIOPHYS J, V72, P1295, DOI 10.1016/S0006-3495(97)78776-9; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Homsher E, 2003, BIOPHYS J, V85, P1046, DOI 10.1016/S0006-3495(03)74543-3; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Voet D, 2004, BIOCHEMISTRY-US, P219	30	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14515	14523		10.1074/jbc.M111.257436	http://dx.doi.org/10.1074/jbc.M111.257436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334656	Green Published, hybrid			2022-12-27	WOS:000304003200018
J	Rhee, J; Ryu, JH; Kim, JH; Chun, CH; Chun, JS				Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Churl-Hong; Chun, Jang-Soo			alpha-Catenin Inhibits beta-Catenin-T-cellFactor/Lymphoid Enhancing Factor Transcriptional Activity and Collagen Type II Expression in Articular Chondrocytes through Formation of Gli3R.alpha-Catenin.beta-Catenin Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED PHENOTYPE; OSTEOARTHRITIS; MAINTENANCE; PATHWAY; DOMAIN; ROLES	Chondrocytes, a unique cell type in cartilage tissue, are responsible for the regulation of anabolic and catabolic homeostasis in cartilage-specific extracellular matrix synthesis. Activation of Wnt/beta-catenin signaling induces dedifferentiation of articular chondrocytes, resulting in suppression of type II collagen expression. Wehave shown previously that beta-catenin inhibits beta-catenin-Tcf/Lef (T-cell factor/lymphoid-enhancing factor) transcriptional activity in articular chondrocytes with a concomitant recovery of type II collagen expression. In the current study, we elucidated the mechanism underlying this inhibition of beta-catenin-Tcf/Lef transcriptional activity by beta-catenin, showing that it requires direct interaction between beta-catenin and beta-catenin. We further showed that it involves recruitment of Gli3R, the short transcription-repressing form of the transcription factor Gli3, to beta-catenin by beta-catenin. The resulting inhibition of beta-catenin transcriptional activity leads to increased expression of type II collagen. Gli3R and beta-catenin actions are co-dependent: both are necessary for the observed inhibitory effects on beta-catenin transcriptional activity. Reducing Gli3R expression levels through activation of Indian Hedgehog (Ihh) signaling also is sufficient to activate beta-catenin transcriptional activity, suggesting that the ternary complex, Gli3R.beta-catenin.beta-catenin, mediates Ihh-dependent activation of Wnt/beta-catenin signaling in articular chondrocytes. Collectively, this study shows that beta-catenin functions as a nuclear factor that recruits the transcriptional repressor Gli3R to beta-catenin to inhibit beta-catenin transcriptional activity and dedifferentiation of articular chondrocytes. Finally, osteoarthritic cartilage showed elevated levels of beta-catenin and decreased levels of beta-catenin and Gli3R, suggesting that decreased levels of -catenin and Gli3R levels contribute to increased beta-catenin transcriptional activity during osteoarthritic cartilage destruction.	[Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Rhee, Jinseol; Ryu, Je-Hwang; Kim, Jin-Hong; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Wonkwang University	Chun, JS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea.	jschun@gist.ac.kr		Kim, Jin-Hong/0000-0002-6480-1929	National Research Foundation of Korea [2009-0074544, 2010-0012410, 2011-0001158, 2010-0026293]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea Grants 2009-0074544 and 2010-0012410 (to J. R.) and 2011-0001158 and 2010-0026293 (to J.-S. C.).	Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; El-Bahrawy M, 2002, LAB INVEST, V82, P1167, DOI 10.1097/01.LAB.0000028821.41246.6A; Giannini AL, 2000, J BIOL CHEM, V275, P21883, DOI 10.1074/jbc.M001929200; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Huber O, 1997, J CELL SCI, V110, P1759; Hwang SG, 2005, J BIOL CHEM, V280, P12758, DOI 10.1074/jbc.M413367200; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003; Scott JA, 2006, J CELL SCI, V119, P4599, DOI 10.1242/jcs.03267; Sehgal RNM, 1997, J CELL BIOL, V139, P1033, DOI 10.1083/jcb.139.4.1033; Ulloa F, 2007, CURR BIOL, V17, P545, DOI 10.1016/j.cub.2007.01.062; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	34	10	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11751	11760		10.1074/jbc.M111.281014	http://dx.doi.org/10.1074/jbc.M111.281014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22298781	Green Published, hybrid			2022-12-27	WOS:000302782200014
J	Song, XL; Thalacker, FW; Nilsen-Hamilton, M				Song, Xiaoling; Thalacker, Frederic W.; Nilsen-Hamilton, Marit			Synergistic and Multidimensional Regulation of Plasminogen Activator Inhibitor Type 1 Expression by Transforming Growth Factor Type beta and Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; MESSENGER-RNA STABILITY; HUMAN ENDOTHELIAL-CELLS; TGF-BETA; FACTOR INCREASES; GENE-EXPRESSION; FACTOR-ALPHA; PAI-1; TRANSCRIPTION; PROTEIN	The major physiological inhibitor of plasminogen activator, type I plasminogen activator inhibitor (PAI-1), controls blood clotting and tissue remodeling events that involve cell migration. Transforming growth factor type beta (TGF beta) and epidermal growth factor (EGF) interact synergistically to increase PAI-1 mRNA and protein levels in human HepG2 and mink Mv1Lu cells. Other growth factors that activate tyrosine kinase receptors can substitute for EGF. EGF and TGF beta regulate PAI-1 by synergistically activating transcription, which is further amplified by a decrease in the rate of mRNA degradation, the latter being regulated only by EGF. The combined effect of transcriptional activation and mRNA stabilization results in a rapid 2-order of magnitude increase in the level of PAI-1. TGF beta also increases the sensitivity of the cells to EGF, thereby recruiting the cooperation of EGF at lower than normally effective concentrations. The contribution of EGF to the regulation of PAI-1 involves the MAPK pathway, and the synergistic interface with the TGF beta pathway is downstream of MEK1/2 and involves phosphorylation of neither ERK1/2 nor Smad2/3. Synergism requires the presence of both Smad and AP-1 recognition sites in the promoter. This work demonstrates the existence of a multidimensional cellular mechanism by which EGF and TGF beta are able to promote large and rapid changes in PAI-1 expression.	[Song, Xiaoling; Thalacker, Frederic W.; Nilsen-Hamilton, Marit] Iowa State & Ames Natl Labs, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA		Nilsen-Hamilton, M (corresponding author), Iowa State & Ames Natl Labs, Dept Biochem Biophys & Mol Biol, 3206 Mol Biol Bldg, Ames, IA 50011 USA.	marit@iastate.edu	Nilsen-Hamilton, Marit/V-2796-2019	Song, Xiaoling/0000-0002-0321-5379	National Institutes of Health [1-R01-GM33528]; United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory; United States Department of Energy [DE-AC02-07CH11358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-GM33528. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory. The Ames Laboratory is operated for the United States Department of Energy by Iowa State University under Contract DE-AC02-07CH11358.	de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dufourny B, 2000, J ENDOCRINOL, V166, P329, DOI 10.1677/joe.0.1660329; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; FERNANDEZPOL JA, 1989, J BIOL CHEM, V264, P4151; Freytag J, 2009, J ONCOL, V2009, DOI 10.1155/2009/963209; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; HAGGROTH L, 1986, THROMB RES, V42, P585, DOI 10.1016/0049-3848(86)90337-3; HOPKINS WE, 1991, THROMB HAEMOSTASIS, V66, P239; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LANDIN K, 1991, THROMB HAEMOSTASIS, V65, P130; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NILSENHAMILTON M, 1982, CELL, V31, P237, DOI 10.1016/0092-8674(82)90423-8; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Peiretti F, 1997, ARTERIOSCL THROM VAS, V17, P1550, DOI 10.1161/01.ATV.17.8.1550; RANGANATHAN G, 1990, J BIOL CHEM, V265, P3001; RHEINWALD JG, 1987, J CELL BIOL, V104, P263, DOI 10.1083/jcb.104.2.263; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Saha Debabrata, 1999, Neoplasia (New York), V1, P508; Schluns KS, 1997, J IMMUNOL, V158, P2704; SCHNEIDER DJ, 1991, P NATL ACAD SCI USA, V88, P9959, DOI 10.1073/pnas.88.22.9959; SHAPIRO DJ, 1987, BIOESSAYS, V6, P221, DOI 10.1002/bies.950060507; Song JW, 2006, YONSEI MED J, V47, P201, DOI 10.3349/ymj.2006.47.2.201; SPRENGERS ED, 1987, BLOOD, V69, P381; Stern HM, 1997, DEVELOPMENT, V124, P3511; Stoll SW, 1999, BIOCHEM BIOPH RES CO, V265, P214, DOI 10.1006/bbrc.1999.1654; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; THALACKER FW, 1992, BIOCHEM J, V287, P855, DOI 10.1042/bj2870855; THALACKER FW, 1987, J BIOL CHEM, V262, P2283; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Watanabe A, 2001, CARDIOVASC RES, V51, P151, DOI 10.1016/S0008-6363(01)00274-7; Wilkins-Port CE, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85208; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	48	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12520	12528		10.1074/jbc.M111.338079	http://dx.doi.org/10.1074/jbc.M111.338079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334677	Green Published, hybrid			2022-12-27	WOS:000302782200091
J	Stocki, P; Wang, XN; Dickinson, AM				Stocki, Pawel; Wang, Xiao N.; Dickinson, Anne M.			Inducible Heat Shock Protein 70 Reduces T Cell Responses and Stimulatory Capacity of Monocyte-derived Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; ANTIGEN PRESENTATION; EXTRACELLULAR HSP70; CROSS-PRESENTATION; BONE-MARROW; PATHWAY; CONTAMINATION; EXPRESSION; SIGNAL	Heat shock protein 70 (Hsp70) has gained a lot of attention in the past decade due to its potential immunoregulatory functions. Some of the described proinflammatory functions of Hsp70 became controversial as they were based on recombinant Hsp70 proteins specimens, which were later shown to be endotoxin-contaminated. In this study we used low endotoxin inducible Hsp70 (also known as Hsp72, HSPA1A), and we observed that after a 24-h incubation of monocyte-derived immature dendritic cells (mo-iDCs) with 20 mu g/ml of low endotoxin Hsp70, their ability to stimulate allogenic T cells was reduced. Interestingly, low endotoxin Hsp70 also significantly reduced T cell responses when they were simulated with either IL-2 or phytohemagglutinin, therefore showing that Hsp70 could alter T cell responses independently from its effect on mo-iDCs. We also reported a greater response of Hsp70 treatment when activated versus nonactivated T cells were used. This effect of Hsp70 was similar for all tested populations of T cells that included CD3(+), CD4(+), or CD8(+). Taken together, our observations strongly suggest that Hsp70 might dampen, rather than provoke, T cell-mediated inflammatory reactions in many clinical conditions where up-regulation of Hsp70 is observed.	[Stocki, Pawel; Wang, Xiao N.; Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Dept Haematol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Stocki, P (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	pawel.stocki@utoronto.ca			Leukaemia Research Fund, United Kingdom [04070]; Tyneside Leukaemia Research Fund, United Kingdom; European Commission "Trans-Net" [MRTN-CT-2004-512253]	Leukaemia Research Fund, United Kingdom; Tyneside Leukaemia Research Fund, United Kingdom; European Commission "Trans-Net"	This work was supported by Leukaemia Research Fund, United Kingdom, Grant 04070; a grant from the Tyneside Leukaemia Research Fund, United Kingdom; and European Commission "Trans-Net" Grant MRTN-CT-2004-512253.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Baba HA, 1997, TRANSPLANTATION, V64, P1035, DOI 10.1097/00007890-199710150-00016; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bendz H, 2008, J BIOL CHEM, V283, P26477, DOI 10.1074/jbc.M803310200; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Binder RJ, 2000, J IMMUNOL, V165, P2582, DOI 10.4049/jimmunol.165.5.2582; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Hantschel M, 2000, CELL STRESS CHAPERON, V5, P438, DOI 10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Jarvis M, 2003, TRANSPLANTATION, V76, P849, DOI 10.1097/01.TP.0000083556.73555.78; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stocki P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.179630; Stocki P, 2010, CELL STRESS CHAPERON, V15, P729, DOI 10.1007/s12192-010-0184-z; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200; Zheng H., J BIOL CHEM, V285, P349	33	51	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12387	12394		10.1074/jbc.M111.307579	http://dx.doi.org/10.1074/jbc.M111.307579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334699	Green Published, hybrid			2022-12-27	WOS:000302782200078
J	Antonopoulos, A; Demotte, N; Stroobant, V; Haslam, SM; van der Bruggen, P; Dell, A				Antonopoulos, Aristotelis; Demotte, Nathalie; Stroobant, Vincent; Haslam, Stuart M.; van der Bruggen, Pierre; Dell, Anne			Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations in N- and O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ENDO-BETA-GALACTOSIDASE; ESCHERICHIA-FREUNDII; GLYCAN INTERACTIONS; CELL-RECEPTOR; HIGH-AFFINITY; CD8; ACTIVATION; BINDING; COMPLEX	Most human tumors are not eliminated by the immune system, and therapeutic vaccination shows poor results, a fact that can be explained at least partially by an immunosuppressive tumor microenvironment that is abundant in galectin-3. On cytolytic T lymphocyte (CTL) clones, maintained in culture by regular stimulation, recently activated CTLs present low effector functions. However, these functions are restored after a short treatment with LacNAc. The latter, which is in agreement with the glycoprotein-galectin lattice concept involving reduced motility, poses the question why galectin-3 ligands improve effector functions. We employed ultrasensitive MALDI-TOF-MS on resting and recently activated CTL clones combined with various glycosidase digestions and GC-MS linkage analyses. Our results showed that compared with the resting CTLs, the N-glycans of the recently activated CTLs consisted of (i) larger LacNAc oligomers of which a significant portion was longer than four-units and (ii) more multi-antennary structures. Interestingly, our results showed that the poly-LacNAc appeared to be equally distributed on all available N-glycan branches and not selectively enriched on a specific branch. The above structural alterations in the recently activated CTLs are expected to increase the galectin-3-LacNAc lattices and multivalent interactions and, therefore, reduce the motility of surface glycoproteins, such as the T-cell receptor. These findings suggest that the loss of effector functions on CTLs may be linked to reduced motility of surface glycoproteins. In addition, our results showed that recently activated CTLs had a reduced abundance of NeuAc alpha 2,6-linked N-glycans and an increased abundance of disialylated core 1 and monosialylated core 2 O-glycan structures.	[Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Demotte, Nathalie; Stroobant, Vincent; van der Bruggen, Pierre] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Demotte, Nathalie; Stroobant, Vincent; van der Bruggen, Pierre] WELBIO, Ludwig Inst Canc Res, B-1200 Brussels, Belgium	Imperial College London; Universite Catholique Louvain; Ludwig Institute for Cancer Research; WELBIO	Dell, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, S Kensington Campus, London SW7 2AZ, England.	a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	Biotechnology and Biological Sciences Research Council [B19088, BBF0083091]; Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique Medicale (Belgium)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique Medicale (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported from Biotechnology and Biological Sciences Research Council Grants B19088 and BBF0083091 (to A. D. and S. M. H.). This work was also supported by grants from the Fondation contre le Cancer (Belgium) and Fonds de la Recherche Scientifique Medicale (Belgium) (to P. B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Antonopoulos A, 2011, BIOCHEM SOC T, V39, P1334, DOI 10.1042/BST0391334; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dam TK, 2010, GLYCOBIOLOGY, V20, P1061, DOI 10.1093/glycob/cwq084; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Merry AH, 2003, J BIOL CHEM, V278, P27119, DOI 10.1074/jbc.M213056200; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; NAKAGAWA H, 1980, J BIOL CHEM, V255, P5955; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pace KE, 1999, J IMMUNOL, V163, P3801; PILLER F, 1988, J BIOL CHEM, V263, P15146; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VanderHove LE, 1997, CLIN EXP IMMUNOL, V109, P501, DOI 10.1046/j.1365-2249.1997.4771375.x; Wang SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017621; Wieers Gregoire, 2011, Cancers (Basel), V3, P2904, DOI 10.3390/cancers3032904; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	41	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11240	11251		10.1074/jbc.M111.320820	http://dx.doi.org/10.1074/jbc.M111.320820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334653	Green Published, hybrid			2022-12-27	WOS:000302780100052
J	Chaparro-Riggers, J; Liang, H; Devay, RM; Bai, LF; Sutton, JE; Chen, W; Geng, T; Lindquist, K; Casas, MG; Boustany, LM; Brown, CL; Chabot, J; Gomes, B; Garzone, P; Rossi, A; Strop, P; Shelton, D; Pons, J; Rajpal, A				Chaparro-Riggers, Javier; Liang, Hong; DeVay, Rachel M.; Bai, Lanfang; Sutton, Janette E.; Chen, Wei; Geng, Tao; Lindquist, Kevin; Casas, Meritxell Galindo; Boustany, Leila M.; Brown, Colleen L.; Chabot, Jeffrey; Gomes, Bruce; Garzone, Pamela; Rossi, Andrea; Strop, Pavel; Shelton, Dave; Pons, Jaume; Rajpal, Arvind			Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC MONOCLONAL-ANTIBODIES; DENSITY-LIPOPROTEIN CHOLESTEROL; POPULATION PHARMACOKINETICS; NONHUMAN-PRIMATES; LDL-CHOLESTEROL; RECEPTOR; HYPERCHOLESTEROLEMIA; PHARMACODYNAMICS; MECHANISMS; DEPENDENCE	Background: An antagonistic anti-PCSK9 antibody exhibits target- mediated clearance, resulting in a dose-dependent PK. Results: Engineering of an antibody with pH-sensitive binding to PCSK9 decreases target-mediated clearance, resulting in increased PK and efficacy in vivo. Conclusion: pH-sensitive anti-PCSK9 antibodies are excellent candidates for therapeutic development. Significance: pH-sensitive antibodies may enable less frequent or lower dosing of antibodies hampered by target-mediated clearance and high antigen load.	[Chaparro-Riggers, Javier; Liang, Hong; DeVay, Rachel M.; Bai, Lanfang; Sutton, Janette E.; Chen, Wei; Geng, Tao; Lindquist, Kevin; Casas, Meritxell Galindo; Boustany, Leila M.; Brown, Colleen L.; Chabot, Jeffrey; Garzone, Pamela; Rossi, Andrea; Strop, Pavel; Shelton, Dave; Pons, Jaume; Rajpal, Arvind] Rinat Pfizer Inc, San Francisco, CA 94080 USA; [Gomes, Bruce] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Pfizer; Novartis	Pons, J (corresponding author), Rinat Pfizer Inc, 230 E Grand Ave, San Francisco, CA 94080 USA.	jaume.pons@pfizer.com; arvind.rajpal@pfizer.com		Lindquist, Kevin/0000-0001-6059-7425; Galindo Casas, Meritxell/0000-0002-5034-1722				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abifadel M, 2010, EXPERT OPIN THER PAT, V20, P1547, DOI 10.1517/13543776.2010.518615; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dirks NL, 2010, CLIN PHARMACOKINET, V49, P633, DOI 10.2165/11535960-000000000-00000; Hayashi N, 2007, BRIT J CLIN PHARMACO, V63, P548, DOI 10.1111/j.1365-2125.2006.02803.x; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Maeda K, 2002, J CONTROL RELEASE, V82, P71, DOI 10.1016/S0168-3659(02)00126-8; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Rehlaender BN, 1998, PHARMACEUT RES, V15, P1652, DOI 10.1023/A:1011936007457; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	33	125	173	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11090	11097		10.1074/jbc.M111.319764	http://dx.doi.org/10.1074/jbc.M111.319764			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22294692	Green Published, hybrid			2022-12-27	WOS:000302780100037
J	Park, S; Kim, D; Dan, HC; Chen, HH; Testa, JR; Cheng, JQ				Park, Sungman; Kim, Donghwa; Dan, Han C.; Chen, Huihua; Testa, Joseph R.; Cheng, Jin Q.			Identification of Akt Interaction Protein PHF20/TZP That Transcriptionally Regulates p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; AKT/PROTEIN KINASE-B; CANCER-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; ONCOGENIC TRANSFORMATION; MOLECULAR-CLONING; GENE-EXPRESSION; PHOSPHORYLATION; SUPPRESSOR; DNA	Background: Akt exerts its cellular function through interaction/phosphorylation of downstream proteins. Results: Akt interacts with and phosphorylates PHF20, which regulates p53 and inhibits cell proliferation and survival, resulting in loss of its function. Conclusion: PHF20 up-regulates p53. Akt phosphorylates and abrogates PHF20 function. Significance: We identified a novel interactor/substrate of Akt and an additional link between Akt and p53 cascades.	[Testa, Joseph R.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Park, Sungman; Kim, Donghwa; Dan, Han C.; Chen, Huihua; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	Fox Chase Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Testa, JR (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	joseph.testa@fccc.edu; jin.cheng@moffitt.org	Chen, Huihua/D-9162-2019	Chen, Huihua/0000-0002-5045-6845	National Institutes of Health [CA137041, CA77429]; Florida James and Esther King Biomedical Research Program [1KG02]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA137041, R01CA077429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA137041 (to J. Q. C.) and CA77429 (to J. R. T.). This work was also supported by Florida James and Esther King Biomedical Research Program Grant 1KG02 (to J. Q. C.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BELLACOSA A, 1995, INT J CANCER, V64, P280, DOI 10.1002/ijc.2910640412; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Bourdon JC, 2003, CELL DEATH DIFFER, V10, P397, DOI 10.1038/sj.cdd.4401243; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DEFFIE A, 1993, MOL CELL BIOL, V13, P3415, DOI 10.1128/MCB.13.6.3415; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Hellin AC, 1998, ONCOGENE, V16, P1187, DOI 10.1038/sj.onc.1201638; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee H, 2007, MOL CELL BIOL, V27, P2103, DOI 10.1128/MCB.00572-06; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Lee K, 2005, GLIA, V51, P1, DOI 10.1002/glia.20179; Liu AX, 1998, CANCER RES, V58, P2973; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Owada Y, 1997, J MOL NEUROSCI, V9, P27, DOI 10.1007/BF02789392; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Peng ZH, 2002, CHINESE MED J-PEKING, V115, P1529; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raman V, 2000, J BIOL CHEM, V275, P26551, DOI 10.1074/jbc.C000324200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; SUN XG, 1995, MOL CELL BIOL, V15, P4489; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Vauhkonen H, 2006, CANCER GENET CYTOGEN, V167, P150, DOI 10.1016/j.cancergencyto.2005.11.014; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	67	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11151	11163		10.1074/jbc.M111.333922	http://dx.doi.org/10.1074/jbc.M111.333922			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334668	Green Published, hybrid			2022-12-27	WOS:000302780100043
J	Rombouts, Y; Brust, B; Ojha, AK; Maes, E; Coddeville, B; Elass-Rochard, E; Kremer, L; Guerardel, Y				Rombouts, Yoann; Brust, Belinda; Ojha, Anil K.; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Kremer, Laurent; Guerardel, Yann			Exposure of Mycobacteria to Cell Wall-inhibitory Drugs Decreases Production of Arabinoglycerolipid Related to Mycolyl-arabinogalactan-peptidoglycan Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; TUBERCULOSIS; BIOSYNTHESIS; THIACETAZONE; ACIDS; IDENTIFICATION; ENVELOPE; AVIUM; ARABINOFURANOSYLTRANSFERASE; LIPOOLIGOSACCHARIDES	Background: Mycolyl-arabinogalactan-peptidoglycan (mAGP) represents the hallmark of the mycobacterial cell envelope and the target of several antitubercular drugs. Results: Loss of a glycolipid structurally analogous to the terminal portion of mAGP correlates with drug treatment in mycobacteria. Conclusion: This work establishes the versatility of arabinoglycerolipids in M. tuberculosis. Significance: Further work will define the importance of the metabolic relationship between the two components in cell wall remodeling and/or pathogenesis.	[Rombouts, Yoann; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Guerardel, Yann] Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct UGSF, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Maes, Emmanuel; Coddeville, Bernadette; Elass-Rochard, Elisabeth; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Brust, Belinda; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Brust, Belinda; Kremer, Laurent] Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Ojha, Anil K.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Brust, Belinda] Biorad Labs, Div Clin Microbiol, F-59114 Steenvoorde, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Guerardel, Y (corresponding author), Univ Lille 1, Univ Lille Nord France, Unite Glycobiol Struct & Fonct UGSF, F-59650 Villeneuve Dascq, France.	yann.guerardel@univ-lille1.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	French National Research Agency [ANR-05-MIIM-025]; Ministere de l'Enseignement Superieur; Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant [Fr3050]; Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories; Region Nord-Pas de Calais; European Union; Ministere Francais de la Recherche; Universite Lille1-Sciences et Technologies; CNRS; Institut Pasteur de Lille	French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur; Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant; Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union(European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille1-Sciences et Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur de Lille	This study was supported by French National Research Agency Grant ANR-05-MIIM-025 (to Y. G. and L. K.), a grant from the Ministere de l'Enseignement Superieur (to Y. R.), Tres Grand Equipment de Resonance Magnetique Nucleaire a Tres Hauts Champs Grant Fr3050 (for conducting the research on the 800 and 900 MHz spectrometers), and the Association Nationale de la Recherche et de la Technologie and Bio-Rad Laboratories (to B. B.).; The 800 and 900 MHz spectrometers were funded by Region Nord-Pas de Calais, European Union (Fonds Europeen de Developpement Regional), Ministere Francais de la Recherche, Universite Lille1-Sciences et Technologies, and CNRS. The 600 MHz facility used in this study was funded by the European Union, Region Nord-Pas de Calais, CNRS, and Institut Pasteur de Lille.	Alahari A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001343; Alahari A, 2009, MOL MICROBIOL, V71, P1263, DOI 10.1111/j.1365-2958.2009.06604.x; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; BOCK K, 1973, TETRAHEDRON LETT, P1037; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; BRUCKNER J, 1955, BIOCHEM J, V60, P200; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DENG LY, 1995, ANTIMICROB AGENTS CH, V39, P694, DOI 10.1128/AAC.39.3.694; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Fujita Y, 2005, MICROBIOL-SGM, V151, P3403, DOI 10.1099/mic.0.28158-0; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HONDA I, 1993, RES MICROBIOL, V144, P229, DOI 10.1016/0923-2508(93)90048-7; HOUSTON S, 1994, DRUGS, V48, P689, DOI 10.2165/00003495-199448050-00004; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mizutani K., 1983, CARBOHYD RES, V185, P27; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sakamoto T, 2004, BBA-GEN SUBJECTS, V1674, P85, DOI 10.1016/j.bbagen.2004.06.001; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Watanabe M, 1997, EUR J BIOCHEM, V248, P93, DOI 10.1111/j.1432-1033.1997.00093.x; WATANABE M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P53, DOI 10.1016/0005-2760(92)90075-7; WINDER F G, 1970, Journal of General Microbiology, V63, P41; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4; Zanetta JP, 1999, GLYCOCONJUGATE J, V16, P617, DOI 10.1023/A:1007076900562; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	48	20	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11060	11069		10.1074/jbc.M111.327387	http://dx.doi.org/10.1074/jbc.M111.327387			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22315220	Green Published, hybrid			2022-12-27	WOS:000302780100034
J	Ucker, DS; Jain, MR; Pattabiraman, G; Palasiewicz, K; Birge, RB; Li, H				Ucker, David S.; Jain, Mohit Raja; Pattabiraman, Goutham; Palasiewicz, Karol; Birge, Raymond B.; Li, Hong			Externalized Glycolytic Enzymes Are Novel, Conserved, and Early Biomarkers of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; PROGRAMMED CELL-DEATH; HUMAN ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BINDING-PROTEIN; CYTOCHROME-C; ANNEXIN-II; TRIOSEPHOSPHATE ISOMERASE; STREPTOCOCCUS-PNEUMONIAE; ENDOPLASMIC-RETICULUM	The intriguing cell biology of apoptotic cell death results in the externalization of numerous autoantigens on the apoptotic cell surface, including protein determinants for specific recognition, linked to immune responses. Apoptotic cells are recognized by phagocytes and trigger an active immunosuppressive response ("innate apoptotic immunity" (IAI)) even in the absence of engulfment. IAI is responsible for the lack of inflammation associated normally with the clearance of apoptotic cells; its failure also has been linked to inflammatory and autoimmune pathology, including systemic lupus erythematosus and rheumatic diseases. Apoptotic recognition determinants underlying IAI have yet to be identified definitively; we argue that these molecules are surface-exposed (during apoptotic cell death), ubiquitously expressed, protease-sensitive, evolutionarily conserved, and resident normally in viable cells (SUPER). Using independent and unbiased quantitative proteomic approaches to characterize apoptotic cell surface proteins and identify candidate SUPER determinants, we made the surprising discovery that components of the glycolytic pathway are enriched on the apoptotic cell surface. Our data demonstrate that glycolytic enzyme externalization is a common and early aspect of cell death in different cell types triggered to die with distinct suicidal stimuli. Exposed glycolytic enzyme molecules meet the criteria for IAI-associated SUPER determinants. In addition, our characterization of the apoptosis-specific externalization of glycolytic enzyme molecules may provide insight into the significance of previously reported cases of plasminogen binding to beta-enolase on mammalian cells, as well as mechanisms by which commensal bacteria and pathogens maintain immune privilege.	[Ucker, David S.; Pattabiraman, Goutham; Palasiewicz, Karol] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Jain, Mohit Raja; Li, Hong] UMDNJ New Jersey Med Sch Canc Ctr, Ctr Adv Prote Res, Newark, NJ 07214 USA; [Jain, Mohit Raja; Birge, Raymond B.; Li, Hong] UMDNJ New Jersey Med Sch Canc Ctr, Dept Biochem & Mol Biol, Newark, NJ 07214 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ucker, DS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol MC 790, 835 S Wolcott, Chicago, IL 60612 USA.	duck@uic.edu; liho2@umdnj.edu	JAIN, MOHIT/E-8230-2012	Pattabiraman, Goutham/0000-0002-5196-8279; Li, Hong/0000-0001-5731-5335; Palasiewicz, Karol/0000-0002-2894-6047	National Institutes of Health [AG029633, NS046593]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG029633 (to D. S. U.) and NS046593 (to H. L., for the support of a UMDNJ Neuroproteomics Core Facility).	Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Barcinski Marcello A, 2003, Kinetoplastid Biol Dis, V2, P6, DOI 10.1186/1475-9292-2-6; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; BUTTYAN R, 1988, MOL ENDOCRINOL, V2, P650, DOI 10.1210/mend-2-7-650; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chang SH, 2002, EXP CELL RES, V277, P15, DOI 10.1006/excr.2002.5539; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; D'Herde K, 2000, CELL DEATH DIFFER, V7, P331, DOI 10.1038/sj.cdd.4400655; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Dudani AK, 1996, BRIT J HAEMATOL, V95, P168, DOI 10.1046/j.1365-2141.1996.7482367.x; Eguchi Y, 1997, CANCER RES, V57, P1835; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; FELEZ J, 1993, BLOOD, V82, P2433, DOI 10.1182/blood.V82.8.2433.bloodjournal8282433; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Fujii A, 2005, J NEUROIMMUNOL, V162, P130, DOI 10.1016/j.jneuroim.2005.02.004; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; GilNavarro I, 1997, J BACTERIOL, V179, P4992, DOI 10.1128/jb.179.16.4992-4999.1997; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; Gracy R W, 1975, Methods Enzymol, V41, P442; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Hawley SB, 2000, THROMB HAEMOSTASIS, V84, P882; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Jain MR, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-25; Jain Mohit Raja, 2008, Open Proteomics J, V1, P40, DOI 10.2174/1875039700801010040; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jin M, 2005, PROTEOMICS, V5, P1940, DOI 10.1002/pmic.200401057; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KANAPKA JA, 1971, ARCH BIOCHEM BIOPHYS, V146, P167, DOI 10.1016/S0003-9861(71)80053-X; KATO H, 1989, P NATL ACAD SCI USA, V86, P7861, DOI 10.1073/pnas.86.20.7861; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lama A, 2009, INFECT IMMUN, V77, P2703, DOI 10.1128/IAI.00157-09; Laster SM, 1996, MICROSC RES TECHNIQ, V34, P272, DOI 10.1002/(SICI)1097-0029(19960615)34:3<272::AID-JEMT10>3.0.CO;2-J; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Manjili MH, 2005, IMMUNOBIOLOGY, V210, P295, DOI 10.1016/j.imbio.2005.04.002; Mannherz HG, 2005, EUR J CELL BIOL, V84, P503, DOI 10.1016/j.ejcb.2004.11.008; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; Moscato S, 2000, EUR J IMMUNOL, V30, P3575, DOI 10.1002/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Mullane MJ, 1998, EXP CELL RES, V242, P153, DOI 10.1006/excr.1998.4067; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Oremek GM, 2003, ANTICANCER RES, V23, P1131; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Pratesi F, 2000, J RHEUMATOL, V27, P109; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Roozendaal C, 1998, CLIN EXP IMMUNOL, V112, P10; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sabbatini A, 1997, CLIN EXP RHEUMATOL, V15, P655; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Sasajima T, 2006, J NEUROIMMUNOL, V181, P150, DOI 10.1016/j.jneuroim.2006.09.003; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; Srere PA, 1998, TRENDS BIOCHEM SCI, V23, P319, DOI 10.1016/S0968-0004(98)01262-6; SUNAGA K, 1995, NEUROSCI LETT, V200, P133, DOI 10.1016/0304-3940(95)12098-O; Thorp EB, 2010, APOPTOSIS, V15, P1124, DOI 10.1007/s10495-010-0516-6; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Tisdale EJ, 2009, J BIOL CHEM, V284, P5876, DOI 10.1074/jbc.M807756200; Ucker David S., 2009, P163, DOI 10.1007/978-1-4020-9292-3_6; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Xiang Y, 2004, ARTHRITIS RHEUM-US, V50, P1511, DOI 10.1002/art.20189; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	106	41	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10325	10343		10.1074/jbc.M111.314971	http://dx.doi.org/10.1074/jbc.M111.314971			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22262862	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000302167200061
J	Declercq, J; Meulemans, S; Plets, E; Creemers, JWM				Declercq, Jeroen; Meulemans, Sandra; Plets, Evelyn; Creemers, John W. M.			Internalization of Proprotein Convertase PC7 from Plasma Membrane Is Mediated by a Novel Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; TAIL SORTING SIGNALS; CYTOPLASMIC TAIL; INTRACELLULAR TRAFFICKING; CELL-SURFACE; GENE FAMILY; FURIN; LOCALIZATION; PROTEINS; COMPARTMENTS	Proprotein convertase 7 (PC7) is a member of the subtilisin-like proprotein convertase family, which is involved in the endoproteolysis of a variety of precursor proteins. Under steady state conditions, PC7 is mainly localized in the trans-Golgi network, but a small fraction is found at the cell surface. So far, no sorting signals for membrane trafficking have been identified in PC7. In this study, we have examined the internalization of PC7 from the plasma membrane. Our results show that internalization of PC7 is mediated by clathrin-coated vesicles. After inhibition of clathrin-mediated endocytosis using hypertonic conditions or the small molecule inhibitor, Pitstop 2, PC7 accumulated at the plasma membrane. Furthermore, PC7 was present in isolated clathrin-coated vesicles. To determine the internalization motif, constructs were generated in which parts of the N and C terminus of the cytoplasmic tail of PC7 were deleted, and chimeric proteins were constructed consisting of the luminal and transmembrane domains of Tac (CD25) and parts of the cytoplasmic domain of PC7. Antibody uptake experiments as well as surface biotinylation experiments demonstrated that the region between Ala(713) and Cys(726) in the cytoplasmic domain of PC7 is essential and sufficient for the internalization of PC7 but not for trans-Golgi network localization. Individual amino acids in this region were substituted with alanine, which identified Pro, Leu, and Cys as the essential amino acids. In conclusion, internalization of PC7 depends on a short transferable sequence in the cytoplasmic tail, which contains the three crucial amino acids PLC.	[Declercq, Jeroen; Meulemans, Sandra; Plets, Evelyn; Creemers, John W. M.] Univ Louvain, Dept Human Genet, Lab Biochem Neuroendocrinol, B-3000 Louvain, Belgium		Creemers, JWM (corresponding author), Univ Louvain, Dept Human Genet, Lab Biochem Neuroendocrinol, O&N1,Herestr 49 Bus 602, B-3000 Louvain, Belgium.	john.creemers@med.kuleuven.be		Plets, Evelyn/0000-0001-7312-8804	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO); Geconcerteerde Onderzoeksacties (GOA) [2008/16, GOA/12/016]	"Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO)(FWO); Geconcerteerde Onderzoeksacties (GOA)	This work was supported in part by grants from the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" (FWO) and "Geconcerteerde Onderzoeksacties" (GOA 2008/16 and GOA/12/016).	Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bruzzaniti A, 1996, BIOCHEM J, V314, P727, DOI 10.1042/bj3140727; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Creemers JWM, 2000, J BIOL CHEM, V275, P38842, DOI 10.1074/jbc.M006758200; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; JONES BG, 1995, EMBO J, V14, P5869, DOI 10.1002/j.1460-2075.1995.tb00275.x; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Meerabux J, 1996, CANCER RES, V56, P448; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siegfried G, 2003, CANCER RES, V63, P1458; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257	37	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9052	9060		10.1074/jbc.M111.306407	http://dx.doi.org/10.1074/jbc.M111.306407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294700	Green Published, hybrid			2022-12-27	WOS:000301797800035
J	Foeger, NC; Norris, AJ; Wren, LM; Nerbonne, JM				Foeger, Nicholas C.; Norris, Aaron J.; Wren, Lisa M.; Nerbonne, Jeanne M.			Augmentation of Kv4.2-encoded Currents by Accessory Dipeptidyl Peptidase 6 and 10 Subunits Reflects Selective Cell Surface Kv4.2 Protein Stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL PYRAMIDAL NEURONS; GATED POTASSIUM CHANNELS; ADULT-MOUSE VENTRICLES; K+ CURRENTS; ALPHA-SUBUNITS; I-A; HIPPOCAMPAL-NEURONS; EXPRESSION; COMPLEXES; DPPX	Rapidly activating and inactivating somatodendritic voltage-gated K+ (Kv) currents, I-A, play critical roles in the regulation of neuronal excitability. Considerable evidence suggests that native neuronal I-A channels function in macromolecular protein complexes comprising pore-forming (alpha) subunits of the Kv4 subfamily together with cytosolic, K+ channel interacting proteins (KChIPs) and transmembrane, dipeptidyl peptidase 6 and 10 (DPP6/10) accessory subunits, as well as other accessory and regulatory proteins. Several recent studies have demonstrated a critical role for the KChIP subunits in the generation of native Kv4.2-encoded channels and that Kv4.2-KChIP complex formation results in mutual (Kv4.2-KChIP) protein stabilization. The results of the experiments here, however, demonstrate that expression of DPP6 in the mouse cortex is unaffected by the targeted deletion of Kv4.2 and/or Kv4.3. Further experiments revealed that heterologously expressed DPP6 and DPP10 localize to the cell surface in the absence of Kv4.2, and that co-expression with Kv4.2 does not affect total or cell surface DPP6 or DPP10 protein levels. In the presence of DPP6 or DPP10, however, cell surface Kv4.2 protein expression is selectively increased. Further addition of KChIP3 in the presence of DPP10 markedly increases total and cell surface Kv4.2 protein levels, compared with cells expressing only Kv4.2 and DPP10. Taken together, the results presented here demonstrate that the expression and localization of the DPP accessory subunits are independent of Kv4 alpha subunits and further that the DPP6/10 and KChIP accessory subunits independently stabilize the surface expression of Kv4.2.	[Foeger, Nicholas C.; Norris, Aaron J.; Wren, Lisa M.; Nerbonne, Jeanne M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nerbonne, JM (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, Campus Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	jnerbonne@wustl.edu		Norris, Aaron/0000-0001-7825-1756	National Institutes of Health [HL034161]; NHLBI, National Institutes of Health [T32-HL007275]; National Eye Institute [T32-EY013360]; NATIONAL EYE INSTITUTE [T32EY013360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL034161 (to J. M. N.).; Supported by Grant T32-HL007275 from the NHLBI, National Institutes of Health.; Supported by Grant T32-EY013360 from the National Eye Institute.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson D, 2010, CHANNELS, V4, P163, DOI 10.4161/chan.4.3.11955; Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bahring R, 2001, J BIOL CHEM, V276, P23888, DOI 10.1074/jbc.M101320200; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Clark B. D., 2008, FRONT MOL NEUROSCI, V1, DOI [10.3389/neuro.3302.3008.2008, DOI 10.3389/NEURO.3302.3008.2008]; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Johns DC, 1999, J NEUROSCI, V19, P1691; Kang J, 2000, J NEUROPHYSIOL, V83, P70, DOI 10.1152/jn.2000.83.1.70; Kaulin YA, 2009, J NEUROSCI, V29, P3242, DOI 10.1523/JNEUROSCI.4767-08.2009; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kin Y, 2001, J BIOCHEM-TOKYO, V129, P289, DOI 10.1093/oxfordjournals.jbchem.a002856; Kunjilwar K, 2004, J BIOL CHEM, V279, P54542, DOI 10.1074/jbc.M409721200; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Maffie J, 2008, J PHYSIOL-LONDON, V586, P5609, DOI 10.1113/jphysiol.2008.161620; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Marionneau C, 2009, CHANNELS, V3, P284; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Menegola M, 2006, J NEUROSCI, V26, P12137, DOI 10.1523/JNEUROSCI.2783-06.2006; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Niwa N, 2008, J MOL CELL CARDIOL, V44, P95, DOI 10.1016/j.yjmcc.2007.10.007; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Norris AJ, 2010, J NEUROSCI, V30, P5092, DOI 10.1523/JNEUROSCI.5890-09.2010; Petrecca K, 2000, J NEUROSCI, V20, P8736; Phelan Mary C, 2007, Curr Protoc Cell Biol, VChapter 1, DOI 10.1002/0471143030.cb0101s36; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; ROGAWSKI MA, 1985, TRENDS NEUROSCI, V8, P214, DOI 10.1016/0166-2236(85)90082-7; SEGAL M, 1984, J NEUROSCI, V4, P604; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P387	55	27	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9640	9650		10.1074/jbc.M111.324574	http://dx.doi.org/10.1074/jbc.M111.324574			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22311982	Green Published, hybrid			2022-12-27	WOS:000301797800095
J	Ikenouchi, J; Suzuki, M; Umeda, K; Ikeda, K; Taguchi, R; Kobayashi, T; Sato, SB; Kobayashi, T; Stolz, DB; Umeda, M				Ikenouchi, Junichi; Suzuki, Mayu; Umeda, Kazuaki; Ikeda, Kazutaka; Taguchi, Ryo; Kobayashi, Tetsuyuki; Sato, Satoshi B.; Kobayashi, Toshihide; Stolz, Donna B.; Umeda, Masato			Lipid Polarity Is Maintained in Absence of Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOLATERAL PLASMA-MEMBRANE; SEPTIN DIFFUSION BARRIER; BELT-LIKE ADHERENS; EPITHELIAL-CELLS; MDCK CELLS; SPHINGOMYELIN; PROTEIN; CHOLESTEROL; LYSENIN; DOMAIN	The role of tight junctions (TJs) in the establishment and maintenance of lipid polarity in epithelial cells has long been a subject of controversy. We have addressed this issue using lysenin, a toxin derived from earthworms, and an influenza virus labeled with a fluorescent lipid, octadecylrhodamine B (R18). When epithelial cells are stained with lysenin, lysenin selectively binds to their apical membranes. Using an artificial liposome, we demonstrated that lysenin recognizes the membrane domains where sphingomyelins are clustered. Interestingly, lysenin selectively stained the apical membranes of epithelial cells depleted of zonula occludens proteins (ZO-deficient cells), which completely lack TJs. Furthermore, the fluorescent lipid inserted into the apical membrane by fusion with the influenza virus did not diffuse to the lateral membrane in ZO-deficient epithelial cells. This study revealed that sphingomyelin-cluster formation occurs only in the apical membrane and that lipid polarity is maintained even in the absence of TJs.	[Ikenouchi, Junichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Umeda, Masato] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan; [Umeda, Kazuaki] Kumamoto Univ, Dept Mol Pharmacol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo; Kobayashi, Tetsuyuki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; Ochanomizu Univ, Dept Biol, Fac Sci, Tokyo 1128610, Japan; [Sato, Satoshi B.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan; [Kobayashi, Toshihide] RIKEN, Wako, Saitama 3510198, Japan; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Japan Science & Technology Agency (JST); Kyoto University; Kumamoto University; University of Tokyo; Japan Science & Technology Agency (JST); Ochanomizu University; Kyoto University; RIKEN; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ikenouchi, J (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.	ikenouchi@sbchem.kyoto-u.ac.jp	Kobayashi, Toshihide/B-6298-2015; Ikenouchi, Junichi/X-2871-2019; Kobayashi, Tetsuyuki/AAH-2985-2020; KOBAYASHI, TOSHIHIDE/S-8313-2019	Kobayashi, Toshihide/0000-0002-4811-7270; Ikenouchi, Junichi/0000-0002-2936-3548; Kobayashi, Tetsuyuki/0000-0002-9285-0859; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. U. and J. I.) and from the Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency (to J. I.).	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2007, BIOCHEMISTRY-US, V46, P1495, DOI 10.1021/bi061290k; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; LOWY RJ, 1995, EXP CELL RES, V216, P411, DOI 10.1006/excr.1995.1052; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pandit SA, 2004, BIOPHYS J, V87, P3312, DOI 10.1529/biophysj.104.046078; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; STOLZ DB, 1992, J CELL SCI, V103, P53; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamazaki Y, 2008, MOL BIOL CELL, V19, P3801, DOI 10.1091/mbc.E08-04-0352; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004	34	34	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9525	9533		10.1074/jbc.M111.327064	http://dx.doi.org/10.1074/jbc.M111.327064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294698	Green Published, hybrid			2022-12-27	WOS:000301797800083
J	Romero-Ruiz, A; Bautista, L; Navarro, V; Heras-Garvin, A; March-Diaz, R; Castellano, A; Gomez-Diaz, R; Castro, MJ; Berra, E; Lopez-Barneo, J; Pascual, A				Romero-Ruiz, Antonio; Bautista, Lucia; Navarro, Virginia; Heras-Garvin, Antonio; March-Diaz, Rosana; Castellano, Antonio; Gomez-Diaz, Raquel; Castro, Maria J.; Berra, Edurne; Lopez-Barneo, Jose; Pascual, Alberto			Prolyl Hydroxylase-dependent Modulation of Eukaryotic Elongation Factor 2 Activity and Protein Translation under Acute Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; FACTOR-II; CELL-PROLIFERATION; ENERGY STRESS; KINASE LEADS; HIF-ALPHA; PHOSPHORYLATION; SITE; IDENTIFICATION; ACTIVATION	Early adaptive responses to hypoxia are essential for cell survival, but their nature and underlying mechanisms are poorly known. We have studied the post-transcriptional changes in the proteome of mammalian cells elicited by acute hypoxia and found that phosphorylation of eukaryotic elongation factor 2 (eEF2), a ribosomal translocase whose phosphorylation inhibits protein synthesis, is under the precise and reversible control of O-2 tension. Upon exposure to hypoxia, phosphorylation of eEF2 at Thr(56) occurred rapidly (<15 min) and resulted in modest translational arrest, a fundamental homeostatic response to hypoxia that spares ATP and thus facilitates cell survival. Acute inhibitory eEF2 phosphorylation occurred without ATP depletion or AMP kinase activation. Furthermore, eEF2 phosphorylation was mimicked by prolyl hydroxylase (PHD) inhibition with dimethyloxalylglycine or by selective PHD2 siRNA silencing but was independent of hypoxia-inducible factor alpha stabilization. Moreover, overexpression of PHD2 blocked hypoxic accumulation of phosphorylated eEF2. Therefore, our findings suggest that eEF2 phosphorylation status (and, as a consequence, translation rate) is controlled by PHD2 activity. They unravel a novel pathway for cell adaptation to hypoxia that could have pathophysiologic relevance in tissue ischemia and cancer.	[Romero-Ruiz, Antonio; Bautista, Lucia; Heras-Garvin, Antonio; March-Diaz, Rosana; Castellano, Antonio; Gomez-Diaz, Raquel; Castro, Maria J.; Lopez-Barneo, Jose; Pascual, Alberto] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC, Seville 41013, Spain; [Navarro, Virginia; Berra, Edurne] CIC BioGUNE, Ctr Invest Cooperat Biociencias, Derio 48160, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIC bioGUNE	Lopez-Barneo, J (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, CSIC, Av Manuel Siurot S-N, Seville 41013, Spain.	lbarneo@us.es; apascual-ibis@us.es	IBIS, NEURONAL/O-9910-2015; Gómez-Díaz, Raquel/D-9886-2013; IBIS, NEUROBIOLOGIA/O-9922-2015; Pascual, Alberto/L-2014-2019; Castellano, Antonio/AAH-8829-2021; cancer, biogune/H-7276-2012; Romero-Ruiz, Antonio/ABF-2083-2020; Navarro, Virginia/Q-2213-2015; IBIS, VASCULAR/P-3934-2015; Berra, Edurne/F-9692-2011; Pascual, Alberto P/E-9609-2015; Castellano, Antonio/E-6285-2010; Romero Ruiz, Antonio/K-3902-2014	Gómez-Díaz, Raquel/0000-0002-1423-1315; Pascual, Alberto/0000-0001-5459-6207; Castellano, Antonio/0000-0003-3955-5137; Navarro, Virginia/0000-0003-0108-7171; Berra, Edurne/0000-0002-3820-5744; Pascual, Alberto P/0000-0001-5459-6207; Castellano, Antonio/0000-0003-3955-5137; Castro Perez, Maria Jose/0000-0001-5221-0032; Romero Ruiz, Antonio/0000-0002-7651-9402; HERAS-GARVIN, ANTONIO/0000-0003-2231-2681	Spanish Ministry of Science and Health; Marcelino Botin Foundation; Andalusian Government	Spanish Ministry of Science and Health; Marcelino Botin Foundation; Andalusian Government	This work was supported by the Spanish Ministry of Science and Health, the Marcelino Botin Foundation, and the Andalusian Government.	Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Avila MA, 1998, GASTROENTEROLOGY, V114, P364, DOI 10.1016/S0016-5085(98)70489-5; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; LEFEBVRE VHL, 1993, ARCH BIOCHEM BIOPHYS, V304, P322, DOI 10.1006/abbi.1993.1357; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Pascual A, 2009, PROTEOMICS, V9, P2946, DOI 10.1002/pmic.200800748; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175; REDPATH NT, 1991, BIOCHIM BIOPHYS ACTA, V1093, P36, DOI 10.1016/0167-4889(91)90135-K; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Takeda K, 2007, HYPERTENSION, V49, P178, DOI 10.1161/01.HYP.0000251360.40838.0f; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009	41	25	27	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9651	9658		10.1074/jbc.M111.299180	http://dx.doi.org/10.1074/jbc.M111.299180			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22308030	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000301797800096
J	Besserer, GM; Nicoll, DA; Abramson, J; Philipson, KD				Besserer, Gabriel Mercado; Nicoll, Debora A.; Abramson, Jeff; Philipson, Kenneth D.			Characterization and Purification of a Na+/Ca2+ Exchanger from an Archaebacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOLEMMAL NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; MEMBRANE-PROTEINS; INTERNAL REPEATS; CA2+ TRANSPORT; VESICLES; OVEREXPRESSION; STOICHIOMETRY; TOPOLOGY; SYSTEM	Background: Databases include many putative prokaryotic Na+/Ca2+ exchangers, but none have been functionally expressed. Results: A membrane protein (MaX1) of Methanosarcina acetivorans catalyzes electrogenic countertransport of Na+ and Ca2(+). Conclusion: MaX1 has properties similar to those of mammalian Na+/Ca2+ exchangers. Significance: The characterization and purification of MaX1 should facilitate structure/function studies.	[Besserer, Gabriel Mercado; Nicoll, Debora A.; Abramson, Jeff; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Nicoll, Debora A.; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abramson, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	jabramson@mednet.ucla.edu; kphilipson@mednet.ucla.edu			National Institutes of Health [R01 HL49101, R21 HL093278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093278, R01HL049101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL49101 (to K.D.P.) and R21 HL093278 (to J.A.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; ANDO A, 1981, BIOCHIM BIOPHYS ACTA, V640, P179, DOI 10.1016/0005-2736(81)90543-5; BELLIVEAU JW, 1978, ARCH BIOCHEM BIOPHYS, V186, P98, DOI 10.1016/0003-9861(78)90468-X; BERS DM, 1980, BIOCHIM BIOPHYS ACTA, V601, P358, DOI 10.1016/0005-2736(80)90540-4; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Dong H, 2002, BIOPHYS J, V82, P1943, DOI 10.1016/S0006-3495(02)75543-4; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; LI ZP, 1991, J BIOL CHEM, V266, P1014; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Miller J.H., 1972, EXPT MOL GENETICS; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; PHILIPSON KD, 1980, J BIOL CHEM, V255, P6880; REEVES JP, 1984, J BIOL CHEM, V259, P7733; REEVES JP, 1983, J BIOL CHEM, V258, P3178; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROSPER TL, 1983, BIOCHIM BIOPHYS ACTA, V731, P63, DOI 10.1016/0005-2736(83)90398-X; VEMURI R, 1988, BIOCHIM BIOPHYS ACTA, V937, P258, DOI 10.1016/0005-2736(88)90248-9; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671	35	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8652	8659		10.1074/jbc.M111.331280	http://dx.doi.org/10.1074/jbc.M111.331280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22287543	Green Published, hybrid			2022-12-27	WOS:000301349400077
J	Dey, SS; Xue, YH; Joachimiak, MP; Friedland, GD; Burnett, JC; Zhou, Q; Arkin, AP; Schaffer, DV				Dey, Siddharth S.; Xue, Yuhua; Joachimiak, Marcin P.; Friedland, Gregory D.; Burnett, John C.; Zhou, Qiang; Arkin, Adam P.; Schaffer, David V.			Mutual Information Analysis Reveals Coevolving Residues in Tat That Compensate for Two Distinct Functions in HIV-1 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA-POLYMERASE-II; CHROMATIN-REMODELING COMPLEX; LONG TERMINAL REPEAT; TYPE-1 SUBTYPE-C; TRANSCRIPTIONAL ACTIVITY; CORRELATED MUTATIONS; PROTEIN; TRANSACTIVATION; PHOSPHORYLATION	Viral genomes are continually subjected to mutations, and functionally deleterious ones can be rescued by reversion or additional mutations that restore fitness. The error prone nature of HIV-1 replication has resulted in highly diverse viral sequences, and it is not clear how viral proteins such as Tat, which plays a critical role in viral gene expression and replication, retain their complex functions. Although several important amino acid positions in Tat are conserved, we hypothesized that it may also harbor functionally important residues that may not be individually conserved yet appear as correlated pairs, whose analysis could yield new mechanistic insights into Tat function and evolution. To identify such sites, we combined mutual information analysis and experimentation to identify coevolving positions and found that residues 35 and 39 are strongly correlated. Mutation of either residue of this pair into amino acids that appear in numerous viral isolates yields a defective virus; however, simultaneous introduction of both mutations into the heterologous Tat sequence restores gene expression close to wild-type Tat. Furthermore, in contrast to most coevolving protein residues that contribute to the same function, structural modeling and biochemical studies showed that these two residues contribute to two mechanistically distinct steps in gene expression: binding P-TEFb and promoting P-TEFb phosphorylation of the C-terminal domain in RNAPII. Moreover, Tat variants that mimic HIV-1 subtypes B or C at sites 35 and 39 have evolved orthogonal strengths of P-TEFb binding versus RNAPII phosphorylation, suggesting that subtypes have evolved alternate transcriptional strategies to achieve similar gene expression levels.	[Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Dey, Siddharth S.; Burnett, John C.; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Dey, Siddharth S.; Burnett, John C.; Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Xue, Yuhua; Zhou, Qiang] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Joachimiak, Marcin P.; Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Joachimiak, Marcin P.; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Energy, Joint BioEnergy Inst, Berkeley, CA 94720 USA; [Friedland, Gregory D.] Joint BioEnergy Inst, Div Technol, Emeryville, CA 94608 USA; [Friedland, Gregory D.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA 94551 USA; [Xue, Yuhua] Xiamen Univ, Sch Pharmaceut Sci, Xiamen 361005, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories; Xiamen University	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov; schaffer@berkeley.edu	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Burnett, John/0000-0002-8817-6064; Dey, Siddharth S./0000-0002-1161-1654; joachimiak, marcin/0000-0001-8175-045X	National Institutes of Health [R01GM073058, R01AI41757-11, R01AI41757-11S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM073058 (to A. P. A. and D. V. S.) and Grants R01AI41757-11 and R01AI41757-11S1 (to Q. Z.).	Agbottah E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-48; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Bres V, 2009, MOL CELL, V36, P75, DOI 10.1016/j.molcel.2009.08.015; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Cimarelli A, 2000, J VIROL, V74, P4273, DOI 10.1128/JVI.74.9.4273-4283.2000; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; del Alamo M, 2005, J MOL BIOL, V345, P893, DOI 10.1016/j.jmb.2004.10.086; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Desfosses Y, 2005, J VIROL, V79, P9180, DOI 10.1128/JVI.79.14.9180-9191.2005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jain C, 1996, CELL, V87, P115, DOI 10.1016/S0092-8674(00)81328-8; Johnson Victoria A, 2009, Top HIV Med, V17, P138; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; LI NX, 1994, ONCOGENE, V9, P3457; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; Negroni M, 2001, ANNU REV GENET, V35, P275, DOI 10.1146/annurev.genet.35.102401.090551; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; Tachedjian G, 2000, P NATL ACAD SCI USA, V97, P6334, DOI 10.1073/pnas.97.12.6334; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; Verhoef K, 1999, J VIROL, V73, P2781, DOI 10.1128/JVI.73.4.2781-2789.1999; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000	51	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7945	7955		10.1074/jbc.M111.302653	http://dx.doi.org/10.1074/jbc.M111.302653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22253435	Green Published, hybrid			2022-12-27	WOS:000301349400011
J	Lillehoj, EP; Hyun, SW; Feng, CG; Zhang, L; Liu, AG; Guang, W; Nguyen, C; Luzina, IG; Atamas, SP; Passaniti, A; Twaddell, WS; Puche, AC; Wang, LX; Cross, AS; Goldblum, SE				Lillehoj, Erik P.; Hyun, Sang Won; Feng, Chiguang; Zhang, Lei; Liu, Anguo; Guang, Wei; Nguyen, Chinh; Luzina, Irina G.; Atamas, Sergei P.; Passaniti, Antonino; Twaddell, William S.; Puche, Adam C.; Wang, Lai-Xi; Cross, Alan S.; Goldblum, Simeon E.			NEU1 Sialidase Expressed in Human Airway Epithelia Regulates Epidermal Growth Factor Receptor (EGFR) and MUC1 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA FLAGELLIN; TOLL-LIKE RECEPTOR-5; CELL-SURFACE MUCIN; LYSOSOMAL SIALIDASE; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; ELASTIN RECEPTOR; CANCER CELLS; PARACELLULAR PATHWAY; KINASE ACTIVATION	Epithelial cells (ECs) lining the airways provide a protective barrier between the external environment and the internal host milieu. These same airway epithelia express receptors that respond to danger signals and initiate repair programs. Because the sialylation state of a receptor can influence its function and is dictated in part by sialidase activity, we asked whether airway epithelia express catalytically active sialidase(s). Human primary small airway and A549 ECs expressed NEU1 sialidase at the mRNA and protein levels, and NEU1 accounted for >70% of EC sialidase activity. Blotting with Maackia amurensis and peanut agglutinin lectins established epidermal growth factor receptor (EGFR) and MUC1 as in vivo substrates for NEU1. NEU1 associated with EGFR and MUC1, and NEU1-EGFR association was regulated by EGF stimulation. NEU1 overexpression diminished EGF-stimulated EGFR Tyr-1068 autophosphorylation by up to 44% but enhanced MUC1-dependent Pseudomonas aeruginosa adhesion by 1.6-1.7-fold and flagellin-stimulated ERK1/2 activation by 1.7-1.9-fold. In contrast, NEU1 depletion increased EGFR activation (1.5-fold) and diminished MUC1-mediated bacterial adhesion (38-56%) and signaling (73%). These data indicate for the first time that human airway epithelia express catalytically active NEU1 sialidase that regulates EGFR-and MUC1-dependent signaling and bacterial adhesion. NEU1 catalytic activity may offer an additional level of regulation over the airway epithelial response to ligands, pathogens, and injurious stimuli.	[Lillehoj, Erik P.; Hyun, Sang Won; Liu, Anguo; Nguyen, Chinh; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Lillehoj, Erik P.; Guang, Wei] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Luzina, Irina G.; Atamas, Sergei P.; Cross, Alan S.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Passaniti, Antonino; Twaddell, William S.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Feng, Chiguang; Zhang, Lei; Cross, Alan S.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	wang, xl/Y-8251-2019; Wang, Lai-Xi/E-8755-2019; Wang, Xin/AAN-8435-2021; Wang, Lai-Xi/E-8790-2019	Wang, Xin/0000-0002-4457-7376; Wang, Lai-Xi/0000-0003-4293-5819; , Erik/0000-0003-0910-6074; Lillehoj, Erik/0000-0002-2710-1704	National Institutes of Health [HL084223, HL070155, AI072291, AI083463, HL086933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084223, R01HL070155, R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072291, R21AI083463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant HL084223 and HL070155 (to S. E. G.), AI072291 and AI083463 (to E. P. L.), and HL086933 (to A. S. C.).	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Anthony RM, 2010, J CLIN IMMUNOL, V30, pS9, DOI 10.1007/s10875-010-9405-6; Antonicelli F, 2009, WOUND REPAIR REGEN, V17, P631, DOI 10.1111/j.1524-475X.2009.00525.x; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Champigny MJ, 2003, GENE, V319, P177, DOI 10.1016/S0378-1119(03)00808-4; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Costa NR, 2008, WORLD J GASTROENTERO, V14, P1411, DOI 10.3748/wjg.14.1411; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; d'Azzo A, 2010, BIOCHEM SOC T, V38, P1453, DOI 10.1042/BST0381453; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gallego MP, 2006, COLLOID SURFACE B, V52, P154, DOI 10.1016/j.colsurfb.2006.04.013; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Guang W, 2010, J BIOL CHEM, V285, P20547, DOI 10.1074/jbc.M110.121319; Gupta SK, 1997, INFECT IMMUN, V65, P2747, DOI 10.1128/IAI.65.7.2747-2753.1997; HANISCH FG, 1995, CANCER RES, V55, P4036; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kato Kosuke, 2010, Front Biosci (Elite Ed), V2, P68, DOI 10.2741/e67; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; KAWAGUCHI T, 1974, J BIOL CHEM, V249, P2786; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lillehoj EP, 2001, AM J PHYSIOL-LUNG C, V280, pL181, DOI 10.1152/ajplung.2001.280.1.L181; Lindorfer MA, 2001, J IMMUNOL, V167, P2240, DOI 10.4049/jimmunol.167.4.2240; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Meuillet EJ, 1999, CANCER RES, V59, P234; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 1999, GLYCOBIOLOGY, V9, P1313, DOI 10.1093/glycob/9.12.1313; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; MORREAU H, 1992, J BIOL CHEM, V267, P17949; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parker P, 2010, GLYCOCONJUGATE J, V27, P89, DOI 10.1007/s10719-009-9269-2; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; SAIMAN L, 1993, J CLIN INVEST, V92, P1875, DOI 10.1172/JCI116779; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Starcher B, 2008, AM J PHYSIOL-LUNG C, V295, pL637, DOI 10.1152/ajplung.90346.2008; Steelant WFA, 1999, CLIN EXP METASTAS, V17, P245, DOI 10.1023/A:1006639804430; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Uehara F, 2002, JPN J OPHTHALMOL, V46, P237, DOI 10.1016/S0021-5155(02)00472-0; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wang P, 2004, BIOCHEM J, V380, P425, DOI 10.1042/BJ20031896; Wu WY, 1997, GLYCOBIOLOGY, V7, P349, DOI 10.1093/glycob/7.3.349; Yamaguchi K, 2006, BIOCHEM BIOPH RES CO, V346, P484, DOI 10.1016/j.bbrc.2006.05.136; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	80	59	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8214	8231		10.1074/jbc.M111.292888	http://dx.doi.org/10.1074/jbc.M111.292888			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22247545	Green Published, hybrid			2022-12-27	WOS:000301349400037
J	Niwa, H; Ewens, CA; Tsang, C; Yeung, HO; Zhang, XD; Freemont, PS				Niwa, Hajime; Ewens, Caroline A.; Tsang, Chun; Yeung, Heidi O.; Zhang, Xiaodong; Freemont, Paul S.			The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; ENDOPLASMIC-RETICULUM; P97/VALOSIN-CONTAINING PROTEIN; CONFORMATIONAL-CHANGES; VCP MUTATIONS; D1 RING	p97/valosin-containing protein (VCP) is a type II ATPase associated with various cellular activities that forms a homohexamer with each protomer containing an N-terminal domain (N-domain); two ATPase domains, D1 and D2; and a disordered C-terminal region. Little is known about the role of the N-domain or the C-terminal region in the p97 ATPase cycle. In the p97-associated human disease inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia, the majority of missense mutations are located at the N-domain D1 interface. Structure-based predictions suggest that such mutations affect the interaction of the N-domain with D1. Here we have tested ten major inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia-linked mutants for ATPase activity and found that all have increased activity over the wild type, with one mutant, p97(A232E), having three times higher activity. Further mutagenesis of p97(A232E) shows that the increase in ATPase activity is mediated through D2 and requires both the N-domain and a flexible ND1 linker. A disulfide mutation that locks the N-domain to D1 in a coplanar position reversibly abrogates ATPase activity. A cryo-EM reconstruction of p97(A232E) suggests that the N-domains are flexible. Removal of the C-terminal region also reduces ATPase activity. Taken together, our data suggest that the conformation of the N-domain in relation to the D1-D2 hexamer is directly linked to ATP hydrolysis and that the C-terminal region is required for hexamer stability. This leads us to propose a model where the N-domain adopts either of two conformations: a flexible conformation compatible with ATP hydrolysis or a coplanar conformation that is inactive.	[Niwa, Hajime; Ewens, Caroline A.; Tsang, Chun; Yeung, Heidi O.; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, Struct Biol Ctr, London SW7 2AZ, England	Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, Struct Biol Ctr, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Freemont, Paul/0000-0002-5658-8486; Zhang, Xiaodong/0000-0001-9786-7038	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; EGERTON M, 1994, J BIOL CHEM, V269, P11435; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rothballer A, 2007, FEBS LETT, V581, P1197, DOI 10.1016/j.febslet.2007.02.031; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tanner JA, 2002, J BIOL CHEM, V277, P3073, DOI 10.1074/jbc.M106588200; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	56	89	89	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8561	8570		10.1074/jbc.M111.302778	http://dx.doi.org/10.1074/jbc.M111.302778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270372	Green Published, hybrid			2022-12-27	WOS:000301349400069
J	Rouaud, P; Vincent-Fabert, C; Fiancette, R; Cogne, M; Pinaud, E; Denizot, Y				Rouaud, Pauline; Vincent-Fabert, Christelle; Fiancette, Remi; Cogne, Michel; Pinaud, Eric; Denizot, Yves			Enhancers Located in Heavy Chain Regulatory Region (hs3a, hs1,2, hs3b, and hs4) Are Dispensable for Diversity of VDJ Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; B-CELL DEVELOPMENT; V(D)J RECOMBINATION; INTRONIC ENHANCER; IGH LOCUS; ELEMENTS; GENE; DELETION; INSULATORS; EXPRESSION	V(D)J recombination occurs during the antigen-independent early steps of B-cell ontogeny. Multiple IgH cis-regulatory elements control B-cell ontogeny. IGCR1 (intergenic control region 1), the DQ52 promoter/enhancer, and the intronic Emu enhancer, all three located upstream of Cmu, have important roles during V(D)J recombination, whereas there is no clue about a role of the IgH regulatory region (RR) encompassing the four transcriptional enhancers hs3a, hs1,2, hs3b, and hs4 during these early stages. To clarify the role of the RR in V(D)J recombination, we totally deleted it in the mouse genome. Here, we show that V(D)J recombination is unaffected by the complete absence of the IgH RR, highlighting that this region only orchestrates IgH locus activity during the late stages of B-cell differentiation. In contrast, the earliest antigen-independent steps of B-cell ontogeny would be under the control of only the upstream Cmu elements of the locus.	[Denizot, Yves] Univ Limoges, CNRS, UMR 7276, Immunol Lab, F-87025 Limoges, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges	Denizot, Y (corresponding author), Univ Limoges, CNRS, UMR 7276, Immunol Lab, 2 Rue Dr Marcland, F-87025 Limoges, France.	yves.denizot@unilim.fr	Vincent-Fabert, Christelle/AGZ-5883-2022; Denizot, Yves/H-9769-2016; PINAUD, Eric/O-8443-2016; cogné, michel/D-7370-2015	PINAUD, Eric/0000-0001-7405-9273; cogné, michel/0000-0002-8519-4427; Rouaud-Tinguely, Pauline/0000-0003-2238-7077; VINCENT-FABERT, Christelle/0000-0002-5799-980X	Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze); Conseil Regional du Limousin; Agence Nationale de Recherche; Association pour la Recherche sur le Cancer (ARC)	Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); Agence Nationale de Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by grants from the Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze), the Conseil Regional du Limousin, and Agence Nationale de Recherche (Projets Blanc 2011).; Supported by a grant from the Association pour la Recherche sur le Cancer (ARC). Present address: Centre de Recherche en Cancerologie de Marseille, INSERM U891, 13009 Marseille, France.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Guglielmi L, 2003, BBA-MOL CELL RES, V1642, P181, DOI 10.1016/j.bbamcr.2003.08.005; Guglielmi L, 2003, BIOCHEM BIOPH RES CO, V307, P466, DOI 10.1016/S0006-291X(03)01185-9; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Le Morvan C, 2003, BLOOD, V102, P1421, DOI 10.1182/blood-2002-12-3827; Nitschke L, 2001, J IMMUNOL, V166, P2540, DOI 10.4049/jimmunol.166.4.2540; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Vincent-Fabert C, 2010, EUR J IMMUNOL, V40, P3306, DOI 10.1002/eji.201040778; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Yan Y, 2011, J BIOL CHEM, V286, P27123, DOI 10.1074/jbc.M111.230995	22	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8356	8360		10.1074/jbc.M112.341024	http://dx.doi.org/10.1074/jbc.M112.341024			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270371	hybrid, Green Published			2022-12-27	WOS:000301349400050
J	Storti, B; Bizzarri, R; Cardarelli, F; Beltram, F				Storti, Barbara; Bizzarri, Ranieri; Cardarelli, Francesco; Beltram, Fabio			Intact Microtubules Preserve Transient Receptor Potential Vanilloid 1 (TRPV1) Functionality through Receptor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; CHANNEL; FRET; NUMBER; IDENTIFICATION; ORGANIZATION; BRIGHTNESS; ACTIVATION; PROTEINS; DYNAMICS	The transient receptor potential cation channel subfamily V member 1 (TRPV1) is a protein currently under scrutiny as a pharmacological target for pain management therapies. Recently, the role of TRPV1-microtubule interaction in transducing nociception stimuli to cells by cytoskeletal rearrangement was proposed. In this work, we investigate TRPV1-microtubule interaction in living cells under the resting or activated state of TRPV1, as well as in presence of structurally intact or depolymerized cytoskeletal microtubules. We combined a tool-box of high resolution/high sensitivity fluorescence imaging techniques (such as FRET, correlation spectroscopy, and fluorescence anisotropy) to monitor TRPV1 aggregation status, membrane mobility, and interaction with microtubules. We found that TRPV1 is a dimeric membrane protein characterized by two populations with different diffusion properties in basal condition. After stimulation with resiniferatoxin, TRPV1 dimers tetramerize. The tetramers and the slower population of TRPV1 dimers bind dynamically to intact microtubules but not to tubulin dimers. Upon microtubule disassembly, the interaction with TRPV1 is lost thereby inducing receptor self-aggregation with partial loss of functionality. Intact microtubules play an essential role in maintaining TRPV1 functionality toward activation stimuli. This previously undisclosed property mirrors the recently reported role of TRPV1 in modulating microtubule assembly/disassembly and suggests the participation of these two players in a feedback cycle linking nociception and cytoskeletal remodeling.	[Storti, Barbara; Bizzarri, Ranieri; Beltram, Fabio] Scuola Normale Super Pisa, Natl Enterprise NanoSci & NanoTechnol NEST, I-56127 Pisa, Italy; [Storti, Barbara; Bizzarri, Ranieri; Beltram, Fabio] CNR, Ist Nanosci, I-56127 Pisa, Italy; [Storti, Barbara; Bizzarri, Ranieri; Cardarelli, Francesco; Beltram, Fabio] Ist Italiano Tecnol, Ctr Nanotechnol Innovat, NEST, I-56127 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Storti, B (corresponding author), Scuola Normale Super Pisa, Natl Enterprise NanoSci & NanoTechnol NEST, Piazza S Silvestro 12, I-56127 Pisa, Italy.	barbara.storti@sns.it	Storti, Barbara/AAB-7791-2019; Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/ABH-8343-2020; Bizzarri, Ranieri/H-1779-2011	Storti, Barbara/0000-0002-2758-0426; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672	Italian Ministry for University and Research [RBLA03ER38, RBPR05JH2P, PRIN 2008JZ4MLB_002]	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for University and Research under the framework of FIRB Projects RBLA03ER38, RBPR05JH2P, and PRIN 2008JZ4MLB_002.	Abbruzzetti S, 2010, PHOTOCH PHOTOBIO SCI, V9, P1307, DOI 10.1039/c0pp00189a; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; MILLS JW, 1994, FASEB J, V8, P1161, DOI 10.1096/fasebj.8.14.7958622; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Ossato G, 2010, BIOPHYS J, V98, P3078, DOI 10.1016/j.bpj.2010.02.058; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Tramier M, 2008, METHOD CELL BIOL, V85, P395, DOI 10.1016/S0091-679X(08)85017-0; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	36	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7803	7811		10.1074/jbc.M111.332296	http://dx.doi.org/10.1074/jbc.M111.332296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262838	hybrid, Green Published			2022-12-27	WOS:000301060200078
J	Sullenger, B; Woodruff, R; Monroe, DM				Sullenger, Bruce; Woodruff, Rebecca; Monroe, Dougald M.			Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID EXTRUSION PROCEDURE; CARDIOPULMONARY BYPASS; FACTOR-VIIA; FACTOR-X; BLOOD-COAGULATION; TISSUE FACTOR; FACTOR XIA; IN-VIVO; INHIBITION; EXOSITE	An aptamer targeting factor IXa has been evaluated in animal models and several clinical studies as a potential antithombotic therapy. We elucidate the molecular mechanism by which this aptamer acts as an anticoagulant. The aptamer binds tightly to factor IXa and prolongs the clotting time of human plasma. The aptamer completely blocks factor IXa activation of factor X regardless of the presence of factor VIIIa. However, the aptamer does not completely block small synthetic substrate cleavage, although it does slow the rate of cleavage. These data are consistent with the aptamer binding to the catalytic domain of factor IXa in such a way as to block an extended substrate-binding site. Therefore, unlike small molecule inhibitors, aptamers appear to be able to bind surfaces surrounding an active site and thereby sterically interfere with enzyme activity. Thus, aptamers may be useful agents to probe and block substrate-binding sites outside of the active site of an enzyme.	[Monroe, Dougald M.] Univ N Carolina, Div Hematol & Oncol, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Sullenger, Bruce; Woodruff, Rebecca] Duke Univ, Med Ctr, Dept Surg, Duke Translat Res Inst, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Monroe, DM (corresponding author), Univ N Carolina, Div Hematol & Oncol, Sch Med, Dept Med, 310 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 USA.	dmonroe@med.unc.edu		Monroe, Dougald/0000-0002-0493-2943	National Institutes of Health [HL065222]; Coagulation Research Trust from the University of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coagulation Research Trust from the University of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065222. This work was also supported by the Coagulation Research Trust Fund from the University of North Carolina.	Aktimur A, 2003, J BIOL CHEM, V278, P7981, DOI 10.1074/jbc.M212748200; Bauer KA, 2002, SEMIN THROMB HEMOST, V28, P15, DOI 10.1055/s-2002-32313; BEGUIN S, 1991, THROMB HAEMOSTASIS, V66, P306; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Chan MY, 2008, J THROMB HAEMOST, V6, P789, DOI 10.1111/j.1538-7836.2008.02932.x; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Chen SWW, 2002, THROMB HAEMOSTASIS, V88, P74; Cohen MG, 2010, CIRCULATION, V122, P614, DOI 10.1161/CIRCULATIONAHA.109.927756; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gopinath SCB, 2006, THROMB HAEMOSTASIS, V95, P767, DOI 10.1160/TH06-01-0047; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; GRIFFITH MJ, 1985, J CLIN INVEST, V75, P4, DOI 10.1172/JCI111694; HAMAGUCHI N, 1993, BIOCHEMISTRY-US, V32, P6324, DOI 10.1021/bi00076a004; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; LOLLAR P, 1984, ARCH BIOCHEM BIOPHYS, V233, P438, DOI 10.1016/0003-9861(84)90465-X; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MCNEELY TB, 1985, BLOOD, V65, P1226; Millar JA, 2008, MED J AUSTRALIA, V189, P504, DOI 10.5694/j.1326-5377.2008.tb02145.x; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nimjee SM, 2009, RNA, V15, P2105, DOI 10.1261/rna.1240109; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Perka C, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-17; Refino CJ, 1999, THROMB HAEMOSTASIS, V82, P1188; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Spanier TB, 1998, J THORAC CARDIOV SUR, V116, P860, DOI 10.1016/S0022-5223(98)00437-1; Spanier TB, 1998, J THORAC CARDIOV SUR, V115, P1179, DOI 10.1016/S0022-5223(98)70419-2; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; TELGT DSC, 1989, THROMB RES, V56, P603, DOI 10.1016/0049-3848(89)90268-5; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yavari M, 2008, J THROMB THROMBOLYS, V26, P218, DOI 10.1007/s11239-008-0280-4; Zhang Y, 1998, BIOCHEMISTRY-US, V37, P10681, DOI 10.1021/bi973050y	43	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12779	12786		10.1074/jbc.M111.300772	http://dx.doi.org/10.1074/jbc.M111.300772			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334679	Green Published, hybrid			2022-12-27	WOS:000302903700017
J	Lemkau, LR; Comellas, G; Kloepper, KD; Woods, WS; George, JM; Rienstra, CM				Lemkau, Luisel R.; Comellas, Gemma; Kloepper, Kathryn D.; Woods, Wendy S.; George, Julia M.; Rienstra, Chad M.			Mutant Protein A30P alpha-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; FAMILIAL PARKINSONS-DISEASE; ANGLE-SPINNING NMR; POINT MUTATIONS A30P; HUMAN PRION PROTEIN; CHEMICAL-SHIFT; AMYLOID FIBRILS; SECONDARY STRUCTURE; MOLECULAR-CONFORMATION; RESONANCE ASSIGNMENTS	alpha-Synuclein (AS) is associated with both sporadic and familial forms of Parkinson disease (PD). In sporadic disease, wild-type AS fibrillates and accumulates as Lewy bodies within dopaminergic neurons of the substantia nigra. The accumulation of misfolded AS is associated with the death of these neurons, which underlies many of the clinical features of PD. In addition, a rare missense mutation in AS, A30P, is associated with highly penetrant, autosomal dominant PD, although the pathogenic mechanism is unclear. A30P AS fibrillates more slowly than the wild-type (WT) protein in vitro and has been reported to preferentially adopt a soluble, protofibrillar conformation. This has led to speculation that A30P forms aggregates that are distinct in structure compared with wild-type AS. Here, we perform a detailed comparison of the chemical shifts and secondary structures of these fibrillar species, based upon our recent characterization of full-length WT fibrils. We have assigned A30P AS fibril chemical shifts de novo and used them to determine its secondary structure empirically. Our results illustrate that although A30P forms fibrils more slowly than WT in vitro, the chemical shifts and secondary structure of the resultant fibrils are in high agreement, demonstrating a conserved beta-sheet core.	[Lemkau, Luisel R.; Kloepper, Kathryn D.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Comellas, Gemma; Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Woods, Wendy S.; George, Julia M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Rienstra, Chad M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rienstra, CM (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	rienstra@scs.illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	National Institutes of Health [R01-GM073770]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM073770.	Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Comellas G, 2011, J MAGN RESON, V209, P131, DOI 10.1016/j.jmr.2010.12.011; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goddard T. D., 2006, SPARKY 3 106; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Huang L, 2008, BBA-BIOENERGETICS, V1777, P1098, DOI 10.1016/j.bbabio.2008.01.006; Igumenova TI, 2004, J AM CHEM SOC, V126, P5323, DOI 10.1021/ja030546w; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li Y, 2008, PROTEIN SCI, V17, P199, DOI 10.1110/ps.073225008; Marulanda D, 2005, J PHYS CHEM B, V109, P18135, DOI 10.1021/jp052774d; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Pauli J, 2001, CHEMBIOCHEM, V2, P272, DOI 10.1002/1439-7633(20010401)2:4<272::AID-CBIC272>3.3.CO;2-U; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pintacuda G, 2007, ANGEW CHEM INT EDIT, V46, P1079, DOI 10.1002/anie.200603093; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schmidt HLF, 2007, J PHYS CHEM B, V111, P14362, DOI 10.1021/jp075531p; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wylie BJ, 2009, J AM CHEM SOC, V131, P985, DOI 10.1021/ja804041p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	56	52	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11526	11532		10.1074/jbc.M111.306902	http://dx.doi.org/10.1074/jbc.M111.306902			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334684	Green Published, hybrid			2022-12-27	WOS:000302780100080
J	Fueller, F; Jehle, B; Putzker, K; Lewis, JD; Krauth-Siegel, RL				Fueller, Florian; Jehle, Britta; Putzker, Kerstin; Lewis, Joe D.; Krauth-Siegel, R. Luise			High Throughput Screening against the Peroxidase Cascade of African Trypanosomes Identifies Antiparasitic Compounds That Inactivate Tryparedoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOTHIONE REDUCTASE; CRITHIDIA-FASCICULATA; BRUCEI TRYPAREDOXIN; CATALYTIC MECHANISM; THERAPEUTIC TARGETS; METABOLISM; THIOREDOXIN; INHIBITORS; PROTEIN; CRUZI	In African trypanosomes, the detoxification of broad spectrum hydroperoxides relies on a unique cascade composed of trypanothione (T(SH)(2)), trypanothione reductase, tryparedoxin (Tpx), and nonselenium glutathione peroxidase-type enzymes. All three proteins are essential for Trypanosoma brucei. Here, we subjected the complete system to a high throughput screening approach with nearly 80,000 chemicals. Twelve compounds inhibited the peroxidase system. All but one carried chloroalkyl substituents. The detailed kinetic analysis showed that two compounds weakly inhibited trypanothione reductase, but none of them specifically interacted with the peroxidase. They proved to be time-dependent inhibitors of Tpx-modifying Cys-40, the first cysteine of its active site WCPPC motif. Importantly, gel shift assays verified Tpx as a target in the intact parasites. T(SH)(2), present in the in vitro assays and in the cells in high molar excess, did not interfere with Tpx inactivation. The compounds inhibited the proliferation of bloodstream T. brucei with EC50 values down to < 1 mu M and exerted up to 83-fold lower toxicity toward HeLa cells. Irreversible inhibitors are traditionally regarded as unfavorable. However, a large number of anti-microbials and anticancer therapeutics acts covalently with their target protein. The compounds identified here also interacted with recombinant human thioredoxin, a distant relative of Tpx. This finding might even be exploited for thioredoxin-based anticancer drug development approaches reported recently. The fact that the T(SH)(2)/Tpx couple occupies a central position within the trypanosomal thiol metabolism and delivers electrons also for the synthesis of DNA precursors renders the parasite-specific oxidoreductase an attractive drug target molecule.	[Fueller, Florian; Krauth-Siegel, R. Luise] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; [Jehle, Britta; Putzker, Kerstin; Lewis, Joe D.] EMBL Heidelberg, Chem Biol Core Facil, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Krauth-Siegel, RL (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	luise.krauth-siegel@bzh.uni-heidelberg.de		Lewis, Joe/0000-0002-9926-1328; Putzker, Kerstin/0000-0001-8375-5908	Deutsche Forschungsgemeinschaft [SFB 544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 544, Project B3 (to L.K.-S.).	Alphey MS, 1999, J BIOL CHEM, V274, P25613, DOI 10.1074/jbc.274.36.25613; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Budde H, 2003, BIOL CHEM, V384, P1305, DOI 10.1515/BC.2003.146; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Eberle C, 2011, CHEMMEDCHEM, V6, P292, DOI 10.1002/cmdc.201000420; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; Hall G, 2011, PROTEIN SCI, V20, P210, DOI 10.1002/pro.533; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; Holloway GA, 2009, ANTIMICROB AGENTS CH, V53, P2824, DOI 10.1128/AAC.01568-08; Jarvinen PP, 2010, COMB CHEM HIGH T SCR, V13, P278, DOI 10.2174/138620710790980559; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; Konig J, 2011, J BIOL CHEM, V286, P8523, DOI 10.1074/jbc.M110.214833; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; Mackey ZB, 2006, CHEM BIOL DRUG DES, V67, P355, DOI 10.1111/j.1747-0285.2006.00389.x; Martyn DC, 2007, BIOORG MED CHEM LETT, V17, P1280, DOI 10.1016/j.bmcl.2006.12.016; Melchers J, 2008, J BIOL CHEM, V283, P30401, DOI 10.1074/jbc.M803563200; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Mukherjee A, 2007, BRIT J PHARMACOL, V151, P1167, DOI 10.1038/sj.bjp.0707342; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Otero L, 2006, J MED CHEM, V49, P3322, DOI 10.1021/jm0512241; Perez DI, 2009, BIOORGAN MED CHEM, V17, P6914, DOI 10.1016/j.bmc.2009.08.042; Rist W, 2005, ANAL BIOCHEM, V342, P160, DOI 10.1016/j.ab.2004.11.043; Rivera G, 2009, CURR MED CHEM, V16, P3286, DOI 10.2174/092986709788803303; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	46	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8792	8802		10.1074/jbc.M111.338285	http://dx.doi.org/10.1074/jbc.M111.338285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275351	Green Published, hybrid			2022-12-27	WOS:000301797800012
J	Paget, C; Ivanov, S; Fontaine, J; Renneson, J; Blanc, F; Pichavant, M; Dumoutier, L; Ryffel, B; Renauld, JC; Gosset, P; Gosset, P; Si-Tahar, M; Faveeuw, C; Trottein, F				Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Blanc, Fany; Pichavant, Muriel; Dumoutier, Laure; Ryffel, Bernhard; Renauld, Jean Christophe; Gosset, Philippe; Gosset, Pierre; Si-Tahar, Mustapha; Faveeuw, Christelle; Trottein, Francois			Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus Infection POTENTIAL ROLE IN PROTECTION AGAINST LUNG EPITHELIAL DAMAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; HERPES-SIMPLEX-VIRUS; DOUBLE-STRANDED-RNA; NKT CELLS; VIRAL-INFECTION; RIG-I; ANTIVIRAL RESPONSES; MUCOSAL IMMUNITY; CUTTING EDGE; MICROBIAL INFECTION	Invariant natural killer T (iNKT) cells are non-conventional lipid-reactive alpha beta T lymphocytes that play a key role in host responses during viral infections, in particular through the swift production of cytokines. Their beneficial role during experimental influenza A virus (IAV) infection has recently been proposed, although the mechanisms involved remain elusive. Here we show that during in vivo IAV infection, mouse pulmonary iNKT cells produce IFN-gamma and IL-22, a Th17-related cytokine critical in mucosal immunity. Although permissive to viral replication, IL-22 production by iNKT cells is not due to IAV infection per se of these cells but is indirectly mediated by IAV-infected dendritic cells (DCs). We show that activation of the viral RNA sensors TLR7 and RIG-I in DCs is important for triggering IL-22 secretion by iNKT cells, whereas the NOD-like receptors NOD2 and NLRP3 are dispensable. Invariant NKT cells respond to IL-1 beta and IL-23 provided by infected DCs independently of the CD1d molecule to release IL-22. In vitro, IL-22 protects IAV-infected airway epithelial cells against mortality but has no role on viral replication. Finally, during early IAV infection, IL-22 plays a positive role in the control of lung epithelial damages. Overall, IAV infection of DCs activates iNKT cells, providing a rapid source of IL-22 that might be beneficial to preserve the lung epithelium integrity.	[Trottein, Francois] Inst Pasteur, CNRS, INSERM, Ctr Infect & Immun Lille,UMR 8204,U1019, F-59019 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] Univ Lille Nord France, F-59000 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] CNRS, UMR 8204, F-59021 Lille, France; [Paget, Christophe; Ivanov, Stoyan; Fontaine, Josette; Renneson, Joelle; Pichavant, Muriel; Gosset, Philippe; Faveeuw, Christelle; Trottein, Francois] Inst Federatif Rech, F-59019 Lille, France; [Blanc, Fany; Si-Tahar, Mustapha] Inst Pasteur, F-75015 Paris, France; [Blanc, Fany; Si-Tahar, Mustapha] INSERM, U874, F-75015 Paris, France; [Dumoutier, Laure; Renauld, Jean Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Ryffel, Bernhard] Univ Orleans, CNRS, UMR 6218, F-45071 Orleans, France; [Gosset, Pierre] Univ Catholique Lille, Inst Catholique Lille, Grp Hosp, Hop St Vincent, F-59020 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Universite Catholique de Lille	Trottein, F (corresponding author), Inst Pasteur, CNRS, INSERM, Ctr Infect & Immun Lille,UMR 8204,U1019, 1 Rue Prof Calmette,BP 245, F-59019 Lille, France.	francois.trottein@pasteur-lille.fr	Gosset, Philippe/C-6174-2018; Paget, Christophe/P-5165-2014; Si-Tahar, Mustapha/W-8034-2019; Pichavant, Muriel/B-9036-2018; TROTTEIN, Francois/C-2405-2018; Faveeuw, Christelle/N-6303-2017; SI-TAHAR, Mustapha/L-4149-2014; Renauld, Jean-Christophe/B-7268-2012	Gosset, Philippe/0000-0002-4043-6429; Paget, Christophe/0000-0002-5374-5407; Si-Tahar, Mustapha/0000-0002-5792-7742; Pichavant, Muriel/0000-0002-1315-4397; TROTTEIN, Francois/0000-0003-3373-1814; Faveeuw, Christelle/0000-0002-8373-3992; SI-TAHAR, Mustapha/0000-0002-5792-7742; Dumoutier, Laure/0000-0002-6645-684X; Renauld, Jean-Christophe/0000-0003-1736-2131; Ivanov, Stoyan/0000-0002-0527-2297	Institut National de la Sante et de la Recherche Medicale; CNRS; University of Lille Nord de France; Pasteur Institute of Lille; French National Research Agency (ANR) [ANR-08-MIEN-021-01]; Conseil Regional Nord Pas de Calais/INSERM; Ministere de l'Education Nationale de la Recherche et Technique; French National Research Agency [08-MIEN-R08066ES/RPV08036ESA]; "Fondation pour la Recherche Medicale" (FRM allergy DAL) [2007 0822007]; "Fond Europeen de Developpement Regional" (FEDER Asthme) [1575-32168]; European project Eumodic	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille Nord de France; Pasteur Institute of Lille; French National Research Agency (ANR)(French National Research Agency (ANR)); Conseil Regional Nord Pas de Calais/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Hauts-de-France); Ministere de l'Education Nationale de la Recherche et Technique; French National Research Agency(French National Research Agency (ANR)); "Fondation pour la Recherche Medicale" (FRM allergy DAL); "Fond Europeen de Developpement Regional" (FEDER Asthme); European project Eumodic	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the CNRS, the University of Lille Nord de France, the Pasteur Institute of Lille, and the French National Research Agency (ANR) under reference ANR-08-MIEN-021-01 (to F. T.).; Recipient of a doctoral fellowship from the Conseil Regional Nord Pas de Calais/INSERM.; Recipient of a doctoral fellowship from the Ministere de l'Education Nationale de la Recherche et Technique.; Supported by a postdoctoral fellowship from the French National Research Agency-08-MIEN-R08066ES/RPV08036ESA.; Supported by the "Fondation pour la Recherche Medicale" (FRM allergy DAL 2007 0822007), the "Fond Europeen de Developpement Regional" (FEDER Asthme 1575-32168) and the European project Eumodic.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bender A, 1998, IMMUNOBIOLOGY, V198, P552, DOI 10.1016/S0171-2985(98)80078-8; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Diana J, 2009, EUR J IMMUNOL, V39, P3283, DOI 10.1002/eji.200939800; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Exley MA, 2003, IMMUNOLOGY, V110, P519, DOI 10.1111/j.1365-2567.2003.01779.x; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hao XL, 2008, J VIROL, V82, P4908, DOI 10.1128/JVI.02367-07; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hobbs JA, 2001, J VIROL, V75, P10746, DOI 10.1128/JVI.75.22.10746-10754.2001; Hoegl S, 2011, AM J RESP CELL MOL, V44, P369, DOI 10.1165/rcmb.2009-0440OC; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ilyinskii PO, 2006, J VIROL, V80, P7146, DOI 10.1128/JVI.02745-05; Ishikawa H, 2010, VIROLOGY, V407, P325, DOI 10.1016/j.virol.2010.08.030; Johnson TR, 2002, J VIROL, V76, P4294, DOI 10.1128/JVI.76.9.4294-4303.2002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kok WL, 2012, J LEUKOCYTE BIOL, V91, P357, DOI 10.1189/jlb.0411184; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kulkarni RR, 2010, J LEUKOCYTE BIOL, V88, P635, DOI 10.1189/jlb.0410191; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Leite-De-Moraes MC, 1999, J IMMUNOL, V163, P5871; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Paget C, 2011, J IMMUNOL, V186, P5590, DOI 10.4049/jimmunol.1002348; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Renneson J, 2011, AM J PATHOL, V179, P1872, DOI 10.1016/j.ajpath.2011.06.023; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Skold M, 2003, INFECT IMMUN, V71, P5447, DOI 10.1128/IAI.71.10.5447-5455.2003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stout-Delgado HW, 2009, CELL HOST MICROBE, V6, P446, DOI 10.1016/j.chom.2009.09.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tessmer MS, 2009, EXPERT OPIN THER TAR, V13, P153, DOI [10.1517/14712590802653601 , 10.1517/14712590802653601]; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; Van Kaer L, 2005, CURR BIOL, V15, pR429, DOI 10.1016/j.cub.2005.05.032; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Vivier E, 2009, NAT REV IMMUNOL, V9, P229, DOI 10.1038/nri2522; Wahl C, 2009, J IMMUNOL, V182, P4521, DOI 10.4049/jimmunol.0802810; Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106; Wilson MT, 2002, TRENDS MOL MED, V8, P225, DOI 10.1016/S1471-4914(02)02325-0; Wingender G, 2008, AM J PHYSIOL-GASTR L, V294, pG1, DOI 10.1152/ajpgi.00437.2007; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	96	130	136	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8816	8829		10.1074/jbc.M111.304758	http://dx.doi.org/10.1074/jbc.M111.304758			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22294696	Green Published, hybrid			2022-12-27	WOS:000301797800014
J	Vogel, S; Raulf, N; Bregenhorn, S; Biniossek, ML; Maurer, U; Czabotar, P; Borner, C				Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie; Biniossek, Martin L.; Maurer, Ulrich; Czabotar, Peter; Borner, Christoph			Cytosolic Bax DOES IT REQUIRE BINDING PROTEINS TO KEEP ITS PRO-APOPTOTIC ACTIVITY IN CHECK?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL OUTER-MEMBRANE; BCL-2 FAMILY-MEMBERS; CELL-DEATH; POLYACRYLAMIDE-GELS; BH3-ONLY PROTEINS; HUMANIN PEPTIDE; BCL-X(L); ACTIVATION; LOCALIZATION	Bax is kept inactive in the cytosol by refolding its C-terminal transmembrane domain into the hydrophobic binding pocket. Although energetic calculations predicted this conformation to be stable, numerous Bax binding proteins were reported and suggested to further stabilize inactive Bax. Unfortunately, most of them have not been validated in a physiological context on the endogenous level. Here we use gel filtration analysis of the cytosol of primary and established cells to show that endogenous, inactive Bax runs 20-30 kDa higher than recombinant Bax, suggesting Bax dimerization or the binding of a small protein. Dimerization was excluded by a lack of interaction of differentially tagged Bax proteins and by comparing the sizes of dimerized recombinant Bax with cytosolic Bax on blue native gels. Surprisingly, when analyzing cytosolic Bax complexes by high sensitivity mass spectrometry after anti-Bax immunoprecipitation or consecutive purification by gel filtration and blue native gel electrophoresis, we detected only one protein, called p23 hsp90 co-chaperone, which consistently and specifically co-purified with Bax. However, this protein could not be validated as a crucial inhibitory Bax binding partner as its over- or under expression did not show any apoptosis defects. By contrast, cytosolic Bax exhibits a slight molecular mass shift on SDS-PAGE as compared with recombinant Bax, which suggests a posttranslational modification and/or a structural difference between the two proteins. We propose that in most healthy cells, cytosolic endogenous Bax is a monomeric protein that does not necessarily need a binding partner to keep its pro-apoptotic activity in check.	[Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie; Biniossek, Martin L.; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Vogel, Sandra; Raulf, Nina; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Vogel, Sandra; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Czabotar, Peter] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia; [Czabotar, Peter] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Walter & Eliza Hall Institute; University of Melbourne	Borner, C (corresponding author), Univ Freiburg, Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, Schaenzlestr 1,Stefan Meier Str 17, D-79104 Freiburg, Germany.	christoph.borner@uniklinik-freiburg.de		Czabotar, Peter/0000-0002-2594-496X	Deutsche Forschungsgemeinschaft [BO-1933]; Spemann Graduate School of Biology and Medicine (SGBM) [GSC-4]; Cluster BIOSS [EXC-294]; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Spemann Graduate School of Biology and Medicine (SGBM); Cluster BIOSS; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by the Deutsche Forschungsgemeinschaft (BO-1933) (to S. V. and C. B.) as well as by the Spemann Graduate School of Biology and Medicine (SGBM, GSC-4; to S. V. and N. R.) and the Cluster BIOSS (EXC-294; to S. V.) funded by the Excellence Initiative of the German Federal and State Governments.	ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee J, 2011, INT J EXP PATHOL, V92, P251, DOI 10.1111/j.1365-2613.2011.00762.x; Lindenboim L, 2010, CELL DEATH DIFFER, V17, P346, DOI 10.1038/cdd.2009.145; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Paschen SA, 2007, CELL CYCLE, V6, P2434, DOI 10.4161/cc.6.20.4780; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; SAWADA M, 2007, NAT CELL BIOL, V9, P480; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	66	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9112	9127		10.1074/jbc.M111.248906	http://dx.doi.org/10.1074/jbc.M111.248906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277657	Green Published, hybrid			2022-12-27	WOS:000301797800041
J	Walker, S; Ullman, O; Stultz, CM				Walker, Sophie; Ullman, Orly; Stultz, Collin M.			Using Intramolecular Disulfide Bonds in Tau Protein to Deduce Structural Features of Aggregation-resistant Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; MICROTUBULE-BINDING; THIOFLAVIN-T; IN-VITRO; OLIGOMERS; DEMENTIA; ISOFORMS; DOMAIN; ORDER	Because tau aggregation likely plays a role in a number of neurodegenerative diseases, understanding the processes that affect tau aggregation is of considerable importance. One factor that has been shown to influence the aggregation propensity is the oxidation state of the protein itself. Tau protein, which contains two naturally occurring cysteine residues, can form both intermolecular disulfide bonds and intramolecular disulfide bonds. Several studies suggest that intermolecular disulfide bonds can promote tau aggregation in vitro. By contrast, although there are data to suggest that intramolecular disulfide bond formation retards tau aggregation in vitro, the precise mechanism underlying this observation remains unclear. While it has been hypothesized that a single intramolecular disulfide bond in tau leads to compact conformations that cannot form extended structure consistent with tau fibrils, there are few data to support this conjecture. In the present study we generate oxidized forms of the truncation mutant, K18, which contains all four microtubule binding repeats, and isolate the monomeric fraction, which corresponds to K18 monomers that have a single intramolecular disulfide bond. We study the aggregation propensity of the oxidized monomeric fraction and relate these data to an atomistic model of the K18 unfolded ensemble. Our results argue that the main effect of intramolecular disulfide bond formation is to preferentially stabilize conformers within the unfolded ensemble that place the aggregation-prone tau subsequences, PHF6* and PHF6, in conformations that are inconsistent with the formation of cross-beta-structure. These data further our understanding of the precise structural features that retard tau aggregation.	[Stultz, Collin M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Stultz, Collin M.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Walker, Sophie] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Ullman, Orly] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stultz, CM (corresponding author), MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cmstultz@mit.edu			National Institutes of Health [5R21NS063185-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21NS063185-02.	Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Clos AL, 2011, BRIT J DERMATOL, V165, P1349, DOI 10.1111/j.1365-2133.2011.10508.x; DELAERE P, 1989, ACTA NEUROPATHOL, V77, P645, DOI 10.1007/BF00687893; Di Noto L, 1999, Mol Cell Biol Res Commun, V2, P71, DOI 10.1006/mcbr.1999.0153; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Fisher CK, 2011, J AM CHEM SOC, V133, P10022, DOI 10.1021/ja203075p; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Fisher CK, 2010, J AM CHEM SOC, V132, P14919, DOI 10.1021/ja105832g; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hikosou R, 2007, CHEM PHARM BULL, V55, P1030, DOI 10.1248/cpb.55.1030; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Huang A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000155; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Jiang CT, 2007, BIOCHEMISTRY-US, V46, P602, DOI 10.1021/bi062068i; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kurita J, 2003, J MAGN RESON, V163, P163, DOI 10.1016/S1090-7807(03)00080-6; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; LEE G, 1992, J CELL SCI, V102, P227; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Tang H. Y., 2004, CURR PROTOC PROTEIN, V11, P1; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600	54	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9591	9600		10.1074/jbc.M111.336107	http://dx.doi.org/10.1074/jbc.M111.336107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291015	Green Published, hybrid			2022-12-27	WOS:000301797800090
J	Uchida, Y; Osaki, T; Yamasaki, T; Shimomura, T; Hata, S; Horikawa, K; Shibata, S; Todo, T; Hirayama, J; Nishina, H				Uchida, Yoshimi; Osaki, Tomomi; Yamasaki, Tokiwa; Shimomura, Tadanori; Hata, Shoji; Horikawa, Kazumasa; Shibata, Shigenobu; Todo, Takeshi; Hirayama, Jun; Nishina, Hiroshi			Involvement of Stress Kinase Mitogen-activated Protein Kinase Kinase 7 in Regulation of Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SLEEP PHASE SYNDROME; DNA-DAMAGE; I-EPSILON; TUMOR SUPPRESSION; CULTURED-CELLS; CKI-EPSILON; JNK; BMAL1; MKK7	The stress kinase mitogen-activated protein kinase kinase 7 (MKK7) is a specific activator of c-Jun N-terminal kinase (JNK), which controls various physiological processes, such as cell proliferation, apoptosis, differentiation, and migration. Here we show that genetic inactivation of MKK7 resulted in an extended period of oscillation in circadian gene expression in mouse embryonic fibroblasts. Exogenous expression in cultured mammalian cells of an MKK7-JNK fusion protein that functions as a constitutively active form of JNK induced phosphorylation of PER2, an essential circadian component. Furthermore, JNK interacted with PER2 at both the exogenous and endogenous levels, and MKK7-mediated JNK activation increased the half-life of PER2 protein by inhibiting its ubiquitination. Notably, the PER2 protein stabilization induced by MKK7-JNK fusion protein reduced the degradation of PER2 induced by casein kinase 1 epsilon. Taken together, our results support a novel function for the stress kinase MKK7 as a regulator of the circadian clock in mammalian cells at steady state.	[Uchida, Yoshimi; Osaki, Tomomi; Yamasaki, Tokiwa; Shimomura, Tadanori; Hata, Shoji; Hirayama, Jun; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Horikawa, Kazumasa; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan; [Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Suita, Osaka 5650871, Japan	Tokyo Medical & Dental University (TMDU); Waseda University; Osaka University	Hirayama, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	hirayama.dbio@mri.tmd.ac.jp		Hirayama, Jun/0000-0002-8485-3320	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23657085, 23241023] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on a Priority Area from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and the Ministry of Health, Labor, and Welfare of Japan.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chansard M, 2007, NEUROSCIENCE, V145, P812, DOI 10.1016/j.neuroscience.2006.12.037; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kishimoto H, 2003, J BIOL CHEM, V278, P16595, DOI 10.1074/jbc.M213182200; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Takano A, 2000, FEBS LETT, V477, P106, DOI 10.1016/S0014-5793(00)01755-5; Tanemura S, 2009, J BIOCHEM, V145, P345, DOI 10.1093/jb/mvn172; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsuchiya Y, 2003, J BIOCHEM, V134, P785, DOI 10.1093/jb/mvg220; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yagita K, 2009, ACTA HISTOCHEM CYTOC, V42, P89, DOI 10.1267/ahc.09015; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8318	8326		10.1074/jbc.M111.308908	http://dx.doi.org/10.1074/jbc.M111.308908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267733	Green Published, hybrid			2022-12-27	WOS:000301349400046
J	Boitz, JM; Strasser, R; Hartman, CU; Jardim, A; Ullman, B				Boitz, Jan M.; Strasser, Rona; Hartman, Charles U.; Jardim, Armando; Ullman, Buddy			Adenine Aminohydrolase from Leishmania donovani UNIQUE ENZYME IN PARASITE PURINE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; MURINE ADENOSINE-DEAMINASE; VISCERAL LEISHMANIASIS; GENETIC-ANALYSIS; XANTHINE PHOSPHORIBOSYLTRANSFERASES; CONFORMATIONAL-CHANGE; STABLE TRANSFECTION; MOLECULAR-CLONING; ESCHERICHIA-COLI; SALVAGE PATHWAY	Adenine aminohydrolase (AAH) is an enzyme that is not present in mammalian cells and is found exclusively in Leishmania among the protozoan parasites that infect humans. AAH plays a paramount role in purine metabolism in this genus by steering 6-aminopurines into 6-oxypurines. Leishmania donovani AAH is 38 and 23% identical to Saccharomyces cerevisiae AAH and human adenosine deaminase enzymes, respectively, catalyzes adenine deamination to hypoxanthine with an apparent K-m of 15.4 mu M, and does not recognize adenosine as a substrate. Western blot analysis established that AAH is expressed in both life cycle stages of L. donovani, whereas subcellular fractionation and immunofluorescence studies confirmed that AAH is localized to the parasite cytosol. Deletion of the AAH locus in intact parasites established that AAH is not an essential gene and that Delta aah cells are capable of salvaging the same range of purine nucleobases and nucleosides as wild type L. donovani. The Delta aah null mutant was able to infect murine macrophages in vitro and in mice, although the parasite loads in both model systems were modestly reduced compared with wild type infections. The Delta aah lesion was also introduced into a conditionally lethal Delta hgprt/Delta xprt mutant in which viability was dependent on pharmacologic ablation of AAH by 2'-deoxycoformycin. The Delta aah/Delta hgprt/Delta xprt triple knock-out no longer required 2'-deoxycoformycin for growth and was avirulent in mice with no persistence after a 4-week infection. These genetic studies underscore the paramount importance of AAH to purine salvage by L. donovani.	[Boitz, Jan M.; Hartman, Charles U.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Strasser, Rona; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Oregon Health & Science University; McGill University	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	ullmanb@ohsu.edu			National Institutes of Health from NIAID [AI023682]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 from NIAID (to B. U.). This work was also supported by a grant from the Canadian Institutes of Health Research (to A. J.).	Agarwal R P, 1978, Methods Enzymol, V51, P502; AGARWAL RP, 1977, BIOCHEM PHARMACOL, V26, P359, DOI 10.1016/0006-2952(77)90192-7; Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; ALLEN TE, 1995, MOL BIOCHEM PARASIT, V73, P133, DOI 10.1016/0166-6851(94)00105-V; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2010, J BIOL CHEM, V285, P18555, DOI 10.1074/jbc.M110.125393; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Breton M, 2005, INFECT IMMUN, V73, P6372, DOI 10.1128/IAI.73.10.6372-6382.2005; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CHAPPELL DJ, 1993, INSECT BIOCHEM MOLEC, V23, P499, DOI 10.1016/0965-1748(93)90058-Z; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; DADDONA PE, 1984, J BIOL CHEM, V259, P1472; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DEELEY MC, 1992, J BACTERIOL, V174, P3102, DOI 10.1128/jb.174.10.3102-3110.1992; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Galazka J, 2006, MOL BIOCHEM PARASIT, V149, P223, DOI 10.1016/j.molbiopara.2006.06.001; Garg R, 2006, INDIAN J MED RES, V123, P439; Gherardi A, 1999, LIFE SCI, V65, P1733, DOI 10.1016/S0024-3205(99)00425-7; Goyard S, 2000, MOL BIOCHEM PARASIT, V108, P249, DOI 10.1016/S0166-6851(00)00210-3; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; HARTENSTEIN RC, 1967, J BIOL CHEM, V242, P740; HASHIMOTO S, 1974, ANAL BIOCHEM, V62, P426, DOI 10.1016/0003-2697(74)90175-4; Ho MC, 2009, BIOCHEMISTRY-US, V48, P9618, DOI 10.1021/bi9012484; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; INGOLIA DE, 1986, MOL CELL BIOL, V6, P4458, DOI 10.1128/MCB.6.12.4458; Iovannisci D M, 1984, Adv Exp Med Biol, V165 Pt A, P239; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1984, MOL BIOCHEM PARASIT, V12, P139, DOI 10.1016/0166-6851(84)90131-2; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Iwaki-Egawa S, 2002, COMP BIOCHEM PHYS B, V133, P173, DOI 10.1016/S1096-4959(02)00122-7; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KIDDER GW, 1979, P NATL ACAD SCI USA, V76, P3670, DOI 10.1073/pnas.76.8.3670; KIDDER GW, 1977, ARCH BIOCHEM BIOPHYS, V183, P7, DOI 10.1016/0003-9861(77)90412-X; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V373, P53, DOI 10.1016/j.bbrc.2008.05.180; KOCH AL, 1959, J BIOL CHEM, V234, P1213; LAFON SW, 1982, BIOCHEM PHARMACOL, V31, P231, DOI 10.1016/0006-2952(82)90216-7; Larson ET, 2008, J MOL BIOL, V381, P975, DOI 10.1016/j.jmb.2008.06.048; LOOKER DL, 1983, MOL BIOCHEM PARASIT, V9, P15, DOI 10.1016/0166-6851(83)90053-1; MARR JJ, 1978, BIOCHIM BIOPHYS ACTA, V544, P360, DOI 10.1016/0304-4165(78)90104-6; Matsui H, 2001, BIOSCI BIOTECH BIOCH, V65, P1112, DOI 10.1271/bbb.65.1112; Michaelis L, 1913, BIOCHEM Z, V49, P333; Michels PAM, 2000, PARASITOL TODAY, V16, P482, DOI 10.1016/S0169-4758(00)01810-X; Motulsky H., 1999, ANAL DATA GRAPHPAD P, P327; Mullen AB, 1998, ANTIMICROB AGENTS CH, V42, P2722, DOI 10.1128/AAC.42.10.2722; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murray A W, 1970, Prog Nucleic Acid Res Mol Biol, V10, P87; Niu WL, 2010, J PHYS CHEM B, V114, P16156, DOI 10.1021/jp106041v; Nygaard P, 1996, J BACTERIOL, V178, P846, DOI 10.1128/jb.178.3.846-853.1996; Oestrelcher N, 2008, FUNGAL GENET BIOL, V45, P760, DOI 10.1016/j.fgb.2007.10.015; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; Pospisilova Hana, 2007, Biomedical Papers (Olomouc), V151, P3; POSTER DS, 1981, CANCER CLIN TRIALS, V4, P209; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAMBROOK J, 1989, LAB MAN, V9, P31; SHARFF AJ, 1992, J MOL BIOL, V226, P917, DOI 10.1016/0022-2836(92)91040-V; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shih S, 1998, J BIOL CHEM, V273, P1534, DOI 10.1074/jbc.273.3.1534; Singh LS, 2000, MOL CELL BIOCHEM, V204, P127, DOI 10.1023/A:1007087905192; TUTTLE JV, 1980, J BIOL CHEM, V255, P909; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; WORRELL VE, 1990, J BACTERIOL, V172, P3328, DOI 10.1128/jb.172.6.3328-3334.1990; YABUKI N, 1991, BIOCHIM BIOPHYS ACTA, V1073, P474, DOI 10.1016/0304-4165(91)90218-6; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	91	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7626	7639		10.1074/jbc.M111.307884	http://dx.doi.org/10.1074/jbc.M111.307884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22238346	Green Published, hybrid			2022-12-27	WOS:000301060200062
J	Rahmanto, YS; Kalinowski, DS; Lane, DJR; Lok, HC; Richardson, V; Richardson, DR				Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Lane, Darius J. R.; Lok, Hiu Chuen; Richardson, Vera; Richardson, Des R.			Nitrogen Monoxide (NO) Storage and Transport by Dinitrosyl-Dithiol-Iron Complexes: Long-lived NO That Is Trafficked by Interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUTATHIONE-S-TRANSFERASE; MULTIDRUG-RESISTANCE PROTEIN; ELECTRON-PARAMAGNETIC-RESONANCE; CYTOTOXIC ACTIVATED MACROPHAGES; NITRIC-OXIDE SYNTHESIS; IN-VIVO DISTRIBUTION; CANCER CELL-LINE; L-ARGININE; 4-NITROQUINOLINE 1-OXIDE; METASTASIS SUPPRESSOR	Nitrogen monoxide (NO) markedly affects intracellular iron metabolism, and recent studies have shown that molecules traditionally involved in drug resistance, namely GST and MRP1 (multidrug resistance-associated protein 1), are critical molecular players in this process. This is mediated by interaction of these proteins with dinitrosyl-dithiol-iron complexes (Watts, R. N., Hawkins, C., Ponka, P., and Richardson, D. R. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 7670-7675; Lok, H. C., Suryo Rahmanto, Y., Hawkins, C. L., Kalinowski, D. S., Morrow, C. S., Townsend, A. J., Ponka, P., and Richardson, D. R. (2012) J. Biol. Chem. 287, 607-618). These complexes are bioavailable, have a markedly longer half-life compared with free NO, and form in cells after an interaction between iron, NO, and glutathione. The generation of dinitrosyl-dithiol-iron complexes acts as a common currency for NO transport and storage by MRP1 and GST P1-1, respectively. Understanding the biological trafficking mechanisms involved in the metabolism of NO is vital for elucidating its many roles in cellular signaling and cytotoxicity and for development of new therapeutic targets.	[Rahmanto, Yohan Suryo; Kalinowski, Danuta S.; Lane, Darius J. R.; Lok, Hiu Chuen; Richardson, Vera; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	University of Sydney	Richardson, DR (corresponding author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.	d.richardson@med.usyd.edu.au	Suryo Rahmanto, Yohan/K-8043-2018	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274; Kalinowski, Danuta/0000-0002-9303-7405; Lane, Darius/0000-0001-8725-6903	Australian Research Council [DP1092734]; Cancer Institute NSW [08/ECF/1-36, 08/ECF/1-30, 10/ECF/2-18]; Peter Doherty postdoctoral fellowship; Senior Principal Research Fellowship [571123]; National Health and Medical Research Council of Australia [632778, 632698]	Australian Research Council(Australian Research Council); Cancer Institute NSW; Peter Doherty postdoctoral fellowship; Senior Principal Research Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Discovery Grant DP1092734 from the Australian Research Council (to D. R. R.); Cancer Institute NSW Early Career Fellowships 08/ECF/1-36 (to Y. S. R.), 08/ECF/1-30 (to D. S. K.), and 10/ECF/2-18 (to D. J. R. L.); and a Peter Doherty postdoctoral fellowship (to D. J. R. L.) and Senior Principal Research Fellowship 571123 and Project Grants 632778 and 632698 (to D. R. R.) from the National Health and Medical Research Council of Australia.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Alencar JL, 2003, BIOCHEM PHARMACOL, V66, P2365, DOI 10.1016/j.bcp.2003.07.017; Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BOESE M, 1995, J BIOL CHEM, V270, P29244, DOI 10.1074/jbc.270.49.29244; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Chang XB, 2010, METHODS MOL BIOL, V596, P223, DOI 10.1007/978-1-60761-416-6_11; Chen YJ, 2008, J AM CHEM SOC, V130, P10929, DOI 10.1021/ja711494m; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; De Luca A, 2011, BIOCHEM J, V440, P175, DOI 10.1042/BJ20111333; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; DRAPIER JC, 1991, J BIOL CHEM, V266, P10162; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Flens MJ, 1996, AM J PATHOL, V148, P1237; GIFFORD GE, 1987, J NATL CANCER I, V78, P121, DOI 10.1093/jnci/78.1.121; Giliano NY, 2011, NITRIC OXIDE-BIOL CH, V24, P151, DOI 10.1016/j.niox.2011.02.005; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; He YY, 2003, J BIOL CHEM, V278, P8058, DOI 10.1074/jbc.M207781200; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HIBBS JB, 1992, J CLIN INVEST, V89, P867, DOI 10.1172/JCI115666; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1977, SCIENCE, V197, P279, DOI 10.1126/science.327547; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; JACOBS A, 1977, BLOOD, V50, P433; Kawakatsu M, 2011, BIOCHEM BIOPH RES CO, V411, P745, DOI 10.1016/j.bbrc.2011.07.018; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; Kim YM, 2000, J BIOL CHEM, V275, P10954, DOI 10.1074/jbc.275.15.10954; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Kleschyov AL, 2006, FREE RADICAL BIO MED, V40, P1340, DOI 10.1016/j.freeradbiomed.2005.12.001; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; LEE MH, 1994, BIOCHEMISTRY-US, V33, P3679, DOI 10.1021/bi00178a026; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Lok HC, 2012, J BIOL CHEM, V287, P607, DOI 10.1074/jbc.M111.310987; Lomonosova EE, 1998, FREE RADICAL BIO MED, V25, P493, DOI 10.1016/S0891-5849(98)00080-X; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Morrow CS, 1998, CARCINOGENESIS, V19, P109, DOI 10.1093/carcin/19.1.109; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Morrow CS, 1998, BIOCHEM PHARMACOL, V56, P1013, DOI 10.1016/S0006-2952(98)00240-8; MULSCH A, 1991, FEBS LETT, V294, P252, DOI 10.1016/0014-5793(91)81441-A; MULSCH A, 1993, BIOCHEM BIOPH RES CO, V196, P1303, DOI 10.1006/bbrc.1993.2394; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; Peklak-Scott C, 2005, BIOCHEMISTRY-US, V44, P4426, DOI 10.1021/bi047810y; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Qazi SS, 2011, DRUG METAB DISPOS, V39, P1122, DOI 10.1124/dmd.111.039362; Remizova MI, 2011, EUR J PHARMACOL, V662, P40, DOI 10.1016/j.ejphar.2011.04.046; Richardson Des R., 2007, P97, DOI 10.1016/B978-044452236-8/50004-6; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; RICHARDSON DR, 1995, BLOOD, V86, P3211; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; SCHNEIDER E, 1994, CANCER RES, V54, P152; Severina IS, 2003, NITRIC OXIDE-BIOL CH, V8, P155, DOI 10.1016/S1089-8603(03)00002-8; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Shumaev KB, 2008, NITRIC OXIDE-BIOL CH, V18, P37, DOI 10.1016/j.niox.2007.09.085; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Tinberg CE, 2010, J AM CHEM SOC, V132, P18168, DOI 10.1021/ja106290p; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Ueno T, 1999, FREE RADICAL RES, V31, P525, DOI 10.1080/10715769900301101; Ueno T, 2000, JPN J PHARMACOL, V82, P95, DOI 10.1254/jjp.82.95; Vanin AF, 1997, NITRIC OXIDE-BIOL CH, V1, P191, DOI 10.1006/niox.1997.0122; VANIN AF, 1991, FEBS LETT, V289, P1, DOI 10.1016/0014-5793(91)80894-9; Vanin AF, 1998, BIOCHEMISTRY-MOSCOW+, V63, P782; Vanin AF, 2009, NITRIC OXIDE-BIOL CH, V21, P1, DOI 10.1016/j.niox.2009.03.005; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wardrop SL, 2000, BIOCHEMISTRY-US, V39, P2748, DOI 10.1021/bi991099t; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Watts RN, 2004, BBA-MOL CELL RES, V1692, P1, DOI 10.1016/j.bbamcr.2004.02.004; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; Watts RN, 2002, EUR J BIOCHEM, V269, P3383, DOI 10.1046/j.1432-1033.2002.02987.x; Watts RN, 2001, J BIOL CHEM, V276, P4724, DOI 10.1074/jbc.M006318200; Watts RN, 2000, J LAB CLIN MED, V136, P149, DOI 10.1067/mlc.2000.108152; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; WEISS G, 1994, J EXP MED, V180, P969, DOI 10.1084/jem.180.3.969; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	100	43	50	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					6960	6968		10.1074/jbc.R111.329847	http://dx.doi.org/10.1074/jbc.R111.329847			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22262835	Green Published, hybrid			2022-12-27	WOS:000301060200001
J	Bortner, CD; Scoltock, AB; Sifre, MI; Cidlowski, JA				Bortner, Carl D.; Scoltock, Alyson B.; Sifre, Maria I.; Cidlowski, John A.			Osmotic Stress Resistance Imparts Acquired Anti-apoptotic Mechanisms in Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CATION CHANNELS; CELL-VOLUME REGULATION; ANISOTONIC MEDIA; HELA-CELLS; ACTIVATION; SHRINKAGE; K+; PREREQUISITE; INHIBITION; DEATH	Apoptosis is a stochastic, physiological form of cell death that is characterized by unique morphological and biochemical properties. A defining feature of apoptosis in all cells is the apoptotic volume decrease or AVD, which has been considered a passive component of the cell death process. Most cells have inherent volume regulatory increase (RVI) mechanisms to contest an imposed loss in cell size, however T-cells are unique in that they do not have a RVI response. We utilized this property to explore potential regulatory roles of a RVI response in apoptosis. Exposure of immature T-cells to hyperosmotic stress resulted in a rapid, synchronous, and caspase-dependent apoptosis. Multiple rounds of osmotic stress followed by recovery of cells in normal media resulted in the development of a population of cells that were resistant to osmotic stress induced apoptosis. These cells were also resistant to other apoptotic stimuli that activate via the intrinsic cell death pathway, while remaining sensitive to extrinsic apoptotic stimuli. Interestingly, these osmotic stress resistant cells showed no increase in anti-apoptotic proteins, and released cytochrome c from their mitochondria following exposure to intrinsic apoptotic stimuli. The osmotic stress resistant cells developed a RVI response, and inhibition of the RVI restored sensitivity to apoptotic agents. Analysis of apoptotic signaling pathways showed a sustained increase in phospho-AKT, whose inhibition also prevented an RVI response resulting in apoptosis. These results define a critical role of volume regulation mechanisms in apoptotic resistance.	[Bortner, Carl D.; Scoltock, Alyson B.; Sifre, Maria I.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	cidlowski@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	National Institutes of Health, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057, ZICES102486, ZIAES090079] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institutes of Health, NIEHS.	Bortner CD, 2008, J BIOL CHEM, V283, P7219, DOI 10.1074/jbc.M707809200; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Ernest NJ, 2008, J CELL SCI, V121, P290, DOI 10.1242/jcs.017343; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; GRINSTEIN S, 1983, J GEN PHYSIOL, V82, P619, DOI 10.1085/jgp.82.5.619; GRINSTEIN S, 1984, AM J PHYSIOL, V246, pC204, DOI 10.1152/ajpcell.1984.246.3.C204; HEMPLING HG, 1977, J CELL PHYSIOL, V93, P293, DOI 10.1002/jcp.1040930215; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Numata T, 2008, APOPTOSIS, V13, P895, DOI 10.1007/s10495-008-0220-y; ROTIROTI LW, 1973, EXP CELL RES, V79, P295, DOI 10.1016/0014-4827(73)90448-5; Shimizu T, 2006, CELL PHYSIOL BIOCHEM, V18, P295, DOI 10.1159/000097607; Shimizu Takahiro, 2007, Shengli Xuebao, V59, P512; Subramanyam M, 2010, J BIOL CHEM, V285, P6109, DOI 10.1074/jbc.M109.072785; Sugden PH, 2001, CIRC RES, V88, P975, DOI 10.1161/hh1001.091864; Thompson GJ, 2001, BIOCHEM J, V357, P137, DOI 10.1042/0264-6021:3570137; Wehner F, 2006, ACTA PHYSIOL, V187, P21, DOI 10.1111/j.1748-1716.2006.01561.x; Wehner F, 2003, FEBS LETT, V551, P20, DOI 10.1016/S0014-5793(03)00868-8	28	17	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6284	6295		10.1074/jbc.M111.293001	http://dx.doi.org/10.1074/jbc.M111.293001			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228768	Green Published, hybrid			2022-12-27	WOS:000300791800021
J	Zhang, H; Han, JH; Kang, B; Burgess, R; Zhang, ZG				Zhang, Hui; Han, Junhong; Kang, Bin; Burgess, Rebecca; Zhang, Zhiguo			Human Histone Acetyltransferase 1 Protein Preferentially Acetylates H4 Histone Molecules in H3.1-H4 over H3.3-H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY SYNTHESIZED HISTONES; DNA-REPLICATION; VARIANT H3.3; STRUCTURAL BASIS; CHROMATIN; NUCLEOSOMES; RECOGNITION; DEPOSITION; LYSINE-56; REGIONS	In mammalian cells, canonical histone H3 (H3.1) and H3 variant (H3.3) differ by five amino acids and are assembled, along with histone H4, into nucleosomes via distinct nucleosome assembly pathways. H3.1-H4 molecules are assembled by histone chaperone CAF-1 in a replication-coupled process, whereas H3.3-H4 are assembled via HIRA in a replication-independent pathway. Newly synthesized histone H4 is acetylated at lysine 5 and 12 (H4K5,12) by histone acetyltransferase 1 (HAT1). However, it remains unclear whether HAT1 and H4K5,12ac differentially regulate these two nucleosome assembly processes. Here, we show that HAT1 binds and acetylates H4 in H3.1-H4 molecules preferentially over H4 in H3.3-H4. Depletion of Hat1, the catalytic subunit of HAT1 complex, results in reduced H3.1 occupancy at H3.1-enriched genes and reduced association of Importin 4 with H3.1, but not H3.3. Finally, depletion of Hat1 or CAF-1p150 leads to changes in expression of a H3.1-enriched gene. These results indicate that HAT1 differentially impacts nucleosome assembly of H3.1-H4 and H3.3-H4.	[Zhang, Hui; Han, Junhong; Kang, Bin; Burgess, Rebecca; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	Zhang.Zhiguo@mayo.edu	Han, Junhong/L-5264-2013	Han, Junhong/0000-0002-3371-8698	National Institutes of Health [GM81838]; NATIONAL CANCER INSTITUTE [P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grant GM81838.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Glowczewski L, 2004, MOL CELL BIOL, V24, P10180, DOI 10.1128/MCB.24.23.10180-10192.2004; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kang B, 2011, GENE DEV, V25, P1359, DOI 10.1101/gad.2055511; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4	26	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 24	2012	287	9					6573	6581		10.1074/jbc.M111.312637	http://dx.doi.org/10.1074/jbc.M111.312637			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	899CQ	22228774	Green Published, hybrid			2022-12-27	WOS:000300791800045
